D03.438.221.173;Calcimycin;D000001
D02.705.400.625.800;Temefos;D000002
D02.705.539.345.800;Temefos;D000002
D02.886.300.692.800;Temefos;D000002
J01.576.423.200.700.100;Abattoirs;D000003
L01.143.506.598.400.556.131;Abbreviations as Topic;D000004
A01.923.047;Abdomen;D000005
C23.888.646.100.200;Abdomen, Acute;D000006
C23.888.821.030.249;Abdomen, Acute;D000006
C26.017;Abdominal Injuries;D000007
C04.588.033;Abdominal Neoplasms;D000008
A02.633.567.050;Abdominal Muscles;D000009
A08.800.800.120.030;Abducens Nerve;D000010
B04.820.650.375.525.020;Abelson murine leukemia virus;D000011
B04.909.574.807.375.525.020;Abelson murine leukemia virus;D000011
B04.909.777.731.375.525.020;Abelson murine leukemia virus;D000011
C16.320.565.398.500.440.500;Abetalipoproteinemia;D000012
C18.452.584.500.875.440.500;Abetalipoproteinemia;D000012
C18.452.648.398.500.440.500;Abetalipoproteinemia;D000012
C16.131;Congenital Abnormalities;D000013
C16.131.042;Abnormalities, Drug-Induced;D000014
C16.131.077;Abnormalities, Multiple;D000015
C16.131.080;Abnormalities, Radiation-Induced;D000016
C26.733.031;Abnormalities, Radiation-Induced;D000016
N06.850.810.300.360.031;Abnormalities, Radiation-Induced;D000016
D23.050.301.290.031;ABO Blood-Group System;D000017
D23.050.705.230.031;ABO Blood-Group System;D000017
A13.869.106;Abomasum;D000018
D27.505.696.875.131;Abortifacient Agents;D000019
D27.505.954.705.131;Abortifacient Agents;D000019
D27.505.696.875.131.100;Abortifacient Agents, Nonsteroidal;D000020
D27.505.954.705.131.100;Abortifacient Agents, Nonsteroidal;D000020
D27.505.696.875.131.200;Abortifacient Agents, Steroidal;D000021
D27.505.954.705.131.200;Abortifacient Agents, Steroidal;D000021
C13.703.039;Abortion, Spontaneous;D000022
M01.050;Abortion Applicants;D000023
I01.198.240.089;Abortion, Criminal;D000024
E04.520.050.050;Abortion, Eugenic;D000025
C13.703.039.089;Abortion, Habitual;D000026
C13.703.039.093;Abortion, Incomplete;D000027
E04.520.050;Abortion, Induced;D000028
E04.520.050.055;Abortion, Legal;D000029
C13.703.039.173;Abortion, Missed;D000030
C01.539.674.173;Abortion, Septic;D000031
C13.703.039.256;Abortion, Septic;D000031
C13.703.700.173;Abortion, Septic;D000031
E04.520.050.060;Abortion, Therapeutic;D000032
C13.703.039.339;Abortion, Threatened;D000033
C13.703.039.422;Abortion, Veterinary;D000034
C22.021;Abortion, Veterinary;D000034
F04.754.720.107;Abreaction;D000035
D08.811.277.450.430.700.750.111;Abrin;D000036
D12.776.503.499.249;Abrin;D000036
D12.776.765.678.906.111;Abrin;D000036
C13.703.420.078;Abruptio Placentae;D000037
C13.703.590.132;Abruptio Placentae;D000037
C01.539.830.025;Abscess;D000038
C23.550.470.756.100;Abscess;D000038
C01.539.830.025.675;Peritonsillar Abscess;D000039
C07.550.781.750.500;Peritonsillar Abscess;D000039
C08.730.561.750.500;Peritonsillar Abscess;D000039
C09.775.649.750.500;Peritonsillar Abscess;D000039
D02.241.223.268.034;Abscisic Acid;D000040
D02.455.326.271.665.202.061;Abscisic Acid;D000040
D02.455.426.392.368.367.379.249.024;Abscisic Acid;D000040
D02.455.849.131.061;Abscisic Acid;D000040
D02.455.849.765.033;Abscisic Acid;D000040
F02.784.692.107;Absenteeism;D000041
G02.149.023;Absorption;D000042
G02.149.767.019;Absorption;D000042
G02.842.750.019;Absorption;D000042
G03.495.023;Absorption;D000042
L01.453.245.100;Abstracting and Indexing as Topic;D000043
E06.780.345.500;Dental Abutments;D000044
E07.695.190.175;Dental Abutments;D000044
B01.650.940.800.575.100.401.025;Acacia;D000045
N02.278.020;Academic Medical Centers;D000046
N03.540.052;Academies and Institutes;D000047
B01.046.500.100.075.080;Acanthamoeba;D000048
B01.050.500.500.132;Acanthocephala;D000049
A11.118.290.330.100;Acanthocytes;D000050
A11.443.240.330.100;Acanthocytes;D000050
A15.145.229.334.330.100;Acanthocytes;D000050
C17.800.865.070;Acantholysis;D000051
C23.550.035;Acantholysis;D000051
C17.800.621.430.530.100;Acanthosis Nigricans;D000052
B01.050.500.131.166.132;Acari;D000053
G01.595.560.107;Acceleration;D000054
A08.800.800.120.060;Accessory Nerve;D000055
N06.850.135.060;Accident Prevention;D000056
F01.145.015;Accident Proneness;D000057
N06.850.135.122;Accidental Falls;D000058
N06.850.135;Accidents;D000059
N06.850.135.185;Accidents, Aviation;D000060
N06.850.135.217;Accidents, Home;D000061
N06.850.135.240;Accidents, Occupational;D000062
N06.850.135.392;Accidents, Traffic;D000063
G07.700.062.133;Acclimatization;D000064
G16.100.057.500.133;Acclimatization;D000064
G14.640.079;Accommodation, Ocular;D000065
N03.219.463.030;Accounting;D000066
N03.219.463.030.080;Accounts Payable and Receivable;D000067
N03.706.110.070;Accreditation;D000068
N05.700.200.100;Accreditation;D000068
I01.076.201.450.050;Acculturation;D000069
I01.880.143.079;Acculturation;D000069
D02.033.100.624.025;Acebutolol;D000070
D02.033.100.624.698.025;Acebutolol;D000070
D02.033.755.624.025;Acebutolol;D000070
D02.033.755.624.698.025;Acebutolol;D000070
D02.092.063.624.698.025;Acebutolol;D000070
D02.886.590.263.050;Acedapsone;D000072
D02.455.426.559.847.638.059;Acenaphthenes;D000073
D04.615.638.059;Acenaphthenes;D000073
D03.438.150.446.520.079;Acenocoumarol;D000074
D03.830.219.446.520.079;Acenocoumarol;D000074
D02.886.369.029;Acepromazine;D000075
D03.494.741.029;Acepromazine;D000075
B01.650.940.150.133;Acetabularia;D000076
A02.835.232.043.825.108;Acetabulum;D000077
D02.047.064;Acetaldehyde;D000079
D02.355.071;Acetals;D000080
D02.065.064;Acetamides;D000081
D02.241.081.018.110;Acetamides;D000081
D02.065.199.092.040;Acetaminophen;D000082
D02.065.199.092;Acetanilides;D000083
D08.811.913.696.630.025;Acetate Kinase;D000084
D02.241.081.018;Acetates;D000085
D10.251.400.045;Acetates;D000085
D02.886.675.867.060;Acetazolamide;D000086
D03.383.129.708.867.060;Acetazolamide;D000086
D02.113.075;Acetic Anhydrides;D000089
D02.241.081.018.193;Acetic Anhydrides;D000089
D02.241.755.080;Acetoacetates;D000090
D02.522.585.175;Acetoacetates;D000090
B03.440.400.425.100.100;Acetobacter;D000091
B03.660.050.663.050.010;Acetobacter;D000091
D02.886.590.795.071;Acetohexamide;D000092
D02.948.828.071;Acetohexamide;D000092
D02.522.296.100;Acetoin;D000093
D08.811.682.047.050;Acetoin Dehydrogenase;D000094
D08.811.913.200.324;Acetolactate Synthase;D000095
D12.776.331.049;Acetolactate Synthase;D000095
D02.522.064;Acetone;D000096
D02.522.585.342;Acetone;D000096
D02.626.080;Acetonitriles;D000097
D02.522.120;Acetophenones;D000098
D02.065.064.150.100;Acetoxyacetylaminofluorene;D000099
D02.241.081.018.110.080.070;Acetoxyacetylaminofluorene;D000099
D02.455.426.559.847.389.050.060;Acetoxyacetylaminofluorene;D000099
D04.615.389.050.060;Acetoxyacetylaminofluorene;D000099
D02.241.223.100.050.300.100;Acetrizoic Acid;D000100
D02.241.223.100.400.880.020;Acetrizoic Acid;D000100
D02.455.426.559.389.127.020.452.249;Acetrizoic Acid;D000100
D02.455.426.559.389.127.375.880.020;Acetrizoic Acid;D000100
D08.811.913.050.134.025;Acetyl-CoA C-Acetyltransferase;D000101
D08.811.913.050.080;Acetyl-CoA C-Acyltransferase;D000102
D08.811.464.257.050;Acetyl-CoA Carboxylase;D000103
D08.811.277.352.897.075;Acetyl-CoA Hydrolase;D000104
D03.438.759.646.138.382.300.020;Acetyl Coenzyme A;D000105
D08.211.211.300.075;Acetyl Coenzyme A;D000105
D13.695.667.138.382.300.020;Acetyl Coenzyme A;D000105
D13.695.827.068.382.300.020;Acetyl Coenzyme A;D000105
D08.811.464.267.500.200;Acetate-CoA Ligase;D000106
G02.111.087.019.052;Acetylation;D000107
G02.149.115.019.052;Acetylation;D000107
G02.149.465.030.052;Acetylation;D000107
G02.607.750.030.052;Acetylation;D000107
G03.495.095.052;Acetylation;D000107
D02.092.877.883.099.090;Acetylcarnitine;D000108
D02.092.211.111;Acetylcholine;D000109
D08.811.277.352.100.170.176;Acetylcholinesterase;D000110
D02.886.030.230.259;Acetylcysteine;D000111
D12.125.166.230.259;Acetylcysteine;D000111
D04.808.155.160.278.259;Acetyldigitoxins;D000112
D04.808.155.580.130.500.336.259;Acetyldigitoxins;D000112
D09.408.180.261.336.259;Acetyldigitoxins;D000112
D04.808.155.160.349.050;Acetyldigoxins;D000113
D04.808.155.580.130.500.436.050;Acetyldigoxins;D000113
D09.408.180.261.436.050;Acetyldigoxins;D000113
D02.455.326.397.259;Acetylene;D000114
D08.811.277.352.100.050;Acetylesterase;D000115
D09.067.342.356.050;Acetylgalactosamine;D000116
D09.067.342.531.050;Acetylglucosamine;D000117
D08.811.277.450.483.180.500;Acetylglucosaminidase;D000118
D09.067.550.050;Acetylmuramyl-Alanyl-Isoglutamine;D000119
D09.811.522.050;Acetylmuramyl-Alanyl-Isoglutamine;D000119
D12.644.233.050;Acetylmuramyl-Alanyl-Isoglutamine;D000119
D02.241.223.100.050.500.625;Acecainide;D000120
D02.241.223.100.100.033;Acecainide;D000120
D02.455.426.559.389.127.020.937.625;Acecainide;D000120
D02.455.426.559.389.127.085.033;Acecainide;D000120
D08.811.913.555.500.100;Acetylserotonin O-Methyltransferase;D000121
D02.092.877.883.333.800.030;Acetylthiocholine;D000122
D02.675.276.232.800.030;Acetylthiocholine;D000122
D02.886.489.789.030;Acetylthiocholine;D000122
D08.811.913.050.134;Acetyltransferases;D000123
F01.658.059;Achievement;D000124
F02.784.629.054;Achievement;D000124
A02.880.176;Achilles Tendon;D000125
C06.405.748.045;Achlorhydria;D000126
C18.452.076.087;Achlorhydria;D000126
B03.440.860.074.150;Acholeplasma;D000127
B03.440.860.074.150.500;Acholeplasma laidlawii;D000128
B03.440.860.074;Acholeplasmataceae;D000129
C05.116.099.343.110;Achondroplasia;D000130
C05.116.099.708.017;Achondroplasia;D000130
C16.320.240.500;Achondroplasia;D000130
E06.931.475.111;Acid Etching, Dental;D000134
D08.811.277.352.650.025;Acid Phosphatase;D000135
G02.111.029;Acid-Base Equilibrium;D000136
G02.300.176;Acid-Base Equilibrium;D000136
G03.030;Acid-Base Equilibrium;D000136
G07.700.360.110;Acid-Base Equilibrium;D000136
G09.188.050;Acid-Base Equilibrium;D000136
C18.452.076;Acid-Base Imbalance;D000137
C18.452.076.176;Acidosis;D000138
C18.452.076.176.180;Acidosis, Lactic;D000140
C12.777.419.815.093;Acidosis, Renal Tubular;D000141
C13.351.968.419.815.093;Acidosis, Renal Tubular;D000141
C16.320.565.861.093;Acidosis, Renal Tubular;D000141
C18.452.076.176.210;Acidosis, Renal Tubular;D000141
C18.452.648.861.093;Acidosis, Renal Tubular;D000141
C08.618.846.093;Acidosis, Respiratory;D000142
C18.452.076.176.310;Acidosis, Respiratory;D000142
D01.029;Acids;D000143
D02.241.081;Acids, Acyclic;D000144
D02.241.152;Acids, Aldehydic;D000145
D02.241.223;Acids, Carbocyclic;D000146
D03.066;Acids, Heterocyclic;D000147
D01.029.260;Acids, Noncarboxylic;D000148
D01.303.350.300.875.050;Acidulated Phosphate Fluoride;D000149
D01.695.625.675.650.025;Acidulated Phosphate Fluoride;D000149
D01.857.725.050;Acidulated Phosphate Fluoride;D000149
D25.223.015;Acidulated Phosphate Fluoride;D000149
J01.637.051.223.015;Acidulated Phosphate Fluoride;D000149
B03.440.400.425.537.050;Acinetobacter;D000150
B03.660.250.530.050;Acinetobacter;D000150
C01.252.400.560.022;Acinetobacter Infections;D000151
C17.800.030.150;Acne Vulgaris;D000152
C17.800.271.125.200;Acne Vulgaris;D000152
C17.800.794.111;Acne Vulgaris;D000152
A10.165.450.300.425.125;Acne Keloid;D000153
C17.300.200.425.125;Acne Keloid;D000153
C17.800.030.030;Acne Keloid;D000153
C17.800.271.125.125;Acne Keloid;D000153
C17.800.329.500.261;Acne Keloid;D000153
D08.811.520.241.300.050;Aconitate Hydratase;D000154
D02.241.081.901.177;Aconitic Acid;D000156
D02.455.849.291.037;Aconitine;D000157
D03.132.030;Aconitine;D000157
E01.370.382.375.050;Acoustic Impedance Tests;D000158
A08.800.800.120.910;Vestibulocochlear Nerve;D000159
C09.218.807.800;Vestibulocochlear Nerve Diseases;D000160
C10.292.910;Vestibulocochlear Nerve Diseases;D000160
E02.037;Acoustic Stimulation;D000161
E02.190.888.030;Acoustic Stimulation;D000161
E05.723.136;Acoustic Stimulation;D000161
H01.671.031;Acoustics;D000162
C02.782.815.616.400.040;Acquired Immunodeficiency Syndrome;D000163
C02.800.801.400.040;Acquired Immunodeficiency Syndrome;D000163
C02.839.040;Acquired Immunodeficiency Syndrome;D000163
C20.673.480.040;Acquired Immunodeficiency Syndrome;D000163
B01.300.381.025;Acremonium;D000164
D03.494.046.250.150;Acridine Orange;D000165
D03.494.046;Acridines;D000166
D03.494.046.250.177;Acriflavine;D000167
C05.116.099.370.894.232.015;Acrocephalosyndactylia;D000168
C05.116.099.370.894.819.100;Acrocephalosyndactylia;D000168
C05.660.207.240.100;Acrocephalosyndactylia;D000168
C05.660.207.707.249.100;Acrocephalosyndactylia;D000168
C05.660.585.800.100;Acrocephalosyndactylia;D000168
C05.660.906.364.100;Acrocephalosyndactylia;D000168
C05.660.906.819.100;Acrocephalosyndactylia;D000168
C16.131.621.207.240.100;Acrocephalosyndactylia;D000168
C16.131.621.207.707.249.100;Acrocephalosyndactylia;D000168
C16.131.621.585.800.100;Acrocephalosyndactylia;D000168
C16.131.621.906.364.100;Acrocephalosyndactylia;D000168
C16.131.621.906.819.100;Acrocephalosyndactylia;D000168
C16.131.831.066;Acrodermatitis;D000169
C17.800.174.100;Acrodermatitis;D000169
C17.800.804.066;Acrodermatitis;D000169
C10.668.829.025;Acrodynia;D000170
C10.720.475.600.150;Acrodynia;D000170
C25.723.647.500.100;Acrodynia;D000170
D02.047.122;Acrolein;D000171
C05.116.132.082;Acromegaly;D000172
C10.228.140.617.738.250.100;Acromegaly;D000172
C19.700.355.179;Acromegaly;D000172
A02.835.583.032;Acromioclavicular Joint;D000173
A02.835.232.087.783.261;Acromion;D000174
D03.132.032.077;Acronine;D000175
D03.494.046.109.077;Acronine;D000175
D08.811.277.656.300.760.030;Acrosin;D000176
D08.811.277.656.959.350.030;Acrosin;D000176
A05.360.490.890.820.100;Acrosome;D000177
A11.284.430.214.190.875.190.550.040;Acrosome;D000177
A11.497.760.400.100;Acrosome;D000177
D02.065.122;Acrylamides;D000178
D02.241.081.069.094;Acrylamides;D000178
D02.241.081.069;Acrylates;D000179
D05.750.716.822.111;Acrylic Resins;D000180
D25.720.716.822.111;Acrylic Resins;D000180
J01.637.051.720.716.822.111;Acrylic Resins;D000180
D02.626.095;Acrylonitrile;D000181
C04.730.713.317;ACTH Syndrome, Ectopic;D000182
D20.777.050;Actihaemyl;D000183
F01.393.047;Acting Out;D000184
D05.750.078.730.248;Actinin;D000185
D12.776.210.500.095;Actinin;D000185
D12.776.220.525.250;Actinin;D000185
D01.268.033.033;Actinium;D000186
D01.268.271.100.033;Actinium;D000186
D01.268.556.025;Actinium;D000186
D01.552.020.042;Actinium;D000186
D01.552.544.025;Actinium;D000186
C01.252.400.700.030.178;Actinobacillosis;D000187
C22.039;Actinobacillosis;D000187
B03.440.450.009;Actinobacillus;D000188
B03.660.250.550.050;Actinobacillus;D000188
C01.252.400.700.030;Actinobacillus Infections;D000189
B03.510.024.049.050.050;Actinomyces;D000190
B03.510.460.400.400.049.049.178;Actinomyces;D000190
B03.510.024.049.050;Actinomycetaceae;D000191
B03.510.460.400.400.049.049;Actinomycetaceae;D000191
B03.510.024.049;Actinomycetales;D000192
C01.252.410.040;Actinomycetales Infections;D000193
C01.252.410.040.137;Actinomycosis;D000196
C01.252.410.040.137.262;Actinomycosis, Cervicofacial;D000197
C01.252.825.110;Actinomycosis, Cervicofacial;D000197
C01.539.800.720.110;Actinomycosis, Cervicofacial;D000197
C17.800.838.765.110;Actinomycosis, Cervicofacial;D000197
D03.383.231.388.712;Spectinomycin;D000198
D03.494.835;Spectinomycin;D000198
D09.408.051.836;Spectinomycin;D000198
D05.750.078.730.250;Actins;D000199
D12.776.210.500.100;Actins;D000199
D12.776.220.525.255;Actins;D000199
G04.580.100;Action Potentials;D000200
G07.265.750.100;Action Potentials;D000200
G11.561.570.100;Action Potentials;D000200
E05.196.039;Activation Analysis;D000201
E06.658.453.560.100;Activator Appliances;D000202
E06.658.453.578.100;Activator Appliances;D000202
E02.831.067;Activities of Daily Living;D000203
I03.050;Activities of Daily Living;D000203
N02.421.784.110;Activities of Daily Living;D000203
G07.180.562.190.025;Activity Cycles;D000204
D12.776.210.500.154;Actomyosin;D000205
E05.318.740.100;Actuarial Analysis;D000206
N05.715.360.750.100;Actuarial Analysis;D000206
N06.850.520.830.100;Actuarial Analysis;D000206
C23.550.291.125;Acute Disease;D000208
D12.776.124.050;Acute-Phase Proteins;D000209
C23.550.470.099;Acute-Phase Reaction;D000210
D03.438.759.758.399.454.250;Acyclovir;D000212
D12.776.157.050;Acyl Carrier Protein;D000213
D03.438.759.646.138.382.300;Acyl Coenzyme A;D000214
D08.211.211.300;Acyl Coenzyme A;D000214
D13.695.667.138.382.300;Acyl Coenzyme A;D000214
D13.695.827.068.382.300;Acyl Coenzyme A;D000214
G02.111.087.019;Acylation;D000215
G02.149.115.019;Acylation;D000215
G02.149.465.030;Acylation;D000215
G02.607.750.030;Acylation;D000215
G03.495.095;Acylation;D000215
D08.811.913.696.445.035;N-Acylneuraminate Cytidylyltransferase;D000216
D08.811.913.050;Acyltransferases;D000217
D02.455.426.100.050;Adamantane;D000218
D02.455.426.392.368.075;Adamantane;D000218
C14.280.067.558.137;Adams-Stokes Syndrome;D000219
C23.550.073.425.025;Adams-Stokes Syndrome;D000219
G16.100.057;Adaptation, Biological;D000220
G14.640.154;Adaptation, Ocular;D000221
G07.700.062;Adaptation, Physiological;D000222
G16.100.057.500;Adaptation, Physiological;D000222
F01.058;Adaptation, Psychological;D000223
C19.053.500.263;Addison Disease;D000224
C20.111.163;Addison Disease;D000224
D03.438.759.138;Adenine;D000225
D12.776.157.530.625.875.500;Mitochondrial ADP, ATP Translocases;D000226
D12.776.543.585.450.162.225;Mitochondrial ADP, ATP Translocases;D000226
D12.776.543.585.475.500;Mitochondrial ADP, ATP Translocases;D000226
D12.776.543.585.625.875.500;Mitochondrial ADP, ATP Translocases;D000226
D12.776.575.750.500;Mitochondrial ADP, ATP Translocases;D000226
D03.438.759.646.138;Adenine Nucleotides;D000227
D13.695.667.138;Adenine Nucleotides;D000227
D13.695.827.068;Adenine Nucleotides;D000227
D08.811.913.400.725.100;Adenine Phosphoribosyltransferase;D000228
B04.280.580.650.170;Dependovirus;D000229
B04.909.204.671.650.170;Dependovirus;D000229
C04.557.470.200.025;Adenocarcinoma;D000230
C04.557.470.200.025.085;Adenocarcinoma, Papillary;D000231
C04.557.450.565.590.595.050;Adenofibroma;D000232
C04.557.470.625.050;Adenofibroma;D000232
E04.580.068;Adenoidectomy;D000233
A04.623.557.500;Adenoids;D000234
A10.549.100;Adenoids;D000234
A14.724.557.500;Adenoids;D000234
A15.382.520.604.100;Adenoids;D000234
C04.557.435.075;Adenolymphoma;D000235
C04.557.470.035;Adenoma;D000236
C04.557.465.625.650.075;Adenoma, Basophil;D000237
C04.557.470.035.075;Adenoma, Basophil;D000237
C04.557.580.625.650.075;Adenoma, Basophil;D000237
C04.557.465.625.650.095;Adenoma, Chromophobe;D000238
C04.557.470.035.095;Adenoma, Chromophobe;D000238
C04.557.580.625.650.095;Adenoma, Chromophobe;D000238
C04.557.465.625.650.025;Adenoma, Acidophil;D000239
C04.557.470.035.025;Adenoma, Acidophil;D000239
C04.557.580.625.650.025;Adenoma, Acidophil;D000239
D03.438.759.590.138;Adenosine;D000241
D13.570.583.138;Adenosine;D000241
D13.570.800.096;Adenosine;D000241
D03.438.759.646.138.395;Cyclic AMP;D000242
D13.695.462.200;Cyclic AMP;D000242
D13.695.667.138.395;Cyclic AMP;D000242
D13.695.827.068.395;Cyclic AMP;D000242
D08.811.277.151.486.075;Adenosine Deaminase;D000243
D03.438.759.646.138.124;Adenosine Diphosphate;D000244
D13.695.667.138.124;Adenosine Diphosphate;D000244
D13.695.827.068.124;Adenosine Diphosphate;D000244
D03.438.759.646.138.124.070.075;Adenosine Diphosphate Glucose;D000245
D09.408.620.569.070.075;Adenosine Diphosphate Glucose;D000245
D13.695.667.138.124.070.075;Adenosine Diphosphate Glucose;D000245
D13.695.827.068.124.070.075;Adenosine Diphosphate Glucose;D000245
D13.695.827.708.070.075;Adenosine Diphosphate Glucose;D000245
D03.438.759.646.138.124.070.125;Adenosine Diphosphate Ribose;D000246
D09.408.620.569.070.125;Adenosine Diphosphate Ribose;D000246
D13.695.667.138.124.070.125;Adenosine Diphosphate Ribose;D000246
D13.695.827.068.124.070.125;Adenosine Diphosphate Ribose;D000246
D13.695.827.708.070.125;Adenosine Diphosphate Ribose;D000246
D03.438.759.646.138.124.070;Adenosine Diphosphate Sugars;D000247
D09.408.620.569.070;Adenosine Diphosphate Sugars;D000247
D13.695.667.138.124.070;Adenosine Diphosphate Sugars;D000247
D13.695.827.068.124.070;Adenosine Diphosphate Sugars;D000247
D13.695.827.708.070;Adenosine Diphosphate Sugars;D000247
D08.811.913.696.620.010;Adenosine Kinase;D000248
D03.438.759.646.138.180;Adenosine Monophosphate;D000249
D13.695.667.138.180;Adenosine Monophosphate;D000249
D13.695.827.068.180;Adenosine Monophosphate;D000249
D03.438.759.646.138.180.080;Adenosine Phosphosulfate;D000250
D13.695.667.138.180.080;Adenosine Phosphosulfate;D000250
D13.695.827.068.180.080;Adenosine Phosphosulfate;D000250
D08.811.277.040.025;Adenosine Triphosphatases;D000251
D08.811.277.040.025.125;Calcium-Transporting ATPases;D000252
D12.776.157.530.450.250.500;Calcium-Transporting ATPases;D000252
D12.776.543.585.450.250.500;Calcium-Transporting ATPases;D000252
D08.811.277.040.025.810;Sodium-Potassium-Exchanging ATPase;D000254
D12.776.157.530.450.162.780;Sodium-Potassium-Exchanging ATPase;D000254
D12.776.157.530.450.250.880;Sodium-Potassium-Exchanging ATPase;D000254
D12.776.543.585.450.162.800;Sodium-Potassium-Exchanging ATPase;D000254
D12.776.543.585.450.250.890;Sodium-Potassium-Exchanging ATPase;D000254
D03.438.759.646.138.236;Adenosine Triphosphate;D000255
D13.695.667.138.236;Adenosine Triphosphate;D000255
D13.695.827.068.236;Adenosine Triphosphate;D000255
B04.280.030;Adenoviridae;D000256
B04.909.204.097;Adenoviridae;D000256
C02.256.076;Adenoviridae Infections;D000257
C02.256.076.045;Adenovirus Infections, Human;D000258
B04.280.030.100;Aviadenovirus;D000259
B04.909.204.097.100;Aviadenovirus;D000259
B04.280.030.500.350;Adenoviruses, Human;D000260
B04.909.204.097.500.350;Adenoviruses, Human;D000260
B04.280.030.500.700;Adenoviruses, Simian;D000261
B04.909.204.097.500.700;Adenoviruses, Simian;D000261
D08.811.520.650.200;Adenylate Cyclase;D000262
D12.644.360.050;Adenylate Cyclase;D000262
D12.776.476.050;Adenylate Cyclase;D000262
D08.811.913.696.650.025;Adenylate Kinase;D000263
D08.811.520.232.300.200;Adenylosuccinate Lyase;D000264
D08.811.464.259.100;Adenylosuccinate Synthase;D000265
D03.438.759.646.138.236.050;Adenylyl Imidodiphosphate;D000266
D13.695.667.138.236.050;Adenylyl Imidodiphosphate;D000266
D13.695.827.068.236.050;Adenylyl Imidodiphosphate;D000266
C23.550.355.274.840;Tissue Adhesions;D000267
G02.842.850.139;Adhesiveness;D000268
D27.720.013;Adhesives;D000269
J01.637.016;Adhesives;D000269
C10.177.045;Adie Syndrome;D000270
C10.292.600.200;Adie Syndrome;D000270
C11.590.436.200;Adie Syndrome;D000270
C11.710.800.180;Adie Syndrome;D000270
D02.241.081.337.052;Adipates;D000272
A10.165.114;Adipose Tissue;D000273
C17.800.463.249;Adiposis Dolorosa;D000274
C18.452.584.718.500;Adiposis Dolorosa;D000274
F03.075;Adjustment Disorders;D000275
D27.505.696.477.067;Adjuvants, Immunologic;D000276
D26.650.064;Adjuvants, Pharmaceutic;D000277
D27.720.744.064;Adjuvants, Pharmaceutic;D000277
E02.319.267.100.028;Administration, Buccal;D000278
E02.319.267.120.040;Administration, Buccal;D000278
E02.319.267.120.060;Administration, Cutaneous;D000279
E02.319.267.050;Administration, Inhalation;D000280
E02.319.267.080;Administration, Intranasal;D000281
E02.319.267.120.080;Administration, Intranasal;D000281
E02.319.267.120.500;Administration, Intravaginal;D000282
E02.319.267.120.505;Administration, Intravesical;D000283
E02.319.267.100;Administration, Oral;D000284
E02.319.267.110;Administration, Rectal;D000285
E02.319.267.120.806;Administration, Rectal;D000285
E02.319.267.100.878;Administration, Sublingual;D000286
E02.319.267.120;Administration, Topical;D000287
M01.526.070;Administrative Personnel;D000288
N02.278.354.422.040;Admitting Department, Hospital;D000289
N04.452.442.422.040;Admitting Department, Hospital;D000289
A05.360.319.114;Adnexa Uteri;D000290
C13.351.500.056;Adnexal Diseases;D000291
C01.539.635.500;Pelvic Inflammatory Disease;D000292
C13.351.500.056.750;Pelvic Inflammatory Disease;D000292
M01.060.057;Adolescent;D000293
F01.145.022;Adolescent Behavior;D000294
H02.403.014;Adolescent Medicine;D000295
F04.096.544.065;Adolescent Psychiatry;D000296
H02.403.690.080;Adolescent Psychiatry;D000296
F04.096.628.065;Adolescent Psychology;D000297
M01.643.050;Adolescent, Hospitalized;D000298
M01.643.154;Adolescent, Institutionalized;D000299
I01.880.225.140;Adoption;D000300
D04.808.247.808.050;Adosterol;D000301
A06.407.071.140;Adrenal Cortex;D000302
C19.053.098;Adrenal Cortex Diseases;D000303
E01.370.374.050;Adrenal Cortex Function Tests;D000304
D06.472.040;Adrenal Cortex Hormones;D000305
C04.588.322.078.265;Adrenal Cortex Neoplasms;D000306
C19.053.098.265;Adrenal Cortex Neoplasms;D000306
C19.053.347.500;Adrenal Cortex Neoplasms;D000306
C19.344.078.265;Adrenal Cortex Neoplasms;D000306
C19.053;Adrenal Gland Diseases;D000307
C19.053.800;Adrenocortical Hyperfunction;D000308
C19.053.500;Adrenal Insufficiency;D000309
C04.588.322.078;Adrenal Gland Neoplasms;D000310
C19.053.347;Adrenal Gland Neoplasms;D000310
C19.344.078;Adrenal Gland Neoplasms;D000310
A06.407.071;Adrenal Glands;D000311
C12.706.316.129.500;Adrenal Hyperplasia, Congenital;D000312
C13.351.875.253.129.500;Adrenal Hyperplasia, Congenital;D000312
C16.131.939.316.129.500;Adrenal Hyperplasia, Congenital;D000312
C16.320.033;Adrenal Hyperplasia, Congenital;D000312
C16.320.565.925.249;Adrenal Hyperplasia, Congenital;D000312
C18.452.648.925.249;Adrenal Hyperplasia, Congenital;D000312
C19.053.440;Adrenal Hyperplasia, Congenital;D000312
C19.391.119.129.500;Adrenal Hyperplasia, Congenital;D000312
A06.407.071.265;Adrenal Medulla;D000313
C04.557.470.035.232;Adrenal Rest Tumor;D000314
E04.270.115;Adrenalectomy;D000315
D27.505.519.625.050.100.100;Adrenergic alpha-Agonists;D000316
D27.505.696.577.050.100.100;Adrenergic alpha-Agonists;D000316
D27.505.519.625.050.200.100;Adrenergic alpha-Antagonists;D000317
D27.505.696.577.050.200.100;Adrenergic alpha-Antagonists;D000317
D27.505.519.625.050.100.200;Adrenergic beta-Agonists;D000318
D27.505.696.577.050.100.200;Adrenergic beta-Agonists;D000318
D27.505.519.625.050.200.200;Adrenergic beta-Antagonists;D000319
D27.505.696.577.050.200.200;Adrenergic beta-Antagonists;D000319
A08.663.542.075;Adrenergic Fibers;D000320
D27.505.519.625.050.100;Adrenergic Agonists;D000322
D27.505.696.577.050.100;Adrenergic Agonists;D000322
D03.438.473.025;Adrenochrome;D000323
D23.767.061;Adrenochrome;D000323
D06.472.699.327.935.059;Adrenocorticotropic Hormone;D000324
D06.472.699.327.935.531.500;Adrenocorticotropic Hormone;D000324
D06.472.699.631.525.600.059;Adrenocorticotropic Hormone;D000324
D06.472.699.631.525.600.531.500;Adrenocorticotropic Hormone;D000324
D12.644.400.400.935.059;Adrenocorticotropic Hormone;D000324
D12.644.400.400.935.531.500;Adrenocorticotropic Hormone;D000324
D12.644.548.365.935.059;Adrenocorticotropic Hormone;D000324
D12.644.548.365.935.531.500;Adrenocorticotropic Hormone;D000324
D12.644.548.691.525.690.059;Adrenocorticotropic Hormone;D000324
D12.644.548.691.525.690.531.500;Adrenocorticotropic Hormone;D000324
D12.776.641.650.405.935.059;Adrenocorticotropic Hormone;D000324
D12.776.641.650.405.935.531.500;Adrenocorticotropic Hormone;D000324
D12.776.157.427.374.375.025;Adrenodoxin;D000325
D12.776.556.579.374.375.025;Adrenodoxin;D000325
C10.228.140.163.100.362.250;Adrenoleukodystrophy;D000326
C10.228.140.163.100.680.100;Adrenoleukodystrophy;D000326
C10.228.140.695.625.250;Adrenoleukodystrophy;D000326
C10.228.518.625.250;Adrenoleukodystrophy;D000326
C10.314.400.250;Adrenoleukodystrophy;D000326
C10.597.606.643.455.124;Adrenoleukodystrophy;D000326
C16.320.322.500.124;Adrenoleukodystrophy;D000326
C16.320.400.525.124;Adrenoleukodystrophy;D000326
C16.320.565.189.362.250;Adrenoleukodystrophy;D000326
C16.320.565.189.680.100;Adrenoleukodystrophy;D000326
C16.320.565.663.112;Adrenoleukodystrophy;D000326
C18.452.132.100.362.250;Adrenoleukodystrophy;D000326
C18.452.132.100.680.100;Adrenoleukodystrophy;D000326
C18.452.648.189.362.250;Adrenoleukodystrophy;D000326
C18.452.648.189.680.100;Adrenoleukodystrophy;D000326
C18.452.648.663.112;Adrenoleukodystrophy;D000326
C19.053.500.270;Adrenoleukodystrophy;D000326
G02.149.047;Adsorption;D000327
G02.149.767.029;Adsorption;D000327
G02.842.750.029;Adsorption;D000327
M01.060.116;Adult;D000328
J01.219.687.274;Advertising as Topic;D000329
L01.143.050;Advertising as Topic;D000329
B01.050.500.131.617.289.275.100;Aedes;D000330
D12.776.532.020;Aequorin;D000331
G02.111.087.024;Aerobiosis;D000332
G02.149.115.024;Aerobiosis;D000332
G03.495.112;Aerobiosis;D000332
B03.440.450.019.025;Aeromonas;D000333
B03.660.250.017.025;Aeromonas;D000333
C23.888.821.061;Aerophagy;D000334
D26.255.165.055.055;Aerosol Propellants;D000335
D27.720.280.165.055.055;Aerosol Propellants;D000335
D20.280.055;Aerosols;D000336
D26.255.165.055;Aerosols;D000336
D27.720.280.165.055;Aerosols;D000336
H02.403.029;Aerospace Medicine;D000337
D02.886.904.100;beta-Aminoethyl Isothiourea;D000338
D02.948.898.100;beta-Aminoethyl Isothiourea;D000338
F01.470.047;Affect;D000339
F03.600.150;Affective Disorders, Psychotic;D000341
F01.145.126.100;Affective Symptoms;D000342
C06.405.469.531.099;Afferent Loop Syndrome;D000343
C23.550.767.050;Afferent Loop Syndrome;D000343
A08.612.220;Afferent Pathways;D000344
D27.720.470.410.080;Affinity Labels;D000345
Z01.252.245.500.125;Afghanistan;D000346
Z01.586.500.125;Afghanistan;D000346
C15.378.100.100.056;Afibrinogenemia;D000347
C15.378.100.141.072;Afibrinogenemia;D000347
C15.378.463.067;Afibrinogenemia;D000347
C16.320.099.056;Afibrinogenemia;D000347
D03.438.150.119;Aflatoxins;D000348
D03.830.219.119;Aflatoxins;D000348
D23.946.587.142;Aflatoxins;D000348
Z01.058;Africa;D000349
Z01.058.290.100;Africa, Central;D000350
Z01.058.290.120;Africa, Eastern;D000351
Z01.058.266;Africa, Northern;D000352
Z01.058.290.175;Africa, Southern;D000353
Z01.058.290.190;Africa, Western;D000354
C02.081.030;African Horse Sickness;D000355
C02.782.791.142;African Horse Sickness;D000355
C22.488.088;African Horse Sickness;D000355
B04.820.630.550.050;African horse sickness virus;D000356
B04.909.777.714.550.050;African horse sickness virus;D000356
C02.081.885.125;African Swine Fever;D000357
C02.256.142;African Swine Fever;D000357
C22.905.072;African Swine Fever;D000357
B04.280.049.035;African Swine Fever Virus;D000358
B04.909.204.102.035;African Swine Fever Virus;D000358
E02.760.058;Aftercare;D000359
N02.421.585.058;Aftercare;D000359
F02.463.593.932.073;Afterimage;D000360
G14.040;Afterimage;D000360
C15.378.147.142;Agammaglobulinemia;D000361
C15.604.515.032;Agammaglobulinemia;D000361
C20.673.088;Agammaglobulinemia;D000361
D09.698.360.041;Agar;D000362
B01.300.179.100;Agaricales;D000363
B01.300.179.100.105;Agaricus;D000364
E01.370.049;Age Determination by Skeleton;D000365
E01.370.350.700.050;Age Determination by Skeleton;D000365
E01.370.350.700.720.050;Age Determination by Teeth;D000366
E06.342.764.142;Age Determination by Teeth;D000366
N05.715.350.075;Age Factors;D000367
N06.850.490.250;Age Factors;D000367
M01.060.116.100;Aged;D000368
M01.060.116.100.080;Aged, 80 and over;D000369
C10.597.751.861.184;Ageusia;D000370
C23.888.592.763.861.184;Ageusia;D000370
G02.111.087.026;Agglutination;D000371
G02.149.115.026;Agglutination;D000371
G12.425.143.100;Agglutination;D000371
E01.370.225.812.735.050;Agglutination Tests;D000372
E05.200.812.735.050;Agglutination Tests;D000372
E05.478.594.760.050;Agglutination Tests;D000372
D27.505.696.477.136;Agglutinins;D000373
F01.145.126.125;Aggression;D000374
F01.145.813.045;Aggression;D000374
G07.700.320.124;Aging;D000375
D02.078.370.060;Agmatine;D000376
C10.597.606.762.100;Agnosia;D000377
C23.888.592.604.764.100;Agnosia;D000377
F01.700.750.100;Agnosia;D000377
F01.145.126.125.100;Agonistic Behavior;D000378
F03.080.100;Agoraphobia;D000379
C15.378.553.546.184;Agranulocytosis;D000380
C10.597.606.150.500.050;Agraphia;D000381
C23.888.592.604.150.500.050;Agraphia;D000381
C24.080;Agricultural Workers' Diseases;D000382
J01.040;Agriculture;D000383
N03.219.521.346.506.849.095;Aid to Families with Dependent Children;D000385
C02.782.815.616.400.080;AIDS-Related Complex;D000386
C02.800.801.400.080;AIDS-Related Complex;D000386
C02.839.080;AIDS-Related Complex;D000386
C20.673.480.080;AIDS-Related Complex;D000386
C05.116.264.143;Ainhum;D000387
G16.500.275.063.150;Air;D000388
N06.230.300.100.150;Air;D000388
N06.230.150.050;Air Conditioning;D000389
G02.149.060;Air Ionization;D000390
G02.149.767.040;Air Ionization;D000390
G02.842.750.040;Air Ionization;D000390
G16.500.240.070;Air Ionization;D000390
N06.230.300.100.150.100;Air Ionization;D000390
H01.158.273.540.274.110;Air Microbiology;D000391
N06.850.425.110;Air Microbiology;D000391
G16.500.240.135.249;Air Movements;D000392
G16.500.275.063.725.154;Air Movements;D000392
N06.230.300.100.150.185;Air Movements;D000392
D27.888.284.101;Air Pollutants;D000393
D27.888.284.101.268;Air Pollutants, Occupational;D000395
D20.693.101;Air Pollutants, Radioactive;D000396
D27.888.284.101.393;Air Pollutants, Radioactive;D000396
N06.850.460.100;Air Pollution;D000397
N06.850.460.100.110;Air Pollution, Radioactive;D000398
N06.850.810.080;Air Pollution, Radioactive;D000398
G16.500.750.274.100;Air Pressure;D000399
N06.230.300.100.185.100;Air Pressure;D000399
A13.048;Air Sacs;D000400
J01.937.285.100;Aircraft;D000401
C08.618.846.185;Airway Obstruction;D000402
E01.370.386.700.050;Airway Resistance;D000403
G09.772.060;Airway Resistance;D000403
D03.132.436.681.077;Ajmaline;D000404
D03.438.473.402.681.077;Ajmaline;D000404
C10.228.140.042;Akinetic Mutism;D000405
B04.820.650.375.525.050;AKR murine leukemia virus;D000406
B04.909.574.807.375.525.050;AKR murine leukemia virus;D000406
B04.909.777.731.375.525.050;AKR murine leukemia virus;D000406
Z01.107.567.875.075.100;Alabama;D000407
Z01.107.567.875.750.100;Alabama;D000407
D04.345.566.040;Alamethicin;D000408
D12.644.504.111;Alamethicin;D000408
D12.644.641.040;Alamethicin;D000408
D12.125.042;Alanine;D000409
D08.811.913.477.700.100;Alanine Transaminase;D000410
D08.811.399.894.200.200;Alanine Racemase;D000411
D08.811.464.263.200.050;Alanine-tRNA Ligase;D000412
Z01.107.567.875.580.100;Alaska;D000413
Z01.542.248.020;Albania;D000415
Z01.107.567.176.064;Alberta;D000416
C11.270.040;Albinism;D000417
C16.320.290.040;Albinism;D000417
C16.320.565.100.102;Albinism;D000417
C16.320.850.080;Albinism;D000417
C17.800.621.440.102;Albinism;D000417
C17.800.827.080;Albinism;D000417
C18.452.648.100.102;Albinism;D000417
D12.776.034;Albumins;D000418
C12.777.934.734.269;Albuminuria;D000419
C13.351.968.934.734.269;Albuminuria;D000419
C23.888.942.750.269;Albuminuria;D000419
D02.033.100.291.057;Albuterol;D000420
D02.092.063.291.057;Albuterol;D000420
D02.092.471.683.061;Albuterol;D000420
B03.440.400.425.117.050;Alcaligenes;D000421
B03.660.075.027.050;Alcaligenes;D000421
K01.400.075;Alchemy;D000422
D03.438.473.050;Alcian Blue;D000423
C10.720.112.100;Alcohol Amnestic Disorder;D000425
C25.100.087.193.100;Alcohol Amnestic Disorder;D000425
C25.723.705.150.100;Alcohol Amnestic Disorder;D000425
F03.087.200.125;Alcohol Amnestic Disorder;D000425
F03.900.100.050;Alcohol Amnestic Disorder;D000425
D08.811.682.047.070;Alcohol Dehydrogenase;D000426
D27.505.954.427.020;Alcohol Deterrents;D000427
F01.145.317.269;Alcohol Drinking;D000428
D08.811.682.047;Alcohol Oxidoreductases;D000429
C10.720.112.200;Alcohol Withdrawal Delirium;D000430
C25.100.087.193.200;Alcohol Withdrawal Delirium;D000430
C25.723.705.150.200;Alcohol Withdrawal Delirium;D000430
C25.835.250;Alcohol Withdrawal Delirium;D000430
F03.900.100.100;Alcohol Withdrawal Delirium;D000430
F03.900.825.500;Alcohol Withdrawal Delirium;D000430
D02.033.375;Ethanol;D000431
D02.033.623;Methanol;D000432
D02.033.755.600;1-Propanol;D000433
J02.200.100;Alcoholic Beverages;D000434
C25.100.175;Alcoholic Intoxication;D000435
F03.900.100.300;Alcoholic Intoxication;D000435
N03.540.782.270;Alcoholics Anonymous;D000436
C25.100.250;Alcoholism;D000437
F03.900.100.350;Alcoholism;D000437
D02.033;Alcohols;D000438
D02.033.415.640;Pentanols;D000439
D10.289.640;Pentanols;D000439
D02.033.415.110;Butanols;D000440
D10.289.110;Butanols;D000440
D02.033.415.510;Hexanols;D000441
D02.033.480;Hexanols;D000441
D10.289.510;Hexanols;D000441
D02.033.415.600;Octanols;D000442
D10.289.600;Octanols;D000442
D02.092.877.844.050;Alcuronium;D000443
D02.675.276.844.050;Alcuronium;D000443
D03.132.098.833.050;Alcuronium;D000443
D03.438.531.085.777.050;Alcuronium;D000443
D03.438.531.820.687.050;Alcuronium;D000443
D08.811.682.657.163.249;Aldehyde Dehydrogenase;D000444
D08.811.682.657.163;Aldehyde Oxidoreductases;D000445
D08.811.520.224.062;Aldehyde-Lyases;D000446
D02.047;Aldehydes;D000447
D02.241.081.251.046;Aldicarb;D000448
D08.811.682.047.150.700.075;Aldehyde Reductase;D000449
D04.808.745.745.654.062;Aldosterone;D000450
D06.472.040.585.353.118;Aldosterone;D000450
D06.347.700;Mineralocorticoid Receptor Antagonists;D000451
D27.505.696.399.450.600;Mineralocorticoid Receptor Antagonists;D000451
D27.505.696.560.500.726.249;Mineralocorticoid Receptor Antagonists;D000451
D02.455.526.439.042;Aldrin;D000452
C02.256.700.091;Aleutian Mink Disease;D000453
C02.839.091;Aleutian Mink Disease;D000453
C20.673.774.257.270;Aleutian Mink Disease;D000453
C22.062;Aleutian Mink Disease;D000453
B04.280.580.650.040.050;Aleutian Mink Disease Virus;D000454
B04.909.204.671.650.040.050;Aleutian Mink Disease Virus;D000454
B01.650.940.800.575.100.401.590.500;Medicago sativa;D000455
J02.500.300.100.555;Medicago sativa;D000455
B03.280;Cyanobacteria;D000458
B03.440.475.100;Cyanobacteria;D000458
B01.750.600;Phaeophyta;D000459
B01.650.940.150;Chlorophyta;D000460
B01.650.700;Rhodophyta;D000461
Z01.058.266.104;Algeria;D000462
D04.808.745.745.654.829.025.025;Algestone Acetophenide;D000463
D09.698.068;Alginates;D000464
G17.035;Algorithms;D000465
L01.224.050;Algorithms;D000465
D02.455.326.271.665.146;Alkadienes;D000466
D01.045;Alkalies;D000468
D08.811.277.352.650.035;Alkaline Phosphatase;D000469
D03.132;Alkaloids;D000470
C18.452.076.354;Alkalosis;D000471
C08.618.501.271;Alkalosis, Respiratory;D000472
C18.452.076.354.271;Alkalosis, Respiratory;D000472
D02.455.326.146;Alkanes;D000473
C16.320.565.100.187;Alkaptonuria;D000474
C18.452.648.100.187;Alkaptonuria;D000474
D02.455.326.271;Alkenes;D000475
D02.455.326.146.100.050;Alkanesulfonates;D000476
D02.886.645.600.055.050;Alkanesulfonates;D000476
D27.505.519.124;Alkylating Agents;D000477
D27.888.569.035;Alkylating Agents;D000477
G02.111.087.029;Alkylation;D000478
G02.149.115.029;Alkylation;D000478
G02.149.465.040;Alkylation;D000478
G02.607.750.040;Alkylation;D000478
G03.495.130;Alkylation;D000478
D02.691.750.100;Alkylmercury Compounds;D000479
D02.455.326.397;Alkynes;D000480
D02.948.058;Allantoin;D000481
D03.383.129.308.432.555.105;Allantoin;D000481
A10.615.284.147;Allantois;D000482
A16.254.750.147;Allantois;D000482
G05.360.340.024.340.030;Alleles;D000483
D23.050.063;Allergens;D000485
H02.403.044;Allergy and Immunology;D000486
D02.455.849.575.812.272;Allethrin;D000487
M01.526.485.067;Allied Health Personnel;D000488
N02.360.067;Allied Health Personnel;D000488
B01.050.150.900.833.100;Alligators and Crocodiles;D000489
B01.650.940.800.575.100.610.100;Allium;D000490
J02.500.850.100;Allium;D000490
D08.811.277.087.060;Allophanate Hydrolase;D000492
D03.438.759.160;Allopurinol;D000493
G02.111.087.040;Allosteric Regulation;D000494
G02.149.115.040;Allosteric Regulation;D000494
G02.111.570.120.147;Allosteric Site;D000495
D03.383.742.698.122;Alloxan;D000496
D01.552.033;Alloys;D000497
D25.058;Alloys;D000497
J01.637.051.058;Alloys;D000497
D02.455.326.271.122;Allyl Compounds;D000498
D02.092.050;Allylamine;D000499
D02.455.326.271.122.100;Allylamine;D000499
D04.808.365.415.050;Allylestrenol;D000500
D02.455.326.271.122.260;Allylglycine;D000501
D12.125.481.100;Allylglycine;D000501
D02.065.064.189;Allylisopropylacetamide;D000502
D02.241.081.018.110.189;Allylisopropylacetamide;D000502
D02.455.326.271.122.272;Allylisopropylacetamide;D000502
L01.178.682.192.836.072;Almanacs as Topic;D000503
B01.650.940.800.575.100.027;Aloe;D000504
C17.800.329.937.122;Alopecia;D000505
C23.300.035;Alopecia;D000505
C17.800.329.937.122.147;Alopecia Areata;D000506
C17.300.550.550;Mucinosis, Follicular;D000507
C17.800.329.937.122.550;Mucinosis, Follicular;D000507
C17.800.794.550;Mucinosis, Follicular;D000507
B01.050.150.900.649.801.400.600.075.050.075;Alouatta;D000508
D12.776.124.790.106.092;alpha-Fetoproteins;D000509
D12.776.320.525.500;alpha-Fetoproteins;D000509
D12.776.377.228.500;alpha-Fetoproteins;D000509
D12.776.377.715.085.092;alpha-Fetoproteins;D000509
D23.101.840.050;alpha-Fetoproteins;D000509
D12.776.124.790.106;Alpha-Globulins;D000510
D12.776.377.715.085;Alpha-Globulins;D000510
D12.776.124.050.080;alpha-Macroglobulins;D000511
D12.776.124.790.106.100;alpha-Macroglobulins;D000511
D12.776.124.790.720.100;alpha-Macroglobulins;D000511
D12.776.377.715.085.100;alpha-Macroglobulins;D000511
D12.776.377.715.647.100;alpha-Macroglobulins;D000511
G01.750.750.055;Alpha Particles;D000512
E01.370.376.300.150.374;Alpha Rhythm;D000513
E01.370.405.245.287.374;Alpha Rhythm;D000513
G07.265.087.500;Alpha Rhythm;D000513
G11.561.127.500;Alpha Rhythm;D000513
D12.644.822.750.030;alpha 1-Antichymotrypsin;D000514
D12.644.861.030;alpha 1-Antichymotrypsin;D000514
D12.776.124.050.050;alpha 1-Antichymotrypsin;D000514
D12.776.124.790.106.050;alpha 1-Antichymotrypsin;D000514
D12.776.377.715.085.050;alpha 1-Antichymotrypsin;D000514
D12.776.395.045;alpha 1-Antichymotrypsin;D000514
D12.776.645.750.030;alpha 1-Antichymotrypsin;D000514
D12.776.872.030;alpha 1-Antichymotrypsin;D000514
D12.644.822.750.035;alpha 1-Antitrypsin;D000515
D12.644.861.035;alpha 1-Antitrypsin;D000515
D12.776.124.050.070;alpha 1-Antitrypsin;D000515
D12.776.124.790.106.085;alpha 1-Antitrypsin;D000515
D12.776.377.715.085.085;alpha 1-Antitrypsin;D000515
D12.776.395.068;alpha 1-Antitrypsin;D000515
D12.776.645.750.035;alpha 1-Antitrypsin;D000515
D12.776.872.035;alpha 1-Antitrypsin;D000515
D08.811.277.450.066.050;alpha-Amylases;D000516
D02.033.260.100;alpha-Chlorohydrin;D000517
D02.033.455.706.100;alpha-Chlorohydrin;D000517
D12.125.068.665.340;Eflornithine;D000518
D12.125.095.765.340;Eflornithine;D000518
D08.811.277.450.410.050;alpha-Galactosidase;D000519
D08.811.277.450.420.050;alpha-Glucosidases;D000520
D06.472.699.327.935.179;alpha-MSH;D000521
D06.472.699.327.935.531.750.050;alpha-MSH;D000521
D06.472.699.631.525.600.179;alpha-MSH;D000521
D06.472.699.631.525.600.531.750.050;alpha-MSH;D000521
D12.644.400.400.935.179;alpha-MSH;D000521
D12.644.400.400.935.531.750.050;alpha-MSH;D000521
D12.644.400.460.050;alpha-MSH;D000521
D12.644.548.365.935.179;alpha-MSH;D000521
D12.644.548.365.935.531.750.050;alpha-MSH;D000521
D12.644.548.691.525.690.179;alpha-MSH;D000521
D12.644.548.691.525.690.531.750.050;alpha-MSH;D000521
D12.776.641.650.405.935.179;alpha-MSH;D000521
D12.776.641.650.405.935.531.750.050;alpha-MSH;D000521
D12.776.641.650.460.050;alpha-MSH;D000521
D03.383.621.040;Alphaprodine;D000522
D04.808.745.745.654.829.025;Algestone;D000523
B04.820.850.054;Alphavirus;D000524
B04.909.777.923.054;Alphavirus;D000524
D03.438.079.080.030;Alprazolam;D000525
D02.033.100.624.058;Alprenolol;D000526
D02.033.100.624.698.055;Alprenolol;D000526
D02.033.755.624.058;Alprenolol;D000526
D02.033.755.624.698.055;Alprenolol;D000526
D02.092.063.624.698.055;Alprenolol;D000526
D10.251.355.255.550.250.050;Alprostadil;D000527
D10.251.355.325.050;Alprostadil;D000527
D23.469.050.175.725.780.050;Alprostadil;D000527
B01.300.381.075;Alternaria;D000528
E02.190;Complementary Therapies;D000529
D04.808.745.558.050;Alfaxalone Alfadolone Mixture;D000530
G16.500.275.058;Altitude;D000531
N06.230.058;Altitude;D000531
C08.618.020;Altitude Sickness;D000532
F01.145.813.090;Altruism;D000533
D01.056.025;Alum Compounds;D000534
D01.875.800.800.850.025;Alum Compounds;D000534
D01.268.557.050;Aluminum;D000535
D01.552.547.050;Aluminum;D000535
D01.045.250.050;Aluminum Hydroxide;D000536
D01.056.037;Aluminum Hydroxide;D000536
D01.455.150;Aluminum Hydroxide;D000536
D01.056.050;Aluminum Oxide;D000537
D01.650.550.050;Aluminum Oxide;D000537
D01.056.050.075;Aluminum Silicates;D000538
D01.578.725.025;Aluminum Silicates;D000538
D01.650.550.050.075;Aluminum Silicates;D000538
D01.837.725.700.760.050;Aluminum Silicates;D000538
A02.835.232.781.324.502.125;Alveolar Process;D000539
A14.521.125;Alveolar Process;D000539
A14.549.167.646.094;Alveolar Process;D000539
E04.545.550.100;Alveolar Ridge Augmentation;D000540
E06.645.550.100;Alveolar Ridge Augmentation;D000540
E04.545.550.110;Alveolectomy;D000541
E06.645.550.110;Alveolectomy;D000541
C08.381.483.125;Alveolitis, Extrinsic Allergic;D000542
C08.674.055;Alveolitis, Extrinsic Allergic;D000542
C20.543.480.680.075;Alveolitis, Extrinsic Allergic;D000542
E04.545.550.120;Alveoloplasty;D000543
E06.645.550.120;Alveoloplasty;D000543
C10.228.140.380.100;Alzheimer Disease;D000544
C10.574.945.249;Alzheimer Disease;D000544
F03.087.400.100;Alzheimer Disease;D000544
B01.300.179.100.110;Amanita;D000545
D04.345.566.050;Amanitins;D000546
D12.644.456.050;Amanitins;D000546
D12.644.641.050;Amanitins;D000546
D23.946.587.175;Amanitins;D000546
D02.455.426.100.050.035;Amantadine;D000547
D02.172.025;Amaranth Dye;D000548
D02.455.426.559.847.638.555.200;Amaranth Dye;D000548
D02.886.645.600.080.050.650.012;Amaranth Dye;D000548
D04.615.638.555.200;Amaranth Dye;D000548
D02.092.877.096.019;Ambenonium Chloride;D000549
D02.675.276.046;Ambenonium Chloride;D000549
C10.228.140.055;Amblyopia;D000550
C10.597.751.941.073;Amblyopia;D000550
C11.966.073;Amblyopia;D000550
C23.888.592.763.941.073;Amblyopia;D000550
D02.092.146.271.100;Ambroxol;D000551
D02.092.384.175.100;Ambroxol;D000551
J01.937.500.050;Ambulances;D000552
N02.421.297.879.100;Ambulances;D000552
E02.760.106;Ambulatory Care;D000553
N02.421.585.106;Ambulatory Care;D000553
N02.278.035;Ambulatory Care Facilities;D000554
L01.700.508.300.680.030;Ambulatory Care Information Systems;D000555
N04.452.515.050;Ambulatory Care Information Systems;D000555
N04.452.515.360.050;Ambulatory Care Information Systems;D000555
E04.030;Ambulatory Surgical Procedures;D000556
B01.050.150.900.090.608.080.068;Ambystoma;D000557
B01.050.150.900.090.608.080.068.525;Ambystoma mexicanum;D000558
B01.050.150.900.090.608.080;Ambystomatidae;D000559
D02.065.589.099.750.124;Amdinocillin;D000560
D02.886.108.750.124;Amdinocillin;D000560
D03.438.260.825.124;Amdinocillin;D000560
D03.605.084.737.124;Amdinocillin;D000560
D04.075.080.875.099.221.750.124;Amdinocillin;D000560
D02.065.589.099.750.124.036;Amdinocillin Pivoxil;D000561
D02.886.108.750.124.036;Amdinocillin Pivoxil;D000561
D03.438.260.825.124.036;Amdinocillin Pivoxil;D000561
D03.605.084.737.124.036;Amdinocillin Pivoxil;D000561
D04.075.080.875.099.221.750.124.036;Amdinocillin Pivoxil;D000561
C03.752.049;Amebiasis;D000562
D27.505.954.122.250.100.055;Amebicides;D000563
C04.557.695.065;Ameloblastoma;D000564
A11.436.107;Ameloblasts;D000565
G07.700.320.500.325.377.750.190;Amelogenesis;D000566
C07.650.800.255.500;Amelogenesis Imperfecta;D000567
C07.793.700.255.500;Amelogenesis Imperfecta;D000567
C16.131.850.800.255.500;Amelogenesis Imperfecta;D000567
C23.550.568.500;Amenorrhea;D000568
Z01.107;Americas;D000569
N03.540.630.780.080;American Cancer Society;D000570
N03.540.828.506.274;American Dental Association;D000571
N03.540.630.780.110;American Heart Association;D000572
N03.540.828.540.080;American Hospital Association;D000573
N03.540.828.589.274;American Medical Association;D000574
N03.540.828.672.274;American Nurses' Association;D000575
D01.268.033.050;Americium;D000576
D01.268.271.100.050;Americium;D000576
D01.268.556.037;Americium;D000576
D01.552.020.086;Americium;D000576
D01.552.544.037;Americium;D000576
D02.065;Amides;D000577
D02.078;Amidines;D000578
D08.811.913.555.150;Amidinotransferases;D000579
D02.172.029;Amido Black;D000580
D02.455.426.559.847.638.555.220;Amido Black;D000580
D02.886.645.600.080.050.650.025;Amido Black;D000580
D04.615.638.555.220;Amido Black;D000580
D08.811.277.087;Amidohydrolases;D000581
D08.811.913.400.725.130;Amidophosphoribosyltransferase;D000582
D09.408.051.476.060;Amikacin;D000583
D03.383.679.149;Amiloride;D000584
D03.494.046.250.200;Aminacrine;D000585
G02.111.087.045;Amination;D000586
G02.149.115.045;Amination;D000586
G02.149.465.050;Amination;D000586
G02.607.750.050;Amination;D000586
G03.495.140;Amination;D000586
D08.811.682.662;Oxidoreductases Acting on CH-NH Group Donors;D000587
D02.092;Amines;D000588
D12.125.065;Amino Acid Chloromethyl Ketones;D000590
D08.811.399.894.200;Amino Acid Isomerases;D000591
C16.320.565.100;Amino Acid Metabolism, Inborn Errors;D000592
C18.452.648.100;Amino Acid Metabolism, Inborn Errors;D000592
D08.811.682.664.500;Amino Acid Oxidoreductases;D000594
G02.111.570.060;Amino Acid Sequence;D000595
L01.453.245.667.060;Amino Acid Sequence;D000595
D12.125;Amino Acids;D000596
D12.125.070;Amino Acids, Branched-Chain;D000597
D12.125.072;Amino Acids, Cyclic;D000598
D12.125.095;Amino Acids, Diamino;D000599
D12.125.119;Amino Acids, Dicarboxylic;D000600
D12.125.142;Amino Acids, Essential;D000601
D12;Amino Acids, Peptides, and Proteins;D000602
D02.886.030;Amino Acids, Sulfur;D000603
D12.125.166;Amino Acids, Sulfur;D000603
D08.811.464.263.200;Amino Acyl-tRNA Synthetases;D000604
D02.033.100;Amino Alcohols;D000605
D02.092.063;Amino Alcohols;D000605
D09.067;Amino Sugars;D000606
D02.626.080.085;Aminoacetonitrile;D000607
C12.777.419.815.885;Renal Aminoacidurias;D000608
C13.351.968.419.815.885;Renal Aminoacidurias;D000608
C16.320.565.861.885;Renal Aminoacidurias;D000608
C18.452.648.861.885;Renal Aminoacidurias;D000608
D03.494.046.250;Aminoacridines;D000609
D02.455.426.559.389.185.060;Aminobiphenyl Compounds;D000611
D08.811.913.477.700.200;4-Aminobutyrate Transaminase;D000612
D02.241.081.114.500;Aminobutyrates;D000613
D12.125.190;Aminobutyrates;D000613
D02.241.081.193.150;Aminocaproic Acids;D000614
D12.125.213;Aminocaproic Acids;D000614
D02.705.429.249;Aminoethylphosphonic Acid;D000615
D03.383.621.808.425.100;Aminoglutethimide;D000616
D09.408.051;Aminoglycosides;D000617
D02.065.277.431.192;Aminohippuric Acids;D000618
D02.241.223.100.100.100;Aminohippuric Acids;D000618
D02.241.755.360.192;Aminohippuric Acids;D000618
D02.455.426.559.389.127.085.067;Aminohippuric Acids;D000618
D08.811.277.151;Aminohydrolases;D000619
D03.383.129.308.030;Aminoimidazole Carboxamide;D000620
D02.241.081.114.968.249;Aminoisobutyric Acids;D000621
D12.125.070.075;Aminoisobutyric Acids;D000621
D12.125.190.055;Aminoisobutyric Acids;D000621
D02.241.755.547.276;Aminolevulinic Acid;D000622
D12.125.262;Aminolevulinic Acid;D000622
D08.811.520.241.300.550;Porphobilinogen Synthase;D000623
D08.811.913.050.276;5-Aminolevulinate Synthetase;D000624
D02.092.570.050;Aminooxyacetic Acid;D000625
D02.241.081.018.207;Aminooxyacetic Acid;D000625
D08.811.277.656.350.100;Aminopeptidases;D000626
D02.092.146.100;Aminophenols;D000627
D02.455.426.559.389.657.050;Aminophenols;D000627
D02.092.782.258.368.050;Aminophylline;D000628
D03.438.759.758.824.751.075;Aminophylline;D000628
D02.626.151;Aminopropionitrile;D000629
D03.438.733.631.192;Aminopterin;D000630
D02.092.080;Aminopyridines;D000631
D03.383.725.050;Aminopyridines;D000631
D03.383.129.539.850.077;Aminopyrine;D000632
D08.811.682.662.582.276;Aminopyrine N-Demethylase;D000633
D03.438.810.050;Aminoquinolines;D000634
D03.383.129.462.050;Aminorex;D000635
D02.241.223.100.300.595.100;Aminosalicylic Acids;D000636
D02.241.511.390.595.100;Aminosalicylic Acids;D000636
D02.455.426.559.389.127.281.595.100;Aminosalicylic Acids;D000636
D02.455.426.559.389.657.410.595.100;Aminosalicylic Acids;D000636
D08.811.913.477.700;Transaminases;D000637
D03.438.127.075;Amiodarone;D000638
D02.455.426.559.847.181.384.100;Amitriptyline;D000639
D04.615.181.384.100;Amitriptyline;D000639
D03.383.129.799.100;Amitrole;D000640
D01.362.075;Ammonia;D000641
D01.625.050;Ammonia;D000641
D08.811.520.232.400;Ammonia-Lyases;D000642
D01.210.450.150.050;Ammonium Chloride;D000643
D01.625.075.025;Ammonium Chloride;D000643
D01.625.075;Quaternary Ammonium Compounds;D000644
D02.092.877;Quaternary Ammonium Compounds;D000644
D02.675.276;Quaternary Ammonium Compounds;D000644
D01.625.075.050;Ammonium Sulfate;D000645
D01.875.800.800.850.050;Ammonium Sulfate;D000645
E02.056.020;Ammotherapy;D000646
E02.565.020;Ammotherapy;D000646
E02.779.249.020;Ammotherapy;D000646
E02.779.496.020;Ammotherapy;D000646
C10.597.606.525.100;Amnesia;D000647
C23.888.592.604.529.100;Amnesia;D000647
F01.700.625.100;Amnesia;D000647
F03.087.200;Amnesia;D000647
C10.597.606.525.100.150;Amnesia, Retrograde;D000648
C23.888.592.604.529.100.150;Amnesia, Retrograde;D000648
F01.700.625.100.150;Amnesia, Retrograde;D000648
F03.087.200.150;Amnesia, Retrograde;D000648
E01.370.225.500.384.050;Amniocentesis;D000649
E01.370.225.998.329.309;Amniocentesis;D000649
E01.370.378.630.050;Amniocentesis;D000649
E04.665.600.309;Amniocentesis;D000649
E05.200.500.384.050;Amniocentesis;D000649
E05.200.998.329.309;Amniocentesis;D000649
E05.242.384.050;Amniocentesis;D000649
A10.615.284.277;Amnion;D000650
A16.254.750.277;Amnion;D000650
C16.614.042;Amniotic Band Syndrome;D000652
A12.098;Amniotic Fluid;D000653
A16.378.149;Amniotic Fluid;D000653
D03.383.742.698.253.077;Amobarbital;D000654
D03.438.810.050.060;Amodiaquine;D000655
B01.046.500.100.700.089;Amoeba;D000656
D03.494.347.500.040;Amoxapine;D000657
D02.065.589.099.750.750.050.050;Amoxicillin;D000658
D02.886.108.750.750.050.050;Amoxicillin;D000658
D03.438.260.825.750.050.050;Amoxicillin;D000658
D03.605.084.737.750.050.050;Amoxicillin;D000658
D04.075.080.875.099.221.750.750.050.050;Amoxicillin;D000658
D08.811.277.151.653.060;AMP Deaminase;D000659
D02.092.471.683.152.110;Amphetamine;D000661
D02.092.471.683.152;Amphetamines;D000662
B01.050.150.900.090;Amphibians;D000663
D20.888.033;Amphibian Venoms;D000664
D23.946.833.033;Amphibian Venoms;D000664
D27.720.470.280.060;Ampholyte Mixtures;D000665
D02.540.505.050;Amphotericin B;D000666
D02.065.589.099.750.750.050;Ampicillin;D000667
D02.886.108.750.750.050;Ampicillin;D000667
D03.438.260.825.750.050;Ampicillin;D000667
D03.605.084.737.750.050;Ampicillin;D000667
D04.075.080.875.099.221.750.750.050;Ampicillin;D000667
G06.099.225.500.600.050;Ampicillin Resistance;D000668
G06.225.347.500.600.050;Ampicillin Resistance;D000668
G07.690.320.269.347.500.600.050;Ampicillin Resistance;D000668
E07.305.061;Amplifiers, Electronic;D000669
D03.383.725.676.152;Amprolium;D000670
E04.555.080;Amputation;D000671
A01.378.100;Amputation Stumps;D000672
C26.062;Amputation, Traumatic;D000673
M01.150.100;Amputees;D000674
D03.383.129.539.850.077.025;Ampyrone;D000675
D02.092.080.085;Amrinone;D000676
D03.383.725.050.085;Amrinone;D000676
D03.494.046.250.225;Amsacrine;D000677
D02.626.175;Amygdalin;D000678
D09.408.348.050;Amygdalin;D000678
A08.186.211.464.090;Amygdala;D000679
A08.186.211.730.885.287.249.152;Amygdala;D000679
D02.633.025;Amyl Nitrite;D000680
D08.811.277.450.066;Amylases;D000681
D05.500.049;Amyloid;D000682
D12.776.049;Amyloid;D000682
D12.776.049.407.875;Serum Amyloid P-Component;D000683
D12.776.124.050.730;Serum Amyloid P-Component;D000683
D12.776.395.690;Serum Amyloid P-Component;D000683
D12.776.049.407.750;Serum Amyloid A Protein;D000685
D12.776.124.050.725;Serum Amyloid A Protein;D000685
C18.452.845.500;Amyloidosis;D000686
D09.698.365.855.194;Amylopectin;D000687
D09.698.365.855.361;Amylose;D000688
C10.228.854.139;Amyotrophic Lateral Sclerosis;D000690
C10.574.562.250;Amyotrophic Lateral Sclerosis;D000690
C10.574.950.050;Amyotrophic Lateral Sclerosis;D000690
C10.668.467.250;Amyotrophic Lateral Sclerosis;D000690
C18.452.845.800.050;Amyotrophic Lateral Sclerosis;D000690
D03.132.066;Anabasine;D000691
D03.383.621.050;Anabasine;D000691
G02.111.087.050;Anaerobiosis;D000693
G02.149.115.050;Anaerobiosis;D000693
G03.495.146;Anaerobiosis;D000693
C04.588.083;Anal Gland Neoplasms;D000694
C04.588.274.476.411.307.790.040.040;Anal Gland Neoplasms;D000694
C06.301.371.411.307.790.040.040;Anal Gland Neoplasms;D000694
C06.405.249.411.307.790.040.040;Anal Gland Neoplasms;D000694
C06.405.469.491.307.790.040.040;Anal Gland Neoplasms;D000694
C06.405.469.860.101.163.083;Anal Gland Neoplasms;D000694
C06.405.469.860.180.500.040.040;Anal Gland Neoplasms;D000694
C22.073;Anal Gland Neoplasms;D000694
A13.073;Anal Sacs;D000695
D27.505.696.282;Central Nervous System Stimulants;D000697
D27.505.954.427.220;Central Nervous System Stimulants;D000697
E03.091;Analgesia;D000698
C10.668.829.700;Pain Insensitivity, Congenital;D000699
C16.320.775;Pain Insensitivity, Congenital;D000699
D27.505.696.663.850.014;Analgesics;D000700
D27.505.954.427.040;Analgesics;D000700
D27.505.696.663.850.014.520;Analgesics, Opioid;D000701
D27.505.954.427.040.325;Analgesics, Opioid;D000701
D27.505.954.427.210.049;Analgesics, Opioid;D000701
L01.224.230.260.280.080;Analog-Digital Conversion;D000703
E05.318.740.150;Analysis of Variance;D000704
N05.715.360.750.125;Analysis of Variance;D000704
N06.850.520.830.150;Analysis of Variance;D000704
G04.299.134.220.220.500;Anaphase;D000705
G04.299.134.220.220.781.050;Anaphase;D000705
G05.355.105.220.500;Anaphase;D000705
G05.355.105.220.781.050;Anaphase;D000705
D12.776.124.486.274.024;Anaphylatoxins;D000706
C20.543.480.099;Anaphylaxis;D000707
C04.697.045;Anaplasia;D000708
C23.550.727.045;Anaplasia;D000708
B03.440.040.050;Anaplasma;D000709
B03.660.050.020.050;Anaplasma;D000709
B03.440.040;Anaplasmataceae;D000710
B03.660.050.020;Anaplasmataceae;D000710
C01.252.400.054;Anaplasmataceae Infections;D000711
C01.252.400.054.050;Anaplasmosis;D000712
C01.252.400.825.050;Anaplasmosis;D000712
C22.085;Anaplasmosis;D000712
E04.035.070;Anastomosis, Roux-en-Y;D000713
E04.210.070;Anastomosis, Roux-en-Y;D000713
E04.035;Anastomosis, Surgical;D000714
H01.158.100;Anatomy;D000715
H01.158.100.091;Anatomy, Artistic;D000716
K01.093.410.100;Anatomy, Artistic;D000716
H01.158.100.154;Anatomy, Comparative;D000717
H01.158.100.216;Anatomy, Regional;D000718
H01.158.100.279;Anatomy, Veterinary;D000719
N02.278.354.060;Ancillary Services, Hospital;D000720
N04.452.442.060;Ancillary Services, Hospital;D000720
D08.811.277.656.300.760.955.060;Ancrod;D000721
D08.811.277.656.959.350.955.060;Ancrod;D000721
D20.888.850.960.200.050;Ancrod;D000721
D23.946.833.850.960.200.050;Ancrod;D000721
B01.050.500.500.294.700.775.100.100;Ancylostoma;D000722
B01.050.500.500.294.700.775.100;Ancylostomatoidea;D000723
C03.335.508.700.775.455.154;Ancylostomiasis;D000724
Z01.542.049;Andorra;D000725
D06.347.065;Androgen Antagonists;D000726
D27.505.696.399.450.065;Androgen Antagonists;D000726
D12.776.157.065;Androgen-Binding Protein;D000727
D27.505.696.399.472.161;Androgens;D000728
D04.808.054.079.129;Androstadienes;D000730
D04.808.054;Androstanes;D000731
D04.808.054.040;Androstanols;D000732
D04.808.054.079.229;Androstatrienes;D000733
D04.808.054.079.429.154;Androstenediols;D000734
D04.808.054.079.329;Androstenedione;D000735
D04.808.578.502.112;Androstenedione;D000735
D06.472.040.502.112;Androstenedione;D000735
D06.472.334.851.968.875;Androstenedione;D000735
D04.808.054.079;Androstenes;D000736
D04.808.054.079.429;Androstenols;D000737
D04.808.054.040.129;Androsterone;D000738
D04.808.578.502.195;Androsterone;D000738
D06.472.040.502.195;Androsterone;D000738
D06.472.334.851.968.937;Androsterone;D000738
K01.517.067;Anecdotes as Topic;D000739
C15.378.071;Anemia;D000740
C15.378.071.085;Anemia, Aplastic;D000741
C15.378.190.196;Anemia, Aplastic;D000741
C15.378.071.141.150.095;Anemia, Dyserythropoietic, Congenital;D000742
C16.320.070.095;Anemia, Dyserythropoietic, Congenital;D000742
C15.378.071.141;Anemia, Hemolytic;D000743
C15.378.071.141.125;Anemia, Hemolytic, Autoimmune;D000744
C20.111.175;Anemia, Hemolytic, Autoimmune;D000744
C15.378.071.141.150;Anemia, Hemolytic, Congenital;D000745
C16.320.070;Anemia, Hemolytic, Congenital;D000745
C15.378.071.141.150.100;Anemia, Hemolytic, Congenital Nonspherocytic;D000746
C16.320.070.100;Anemia, Hemolytic, Congenital Nonspherocytic;D000746
C15.378.071.196;Anemia, Hypochromic;D000747
C15.378.071.252;Anemia, Macrocytic;D000748
C15.378.071.252.196;Anemia, Megaloblastic;D000749
C15.378.071.307;Anemia, Myelophthisic;D000750
C15.378.190.636.085;Anemia, Myelophthisic;D000750
C15.378.071.363;Anemia, Neonatal;D000751
C16.614.053;Anemia, Neonatal;D000751
C15.378.071.252.196.500;Anemia, Pernicious;D000752
C18.654.521.500.133.699.923.280;Anemia, Pernicious;D000752
C15.378.071.400;Anemia, Refractory;D000753
C15.378.190.625.062;Anemia, Refractory;D000753
C15.378.071.400.080;Anemia, Refractory, with Excess of Blasts;D000754
C15.378.190.625.062.080;Anemia, Refractory, with Excess of Blasts;D000754
C15.378.071.141.150.150;Anemia, Sickle Cell;D000755
C15.378.420.155;Anemia, Sickle Cell;D000755
C16.320.070.150;Anemia, Sickle Cell;D000755
C16.320.365.155;Anemia, Sickle Cell;D000755
C15.378.071.419;Anemia, Sideroblastic;D000756
C15.378.190.625.070;Anemia, Sideroblastic;D000756
C10.500.680.196;Anencephaly;D000757
C16.131.085.197;Anencephaly;D000757
C16.131.666.680.196;Anencephaly;D000757
E03.155;Anesthesia;D000758
D27.505.954.427.010;Adjuvants, Anesthesia;D000759
E03;Anesthesia and Analgesia;D000760
N02.278.354.422.070;Anesthesia Department, Hospital;D000761
N04.452.442.422.070;Anesthesia Department, Hospital;D000761
E03.160;Anesthesia Recovery Period;D000762
E04.614.750.055;Anesthesia Recovery Period;D000762
N02.421.585.753.750.055;Anesthesia Recovery Period;D000762
E03.155.086.131.100;Anesthesia, Caudal;D000763
E03.155.197.197.280;Anesthesia, Closed-Circuit;D000764
E03.155.086;Anesthesia, Conduction;D000765
E03.155.141;Anesthesia, Dental;D000766
E06.045;Anesthesia, Dental;D000766
E03.155.086.131;Anesthesia, Epidural;D000767
E03.155.197;Anesthesia, General;D000768
E03.155.197.197;Anesthesia, Inhalation;D000769
E03.155.253;Anesthesia, Intratracheal;D000770
E03.155.308;Anesthesia, Intravenous;D000771
E03.155.086.231;Anesthesia, Local;D000772
E03.155.364;Anesthesia, Obstetrical;D000773
E03.155.197.364;Anesthesia, Rectal;D000774
E03.155.086.331;Anesthesia, Spinal;D000775
H02.403.066;Anesthesiology;D000776
D27.505.696.277.100;Anesthetics;D000777
D27.505.954.427.210.100;Anesthetics;D000777
D27.505.696.277.100.035.075.035;Anesthetics, Dissociative;D000778
D27.505.954.427.210.100.035.075.035;Anesthetics, Dissociative;D000778
D27.505.696.277.100.200;Anesthetics, Local;D000779
D27.505.696.663.850.025;Anesthetics, Local;D000779
D27.505.954.427.210.100.200;Anesthetics, Local;D000779
G08.686.195.249;Anestrus;D000780
D02.355.601.200.100;Anethole Trithione;D000781
D02.355.726.158.100;Anethole Trithione;D000781
D02.455.426.559.389.657.654.158.100;Anethole Trithione;D000781
D02.886.753.077;Anethole Trithione;D000781
C23.550.210.050;Aneuploidy;D000782
G05.365.590.175.050;Aneuploidy;D000782
G05.700.131;Aneuploidy;D000782
C14.907.055;Aneurysm;D000783
C14.907.055.050;Aneurysm, Dissecting;D000784
C01.539.069;Aneurysm, Infected;D000785
C14.907.055.131;Aneurysm, Infected;D000785
F01.470.093;Anger;D000786
C14.280.647.187;Angina Pectoris;D000787
C14.907.585.187;Angina Pectoris;D000787
C23.888.646.215.500;Angina Pectoris;D000787
C14.280.647.187.150.150;Angina Pectoris, Variant;D000788
C14.907.585.187.150.500;Angina Pectoris, Variant;D000788
C23.888.646.215.500.150.150;Angina Pectoris, Variant;D000788
C14.280.647.187.150;Angina, Unstable;D000789
C14.907.585.187.150;Angina, Unstable;D000789
C23.888.646.215.500.150;Angina, Unstable;D000789
E01.370.350.130.249;Angiocardiography;D000790
E01.370.350.700.060.050;Angiocardiography;D000790
E01.370.370.050.050;Angiocardiography;D000790
E01.370.370.380.050;Angiocardiography;D000790
E01.370.350.700.060;Angiography;D000792
E01.370.370.050;Angiography;D000792
C11.768.094;Angioid Streaks;D000793
C04.557.645.115;Angiokeratoma;D000794
C10.228.140.163.100.435.825.200;Fabry Disease;D000795
C10.228.140.300.275.374;Fabry Disease;D000795
C14.907.253.329.374;Fabry Disease;D000795
C16.320.322.124;Fabry Disease;D000795
C16.320.565.189.435.825.200;Fabry Disease;D000795
C16.320.565.398.641.803.300;Fabry Disease;D000795
C16.320.565.595.554.825.200;Fabry Disease;D000795
C18.452.132.100.435.825.200;Fabry Disease;D000795
C18.452.584.687.803.300;Fabry Disease;D000795
C18.452.648.189.435.825.200;Fabry Disease;D000795
C18.452.648.398.641.803.300;Fabry Disease;D000795
C18.452.648.595.554.825.200;Fabry Disease;D000795
C15.378.553.231.085;Angiolymphoid Hyperplasia with Eosinophilia;D000796
C15.604.515.292.007;Angiolymphoid Hyperplasia with Eosinophilia;D000796
C17.800.060;Angiolymphoid Hyperplasia with Eosinophilia;D000796
C14.907.077;Angiomatosis;D000798
C14.907.079;Angioedema;D000799
C17.800.862.945.066;Angioedema;D000799
C20.543.480.904.066;Angioedema;D000799
E02.148.050.060;Angioplasty, Balloon;D000800
E04.100.814.529.124.060;Angioplasty, Balloon;D000800
E04.800.382.124.060;Angioplasty, Balloon;D000800
B01.050.500.500.294.700.775.588.080;Angiostrongylus;D000801
D12.644.456.073.041.050;Angiotensin Amide;D000802
D23.469.050.050.050.050;Angiotensin Amide;D000802
D06.472.699.094.075;Angiotensin I;D000803
D12.644.400.070.075;Angiotensin I;D000803
D12.644.456.073.021;Angiotensin I;D000803
D12.644.548.058.075;Angiotensin I;D000803
D12.776.641.650.070.075;Angiotensin I;D000803
D23.469.050.050.025;Angiotensin I;D000803
D06.472.699.094.078;Angiotensin II;D000804
D12.644.400.070.078;Angiotensin II;D000804
D12.644.456.073.041;Angiotensin II;D000804
D12.644.548.058.078;Angiotensin II;D000804
D12.776.641.650.070.078;Angiotensin II;D000804
D23.469.050.050.050;Angiotensin II;D000804
D06.472.699.094.080;Angiotensin III;D000805
D12.644.400.070.080;Angiotensin III;D000805
D12.644.456.073.055;Angiotensin III;D000805
D12.644.548.058.080;Angiotensin III;D000805
D12.776.641.650.070.080;Angiotensin III;D000805
D23.469.050.050.075;Angiotensin III;D000805
D27.505.519.389.745.085;Angiotensin-Converting Enzyme Inhibitors;D000806
D12.644.456.073.070;Angiotensinogen;D000808
D12.644.822.750.020;Angiotensinogen;D000808
D12.644.861.020;Angiotensinogen;D000808
D12.776.645.750.020;Angiotensinogen;D000808
D12.776.811.070;Angiotensinogen;D000808
D12.776.872.020;Angiotensinogen;D000808
D06.472.699.094;Angiotensins;D000809
D12.644.400.070;Angiotensins;D000809
D12.644.456.073;Angiotensins;D000809
D12.644.548.058;Angiotensins;D000809
D12.776.641.650.070;Angiotensins;D000809
D23.469.050.050;Angiotensins;D000809
Z01.058.290.175.095;Angola;D000810
B01.050.150.900.493.338.282;Anguilla;D000811
D02.113;Anhydrides;D000812
D02.065.199;Anilides;D000813
D02.092.146;Aniline Compounds;D000814
D08.244.453.040.050;Aniline Hydroxylase;D000815
D08.811.682.690.708.170.040.050;Aniline Hydroxylase;D000815
D12.776.422.220.453.040.050;Aniline Hydroxylase;D000815
D02.455.526.728.650.050;Aniline Mustard;D000816
D02.092.146.125;Anilino Naphthalenesulfonates;D000817
D02.455.426.559.847.638.555.282;Anilino Naphthalenesulfonates;D000817
D02.886.645.600.080.050.650.050;Anilino Naphthalenesulfonates;D000817
D04.615.638.555.282;Anilino Naphthalenesulfonates;D000817
B01.050;Animals;D000818
F01.145.113.055;Animal Communication;D000819
C22;Animal Diseases;D000820
J02.500.300.100;Animal Feed;D000821
J01.040.090;Animal Husbandry;D000822
E05.035;Animal Identification Systems;D000823
G07.610.161;Animal Nutritional Physiological Phenomena;D000824
A13;Animal Structures;D000825
E05.017.080.100;Animal Testing Alternatives;D000826
I01.880.604.100;Animal Welfare;D000827
B01.050.050;Animal Population Groups;D000828
B01.050.050.116;Animals, Domestic;D000829
B01.050.050.199;Animals, Laboratory;D000830
B01.050.050.282;Animals, Newborn;D000831
B01.050.050.286;Animals, Poisonous;D000832
B01.050.050.293;Animals, Suckling;D000833
B01.050.050.300;Animals, Wild;D000835
B01.050.050.448;Animals, Zoo;D000836
D27.720.470.420.050;Anion Exchange Resins;D000837
D01.248.497.158;Anions;D000838
C11.744.116;Aniseikonia;D000839
D02.355.601.200;Anisoles;D000840
D02.355.726.158;Anisoles;D000840
D02.455.426.559.389.657.654.158;Anisoles;D000840
D03.383.773.050;Anisomycin;D000841
A01.378.610.250.149;Ankle;D000842
A02.835.583.378.062;Ankle Joint;D000843
C05.550.069;Ankylosis;D000844
B01.050.500.091;Annelida;D000845
K01.400.095;Anniversaries and Special Events;D000846
N04.452.822.070;Anniversaries and Special Events;D000846
N04.452.070;Annual Reports as Topic;D000847
C07.650.800.100;Anodontia;D000848
C07.793.700.100;Anodontia;D000848
C16.131.850.800.100;Anodontia;D000848
C10.597.606.150.500.090;Anomia;D000849
C23.888.592.604.150.500.090;Anomia;D000849
F01.145.813.093;Anomie;D000850
I01.880.578.283;Anomie;D000850
L01.143.506.598.400.556.283;Anonyms and Pseudonyms;D000851
B01.050.500.131.617.289.275.120;Anopheles;D000852
C11.250.080;Anophthalmos;D000853
C16.131.384.159;Anophthalmos;D000853
B01.050.500.131.617.690.060;Anoplura;D000854
C23.888.821.108;Anorexia;D000855
F03.375.100;Anorexia Nervosa;D000856
C10.597.751.600;Olfaction Disorders;D000857
C23.888.592.763.550;Olfaction Disorders;D000857
C13.351.500.056.630.050;Anovulation;D000858
C19.391.630.050;Anovulation;D000858
G08.686.785.760.690.080;Anovulation;D000858
C23.888.852.079;Anoxia;D000860
D12.644.456.345.159;Anserine;D000861
D20.888.065.055;Ant Venoms;D000862
D23.946.833.065.055;Ant Venoms;D000862
D27.505.519.170;Antacids;D000863
Z01.158;Antarctic Regions;D000864
Z01.639.019;Antarctic Regions;D000864
D03.383.129.308.040;Antazoline;D000865
B01.050.150.900.649.077.380.100;Antelopes;D000866
A09.371.060.067;Anterior Chamber;D000867
C05.651.180.063;Anterior Compartment Syndrome;D000868
C14.907.303.063;Anterior Compartment Syndrome;D000868
A09.371.060;Anterior Eye Segment;D000869
A08.186.854.080;Anterior Horn Cells;D000870
A08.663.655.500.050;Anterior Horn Cells;D000870
A11.671.655.500.050;Anterior Horn Cells;D000870
D27.505.954.122.250.075;Anthelmintics;D000871
D03.438.150.266.450.087;Anthocyanins;D000872
D03.830.219.266.450.087;Anthocyanins;D000872
D09.408.084;Anthocyanins;D000872
D23.767.124;Anthocyanins;D000872
D02.455.426.559.847.117;Anthracenes;D000873
D04.615.117;Anthracenes;D000873
C08.381.483.581.062.500;Anthracosilicosis;D000874
C08.381.483.581.760.125;Anthracosilicosis;D000874
C08.381.520.702.062.500;Anthracosilicosis;D000874
C08.381.520.702.760.125;Anthracosilicosis;D000874
C24.800.834.201;Anthracosilicosis;D000874
D02.455.426.559.847.117.050;Anthralin;D000875
D04.615.117.050;Anthralin;D000875
D03.438.079.080.070.050;Anthramycin;D000876
D03.494.060;Anthramycin;D000876
D08.811.600.075;Anthranilate Phosphoribosyltransferase;D000877
D08.811.913.400.725.160;Anthranilate Phosphoribosyltransferase;D000877
D08.811.520.224.600.200;Anthranilate Synthase;D000878
D08.811.600.085;Anthranilate Synthase;D000878
D02.455.426.559.847.117.159;Anthraquinones;D000880
D02.806.100;Anthraquinones;D000880
D04.615.117.159;Anthraquinones;D000880
C01.252.410.090.072;Anthrax;D000881
B01.050.150.900.649.801.400;Haplorhini;D000882
F04.096.879.201;Anthropology;D000883
I01.076;Anthropology;D000883
I01.076.201;Anthropology, Cultural;D000884
I01.076.368;Anthropology, Physical;D000885
E01.370.600.024;Anthropometry;D000886
E05.041;Anthropometry;D000886
N06.850.505.200.100;Anthropometry;D000886
E02.190.088;Anthroposophy;D000887
K01.844.058;Anthroposophy;D000887
D12.776.124.486.485.114.071;Antibodies, Anti-Idiotypic;D000888
D12.776.124.790.651.114.071;Antibodies, Anti-Idiotypic;D000888
D12.776.377.715.548.114.071;Antibodies, Anti-Idiotypic;D000888
D27.505.954.411.097;Anti-Arrhythmia Agents;D000889
D27.505.954.122;Anti-Infective Agents;D000890
D27.505.954.122.187;Anti-Infective Agents, Local;D000891
D27.505.954.122.237;Anti-Infective Agents, Urinary;D000892
D27.505.954.613.056;Anti-Infective Agents, Urinary;D000892
D27.505.954.158;Anti-Inflammatory Agents;D000893
D27.505.696.663.850.014.040.500;Anti-Inflammatory Agents, Non-Steroidal;D000894
D27.505.954.158.030;Anti-Inflammatory Agents, Non-Steroidal;D000894
D27.505.954.329.030;Anti-Inflammatory Agents, Non-Steroidal;D000894
D27.505.954.483.203;Anti-Ulcer Agents;D000897
G06.590.580.050;Antibiosis;D000898
G16.100.065;Antibiosis;D000898
D02.455.326.271.665.155;Aurodox;D000899
D27.505.954.122.085;Anti-Bacterial Agents;D000900
D27.505.954.248.106;Antibiotics, Antineoplastic;D000903
D27.505.954.122.085.089;Antibiotics, Antitubercular;D000904
D27.505.954.122.085.255.135;Antibiotics, Antitubercular;D000904
D12.776.124.486.485.114;Antibodies;D000906
D12.776.124.790.651.114;Antibodies;D000906
D12.776.377.715.548.114;Antibodies;D000906
D12.776.124.486.485.114.107;Antibodies, Bacterial;D000907
D12.776.124.790.651.114.125;Antibodies, Bacterial;D000907
D12.776.377.715.548.114.125;Antibodies, Bacterial;D000907
D12.776.124.486.485.114.179;Antibodies, Fungal;D000908
D12.776.124.790.651.114.179;Antibodies, Fungal;D000908
D12.776.377.715.548.114.179;Antibodies, Fungal;D000908
D12.776.124.486.485.114.185;Antibodies, Helminth;D000909
D12.776.124.790.651.114.185;Antibodies, Helminth;D000909
D12.776.377.715.548.114.185;Antibodies, Helminth;D000909
D12.776.124.486.485.114.191;Antibodies, Heterophile;D000910
D12.776.124.790.651.114.191;Antibodies, Heterophile;D000910
D12.776.377.715.548.114.191;Antibodies, Heterophile;D000910
D12.776.124.486.485.114.224;Antibodies, Monoclonal;D000911
D12.776.124.790.651.114.224;Antibodies, Monoclonal;D000911
D12.776.377.715.548.114.224;Antibodies, Monoclonal;D000911
D12.776.124.486.485.114.240;Antibodies, Neoplasm;D000912
D12.776.124.790.651.114.240;Antibodies, Neoplasm;D000912
D12.776.377.715.548.114.240;Antibodies, Neoplasm;D000912
D12.776.124.486.485.114.252;Antibodies, Protozoan;D000913
D12.776.124.790.651.114.252;Antibodies, Protozoan;D000913
D12.776.377.715.548.114.252;Antibodies, Protozoan;D000913
D12.776.124.486.485.114.254;Antibodies, Viral;D000914
D12.776.124.790.651.114.254;Antibodies, Viral;D000914
D12.776.377.715.548.114.254;Antibodies, Viral;D000914
G12.040;Antibody Affinity;D000915
G12.425.143.125;Antibody Affinity;D000915
G05.365.036;Antibody Diversity;D000916
G12.051;Antibody Diversity;D000916
G12.500.199;Antibody Diversity;D000916
G12.425.071;Antibody Formation;D000917
G12.100;Antibody Specificity;D000918
E01.370.225.500.607.512.240.149;Antibody-Coated Bacteria Test, Urinary;D000919
E01.370.225.750.551.512.240.149;Antibody-Coated Bacteria Test, Urinary;D000919
E01.370.225.812.049;Antibody-Coated Bacteria Test, Urinary;D000919
E01.370.390.050;Antibody-Coated Bacteria Test, Urinary;D000919
E05.200.500.607.512.240.149;Antibody-Coated Bacteria Test, Urinary;D000919
E05.200.750.551.512.240.149;Antibody-Coated Bacteria Test, Urinary;D000919
E05.200.812.049;Antibody-Coated Bacteria Test, Urinary;D000919
E05.478.412.050;Antibody-Coated Bacteria Test, Urinary;D000919
E05.478.583.375.050;Antibody-Coated Bacteria Test, Urinary;D000919
E05.478.594.049;Antibody-Coated Bacteria Test, Urinary;D000919
G12.425.270.070;Antibody-Dependent Cell Cytotoxicity;D000920
A11.063;Antibody-Producing Cells;D000921
A15.382.032;Antibody-Producing Cells;D000921
D12.776.124.486.485.114.580.450;Immunotoxins;D000922
D12.776.124.790.651.114.580.450;Immunotoxins;D000922
D12.776.377.715.548.114.580.450;Immunotoxins;D000922
D27.888.569.271;Immunotoxins;D000922
D27.505.954.122.250.075.100.040;Anticestodal Agents;D000923
D27.505.519.186.071.202;Anticholesteremic Agents;D000924
D27.505.954.557.500.202;Anticholesteremic Agents;D000924
D27.505.954.502.119;Anticoagulants;D000925
D13.444.735.757.286;Anticodon;D000926
G05.360.335.060;Anticodon;D000926
D27.505.954.427.080;Anticonvulsants;D000927
D27.505.954.427.700.122;Antidepressive Agents;D000928
D27.505.954.427.700.122.055;Antidepressive Agents, Tricyclic;D000929
D27.505.954.483.161;Antidiarrheals;D000930
D27.505.696.706.037;Antidotes;D000931
D27.720.799.037;Antidotes;D000931
D27.505.696.663.050.030;Antiemetics;D000932
D27.505.954.427.095;Antiemetics;D000932
D27.505.954.483.200;Antiemetics;D000932
D27.505.519.421.500;Antifibrinolytic Agents;D000933
D27.505.954.502.270.463.091;Antifibrinolytic Agents;D000933
D27.720.877.048;Antifoaming Agents;D000934
D27.505.954.122.136;Antifungal Agents;D000935
D12.776.124.486.485.114.257;Antigen-Antibody Complex;D000936
D12.776.124.790.651.114.257;Antigen-Antibody Complex;D000936
D12.776.377.715.548.114.257;Antigen-Antibody Complex;D000936
D23.050.101;Antigen-Antibody Complex;D000936
G12.425.143;Antigen-Antibody Reactions;D000937
A11.066;Antigen-Presenting Cells;D000938
A15.382.066;Antigen-Presenting Cells;D000938
D23.050.550;Epitopes;D000939
G05.365.073;Antigenic Variation;D000940
G12.500.249;Antigenic Variation;D000940
D23.050;Antigens;D000941
D23.050.161;Antigens, Bacterial;D000942
D23.050.301.264;Antigens, Differentiation;D000943
D23.101.100;Antigens, Differentiation;D000943
D23.050.301.264.051;Antigens, Differentiation, B-Lymphocyte;D000944
D23.101.100.150;Antigens, Differentiation, B-Lymphocyte;D000944
D23.050.301.264.894;Antigens, Differentiation, T-Lymphocyte;D000945
D23.101.100.894;Antigens, Differentiation, T-Lymphocyte;D000945
D23.050.202;Antigens, Fungal;D000946
D23.050.223;Antigens, Helminth;D000947
D12.776.395.550.509;Histocompatibility Antigens Class II;D000949
D12.776.543.550.423;Histocompatibility Antigens Class II;D000949
D23.050.301.500.400;Histocompatibility Antigens Class II;D000949
D23.050.705.552.410;Histocompatibility Antigens Class II;D000949
D23.050.301.264.920;Antigens, Ly;D000950
D23.101.100.920;Antigens, Ly;D000950
D23.050.285;Antigens, Neoplasm;D000951
D12.776.624.664.520.090;Antigens, Polyomavirus Transforming;D000952
D12.776.964.700.090;Antigens, Polyomavirus Transforming;D000952
D23.050.285.062.090;Antigens, Polyomavirus Transforming;D000952
D23.050.327.062.090;Antigens, Polyomavirus Transforming;D000952
D23.050.293;Antigens, Protozoan;D000953
D23.050.301;Antigens, Surface;D000954
D23.050.324;Antigens, T-Independent;D000955
D23.050.327;Antigens, Viral;D000956
D23.050.285.062;Antigens, Viral, Tumor;D000957
D23.050.327.062;Antigens, Viral, Tumor;D000957
Z01.107.084.900.050;Antigua and Barbuda;D000958
Z01.639.880.050;Antigua and Barbuda;D000958
D27.505.954.411.162;Antihypertensive Agents;D000959
D27.505.519.186.071;Hypolipidemic Agents;D000960
D27.505.954.557.500;Hypolipidemic Agents;D000960
A12.207.152.846.500.203;Antilymphocyte Serum;D000961
D12.776.124.486.485.114.573.203;Antilymphocyte Serum;D000961
D12.776.124.790.651.114.573.203;Antilymphocyte Serum;D000961
D12.776.377.715.548.114.573.203;Antilymphocyte Serum;D000961
D20.215.401.203;Antilymphocyte Serum;D000961
D27.505.954.122.250.100.085;Antimalarials;D000962
D27.505.519.186;Antimetabolites;D000963
D27.888.569.042;Antimetabolites;D000963
D27.505.519.186.144;Antimetabolites, Antineoplastic;D000964
D27.505.954.248.144;Antimetabolites, Antineoplastic;D000964
D27.888.569.042.030;Antimetabolites, Antineoplastic;D000964
D01.268.513.124;Antimony;D000965
D01.268.556.050;Antimony;D000965
D01.552.544.050;Antimony;D000965
D02.691.075;Antimony Potassium Tartrate;D000966
D02.241.081.844.322.060;Antimony Sodium Gluconate;D000967
D02.241.511.902.322.060;Antimony Sodium Gluconate;D000967
D02.691.080;Antimony Sodium Gluconate;D000967
D09.811.308.060;Antimony Sodium Gluconate;D000967
D02.540.505.075;Antimycin A;D000968
D27.505.954.122.250.075.080;Antinematodal Agents;D000969
D27.505.954.248;Antineoplastic Agents;D000970
E02.183.750.500;Antineoplastic Combined Chemotherapy Protocols;D000971
E02.319.077.500;Antineoplastic Combined Chemotherapy Protocols;D000971
E02.319.310.037;Antineoplastic Combined Chemotherapy Protocols;D000971
D27.505.954.248.179;Antineoplastic Agents, Phytogenic;D000972
D12.776.124.486.485.114.323.204;Antibodies, Antinuclear;D000974
D12.776.124.790.651.114.323.204;Antibodies, Antinuclear;D000974
D12.776.377.715.548.114.323.204;Antibodies, Antinuclear;D000974
D27.505.519.217;Antioxidants;D000975
D27.505.696.706.125;Antioxidants;D000975
D27.720.799.047;Antioxidants;D000975
D12.644.456.120;Antipain;D000976
D27.505.954.122.250;Antiparasitic Agents;D000977
D27.505.954.427.090.050;Antiparkinson Agents;D000978
D12.644.822.750.050;alpha-2-Antiplasmin;D000979
D12.644.861.050;alpha-2-Antiplasmin;D000979
D12.776.124.790.106.118;alpha-2-Antiplasmin;D000979
D12.776.377.715.085.118;alpha-2-Antiplasmin;D000979
D12.776.395.080;alpha-2-Antiplasmin;D000979
D12.776.645.750.050;alpha-2-Antiplasmin;D000979
D12.776.872.050;alpha-2-Antiplasmin;D000979
D27.505.954.122.250.075.100;Antiplatyhelmintic Agents;D000980
D27.505.954.122.250.100;Antiprotozoal Agents;D000981
D27.505.954.444.075;Antipruritics;D000982
D03.383.129.539.850.088;Antipyrine;D000983
N06.850.780.200.450.150;Antisepsis;D000985
D27.505.954.502.135;Antisickling Agents;D000986
F03.675.050;Antisocial Personality Disorder;D000987
D27.505.696.138;Antispermatogenic Agents;D000988
D27.505.696.875.360.443.068;Antispermatogenic Agents;D000988
D27.505.954.705.360.443.068;Antispermatogenic Agents;D000988
D27.888.569.071;Antispermatogenic Agents;D000988
D12.776.124.486.485.114.107.288;Antistreptolysin;D000989
D12.776.124.790.651.114.125.288;Antistreptolysin;D000989
D12.776.377.715.548.114.125.288;Antistreptolysin;D000989
D12.644.822.750.060.500;Antithrombin III;D000990
D12.644.861.060.500;Antithrombin III;D000990
D12.776.124.790.106.125;Antithrombin III;D000990
D12.776.377.715.085.125;Antithrombin III;D000990
D12.776.645.750.060.500;Antithrombin III;D000990
D12.776.872.060.500;Antithrombin III;D000990
D23.113.025;Antithrombin III;D000990
D27.505.519.389.745.800.449;Antithrombins;D000991
D27.505.954.502.119.500;Antithrombins;D000991
D12.776.124.486.485.114.301;Antitoxins;D000992
D12.776.124.486.485.114.573.601;Antitoxins;D000992
D12.776.124.790.651.114.301;Antitoxins;D000992
D12.776.377.715.548.114.301;Antitoxins;D000992
D20.215.121;Antitoxins;D000992
D27.505.954.122.085.222;Antitreponemal Agents;D000993
D27.505.954.122.250.100.115;Antitrichomonal Agents;D000994
D27.505.954.122.085.255;Antitubercular Agents;D000995
D27.505.954.427.153;Antitussive Agents;D000996
D27.505.954.796.090;Antitussive Agents;D000996
D12.776.124.486.485.114.301.138;Antivenins;D000997
D12.776.124.486.485.114.573.601.138;Antivenins;D000997
D12.776.124.790.651.114.301.138;Antivenins;D000997
D12.776.377.715.548.114.301.138;Antivenins;D000997
D20.215.121.163;Antivenins;D000997
D27.505.954.122.388;Antiviral Agents;D000998
A13.507.288;Antlers;D000999
B01.050.500.131.617.479.205;Ants;D001000
B01.050.150.900.090.180;Anura;D001001
C12.777.419.078;Anuria;D001002
C12.777.934.141;Anuria;D001002
C13.351.968.419.078;Anuria;D001002
C13.351.968.934.070;Anuria;D001002
A03.556.124.526.070;Anal Canal;D001003
A03.556.249.249.070;Anal Canal;D001003
C06.405.469.860.101;Anus Diseases;D001004
C04.588.274.476.411.307.790.040;Anus Neoplasms;D001005
C06.301.371.411.307.790.040;Anus Neoplasms;D001005
C06.405.249.411.307.790.040;Anus Neoplasms;D001005
C06.405.469.491.307.790.040;Anus Neoplasms;D001005
C06.405.469.860.101.163;Anus Neoplasms;D001005
C06.405.469.860.180.500.040;Anus Neoplasms;D001005
C06.198.050;Anus, Imperforate;D001006
C16.131.314.094;Anus, Imperforate;D001006
F01.470.132;Anxiety;D001007
F03.080;Anxiety Disorders;D001008
F01.470.132.150;Anxiety, Castration;D001009
F03.550.075;Anxiety, Separation;D001010
A07.231.114.056;Aorta;D001011
A07.231.114.056.205;Aorta, Abdominal;D001012
A07.231.114.056.372;Aorta, Thoracic;D001013
C14.907.055.239;Aortic Aneurysm;D001014
C14.907.109.139;Aortic Aneurysm;D001014
C14.907.109.239;Aortic Arch Syndromes;D001015
A08.663.650.915.500.600.050;Aortic Bodies;D001016
A08.800.950.500.600.050;Aortic Bodies;D001016
A11.671.650.915.500.600.050;Aortic Bodies;D001016
C14.240.400.090;Aortic Coarctation;D001017
C14.280.400.090;Aortic Coarctation;D001017
C16.131.240.400.090;Aortic Coarctation;D001017
C14.907.109;Aortic Diseases;D001018
C14.907.055.185.125;Aortic Rupture;D001019
C14.907.055.239.175;Aortic Rupture;D001019
C14.907.109.139.175;Aortic Rupture;D001019
C26.761.125;Aortic Rupture;D001019
C14.280.484.150.070;Aortic Stenosis, Subvalvular;D001020
C14.280.955.249.070;Aortic Stenosis, Subvalvular;D001020
A07.541.510.110;Aortic Valve;D001021
C14.280.484.095;Aortic Valve Insufficiency;D001022
C14.280.484.400.100;Aortic Valve Prolapse;D001023
C14.280.484.150;Aortic Valve Stenosis;D001024
C14.280.955.249;Aortic Valve Stenosis;D001024
C14.907.109.320;Aortitis;D001025
C14.907.940.080;Aortitis;D001025
E04.100.376.719.332;Coronary Artery Bypass;D001026
E04.100.814.868.750;Coronary Artery Bypass;D001026
E04.928.220.520.220;Coronary Artery Bypass;D001026
E01.370.350.700.060.070;Aortography;D001027
E01.370.370.050.070;Aortography;D001027
C14.240.400.560.098;Aortopulmonary Septal Defect;D001028
C14.280.400.560.098;Aortopulmonary Septal Defect;D001028
C16.131.240.400.560.098;Aortopulmonary Septal Defect;D001028
B01.050.150.900.649.801.400.600.037.092;Aotus trivirgatus;D001029
D20.888.065.115.060;Apamin;D001030
D23.946.833.065.115.060;Apamin;D001030
D01.146.360.050;Apatites;D001031
D01.578.122;Apatites;D001031
D01.695.625.675.650.075.025;Apatites;D001031
D03.383.931.190;Apazone;D001032
E01.370.600.050;Apgar Score;D001034
C11.510.103;Aphakia;D001035
C11.510.103.110;Aphakia, Postcataract;D001036
C10.597.606.150.500.800.100;Aphasia;D001037
C23.888.592.604.150.500.800.100;Aphasia;D001037
C10.597.606.150.500.800.100.100;Aphasia, Broca;D001039
C23.888.592.604.150.500.800.100.100;Aphasia, Broca;D001039
C10.597.606.150.500.800.100.166;Aphasia, Wernicke;D001041
C23.888.592.604.150.500.800.100.166;Aphasia, Wernicke;D001041
B01.050.500.131.617.412.165;Aphids;D001042
C08.360.940.160;Aphonia;D001044
C09.400.940.160;Aphonia;D001044
C10.597.975.100;Aphonia;D001044
C23.888.592.979.100;Aphonia;D001044
K01.517.116;Aphorisms and Proverbs as Topic;D001045
D27.505.696.282.045;Aphrodisiacs;D001046
D27.505.954.427.220.045;Aphrodisiacs;D001046
E04.545.100;Apicoectomy;D001047
E06.397.102;Apicoectomy;D001047
E06.645.100;Apicoectomy;D001047
B01.050.500.644.400.060;Aplysia;D001048
C08.618.085;Apnea;D001049
C23.888.852.130;Apnea;D001049
A10.336.899.206;Apocrine Glands;D001050
A17.815.830.206;Apocrine Glands;D001050
D08.811.255.500;Apoenzymes;D001051
D12.776.070.290;Apoenzymes;D001051
D12.776.070.345;Apoferritins;D001052
D12.776.157.427.249.290;Apoferritins;D001052
D12.776.556.579.249.290;Apoferritins;D001052
D10.532.091;Apolipoproteins;D001053
D12.776.070.400;Apolipoproteins;D001053
D12.776.521.120;Apolipoproteins;D001053
D10.532.091.200;Apolipoproteins A;D001054
D12.776.070.400.200;Apolipoproteins A;D001054
D12.776.521.120.200;Apolipoproteins A;D001054
D10.532.091.300;Apolipoproteins B;D001055
D12.776.070.400.300;Apolipoproteins B;D001055
D12.776.521.120.300;Apolipoproteins B;D001055
D10.532.091.400;Apolipoproteins C;D001056
D12.776.070.400.400;Apolipoproteins C;D001056
D12.776.521.120.400;Apolipoproteins C;D001056
D10.532.091.500;Apolipoproteins E;D001057
D12.776.070.400.500;Apolipoproteins E;D001057
D12.776.521.120.500;Apolipoproteins E;D001057
D03.132.098.038.290;Apomorphine;D001058
D03.438.531.085.030.290;Apomorphine;D001058
D03.549.095.290;Apomorphine;D001058
D12.776.070;Apoproteins;D001059
D03.132.098.038;Aporphines;D001060
D03.438.531.085.030;Aporphines;D001060
D03.549.095;Aporphines;D001060
Z01.107.567.875.075;Appalachian Region;D001061
E04.210.078;Appendectomy;D001062
C04.588.274.476.411.184.290;Appendiceal Neoplasms;D001063
C06.301.371.411.184.290;Appendiceal Neoplasms;D001063
C06.405.249.411.184.290;Appendiceal Neoplasms;D001063
C06.405.469.110.417.290;Appendiceal Neoplasms;D001063
C06.405.469.491.184.290;Appendiceal Neoplasms;D001063
C01.539.463.099;Appendicitis;D001064
C06.405.205.099;Appendicitis;D001064
C06.405.469.110.207;Appendicitis;D001064
A03.556.124.526.209.290;Appendix;D001065
A03.556.249.249.209.290;Appendix;D001065
F02.830.071;Appetite;D001066
G07.610.390.070;Appetite;D001066
G10.261.390.070;Appetite;D001066
D27.505.954.427.140.155;Appetite Depressants;D001067
F03.375;Eating Disorders;D001068
G07.610.390.070.290;Appetite Regulation;D001069
G07.610.593.080;Appetite Regulation;D001069
G07.700.620.080;Appetite Regulation;D001069
G10.261.390.070.290;Appetite Regulation;D001069
F01.145.113.111;Appetitive Behavior;D001070
N04.452.095;Appointments and Schedules;D001071
C10.597.606.881.350;Apraxias;D001072
C23.888.592.604.080;Apraxias;D001072
C23.888.592.604.882.350;Apraxias;D001072
F01.700.080;Apraxias;D001072
F01.700.875.350;Apraxias;D001072
D02.455.426.559.847.486.487.060;Aprindine;D001073
D04.615.486.487.060;Aprindine;D001073
D02.241.081.251.583.788;Propoxur;D001074
F02.784.629.131;Aptitude;D001076
F04.711.141;Aptitude Tests;D001077
A11.382.249;APUD Cells;D001078
A11.382.944.500;APUD Cells;D001078
C04.557.465.625.650.135;Apudoma;D001079
C04.557.470.035.250;Apudoma;D001079
C04.557.580.625.650.135;Apudoma;D001079
D03.383.742.686.050;Apurinic Acid;D001080
D13.695.578.500.050;Apurinic Acid;D001080
D13.695.578.550.050;Apurinic Acid;D001080
D13.695.740.050;Apurinic Acid;D001080
D08.811.277.040.050;Apyrase;D001081
A09.371.060.067.070;Aqueous Humor;D001082
A12.207.270.040;Aqueous Humor;D001082
Z01.586.035.100;Arabia;D001083
D03.438.759.646.138.925;Vidarabine Phosphate;D001084
D13.695.065.900;Vidarabine Phosphate;D001084
D13.695.667.138.925;Vidarabine Phosphate;D001084
D03.383.742.686.246.050;Arabinofuranosylcytosine Triphosphate;D001085
D13.695.065.200;Arabinofuranosylcytosine Triphosphate;D001085
D13.695.740.246.050;Arabinofuranosylcytosine Triphosphate;D001085
D03.383.742.680.852.150;Arabinofuranosyluracil;D001086
D13.570.065.090;Arabinofuranosyluracil;D001086
D13.570.685.852.150;Arabinofuranosyluracil;D001086
D13.570.065;Arabinonucleosides;D001087
D13.695.065;Arabinonucleotides;D001088
D09.546.627.166;Arabinose;D001089
D08.811.682.690.416.583.500;Arachidonate Lipoxygenases;D001091
D12.776.556.579.374.568.500;Arachidonate Lipoxygenases;D001091
D08.811.682.690.416.583.500.060;Arachidonate 12-Lipoxygenase;D001092
D12.776.556.579.374.568.500.025;Arachidonate 12-Lipoxygenase;D001092
D08.811.682.690.416.583.500.065;Arachidonate 15-Lipoxygenase;D001093
D12.776.556.579.374.568.500.030;Arachidonate 15-Lipoxygenase;D001093
D08.811.682.690.416.583.500.055;Arachidonate 5-Lipoxygenase;D001094
D12.776.556.579.374.568.500.020;Arachidonate 5-Lipoxygenase;D001094
D10.251.355.096;Arachidonic Acids;D001095
D10.251.355.255.100;Arachidonic Acids;D001095
D10.251.355.310.166;Arachidonic Acids;D001095
N06.850.310.350.100.100;Arachnid Vectors;D001096
B01.050.500.131.166;Arachnida;D001097
C25.723.127.141;Arachnidism;D001098
A08.186.566.166;Arachnoid;D001099
C10.228.228.507.097;Arachnoiditis;D001100
D10.251.355.255.550.700.450.050;Arbaprostil;D001101
D23.469.700.660.050;Arbaprostil;D001101
C02.081;Arbovirus Infections;D001102
B04.080;Arboviruses;D001103
D09.408.348.075;Arbutin;D001104
B02;Archaea;D001105
I01.076.201.208;Archaeology;D001106
J01.086.339.070;Architectural Accessibility;D001107
J01.086;Architecture as Topic;D001108
K01.400.152;Archives;D001109
L01.346.208;Archives;D001109
Z01.208;Arctic Regions;D001110
A08.186.211.730.317.357.352.081;Arcuate Nucleus;D001111
C11.204.299.070;Arcus Senilis;D001112
I02.783.660.125;Area Health Education Centers;D001113
B01.650.940.800.575.100.093.088;Areca;D001114
D03.066.515.292;Arecoline;D001115
D03.132.080;Arecoline;D001115
D03.383.725.547.292;Arecoline;D001115
B04.820.057;Arenaviridae;D001116
B04.909.777.080;Arenaviridae;D001116
C02.782.082;Arenaviridae Infections;D001117
Z01.107.757.077;Argentina;D001118
D08.811.277.913.292;Arginase;D001119
D12.125.068.050;Arginine;D001120
D12.125.095.104;Arginine;D001120
D12.125.142.087;Arginine;D001120
D08.811.277.656.350.245.450;Lysine Carboxypeptidase;D001121
D08.811.277.656.350.555.750;Lysine Carboxypeptidase;D001121
D08.811.277.656.675.555.750;Lysine Carboxypeptidase;D001121
D08.811.913.696.640.025;Arginine Kinase;D001122
D08.811.520.232.300.400;Argininosuccinate Lyase;D001123
D08.811.464.259.300;Argininosuccinate Synthase;D001124
D02.241.081.337.759.124;Argininosuccinic Acid;D001125
D12.125.068.050.075;Argininosuccinic Acid;D001125
D12.125.095.104.075;Argininosuccinic Acid;D001125
D08.811.464.263.200.100;Arginine-tRNA Ligase;D001126
D06.472.699.631.692.781.100;Arginine Vasopressin;D001127
D12.644.400.900.100;Arginine Vasopressin;D001127
D12.644.456.925.100;Arginine Vasopressin;D001127
D12.644.548.691.692.781.100;Arginine Vasopressin;D001127
D12.776.641.650.937.100;Arginine Vasopressin;D001127
D01.268.613.050;Argon;D001128
D01.362.641.113;Argon;D001128
C17.800.621.166;Argyria;D001129
C25.723.068;Argyria;D001129
Z01.107.567.875.760.100;Arizona;D001130
Z01.107.567.875.750.110;Arkansas;D001131
A01.378.800.075;Arm;D001132
A02.835.232.087;Bones of Upper Extremity;D001133
C26.088;Arm Injuries;D001134
B01.050.150.900.649.900.200;Armadillos;D001135
Z01.542.900.099;Armenia;D001136
Z01.586.035.150;Armenia;D001136
Z01.586.200.099;Armenia;D001136
Z01.586.950.099;Armenia;D001136
D02.705.429.374;Armin;D001138
C10.500.680.291;Arnold-Chiari Malformation;D001139
C16.131.666.680.291;Arnold-Chiari Malformation;D001139
D02.455.526.439.773.292;Aroclors;D001140
D02.455.526.439.785.292;Aroclors;D001140
D08.244.453.915.099;Aromatase;D001141
D08.811.682.690.708.170.915.099;Aromatase;D001141
D08.811.682.690.708.783.099;Aromatase;D001141
D12.776.422.220.453.915.099;Aromatase;D001141
D08.811.520.224.125.100;Aromatic-L-Amino-Acid Decarboxylases;D001142
F02.830.104;Arousal;D001143
G11.561.600.042;Arousal;D001143
C14.280.067;Arrhythmias, Cardiac;D001145
C23.550.073;Arrhythmias, Cardiac;D001145
C14.280.067.093;Arrhythmia, Sinus;D001146
C23.550.073.093;Arrhythmia, Sinus;D001146
D02.691.088.030;Arsanilic Acid;D001147
D02.691.088.040;Arsenamide;D001148
D01.075.025;Arsenates;D001149
D01.248.497.158.050;Arsenates;D001149
D02.691.088.042;Arsenates;D001149
D02.172.040;Arsenazo III;D001150
D02.691.088.044;Arsenazo III;D001150
D01.268.067;Arsenic;D001151
D01.268.513.249;Arsenic;D001151
D01.075;Arsenicals;D001152
D02.691.088;Arsenicals;D001152
D02.691.088.050;Arsphenamine;D001153
K01.093;Art;D001154
E02.190.888.124;Art Therapy;D001155
E02.831.100;Art Therapy;D001155
F04.754.070;Art Therapy;D001155
B01.050.500.131.365.060.050;Artemia;D001156
C14.907.137;Arterial Occlusive Diseases;D001157
A07.231.114;Arteries;D001158
C14.240.850.984.500;Arterio-Arterial Fistula;D001159
C14.907.933.110;Arterio-Arterial Fistula;D001159
C16.131.240.850.500;Arterio-Arterial Fistula;D001159
C23.300.575.950.150;Arterio-Arterial Fistula;D001159
A07.231.114.060;Arterioles;D001160
A07.231.461.080;Arterioles;D001160
C14.907.137.126;Arteriosclerosis;D001161
C14.907.137.126.114;Arteriosclerosis Obliterans;D001162
A07.231.461.085;Arteriovenous Anastomosis;D001163
C14.240.850.750.147;Arteriovenous Fistula;D001164
C14.240.850.984.750;Arteriovenous Fistula;D001164
C14.907.150.125;Arteriovenous Fistula;D001164
C14.907.933.555;Arteriovenous Fistula;D001164
C16.131.240.850.750.125;Arteriovenous Fistula;D001164
C23.300.575.950.250;Arteriovenous Fistula;D001164
C14.240.850.750;Arteriovenous Malformations;D001165
C14.907.150;Arteriovenous Malformations;D001165
C16.131.240.850.750;Arteriovenous Malformations;D001165
E04.035.087;Arteriovenous Shunt, Surgical;D001166
E04.100.814.868.249;Arteriovenous Shunt, Surgical;D001166
C14.907.184;Arteritis;D001167
C14.907.940.090;Arteritis;D001167
C05.550.114;Arthritis;D001168
C05.550.114.015;Arthritis, Experimental;D001169
E05.598.500.249;Arthritis, Experimental;D001169
C01.539.100;Arthritis, Infectious;D001170
C05.550.114.099;Arthritis, Infectious;D001170
C05.550.114.154.114;Arthritis, Juvenile Rheumatoid;D001171
C05.799.114.114;Arthritis, Juvenile Rheumatoid;D001171
C17.300.775.099.114;Arthritis, Juvenile Rheumatoid;D001171
C20.111.199.114;Arthritis, Juvenile Rheumatoid;D001171
C05.550.114.154;Arthritis, Rheumatoid;D001172
C05.799.114;Arthritis, Rheumatoid;D001172
C17.300.775.099;Arthritis, Rheumatoid;D001172
C20.111.199;Arthritis, Rheumatoid;D001172
B03.510.024.049.475.050;Arthrobacter;D001173
B03.510.460.400.400.049.074;Arthrobacter;D001173
E04.555.100;Arthrodesis;D001174
E01.370.350.700.070;Arthrography;D001175
C05.550.150;Arthrogryposis;D001176
C05.651.102;Arthrogryposis;D001176
C05.660.077;Arthrogryposis;D001176
C16.131.621.077;Arthrogryposis;D001176
C05.550.186;Arthropathy, Neurogenic;D001177
E04.555.110;Arthroplasty;D001178
N06.850.310.350.100;Arthropod Vectors;D001179
D20.888.065;Arthropod Venoms;D001180
D23.946.833.065;Arthropod Venoms;D001180
B01.050.500.131;Arthropods;D001181
E01.370.388.250.070;Arthroscopy;D001182
E04.555.113;Arthroscopy;D001182
E04.800.250.070;Arthroscopy;D001182
C20.543.520.100;Arthus Reaction;D001183
C10.597.606.150.500.800.150;Articulation Disorders;D001184
C23.888.592.604.150.500.800.150;Articulation Disorders;D001184
L01.224.065;Artificial Intelligence;D001185
E07.695.050;Artificial Limbs;D001186
E07.858.082.050;Artificial Limbs;D001186
E07.858.442.050;Artificial Limbs;D001186
E07.858.082;Artificial Organs;D001187
B01.050.150.900.649.077;Artiodactyla;D001188
D08.244.453.040;Aryl Hydrocarbon Hydroxylases;D001189
D08.811.682.690.708.170.040;Aryl Hydrocarbon Hydroxylases;D001189
D12.776.422.220.453.040;Aryl Hydrocarbon Hydroxylases;D001189
D02.886.645.600.080.050;Arylsulfonates;D001190
D08.811.913.050.134.138;Arylamine N-Acetyltransferase;D001191
D08.811.277.352.827.070;Arylsulfatases;D001192
A02.165.257.625.083;Arytenoid Cartilage;D001193
A02.165.407.500.083;Arytenoid Cartilage;D001193
A04.329.591.085;Arytenoid Cartilage;D001193
D01.578.725.050;Asbestos;D001194
D01.837.725.700.760.070;Asbestos;D001194
C08.381.483.581.125;Asbestosis;D001195
C08.381.520.702.125;Asbestosis;D001195
C24.800.127;Asbestosis;D001195
C03.335.508.700.100.070;Ascariasis;D001196
B01.050.500.500.294.700.100.090;Ascaridia;D001197
C03.335.508.700.100.080;Ascaridiasis;D001198
B01.050.500.500.294.700.100.100;Ascaridoidea;D001199
B01.050.500.500.294.700.100.100.108;Ascaris;D001200
C23.550.081;Ascites;D001201
A12.207.119;Ascitic Fluid;D001202
B01.300.107;Ascomycota;D001203
D08.811.682.180;Ascorbate Oxidase;D001204
D02.241.081.844.107;Ascorbic Acid;D001205
D02.241.511.902.107;Ascorbic Acid;D001205
D09.811.100;Ascorbic Acid;D001205
C18.654.521.500.133.115;Ascorbic Acid Deficiency;D001206
N06.850.780.200.450.150.160;Asepsis;D001207
Z01.252;Asia;D001208
Z01.252.100;Asia, Central;D001209
Z01.252.145;Asia, Southeastern;D001210
Z01.252.245;Asia, Western;D001211
D12.776.395.140;Asialoglycoproteins;D001212
M01.686.508.200.100;Asian Americans;D001213
M01.686.754.225;Asian Americans;D001213
D08.811.277.087.116;Asparaginase;D001215
D12.125.068.060;Asparagine;D001216
D12.125.095.165;Asparagine;D001216
D12.125.154.049;Asparagine;D001216
D08.811.464.259.200.200;Aspartate-Ammonia Ligase;D001217
D12.644.456.345.190;Aspartame;D001218
D08.811.913.477.700.225;Aspartate Aminotransferases;D001219
D08.811.520.232.400.200;Aspartate Ammonia-Lyase;D001220
D08.811.600.116;Aspartate Carbamoyltransferase;D001221
D08.811.913.555.275.200;Aspartate Carbamoyltransferase;D001221
D08.811.913.696.630.050;Aspartate Kinase;D001222
D08.811.682.657.163.374;Aspartate-Semialdehyde Dehydrogenase;D001223
D12.125.067.500;Aspartic Acid;D001224
D12.125.119.170;Aspartic Acid;D001224
D12.125.427.040;Aspartic Acid;D001224
D08.811.600.130;Aspartokinase Homoserine Dehydrogenase;D001225
D08.811.682.047.370.060;Aspartokinase Homoserine Dehydrogenase;D001225
D08.811.913.696.630.050.050;Aspartokinase Homoserine Dehydrogenase;D001225
D08.811.464.263.200.150;Aspartate-tRNA Ligase;D001226
D08.811.277.087.125;Aspartylglucosylaminase;D001227
C01.539.800.200.383.249;Aspergillosis;D001228
C01.703.295.328.249;Aspergillosis;D001228
C01.703.513.249;Aspergillosis;D001228
C17.800.838.208.416.249;Aspergillosis;D001228
C01.539.800.200.383.249.074;Aspergillosis, Allergic Bronchopulmonary;D001229
C01.703.295.328.249.074;Aspergillosis, Allergic Bronchopulmonary;D001229
C01.703.513.249.074;Aspergillosis, Allergic Bronchopulmonary;D001229
C01.703.534.090;Aspergillosis, Allergic Bronchopulmonary;D001229
C08.381.472.850.500;Aspergillosis, Allergic Bronchopulmonary;D001229
C08.674.060;Aspergillosis, Allergic Bronchopulmonary;D001229
C08.730.435.090;Aspergillosis, Allergic Bronchopulmonary;D001229
C17.800.838.208.416.249.074;Aspergillosis, Allergic Bronchopulmonary;D001229
C20.543.480.680.085;Aspergillosis, Allergic Bronchopulmonary;D001229
B01.300.381.081;Aspergillus;D001230
B01.300.381.081.170;Aspergillus flavus;D001231
B01.300.381.081.295;Aspergillus fumigatus;D001232
B01.300.381.081.420;Aspergillus nidulans;D001233
B01.300.381.081.450;Aspergillus niger;D001234
B01.300.381.081.480;Aspergillus ochraceus;D001235
B01.300.381.081.500;Aspergillus oryzae;D001236
C23.550.260.095;Asphyxia;D001237
C26.103;Asphyxia;D001237
C16.614.092;Asphyxia Neonatorum;D001238
G09.772.770.755.700.390;Inhalation;D001239
F01.658.100;Aspirations (Psychology);D001240
F02.784.629.155;Aspirations (Psychology);D001240
D02.455.426.559.389.657.410.595.176;Aspirin;D001241
F01.752.049;Assertiveness;D001242
E04.050;Assisted Circulation;D001243
F02.463.425.069;Association;D001244
F04.754.720.346;Association;D001244
F02.463.425.069.296;Association Learning;D001245
D01.268.271.110;Astatine;D001246
D01.268.380.075;Astatine;D001246
C23.888.089;Asthenia;D001247
C11.093;Asthenopia;D001248
C08.127.108;Asthma;D001249
C08.381.495.108;Asthma;D001249
C08.674.095;Asthma;D001249
C20.543.480.680.095;Asthma;D001249
C08.127.108.110;Asthma, Exercise-Induced;D001250
C08.674.095.110;Asthma, Exercise-Induced;D001250
C20.543.480.680.095.110;Asthma, Exercise-Induced;D001250
C11.744.212;Astigmatism;D001251
D27.505.696.207;Astringents;D001252
D27.505.954.444.100;Astringents;D001252
A08.637.200;Astrocytes;D001253
A11.650.200;Astrocytes;D001253
C04.557.465.625.600.380.080;Astrocytoma;D001254
C04.557.470.670.380.080;Astrocytoma;D001254
C04.557.580.625.600.380.080;Astrocytoma;D001254
K01.672.296;Astrology;D001255
H01.671.065;Astronomy;D001256
B04.820.069.500;Mamastrovirus;D001257
B04.909.777.099.500;Mamastrovirus;D001257
C10.597.350.090;Ataxia;D001259
C23.888.592.350.090;Ataxia;D001259
C10.228.140.252.190.530.060;Ataxia Telangiectasia;D001260
C10.562.100;Ataxia Telangiectasia;D001260
C10.597.350.090.500.530.060;Ataxia Telangiectasia;D001260
C14.907.823.213;Ataxia Telangiectasia;D001260
C16.320.080;Ataxia Telangiectasia;D001260
C18.452.284.060;Ataxia Telangiectasia;D001260
C20.673.290;Ataxia Telangiectasia;D001260
C08.381.730;Pulmonary Atelectasis;D001261
D02.033.100.624.085;Atenolol;D001262
D02.033.100.624.698.070;Atenolol;D001262
D02.033.755.624.085;Atenolol;D001262
D02.033.755.624.698.070;Atenolol;D001262
D02.092.063.624.698.070;Atenolol;D001262
C10.597.350.110;Athetosis;D001264
C23.888.592.350.110;Athetosis;D001264
C26.115;Athletic Injuries;D001265
Z01.639.040;Atlantic Islands;D001266
Z01.756.092;Atlantic Ocean;D001267
A02.835.583.097;Atlanto-Axial Joint;D001268
A02.835.583.101;Atlanto-Occipital Joint;D001269
A02.835.232.834.151.500;Cervical Atlas;D001270
L01.178.682.192.836.147;Atlases as Topic;D001271
G16.500.275.063;Atmosphere;D001272
N06.230.300.100;Atmosphere;D001272
E07.079;Atmosphere Exposure Chambers;D001273
G16.500.750.274;Atmospheric Pressure;D001274
N06.230.300.100.185;Atmospheric Pressure;D001274
D08.811.913.050.331;ATP Citrate (pro-S)-Lyase;D001275
D08.811.913.400.725.200;ATP Phosphoribosyltransferase;D001276
D08.811.913.696.175.300;GTP Pyrophosphokinase;D001277
D02.455.849.291.162;Atractyloside;D001278
D09.408.105;Atractyloside;D001278
D03.438.531.085.061;Atracurium;D001279
D03.383.931.247;Atrazine;D001280
C14.280.067.198;Atrial Fibrillation;D001281
C23.550.073.198;Atrial Fibrillation;D001281
C14.280.067.248;Atrial Flutter;D001282
C23.550.073.248;Atrial Flutter;D001282
A07.541.409.147;Atrioventricular Node;D001283
C23.300.070;Atrophy;D001284
D02.145.074.722.189;Atropine;D001285
D03.132.760.180.297;Atropine;D001285
D03.132.889.180.297;Atropine;D001285
D03.605.869.189;Atropine;D001285
D04.075.080.875.099.722.189;Atropine;D001285
D02.145.074.722.189.297;Atropine Derivatives;D001286
D03.132.889.180.297.297;Atropine Derivatives;D001286
D03.605.869.189.297;Atropine Derivatives;D001286
D04.075.080.875.099.722.189.297;Atropine Derivatives;D001286
G05.360.340.024.079;Attachment Sites, Microbiological;D001287
F02.830.104.214;Attention;D001288
F03.550.150.150;Attention Deficit Disorder with Hyperactivity;D001289
F01.100;Attitude;D001290
F01.100.050;Attitude of Health Personnel;D001291
N05.300.100;Attitude of Health Personnel;D001291
F01.100.100;Attitude to Computers;D001292
F01.100.125;Attitude to Death;D001293
N05.300.125;Attitude to Death;D001293
F01.100.150;Attitude to Health;D001294
N05.300.150;Attitude to Health;D001294
B03.110;Atypical Bacterial Forms;D001295
B05.110;Atypical Bacterial Forms;D001295
J01.897.280.500;Audiovisual Aids;D001296
L01.178.820.090;Audiovisual Aids;D001296
E03.091.214;Audioanalgesia;D001297
H02.010.150;Audiology;D001298
E01.370.382.375.060;Audiometry;D001299
E01.370.382.375.060.050;Audiometry, Evoked Response;D001300
E01.370.382.375.060.055;Audiometry, Pure-Tone;D001301
E01.370.382.375.060.060;Audiometry, Speech;D001302
A08.186.211.730.885.287.500.863.297;Auditory Cortex;D001303
C09.218.807.186;Auditory Diseases, Central;D001304
C10.228.140.068;Auditory Diseases, Central;D001304
F02.463.593.071.173.095;Auditory Fatigue;D001305
A08.612.220.110;Auditory Pathways;D001306
F02.463.593.071;Auditory Perception;D001307
C09.218.807.186.094;Auditory Perceptual Disorders;D001308
C10.228.140.068.094;Auditory Perceptual Disorders;D001308
C10.597.606.762.200;Auditory Perceptual Disorders;D001308
C23.888.592.604.764.200;Auditory Perceptual Disorders;D001308
F01.700.750.200;Auditory Perceptual Disorders;D001308
F03.087.250.100;Auditory Perceptual Disorders;D001308
F02.463.593.071.173;Auditory Threshold;D001309
F02.463.593.710.190;Auditory Threshold;D001309
D02.691.675.249.150;Auranofin;D001310
D02.241.223.268.070;Aurintricarboxylic Acid;D001312
D03.383.663.075;Aurovertins;D001313
D03.830.075;Aurovertins;D001313
E01.370.600.060;Auscultation;D001314
Z01.338;Australia;D001315
Z01.639.100;Australia;D001315
Z01.678.100.373;Australia;D001315
Z01.542.088;Austria;D001317
F01.752.098;Authoritarianism;D001318
L01.143.506.423.906.215;Authorship;D001319
F03.550.325.125;Autistic Disorder;D001321
E05.059;Autoanalysis;D001322
D12.776.124.486.485.114.323;Autoantibodies;D001323
D12.776.124.790.651.114.323;Autoantibodies;D001323
D12.776.377.715.548.114.323;Autoantibodies;D001323
D23.050.422;Autoantigens;D001324
K01.517.211.215;Autobiography as Topic;D001325
E02.190.525.217.100;Autogenic Training;D001326
F04.754.103;Autogenic Training;D001326
C20.111;Autoimmune Diseases;D001327
C23.550.260.224.617.236;Autolysis;D001329
L01.224.085;Automatic Data Processing;D001330
J01.897.104;Automation;D001331
F02.463.425.179.149;Automatism;D001332
I03.125.299;Automobile Driver Examination;D001333
I03.125;Automobile Driving;D001334
D20.832;Vehicle Emissions;D001335
J01.937.500.100;Automobiles;D001336
D27.505.696.663.050;Autonomic Agents;D001337
A08.663.542.100;Autonomic Fibers, Postganglionic;D001338
A08.800.050.050.050;Autonomic Fibers, Postganglionic;D001338
A08.800.800.060.050;Autonomic Fibers, Postganglionic;D001338
A11.671.078;Autonomic Fibers, Postganglionic;D001338
A08.663.542.122;Autonomic Fibers, Preganglionic;D001339
A08.663.542.234.060;Autonomic Fibers, Preganglionic;D001339
A08.800.050.050.060;Autonomic Fibers, Preganglionic;D001339
A08.800.800.060.060;Autonomic Fibers, Preganglionic;D001339
A11.671.107;Autonomic Fibers, Preganglionic;D001339
E03.155.086.711.299;Autonomic Nerve Block;D001340
E04.525.210.550.500;Autonomic Nerve Block;D001340
A08.800.050;Autonomic Nervous System;D001341
C10.177;Autonomic Nervous System Diseases;D001342
G04.299.139.399;Autophagy;D001343
G04.299.482.350.091;Autophagy;D001343
E01.370.060;Autopsy;D001344
E05.070;Autopsy;D001344
I01.198.780.937.120;Autopsy;D001344
E01.370.225.750.132;Autoradiography;D001345
E05.200.750.132;Autoradiography;D001345
E05.799.256;Autoradiography;D001345
E02.190.525.217.771.100;Autosuggestion;D001346
F04.754.424.771.299;Autosuggestion;D001346
F04.754.137.174;Aversive Therapy;D001348
B04.820.565.400.250;Encephalomyelitis Virus, Avian;D001350
B04.909.777.618.400.250;Encephalomyelitis Virus, Avian;D001350
B04.820.504.540.150.500;Infectious bronchitis virus;D001351
B04.909.777.500.540.150.500;Infectious bronchitis virus;D001351
B04.280.382.100.374.450;Herpesvirus 1, Gallid;D001352
B04.909.204.382.100.374.450;Herpesvirus 1, Gallid;D001352
C02.782.815.096;Avian Leukosis;D001353
C02.928.120;Avian Leukosis;D001353
C04.557.337.372.216;Avian Leukosis;D001353
C04.619.531.216;Avian Leukosis;D001353
C04.619.935.120;Avian Leukosis;D001353
C04.925.120;Avian Leukosis;D001353
C22.131.094;Avian Leukosis;D001353
B04.820.650.070.100;Avian leukosis virus;D001354
B04.909.574.807.070.100;Avian leukosis virus;D001354
B04.909.777.731.070.100;Avian leukosis virus;D001354
B04.820.650.070;Alpharetrovirus;D001355
B04.909.574.807.070;Alpharetrovirus;D001355
B04.909.777.731.070;Alpharetrovirus;D001355
B04.820.650.375.700.700;Reticuloendotheliosis virus;D001356
B04.909.574.807.375.700.700;Reticuloendotheliosis virus;D001356
B04.909.777.731.375.700.700;Reticuloendotheliosis virus;D001356
C02.782.815.800;Sarcoma, Avian;D001357
C02.928.800;Sarcoma, Avian;D001357
C04.557.450.795.830.800;Sarcoma, Avian;D001357
C04.619.857.800;Sarcoma, Avian;D001357
C04.619.935.800;Sarcoma, Avian;D001357
C04.925.700;Sarcoma, Avian;D001357
C22.131.800;Sarcoma, Avian;D001357
B04.820.650.070.120;Avian Sarcoma Viruses;D001358
B04.909.574.807.070.120;Avian Sarcoma Viruses;D001358
B04.909.777.731.070.120;Avian Sarcoma Viruses;D001358
J01.937.285;Aviation;D001359
D12.776.034.614.300;Avidin;D001360
D12.776.256.317.663.300;Avidin;D001360
D12.776.290.663.100;Avidin;D001360
D12.776.395.175;Avidin;D001360
C18.654.521.500.133;Avitaminosis;D001361
F02.463.425.097;Avoidance Learning;D001362
K01.150;Awards and Prizes;D001363
F02.463.188.150;Awareness;D001364
A01.378.800.090;Axilla;D001365
A07.231.114.085;Axillary Artery;D001366
A07.231.908.077;Axillary Vein;D001367
A02.835.232.834.151.383;Axis;D001368
A08.663.542.145;Axons;D001369
A11.284.180.075;Axons;D001369
A11.671.137;Axons;D001369
G03.495.166.355.040;Axonal Transport;D001370
G04.299.418.040;Axonal Transport;D001370
G11.561.600.085;Axonal Transport;D001370
D02.455.426.392.368.367.900;trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride;D001371
D02.145;Aza Compounds;D001372
D04.808.247.222.284.070;Azacosterol;D001373
D04.808.247.808.197.070;Azacosterol;D001373
D10.570.938.208.070;Azacosterol;D001373
D02.145.150;Azacitidine;D001374
D03.383.742.680.245.217;Azacitidine;D001374
D13.570.685.245.217;Azacitidine;D001374
D13.570.800.286.300;Azacitidine;D001374
D02.145.250;Azaguanine;D001375
D03.438.759.758.399.454.300;Azaguanine;D001375
D02.522.352.110;Azaperone;D001376
D12.125.837.075;Azaserine;D001377
D04.808.925.100;Azasteroids;D001378
D02.886.759.111;Azathioprine;D001379
D03.438.759.534.090;Azathioprine;D001379
D13.570.900.111;Azathioprine;D001379
D02.145.451;Azauridine;D001380
D03.383.742.680.852.176;Azauridine;D001380
D13.570.685.852.176;Azauridine;D001380
D13.570.800.892.176;Azauridine;D001380
D03.383.066;Azepines;D001381
Z01.542.900.120;Azerbaijan;D001382
Z01.586.200.120;Azerbaijan;D001382
Z01.586.950.120;Azerbaijan;D001382
D02.241.081.583.100;Azetidinecarboxylic Acid;D001383
D02.491.485.100;Azetidinecarboxylic Acid;D001383
D03.383.082.301.100;Azetidinecarboxylic Acid;D001383
D12.125.072.401.200;Azetidinecarboxylic Acid;D001383
D03.383.082.301;Azetidines;D001384
D03.383.082;Azetines;D001385
D01.625.100;Azides;D001386
D02.159;Azides;D001386
D02.705.400.625.060;Azinphosmethyl;D001387
D02.705.539.345.060;Azinphosmethyl;D001387
D02.886.300.692.060;Azinphosmethyl;D001387
D03.383.097.217;Aziridines;D001388
D03.383.097;Azirines;D001389
D02.065.589.099.750.750.050.075;Azlocillin;D001390
D02.886.108.750.750.050.075;Azlocillin;D001390
D03.438.260.825.750.050.075;Azlocillin;D001390
D03.605.084.737.750.050.075;Azlocillin;D001390
D04.075.080.875.099.221.750.750.050.075;Azlocillin;D001390
D02.172;Azo Compounds;D001391
D03.383.113;Azocines;D001392
D03.383.129;Azoles;D001393
Z01.639.040.218;Azores;D001394
B03.440.400.425.625.050;Azotobacter;D001395
B03.660.250.580.022;Azotobacter;D001395
D02.172.080;Azoxymethane;D001397
D02.065.589.099.500.044;Aztreonam;D001398
D02.886.108.500.044;Aztreonam;D001398
D03.383.411.350.044;Aztreonam;D001398
D04.075.080.875.099.221.500.044;Aztreonam;D001398
D02.886.369.080;Azure Stains;D001399
D03.494.741.080;Azure Stains;D001399
D12.776.097.100;Azurin;D001400
D12.776.556.080;Azurin;D001400
A07.231.908.106;Azygos Vein;D001401
A11.063.438;B-Lymphocytes;D001402
A11.118.637.555.567.562;B-Lymphocytes;D001402
A15.145.229.637.555.567.562;B-Lymphocytes;D001402
A15.382.032.438;B-Lymphocytes;D001402
A15.382.490.555.567.562;B-Lymphocytes;D001402
B01.043.075.600.580.070;Babesia;D001403
C03.701.188;Babesiosis;D001404
C03.701.688.122;Babesiosis;D001404
C03.752.625.122;Babesiosis;D001404
C03.752.875.175;Babesiosis;D001404
C22.674.710.122;Babesiosis;D001404
C10.597.704.400;Reflex, Babinski;D001405
C23.888.592.717.400;Reflex, Babinski;D001405
E01.370.376.550.650.655.400;Reflex, Babinski;D001405
E01.370.600.550.650.655.400;Reflex, Babinski;D001405
B03.300.390.400.158;Bacillaceae;D001406
B03.510.100.100;Bacillaceae;D001406
B03.510.415.400.158;Bacillaceae;D001406
B03.510.460.410.158;Bacillaceae;D001406
B03.300.390.400.158.218;Bacillus;D001407
B03.510.100.100.218;Bacillus;D001407
B03.510.415.400.158.218;Bacillus;D001407
B03.510.460.410.158.218;Bacillus;D001407
B03.300.390.400.158.218.151;Bacillus anthracis;D001408
B03.510.100.100.218.151;Bacillus anthracis;D001408
B03.510.415.400.158.218.151;Bacillus anthracis;D001408
B03.510.460.410.158.218.151;Bacillus anthracis;D001408
B03.300.390.400.158.218.252;Bacillus cereus;D001409
B03.510.100.100.218.252;Bacillus cereus;D001409
B03.510.415.400.158.218.252;Bacillus cereus;D001409
B03.510.460.410.158.218.252;Bacillus cereus;D001409
B03.300.390.400.158.218.500;Bacillus megaterium;D001410
B03.510.100.100.218.500;Bacillus megaterium;D001410
B03.510.415.400.158.218.500;Bacillus megaterium;D001410
B03.510.460.410.158.218.500;Bacillus megaterium;D001410
B03.300.390.400.158.400.400;Geobacillus stearothermophilus;D001411
B03.510.100.100.400.400;Geobacillus stearothermophilus;D001411
B03.510.415.400.158.400.400;Geobacillus stearothermophilus;D001411
B03.510.460.410.158.400.400;Geobacillus stearothermophilus;D001411
B03.300.390.400.158.218.725;Bacillus subtilis;D001412
B03.510.100.100.218.725;Bacillus subtilis;D001412
B03.510.415.400.158.218.725;Bacillus subtilis;D001412
B03.510.460.410.158.218.725;Bacillus subtilis;D001412
B03.300.390.400.158.218.800;Bacillus thuringiensis;D001413
B03.510.100.100.218.800;Bacillus thuringiensis;D001413
B03.510.415.400.158.218.800;Bacillus thuringiensis;D001413
B03.510.460.410.158.218.800;Bacillus thuringiensis;D001413
D04.345.566.075;Bacitracin;D001414
D12.644.641.075;Bacitracin;D001414
A01.923.176;Back;D001415
C10.597.617.232;Back Pain;D001416
C23.888.592.612.107;Back Pain;D001416
C23.888.646.172;Back Pain;D001416
G01.750.750.115;Background Radiation;D001417
D02.241.081.114.500.350.100;Baclofen;D001418
B03;Bacteria;D001419
B03.120;Bacteria, Aerobic;D001420
B03.130;Bacteria, Anaerobic;D001421
G06.099.112.100;Bacterial Adhesion;D001422
G06.590.110.100;Bacterial Adhesion;D001422
C01;Bacterial Infections and Mycoses;D001423
C01.252;Bacterial Infections;D001424
D12.776.097.120;Bacterial Outer Membrane Proteins;D001425
D12.776.543.100;Bacterial Outer Membrane Proteins;D001425
D12.776.097;Bacterial Proteins;D001426
D23.946.123;Bacterial Toxins;D001427
D20.215.894.135;Bacterial Vaccines;D001428
D03.383.129.578.840.374.100;Bacteriochlorophylls;D001429
D03.383.129.578.840.500.640.220.100;Bacteriochlorophylls;D001429
D03.549.909.374.100;Bacteriochlorophylls;D001429
D03.549.909.500.640.220.100;Bacteriochlorophylls;D001429
D04.345.783.374.100;Bacteriochlorophylls;D001429
D04.345.783.500.640.220.100;Bacteriochlorophylls;D001429
D12.776.752.249;Bacteriochlorophylls;D001429
D23.767.727.220.100;Bacteriochlorophylls;D001429
D23.767.727.640.220.100;Bacteriochlorophylls;D001429
D12.776.097.151;Bacteriocins;D001430
D12.776.543.695.110;Bacteriocins;D001430
E01.370.225.875.150;Bacteriological Techniques;D001431
E05.200.875.150;Bacteriological Techniques;D001431
H01.158.273.540.177;Bacteriology;D001432
G06.099.112.120;Bacteriolysis;D001433
G06.590.110.120;Bacteriolysis;D001433
E01.370.225.875.150.125.150;Bacteriophage Typing;D001434
E05.200.875.150.125.150;Bacteriophage Typing;D001434
B04.123;Bacteriophages;D001435
D12.776.090.200;Bacteriorhodopsins;D001436
D12.776.157.530.450.250.875.249;Bacteriorhodopsins;D001436
D12.776.543.585.450.250.875.249;Bacteriorhodopsins;D001436
D12.776.752.812.249;Bacteriorhodopsins;D001436
C01.539.895.219;Bacteriuria;D001437
C12.777.892.219;Bacteriuria;D001437
C13.351.968.892.219;Bacteriuria;D001437
B03.140.094;Bacteroidaceae;D001438
B03.440.425.410.194;Bacteroidaceae;D001438
B03.140.094.152;Bacteroides;D001439
B03.440.425.410.194.152;Bacteroides;D001439
B03.140.094.152.400;Bacteroides fragilis;D001441
B03.440.425.410.194.152.400;Bacteroides fragilis;D001441
C01.252.400.110.109;Bacteroides Infections;D001442
B03.140.094.640.500;Prevotella melaninogenica;D001443
B03.440.425.410.194.640.500;Prevotella melaninogenica;D001443
Z01.107.084.900.100;Bahamas;D001444
Z01.639.880.100;Bahamas;D001444
Z01.252.245.500.175;Bahrain;D001445
Z01.586.500.175;Bahrain;D001445
C12.294.494.136;Balanitis;D001446
C03.432.146;Balantidiasis;D001447
C03.752.200.146;Balantidiasis;D001447
C06.405.469.452.146;Balantidiasis;D001447
B01.043.185.375.650.650.153;Balantidium;D001448
C12.777.419.570.643.150;Balkan Nephropathy;D001449
C13.351.968.419.570.643.150;Balkan Nephropathy;D001449
E01.370.370.380.100;Ballistocardiography;D001450
E02.056;Balneology;D001452
E02.779.249;Balneology;D001452
D05.750.078.840.219;Balsams;D001453
D20.215.721.500.219;Balsams;D001453
Z01.542.248.136;Baltic States;D001454
Z01.586.950.140;Baltic States;D001454
D09.698.718.220;Bambermycins;D001455
D12.776.124.078;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.157.530.450.162.110;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.157.530.450.162.193.500;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.543.550.190.110;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.543.550.190.276.500;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.543.585.450.162.110;Anion Exchange Protein 1, Erythrocyte;D001457
D12.776.543.585.450.162.193.500;Anion Exchange Protein 1, Erythrocyte;D001457
E07.101;Bandages;D001458
Z01.252.245.131;Bangladesh;D001459
Z01.107.084.900.140;Barbados;D001460
Z01.639.880.140;Barbados;D001460
J01.576.082;Barbering;D001461
D03.383.742.698.253.150;Barbital;D001462
D03.383.742.698.253;Barbiturates;D001463
D01.268.552.050;Barium;D001464
D01.268.556.062;Barium;D001464
D01.552.539.124;Barium;D001464
D01.552.544.062;Barium;D001464
D01.496.749.075;Barium Radioisotopes;D001465
D01.103.075;Barium Sulfate;D001466
D01.875.800.800.850.075;Barium Sulfate;D001466
B01.650.940.800.575.100.822.481;Hordeum;D001467
J02.500.200.333;Hordeum;D001467
B01.050.500.131.365.880;Thoracica;D001468
C26.120;Barotrauma;D001469
C06.198.102;Barrett Esophagus;D001471
C06.405.117.102;Barrett Esophagus;D001471
A05.360.319.887.220;Bartholin's Glands;D001472
A10.336.095;Bartholin's Glands;D001472
B03.440.090.100;Bartonella;D001473
B03.660.050.030.040;Bartonella;D001473
C01.252.400.126.100;Bartonella Infections;D001474
B03.440.090;Bartonellaceae;D001475
B03.660.050.030;Bartonellaceae;D001475
C01.252.400.126;Bartonellaceae Infections;D001476
C12.777.419.815.279;Bartter Syndrome;D001477
C13.351.968.419.815.279;Bartter Syndrome;D001477
C19.053.800.604.249;Bartter Syndrome;D001477
C04.182.089.530.690.150;Basal Cell Nevus Syndrome;D001478
C04.557.470.200.165.150;Basal Cell Nevus Syndrome;D001478
C04.557.470.565.165.150;Basal Cell Nevus Syndrome;D001478
C04.700.175;Basal Cell Nevus Syndrome;D001478
C05.116.099.105;Basal Cell Nevus Syndrome;D001478
C05.500.470.690.150;Basal Cell Nevus Syndrome;D001478
C07.320.450.670.130;Basal Cell Nevus Syndrome;D001478
C16.131.077.130;Basal Cell Nevus Syndrome;D001478
C16.320.700.175;Basal Cell Nevus Syndrome;D001478
A08.186.211.730.885.287.249;Basal Ganglia;D001479
C10.228.140.079;Basal Ganglia Diseases;D001480
E01.370.374.750.100;Basal Metabolism;D001481
G03.495.335.154;Basal Metabolism;D001481
G02.111.080;Base Composition;D001482
G02.111.570.080;Base Sequence;D001483
G05.360.080;Base Sequence;D001483
L01.453.245.667.080;Base Sequence;D001483
I03.450.642.845.110;Baseball;D001484
A10.272.220;Basement Membrane;D001485
A10.615.179;Basement Membrane;D001485
Z01.542.248.775.150;Bashkiria;D001486
Z01.586.200.775.150;Bashkiria;D001486
Z01.586.950.775.150;Bashkiria;D001486
B01.300.179;Basidiomycota;D001487
A07.231.114.106;Basilar Artery;D001488
A09.246.631.246.125;Basilar Membrane;D001489
A10.615.179.124;Basilar Membrane;D001489
I03.450.642.845.117;Basketball;D001490
A11.118.637.415.120;Basophils;D001491
A11.627.340.120;Basophils;D001491
A15.145.229.637.415.120;Basophils;D001491
A15.382.490.315.120;Basophils;D001491
B01.050.150.900.493.602.105;Bass;D001492
N06.850.860.410.110;Bathing Beaches;D001493
E02.056.110;Baths;D001494
E02.779.249.110;Baths;D001494
D20.888.033.112;Batrachotoxins;D001496
D23.946.833.033.112;Batrachotoxins;D001496
I01.880.787.293.292.304;Battered Child Syndrome;D001497
D03.383.725.203.600;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester;D001498
D03.383.725.547.900;3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester;D001498
E05.318.740.600.200;Bayes Theorem;D001499
N05.715.360.750.625.150;Bayes Theorem;D001499
N06.850.520.830.600.200;Bayes Theorem;D001499
D20.215.894.135.825.100;BCG Vaccine;D001500
B03.440.400.425.180;Bdellovibrio;D001501
B03.660.125.050;Bdellovibrio;D001501
A13.114;Beak;D001502
B01.050.150.900.649.147.890;Ursidae;D001503
F02.463.785.477.304;Beauty;D001504
K01.752.210.304;Beauty;D001504
J01.576.112;Beauty Culture;D001505
C16.131.077.133;Beckwith-Wiedemann Syndrome;D001506
C16.131.260.080;Beckwith-Wiedemann Syndrome;D001506
C16.320.180.080;Beckwith-Wiedemann Syndrome;D001506
D04.808.745.432.769.125;Beclomethasone;D001507
D04.808.883.154;Beclomethasone;D001507
N03.349.650.250.080;Bed Conversion;D001508
N02.278.050;Bed Occupancy;D001509
E02.075;Bed Rest;D001510
B01.050.500.131.617.412.420.150.100;Bedbugs;D001511
E07.325.137;Bedding and Linens;D001512
J01.494.221;Bedding and Linens;D001512
E07.325.220;Beds;D001513
D20.888.065.115;Bee Venoms;D001514
D23.946.833.065.115;Bee Venoms;D001514
J02.200.100.200;Beer;D001515
B01.050.500.131.617.479.387;Bees;D001516
B01.050.500.131.617.069;Beetles;D001517
F01.145;Behavior;D001519
F01;Behavior and Behavior Mechanisms;D001520
F04.754.137;Behavior Therapy;D001521
F01.145.113;Behavior, Animal;D001522
F03;Mental Disorders;D001523
F04.096.080;Behavioral Medicine;D001524
H02.403.090;Behavioral Medicine;D001524
F04.096;Behavioral Sciences;D001525
F01.145.126;Behavioral Symptoms;D001526
F02.739.138;Behaviorism;D001527
C07.465.075;Behcet Syndrome;D001528
C11.941.879.780.880.200;Behcet Syndrome;D001528
C14.907.940.100;Behcet Syndrome;D001528
C17.800.862.150;Behcet Syndrome;D001528
Z01.542.115;Belgium;D001530
Z01.107.169.133;Belize;D001531
B01.650.940.800.575.100.905.049.222;Atropa belladonna;D001532
D03.132.760.180;Belladonna Alkaloids;D001533
D03.132.889.180;Belladonna Alkaloids;D001533
D03.383.725.791.100;Bemegride;D001534
D02.241.223.601.238.306.140;Benactyzine;D001535
D02.241.511.085.140;Benactyzine;D001535
D12.776.124.486.485.900.120;Bence Jones Protein;D001536
D12.776.124.790.651.900.120;Bence Jones Protein;D001536
D12.776.377.715.548.900.120;Bence Jones Protein;D001536
D02.455.426.392.368.284.100;Bencyclane;D001537
F04.711.513.180;Bender-Gestalt Test;D001538
F04.711.647.138;Bender-Gestalt Test;D001538
D02.886.590.700.135.138;Bendroflumethiazide;D001539
D02.886.655.500.138;Bendroflumethiazide;D001539
D03.438.174.138;Bendroflumethiazide;D001539
Z01.058.290.190.200;Benin;D001541
D02.241.081.251.125;Benomyl;D001542
D03.438.103.140;Benomyl;D001542
D02.522.352.155;Benperidol;D001544
D02.442.175;Benserazide;D001545
D01.056.050.075.100;Bentonite;D001546
D01.578.725.025.100;Bentonite;D001546
D01.650.550.050.075.100;Bentonite;D001546
D01.837.725.700.760.050.100;Bentonite;D001546
D02.047.222;Benzaldehydes;D001547
D02.092.877.096.040;Benzalkonium Compounds;D001548
D02.675.276.080;Benzalkonium Compounds;D001548
D02.065.277;Benzamides;D001549
D02.241.223.100.100;Benzamides;D001549
D02.455.426.559.389.127.085;Benzamides;D001549
D02.078.100;Benzamidines;D001550
D02.455.426.559.847.149;Benz(a)Anthracenes;D001551
D04.615.149;Benz(a)Anthracenes;D001551
D03.438.079;Benzazepines;D001552
D03.438.127.110;Benzbromarone;D001553
D02.455.426.559.389.023;Benzene;D001554
D02.455.426.559.389;Benzene Derivatives;D001555
D02.455.526.439.600;Lindane;D001556
D02.455.426.559.389.097;Benzenesulfonates;D001557
D02.886.645.600.080.050.100;Benzenesulfonates;D001557
D02.092.877.096.082;Benzethonium;D001558
D02.675.276.090;Benzethonium;D001558
D02.455.426.559.389.115;Benzhydryl Compounds;D001559
D02.455.426.559.389.185.100;Benzidines;D001560
D02.241.223.601.238.306;Benzilates;D001561
D02.241.511.085;Benzilates;D001561
D03.438.103;Benzimidazoles;D001562
D02.455.426.559.847.799.306.300;Benzo(a)pyrene;D001564
D04.615.799.306.300;Benzo(a)pyrene;D001564
D02.241.223.100;Benzoates;D001565
D02.455.426.559.389.127;Benzoates;D001565
D02.241.223.100.050.500.687;Benzocaine;D001566
D02.455.426.559.389.127.020.937.687;Benzocaine;D001566
D02.455.426.559.847.181;Benzocycloheptenes;D001567
D04.615.181;Benzocycloheptenes;D001567
D03.438.079.080;Benzodiazepines;D001569
D03.438.079.080.070;Benzodiazepinones;D001570
D03.438.150.266.450.175;Benzoflavones;D001571
D03.830.219.266.450.175;Benzoflavones;D001571
D03.438.127;Benzofurans;D001572
D02.522.120.100;Benzoin;D001573
D02.065.884.120;Benzolamide;D001574
D02.886.590.700.120;Benzolamide;D001574
D02.886.675.867.120;Benzolamide;D001574
D03.383.129.708.867.120;Benzolamide;D001574
D03.132.577.249.106;Benzomorphans;D001575
D04.615.723.795.106;Benzomorphans;D001575
D02.092.146.215;Benzophenoneidum;D001576
D02.455.426.559.389.115.124;Benzophenones;D001577
D02.522.223;Benzophenones;D001577
D03.438.150;Benzopyrans;D001578
D03.830.219;Benzopyrans;D001578
D08.244.453.040.110;Benzopyrene Hydroxylase;D001579
D08.811.682.690.708.170.040.110;Benzopyrene Hydroxylase;D001579
D12.776.422.220.453.040.110;Benzopyrene Hydroxylase;D001579
D02.455.426.559.847.799.306;Benzopyrenes;D001580
D04.615.799.306;Benzopyrenes;D001580
D02.886.590.700.135;Benzothiadiazines;D001581
D02.886.655.500;Benzothiadiazines;D001581
D03.438.174;Benzothiadiazines;D001581
D02.886.092;Benzothiepins;D001582
D03.438.197;Benzothiepins;D001582
D03.438.221;Benzoxazoles;D001583
D03.438.245;Benzoxepins;D001584
D02.241.223.100.133;Benzoyl Peroxide;D001585
D02.455.426.559.389.127.133;Benzoyl Peroxide;D001585
D02.065.199.200;Benzoylarginine Nitroanilide;D001586
D12.125.068.050.100;Benzoylarginine Nitroanilide;D001586
D12.125.095.104.100;Benzoylarginine Nitroanilide;D001586
D02.065.300;Benzoylarginine-2-Naphthylamide;D001587
D12.125.068.050.095;Benzoylarginine-2-Naphthylamide;D001587
D12.125.095.104.095;Benzoylarginine-2-Naphthylamide;D001587
D02.092.877.883.333.100;Benzoylcholine;D001588
D02.241.223.100.141;Benzoylcholine;D001588
D02.455.426.559.389.127.141;Benzoylcholine;D001588
D02.675.276.232.100;Benzoylcholine;D001588
D02.092.471.683.152.619.307;Benzphetamine;D001589
D02.145.074.722.270;Benztropine;D001590
D03.132.889.244;Benztropine;D001590
D03.605.869.270;Benztropine;D001590
D04.075.080.875.099.722.270;Benztropine;D001590
D03.383.129.539.487.130;Benzydamine;D001591
D03.438.449.130;Benzydamine;D001591
D02.033.160;Benzyl Alcohols;D001592
D02.455.426.559.389.140.200;Benzyl Alcohols;D001592
D02.455.426.559.389.140;Benzyl Compounds;D001593
D03.383.725.762.925.100;Benzyl Viologen;D001594
D08.811.682.664.750.100;Benzylamine Oxidase;D001595
D02.092.200;Benzylamines;D001596
D02.455.426.559.389.140.210;Benzylamines;D001596
D02.455.426.559.389.150;Benzylidene Compounds;D001597
D02.092.877.096.166;Bephenium Compounds;D001598
D02.675.276.102;Bephenium Compounds;D001598
D03.132.098.057.100;Berberine;D001599
D03.549.168.100;Berberine;D001599
D03.132.098.057;Berberine Alkaloids;D001600
D03.549.168;Berberine Alkaloids;D001600
F01.470.142;Bereavement;D001601
C18.654.521.500.133.699.827.223;Beriberi;D001602
D01.268.033.100;Berkelium;D001603
D01.268.271.100.100;Berkelium;D001603
D01.268.556.075;Berkelium;D001603
D01.552.020.150;Berkelium;D001603
D01.552.544.075;Berkelium;D001603
Z01.433.128;Berlin;D001604
Z01.542.315.182;Berlin;D001604
Z01.639.040.390;Bermuda;D001605
C15.378.100.100.080;Bernard-Soulier Syndrome;D001606
C15.378.140.120;Bernard-Soulier Syndrome;D001606
C15.378.463.080;Bernard-Soulier Syndrome;D001606
C16.320.099.080;Bernard-Soulier Syndrome;D001606
C08.381.483.581.225;Berylliosis;D001607
C08.381.520.702.225;Berylliosis;D001607
C24.800.225;Berylliosis;D001607
D01.268.552.075;Beryllium;D001608
D01.268.557.080;Beryllium;D001608
D01.552.547.080;Beryllium;D001608
D12.776.124.790.223;Beta-Globulins;D001609
D12.776.377.715.182;Beta-Globulins;D001609
G01.750.750.125;Beta Particles;D001610
E01.370.376.300.150.750;Beta Rhythm;D001611
E01.370.405.245.287.750;Beta Rhythm;D001611
G07.265.087.750;Beta Rhythm;D001611
G11.561.127.750;Beta Rhythm;D001611
D12.776.124.790.223.100;beta 2-Microglobulin;D001613
D12.776.377.715.182.100;beta 2-Microglobulin;D001613
D08.811.277.450.066.100;beta-Amylase;D001614
D06.472.699.327.935.239;beta-Endorphin;D001615
D06.472.699.631.525.600.239;beta-Endorphin;D001615
D12.644.400.400.935.239;beta-Endorphin;D001615
D12.644.400.575.241.080;beta-Endorphin;D001615
D12.644.468.241.080;beta-Endorphin;D001615
D12.644.548.365.935.239;beta-Endorphin;D001615
D12.644.548.691.525.690.239;beta-Endorphin;D001615
D12.776.641.650.405.935.239;beta-Endorphin;D001615
D12.776.641.650.575.241.080;beta-Endorphin;D001615
D08.811.277.450.410.100;beta-Galactosidase;D001616
D08.811.277.450.420.200.100;beta-Glucosidase;D001617
D08.811.277.087.180;beta-Lactamases;D001618
D08.811.277.450.483.180;beta-N-Acetylhexosaminidases;D001619
D12.644.276.374.200.070;beta-Thromboglobulin;D001620
D12.776.124.125.050;beta-Thromboglobulin;D001620
D12.776.124.790.223.160;beta-Thromboglobulin;D001620
D12.776.377.715.182.160;beta-Thromboglobulin;D001620
D12.776.467.374.200.070;beta-Thromboglobulin;D001620
D23.119.050;beta-Thromboglobulin;D001620
D23.125.300.070;beta-Thromboglobulin;D001620
D23.469.200.070;beta-Thromboglobulin;D001620
D23.529.374.200.070;beta-Thromboglobulin;D001620
D03.383.725.086;Betahistine;D001621
D02.092.877.883.077;Betaine;D001622
D02.675.276.125;Betaine;D001622
D04.808.745.432.769.199;Betamethasone;D001623
D04.808.908.093;Betamethasone;D001623
D04.808.745.432.769.199.150;Betamethasone 17-Valerate;D001624
D04.808.908.093.150;Betamethasone 17-Valerate;D001624
D03.383.129.539.100;Betazole;D001625
D02.092.877.883.088;Bethanechol Compounds;D001626
D02.675.276.148;Bethanechol Compounds;D001626
D02.078.370.120;Bethanidine;D001627
J02.200;Beverages;D001628
D02.065.277.067;Bezafibrate;D001629
D02.241.081.114.968.500.249;Bezafibrate;D001629
D02.241.223.100.100.120;Bezafibrate;D001629
D02.241.223.100.200.249;Bezafibrate;D001629
D02.355.726.305.249;Bezafibrate;D001629
D02.455.426.559.389.127.085.101;Bezafibrate;D001629
D02.455.426.559.389.127.250.249;Bezafibrate;D001629
D02.455.426.559.389.657.654.305.249;Bezafibrate;D001629
C26.392.183;Bezoars;D001630
Z01.252.245.162;Bhutan;D001631
D02.455.426.559.389.140.308;Bibenzyls;D001632
D02.455.426.559.389.150.700.075;Bibenzyls;D001632
K01.517.172;Bible;D001633
L01.178.682.099;Bibliography as Topic;D001634
L01.453.183;Bibliography as Topic;D001634
L01.178.682.099.308;Bibliography of Medicine;D001635
L01.453.183.224;Bibliography of Medicine;D001635
L01.453.183.190;Bibliography, Descriptive;D001636
L01.178.682.099.183;Bibliography, National;D001637
E02.831.169;Bibliotherapy;D001638
F04.754.168;Bibliotherapy;D001638
D01.200.275.150.100;Bicarbonates;D001639
D01.248.497.158.165.100;Bicarbonates;D001639
D03.132.098.077;Bicuculline;D001640
D03.438.531.085.077;Bicuculline;D001640
A14.549.167.860.150;Bicuspid;D001641
I03.450.642.845.140;Bicycling;D001642
D02.455.426.100.080;Bicyclo Compounds;D001643
D04.075.080;Bicyclo Compounds;D001643
B03.510.024.100;Bifidobacterium;D001644
B03.510.460.400.400.049.100;Bifidobacterium;D001644
D02.078.370.141;Biguanides;D001645
A12.200.087;Bile;D001646
D04.808.105;Bile Acids and Salts;D001647
A03.159.183.158.125;Bile Canaliculi;D001648
A03.620.150.125;Bile Canaliculi;D001648
C06.130.120;Bile Duct Diseases;D001649
C04.588.274.120.250;Bile Duct Neoplasms;D001650
C06.130.120.120;Bile Duct Neoplasms;D001650
C06.130.320.120;Bile Duct Neoplasms;D001650
C06.301.120.250;Bile Duct Neoplasms;D001650
C06.130.120.135.150;Cholestasis, Extrahepatic;D001651
A03.159.183;Bile Ducts;D001652
A03.159.183.158;Bile Ducts, Intrahepatic;D001653
A03.620.150;Bile Ducts, Intrahepatic;D001653
D03.383.129.578.840.249;Bile Pigments;D001654
D03.549.909.249;Bile Pigments;D001654
D04.345.783.249;Bile Pigments;D001654
D23.767.193;Bile Pigments;D001654
C06.130.140;Bile Reflux;D001655
C06.405.748.240.140;Bile Reflux;D001655
C06.130.120.123;Biliary Atresia;D001656
C06.198.125;Biliary Atresia;D001656
C16.131.314.125;Biliary Atresia;D001656
C06.130.120.250.098;Biliary Dyskinesia;D001657
C06.267.150;Biliary Fistula;D001658
C23.300.575.185.150;Biliary Fistula;D001658
A03.159;Biliary Tract;D001659
C06.130;Biliary Tract Diseases;D001660
C04.588.274.120;Biliary Tract Neoplasms;D001661
C06.130.320;Biliary Tract Neoplasms;D001661
C06.301.120;Biliary Tract Neoplasms;D001661
E04.210.120;Biliary Tract Surgical Procedures;D001662
D03.383.129.578.840.249.184;Bilirubin;D001663
D03.549.909.249.184;Bilirubin;D001663
D04.345.783.249.184;Bilirubin;D001663
D23.767.193.184;Bilirubin;D001663
D03.383.129.578.840.249.184.200;Biliverdine;D001664
D03.549.909.249.184.200;Biliverdine;D001664
D04.345.783.249.184.200;Biliverdine;D001664
D23.767.193.184.200;Biliverdine;D001664
G02.111.570.120;Binding Sites;D001665
G02.111.570.060.425.079;Binding Sites, Antibody;D001666
G02.111.570.120.408;Binding Sites, Antibody;D001666
G12.125;Binding Sites, Antibody;D001666
G12.425.143.232;Binding Sites, Antibody;D001666
E05.196.080;Binding, Competitive;D001667
G02.111.087.090;Binding, Competitive;D001667
G02.111.570.120.309;Binding, Competitive;D001667
G02.149.115.090;Binding, Competitive;D001667
L01.178.682.099.434;Biobibliography as Topic;D001668
L01.453.183.392;Biobibliography as Topic;D001668
G02.111;Biochemical Phenomena;D001669
H01.158.201;Biochemistry;D001671
H01.181.122;Biochemistry;D001671
D25.130;Biocompatible Materials;D001672
D27.720.102.130;Biocompatible Materials;D001672
J01.637.051.130;Biocompatible Materials;D001672
N06.850.460.375.500;Biodegradation, Environmental;D001673
N06.850.860.510.900.299;Biodegradation, Environmental;D001673
E07.305.124.150;Bioelectric Energy Sources;D001674
K01.316.070;Bioethics;D001675
N05.350.200;Bioethics;D001675
E02.190.525.123;Biofeedback, Psychology;D001676
F02.830.131;Biofeedback, Psychology;D001676
F04.754.137.301;Biofeedback, Psychology;D001676
F04.754.308.500;Biofeedback, Psychology;D001676
L01.143.283.425.624.500;Biofeedback, Psychology;D001676
G16.100.157;Biogenesis;D001678
D02.092.211;Biogenic Amines;D001679
K01.517.211;Biography as Topic;D001680
E05.091;Biological Assay;D001681
G03.787.151;Biological Availability;D001682
G07.690.725.129;Biological Availability;D001682
G07.180.562.094;Biological Clocks;D001683
E07.101.150;Biological Dressings;D001684
D23;Biological Factors;D001685
G16;Biological Phenomena;D001686
D20.215;Biological Agents;D001688
F04.096.544.090;Biological Psychiatry;D001689
H02.403.690.100;Biological Psychiatry;D001689
H01.158;Biological Science Disciplines;D001690
E02.095;Biological Therapy;D001691
G03.495.166;Biological Transport;D001692
G03.495.166.310;Biological Transport, Active;D001693
I01.880.735.944.226;Biological Warfare;D001694
H01.158.273;Biology;D001695
G01.154.090;Biomechanics;D001696
G01.374.089;Biomechanics;D001696
D25;Biomedical and Dental Materials;D001697
D27.720.102;Biomedical and Dental Materials;D001697
J01.637.051;Biomedical and Dental Materials;D001697
H02.070;Biomedical Engineering;D001698
J01.293.140;Biomedical Engineering;D001698
E05.318.740.225;Biometry;D001699
N06.850.505.200;Biometry;D001699
B01.050.500.644.400.750.185;Biomphalaria;D001700
H01.158.344.310;Bionics;D001701
H01.671.100.202;Bionics;D001701
H01.671.293.159;Bionics;D001701
H01.158.703.003;Biopharmaceutics;D001702
H02.628.049;Biopharmaceutics;D001702
H01.158.344;Biophysics;D001703
H01.671.100;Biophysics;D001703
D05.750.078;Biopolymers;D001704
D25.720.099;Biopolymers;D001704
J01.637.051.720.099;Biopolymers;D001704
E07.695.100;Bioprosthesis;D001705
E07.945.750;Bioprosthesis;D001705
E01.370.225.500.384.100;Biopsy;D001706
E01.370.225.998.054;Biopsy;D001706
E01.370.388.100;Biopsy;D001706
E04.074;Biopsy;D001706
E05.200.500.384.100;Biopsy;D001706
E05.200.998.054;Biopsy;D001706
E05.242.384.100;Biopsy;D001706
E01.370.225.500.384.100.119;Biopsy, Needle;D001707
E01.370.225.998.054.119;Biopsy, Needle;D001707
E01.370.388.100.100;Biopsy, Needle;D001707
E04.074.119;Biopsy, Needle;D001707
E04.665.100;Biopsy, Needle;D001707
E05.200.500.384.100.119;Biopsy, Needle;D001707
E05.200.998.054.119;Biopsy, Needle;D001707
E05.242.384.100.119;Biopsy, Needle;D001707
D03.438.733.631.202;Biopterin;D001708
D08.211.090;Biopterin;D001708
H01.158.550;Biotechnology;D001709
J01.897.120;Biotechnology;D001709
D03.383.129.308.080;Biotin;D001710
D08.211.096;Biotin;D001710
G03.495.244;Biotransformation;D001711
G07.690.812.097;Biotransformation;D001711
G07.700.680.097;Biotransformation;D001711
D02.455.426.100.080.100;Biperiden;D001712
D03.383.621.110;Biperiden;D001712
D04.075.080.875.099.332;Biperiden;D001712
D02.455.426.559.389.185;Biphenyl Compounds;D001713
F03.600.150.150;Bipolar Disorder;D001714
C22.131;Bird Diseases;D001715
C08.381.483.125.125;Bird Fancier's Lung;D001716
C08.674.055.125;Bird Fancier's Lung;D001716
C20.543.480.680.075.125;Bird Fancier's Lung;D001716
C24.125;Bird Fancier's Lung;D001716
B01.050.150.900.248;Birds;D001717
G01.590.080;Birefringence;D001718
E05.318.308.940.250;Birth Certificates;D001719
L01.280.900.250;Birth Certificates;D001719
N04.452.859.132;Birth Certificates;D001719
N05.715.360.300.715.175;Birth Certificates;D001719
N06.850.520.308.940.250;Birth Certificates;D001719
C16.614.131;Birth Injuries;D001720
C26.141;Birth Injuries;D001720
I01.240.361.150;Birth Intervals;D001721
N01.224.361.150;Birth Intervals;D001721
F01.829.263.132;Birth Order;D001722
I01.240.361.160;Birth Order;D001722
N01.224.361.160;Birth Order;D001722
N06.850.505.400.400.160;Birth Order;D001722
E05.318.308.985.775.500;Birth Rate;D001723
L01.280.975.775.500;Birth Rate;D001723
N01.224.935.849.500;Birth Rate;D001723
N06.850.505.400.975.775.500;Birth Rate;D001723
N06.850.520.308.985.775.500;Birth Rate;D001723
C23.888.144.186;Birth Weight;D001724
E01.370.600.115.100.160.120.186;Birth Weight;D001724
E05.041.124.160.750.149;Birth Weight;D001724
G07.100.100.160.120.186;Birth Weight;D001724
G07.700.320.249.314.120.186;Birth Weight;D001724
D02.355.601.250;Bis(Chloromethyl) Ether;D001725
D02.455.426.559.389.657.239.132;Bisacodyl;D001726
F01.145.802.975.200;Bisexuality;D001727
G08.686.867.200;Bisexuality;D001727
D03.438.150.446.520.203;Dicumarol;D001728
D03.830.219.446.520.203;Dicumarol;D001728
D01.268.556.100;Bismuth;D001729
D01.552.544.100;Bismuth;D001729
D08.811.399.520.750.250;Bisphosphoglycerate Mutase;D001731
E06.276.125;Bite Force;D001732
C25.723.127;Bites and Stings;D001733
C26.153;Bites and Stings;D001733
C26.153.311;Bites, Human;D001734
D02.455.426.559.389.657.120;Bithionol;D001735
D02.948.117;Biureas;D001736
D02.948.130;Biuret;D001737
E05.196.085;Biuret Reaction;D001738
B04.280.640.615.100;BK Virus;D001739
B04.909.204.210.620.615.100;BK Virus;D001739
B04.909.574.204.670.615.100;BK Virus;D001739
B04.909.675.615.100;BK Virus;D001739
B01.050.500.131.166.803.200;Black Widow Spider;D001740
M01.686.508.100.100;African Americans;D001741
M01.686.754.100;African Americans;D001741
C03.752.530.650.228;Blackwater Fever;D001742
A05.810.890;Urinary Bladder;D001743
C12.777.829.720;Urinary Bladder Calculi;D001744
C12.777.967.500.925;Urinary Bladder Calculi;D001744
C13.351.968.829.521;Urinary Bladder Calculi;D001744
C13.351.968.967.500.925;Urinary Bladder Calculi;D001744
C23.300.175.850.875;Urinary Bladder Calculi;D001744
C12.777.829;Urinary Bladder Diseases;D001745
C13.351.968.829;Urinary Bladder Diseases;D001745
C12.706.132;Bladder Exstrophy;D001746
C12.777.829.132;Bladder Exstrophy;D001746
C13.351.875.132;Bladder Exstrophy;D001746
C13.351.968.829.132;Bladder Exstrophy;D001746
C16.131.939.132;Bladder Exstrophy;D001746
C12.706.881.312;Urinary Bladder Fistula;D001747
C12.777.829.733;Urinary Bladder Fistula;D001747
C13.351.875.881.312;Urinary Bladder Fistula;D001747
C13.351.968.829.548;Urinary Bladder Fistula;D001747
C23.300.575.825.250;Urinary Bladder Fistula;D001747
C12.777.767.700.962;Urinary Bladder Neck Obstruction;D001748
C12.777.829.760;Urinary Bladder Neck Obstruction;D001748
C13.351.968.767.700.850;Urinary Bladder Neck Obstruction;D001748
C13.351.968.829.601;Urinary Bladder Neck Obstruction;D001748
C04.588.945.947.960;Urinary Bladder Neoplasms;D001749
C12.758.820.968;Urinary Bladder Neoplasms;D001749
C12.777.829.813;Urinary Bladder Neoplasms;D001749
C13.351.937.820.945;Urinary Bladder Neoplasms;D001749
C13.351.968.829.707;Urinary Bladder Neoplasms;D001749
C10.597.900;Urinary Bladder, Neurogenic;D001750
C12.777.829.839;Urinary Bladder, Neurogenic;D001750
C13.351.968.829.760;Urinary Bladder, Neurogenic;D001750
C23.888.592.900;Urinary Bladder, Neurogenic;D001750
E04.545.550.280.280.150;Blade Implantation;D001751
E06.231.310.340;Blade Implantation;D001751
E06.645.550.280.280.150;Blade Implantation;D001751
E06.780.314.310.340;Blade Implantation;D001751
C04.557.337.539.250.100;Blast Crisis;D001752
C04.697.152.110;Blast Crisis;D001752
C15.378.190.636.370.100;Blast Crisis;D001752
C23.550.727.152.110;Blast Crisis;D001752
C26.120.126;Blast Injuries;D001753
B01.300.230.150;Blastocladiella;D001754
A16.254.500;Blastocyst;D001755
A16.331.024;Blastoderm;D001756
A11.104;Blastomeres;D001757
A16.094;Blastomeres;D001757
B01.300.381.125;Blastomyces;D001758
C01.539.800.200.055;Blastomycosis;D001759
C01.703.128;Blastomycosis;D001759
C01.703.295.055;Blastomycosis;D001759
C17.800.838.208.055;Blastomycosis;D001759
E01.370.225.625.625.100;Bleeding Time;D001760
E05.200.625.625.100;Bleeding Time;D001760
G09.188.087;Bleeding Time;D001760
D09.400.420.110;Bleomycin;D001761
D12.644.233.110;Bleomycin;D001761
C11.338.133;Blepharitis;D001762
C11.338.204;Blepharoptosis;D001763
C11.338.250;Blepharospasm;D001764
C06.405.469.637.145;Blind Loop Syndrome;D001765
C18.452.603.145;Blind Loop Syndrome;D001765
C10.597.751.941.162;Blindness;D001766
C11.966.075;Blindness;D001766
C23.888.592.763.941.162;Blindness;D001766
G11.561.600.765.127;Blinking;D001767
G14.640.182;Blinking;D001767
C17.800.865.187;Blister;D001768
C23.300.122;Blister;D001768
A12.207.152;Blood;D001769
A15.145;Blood;D001769
G09.188.100;Blood Bactericidal Activity;D001770
G09.188.124.145;Blood Bactericidal Activity;D001770
G12.450.564.204;Blood Bactericidal Activity;D001770
N02.278.065.200;Blood Banks;D001771
E01.370.225.500.195.107;Blood Cell Count;D001772
E01.370.225.625.107;Blood Cell Count;D001772
E05.200.500.195.107;Blood Cell Count;D001772
E05.200.625.107;Blood Cell Count;D001772
E05.242.195.107;Blood Cell Count;D001772
G04.170.107;Blood Cell Count;D001772
G09.188.105;Blood Cell Count;D001772
A11.118;Blood Cells;D001773
A15.145.229;Blood Cells;D001773
E01.370.225.124.100;Blood Chemical Analysis;D001774
E05.200.124.100;Blood Chemical Analysis;D001774
G09.330.190.163;Blood Circulation;D001775
E01.370.370.120;Blood Circulation Time;D001776
G09.188.124.560.150;Blood Coagulation;D001777
C15.378.100;Blood Coagulation Disorders;D001778
D12.776.124.125;Blood Coagulation Factors;D001779
D23.119;Blood Coagulation Factors;D001779
E01.370.225.625.115;Blood Coagulation Tests;D001780
E05.200.625.115;Blood Coagulation Tests;D001780
E02.120;Blood Component Removal;D001781
M01.898.313;Blood Donors;D001782
E01.370.370.130;Blood Flow Velocity;D001783
G09.330.380.630.080;Blood Flow Velocity;D001783
E01.370.225.124.100.100;Blood Gas Analysis;D001784
E01.370.386.700.100;Blood Gas Analysis;D001784
E05.200.124.100.100;Blood Gas Analysis;D001784
E01.370.225.124.100.100.600.100;Blood Gas Monitoring, Transcutaneous;D001785
E01.370.370.380.600.100;Blood Gas Monitoring, Transcutaneous;D001785
E01.370.386.700.100.600.100;Blood Gas Monitoring, Transcutaneous;D001785
E05.200.124.100.100.600.100;Blood Gas Monitoring, Transcutaneous;D001785
D09.546.359.448.500;Blood Glucose;D001786
C15.378.120;Blood Group Incompatibility;D001787
C20.188;Blood Group Incompatibility;D001787
E01.370.225.625.120;Blood Grouping and Crossmatching;D001788
E01.370.225.812.385.120;Blood Grouping and Crossmatching;D001788
E05.200.625.120;Blood Grouping and Crossmatching;D001788
E05.200.812.385.120;Blood Grouping and Crossmatching;D001788
E05.478.594.385.120;Blood Grouping and Crossmatching;D001788
D23.050.301.290;Blood Group Antigens;D001789
D23.050.705.230;Blood Group Antigens;D001789
G09.188;Blood Physiological Phenomena;D001790
C15.378.140;Blood Platelet Disorders;D001791
A11.118.188;Blood Platelets;D001792
A15.145.229.188;Blood Platelets;D001792
E02.792.833.230;Blood Preservation;D001793
E05.760.833.230;Blood Preservation;D001793
E01.370.600.875.249;Blood Pressure;D001794
G09.330.380.076;Blood Pressure;D001794
E01.370.370.140;Blood Pressure Determination;D001795
E01.370.600.100;Blood Pressure Determination;D001795
C15.378.147;Blood Protein Disorders;D001796
E01.370.225.124.100.110;Blood Protein Electrophoresis;D001797
E05.196.401.076;Blood Protein Electrophoresis;D001797
E05.200.124.100.110;Blood Protein Electrophoresis;D001797
E05.301.300.049;Blood Protein Electrophoresis;D001797
D12.776.124;Blood Proteins;D001798
E01.370.225.625.125;Blood Sedimentation;D001799
E05.200.625.125;Blood Sedimentation;D001799
E01.370.225.998.110;Blood Specimen Collection;D001800
E04.665.150;Blood Specimen Collection;D001800
E05.200.998.110;Blood Specimen Collection;D001800
I01.198.780.937.206;Blood Stains;D001801
D27.505.954.502.140;Blood Substitutes;D001802
J01.637.087.249;Blood Substitutes;D001802
E02.095.135;Blood Transfusion;D001803
E02.095.135.164;Blood Transfusion, Autologous;D001804
E02.095.135.264;Blood Transfusion, Intrauterine;D001805
E02.467.500;Blood Transfusion, Intrauterine;D001805
E01.370.225.124.100.115;Blood Urea Nitrogen;D001806
E01.370.390.400.100;Blood Urea Nitrogen;D001806
E05.200.124.100.115;Blood Urea Nitrogen;D001806
E07.695.110;Blood Vessel Prosthesis;D001807
A07.231;Blood Vessels;D001808
G09.188.370.124;Blood Viscosity;D001809
G09.330.380.630.110;Blood Viscosity;D001809
G09.188.130;Blood Volume;D001810
G09.330.380.092;Blood Volume;D001810
E01.370.370.150;Blood Volume Determination;D001811
A07.035;Blood-Brain Barrier;D001812
A08.186.211.035;Blood-Brain Barrier;D001812
A07.040;Blood-Retinal Barrier;D001813
A09.371.729.055;Blood-Retinal Barrier;D001813
A05.360.444.849.700.349;Blood-Testis Barrier;D001814
A07.045;Blood-Testis Barrier;D001814
E02.800.558.500;Bloodletting;D001815
C16.131.077.137;Bloom Syndrome;D001816
C18.452.284.100;Bloom Syndrome;D001816
C02.081.125;Bluetongue;D001819
C02.782.791.315;Bluetongue;D001819
C22.836.120;Bluetongue;D001819
B04.820.630.550.100;Bluetongue virus;D001820
B04.909.777.714.550.100;Bluetongue virus;D001820
F01.145.209.530.136;Blushing;D001821
F02.830.158;Blushing;D001821
E05.799.638.231;Body Burden;D001822
N06.850.460.200;Body Burden;D001822
G02.111.097;Body Composition;D001823
G03.180;Body Composition;D001823
G07.100.049;Body Composition;D001823
E01.370.600.115;Body Constitution;D001824
G07.100;Body Constitution;D001824
A10.082;Body Fluid Compartments;D001825
A12.207.180;Body Fluid Compartments;D001825
A12.207;Body Fluids;D001826
E01.370.600.115.100.160.100;Body Height;D001827
E05.041.124.160.500;Body Height;D001827
G07.100.100.160.100;Body Height;D001827
G07.700.320.249.314.100;Body Height;D001827
F02.463.593.112;Body Image;D001828
A01;Body Regions;D001829
E01.370.600.115.100.231;Body Surface Area;D001830
E05.041.124.231;Body Surface Area;D001830
G07.100.100.231;Body Surface Area;D001830
E01.370.600.875.374;Body Temperature;D001831
G07.110;Body Temperature;D001831
C23.888.119;Body Temperature Changes;D001832
G07.110.232;Body Temperature Regulation;D001833
G07.700.100;Body Temperature Regulation;D001833
G07.700.360.265;Body Temperature Regulation;D001833
A12.207.200;Body Water;D001834
C23.888.144;Body Weight;D001835
E01.370.600.115.100.160.120;Body Weight;D001835
E05.041.124.160.750;Body Weight;D001835
G07.100.100.160.120;Body Weight;D001835
G07.700.320.249.314.120;Body Weight;D001835
C23.888.144.243;Body Weight Changes;D001836
G07.700.320.249.314.120.200;Body Weight Changes;D001836
E01.370.600.115.100;Body Weights and Measures;D001837
E05.041.124;Body Weights and Measures;D001837
G07.100.100;Body Weights and Measures;D001837
Z01.107.757.136;Bolivia;D001838
D06.472.699.100;Bombesin;D001839
D12.644.400.085;Bombesin;D001839
D12.644.548.100;Bombesin;D001839
D12.776.641.650.085;Bombesin;D001839
D20.888.033.137;Bombesin;D001839
D23.946.833.033.137;Bombesin;D001839
E06.095;Dental Bonding;D001840
F02.739.794.624.120;Bonding, Human-Pet;D001841
A02.835.232;Bone and Bones;D001842
A10.165.265;Bone and Bones;D001842
D05.750.716.822.300;Bone Cements;D001843
D25.720.716.822.300;Bone Cements;D001843
D27.720.102.158;Bone Cements;D001843
J01.637.051.720.716.822.300;Bone Cements;D001843
F02.830.816.263.500;Bone Conduction;D001844
G11.561.600.810.263.398;Bone Conduction;D001844
C04.182.089;Bone Cysts;D001845
C05.116.070;Bone Cysts;D001845
G07.700.320.500.325.377.625.100;Bone Development;D001846
G11.427.590.560.100;Bone Development;D001846
C05.116;Bone Diseases;D001847
C05.116.099;Bone Diseases, Developmental;D001848
C05.116.132;Bone Diseases, Endocrine;D001849
C19.149;Bone Diseases, Endocrine;D001849
C01.539.160;Bone Diseases, Infectious;D001850
C05.116.165;Bone Diseases, Infectious;D001850
C05.116.198;Bone Diseases, Metabolic;D001851
E04.555.120;Bone Lengthening;D001852
A15.382.216;Bone Marrow;D001853
A11.148;Bone Marrow Cells;D001854
A15.378.316;Bone Marrow Cells;D001854
C15.378.190;Bone Marrow Diseases;D001855
E01.370.225.625.135;Bone Marrow Examination;D001856
E05.200.625.135;Bone Marrow Examination;D001856
A10.165.265.166;Bone Matrix;D001857
E07.695.120;Bone Nails;D001858
E07.858.442.660.100;Bone Nails;D001858
E07.858.690.650.100;Bone Nails;D001858
C04.588.149;Bone Neoplasms;D001859
C05.116.231;Bone Neoplasms;D001859
E07.695.125;Bone Plates;D001860
E07.858.442.660.110;Bone Plates;D001860
E07.858.690.650.110;Bone Plates;D001860
G11.427.590.195.140;Bone Regeneration;D001861
G16.100.856.150.150;Bone Regeneration;D001861
C05.116.264;Bone Resorption;D001862
G11.427.590.195.150;Bone Resorption;D001862
E07.695.130;Bone Screws;D001863
E07.858.442.660.115;Bone Screws;D001863
E07.858.690.650.115;Bone Screws;D001863
E07.858.442.660.120;Bone Wires;D001864
E07.858.690.650.120;Bone Wires;D001864
D02.241.081.337.075;Bongkrekic Acid;D001865
L01.453.245.250.150;Book Classification;D001867
L01.453.819.250.150;Book Classification;D001867
L01.040;Book Collecting;D001868
L01.178.682.192.122;Book Imprints;D001869
J01.576.154;Book Industry;D001870
L01.737.150;Book Industry;D001870
L01.178.682.192.178;Book Ornamentation;D001871
L01.737.150.340.250;Book Prices;D001872
L01.178.682.150;Book Reviews as Topic;D001873
L01.453.220;Book Selection;D001874
L01.737.150.317;Bookbinding;D001875
L01.178.682.192.234;Bookplates as Topic;D001876
L01.178.682.192;Books;D001877
J01.897.280.500.117;Books, Illustrated;D001878
L01.178.682.192.289;Books, Illustrated;D001878
L01.737.150.340;Bookselling;D001879
D01.132.105;Boranes;D001880
D02.203.087;Boranes;D001880
D01.132.250.075;Borates;D001881
D01.248.497.158.076;Borates;D001881
D02.203.130.075;Borates;D001881
C02.782.350.675.100;Border Disease;D001882
C22.836.160;Border Disease;D001882
F03.675.100;Borderline Personality Disorder;D001883
B03.440.400.425.117.075;Bordetella;D001884
B03.660.075.027.075;Bordetella;D001884
C01.252.400.143;Bordetella Infections;D001885
B03.440.400.425.117.075.550;Bordetella pertussis;D001886
B03.660.075.027.075.600;Bordetella pertussis;D001886
F01.470.192;Boredom;D001887
D01.029.260.093;Boric Acids;D001888
D01.132.250;Boric Acids;D001888
D02.203.130;Boric Acids;D001888
D01.029.260.100;Borinic Acids;D001889
D01.132.275;Borinic Acids;D001889
D02.203.187;Borinic Acids;D001889
C02.782.580.124;Borna Disease;D001890
C22.152;Borna Disease;D001890
B04.820.455.149.135;Borna disease virus;D001891
B04.909.777.455.149.135;Borna disease virus;D001891
D02.455.849.575.781.234;Bornanes;D001892
Z01.252.145.103;Borneo;D001893
Z01.639.160;Borneo;D001893
D01.132.105.050;Borohydrides;D001894
D02.203.087.050;Borohydrides;D001894
D01.268.108;Boron;D001895
D01.268.513.500;Boron;D001895
D01.132;Boron Compounds;D001896
D02.203;Boron Compounds;D001896
D01.029.260.110;Boronic Acids;D001897
D01.132.285;Boronic Acids;D001897
D02.203.200;Boronic Acids;D001897
B03.440.425.410.711.193;Borrelia;D001898
B03.851.595.193;Borrelia;D001898
C01.252.400.155;Borrelia Infections;D001899
C01.252.847.193;Borrelia Infections;D001899
Z01.107.567.875.550.510.210;Boston;D001900
Z01.433.210;Boston;D001900
H01.158.273.118;Botany;D001901
Z01.058.290.175.230;Botswana;D001902
E02.421.150;Bottle Feeding;D001903
F01.145.407.099;Bottle Feeding;D001903
D12.776.124.486.485.114.301.268;Botulinum Antitoxin;D001904
D12.776.124.486.485.114.573.601.268;Botulinum Antitoxin;D001904
D12.776.124.790.651.114.301.268;Botulinum Antitoxin;D001904
D12.776.377.715.548.114.301.268;Botulinum Antitoxin;D001904
D08.811.277.656.300.480.153;Botulinum Toxins;D001905
D08.811.277.656.675.374.153;Botulinum Toxins;D001905
D12.776.097.156;Botulinum Toxins;D001905
D23.946.123.179;Botulinum Toxins;D001905
C01.252.410.222.151;Botulism;D001906
C10.668.758.200;Botulism;D001906
C10.720.150;Botulism;D001906
C25.723.415.151;Botulism;D001906
C01.252.400.780.790.125;Boutonneuse Fever;D001907
C01.252.400.825.125;Boutonneuse Fever;D001907
B04.820.250.700.150;Diarrhea Viruses, Bovine Viral;D001908
B04.909.777.310.700.150;Diarrhea Viruses, Bovine Viral;D001908
B04.820.650.200.600;Leukemia Virus, Bovine;D001909
B04.909.574.807.200.600;Leukemia Virus, Bovine;D001909
B04.909.777.731.200.600;Leukemia Virus, Bovine;D001909
B04.280.382.100.750.200;Herpesvirus 2, Bovine;D001911
B04.909.204.382.100.750.200;Herpesvirus 2, Bovine;D001911
C02.782.350.675.106;Bovine Virus Diarrhea-Mucosal Disease;D001912
C22.196.106;Bovine Virus Diarrhea-Mucosal Disease;D001912
C04.557.470.200.400.130;Bowen's Disease;D001913
C04.557.470.700.400.130;Bowen's Disease;D001913
I03.450.642.845.210;Boxing;D001914
E07.858.442.743.319;Braces;D001915
A07.231.114.139;Brachial Artery;D001916
A08.800.800.720.050;Brachial Plexus;D001917
E02.815.150;Brachytherapy;D001918
C14.280.067.319;Bradycardia;D001919
C23.550.073.300;Bradycardia;D001919
D12.644.276.812.169;Bradykinin;D001920
D12.644.400.090;Bradykinin;D001920
D12.644.456.193;Bradykinin;D001920
D12.776.467.812.169;Bradykinin;D001920
D12.776.641.650.090;Bradykinin;D001920
D23.469.050.375.110;Bradykinin;D001920
D23.529.812.169;Bradykinin;D001920
A08.186.211;Brain;D001921
C01.252.200.100;Brain Abscess;D001922
C01.323;Brain Abscess;D001922
C01.539.830.025.160;Brain Abscess;D001922
C10.228.140.116;Brain Abscess;D001922
C10.228.228.090;Brain Abscess;D001922
C10.228.228.180.100;Brain Abscess;D001922
G02.111.100;Brain Chemistry;D001923
G03.200;Brain Chemistry;D001923
C10.228.140.199.250;Brain Concussion;D001924
C10.900.300.087.125;Brain Concussion;D001924
C10.900.300.350.300;Brain Concussion;D001924
C26.260.118.150;Brain Concussion;D001924
C26.915.300.200.150;Brain Concussion;D001924
C26.974.150;Brain Concussion;D001924
C26.974.382.200;Brain Concussion;D001924
C10.228.140.140;Brain Damage, Chronic;D001925
C10.228.140.151;Brain Death;D001926
C10.597.606.358.800.200.100;Brain Death;D001926
C23.550.260.159;Brain Death;D001926
C10.228.140;Brain Diseases;D001927
C10.228.140.163;Brain Diseases, Metabolic;D001928
C18.452.132;Brain Diseases, Metabolic;D001928
C10.228.140.187;Brain Edema;D001929
C10.228.140.199;Brain Injuries;D001930
C10.900.300.087;Brain Injuries;D001930
C26.260.118;Brain Injuries;D001930
C26.915.300.200;Brain Injuries;D001930
E01.370.350.578.875.500;Brain Mapping;D001931
E01.370.376.537.625.500;Brain Mapping;D001931
E05.629.875.500;Brain Mapping;D001931
C04.588.614.250.195;Brain Neoplasms;D001932
C10.228.140.211;Brain Neoplasms;D001932
C10.551.240.250;Brain Neoplasms;D001932
A08.186.211.132;Brain Stem;D001933
A16.142;Branchial Region;D001934
C04.182.117;Branchioma;D001935
B03.440.400.425.537.525.200;Moraxella (Branhamella) catarrhalis;D001936
B03.660.250.530.525.200;Moraxella (Branhamella) catarrhalis;D001936
B01.650.940.800.575.100.157.200;Brassica;D001937
J02.500.850.150;Brassica;D001937
Z01.107.757.176;Brazil;D001938
J02.500.100;Bread;D001939
A01.236;Breast;D001940
C17.800.090;Breast Diseases;D001941
F01.145.407.199;Breast Feeding;D001942
G07.610.220.500.500;Breast Feeding;D001942
G07.610.593.185;Breast Feeding;D001942
G07.700.620.185;Breast Feeding;D001942
C04.588.180;Breast Neoplasms;D001943
C17.800.090.500;Breast Neoplasms;D001943
E01.370.100;Breath Tests;D001944
E02.190.525.186;Breathing Exercises;D001945
E02.779.474.124;Breathing Exercises;D001945
C13.703.420.183;Breech Presentation;D001946
G08.686.520.150;Breech Presentation;D001946
G08.686.785.760.769.326.520.150;Breech Presentation;D001946
E05.820.150;Breeding;D001947
G05.355.090;Breeding;D001947
C04.557.450.565.590.595.150;Brenner Tumor;D001948
C04.557.470.625.150;Brenner Tumor;D001948
C13.351.500.056.630.705.265;Brenner Tumor;D001948
C13.351.937.418.685.265;Brenner Tumor;D001948
C19.391.630.705.265;Brenner Tumor;D001948
D02.092.877.096.333;Bretylium Compounds;D001949
D02.675.276.175;Bretylium Compounds;D001949
D02.092.877.096.333.150;Bretylium Tosylate;D001950
D02.675.276.175.150;Bretylium Tosylate;D001950
B03.510.024.049.100;Brevibacterium;D001951
B03.510.460.400.400.049.550;Brevibacterium;D001951
D02.455.426.100;Bridged Compounds;D001952
D04.075;Bridged Compounds;D001952
D08.811.277.656.300.099;Brinolase;D001954
Z01.107.567.176.160;British Columbia;D001955
A02.513.170;Broad Ligament;D001956
A05.360.319.114.170;Broad Ligament;D001956
L01.178.682.236;Broadsides as Topic;D001957
D02.455.426.559.389.657.239.180;Brocresine;D001958
D01.139.100;Bromates;D001959
D01.248.497.158.100;Bromates;D001959
D03.438.079.080.070.110;Bromazepam;D001960
D02.455.426.559.389.657.239.190;Bromcresol Green;D001961
D02.455.426.559.389.832.140;Bromcresol Green;D001961
D02.886.590.887.140;Bromcresol Green;D001961
D02.455.426.559.389.657.239.195;Bromcresol Purple;D001962
D02.455.426.559.389.832.150;Bromcresol Purple;D001962
D02.886.590.887.150;Bromcresol Purple;D001962
D08.811.277.656.262.500.096;Bromelains;D001963
D08.811.277.656.300.200.096;Bromelains;D001963
D02.092.146.271;Bromhexine;D001964
D02.092.384.175;Bromhexine;D001964
D01.139.300.050;Bromides;D001965
D01.248.497.158.125;Bromides;D001965
D01.268.380.112;Bromine;D001966
D01.496.749.090;Bromine Radioisotopes;D001967
D02.948.160;Bromisovalum;D001968
D02.455.426.559.389.220;Bromobenzenes;D001969
D02.455.526.368.150;Bromobenzenes;D001969
D02.241.223.100.150;Bromobenzoates;D001970
D02.455.426.559.389.127.150;Bromobenzoates;D001970
D03.132.327.412.100;Bromocriptine;D001971
D03.549.439.131;Bromocriptine;D001971
D03.549.562.100;Bromocriptine;D001971
D03.383.742.680.245.500.250;Bromodeoxycytidine;D001972
D13.570.230.329.100;Bromodeoxycytidine;D001972
D13.570.685.245.500.250;Bromodeoxycytidine;D001972
D03.383.742.680.852.300.150;Bromodeoxyuridine;D001973
D13.570.230.430.196;Bromodeoxyuridine;D001973
D13.570.685.852.300.150;Bromodeoxyuridine;D001973
D02.478.770.150;Bromosuccinimide;D001974
D03.383.773.812.852.150;Bromosuccinimide;D001974
D02.455.526.368.200;Bromotrichloromethane;D001975
D02.455.526.439.224.200;Bromotrichloromethane;D001975
D03.383.742.698.875.237;Bromouracil;D001976
D03.383.725.620.129;Brompheniramine;D001977
D02.455.426.559.389.657.150;Bromphenol Blue;D001978
D02.455.426.559.389.832.180;Bromphenol Blue;D001978
D02.886.590.887.180;Bromphenol Blue;D001978
D02.455.426.559.389.832.200;Bromthymol Blue;D001979
D02.455.849.575.875.200;Bromthymol Blue;D001979
D02.886.590.887.200;Bromthymol Blue;D001979
A04.411.125;Bronchi;D001980
A07.231.114.158;Bronchial Arteries;D001981
C08.127;Bronchial Diseases;D001982
C08.127.196;Bronchial Fistula;D001983
C08.702.196;Bronchial Fistula;D001983
C23.300.575.687.225;Bronchial Fistula;D001983
C04.588.894.797.520.109;Bronchial Neoplasms;D001984
C08.127.265;Bronchial Neoplasms;D001984
C08.785.520.100;Bronchial Neoplasms;D001984
E01.370.386.700.125;Bronchial Provocation Tests;D001985
C08.127.321;Bronchial Spasm;D001986
C08.127.384;Bronchiectasis;D001987
C08.127.446.135;Bronchiolitis;D001988
C08.381.495.146.135;Bronchiolitis;D001988
C08.730.099.135;Bronchiolitis;D001988
C08.127.446.135.140;Bronchiolitis Obliterans;D001989
C08.381.495.146.135.140;Bronchiolitis Obliterans;D001989
C02.109;Bronchiolitis, Viral;D001990
C08.127.446.135.321;Bronchiolitis, Viral;D001990
C08.381.495.146.135.321;Bronchiolitis, Viral;D001990
C08.730.099.135.321;Bronchiolitis, Viral;D001990
C08.127.446;Bronchitis;D001991
C08.381.495.146;Bronchitis;D001991
C08.730.099;Bronchitis;D001991
E05.927.100.500;Bronchoalveolar Lavage Fluid;D001992
D27.505.696.663.050.110;Bronchodilator Agents;D001993
D27.505.954.796.050.100;Bronchodilator Agents;D001993
C04.182.195;Bronchogenic Cyst;D001994
C08.127.480;Bronchogenic Cyst;D001994
C08.695.195;Bronchogenic Cyst;D001994
C16.131.740.195;Bronchogenic Cyst;D001994
E01.370.350.700.730.100;Bronchography;D001995
E01.370.386.100;Bronchography;D001995
C08.127.509;Bronchopneumonia;D001996
C08.381.677.127;Bronchopneumonia;D001996
C08.730.610.127;Bronchopneumonia;D001996
C08.381.520.750.500;Bronchopulmonary Dysplasia;D001997
C16.614.521.125;Bronchopulmonary Dysplasia;D001997
C08.695.214;Bronchopulmonary Sequestration;D001998
C16.131.740.214;Bronchopulmonary Sequestration;D001998
E01.370.386.105;Bronchoscopy;D001999
E01.370.388.250.100;Bronchoscopy;D001999
E04.800.250.100;Bronchoscopy;D001999
E04.928.600.080;Bronchoscopy;D001999
E01.370.386.700.750.100;Bronchospirometry;D002000
A10.165.114.322;Adipose Tissue, Brown;D002001
B03.440.400.425.215.500;Brucella;D002002
B03.660.050.070.100;Brucella;D002002
B03.440.400.425.215.500.100;Brucella abortus;D002003
B03.660.050.070.100.100;Brucella abortus;D002003
D20.215.894.135.134;Brucella Vaccine;D002004
C01.252.400.167;Brucellosis;D002006
C01.252.400.167.322;Brucellosis, Bovine;D002007
C22.021.322;Brucellosis, Bovine;D002007
C22.196.148;Brucellosis, Bovine;D002007
B01.050.500.500.294.700.750.700.300.088;Brugia;D002009
Z01.252.145.130;Brunei;D002010
A03.556.124.684.124.322;Brunner Glands;D002011
A03.556.875.249.322;Brunner Glands;D002011
C07.793.099;Bruxism;D002012
B01.050.500.217;Bryozoa;D002013
D02.241.081.069.366.200;Bucrylate;D002015
D02.626.290.200;Bucrylate;D002015
D05.750.259.341.110;Bucrylate;D002015
D25.720.259.341.110;Bucrylate;D002015
D25.919.367.341.110;Bucrylate;D002015
J01.637.051.720.259.341.110;Bucrylate;D002015
J01.637.051.919.367.341.110;Bucrylate;D002015
K01.844.117;Buddhism;D002016
N03.219.463.060;Budgets;D002017
D04.808.155.580.064;Bufanolides;D002018
D02.065.064.294.088;Bufexamac;D002019
D02.092.570.394.150;Bufexamac;D002019
D02.241.511.372.150;Bufexamac;D002019
D02.455.426.559.389.048.088;Bufexamac;D002019
B01.050.150.900.649.077.380.135;Buffaloes;D002020
D27.720.470.280;Buffers;D002021
B01.050.150.900.090.180.210.080;Bufo arenarum;D002022
B01.050.150.900.090.180.210.108;Bufo bufo;D002023
B01.050.150.900.090.180.210.580;Bufo marinus;D002024
B01.050.150.900.090.180.210;Bufonidae;D002025
D02.078.370.141.075;Buformin;D002026
D03.438.473.914.237.150;Bufotenin;D002027
D03.438.473.914.814.150;Bufotenin;D002027
D20.888.033.163;Bufotenin;D002027
D23.946.833.033.163;Bufotenin;D002027
N02.278.200.100;Building Codes;D002028
A05.360.444.123;Bulbourethral Glands;D002030
A10.336.197;Bulbourethral Glands;D002030
Z01.542.248.180;Bulgaria;D002031
C23.888.821.645.500;Bulimia;D002032
B01.050.500.644.400.750.323;Bulinus;D002033
D02.065.884.150;Bumetanide;D002034
D02.241.223.100.050.300.200;Bumetanide;D002034
D02.455.426.559.389.127.020.452.500;Bumetanide;D002034
D02.886.590.700.150;Bumetanide;D002034
D02.455.426.559.847.638.120;Bunaftine;D002035
D04.615.638.120;Bunaftine;D002035
A07.541.409.273;Bundle of His;D002036
C14.280.067.558.323;Bundle-Branch Block;D002037
C23.550.073.425.100;Bundle-Branch Block;D002037
D20.888.850.325.139;Bungarotoxins;D002038
D23.946.833.850.325.139;Bungarotoxins;D002038
D02.033.100.624.500;Levobunolol;D002040
D02.033.100.624.698.512;Levobunolol;D002040
D02.033.755.624.500;Levobunolol;D002040
D02.033.755.624.698.512;Levobunolol;D002040
D02.092.063.624.698.512;Levobunolol;D002040
D02.455.426.559.847.638.960.492;Levobunolol;D002040
D04.615.638.960.492;Levobunolol;D002040
B04.820.087.640.147;Bunyamwera virus;D002042
B04.909.777.147.640.147;Bunyamwera virus;D002042
B04.820.087;Bunyaviridae;D002043
B04.909.777.147;Bunyaviridae;D002043
C02.782.147;Bunyaviridae Infections;D002044
D02.065.199.239;Bupivacaine;D002045
D03.383.621.758.323;Bupivacaine;D002045
D02.033.100.624.160;Bupranolol;D002046
D02.033.100.624.698.146;Bupranolol;D002046
D02.033.755.624.160;Bupranolol;D002046
D02.033.755.624.698.146;Bupranolol;D002046
D02.092.063.624.698.146;Bupranolol;D002046
D03.132.577.249.150;Buprenorphine;D002047
D03.549.686.150;Buprenorphine;D002047
D03.605.497.150;Buprenorphine;D002047
D04.615.723.795.150;Buprenorphine;D002047
I01.076.201.450.550.150;Burial;D002048
D02.886.904.200;Burimamide;D002049
D02.948.898.200;Burimamide;D002049
Z01.058.290.190.245;Burkina Faso;D002050
C02.256.466.313.165;Burkitt Lymphoma;D002051
C02.928.313.165;Burkitt Lymphoma;D002051
C04.557.386.480.100;Burkitt Lymphoma;D002051
C04.557.386.480.150.165;Burkitt Lymphoma;D002051
C04.619.935.313.165;Burkitt Lymphoma;D002051
C04.925.313.165;Burkitt Lymphoma;D002051
C15.604.515.569.480.100;Burkitt Lymphoma;D002051
C15.604.515.569.480.150.165;Burkitt Lymphoma;D002051
C20.683.515.761.480.100;Burkitt Lymphoma;D002051
C20.683.515.761.480.150.165;Burkitt Lymphoma;D002051
Z01.252.145.570;Myanmar;D002052
N02.278.388.493.160;Burn Units;D002053
C07.465.114;Burning Mouth Syndrome;D002054
F02.830.900.110;Burnout, Professional;D002055
C26.200;Burns;D002056
C26.200.156;Burns, Chemical;D002057
C26.200.239;Burns, Electric;D002058
C26.324.323;Burns, Electric;D002058
C26.200.322;Burns, Inhalation;D002059
A10.549.175;Bursa of Fabricius;D002060
A13.163;Bursa of Fabricius;D002060
A15.382.520.604.114;Bursa of Fabricius;D002060
A02.835.583.156;Bursa, Synovial;D002061
C05.550.251;Bursitis;D002062
Z01.058.290.120.180;Burundi;D002063
D06.472.699.327.740.320.100;Buserelin;D002064
D12.644.400.400.740.320.100;Buserelin;D002064
D12.644.456.460.150;Buserelin;D002064
D12.644.548.365.740.320.100;Buserelin;D002064
D12.776.641.650.405.740.320.100;Buserelin;D002064
D02.455.426.559.847.885.120;Buspirone;D002065
D03.383.742.120;Buspirone;D002065
D04.615.885.120;Buspirone;D002065
D02.033.455.125.125;Busulfan;D002066
D02.455.326.146.100.050.500.100;Busulfan;D002066
D02.886.645.600.055.050.510.100;Busulfan;D002066
D02.455.426.559.847.181.384.230;Butaclamol;D002069
D04.615.181.384.230;Butaclamol;D002069
D02.455.326.271.665.146.240;Butadienes;D002070
D02.033.455.125;Butylene Glycols;D002072
D02.455.326.146.216;Butanes;D002073
D02.522.296;Butanones;D002074
D09.408.051.120;Butirosin Sulfate;D002076
D03.132.577.249.165;Butorphanol;D002077
D03.549.686.165;Butorphanol;D002077
D03.605.497.165;Butorphanol;D002077
D04.615.723.795.165;Butorphanol;D002077
D02.092.471.683.221;Butoxamine;D002078
D10.212.302.199;Butter;D002079
J02.500.350.100;Butter;D002079
J02.500.375.200;Butter;D002079
B01.050.500.131.617.561.200;Butterflies;D002080
A01.378.610.100;Buttocks;D002081
D02.092.264;Butylamines;D002082
D02.355.601.200.324;Butylated Hydroxyanisole;D002083
D02.355.726.158.324;Butylated Hydroxyanisole;D002083
D02.455.426.559.389.657.654.158.324;Butylated Hydroxyanisole;D002083
D02.455.426.559.389.657.239.216;Butylated Hydroxytoluene;D002084
D02.654.442.100;Butylhydroxybutylnitrosamine;D002085
D02.092.877.310;Butylscopolammonium Bromide;D002086
D02.145.074.722.900.700.200;Butylscopolammonium Bromide;D002086
D03.132.889.848.661.200;Butylscopolammonium Bromide;D002086
D03.605.869.900.700.200;Butylscopolammonium Bromide;D002086
D04.075.080.875.099.722.900.700.200;Butylscopolammonium Bromide;D002086
D02.241.081.114;Butyrates;D002087
D10.251.400.143;Butyrates;D002087
D02.522.352;Butyrophenones;D002090
D08.811.277.352.100.170.250;Butyrylcholinesterase;D002091
D02.092.877.883.333.800.200;Butyrylthiocholine;D002092
D02.675.276.232.800.200;Butyrylthiocholine;D002092
D02.886.489.789.200;Butyrylthiocholine;D002092
D02.092.146.290;Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide;D002093
Z01.542.248.700;Republic of Belarus;D002094
Z01.586.200.650;Republic of Belarus;D002094
Z01.586.950.600;Republic of Belarus;D002094
C08.381.483.581.275;Byssinosis;D002095
C08.381.520.702.275;Byssinosis;D002095
C24.800.323;Byssinosis;D002095
D06.472.699.587.200.500.250;C-Peptide;D002096
D12.644.548.586.200.500.250;C-Peptide;D002096
D12.776.034.145;C-Reactive Protein;D002097
D12.776.124.050.120;C-Reactive Protein;D002097
D12.776.124.486.157;C-Reactive Protein;D002097
B01.650.940.800.575.100.915.144;Cacao;D002099
C23.888.144.243.963.500.500;Cachexia;D002100
D02.691.088.100;Cacodylic Acid;D002101
C23.550.260.224;Cadaver;D002102
D02.092.211.415.261;Cadaverine;D002103
D02.092.782.258.174;Cadaverine;D002103
D01.268.556.137;Cadmium;D002104
D01.268.956.061;Cadmium;D002104
D01.552.544.137;Cadmium;D002104
C25.723.165;Cadmium Poisoning;D002105
D01.496.749.108;Cadmium Radioisotopes;D002106
B01.050.500.500.294.700.700.660.250;Caenorhabditis;D002107
D12.644.456.241;Caerulein;D002108
D02.241.223.200.054;Caffeic Acids;D002109
D03.132.960.175;Caffeine;D002110
D03.438.759.758.824.175;Caffeine;D002110
A02.835.232.043.300.710.300;Calcaneus;D002111
D04.808.247.222.159.478.250;Calcifediol;D002112
D04.808.247.808.146.478.250;Calcifediol;D002112
D04.808.812.768.196.478.250;Calcifediol;D002112
D10.570.938.146.478.250;Calcifediol;D002112
G07.700.320.186;Calcification, Physiologic;D002113
G07.700.320.500.325.377.625.100.175;Calcification, Physiologic;D002113
G11.427.590.560.100.175;Calcification, Physiologic;D002113
C18.452.174.130;Calcinosis;D002114
C18.452.174.130.186;Calciphylaxis;D002115
D06.472.699.150;Calcitonin;D002116
D12.644.400.095;Calcitonin;D002116
D12.644.548.150;Calcitonin;D002116
D12.776.641.650.095;Calcitonin;D002116
D04.808.247.222.159.478.387.300;Calcitriol;D002117
D04.808.247.808.146.478.387.300;Calcitriol;D002117
D04.808.812.768.196.478.387.300;Calcitriol;D002117
D10.570.938.146.478.387.300;Calcitriol;D002117
D01.268.552.100;Calcium;D002118
D01.552.539.288;Calcium;D002118
D23.119.100;Calcium;D002118
D01.146.275;Calcium Carbonate;D002119
D01.200.275.150.150;Calcium Carbonate;D002119
D01.578.200;Calcium Carbonate;D002119
D27.505.519.562.124;Calcium Channel Agonists;D002120
D27.505.954.411.793.205;Calcium Channel Agonists;D002120
D27.505.519.562.249;Calcium Channel Blockers;D002121
D27.505.954.411.192;Calcium Channel Blockers;D002121
D01.146.300;Calcium Chloride;D002122
D01.210.450.150.150;Calcium Chloride;D002122
D02.455.426.559.389.097.120;Calcium Dobesilate;D002123
D02.886.645.600.080.050.100.075;Calcium Dobesilate;D002123
D01.146.325;Calcium Fluoride;D002124
D01.303.350.300.150;Calcium Fluoride;D002124
D02.241.081.844.322.200;Calcium Gluconate;D002125
D02.241.511.902.322.200;Calcium Gluconate;D002125
D09.811.308.200;Calcium Gluconate;D002125
D01.146.335;Calcium Hydroxide;D002126
D01.455.275;Calcium Hydroxide;D002126
D01.496.098;Calcium Isotopes;D002127
C18.452.174;Calcium Metabolism Disorders;D002128
D02.241.081.337.593.750.500;Calcium Oxalate;D002129
D01.146.360;Calcium Phosphates;D002130
D01.695.625.675.650.075;Calcium Phosphates;D002130
D01.146.360.150;Calcium Pyrophosphate;D002131
D01.695.625.675.650.075.150;Calcium Pyrophosphate;D002131
D01.695.625.675.650.775.150.150;Calcium Pyrophosphate;D002131
D01.496.098.325;Calcium Radioisotopes;D002132
D01.496.749.113;Calcium Radioisotopes;D002132
D01.146.375;Calcium Sulfate;D002133
D01.578.215;Calcium Sulfate;D002133
D01.875.800.800.850.125;Calcium Sulfate;D002133
D12.776.157.125.130;Calcium-Binding Protein, Vitamin D-Dependent;D002134
D12.776.157.125;Calcium-Binding Proteins;D002135
D01.146.315;Calcium, Dietary;D002136
C23.300.175;Calculi;D002137
E05.140;Calibration;D002138
E05.978.155;Calibration;D002138
B04.820.095;Caliciviridae;D002139
B04.909.777.162;Caliciviridae;D002139
Z01.107.567.875.580.200;California;D002140
Z01.107.567.875.760.200;California;D002140
B04.820.087.640.300;Encephalitis Virus, California;D002141
B04.909.777.147.640.300;Encephalitis Virus, California;D002141
B04.909.777.270.100;Encephalitis Virus, California;D002141
D01.268.033.150;Californium;D002142
D01.268.271.100.150;Californium;D002142
D01.268.556.156;Californium;D002142
D01.552.020.200;Californium;D002142
D01.552.544.156;Californium;D002142
B01.050.150.900.649.801.400.600.150.150;Callitrichinae;D002143
B01.050.150.900.649.801.400.600.150.150.114;Callithrix;D002144
C17.800.428.200;Callosities;D002145
A10.165.265.200;Bony Callus;D002146
D12.644.360.381.249;Calmodulin;D002147
D12.776.157.125.412.249;Calmodulin;D002147
D12.776.476.387.249;Calmodulin;D002147
D12.776.157.142;Calmodulin-Binding Proteins;D002148
G07.610.240.340;Energy Intake;D002149
E01.370.382.900.150;Caloric Tests;D002150
E05.145;Calorimetry;D002151
E05.196.131;Calorimetry;D002151
E05.196.131.310;Calorimetry, Differential Scanning;D002152
E05.196.370.310;Calorimetry, Differential Scanning;D002152
E05.145.250;Calorimetry, Indirect;D002153
D08.811.277.656.262.500.120;Calpain;D002154
D08.811.277.656.300.200.120;Calpain;D002154
D12.776.157.125.155;Calsequestrin;D002155
D12.776.210.500.220;Calsequestrin;D002155
B03.440.450.425.180;Calymmatobacterium;D002157
B03.660.250.150.095;Calymmatobacterium;D002157
D03.438.103.190;Cambendazole;D002159
Z01.252.145.182;Cambodia;D002160
B01.050.150.900.649.077.380.175;Camelids, New World;D002161
B01.050.150.900.649.077.380.201;Camels;D002162
Z01.058.290.100.110;Cameroon;D002163
D02.455.849.575.781.234.326;Camphor;D002164
D02.522.376;Camphor;D002164
I03.450.642.159;Camping;D002165
D03.132.151;Camptothecin;D002166
B03.440.180;Campylobacter;D002167
B03.660.150.100;Campylobacter;D002167
B03.440.180.325;Campylobacter fetus;D002168
B03.660.150.100.220;Campylobacter fetus;D002168
C01.252.400.177;Campylobacter Infections;D002169
Z01.107.567.176;Canada;D002170
B01.050.150.900.248.620.750.250.150;Canaries;D002171
D12.125.311;Canavanine;D002172
N02.278.421.556.070;Cancer Care Facilities;D002173
D02.540.505.125;Candicidin;D002174
B01.300.381.147;Candida;D002175
B01.300.930.176;Candida;D002175
B01.300.381.147.326;Candida albicans;D002176
B01.300.930.176.326;Candida albicans;D002176
C01.703.160;Candidiasis;D002177
C01.539.800.200.100;Candidiasis, Chronic Mucocutaneous;D002178
C01.703.160.165;Candidiasis, Chronic Mucocutaneous;D002178
C01.703.295.165;Candidiasis, Chronic Mucocutaneous;D002178
C17.800.838.208.165;Candidiasis, Chronic Mucocutaneous;D002178
C01.539.800.200.105;Candidiasis, Cutaneous;D002179
C01.703.160.170;Candidiasis, Cutaneous;D002179
C01.703.295.170;Candidiasis, Cutaneous;D002179
C17.800.838.208.170;Candidiasis, Cutaneous;D002179
C01.703.160.180;Candidiasis, Oral;D002180
C07.465.130;Candidiasis, Oral;D002180
C01.703.160.190;Candidiasis, Vulvovaginal;D002181
C13.351.500.894.906.820.500;Candidiasis, Vulvovaginal;D002181
C13.351.500.944.902.737.500;Candidiasis, Vulvovaginal;D002181
J02.500.140;Candy;D002182
E07.858.442.250;Canes;D002183
B04.280.382.100.900.420;Herpesvirus 1, Canid;D002184
B04.909.204.382.100.900.420;Herpesvirus 1, Canid;D002184
D02.455.849.090.100;Cannabidiol;D002185
D02.455.849.090;Cannabinoids;D002186
D02.455.849.090.110;Cannabinol;D002187
B01.650.940.800.575.100.175.500;Cannabis;D002188
C25.635;Marijuana Abuse;D002189
F03.900.635;Marijuana Abuse;D002189
F01.145.113.547.200;Cannibalism;D002190
D04.808.745.432.100;Canrenoate Potassium;D002191
D04.808.745.432.120;Canrenone;D002192
D03.438.127.125;Cantharidin;D002193
F03.700.300;Capgras Syndrome;D002194
B01.050.500.500.294.100.275.780.180;Capillaria;D002195
A07.231.461.165;Capillaries;D002196
G02.842.850.327;Capillary Action;D002197
E01.370.370.170;Capillary Fragility;D002198
G09.330.160;Capillary Fragility;D002198
G03.495.166.330;Capillary Permeability;D002199
G09.330.165;Capillary Permeability;D002199
G09.330.380.921.327;Capillary Resistance;D002200
N03.219.151.450.200;Capital Expenditures;D002201
N03.219.463.085;Capital Financing;D002202
I01.880.604.160;Capital Punishment;D002203
N03.219.442.090;Capitation Fee;D002204
C05.550.114.154.219;Caplan Syndrome;D002205
C05.799.114.219;Caplan Syndrome;D002205
C08.381.483.581.300;Caplan Syndrome;D002205
C08.381.520.702.300;Caplan Syndrome;D002205
C17.300.775.099.219;Caplan Syndrome;D002205
C24.800.340;Caplan Syndrome;D002205
B03.140.190.100;Capnocytophaga;D002206
B03.440.450.340;Capnocytophaga;D002206
D04.345.566.142;Capreomycin;D002207
D12.644.641.142;Capreomycin;D002207
D02.241.081.193;Caproates;D002208
D10.251.400.326;Caproates;D002208
D02.065.589.200;Caprolactam;D002209
D03.383.066.150;Caprolactam;D002209
D03.383.411.200;Caprolactam;D002209
D02.241.081.222;Caprylates;D002210
D10.251.122;Caprylates;D002210
D02.065.160.500;Capsaicin;D002211
D02.455.326.271.060.222;Capsaicin;D002211
D02.455.426.559.389.657.166.099;Capsaicin;D002211
D03.132.760.200;Capsaicin;D002211
D10.251.355.325.190;Capsaicin;D002211
B01.650.940.800.575.100.905.145;Capsicum;D002212
J02.500.850.175;Capsicum;D002212
A21.249.500.250;Capsid;D002213
B04.950.500.250;Capsid;D002213
D26.255.150;Capsules;D002214
D27.720.280.150;Capsules;D002214
D03.438.513.124;Captan;D002215
D12.125.072.401.623.270;Captopril;D002216
D02.092.877.883.333.115;Carbachol;D002217
D02.675.276.232.115;Carbachol;D002217
D02.241.081.251.140;Carbadox;D002218
D03.438.857.140;Carbadox;D002218
D02.241.081.251;Carbamates;D002219
D03.494.240.127;Carbamazepine;D002220
D02.241.081.251.145;Carbamyl Phosphate;D002221
D02.705.400.100;Carbamyl Phosphate;D002221
D08.811.464.259.350;Carbamoyl-Phosphate Synthase (Ammonia);D002222
D08.811.464.259.400.300;Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing);D002223
D02.065.199.326;Carbanilides;D002224
D02.948.684.202;Carbanilides;D002224
D02.806.250.180;Carbazilquinone;D002225
D03.383.097.217.300;Carbazilquinone;D002225
D03.438.473.144;Carbazoles;D002227
D03.494.148;Carbazoles;D002227
D02.065.589.099.750.750.170;Carbenicillin;D002228
D02.886.108.750.750.170;Carbenicillin;D002228
D03.438.260.825.750.170;Carbenicillin;D002228
D03.605.084.737.750.170;Carbenicillin;D002228
D04.075.080.875.099.221.750.750.170;Carbenicillin;D002228
D02.455.849.919.530.444.250;Carbenoxolone;D002229
D02.092.311.200.538.200;Carbidopa;D002230
D02.442.200;Carbidopa;D002230
D03.383.129.308.108;Carbimazole;D002231
D02.455.326.397.300;Carbocyanines;D002232
D02.886.030.230.310;Carbocysteine;D002233
D12.125.119.270;Carbocysteine;D002233
D12.125.166.230.310;Carbocysteine;D002233
D02.491.203;Carbodiimides;D002234
D02.241.081.251.583.166;Carbofuran;D002235
G02.111.570.790.235;Carbohydrate Conformation;D002236
D08.811.682.047.150;Carbohydrate Dehydrogenases;D002237
D08.811.399.894.500;Carbohydrate Epimerases;D002238
C16.320.565.202;Carbohydrate Metabolism, Inborn Errors;D002239
C18.452.648.202;Carbohydrate Metabolism, Inborn Errors;D002239
G02.111.570.160;Carbohydrate Sequence;D002240
L01.453.245.667.160;Carbohydrate Sequence;D002240
D09;Carbohydrates;D002241
D03.383.725.150;Carbolines;D002243
D03.438.473.155;Carbolines;D002243
D03.494.154;Carbolines;D002243
D01.268.150;Carbon;D002244
D01.200.200;Carbon Dioxide;D002245
D01.362.150;Carbon Dioxide;D002245
D01.650.550.200;Carbon Dioxide;D002245
D01.200.210;Carbon Disulfide;D002246
D01.875.350.850.074;Carbon Disulfide;D002246
D01.496.123;Carbon Isotopes;D002247
D01.200.250;Carbon Monoxide;D002248
D01.362.200;Carbon Monoxide;D002248
D01.650.550.250;Carbon Monoxide;D002248
C25.723.455.245;Carbon Monoxide Poisoning;D002249
D01.496.123.328;Carbon Radioisotopes;D002250
D01.496.749.154;Carbon Radioisotopes;D002250
D02.455.526.439.150;Carbon Tetrachloride;D002251
C25.723.177;Carbon Tetrachloride Poisoning;D002252
J02.200.300;Carbonated Beverages;D002253
D01.045.125;Carbonates;D002254
D01.200.275.150;Carbonates;D002254
D01.248.497.158.165;Carbonates;D002254
D01.029.260.150;Carbonic Acid;D002255
D01.200.275;Carbonic Acid;D002255
D08.811.520.241.300.150;Carbonic Anhydrases;D002256
D27.505.519.389.200;Carbonic Anhydrase Inhibitors;D002257
D02.442.288.200;Carbonyl Cyanide m-Chlorophenyl Hydrazone;D002258
D02.626.260;Carbonyl Cyanide m-Chlorophenyl Hydrazone;D002258
D02.442.288.220;Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone;D002259
D02.626.270;Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone;D002259
D10.251.355.255.550.700.500.150;Carboprost;D002260
D23.469.700.670.150;Carboprost;D002260
D02.065.199.350;Carboxin;D002261
D03.383.517.200;Carboxin;D002261
D08.811.520.224.125;Carboxy-Lyases;D002262
D12.776.124.400.141;Carboxyhemoglobin;D002263
D12.776.422.316.762.149;Carboxyhemoglobin;D002263
D02.241;Carboxylic Acids;D002264
D08.811.277.352.100;Carboxylic Ester Hydrolases;D002265
D09.698.365.180.663.329;Carboxymethylcellulose Sodium;D002266
D08.811.277.656.350.245.500;Muramoylpentapeptide Carboxypeptidase;D002267
D08.811.277.656.350.245;Carboxypeptidases;D002268
C01.252.410.868.820.270.200;Carbuncle;D002270
C01.252.825.770.270.200;Carbuncle;D002270
C01.539.800.720.770.270.200;Carbuncle;D002270
C17.800.838.765.770.270.200;Carbuncle;D002270
D02.886.590.795.204;Carbutamide;D002271
D02.948.828.204;Carbutamide;D002271
D12.776.395.550.200.210;Carcinoembryonic Antigen;D002272
D12.776.543.550.200.210;Carcinoembryonic Antigen;D002272
D23.050.285.329;Carcinoembryonic Antigen;D002272
D23.050.301.350.210;Carcinoembryonic Antigen;D002272
D23.101.840.300;Carcinoembryonic Antigen;D002272
D27.888.569.100;Carcinogens;D002273
D27.888.284.198;Carcinogens, Environmental;D002274
D27.888.569.100.125;Carcinogens, Environmental;D002274
C04.557.465.625.650.200.500.205;Carcinoid Heart Disease;D002275
C04.557.470.200.025.200.500.205;Carcinoid Heart Disease;D002275
C04.557.580.625.650.200.500.205;Carcinoid Heart Disease;D002275
C14.280.104;Carcinoid Heart Disease;D002275
C04.557.465.625.650.200;Carcinoid Tumor;D002276
C04.557.470.200.025.200;Carcinoid Tumor;D002276
C04.557.580.625.650.200;Carcinoid Tumor;D002276
C04.557.470.200;Carcinoma;D002277
C04.557.470.200.240;Carcinoma in Situ;D002278
C04.557.435.290.210;Carcinoma 256, Walker;D002279
C04.557.450.795.290.210;Carcinoma 256, Walker;D002279
C04.619.045;Carcinoma 256, Walker;D002279
C04.557.470.200.165;Carcinoma, Basal Cell;D002280
C04.557.470.565.165;Carcinoma, Basal Cell;D002280
C04.557.470.200.170;Carcinoma, Basosquamous;D002281
C04.557.470.565.170;Carcinoma, Basosquamous;D002281
C04.557.470.200.025.030;Adenocarcinoma, Bronchiolo-Alveolar;D002282
C04.588.894.797.520.109.220;Carcinoma, Bronchogenic;D002283
C08.381.540.140;Carcinoma, Bronchogenic;D002283
C08.785.520.100.220;Carcinoma, Bronchogenic;D002283
C04.619.124;Carcinoma, Brown-Pearce;D002284
C04.557.470.200.025.275;Carcinoma, Intraductal, Noninfiltrating;D002285
C04.557.470.615.275;Carcinoma, Intraductal, Noninfiltrating;D002285
C04.557.470.200.200;Carcinoma, Ehrlich Tumor;D002286
C04.619.169;Carcinoma, Ehrlich Tumor;D002286
C04.557.470.200.255;Carcinoma, Krebs 2;D002287
C04.619.214;Carcinoma, Krebs 2;D002287
C04.557.470.200.025.075;Adenocarcinoma, Mucinous;D002288
C04.557.470.590.075;Adenocarcinoma, Mucinous;D002288
C04.588.894.797.520.109.220.249;Carcinoma, Non-Small-Cell Lung;D002289
C08.381.540.140.500;Carcinoma, Non-Small-Cell Lung;D002289
C08.785.520.100.220.500;Carcinoma, Non-Small-Cell Lung;D002289
C04.557.470.200.360;Carcinoma, Papillary;D002291
C04.557.470.700.360;Carcinoma, Papillary;D002291
C04.557.470.200.025.390;Carcinoma, Renal Cell;D002292
C04.588.945.947.535.160;Carcinoma, Renal Cell;D002292
C12.758.820.750.160;Carcinoma, Renal Cell;D002292
C12.777.419.473.160;Carcinoma, Renal Cell;D002292
C13.351.937.820.535.160;Carcinoma, Renal Cell;D002292
C13.351.968.419.473.160;Carcinoma, Renal Cell;D002292
C04.557.470.200.025.095;Adenocarcinoma, Scirrhous;D002293
C04.557.470.200.400;Carcinoma, Squamous Cell;D002294
C04.557.470.700.400;Carcinoma, Squamous Cell;D002294
C04.557.470.200.430;Carcinoma, Transitional Cell;D002295
C04.557.435.290;Carcinosarcoma;D002296
C04.557.450.795.290;Carcinosarcoma;D002296
D04.808.155;Cardanolides;D002297
D04.808.155.160;Cardenolides;D002298
D04.808.155.580.130;Cardenolides;D002298
A03.556.875.875.163;Cardia;D002299
N02.278.421.556.110;Cardiac Care Facilities;D002300
D04.808.155.580;Cardiac Glycosides;D002301
D09.408.180;Cardiac Glycosides;D002301
E01.370.370.380.150;Cardiac Output;D002302
G09.330.380.124;Cardiac Output;D002302
C14.280.148;Cardiac Output, Low;D002303
C23.888.192;Cardiac Output, Low;D002303
E02.342.124;Cardiac Pacing, Artificial;D002304
C14.280.155;Cardiac Tamponade;D002305
G09.330.380.249;Cardiac Volume;D002306
E01.370.370.380.160;Cardiography, Impedance;D002307
E01.370.370.610.610.200;Cardiography, Impedance;D002307
E01.370.610.610.200;Cardiography, Impedance;D002307
D10.570.755.375.760.400.885.185;Cardiolipins;D002308
D23.050.550.480.330;Cardiolipins;D002308
H02.403.429.163;Cardiology;D002309
C14.280.238.057;Cardiomyopathy, Alcoholic;D002310
C25.100.087.250;Cardiomyopathy, Alcoholic;D002310
C14.280.195.160;Cardiomyopathy, Dilated;D002311
C14.280.238.070;Cardiomyopathy, Dilated;D002311
C14.280.238.100;Cardiomyopathy, Hypertrophic;D002312
C14.280.484.150.070.160;Cardiomyopathy, Hypertrophic;D002312
C14.280.238.160;Cardiomyopathy, Restrictive;D002313
D26.776.708.160;Cardioplegic Solutions;D002314
D27.505.954.411.207;Cardioplegic Solutions;D002314
D27.720.280.775.322;Cardioplegic Solutions;D002314
E04.292.413;Cardiopulmonary Bypass;D002315
D27.505.954.411.222;Cardiotonic Agents;D002316
D27.720.799.080;Cardiotonic Agents;D002316
D27.505.954.411;Cardiovascular Agents;D002317
C14;Cardiovascular Diseases;D002318
A07;Cardiovascular System;D002319
G09.330;Cardiovascular Physiological Phenomena;D002320
F02.463.785.373.346.400;Career Choice;D002321
I01.880.840.200;Career Mobility;D002322
N01.824.175;Career Mobility;D002322
N01.824.547.330;Career Mobility;D002322
N04.452.677.300;Career Mobility;D002322
D02.065.589.099.750.750.170.200;Carfecillin;D002323
D02.886.108.750.750.170.200;Carfecillin;D002323
D03.438.260.825.750.170.200;Carfecillin;D002323
D03.605.084.737.750.170.200;Carfecillin;D002323
D04.075.080.875.099.221.750.750.170.200;Carfecillin;D002323
K01.093.206;Caricatures as Topic;D002325
D25.187;Cariogenic Agents;D002326
D27.720.102.187;Cariogenic Agents;D002326
J01.637.051.187;Cariogenic Agents;D002326
D25.223;Cariostatic Agents;D002327
D27.505.696.706.222;Cariostatic Agents;D002327
D27.720.102.223;Cariostatic Agents;D002327
D27.720.799.113;Cariostatic Agents;D002327
J01.637.051.223;Cariostatic Agents;D002327
D02.241.081.251.165;Carisoprodol;D002328
D02.455.426.559.847.117.159.200;Carmine;D002329
D02.806.100.200;Carmine;D002329
D04.615.117.159.200;Carmine;D002329
D02.654.692.247;Carmustine;D002330
D02.948.594.247;Carmustine;D002330
D02.092.877.883.099;Carnitine;D002331
D08.811.913.050.134.150;Carnitine O-Acetyltransferase;D002332
D08.811.913.050.350.170;Carnitine O-Acetyltransferase;D002332
D08.811.913.050.350;Carnitine Acyltransferases;D002333
D08.811.913.050.350.200;Carnitine O-Palmitoyltransferase;D002334
B01.050.150.900.649.147;Carnivora;D002335
D12.644.400.100;Carnosine;D002336
D12.644.456.345.331;Carnosine;D002336
D12.776.641.650.100;Carnosine;D002336
D02.455.326.271.665.202;Carotenoids;D002338
D02.455.426.392.368.367.379.249;Carotenoids;D002338
D02.455.849.131;Carotenoids;D002338
D23.767.261;Carotenoids;D002338
A07.231.114.186;Carotid Arteries;D002339
C10.228.140.300.200;Carotid Artery Diseases;D002340
C14.907.253.123;Carotid Artery Diseases;D002340
C10.228.140.300.200.355;Carotid Artery Thrombosis;D002341
C14.907.253.123.355;Carotid Artery Thrombosis;D002341
C14.907.253.566.206;Carotid Artery Thrombosis;D002341
C14.907.355.590.213.206;Carotid Artery Thrombosis;D002341
C14.907.355.830.850.213.206;Carotid Artery Thrombosis;D002341
A07.231.114.186.200.210;Carotid Artery, External;D002342
A07.231.114.186.200.230;Carotid Artery, Internal;D002343
A08.663.650.915.500.600.150;Carotid Body;D002344
A08.800.950.500.600.150;Carotid Body;D002344
A11.671.650.915.500.600.150;Carotid Body;D002344
C04.557.465.625.650.700.705.220;Carotid Body Tumor;D002345
C04.557.580.625.650.700.705.220;Carotid Body Tumor;D002345
A07.231.114.186.456;Carotid Sinus;D002346
B01.050.150.900.493.200.244.248;Carps;D002347
A02.835.232.087.319.150;Carpal Bones;D002348
C10.668.829.500.500.200;Carpal Tunnel Syndrome;D002349
C10.668.829.550.200;Carpal Tunnel Syndrome;D002349
C26.844.150.206;Carpal Tunnel Syndrome;D002349
A13.395.248;Carpus, Animal;D002350
D09.698.152;Carrageenan;D002351
D12.776.157;Carrier Proteins;D002352
N06.850.160;Carrier State;D002353
D02.033.100.624.210;Carteolol;D002354
D02.033.100.624.698.207;Carteolol;D002354
D02.033.755.624.210;Carteolol;D002354
D02.033.755.624.698.207;Carteolol;D002354
D02.092.063.624.698.207;Carteolol;D002354
D03.438.810.835.188;Carteolol;D002354
D02.886.778.150;Carticaine;D002355
D03.383.903.150;Carticaine;D002355
A02.165;Cartilage;D002356
A10.165.382;Cartilage;D002356
C05.182;Cartilage Diseases;D002357
C17.300.182;Cartilage Diseases;D002357
A02.165.407.150;Cartilage, Articular;D002358
A02.835.583.192;Cartilage, Articular;D002358
K01.093.206.332;Cartoons as Topic;D002359
D02.455.426.559.847.562.050.200.150;Carubicin;D002360
D04.615.562.050.200.150;Carubicin;D002360
D09.408.051.059.200.150;Carubicin;D002360
D02.455.426.559.847.117.159.205;Cascara;D002362
D02.806.100.205;Cascara;D002362
D04.615.117.159.205;Cascara;D002362
D20.215.784.500.175;Cascara;D002362
V03.100;Case Reports;D002363
D12.776.256.626.207;Caseins;D002364
D12.776.744.150;Caseins;D002364
B01.650.940.800.575.100.350.535;Manihot;D002365
B01.650.940.800.575.100.401.100;Cassia;D002366
B01.650.940.800.575.100.350.650.300;Castor Bean;D002367
D10.212.507.300;Castor Oil;D002368
D10.627.700.132;Castor Oil;D002368
D20.215.784.750.132;Castor Oil;D002368
E04.270.282;Castration;D002369
E04.950.165;Castration;D002369
E07.858.442.660.414;Casts, Surgical;D002370
E07.858.690.650.414;Casts, Surgical;D002370
C22.180;Cat Diseases;D002371
C01.252.400.126.100.150;Cat-Scratch Disease;D002372
C01.252.400.200;Cat-Scratch Disease;D002372
C15.604.315.249;Cat-Scratch Disease;D002372
D12.776.930.165;Cyclic AMP Receptor Protein;D002373
D08.811.682.732.332;Catalase;D002374
C10.597.350.200;Catalepsy;D002375
C23.888.592.350.200;Catalepsy;D002375
L01.453.245.250;Cataloging;D002376
L01.453.819.250;Cataloging;D002376
L01.178.682.290;Catalogs as Topic;D002377
L01.178.682.290.183.249;Catalogs, Booksellers';D002378
L01.178.682.290.183;Catalogs, Commercial;D002379
L01.178.682.290.283;Catalogs, Drug;D002380
L01.178.682.290.383;Catalogs, Library;D002381
L01.178.682.290.183.416;Catalogs, Publishers';D002382
L01.178.682.290.483;Catalogs, Union;D002383
G02.149.170;Catalysis;D002384
G02.149.767.500;Catalysis;D002384
G02.842.750.500;Catalysis;D002384
C10.886.425.800.200.750.500;Cataplexy;D002385
F03.870.400.800.200.750.500;Cataplexy;D002385
C11.510.245;Cataract;D002386
E04.540.825.249;Cataract Extraction;D002387
C23.550.291.250;Catastrophic Illness;D002388
C10.597.606.115;Catatonia;D002389
C23.888.592.604.115;Catatonia;D002389
F01.145.126.156;Catatonia;D002389
F01.700.165;Catatonia;D002389
N01.224.791.200;Catchment Area (Health);D002391
N03.349.650.095;Catchment Area (Health);D002391
N06.850.505.400.800.200;Catchment Area (Health);D002391
D03.438.150.240.190;Catechin;D002392
D03.438.150.266.450.206;Catechin;D002392
D03.830.219.240.190;Catechin;D002392
D03.830.219.266.450.206;Catechin;D002392
D02.455.426.559.389.657.166.350;Estrogens, Catechol;D002393
D06.472.334.851.437.984;Estrogens, Catechol;D002393
D08.811.913.555.500.250;Catechol O-Methyltransferase;D002394
D02.092.211.215.311;Catecholamines;D002395
D02.092.311;Catecholamines;D002395
D02.455.426.559.389.657.166;Catechols;D002396
B01.050.150.900.493.080;Catfishes;D002397
E07.858.690.820.250;Catgut;D002398
F04.754.720.107.333;Catharsis;D002399
D27.505.954.483.396;Cathartics;D002400
D08.811.277.656.224.125;Cathepsin B;D002401
D08.811.277.656.262.500.133;Cathepsin B;D002401
D08.811.277.656.300.200.133;Cathepsin B;D002401
D08.811.277.656.074.500.180;Cathepsin D;D002402
D08.811.277.656.224.187;Cathepsin D;D002402
D08.811.277.656.300.048.180;Cathepsin D;D002402
D08.811.277.656.224;Cathepsins;D002403
E02.148;Catheterization;D002404
E05.157;Catheterization;D002404
E02.148.167;Catheterization, Central Venous;D002405
E04.100.814.529.875;Catheterization, Central Venous;D002405
E04.800.382.875;Catheterization, Central Venous;D002405
E02.148.224;Catheterization, Peripheral;D002406
E04.100.814.529.937;Catheterization, Peripheral;D002406
E04.800.382.937;Catheterization, Peripheral;D002406
E01.370.370.380.140.210;Catheterization, Swan-Ganz;D002407
E02.148.224.165;Catheterization, Swan-Ganz;D002407
E02.148.442.165;Catheterization, Swan-Ganz;D002407
E04.100.814.529.937.165;Catheterization, Swan-Ganz;D002407
E04.800.382.937.165;Catheterization, Swan-Ganz;D002407
E07.132.500;Catheters, Indwelling;D002408
F01.393.246.250;Cathexis;D002409
K01.844.188.250;Catholicism;D002410
D27.720.470.420.275;Cation Exchange Resins;D002411
D01.248.497.300;Cations;D002412
D01.248.497.300.333;Cations, Divalent;D002413
D01.248.497.300.459;Cations, Monovalent;D002414
B01.050.150.900.649.147.354.250.125;Cats;D002415
F04.711.647.513.146;Cattell Personality Factor Questionnaire;D002416
B01.050.150.900.649.077.380.271;Cattle;D002417
C22.196;Cattle Diseases;D002418
A08.800.800.720.725.150;Cauda Equina;D002420
A08.186.211.730.885.287.249.487.550.184;Caudate Nucleus;D002421
C10.177.195.200;Causalgia;D002422
C10.668.829.250.200;Causalgia;D002422
C10.668.829.600.200;Causalgia;D002422
E05.318.308.985.550.250;Cause of Death;D002423
L01.280.975.550.250;Cause of Death;D002423
N01.224.935.698.100;Cause of Death;D002423
N06.850.505.400.975.550.250;Cause of Death;D002423
N06.850.520.308.985.550.250;Cause of Death;D002423
D27.720.185;Caustics;D002424
D27.888.569.185;Caustics;D002424
E02.154;Cautery;D002425
E04.014.170;Cautery;D002425
A07.231.908.224.334;Cavernous Sinus;D002426
B01.050.150.900.649.801.400.600.150;Cebidae;D002427
B01.050.150.900.649.801.400.600.150.120.120;Cebus;D002428
C06.405.469.110;Cecal Diseases;D002429
C04.588.274.476.411.184;Cecal Neoplasms;D002430
C06.301.371.411.184;Cecal Neoplasms;D002430
C06.405.249.411.184;Cecal Neoplasms;D002430
C06.405.469.110.417;Cecal Neoplasms;D002430
C06.405.469.491.184;Cecal Neoplasms;D002430
E04.210.338.175;Cecostomy;D002431
E04.579.338.175;Cecostomy;D002431
A03.556.124.526.209;Cecum;D002432
A03.556.249.249.209;Cecum;D002432
D02.065.589.099.249.200.155;Cefaclor;D002433
D02.886.665.074.200.155;Cefaclor;D002433
D04.075.080.875.099.221.249.200.155;Cefaclor;D002433
D02.065.589.099.249.200.165;Cefadroxil;D002434
D02.886.665.074.200.165;Cefadroxil;D002434
D04.075.080.875.099.221.249.200.165;Cefadroxil;D002434
D02.065.589.099.249.150;Cefamandole;D002435
D02.886.665.074.150;Cefamandole;D002435
D04.075.080.875.099.221.249.150;Cefamandole;D002435
D02.065.589.099.249.200.165.125;Cefatrizine;D002436
D02.886.665.074.200.165.125;Cefatrizine;D002436
D04.075.080.875.099.221.249.200.165.125;Cefatrizine;D002436
D02.065.589.099.249.160;Cefazolin;D002437
D02.886.665.074.160;Cefazolin;D002437
D04.075.080.875.099.221.249.160;Cefazolin;D002437
D02.065.589.099.249.150.160;Cefoperazone;D002438
D02.886.665.074.150.160;Cefoperazone;D002438
D04.075.080.875.099.221.249.150.160;Cefoperazone;D002438
D02.065.589.099.249.190.190;Cefotaxime;D002439
D02.886.665.074.190.190;Cefotaxime;D002439
D04.075.080.875.099.221.249.190.190;Cefotaxime;D002439
D02.065.589.099.249.250.222;Cefoxitin;D002440
D02.886.665.074.250.222;Cefoxitin;D002440
D04.075.080.875.099.221.249.250.222;Cefoxitin;D002440
D02.065.589.099.249.185;Cefsulodin;D002441
D02.886.665.074.185;Cefsulodin;D002441
D04.075.080.875.099.221.249.185;Cefsulodin;D002441
D02.065.589.099.249.210.150;Ceftazidime;D002442
D02.886.665.074.210.150;Ceftazidime;D002442
D04.075.080.875.099.221.249.210.150;Ceftazidime;D002442
D02.065.589.099.249.190.190.155;Ceftriaxone;D002443
D02.886.665.074.190.190.155;Ceftriaxone;D002443
D04.075.080.875.099.221.249.190.190.155;Ceftriaxone;D002443
D02.065.589.099.249.190.190.165;Cefuroxime;D002444
D02.886.665.074.190.190.165;Cefuroxime;D002444
D04.075.080.875.099.221.249.190.190.165;Cefuroxime;D002444
A07.231.114.207;Celiac Artery;D002445
C06.405.469.637.250;Celiac Disease;D002446
C18.452.603.250;Celiac Disease;D002446
A08.800.050.050.150;Celiac Plexus;D002447
A08.800.800.060.150;Celiac Plexus;D002447
G04.299.117;Cell Adhesion;D002448
G04.299.283.251;Cell Aggregation;D002449
G04.299.122;Cell Communication;D002450
G04.299.125;Cell Compartmentation;D002451
E01.370.225.500.195;Cell Count;D002452
E05.200.500.195;Cell Count;D002452
E05.242.195;Cell Count;D002452
G04.170;Cell Count;D002452
G04.299.134;Cell Cycle;D002453
G04.299.151;Cell Differentiation;D002454
G04.299.134.220;Cell Division;D002455
G04.299.233.750.500;Cell Division;D002455
G05.355.105;Cell Division;D002455
G07.700.320.249.410.750.500;Cell Division;D002455
D20.777.162;Cell Extracts;D002457
E05.242.251;Cell Fractionation;D002458
E05.242.307;Cell Fusion;D002459
G04.299.217;Cell Fusion;D002459
A11.251.210;Cell Line;D002460
A11.251.210.172;Cell Line, Transformed;D002461
A11.284.149;Cell Membrane;D002462
G03.495.166.335;Cell Membrane Permeability;D002463
G04.175;Cell Membrane Permeability;D002463
G04.299.283.337;Cell Migration Inhibition;D002464
G04.299.283;Cell Movement;D002465
G07.700.560.500.180;Cell Movement;D002465
A11.284.430.106.279.345.175;Cell Nucleolus;D002466
A11.284.430.106;Cell Nucleus;D002467
A11.284.430.214.190.875.117;Cell Nucleus;D002467
G04;Cell Physiological Phenomena;D002468
E01.370.225.500.363;Cell Separation;D002469
E05.200.500.363;Cell Separation;D002469
E05.242.363;Cell Separation;D002469
G04.299.316;Cell Survival;D002470
C04.697.152;Cell Transformation, Neoplastic;D002471
C23.550.727.152;Cell Transformation, Neoplastic;D002471
C04.697.152.160;Cell Transformation, Viral;D002472
C23.550.727.152.160;Cell Transformation, Viral;D002472
G06.590.875.210;Cell Transformation, Viral;D002472
G06.920.875.210;Cell Transformation, Viral;D002472
A11.284.183;Cell Wall;D002473
A11.284.835.168;Cell-Free System;D002474
D09.698.365.180.180;Cellobiose;D002475
D09.698.629.305.200;Cellobiose;D002475
D25.720.099.500.252;Cellophane;D002476
J01.637.051.720.099.500.252;Cellophane;D002476
J01.637.118;Cellophane;D002476
A11;Cells;D002477
A11.251;Cells, Cultured;D002478
A11.284.420;Inclusion Bodies;D002479
D08.811.277.450.420.200.200;Cellulase;D002480
C01.539.800.130;Cellulitis;D002481
C01.539.830.200;Cellulitis;D002481
C17.300.185;Cellulitis;D002481
C23.550.470.756.200;Cellulitis;D002481
D05.750.078.562.180;Cellulose;D002482
D09.698.365.180;Cellulose;D002482
D25.720.099.500;Cellulose;D002482
J01.637.051.720.099.500;Cellulose;D002482
D05.750.078.562.180.200;Cellulose, Oxidized;D002483
D09.698.365.180.200;Cellulose, Oxidized;D002483
E05.170;Cementation;D002484
E06.095.170;Cementation;D002484
C04.557.695.210;Cementoma;D002485
D03.438.150.240.225;Centchroman;D002486
D03.830.219.240.225;Centchroman;D002486
I01.409.137.500.600.650.225;Centers for Disease Control and Prevention (U.S.);D002487
N03.540.348.500.500.600.650.225;Centers for Disease Control and Prevention (U.S.);D002487
Z01.058.290.100.120;Central African Republic;D002488
Z01.107.169;Central America;D002489
A08.186;Central Nervous System;D002490
D27.505.954.427;Central Nervous System Agents;D002491
D27.505.696.277;Central Nervous System Depressants;D002492
D27.505.954.427.210;Central Nervous System Depressants;D002492
C10.228;Central Nervous System Diseases;D002493
C01.395;Central Nervous System Infections;D002494
C10.228.228;Central Nervous System Infections;D002494
N02.278.354.422.260;Central Supply, Hospital;D002495
N04.452.442.422.260;Central Supply, Hospital;D002495
G09.330.380.076.732.336;Central Venous Pressure;D002496
N02.278.354.110;Centralized Hospital Services;D002497
N04.452.442.110;Centralized Hospital Services;D002497
E05.181;Centrifugation;D002498
E05.181.724.336;Centrifugation, Density Gradient;D002499
E05.196.941.336;Centrifugation, Density Gradient;D002499
E05.181.724.336.253;Centrifugation, Isopycnic;D002500
E05.196.941.336.253;Centrifugation, Isopycnic;D002500
E05.181.724.336.336;Centrifugation, Zonal;D002501
E05.196.941.336.419;Centrifugation, Zonal;D002501
A11.284.430.214.190.750.585.160.130;Centrioles;D002502
A11.284.430.106.279.345.190.160.165;Centromere;D002503
G05.360.160.165;Centromere;D002503
D02.241.081.018.386.682.875;Meclofenoxate;D002504
D02.241.511.316.495;Meclofenoxate;D002504
D02.065.589.099.249.190;Cephacetrile;D002505
D02.886.665.074.190;Cephacetrile;D002505
D04.075.080.875.099.221.249.190;Cephacetrile;D002505
D02.065.589.099.249.200;Cephalexin;D002506
D02.886.665.074.200;Cephalexin;D002506
D04.075.080.875.099.221.249.200;Cephalexin;D002506
D02.065.589.099.249.200.180;Cephaloglycin;D002507
D02.886.665.074.200.180;Cephaloglycin;D002507
D04.075.080.875.099.221.249.200.180;Cephaloglycin;D002507
E01.370.600.024.250;Cephalometry;D002508
E05.041.250;Cephalometry;D002508
N06.850.505.200.100.300;Cephalometry;D002508
D02.065.589.099.249.210;Cephaloridine;D002509
D02.886.665.074.210;Cephaloridine;D002509
D04.075.080.875.099.221.249.210;Cephaloridine;D002509
D08.811.277.087.180.229;Cephalosporinase;D002510
D02.065.589.099.249;Cephalosporins;D002511
D02.886.665.074;Cephalosporins;D002511
D04.075.080.875.099.221.249;Cephalosporins;D002511
D02.065.589.099.249.190.210;Cephalothin;D002512
D02.886.665.074.190.210;Cephalothin;D002512
D04.075.080.875.099.221.249.190.210;Cephalothin;D002512
D02.065.589.099.249.250;Cephamycins;D002513
D02.886.665.074.250;Cephamycins;D002513
D04.075.080.875.099.221.249.250;Cephamycins;D002513
D02.065.589.099.249.190.230;Cephapirin;D002514
D02.886.665.074.190.230;Cephapirin;D002514
D04.075.080.875.099.221.249.190.230;Cephapirin;D002514
D02.065.589.099.249.200.185;Cephradine;D002515
D02.886.665.074.200.185;Cephradine;D002515
D04.075.080.875.099.221.249.200.185;Cephradine;D002515
D25.264;Ceramics;D002516
J01.637.051.264;Ceramics;D002516
J01.637.153;Ceramics;D002516
D08.811.277.450.410.150;Galactosylgalactosylglucosylceramidase;D002517
D02.065.313;Ceramides;D002518
D09.400.410.420.525.200;Ceramides;D002518
D10.390.470.675.200;Ceramides;D002518
D10.570.877.360.612.200;Ceramides;D002518
B01.050.500.131.617.289.208;Ceratopogonidae;D002519
B01.050.150.900.649.801.400.112.199;Cercopithecidae;D002520
B01.050.150.900.649.801.400.112.199.120.126;Cercopithecus;D002521
B01.050.150.900.649.801.400.112.199.120.126.110;Cercopithecus aethiops;D002522
B01.650.510.253;Cereals;D002523
J02.500.200;Cereals;D002523
C10.228.140.252.190;Cerebellar Ataxia;D002524
C10.597.350.090.500;Cerebellar Ataxia;D002524
C23.888.592.350.090.200;Cerebellar Ataxia;D002524
A08.186.211.132.810.428.200.212;Cerebellar Cortex;D002525
A08.186.211.865.428.200.212;Cerebellar Cortex;D002525
C10.228.140.252;Cerebellar Diseases;D002526
C10.228.140.252.700.250;Myoclonic Cerebellar Dyssynergia;D002527
C10.228.854.787.500;Myoclonic Cerebellar Dyssynergia;D002527
C10.574.500.825.250;Myoclonic Cerebellar Dyssynergia;D002527
C16.320.400.780.500;Myoclonic Cerebellar Dyssynergia;D002527
C04.588.614.250.195.411.211;Cerebellar Neoplasms;D002528
C10.228.140.211.500.200;Cerebellar Neoplasms;D002528
C10.228.140.252.200;Cerebellar Neoplasms;D002528
C10.551.240.250.400.300;Cerebellar Neoplasms;D002528
A08.186.211.132.810.428.200.337;Cerebellar Nuclei;D002529
A08.186.211.865.428.200.337;Cerebellar Nuclei;D002529
A08.186.211.132.810.428.200.462;Cerebellopontine Angle;D002530
A08.186.211.865.428.200.462;Cerebellopontine Angle;D002530
A08.186.211.132.810.428.200;Cerebellum;D002531
A08.186.211.865.428.200;Cerebellum;D002531
C10.228.140.300.510.600;Intracranial Aneurysm;D002532
C14.907.055.635;Intracranial Aneurysm;D002532
C14.907.253.560.300;Intracranial Aneurysm;D002532
E01.370.350.578.937.180;Cerebral Angiography;D002533
E01.370.350.700.060.180;Cerebral Angiography;D002533
E01.370.350.700.560.180;Cerebral Angiography;D002533
E01.370.370.050.180;Cerebral Angiography;D002533
E01.370.376.537.750.180;Cerebral Angiography;D002533
E05.629.937.180;Cerebral Angiography;D002533
C10.228.140.624;Hypoxia, Brain;D002534
A08.186.211.132.659.822.187;Cerebral Aqueduct;D002535
A08.186.211.276.187;Cerebral Aqueduct;D002535
A08.186.211.653.822.187;Cerebral Aqueduct;D002535
A07.231.114.228;Cerebral Arteries;D002536
C10.228.140.300.510.800;Intracranial Arteriosclerosis;D002537
C14.907.137.126.372;Intracranial Arteriosclerosis;D002537
C14.907.253.560.350;Intracranial Arteriosclerosis;D002537
C10.228.140.300.520;Intracranial Arteriovenous Malformations;D002538
C10.500.190.500;Intracranial Arteriovenous Malformations;D002538
C14.240.850.750.295;Intracranial Arteriovenous Malformations;D002538
C14.240.850.875.500;Intracranial Arteriovenous Malformations;D002538
C14.907.150.295;Intracranial Arteriovenous Malformations;D002538
C14.907.253.560.400;Intracranial Arteriovenous Malformations;D002538
C16.131.240.850.750.295;Intracranial Arteriovenous Malformations;D002538
C16.131.240.850.875.500;Intracranial Arteriovenous Malformations;D002538
C16.131.666.190.500;Intracranial Arteriovenous Malformations;D002538
C10.228.140.300.510.200;Cerebral Arterial Diseases;D002539
C14.907.253.560.200;Cerebral Arterial Diseases;D002539
A08.186.211.730.885.287.500;Cerebral Cortex;D002540
E04.525.160;Cerebral Decortication;D002541
C10.228.140.300.525;Intracranial Embolism and Thrombosis;D002542
C14.907.253.566;Intracranial Embolism and Thrombosis;D002542
C14.907.355.590.213;Intracranial Embolism and Thrombosis;D002542
C14.907.355.830.850.213;Intracranial Embolism and Thrombosis;D002542
C10.228.140.300.535.200;Cerebral Hemorrhage;D002543
C14.907.253.573.200;Cerebral Hemorrhage;D002543
C23.550.414.913.100;Cerebral Hemorrhage;D002543
C10.228.140.300.150.477.200;Cerebral Infarction;D002544
C10.228.140.300.775.200.200;Cerebral Infarction;D002544
C14.907.253.092.477.200;Cerebral Infarction;D002544
C14.907.253.855.200.200;Cerebral Infarction;D002544
C10.228.140.300.150;Brain Ischemia;D002545
C14.907.253.092;Brain Ischemia;D002545
C10.228.140.300.150.836;Ischemic Attack, Transient;D002546
C14.907.253.092.836;Ischemic Attack, Transient;D002546
C10.228.140.140.254;Cerebral Palsy;D002547
E04.100.814.868.625;Cerebral Revascularization;D002548
E04.494.150;Cerebral Revascularization;D002548
C10.114.375.112;Diffuse Cerebral Sclerosis of Schilder;D002549
C10.228.140.400;Diffuse Cerebral Sclerosis of Schilder;D002549
C10.228.140.695.562.112;Diffuse Cerebral Sclerosis of Schilder;D002549
C10.228.518.562.112;Diffuse Cerebral Sclerosis of Schilder;D002549
C10.314.350.112;Diffuse Cerebral Sclerosis of Schilder;D002549
C20.111.258.250.175;Diffuse Cerebral Sclerosis of Schilder;D002549
A07.231.908.155;Cerebral Veins;D002550
C04.588.614.250.195.205;Cerebral Ventricle Neoplasms;D002551
C10.228.140.211.280;Cerebral Ventricle Neoplasms;D002551
C10.551.240.250.200;Cerebral Ventricle Neoplasms;D002551
A08.186.211.276;Cerebral Ventricles;D002552
D08.811.277.352.827.070.250;Cerebroside-Sulfatase;D002553
D02.065.313.250;Cerebrosides;D002554
D09.400.410.420.525.200.250;Cerebrosides;D002554
D10.390.470.675.200.250;Cerebrosides;D002554
D10.570.877.360.612.200.250;Cerebrosides;D002554
A12.207.270.210;Cerebrospinal Fluid;D002555
D12.776.178;Cerebrospinal Fluid Proteins;D002556
E04.035.188;Cerebrospinal Fluid Shunts;D002557
E04.525.170;Cerebrospinal Fluid Shunts;D002557
C10.597.230;Cerebrospinal Fluid Otorrhea;D002558
C10.900.300.131;Cerebrospinal Fluid Otorrhea;D002558
C23.888.592.230;Cerebrospinal Fluid Otorrhea;D002558
C26.260.177;Cerebrospinal Fluid Otorrhea;D002558
C26.915.300.250;Cerebrospinal Fluid Otorrhea;D002558
C10.597.267;Cerebrospinal Fluid Rhinorrhea;D002559
C10.900.300.153;Cerebrospinal Fluid Rhinorrhea;D002559
C23.888.592.264;Cerebrospinal Fluid Rhinorrhea;D002559
C26.260.207;Cerebrospinal Fluid Rhinorrhea;D002559
C26.915.300.300;Cerebrospinal Fluid Rhinorrhea;D002559
G09.330.190.163.159;Cerebrovascular Circulation;D002560
C10.228.140.300;Cerebrovascular Disorders;D002561
C14.907.253;Cerebrovascular Disorders;D002561
F01.145.813.097;Ceremonial Behavior;D002562
I01.076.201.450.170;Ceremonial Behavior;D002562
D01.268.477.249;Cerium;D002563
D01.268.558.362.249;Cerium;D002563
D01.552.550.399.249;Cerium;D002563
D01.496.156;Cerium Isotopes;D002564
D01.496.156.300;Cerium Radioisotopes;D002565
D01.496.749.185;Cerium Radioisotopes;D002565
D10.150;Ceroid;D002566
D23.767.300;Ceroid;D002566
N03.349.650.120;Certificate of Need;D002567
N03.706.110.120;Certification;D002568
N05.700.200.190;Certification;D002568
D02.065.327;Cerulenin;D002569
D08.811.682.226;Ceruloplasmin;D002570
D12.776.124.050.130;Ceruloplasmin;D002570
D12.776.124.790.106.214;Ceruloplasmin;D002570
D12.776.157.160;Ceruloplasmin;D002570
D12.776.377.715.085.214;Ceruloplasmin;D002570
D12.776.556.151;Ceruloplasmin;D002570
A12.200.147;Cerumen;D002571
A08.800.800.720.150;Cervical Plexus;D002572
C10.668.829.550.850.200;Cervical Rib Syndrome;D002573
C14.907.863.200;Cervical Rib Syndrome;D002573
C16.131.621.174;Cervical Rib Syndrome;D002573
A02.835.232.834.151;Cervical Vertebrae;D002574
C13.351.500.852.593.150;Uterine Cervicitis;D002575
C13.351.500.852.593;Uterine Cervical Diseases;D002577
C04.834.818;Uterine Cervical Dysplasia;D002578
C13.351.500.852.593.074;Uterine Cervical Dysplasia;D002578
C13.351.500.852.593.112;Uterine Cervical Erosion;D002579
C13.351.500.852.593.120;Uterine Cervical Incompetence;D002581
C13.703.039.089.339;Uterine Cervical Incompetence;D002581
A12.200.503.339;Cervix Mucus;D002582
C04.588.945.418.948.850;Uterine Cervical Neoplasms;D002583
C13.351.500.852.593.131;Uterine Cervical Neoplasms;D002583
C13.351.500.852.762.850;Uterine Cervical Neoplasms;D002583
C13.351.937.418.875.850;Uterine Cervical Neoplasms;D002583
A05.360.319.679.256;Cervix Uteri;D002584
E04.520.252.500;Cesarean Section;D002585
D01.268.549.125;Cesium;D002586
D01.268.556.165;Cesium;D002586
D01.552.528.160;Cesium;D002586
D01.552.544.165;Cesium;D002586
D01.496.180;Cesium Isotopes;D002587
D01.496.180.300;Cesium Radioisotopes;D002588
D01.496.749.190;Cesium Radioisotopes;D002588
B01.050.500.500.736.215;Cestoda;D002589
C03.335.190;Cestode Infections;D002590
B01.050.150.900.649.189;Cetacea;D002591
D02.033.455.250.700.150;Cetomacrogol;D002592
D05.750.741.250;Cetomacrogol;D002592
D25.720.741.250;Cetomacrogol;D002592
J01.637.051.720.741.250;Cetomacrogol;D002592
D02.092.877.883.111;Cetrimonium Compounds;D002593
D02.675.276.190;Cetrimonium Compounds;D002593
D03.383.725.762.232;Cetylpyridinium;D002594
D03.132.920.256;Cevanes;D002595
D03.549.256;Cevanes;D002595
Z01.058.290.100.130;Chad;D002596
B01.300.107.800.150;Chaetomium;D002597
C03.752.300.900.200.190;Chagas Cardiomyopathy;D002598
C14.280.238.190;Chagas Cardiomyopathy;D002598
D02.522.818.222.500;Chalcone;D002599
D03.438.150.266.450.221.500;Chalcone;D002599
D03.830.219.266.450.221.500;Chalcone;D002599
C01.252.400.840.744.161;Chancre;D002601
C01.252.847.840.744.161;Chancre;D002601
C01.252.400.700.433.257;Chancroid;D002602
C01.252.810.201;Chancroid;D002602
C01.539.778.281.201;Chancroid;D002602
C12.294.668.281.201;Chancroid;D002602
C13.351.500.711.281.201;Chancroid;D002602
Z01.542.363.161;Channel Islands;D002603
Z01.639.280.161;Channel Islands;D002603
N02.278.354.422.270;Chaplaincy Service, Hospital;D002604
N04.452.442.422.270;Chaplaincy Service, Hospital;D002604
F01.752.190;Character;D002605
D01.268.150.150;Charcoal;D002606
C10.500.300.200;Charcot-Marie-Tooth Disease;D002607
C10.574.500.495.200;Charcot-Marie-Tooth Disease;D002607
C10.668.829.800.300.200;Charcot-Marie-Tooth Disease;D002607
C16.131.666.300.200;Charcot-Marie-Tooth Disease;D002607
C16.320.400.375.200;Charcot-Marie-Tooth Disease;D002607
I01.880.787.190;Charities;D002608
N03.540.125;Charities;D002608
C15.378.553.774.257;Chediak-Higashi Syndrome;D002609
C20.673.774.257;Chediak-Higashi Syndrome;D002609
A01.456.505.173;Cheek;D002610
A14.194;Cheek;D002610
J02.500.350.200;Cheese;D002611
B01.050.150.900.649.147.354.030;Acinonyx;D002612
C07.465.409.215;Cheilitis;D002613
D27.505.519.249;Chelating Agents;D002614
D27.720.222;Chelating Agents;D002614
E02.218.170;Chemexfoliation;D002615
E04.680.275.200;Chemexfoliation;D002615
J01.293.257;Chemical Engineering;D002616
J01.576.207;Chemical Industry;D002617
I01.880.735.944.340;Chemical Warfare;D002618
D27.720.777.300;Chemical Warfare Agents;D002619
D27.888.569.612.150;Chemical Warfare Agents;D002619
J01.637.870.200;Chemical Warfare Agents;D002619
J01.637.870.900.200;Chemical Warfare Agents;D002619
G07.690;Pharmacological Phenomena;D002620
H01.181;Chemistry;D002621
H01.181.216;Chemistry, Agricultural;D002622
E05.196;Chemistry Techniques, Analytical;D002623
H01.181.341;Chemistry, Clinical;D002624
H01.181.404;Chemistry, Organic;D002625
H01.158.703.007;Chemistry, Pharmaceutical;D002626
H01.181.466;Chemistry, Pharmaceutical;D002626
H01.181.529;Chemistry, Physical;D002627
A08.663.650.915.500;Chemoreceptor Cells;D002628
A08.800.950.500;Chemoreceptor Cells;D002628
A11.671.650.915.500;Chemoreceptor Cells;D002628
D27.720.031.700.141;Chemosterilants;D002629
D27.720.723.141;Chemosterilants;D002629
D27.888.723.141;Chemosterilants;D002629
D23.125;Chemotactic Factors;D002630
D23.125.320;Chemotactic Factors, Eosinophil;D002631
G04.299.283.424;Chemotaxis;D002633
G04.299.283.424.233;Chemotaxis, Leukocyte;D002634
D04.808.105.225.272.150;Chenodeoxycholic Acid;D002635
D04.808.221.430.342.300;Chenodeoxycholic Acid;D002635
C05.116.099.708.375.199;Cherubism;D002636
C05.500.174;Cherubism;D002636
C07.320.173;Cherubism;D002636
C16.131.621.207.540.170;Cherubism;D002636
C16.320.170;Cherubism;D002636
C23.888.646.215;Chest Pain;D002637
D05.750.078.739.249;Chewing Gum;D002638
D09.698.700.249;Chewing Gum;D002638
D20.215.721.249.249;Chewing Gum;D002638
J02.500.140.200;Chewing Gum;D002638
C08.618.182;Cheyne-Stokes Respiration;D002639
C23.888.852.227;Cheyne-Stokes Respiration;D002639
C13.703.844.506.389.500;Chiari-Frommel Syndrome;D002640
C17.800.090.937.439.500;Chiari-Frommel Syndrome;D002640
Z01.107.567.875.350.350.200;Chicago;D002641
Z01.107.567.875.510.350.200;Chicago;D002641
Z01.433.305;Chicago;D002641
A13.350.150;Chick Embryo;D002642
A16.331.200;Chick Embryo;D002642
C02.256.466.175;Chickenpox;D002644
B01.050.150.900.248.350.150;Chickens;D002645
B01.050.150.900.248.617.192;Chickens;D002645
B04.820.850.054.198;Chikungunya virus;D002646
B04.909.777.923.054.198;Chikungunya virus;D002646
C26.417.217;Chilblains;D002647
M01.060.406;Child;D002648
I01.198.240.856.350.250;Child Abuse;D002649
I01.880.735.900.350.250;Child Abuse;D002649
I01.880.787.293.292;Child Abuse;D002649
I01.198.240.748.300;Child Abuse, Sexual;D002650
I01.198.240.856.350.250.255;Child Abuse, Sexual;D002650
I01.880.735.900.350.250.255;Child Abuse, Sexual;D002650
I01.880.787.293.292.325;Child Abuse, Sexual;D002650
I01.880.604.473.300;Child Advocacy;D002651
I01.880.787.293.350;Child Advocacy;D002651
N03.706.437.300;Child Advocacy;D002651
F01.145.179;Child Behavior;D002652
F03.550.300;Child Behavior Disorders;D002653
N02.421.088;Child Care;D002654
I01.880.787.293.370;Child Custody;D002655
I01.880.787.293.392;Child Day Care Centers;D002656
F01.525.200;Child Development;D002657
G07.700.320.374.750;Child Development;D002657
F03.550.362;Developmental Disabilities;D002658
F03.550.325;Child Development Disorders, Pervasive;D002659
F02.784.629.272;Child Guidance;D002660
F04.408.192;Child Guidance;D002660
N02.278.035.158.300;Child Guidance Clinics;D002661
N02.421.143.130;Child Health Services;D002662
F01.525.200.310.250;Child Language;D002663
G07.610.220;Child Nutritional Physiological Phenomena;D002664
F04.096.544.193;Child Psychiatry;D002665
H02.403.690.130;Child Psychiatry;D002665
F04.096.628.193;Child Psychology;D002666
F01.145.126.159;Child Reactive Disorders;D002667
F01.318;Child Rearing;D002668
I01.880.787.293;Child Welfare;D002669
M01.097;Child, Abandoned;D002670
F02.784.629.228;Child, Exceptional;D002671
M01.102;Child, Exceptional;D002671
F02.784.629.228.350;Child, Gifted;D002672
M01.102.350;Child, Gifted;D002672
M01.643.259;Child, Hospitalized;D002673
M01.643.364;Child, Institutionalized;D002674
M01.060.406.448;Child, Preschool;D002675
M01.111;Child, Unwanted;D002676
Z01.107.757.235;Chile;D002677
B01.050.050.530;Chimera;D002678
B01.650.085;Chimera;D002678
B05.200;Chimera;D002678
B01.050.150.900.649.801.400.112.400.620;Pan troglodytes;D002679
A01.456.505.259;Chin;D002680
A02.835.232.781.324.502.632.130;Chin;D002680
A14.521.632.300;Chin;D002680
Z01.252.474.164;China;D002681
B01.050.150.900.649.865.328;Chinchilla;D002682
B01.050.500.131.617.289.260;Chironomidae;D002683
H02.110;Chiropractic;D002684
B01.050.150.900.649.225;Chiroptera;D002685
D05.750.078.139;Chitin;D002686
D09.698.211;Chitin;D002686
D08.811.913.400.450.460.200;Chitin Synthase;D002687
D08.811.277.450.207;Chitinase;D002688
B03.440.190.190.190;Chlamydia;D002689
C01.252.400.210.210;Chlamydia Infections;D002690
C01.252.810.301;Chlamydia Infections;D002690
C01.539.778.281.301;Chlamydia Infections;D002690
C12.294.668.281.301;Chlamydia Infections;D002690
C13.351.500.711.281.301;Chlamydia Infections;D002690
B03.440.190.190.230.500;Chlamydophila psittaci;D002691
B03.440.190.190.190.750;Chlamydia trachomatis;D002692
B03.440.190.190;Chlamydiaceae;D002693
C01.252.400.210;Chlamydiaceae Infections;D002694
B03.440.190;Chlamydiales;D002695
B01.650.940.150.925.344;Chlamydomonas;D002696
D02.033.455.250.130;Chloral Hydrate;D002697
D02.033.455.250.130.150;Chloralose;D002698
D09.408.348.150;Chloralose;D002698
D02.455.526.728.650.156;Chlorambucil;D002699
D02.065.884.344;Chloramines;D002700
D02.886.590.700.344;Chloramines;D002700
D02.033.455.706.300;Chloramphenicol;D002701
D02.455.426.559.389.565.175;Chloramphenicol;D002701
D02.640.529.175;Chloramphenicol;D002701
G06.099.225.750;Chloramphenicol Resistance;D002702
G06.225.347.750;Chloramphenicol Resistance;D002702
G07.690.320.269.347.750;Chloramphenicol Resistance;D002702
D02.806.250.210;Chloranil;D002703
D01.210.300;Chlorates;D002704
D01.248.497.158.190;Chlorates;D002704
D02.455.526.439.180;Chlordan;D002706
D03.438.079.080.150;Chlordiazepoxide;D002707
B01.650.940.150.469;Chlorella;D002708
D02.705.400.120;Chlorfenvinphos;D002709
D02.078.370.141.100;Chlorhexidine;D002710
D08.811.682.732.360;Chloride Peroxidase;D002711
D01.210.450.150;Chlorides;D002712
D01.248.497.158.215;Chlorides;D002712
D01.268.380.150;Chlorine;D002713
D01.362.225;Chlorine;D002713
D02.092.877.883.222;Chlorisondamine;D002714
D02.675.276.200;Chlorisondamine;D002714
D03.438.513.249;Chlorisondamine;D002714
D04.808.745.432.144;Chlormadinone Acetate;D002715
D04.808.883.294;Chlormadinone Acetate;D002715
D02.092.877.883.277;Chlormequat;D002716
D02.675.276.207;Chlormequat;D002716
D02.691.750.100.229;Chlormerodrin;D002717
D02.886.675.180;Chlormethiazole;D002719
D03.383.129.708.180;Chlormethiazole;D002719
D02.886.665.150;Chlormezanone;D002720
D03.383.855.150;Chlormezanone;D002720
D02.522.120.575;omega-Chloroacetophenone;D002721
D02.455.426.559.389.261;Chlorobenzenes;D002722
D02.455.526.439.202;Chlorobenzenes;D002722
D02.241.223.100.200;Chlorobenzoates;D002723
D02.455.426.559.389.127.250;Chlorobenzoates;D002723
D02.033.260.220;Chlorobutanol;D002724
D02.033.415.110.220;Chlorobutanol;D002724
D10.289.110.220;Chlorobutanol;D002724
D02.455.526.439.224;Chloroform;D002725
D02.455.526.913.810;Chloroform;D002725
D02.241.223.200.185;Chlorogenic Acid;D002726
D02.241.223.268.220;Chlorogenic Acid;D002726
D02.078.370.141.710;Proguanil;D002727
D02.033.260;Chlorohydrins;D002728
D02.241.223.100.200.311;Chloromercuribenzoates;D002729
D02.241.223.100.500.261;Chloromercuribenzoates;D002729
D02.455.426.559.389.127.250.311;Chloromercuribenzoates;D002729
D02.455.426.559.389.127.500.261;Chloromercuribenzoates;D002729
D02.691.750.740.644.261;Chloromercuribenzoates;D002729
D02.691.750.740.225;Chloromercurinitrophenols;D002730
D02.455.426.559.389.097.150;4-Chloromercuribenzenesulfonate;D002731
D02.691.750.740.220;4-Chloromercuribenzenesulfonate;D002731
D02.886.645.600.080.050.100.100;4-Chloromercuribenzenesulfonate;D002731
D02.455.426.559.389.261.190;Chlorophenols;D002733
D02.455.426.559.389.657.190;Chlorophenols;D002733
D03.383.129.578.840.374;Chlorophyll;D002734
D03.383.129.578.840.500.640.220;Chlorophyll;D002734
D03.549.909.374;Chlorophyll;D002734
D03.549.909.500.640.220;Chlorophyll;D002734
D04.345.783.374;Chlorophyll;D002734
D04.345.783.500.640.220;Chlorophyll;D002734
D23.767.727.220;Chlorophyll;D002734
D23.767.727.640.220;Chlorophyll;D002734
D03.383.129.578.840.374.180;Chlorophyllides;D002735
D03.383.129.578.840.500.640.220.180;Chlorophyllides;D002735
D03.549.909.374.180;Chlorophyllides;D002735
D03.549.909.500.640.220.180;Chlorophyllides;D002735
D04.345.783.374.180;Chlorophyllides;D002735
D04.345.783.500.640.220.180;Chlorophyllides;D002735
D23.767.727.220.180;Chlorophyllides;D002735
D23.767.727.640.220.180;Chlorophyllides;D002735
A11.284.430.214.190.875.700.140;Chloroplasts;D002736
D02.455.326.271.665.146.280;Chloroprene;D002737
D03.438.810.050.180;Chloroquine;D002738
D03.438.810.350.625.250;Chloroquinolinols;D002739
D02.886.590.700.135.261;Chlorothiazide;D002740
D02.886.655.500.261;Chlorothiazide;D002740
D03.438.174.261;Chlorothiazide;D002740
D02.455.426.559.389.150.700.100;Chlorotrianisene;D002741
D02.078.200;Chlorphenamidine;D002742
D02.033.455.706.345;Chlorphenesin;D002743
D03.383.725.620.150;Chlorpheniramine;D002744
D02.092.471.683.152.766.262;Chlorphentermine;D002745
D02.886.369.198;Chlorpromazine;D002746
D03.494.741.198;Chlorpromazine;D002746
D02.886.590.795.283;Chlorpropamide;D002747
D02.948.828.283;Chlorpropamide;D002747
D02.241.081.251.583.177;Chlorpropham;D002748
D02.886.952.250;Chlorprothixene;D002749
D03.494.953.704.250;Chlorprothixene;D002749
D03.438.810.350.625.250.260;Chlorquinaldol;D002750
D02.455.426.559.847.562.900.146;Chlortetracycline;D002751
D04.615.562.900.146;Chlortetracycline;D002751
D02.065.884.365;Chlorthalidone;D002752
D02.455.426.559.389.115.124.500;Chlorthalidone;D002752
D02.478.600.500;Chlorthalidone;D002752
D02.522.223.500;Chlorthalidone;D002752
D02.886.590.700.365;Chlorthalidone;D002752
D03.438.513.750.500;Chlorthalidone;D002752
D03.438.221.346;Chlorzoxazone;D002753
C08.460.171;Choanal Atresia;D002754
C08.695.271;Choanal Atresia;D002754
C09.603.171;Choanal Atresia;D002754
C16.131.740.271;Choanal Atresia;D002754
F02.463.785.373.346;Choice Behavior;D002755
D27.505.954.483.508;Cholagogues and Choleretics;D002756
D04.808.221;Cholanes;D002757
E01.370.350.700.715.200;Cholangiography;D002758
E01.370.372.200;Cholangiography;D002758
C04.557.470.035.085;Adenoma, Bile Duct;D002759
E01.370.350.700.715.200.200;Cholangiopancreatography, Endoscopic Retrograde;D002760
E01.370.372.200.200;Cholangiopancreatography, Endoscopic Retrograde;D002760
E01.370.372.250.200;Cholangiopancreatography, Endoscopic Retrograde;D002760
E01.370.388.250.250.160;Cholangiopancreatography, Endoscopic Retrograde;D002760
E04.210.240.160;Cholangiopancreatography, Endoscopic Retrograde;D002760
E04.800.250.250.160;Cholangiopancreatography, Endoscopic Retrograde;D002760
C06.130.120.200;Cholangitis;D002761
D04.808.247.222.159;Cholecalciferol;D002762
D04.808.247.808.146;Cholecalciferol;D002762
D04.808.812.768.196;Cholecalciferol;D002762
D10.570.938.146;Cholecalciferol;D002762
E04.210.120.172;Cholecystectomy;D002763
C06.130.564.263;Cholecystitis;D002764
E01.370.350.700.715.210;Cholecystography;D002765
E01.370.372.210;Cholecystography;D002765
D06.472.317.152;Cholecystokinin;D002766
D12.644.120;Cholecystokinin;D002766
D12.644.400.105;Cholecystokinin;D002766
D12.776.641.650.105;Cholecystokinin;D002766
E04.035.195;Cholecystostomy;D002767
E04.210.120.195;Cholecystostomy;D002767
E04.035.200;Choledochostomy;D002768
E04.210.120.200;Choledochostomy;D002768
C06.130.409;Cholelithiasis;D002769
D04.808.221.263;Cholenes;D002770
C01.252.400.959.347;Cholera;D002771
D08.811.913.400.725.115.180;Cholera Toxin;D002772
D23.946.123.194;Cholera Toxin;D002772
D23.946.330.150;Cholera Toxin;D002772
D04.808.247.222.222;Cholestadienes;D002774
D04.808.247.222.222.347;Cholestadienols;D002775
D04.808.247;Cholestanes;D002776
D04.808.247.100;Cholestanols;D002777
D04.808.247.125;Cholestanones;D002778
C06.130.120.135;Cholestasis;D002779
C06.130.120.135.250;Cholestasis, Intrahepatic;D002780
C06.552.150;Cholestasis, Intrahepatic;D002780
C17.800.428.260;Cholesteatoma;D002781
D04.808.247.222;Cholestenes;D002782
D04.808.247.222.265;Cholestenones;D002783
D04.808.247.222.284;Cholesterol;D002784
D04.808.247.808.197;Cholesterol;D002784
D10.570.938.208;Cholesterol;D002784
D10.851.208;Cholesterol;D002784
D08.811.913.050.799;Sterol O-Acyltransferase;D002785
D08.244.453.915.212;Cholesterol Side-Chain Cleavage Enzyme;D002786
D08.811.600.200;Cholesterol Side-Chain Cleavage Enzyme;D002786
D08.811.682.690.708.170.915.212;Cholesterol Side-Chain Cleavage Enzyme;D002786
D08.811.682.690.708.783.212;Cholesterol Side-Chain Cleavage Enzyme;D002786
D12.776.422.220.453.915.212;Cholesterol Side-Chain Cleavage Enzyme;D002786
D08.811.277.352.100.700;Sterol Esterase;D002787
D04.808.247.222.284.200;Cholesterol Esters;D002788
D04.808.247.808.197.200;Cholesterol Esters;D002788
D10.570.938.208.250;Cholesterol Esters;D002788
D08.811.682.047.436.350.150;Cholesterol Oxidase;D002789
D08.244.453.915.200;Cholesterol 7-alpha-Hydroxylase;D002790
D08.811.682.690.708.170.915.200;Cholesterol 7-alpha-Hydroxylase;D002790
D08.811.682.690.708.783.200;Cholesterol 7-alpha-Hydroxylase;D002790
D12.776.422.220.453.915.200;Cholesterol 7-alpha-Hydroxylase;D002790
D10.212.302.347;Cholesterol, Dietary;D002791
D10.570.938.208.222;Cholesterol, Dietary;D002791
D05.750.716.579.159;Cholestyramine Resin;D002792
D25.720.716.579.159;Cholestyramine Resin;D002792
J01.637.051.720.716.579.159;Cholestyramine Resin;D002792
D04.808.105.225;Cholic Acids;D002793
D04.808.221.430;Cholic Acids;D002793
D02.033.100.291.211;Choline;D002794
D02.092.063.291.211;Choline;D002794
D02.092.877.883.333;Choline;D002794
D02.675.276.232;Choline;D002794
D08.811.913.050.134.180;Choline O-Acetyltransferase;D002795
C18.654.521.500.133.699.160;Choline Deficiency;D002796
D08.811.913.696.620.155;Choline Kinase;D002797
D08.811.913.696.900.200;Diacylglycerol Cholinephosphotransferase;D002798
A08.663.542.234;Cholinergic Fibers;D002799
D27.505.519.389.275;Cholinesterase Inhibitors;D002800
D27.505.519.625.120.300;Cholinesterase Inhibitors;D002800
D27.505.696.577.120.300;Cholinesterase Inhibitors;D002800
D27.505.519.405.347;Cholinesterase Reactivators;D002801
D27.505.519.625.120.400;Cholinesterase Reactivators;D002801
D27.505.696.577.120.400;Cholinesterase Reactivators;D002801
D08.811.277.352.100.170;Cholinesterases;D002802
D08.811.277.352.827.180.175.275;Chondro-4-Sulfatase;D002803
C04.557.450.565.250;Chondroblastoma;D002804
C05.550.114.264;Chondrocalcinosis;D002805
C05.116.099.708.195;Chondrodysplasia Punctata;D002806
D09.698.373.200;Chondroitin;D002807
D08.811.520.241.700.350.500;Chondroitin Lyases;D002808
D09.698.373.200.300;Chondroitin Sulfates;D002809
D08.811.277.352.827.180;Chondroitinases and Chondroitin Lyases;D002810
D08.811.520.241.700.350;Chondroitinases and Chondroitin Lyases;D002810
D08.811.277.352.827.180.175;Chondroitinsulfatases;D002811
C04.557.450.565.265;Chondroma;D002812
C04.557.450.565.280;Chondrosarcoma;D002813
C04.557.450.795.300;Chondrosarcoma;D002813
A08.800.800.120.250.120;Chorda Tympani Nerve;D002814
A07.541.510.240;Chordae Tendineae;D002815
B01.050.150.200;Chordata, Nonvertebrate;D002816
B01.050.500.272;Chordata, Nonvertebrate;D002816
C04.557.465.220;Chordoma;D002817
E04.525.210.210;Cordotomy;D002818
C10.228.662.262.249;Chorea;D002819
C10.597.350.250;Chorea;D002819
C23.888.592.350.250;Chorea;D002819
C04.557.465.955.416.812.500;Hydatidiform Mole, Invasive;D002820
C04.850.908.416.750.500;Hydatidiform Mole, Invasive;D002820
C13.703.720.949.416.875.500;Hydatidiform Mole, Invasive;D002820
C13.703.277.030;Chorioamnionitis;D002821
C13.703.420.339.260;Chorioamnionitis;D002821
C13.703.590.268;Chorioamnionitis;D002821
C16.300.030;Chorioamnionitis;D002821
C04.557.465.955.207;Choriocarcinoma;D002822
C04.557.465.955.416.202;Choriocarcinoma;D002822
C04.557.470.200.025.455;Choriocarcinoma;D002822
C04.850.908.416.186;Choriocarcinoma;D002822
C13.703.720.949.416.218;Choriocarcinoma;D002822
A10.615.284.473;Chorion;D002823
A16.254.750.473;Chorion;D002823
A10.615.284.473.200;Chorionic Villi;D002824
A16.254.750.473.200;Chorionic Villi;D002824
A16.710.189;Chorionic Villi;D002824
C11.768.773.348;Chorioretinitis;D002825
C11.941.160.478.400;Chorioretinitis;D002825
C11.941.879.780.900.300.318;Chorioretinitis;D002825
D08.811.399.520.250;Chorismate Mutase;D002826
D02.241.223.268.250;Chorismic Acid;D002827
D02.455.426.392.368.367.379.374;Chorismic Acid;D002827
C23.300.250;Choristoma;D002828
A09.371.894.223;Choroid;D002829
C04.588.364.978.223;Choroid Neoplasms;D002830
C11.319.494.198;Choroid Neoplasms;D002830
C11.941.160.238;Choroid Neoplasms;D002830
C11.941.855.198;Choroid Neoplasms;D002830
A08.186.211.276.298;Choroid Plexus;D002831
C11.290.195;Choroid Hemorrhage;D002832
C11.941.160.177;Choroid Hemorrhage;D002832
C23.550.414.756.300;Choroid Hemorrhage;D002832
C11.941.160.478;Choroiditis;D002833
C11.941.879.780.900.300;Choroiditis;D002833
K01.844.188.431;Christian Science;D002834
K01.844.188;Christianity;D002835
C15.378.100.100.510;Hemophilia B;D002836
C15.378.100.141.510;Hemophilia B;D002836
C15.378.463.510;Hemophilia B;D002836
C16.320.099.510;Hemophilia B;D002836
C16.320.322.235;Hemophilia B;D002836
A06.224.161.500;Chromaffin Granules;D002837
A11.284.430.214.190.500.207;Chromaffin Granules;D002837
A11.284.430.214.190.875.190.190.207;Chromaffin Granules;D002837
A06.224;Chromaffin System;D002838
D03.438.150.240;Chromans;D002839
D03.830.219.240;Chromans;D002839
D01.220.150;Chromates;D002840
D01.248.497.158.235;Chromates;D002840
B03.660.250.110;Chromatiaceae;D002841
A11.284.430.106.279.345.190.160.175;Chromatids;D002842
G05.360.160.175;Chromatids;D002842
A11.284.430.106.279.345.190.160.180;Chromatin;D002843
D12.776.664.224;Chromatin;D002843
G05.360.160.180;Chromatin;D002843
B03.440.425.410.290;Chromatium;D002844
B03.660.250.110.150;Chromatium;D002844
E05.196.181;Chromatography;D002845
E05.196.181.400.170;Chromatography, Affinity;D002846
E05.196.181.400.250.200;Chromatography, Agarose;D002847
E05.196.181.400.383.349;Chromatography, DEAE-Cellulose;D002848
E05.196.181.349;Chromatography, Gas;D002849
E05.196.181.400.250;Chromatography, Gel;D002850
E05.196.181.400.300;Chromatography, High Pressure Liquid;D002851
E05.196.181.400.383;Chromatography, Ion Exchange;D002852
E05.196.181.400;Chromatography, Liquid;D002853
E05.196.181.400.454;Chromatography, Paper;D002854
E05.196.181.400.537;Chromatography, Thin Layer;D002855
A11.436.265;Chromatophores;D002856
D01.268.556.175;Chromium;D002857
D01.268.956.124;Chromium;D002857
D01.552.544.175;Chromium;D002857
D01.220.175;Chromium Alloys;D002858
D01.552.033.182;Chromium Alloys;D002858
D25.058.224;Chromium Alloys;D002858
D25.339.208.224;Chromium Alloys;D002858
J01.637.051.058.224;Chromium Alloys;D002858
J01.637.051.339.208.224;Chromium Alloys;D002858
D01.496.212;Chromium Isotopes;D002859
D01.496.212.349;Chromium Radioisotopes;D002860
D01.496.749.213;Chromium Radioisotopes;D002860
B03.440.450.360;Chromobacterium;D002861
B03.660.075.525.100;Chromobacterium;D002861
C01.539.800.200.110;Chromoblastomycosis;D002862
C01.703.295.182;Chromoblastomycosis;D002862
C17.800.838.208.241;Chromoblastomycosis;D002862
D27.720.233.173;Chromogenic Compounds;D002863
D27.720.470.410.200;Chromogenic Compounds;D002863
D12.776.641.199;Chromogranins;D002864
D12.776.811.185;Chromogranins;D002864
D09.408.210;Chromomycins;D002865
D03.438.150.446.280;Chromonar;D002866
D03.830.219.446.280;Chromonar;D002866
D03.438.150.266;Chromones;D002867
D03.830.219.266;Chromones;D002867
D12.776.660.235;Chromosomal Proteins, Non-Histone;D002868
D12.776.664.235;Chromosomal Proteins, Non-Histone;D002868
C23.550.210;Chromosome Aberrations;D002869
G05.365.590.175;Chromosome Aberrations;D002869
E01.370.225.500.385.130;Chromosome Banding;D002871
E01.370.225.500.620.670.130;Chromosome Banding;D002871
E01.370.225.750.600.670.130;Chromosome Banding;D002871
E05.200.500.385.130;Chromosome Banding;D002871
E05.200.500.620.670.130;Chromosome Banding;D002871
E05.200.750.600.670.130;Chromosome Banding;D002871
E05.242.385.130;Chromosome Banding;D002871
E05.393.285.130;Chromosome Banding;D002871
C23.550.210.050.500.500;Chromosome Deletion;D002872
G05.355.600.800.180;Chromosome Deletion;D002872
G05.365.590.029.530.175;Chromosome Deletion;D002872
G05.365.590.175.050.500.500;Chromosome Deletion;D002872
G05.365.590.762.180;Chromosome Deletion;D002872
G05.700.131.500.500;Chromosome Deletion;D002872
C23.550.210.110.180;Chromosome Fragility;D002873
C23.550.362.180.180;Chromosome Fragility;D002873
G05.365.590.175.165.180;Chromosome Fragility;D002873
G05.370.180.180;Chromosome Fragility;D002873
E05.393.183;Chromosome Mapping;D002874
A11.284.187;Chromosomes;D002875
A11.284.430.106.279.345.190;Chromosomes;D002875
G05.360.162;Chromosomes;D002875
A11.284.187.190;Chromosomes, Bacterial;D002876
A20.812;Chromosomes, Bacterial;D002876
G05.360.162.190;Chromosomes, Bacterial;D002876
A11.284.187.520.300;Chromosomes, Human;D002877
G05.360.162.520.300;Chromosomes, Human;D002877
A11.284.187.520.300.235.240;Chromosomes, Human, Pair 1;D002878
G05.360.162.520.300.235.240;Chromosomes, Human, Pair 1;D002878
A11.284.187.520.300.325.350;Chromosomes, Human, Pair 10;D002879
G05.360.162.520.300.325.350;Chromosomes, Human, Pair 10;D002879
A11.284.187.520.300.325.355;Chromosomes, Human, Pair 11;D002880
G05.360.162.520.300.325.355;Chromosomes, Human, Pair 11;D002880
A11.284.187.520.300.325.360;Chromosomes, Human, Pair 12;D002881
G05.360.162.520.300.325.360;Chromosomes, Human, Pair 12;D002881
A11.284.187.520.300.370.375;Chromosomes, Human, Pair 13;D002882
G05.360.162.520.300.370.375;Chromosomes, Human, Pair 13;D002882
A11.284.187.520.300.370.380;Chromosomes, Human, Pair 14;D002883
G05.360.162.520.300.370.380;Chromosomes, Human, Pair 14;D002883
A11.284.187.520.300.370.385;Chromosomes, Human, Pair 15;D002884
G05.360.162.520.300.370.385;Chromosomes, Human, Pair 15;D002884
A11.284.187.520.300.415.420;Chromosomes, Human, Pair 16;D002885
G05.360.162.520.300.415.420;Chromosomes, Human, Pair 16;D002885
A11.284.187.520.300.415.425;Chromosomes, Human, Pair 17;D002886
G05.360.162.520.300.415.425;Chromosomes, Human, Pair 17;D002886
A11.284.187.520.300.415.430;Chromosomes, Human, Pair 18;D002887
G05.360.162.520.300.415.430;Chromosomes, Human, Pair 18;D002887
A11.284.187.520.300.460.465;Chromosomes, Human, Pair 19;D002888
G05.360.162.520.300.460.465;Chromosomes, Human, Pair 19;D002888
A11.284.187.520.300.235.245;Chromosomes, Human, Pair 2;D002889
G05.360.162.520.300.235.245;Chromosomes, Human, Pair 2;D002889
A11.284.187.520.300.460.470;Chromosomes, Human, Pair 20;D002890
G05.360.162.520.300.460.470;Chromosomes, Human, Pair 20;D002890
A11.284.187.520.300.505.510;Chromosomes, Human, Pair 21;D002891
G05.360.162.520.300.505.510;Chromosomes, Human, Pair 21;D002891
A11.284.187.520.300.505.515;Chromosomes, Human, Pair 22;D002892
G05.360.162.520.300.505.515;Chromosomes, Human, Pair 22;D002892
A11.284.187.520.300.235.250;Chromosomes, Human, Pair 3;D002893
G05.360.162.520.300.235.250;Chromosomes, Human, Pair 3;D002893
A11.284.187.520.300.280.285;Chromosomes, Human, Pair 4;D002894
G05.360.162.520.300.280.285;Chromosomes, Human, Pair 4;D002894
A11.284.187.520.300.280.290;Chromosomes, Human, Pair 5;D002895
G05.360.162.520.300.280.290;Chromosomes, Human, Pair 5;D002895
A11.284.187.520.300.325.330;Chromosomes, Human, Pair 6;D002896
G05.360.162.520.300.325.330;Chromosomes, Human, Pair 6;D002896
A11.284.187.520.300.325.335;Chromosomes, Human, Pair 7;D002897
G05.360.162.520.300.325.335;Chromosomes, Human, Pair 7;D002897
A11.284.187.520.300.325.340;Chromosomes, Human, Pair 8;D002898
G05.360.162.520.300.325.340;Chromosomes, Human, Pair 8;D002898
A11.284.187.520.300.325.345;Chromosomes, Human, Pair 9;D002899
G05.360.162.520.300.325.345;Chromosomes, Human, Pair 9;D002899
A11.284.187.520.300.235;Chromosomes, Human, 1-3;D002900
G05.360.162.520.300.235;Chromosomes, Human, 1-3;D002900
A11.284.187.520.300.370;Chromosomes, Human, 13-15;D002901
G05.360.162.520.300.370;Chromosomes, Human, 13-15;D002901
A11.284.187.520.300.415;Chromosomes, Human, 16-18;D002902
G05.360.162.520.300.415;Chromosomes, Human, 16-18;D002902
A11.284.187.520.300.460;Chromosomes, Human, 19-20;D002903
G05.360.162.520.300.460;Chromosomes, Human, 19-20;D002903
A11.284.187.520.300.505;Chromosomes, Human, 21-22 and Y;D002904
G05.360.162.520.300.505;Chromosomes, Human, 21-22 and Y;D002904
A11.284.187.520.300.280;Chromosomes, Human, 4-5;D002905
G05.360.162.520.300.280;Chromosomes, Human, 4-5;D002905
A11.284.187.520.300.325;Chromosomes, Human, 6-12 and X;D002906
G05.360.162.520.300.325;Chromosomes, Human, 6-12 and X;D002906
E05.723.402.201;Chronaxy;D002907
G07.265.175;Chronaxy;D002907
G11.561.175;Chronaxy;D002907
C23.550.291.500;Chronic Disease;D002908
G07.180;Chronobiology Phenomena;D002909
G01.910.200;Chronology as Topic;D002910
L01.080;Chronology as Topic;D002910
D02.455.426.559.847.723.180;Chrysenes;D002911
D04.615.723.180;Chrysenes;D002911
B01.300.381.170;Chrysosporium;D002912
A12.207.270.606.350;Chyle;D002913
A15.382.520.150.350;Chyle;D002913
D10.532.183;Chylomicrons;D002914
D12.776.521.242;Chylomicrons;D002914
C06.844.200;Chylous Ascites;D002915
C08.528.142;Chylothorax;D002916
D08.811.277.656.262.500.160;Chymopapain;D002917
D08.811.277.656.300.200.160;Chymopapain;D002917
D08.811.277.656.300.760.176;Chymotrypsin;D002918
D08.811.277.656.959.350.176;Chymotrypsin;D002918
D08.622.184;Chymotrypsinogen;D002919
D02.691.750.100.347.350;Cialit;D002920
D03.438.221.370;Cialit;D002920
A10.165.450.300;Cicatrix;D002921
C23.550.355.274;Cicatrix;D002921
G16.100.856.891.249;Cicatrix;D002921
D02.355.291.205;Ciguatoxins;D002922
D23.946.580.160;Ciguatoxins;D002922
A11.284.180.165;Cilia;D002923
A09.371.060.160;Ciliary Body;D002924
A09.371.894.280;Ciliary Body;D002924
C08.200;Ciliary Motility Disorders;D002925
C09.150;Ciliary Motility Disorders;D002925
D02.078.370.200;Cimetidine;D002927
D03.383.129.308.130;Cimetidine;D002927
D02.241.223.200.200;Cinanserin;D002928
B01.650.940.800.575.100.850.250;Cinchona;D002929
D03.132.206;Cinchona Alkaloids;D002930
E01.370.350.700.060.190;Cineangiography;D002932
E01.370.350.700.150.190;Cineangiography;D002932
E01.370.370.050.190;Cineangiography;D002932
E01.370.350.700.150;Cineradiography;D002933
D02.241.223.200;Cinnamates;D002934
B01.650.940.800.575.100.590.149.500;Cinnamomum zeylanicum;D002935
D03.383.606.290;Cinnarizine;D002936
D03.066.160;Cinoxacin;D002937
D03.494.160;Cinoxacin;D002937
B01.050.150.200.727.300;Ciona intestinalis;D002938
B01.050.500.272.727.300;Ciona intestinalis;D002938
D03.438.810.835.322.186;Ciprofloxacin;D002939
G07.180.562.190;Circadian Rhythm;D002940
A07.231.114.228.351;Circle of Willis;D002941
E05.196.867.151;Circular Dichroism;D002942
G09;Circulatory and Respiratory Physiological Phenomena;D002943
E02.218.085.170;Circumcision, Male;D002944
E04.085.170;Circumcision, Male;D002944
E04.950.774.860.226;Circumcision, Male;D002944
D01.210.375;Cisplatin;D002945
D01.625.125;Cisplatin;D002945
D01.710.100;Cisplatin;D002945
A08.186.566.166.686.351;Cisterna Magna;D002946
G16.500.275.069;Cities;D002947
N06.230.069;Cities;D002947
Z01.433;Cities;D002947
D02.113.250;Citraconic Anhydrides;D002949
D03.383.312.250;Citraconic Anhydrides;D002949
D08.811.913.050.368;Citrate (si)-Synthase;D002950
D02.241.081.901.434;Citrates;D002951
G02.111.087.165;Citric Acid Cycle;D002952
G02.149.115.165;Citric Acid Cycle;D002952
G03.495.335.342;Citric Acid Cycle;D002952
G03.495.553.170;Citric Acid Cycle;D002952
D03.438.150.320;Citrinin;D002953
D03.830.219.320;Citrinin;D002953
D23.946.587.272;Citrinin;D002953
B03.440.450.425.200;Citrobacter;D002954
B03.660.250.150.100;Citrobacter;D002954
D03.438.733.631.400.800.350.450;Leucovorin;D002955
D08.211.840.300.500;Leucovorin;D002955
D12.125.095.226;Citrulline;D002956
B01.650.940.800.575.100.875.177;Citrus;D002957
I01.880.709.202;City Planning;D002958
I01.451.227;Civil Defense;D002959
I01.880.735.140;Civil Disorders;D002960
I01.880.604.473.352;Civil Rights;D002961
N03.706.437.352;Civil Rights;D002961
I01.076.201.450.226;Civilization;D002962
B01.300.381.200;Cladosporium;D002963
L01.100;Classification;D002965
L01.453.245.275;Classification;D002965
D12.776.543.990.200;Clathrin;D002966
B01.300.107.501.200;Claviceps;D002967
A02.835.232.087.227;Clavicle;D002968
D02.065.589.099.374;Clavulanic Acids;D002969
D04.075.080.875.099.221.374;Clavulanic Acids;D002969
A16.166;Cleavage Stage, Ovum;D002970
C07.465.409.225;Cleft Lip;D002971
C07.465.525.164;Cleft Lip;D002971
C07.650.525.164;Cleft Lip;D002971
C16.131.850.525.164;Cleft Lip;D002971
C05.500.460.185;Cleft Palate;D002972
C05.660.207.540.460.185;Cleft Palate;D002972
C07.320.440.185;Cleft Palate;D002972
C07.465.525.185;Cleft Palate;D002972
C07.650.500.460.185;Cleft Palate;D002972
C07.650.525.185;Cleft Palate;D002972
C16.131.621.207.540.460.185;Cleft Palate;D002972
C16.131.850.500.460.185;Cleft Palate;D002972
C16.131.850.525.185;Cleft Palate;D002972
C05.116.099.708.207;Cleidocranial Dysplasia;D002973
C05.660.207.207;Cleidocranial Dysplasia;D002973
C16.131.621.207.207;Cleidocranial Dysplasia;D002973
D03.383.773.165;Clemastine;D002974
D02.033.100.291.231;Clenbuterol;D002976
D02.092.063.291.231;Clenbuterol;D002976
M01.526.213;Clergy;D002977
G08.686.157;Climacteric;D002979
G08.686.785.880.249;Climacteric;D002979
G16.500.275.071;Climate;D002980
N06.230.300.100.250;Climate;D002980
D03.383.773.532.500.125;Clindamycin;D002981
D09.408.471.500.125;Clindamycin;D002981
I02.358.105;Clinical Clerkship;D002982
I02.399.630.210;Clinical Competence;D002983
N04.761.210;Clinical Competence;D002983
L01.700.508.300.110;Clinical Laboratory Information Systems;D002984
L01.700.508.300.680.065;Clinical Laboratory Information Systems;D002984
N04.452.515.080;Clinical Laboratory Information Systems;D002984
N04.452.515.360.110;Clinical Laboratory Information Systems;D002984
E02.183;Clinical Protocols;D002985
N05.715.360.775.225;Clinical Protocols;D002985
E05.318.760.535;Clinical Trials as Topic;D002986
E05.337.250;Clinical Trials as Topic;D002986
N05.715.360.775.235;Clinical Trials as Topic;D002986
N06.850.520.450.535;Clinical Trials as Topic;D002986
A05.360.319.887.436;Clitoris;D002987
A13.223;Cloaca;D002988
A16.178;Cloaca;D002988
D12.776.097.151.190;Cloacin;D002989
D04.808.908.093.250;Clobetasol;D002990
D03.494.704.353;Clofazimine;D002991
D02.241.081.114.968.500.374;Clofenapate;D002992
D02.355.726.305.374;Clofenapate;D002992
D02.455.426.559.389.185.210;Clofenapate;D002992
D02.455.426.559.389.657.654.305.374;Clofenapate;D002992
D02.241.081.114.968.500.500.195;Clofibrate;D002994
D02.355.726.305.500.195;Clofibrate;D002994
D02.455.426.559.389.657.654.305.500.195;Clofibrate;D002994
D02.241.081.114.968.500.500;Clofibric Acid;D002995
D02.355.726.305.500;Clofibric Acid;D002995
D02.455.426.559.389.657.654.305.500;Clofibric Acid;D002995
D02.455.426.559.389.150.700.125;Clomiphene;D002996
D03.494.240.194;Clomipramine;D002997
D03.438.079.080.070.150;Clonazepam;D002998
A11.251.353;Clone Cells;D002999
D03.383.129.308.436.500;Clonidine;D003000
E05.393.220;Cloning, Molecular;D003001
D03.066.515.375;Clonixin;D003002
D03.383.725.547.375;Clonixin;D003002
C03.335.865.148;Clonorchiasis;D003003
B01.050.500.500.736.715.520.210;Clonorchis sinensis;D003004
D02.065.884.390;Clopamide;D003005
D02.886.590.700.390;Clopamide;D003005
D03.383.621.147;Clopamide;D003005
D02.886.952.305;Clopenthixol;D003006
D03.494.953.704.269;Clopenthixol;D003006
D03.383.725.180;Clopidol;D003007
D10.251.355.255.550.700.500.175;Cloprostenol;D003008
D23.469.700.670.175;Cloprostenol;D003008
D03.438.079.080.180;Clorazepate Dipotassium;D003009
D02.092.831.180;Clorgyline;D003010
E01.370.386.700.485.750.150;Closing Volume;D003011
G09.772.850.250;Closing Volume;D003011
D08.811.277.656.300.480.205.500;Microbial Collagenase;D003012
D08.811.277.656.675.374.205.500;Microbial Collagenase;D003012
B03.300.390.400.200;Clostridium;D003013
B03.510.415.400.200;Clostridium;D003013
B03.300.390.400.200.160;Clostridium botulinum;D003014
B03.510.415.400.200.160;Clostridium botulinum;D003014
C01.252.410.222;Clostridium Infections;D003015
B03.300.390.400.200.575;Clostridium perfringens;D003016
B03.510.415.400.200.575;Clostridium perfringens;D003016
B03.300.390.400.200.725;Clostridium tetani;D003017
B03.510.415.400.200.725;Clostridium tetani;D003017
E01.370.225.625.625.160;Clot Retraction;D003018
E05.200.625.625.160;Clot Retraction;D003018
G09.188.124.560.600.180;Clot Retraction;D003018
J01.637.215;Clothing;D003020
D03.383.129.308.175;Clotrimazole;D003022
D02.065.589.099.750.625.150;Cloxacillin;D003023
D02.886.108.750.625.150;Cloxacillin;D003023
D03.438.260.825.625.150;Cloxacillin;D003023
D03.605.084.737.625.150;Cloxacillin;D003023
D04.075.080.875.099.221.750.625.150;Cloxacillin;D003023
D03.494.240.220;Clozapine;D003024
C05.330.495.150;Clubfoot;D003025
C05.660.585.512.380.500;Clubfoot;D003025
C16.131.621.585.380.500;Clubfoot;D003025
D12.776.660.750.270;Clupeine;D003026
D12.776.664.750.270;Clupeine;D003026
C10.228.140.546.399.937.500;Cluster Headache;D003027
D02.491.203.340;CME-Carbodiimide;D003028
D27.505.954.502.270;Coagulants;D003029
D08.811.277.656.300.174;Coagulase;D003030
D12.776.097.181;Coagulase;D003030
D20.345.108;Coal;D003031
N06.230.132.258.108;Coal;D003031
J01.576.370.500.500;Coal Mining;D003032
D20.749.354;Coal Tar;D003033
A11.284.149.165.175;Coated Pits, Cell-Membrane;D003034
D01.268.556.185;Cobalt;D003035
D01.268.956.155;Cobalt;D003035
D01.552.544.185;Cobalt;D003035
D01.496.239;Cobalt Isotopes;D003036
D01.496.239.354;Cobalt Radioisotopes;D003037
D01.496.749.256;Cobalt Radioisotopes;D003037
D03.383.129.578.840.437.777.270;Cobamides;D003038
D03.549.909.437.777.270;Cobamides;D003038
D04.345.783.437.777.270;Cobamides;D003038
D08.211.175;Cobamides;D003038
D12.776.831.244;Cobra Neurotoxin Proteins;D003039
D20.888.850.325.220.190;Cobra Neurotoxin Proteins;D003039
D23.946.833.850.325.220.190;Cobra Neurotoxin Proteins;D003039
D20.888.850.325.220;Cobra Venoms;D003040
D23.946.833.850.325.220;Cobra Venoms;D003040
B01.650.940.800.575.100.346.500;Coca;D003041
D02.145.074.722.388;Cocaine;D003042
D03.132.889.354;Cocaine;D003042
D03.605.869.388;Cocaine;D003042
D04.075.080.875.099.722.388;Cocaine;D003042
C04.697.160;Cocarcinogenesis;D003043
C23.550.727.160;Cocarcinogenesis;D003043
B01.043.075.189;Coccidia;D003044
B01.300.381.230;Coccidioides;D003045
D23.050.202.180;Coccidioidin;D003046
C01.703.203;Coccidioidomycosis;D003047
C03.752.250;Coccidiosis;D003048
D27.505.954.122.250.100.170;Coccidiostats;D003049
A02.835.232.834.229;Coccyx;D003050
A09.246.631.246;Cochlea;D003051
A09.246.631.246.280;Cochlear Aqueduct;D003052
A09.246.631.246.292;Cochlear Duct;D003053
E07.305.250.319.381.500.500;Cochlear Implants;D003054
E07.695.150;Cochlear Implants;D003054
E07.695.202.381.500.500;Cochlear Implants;D003054
E07.814.458.150;Cochlear Implants;D003054
G07.265.500.370.223;Cochlear Microphonic Potentials;D003055
G11.561.270.370.223;Cochlear Microphonic Potentials;D003055
A08.800.800.120.910.120;Cochlear Nerve;D003056
C05.116.099.343.250;Cockayne Syndrome;D003057
C10.574.500.362;Cockayne Syndrome;D003057
C16.131.077.250;Cockayne Syndrome;D003057
C16.320.240.562;Cockayne Syndrome;D003057
C16.320.400.200;Cockayne Syndrome;D003057
C18.452.284.250;Cockayne Syndrome;D003057
B01.050.500.131.617.140;Cockroaches;D003058
B01.650.940.800.575.100.093.211;Cocos;D003059
D10.212.302.380.360;Cod Liver Oil;D003060
D10.212.507.325;Cod Liver Oil;D003060
D10.627.430.354;Cod Liver Oil;D003060
D03.132.577.249.547.547.149;Codeine;D003061
D03.549.686.575.547.204;Codeine;D003061
D03.605.497.575.547.204;Codeine;D003061
D04.615.723.795.547.547.149;Codeine;D003061
D13.444.735.544.355;Codon;D003062
G05.360.335.355;Codon;D003062
G05.360.340.024.340.137.190;Codon;D003062
B01.050.500.308;Cnidaria;D003063
D20.888.230;Cnidarian Venoms;D003064
D23.946.580.230;Cnidarian Venoms;D003064
D23.946.833.230;Cnidarian Venoms;D003064
D03.438.759.646.138.382;Coenzyme A;D003065
D08.211.211;Coenzyme A;D003065
D13.695.667.138.382;Coenzyme A;D003065
D13.695.827.068.382;Coenzyme A;D003065
D08.811.464.267.500;Coenzyme A Ligases;D003066
D08.211;Coenzymes;D003067
I01.880.604.316;Coercion;D003068
I01.880.630.200;Coercion;D003068
D20.215.784.249;Coffee;D003069
J02.200.325;Coffee;D003069
D03.383.742.680.350.200;Coformycin;D003070
D13.570.685.350.200;Coformycin;D003070
D13.570.800.410.200;Coformycin;D003070
F02.463.188;Cognition;D003071
F03.087.250;Cognition Disorders;D003072
F02.463.188.305;Cognitive Dissonance;D003073
C04.588.894.797.520.966;Solitary Pulmonary Nodule;D003074
C08.381.540.933;Solitary Pulmonary Nodule;D003074
C08.381.884;Solitary Pulmonary Nodule;D003074
C08.785.520.933;Solitary Pulmonary Nodule;D003074
F01.145.802.188;Coitus;D003075
G08.686.785.760.041;Coitus;D003075
E02.875.194.250;Coitus Interruptus;D003076
F01.145.802.188.300;Coitus Interruptus;D003076
D20.345.108.110;Coke;D003077
N06.230.132.258.108.110;Coke;D003077
D03.132.225;Colchicine;D003078
B01.650.940.800.575.100.610.200;Colchicum;D003079
G01.906.595.272;Cold Temperature;D003080
G16.500.275.063.725.710.300;Cold Temperature;D003080
G16.500.750.775.710.300;Cold Temperature;D003080
N06.230.300.100.725.154;Cold Temperature;D003080
N06.230.300.100.725.710.300;Cold Temperature;D003080
G16.500.275.071.275;Cold Climate;D003081
N06.230.300.100.250.275;Cold Climate;D003081
E04.210.219;Colectomy;D003082
D02.092.782.200;Colestipol;D003084
D05.750.200;Colestipol;D003084
D25.720.200;Colestipol;D003084
J01.637.051.720.200;Colestipol;D003084
C23.888.646.100.600;Colic;D003085
C23.888.821.030.500;Colic;D003085
G05.360.600.080;Bacteriocin Plasmids;D003086
D12.776.097.200;Colicins;D003087
D12.776.097.275.750;Colicins;D003087
B01.050.150.900.248.350.650.300;Colinus;D003088
D12.776.200;Colipases;D003089
B04.123.205;Coliphages;D003090
D04.345.566.780.110;Colistin;D003091
D10.477.750.110;Colistin;D003091
D12.644.050.600.110;Colistin;D003091
D12.644.641.780.110;Colistin;D003091
D12.776.543.695.054.600.110;Colistin;D003091
C06.405.205.265;Colitis;D003092
C06.405.469.158.188;Colitis;D003092
C06.405.205.265.231;Colitis, Ulcerative;D003093
C06.405.205.731.249;Colitis, Ulcerative;D003093
C06.405.469.158.188.231;Colitis, Ulcerative;D003093
C06.405.469.432.249;Colitis, Ulcerative;D003093
D05.750.078.280;Collagen;D003094
D12.776.860.300.250;Collagen;D003094
C17.300.200;Collagen Diseases;D003095
E04.928.600.220;Collapse Therapy;D003096
G09.330.190.163.248;Collateral Circulation;D003097
N03.540.571.356;Collective Bargaining;D003098
N04.452.677.356;Collective Bargaining;D003098
I02.399.272;College Admission Test;D003099
C26.404.562.356;Colles' Fracture;D003100
D25.720.099.500.439;Collodion;D003101
J01.637.051.720.099.500.439;Collodion;D003101
D20.280;Colloids;D003102
D26.255.165;Colloids;D003102
D27.720.280.165;Colloids;D003102
C11.250.110;Coloboma;D003103
C16.131.384.282;Coloboma;D003103
B01.050.150.900.649.801.400.112.199.150.150;Colobus;D003104
Z01.107.757.284;Colombia;D003105
A03.556.124.526.356;Colon;D003106
A03.556.249.249.356;Colon;D003106
H02.403.810.208;Colorectal Surgery;D003107
C06.405.469.158;Colonic Diseases;D003108
C06.405.469.158.272;Colonic Diseases, Functional;D003109
C04.588.274.476.411.307.180;Colonic Neoplasms;D003110
C06.301.371.411.307.180;Colonic Neoplasms;D003110
C06.405.249.411.307.180;Colonic Neoplasms;D003110
C06.405.469.158.356.180;Colonic Neoplasms;D003110
C06.405.469.491.307.180;Colonic Neoplasms;D003110
C23.300.825.411.235;Colonic Polyps;D003111
C06.405.469.158.272.217;Colonic Pseudo-Obstruction;D003112
C06.405.469.531.492.500.217;Colonic Pseudo-Obstruction;D003112
E01.370.372.250.250.200;Colonoscopy;D003113
E01.370.388.250.250.250.160;Colonoscopy;D003113
E04.210.240.250.160;Colonoscopy;D003113
E04.800.250.250.250.160;Colonoscopy;D003113
E01.370.225.500.383;Colony-Forming Units Assay;D003114
E05.200.500.383;Colony-Forming Units Assay;D003114
E05.242.383;Colony-Forming Units Assay;D003114
D12.644.276.374.410.240;Colony-Stimulating Factors;D003115
D12.776.395.240;Colony-Stimulating Factors;D003115
D12.776.467.374.410.240;Colony-Stimulating Factors;D003115
D23.529.374.410.240;Colony-Stimulating Factors;D003115
G01.590.540.199;Color;D003116
C10.597.751.941.256;Color Vision Defects;D003117
C11.966.256;Color Vision Defects;D003117
C23.888.592.763.941.256;Color Vision Defects;D003117
F02.463.593.932.217;Color Perception;D003118
E01.370.380.850.150;Color Perception Tests;D003119
Z01.107.567.875.760.210;Colorado;D003120
C02.081.885.200;Colorado Tick Fever;D003121
C02.782.791.482;Colorado Tick Fever;D003121
B04.820.630.160.200;Colorado tick fever virus;D003122
B04.909.777.714.160.200;Colorado tick fever virus;D003122
C04.588.274.476.411.307.190;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C04.700.250;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C06.301.371.411.307.190;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C06.405.249.411.307.190;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C06.405.469.158.356.190;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C06.405.469.491.307.190;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C16.320.700.250;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
C18.452.284.255;Colorectal Neoplasms, Hereditary Nonpolyposis;D003123
E05.196.922.250;Colorimetry;D003124
E04.210.338.225;Colostomy;D003125
E04.579.338.225;Colostomy;D003125
A12.200.194;Colostrum;D003126
E01.370.378.150;Colposcopy;D003127
E01.370.388.250.150;Colposcopy;D003127
E04.520.150;Colposcopy;D003127
E04.800.250.150;Colposcopy;D003127
E04.950.300.210;Colposcopy;D003127
C10.597.606.358.800.200;Coma;D003128
C23.888.592.604.359.800.200;Coma;D003128
A13.242;Comb and Wattles;D003129
F03.080.931.249;Combat Disorders;D003130
E02.186;Combined Modality Therapy;D003131
J01.219;Commerce;D003132
N04.761.700.250.500.100;Commission on Professional and Hospital Activities;D003133
N05.700.175.500.200;Commission on Professional and Hospital Activities;D003133
F04.096.544.335.200;Commitment of Mentally Ill;D003134
N03.706.535.351.200;Commitment of Mentally Ill;D003134
A03.159.183.079.300;Common Bile Duct;D003135
C06.130.120.250;Common Bile Duct Diseases;D003137
C04.588.274.120.250.250;Common Bile Duct Neoplasms;D003138
C06.130.120.120.280;Common Bile Duct Neoplasms;D003138
C06.130.120.250.280;Common Bile Duct Neoplasms;D003138
C06.130.320.120.280;Common Bile Duct Neoplasms;D003138
C06.301.120.250.250;Common Bile Duct Neoplasms;D003138
C02.782.687.207;Common Cold;D003139
C08.730.162;Common Cold;D003139
N06.850.780.200;Communicable Disease Control;D003140
C01.539.221;Communicable Diseases;D003141
F01.145.209;Communication;D003142
L01.143;Communication;D003142
E07.796.250;Communication Aids for Disabled;D003143
L01.143.230;Communication Barriers;D003144
E02.831.671.221;Communication Methods, Total;D003145
L01.178;Communications Media;D003146
C10.597.606.150;Communication Disorders;D003147
C23.888.592.604.150;Communication Disorders;D003147
F03.550.350;Communication Disorders;D003147
I01.696.232;Communism;D003148
H02.163.876.770.357;Community Dentistry;D003149
M01.526.485.067.080;Community Health Workers;D003150
N02.360.067.080;Community Health Workers;D003150
N02.278.035.128;Community Health Centers;D003151
H02.478.676.150;Community Health Nursing;D003152
N02.421.143.150;Community Health Nursing;D003152
N02.421.143;Community Health Services;D003153
H02.403.220;Community Medicine;D003154
N02.278.035.158;Community Mental Health Centers;D003155
F04.408.307;Community Mental Health Services;D003156
N02.421.143.183;Community Mental Health Services;D003156
N02.421.461.232;Community Mental Health Services;D003156
N02.421.143.221;Community Pharmacy Services;D003157
N02.421.668.274;Community Pharmacy Services;D003157
F04.096.544.215;Community Psychiatry;D003158
H02.403.690.150;Community Psychiatry;D003158
N04.452.822.210;Community-Institutional Relations;D003159
V03.250;Comparative Study;D003160
C05.651.180;Compartment Syndromes;D003161
C14.907.303;Compartment Syndromes;D003161
I02.158.210;Competency-Based Education;D003162
F01.145.813.105;Competitive Behavior;D003163
N03.219.463.100.110;Competitive Bidding;D003164
D12.776.124.486.274;Complement System Proteins;D003165
D08.811.277.300;Complement Activating Enzymes;D003166
D12.776.124.486.274.045;Complement Activating Enzymes;D003166
G12.425.255;Complement Activation;D003167
E01.370.225.812.735.150;Complement Fixation Tests;D003168
E05.200.812.735.150;Complement Fixation Tests;D003168
E05.478.594.760.150;Complement Fixation Tests;D003168
D12.776.124.486.274.920;Complement Inactivator Proteins;D003169
G12.425.255.695;Complement Pathway, Alternative;D003170
G12.425.255.698;Complement Pathway, Classical;D003171
D12.776.124.486.274.050;Complement C1;D003172
D08.811.277.300.290;Complement C1s;D003173
D12.776.124.486.274.045.290;Complement C1s;D003173
D12.776.124.486.274.050.290;Complement C1s;D003173
D12.644.822.750.140;Complement C1 Inactivator Proteins;D003174
D12.644.861.140;Complement C1 Inactivator Proteins;D003174
D12.776.124.486.274.920.250;Complement C1 Inactivator Proteins;D003174
D12.776.645.750.140;Complement C1 Inactivator Proteins;D003174
D12.776.872.140;Complement C1 Inactivator Proteins;D003174
D12.776.124.486.274.150;Complement C2;D003175
D12.776.124.050.140;Complement C3;D003176
D12.776.124.486.274.250;Complement C3;D003176
D12.776.124.486.274.920.287;Complement C3 Nephritic Factor;D003178
D12.776.124.486.485.114.323.300;Complement C3 Nephritic Factor;D003178
D12.776.124.790.651.114.323.300;Complement C3 Nephritic Factor;D003178
D12.776.377.715.548.114.323.300;Complement C3 Nephritic Factor;D003178
D12.776.124.486.274.250.260;Complement C3b;D003179
D12.776.124.486.274.920.325;Complement C3b Inactivator Proteins;D003180
D12.776.124.486.274.350;Complement C4;D003181
D12.776.124.486.274.450;Complement C5;D003182
D12.776.124.486.274.550;Complement C6;D003183
D12.776.124.486.274.650;Complement C7;D003184
D12.776.124.486.274.750;Complement C8;D003185
D12.776.124.486.274.850;Complement C9;D003186
G01.374.590.210;Compliance;D003187
D05.750.716.822.308;Composite Resins;D003188
D25.339.816.500;Composite Resins;D003188
D25.720.716.822.308;Composite Resins;D003188
J01.637.051.339.816.500;Composite Resins;D003188
J01.637.051.720.716.822.308;Composite Resins;D003188
D02.092.471.683.670;p-Methoxy-N-methylphenethylamine;D003189
N04.590.233.250;Comprehensive Dental Care;D003190
N04.590.233;Comprehensive Health Care;D003191
F01.145.527.100;Compulsive Behavior;D003192
F03.675.150;Compulsive Personality Disorder;D003193
I02.903.573.208;Computer-Assisted Instruction;D003194
L01.224.230.110;Computer Communication Networks;D003195
L01.224.108;Computer Graphics;D003196
L01.296.110;Computer Graphics;D003196
L01.143.256;Computer Literacy;D003197
L01.224.160;Computer Simulation;D003198
L01.224.230;Computer Systems;D003199
I02.903.080;Computer User Training;D003200
L01.224.230.260;Computers;D003201
L01.224.230.260.230;Computers, Analog;D003202
L01.224.230.260.280;Computers, Hybrid;D003203
L01.224.230.260.308;Computers, Mainframe;D003204
L01.224;Computing Methodologies;D003205
D12.776.034.180;Conalbumin;D003207
D12.776.157.427.750.124;Conalbumin;D003207
D12.776.256.317.180;Conalbumin;D003207
D12.776.290.180;Conalbumin;D003207
D12.776.556.579.750.124;Conalbumin;D003207
D12.776.503.499.500;Concanavalin A;D003208
D12.776.765.678.500;Concanavalin A;D003208
I01.880.604.787.358;Concentration Camps;D003209
F02.463.785.233;Concept Formation;D003210
N04.761.879.200;Concurrent Review;D003211
N05.700.900.200;Concurrent Review;D003211
J02.500.250;Condiments;D003212
F02.463.425.179;Conditioning (Psychology);D003213
F02.463.425.179.308;Conditioning, Classical;D003214
F02.463.425.179.408;Conditioning, Eyelid;D003215
F02.463.425.179.509;Conditioning, Operant;D003216
E05.196.922.500;Conductometry;D003217
E05.301.160;Conductometry;D003217
C02.256.650.810.217;Condylomata Acuminata;D003218
C02.800.801.220;Condylomata Acuminata;D003218
C02.825.810.110;Condylomata Acuminata;D003218
C02.928.914.217;Condylomata Acuminata;D003218
C17.800.838.790.810.110;Condylomata Acuminata;D003218
F04.096.544.335.240;Confidentiality;D003219
I01.880.604.473.650.500;Confidentiality;D003219
I01.880.604.583.080;Confidentiality;D003219
N03.706.437.650.124;Confidentiality;D003219
N03.706.535.230;Confidentiality;D003219
F01.658.209;Conflict (Psychology);D003220
C10.597.606.337;Confusion;D003221
C23.888.592.604.339;Confusion;D003221
F01.700.250;Confusion;D003221
Z01.058.290.100.140;Congo;D003223
D02.455.426.559.847.638.555.300;Congo Red;D003224
D02.886.645.600.080.050.650.250;Congo Red;D003224
D04.615.638.555.300;Congo Red;D003224
B04.820.087.565.400;Hemorrhagic Fever Virus, Crimean-Congo;D003225
B04.909.777.147.565.400;Hemorrhagic Fever Virus, Crimean-Congo;D003225
N03.540.199;Congresses as Topic;D003226
G05.355.760.200;Conjugation, Genetic;D003227
A09.371.060.200;Conjunctiva;D003228
A09.371.337.168;Conjunctiva;D003228
C11.187;Conjunctival Diseases;D003229
C04.588.364.235;Conjunctival Neoplasms;D003230
C11.187.169;Conjunctival Neoplasms;D003230
C11.319.217;Conjunctival Neoplasms;D003230
C11.187.183;Conjunctivitis;D003231
C02.325.250.250;Conjunctivitis, Acute Hemorrhagic;D003232
C02.782.687.359.201;Conjunctivitis, Acute Hemorrhagic;D003232
C02.782.687.359.213.165;Conjunctivitis, Acute Hemorrhagic;D003232
C11.187.183.240.216;Conjunctivitis, Acute Hemorrhagic;D003232
C11.294.800.250.250;Conjunctivitis, Acute Hemorrhagic;D003232
C11.187.183.200;Conjunctivitis, Allergic;D003233
C20.543.480.200;Conjunctivitis, Allergic;D003233
C01.252.354.225;Conjunctivitis, Bacterial;D003234
C01.539.375.354.220;Conjunctivitis, Bacterial;D003234
C11.187.183.220;Conjunctivitis, Bacterial;D003234
C11.294.354.220;Conjunctivitis, Bacterial;D003234
C01.252.354.225.250;Conjunctivitis, Inclusion;D003235
C01.252.400.210.210.250;Conjunctivitis, Inclusion;D003235
C01.539.375.354.220.250;Conjunctivitis, Inclusion;D003235
C11.187.183.220.250;Conjunctivitis, Inclusion;D003235
C11.294.354.220.250;Conjunctivitis, Inclusion;D003235
C02.325.250;Conjunctivitis, Viral;D003236
C11.187.183.240;Conjunctivitis, Viral;D003236
C11.294.800.250;Conjunctivitis, Viral;D003236
Z01.107.567.875.550.200;Connecticut;D003237
A10.165;Connective Tissue;D003238
A11.329;Connective Tissue Cells;D003239
C17.300;Connective Tissue Diseases;D003240
G05.180;Consanguinity;D003241
G05.355.090.403.180;Consanguinity;D003241
F01.829.500.359;Conscience;D003242
K01.316.630.350;Conscience;D003242
K01.752.256.547.359;Conscience;D003242
F02.463.188.409;Consciousness;D003243
F02.830.233;Consciousness;D003243
C10.597.606.358;Consciousness Disorders;D003244
C23.888.592.604.359;Consciousness Disorders;D003244
F01.700.315;Consciousness Disorders;D003244
F03.087.300;Consciousness Disorders;D003244
L01.178.682.759.150;Consensus Development Conferences as Topic;D003245
N03.540.199.205;Consensus Development Conferences as Topic;D003245
J01.256.078;Conservation of Energy Resources;D003246
N06.230.080.078;Conservation of Energy Resources;D003246
J01.256;Conservation of Natural Resources;D003247
N06.230.080;Conservation of Natural Resources;D003247
C23.888.821.150;Constipation;D003248
N04.452.150;Constitution and Bylaws;D003249
E05.225;Constriction;D003250
C23.300.287;Constriction, Pathologic;D003251
J01.637.241;Construction Materials;D003252
M01.120;Consultants;D003253
I01.880.604.473.368;Consumer Advocacy;D003254
N03.706.437.368;Consumer Advocacy;D003254
N03.540.245;Consumer Organizations;D003255
N02.421.143.262;Consumer Participation;D003256
N03.540.245.360;Consumer Participation;D003256
N06.850.210;Consumer Product Safety;D003257
N04.452.822.360;Consumer Satisfaction;D003258
F01.145.113.252;Consummatory Behavior;D003259
G04.299.355;Contact Inhibition;D003260
E07.632.500.276;Contact Lenses;D003261
E07.632.500.276.360.220;Contact Lenses, Extended-Wear;D003262
E07.632.500.276.360;Contact Lenses, Hydrophilic;D003263
E05.235;Containment of Biohazards;D003264
G07.265.500.250;Contingent Negative Variation;D003265
G11.561.270.250;Contingent Negative Variation;D003265
N04.590.233.727.210;Continuity of Patient Care;D003266
E02.875.194;Contraception;D003267
F01.145.688.500;Contraception Behavior;D003268
G08.686.785.760.891.500;Contraception Behavior;D003268
E02.875.194.300;Contraception, Immunologic;D003269
D27.505.696.875.360;Contraceptive Agents;D003270
D27.505.954.705.360;Contraceptive Agents;D003270
D27.505.696.875.360.276;Contraceptive Agents, Female;D003271
D27.505.954.705.360.276;Contraceptive Agents, Female;D003271
D27.505.696.875.360.443;Contraceptive Agents, Male;D003272
D27.505.954.705.360.443;Contraceptive Agents, Male;D003272
E07.190;Contraceptive Devices;D003273
E07.190.250;Contraceptive Devices, Female;D003274
E07.190.270;Contraceptive Devices, Male;D003275
D27.505.696.875.360.276.210;Contraceptives, Oral;D003276
D27.505.954.705.360.276.210;Contraceptives, Oral;D003276
D27.505.696.875.360.276.210.100;Contraceptives, Oral, Combined;D003277
D27.505.954.705.360.276.210.100;Contraceptives, Oral, Combined;D003277
D27.505.696.875.360.276.210.277;Contraceptives, Oral, Hormonal;D003278
D27.505.954.705.360.276.210.277;Contraceptives, Oral, Hormonal;D003278
D27.505.696.875.360.276.210.400;Contraceptives, Oral, Sequential;D003279
D27.505.954.705.360.276.210.400;Contraceptives, Oral, Sequential;D003279
D27.505.696.875.360.276.210.443;Contraceptives, Oral, Synthetic;D003280
D27.505.954.705.360.276.210.443;Contraceptives, Oral, Synthetic;D003280
D27.505.696.875.360.276.310;Contraceptives, Postcoital;D003281
D27.505.954.705.360.276.310;Contraceptives, Postcoital;D003281
D27.505.696.875.360.276.310.235;Contraceptives, Postcoital, Hormonal;D003282
D27.505.954.705.360.276.310.235;Contraceptives, Postcoital, Hormonal;D003282
D27.505.696.875.360.276.310.360;Contraceptives, Postcoital, Synthetic;D003283
D27.505.954.705.360.276.310.360;Contraceptives, Postcoital, Synthetic;D003283
N03.219.463.100;Contract Services;D003284
D12.776.210;Contractile Proteins;D003285
C05.550.323;Contracture;D003286
C05.651.197;Contracture;D003286
D27.720.259;Contrast Media;D003287
C26.248;Contusions;D003288
C26.974.250;Contusions;D003288
C23.550.291.562;Convalescence;D003289
G14.640.260.217;Convergence, Ocular;D003290
F03.875.300;Conversion Disorder;D003291
D27.505.696.282.224;Convulsants;D003292
D27.505.954.427.220.224;Convulsants;D003292
C10.228.140.490.650;Seizures, Febrile;D003294
F04.570.200;Convulsive Therapy;D003295
J01.576.423.200.200;Cooking;D003296
J01.494.300;Cooking and Eating Utensils;D003297
J01.576.423.200.300;Cooking and Eating Utensils;D003297
J01.637.370;Cooking and Eating Utensils;D003297
E01.370.225.812.735.050.375.150;Coombs Test;D003298
E05.200.812.735.050.375.150;Coombs Test;D003298
E05.478.594.760.050.375.150;Coombs Test;D003298
F01.145.813.115;Cooperative Behavior;D003299
D01.268.556.195;Copper;D003300
D01.268.956.170;Copper;D003300
D01.552.544.195;Copper;D003300
D01.496.749.270;Copper Radioisotopes;D003301
B01.300.179.100.200;Coprinus;D003302
F01.145.126.175;Human Coprophagia;D003303
D08.811.682.660.250;Coproporphyrinogen Oxidase;D003304
D03.383.129.578.840.500.700.250;Coproporphyrinogens;D003305
D03.549.909.500.700.250;Coproporphyrinogens;D003305
D04.345.783.500.700.250;Coproporphyrinogens;D003305
D03.383.129.578.840.500.250;Coproporphyrins;D003306
D03.549.909.500.250;Coproporphyrins;D003306
D04.345.783.500.250;Coproporphyrins;D003306
D23.767.727.250;Coproporphyrins;D003306
F01.145.113.252.748.200;Copulation;D003307
L01.240;Copying Processes;D003308
I01.880.604.583.458.300;Copyright;D003309
L01.737.360;Copyright;D003309
N03.706.535.518.300;Copyright;D003309
C14.240.400.200;Cor Triatriatum;D003310
C14.280.400.200;Cor Triatriatum;D003310
C16.131.240.400.200;Cor Triatriatum;D003310
D10.390.240;Cord Factors;D003311
D23.946.123.208;Cord Factors;D003311
G01.595.560.311;Coriolis Force;D003312
B01.650.940.800.575.100.822.966;Zea mays;D003313
J02.500.200.909;Zea mays;D003313
J02.500.300.100.977;Zea mays;D003313
D10.212.302.380.370;Corn Oil;D003314
D10.212.507.340;Corn Oil;D003314
D10.627.700.240;Corn Oil;D003314
D20.215.784.750.240;Corn Oil;D003314
J02.500.375.400.250;Corn Oil;D003314
A09.371.060.217;Cornea;D003315
C11.204;Corneal Diseases;D003316
C11.204.236;Corneal Dystrophies, Hereditary;D003317
C11.270.162;Corneal Dystrophies, Hereditary;D003317
C16.320.290.162;Corneal Dystrophies, Hereditary;D003317
C11.204.299;Corneal Opacity;D003318
A09.371.060.217.228;Corneal Stroma;D003319
C01.539.375.177;Corneal Ulcer;D003320
C11.204.564.225;Corneal Ulcer;D003320
C11.294.177;Corneal Ulcer;D003320
E01.370.510.150;Cornell Medical Index;D003321
C14.280.647.250.250;Coronary Aneurysm;D003323
C14.907.055.395;Coronary Aneurysm;D003323
C14.907.585.250.250;Coronary Aneurysm;D003323
C14.280.647.250.260;Coronary Artery Disease;D003324
C14.907.137.126.339;Coronary Artery Disease;D003324
C14.907.585.250.260;Coronary Artery Disease;D003324
N02.278.388.493.211;Coronary Care Units;D003325
G09.330.190.163.324;Coronary Circulation;D003326
C14.280.647.250;Coronary Disease;D003327
C14.907.585.250;Coronary Disease;D003327
C14.280.647.250.290;Coronary Thrombosis;D003328
C14.907.355.830.220;Coronary Thrombosis;D003328
C14.907.585.250.290;Coronary Thrombosis;D003328
C14.280.647.250.295;Coronary Vasospasm;D003329
C14.907.585.250.295;Coronary Vasospasm;D003329
C14.240.400.210;Coronary Vessel Anomalies;D003330
C14.280.400.210;Coronary Vessel Anomalies;D003330
C16.131.240.400.210;Coronary Vessel Anomalies;D003330
A07.231.114.269;Coronary Vessels;D003331
A07.231.908.194;Coronary Vessels;D003331
B04.820.504.540;Coronaviridae;D003332
B04.909.777.500.540;Coronaviridae;D003332
C02.782.600.550;Coronaviridae Infections;D003333
M01.526.485.230;Coroners and Medical Examiners;D003334
N02.360.230;Coroners and Medical Examiners;D003334
A08.713.100;Corpora Allata;D003335
A13.250;Corpora Allata;D003335
A08.186.211.132.659.727;Tectum Mesencephali;D003336
A08.186.211.653.727;Tectum Mesencephali;D003336
A08.186.211.730.885.362;Corpus Callosum;D003337
A05.360.319.114.630.278;Corpus Luteum;D003338
A06.407.312.497.278;Corpus Luteum;D003338
D06.472.334.734;Corpus Luteum Hormones;D003339
G08.686.785.760.690.355.500;Corpus Luteum Maintenance;D003340
G08.686.785.760.769.520.500;Corpus Luteum Maintenance;D003340
G08.686.785.760.690.380;Luteolysis;D003341
A08.186.211.730.885.287.249.487;Corpus Striatum;D003342
G02.149.200;Corrosion;D003343
E01.370.376.300.437.500;Cortical Synchronization;D003344
E01.370.405.245.575.500;Cortical Synchronization;D003344
G07.265.337.200.249;Cortical Synchronization;D003344
D04.808.745.745.654.237;Corticosterone;D003345
D06.472.040.585.353.237;Corticosterone;D003345
D06.472.699.327.740.140;Corticotropin-Releasing Hormone;D003346
D12.644.400.400.740.140;Corticotropin-Releasing Hormone;D003346
D12.644.548.365.740.140;Corticotropin-Releasing Hormone;D003346
D12.776.641.650.405.740.140;Corticotropin-Releasing Hormone;D003346
D04.808.745.745.183;Cortisone;D003348
D06.472.040.585.478.195;Cortisone;D003348
D08.811.682.047.436.400.150;Cortisone Reductase;D003349
D04.808.745.745.654.252;Cortodoxone;D003350
D06.472.040.585.478.225;Cortodoxone;D003350
B03.510.024.049.180;Corynebacterium;D003352
B03.510.460.400.400.200;Corynebacterium;D003352
B03.510.024.049.180.150;Corynebacterium diphtheriae;D003353
B03.510.460.400.400.200.150;Corynebacterium diphtheriae;D003353
C01.252.410.040.246;Corynebacterium Infections;D003354
B03.510.024.049.180.625;Corynebacterium pyogenes;D003355
B03.510.460.400.400.200.625;Corynebacterium pyogenes;D003355
E02.218;Cosmetic Techniques;D003357
D27.720.269;Cosmetics;D003358
J01.516.213;Cosmetics;D003358
G01.060.374.134;Cosmic Radiation;D003359
G01.595.060.134;Cosmic Radiation;D003359
G01.750.750.235;Cosmic Radiation;D003359
G16.500.240.200;Cosmic Radiation;D003359
N06.230.300.100.300;Cosmic Radiation;D003359
G05.360.337.500;Cosmids;D003360
G05.360.600.250;Cosmids;D003360
N03.219.151.080;Cost Allocation;D003361
N03.219.151.125;Cost-Benefit Analysis;D003362
N03.219.151.160;Cost Control;D003363
Z01.107.169.238;Costa Rica;D003364
N03.219.151;Costs and Cost Analysis;D003365
D06.472.699.327.935.531.500.200;Cosyntropin;D003366
D06.472.699.631.525.600.531.500.200;Cosyntropin;D003366
D12.644.400.400.935.531.500.200;Cosyntropin;D003366
D12.644.548.365.935.531.500.200;Cosyntropin;D003366
D12.644.548.691.525.690.531.500.200;Cosyntropin;D003366
D12.776.641.650.405.935.531.500.200;Cosyntropin;D003366
D03.383.773.812.180;Cotinine;D003367
B01.650.940.800.575.100.700.244;Gossypium;D003368
D10.212.302.380.380;Cottonseed Oil;D003369
D10.212.507.350;Cottonseed Oil;D003369
D10.627.700.263;Cottonseed Oil;D003369
D20.215.784.750.263;Cottonseed Oil;D003369
J02.500.375.400.300;Cottonseed Oil;D003369
B01.050.150.900.248.350.650.350;Coturnix;D003370
C08.618.248;Cough;D003371
C23.888.852.293;Cough;D003371
D02.705.400.625.120;Coumaphos;D003372
D02.705.539.345.120;Coumaphos;D003372
D02.886.300.692.120;Coumaphos;D003372
D03.438.150.446.912.326;Coumaphos;D003372
D03.830.219.446.912.326;Coumaphos;D003372
D02.241.223.200.210;Coumaric Acids;D003373
D03.438.150.446;Coumarins;D003374
D03.830.219.446;Coumarins;D003374
D03.438.150.266.450.400.187;Coumestrol;D003375
D03.438.150.446.350;Coumestrol;D003375
D03.830.219.266.450.400.187;Coumestrol;D003375
D03.830.219.446.350;Coumestrol;D003375
F02.784.176;Counseling;D003376
F04.408.413;Counseling;D003376
N02.421.143.303;Counseling;D003376
N02.421.461.363;Counseling;D003376
E05.196.181.400.555;Countercurrent Distribution;D003377
E05.196.278;Countercurrent Distribution;D003377
E01.370.225.812.735.645.350.350.150;Counterimmunoelectrophoresis;D003378
E05.196.401.568.250;Counterimmunoelectrophoresis;D003378
E05.200.812.735.645.350.350.150;Counterimmunoelectrophoresis;D003378
E05.301.300.568.250;Counterimmunoelectrophoresis;D003378
E05.478.594.760.645.350.350.150;Counterimmunoelectrophoresis;D003378
E05.478.605.492.350.350.150;Counterimmunoelectrophoresis;D003378
F04.754.720.864.363;Countertransference (Psychology);D003379
F01.145.802.279;Courtship;D003380
B03.440.400.425.297.150;Coxiella;D003381
B03.660.250.132.150;Coxiella;D003381
C02.782.687.359.213;Coxsackievirus Infections;D003384
B01.050.500.131.365.190.110;Brachyura;D003386
C07.793.850.750.300;Cracked Tooth Syndrome;D003387
C26.900.750.300;Cracked Tooth Syndrome;D003387
A01.456.830.200;Cranial Fossa, Posterior;D003388
A02.835.232.781.750.400;Cranial Fossa, Posterior;D003388
C10.292;Cranial Nerve Diseases;D003389
C04.588.614.300;Cranial Nerve Neoplasms;D003390
C04.588.614.596.240;Cranial Nerve Neoplasms;D003390
C10.292.225;Cranial Nerve Neoplasms;D003390
C10.551.360;Cranial Nerve Neoplasms;D003390
A08.800.800.120;Cranial Nerves;D003391
A07.231.908.224;Cranial Sinuses;D003392
A02.835.232.781.200;Cranial Sutures;D003393
C05.116.099.370.231;Craniofacial Dysostosis;D003394
C05.660.207.231;Craniofacial Dysostosis;D003394
C16.131.621.207.231;Craniofacial Dysostosis;D003394
I01.076.368.239;Craniology;D003395
C04.557.465.625.200;Craniopharyngioma;D003397
C04.557.580.625.200;Craniopharyngioma;D003397
C05.116.099.370.894.232;Craniosynostoses;D003398
C05.660.207.240;Craniosynostoses;D003398
C05.660.207.707.249;Craniosynostoses;D003398
C05.660.906.364;Craniosynostoses;D003398
C16.131.621.207.240;Craniosynostoses;D003398
C16.131.621.207.707.249;Craniosynostoses;D003398
C16.131.621.906.364;Craniosynostoses;D003398
E04.525.190;Craniotomy;D003399
B01.050.500.131.365.190.070;Astacoidea;D003400
D02.078.370.280;Creatine;D003401
D12.125.373;Creatine;D003401
D08.811.913.696.640.150;Creatine Kinase;D003402
D03.383.129.308.207;Creatinine;D003404
F01.752.264;Creativity;D003405
F02.463.785.302;Creativity;D003405
N03.706.110;Credentialing;D003406
N05.700.200;Credentialing;D003406
D02.455.426.559.389.657.239.327;Creosote;D003407
D02.455.426.559.389.657.239;Cresols;D003408
C05.116.099.343.347;Congenital Hypothyroidism;D003409
C05.116.132.256;Congenital Hypothyroidism;D003409
C16.320.240.625;Congenital Hypothyroidism;D003409
C19.297.155;Congenital Hypothyroidism;D003409
C19.874.482.281;Congenital Hypothyroidism;D003409
C10.597.606.643.180;Cri-du-Chat Syndrome;D003410
C16.131.077.262;Cri-du-Chat Syndrome;D003410
C16.131.260.190;Cri-du-Chat Syndrome;D003410
C16.320.180.190;Cri-du-Chat Syndrome;D003410
B01.050.150.900.649.865.635.070;Arvicolinae;D003411
B01.050.150.900.649.865.635.150.250;Cricetulus;D003412
A02.165.257.625.211;Cricoid Cartilage;D003413
A02.165.407.500.211;Cricoid Cartilage;D003413
A04.329.591.211;Cricoid Cartilage;D003413
C16.320.565.300.281;Crigler-Najjar Syndrome;D003414
C18.452.648.300.281;Crigler-Najjar Syndrome;D003414
I01.198.240;Crime;D003415
I01.880.735.191;Crime;D003415
I01.198.290;Criminal Law;D003416
I01.880.604.583.100;Criminal Law;D003416
F02.784.240;Criminal Psychology;D003417
I01.198;Criminology;D003418
F04.754.252;Crisis Intervention;D003419
C14.240.400.220;Crisscross Heart;D003420
C14.280.400.220;Crisscross Heart;D003420
C16.131.240.400.220;Crisscross Heart;D003420
B01.268.475.868.110;Crithidia;D003421
E02.760.190;Critical Care;D003422
N02.421.585.190;Critical Care;D003422
F02.463.425.209;Critical Period (Psychology);D003423
C06.405.205.731.500;Crohn Disease;D003424
C06.405.469.432.500;Crohn Disease;D003424
D04.808.745.745.654.485;Flurogestone Acetate;D003425
D04.808.908.550;Flurogestone Acetate;D003425
A13.265;Crop, Avian;D003426
E05.660.365;Cross Circulation;D003427
C01.539.248;Cross Infection;D003428
G12.425.143.281;Cross Reactions;D003429
E05.318.760.500.875;Cross-Sectional Studies;D003430
N05.715.360.775.175.275;Cross-Sectional Studies;D003430
N06.850.520.450.500.875;Cross-Sectional Studies;D003430
I01.076.201.450.281;Cross-Cultural Comparison;D003431
I01.880.143.257;Cross-Cultural Comparison;D003431
D27.720.470.410.210;Cross-Linking Reagents;D003432
E05.393.281;Crosses, Genetic;D003433
G05.355.760.615.200;Crossing Over, Genetic;D003434
D20.888.850.960.200;Crotalid Venoms;D003435
D23.946.833.850.960.200;Crotalid Venoms;D003435
D10.212.507.375;Croton Oil;D003436
D10.627.700.315;Croton Oil;D003436
D20.215.784.750.315;Croton Oil;D003436
D02.241.081.114.875;Crotonates;D003437
D10.251.400.143.687;Crotonates;D003437
D20.888.850.960.200.210;Crotoxin;D003439
D23.946.833.850.960.200.210;Crotoxin;D003439
C08.360.535.365;Croup;D003440
C09.400.535.365;Croup;D003440
F01.145.875.281;Crowding;D003441
E06.323.428.100;Crowns;D003442
E06.323.528.250;Crowns;D003442
E06.780.345.250;Crowns;D003442
E06.780.345.737.100;Crowns;D003442
E07.695.190.190.150;Crowns;D003442
C26.797.240;Crush Syndrome;D003444
B01.050.500.131.365;Crustacea;D003445
E07.858.442.281;Crutches;D003446
F01.145.209.530.258;Crying;D003448
F01.525.200.310.300;Crying;D003448
C14.907.454.140;Cryoglobulinemia;D003449
C15.378.147.780.243;Cryoglobulinemia;D003449
C15.378.463.515.140;Cryoglobulinemia;D003449
C20.683.780.250;Cryoglobulinemia;D003449
D12.776.124.486.485.900.225;Cryoglobulins;D003450
D12.776.124.790.651.900.225;Cryoglobulins;D003450
D12.776.377.715.548.900.225;Cryoglobulins;D003450
D27.505.696.706.320;Cryoprotective Agents;D003451
D27.720.799.180;Cryoprotective Agents;D003451
E04.014.180;Cryosurgery;D003452
C01.703.248;Cryptococcosis;D003453
B01.300.381.258;Cryptococcus;D003454
B01.300.930.316;Cryptococcus;D003454
B01.300.381.258.366;Cryptococcus neoformans;D003455
B01.300.930.316.366;Cryptococcus neoformans;D003455
C12.294.829.258;Cryptorchidism;D003456
C12.706.258;Cryptorchidism;D003456
C16.131.939.258;Cryptorchidism;D003456
C19.391.829.258;Cryptorchidism;D003456
C03.432.269;Cryptosporidiosis;D003457
C03.701.688.235;Cryptosporidiosis;D003457
C03.752.250.269;Cryptosporidiosis;D003457
C03.752.625.235;Cryptosporidiosis;D003457
C06.405.469.452.269;Cryptosporidiosis;D003457
C22.674.710.235;Cryptosporidiosis;D003457
B01.043.075.189.250.150.160;Cryptosporidium;D003458
D12.776.306.366;Crystallins;D003459
E05.196.300;Crystallization;D003460
G02.149.767.505;Crystallization;D003460
G02.842.750.505;Crystallization;D003460
E05.196.309;Crystallography;D003461
H01.181.529.240;Crystallography;D003461
Z01.107.084.900.225;Cuba;D003462
Z01.639.880.225;Cuba;D003462
F02.463.425.234;Cues;D003463
E01.370.378.155;Culdoscopy;D003464
E01.370.388.250.160;Culdoscopy;D003464
E04.520.160;Culdoscopy;D003464
E04.800.250.160;Culdoscopy;D003464
E04.950.300.259;Culdoscopy;D003464
B01.050.500.131.617.289.275.225;Culex;D003465
I01.076.201.450.324;Cultural Characteristics;D003466
I01.880.143.329;Cultural Characteristics;D003466
I01.880.143.400;Cultural Deprivation;D003467
I01.076.201.450.370;Cultural Evolution;D003468
I01.076.201.450;Culture;D003469
I01.880.143;Culture;D003469
D27.720.470.305;Culture Media;D003470
E07.206;Culture Media;D003470
D02.455.426.392.368.367.190;Cuprizone;D003471
D20.215.784.500.200;Curare;D003472
D27.505.696.663.700.710.575;Neuromuscular Nondepolarizing Agents;D003473
D02.455.326.146.485.222.222;Curcumin;D003474
D02.455.426.559.389.657.166.200;Curcumin;D003474
D02.455.426.559.694.222;Curcumin;D003474
E04.157;Curettage;D003475
D01.268.033.175;Curium;D003476
D01.268.271.100.175;Curium;D003476
D01.268.556.200;Curium;D003476
D01.552.020.272;Curium;D003476
D01.552.544.200;Curium;D003476
I02.158;Curriculum;D003479
C19.053.800.367;Cushing Syndrome;D003480
A14.549.167.860.200;Cuspid;D003481
E02.760.215;Custodial Care;D003482
N02.421.585.215;Custodial Care;D003482
C16.320.850.180;Cutis Laxa;D003483
C17.300.230;Cutis Laxa;D003483
C17.800.827.180;Cutis Laxa;D003483
D01.625.400.100.150;Cyanamide;D003484
D02.491.203.362;Cyanamide;D003484
D02.262;Cyanates;D003485
D01.248.497.158.291;Cyanides;D003486
D01.625.400.100;Cyanides;D003486
D02.241.081.069.366;Cyanoacrylates;D003487
D02.626.290;Cyanoacrylates;D003487
D05.750.259;Cyanoacrylates;D003487
D25.720.259;Cyanoacrylates;D003487
D25.919.367;Cyanoacrylates;D003487
J01.637.051.720.259;Cyanoacrylates;D003487
J01.637.051.919.367;Cyanoacrylates;D003487
D01.139.300.050.100;Cyanogen Bromide;D003488
D01.625.175;Cyanogen Bromide;D003488
D04.808.054.079.429.320;Cyanoketone;D003489
C23.888.248;Cyanosis;D003490
L01.143.283;Cybernetics;D003491
D02.172.080.200;Cycasin;D003492
D02.065.589.099.750.249;Cyclacillin;D003493
D02.886.108.750.249;Cyclacillin;D003493
D03.438.260.825.249;Cyclacillin;D003493
D03.605.084.737.249;Cyclacillin;D003493
D04.075.080.875.099.221.750.249;Cyclacillin;D003493
D02.455.426.392.368.367.204;Cyclamates;D003494
D02.241.223.475.180;Cyclandelate;D003495
D02.241.511.536.180;Cyclandelate;D003495
D03.383.113.367;Cyclazocine;D003496
D03.605.168;Cyclazocine;D003496
D03.661.243;Cyclic N-Oxides;D003497
D03.661.368;Cyclic P-Oxides;D003498
D02.886.124;Cyclic S-Oxides;D003499
D03.661.493;Cyclic S-Oxides;D003499
G02.111.087.170;Cyclization;D003500
G02.149.115.170;Cyclization;D003500
G02.149.465.190;Cyclization;D003500
G02.607.750.190;Cyclization;D003500
G03.495.300;Cyclization;D003500
D03.383.606.320;Cyclizine;D003501
D02.455.426.392.368.201;Cyclobutanes;D003503
D03.383.742.680.245.453.050;Ancitabine;D003504
D13.570.065.300.050;Ancitabine;D003504
D13.570.685.245.453.050;Ancitabine;D003504
D04.345.103;Cyclodextrins;D003505
D09.698.365.855.400.375;Cyclodextrins;D003505
D02.455.426.559.389.657.239.402;Cyclofenil;D003506
D02.455.426.392.368.284;Cycloheptanes;D003508
D02.241.223.268;Cyclohexanecarboxylic Acids;D003509
D02.455.426.392.368.367.218;Cyclohexanecarboxylic Acids;D003509
D02.455.426.392.368.367;Cyclohexanes;D003510
D02.033.480.300;Cyclohexanols;D003511
D02.455.426.392.368.367.318;Cyclohexanols;D003511
D02.455.426.392.368.367.340;Cyclohexanones;D003512
D02.522.400;Cyclohexanones;D003512
D03.383.621.808.240;Cycloheximide;D003513
D02.092.384;Cyclohexylamines;D003514
D02.455.426.392.368.367.418;Cyclohexylamines;D003514
D02.455.426.392.368.450.350;Cycloleucine;D003515
D12.125.072.170;Cycloleucine;D003515
D02.455.426.392.368;Cycloparaffins;D003516
D04.345.133;Cycloparaffins;D003516
D02.455.426.392.368.450;Cyclopentanes;D003517
D02.886.590.700.135.285;Cyclopenthiazide;D003518
D02.886.655.500.285;Cyclopenthiazide;D003518
D03.438.174.285;Cyclopenthiazide;D003518
D02.241.223.601.200;Cyclopentolate;D003519
D02.455.526.728.650.730.243;Cyclophosphamide;D003520
D02.705.672.500.243;Cyclophosphamide;D003520
D02.455.426.392.368.533;Cyclopropanes;D003521
D03.383.129.385.162;Cycloserine;D003523
D03.383.129.462.600.162;Cycloserine;D003523
D12.125.837.150;Cycloserine;D003523
D04.345.566.235;Cyclosporins;D003524
D12.644.641.235;Cyclosporins;D003524
D04.808.294;Cyclosteroids;D003525
F03.600.150.150.300;Cyclothymic Disorder;D003527
C04.557.470.200.025.220;Carcinoma, Adenoid Cystic;D003528
D04.808.155.160.861.250;Cymarine;D003529
D04.808.155.580.130.750.250;Cymarine;D003529
D09.408.180.810.250;Cymarine;D003529
B01.050.150.900.493.200.244;Cyprinidae;D003530
B01.050.150.900.493.200;Cypriniformes;D003531
B01.050.150.900.493.850.280;Cyprinodontiformes;D003532
D02.455.426.559.847.181.384.340;Cyproheptadine;D003533
D03.383.621.160;Cyproheptadine;D003533
D04.615.181.384.340;Cyproheptadine;D003533
D04.808.745.432.219;Cyproterone;D003534
D04.808.883.419;Cyproterone;D003534
Z01.542.580.500.300;Cyprus;D003535
Z01.639.640.300;Cyprus;D003535
C04.557.470.200.025.480;Cystadenocarcinoma;D003536
C04.557.470.590.480;Cystadenocarcinoma;D003536
C04.557.470.035.320;Cystadenoma;D003537
C04.557.470.590.485;Cystadenoma;D003537
D02.092.471.200;Cystamine;D003538
D02.705.400.625.130;Cystaphos;D003539
D02.705.539.345.130;Cystaphos;D003539
D02.886.300.692.130;Cystaphos;D003539
D02.886.030.175;Cystathionine;D003540
D12.125.095.307;Cystathionine;D003540
D12.125.119.307;Cystathionine;D003540
D12.125.166.175;Cystathionine;D003540
D08.811.520.241.300.200;Cystathionine beta-Synthase;D003541
D08.811.520.300.250;Cystathionine gamma-Lyase;D003542
D02.092.471.562.369;Cysteamine;D003543
D02.886.489.472.369;Cysteamine;D003543
D02.886.030.215;Cysteic Acid;D003544
D12.125.166.215;Cysteic Acid;D003544
D02.886.030.230;Cysteine;D003545
D02.886.489.155;Cysteine;D003545
D12.125.154.299;Cysteine;D003545
D12.125.166.230;Cysteine;D003545
D08.811.277.656.262.500;Cysteine Endopeptidases;D003546
D08.811.277.656.300.200;Cysteine Endopeptidases;D003546
D08.811.913.225.224;Cysteine Synthase;D003547
D02.092.311.200.180;Cysteinyldopa;D003548
D02.886.030.230.330;Cysteinyldopa;D003548
D12.125.072.050.685.400.180;Cysteinyldopa;D003548
D12.125.072.050.875.130.180;Cysteinyldopa;D003548
D12.125.166.230.330;Cysteinyldopa;D003548
A03.159.183.079.450;Cystic Duct;D003549
C06.689.202;Cystic Fibrosis;D003550
C08.381.187;Cystic Fibrosis;D003550
C16.320.190;Cystic Fibrosis;D003550
C16.614.213;Cystic Fibrosis;D003550
C03.335.190.902.185;Cysticercosis;D003551
C23.996.250;Cysticercosis;D003551
B01.050.500.500.736.215.895.286;Cysticercus;D003552
D01.248.497.158.874.390.369;Cystine;D003553
D01.875.350.850.150.369;Cystine;D003553
D02.886.030.230.369;Cystine;D003553
D02.886.520.150.087;Cystine;D003553
D12.125.095.369;Cystine;D003553
D12.125.119.369;Cystine;D003553
D12.125.166.230.369;Cystine;D003553
C16.320.565.595.377;Cystinosis;D003554
C18.452.648.595.377;Cystinosis;D003554
C12.777.419.815.885.250;Cystinuria;D003555
C13.351.968.419.815.885.250;Cystinuria;D003555
C16.320.565.861.885.250;Cystinuria;D003555
C18.452.648.861.885.250;Cystinuria;D003555
C12.777.829.495;Cystitis;D003556
C13.351.968.829.495;Cystitis;D003556
C04.557.450.795.650;Phyllodes Tumor;D003557
E01.370.388.250.180;Cystoscopy;D003558
E01.370.390.175;Cystoscopy;D003558
E04.800.250.180;Cystoscopy;D003558
E04.950.774.155;Cystoscopy;D003558
E04.579.240;Cystostomy;D003559
E04.950.774.156;Cystostomy;D003559
E04.950.774.852.240;Cystostomy;D003559
C04.182;Cysts;D003560
C23.300.306;Cysts;D003560
D03.383.742.680.245.453;Cytarabine;D003561
D13.570.065.300;Cytarabine;D003561
D13.570.685.245.453;Cytarabine;D003561
D03.383.742.680.245;Cytidine;D003562
D13.570.685.245;Cytidine;D003562
D13.570.800.286;Cytidine;D003562
D03.383.742.686.246.115;Cyclic CMP;D003563
D13.695.462.250;Cyclic CMP;D003563
D13.695.740.246.115;Cyclic CMP;D003563
D13.695.827.232.115;Cyclic CMP;D003563
D08.811.277.151.486.250;Cytidine Deaminase;D003564
D03.383.742.686.246.150;Cytidine Diphosphate;D003565
D13.695.740.246.150;Cytidine Diphosphate;D003565
D13.695.827.232.150;Cytidine Diphosphate;D003565
D02.092.877.883.333.130;Cytidine Diphosphate Choline;D003566
D02.675.276.232.130;Cytidine Diphosphate Choline;D003566
D03.383.742.686.246.150.180;Cytidine Diphosphate Choline;D003566
D13.695.740.246.150.180;Cytidine Diphosphate Choline;D003566
D13.695.827.232.150.180;Cytidine Diphosphate Choline;D003566
D03.383.742.686.246.150.210;Cytidine Diphosphate Diglycerides;D003567
D09.408.620.569.200;Cytidine Diphosphate Diglycerides;D003567
D13.695.740.246.150.210;Cytidine Diphosphate Diglycerides;D003567
D13.695.827.232.150.210;Cytidine Diphosphate Diglycerides;D003567
D13.695.827.708.260;Cytidine Diphosphate Diglycerides;D003567
D03.383.742.686.246.370;Cytidine Monophosphate;D003568
D13.695.740.246.370;Cytidine Monophosphate;D003568
D13.695.827.232.370;Cytidine Monophosphate;D003568
D02.241.081.844.562.668.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D02.241.511.902.562.668.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D03.383.742.686.246.370.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D09.067.687.668.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D09.811.589.668.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D13.695.740.246.370.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D13.695.827.232.370.250;Cytidine Monophosphate N-Acetylneuraminic Acid;D003569
D03.383.742.686.246.400;Cytidine Triphosphate;D003570
D13.695.740.246.400;Cytidine Triphosphate;D003570
D13.695.827.232.400;Cytidine Triphosphate;D003570
D03.438.473.231.370;Cytochalasin B;D003571
D23.946.587.370.370;Cytochalasin B;D003571
D03.438.473.231;Cytochalasins;D003572
D23.946.587.370;Cytochalasins;D003572
D08.244.187;Cytochrome b Group;D003573
D12.776.422.220.187;Cytochrome b Group;D003573
D08.244.286;Cytochrome c Group;D003574
D12.776.422.220.286;Cytochrome c Group;D003574
D08.244.286.200;Cytochromes c1;D003575
D12.776.422.220.286.200;Cytochromes c1;D003575
D05.500.562.374;Electron Transport Complex IV;D003576
D08.811.600.250.687;Electron Transport Complex IV;D003576
D08.811.682.285;Electron Transport Complex IV;D003576
D12.776.157.530.450.250.875.304;Electron Transport Complex IV;D003576
D12.776.543.277.687;Electron Transport Complex IV;D003576
D12.776.543.585.450.250.875.484;Electron Transport Complex IV;D003576
D08.244.453;Cytochrome P-450 Enzyme System;D003577
D08.811.682.690.708.170;Cytochrome P-450 Enzyme System;D003577
D12.776.422.220.453;Cytochrome P-450 Enzyme System;D003577
D08.811.682.732.380;Cytochrome-c Peroxidase;D003578
D08.811.682.608.191;Cytochrome Reductases;D003579
D08.244;Cytochromes;D003580
D12.776.422.220;Cytochromes;D003580
E01.370.225.500.384;Cytodiagnosis;D003581
E05.200.500.384;Cytodiagnosis;D003581
E05.242.384;Cytodiagnosis;D003581
H01.158.273.343.180;Cytogenetics;D003582
D03.438.759.138.525;Cytokinins;D003583
E01.370.225.500;Cytological Techniques;D003584
E05.200.500;Cytological Techniques;D003584
E05.242;Cytological Techniques;D003584
H01.158.100.433;Cell Biology;D003585
H01.158.273.190;Cell Biology;D003585
C02.256.466.245;Cytomegalovirus Infections;D003586
B04.280.382.150.150;Cytomegalovirus;D003587
B04.909.204.382.150.150;Cytomegalovirus;D003587
E01.370.225.500.384.235;Cytopathogenic Effect, Viral;D003588
E05.200.500.384.235;Cytopathogenic Effect, Viral;D003588
E05.242.384.235;Cytopathogenic Effect, Viral;D003588
G06.920.190;Cytopathogenic Effect, Viral;D003588
B03.140.130.150;Cytophaga;D003589
B03.440.400.425.300.150;Cytophaga;D003589
E01.370.225.500.386;Cytophotometry;D003592
E05.196.712.516.600.240;Cytophotometry;D003592
E05.200.500.386;Cytophotometry;D003592
E05.242.386;Cytophotometry;D003592
A11.284.430.214;Cytoplasm;D003593
A11.284.430.214.190.500;Cytoplasmic Granules;D003594
A11.284.430.214.190.875.190.190;Cytoplasmic Granules;D003594
G03.495.166.355;Cytoplasmic Streaming;D003595
G04.299.418;Cytoplasmic Streaming;D003595
D03.383.742.698.421;Cytosine;D003596
D03.383.742.686.246;Cytosine Nucleotides;D003597
D13.695.740.246;Cytosine Nucleotides;D003597
D13.695.827.232;Cytosine Nucleotides;D003597
D12.776.220;Cytoskeletal Proteins;D003598
A11.284.430.214.190.750;Cytoskeleton;D003599
A11.284.430.214.200;Cytosol;D003600
A11.284.430.429.200;Cytosol;D003600
A11.284.835.450.200;Cytosol;D003600
E01.370.225.812.160;Cytotoxicity Tests, Immunologic;D003601
E05.200.812.160;Cytotoxicity Tests, Immunologic;D003601
E05.478.594.160;Cytotoxicity Tests, Immunologic;D003601
E05.940.245;Cytotoxicity Tests, Immunologic;D003601
G12.425.270;Cytotoxicity, Immunologic;D003602
D27.888.569.213;Cytotoxins;D003603
Z01.586.250;Czechoslovakia;D003604
D08.811.682.664.500.125;D-Amino-Acid Oxidase;D003605
D02.925.200;Dacarbazine;D003606
D03.383.129.308.240;Dacarbazine;D003606
C11.496.221;Dacryocystitis;D003607
E04.540.255;Dacryocystorhinostomy;D003608
E04.579.255;Dacryocystorhinostomy;D003608
D03.494.200;Dactinomycin;D003609
D04.345.566.252;Dactinomycin;D003609
D12.644.641.252;Dactinomycin;D003609
Z01.542.248.775.310;Dagestan;D003610
Z01.586.200.775.310;Dagestan;D003610
Z01.586.950.775.310;Dagestan;D003610
J02.500.350;Dairy Products;D003611
J01.040.246;Dairying;D003612
D04.808.745.432.235;Danazol;D003613
E02.190.888.374;Dance Therapy;D003614
E02.779.474.186;Dance Therapy;D003614
E02.831.230;Dance Therapy;D003614
F04.754.278;Dance Therapy;D003614
I03.450.642.287;Dancing;D003615
C10.228.140.252.300;Dandy-Walker Syndrome;D003616
C10.228.140.602.288;Dandy-Walker Syndrome;D003616
C10.228.140.631.450.500;Dandy-Walker Syndrome;D003616
C10.500.205;Dandy-Walker Syndrome;D003616
C16.131.666.205;Dandy-Walker Syndrome;D003616
F01.145.263;Dangerous Behavior;D003617
I01.880.735.223;Dangerous Behavior;D003617
D02.455.426.559.847.638.204;Dansyl Compounds;D003619
D02.886.590.192;Dansyl Compounds;D003619
D04.615.638.204;Dansyl Compounds;D003619
D03.383.129.308.432.555.287;Dantrolene;D003620
B01.050.500.131.365.150.200;Daphnia;D003621
D02.886.590.263;Dapsone;D003622
G14.640.154.371;Dark Adaptation;D003623
G01.590.540.233;Darkness;D003624
E05.318.308;Data Collection;D003625
L01.280;Data Collection;D003625
N05.715.360.300;Data Collection;D003625
N06.850.520.308;Data Collection;D003625
F02.784.412.221;Data Display;D003626
L01.296;Data Display;D003626
E05.245.380;Data Interpretation, Statistical;D003627
E05.318.740.300;Data Interpretation, Statistical;D003627
L01.700.508.190.380;Data Interpretation, Statistical;D003627
N05.715.360.750.300;Data Interpretation, Statistical;D003627
N06.850.520.830.300;Data Interpretation, Statistical;D003627
L01.224.900.280;Database Management Systems;D003628
L01.700.508.300.680.110;Database Management Systems;D003628
N04.452.515.110;Database Management Systems;D003628
L01.178.847.698.500;Modems;D003629
L01.224.230.260.115.750;Modems;D003629
D02.455.426.559.847.562.050.200;Daunorubicin;D003630
D04.615.562.050.200;Daunorubicin;D003630
D09.408.051.059.200;Daunorubicin;D003630
E02.760.246;Day Care;D003631
N02.421.585.246;Day Care;D003631
D02.455.526.439.294;Dichlorodiphenyldichloroethane;D003632
D02.455.526.439.292;Dichlorodiphenyl Dichloroethylene;D003633
D02.455.526.439.255;DDT;D003634
C10.597.606.643.210;De Lange Syndrome;D003635
C16.131.077.272;De Lange Syndrome;D003635
C16.131.260.210;De Lange Syndrome;D003635
C16.320.180.210;De Lange Syndrome;D003635
D09.698.365.180.247;DEAE-Cellulose;D003636
D09.698.365.272.250;DEAE-Dextran;D003637
C09.218.458.341.186;Deafness;D003638
C10.597.751.418.341.186;Deafness;D003638
C23.888.592.763.393.341.186;Deafness;D003638
C09.218.458.341.900;Hearing Loss, Sudden;D003639
C10.597.751.418.341.900;Hearing Loss, Sudden;D003639
C23.888.592.763.393.341.900;Hearing Loss, Sudden;D003639
G02.111.087.200;Dealkylation;D003640
G02.149.115.200;Dealkylation;D003640
G02.149.465.200;Dealkylation;D003640
G02.607.750.200;Dealkylation;D003640
G03.495.305;Dealkylation;D003640
G02.111.087.205;Deamination;D003641
G02.149.115.205;Deamination;D003641
G02.149.465.210;Deamination;D003641
G02.607.750.210;Deamination;D003641
G03.495.310;Deamination;D003641
D02.033.100.291.274;Deanol;D003642
D02.092.063.291.274;Deanol;D003642
C23.550.260;Death;D003643
E05.318.308.940.350;Death Certificates;D003644
L01.280.900.350;Death Certificates;D003644
N04.452.859.264;Death Certificates;D003644
N05.715.360.300.715.315;Death Certificates;D003644
N06.850.520.308.940.350;Death Certificates;D003644
C23.550.260.322;Death, Sudden;D003645
E04.176;Debridement;D003646
D03.438.531.205;Debrisoquin;D003647
E01.370.225.750.288;Decalcification Technique;D003648
E05.200.750.288;Decalcification Technique;D003648
C05.116.198.247.400;Decalcification, Pathologic;D003649
C18.452.174.289;Decalcification, Pathologic;D003649
D02.092.877.250.372;Decamethonium Compounds;D003650
D02.675.276.558.372;Decamethonium Compounds;D003650
D10.251.175.200;Decanoates;D003651
D10.251.175;Decanoic Acids;D003652
G02.111.087.210;Decarboxylation;D003653
G02.149.115.210;Decarboxylation;D003653
G02.149.465.220;Decarboxylation;D003653
G02.607.750.220;Decarboxylation;D003653
G03.495.315;Decarboxylation;D003653
G01.595.560.107.373;Deceleration;D003654
C10.597.305;Decerebrate State;D003655
C23.888.592.298;Decerebrate State;D003655
A05.360.319.679.490.373;Decidua;D003656
A16.710.289;Decidua;D003656
F02.463.785.373;Decision Making;D003657
L01.700.508.100;Decision Making, Computer-Assisted;D003658
N04.452.190;Decision Making, Organizational;D003659
L01.700.508.300.680.135;Decision Support Systems, Management;D003660
N04.452.515.135;Decision Support Systems, Management;D003660
E05.245;Decision Support Techniques;D003661
L01.700.508.190;Decision Support Techniques;D003661
G17.162;Decision Theory;D003662
G17.162.500;Decision Trees;D003663
E02.278;Decompression;D003664
G01.374.715.250;Decompression;D003664
C26.120.248;Decompression Sickness;D003665
N06.850.780.325;Decontamination;D003666
D03.438.810.350.250;Decoquinate;D003667
C17.800.893.665;Pressure Ulcer;D003668
N03.219.151.170.300;Deductibles and Coinsurance;D003669
N03.219.521.576.090.300;Deductibles and Coinsurance;D003669
B01.050.150.900.649.077.380.373;Deer;D003670
D02.065.277.194;DEET;D003671
D02.241.223.100.100.230;DEET;D003671
D02.455.426.559.389.127.085.230;DEET;D003671
G10.261.326.210;Defecation;D003672
B04.265;Defective Viruses;D003673
F01.393;Defense Mechanisms;D003674
I01.880.604.583.524.300;Defensive Medicine;D003675
N03.706.535.606.300;Defensive Medicine;D003675
D02.092.570.394.265;Deferoxamine;D003676
D02.241.511.372.265;Deferoxamine;D003676
C18.654.521.500;Deficiency Diseases;D003677
D27.720.031.700.366.181;Defoliants, Chemical;D003678
D27.720.723.366.181;Defoliants, Chemical;D003678
D27.888.723.366.181;Defoliants, Chemical;D003678
G10.261.326.215;Deglutition;D003679
C06.405.117.119;Deglutition Disorders;D003680
C09.775.174;Deglutition Disorders;D003680
C18.452.950.179;Dehydration;D003681
C23.550.274;Dehydration;D003681
D08.811.277.352.100.220;Dehydroascorbatase;D003682
D02.241.081.844.107.260;Dehydroascorbic Acid;D003683
D02.241.511.902.107.260;Dehydroascorbic Acid;D003683
D02.540.260;Dehydroascorbic Acid;D003683
D09.811.100.260;Dehydroascorbic Acid;D003683
D04.808.247.222.222.347.200;Dehydrocholesterols;D003684
D04.808.247.808.197.250;Dehydrocholesterols;D003684
D10.570.938.208.320;Dehydrocholesterols;D003684
D04.808.105.225.261;Dehydrocholic Acid;D003685
D04.808.221.430.265;Dehydrocholic Acid;D003685
D04.808.054.079.429.625;Dehydroepiandrosterone;D003687
D04.808.578.502.400;Dehydroepiandrosterone;D003687
D06.472.040.502.400;Dehydroepiandrosterone;D003687
D06.472.334.851.968.952;Dehydroepiandrosterone;D003687
E02.760.415.280;Deinstitutionalization;D003688
N02.421.585.415.280;Deinstitutionalization;D003688
A08.186.211.132.810.428.600.800.800;Vestibular Nucleus, Lateral;D003689
A08.186.211.865.428.600.800.800;Vestibular Nucleus, Lateral;D003689
F02.463.425.540.203;Deja Vu;D003690
Z01.107.567.875.500.200;Delaware;D003691
D26.255.210;Delayed-Action Preparations;D003692
D27.720.280.210;Delayed-Action Preparations;D003692
E02.319.300.253;Delayed-Action Preparations;D003692
C10.597.606.337.500;Delirium;D003693
C23.888.592.604.339.500;Delirium;D003693
F01.700.250.500;Delirium;D003693
F03.087.350;Delirium;D003693
N04.590.374;Delivery of Health Care;D003695
N05.300;Delivery of Health Care;D003695
N02.278.388.150;Delivery Rooms;D003696
L01.280.800.310;Delphi Technique;D003697
B04.265.270;Hepatitis Delta Virus;D003698
B04.450.411;Hepatitis Delta Virus;D003698
B04.909.777.411;Hepatitis Delta Virus;D003698
C02.440.450;Hepatitis D;D003699
C02.782.450;Hepatitis D;D003699
C06.552.380.705.450;Hepatitis D;D003699
E01.370.376.300.150.875;Delta Rhythm;D003700
E01.370.405.245.287.875;Delta Rhythm;D003700
G07.265.087.875;Delta Rhythm;D003700
G11.561.127.875;Delta Rhythm;D003700
D12.644.400.200;Delta Sleep-Inducing Peptide;D003701
D12.644.456.300;Delta Sleep-Inducing Peptide;D003701
D12.776.641.650.200;Delta Sleep-Inducing Peptide;D003701
F01.145.126.200;Delusions;D003702
D03.132.225.374;Demecolcine;D003703
C10.228.140.380;Dementia;D003704
F03.087.400;Dementia;D003704
D02.455.426.559.847.562.900.185;Demeclocycline;D003707
D04.615.562.900.185;Demeclocycline;D003707
D03.438.079.080.070.216.500;Nordazepam;D003708
I01.696.374;Democracy;D003709
I01.240;Demography;D003710
N01.224;Demography;D003710
N06.850.505.400;Demography;D003710
C10.314;Demyelinating Diseases;D003711
A08.663.256;Dendrites;D003712
A11.284.180.225;Dendrites;D003712
A11.671.240;Dendrites;D003712
A11.066.270;Dendritic Cells;D003713
A11.436.270;Dendritic Cells;D003713
A15.382.066.270;Dendritic Cells;D003713
A15.382.812.260;Dendritic Cells;D003713
E04.525.210;Denervation;D003714
C02.081.270;Dengue;D003715
C02.782.350.250.214;Dengue;D003715
C02.782.417.214;Dengue;D003715
C23.996.300;Dengue;D003715
B04.820.250.350.270;Dengue Virus;D003716
B04.909.777.310.350.270;Dengue Virus;D003716
F01.393.200;Denial (Psychology);D003717
Z01.542.808.224;Denmark;D003718
C07.650.800.250;Dens in Dente;D003719
C07.793.700.250;Dens in Dente;D003719
C16.131.850.800.250;Dens in Dente;D003719
E05.196.712.224;Densitometry;D003720
D25.339.208;Dental Alloys;D003722
J01.637.051.339.208;Dental Alloys;D003722
D25.339.208.291;Dental Amalgam;D003723
J01.637.051.339.208.291;Dental Amalgam;D003723
A02.835.232.781.324.502.320;Dental Arch;D003724
A14.521.320;Dental Arch;D003724
E06.186.210;Dental Articulators;D003725
E07.222.210;Dental Articulators;D003725
M01.526.485.067.105.250;Dental Assistants;D003726
N02.360.067.105.250;Dental Assistants;D003726
M01.526.485.067.105;Dental Auxiliaries;D003727
N02.360.067.105;Dental Auxiliaries;D003727
C07.793.208.250;Dental Calculus;D003728
C23.300.175.350;Dental Calculus;D003728
E06.170;Dental Care;D003729
N02.421.240.190;Dental Care;D003729
E06.170.310;Dental Care for Disabled;D003730
N02.421.240.190.230;Dental Care for Disabled;D003730
C07.793.720.210;Dental Caries;D003731
E06.342.250;Dental Caries Activity Tests;D003732
G10.549.140;Dental Caries Susceptibility;D003733
D25.339.250;Dental Casting Investment;D003734
J01.637.051.339.250;Dental Casting Investment;D003734
E06.780.250;Dental Casting Technique;D003735
E06.912.115;Dental Casting Technique;D003735
E06.323.225;Dental Cavity Lining;D003736
E06.931.325;Dental Cavity Preparation;D003737
D25.339.291;Dental Cements;D003738
J01.637.051.339.291;Dental Cements;D003738
A14.549.167.646.267;Dental Cementum;D003739
A14.549.167.900.250;Dental Cementum;D003739
N02.278.192.250;Dental Clinics;D003740
C07.793.208;Dental Deposits;D003741
E06.186.250;Dental Devices, Home Care;D003742
E06.761.726.292;Dental Devices, Home Care;D003742
E07.222.250;Dental Devices, Home Care;D003742
A14.549.167.900.255;Dental Enamel;D003743
C07.650.800.255;Dental Enamel Hypoplasia;D003744
C07.793.700.255;Dental Enamel Hypoplasia;D003744
C16.131.850.800.255;Dental Enamel Hypoplasia;D003744
G10.549.845.292;Dental Enamel Permeability;D003745
D12.776.231;Dental Enamel Proteins;D003746
G10.549.181;Dental Enamel Solubility;D003747
E06.186;Dental Equipment;D003748
E07.222;Dental Equipment;D003748
N02.278.192;Dental Facilities;D003749
C07.793.720.210.220;Dental Fissures;D003750
C07.465.614.187;Dental Fistula;D003751
C23.300.575.500.275;Dental Fistula;D003751
N02.421.240;Dental Health Services;D003752
E05.318.308.250.300;Dental Health Surveys;D003753
E06.208;Dental Health Surveys;D003753
N05.715.360.300.375.300;Dental Health Surveys;D003753
N06.850.520.308.250.300;Dental Health Surveys;D003753
N06.890.160;Dental Health Surveys;D003753
E06.186.376;Dental High-Speed Equipment;D003754
E07.222.376;Dental High-Speed Equipment;D003754
E06.216;Dental High-Speed Technique;D003755
M01.526.485.067.105.376;Dental Hygienists;D003756
N02.360.067.105.376;Dental Hygienists;D003756
E04.545.550.280;Dental Implantation;D003757
E04.650.230;Dental Implantation;D003757
E06.231;Dental Implantation;D003757
E06.645.550.280;Dental Implantation;D003757
E06.780.314;Dental Implantation;D003757
E04.545.550.280.280;Dental Implantation, Endosseous;D003758
E06.231.310;Dental Implantation, Endosseous;D003758
E06.645.550.280.280;Dental Implantation, Endosseous;D003758
E06.780.314.310;Dental Implantation, Endosseous;D003758
E04.545.550.280.280.280;Dental Implantation, Endosseous, Endodontic;D003759
E06.231.310.360;Dental Implantation, Endosseous, Endodontic;D003759
E06.397.345;Dental Implantation, Endosseous, Endodontic;D003759
E06.645.550.280.280.280;Dental Implantation, Endosseous, Endodontic;D003759
E06.780.314.310.360;Dental Implantation, Endosseous, Endodontic;D003759
D25.339.334;Dental Impression Materials;D003760
J01.637.051.339.334;Dental Impression Materials;D003760
E06.912.130;Dental Impression Technique;D003761
E06.186.501;Dental Instruments;D003762
E07.222.501;Dental Instruments;D003762
C07.793.221;Dental Leakage;D003763
D25.339;Dental Materials;D003764
D27.720.102.339;Dental Materials;D003764
J01.637.051.339;Dental Materials;D003764
E06.261;Dental Models;D003765
E06.276;Dental Occlusion;D003766
G10.549.235.202;Dental Occlusion;D003766
E06.276.293;Dental Occlusion, Balanced;D003767
E06.276.459;Dental Occlusion, Centric;D003768
C07.793.494.293;Dental Occlusion, Traumatic;D003769
N02.278.192.377;Dental Offices;D003770
A14.549.167.900.720.250;Dental Papilla;D003771
E06.292;Dental Pins;D003772
C07.793.208.377;Dental Plaque;D003773
E05.318.308.250.300.300;Dental Plaque Index;D003774
E06.208.250;Dental Plaque Index;D003774
N05.715.360.300.375.300.325;Dental Plaque Index;D003774
N06.850.520.308.250.300.300;Dental Plaque Index;D003774
N06.890.160.090;Dental Plaque Index;D003774
E06.298;Dental Polishing;D003775
D25.264.377;Dental Porcelain;D003776
D25.339.376;Dental Porcelain;D003776
J01.637.051.264.377;Dental Porcelain;D003776
J01.637.051.339.376;Dental Porcelain;D003776
E06.721.189;Dental Prophylaxis;D003777
E06.761.227;Dental Prophylaxis;D003777
E06.780.345.760;Dentures;D003778
E07.695.190.200;Dentures;D003778
E06.780.345.760.300;Denture Design;D003779
E06.912.250;Denture Design;D003779
E06.780.345.760.500;Denture Repair;D003780
E06.912.285;Denture Repair;D003780
E06.780.345.760.550;Denture Retention;D003781
A14.549.167.900.260;Dental Pulp;D003782
C07.793.237.252;Dental Pulp Calcification;D003784
E06.397.370;Dental Pulp Capping;D003785
A14.549.167.900.265;Dental Pulp Cavity;D003786
E06.397.778.377;Dental Pulp Devitalization;D003787
C07.793.237;Dental Pulp Diseases;D003788
C07.793.237.283;Dental Pulp Exposure;D003789
C07.793.237.315;Dental Pulp Necrosis;D003790
C23.550.717.182;Dental Pulp Necrosis;D003790
E06.342.377;Dental Pulp Test;D003791
E05.318.308.940.375;Dental Records;D003792
L01.280.900.375;Dental Records;D003792
N04.452.859.341;Dental Records;D003792
N05.715.360.300.715.330;Dental Records;D003792
N06.850.520.308.940.375;Dental Records;D003792
E06.323.428;Dental Restoration, Permanent;D003793
E06.780.345.737;Dental Restoration, Permanent;D003793
E07.695.190.190;Dental Restoration, Permanent;D003793
E06.323.528;Dental Restoration, Temporary;D003794
E06.780.345.740;Dental Restoration, Temporary;D003794
E07.695.190.192;Dental Restoration, Temporary;D003794
A14.549.167.900.720.255;Dental Sac;D003795
N02.278.354.422.298;Dental Service, Hospital;D003796
N02.421.240.200;Dental Service, Hospital;D003796
N04.452.442.422.298;Dental Service, Hospital;D003796
M01.526.485.290;Dental Staff;D003797
N02.360.290;Dental Staff;D003797
M01.526.485.290.490;Dental Staff, Hospital;D003798
M01.526.485.740.322;Dental Staff, Hospital;D003798
N02.360.290.490;Dental Staff, Hospital;D003798
N02.360.740.322;Dental Staff, Hospital;D003798
E06.308;Dental Stress Analysis;D003799
M01.526.485.067.105.503;Dental Technicians;D003800
N02.360.067.105.503;Dental Technicians;D003800
E06.780.345.737.250;Dental Veneers;D003801
E06.780.345.750;Dental Veneers;D003801
D25.376;Dentifrices;D003802
D27.720.269.380;Dentifrices;D003802
J01.637.051.376;Dentifrices;D003802
C04.182.089.530.690.310;Dentigerous Cyst;D003803
C05.500.470.690.310;Dentigerous Cyst;D003803
C07.320.450.670.275;Dentigerous Cyst;D003803
A14.549.167.900.280;Dentin;D003804
C07.650.800.260;Dentin Dysplasia;D003805
C07.793.700.260;Dentin Dysplasia;D003805
C16.131.850.800.260;Dentin Dysplasia;D003805
G10.549.845.461;Dentin Permeability;D003806
C07.793.266;Dentin Sensitivity;D003807
G10.549.245;Dentin Solubility;D003808
A14.549.167.900.280.280;Dentin, Secondary;D003809
C07.793.237.378;Dentin, Secondary;D003809
G07.700.320.500.325.377.750.461;Dentinogenesis;D003810
C07.650.800.270;Dentinogenesis Imperfecta;D003811
C07.793.700.270;Dentinogenesis Imperfecta;D003811
C16.131.850.800.270;Dentinogenesis Imperfecta;D003811
F01.829.401.650.410;Dentist-Patient Relations;D003812
N05.300.660.325;Dentist-Patient Relations;D003812
E06;Dentistry;D003813
H02.163;Dentistry;D003813
E06.323;Dentistry, Operative;D003814
H02.163.180;Dentistry, Operative;D003814
M01.526.485.330;Dentists;D003815
N02.360.330;Dentists;D003815
M01.526.485.330.310;Dentists, Women;D003816
M01.975.310;Dentists, Women;D003816
N02.360.330.310;Dentists, Women;D003816
A03.556.500.379;Dentition;D003817
A14.549.167;Dentition;D003817
A14.549.167.229;Dentition, Mixed;D003818
E06.780.345.760.281;Denture Bases;D003819
E07.695.190.200.200;Denture Bases;D003819
D25.376.262;Denture Cleansers;D003820
J01.637.051.376.262;Denture Cleansers;D003820
E06.912.275;Denture Identification Marking;D003821
E06.780.345.760.357;Denture Liners;D003822
E07.695.190.200.210;Denture Liners;D003822
E06.780.345.760.471;Denture Rebasing;D003823
E06.912.280;Denture Rebasing;D003823
E06.780.345.760.290;Denture, Complete;D003824
E07.695.190.200.205;Denture, Complete;D003824
E06.780.345.760.290.254;Denture, Complete, Immediate;D003825
E07.695.190.200.205.205;Denture, Complete, Immediate;D003825
E06.780.345.760.290.379;Denture, Complete, Lower;D003826
E07.695.190.200.205.210;Denture, Complete, Lower;D003826
E06.780.345.760.290.504;Denture, Complete, Upper;D003827
E07.695.190.200.205.215;Denture, Complete, Upper;D003827
E06.780.345.760.395;Denture, Overlay;D003828
E07.695.190.200.215;Denture, Overlay;D003828
E06.780.345.760.433;Denture, Partial;D003829
E07.695.190.200.220;Denture, Partial;D003829
E06.780.345.760.433.271;Denture, Partial, Fixed;D003830
E07.695.190.200.220.220;Denture, Partial, Fixed;D003830
E06.780.345.760.433.342;Denture, Partial, Immediate;D003831
E07.695.190.200.220.225;Denture, Partial, Immediate;D003831
E06.780.345.760.433.413;Denture, Partial, Removable;D003832
E07.695.190.200.220.230;Denture, Partial, Removable;D003832
E06.780.345.760.433.484;Denture, Partial, Temporary;D003833
E07.695.190.200.220.235;Denture, Partial, Temporary;D003833
E06.780.345.760.433.555;Denture Precision Attachment;D003834
E07.695.190.200.220.245;Denture Precision Attachment;D003834
M01.526.485.067.105.751;Denturists;D003835
N02.360.067.105.751;Denturists;D003835
D27.720.269.385;Deodorants;D003836
D09.254;Deoxy Sugars;D003837
D03.438.759.646.138.410;Deoxyadenine Nucleotides;D003838
D13.695.201.100;Deoxyadenine Nucleotides;D003838
D13.695.667.138.410;Deoxyadenine Nucleotides;D003838
D03.438.759.590.138.325;Deoxyadenosines;D003839
D13.570.230.229;Deoxyadenosines;D003839
D13.570.583.138.325;Deoxyadenosines;D003839
D04.808.105.225.272;Deoxycholic Acid;D003840
D04.808.221.430.342;Deoxycholic Acid;D003840
D03.383.742.680.245.500;Deoxycytidine;D003841
D13.570.230.329;Deoxycytidine;D003841
D13.570.685.245.500;Deoxycytidine;D003841
D08.811.913.696.620.175;Deoxycytidine Kinase;D003842
D03.383.742.686.246.425.300;Deoxycytidine Monophosphate;D003843
D13.695.201.150.200;Deoxycytidine Monophosphate;D003843
D13.695.740.246.425.300;Deoxycytidine Monophosphate;D003843
D08.811.277.151.653.200;DCMP Deaminase;D003844
D03.383.742.686.246.425;Deoxycytosine Nucleotides;D003845
D13.695.201.150;Deoxycytosine Nucleotides;D003845
D13.695.740.246.425;Deoxycytosine Nucleotides;D003845
D02.092.311.342.300;Deoxyepinephrine;D003846
D02.092.311.461.200;Deoxyepinephrine;D003846
D09.254.229;Deoxyglucose;D003847
D03.438.759.646.454.200;Deoxyguanine Nucleotides;D003848
D13.695.201.175;Deoxyguanine Nucleotides;D003848
D13.695.667.454.200;Deoxyguanine Nucleotides;D003848
D03.438.759.590.454.240;Deoxyguanosine;D003849
D13.570.230.360;Deoxyguanosine;D003849
D13.570.583.454.240;Deoxyguanosine;D003849
D08.811.277.352.335.350.250;Deoxyribonuclease I;D003850
D08.811.277.352.335;Deoxyribonucleases;D003851
D12.776.664.275;Deoxyribonucleoproteins;D003852
D13.570.230;Deoxyribonucleosides;D003853
D13.695.201;Deoxyribonucleotides;D003854
D09.254.330;Deoxyribose;D003855
D03.383.742.686.850.210;Deoxyuracil Nucleotides;D003856
D13.695.201.200;Deoxyuracil Nucleotides;D003856
D13.695.740.850.210;Deoxyuracil Nucleotides;D003856
D03.383.742.680.852.300;Deoxyuridine;D003857
D13.570.230.430;Deoxyuridine;D003857
D13.570.685.852.300;Deoxyuridine;D003857
F01.752.330;Dependency (Psychology);D003858
F03.675.200;Dependent Personality Disorder;D003859
F01.145.126.300;Depersonalization;D003861
N03.219.463.030.120;Depreciation;D003862
F01.145.126.350;Depression;D003863
G07.690.812.210;Depression, Chemical;D003864
G07.700.680.210;Depression, Chemical;D003864
F03.600.300.375;Depressive Disorder, Major;D003865
F03.600.300;Depressive Disorder;D003866
F02.463.593.200;Depth Perception;D003867
F02.463.593.932.869.255;Depth Perception;D003867
D03.438.810.824.200;Dequalinium;D003868
E02.218.210;Dermabrasion;D003869
E04.680.275.250;Dermabrasion;D003869
B01.050.500.131.166.132.832.400.200;Dermacentor;D003870
D09.698.373.200.380;Dermatan Sulfate;D003871
C17.800.174;Dermatitis;D003872
C17.800.174.318;Dermatitis, Exfoliative;D003873
C17.800.815.318;Dermatitis, Exfoliative;D003873
C17.800.174.360;Dermatitis Herpetiformis;D003874
C17.800.865.360;Dermatitis Herpetiformis;D003874
C20.111.318;Dermatitis Herpetiformis;D003874
C17.800.174.600;Drug Eruptions;D003875
C20.543.206.380;Drug Eruptions;D003875
C25.723.276.505;Drug Eruptions;D003875
C16.320.850.210;Dermatitis, Atopic;D003876
C17.800.174.193;Dermatitis, Atopic;D003876
C17.800.815.193;Dermatitis, Atopic;D003876
C17.800.827.210;Dermatitis, Atopic;D003876
C20.543.480.343;Dermatitis, Atopic;D003876
C17.800.174.255;Dermatitis, Contact;D003877
C17.800.815.255;Dermatitis, Contact;D003877
E05.256;Dermatoglyphics;D003878
I01.198.780.937.343;Dermatoglyphics;D003878
D27.505.954.444;Dermatologic Agents;D003879
H02.403.225;Dermatology;D003880
C01.539.800.200;Dermatomycoses;D003881
C01.703.295;Dermatomycoses;D003881
C17.800.838.208;Dermatomycoses;D003881
C05.651.594.297;Dermatomyositis;D003882
C05.651.594.819.500;Dermatomyositis;D003882
C10.668.491.562.150;Dermatomyositis;D003882
C10.668.491.562.575.500;Dermatomyositis;D003882
C17.300.250;Dermatomyositis;D003882
C17.800.185;Dermatomyositis;D003882
B01.300.107.650.080;Arthrodermataceae;D003883
C04.182.201;Dermoid Cyst;D003884
C04.557.465.910.250;Dermoid Cyst;D003884
D27.888.569.242;Dermotoxins;D003885
A09.371.060.217.271;Descemet Membrane;D003886
A10.615.179.437;Descemet Membrane;D003886
F04.754.137.506;Desensitization, Psychologic;D003887
E02.095.465.425.450.310;Desensitization, Immunologic;D003888
E05.478.610.310;Desensitization, Immunologic;D003888
G16.500.275.071.325;Desert Climate;D003889
N06.230.300.100.250.325;Desert Climate;D003889
E05.196.335;Desiccation;D003890
G02.149.767.530;Desiccation;D003890
G02.842.750.530;Desiccation;D003890
D03.494.240.281;Desipramine;D003891
D04.808.155.580.130.500.657.200;Deslanoside;D003892
D09.408.180.261.657.200;Deslanoside;D003892
D05.750.078.593.200;Desmin;D003893
D12.776.220.475.200;Desmin;D003893
D06.472.699.631.692.781.100.250;Deamino Arginine Vasopressin;D003894
D12.644.400.900.100.250;Deamino Arginine Vasopressin;D003894
D12.644.456.925.100.250;Deamino Arginine Vasopressin;D003894
D12.644.548.691.692.781.100.250;Deamino Arginine Vasopressin;D003894
D12.776.641.650.937.100.250;Deamino Arginine Vasopressin;D003894
D03.383.725.762.300;Desmosine;D003895
D12.125.072.200;Desmosine;D003895
A11.284.149.165.420.297;Desmosomes;D003896
D04.808.247.222.222.347.231;Desmosterol;D003897
D04.808.247.808.197.250.281;Desmosterol;D003897
D10.570.938.208.320.297;Desmosterol;D003897
D04.808.745.432.769.325;Desonide;D003898
D04.808.745.432.719.260;Desoximetasone;D003899
D04.808.908.238.250;Desoximetasone;D003899
D04.808.745.745.654.339;Desoxycorticosterone;D003900
D06.472.040.585.611;Desoxycorticosterone;D003900
B03.440.425.410.350;Desulfovibrio;D003901
B03.660.125.125;Desulfovibrio;D003901
B03.900.350;Desulfovibrio;D003901
D27.720.877.265;Detergents;D003902
J01.516.381;Detergents;D003902
D01.435.256;Deuterium;D003903
D01.496.289;Deuterium;D003903
B01.300.381;Mitosporic Fungi;D003904
D03.383.129.578.840.500.280;Deuteroporphyrins;D003905
D03.549.909.500.280;Deuteroporphyrins;D003905
D04.345.783.500.280;Deuteroporphyrins;D003905
D23.767.727.280;Deuteroporphyrins;D003905
I01.615.500.300;Developing Countries;D003906
D04.808.745.432.769.344;Dexamethasone;D003907
D04.808.908.238;Dexamethasone;D003907
D04.808.745.432.769.344.300;Dexamethasone Isonicotinate;D003908
D04.808.908.238.300;Dexamethasone Isonicotinate;D003908
D03.383.621.808.250;Dexetimide;D003909
D08.811.277.450.283;Dextranase;D003910
D05.750.078.562.272;Dextrans;D003911
D09.698.365.272;Dextrans;D003911
D09.698.365.855.400;Dextrins;D003912
D02.092.471.683.152.110.200;Dextroamphetamine;D003913
C14.240.400.280;Dextrocardia;D003914
C14.280.400.280;Dextrocardia;D003914
C16.131.240.400.280;Dextrocardia;D003914
C16.131.810.250;Dextrocardia;D003914
D03.132.577.249.200;Dextromethorphan;D003915
D03.549.686.212;Dextromethorphan;D003915
D03.605.497.212;Dextromethorphan;D003915
D04.615.723.795.200;Dextromethorphan;D003915
D03.383.533.640.250;Dextromoramide;D003916
D03.132.577.249.235;Dextrorphan;D003917
D03.549.686.260;Dextrorphan;D003917
D03.605.497.260;Dextrorphan;D003917
D04.615.723.795.235;Dextrorphan;D003917
D06.472.931.103;Dextrothyroxine;D003918
D12.125.072.050.342;Dextrothyroxine;D003918
C12.777.419.135;Diabetes Insipidus;D003919
C13.351.968.419.135;Diabetes Insipidus;D003919
C19.700.159;Diabetes Insipidus;D003919
C18.452.394.750;Diabetes Mellitus;D003920
C19.246;Diabetes Mellitus;D003920
C18.452.394.750.074;Diabetes Mellitus, Experimental;D003921
C19.246.240;Diabetes Mellitus, Experimental;D003921
E05.598.500.374;Diabetes Mellitus, Experimental;D003921
C18.452.394.750.124;Diabetes Mellitus, Type 1;D003922
C19.246.267;Diabetes Mellitus, Type 1;D003922
C20.111.327;Diabetes Mellitus, Type 1;D003922
C18.452.394.750.149.500;Diabetes Mellitus, Lipoatrophic;D003923
C19.246.300.500;Diabetes Mellitus, Lipoatrophic;D003923
C18.452.394.750.149;Diabetes Mellitus, Type 2;D003924
C19.246.300;Diabetes Mellitus, Type 2;D003924
C14.907.320;Diabetic Angiopathies;D003925
C19.246.099.500;Diabetic Angiopathies;D003925
C19.246.099.750;Diabetic Coma;D003926
E02.642.249.240;Diabetic Diet;D003927
G07.610.240.240;Diabetic Diet;D003927
C12.777.419.192;Diabetic Nephropathies;D003928
C13.351.968.419.192;Diabetic Nephropathies;D003928
C19.246.099.875;Diabetic Nephropathies;D003928
C10.668.829.300;Diabetic Neuropathies;D003929
C19.246.099.937;Diabetic Neuropathies;D003929
C11.768.257;Diabetic Retinopathy;D003930
C14.907.320.382;Diabetic Retinopathy;D003930
C19.246.099.500.382;Diabetic Retinopathy;D003930
D02.522.296.400;Diacetyl;D003931
D03.132.577.249.547.547.445;Heroin;D003932
D03.549.686.575.547.490;Heroin;D003932
D03.605.497.575.547.490;Heroin;D003932
D04.615.723.795.547.547.445;Heroin;D003932
E01;Diagnosis;D003933
E01.370.370;Diagnostic Techniques, Cardiovascular;D003935
E01.158;Diagnosis, Computer-Assisted;D003936
L01.700.508.100.158;Diagnosis, Computer-Assisted;D003936
E01.171;Diagnosis, Differential;D003937
E01.370.372;Diagnostic Techniques, Digestive System;D003938
E01.370.382;Diagnostic Techniques, Otological;D003939
E01.370.374;Diagnostic Techniques, Endocrine;D003940
E01.370.380;Diagnostic Techniques, Ophthalmological;D003941
E01.370.376;Diagnostic Techniques, Neurological;D003943
E01.370.378;Diagnostic Techniques, Obstetrical and Gynecological;D003944
E06.342;Diagnosis, Oral;D003945
E01.370.384;Diagnostic Techniques, Radioisotope;D003947
E01.370.386;Diagnostic Techniques, Respiratory System;D003948
E01.370.388;Diagnostic Techniques, Surgical;D003949
E01.370.390;Diagnostic Techniques, Urological;D003950
E01.354;Diagnostic Errors;D003951
N02.421.450.280;Diagnostic Errors;D003951
E01.370.350;Diagnostic Imaging;D003952
N03.219.521.710.305.200.080;Diagnosis-Related Groups;D003953
N02.421.143.827.233;Diagnostic Services;D003954
N02.421.726.233;Diagnostic Services;D003954
E01.370.395;Diagnostic Tests, Routine;D003955
E05.196.353;Dialysis;D003956
G02.149.767.540;Dialysis;D003956
G02.842.750.540;Dialysis;D003956
D02.065.199.092.250;Diamfenetide;D003957
D02.172.300;Diamide;D003958
D02.092.782.258;Diamines;D003959
D02.241.081.337.699.250;Diaminopimelic Acid;D003960
D12.125.095.390;Diaminopimelic Acid;D003960
D02.033.800.400.350;Dianhydrogalactitol;D003961
D09.853.400.350;Dianhydrogalactitol;D003961
D02.455.426.559.389.185.220;Dianisidine;D003962
C17.800.174.255.400.250;Diaper Rash;D003963
C17.800.815.255.400.250;Diaper Rash;D003963
A02.633.567.900.300;Diaphragm;D003964
C06.198.257;Diaphragmatic Eventration;D003965
C16.131.314.244;Diaphragmatic Eventration;D003965
C05.116.099.708.180;Camurati-Engelmann Syndrome;D003966
C16.320.144;Camurati-Engelmann Syndrome;D003966
C23.888.821.214;Diarrhea;D003967
C23.888.821.214.500;Diarrhea, Infantile;D003968
C04.557.465.625.650.240.847;Vipoma;D003969
C04.557.470.200.025.370.847;Vipoma;D003969
C04.588.274.761.500.750;Vipoma;D003969
C04.588.322.475.500.750;Vipoma;D003969
C06.301.761.500.750;Vipoma;D003969
C06.689.667.500.750;Vipoma;D003969
C19.344.421.500.750;Vipoma;D003969
A14.549.167.333;Diastema;D003970
C07.793.494.466;Diastema;D003970
G09.330.190.541.295;Diastole;D003971
G11.427.590.540.554.250;Diastole;D003971
G11.427.590.540.570.295;Diastole;D003971
E02.565.280;Diathermy;D003972
E02.779.496.280;Diathermy;D003972
D02.241.223.100.400.880.270;Diatrizoate;D003973
D02.455.426.559.389.127.375.880.270;Diatrizoate;D003973
D02.033.800.813.550.500;Diatrizoate Meglumine;D003974
D02.241.223.100.400.880.270.500;Diatrizoate Meglumine;D003974
D02.455.426.559.389.127.375.880.270.500;Diatrizoate Meglumine;D003974
D09.067.342.600.500;Diatrizoate Meglumine;D003974
D09.853.813.550.500;Diatrizoate Meglumine;D003974
D03.438.079.080.070.216;Diazepam;D003975
D02.705.400.625.200;Diazinon;D003976
D02.705.539.345.200;Diazinon;D003976
D02.886.300.692.200;Diazinon;D003976
D02.172.383.383;Diazomethane;D003978
D02.172.383;Diazonium Compounds;D003979
D02.172.508;Diazooxonorleucine;D003980
D12.125.213.568.175;Diazooxonorleucine;D003980
D02.886.590.700.135.300;Diazoxide;D003981
D02.886.655.500.300;Diazoxide;D003981
D03.438.174.300;Diazoxide;D003981
D09.408.051.476.200;Dibekacin;D003982
D02.092.471.245;Dibenzylchlorethamine;D003983
D03.494.240;Dibenzazepines;D003984
D02.455.426.559.847.181.384;Dibenzocycloheptenes;D003986
D04.615.181.384;Dibenzocycloheptenes;D003986
D02.886.680.702.500;Dibenzothiazepines;D003987
D03.494.276;Dibenzothiazepines;D003987
D02.886.680.350;Dibenzothiepins;D003988
D03.494.311;Dibenzothiepins;D003988
D03.494.347;Dibenzoxazepines;D003989
D03.494.382;Dibenzoxepins;D003990
D02.806.250.280;Dibromothymoquinone;D003991
D02.065.355;Dibucaine;D003992
D03.438.810.125;Dibucaine;D003992
D02.241.223.805.225;Dibutyl Phthalate;D003993
D03.438.759.646.138.395.250;Bucladesine;D003994
D13.695.462.200.250;Bucladesine;D003994
D13.695.667.138.395.250;Bucladesine;D003994
D13.695.827.068.395.250;Bucladesine;D003994
D03.438.759.646.454.160.325;Dibutyryl Cyclic GMP;D003995
D13.695.462.275.325;Dibutyryl Cyclic GMP;D003995
D13.695.667.454.160.325;Dibutyryl Cyclic GMP;D003995
D13.695.827.426.160.325;Dibutyryl Cyclic GMP;D003995
D02.241.223.100.200.500;Dicamba;D003996
D02.241.223.100.300.595.202;Dicamba;D003996
D02.241.511.390.595.202;Dicamba;D003996
D02.455.426.559.389.127.250.500;Dicamba;D003996
D02.455.426.559.389.127.281.595.202;Dicamba;D003996
D02.455.426.559.389.657.410.595.202;Dicamba;D003996
D03.383.725.203.200;Dicarbethoxydihydrocollidine;D003997
D02.241.081.337;Dicarboxylic Acids;D003998
D02.241.081.018.214.500;Dichloroacetic Acid;D003999
D02.455.526.439.196.500;Dichloroacetic Acid;D003999
D02.455.326.271.367.300;Dichloroethylenes;D004000
D02.455.526.439.350;Dichloroethylenes;D004000
D02.705.429.500.200;Clodronic Acid;D004002
D02.455.426.559.389.657.190.270;Dichlorophen;D004003
D13.570.800.330;Dichlororibofuranosylbenzimidazole;D004004
D02.065.884.485;Dichlorphenamide;D004005
D02.886.590.700.410;Dichlorphenamide;D004005
D02.705.400.130;Dichlorvos;D004006
E01.370.382.375.200;Dichotic Listening Tests;D004007
D02.241.223.601.210;Diclofenac;D004008
D02.065.589.099.750.625.150.205;Dicloxacillin;D004009
D02.886.108.750.625.150.205;Dicloxacillin;D004009
D03.438.260.825.625.150.205;Dicloxacillin;D004009
D03.605.084.737.625.150.205;Dicloxacillin;D004009
D04.075.080.875.099.221.750.625.150.205;Dicloxacillin;D004009
D02.455.426.559.389.261.220;Dicofol;D004010
D02.455.526.439.202.190;Dicofol;D004010
C03.335.865.224;Dicrocoeliasis;D004011
B01.050.500.500.736.715.300;Dicrocoeliidae;D004012
B01.050.500.500.736.715.300.308;Dicrocoelium;D004013
L01.178.682.192.836.285;Dictionaries as Topic;D004014
L01.178.682.192.836.285.206;Dictionaries, Chemical;D004015
L01.178.682.192.836.285.277;Dictionaries, Classical;D004016
L01.178.682.192.836.285.348;Dictionaries, Dental;D004017
L01.178.682.192.836.285.419;Dictionaries, Medical;D004018
L01.178.682.192.836.842.385;Dictionaries, Medical;D004018
L01.178.682.192.836.285.490;Dictionaries, Pharmaceutic;D004019
L01.178.682.192.836.285.561;Dictionaries, Polyglot;D004020
B01.050.500.500.294.700.775.746.300;Dictyocaulus;D004021
C03.335.349.315;Dictyocaulus Infections;D004022
C03.335.508.700.775.825.315;Dictyocaulus Infections;D004022
C03.701.377.315;Dictyocaulus Infections;D004022
C22.674.377.315;Dictyocaulus Infections;D004022
B01.046.550.200.300;Dictyostelium;D004023
D02.491.203.385;Dicyclohexylcarbodiimide;D004024
D02.241.223.268.300;Dicyclomine;D004025
D02.455.426.392.368.367.440;Dicyclomine;D004025
D02.455.526.439.371;Dieldrin;D004026
A08.186.211.730.317;Diencephalon;D004027
D02.455.426.559.389.657.290;Dienestrol;D004028
B01.630.800.180;Dientamoeba;D004029
C03.432.275;Dientamoebiasis;D004030
C03.752.275;Dientamoebiasis;D004030
C06.405.469.452.275;Dientamoebiasis;D004030
G08.686.195.374;Diestrus;D004031
G07.610.240;Diet;D004032
G07.610.240.250;Diet Fads;D004033
I03.287;Diet Fads;D004033
E05.318.308.250.600.350;Diet Surveys;D004034
E05.318.308.585.550.350;Diet Surveys;D004034
N05.715.360.300.375.560.300;Diet Surveys;D004034
N05.715.360.300.560.565.300;Diet Surveys;D004034
N06.850.520.308.250.600.350;Diet Surveys;D004034
N06.850.520.308.585.550.350;Diet Surveys;D004034
E02.642.249;Diet Therapy;D004035
E05.263;Diet, Atherogenic;D004036
G07.610.240.242;Diet, Atherogenic;D004036
E05.270;Diet, Cariogenic;D004037
G07.610.240.255;Diet, Cariogenic;D004037
E02.642.249.285;Diet, Reducing;D004038
G07.610.240.285;Diet, Reducing;D004038
E02.642.249.290;Diet, Sodium-Restricted;D004039
G07.610.240.290;Diet, Sodium-Restricted;D004039
D09.301;Dietary Carbohydrates;D004040
J02.500.362;Dietary Carbohydrates;D004040
D10.212.302;Dietary Fats;D004041
J02.500.375;Dietary Fats;D004041
D10.212.302.380;Dietary Fats, Unsaturated;D004042
J02.500.375.400;Dietary Fats, Unsaturated;D004042
J02.500.400;Dietary Fiber;D004043
D12.776.256;Dietary Proteins;D004044
J02.500.428;Dietary Proteins;D004044
N02.421.242;Dietary Services;D004045
H02.533.290;Dietetics;D004046
D02.241.081.420.750.250;Diethyl Pyrocarbonate;D004047
D02.092.471.302;Diethylamines;D004048
D02.241.081.251.240;Diethylcarbamazine;D004049
D03.383.606.380;Diethylcarbamazine;D004049
D02.241.081.251.869.220;Ditiocarb;D004050
D02.886.706.200;Ditiocarb;D004050
D02.241.223.805.250;Diethylhexyl Phthalate;D004051
D02.654.442.200;Diethylnitrosamine;D004052
D02.092.471.308;Diethylpropion;D004053
D02.455.426.559.389.150.700.175;Diethylstilbestrol;D004054
E05.196.370;Differential Thermal Analysis;D004055
F02.463.593.230;Differential Threshold;D004056
F02.463.593.710.370;Differential Threshold;D004056
C05.116.540.410;Hyperostosis, Diffuse Idiopathic Skeletal;D004057
C05.116.900.815.651;Hyperostosis, Diffuse Idiopathic Skeletal;D004057
G01.595.200;Diffusion;D004058
G02.149.767.560;Diffusion;D004058
G02.842.750.560;Diffusion;D004058
L01.143.320;Diffusion of Innovation;D004059
D04.808.745.432.719.320.250;Diflucortolone;D004060
D04.808.908.405.250;Diflucortolone;D004060
D02.455.426.559.389.657.410.595.303;Diflunisal;D004061
C05.660.207.103.500;DiGeorge Syndrome;D004062
C14.240.400.021.500;DiGeorge Syndrome;D004062
C14.280.400.044.500;DiGeorge Syndrome;D004062
C15.604.451.249.500;DiGeorge Syndrome;D004062
C16.131.077.019.500;DiGeorge Syndrome;D004062
C16.131.240.400.021.500;DiGeorge Syndrome;D004062
C16.131.260.019.500;DiGeorge Syndrome;D004062
C16.131.482.249.500;DiGeorge Syndrome;D004062
C16.131.621.207.103.500;DiGeorge Syndrome;D004062
C16.320.180.019.500;DiGeorge Syndrome;D004062
C19.642.482.500.500;DiGeorge Syndrome;D004062
G07.610.593.220;Digestion;D004063
G07.700.620.220;Digestion;D004063
G10.261.326.222;Digestion;D004063
A03;Digestive System;D004064
C06.198;Digestive System Abnormalities;D004065
C16.131.314;Digestive System Abnormalities;D004065
C06;Digestive System Diseases;D004066
C04.588.274;Digestive System Neoplasms;D004067
C06.301;Digestive System Neoplasms;D004067
G10.261;Digestive System Physiological Phenomena;D004068
B01.650.940.800.575.100.892.333;Digitalis;D004070
D04.808.155.580.130.500;Digitalis Glycosides;D004071
D09.408.180.261;Digitalis Glycosides;D004071
D04.808.155.580.130.500.236;Digitonin;D004072
D09.408.180.261.236;Digitonin;D004072
D04.808.155.160.278.350;Digitoxigenin;D004073
D04.808.155.160.278;Digitoxin;D004074
D04.808.155.580.130.500.336;Digitoxin;D004074
D09.408.180.261.336;Digitoxin;D004074
D10.351.303;Diglycerides;D004075
D04.808.155.160.349.350;Digoxigenin;D004076
D04.808.155.160.349;Digoxin;D004077
D04.808.155.580.130.500.436;Digoxin;D004077
D09.408.180.261.436;Digoxin;D004077
D03.383.710.605.500.250;Dihydralazine;D004078
D03.132.285;Dihydro-beta-Erythroidine;D004079
D03.549.380;Dihydro-beta-Erythroidine;D004079
D08.811.277.087.280;Dihydroorotase;D004080
D08.811.682.660.300;Dihydroorotate Oxidase;D004081
D02.033.100.624.058.200;Dihydroalprenolol;D004082
D02.033.100.624.698.055.200;Dihydroalprenolol;D004082
D02.033.755.624.058.200;Dihydroalprenolol;D004082
D02.033.755.624.698.055.200;Dihydroalprenolol;D004082
D02.092.063.624.698.055.200;Dihydroalprenolol;D004082
D04.808.247.100.250;Cholestanol;D004083
D04.808.247.808.197.135;Cholestanol;D004083
D10.570.938.208.160;Cholestanol;D004083
D03.132.327.412.225;Dihydroergotamine;D004087
D03.549.562.300;Dihydroergotamine;D004087
D03.132.327.412.250;Dihydroergotoxine;D004088
D03.549.562.400;Dihydroergotoxine;D004088
D03.132.577.249.547.547.350;Dihydromorphine;D004090
D03.549.686.575.547.420;Dihydromorphine;D004090
D03.605.497.575.547.420;Dihydromorphine;D004090
D04.615.723.795.547.547.350;Dihydromorphine;D004090
D03.132.577.249.547.547.450;Hydromorphone;D004091
D03.549.686.575.547.500;Hydromorphone;D004091
D03.605.497.575.547.500;Hydromorphone;D004091
D04.615.723.795.547.547.450;Hydromorphone;D004091
D04.808.745.745.654.829.100;20-alpha-Dihydroprogesterone;D004092
D06.472.334.851.687.750.074;20-alpha-Dihydroprogesterone;D004092
D08.811.682.662.162;Dihydropteridine Reductase;D004093
D08.811.682.662.582.361;Dihydropteridine Reductase;D004093
D08.811.913.225.300;Dihydropteroate Synthase;D004094
D03.383.725.203;Dihydropyridines;D004095
D09.408.051.885.387;Dihydrostreptomycin Sulfate;D004096
D04.808.247.222.387;Dihydrotachysterol;D004097
D04.808.247.222.474.250;Dihydrotachysterol;D004097
D04.808.247.808.337;Dihydrotachysterol;D004097
D04.808.247.808.412.250;Dihydrotachysterol;D004097
D04.808.812.768.462.250;Dihydrotachysterol;D004097
D10.570.938.359;Dihydrotachysterol;D004097
D09.546.465.200;Dihydroxyacetone;D004098
D09.546.894.200;Dihydroxyacetone;D004098
D09.894.150;Dihydroxyacetone Phosphate;D004099
D04.808.247.222.159.478.387;Dihydroxycholecalciferols;D004100
D04.808.247.808.146.478.387;Dihydroxycholecalciferols;D004100
D04.808.812.768.196.478.387;Dihydroxycholecalciferols;D004100
D10.570.938.146.478.387;Dihydroxycholecalciferols;D004100
D02.455.426.559.847.799.306.400;Dihydroxydihydrobenzopyrenes;D004101
D04.615.799.306.400;Dihydroxydihydrobenzopyrenes;D004101
D03.438.473.914.201;Dihydroxytryptamines;D004102
D03.438.810.350.625.420;Iodoquinol;D004103
D06.472.931.740.180;Diiodothyronines;D004104
D12.125.072.050.767.741.180;Diiodothyronines;D004104
D06.472.931.208;Diiodotyrosine;D004105
D12.125.072.050.875.262;Diiodotyrosine;D004105
E05.284;Dilatation;D004106
E04.157.310;Dilatation and Curettage;D004107
E04.950.300.299;Dilatation and Curettage;D004107
C23.300.325;Dilatation, Pathologic;D004108
D03.383.066.200;Dilazep;D004109
D03.438.079.150;Diltiazem;D004110
D02.092.471.320.250;Dimenhydrinate;D004111
D02.455.426.559.389.115.250.250;Dimenhydrinate;D004111
D03.438.759.758.824.751.162;Dimenhydrinate;D004111
D02.886.489.180;Dimercaprol;D004112
D02.241.081.337.759.500;Succimer;D004113
D02.886.489.750;Succimer;D004113
D03.383.129.462.175;Dimethadione;D004114
D02.455.426.559.847.486.250;Dimethindene;D004115
D03.383.725.210;Dimethindene;D004115
D04.615.486.250;Dimethindene;D004115
D04.808.745.745.279;Dimethisterone;D004116
D02.705.400.625.220;Dimethoate;D004117
D02.705.539.345.220;Dimethoate;D004117
D02.886.300.692.220;Dimethoate;D004117
D02.092.471.683.386;Dimethoxyphenylethylamine;D004118
D02.241.081.337.052.250;Dimethyl Adipimidate;D004119
D02.478.400.175;Dimethyl Adipimidate;D004119
D02.478.400.200;Dimethyl Suberimidate;D004120
D02.886.640.150;Dimethyl Sulfoxide;D004121
D08.811.913.225.400;Dimethylallyltranstransferase;D004122
D02.092.668.387;Dimethylamines;D004123
D02.092.146.325;p-Dimethylaminoazobenzene;D004124
D02.241.081.251.869.210;Dimethyldithiocarbamate;D004125
D02.886.706.175;Dimethyldithiocarbamate;D004125
D02.065.463.387;Dimethylformamide;D004126
D02.241.081.420.500.387;Dimethylformamide;D004126
D02.442.600.400;Dimethylhydrazines;D004127
D02.654.442.225;Dimethylnitrosamine;D004128
D02.715.650.700.150;Dimethylpolysiloxanes;D004129
D05.750.900.850.150;Dimethylpolysiloxanes;D004129
D25.720.900.850.150;Dimethylpolysiloxanes;D004129
J01.637.051.720.900.850.150;Dimethylpolysiloxanes;D004129
D02.092.211.215.801.451;N,N-Dimethyltryptamine;D004130
D03.438.473.914.237;N,N-Dimethyltryptamine;D004130
D02.640.672.200;Dimetridazole;D004131
D03.383.129.308.658.200;Dimetridazole;D004131
D02.948.684.280;Diflubenzuron;D004132
D06.472.445.573.666.170;Diflubenzuron;D004132
D02.078.100.260;Diminazene;D004133
D02.925.240;Diminazene;D004133
D10.570.755.375.760.400.800.200;Dimyristoylphosphatidylcholine;D004134
D02.065.277.225;Dinitolmide;D004135
D02.241.223.100.100.240;Dinitolmide;D004135
D02.455.426.559.389.127.085.240;Dinitolmide;D004135
D02.455.426.559.389.565.225;Dinitrobenzenes;D004136
D02.640.529.240;Dinitrobenzenes;D004136
D02.455.426.559.389.261.250;Dinitrochlorobenzene;D004137
D02.455.426.559.389.565.250;Dinitrochlorobenzene;D004137
D02.455.526.439.202.200;Dinitrochlorobenzene;D004137
D02.640.529.240.250;Dinitrochlorobenzene;D004137
D23.050.550.480.350;Dinitrochlorobenzene;D004137
D02.455.426.559.389.657.239.493;Dinitrocresols;D004138
D02.640.280;Dinitrocresols;D004138
D02.455.426.559.389.565.280;Dinitrofluorobenzene;D004139
D02.640.529.240.280;Dinitrofluorobenzene;D004139
D02.455.426.559.389.657.566.304;Dinitrophenols;D004140
D02.640.743.304;Dinitrophenols;D004140
B01.043.214;Dinoflagellida;D004141
D02.241.081.337.759.249;Dioctyl Sulfosuccinic Acid;D004143
D04.808.247.515.500;Diosgenin;D004144
D03.438.150.266.450.260.222;Diosmin;D004145
D03.830.219.266.450.260.222;Diosmin;D004145
D03.383.231.388;Dioxanes;D004146
D03.383.231;Dioxins;D004147
D03.383.246.238;Dioxolanes;D004148
D03.383.246;Dioxoles;D004149
D08.811.277.656.350.297;Dipeptidases;D004150
D12.644.456.345;Dipeptides;D004151
D08.811.277.656.350.350;Dipeptidyl-Peptidases and Tripeptidyl-Peptidases;D004152
B01.050.500.500.294.700.750.700.300.208;Dipetalonema;D004153
C03.335.508.700.750.361.275;Dipetalonema Infections;D004154
D02.092.471.320;Diphenhydramine;D004155
D02.455.426.559.389.115.250;Diphenhydramine;D004155
D08.811.682.690.708.125;Catechol Oxidase;D004156
D03.066.399.300;Diphenoxylate;D004157
D03.383.621.349.300;Diphenoxylate;D004157
D02.241.223.601.238;Diphenylacetic Acids;D004158
D02.092.146.350;Diphenylamine;D004159
D02.845.250;Diphenylcarbazide;D004160
D02.455.326.271.665.250;Diphenylhexatriene;D004161
D02.241.081.844.387.388;Diphosphoglyceric Acids;D004163
D02.241.511.902.387.388;Diphosphoglyceric Acids;D004163
D02.705.400.140;Diphosphoglyceric Acids;D004163
D09.811.366.388;Diphosphoglyceric Acids;D004163
D02.705.429.500;Diphosphonates;D004164
C01.252.410.040.246.388;Diphtheria;D004165
D12.776.124.486.485.114.301.438;Diphtheria Antitoxin;D004166
D12.776.124.486.485.114.573.601.438;Diphtheria Antitoxin;D004166
D12.776.124.790.651.114.301.438;Diphtheria Antitoxin;D004166
D12.776.377.715.548.114.301.438;Diphtheria Antitoxin;D004166
D20.215.121.388;Diphtheria Antitoxin;D004166
D08.811.913.400.725.115.220;Diphtheria Toxin;D004167
D23.946.123.305;Diphtheria Toxin;D004167
D20.215.894.691.263;Diphtheria Toxoid;D004168
C03.335.190.304;Diphyllobothriasis;D004169
B01.050.500.500.736.215.228;Diphyllobothrium;D004170
G05.700.264;Diploidy;D004171
C10.597.751.941.339;Diplopia;D004172
C11.966.339;Diplopia;D004172
C23.888.592.763.941.339;Diplopia;D004172
B01.050.150.900.649.865.510;Dipodomys;D004173
D03.132.577.249.250;Diprenorphine;D004174
D03.549.686.275;Diprenorphine;D004174
D03.605.497.280;Diprenorphine;D004174
D04.615.723.795.250;Diprenorphine;D004174
B01.050.500.131.617.289;Diptera;D004175
D03.383.742.175;Dipyridamole;D004176
D03.383.129.539.850.077.150;Dipyrone;D004177
D03.383.725.762.352;Diquat;D004178
D12.776.831.222;Cobra Cardiotoxin Proteins;D004179
D20.888.850.325.220.260;Cobra Cardiotoxin Proteins;D004179
D23.946.833.850.325.220.260;Cobra Cardiotoxin Proteins;D004179
N03.219.151.400.325;Direct Service Costs;D004180
N05.300.375.250;Direct Service Costs;D004180
L01.178.682.192.836.339;Directories as Topic;D004181
B01.050.500.500.294.700.750.700.300.230;Dirofilaria;D004182
B01.050.500.500.294.700.750.700.300.230.300;Dirofilaria immitis;D004183
C03.335.349.320;Dirofilariasis;D004184
C03.335.508.700.750.361.290;Dirofilariasis;D004184
C03.701.377.320;Dirofilariasis;D004184
C22.674.377.320;Dirofilariasis;D004184
E01.370.400;Disability Evaluation;D004185
D08.811.277.450.329;Disaccharidases;D004186
D09.698.629.305;Disaccharides;D004187
E04.555.080.250;Disarticulation;D004188
N06.230.100.035;Disaster Planning;D004189
N06.230.100;Disasters;D004190
F04;Behavioral Disciplines and Activities;D004191
F02.463.593.257;Discrimination (Psychology);D004192
F02.463.425.280;Discrimination Learning;D004193
C23.550.288;Disease;D004194
C22.232;Disease Models, Animal;D004195
E05.598.500;Disease Models, Animal;D004195
E05.599.395.080;Disease Models, Animal;D004195
N06.850.290;Disease Outbreaks;D004196
N06.850.295;Disease Reservoirs;D004197
C23.550.291.687;Disease Susceptibility;D004198
G07.100.250;Disease Susceptibility;D004198
N06.850.310.350;Disease Vectors;D004199
C23.550.291.750;Diseases in Twins;D004200
D27.505.954.122.425;Disinfectants;D004202
D27.720.274;Disinfectants;D004202
N06.850.780.200.450.850.375;Disinfection;D004203
C26.289;Dislocations;D004204
D03.438.150.266.300;Cromolyn Sodium;D004205
D03.830.219.266.300;Cromolyn Sodium;D004205
D03.383.725.227;Disopyramide;D004206
L01.178.682.192.836.390;Dispensatories;D004207
F01.393.246;Displacement (Psychology);D004208
E07.252;Disposable Equipment;D004209
E01.370.225.998.221;Dissection;D004210
E04.221;Dissection;D004210
E05.200.998.221;Dissection;D004210
C15.378.100.220;Disseminated Intravascular Coagulation;D004211
C15.378.463.250;Disseminated Intravascular Coagulation;D004211
C15.378.925.220;Disseminated Intravascular Coagulation;D004211
L01.178.682.389;Dissertations, Academic as Topic;D004212
F03.300;Dissociative Disorders;D004213
D12.644.140;Distamycins;D004214
F02.463.593.200.390;Distance Perception;D004215
F02.463.593.932.869.255.390;Distance Perception;D004215
C02.782.580.600.500.285;Distemper;D004216
C22.268.265;Distemper;D004216
B04.820.455.600.650.500.280;Distemper Virus, Canine;D004217
B04.909.777.455.600.650.500.280;Distemper Virus, Canine;D004217
Z01.107.567.875.500.210;District of Columbia;D004219
Z01.433.429;District of Columbia;D004219
D01.248.497.158.874.390;Disulfides;D004220
D01.875.350.850.150;Disulfides;D004220
D02.886.520.150;Disulfides;D004220
D02.241.081.251.869.220.250;Disulfiram;D004221
D02.886.520.150.175;Disulfiram;D004221
D02.886.706.200.200;Disulfiram;D004221
D02.705.400.625.230;Disulfoton;D004222
D02.705.539.345.230;Disulfoton;D004222
D02.886.300.692.230;Disulfoton;D004222
D02.455.849.291;Diterpenes;D004224
D02.886.675.188;Dithiazanine;D004225
D03.383.129.708.089.222;Dithiazanine;D004225
D03.438.185.222;Dithiazanine;D004225
D02.033.800.175;Dithioerythritol;D004226
D02.886.740.149;Dithioerythritol;D004226
D09.853.175;Dithioerythritol;D004226
D01.248.497.158.904.150;Dithionite;D004227
D01.875.750.200;Dithionite;D004227
D02.241.223.100.600.300;Dithionitrobenzoic Acid;D004228
D02.455.426.559.389.127.650.300;Dithionitrobenzoic Acid;D004228
D02.033.800.196;Dithiothreitol;D004229
D02.886.740.224;Dithiothreitol;D004229
D09.853.196;Dithiothreitol;D004229
D02.172.530;Dithizone;D004230
D02.442.726.200;Dithizone;D004230
G08.852.796.241;Diuresis;D004231
D27.505.696.560.500;Diuretics;D004232
D27.505.696.560.500.453;Diuretics, Osmotic;D004234
D02.948.684.397;Diuron;D004237
C01.539.463.298;Diverticulitis;D004238
C06.405.205.298;Diverticulitis;D004238
C06.405.469.158.587.500;Diverticulitis, Colonic;D004239
C23.300.415;Diverticulum;D004240
C23.300.415.500;Diverticulum, Colon;D004241
I03.450.642.845.869.110;Diving;D004242
N06.230.150.150;Diving;D004242
F01.829.263.315.500.300;Divorce;D004243
I01.240.361.500.300;Divorce;D004243
I01.880.225.423.500.300;Divorce;D004243
I01.880.735.255;Divorce;D004243
N01.224.361.500.300;Divorce;D004243
N01.824.308.500.300;Divorce;D004243
C10.597.751.237;Dizziness;D004244
C23.888.592.763.237;Dizziness;D004244
E05.318.308.250.300.350;DMF Index;D004245
E06.208.266;DMF Index;D004245
N05.715.360.300.375.300.340;DMF Index;D004245
N06.850.520.308.250.300.350;DMF Index;D004245
N06.890.160.100;DMF Index;D004245
D03.383.606.390;Dimethylphenylpiperazinium Iodide;D004246
D13.444.308;DNA;D004247
D08.811.913.555.500.350.100.500;DNA (Cytosine-5-)-Methyltransferase;D004248
G05.355.180;DNA Damage;D004249
D08.811.399.403.741;DNA Topoisomerases, Type II;D004250
D13.444.308.520;DNA Transposable Elements;D004251
G02.111.570.080.708.330.200;DNA Transposable Elements;D004251
G05.360.080.708.330.200;DNA Transposable Elements;D004251
G05.360.340.024.425.200;DNA Transposable Elements;D004251
E05.393.760.700.300;DNA Mutational Analysis;D004252
D08.811.913.696.445.308.325;DNA Nucleotidylexotransferase;D004253
D08.811.913.696.445.308;DNA Nucleotidyltransferases;D004254
D08.811.074.124;Deoxyribodipyrimidine Photo-Lyase;D004255
D08.811.520.224.187;Deoxyribodipyrimidine Photo-Lyase;D004255
D08.811.913.696.445.308.300.225;DNA Polymerase I;D004256
D08.811.913.696.445.308.300.230;DNA Polymerase II;D004257
D08.811.913.696.445.308.300.235;DNA Polymerase III;D004258
D08.811.913.696.445.308.300;DNA-Directed DNA Polymerase;D004259
G02.111.087.219;DNA Repair;D004260
G02.149.115.219;DNA Repair;D004260
G05.355.195;DNA Repair;D004260
G02.111.087.222;DNA Replication;D004261
G02.149.115.222;DNA Replication;D004261
G05.355.200;DNA Replication;D004261
D08.811.150.280;DNA Restriction Enzymes;D004262
D08.811.277.352.335.350.300;DNA Restriction Enzymes;D004262
D08.811.277.352.355.325.300;DNA Restriction Enzymes;D004262
B04.909.204.210;DNA Tumor Viruses;D004263
B04.909.574.204;DNA Tumor Viruses;D004263
D08.811.399.403.483;DNA Topoisomerases, Type I;D004264
D08.811.277.040.025.159;DNA Helicases;D004265
D08.811.399.340;DNA Helicases;D004265
C02.256;DNA Virus Infections;D004266
B04.280;DNA Viruses;D004267
B04.909.204;DNA Viruses;D004267
D12.776.260;DNA-Binding Proteins;D004268
D13.444.308.212;DNA, Bacterial;D004269
D13.444.308.283;DNA, Circular;D004270
G02.111.570.790.486.212;DNA, Circular;D004270
G05.360.580.156;DNA, Circular;D004270
D13.444.308.300;DNA, Fungal;D004271
D13.444.308.283.225;DNA, Mitochondrial;D004272
D13.444.308.425;DNA, Neoplasm;D004273
D13.444.308.460;DNA, Recombinant;D004274
D13.444.308.475;DNA, Ribosomal;D004275
D13.444.308.480;DNA, Satellite;D004276
G02.111.570.080.708.800.150;DNA, Satellite;D004276
G05.360.080.708.800.150;DNA, Satellite;D004276
G05.360.340.024.220.150;DNA, Satellite;D004276
G05.360.340.024.850.150;DNA, Satellite;D004276
D13.444.308.497;DNA, Single-Stranded;D004277
G02.111.570.790.486.437;DNA, Single-Stranded;D004277
G05.360.580.437;DNA, Single-Stranded;D004277
D13.444.308.283.250;DNA, Superhelical;D004278
G02.111.570.790.486.212.250;DNA, Superhelical;D004278
G05.360.580.156.250;DNA, Superhelical;D004278
D13.444.308.568;DNA, Viral;D004279
D02.092.311.220;Dobutamine;D004280
D02.092.471.683.410;Dobutamine;D004280
D10.212.302.380.410.210;Docosahexaenoic Acids;D004281
D10.251.355.337.250;Docosahexaenoic Acids;D004281
D10.627.430.450.375;Docosahexaenoic Acids;D004281
L01.453.245;Documentation;D004282
C22.268;Dog Diseases;D004283
B01.050.150.900.493.370.853.392;Dogfish;D004284
B01.050.150.900.649.147.153.200;Dogs;D004285
D02.033.415.230;Dolichol;D004286
D02.455.849.365;Dolichol;D004286
D10.289.230;Dolichol;D004286
D02.455.849.690.700.700.250;Dolichol Monophosphate Mannose;D004287
D09.894.680.700.250;Dolichol Monophosphate Mannose;D004287
D10.390.700.700.250;Dolichol Monophosphate Mannose;D004287
D02.033.415.230.250;Dolichol Phosphates;D004288
D02.455.849.365.250;Dolichol Phosphates;D004288
D02.455.849.690.250;Dolichol Phosphates;D004288
D02.705.400.725.200;Dolichol Phosphates;D004288
D10.289.230.250;Dolichol Phosphates;D004288
B01.050.150.900.649.189.267;Dolphins;D004289
D02.092.471.683.152.391;2,5-Dimethoxy-4-Methylamphetamine;D004290
F01.145.813.650.400;Dominance-Subordination;D004291
F02.830.297;Dominance, Cerebral;D004292
G11.561.225;Dominance, Cerebral;D004292
Z01.107.084.900.300;Dominican Republic;D004293
Z01.639.880.300;Dominican Republic;D004293
D03.383.621.210;Domperidone;D004294
D03.438.103.370;Domperidone;D004294
D02.092.311.200;Dihydroxyphenylalanine;D004295
D12.125.072.050.685.400;Dihydroxyphenylalanine;D004295
D12.125.072.050.875.130;Dihydroxyphenylalanine;D004295
D08.811.520.224.125.100.500;Dopa Decarboxylase;D004296
D02.092.211.215.311.342;Dopamine;D004298
D02.092.311.342;Dopamine;D004298
D08.811.682.690.708.292;Dopamine beta-Hydroxylase;D004299
I01.880.735.265;Doping in Sports;D004300
G01.595.210;Doppler Effect;D004301
A08.186.211.730.317.357.352.270;Dorsomedial Hypothalamic Nucleus;D004302
G05.355.315.203.249;Dosage Compensation, Genetic;D004303
D26.255;Dosage Forms;D004304
D27.720.280;Dosage Forms;D004304
E05.916.250;Dosage Forms;D004304
G07.690.220;Dose-Response Relationship, Drug;D004305
G12.300;Dose-Response Relationship, Immunologic;D004306
E05.799.513.500;Dose-Response Relationship, Radiation;D004307
G01.750.740.500;Dose-Response Relationship, Radiation;D004307
G04.299.680.500;Dose-Response Relationship, Radiation;D004307
G07.225;Dose-Response Relationship, Radiation;D004307
G07.700.760.500;Dose-Response Relationship, Radiation;D004307
N06.850.810.250.180;Dose-Response Relationship, Radiation;D004307
D02.886.680.350.250;Dothiepin;D004308
D03.494.311.250;Dothiepin;D004308
F01.829.131;Double Bind Interaction;D004309
C14.240.400.915.300;Double Outlet Right Ventricle;D004310
C14.280.400.915.300;Double Outlet Right Ventricle;D004310
C16.131.240.400.915.300;Double Outlet Right Ventricle;D004310
E05.318.780.300;Double-Blind Method;D004311
E05.581.500.300;Double-Blind Method;D004311
N05.715.360.780.320;Double-Blind Method;D004311
N06.850.520.445.300;Double-Blind Method;D004311
A01.923.047.025.600.225;Douglas' Pouch;D004312
C03.701.688.367;Dourine;D004313
C03.752.300.200;Dourine;D004313
C03.752.300.900.226;Dourine;D004313
C03.752.625.367;Dourine;D004313
C22.674.710.367;Dourine;D004313
C10.597.606.643.220;Down Syndrome;D004314
C16.131.077.327;Down Syndrome;D004314
C16.131.260.260;Down Syndrome;D004314
C16.320.180.260;Down Syndrome;D004314
D03.383.773.812.226;Doxapram;D004315
D02.355.291.852.500;Doxepin;D004316
D03.494.382.393;Doxepin;D004316
D02.455.426.559.847.562.050.200.175;Doxorubicin;D004317
D04.615.562.050.200.175;Doxorubicin;D004317
D09.408.051.059.200.175;Doxorubicin;D004317
D02.455.426.559.847.562.900.200;Doxycycline;D004318
D04.615.562.900.200;Doxycycline;D004318
D03.383.725.259;Doxylamine;D004319
C03.335.508.700.750.299;Dracunculiasis;D004320
C23.996.375;Dracunculiasis;D004320
B01.050.500.500.294.700.750.225.250.250;Dracunculus Nematode;D004321
E02.309;Drainage;D004322
E04.237;Drainage;D004322
N06.850.780.200.800.800.350;Drainage, Sanitary;D004323
K01.517.333;Drama;D004324
F02.463.188.634.309;Dreams;D004325
F02.830.855.268;Dreams;D004325
G07.610.593.260.249;Drinking;D004326
G07.700.620.260.249;Drinking;D004326
G10.261.326.240.249;Drinking;D004326
F01.145.317;Drinking Behavior;D004327
F01.658.293;Drive;D004328
D02.522.352.343;Droperidol;D004329
D03.438.103.393;Droperidol;D004329
B01.050.500.131.617.289.310.250;Drosophila;D004330
B01.050.500.131.617.289.310.250.500;Drosophila melanogaster;D004331
C23.550.260.393;Drowning;D004332
C26.304;Drowning;D004332
N06.850.135.696;Drowning;D004332
E02.319.267;Drug Administration Routes;D004333
E02.319.283;Drug Administration Schedule;D004334
I01.880.604.605.250;Drug and Narcotic Control;D004335
N03.706.615.402.250;Drug and Narcotic Control;D004335
N04.452.706.310;Drug and Narcotic Control;D004335
G07.690.812.240.310;Drug Antagonism;D004336
G07.700.680.240.310;Drug Antagonism;D004336
D26.255.260;Drug Carriers;D004337
D27.720.280.260;Drug Carriers;D004337
E02.319.300.380;Drug Carriers;D004337
D26.310;Drug Combinations;D004338
E05.916.270;Drug Compounding;D004339
N06.850.360;Drug Contamination;D004340
E05.337.425;Drug Evaluation;D004341
C20.543.206;Drug Hypersensitivity;D004342
D26.255.210.315;Drug Implants;D004343
D27.720.280.210.315;Drug Implants;D004343
E05.916.290;Drug Incompatibility;D004344
J01.576.318;Drug Industry;D004345
L01.453.270;Drug Information Services;D004346
N02.421.668.320;Drug Information Services;D004346
G07.690.812.240;Drug Interactions;D004347
G07.700.680.240;Drug Interactions;D004347
E05.916.310;Drug Labeling;D004348
J01.576.318.321.400;Drug Labeling;D004348
J01.576.761.300.400;Drug Labeling;D004348
E05.916.320;Drug Packaging;D004349
J01.576.318.321;Drug Packaging;D004349
J01.576.761.300;Drug Packaging;D004349
N06.850.460.200.250;Drug Residues;D004350
G07.690.320;Drug Resistance;D004351
G06.225;Drug Resistance, Microbial;D004352
G07.690.320.269;Drug Resistance, Microbial;D004352
E05.295.750;Drug Evaluation, Preclinical;D004353
E05.337.550;Drug Evaluation, Preclinical;D004353
E01.370.225.500.388;Drug Screening Assays, Antitumor;D004354
E05.200.500.388;Drug Screening Assays, Antitumor;D004354
E05.242.388;Drug Screening Assays, Antitumor;D004354
E05.337.550.200;Drug Screening Assays, Antitumor;D004354
E05.916.330;Drug Stability;D004355
E05.916.350;Drug Storage;D004356
G07.690.812.240.477;Drug Synergism;D004357
G07.700.680.240.477;Drug Synergism;D004357
E02.319;Drug Therapy;D004358
E02.319.310;Drug Therapy, Combination;D004359
E02.319.335;Drug Therapy, Computer-Assisted;D004360
L01.700.508.100.710.180;Drug Therapy, Computer-Assisted;D004360
G07.690.812.260;Drug Tolerance;D004361
G07.700.680.260;Drug Tolerance;D004361
C25.723.276;Drug Toxicity;D004362
N04.452.706.477;Drug Utilization;D004363
D26;Pharmaceutical Preparations;D004364
D20.215.784.500.350;Drugs, Chinese Herbal;D004365
D26.335;Drugs, Chinese Herbal;D004365
D26.530;Nonprescription Drugs;D004366
D01.200.200.250;Dry Ice;D004367
D01.650.550.200.250;Dry Ice;D004367
C07.465.227;Dry Socket;D004368
D02.092.782.590;Pentetic Acid;D004369
D02.241.081.018.639;Pentetic Acid;D004369
C10.292.562.250;Duane Retraction Syndrome;D004370
C11.270.235;Duane Retraction Syndrome;D004370
C11.590.224;Duane Retraction Syndrome;D004370
C16.320.290.235;Duane Retraction Syndrome;D004370
B04.450.416;Hepatitis Virus, Duck;D004371
B04.820.565.342;Hepatitis Virus, Duck;D004371
B04.909.777.618.342;Hepatitis Virus, Duck;D004371
B01.050.150.900.248.050.200;Ducks;D004372
B01.050.150.900.248.617.345;Ducks;D004372
A07.541.278.395;Ductus Arteriosus;D004373
A16.378.303.395;Ductus Arteriosus;D004373
C14.240.400.340;Ductus Arteriosus, Patent;D004374
C14.280.400.340;Ductus Arteriosus, Patent;D004374
C16.131.240.400.340;Ductus Arteriosus, Patent;D004374
D23.050.301.290.301;Duffy Blood-Group System;D004375
D23.050.705.230.301;Duffy Blood-Group System;D004375
D02.033.800.400;Galactitol;D004376
D09.853.400;Galactitol;D004376
C06.405.748.630.310;Dumping Syndrome;D004377
C23.550.767.812.500;Dumping Syndrome;D004377
C06.405.469.275;Duodenal Diseases;D004378
C04.588.274.476.411.445;Duodenal Neoplasms;D004379
C06.301.371.411.445;Duodenal Neoplasms;D004379
C06.405.249.411.445;Duodenal Neoplasms;D004379
C06.405.469.275.270;Duodenal Neoplasms;D004379
C06.405.469.491.445;Duodenal Neoplasms;D004379
C06.405.469.275.395;Duodenal Obstruction;D004380
C06.405.469.531.311;Duodenal Obstruction;D004380
C06.405.469.275.800.348;Duodenal Ulcer;D004381
C06.405.608.173;Duodenal Ulcer;D004381
C06.405.205.462.249;Duodenitis;D004382
C06.405.469.275.600;Duodenitis;D004382
C06.405.469.326.750;Duodenitis;D004382
C06.405.469.275.700;Duodenogastric Reflux;D004383
C06.405.748.240;Duodenogastric Reflux;D004383
E01.370.372.250.250.225;Duodenoscopy;D004384
E01.370.388.250.250.250.200;Duodenoscopy;D004384
E04.210.240.250.200;Duodenoscopy;D004384
E04.800.250.250.250.200;Duodenoscopy;D004384
E04.210.338.303;Duodenostomy;D004385
E04.579.338.303;Duodenostomy;D004385
A03.556.124.684.124;Duodenum;D004386
A03.556.875.249;Duodenum;D004386
C05.651.197.270;Dupuytren Contracture;D004387
C17.300.270;Dupuytren Contracture;D004387
A08.186.566.395;Dura Mater;D004388
E07.278;Durable Medical Equipment;D004389
D02.705.400.625.100;Chlorpyrifos;D004390
D02.705.539.345.100;Chlorpyrifos;D004390
D02.886.300.692.100;Chlorpyrifos;D004390
D20.633.222;Dust;D004391
C05.116.099.343;Dwarfism;D004392
C16.320.240;Dwarfism;D004392
C19.297;Dwarfism;D004392
C05.116.099.343.445;Dwarfism, Pituitary;D004393
C05.116.132.358;Dwarfism, Pituitary;D004393
C10.228.140.617.738.300.300;Dwarfism, Pituitary;D004393
C19.297.312;Dwarfism, Pituitary;D004393
C19.700.482.311;Dwarfism, Pituitary;D004393
D04.808.745.432.296;Dydrogesterone;D004394
E05.484.250;Dye Dilution Technique;D004395
D27.720.233;Coloring Agents;D004396
D27.720.470.330;Coloring Agents;D004396
D02.705.429.812.249;Fonofos;D004397
D02.705.539.692.249;Fonofos;D004397
D02.886.300.846.249;Fonofos;D004397
D08.811.277.040.025.193.249;Dyneins;D004398
D12.776.220.600.200;Dyneins;D004398
D12.644.400.575.180;Dynorphins;D004399
D12.644.468.180;Dynorphins;D004399
D12.776.641.650.575.180;Dynorphins;D004399
D03.438.759.758.824.751.250;Dyphylline;D004400
C10.597.606.150.500.800.150.200;Dysarthria;D004401
C23.888.592.604.150.500.800.150.200;Dysarthria;D004401
C10.114.750.137.250;Dysautonomia, Familial;D004402
C10.177.575.300;Dysautonomia, Familial;D004402
C10.314.750.600.250;Dysautonomia, Familial;D004402
C10.500.310.309;Dysautonomia, Familial;D004402
C10.574.500.496.250;Dysautonomia, Familial;D004402
C10.668.829.800.625.200;Dysautonomia, Familial;D004402
C10.668.829.800.750.450.250;Dysautonomia, Familial;D004402
C16.131.666.310.309;Dysautonomia, Familial;D004402
C16.320.400.415.309;Dysautonomia, Familial;D004402
C20.111.258.750.600.250;Dysautonomia, Familial;D004402
C06.405.205.331;Dysentery;D004403
C06.405.469.300;Dysentery;D004403
C03.432.396;Dysentery, Amebic;D004404
C03.752.049.328;Dysentery, Amebic;D004404
C06.405.205.331.312;Dysentery, Amebic;D004404
C06.405.469.300.312;Dysentery, Amebic;D004404
C06.405.469.452.396;Dysentery, Amebic;D004404
C01.252.400.310.229;Dysentery, Bacillary;D004405
C06.405.205.331.479;Dysentery, Bacillary;D004405
C06.405.469.300.479;Dysentery, Bacillary;D004405
C15.378.147.333;Dysgammaglobulinemia;D004406
C20.673.430;Dysgammaglobulinemia;D004406
C04.557.465.330.300;Dysgerminoma;D004407
C10.597.751.861.479;Dysgeusia;D004408
C23.888.592.763.861.479;Dysgeusia;D004408
C10.228.662.262.500;Dyskinesia, Drug-Induced;D004409
C10.720.312;Dyskinesia, Drug-Induced;D004409
C25.723.276.612;Dyskinesia, Drug-Induced;D004409
C25.723.705.200;Dyskinesia, Drug-Induced;D004409
C10.597.606.150.500.300;Dyslexia;D004410
C10.597.606.150.550.200;Dyslexia;D004410
C23.888.592.604.150.500.300;Dyslexia;D004410
C23.888.592.604.150.550.200;Dyslexia;D004410
F03.550.350.500.200;Dyslexia;D004410
F03.550.450.400;Dyslexia;D004410
C10.597.606.150.500.300.200;Dyslexia, Acquired;D004411
C10.597.606.150.550.200.500;Dyslexia, Acquired;D004411
C23.888.592.604.150.500.300.200;Dyslexia, Acquired;D004411
C23.888.592.604.150.550.200.500;Dyslexia, Acquired;D004411
F03.087.700;Dyslexia, Acquired;D004411
F03.550.350.500.200.500;Dyslexia, Acquired;D004411
F03.550.450.400.500;Dyslexia, Acquired;D004411
C23.550.568.750;Dysmenorrhea;D004412
C23.888.646.587.500;Dysmenorrhea;D004412
C05.116.099.370;Dysostoses;D004413
C12.294.644.242;Dyspareunia;D004414
C13.351.500.665.313;Dyspareunia;D004414
F03.800.800.199;Dyspareunia;D004414
C23.888.821.236;Dyspepsia;D004415
C04.557.665.560.260;Dysplastic Nevus Syndrome;D004416
C04.700.305;Dysplastic Nevus Syndrome;D004416
C16.320.700.305;Dysplastic Nevus Syndrome;D004416
C08.618.326;Dyspnea;D004417
C23.888.852.371;Dyspnea;D004417
C08.618.326.396;Dyspnea, Paroxysmal;D004418
C14.280.434.313;Dyspnea, Paroxysmal;D004418
C23.888.852.371.396;Dyspnea, Paroxysmal;D004418
D01.268.477.374;Dysprosium;D004419
D01.268.558.362.374;Dysprosium;D004419
D01.552.550.399.374;Dysprosium;D004419
C13.703.420.288;Dystocia;D004420
C10.597.350.300;Dystonia;D004421
C23.888.592.350.300;Dystonia;D004421
C10.228.140.079.357;Dystonia Musculorum Deformans;D004422
C10.228.662.300.200;Dystonia Musculorum Deformans;D004422
C10.574.500.393;Dystonia Musculorum Deformans;D004422
C16.320.400.330;Dystonia Musculorum Deformans;D004422
A01.456.313;Ear;D004423
A09.246;Ear;D004423
A09.246.272.396;Ear Canal;D004424
A02.165.257.250;Ear Cartilage;D004425
A09.246.272.549;Ear Cartilage;D004425
C09.218.271;Ear Deformities, Acquired;D004426
C09.218;Ear Diseases;D004427
C04.588.443.665.312;Ear Neoplasms;D004428
C09.218.334;Ear Neoplasms;D004428
C09.647.312;Ear Neoplasms;D004428
A09.246.397.247;Ear Ossicles;D004429
E07.700.250;Ear Protective Devices;D004430
J01.637.215.600.199;Ear Protective Devices;D004430
J01.637.708.250;Ear Protective Devices;D004430
A09.246.272;Ear, External;D004431
A09.246.397;Ear, Middle;D004432
C09.218.350;Earache;D004433
C23.888.646.386;Earache;D004433
E02.831.335;Early Ambulation;D004434
G07.610.593.260;Eating;D004435
G07.700.620.260;Eating;D004435
G10.261.326.240;Eating;D004435
C14.240.400.395;Ebstein Anomaly;D004437
C14.280.400.395;Ebstein Anomaly;D004437
C16.131.240.400.395;Ebstein Anomaly;D004437
C15.378.100.452;Ecchymosis;D004438
C23.550.414.625;Ecchymosis;D004438
C23.888.885.312;Ecchymosis;D004438
A10.336.899.480;Eccrine Glands;D004439
A17.815.830.480;Eccrine Glands;D004439
D04.808.247.222.265.165.500;Ecdysone;D004440
D06.472.445.573.271.500;Ecdysone;D004440
D04.808.247.222.265.165.750;Ecdysterone;D004441
D06.472.445.573.271.750;Ecdysterone;D004441
B01.050.150.900.649.627.300;Echidna;D004442
C03.335.190.396;Echinococcosis;D004443
C23.996.400;Echinococcosis;D004443
C03.335.190.396.314;Echinococcosis, Hepatic;D004444
C03.518.314;Echinococcosis, Hepatic;D004444
C06.552.664.272;Echinococcosis, Hepatic;D004444
C03.335.190.396.480;Echinococcosis, Pulmonary;D004445
C03.582.314;Echinococcosis, Pulmonary;D004445
C08.381.517.314;Echinococcosis, Pulmonary;D004445
C08.730.450.314;Echinococcosis, Pulmonary;D004445
B01.050.500.500.736.215.327;Echinococcus;D004446
B01.050.500.408;Echinodermata;D004447
D03.438.857.233;Echinomycin;D004448
D04.345.566.325;Echinomycin;D004448
D12.644.641.325;Echinomycin;D004448
B01.050.500.500.736.715.360.310;Echinostoma;D004449
B01.050.500.500.736.715.360;Echinostomatidae;D004450
C03.335.865.282;Echinostomiasis;D004451
E01.370.350.130.750;Echocardiography;D004452
E01.370.350.850.220;Echocardiography;D004452
E01.370.370.380.220;Echocardiography;D004452
E01.370.350.578.937.260;Echoencephalography;D004453
E01.370.350.700.560.260;Echoencephalography;D004453
E01.370.350.850.260;Echoencephalography;D004453
E01.370.376.537.750.260;Echoencephalography;D004453
E05.629.937.260;Echoencephalography;D004453
C10.597.606.150.500.800.300;Echolalia;D004454
C23.888.592.604.150.500.800.300;Echolalia;D004454
F01.145.113.055.400;Echolocation;D004455
D02.705.400.625.240;Echothiophate Iodide;D004456
D02.705.539.345.240;Echothiophate Iodide;D004456
D02.886.300.692.240;Echothiophate Iodide;D004456
C02.782.687.359.347;Echovirus Infections;D004457
B04.820.565.284.182.225;Echovirus 6, Human;D004458
B04.909.777.618.284.182.225;Echovirus 6, Human;D004458
B04.820.565.284.182.250;Echovirus 9;D004459
B04.909.777.618.284.182.250;Echovirus 9;D004459
C13.703.395.124;Eclampsia;D004461
H01.158.273.248;Ecology;D004463
H01.277.249;Ecology;D004463
D03.383.129.308.250;Econazole;D004464
N03.219.188;Economic Competition;D004465
I01.261;Economics;D004467
N03.219;Economics;D004467
N03.219.224;Economics, Dental;D004468
N03.219.262;Economics, Hospital;D004469
N03.219.300;Economics, Medical;D004470
N03.219.338;Economics, Nursing;D004471
N03;Health Care Economics and Organizations;D004472
C01.252.410.890.210;Ecthyma;D004473
C01.252.825.210;Ecthyma;D004473
C01.539.800.720.210;Ecthyma;D004473
C17.800.695.210;Ecthyma;D004473
C17.800.838.765.210;Ecthyma;D004473
C02.256.743.193;Ecthyma, Contagious;D004474
C22.836.259;Ecthyma, Contagious;D004474
A16.504.273;Ectoderm;D004475
C16.131.077.350;Ectodermal Dysplasia;D004476
C16.131.831.350;Ectodermal Dysplasia;D004476
C16.320.850.250;Ectodermal Dysplasia;D004476
C17.800.804.350;Ectodermal Dysplasia;D004476
C17.800.827.250;Ectodermal Dysplasia;D004476
G07.700.320.500.325.089;Ectogenesis;D004477
C03.858.211;Ectoparasitic Infestations;D004478
C11.250.300;Ectopia Lentis;D004479
C11.510.598.373;Ectopia Lentis;D004479
C16.131.384.405;Ectopia Lentis;D004479
C05.660.585.350;Ectromelia;D004480
C16.131.621.585.350;Ectromelia;D004480
B04.280.650.160.650.200;Ectromelia virus;D004481
B04.909.204.783.160.650.200;Ectromelia virus;D004481
C02.256.743.239;Ectromelia, Infectious;D004482
C22.795.239;Ectromelia, Infectious;D004482
C11.338.362;Ectropion;D004483
Z01.107.757.362;Ecuador;D004484
C17.800.174.620;Eczema;D004485
C17.800.815.620;Eczema;D004485
D12.644.146;Edeine;D004486
C23.888.277;Edema;D004487
C22.905.260;Edema Disease of Swine;D004488
C14.280.434.482;Edema, Cardiac;D004489
C23.888.277.197;Edema, Cardiac;D004489
B01.050.150.900.649.900;Xenarthra;D004490
D02.092.877.674.333;Edrophonium;D004491
D02.675.276.352;Edrophonium;D004491
D02.092.782.258.368.250;Edetic Acid;D004492
D02.241.081.018.253;Edetic Acid;D004492
I02;Education;D004493
N02.278.354.422.310;Education Department, Hospital;D004494
N04.452.442.422.310;Education Department, Hospital;D004494
F02.784.629.375;Education of Intellectually Disabled;D004495
I02.233.213.400;Education of Intellectually Disabled;D004495
I02.358.212;Education, Continuing;D004496
I02.358.274;Education, Dental;D004497
I02.358.212.249;Education, Dental, Continuing;D004498
I02.358.274.316;Education, Dental, Continuing;D004498
I02.358.274.482;Education, Dental, Graduate;D004499
I02.358.337.249;Education, Dental, Graduate;D004499
I02.358.337;Education, Graduate;D004500
I02.358.399;Education, Medical;D004501
I02.358.212.350;Education, Medical, Continuing;D004502
I02.358.399.250;Education, Medical, Continuing;D004502
I02.358.337.350;Education, Medical, Graduate;D004503
I02.358.399.350;Education, Medical, Graduate;D004503
I02.358.399.450;Education, Medical, Undergraduate;D004504
I02.233;Education, Nonprofessional;D004505
I02.358.462;Education, Nursing;D004506
I02.358.462.233;Education, Nursing, Associate;D004507
I02.358.462.316;Education, Nursing, Baccalaureate;D004508
I02.358.212.450;Education, Nursing, Continuing;D004509
I02.358.462.399;Education, Nursing, Continuing;D004509
I02.358.462.482;Education, Nursing, Diploma Programs;D004510
I02.358.337.450;Education, Nursing, Graduate;D004511
I02.358.462.565;Education, Nursing, Graduate;D004511
I02.358.525;Education, Pharmacy;D004512
I02.358.212.550;Education, Pharmacy, Continuing;D004513
I02.358.525.317;Education, Pharmacy, Continuing;D004513
I02.358.337.550;Education, Pharmacy, Graduate;D004514
I02.358.525.483;Education, Pharmacy, Graduate;D004514
I02.275;Education, Predental;D004515
I02.316;Education, Premedical;D004516
I02.358;Education, Professional;D004517
I02.358.212.590;Education, Professional, Retraining;D004518
I02.233.213;Education, Special;D004519
I02.358.588;Education, Veterinary;D004520
I02.399;Educational Measurement;D004521
N01.824.196;Educational Status;D004522
B01.050.150.900.493.338;Eels;D004524
A08.612.380;Efferent Pathways;D004525
F02.784.692.351;Efficiency;D004526
D12.776.290;Egg Proteins;D004527
A13.316;Egg Shell;D004528
J02.500.470.700;Egg White;D004529
A16.690.325;Egg Yolk;D004530
J02.500.470.800;Egg Yolk;D004530
J02.500.470;Eggs;D004531
F01.752.747.189;Ego;D004532
F02.739.794.206;Ego;D004532
D02.092.782.258.368.257;Egtazic Acid;D004533
D02.241.081.018.269;Egtazic Acid;D004533
Z01.058.266.317;Egypt;D004534
Z01.586.035.200;Egypt;D004534
Z01.586.500.300;Egypt;D004534
C14.907.454.240;Ehlers-Danlos Syndrome;D004535
C15.378.463.515.240;Ehlers-Danlos Syndrome;D004535
C16.131.831.428;Ehlers-Danlos Syndrome;D004535
C16.320.850.260;Ehlers-Danlos Syndrome;D004535
C17.300.200.310;Ehlers-Danlos Syndrome;D004535
C17.800.804.428;Ehlers-Danlos Syndrome;D004535
C17.800.827.260;Ehlers-Danlos Syndrome;D004535
B03.440.040.287;Ehrlichia;D004536
B03.660.050.020.287;Ehrlichia;D004536
D10.251.220;Eicosanoic Acids;D004537
F02.463.593.292;Eidetic Imagery;D004538
B01.043.075.189.250.250.250;Eimeria;D004539
D01.268.033.250;Einsteinium;D004540
D01.268.271.100.250;Einsteinium;D004540
D01.268.556.244;Einsteinium;D004540
D01.552.020.337;Einsteinium;D004540
D01.552.544.244;Einsteinium;D004540
C14.240.400.450;Eisenmenger Complex;D004541
C14.280.400.450;Eisenmenger Complex;D004541
C16.131.240.400.450;Eisenmenger Complex;D004541
G08.686.785.760.084;Ejaculation;D004542
A05.360.444.251;Ejaculatory Ducts;D004543
Z01.107.169.339;El Salvador;D004544
D20.888.850.325;Elapid Venoms;D004546
D23.946.833.850.325;Elapid Venoms;D004546
A10.165.400;Elastic Tissue;D004547
G01.374.590;Elasticity;D004548
D05.750.078.421;Elastin;D004549
D12.776.860.300.350;Elastin;D004549
A01.378.800.420;Elbow;D004550
A02.835.583.290;Elbow Joint;D004551
I01.198.240.856.350.390;Elder Abuse;D004552
I01.880.735.900.350.390;Elder Abuse;D004552
G01.358.500.249.277;Electric Conductivity;D004553
E02.342.287;Electric Countershock;D004554
B01.050.150.900.493.378;Electric Fish;D004555
C26.324;Electric Injuries;D004556
A13.332;Electric Organ;D004557
E05.723.402;Electric Stimulation;D004558
E07.305.245;Electric Wiring;D004559
G01.358.500.249;Electricity;D004560
E02.342.800;Transcutaneous Electric Nerve Stimulation;D004561
E02.779.468.800;Transcutaneous Electric Nerve Stimulation;D004561
E03.091.823;Transcutaneous Electric Nerve Stimulation;D004561
E01.370.370.380.240;Electrocardiography;D004562
E01.370.405.240;Electrocardiography;D004562
H01.181.529.307;Electrochemistry;D004563
E02.154.402;Electrocoagulation;D004564
E04.014.170.402;Electrocoagulation;D004564
F04.570.200.583;Electroconvulsive Therapy;D004565
F04.669.224.300;Electroconvulsive Therapy;D004565
E07.305.250;Electrodes;D004566
E07.305.250.319;Electrodes, Implanted;D004567
E07.695.202;Electrodes, Implanted;D004567
E01.370.405;Electrodiagnosis;D004568
E01.370.376.300;Electroencephalography;D004569
E01.370.405.245;Electroencephalography;D004569
E06.377;Electrogalvanism, Intraoral;D004570
E01.370.350.700.200;Electrokymography;D004571
E01.370.405.250;Electrokymography;D004571
E01.370.475.200;Electrokymography;D004571
E05.301.250;Electrolysis;D004572
D01.248;Electrolytes;D004573
G01.358.500.260;Electromagnetic Fields;D004574
G01.358.750.500;Electromagnetic Fields;D004574
E01.370.405.255;Electromyography;D004576
E01.370.530.255;Electromyography;D004576
E01.370.350.515.402.250;Electron Probe Microanalysis;D004577
E05.196.867.800.360;Electron Probe Microanalysis;D004577
E05.595.402.250;Electron Probe Microanalysis;D004577
E05.799.830.360;Electron Probe Microanalysis;D004577
E05.196.867.519.274;Electron Spin Resonance Spectroscopy;D004578
G02.111.087.240;Electron Transport;D004579
G02.149.115.240;Electron Transport;D004579
G03.495.335.531.403;Electron Transport;D004579
G03.495.553.350;Electron Transport;D004579
E03.340;Electronarcosis;D004580
H01.671.293;Electronics;D004581
H01.671.293.319;Electronics, Medical;D004582
G01.249.335;Electrons;D004583
G01.358.500.750;Electrons;D004583
E01.370.380.230.280;Electronystagmography;D004584
E01.370.382.900.280;Electronystagmography;D004584
E01.370.405.260;Electronystagmography;D004584
E01.370.380.230.285;Electrooculography;D004585
E01.370.405.265;Electrooculography;D004585
E05.196.401;Electrophoresis;D004586
E05.301.300;Electrophoresis;D004586
E05.196.401.153;Electrophoresis, Agar Gel;D004587
E05.301.300.100;Electrophoresis, Agar Gel;D004587
E05.196.401.200;Electrophoresis, Cellulose Acetate;D004588
E05.301.300.200;Electrophoresis, Cellulose Acetate;D004588
E05.196.401.402.236;Electrophoresis, Disc;D004589
E05.301.300.319.403;Electrophoresis, Disc;D004589
E05.196.401.319;Electrophoresis, Paper;D004590
E05.301.300.236;Electrophoresis, Paper;D004590
E05.196.401.402;Electrophoresis, Polyacrylamide Gel;D004591
E05.301.300.319;Electrophoresis, Polyacrylamide Gel;D004591
E05.196.401.485;Electrophoresis, Starch Gel;D004592
E05.301.300.402;Electrophoresis, Starch Gel;D004592
B01.050.150.900.493.378.430.250;Electrophorus;D004593
H01.158.344.528;Electrophysiology;D004594
H01.158.782.236;Electrophysiology;D004594
E05.301.250.348;Electroplating;D004595
E01.370.380.225;Electroretinography;D004596
E01.370.405.270;Electroretinography;D004596
E05.723.402.403;Electroshock;D004597
F04.669.224;Electroshock;D004597
E04.262;Electrosurgery;D004598
E02.342;Electric Stimulation Therapy;D004599
E02.779.468;Electric Stimulation Therapy;D004599
D12.644.276.812.900.354;Eledoisin;D004600
D12.644.400.800.354;Eledoisin;D004600
D12.644.456.800.354;Eledoisin;D004600
D12.776.467.812.900.354;Eledoisin;D004600
D12.776.641.650.800.354;Eledoisin;D004600
D20.888.590.325;Eledoisin;D004600
D23.469.050.375.850.275;Eledoisin;D004600
D23.529.812.900.354;Eledoisin;D004600
D23.946.580.590.325;Eledoisin;D004600
D23.946.833.590.325;Eledoisin;D004600
G01.249;Elementary Particles;D004601
D01.268;Elements;D004602
D01.268.271;Elements, Radioactive;D004603
C15.604.496.320;Elephantiasis;D004604
C23.996.450;Elephantiasis;D004604
C03.335.508.700.750.361.350;Elephantiasis, Filarial;D004605
C15.604.496.320.350;Elephantiasis, Filarial;D004605
C23.996.450.460;Elephantiasis, Filarial;D004605
C23.996.475;Elephantiasis, Filarial;D004605
B01.050.150.900.649.833.249;Elephants;D004606
J01.086.339.115;Elevators and Escalators;D004607
N04.452.264;Eligibility Determination;D004608
F01.145.113.367;Eliminative Behavior, Animal;D004609
D03.438.150.500;Ellagic Acid;D004610
D03.830.219.500;Ellagic Acid;D004610
D03.132.436.681.333;Ellipticines;D004611
D03.438.473.144.249;Ellipticines;D004611
D03.438.473.402.681.333;Ellipticines;D004611
D03.494.148.249;Ellipticines;D004611
C15.378.071.141.150.365;Elliptocytosis, Hereditary;D004612
C16.320.070.365;Elliptocytosis, Hereditary;D004612
C05.116.099.708.327;Ellis-Van Creveld Syndrome;D004613
C16.131.077.350.398;Ellis-Van Creveld Syndrome;D004613
C16.131.831.350.398;Ellis-Van Creveld Syndrome;D004613
C16.320.850.250.398;Ellis-Van Creveld Syndrome;D004613
C17.800.804.350.398;Ellis-Van Creveld Syndrome;D004613
C17.800.827.250.398;Ellis-Van Creveld Syndrome;D004613
C23.888.144.243.963.500;Emaciation;D004614
I01.076.201.450.550.250;Embalming;D004615
K01.400.255;Emblems and Insignia;D004616
C14.907.355.350;Embolism;D004617
C14.907.355.350.254;Embolism, Air;D004618
C13.703.634.404;Embolism, Amniotic Fluid;D004619
C14.583.404;Embolism, Amniotic Fluid;D004619
C14.907.355.350.354;Embolism, Amniotic Fluid;D004619
C14.907.355.350.454;Embolism, Fat;D004620
E02.520.360;Embolization, Therapeutic;D004621
E02.926.500;Embolization, Therapeutic;D004621
A16.254;Embryo, Mammalian;D004622
E02.875.800.500;Embryo Transfer;D004624
E05.820.800.500;Embryo Transfer;D004624
A13.350;Embryo, Nonmammalian;D004625
A16.331;Embryo, Nonmammalian;D004625
H01.158.100.529;Embryology;D004626
H01.158.273.200.350;Embryology;D004626
G04.299.122.300;Embryonic Induction;D004627
G04.299.151.300;Embryonic Induction;D004627
G07.700.320.500.100.250;Embryonic Induction;D004627
G07.700.320.500.325.180.750;Embryonic Induction;D004627
G08.686.785.760.170.104.750;Embryonic Induction;D004627
A16;Embryonic Structures;D004628
D02.092.877.370;Emepronium;D004629
D02.675.276.370;Emepronium;D004629
C23.550.291.781;Emergencies;D004630
N06.230.100.083;Emergencies;D004630
N06.850.376;Emergencies;D004630
N02.421.297.058;Emergency Medical Service Communication Systems;D004631
N02.421.297;Emergency Medical Services;D004632
E07.315;Emergency Medical Tags;D004633
M01.526.373.250;Emergency Medical Technicians;D004634
M01.526.485.067.150;Emergency Medical Technicians;D004634
N02.360.067.150;Emergency Medical Technicians;D004634
H02.403.250;Emergency Medicine;D004635
N02.278.354.422.336;Emergency Service, Hospital;D004636
N02.421.297.195;Emergency Service, Hospital;D004636
N04.452.442.422.336;Emergency Service, Hospital;D004636
F04.408.525;Emergency Services, Psychiatric;D004637
N02.421.297.200;Emergency Services, Psychiatric;D004637
E02.365;Emergency Treatment;D004638
D27.505.696.329;Emetics;D004639
D27.505.696.663.050.225;Emetics;D004639
D27.505.954.427.270;Emetics;D004639
D27.505.954.483.560;Emetics;D004639
D03.132.316;Emetine;D004640
D03.438.531.321;Emetine;D004640
I01.240.600.525.500;Emigration and Immigration;D004641
N01.224.625.525.500;Emigration and Immigration;D004641
N06.850.505.400.700.525.500;Emigration and Immigration;D004641
D02.455.426.559.847.117.159.205.400;Emodin;D004642
D02.806.100.205.400;Emodin;D004642
D04.615.117.159.205.400;Emodin;D004642
D27.505.954.444.200;Emollients;D004643
F01.470;Emotions;D004644
F01.752.355;Empathy;D004645
F01.752.543.500.500;Empathy;D004645
C23.550.325;Emphysema;D004646
N04.452.677.358;Employee Discipline;D004647
N04.452.677.362;Employee Grievances;D004648
N04.452.677.368;Employee Incentive Plans;D004649
N04.452.677.370;Employee Performance Appraisal;D004650
N01.824.245;Employment;D004651
C10.228.140.617.738.200;Empty Sella Syndrome;D004652
C19.700.320;Empty Sella Syndrome;D004652
C01.539.830.305;Empyema;D004653
C23.550.470.756.305;Empyema;D004653
C01.252.410.040.552.846.877.405;Empyema, Tuberculous;D004654
C01.539.739.484.320;Empyema, Tuberculous;D004654
C01.539.830.305.310.320;Empyema, Tuberculous;D004654
C08.528.240.320;Empyema, Tuberculous;D004654
C08.528.928.405;Empyema, Tuberculous;D004654
C08.730.265.320;Empyema, Tuberculous;D004654
C08.730.912.405;Empyema, Tuberculous;D004654
D20.280.260;Emulsions;D004655
D26.255.165.260;Emulsions;D004655
D12.644.456.345.360;Enalapril;D004656
A14.549.167.900.720.265;Enamel Organ;D004658
D02.241.081.069.366.350;Enbucrilate;D004659
D02.626.290.350;Enbucrilate;D004659
D05.750.259.341;Enbucrilate;D004659
D25.720.259.341;Enbucrilate;D004659
D25.919.367.341;Enbucrilate;D004659
J01.637.051.720.259.341;Enbucrilate;D004659
J01.637.051.919.367.341;Enbucrilate;D004659
C02.182.500;Encephalitis;D004660
C10.228.140.430;Encephalitis;D004660
C10.228.228.210.150;Encephalitis;D004660
C10.228.228.245;Encephalitis;D004660
B04.820.850.054.320;Encephalitis Virus, Eastern Equine;D004663
B04.909.777.270.150;Encephalitis Virus, Eastern Equine;D004663
B04.909.777.923.054.320;Encephalitis Virus, Eastern Equine;D004663
B04.820.250.350.300.227;Encephalitis Virus, Japanese;D004664
B04.909.777.270.475.227;Encephalitis Virus, Japanese;D004664
B04.909.777.310.350.300.227;Encephalitis Virus, Japanese;D004664
B04.820.250.350.300.330;Encephalitis Virus, St. Louis;D004665
B04.909.777.270.475.330;Encephalitis Virus, St. Louis;D004665
B04.909.777.310.350.300.330;Encephalitis Virus, St. Louis;D004665
B04.820.850.054.340;Encephalitis Virus, Venezuelan Equine;D004666
B04.909.777.270.369;Encephalitis Virus, Venezuelan Equine;D004666
B04.909.777.923.054.340;Encephalitis Virus, Venezuelan Equine;D004666
B04.820.850.054.360;Encephalitis Virus, Western Equine;D004667
B04.909.777.270.440;Encephalitis Virus, Western Equine;D004667
B04.909.777.923.054.360;Encephalitis Virus, Western Equine;D004667
B04.909.777.270;Encephalitis Viruses;D004668
B04.820.250.350.350;Encephalitis Viruses, Tick-Borne;D004669
B04.909.777.270.511;Encephalitis Viruses, Tick-Borne;D004669
B04.909.777.310.350.350;Encephalitis Viruses, Tick-Borne;D004669
C02.081.343.340;Encephalitis, California;D004670
C02.182.500.300.300.200;Encephalitis, California;D004670
C02.290.310.140;Encephalitis, California;D004670
C02.782.147.340;Encephalitis, California;D004670
C02.782.310.340;Encephalitis, California;D004670
C10.228.228.210.150.300.300.200;Encephalitis, California;D004670
C10.228.228.245.340.310.140;Encephalitis, California;D004670
C02.081.343;Encephalitis, Arbovirus;D004671
C02.182.500.300.300;Encephalitis, Arbovirus;D004671
C02.290.310;Encephalitis, Arbovirus;D004671
C02.782.310;Encephalitis, Arbovirus;D004671
C10.228.228.210.150.300.300;Encephalitis, Arbovirus;D004671
C10.228.228.245.340.310;Encephalitis, Arbovirus;D004671
C02.081.343.345;Encephalitis, Japanese;D004672
C02.182.500.300.300.250;Encephalitis, Japanese;D004672
C02.290.310.280;Encephalitis, Japanese;D004672
C02.782.310.345;Encephalitis, Japanese;D004672
C02.782.350.250.300;Encephalitis, Japanese;D004672
C10.228.228.210.150.300.300.400;Encephalitis, Japanese;D004672
C10.228.228.245.340.310.280;Encephalitis, Japanese;D004672
C10.114.375.225;Encephalomyelitis, Acute Disseminated;D004673
C10.228.140.695.562.225;Encephalomyelitis, Acute Disseminated;D004673
C10.228.518.562.225;Encephalomyelitis, Acute Disseminated;D004673
C10.314.350.225;Encephalomyelitis, Acute Disseminated;D004673
C20.111.258.250.350;Encephalomyelitis, Acute Disseminated;D004673
C02.081.343.350;Encephalitis, St. Louis;D004674
C02.182.500.300.300.300;Encephalitis, St. Louis;D004674
C02.290.310.406;Encephalitis, St. Louis;D004674
C02.782.310.350;Encephalitis, St. Louis;D004674
C02.782.350.250.450;Encephalitis, St. Louis;D004674
C10.228.228.210.150.300.300.550;Encephalitis, St. Louis;D004674
C10.228.228.245.340.310.406;Encephalitis, St. Louis;D004674
C02.081.343.360;Encephalitis, Tick-Borne;D004675
C02.081.885.400;Encephalitis, Tick-Borne;D004675
C02.182.500.300.300.350;Encephalitis, Tick-Borne;D004675
C02.290.310.530;Encephalitis, Tick-Borne;D004675
C02.782.310.360;Encephalitis, Tick-Borne;D004675
C02.782.350.250.500;Encephalitis, Tick-Borne;D004675
C10.228.228.210.150.300.300.775;Encephalitis, Tick-Borne;D004675
C10.228.228.245.340.310.500;Encephalitis, Tick-Borne;D004675
D12.776.543.620.540;Myelin Basic Protein;D004676
D12.776.641.580.510;Myelin Basic Protein;D004676
C10.500.680.488;Encephalocele;D004677
C16.131.666.680.488;Encephalocele;D004677
C23.300.707.186;Encephalocele;D004677
C10.228.140.461;Encephalomalacia;D004678
C10.228.140.430.500;Encephalomyelitis;D004679
C10.228.228.291;Encephalomyelitis;D004679
C10.228.440;Encephalomyelitis;D004679
B04.820.565.170.200.480;Maus Elberfeld virus;D004680
B04.909.777.618.170.200.480;Maus Elberfeld virus;D004680
C10.114.703.300;Encephalomyelitis, Autoimmune, Experimental;D004681
C10.228.140.695.562.250;Encephalomyelitis, Autoimmune, Experimental;D004681
C10.228.518.562.250;Encephalomyelitis, Autoimmune, Experimental;D004681
C10.314.350.250;Encephalomyelitis, Autoimmune, Experimental;D004681
C20.111.258.625.300;Encephalomyelitis, Autoimmune, Experimental;D004681
E05.598.500.500.500;Encephalomyelitis, Autoimmune, Experimental;D004681
C02.782.687.359.456;Encephalomyelitis, Enzootic Porcine;D004682
C22.905.323;Encephalomyelitis, Enzootic Porcine;D004682
C02.081.355;Encephalomyelitis, Equine;D004683
C02.182.500.300.450;Encephalomyelitis, Equine;D004683
C02.290.450;Encephalomyelitis, Equine;D004683
C02.782.930.100.370;Encephalomyelitis, Equine;D004683
C10.228.228.210.150.300.450;Encephalomyelitis, Equine;D004683
C10.228.228.245.340.450;Encephalomyelitis, Equine;D004683
C10.228.228.291.323;Encephalomyelitis, Equine;D004683
C10.228.440.406;Encephalomyelitis, Equine;D004683
C10.114.375.362;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.114.562;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.228.140.695.562.375;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.228.228.245.670;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.228.440.650;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.228.518.562.375;Leukoencephalitis, Acute Hemorrhagic;D004684
C10.314.350.375;Leukoencephalitis, Acute Hemorrhagic;D004684
C20.111.258.250.425;Leukoencephalitis, Acute Hemorrhagic;D004684
C20.111.258.450;Leukoencephalitis, Acute Hemorrhagic;D004684
C02.081.355.355;Encephalomyelitis, Venezuelan Equine;D004685
C02.182.500.300.450.250;Encephalomyelitis, Venezuelan Equine;D004685
C02.290.450.225;Encephalomyelitis, Venezuelan Equine;D004685
C02.782.930.100.370.325;Encephalomyelitis, Venezuelan Equine;D004685
C10.228.228.210.150.300.450.600;Encephalomyelitis, Venezuelan Equine;D004685
C10.228.228.245.340.450.225;Encephalomyelitis, Venezuelan Equine;D004685
C10.228.228.291.323.325;Encephalomyelitis, Venezuelan Equine;D004685
C10.228.440.406.225;Encephalomyelitis, Venezuelan Equine;D004685
B04.820.565.170.200;Encephalomyocarditis virus;D004686
B04.909.777.618.170.200;Encephalomyocarditis virus;D004686
C05.116.099.708.338;Enchondromatosis;D004687
C23.888.821.266;Encopresis;D004688
F01.145.126.837;Encopresis;D004688
F03.550.375.300;Encopresis;D004688
L01.178.682.192.836.456;Encyclopedias as Topic;D004690
E04.100.814.456;Endarterectomy;D004691
C14.907.184.281;Endarteritis;D004692
C14.907.940.090.340;Endarteritis;D004692
D08.811.277.450.420.200.600;Glucan Endo-1,3-beta-D-Glucosidase;D004693
C14.240.400.560.350;Endocardial Cushion Defects;D004694
C14.280.400.560.350;Endocardial Cushion Defects;D004694
C16.131.240.400.560.350;Endocardial Cushion Defects;D004694
C14.280.238.281;Endocardial Fibroelastosis;D004695
C14.280.282;Endocarditis;D004696
C01.252.300;Endocarditis, Bacterial;D004697
C01.539.190.249;Endocarditis, Bacterial;D004697
C14.260.249;Endocarditis, Bacterial;D004697
C14.280.282.407;Endocarditis, Bacterial;D004697
C01.252.300.407;Endocarditis, Subacute Bacterial;D004698
C01.252.410.890.240;Endocarditis, Subacute Bacterial;D004698
C01.539.190.249.407;Endocarditis, Subacute Bacterial;D004698
C14.260.249.407;Endocarditis, Subacute Bacterial;D004698
C14.280.282.407.407;Endocarditis, Subacute Bacterial;D004698
A07.541.207;Endocardium;D004699
C19;Endocrine System Diseases;D004700
C04.588.322;Endocrine Gland Neoplasms;D004701
C19.344;Endocrine Gland Neoplasms;D004701
A06.407;Endocrine Glands;D004702
A06;Endocrine System;D004703
H01.158.782.323;Endocrinology;D004704
H02.403.429.323;Endocrinology;D004704
G04.299.482;Endocytosis;D004705
D08.811.277.352.335.350;Endodeoxyribonucleases;D004706
D08.811.277.352.355.325;Endodeoxyribonucleases;D004706
A16.504.407;Endoderm;D004707
E06.397;Endodontics;D004708
H02.163.876.213;Endodontics;D004708
B01.046.500.100.700.325;Endolimax;D004709
A12.207.270.517.324;Endolymph;D004710
A09.246.631.909.957.360;Endolymphatic Duct;D004711
A09.246.631.909.957.360.701;Endolymphatic Sac;D004712
E04.035.335;Endolymphatic Shunt;D004713
E04.580.450.230;Endolymphatic Shunt;D004713
C13.351.500.852.228;Endometrial Hyperplasia;D004714
C13.351.500.163;Endometriosis;D004715
C13.351.500.056.750.249;Endometritis;D004716
C13.351.500.852.299;Endometritis;D004716
A05.360.319.679.490;Endometrium;D004717
B01.300.107.795;Saccharomycetales;D004718
C14.280.238.406;Endomyocardial Fibrosis;D004719
D08.811.277.352.355;Endonucleases;D004720
A11.284.430.214.190.875.248;Endoplasmic Reticulum;D004721
D08.811.277.352.355.350;Endoribonucleases;D004722
D08.811.277.352.700.350;Endoribonucleases;D004722
D12.644.400.575.241;Endorphins;D004723
D12.644.468.241;Endorphins;D004723
D12.776.641.650.575.241;Endorphins;D004723
E01.370.388.250;Endoscopy;D004724
E04.800.250;Endoscopy;D004724
B03.300;Endospore-Forming Bacteria;D004725
D02.886.092.408;Endosulfan;D004726
D03.438.197.408;Endosulfan;D004726
A10.272.491;Endothelium;D004727
A09.371.060.067.318;Endothelium, Corneal;D004728
A09.371.060.217.318;Endothelium, Corneal;D004728
A10.272.491.318;Endothelium, Corneal;D004728
A10.272.491.332;Endothelium, Lymphatic;D004729
A15.382.520.301.500;Endothelium, Lymphatic;D004729
A07.231.330;Endothelium, Vascular;D004730
A10.272.491.355;Endothelium, Vascular;D004730
D23.946.123.329;Endotoxins;D004731
D02.455.526.439.416;Endrin;D004732
E02.319.347;Enema;D004733
G03.495.335;Energy Metabolism;D004734
G01.154.100.240;Energy Transfer;D004735
G01.595.100.240;Energy Transfer;D004735
G02.111.087.242;Energy Transfer;D004735
G02.149.115.242;Energy Transfer;D004735
G02.149.767.580;Energy Transfer;D004735
G02.842.750.580;Energy Transfer;D004735
N06.230.132;Energy-Generating Resources;D004736
D02.355.601.400;Enflurane;D004737
J01.293;Engineering;D004738
Z01.542.363.300;England;D004739
Z01.639.280.300;England;D004739
V01.260;English Abstract;D004740
K01.093.346;Engraving and Engravings;D004741
G02.111.570.080.689.330;Enhancer Elements, Genetic;D004742
G05.360.080.689.330;Enhancer Elements, Genetic;D004742
G05.360.340.024.340.137.750.249;Enhancer Elements, Genetic;D004742
D12.644.400.575.281.231;Enkephalin, Leucine;D004743
D12.644.468.281.231;Enkephalin, Leucine;D004743
D12.776.641.650.575.281.231;Enkephalin, Leucine;D004743
D12.644.400.575.281.381;Enkephalin, Methionine;D004744
D12.644.468.281.381;Enkephalin, Methionine;D004744
D12.776.641.650.575.281.381;Enkephalin, Methionine;D004744
D12.644.400.575.281;Enkephalins;D004745
D12.644.468.281;Enkephalins;D004745
D12.776.641.650.575.281;Enkephalins;D004745
D08.811.520.241.300.250;Enoyl-CoA Hydratase;D004746
B01.046.500.100.700.335;Entamoeba;D004747
B01.046.500.100.700.335.330;Entamoeba histolytica;D004748
C03.752.049.407;Entamoebiasis;D004749
E02.421.360;Enteral Nutrition;D004750
E02.642.500.360;Enteral Nutrition;D004750
C06.405.205.462;Enteritis;D004751
C06.405.469.326;Enteritis;D004751
B04.820.504.540.150.300;Coronavirus, Turkey;D004752
B04.909.777.500.540.150.300;Coronavirus, Turkey;D004752
C02.782.600.550.200.325;Enteritis, Transmissible, of Turkeys;D004753
C22.131.728.250;Enteritis, Transmissible, of Turkeys;D004753
B03.440.450.425.275;Enterobacter;D004754
B03.660.250.150.170;Enterobacter;D004754
B03.440.450.425;Enterobacteriaceae;D004755
B03.660.250.150;Enterobacteriaceae;D004755
C01.252.400.310;Enterobacteriaceae Infections;D004756
B01.050.500.500.294.700.500.500.308;Enterobius;D004757
D04.345.566.352;Enterobactin;D004758
D12.125.837.300;Enterobactin;D004758
D12.644.641.352;Enterobactin;D004758
A03.556.875.875.440.250;Enterochromaffin Cells;D004759
A06.224.358;Enterochromaffin Cells;D004759
A06.390.021;Enterochromaffin Cells;D004759
A10.615.550.291.162;Enterochromaffin Cells;D004759
A11.382.625.031;Enterochromaffin Cells;D004759
A11.436.294.031;Enterochromaffin Cells;D004759
A15.382.250;Enterochromaffin Cells;D004759
C06.405.205.596;Enterocolitis;D004760
C06.405.469.363;Enterocolitis;D004760
C01.252.410.222.310;Enterocolitis, Pseudomembranous;D004761
C06.405.205.596.800;Enterocolitis, Pseudomembranous;D004761
C06.405.469.363.800;Enterocolitis, Pseudomembranous;D004761
D06.472.317.469.500;Glucagon-Like Peptides;D004763
G03.495.355;Enterohepatic Circulation;D004764
D08.811.277.656.300.760.284;Enteropeptidase;D004765
D08.811.277.656.959.350.284;Enteropeptidase;D004765
E04.210.338;Enterostomy;D004766
E04.579.338;Enterostomy;D004766
C01.252.410.222.325;Enterotoxemia;D004767
C22.313;Enterotoxemia;D004767
D23.946.330;Enterotoxins;D004768
C02.782.687.359;Enterovirus Infections;D004769
B04.820.565.284;Enterovirus;D004770
B04.909.777.618.284;Enterovirus;D004770
B04.820.565.284.550;Enteroviruses, Porcine;D004771
B04.909.777.618.284.600;Enteroviruses, Porcine;D004771
H01.158.273.943.409;Entomology;D004772
B01.300.300.300.300;Entomophthora;D004773
C11.338.443;Entropion;D004774
C12.777.934.284;Enuresis;D004775
C13.351.968.934.252;Enuresis;D004775
F01.145.126.856;Enuresis;D004775
F03.550.375.400;Enuresis;D004775
D04.345.566.875.250;Enviomycin;D004776
D12.644.641.875.250;Enviomycin;D004776
G16.500.275;Environment;D004777
N06.230;Environment;D004777
N06;Environment and Public Health;D004778
I01.283;Environment Design;D004779
I01.880.709.359;Environment Design;D004779
N06.230.200;Environment Design;D004779
N06.230.150;Environment, Controlled;D004780
N06.850.460.350;Environmental Exposure;D004781
H02.229;Environmental Health;D004782
H01.158.273.540.274;Environmental Microbiology;D004783
N06.850.425;Environmental Microbiology;D004783
N06.850.460.350.080;Environmental Monitoring;D004784
N06.850.780.375;Environmental Monitoring;D004784
D27.888.284;Environmental Pollutants;D004785
D27.888;Toxic Actions;D004786
N06.850.460;Environmental Pollution;D004787
G02.111.087.245;Enzyme Activation;D004789
G02.149.115.245;Enzyme Activation;D004789
G03.495.368;Enzyme Activation;D004789
G05.355.315.320.200;Enzyme Induction;D004790
D27.505.519.389;Enzyme Inhibitors;D004791
D08.622;Enzyme Precursors;D004792
D27.505.519.405;Enzyme Reactivators;D004793
G05.355.315.320.300;Enzyme Repression;D004794
E05.916.360;Enzyme Stability;D004795
G02.111.700.500;Enzyme Stability;D004795
E01.370.225.124.200;Clinical Enzyme Tests;D004796
E05.196.427.200;Clinical Enzyme Tests;D004796
E05.200.124.200;Clinical Enzyme Tests;D004796
E05.478.566.350.170;Enzyme-Linked Immunosorbent Assay;D004797
E05.478.566.380.360;Enzyme-Linked Immunosorbent Assay;D004797
E05.478.583.400.170;Enzyme-Linked Immunosorbent Assay;D004797
E05.601.495.350.170;Enzyme-Linked Immunosorbent Assay;D004797
E05.601.495.380.360;Enzyme-Linked Immunosorbent Assay;D004797
D08.811;Enzymes;D004798
D08.811.180;Enzymes, Immobilized;D004800
D12.776.463.500;Enzymes, Immobilized;D004800
D02.455.426.559.847.885.347.325;Eosine Yellowish-(YS);D004801
D03.494.953.275.325;Eosine Yellowish-(YS);D004801
D04.615.885.347.325;Eosine Yellowish-(YS);D004801
C15.378.553.231;Eosinophilia;D004802
C05.116.391;Eosinophilic Granuloma;D004803
C08.381.483.375.500;Eosinophilic Granuloma;D004803
C15.378.553.231.348;Eosinophilic Granuloma;D004803
C15.604.250.400.360;Eosinophilic Granuloma;D004803
C23.550.382.250;Eosinophilic Granuloma;D004803
A11.118.637.415.345;Eosinophils;D004804
A11.627.340.345;Eosinophils;D004804
A15.145.229.637.415.345;Eosinophils;D004804
A15.382.490.315.251;Eosinophils;D004804
A08.186.211.276.460;Ependyma;D004805
A08.561.326;Ependyma;D004805
A10.755.260;Ependyma;D004805
C04.557.465.625.600.380.290;Ependymoma;D004806
C04.557.470.670.380.290;Ependymoma;D004806
C04.557.580.625.600.380.290;Ependymoma;D004806
D02.033.100.624.302;Ephedrine;D004809
D02.033.755.624.302;Ephedrine;D004809
D02.092.063.624.302;Ephedrine;D004809
D02.092.471.683.430;Ephedrine;D004809
C02.782.580.830.375;Ephemeral Fever;D004810
C22.196.274;Ephemeral Fever;D004810
D02.355.291.411.400;Epichlorohydrin;D004811
E05.318;Epidemiologic Methods;D004812
N06.850.520;Epidemiologic Methods;D004812
H02.403.720.500;Epidemiology;D004813
C04.182.254;Epidermal Cyst;D004814
D06.472.317.350;Epidermal Growth Factor;D004815
D12.644.276.561;Epidermal Growth Factor;D004815
D12.776.467.561;Epidermal Growth Factor;D004815
D23.529.561;Epidermal Growth Factor;D004815
C17.800.174.600.350;Epidermal Necrolysis, Toxic;D004816
C20.543.206.380.350;Epidermal Necrolysis, Toxic;D004816
C25.723.276.505.350;Epidermal Necrolysis, Toxic;D004816
A10.272.497;Epidermis;D004817
A17.815.250;Epidermis;D004817
C22.905.382;Epidermitis, Exudative, of Swine;D004818
C02.256.650.810.345;Epidermodysplasia Verruciformis;D004819
C02.825.810.260;Epidermodysplasia Verruciformis;D004819
C02.928.914.345;Epidermodysplasia Verruciformis;D004819
C04.925.744.500;Epidermodysplasia Verruciformis;D004819
C17.800.838.790.810.260;Epidermodysplasia Verruciformis;D004819
C16.131.831.493;Epidermolysis Bullosa;D004820
C16.320.850.275;Epidermolysis Bullosa;D004820
C17.800.804.493;Epidermolysis Bullosa;D004820
C17.800.827.275;Epidermolysis Bullosa;D004820
C17.800.865.410;Epidermolysis Bullosa;D004820
B01.300.381.340;Epidermophyton;D004821
A05.360.444.371;Epididymis;D004822
C12.294.199;Epididymitis;D004823
A02.835.232.834.803.350;Epidural Space;D004824
A02.165.257.625.411;Epiglottis;D004825
A02.165.407.500.411;Epiglottis;D004825
A04.329.591.411;Epiglottis;D004825
C08.730.798.200;Epiglottitis;D004826
C10.228.140.490;Epilepsy;D004827
C10.228.140.490.360;Epilepsies, Partial;D004828
C10.228.140.490.375;Epilepsy, Generalized;D004829
C10.228.140.490.375.290;Epilepsy, Tonic-Clonic;D004830
C10.228.140.490.250;Epilepsies, Myoclonic;D004831
C10.228.140.490.375.260;Epilepsy, Absence;D004832
C10.228.140.490.360.290;Epilepsy, Temporal Lobe;D004833
C10.228.140.199.650;Epilepsy, Post-Traumatic;D004834
C10.228.140.490.380;Epilepsy, Post-Traumatic;D004834
C10.900.300.087.600;Epilepsy, Post-Traumatic;D004834
C26.260.118.475;Epilepsy, Post-Traumatic;D004834
C26.915.300.200.475;Epilepsy, Post-Traumatic;D004834
D04.808.365.415.200;Epimestrol;D004836
D02.033.100.291.310;Epinephrine;D004837
D02.092.063.291.310;Epinephrine;D004837
D02.092.211.215.311.461;Epinephrine;D004837
D02.092.311.461;Epinephrine;D004837
A02.835.232.251;Epiphyses;D004838
C05.116.425;Epiphyses, Slipped;D004839
D03.383.129.539.200;Epirizole;D004840
D03.383.742.200;Epirizole;D004840
E04.520.252.750;Episiotomy;D004841
C12.706.374;Epispadias;D004842
C12.777.767.374;Epispadias;D004842
C13.351.875.374;Epispadias;D004842
C13.351.968.767.374;Epispadias;D004842
C16.131.939.374;Epispadias;D004842
G05.355.315.207;Epistasis, Genetic;D004843
C08.460.261;Epistaxis;D004844
C09.603.261;Epistaxis;D004844
C23.550.414.712;Epistaxis;D004844
D04.808.054.079.429.824.275;Epitestosterone;D004845
D06.472.334.851.968.984.500;Epitestosterone;D004845
A14.549.167.646.374;Epithelial Attachment;D004846
A11.436;Epithelial Cells;D004847
A10.272;Epithelium;D004848
D02.705.429.812.750;Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester;D004849
D02.705.539.692.750;Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester;D004849
D02.886.300.846.750;Phenylphosphonothioic Acid, 2-Ethyl 2-(4-Nitrophenyl) Ester;D004849
L01.143.506.598.400.556.536;Eponyms;D004850
D08.811.277.340;Epoxide Hydrolases;D004851
D02.355.291.411;Epoxy Compounds;D004852
D05.750.716.822.461;Epoxy Resins;D004853
D25.720.716.822.461;Epoxy Resins;D004853
J01.637.051.720.716.822.461;Epoxy Resins;D004853
B04.280.382.400.500.450;Herpesvirus 4, Human;D004854
B04.909.204.210.400.500.400;Herpesvirus 4, Human;D004854
B04.909.204.382.400.500.400;Herpesvirus 4, Human;D004854
B04.909.574.204.500.500.400;Herpesvirus 4, Human;D004854
D04.808.365.415.215;Equilenin;D004855
D04.808.578.502.470;Equilenin;D004855
D06.472.334.851.437.249;Equilenin;D004855
G11.427.690;Postural Balance;D004856
G11.561.600.810.541.595;Postural Balance;D004856
D04.808.365.415.220;Equilin;D004857
D04.808.578.502.475;Equilin;D004857
D06.472.334.851.437.374;Equilin;D004857
B04.280.382.100.900.435;Herpesvirus 3, Equid;D004858
B04.909.204.382.100.900.435;Herpesvirus 3, Equid;D004858
C02.782.815.616.300;Equine Infectious Anemia;D004859
C02.839.375;Equine Infectious Anemia;D004859
C22.488.304;Equine Infectious Anemia;D004859
B04.820.650.589.520.400;Infectious Anemia Virus, Equine;D004860
B04.909.777.731.589.520.400;Infectious Anemia Virus, Equine;D004860
B04.280.382.100.900.430;Herpesvirus 1, Equid;D004861
B04.909.204.382.100.900.430;Herpesvirus 1, Equid;D004861
C05.330.488.200;Equinus Deformity;D004863
E07;Equipment and Supplies;D004864
E07.325;Equipment and Supplies, Hospital;D004865
N06.850.540;Equipment Contamination;D004866
E05.320;Equipment Design;D004867
E05.325;Equipment Failure;D004868
E05.330;Equipment Safety;D004869
D12.644.173;Erabutoxins;D004870
D01.268.477.437;Erbium;D004871
D01.268.558.362.437;Erbium;D004871
D01.552.550.399.437;Erbium;D004871
D04.808.247.222.474;Ergocalciferols;D004872
D04.808.247.808.412;Ergocalciferols;D004872
D04.808.812.768.462;Ergocalciferols;D004872
D10.570.938.439;Ergocalciferols;D004872
D03.132.327.287;Ergolines;D004873
D03.549.439;Ergolines;D004873
D03.132.327.287.262;Ergonovine;D004874
D03.549.439.262;Ergonovine;D004874
D04.808.247.222.537;Ergosterol;D004875
D04.808.247.808.756.287;Ergosterol;D004875
D03.132.327;Ergot Alkaloids;D004876
D03.132.327.412.250.500;Ergoloid Mesylates;D004877
D03.549.562.400.500;Ergoloid Mesylates;D004877
D03.132.327.412.400;Ergotamine;D004878
D03.549.562.500;Ergotamine;D004878
D03.132.327.412;Ergotamines;D004879
D03.549.562;Ergotamines;D004879
D02.886.489.225;Ergothioneine;D004880
D12.125.072.329.269;Ergothioneine;D004880
C25.723.327;Ergotism;D004881
C25.723.680.262;Ergotism;D004881
C25.723.756.262;Ergotism;D004881
L01.178.362;Erotica;D004882
D10.251.355.325.300;Erucic Acids;D004883
C23.888.821.297;Eructation;D004884
B03.440.450.425.300;Erwinia;D004885
B03.660.250.150.175;Erwinia;D004885
C01.252.410.890.328;Erysipelas;D004886
C01.252.825.260;Erysipelas;D004886
C01.539.800.720.260;Erysipelas;D004886
C17.800.838.765.260;Erysipelas;D004886
C01.252.410.334.329;Erysipeloid;D004887
B03.510.460.400.410.350;Erysipelothrix;D004888
C01.252.410.334;Erysipelothrix Infections;D004889
C22.331;Erysipelothrix Infections;D004889
C17.800.229;Erythema;D004890
C01.252.410.040.552.846.583.260;Erythema Induratum;D004891
C01.252.825.820.260;Erythema Induratum;D004891
C01.539.800.720.820.260;Erythema Induratum;D004891
C17.300.710.329;Erythema Induratum;D004891
C17.800.229.329;Erythema Induratum;D004891
C17.800.566.329;Erythema Induratum;D004891
C17.800.838.765.820.320;Erythema Induratum;D004891
C17.800.229.400;Erythema Multiforme;D004892
C17.800.865.475;Erythema Multiforme;D004892
C17.800.174.600.375;Erythema Nodosum;D004893
C17.800.229.413;Erythema Nodosum;D004893
C20.543.206.380.375;Erythema Nodosum;D004893
C25.723.276.505.375;Erythema Nodosum;D004893
C01.252.410.040.246.430;Erythrasma;D004894
C01.252.825.320;Erythrasma;D004894
C01.539.800.720.320;Erythrasma;D004894
C17.800.838.765.320;Erythrasma;D004894
B01.650.940.800.575.100.401.200;Erythrina;D004895
D02.033.800.329;Erythritol;D004896
D09.853.329;Erythritol;D004896
D02.033.800.329.225;Erythrityl Tetranitrate;D004897
D02.583.225;Erythrityl Tetranitrate;D004897
D09.853.329.225;Erythrityl Tetranitrate;D004897
C13.703.277.060;Erythroblastosis, Fetal;D004899
C15.378.120.413;Erythroblastosis, Fetal;D004899
C16.300.060;Erythroblastosis, Fetal;D004899
C16.614.304;Erythroblastosis, Fetal;D004899
C20.188.413;Erythroblastosis, Fetal;D004899
A11.148.378.590.837.250.200;Erythroblasts;D004900
A11.443.240.497.200;Erythroblasts;D004900
A15.378.316.378.590.837.250.200;Erythroblasts;D004900
B01.050.150.900.649.801.400.112.199.120.260.260;Erythrocebus patas;D004901
D12.776.124.400.220;Erythrocruorins;D004902
D12.776.422.316.762.260;Erythrocruorins;D004902
E01.370.225.625.225;Erythrocyte Aggregation;D004903
E05.200.625.225;Erythrocyte Aggregation;D004903
G09.188.124.552.249;Erythrocyte Aggregation;D004903
G04.299.119.260;Erythrocyte Aging;D004905
G09.188.124.454;Erythrocyte Aging;D004905
E01.370.225.500.195.107.330;Erythrocyte Count;D004906
E01.370.225.625.107.330;Erythrocyte Count;D004906
E05.200.500.195.107.330;Erythrocyte Count;D004906
E05.200.625.107.330;Erythrocyte Count;D004906
E05.242.195.107.330;Erythrocyte Count;D004906
G04.170.107.330;Erythrocyte Count;D004906
G09.188.105.330;Erythrocyte Count;D004906
G09.188.370.249;Erythrocyte Deformability;D004907
A11.118.290.330.315;Erythrocyte Inclusions;D004908
A11.284.420.204;Erythrocyte Inclusions;D004908
A15.145.229.334.330.340;Erythrocyte Inclusions;D004908
E01.370.225.625.230;Erythrocyte Indices;D004909
E05.200.625.230;Erythrocyte Indices;D004909
G09.188.260;Erythrocyte Indices;D004909
A11.118.290.270;Erythrocyte Membrane;D004910
A11.284.149.356;Erythrocyte Membrane;D004910
A15.145.229.334.270;Erythrocyte Membrane;D004910
G09.188.130.370;Erythrocyte Volume;D004911
G09.330.380.092.370;Erythrocyte Volume;D004911
A11.118.290;Erythrocytes;D004912
A11.443.240;Erythrocytes;D004912
A15.145.229.334;Erythrocytes;D004912
A11.118.290.330;Erythrocytes, Abnormal;D004913
A11.443.240.330;Erythrocytes, Abnormal;D004913
A15.145.229.334.330;Erythrocytes, Abnormal;D004913
C04.557.337.539.275.325;Leukemia, Erythroblastic, Acute;D004915
C15.378.190.636.276;Leukemia, Erythroblastic, Acute;D004915
C14.907.617.500;Erythromelalgia;D004916
D02.540.505.250;Erythromycin;D004917
D02.540.505.250.250;Erythromycin Estolate;D004918
C04.834.288;Erythroplasia;D004919
G04.299.151.825.414;Erythropoiesis;D004920
G09.188.124.544.414;Erythropoiesis;D004920
D12.644.276.374.410.240.150;Erythropoietin;D004921
D12.776.395.240.150;Erythropoietin;D004921
D12.776.467.374.410.240.150;Erythropoietin;D004921
D23.529.374.410.240.150;Erythropoietin;D004921
D02.455.426.559.847.885.347.350;Erythrosine;D004923
D03.494.953.275.350;Erythrosine;D004923
D04.615.885.347.350;Erythrosine;D004923
F01.145.113.448;Escape Reaction;D004924
F01.145.367;Escape Reaction;D004924
B03.440.450.425.325;Escherichia;D004925
B03.660.250.150.180;Escherichia;D004925
B03.440.450.425.325.300;Escherichia coli;D004926
B03.660.250.150.180.100;Escherichia coli;D004926
C01.252.400.310.330;Escherichia coli Infections;D004927
D02.455.849.919.530.333;Escin;D004928
D09.408.782.250;Escin;D004928
D03.438.150.446.400;Esculin;D004929
D03.830.219.446.400;Esculin;D004929
D09.408.348.250;Esculin;D004929
M01.686.508.150.675;Inuits;D004930
M01.686.754.520;Inuits;D004930
C06.405.117.119.500.432;Esophageal Achalasia;D004931
C06.405.117.240;Esophageal and Gastric Varices;D004932
C06.552.494.414;Esophageal and Gastric Varices;D004932
C06.198.330;Esophageal Atresia;D004933
C06.405.117.260;Esophageal Atresia;D004933
C16.131.314.330;Esophageal Atresia;D004933
C04.182.281;Esophageal Cyst;D004934
C06.405.117.316;Esophageal Cyst;D004934
C06.405.117;Esophageal Diseases;D004935
C23.300.415.625;Diverticulum, Esophageal;D004936
C06.267.250;Esophageal Fistula;D004937
C06.405.117.367;Esophageal Fistula;D004937
C23.300.575.185.250;Esophageal Fistula;D004937
C04.588.274.476.205;Esophageal Neoplasms;D004938
C04.588.443.353;Esophageal Neoplasms;D004938
C06.301.371.205;Esophageal Neoplasms;D004938
C06.405.117.430;Esophageal Neoplasms;D004938
C06.405.249.205;Esophageal Neoplasms;D004938
C06.405.117.468;Esophageal Perforation;D004939
C26.348;Esophageal Perforation;D004939
C06.405.117.544;Esophageal Stenosis;D004940
C06.405.117.620;Esophagitis;D004941
C06.405.205.663;Esophagitis;D004941
C06.405.117.620.420;Esophagitis, Peptic;D004942
C06.405.205.663.420;Esophagitis, Peptic;D004942
C06.405.608.348;Esophagitis, Peptic;D004942
A03.556.875.500.414;Esophagogastric Junction;D004943
A03.556.875.875.330;Esophagogastric Junction;D004943
E04.210.355;Esophagoplasty;D004944
E01.370.372.250.250.275;Esophagoscopy;D004945
E01.370.388.250.250.250.260;Esophagoscopy;D004945
E04.210.240.250.260;Esophagoscopy;D004945
E04.800.250.250.250.260;Esophagoscopy;D004945
E04.210.358;Esophagostomy;D004946
E04.579.358;Esophagostomy;D004946
A03.556.875.500;Esophagus;D004947
C10.292.562.887.300;Esotropia;D004948
C11.590.810.400;Esotropia;D004948
D03.438.079.080.250;Estazolam;D004949
D08.811.277.352;Esterases;D004950
G02.111.087.451;Esterification;D004951
G02.149.115.451;Esterification;D004951
G02.149.465.270;Esterification;D004951
G02.607.750.270;Esterification;D004951
G03.495.475;Esterification;D004951
D02.241.400;Esters;D004952
D04.808.365.415.331.320;Estetrol;D004953
D06.472.334.851.437.750.320;Estetrol;D004953
F02.463.785.477;Esthetics;D004954
K01.752.210;Esthetics;D004954
E06.420;Esthetics, Dental;D004955
G07.700.062.415;Estivation;D004956
G16.100.057.500.415;Estivation;D004956
Z01.542.248.136.360;Estonia;D004957
Z01.586.950.140.360;Estonia;D004957
D04.808.365.415.248;Estradiol;D004958
D06.472.334.851.437.500;Estradiol;D004958
D06.347.360.315.300;Estradiol Antagonists;D004959
D27.505.696.399.450.360.315.300;Estradiol Antagonists;D004959
D08.811.682.047.436.375.280;Estradiol Dehydrogenases;D004960
D02.455.526.728.650.275;Estramustine;D004961
D04.808.365.415.248.320;Estramustine;D004961
D04.808.365;Estranes;D004962
D04.808.365.415;Estrenes;D004963
D04.808.365.415.331;Estriol;D004964
D06.472.334.851.437.750;Estriol;D004964
D06.347.360.315;Estrogen Antagonists;D004965
D27.505.696.399.450.360.315;Estrogen Antagonists;D004965
D06.472.334.851.437.988;Estrogens, Conjugated (USP);D004966
D27.505.696.399.472.277;Estrogens;D004967
D27.505.696.399.472.277.540;Estrogens, Non-Steroidal;D004968
D04.808.365.415.414;Estrone;D004970
D04.808.578.502.497;Estrone;D004970
D06.472.040.502.497;Estrone;D004970
D06.472.334.851.437.996;Estrone;D004970
G08.686.195.500;Estrus;D004971
E05.820.150.360;Estrus Detection;D004972
E05.820.150.370;Estrus Synchronization;D004973
G08.686.195.500.500;Estrus Synchronization;D004973
D03.066.515.400;Etazolate;D004974
D03.383.725.547.400;Etazolate;D004974
D03.494.046.250.450;Ethacridine;D004975
D02.241.081.018.386.682.300;Ethacrynic Acid;D004976
D02.241.511.316.682.200;Ethacrynic Acid;D004976
D02.092.782.258.368.265;Ethambutol;D004977
D02.033.375.270;Ethamoxytriphetol;D004978
D02.455.426.559.389.097.250;Ethamsylate;D004979
D02.886.645.600.080.050.100.300;Ethamsylate;D004979
D02.455.326.146.379;Ethane;D004980
D08.811.520.232.400.350;Ethanolamine Ammonia-Lyase;D004981
D08.811.913.696.900.250;Ethanolaminephosphotransferase;D004982
D02.033.100.291;Ethanolamines;D004983
D02.033.375.291;Ethanolamines;D004983
D02.092.063.291;Ethanolamines;D004983
D02.033.260.335;Ethchlorvynol;D004984
D03.438.759.646.138.236.250;Ethenoadenosine Triphosphate;D004985
D13.695.667.138.236.250;Ethenoadenosine Triphosphate;D004985
D13.695.827.068.236.250;Ethenoadenosine Triphosphate;D004985
D02.355.417.332;Ether, Ethyl;D004986
D02.355;Ethers;D004987
D02.355.291;Ethers, Cyclic;D004988
D04.345.241;Ethers, Cyclic;D004988
F01.829.500.519;Ethics;D004989
K01.316;Ethics;D004989
K01.752.256;Ethics;D004989
N05.350;Ethics;D004989
K01.316.333.132.500;Ethics, Dental;D004990
K01.752.622.416;Ethics, Dental;D004990
N05.350.340.162.249;Ethics, Dental;D004990
K01.316.190;Ethics, Institutional;D004991
N05.350.325;Ethics, Institutional;D004991
K01.316.333.132.750;Ethics, Medical;D004992
N05.350.340.162.500;Ethics, Medical;D004992
K01.316.333.132.875;Ethics, Nursing;D004993
K01.752.712.416;Ethics, Nursing;D004993
N05.350.340.162.750;Ethics, Nursing;D004993
K01.316.333.132.937;Ethics, Pharmacy;D004994
N05.350.340.162.875;Ethics, Pharmacy;D004994
K01.316.333;Ethics, Professional;D004995
N05.350.340;Ethics, Professional;D004995
D03.494.633.416;Ethidium;D004996
D04.808.668.651.568.291;Ethinyl Estradiol;D004997
D06.472.334.851.437.968.500;Ethinyl Estradiol;D004997
D10.627.700.550.300;Ethiodized Oil;D004998
D20.215.784.750.550.300;Ethiodized Oil;D004998
D02.705.400.625.050;Amifostine;D004999
D02.705.539.345.050;Amifostine;D004999
D02.886.300.692.050;Amifostine;D004999
D03.066.349.220;Ethionamide;D005000
D03.383.725.394.220;Ethionamide;D005000
D02.886.030.388;Ethionine;D005001
D12.125.166.388;Ethionine;D005001
Z01.058.290.120.310;Ethiopia;D005002
D04.808.745.745.379;Ethisterone;D005003
A02.835.232.781.292;Ethmoid Bone;D005004
A04.531.621.267;Ethmoid Sinus;D005005
M01.686.754;Ethnic Groups;D005006
N01.224.317;Ethnic Groups;D005006
I01.076.201.450.457;Ethnology;D005007
F04.096.544.275;Ethnopsychology;D005008
F04.096.628.317;Ethnopsychology;D005008
D02.355.291.411.408;Ethoglucid;D005009
D02.355.354;Ethoglucid;D005009
F04.096.208;Ethology;D005010
D02.241.223.100.050.500.645;Ethopabate;D005011
D02.455.426.559.389.127.020.937.645;Ethopabate;D005011
D02.478.770.333;Ethosuximide;D005013
D03.383.773.812.852.333;Ethosuximide;D005013
D03.438.810.200;Ethoxyquin;D005015
D02.065.884.500;Ethoxzolamide;D005016
D02.886.590.700.420;Ethoxzolamide;D005016
D02.886.675.197;Ethoxzolamide;D005016
D03.383.129.708.089.416;Ethoxzolamide;D005016
D03.438.185.416;Ethoxzolamide;D005016
D03.438.150.446.520.451;Ethyl Biscoumacetate;D005017
D03.830.219.446.520.451;Ethyl Biscoumacetate;D005017
D02.455.526.439.447;Ethyl Chloride;D005018
D02.355.417;Ethyl Ethers;D005019
D02.455.326.146.100.050.500.300;Ethyl Methanesulfonate;D005020
D02.886.645.600.055.050.510.300;Ethyl Methanesulfonate;D005020
D02.092.471;Ethylamines;D005021
D02.491.203.425;Ethyldimethylaminopropyl Carbodiimide;D005022
D02.033.260.350;Ethylene Chlorohydrin;D005023
D02.033.375.310;Ethylene Chlorohydrin;D005023
D02.455.326.146.379.350;Ethylene Dichlorides;D005025
D02.455.526.439.458;Ethylene Dichlorides;D005025
D02.033.455.250;Ethylene Glycols;D005026
D02.355.291.411.417;Ethylene Oxide;D005027
D02.241.081.251.869.265;Ethylenebis(dithiocarbamates);D005028
D02.886.706.250;Ethylenebis(dithiocarbamates);D005028
D02.092.782.258.368;Ethylenediamines;D005029
D02.455.326.271.367;Ethylenes;D005030
D02.948.898.323;Ethylenethiourea;D005031
D03.383.129.308.432.500;Ethylenethiourea;D005031
D04.808.668.651.693.223;Ethylestrenol;D005032
D02.241.081.337.502.524.418;Ethylmaleimide;D005033
D02.478.440.418;Ethylmaleimide;D005033
D03.383.129.578.399.418;Ethylmaleimide;D005033
D02.691.750.100.347.417;Ethylmercuric Chloride;D005034
D02.691.750.100.347;Ethylmercury Compounds;D005035
D03.132.577.249.547.547.430;Ethylmorphine;D005036
D03.549.686.575.547.460;Ethylmorphine;D005036
D03.605.497.575.547.460;Ethylmorphine;D005036
D04.615.723.795.547.547.430;Ethylmorphine;D005036
D08.811.682.662.582.400;Ethylmorphine-N-Demethylase;D005037
D02.654.692.300;Ethylnitrosourea;D005038
D02.948.594.310;Ethylnitrosourea;D005038
D02.033.100.291.617.300;Etilefrine;D005039
D02.092.063.291.617.300;Etilefrine;D005039
D04.808.668.651.693.279;Ethynodiol Diacetate;D005040
D02.065.199.092.325;Etidocaine;D005041
D03.383.129.308.260;Etimizol;D005042
D04.808.054.040.368;Etiocholanolone;D005043
D04.808.578.502.583;Etiocholanolone;D005043
D06.472.040.502.583;Etiocholanolone;D005043
D06.472.334.851.968.968;Etiocholanolone;D005043
D03.383.129.578.840.500.340;Etioporphyrins;D005044
D03.549.909.500.340;Etioporphyrins;D005044
D04.345.783.500.340;Etioporphyrins;D005044
D23.767.727.340;Etioporphyrins;D005044
D03.383.129.308.265;Etomidate;D005045
D02.455.426.559.847.638.960.675.250;Etoposide;D005047
D04.615.638.960.675.250;Etoposide;D005047
D09.408.348.275;Etoposide;D005047
D03.132.577.249.270;Etorphine;D005048
D03.549.686.320;Etorphine;D005048
D03.605.497.320;Etorphine;D005048
D04.615.723.795.270;Etorphine;D005048
D02.455.326.271.665.202.495.250;Etretinate;D005050
D02.455.849.131.495.250;Etretinate;D005050
D23.767.261.700.250;Etretinate;D005050
B03.510.460.400.400.250;Eubacterium;D005051
B01.650.940.800.575.100.773.366;Eucalyptus;D005052
K01.400.307;Eugenics;D005053
D02.241.223.200.054.500;Eugenol;D005054
B01.268.250.320;Euglena;D005055
B01.268.250.320.418;Euglena gracilis;D005056
A11.450;Eukaryotic Cells;D005057
C19.391.482.293;Eunuchism;D005058
F01.470.323;Euphoria;D005059
Z01.542;Europe;D005060
Z01.542.248;Europe, Eastern;D005061
I01.615.500.250.300;European Union;D005062
Z01.586.300;European Union;D005062
D01.268.477.468;Europium;D005063
D01.268.558.362.468;Europium;D005063
D01.552.550.399.468;Europium;D005063
A09.246.397.369;Eustachian Tube;D005064
E02.760.905.199;Euthanasia;D005065
I01.880.735.344.500;Euthanasia;D005065
N02.421.585.905.199;Euthanasia;D005065
E02.760.905.199.500;Euthanasia, Passive;D005066
E02.760.952.500;Euthanasia, Passive;D005066
N02.421.585.905.199.625;Euthanasia, Passive;D005066
N02.421.585.952.500;Euthanasia, Passive;D005066
C19.874.255;Euthyroid Sick Syndromes;D005067
G16.500.240.300;Eutrophication;D005068
E05.337;Evaluation Studies as Topic;D005069
N05.715.360.335;Evaluation Studies as Topic;D005069
D02.172.560;Evans Blue;D005070
D02.455.426.559.847.638.555.400;Evans Blue;D005070
D02.886.645.600.080.050.650.300;Evans Blue;D005070
D04.615.638.555.400;Evans Blue;D005070
G07.265.500;Evoked Potentials;D005071
G11.561.270;Evoked Potentials;D005071
G07.265.500.370;Evoked Potentials, Auditory;D005072
G11.561.270.370;Evoked Potentials, Auditory;D005072
G07.265.500.400;Evoked Potentials, Somatosensory;D005073
G11.561.270.400;Evoked Potentials, Somatosensory;D005073
G07.265.500.425;Evoked Potentials, Visual;D005074
G11.561.270.425;Evoked Potentials, Visual;D005074
G14.330;Evoked Potentials, Visual;D005074
G05.355.044;Biological Evolution;D005075
G16.100.178;Biological Evolution;D005075
C17.800.257;Exanthema;D005076
C02.256.466.850.290;Exanthema Subitum;D005077
C02.825.290;Exanthema Subitum;D005077
C17.800.257.335;Exanthema Subitum;D005077
C17.800.838.790.290;Exanthema Subitum;D005077
E02.095.135.469;Exchange Transfusion, Whole Blood;D005078
D26.650.700.419;Excipients;D005079
D27.720.744.770.419;Excipients;D005079
E01.370.370.380.250;Exercise Test;D005080
E01.370.386.700.250;Exercise Test;D005080
E05.333.250;Exercise Test;D005080
E02.779.483;Exercise Therapy;D005081
E02.831.387;Exercise Therapy;D005081
G11.427.590.780;Physical Exertion;D005082
D12.776.097.293;Exfoliatins;D005083
D23.946.123.353;Exfoliatins;D005083
D23.946.350.500;Exfoliatins;D005083
F03.800.800.600.300;Exhibitionism;D005084
J01.897.280.500.269;Exhibits as Topic;D005085
L01.178.820.090.269;Exhibits as Topic;D005085
F02.739.418;Existentialism;D005086
K01.752.304;Existentialism;D005086
D08.811.277.450.420.375;Glucan 1,4-alpha-Glucosidase;D005087
A10.336;Exocrine Glands;D005088
G04.299.490;Exocytosis;D005089
D08.811.277.352.335.375;Exodeoxyribonucleases;D005090
D08.811.277.352.365.290;Exodeoxyribonucleases;D005090
G05.360.340.024.340.137.232;Exons;D005091
D08.811.277.352.365;Exonucleases;D005092
B01.300.381.355;Exophiala;D005093
C11.675.349;Exophthalmos;D005094
D08.811.277.352.365.300;Exoribonucleases;D005095
D08.811.277.352.700.375;Exoribonucleases;D005095
C05.116.540.310;Exostoses;D005096
C04.557.450.565.575.610.615.325;Exostoses, Multiple Hereditary;D005097
C04.700.330;Exostoses, Multiple Hereditary;D005097
C05.116.099.708.670.615.325;Exostoses, Multiple Hereditary;D005097
C05.116.540.310.500;Exostoses, Multiple Hereditary;D005097
C16.320.700.330;Exostoses, Multiple Hereditary;D005097
D23.946.350;Exotoxins;D005098
C10.292.562.887.650;Exotropia;D005099
C11.590.810.440;Exotropia;D005099
D27.505.954.796.250;Expectorants;D005100
I03.883.420;Expeditions;D005101
N03.219.151.450;Health Expenditures;D005102
N05.300.385;Health Expenditures;D005102
L01.224.065.190;Expert Systems;D005103
I01.880.604.583.232;Expert Testimony;D005104
N03.706.535.253;Expert Testimony;D005104
E01.370.386.700.485.750.275.260;Expiratory Reserve Volume;D005105
E01.370.386.700.485.750.900.260;Expiratory Reserve Volume;D005105
G09.772.850.390.360;Expiratory Reserve Volume;D005105
G09.772.850.970.360;Expiratory Reserve Volume;D005105
F01.145.387;Exploratory Behavior;D005106
F01.658.370;Exploratory Behavior;D005106
N06.230.208;Explosions;D005107
F02.463.425.770.232;Extinction, Psychological;D005108
A11.284.295.310;Extracellular Matrix;D005109
A10.082.500;Extracellular Space;D005110
A11.284.295;Extracellular Space;D005110
G05.420.275;Extrachromosomal Inheritance;D005111
E04.292;Extracorporeal Circulation;D005112
E04.520.252.875;Extraction, Obstetrical;D005113
F01.145.802.295;Extramarital Relations;D005114
E06.658.453.578.360;Extraoral Traction Appliances;D005115
A08.186.854.253;Extrapyramidal Tracts;D005116
A08.612.380.239;Extrapyramidal Tracts;D005116
C14.280.067.325;Cardiac Complexes, Premature;D005117
C23.550.073.325;Cardiac Complexes, Premature;D005117
G01.060.249.159;Extraterrestrial Environment;D005118
G16.500.275.240;Extraterrestrial Environment;D005118
C23.550.340;Extravasation of Diagnostic and Therapeutic Materials;D005119
C26.371;Extravasation of Diagnostic and Therapeutic Materials;D005119
F01.752.747.246;Extraversion (Psychology);D005120
F02.739.794.253;Extraversion (Psychology);D005120
A01.378;Extremities;D005121
A12.383;Exudates and Transudates;D005122
A01.456.505.420;Eye;D005123
A09.371;Eye;D005123
C11.250;Eye Abnormalities;D005124
C16.131.384;Eye Abnormalities;D005124
N02.278.065.900.400;Eye Banks;D005125
C26.200.503;Eye Burns;D005126
C26.260.275.250.250;Eye Burns;D005126
G14.340;Eye Color;D005127
G16.690.360;Eye Color;D005127
C11;Eye Diseases;D005128
C26.260.275.250.260;Eye Foreign Bodies;D005129
C26.392.421;Eye Foreign Bodies;D005129
C11.290;Eye Hemorrhage;D005130
C23.550.414.756;Eye Hemorrhage;D005130
C23.888.307.500;Eye Hemorrhage;D005130
C11.297;Eye Injuries;D005131
C26.260.275.250;Eye Injuries;D005131
C11.300;Eye Manifestations;D005132
C23.888.307;Eye Manifestations;D005132
G11.427.590.530.140;Eye Movements;D005133
G14.640.260;Eye Movements;D005133
C04.588.364;Eye Neoplasms;D005134
C11.319;Eye Neoplasms;D005134
E07.700.260;Eye Protective Devices;D005135
J01.637.708.260;Eye Protective Devices;D005135
D12.776.306;Eye Proteins;D005136
E07.695.225;Eye, Artificial;D005137
A01.456.505.420.338;Eyebrows;D005138
A17.360.296;Eyebrows;D005138
E07.632.500.300;Eyeglasses;D005139
A01.456.505.420.504.421;Eyelashes;D005140
A09.371.337.338;Eyelashes;D005140
A17.360.421;Eyelashes;D005140
C11.338;Eyelid Diseases;D005141
C04.588.443.392.500;Eyelid Neoplasms;D005142
C11.319.421;Eyelid Neoplasms;D005142
C11.338.526;Eyelid Neoplasms;D005142
A01.456.505.420.504;Eyelids;D005143
A09.371.337;Eyelids;D005143
G05.360.600.300;F Factor;D005144
A01.456.505;Face;D005145
C23.300.505;Facial Asymmetry;D005146
A02.835.232.781.324;Facial Bones;D005147
C17.800.271;Facial Dermatoses;D005148
E01.370.600.225;Facial Expression;D005149
F01.145.209.530.385;Facial Expression;D005149
C07.465.284;Facial Hemiatrophy;D005150
C10.292.300.375;Facial Hemiatrophy;D005150
C26.260.275;Facial Injuries;D005151
A02.633.567.400;Facial Muscles;D005152
A14.363;Facial Muscles;D005152
C04.588.443.392;Facial Neoplasms;D005153
A08.800.050.050.275;Facial Nerve;D005154
A08.800.050.600.149;Facial Nerve;D005154
A08.800.800.060.275;Facial Nerve;D005154
A08.800.800.120.250;Facial Nerve;D005154
C10.292.300;Facial Nerve Diseases;D005155
C07.465.313;Facial Neuralgia;D005156
C10.292.300.625;Facial Neuralgia;D005156
C10.292.375;Facial Neuralgia;D005156
C10.597.617.364;Facial Pain;D005157
C23.888.592.612.330;Facial Pain;D005157
C23.888.646.429;Facial Pain;D005157
C07.465.327;Facial Paralysis;D005158
C10.597.622.214;Facial Paralysis;D005158
C23.888.592.636.214;Facial Paralysis;D005158
N02;Health Care Facilities, Manpower, and Services;D005159
J01.086.339;Facility Design and Construction;D005160
N02.278.200;Facility Design and Construction;D005160
N03.706.280;Facility Regulation and Control;D005161
N05.700.300;Facility Regulation and Control;D005161
F03.400;Factitious Disorders;D005162
E05.318.740.400;Factor Analysis, Statistical;D005163
N05.715.360.750.350;Factor Analysis, Statistical;D005163
N06.850.520.830.400;Factor Analysis, Statistical;D005163
D12.776.124.125.375;Factor IX;D005164
D23.119.375;Factor IX;D005164
D12.776.124.125.300;Factor V;D005165
D23.119.300;Factor V;D005165
C15.378.100.100.300;Factor V Deficiency;D005166
C15.378.100.141.300;Factor V Deficiency;D005166
C15.378.463.300;Factor V Deficiency;D005166
C16.320.099.300;Factor V Deficiency;D005166
D12.776.124.125.325;Factor VII;D005167
D23.119.325;Factor VII;D005167
C15.378.100.100.310;Factor VII Deficiency;D005168
C15.378.100.141.310;Factor VII Deficiency;D005168
C15.378.463.310;Factor VII Deficiency;D005168
C16.320.099.310;Factor VII Deficiency;D005168
D12.776.124.125.350;Factor VIII;D005169
D23.119.350;Factor VIII;D005169
D12.776.124.125.400;Factor X;D005170
D23.119.400;Factor X;D005170
C15.378.100.100.320;Factor X Deficiency;D005171
C15.378.100.141.320;Factor X Deficiency;D005171
C15.378.463.320;Factor X Deficiency;D005171
C16.320.099.320;Factor X Deficiency;D005171
D12.776.124.125.425;Factor XI;D005172
D23.119.425;Factor XI;D005172
C15.378.100.100.325;Factor XI Deficiency;D005173
C15.378.100.141.325;Factor XI Deficiency;D005173
C15.378.463.325;Factor XI Deficiency;D005173
C16.320.099.325;Factor XI Deficiency;D005173
D12.776.124.125.450;Factor XII;D005174
D23.119.450;Factor XII;D005174
C15.378.100.100.330;Factor XII Deficiency;D005175
C15.378.100.141.330;Factor XII Deficiency;D005175
C15.378.463.330;Factor XII Deficiency;D005175
C16.320.099.330;Factor XII Deficiency;D005175
D12.776.124.125.475;Factor XIII;D005176
D23.119.475;Factor XIII;D005176
C15.378.100.100.335;Factor XIII Deficiency;D005177
C15.378.100.141.335;Factor XIII Deficiency;D005177
C15.378.463.335;Factor XIII Deficiency;D005177
C16.320.099.335;Factor XIII Deficiency;D005177
I02.463;Faculty;D005178
M01.526.339;Faculty;D005178
I02.463.273;Faculty, Dental;D005179
M01.526.339.273;Faculty, Dental;D005179
M01.526.485.360;Faculty, Dental;D005179
N02.360.360;Faculty, Dental;D005179
I02.463.373;Faculty, Medical;D005180
M01.526.339.373;Faculty, Medical;D005180
M01.526.485.375;Faculty, Medical;D005180
N02.360.375;Faculty, Medical;D005180
I02.463.473;Faculty, Nursing;D005181
M01.526.339.473;Faculty, Nursing;D005181
M01.526.485.390;Faculty, Nursing;D005181
N02.360.390;Faculty, Nursing;D005181
D03.438.733.315.650.249;Flavin-Adenine Dinucleotide;D005182
D03.438.759.646.138.506;Flavin-Adenine Dinucleotide;D005182
D03.494.507.650.249;Flavin-Adenine Dinucleotide;D005182
D08.211.474.650.249;Flavin-Adenine Dinucleotide;D005182
D13.695.667.138.506;Flavin-Adenine Dinucleotide;D005182
D13.695.827.068.506;Flavin-Adenine Dinucleotide;D005182
D23.767.405.650.249;Flavin-Adenine Dinucleotide;D005182
C23.888.338;Failure to Thrive;D005183
C13.351.500.056.390;Fallopian Tube Diseases;D005184
C04.588.945.418.365;Fallopian Tube Neoplasms;D005185
C13.351.500.056.390.390;Fallopian Tube Neoplasms;D005185
C13.351.937.418.365;Fallopian Tube Neoplasms;D005185
E01.370.378.225;Fallopian Tube Patency Tests;D005186
E02.875.390;Fallopian Tube Patency Tests;D005186
E05.820.390;Fallopian Tube Patency Tests;D005186
A05.360.319.114.373;Fallopian Tubes;D005187
A13.706.500;Fallopian Tubes;D005187
E01.354.340;False Negative Reactions;D005188
E01.354.506;False Positive Reactions;D005189
F01.829.263;Family;D005190
I01.880.225;Family;D005190
F01.829.263.315;Family Characteristics;D005191
I01.240.361;Family Characteristics;D005191
I01.880.225.423;Family Characteristics;D005191
N01.224.361;Family Characteristics;D005191
N01.824.308;Family Characteristics;D005191
N06.850.505.400.400;Family Characteristics;D005191
N01.400.300;Family Health;D005192
N02.421.143.401;Family Planning Services;D005193
N02.421.800.249;Family Planning Services;D005193
H02.403.340.500;Family Practice;D005194
F01.829.263.370;Family Relations;D005195
F04.754.864.581.273;Family Therapy;D005196
K01.517.211.506;Famous Persons;D005197
M01.228;Famous Persons;D005197
C12.777.419.250;Fanconi Syndrome;D005198
C12.777.419.815.450;Fanconi Syndrome;D005198
C13.351.968.419.250;Fanconi Syndrome;D005198
C13.351.968.419.815.450;Fanconi Syndrome;D005198
C16.320.565.861.450;Fanconi Syndrome;D005198
C18.452.648.861.450;Fanconi Syndrome;D005198
C15.378.071.085.080.280;Fanconi Anemia;D005199
C15.378.190.196.080.280;Fanconi Anemia;D005199
C16.320.077.280;Fanconi Anemia;D005199
C18.452.284.280;Fanconi Anemia;D005199
D02.640.600.290;FANFT;D005200
D02.886.675.250;FANFT;D005200
D03.383.129.708.250;FANFT;D005200
D03.383.312.649.290;FANFT;D005200
F01.393.351;Fantasy;D005201
F02.463.188.634.507;Fantasy;D005201
Z01.252.474;Far East;D005202
C08.381.483.125.365;Farmer's Lung;D005203
C08.674.055.365;Farmer's Lung;D005203
C20.543.480.680.075.365;Farmer's Lung;D005203
C24.080.365;Farmer's Lung;D005203
D02.033.415.400;Farnesol;D005204
D02.455.849.765.424;Farnesol;D005204
D10.289.400;Farnesol;D005204
A02.340;Fascia;D005205
A02.340.424;Fascia Lata;D005206
C10.597.613.250;Fasciculation;D005207
C23.888.592.608.250;Fasciculation;D005207
C05.321;Fasciitis;D005208
B01.050.500.500.736.715.408.380;Fasciola;D005209
B01.050.500.500.736.715.408.380.420;Fasciola hepatica;D005210
C03.335.865.354;Fascioliasis;D005211
C03.518.424;Fascioliasis;D005211
C06.552.664.424;Fascioliasis;D005211
C23.996.500;Fascioliasis;D005211
B01.050.500.500.736.715.408;Fasciolidae;D005212
C03.335.349.444;Fascioloidiasis;D005213
C03.335.865.399;Fascioloidiasis;D005213
C03.701.377.444;Fascioloidiasis;D005213
C22.674.377.444;Fascioloidiasis;D005213
G01.249.645.368;Fast Neutrons;D005214
F01.145.407.400;Fasting;D005215
G07.610.240.587;Fasting;D005215
A13.365;Fat Body;D005216
D26.255.165.260.270;Fat Emulsions, Intravenous;D005217
D26.776.708.733.500;Fat Emulsions, Intravenous;D005217
D27.720.280.775.733.500;Fat Emulsions, Intravenous;D005217
C23.550.717.365;Fat Necrosis;D005218
F01.829.263.370.290.110;Father-Child Relations;D005219
F01.829.263.500.320.100;Fathers;D005220
I01.880.225.500.340.210;Fathers;D005220
M01.620.390;Fathers;D005220
C23.888.369;Fatigue;D005221
C23.888.369.500;Mental Fatigue;D005222
F01.145.126.937;Mental Fatigue;D005222
D10.212;Fats;D005223
D10.212.507;Fats, Unsaturated;D005224
D05.500.562.437;Fatty Acid Synthetase Complex;D005226
D08.811.600.317;Fatty Acid Synthetase Complex;D005226
D10.251;Fatty Acids;D005227
D10.251.355.310;Fatty Acids, Essential;D005228
D10.251.355.325;Fatty Acids, Monounsaturated;D005229
D10.251.310;Fatty Acids, Nonesterified;D005230
D10.251.355;Fatty Acids, Unsaturated;D005231
D10.251.400;Fatty Acids, Volatile;D005232
D02.033.415;Fatty Alcohols;D005233
D10.289;Fatty Alcohols;D005233
C06.552.241;Fatty Liver;D005234
C06.552.241.390;Fatty Liver, Alcoholic;D005235
C06.552.645.390;Fatty Liver, Alcoholic;D005235
C25.100.087.645.390;Fatty Liver, Alcoholic;D005235
C15.378.071.141.150.480.370;Favism;D005236
C15.378.071.141.370;Favism;D005236
C16.320.070.480.370;Favism;D005236
C25.723.415.341;Favism;D005236
C25.723.756.375;Favism;D005236
F01.470.361;Fear;D005239
E05.318.760.550;Feasibility Studies;D005240
E05.337.675;Feasibility Studies;D005240
N05.715.360.775.350;Feasibility Studies;D005240
N06.850.520.450.550;Feasibility Studies;D005240
A13.370;Feathers;D005241
C06.405.469.860.300;Fecal Incontinence;D005242
A12.459;Feces;D005243
C06.405.469.531.424;Fecal Impaction;D005244
N04.452.313;Fee Schedules;D005245
L01.143.283.425;Feedback;D005246
F01.145.113.547;Feeding Behavior;D005247
F01.145.407;Feeding Behavior;D005247
E02.421;Feeding Methods;D005248
N03.219.442;Fees and Charges;D005249
N03.219.224.426;Fees, Dental;D005250
N03.219.442.301;Fees, Dental;D005250
N03.219.300.426;Fees, Medical;D005251
N03.219.442.426;Fees, Medical;D005251
N03.219.442.551;Fees, Pharmaceutical;D005252
B04.265.590;Sarcoma Viruses, Feline;D005253
B04.820.650.375.800;Sarcoma Viruses, Feline;D005253
B04.909.574.807.375.800;Sarcoma Viruses, Feline;D005253
B04.909.777.731.375.800;Sarcoma Viruses, Feline;D005253
C02.256.700.363;Feline Panleukopenia;D005254
C22.180.460;Feline Panleukopenia;D005254
B04.820.650.375.500;Leukemia Virus, Feline;D005256
B04.909.574.807.375.500;Leukemia Virus, Feline;D005256
B04.909.777.731.375.500;Leukemia Virus, Feline;D005256
N03.219.483.838.276;Fellowships and Scholarships;D005257
C05.550.114.154.389;Felty Syndrome;D005258
C05.799.114.389;Felty Syndrome;D005258
C17.300.775.099.389;Felty Syndrome;D005258
C20.111.199.389;Felty Syndrome;D005258
D06.472.699.631.692.781.400.350;Felypressin;D005259
D12.644.400.900.400.350;Felypressin;D005259
D12.644.456.925.480.500;Felypressin;D005259
D12.644.548.691.692.781.400.350;Felypressin;D005259
D12.776.641.650.937.400.350;Felypressin;D005259
C13;Female Urogenital Diseases and Pregnancy Complications;D005261
C23.888.378;Feminization;D005262
A07.231.114.351;Femoral Artery;D005263
C26.404.061;Femoral Fractures;D005264
C26.558.276;Femoral Fractures;D005264
C26.404.061.425.500;Femoral Neck Fractures;D005265
C26.558.276.425.500;Femoral Neck Fractures;D005265
C04.588.149.276;Femoral Neoplasms;D005266
C05.116.231.343;Femoral Neoplasms;D005266
A08.800.800.720.450.250;Femoral Nerve;D005267
A07.231.908.314;Femoral Vein;D005268
A02.835.232.043.650.247;Femur;D005269
A02.835.232.043.650.247.343;Femur Head;D005270
C05.116.852.175;Femur Head Necrosis;D005271
C23.550.717.732.368;Femur Head Necrosis;D005271
A02.835.232.043.650.247.510;Femur Neck;D005272
D02.241.081.251.320;Fenbendazole;D005273
D03.438.103.450;Fenbendazole;D005273
D02.092.471.683.450;Fendiline;D005275
E04.580.450.277;Fenestration, Labyrinth;D005276
D02.092.471.683.467;Fenfluramine;D005277
D02.705.400.625.300;Fenitrothion;D005278
D02.705.539.345.300;Fenitrothion;D005278
D02.886.300.692.300;Fenitrothion;D005278
D02.241.223.701.350;Fenoprofen;D005279
D02.033.100.291.465.300;Fenoterol;D005280
D02.092.063.291.465.300;Fenoterol;D005280
D02.092.211.215.311.465.300;Fenoterol;D005280
D02.092.311.660.300;Fenoterol;D005280
D03.383.621.265;Fentanyl;D005283
D02.705.400.625.320;Fenthion;D005284
D02.705.539.345.320;Fenthion;D005284
D02.886.300.692.320;Fenthion;D005284
G02.111.087.160.249;Fermentation;D005285
G02.149.115.160.249;Fermentation;D005285
G03.495.256.249;Fermentation;D005285
D01.268.033.275;Fermium;D005286
D01.268.271.100.275;Fermium;D005286
D01.268.556.266;Fermium;D005286
D01.552.020.394;Fermium;D005286
D01.552.544.266;Fermium;D005286
D08.811.682.667.076;Ferredoxin-NADP Reductase;D005287
D12.776.097.350;Ferredoxins;D005288
D12.776.157.427.374.375.275;Ferredoxins;D005288
D12.776.556.579.374.375.275;Ferredoxins;D005288
D12.776.765.319;Ferredoxins;D005288
B01.050.150.900.649.147.550.350;Ferrets;D005289
D01.490.100;Ferric Compounds;D005290
D02.691.550.100;Ferric Compounds;D005290
D02.092.570.394.380;Ferrichrome;D005291
D02.241.511.372.380;Ferrichrome;D005291
D04.345.566.380;Ferrichrome;D005291
D12.644.641.380;Ferrichrome;D005291
D01.248.497.158.291.350;Ferricyanides;D005292
D01.490.100.300;Ferricyanides;D005292
D01.625.400.100.325;Ferricyanides;D005292
D12.776.157.427.249;Ferritins;D005293
D12.776.556.579.249;Ferritins;D005293
D08.811.520.500;Ferrochelatase;D005294
D12.776.157.427.374.375.957;Ferrochelatase;D005294
D12.776.556.579.374.375.617;Ferrochelatase;D005294
D12.776.575.562;Ferrochelatase;D005294
D01.248.497.158.291.370;Ferrocyanides;D005295
D01.490.200.250;Ferrocyanides;D005295
D01.625.400.100.350;Ferrocyanides;D005295
D01.490.200;Ferrous Compounds;D005296
D02.691.550.200;Ferrous Compounds;D005296
D02.455.426.559.389.097.280;Ferrozine;D005297
D02.886.645.600.080.050.100.325;Ferrozine;D005297
D03.383.931.320;Ferrozine;D005297
G08.686.210;Fertility;D005298
D27.505.696.875.552;Fertility Agents;D005299
D27.505.954.705.552;Fertility Agents;D005299
D27.505.696.875.552.344;Fertility Agents, Female;D005300
D27.505.954.705.552.344;Fertility Agents, Female;D005300
D27.505.696.875.552.510;Fertility Agents, Male;D005303
D27.505.954.705.552.510;Fertility Agents, Male;D005303
G08.686.785.760.277;Fertilization;D005306
E02.875.800.750;Fertilization in Vitro;D005307
E05.820.800.750;Fertilization in Vitro;D005307
D27.720.031.400;Fertilizers;D005308
B01.650.940.800.575.100.075.300;Ferula;D005309
C13.703.277.080;Fetal Alcohol Syndrome;D005310
C16.300.080;Fetal Alcohol Syndrome;D005310
C25.100.087.397;Fetal Alcohol Syndrome;D005310
C13.703.277.390;Fetal Hypoxia;D005311
C16.300.420;Fetal Hypoxia;D005311
C23.888.852.079.594;Fetal Hypoxia;D005311
A12.207.152.200;Fetal Blood;D005312
A15.145.300;Fetal Blood;D005312
A16.378.200;Fetal Blood;D005312
C13.703.243;Fetal Death;D005313
C23.550.260.460;Fetal Death;D005313
G07.700.320.500.325;Embryonic and Fetal Development;D005314
G08.686.785.760.170;Embryonic and Fetal Development;D005314
C13.703.277;Fetal Diseases;D005315
C16.300;Fetal Diseases;D005315
C23.888.380;Fetal Distress;D005316
C13.703.277.370;Fetal Growth Retardation;D005317
C16.300.390;Fetal Growth Retardation;D005317
C23.550.393.450;Fetal Growth Retardation;D005317
A07.541.278;Fetal Heart;D005318
A16.378.303;Fetal Heart;D005318
D12.776.124.400.303;Fetal Hemoglobin;D005319
D12.776.422.316.762.320;Fetal Hemoglobin;D005319
C13.703.170.500;Fetal Macrosomia;D005320
C13.703.277.570;Fetal Macrosomia;D005320
C13.703.726.570;Fetal Macrosomia;D005320
C16.300.570;Fetal Macrosomia;D005320
C19.246.099.968;Fetal Macrosomia;D005320
C23.888.144.186.500;Fetal Macrosomia;D005320
A10.615.284;Extraembryonic Membranes;D005321
A16.254.750;Extraembryonic Membranes;D005321
C13.703.420.339;Fetal Membranes, Premature Rupture;D005322
E01.370.378.230;Fetal Monitoring;D005323
E01.370.520.230;Fetal Monitoring;D005323
G07.700.320.500.325.235.374;Fetal Movement;D005324
G08.686.785.760.170.157.374;Fetal Movement;D005324
G07.700.320.500.325.235.750;Fetal Organ Maturity;D005325
G07.700.320.500.325.377.249;Fetal Organ Maturity;D005325
G08.686.785.760.170.157.750;Fetal Organ Maturity;D005325
D12.776.320;Fetal Proteins;D005326
C13.703.243.300;Fetal Resorption;D005327
C23.550.260.460.260;Fetal Resorption;D005327
G07.280;Fetal Viability;D005328
G07.700.320.500.325.235.875;Fetal Viability;D005328
G08.686.220;Fetal Viability;D005328
F03.800.800.600.350;Fetishism (Psychiatric);D005329
C15.378.071.363.344;Fetofetal Transfusion;D005330
C16.614.053.344;Fetofetal Transfusion;D005330
C15.378.071.363.511;Fetomaternal Transfusion;D005331
C16.614.053.511;Fetomaternal Transfusion;D005331
E01.370.378.630.300;Fetoscopy;D005332
E01.370.388.250.280;Fetoscopy;D005332
E02.467.750;Fetoscopy;D005332
E04.520.280;Fetoscopy;D005332
E04.800.250.280;Fetoscopy;D005332
A16.378;Fetus;D005333
C23.888.119.344;Fever;D005334
C23.888.119.344.345;Fever of Unknown Origin;D005335
H01.671.617.249;Fiber Optic Technology;D005336
D12.776.124.270;Fibrin;D005337
D12.776.124.270.300;Fibrin Fibrinogen Degradation Products;D005338
D12.776.811.300.290;Fibrin Fibrinogen Degradation Products;D005338
D12.776.124.270.302;Fibrin Foam;D005339
D12.776.124.050.250;Fibrinogen;D005340
D12.776.124.125.500;Fibrinogen;D005340
D12.776.811.300;Fibrinogen;D005340
D23.119.490;Fibrinogen;D005340
D08.811.277.656.300.760.330;Fibrinolysin;D005341
D08.811.277.656.959.350.330;Fibrinolysin;D005341
G09.188.124.560.150.390;Fibrinolysis;D005342
D27.505.519.421.750;Fibrinolytic Agents;D005343
D27.505.954.411.320;Fibrinolytic Agents;D005343
D27.505.954.502.427;Fibrinolytic Agents;D005343
D12.644.200;Fibrinopeptide A;D005344
D12.776.124.125.515;Fibrinopeptide A;D005344
D12.776.124.270.310;Fibrinopeptide A;D005344
D12.776.811.300.310;Fibrinopeptide A;D005344
D23.101.340;Fibrinopeptide A;D005344
D23.119.500;Fibrinopeptide A;D005344
D12.644.205;Fibrinopeptide B;D005345
D12.776.124.125.530;Fibrinopeptide B;D005345
D12.776.124.270.320;Fibrinopeptide B;D005345
D12.776.811.300.320;Fibrinopeptide B;D005345
D23.119.510;Fibrinopeptide B;D005345
D12.644.276.624;Fibroblast Growth Factors;D005346
D12.776.467.624;Fibroblast Growth Factors;D005346
D23.529.624;Fibroblast Growth Factors;D005346
A11.329.228;Fibroblasts;D005347
C17.800.090.750;Fibrocystic Breast Disease;D005348
D12.776.092.500.809.500;Fibroins;D005349
D12.776.092.750.500;Fibroins;D005349
C04.557.450.565.590.340;Fibroma;D005350
C07.465.525.304;Fibromatosis, Gingival;D005351
C07.465.714.258.428.200;Fibromatosis, Gingival;D005351
C07.650.525.304;Fibromatosis, Gingival;D005351
C16.131.850.525.304;Fibromatosis, Gingival;D005351
C14.907.137.372;Fibromuscular Dysplasia;D005352
D12.776.377.715.390;Fibronectins;D005353
D12.776.395.550.350;Fibronectins;D005353
D12.776.543.550.350;Fibronectins;D005353
D12.776.860.300.450;Fibronectins;D005353
C04.557.450.565.590.350;Fibrosarcoma;D005354
C04.557.450.795.350;Fibrosarcoma;D005354
C23.550.355;Fibrosis;D005355
C05.651.324;Fibromyalgia;D005356
C05.799.321;Fibromyalgia;D005356
C10.668.491.425;Fibromyalgia;D005356
C05.116.099.708.375;Fibrous Dysplasia of Bone;D005357
C05.116.099.708.375.372;Fibrous Dysplasia, Monostotic;D005358
C05.116.099.708.375.381;Fibrous Dysplasia, Polyostotic;D005359
A02.835.232.043.650.321;Fibula;D005360
D08.811.277.656.262.500.350;Ficain;D005361
D08.811.277.656.300.200.350;Ficain;D005361
D09.698.330;Ficoll;D005362
D03.438.150.446.794.200;Ficusin;D005363
D03.494.770.200;Ficusin;D005363
D03.830.219.446.794.200;Ficusin;D005363
F02.463.593.343;Field Dependence-Independence;D005364
F02.463.593.932.345;Field Dependence-Independence;D005364
E01.370.225.625.300;FIGLU Test;D005365
E05.200.625.300;FIGLU Test;D005365
F02.463.593.932.401;Figural Aftereffect;D005366
G14.360;Figural Aftereffect;D005366
Z01.639.760.590.373;Fiji;D005367
C03.335.508.700.750.361;Filariasis;D005368
D27.505.954.122.250.075.080.275;Filaricides;D005369
B01.050.500.500.294.700.750.700.300;Filarioidea;D005370
L01.453.245.390;Filing;D005371
D02.455.326.271.665.325;Filipin;D005372
D02.540.505.290;Filipin;D005372
E05.799.638.420;Film Dosimetry;D005373
N06.850.810.370.310;Film Dosimetry;D005373
E05.196.454;Filtration;D005374
G01.595.280;Filtration;D005374
G02.149.767.600;Filtration;D005374
G02.842.750.600;Filtration;D005374
N03.219.463.030.160;Financial Audit;D005375
N03.219.463;Financial Management;D005376
N02.278.354.180;Financial Management, Hospital;D005377
N03.219.463.280;Financial Management, Hospital;D005377
N04.452.442.180;Financial Management, Hospital;D005377
N03.219.483;Financial Support;D005378
N03.219.463.300;Financing, Construction;D005379
N03.219.521.346;Financing, Government;D005380
N03.219.521;Financing, Organized;D005381
N03.219.559;Financing, Personal;D005382
C26.448.429;Finger Injuries;D005383
A02.835.583.405.350;Finger Joint;D005384
A01.378.800.667.430;Fingers;D005385
F01.145.466.263;Fingersucking;D005386
Z01.542.267;Finland;D005387
N06.230.216.500;Fire Extinguishing Systems;D005388
J01.637.870.350;Firearms;D005389
N06.230.216;Fires;D005390
F03.500.300;Firesetting Behavior;D005391
E02.365.305;First Aid;D005392
C22.362;Fish Diseases;D005393
J02.500.600.875.400.400;Fish Flour;D005394
D10.627.430;Fish Oils;D005395
J02.500.600.875.400;Fish Products;D005396
D20.888.370;Fish Venoms;D005397
D23.946.580.370;Fish Venoms;D005397
D23.946.833.370;Fish Venoms;D005397
J01.040.168.300;Fisheries;D005398
B01.050.150.900.493;Fishes;D005399
B01.050.050.286.500;Fishes, Poisonous;D005400
B01.050.150.900.493.392;Fishes, Poisonous;D005400
C06.405.469.860.101.430;Fissure in Ano;D005401
C23.300.575;Fistula;D005402
G14.640.260.253;Fixation, Ocular;D005403
D27.720.355;Fixatives;D005404
D12.644.468.281.381.300;D-Ala(2),MePhe(4),Met(0)-ol-enkephalin;D005405
D03.383.129.308.090;Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide;D005406
A11.284.180.290;Flagella;D005407
D12.776.097.380;Flagellin;D005408
C26.891.315;Flail Chest;D005409
E05.196.181.349.390;Flame Ionization;D005410
D27.720.361;Flame Retardants;D005411
B01.050.150.900.493.418;Flatfishes;D005412
C05.330.448;Flatfoot;D005413
C23.888.821.360;Flatulence;D005414
D03.438.733.315;Flavins;D005415
D03.494.507;Flavins;D005415
D08.211.474;Flavins;D005415
D23.767.405;Flavins;D005415
B04.820.250.350;Flavivirus;D005416
B04.909.777.310.350;Flavivirus;D005416
B03.140.190.250;Flavobacterium;D005417
B03.440.400.425.310.250;Flavobacterium;D005417
D12.776.097.400;Flavodoxin;D005418
D12.776.331.400;Flavodoxin;D005418
D03.438.150.266.450;Flavonoids;D005419
D03.830.219.266.450;Flavonoids;D005419
D12.776.331;Flavoproteins;D005420
D27.720.364;Flavoring Agents;D005421
J02.500.512.400;Flavoring Agents;D005421
D03.438.150.266.450.260.444;Flavoxate;D005422
D03.830.219.266.450.260.444;Flavoxate;D005422
B01.050.500.131.617.750;Siphonaptera;D005423
D03.383.621.270;Flecainide;D005424
E01.370.380.245;Flicker Fusion;D005425
F02.463.593.932.458;Flicker Fusion;D005425
G14.370;Flicker Fusion;D005425
G11.427.590.530.568.304;Flight, Animal;D005426
G11.427.590.530.698.416;Flight, Animal;D005426
E05.196.150.347;Flocculation;D005427
G02.149.767.502.347;Flocculation;D005427
G02.842.750.502.347;Flocculation;D005427
E01.370.225.812.735.645.300;Flocculation Tests;D005428
E05.196.150.347.500;Flocculation Tests;D005428
E05.200.812.735.645.300;Flocculation Tests;D005428
E05.478.594.760.645.300;Flocculation Tests;D005428
E05.478.605.492.300;Flocculation Tests;D005428
J01.086.339.140;Floors and Floorcoverings;D005430
Z01.107.567.875.750.350;Florida;D005431
B01.050.150.900.493.418.438;Flounder;D005432
J02.500.484;Flour;D005433
E01.370.225.500.363.342;Flow Cytometry;D005434
E01.370.225.500.386.350;Flow Cytometry;D005434
E05.196.712.516.600.240.350;Flow Cytometry;D005434
E05.200.500.363.342;Flow Cytometry;D005434
E05.200.500.386.350;Flow Cytometry;D005434
E05.242.363.342;Flow Cytometry;D005434
E05.242.386.350;Flow Cytometry;D005434
D02.065.589.099.750.625.150.250;Floxacillin;D005436
D02.886.108.750.625.150.250;Floxacillin;D005436
D03.438.260.825.625.150.250;Floxacillin;D005436
D03.605.084.737.625.150.250;Floxacillin;D005436
D04.075.080.875.099.221.750.625.150.250;Floxacillin;D005436
D03.383.742.698.421.431;Flucytosine;D005437
D04.808.745.745.654.600.500;Fludrocortisone;D005438
D02.241.223.100.050.400.200.249;Flufenamic Acid;D005439
D02.455.426.559.389.127.020.906.750.249;Flufenamic Acid;D005439
E02.319.360;Fluid Therapy;D005440
A12;Fluids and Secretions;D005441
D03.438.079.080.070.305;Flumazenil;D005442
D04.808.745.432.769.465;Flumethasone;D005443
D04.808.908.359;Flumethasone;D005443
D03.383.606.450;Flunarizine;D005444
D03.438.079.080.070.320;Flunitrazepam;D005445
D04.808.745.432.370;Fluocinolone Acetonide;D005446
D04.808.908.394;Fluocinolone Acetonide;D005446
D04.808.745.432.370.325;Fluocinonide;D005447
D04.808.908.394.300;Fluocinonide;D005447
D04.808.745.432.719.320;Fluocortolone;D005448
D04.808.908.405;Fluocortolone;D005448
D02.455.426.559.847.389;Fluorenes;D005449
D04.615.389;Fluorenes;D005449
D02.455.426.559.847.885.345;Fluorescamine;D005450
D04.615.885.345;Fluorescamine;D005450
E01.370.370.050.350;Fluorescein Angiography;D005451
E01.370.380.250;Fluorescein Angiography;D005451
D02.455.426.559.847.885.347;Fluoresceins;D005452
D03.494.953.275;Fluoresceins;D005452
D04.615.885.347;Fluoresceins;D005452
G01.358.500.505.650.665.500;Fluorescence;D005453
G01.590.540.665.500;Fluorescence;D005453
E05.196.712.516.600.390;Fluorescence Polarization;D005454
E01.370.225.500.607.512.240;Fluorescent Antibody Technique;D005455
E01.370.225.750.551.512.240;Fluorescent Antibody Technique;D005455
E05.200.500.607.512.240;Fluorescent Antibody Technique;D005455
E05.200.750.551.512.240;Fluorescent Antibody Technique;D005455
E05.478.412;Fluorescent Antibody Technique;D005455
E05.478.583.375;Fluorescent Antibody Technique;D005455
D27.720.233.348;Fluorescent Dyes;D005456
D27.720.470.330.348;Fluorescent Dyes;D005456
D27.720.470.410.505.500;Fluorescent Dyes;D005456
E06.761.382;Fluoridation;D005457
N06.890.235;Fluoridation;D005457
C25.723.380;Fluoride Poisoning;D005458
D01.248.497.158.380;Fluorides;D005459
D01.303.350.300;Fluorides;D005459
D01.303.350.300.512;Fluorides, Topical;D005460
D25.223.432;Fluorides, Topical;D005460
J01.637.051.223.432;Fluorides, Topical;D005460
D01.268.380.300;Fluorine;D005461
D01.496.749.340;Fluorine Radioisotopes;D005462
D02.241.081.018.285;Fluoroacetates;D005463
D02.455.526.510.286;Fluoroacetates;D005463
D02.455.526.510.432;Fluorobenzenes;D005464
D05.750.395;Fluorocarbon Polymers;D005465
D25.720.395;Fluorocarbon Polymers;D005465
J01.637.051.720.395;Fluorocarbon Polymers;D005465
D02.455.526.510.435;Fluorocarbons;D005466
D03.383.742.680.852.300.350;Floxuridine;D005467
D13.570.230.430.432;Floxuridine;D005467
D13.570.685.852.300.350;Floxuridine;D005467
D03.383.742.686.850.210.200;Fluorodeoxyuridylate;D005468
D13.695.201.200.270;Fluorodeoxyuridylate;D005468
D13.695.740.850.210.200;Fluorodeoxyuridylate;D005468
D04.808.745.432.719.349;Fluorometholone;D005469
D04.808.908.431;Fluorometholone;D005469
E05.196.712.516.600;Fluorometry;D005470
E01.370.350.700.225;Fluoroscopy;D005471
D03.383.742.698.875.404;Fluorouracil;D005472
D02.092.831.280;Fluoxetine;D005473
D04.808.054.079.429.154.349;Fluoxymesterone;D005474
D04.808.908.466;Fluoxymesterone;D005474
D02.886.952.360;Flupenthixol;D005475
D03.383.606.460;Flupenthixol;D005475
D03.494.953.704.360;Flupenthixol;D005475
D02.886.369.326;Fluphenazine;D005476
D03.494.741.326;Fluphenazine;D005476
D04.808.745.432.769.795.307;Fluprednisolone;D005477
D04.808.908.502;Fluprednisolone;D005477
D04.808.745.745.654.473;Flurandrenolone;D005478
D04.808.908.537;Flurandrenolone;D005478
D03.438.079.080.070.348;Flurazepam;D005479
D02.241.081.751.161;Flurbiprofen;D005480
D02.455.426.559.389.185.350;Flurbiprofen;D005480
D02.355.417.515;Flurothyl;D005481
C23.888.388;Flushing;D005483
D02.455.426.559.847.885.350;Fluspirilene;D005484
D03.383.129.308.290;Fluspirilene;D005484
D03.383.621.280;Fluspirilene;D005484
D04.615.885.350;Fluspirilene;D005484
D02.065.199.420;Flutamide;D005485
D03.438.733.315.650.500;Flavin Mononucleotide;D005486
D03.494.507.650.500;Flavin Mononucleotide;D005486
D08.211.474.650.500;Flavin Mononucleotide;D005486
D13.695.827.349;Flavin Mononucleotide;D005486
D23.767.405.650.500;Flavin Mononucleotide;D005486
A11.329.372.368;Foam Cells;D005487
A11.627.482.368;Foam Cells;D005487
A11.733.397.368;Foam Cells;D005487
A15.382.680.397.368;Foam Cells;D005487
A15.382.812.522.368;Foam Cells;D005487
C05.116.099.370.380;Focal Dermal Hypoplasia;D005489
C16.131.077.350.424;Focal Dermal Hypoplasia;D005489
C16.131.831.350.424;Focal Dermal Hypoplasia;D005489
C16.320.322.186;Focal Dermal Hypoplasia;D005489
C16.320.850.250.424;Focal Dermal Hypoplasia;D005489
C17.800.804.350.424;Focal Dermal Hypoplasia;D005489
C17.800.827.250.424;Focal Dermal Hypoplasia;D005489
C01.539.392;Focal Infection;D005490
C01.539.392.433;Focal Infection, Dental;D005491
C07.793.348;Focal Infection, Dental;D005491
D03.438.733.631.400;Folic Acid;D005492
D27.505.519.389.350;Folic Acid Antagonists;D005493
C18.654.521.500.133.699.308;Folic Acid Deficiency;D005494
I01.076.201.450.515;Folklore;D005495
G08.686.785.280;Follicular Atresia;D005496
C04.182.300;Follicular Cyst;D005497
G08.686.605.310;Follicular Phase;D005498
C17.800.329.500;Folliculitis;D005499
E05.318.760.500.750.500.350;Follow-Up Studies;D005500
N05.715.360.775.175.250.350;Follow-Up Studies;D005500
N06.850.520.450.500.750.350;Follow-Up Studies;D005500
J02.500;Food;D005502
D27.720.368;Food Additives;D005503
J02.500.512;Food Additives;D005503
E05.362;Food Analysis;D005504
J01.576.423.850.100;Food Analysis;D005504
D27.720.233.674;Food Coloring Agents;D005505
D27.720.368.355;Food Coloring Agents;D005505
J01.576.423.850.730.500.249;Food Contamination;D005506
N06.850.460.400;Food Contamination;D005506
N06.850.601.500.249;Food Contamination;D005506
J01.576.423.850.730.500.249.250;Food Contamination, Radioactive;D005507
N06.850.460.400.250;Food Contamination, Radioactive;D005507
N06.850.601.500.249.250;Food Contamination, Radioactive;D005507
N06.850.810.125;Food Contamination, Radioactive;D005507
F01.658.433;Food Deprivation;D005508
J01.576.423.200.350;Food Dispensers, Automatic;D005509
F01.145.407.432;Food Habits;D005510
F01.145.466.349;Food Habits;D005510
J01.576.423.200;Food Handling;D005511
C20.543.480.370;Food Hypersensitivity;D005512
J01.576.423.850.730.500.500;Food Inspection;D005513
N06.850.601.500.500;Food Inspection;D005513
N06.850.780.200.800.325;Food Inspection;D005513
J01.576.423.850.700.700.500;Food Irradiation;D005514
J01.576.423.850.600.400;Food Labeling;D005515
J01.576.761.400.450;Food Labeling;D005515
H01.158.273.540.274.332;Food Microbiology;D005516
J01.576.423.850.730.500.249.300;Food Microbiology;D005516
N06.850.425.200;Food Microbiology;D005516
N06.850.460.400.300;Food Microbiology;D005516
N06.850.601.500.249.300;Food Microbiology;D005516
C25.723.415;Foodborne Diseases;D005517
F01.145.407.516;Food Preferences;D005518
J01.576.423.850.700;Food Preservation;D005519
D27.720.368.385;Food Preservatives;D005520
J02.500.512.700;Food Preservatives;D005520
J01.576.423.500.300;Food Service, Hospital;D005521
N02.278.354.422.374;Food Service, Hospital;D005521
N02.421.242.472;Food Service, Hospital;D005521
N04.452.442.422.374;Food Service, Hospital;D005521
J01.576.423.500;Food Services;D005522
J01.576.423.750;Food Supply;D005523
J01.576.423.850;Food Technology;D005524
J01.576.423.200.400;Food-Processing Industry;D005525
J02.500.525.350;Food, Formulated;D005526
J02.500.525.400;Food, Fortified;D005527
A01.378.610.250;Foot;D005528
A02.835.232.043.300;Foot Bones;D005529
C05.330;Foot Deformities;D005530
C05.330.488;Foot Deformities, Acquired;D005531
C05.330.495;Foot Deformities, Congenital;D005532
C05.660.585.512.380;Foot Deformities, Congenital;D005532
C16.131.621.585.380;Foot Deformities, Congenital;D005532
C17.800.321.125;Foot Dermatoses;D005533
C05.360;Foot Diseases;D005534
C17.800.321;Foot Diseases;D005534
C22.394;Foot Rot;D005535
C02.782.687.484;Foot-and-Mouth Disease;D005536
C22.380;Foot-and-Mouth Disease;D005536
B04.820.565.070;Aphthovirus;D005537
B04.909.777.618.070;Aphthovirus;D005537
I03.450.642.845.300;Football;D005538
A02.835.232.781.572.434;Foramen Magnum;D005539
E01.370.386.700.660.225;Forced Expiratory Flow Rates;D005540
G09.772.650.300;Forced Expiratory Flow Rates;D005540
E01.370.386.700.660.230;Forced Expiratory Volume;D005541
G09.772.650.430;Forced Expiratory Volume;D005541
A01.378.800.585;Forearm;D005542
C26.088.268;Forearm Injuries;D005543
I01.320;Forecasting;D005544
A01.378.610.250.300;Forefoot, Human;D005545
A01.456.505.580;Forehead;D005546
C26.392;Foreign Bodies;D005547
C26.392.500;Foreign-Body Migration;D005548
C23.550.470.251;Foreign-Body Reaction;D005549
C26.392.560;Foreign-Body Reaction;D005549
M01.526.407.435;Foreign Medical Graduates;D005550
M01.526.485.810.390;Foreign Medical Graduates;D005550
N02.360.810.390;Foreign Medical Graduates;D005550
M01.526.407;Foreign Professional Personnel;D005551
A13.395;Forelimb;D005552
H02.163.285;Forensic Dentistry;D005553
I01.198.780.875;Forensic Dentistry;D005553
H02.403.330;Forensic Medicine;D005554
I01.198.780.937;Forensic Medicine;D005554
F04.096.544.335;Forensic Psychiatry;D005555
H02.403.690.208;Forensic Psychiatry;D005555
I01.198.780.937.469;Forensic Psychiatry;D005555
I01.880.604.583.310;Forensic Psychiatry;D005555
N03.706.535.351;Forensic Psychiatry;D005555
F02.463.593.373;Form Perception;D005556
F02.463.593.932.869.435;Form Perception;D005556
D02.047.407;Formaldehyde;D005557
D08.811.277.087.100;Arylformamidase;D005558
D02.065.463;Formamides;D005559
D02.241.081.420.500;Formamides;D005559
D08.811.682.657.180;Formate Dehydrogenases;D005560
D02.241.081.420;Formates;D005561
D02.172.600;Formazans;D005562
D02.241.081.420.750;Formic Acid Esters;D005563
D02.241.081.337.351.300;Formiminoglutamic Acid;D005565
D02.047.407.518;Formocresols;D005566
D02.455.426.559.389.657.239.611;Formocresols;D005566
N04.452.758.708.200.400;Forms and Records Control;D005568
L01.178.682.192.836.535;Formularies as Topic;D005569
L01.178.682.192.836.535.310;Formularies, Dental;D005570
L01.178.682.192.836.535.435;Formularies, Homeopathic;D005571
L01.178.682.192.836.535.561;Formularies, Hospital;D005572
D03.383.742.680.350;Formycins;D005573
D13.570.685.350;Formycins;D005573
D13.570.800.410;Formycins;D005573
D08.811.464.259.550;Formate-Tetrahydrofolate Ligase;D005574
D03.438.733.631.400.800.350;Formyltetrahydrofolates;D005575
D08.211.840.300;Formyltetrahydrofolates;D005575
D02.455.849.291.300;Forskolin;D005576
D23.050.244.436;Forssman Antigen;D005577
D02.705.429.625;Fosfomycin;D005578
D20.345;Fossil Fuels;D005579
N06.230.132.258;Fossil Fuels;D005579
I01.076.368.584.311;Fossils;D005580
E02.760.352;Foster Home Care;D005581
I01.880.787.416;Foster Home Care;D005581
N02.421.143.452;Foster Home Care;D005581
N02.421.585.352;Foster Home Care;D005581
N03.219.483.311;Foundations;D005582
N03.540.630.180;Foundations;D005582
E05.377;Fourier Analysis;D005583
G17.226;Fourier Analysis;D005583
L01.224.800.625;Fourier Analysis;D005583
A09.371.729.522.436;Fovea Centralis;D005584
C02.782.620.375;Influenza in Birds;D005585
C22.131.450;Influenza in Birds;D005585
C22.131.728.450;Influenza in Birds;D005585
C02.256.743.366;Fowlpox;D005586
C22.131.321;Fowlpox;D005586
B04.280.650.160.100.300;Fowlpox virus;D005587
B04.909.204.783.160.100.300;Fowlpox virus;D005587
C17.800.946.492.285;Fox-Fordyce Disease;D005588
B01.050.150.900.649.147.153.250;Foxes;D005589
E05.196.150.519;Fractional Precipitation;D005590
E05.196.155;Chemical Fractionation;D005591
E04.555.300;Fracture Fixation;D005592
E04.555.300.300;Fracture Fixation, Internal;D005593
E04.555.300.300.300;Fracture Fixation, Intramedullary;D005594
C26.404.124;Fractures, Closed;D005596
C26.404.311;Fractures, Open;D005597
C26.404.374;Fractures, Spontaneous;D005598
C26.404.468;Fractures, Ununited;D005599
C10.597.606.643.455.500;Fragile X Syndrome;D005600
C16.131.260.830.300;Fragile X Syndrome;D005600
C16.320.180.830.300;Fragile X Syndrome;D005600
C16.320.322.500.500;Fragile X Syndrome;D005600
C16.320.400.525.500;Fragile X Syndrome;D005600
D09.408.051.623.300;Framycetin;D005601
Z01.542.286;France;D005602
B03.440.400.425.340;Francisella;D005603
B03.660.250.200;Francisella;D005603
B03.440.400.425.340.590;Francisella tularensis;D005604
B03.660.250.200.750;Francisella tularensis;D005604
D01.268.271.380;Francium;D005605
D01.268.549.250;Francium;D005605
D01.268.556.277;Francium;D005605
D01.552.528.328;Francium;D005605
D01.552.544.277;Francium;D005605
B01.650.940.800.575.100.840.666;Rhamnus;D005606
I01.198.240.300;Fraud;D005607
F04.754.709.437;Free Association;D005608
D01.339;Free Radicals;D005609
D02.389;Free Radicals;D005609
I01.880.604.473.380;Freedom;D005610
N03.706.437.380;Freedom;D005610
C12.706.316.795.124;Freemartinism;D005611
C13.351.875.253.795.124;Freemartinism;D005611
C16.131.939.316.795.124;Freemartinism;D005611
C19.391.119.795.124;Freemartinism;D005611
C22.196.339;Freemartinism;D005611
E01.370.225.500.620.760.160.260;Freeze Drying;D005612
E01.370.225.750.600.760.160.260;Freeze Drying;D005612
E02.792.156.260;Freeze Drying;D005612
E05.200.500.620.760.160.260;Freeze Drying;D005612
E05.200.750.600.760.160.260;Freeze Drying;D005612
E05.760.156.260;Freeze Drying;D005612
E01.370.225.500.620.620.260.400;Freeze Etching;D005613
E01.370.225.750.600.620.260.400;Freeze Etching;D005613
E05.200.500.620.620.260.400;Freeze Etching;D005613
E05.200.750.600.620.260.400;Freeze Etching;D005613
E01.370.225.500.620.620.260;Freeze Fracturing;D005614
E01.370.225.750.600.620.260;Freeze Fracturing;D005614
E05.200.500.620.620.260;Freeze Fracturing;D005614
E05.200.750.600.620.260;Freeze Fracturing;D005614
G01.595.680.500;Freezing;D005615
G01.906.595.272.437;Freezing;D005615
G02.149.767.680.466;Freezing;D005615
G02.842.750.680.466;Freezing;D005615
Z01.107.757.435;French Guiana;D005616
D02.455.526.439.220.300;Chlorofluorocarbons, Methane;D005617
D02.455.526.510.140.300;Chlorofluorocarbons, Methane;D005617
G16.500.275.280;Fresh Water;D005618
N06.230.232;Fresh Water;D005618
F02.739.794.297;Freudian Theory;D005619
D20.475;Freund's Adjuvant;D005620
C10.228.140.252.700.150;Friedreich Ataxia;D005621
C10.228.854.787.200;Friedreich Ataxia;D005621
C10.574.500.825.200;Friedreich Ataxia;D005621
C16.320.400.780.200;Friedreich Ataxia;D005621
C18.452.660.300;Friedreich Ataxia;D005621
B04.820.650.375.525.225;Friend murine leukemia virus;D005622
B04.909.574.807.375.525.225;Friend murine leukemia virus;D005622
B04.909.777.731.375.525.225;Friend murine leukemia virus;D005622
A02.835.232.781.375;Frontal Bone;D005624
A08.186.211.730.885.287.500.270;Frontal Lobe;D005625
A04.531.621.387;Frontal Sinus;D005626
C26.417;Frostbite;D005627
J02.500.521.500;Frozen Foods;D005628
E01.370.225.500.620.530.160.260;Frozen Sections;D005629
E01.370.225.750.600.530.160.260;Frozen Sections;D005629
E05.200.500.620.530.160.260;Frozen Sections;D005629
E05.200.750.600.530.160.260;Frozen Sections;D005629
D09.698.350;Fructans;D005630
D08.811.913.696.620.225;Fructokinases;D005631
D09.546.359.250;Fructose;D005632
D09.546.465.354;Fructose;D005632
C16.320.565.202.251.271;Fructose Intolerance;D005633
C18.452.648.202.251.271;Fructose Intolerance;D005633
D08.811.520.224.062.400;Fructose-Bisphosphate Aldolase;D005634
D09.894.417.313.300;Fructosediphosphates;D005635
D09.894.417.592.300;Fructosediphosphates;D005635
D09.894.417.313;Fructosephosphates;D005636
D08.811.682.047.150.225;Fructuronate Reductase;D005637
A18.024.500;Fruit;D005638
J02.500.562;Fruit;D005638
F01.470.405;Frustration;D005639
D06.472.699.322.576.288;Follicle Stimulating Hormone;D005640
D06.472.699.631.525.343.288;Follicle Stimulating Hormone;D005640
D12.644.548.691.525.343.288;Follicle Stimulating Hormone;D005640
D03.383.742.698.875.404.850;Tegafur;D005641
C11.204.236.438;Fuchs' Endothelial Dystrophy;D005642
C11.270.162.438;Fuchs' Endothelial Dystrophy;D005642
C16.320.290.162.410;Fuchs' Endothelial Dystrophy;D005642
D09.254.488;Fucose;D005643
D09.546.359.313;Fucose;D005643
D08.811.277.450.050;alpha-L-Fucosidase;D005644
C10.228.140.163.100.435.295;Fucosidosis;D005645
C16.320.565.189.435.295;Fucosidosis;D005645
C16.320.565.202.303;Fucosidosis;D005645
C16.320.565.595.554.295;Fucosidosis;D005645
C18.452.132.100.435.295;Fucosidosis;D005645
C18.452.648.189.435.295;Fucosidosis;D005645
C18.452.648.202.303;Fucosidosis;D005645
C18.452.648.595.554.295;Fucosidosis;D005645
D08.811.913.400.100.200.300;Fucosyl Galactose alpha-N-Acetylgalactosaminyltransferase;D005646
D08.811.913.400.450.300;Fucosyltransferases;D005647
D20.345.630.500;Fuel Oils;D005648
N06.230.132.258.630.500;Fuel Oils;D005648
D08.811.520.241.300.300;Fumarate Hydratase;D005649
D02.241.081.337.302;Fumarates;D005650
N06.850.780.200.300;Fumigation;D005651
E01.370.386.700.485.750.275;Functional Residual Capacity;D005652
G09.772.850.390;Functional Residual Capacity;D005652
N03.219.463.360;Fund Raising;D005653
A09.371.729.313;Fundus Oculi;D005654
I01.076.201.450.550;Funeral Rites;D005655
D12.776.354;Fungal Proteins;D005656
D20.215.894.354;Fungal Vaccines;D005657
B01.300;Fungi;D005658
D27.720.031.700.288;Fungicides, Industrial;D005659
D27.720.723.288;Fungicides, Industrial;D005659
D27.888.723.288;Fungicides, Industrial;D005659
C05.116.099.386;Funnel Chest;D005660
C05.660.386;Funnel Chest;D005660
C16.131.621.386;Funnel Chest;D005660
D02.640.600.308;Furagin;D005661
D03.383.312.649.308;Furagin;D005661
D02.047.466;Furaldehyde;D005662
D03.383.312.355;Furaldehyde;D005662
D03.383.312;Furans;D005663
D02.640.600.313;Furazolidone;D005664
D03.383.129.462.600.500;Furazolidone;D005664
D03.383.312.649.313;Furazolidone;D005664
D02.065.884.725.300;Furosemide;D005665
D02.092.146.807.300;Furosemide;D005665
D02.886.590.700.725.300;Furosemide;D005665
D02.886.675.900.300;Fursultiamin;D005666
D03.383.129.708.900.300;Fursultiamin;D005666
D03.383.742.225;Fursultiamin;D005666
D03.383.742.795.300;Fursultiamin;D005666
C01.252.410.868.820.270;Furunculosis;D005667
C01.252.825.770.270;Furunculosis;D005667
C01.539.800.720.770.270;Furunculosis;D005667
C17.800.838.765.770.270;Furunculosis;D005667
C22.362.224;Furunculosis;D005667
D02.640.600.330;Furylfuramide;D005668
D03.383.312.649.330;Furylfuramide;D005668
D03.066.707.200;Fusaric Acid;D005669
D03.383.725.705.200;Fusaric Acid;D005669
B01.300.381.366;Fusarium;D005670
C07.650.800.370;Fused Teeth;D005671
C07.793.700.370;Fused Teeth;D005671
C16.131.850.800.370;Fused Teeth;D005671
D04.808.247.222.222.347.389;Fusidic Acid;D005672
D04.808.247.808.489;Fusidic Acid;D005672
B03.370.250;Fusobacterium;D005673
B03.440.425.410.420;Fusobacterium;D005673
C01.252.400.388.350;Fusobacterium Infections;D005674
B03.370.250.400;Fusobacterium necrophorum;D005675
B03.440.425.410.420.400;Fusobacterium necrophorum;D005675
E07.440;Gravity Suits;D005676
D09.400.410.420.025.475.390;G(M1) Ganglioside;D005677
D10.390.470.025.475.390;G(M1) Ganglioside;D005677
D10.570.877.360.025.475.390;G(M1) Ganglioside;D005677
D09.400.410.420.025.475.400;G(M2) Ganglioside;D005678
D10.390.470.025.475.400;G(M2) Ganglioside;D005678
D10.570.877.360.025.475.400;G(M2) Ganglioside;D005678
D09.400.410.420.025.475.510;G(M3) Ganglioside;D005679
D10.390.470.025.475.510;G(M3) Ganglioside;D005679
D10.570.877.360.025.475.510;G(M3) Ganglioside;D005679
D02.241.081.114.500.350;gamma-Aminobutyric Acid;D005680
D12.125.190.350;gamma-Aminobutyric Acid;D005680
Z01.058.290.100.380;Gabon;D005681
D01.268.477.484;Gadolinium;D005682
D01.268.558.362.484;Gadolinium;D005682
D01.552.550.399.484;Gadolinium;D005682
C23.888.821.414;Gagging;D005683
G11.561.600.765.251;Gagging;D005683
E01.370.600.250;Gait;D005684
G11.427.590.530.389;Gait;D005684
D09.698.360;Galactans;D005685
D08.811.913.696.620.240;Galactokinase;D005686
C13.703.844.506.389;Galactorrhea;D005687
C17.800.090.937.439;Galactorrhea;D005687
D09.067.342.356;Galactosamine;D005688
D09.546.359.377;Galactose;D005690
D08.811.682.047.150.250;Galactose Dehydrogenases;D005691
D08.811.682.047.210;Galactose Oxidase;D005692
C10.228.140.163.100.320;Galactosemias;D005693
C16.320.565.189.320;Galactosemias;D005693
C16.320.565.202.355;Galactosemias;D005693
C18.452.132.100.320;Galactosemias;D005693
C18.452.648.189.320;Galactosemias;D005693
C18.452.648.202.355;Galactosemias;D005693
D08.811.913.696.445.900;UTP-Hexose-1-Phosphate Uridylyltransferase;D005694
D09.894.417.370;Galactosephosphates;D005695
D08.811.277.450.410;Galactosidases;D005696
D09.408.320;Galactosides;D005697
D08.811.277.450.410.120;Galactosylceramidase;D005698
D02.065.313.250.450;Galactosylceramides;D005699
D09.400.410.420.525.200.250.450;Galactosylceramides;D005699
D10.390.470.675.200.250.450;Galactosylceramides;D005699
D10.570.877.360.612.200.250.450;Galactosylceramides;D005699
D08.811.913.400.450.400;Galactosyltransferases;D005700
B01.050.150.900.649.801.700.572.408;Galago;D005701
D03.132.052.500;Galantamine;D005702
D03.438.079.525;Galantamine;D005702
D02.092.877.400;Gallamine Triethiodide;D005703
D02.675.276.400;Gallamine Triethiodide;D005703
A03.159.439;Gallbladder;D005704
C06.130.564;Gallbladder Diseases;D005705
C04.588.274.120.401;Gallbladder Neoplasms;D005706
C06.130.320.401;Gallbladder Neoplasms;D005706
C06.130.564.401;Gallbladder Neoplasms;D005706
C06.301.120.401;Gallbladder Neoplasms;D005706
D02.241.223.100.300.200;Gallic Acid;D005707
D02.241.511.390.200;Gallic Acid;D005707
D02.455.426.559.389.127.281.200;Gallic Acid;D005707
D02.455.426.559.389.657.410.200;Gallic Acid;D005707
D01.268.556.289;Gallium;D005708
D01.552.544.289;Gallium;D005708
D01.496.360;Gallium Isotopes;D005709
D01.496.360.400;Gallium Radioisotopes;D005710
D01.496.749.360;Gallium Radioisotopes;D005710
D02.092.471.683.953.395;Gallopamil;D005711
F02.830.702.315;Galvanic Skin Response;D005712
F04.669.332;Galvanic Skin Response;D005712
G07.265.337.249;Galvanic Skin Response;D005712
G07.700.240.249;Galvanic Skin Response;D005712
G13.750.829.320;Galvanic Skin Response;D005712
Z01.058.290.190.300;Gambia;D005714
F01.145.722.408;Gambling;D005715
F03.500.400;Gambling;D005715
H01.548.330;Game Theory;D005716
H01.548.330.356;Games, Experimental;D005717
G04.299.151.650;Gametogenesis;D005718
G08.686.785.760.310;Gametogenesis;D005718
D12.776.124.486.485.397;gamma-Globulins;D005719
D12.776.124.790.651.397;gamma-Globulins;D005719
D12.776.377.715.548.397;gamma-Globulins;D005719
G01.358.500.505.300;Gamma Rays;D005720
G01.750.250.300;Gamma Rays;D005720
G01.750.750.400;Gamma Rays;D005720
D08.811.464.259.850.400;Glutamate-Cysteine Ligase;D005721
D08.811.913.050.200.400;gamma-Glutamylcyclotransferase;D005722
D08.811.913.050.200.500;gamma-Glutamyltransferase;D005723
A08.340;Ganglia;D005724
A08.340.315;Ganglia, Autonomic;D005725
A08.800.050.300;Ganglia, Autonomic;D005725
A08.340.315.300;Ganglia, Parasympathetic;D005726
A08.800.050.300.250;Ganglia, Parasympathetic;D005726
A08.800.050.600.300;Ganglia, Parasympathetic;D005726
A08.340.390.340;Ganglia, Spinal;D005727
A08.800.350.340;Ganglia, Spinal;D005727
A08.800.800.720.725.350;Ganglia, Spinal;D005727
A08.340.315.350;Ganglia, Sympathetic;D005728
A08.800.050.300.300;Ganglia, Sympathetic;D005728
A08.800.050.800.300;Ganglia, Sympathetic;D005728
C04.557.465.625.600.355;Ganglioneuroma;D005729
C04.557.470.670.355;Ganglioneuroma;D005729
C04.557.580.625.600.355;Ganglioneuroma;D005729
D27.505.696.663.050.340;Ganglionic Blockers;D005730
D27.505.696.663.050.400;Ganglionic Stimulants;D005731
D09.400.410.420.025.475;Gangliosides;D005732
D10.390.470.025.475;Gangliosides;D005732
D10.570.877.360.025.475;Gangliosides;D005732
C10.228.140.163.100.435.825.300;Gangliosidoses;D005733
C16.320.565.189.435.825.300;Gangliosidoses;D005733
C16.320.565.398.641.803.350;Gangliosidoses;D005733
C16.320.565.595.554.825.300;Gangliosidoses;D005733
C18.452.132.100.435.825.300;Gangliosidoses;D005733
C18.452.584.687.803.350;Gangliosidoses;D005733
C18.452.648.189.435.825.300;Gangliosidoses;D005733
C18.452.648.398.641.803.350;Gangliosidoses;D005733
C18.452.648.595.554.825.300;Gangliosidoses;D005733
C23.550.717.427;Gangrene;D005734
N06.850.860.510.900.600.400;Garbage;D005735
C04.557.470.035.215.100.500;Gardner Syndrome;D005736
C04.588.274.476.411.307.089.393;Gardner Syndrome;D005736
C04.588.274.476.411.307.180.089.500;Gardner Syndrome;D005736
C04.700.100.392;Gardner Syndrome;D005736
C06.301.371.411.307.180.089.500;Gardner Syndrome;D005736
C06.405.249.411.307.180.089.500;Gardner Syndrome;D005736
C06.405.469.158.356.180.089.500;Gardner Syndrome;D005736
C06.405.469.491.307.180.089.500;Gardner Syndrome;D005736
C06.405.469.578.249.393;Gardner Syndrome;D005736
C16.131.077.393;Gardner Syndrome;D005736
C16.320.700.100.393;Gardner Syndrome;D005736
B01.650.940.800.575.100.610.100.300;Garlic;D005737
J02.500.850.100.300;Garlic;D005737
C01.252.410.222.440;Gas Gangrene;D005738
C25.723.455;Gas Poisoning;D005739
D01.362;Gases;D005740
D01.268.613;Noble Gases;D005741
D01.362.641;Noble Gases;D005741
D20.345.630.540;Gasoline;D005742
N06.230.132.258.630.540;Gasoline;D005742
E04.210.419;Gastrectomy;D005743
A12.200.307.603;Gastric Acid;D005744
E01.370.225.124.300;Gastric Acidity Determination;D005745
E01.370.372.300;Gastric Acidity Determination;D005745
E05.200.124.300;Gastric Acidity Determination;D005745
G10.261.326.310.400;Gastric Emptying;D005746
C06.267.375;Gastric Fistula;D005747
C23.300.575.185.375;Gastric Fistula;D005747
A03.556.875.875.419;Gastric Fundus;D005748
D06.472.317.400;Gastric Inhibitory Polypeptide;D005749
D06.472.699.275;Gastric Inhibitory Polypeptide;D005749
D12.644.400.300;Gastric Inhibitory Polypeptide;D005749
D12.644.548.275;Gastric Inhibitory Polypeptide;D005749
D12.776.641.650.300;Gastric Inhibitory Polypeptide;D005749
A12.200.307;Gastric Juice;D005750
E05.927.441;Gastric Lavage;D005751
D12.776.395.560.631.300;Gastric Mucins;D005752
A03.556.875.875.440;Gastric Mucosa;D005753
A10.615.550.291;Gastric Mucosa;D005753
D06.472.317.413;Gastrins;D005755
D06.472.699.280;Gastrins;D005755
D12.644.400.320;Gastrins;D005755
D12.644.548.280;Gastrins;D005755
D12.776.641.650.320;Gastrins;D005755
C06.405.205.697;Gastritis;D005756
C06.405.748.398;Gastritis;D005756
C06.405.205.697.394;Gastritis, Atrophic;D005757
C06.405.748.398.394;Gastritis, Atrophic;D005757
C06.405.205.697.410;Gastritis, Hypertrophic;D005758
C06.405.748.398.410;Gastritis, Hypertrophic;D005758
C06.405.205;Gastroenteritis;D005759
B04.820.504.540.150.800;Transmissible gastroenteritis virus;D005760
B04.909.777.500.540.150.800;Transmissible gastroenteritis virus;D005760
C02.782.600.550.200.400;Gastroenteritis, Transmissible, of Swine;D005761
C22.905.469;Gastroenteritis, Transmissible, of Swine;D005761
H02.403.429.405;Gastroenterology;D005762
E04.035.398;Gastroenterostomy;D005763
E04.210.457;Gastroenterostomy;D005763
C06.405.117.119.500.484;Gastroesophageal Reflux;D005764
D27.505.954.483;Gastrointestinal Agents;D005765
A12.519;Gastrointestinal Contents;D005766
C06.405;Gastrointestinal Diseases;D005767
D06.472.317;Gastrointestinal Hormones;D005768
G10.261.326.310;Gastrointestinal Motility;D005769
C04.588.274.476;Gastrointestinal Neoplasms;D005770
C06.301.371;Gastrointestinal Neoplasms;D005770
C06.405.249;Gastrointestinal Neoplasms;D005770
E01.370.372.310;Gastrointestinal Transit;D005772
G10.261.326.310.525;Gastrointestinal Transit;D005772
E01.370.372.250.250.325;Gastroscopy;D005773
E01.370.388.250.250.250.320;Gastroscopy;D005773
E04.210.240.250.320;Gastroscopy;D005773
E04.800.250.250.250.320;Gastroscopy;D005773
E04.210.496;Gastrostomy;D005774
E04.579.408;Gastrostomy;D005774
A16.331.600;Gastrula;D005775
C10.228.140.163.100.435.825.400;Gaucher Disease;D005776
C16.320.565.189.435.825.400;Gaucher Disease;D005776
C16.320.565.398.641.803.441;Gaucher Disease;D005776
C16.320.565.595.554.825.400;Gaucher Disease;D005776
C18.452.132.100.435.825.400;Gaucher Disease;D005776
C18.452.584.687.803.441;Gaucher Disease;D005776
C18.452.648.189.435.825.400;Gaucher Disease;D005776
C18.452.648.398.641.803.441;Gaucher Disease;D005776
C18.452.648.595.554.825.400;Gaucher Disease;D005776
B01.050.150.900.248.050.350;Geese;D005777
B01.050.150.900.248.617.492;Geese;D005777
D02.455.849.440;Gefarnate;D005778
D10.251.355.350;Gefarnate;D005778
E01.370.225.812.735.645.350;Immunodiffusion;D005779
E05.200.812.735.645.350;Immunodiffusion;D005779
E05.478.594.760.645.350;Immunodiffusion;D005779
E05.478.605.492.350;Immunodiffusion;D005779
D12.776.860.476;Gelatin;D005780
E07.858.740.300;Gelatin Sponge, Absorbable;D005781
D20.280.320;Gels;D005782
D26.255.165.320;Gels;D005782
D27.720.280.165.320;Gels;D005782
F01.393.446.250;Gender Identity;D005783
F01.752.747.385.200;Gender Identity;D005783
F01.752.747.722.200;Gender Identity;D005783
F02.739.794.793.200;Gender Identity;D005783
G05.355.315.250;Gene Amplification;D005784
G05.355.600.315;Gene Amplification;D005784
G05.365.590.310;Gene Amplification;D005784
G05.355.760.615.475;Gene Conversion;D005785
G05.355.315;Gene Expression Regulation;D005786
G05.330;Gene Frequency;D005787
G05.345;Gene Pool;D005788
K01.400.359;Genealogy and Heraldry;D005789
I01.880.735.784.350;General Adaptation Syndrome;D005790
E02.760;Patient Care;D005791
N02.421.585;Patient Care;D005791
H02.163.342;General Practice, Dental;D005792
F02.463.425.357;Generalization (Psychology);D005793
F02.463.425.357.359;Generalization, Response;D005794
F02.463.425.357.526;Generalization, Stimulus;D005795
G05.360.340.024.340;Genes;D005796
G05.360.340.024.340.425.412;Genes, araC;D005797
G05.360.340.024.340.210;Genes, Bacterial;D005798
G05.360.340.300.249;Genes, Bacterial;D005798
G05.360.340.024.340.240;Genes, Dominant;D005799
G05.420.320;Genes, Dominant;D005799
G05.360.340.024.340.290;Genes, Fungal;D005800
G05.360.340.325.500;Genes, Fungal;D005800
G05.360.340.024.340.230.500;Genes, Homeobox;D005801
G05.360.340.024.340.610.600;Genes, MHC Class II;D005802
G05.360.340.024.380.500.600;Genes, MHC Class II;D005802
G12.500.500.600;Genes, MHC Class II;D005802
G05.360.340.024.340.335;Genes, Immunoglobulin;D005803
G12.500.299;Genes, Immunoglobulin;D005803
G05.360.340.024.340.350;Genes, Lethal;D005804
G05.360.340.024.340.610.595;Genes, MHC Class I;D005805
G05.360.340.024.380.500.595;Genes, MHC Class I;D005805
G12.500.500.595;Genes, MHC Class I;D005805
G05.360.340.024.340.385;Genes, Overlapping;D005807
G05.360.340.024.340.415;Genes, Recessive;D005808
G05.420.325;Genes, Recessive;D005808
G05.360.340.024.340.425;Genes, Regulator;D005809
G05.360.340.024.340.645;Multigene Family;D005810
G05.360.340.024.340.425.420;Genes, Switch;D005812
G05.360.340.024.340.465;Genes, Synthetic;D005813
G05.360.340.024.340.490;Genes, Viral;D005814
G05.360.340.400.500;Genes, Viral;D005814
G05.360.335;Genetic Code;D005815
E05.393.281.526;Genetic Complementation Test;D005816
H01.158.273.343.315.384;Genetic Counseling;D005817
N02.421.308.400;Genetic Counseling;D005817
E05.393.420;Genetic Engineering;D005818
D23.101.387;Genetic Markers;D005819
G05.695.450;Genetic Markers;D005819
E01.370.225.562;Genetic Testing;D005820
E05.200.562;Genetic Testing;D005820
E05.393.435;Genetic Testing;D005820
N02.421.143.827.233.221;Genetic Testing;D005820
N02.421.308.430;Genetic Testing;D005820
E05.393;Genetic Techniques;D005821
G05.360.337;Genetic Vectors;D005822
H01.158.273.343;Genetics;D005823
F04.096.276;Genetics, Behavioral;D005824
H01.158.273.343.290;Genetics, Behavioral;D005824
H01.158.273.343.315;Genetics, Medical;D005826
H02.403.350;Genetics, Medical;D005826
H01.158.273.343.330;Genetics, Microbial;D005827
H01.158.273.540.367;Genetics, Microbial;D005827
H01.158.273.343.335;Genetics, Population;D005828
A08.186.211.730.317.826.701.444;Geniculate Bodies;D005829
A08.340.390.380;Geniculate Ganglion;D005830
A08.800.350.380;Geniculate Ganglion;D005830
A08.800.800.120.250.280;Geniculate Ganglion;D005830
C13.351.500;Genital Diseases, Female;D005831
C12.294;Genital Diseases, Male;D005832
C04.588.945.418;Genital Neoplasms, Female;D005833
C13.351.937.418;Genital Neoplasms, Female;D005833
C04.588.945.440;Genital Neoplasms, Male;D005834
C12.294.260;Genital Neoplasms, Male;D005834
C12.758.409;Genital Neoplasms, Male;D005834
A05.360;Genitalia;D005835
A05.360.319;Genitalia, Female;D005836
A05.360.444;Genitalia, Male;D005837
G05.380;Genotype;D005838
D09.408.051.374;Gentamicins;D005839
D02.092.146.400;Gentian Violet;D005840
D02.241.223.100.300.595.405;Gentisates;D005841
D02.241.511.390.595.405;Gentisates;D005841
D02.455.426.559.389.127.281.595.405;Gentisates;D005841
D02.455.426.559.389.657.410.595.405;Gentisates;D005841
Z01;Geographic Locations;D005842
H01.277.500;Geography;D005843
H01.277.562;Geology;D005844
Z01.107.567.875.075.250;Georgia;D005845
Z01.107.567.875.750.370;Georgia;D005845
Z01.542.900.420;Georgia (Republic);D005846
Z01.586.200.420;Georgia (Republic);D005846
Z01.586.950.420;Georgia (Republic);D005846
C01.703.392;Geotrichosis;D005847
B01.300.381.380;Geotrichum;D005848
B01.050.150.900.649.865.635.300;Gerbillinae;D005849
H02.163.394;Geriatric Dentistry;D005850
H02.478.676.236;Geriatric Nursing;D005851
N02.421.533.245;Geriatric Nursing;D005851
F04.096.544.380;Geriatric Psychiatry;D005852
H02.403.690.260;Geriatric Psychiatry;D005852
H02.403.355;Geriatrics;D005853
A05.360.490;Germ Cells;D005854
A11.497;Germ Cells;D005854
A16.504;Germ Layers;D005855
G06.320;Germ-Free Life;D005856
D01.268.513.750;Germanium;D005857
D01.268.556.305;Germanium;D005857
D01.552.544.305;Germanium;D005857
Z01.542.315;Germany;D005858
Z01.586.315;Germany;D005858
Z01.542.315.315;Germany, East;D005859
Z01.586.315.315;Germany, East;D005859
Z01.542.315.440;Germany, West;D005860
Z01.586.315.440;Germany, West;D005860
D03.132.920.256.310;Germine Acetates;D005861
D03.549.256.310;Germine Acetates;D005861
C10.597.606.762.100.300;Gerstmann Syndrome;D005862
C23.888.592.604.764.100.300;Gerstmann Syndrome;D005862
F01.700.750.100.300;Gerstmann Syndrome;D005862
F02.739.527;Gestalt Theory;D005863
F04.754.360;Gestalt Therapy;D005864
G07.700.320.500.325.235.968;Gestational Age;D005865
G08.686.320;Gestational Age;D005865
D04.808.668.651.693.362;Gestonorone Caproate;D005866
D04.808.745.745.654.527;Gestonorone Caproate;D005866
D04.808.668.651.568.620.400;Gestrinone;D005867
F01.145.209.530.538.445;Gestures;D005868
Z01.058.290.190.320;Ghana;D005869
C04.557.450.565.380;Giant Cell Tumors;D005870
C15.604.515.245;Giant Lymph Node Hyperplasia;D005871
C20.683.515.250;Giant Lymph Node Hyperplasia;D005871
B01.237.385;Giardia;D005872
C03.432.481;Giardiasis;D005873
C03.752.400;Giardiasis;D005873
C06.405.469.452.481;Giardiasis;D005873
B01.300.107.501.400;Gibberella;D005874
D02.455.849.291.239.500;Gibberellins;D005875
Z01.542.335;Gibraltar;D005876
C05.116.099.492;Gigantism;D005877
C05.116.132.479;Gigantism;D005877
C19.700.355.528;Gigantism;D005877
C16.320.565.300.528;Gilbert Disease;D005878
C18.452.648.300.528;Gilbert Disease;D005878
C10.228.140.079.898;Tourette Syndrome;D005879
C10.228.662.825.800;Tourette Syndrome;D005879
C10.574.500.850;Tourette Syndrome;D005879
C16.320.400.820;Tourette Syndrome;D005879
F03.550.825.850;Tourette Syndrome;D005879
A13.421;Gills;D005880
A14.549.167.646.480;Gingiva;D005881
C07.465.714.258;Gingival Diseases;D005882
A12.383.500;Gingival Crevicular Fluid;D005883
C07.465.625.446;Gingival Hemorrhage;D005884
C07.465.714.258.250;Gingival Hemorrhage;D005884
C23.550.414.922.500;Gingival Hemorrhage;D005884
C07.465.714.258.428.250;Gingival Hyperplasia;D005885
C07.465.714.258.428.260;Gingival Hypertrophy;D005886
C04.588.443.591.402;Gingival Neoplasms;D005887
C07.465.565.402;Gingival Neoplasms;D005887
C07.465.714.258.409;Gingival Neoplasms;D005887
C07.465.714.258.480.360;Gingival Pocket;D005888
C07.465.714.258.447;Gingival Recession;D005889
C07.465.714.354.625;Gingival Recession;D005889
E04.545.350;Gingivectomy;D005890
E06.645.350;Gingivectomy;D005890
E06.721.321;Gingivectomy;D005890
C07.465.714.258.480;Gingivitis;D005891
C01.252.400.388.350.400;Gingivitis, Necrotizing Ulcerative;D005892
C01.539.424;Gingivitis, Necrotizing Ulcerative;D005892
C07.465.714.258.480.446;Gingivitis, Necrotizing Ulcerative;D005892
E04.545.355;Gingivoplasty;D005893
E06.645.355;Gingivoplasty;D005893
E06.721.384;Gingivoplasty;D005893
B01.650.940.800.575.100.087.500;Panax;D005894
A13.853.363;Gizzard;D005895
C01.252.400.170.400;Glanders;D005896
C22.488.409;Glanders;D005896
D02.241.223.100.050.400.300;Glafenine;D005897
D02.455.426.559.389.127.020.906.875;Glafenine;D005897
J01.637.241.400;Glass;D005898
J01.637.437;Glass;D005898
D25.339.291.402;Glass Ionomer Cements;D005899
J01.637.051.339.291.402;Glass Ionomer Cements;D005899
D02.455.849.919.570.500;Glaucarubin;D005900
D03.830.363;Glaucarubin;D005900
C11.525.381;Glaucoma;D005901
C11.525.381.407;Glaucoma, Open-Angle;D005902
D12.776.765.725.500.500.400;Gliadin;D005903
D05.750.078.593.400;Glial Fibrillary Acidic Protein;D005904
D12.776.220.475.400;Glial Fibrillary Acidic Protein;D005904
D02.886.590.795.575;Glyburide;D005905
D02.948.828.575;Glyburide;D005905
D02.886.590.795.475;Gliclazide;D005907
D02.948.828.475;Gliclazide;D005907
C04.557.465.625.600.380.080.335;Glioblastoma;D005909
C04.557.470.670.380.080.335;Glioblastoma;D005909
C04.557.580.625.600.380.080.335;Glioblastoma;D005909
C04.557.465.625.600.380;Glioma;D005910
C04.557.470.670.380;Glioma;D005910
C04.557.580.625.600.380;Glioma;D005910
C23.550.369;Gliosis;D005911
D03.438.473.360;Gliotoxin;D005912
D23.946.587.401;Gliotoxin;D005912
D02.886.590.795.500;Glipizide;D005913
D12.776.422.316;Globins;D005914
D02.065.313.425;Globosides;D005915
D09.400.410.420.525.200.425;Globosides;D005915
D10.390.470.675.200.425;Globosides;D005915
D10.570.877.360.612.200.425;Globosides;D005915
D12.776.377;Globulins;D005916
A08.186.211.730.885.287.249.487.397;Globus Pallidus;D005917
C04.557.645.350;Glomus Tumor;D005918
E01.370.390.400.300;Glomerular Filtration Rate;D005919
G08.852.357;Glomerular Filtration Rate;D005919
A05.810.453.324.359.620.500;Glomerular Mesangium;D005920
A05.810.453.736.520.620.500;Glomerular Mesangium;D005920
C12.777.419.570.363;Glomerulonephritis;D005921
C13.351.968.419.570.363;Glomerulonephritis;D005921
C12.777.419.570.363.608;Glomerulonephritis, IGA;D005922
C13.351.968.419.570.363.608;Glomerulonephritis, IGA;D005922
C20.111.525;Glomerulonephritis, IGA;D005922
C12.777.419.570.363.660;Glomerulosclerosis, Focal Segmental;D005923
C13.351.968.419.570.363.640;Glomerulosclerosis, Focal Segmental;D005923
A08.663.650.915.500.600.350;Glomus Jugulare;D005924
A08.800.950.500.600.350;Glomus Jugulare;D005924
A11.671.650.915.500.600.350;Glomus Jugulare;D005924
C04.557.465.625.650.700.705.340;Glomus Jugulare Tumor;D005925
C04.557.580.625.650.700.705.340;Glomus Jugulare Tumor;D005925
C07.465.910.280;Glossalgia;D005926
C23.888.646.473;Glossalgia;D005926
E04.545.380;Glossectomy;D005927
E06.645.380;Glossectomy;D005927
C07.465.910.363;Glossitis;D005928
C07.465.910.363.447;Glossitis, Benign Migratory;D005929
A08.800.050.050.337;Glossopharyngeal Nerve;D005930
A08.800.050.600.387;Glossopharyngeal Nerve;D005930
A08.800.800.060.337;Glossopharyngeal Nerve;D005930
A08.800.800.120.290;Glossopharyngeal Nerve;D005930
A04.329.364;Glottis;D005931
E07.700.600.400.400;Gloves, Surgical;D005932
E07.858.594.500;Gloves, Surgical;D005932
J01.637.215.600.400.400;Gloves, Surgical;D005932
J01.637.708.600.400.400;Gloves, Surgical;D005932
D06.472.699.587.469.500;Glucagon;D005934
D12.644.548.586.469.500;Glucagon;D005934
C04.557.470.200.025.290.750;Glucagonoma;D005935
C04.588.274.761.500.249;Glucagonoma;D005935
C04.588.322.475.500.249;Glucagonoma;D005935
C06.301.761.500.249;Glucagonoma;D005935
C06.689.667.500.249;Glucagonoma;D005935
C19.344.421.500.249;Glucagonoma;D005935
D05.750.078.562;Glucans;D005936
D09.698.365;Glucans;D005936
D02.241.081.844.300;Glucaric Acid;D005937
D02.241.511.902.300;Glucaric Acid;D005937
D09.811.295;Glucaric Acid;D005937
D06.472.040.543;Glucocorticoids;D005938
D27.505.696.399.472.488;Glucocorticoids;D005938
D08.811.913.696.620.250;Glucokinase;D005941
D02.241.081.844.322;Gluconates;D005942
D02.241.511.902.322;Gluconates;D005942
D09.811.308;Gluconates;D005942
G02.111.087.160.500;Gluconeogenesis;D005943
G02.149.115.160.500;Gluconeogenesis;D005943
G03.495.256.500;Gluconeogenesis;D005943
D09.067.342.531;Glucosamine;D005944
D08.811.913.477.700.500;Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing);D005945
D09.546.359.448;Glucose;D005947
D08.811.682.047.150.270;Glucose Dehydrogenases;D005948
D08.811.682.047.239;Glucose Oxidase;D005949
D26.776.314.420;Glucose Solution, Hypertonic;D005950
E01.370.225.124.100.355;Glucose Tolerance Test;D005951
E01.370.374.355;Glucose Tolerance Test;D005951
E05.200.124.100.355;Glucose Tolerance Test;D005951
D08.811.277.352.650.225;Glucose-6-Phosphatase;D005952
C16.320.565.202.449.448;Glycogen Storage Disease Type I;D005953
C18.452.648.202.449.448;Glycogen Storage Disease Type I;D005953
D08.811.682.047.150.300;Glucosephosphate Dehydrogenase;D005954
C15.378.071.141.150.480;Glucosephosphate Dehydrogenase Deficiency;D005955
C16.320.070.480;Glucosephosphate Dehydrogenase Deficiency;D005955
C16.320.565.202.402;Glucosephosphate Dehydrogenase Deficiency;D005955
C18.452.648.202.402;Glucosephosphate Dehydrogenase Deficiency;D005955
D08.811.399.475.200.350;Glucose-6-Phosphate Isomerase;D005956
D08.811.913.696.445.875;UTP-Glucose-1-Phosphate Uridylyltransferase;D005957
D09.894.417.448;Glucosephosphates;D005958
D08.811.277.450.420;Glucosidases;D005959
D09.408.348;Glucosides;D005960
D02.886.740.703.350;Glucosinolates;D005961
D09.408.348.820.350;Glucosinolates;D005961
D09.408.903.703.350;Glucosinolates;D005961
D08.811.277.450.420.475.400;Glucosylceramidase;D005962
D02.065.313.250.490;Glucosylceramides;D005963
D09.400.410.420.525.200.250.490;Glucosylceramides;D005963
D10.390.470.675.200.250.490;Glucosylceramides;D005963
D10.570.877.360.612.200.250.490;Glucosylceramides;D005963
D08.811.913.400.450.460;Glucosyltransferases;D005964
D02.241.081.844.915.162;Glucuronates;D005965
D02.241.152.811.162;Glucuronates;D005965
D02.241.511.902.915.162;Glucuronates;D005965
D09.811.922.162;Glucuronates;D005965
D08.811.277.450.426;Glucuronidase;D005966
D12.644.848.249;Glue Proteins, Drosophila;D005967
D12.776.092.500.462.500;Glue Proteins, Drosophila;D005967
D12.776.850.400;Glue Proteins, Drosophila;D005967
D08.811.520.224.125.250;Glutamate Decarboxylase;D005968
D08.811.682.664.500.398;Glutamate Dehydrogenase;D005969
D08.811.682.664.500.470;Glutamate Synthase;D005970
D08.811.913.477.700.470;Glutamate Synthase;D005970
D12.125.067.750.400;Glutamates;D005971
D12.125.119.450.400;Glutamates;D005971
D08.811.277.087.483;Glutaminase;D005972
D12.125.068.330;Glutamine;D005973
D12.125.095.461;Glutamine;D005973
D12.125.154.424;Glutamine;D005973
D08.811.464.259.200.600;Glutamate-Ammonia Ligase;D005974
D08.811.464.263.200.250;Glutamate-tRNA Ligase;D005975
D02.047.532;Glutaral;D005976
D02.241.081.337.351;Glutarates;D005977
D12.644.456.448;Glutathione;D005978
D08.811.682.732.500;Glutathione Peroxidase;D005979
D08.811.682.667.092;Glutathione Reductase;D005980
D08.811.464.259.850.500;Glutathione Synthase;D005981
D08.811.913.225.500;Glutathione Transferase;D005982
D12.776.765.725.500.500;Glutens;D005983
D03.383.621.808.425;Glutethimide;D005984
D02.047.587;Glyceraldehyde;D005985
D09.546.894.449;Glyceraldehyde;D005985
D02.047.587.450;Glyceraldehyde 3-Phosphate;D005986
D09.546.894.449.450;Glyceraldehyde 3-Phosphate;D005986
D08.811.682.657.163.750;Glyceraldehyde-3-Phosphate Dehydrogenases;D005987
D02.241.081.844.387;Glyceric Acids;D005988
D02.241.511.902.387;Glyceric Acids;D005988
D09.811.366;Glyceric Acids;D005988
D10.351;Glycerides;D005989
D02.033.800.421;Glycerol;D005990
D09.853.421;Glycerol;D005990
D08.811.913.696.620.275;Glycerol Kinase;D005991
D08.811.913.050.425;Glycerol-3-Phosphate O-Acyltransferase;D005992
D08.811.682.047.150.700.400;Glycerolphosphate Dehydrogenase;D005993
D09.894.299;Glycerophosphates;D005994
D10.570.755.375;Glycerophosphates;D005994
D02.033.800.421.400;Glyceryl Ethers;D005995
D02.355.460;Glyceryl Ethers;D005995
D02.033.800.421.560;Nitroglycerin;D005996
D02.640.636;Nitroglycerin;D005996
D09.894.299.449;Glycerylphosphorylcholine;D005997
D10.570.755.375.760.400.386;Glycerylphosphorylcholine;D005997
D10.570.755.375.760.400.800.806.500;Glycerylphosphorylcholine;D005997
D12.125.481;Glycine;D005998
D04.808.105.225.272.150.350;Glycochenodeoxycholic Acid;D005999
D04.808.105.225.272.411.360;Glycochenodeoxycholic Acid;D005999
D04.808.105.225.400.380.360;Glycochenodeoxycholic Acid;D005999
D04.808.221.430.342.300.400;Glycochenodeoxycholic Acid;D005999
D04.808.221.430.342.400.450;Glycochenodeoxycholic Acid;D005999
D04.808.221.430.484.430.420;Glycochenodeoxycholic Acid;D005999
D12.125.481.700.249.420.400;Glycochenodeoxycholic Acid;D005999
D04.808.105.225.400;Glycocholic Acid;D006000
D04.808.221.430.484;Glycocholic Acid;D006000
D12.125.481.700.249;Glycocholic Acid;D006000
D09.400;Glycoconjugates;D006001
D04.808.105.225.272.411;Glycodeoxycholic Acid;D006002
D04.808.105.225.400.380;Glycodeoxycholic Acid;D006002
D04.808.221.430.342.400;Glycodeoxycholic Acid;D006002
D04.808.221.430.484.430;Glycodeoxycholic Acid;D006002
D12.125.481.700.249.420;Glycodeoxycholic Acid;D006002
D05.750.078.562.388;Glycogen;D006003
D09.698.365.388;Glycogen;D006003
D08.811.277.450.420.450;Glycogen Debranching Enzyme System;D006004
D08.811.913.400.450.460.350;Glycogen Debranching Enzyme System;D006004
D08.811.913.400.450.460.400;Phosphorylases;D006005
D08.811.913.400.450.460.375;Glycogen Synthase;D006006
D08.811.277.352.650.625.300;Glycogen-Synthase-D Phosphatase;D006007
C16.320.565.202.449;Glycogen Storage Disease;D006008
C18.452.648.202.449;Glycogen Storage Disease;D006008
C10.228.140.163.100.435.340;Glycogen Storage Disease Type II;D006009
C16.320.565.189.435.340;Glycogen Storage Disease Type II;D006009
C16.320.565.202.449.500;Glycogen Storage Disease Type II;D006009
C16.320.565.595.554.340;Glycogen Storage Disease Type II;D006009
C18.452.132.100.435.340;Glycogen Storage Disease Type II;D006009
C18.452.648.189.435.340;Glycogen Storage Disease Type II;D006009
C18.452.648.202.449.500;Glycogen Storage Disease Type II;D006009
C18.452.648.595.554.340;Glycogen Storage Disease Type II;D006009
C16.320.565.202.449.520;Glycogen Storage Disease Type III;D006010
C18.452.648.202.449.520;Glycogen Storage Disease Type III;D006010
C16.320.565.202.449.540;Glycogen Storage Disease Type IV;D006011
C18.452.648.202.449.540;Glycogen Storage Disease Type IV;D006011
C16.320.565.202.449.560;Glycogen Storage Disease Type V;D006012
C18.452.648.202.449.560;Glycogen Storage Disease Type V;D006012
C16.320.565.202.449.580;Glycogen Storage Disease Type VI;D006013
C18.452.648.202.449.580;Glycogen Storage Disease Type VI;D006013
C05.651.534.500.149;Glycogen Storage Disease Type VII;D006014
C16.320.565.202.449.600;Glycogen Storage Disease Type VII;D006014
C16.320.577.149;Glycogen Storage Disease Type VII;D006014
C18.452.648.202.449.600;Glycogen Storage Disease Type VII;D006014
C16.320.322.217;Glycogen Storage Disease Type VIII;D006015
C16.320.565.202.449.620;Glycogen Storage Disease Type VIII;D006015
C18.452.648.202.449.620;Glycogen Storage Disease Type VIII;D006015
D02.241.081.018.386;Glycolates;D006016
D02.241.511.316;Glycolates;D006016
D09.400.410;Glycolipids;D006017
D10.390;Glycolipids;D006017
D02.033.455;Glycols;D006018
G02.111.087.160.750;Glycolysis;D006019
G02.149.115.160.750;Glycolysis;D006019
G03.495.256.750;Glycolysis;D006019
G03.495.335.436;Glycolysis;D006019
G03.495.553.360;Glycolysis;D006019
D09.400.420;Glycopeptides;D006020
D12.644.233;Glycopeptides;D006020
D12.644.233.800.350;Glycophorin;D006021
D12.776.124.300;Glycophorin;D006021
D12.776.395.700.350;Glycophorin;D006021
D08.811.913.400.450.400.450;beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase;D006022
D09.400.430;Glycoproteins;D006023
D12.776.395;Glycoproteins;D006023
D02.092.877.425;Glycopyrrolate;D006024
D02.675.276.425;Glycopyrrolate;D006024
D03.383.773.342;Glycopyrrolate;D006024
D09.698.373;Glycosaminoglycans;D006025
D08.811.277.450;Glycoside Hydrolases;D006026
D09.408;Glycosides;D006027
D09.400.410.420;Glycosphingolipids;D006028
D10.390.470;Glycosphingolipids;D006028
D10.570.877.360;Glycosphingolipids;D006028
C12.777.934.363;Glycosuria;D006029
C13.351.968.934.363;Glycosuria;D006029
C18.452.394.937;Glycosuria;D006029
C12.777.419.815.532;Glycosuria, Renal;D006030
C12.777.934.363.450;Glycosuria, Renal;D006030
C13.351.968.419.815.532;Glycosuria, Renal;D006030
C13.351.968.934.363.450;Glycosuria, Renal;D006030
C16.320.565.861.532;Glycosuria, Renal;D006030
C18.452.394.937.450;Glycosuria, Renal;D006030
C18.452.648.861.532;Glycosuria, Renal;D006030
G02.111.087.160.812;Glycosylation;D006031
G02.149.115.160.812;Glycosylation;D006031
G02.149.465.350;Glycosylation;D006031
G02.607.750.350;Glycosylation;D006031
G03.495.256.812;Glycosylation;D006031
D08.811.464.263.200.350;Glycine-tRNA Ligase;D006032
D12.644.456.345.575;Glycylglycine;D006033
D02.455.849.919.530.444;Glycyrrhetinic Acid;D006034
B01.650.940.800.575.100.401.300;Glycyrrhiza;D006035
D02.047.644;Glyoxal;D006037
D02.241.152.367;Glyoxylates;D006038
B01.050.500.500.294.700.750.700.722.375;Gnathostoma;D006039
F01.658.500;Goals;D006040
B01.050.150.900.649.077.380.513;Goats;D006041
C19.874.283;Goiter;D006042
C19.874.283.300;Goiter, Endemic;D006043
C19.874.283.501;Goiter, Nodular;D006044
C19.874.283.601;Goiter, Substernal;D006045
D01.268.556.322;Gold;D006046
D01.268.956.186;Gold;D006046
D01.552.544.322;Gold;D006046
D01.379.375;Gold Alloys;D006047
D01.552.033.533;Gold Alloys;D006047
D25.058.451;Gold Alloys;D006047
D25.339.208.534;Gold Alloys;D006047
J01.637.051.058.451;Gold Alloys;D006047
J01.637.051.339.208.534;Gold Alloys;D006047
D01.379.400.350;Gold Colloid, Radioactive;D006048
D01.496.381.550.400;Gold Colloid, Radioactive;D006048
D01.496.749.410.400;Gold Colloid, Radioactive;D006048
D01.496.381;Gold Isotopes;D006049
D01.496.381.550;Gold Radioisotopes;D006050
D01.496.749.410;Gold Radioisotopes;D006050
D02.691.675.249;Aurothioglucose;D006051
D02.241.081.337.463.703.451;Gold Sodium Thiomalate;D006052
D02.691.675.500;Gold Sodium Thiomalate;D006052
D02.886.489.891.451;Gold Sodium Thiomalate;D006052
C05.116.099.370.231.576.410;Goldenhar Syndrome;D006053
C05.660.207.231.576.410;Goldenhar Syndrome;D006053
C16.131.621.207.231.576.410;Goldenhar Syndrome;D006053
B01.050.150.900.493.200.244.248.480;Goldfish;D006054
I03.450.642.845.400;Golf;D006055
A11.284.430.214.190.875.336;Golgi Apparatus;D006056
A08.663.650.915.750.300;Golgi-Mazzoni Corpuscles;D006057
A08.800.950.750.300;Golgi-Mazzoni Corpuscles;D006057
A11.671.650.915.750.300;Golgi-Mazzoni Corpuscles;D006057
C19.391;Gonadal Disorders;D006058
C12.706.316.309;Gonadal Dysgenesis;D006059
C13.351.875.253.309;Gonadal Dysgenesis;D006059
C16.131.939.316.309;Gonadal Dysgenesis;D006059
C19.391.119.309;Gonadal Dysgenesis;D006059
C12.706.316.309.391;Gonadal Dysgenesis, Mixed;D006060
C12.706.316.795.249;Gonadal Dysgenesis, Mixed;D006060
C13.351.875.253.309.391;Gonadal Dysgenesis, Mixed;D006060
C13.351.875.253.795.249;Gonadal Dysgenesis, Mixed;D006060
C16.131.260.830.835.249;Gonadal Dysgenesis, Mixed;D006060
C16.131.939.316.309.391;Gonadal Dysgenesis, Mixed;D006060
C16.131.939.316.795.249;Gonadal Dysgenesis, Mixed;D006060
C16.320.180.830.835.249;Gonadal Dysgenesis, Mixed;D006060
C19.391.119.309.391;Gonadal Dysgenesis, Mixed;D006060
C19.391.119.795.249;Gonadal Dysgenesis, Mixed;D006060
C12.706.316.096.687;Gonadal Dysgenesis, 46,XY;D006061
C12.706.316.309.388;Gonadal Dysgenesis, 46,XY;D006061
C13.351.875.253.096.687;Gonadal Dysgenesis, 46,XY;D006061
C13.351.875.253.309.388;Gonadal Dysgenesis, 46,XY;D006061
C16.131.939.316.096.687;Gonadal Dysgenesis, 46,XY;D006061
C16.131.939.316.309.388;Gonadal Dysgenesis, 46,XY;D006061
C19.391.119.096.687;Gonadal Dysgenesis, 46,XY;D006061
C19.391.119.309.388;Gonadal Dysgenesis, 46,XY;D006061
D06.472.699.322;Gonadotropins;D006062
D06.472.699.322.326;Chorionic Gonadotropin;D006063
D06.472.699.649.367;Chorionic Gonadotropin;D006063
D12.644.548.726.367;Chorionic Gonadotropin;D006063
D12.776.780.400;Chorionic Gonadotropin;D006063
D06.472.699.322.451;Gonadotropins, Equine;D006064
D06.472.699.649.451;Gonadotropins, Equine;D006064
D12.644.548.726.451;Gonadotropins, Equine;D006064
D12.776.780.451;Gonadotropins, Equine;D006064
D06.472.699.322.576;Gonadotropins, Pituitary;D006065
D06.472.699.631.525.343;Gonadotropins, Pituitary;D006065
D12.644.548.691.525.343;Gonadotropins, Pituitary;D006065
A05.360.576;Gonads;D006066
A06.407.312;Gonads;D006066
D04.808.451;Gonanes;D006067
E01.370.380.300;Gonioscopy;D006068
C01.252.400.625.391;Gonorrhea;D006069
C01.252.810.401;Gonorrhea;D006069
C01.539.778.281.401;Gonorrhea;D006069
C12.294.668.281.401;Gonorrhea;D006069
C13.351.500.711.281.401;Gonorrhea;D006069
B01.050.150.900.649.801.400.112.400.375;Gorilla gorilla;D006071
D02.455.849.765.444;Gossypol;D006072
C05.550.114.423;Gout;D006073
C05.799.414;Gout;D006073
C16.320.565.798.368;Gout;D006073
C18.452.648.798.368;Gout;D006073
D27.505.954.329.337;Gout Suppressants;D006074
N04.452.394;Governing Board;D006075
I01.409;Government;D006076
N03.540.348;Government;D006076
I01.409.418;Government Agencies;D006077
N03.540.400;Government Agencies;D006077
I01.451;Government Programs;D006078
L01.178.682.492;Government Publications as Topic;D006079
A05.360.319.114.630.535;Ovarian Follicle;D006080
A06.407.312.497.535;Ovarian Follicle;D006080
E02.095.465.425.450.440;Graft Enhancement, Immunologic;D006082
E05.478.610.500;Graft Enhancement, Immunologic;D006082
C23.550.767.400;Graft Occlusion, Vascular;D006083
G12.425.901.545.328;Graft Rejection;D006084
G12.425.901.545.340;Graft Survival;D006085
C20.452;Graft vs Host Disease;D006086
G12.425.901.402;Graft vs Host Reaction;D006087
B03.440.400;Gram-Negative Aerobic Bacteria;D006088
B03.440.425;Gram-Negative Anaerobic Bacteria;D006089
B03.440;Gram-Negative Bacteria;D006090
B03.440.400.450;Gram-Negative Chemolithotrophic Bacteria;D006091
B03.440.450;Gram-Negative Facultatively Anaerobic Rods;D006092
B03.510.460.400;Gram-Positive Asporogenous Rods;D006093
B03.510;Gram-Positive Bacteria;D006094
B03.510.400;Gram-Positive Cocci;D006095
D04.345.566.850.300;Gramicidin;D006096
D12.644.641.850.300;Gramicidin;D006096
D12.644.905.300;Gramicidin;D006096
D12.776.543.695.221;Gramicidin;D006096
A10.165.450;Granulation Tissue;D006097
A11.118.637.415;Granulocytes;D006098
A11.148.350;Granulocytes;D006098
A11.627.340;Granulocytes;D006098
A15.145.229.637.415;Granulocytes;D006098
A15.378.316.340;Granulocytes;D006098
A15.382.490.315;Granulocytes;D006098
C15.604.515.292;Granuloma;D006099
C23.550.382;Granuloma;D006099
C01.252.400.310.416;Granuloma Inguinale;D006100
C01.252.810.451;Granuloma Inguinale;D006100
C01.252.825.360;Granuloma Inguinale;D006100
C01.539.778.281.451;Granuloma Inguinale;D006100
C01.539.800.720.360;Granuloma Inguinale;D006100
C12.294.668.281.451;Granuloma Inguinale;D006100
C13.351.500.711.281.451;Granuloma Inguinale;D006100
C17.800.838.765.360;Granuloma Inguinale;D006100
C05.500.368;Granuloma, Giant Cell;D006101
C07.320.391;Granuloma, Giant Cell;D006101
C07.465.714.258.557;Granuloma, Giant Cell;D006101
C23.550.382.468;Granuloma, Giant Cell;D006101
C08.280.400;Granuloma, Laryngeal;D006102
C08.360.232;Granuloma, Laryngeal;D006102
C08.618.846.414;Granuloma, Laryngeal;D006102
C09.400.232;Granuloma, Laryngeal;D006102
C23.550.382.968.500;Granuloma, Laryngeal;D006102
C08.460.393;Granuloma, Lethal Midline;D006103
C09.603.393;Granuloma, Lethal Midline;D006103
C23.550.382.875;Granuloma, Plasma Cell;D006104
C15.378.553.774.535;Granulomatous Disease, Chronic;D006105
C16.320.322.233;Granulomatous Disease, Chronic;D006105
C20.673.774.535;Granulomatous Disease, Chronic;D006105
C04.557.475.750.656;Granulosa Cell Tumor;D006106
C04.588.322.455.398;Granulosa Cell Tumor;D006106
C13.351.500.056.630.705.398;Granulosa Cell Tumor;D006106
C13.351.937.418.685.398;Granulosa Cell Tumor;D006106
C19.344.410.398;Granulosa Cell Tumor;D006106
C19.391.630.705.398;Granulosa Cell Tumor;D006106
A05.360.319.114.630.535.200;Granulosa Cells;D006107
A06.407.312.497.535.300;Granulosa Cells;D006107
A11.382.812;Granulosa Cells;D006107
A11.436.329;Granulosa Cells;D006107
D01.268.150.300;Graphite;D006108
D01.578.300;Graphite;D006108
B01.650.940.800.575.100.822;Poaceae;D006109
B01.050.500.131.617.678.369;Grasshoppers;D006110
C11.675.349.500;Graves Disease;D006111
C19.874.283.605;Graves Disease;D006111
C19.874.397.370;Graves Disease;D006111
C20.111.555;Graves Disease;D006111
G01.595.060.535;Gravitation;D006112
Z01.542.363;Great Britain;D006113
Z01.639.280;Great Britain;D006113
Z01.107.567.875.350;Great Lakes Region;D006114
Z01.542.383;Greece;D006115
Z01.586.035.450;Greece;D006115
Z01.107.567.403;Greenland;D006116
Z01.639.400;Greenland;D006116
F01.470.142.110;Grief;D006117
D03.438.127.275;Griseofulvin;D006118
A01.923.047.365;Groin;D006119
F01.145.113.111.453;Grooming;D006120
N04.452.758.244;Group Practice;D006123
N04.452.758.244.369;Group Practice, Dental;D006124
N04.452.758.244.400;Group Practice, Prepaid;D006125
F01.829.316;Group Processes;D006126
F01.829.316.274;Group Structure;D006127
G07.700.320.249;Growth;D006128
C23.550.393;Growth Disorders;D006130
D27.505.696.377.450;Growth Inhibitors;D006131
A02.835.232.251.352;Growth Plate;D006132
D27.505.696.377;Growth Substances;D006133
B01.050.500.131.617.678.410;Gryllidae;D006135
D08.811.277.151.300;GTP Cyclohydrolase;D006136
D20.215.721.500.490;Guaiac;D006138
D02.355.601.536;Guaiacol;D006139
D02.355.726.453;Guaiacol;D006139
D02.455.426.559.389.657.166.453;Guaiacol;D006139
D02.455.426.559.389.657.654.453;Guaiacol;D006139
D02.355.601.536.400;Guaifenesin;D006140
D02.355.726.453.400;Guaifenesin;D006140
D02.455.426.559.389.657.166.453.400;Guaifenesin;D006140
D02.455.426.559.389.657.654.453.400;Guaifenesin;D006140
Z01.639.760.680.435;Guam;D006141
D02.078.370.435;Guanabenz;D006143
D03.383.129.799.500;Guanazole;D006144
D02.078.370.460;Guanethidine;D006145
D02.078.370;Guanidines;D006146
D03.438.759.758.399.454;Guanine;D006147
D08.811.277.151.350;Guanine Deaminase;D006148
D03.438.759.646.454;Guanine Nucleotides;D006150
D13.695.667.454;Guanine Nucleotides;D006150
D13.695.827.426;Guanine Nucleotides;D006150
D03.438.759.590.454;Guanosine;D006151
D13.570.583.454;Guanosine;D006151
D13.570.800.453;Guanosine;D006151
D03.438.759.646.454.160;Cyclic GMP;D006152
D13.695.462.275;Cyclic GMP;D006152
D13.695.667.454.160;Cyclic GMP;D006152
D13.695.827.426.160;Cyclic GMP;D006152
D03.438.759.646.454.340;Guanosine Diphosphate;D006153
D13.695.667.454.340;Guanosine Diphosphate;D006153
D13.695.827.426.340;Guanosine Diphosphate;D006153
D03.438.759.646.454.340.350.400;Guanosine Diphosphate Fucose;D006154
D09.408.620.569.400.410;Guanosine Diphosphate Fucose;D006154
D13.695.667.454.340.350.400;Guanosine Diphosphate Fucose;D006154
D13.695.827.426.340.350.400;Guanosine Diphosphate Fucose;D006154
D13.695.827.708.400.410;Guanosine Diphosphate Fucose;D006154
D03.438.759.646.454.340.350.500;Guanosine Diphosphate Mannose;D006155
D09.408.620.569.400.500;Guanosine Diphosphate Mannose;D006155
D13.695.667.454.340.350.500;Guanosine Diphosphate Mannose;D006155
D13.695.827.426.340.350.500;Guanosine Diphosphate Mannose;D006155
D13.695.827.708.400.500;Guanosine Diphosphate Mannose;D006155
D03.438.759.646.454.340.350;Guanosine Diphosphate Sugars;D006156
D09.408.620.569.400;Guanosine Diphosphate Sugars;D006156
D13.695.667.454.340.350;Guanosine Diphosphate Sugars;D006156
D13.695.827.426.340.350;Guanosine Diphosphate Sugars;D006156
D13.695.827.708.400;Guanosine Diphosphate Sugars;D006156
D03.438.759.646.454.525;Guanosine Monophosphate;D006157
D13.695.667.454.525;Guanosine Monophosphate;D006157
D13.695.827.426.525;Guanosine Monophosphate;D006157
D03.438.759.646.454.440;Guanosine Pentaphosphate;D006158
D13.695.667.454.440;Guanosine Pentaphosphate;D006158
D13.695.827.426.440;Guanosine Pentaphosphate;D006158
D03.438.759.646.454.480;Guanosine Tetraphosphate;D006159
D13.695.667.454.480;Guanosine Tetraphosphate;D006159
D13.695.827.426.480;Guanosine Tetraphosphate;D006159
D03.438.759.646.454.504;Guanosine Triphosphate;D006160
D13.695.667.454.504;Guanosine Triphosphate;D006160
D13.695.827.426.504;Guanosine Triphosphate;D006160
D08.811.520.650.600;Guanylate Cyclase;D006162
D12.644.360.350;Guanylate Cyclase;D006162
D12.776.476.350;Guanylate Cyclase;D006162
D08.811.277.352.355.350.725;Ribonuclease T1;D006163
D08.811.277.352.700.350.725;Ribonuclease T1;D006163
D02.886.904.365;Guanylthiourea;D006164
D02.948.898.365;Guanylthiourea;D006164
D03.438.759.646.454.504.400;Guanylyl Imidodiphosphate;D006165
D13.695.667.454.504.400;Guanylyl Imidodiphosphate;D006165
D13.695.827.426.504.400;Guanylyl Imidodiphosphate;D006165
Z01.107.169.454;Guatemala;D006166
F01.470.483;Guilt;D006167
B01.050.150.900.649.865.550;Guinea Pigs;D006168
Z01.058.290.190.380;Guinea-Bissau;D006169
D05.750.078.739.500;Gum Arabic;D006170
D09.698.700.500;Gum Arabic;D006170
D20.215.721.249.500;Gum Arabic;D006170
D20.215.721.061;Gutta-Percha;D006171
D25.339.859.495;Gutta-Percha;D006171
D25.720.327.840.119;Gutta-Percha;D006171
J01.637.051.339.859.495;Gutta-Percha;D006171
Z01.107.757.488;Guyana;D006172
I02.233.543.454;Gymnastics;D006173
I03.450.642.845.417;Gymnastics;D006173
C13.351.500.320;Gynatresia;D006175
H02.403.810.310;Gynecology;D006176
C17.800.090.875;Gynecomastia;D006177
M01.686.754.283;Gypsies;D006178
A08.186.211.464.330;Gyrus Cinguli;D006179
D08.811.277.040.025.325;Proton-Translocating ATPases;D006180
D08.811.913.696.650.150.500;Proton-Translocating ATPases;D006180
D12.776.157.530.450.250.875.500;Proton-Translocating ATPases;D006180
D12.776.543.585.450.250.875.500;Proton-Translocating ATPases;D006180
G11.561.600.765.643.474;H-Reflex;D006181
D23.050.301.500.600.400;H-Y Antigen;D006182
D23.050.705.552.600.400;H-Y Antigen;D006182
D23.050.301.500.100.350;H-2 Antigens;D006183
D23.050.301.500.400.199;H-2 Antigens;D006183
D23.050.705.552.100.350;H-2 Antigens;D006183
D23.050.705.552.410.199;H-2 Antigens;D006183
F01.145.466;Habits;D006184
F02.463.425.393;Habituation, Psychophysiologic;D006185
F02.830.422;Habituation, Psychophysiologic;D006185
G11.561.600.360;Habituation, Psychophysiologic;D006185
C03.335.508.700.775.825.400;Haemonchiasis;D006188
B01.050.500.500.294.700.775.746.410;Haemonchus;D006189
B03.440.450.600.450;Haemophilus;D006190
B03.660.250.550.290;Haemophilus;D006190
B03.440.450.600.450.125;Haemophilus ducreyi;D006191
B03.660.250.550.290.125;Haemophilus ducreyi;D006191
C01.252.400.700.433;Haemophilus Infections;D006192
B03.440.450.600.450.330;Haemophilus influenzae;D006193
B03.660.250.550.290.330;Haemophilus influenzae;D006193
B03.440.450.467.800;Gardnerella vaginalis;D006194
B03.510.024.400.800;Gardnerella vaginalis;D006194
D01.268.556.337;Hafnium;D006195
D01.268.956.249;Hafnium;D006195
D01.552.544.337;Hafnium;D006195
B01.050.150.200.400.380;Hagfishes;D006196
B01.050.150.900.493.516;Hagfishes;D006196
B01.050.500.272.400.380;Hagfishes;D006196
A17.360;Hair;D006197
A08.663.650.250;Hair Cells, Auditory;D006198
A08.663.650.915.750.600.350;Hair Cells, Auditory;D006198
A08.800.950.750.600.350;Hair Cells, Auditory;D006198
A09.246.631.246.577.325;Hair Cells, Auditory;D006198
A11.671.650.250;Hair Cells, Auditory;D006198
A11.671.650.915.750.600.350;Hair Cells, Auditory;D006198
A08.663.650.250.250;Hair Cells, Auditory, Inner;D006199
A08.663.650.915.750.600.350.350;Hair Cells, Auditory, Inner;D006199
A08.800.950.750.600.350.350;Hair Cells, Auditory, Inner;D006199
A09.246.631.246.577.325.315;Hair Cells, Auditory, Inner;D006199
A11.671.650.250.250;Hair Cells, Auditory, Inner;D006199
A11.671.650.915.750.600.350.350;Hair Cells, Auditory, Inner;D006199
G13.500;Hair Color;D006200
G16.690.490;Hair Color;D006200
C17.800.329;Hair Diseases;D006201
D27.720.233.688;Hair Dyes;D006202
D27.720.269.430.430;Hair Dyes;D006202
D27.720.269.430;Hair Preparations;D006203
E02.218.372;Hair Removal;D006204
Z01.107.084.900.425;Haiti;D006205
Z01.639.880.425;Haiti;D006205
D04.808.745.745.654.570;Halcinonide;D006206
G01.910.405;Half-Life;D006207
N02.278.825.408;Halfway Houses;D006208
C23.888.821.475;Halitosis;D006209
C05.116.099.370.231.427;Hallermann's Syndrome;D006210
C05.660.207.231.427;Hallermann's Syndrome;D006210
C16.131.621.207.231.427;Hallermann's Syndrome;D006210
C10.228.140.079.800;Pantothenate Kinase-Associated Neurodegeneration;D006211
C10.228.140.744.320;Pantothenate Kinase-Associated Neurodegeneration;D006211
C10.228.662.575;Pantothenate Kinase-Associated Neurodegeneration;D006211
C10.574.500.700;Pantothenate Kinase-Associated Neurodegeneration;D006211
C16.320.400.650;Pantothenate Kinase-Associated Neurodegeneration;D006211
C10.597.606.762.300;Hallucinations;D006212
C23.888.592.604.764.300;Hallucinations;D006212
F01.700.750.300;Hallucinations;D006212
D27.505.696.388;Hallucinogens;D006213
D27.505.954.427.300;Hallucinogens;D006213
D27.505.954.427.700.372;Hallucinogens;D006213
A01.378.610.250.300.792.380;Hallux;D006214
C05.330.610;Hallux Valgus;D006215
B02.200.400.400;Halobacteriaceae;D006216
B02.200.400.400.410;Halobacterium;D006217
D02.241.081.018.386.682.850;Halofenate;D006218
D02.241.223.601.375;Halofenate;D006218
D02.241.511.316.455;Halofenate;D006218
D01.268.380;Halogens;D006219
D02.522.352.506;Haloperidol;D006220
D02.455.526.340;Halothane;D006221
C04.445;Hamartoma;D006222
C04.445.435;Hamartoma Syndrome, Multiple;D006223
C04.651.435;Hamartoma Syndrome, Multiple;D006223
C04.700.435;Hamartoma Syndrome, Multiple;D006223
C16.320.700.435;Hamartoma Syndrome, Multiple;D006223
B01.050.150.900.649.865.635.150;Cricetinae;D006224
A01.378.800.667;Hand;D006225
C05.390;Hand Deformities;D006226
C05.390.110;Hand Deformities, Acquired;D006227
C05.390.408;Hand Deformities, Congenital;D006228
C05.660.585.988.425;Hand Deformities, Congenital;D006228
C16.131.621.585.425;Hand Deformities, Congenital;D006228
C17.800.338;Hand Dermatoses;D006229
C26.448;Hand Injuries;D006230
C02.782.687.359.213.331;Hand, Foot and Mouth Disease;D006232
M01.150;Disabled Persons;D006233
F01.658.556;Handling (Psychology);D006234
N06.850.780.200.412.500;Hand Disinfection;D006235
L01.143.506.423.906.539;Handwriting;D006236
G05.700.456;Haploidy;D006238
G05.380.360;Haplotypes;D006239
F01.470.516;Happiness;D006240
D23.050.550.480;Haptens;D006241
D12.776.124.050.300;Haptoglobins;D006242
D12.776.124.790.106.394;Haptoglobins;D006242
D12.776.377.715.085.394;Haptoglobins;D006242
D12.776.395.560.373;Haptoglobins;D006242
A13.445;Harderian Gland;D006243
G01.374.647;Hardness;D006244
E05.417;Hardness Tests;D006245
G01.374.647.457;Hardness Tests;D006245
D03.132.436.444;Harmaline;D006246
D03.438.473.402.444;Harmaline;D006246
D03.494.154.333;Harmaline;D006246
D03.132.436.477;Harmine;D006247
D03.438.473.402.477;Harmine;D006247
D03.494.154.344;Harmine;D006247
D03.132.420;Harringtonines;D006248
D03.438.079.533;Harringtonines;D006248
D03.549.624;Harringtonines;D006248
B01.046.500.100.700.430;Hartmannella;D006249
C10.228.140.163.100.355;Hartnup Disease;D006250
C12.777.419.815.885.457;Hartnup Disease;D006250
C13.351.968.419.815.885.625;Hartnup Disease;D006250
C16.320.565.151.355;Hartnup Disease;D006250
C16.320.565.189.355;Hartnup Disease;D006250
C16.320.565.861.885.457;Hartnup Disease;D006250
C18.452.132.100.355;Hartnup Disease;D006250
C18.452.648.151.355;Hartnup Disease;D006250
C18.452.648.189.355;Hartnup Disease;D006250
B04.265.600.400;Harvey murine sarcoma virus;D006251
B04.820.650.375.860.400;Harvey murine sarcoma virus;D006251
B04.909.574.807.375.860.400;Harvey murine sarcoma virus;D006251
B04.909.777.731.375.860.400;Harvey murine sarcoma virus;D006251
F01.470.548;Hate;D006252
A10.165.265.507;Haversian System;D006253
Z01.107.567.875.580.375;Hawaii;D006254
Z01.639.760.815.482;Hawaii;D006254
C08.460.799.633;Rhinitis, Allergic, Seasonal;D006255
C08.674.815;Rhinitis, Allergic, Seasonal;D006255
C09.603.799.633;Rhinitis, Allergic, Seasonal;D006255
C20.543.480.680.795;Rhinitis, Allergic, Seasonal;D006255
D20.944.380;Hazardous Waste;D006256
N06.850.460.710.380;Hazardous Waste;D006256
A01.456;Head;D006257
C04.588.443;Head and Neck Neoplasms;D006258
C10.900.300;Craniocerebral Trauma;D006259
C26.260;Craniocerebral Trauma;D006259
C26.915.300;Craniocerebral Trauma;D006259
E07.700.380;Head Protective Devices;D006260
J01.637.708.380;Head Protective Devices;D006260
C10.597.617.470;Headache;D006261
C23.888.592.612.441;Headache;D006261
C23.888.646.487;Headache;D006261
N01.400;Health;D006262
N01.824.417.700.325;Health Benefit Plans, Employee;D006264
N03.219.521.576.343.290;Health Benefit Plans, Employee;D006264
N04.452.677.800.325;Health Benefit Plans, Employee;D006264
N03.540.452.188;Health Care Coalitions;D006265
I02.233.332;Health Education;D006266
N02.421.143.827.407;Health Education;D006266
N02.421.726.407;Health Education;D006266
I02.233.332.374;Health Education, Dental;D006267
N02.421.143.827.407.457;Health Education, Dental;D006267
N02.421.726.407.457;Health Education, Dental;D006267
N06.890.410;Health Education, Dental;D006267
N02.278;Health Facilities;D006268
N02.278.215;Health Facilities, Proprietary;D006269
M01.526.070.490;Health Facility Administrators;D006270
M01.526.485.430;Health Facility Administrators;D006270
N02.360.430;Health Facility Administrators;D006270
N02.278.218;Health Facility Closure;D006271
N05.300.430.390;Health Facility Closure;D006271
N02.278.220;Health Facility Environment;D006272
N05.300.430.400;Health Facility Environment;D006272
N02.278.235;Health Facility Merger;D006273
N02.278.255;Health Facility Moving;D006274
N03.349.650.250;Health Facility Planning;D006275
N02.278.306;Health Facility Size;D006276
N05.300.430.410;Health Facility Size;D006276
I02.233.332.390;Health Fairs;D006277
N02.421.143.827.407.478;Health Fairs;D006277
N02.421.726.407.478;Health Fairs;D006277
N03.219.521.346.506.564.663;Medicare;D006278
N03.219.521.576.343.840;Medicare;D006278
N03.706.615.696;Medicare;D006278
N03.219.521.576.343.800.400;Health Maintenance Organizations;D006279
N03.219.521.576.343.925.400;Health Maintenance Organizations;D006279
N04.452.758.244.425;Health Maintenance Organizations;D006279
N04.590.374.410.400;Health Maintenance Organizations;D006279
N02.350;Health Manpower;D006280
N05.300.420.400;Health Manpower;D006280
H02;Health Occupations;D006281
M01.526.485;Health Personnel;D006282
N02.360;Health Personnel;D006282
H01.671.368;Health Physics;D006283
H02.229.333;Health Physics;D006283
N03.349.300;Health Plan Implementation;D006284
N03.349;Health Planning;D006285
N03.706.615.302;Health Planning;D006285
N03.540.452.210;Health Planning Councils;D006286
N03.349.315;Health Planning Guidelines;D006287
N03.540.452;Health Planning Organizations;D006288
N03.219.483.408;Health Planning Support;D006289
N03.349.325;Health Planning Technical Assistance;D006290
I01.655.500.608.400;Health Policy;D006291
I01.880.604.825.608.400;Health Policy;D006291
N03.623.500.608.428;Health Policy;D006291
N03.349.330;Health Priorities;D006292
N05.300.400;Health Priorities;D006292
N02.370;Health Promotion;D006293
N02.421.726.507;Health Promotion;D006293
N06.850.860.410.250;Health Resorts;D006294
N03.349.340;Health Resources;D006295
N05.300.420;Health Resources;D006295
N02.421;Health Services;D006296
N04.590.374.350;Health Services Accessibility;D006297
N05.300.430;Health Services Accessibility;D006297
H02.269;Health Services Administration;D006298
N04;Health Services Administration;D006298
N02.421.320;Health Services for the Aged;D006299
N02.421.380;Health Services Misuse;D006300
N05.300.150.395;Health Services Misuse;D006300
N03.349.380.420;Health Services Needs and Demand;D006301
N05.300.450;Health Services Needs and Demand;D006301
H01.770.644.145.360;Health Services Research;D006302
N03.349.380;Health Services Research;D006302
N05.425;Health Services Research;D006302
N02.421.330;Health Services, Indigenous;D006303
I01.240.425;Health Status;D006304
N01.224.425;Health Status;D006304
N06.850.505.400.425;Health Status;D006304
E05.318.308.250.475;Health Status Indicators;D006305
N05.715.360.300.375.375;Health Status Indicators;D006305
N06.850.520.308.250.475;Health Status Indicators;D006305
E05.318.308.250;Health Surveys;D006306
N05.715.360.300.375;Health Surveys;D006306
N06.850.520.308.250;Health Surveys;D006306
N03.540.452.508.440;Health Systems Agencies;D006307
N03.349.650.270;Health Systems Plans;D006308
F02.830.816.263;Hearing;D006309
G11.561.600.810.263;Hearing;D006309
E07.814.458;Hearing Aids;D006310
C09.218.458;Hearing Disorders;D006311
C10.597.751.418;Hearing Disorders;D006311
C23.888.592.763.393;Hearing Disorders;D006311
C09.218.458.341.374;Hearing Loss, Bilateral;D006312
C10.597.751.418.341.374;Hearing Loss, Bilateral;D006312
C23.888.592.763.393.341.374;Hearing Loss, Bilateral;D006312
C09.218.458.341.887.432;Hearing Loss, Central;D006313
C09.218.807.186.432;Hearing Loss, Central;D006313
C10.228.140.068.432;Hearing Loss, Central;D006313
C10.597.751.418.341.887.432;Hearing Loss, Central;D006313
C23.888.592.763.393.341.887.432;Hearing Loss, Central;D006313
C09.218.458.341.562;Hearing Loss, Conductive;D006314
C10.597.751.418.341.562;Hearing Loss, Conductive;D006314
C23.888.592.763.393.341.562;Hearing Loss, Conductive;D006314
C09.218.458.341.750;Hearing Loss, Functional;D006315
C10.597.751.418.341.750;Hearing Loss, Functional;D006315
C23.888.592.763.393.341.750;Hearing Loss, Functional;D006315
F01.145.126.875;Hearing Loss, Functional;D006315
C09.218.458.341.812;Hearing Loss, High-Frequency;D006316
C10.597.751.418.341.812;Hearing Loss, High-Frequency;D006316
C23.888.592.763.393.341.812;Hearing Loss, High-Frequency;D006316
C09.218.458.341.887.460;Hearing Loss, Noise-Induced;D006317
C10.597.751.418.341.887.460;Hearing Loss, Noise-Induced;D006317
C23.888.592.763.393.341.887.460;Hearing Loss, Noise-Induced;D006317
C09.218.458.341.887;Hearing Loss, Sensorineural;D006319
C10.597.751.418.341.887;Hearing Loss, Sensorineural;D006319
C23.888.592.763.393.341.887;Hearing Loss, Sensorineural;D006319
E01.370.382.375;Hearing Tests;D006320
A07.541;Heart;D006321
C14.280.358;Heart Aneurysm;D006322
C14.907.055.608;Heart Aneurysm;D006322
C14.280.383;Heart Arrest;D006323
E04.100.376.374;Heart Arrest, Induced;D006324
E04.928.220.360;Heart Arrest, Induced;D006324
A07.541.358;Heart Atria;D006325
E01.370.370.380.400;Heart Auscultation;D006326
E01.370.600.060.400;Heart Auscultation;D006326
C14.280.067.558;Heart Block;D006327
C23.550.073.425;Heart Block;D006327
E01.370.370.380.140;Cardiac Catheterization;D006328
E02.148.442;Cardiac Catheterization;D006328
A07.541.409;Heart Conduction System;D006329
C14.240.400;Heart Defects, Congenital;D006330
C14.280.400;Heart Defects, Congenital;D006330
C16.131.240.400;Heart Defects, Congenital;D006330
C14.280;Heart Diseases;D006331
C14.280.195;Cardiomegaly;D006332
C23.300.775.250;Cardiomegaly;D006332
C14.280.434;Heart Failure;D006333
E01.370.370.380;Heart Function Tests;D006334
C26.891.375;Heart Injuries;D006335
E02.365.647.375;Heart Massage;D006336
E04.100.376.458;Heart Massage;D006336
E04.928.220.380;Heart Massage;D006336
C23.888.447;Heart Murmurs;D006337
C04.588.894.309;Heart Neoplasms;D006338
C14.280.459;Heart Neoplasms;D006338
E01.370.600.875.500;Heart Rate;D006339
G09.330.380.500;Heart Rate;D006339
G09.330.380.500.430;Heart Rate, Fetal;D006340
C14.280.470;Heart Rupture;D006341
C14.280.470.475;Heart Rupture, Post-Infarction;D006342
C14.240.400.560;Heart Septal Defects;D006343
C14.280.400.560;Heart Septal Defects;D006343
C16.131.240.400.560;Heart Septal Defects;D006343
C14.240.400.560.375;Heart Septal Defects, Atrial;D006344
C14.280.400.560.375;Heart Septal Defects, Atrial;D006344
C16.131.240.400.560.375;Heart Septal Defects, Atrial;D006344
C14.240.400.560.540;Heart Septal Defects, Ventricular;D006345
C14.280.400.560.540;Heart Septal Defects, Ventricular;D006345
C16.131.240.400.560.540;Heart Septal Defects, Ventricular;D006345
A07.541.459;Heart Septum;D006346
G09.330.380.510;Heart Sounds;D006347
E04.100.376;Cardiac Surgical Procedures;D006348
E04.928.220;Cardiac Surgical Procedures;D006348
C14.280.484;Heart Valve Diseases;D006349
E07.695.310;Heart Valve Prosthesis;D006350
A07.541.510;Heart Valves;D006351
A07.541.560;Heart Ventricles;D006352
E04.050.430;Heart-Assist Devices;D006353
E07.695.300.300;Heart-Assist Devices;D006353
E07.858.082.374.300;Heart-Assist Devices;D006353
E07.695.300;Heart, Artificial;D006354
E07.858.082.374;Heart, Artificial;D006354
E07.858.082.458;Heart-Lung Machine;D006355
C23.888.821.525;Heartburn;D006356
C01.252.400.054.160.400;Heartwater Disease;D006357
C01.252.400.825.300;Heartwater Disease;D006357
C22.434;Heartwater Disease;D006357
G01.906.595.543;Hot Temperature;D006358
G16.500.275.063.725.710.380;Hot Temperature;D006358
G16.500.750.775.710.380;Hot Temperature;D006358
N06.230.300.100.725.232;Hot Temperature;D006358
N06.230.300.100.725.710.380;Hot Temperature;D006358
C26.522.250;Heat Exhaustion;D006359
D12.776.580.216;Heat-Shock Proteins;D006360
N06.230.150.300;Heating;D006361
C15.378.147.780.490;Heavy Chain Disease;D006362
C15.604.515.435;Heavy Chain Disease;D006362
C20.683.780.490;Heavy Chain Disease;D006362
Z01.542.363.766.500;Hebrides;D006363
Z01.639.280.766.500;Hebrides;D006363
B01.050.150.900.649.473.376;Hedgehogs;D006364
A01.378.610.250.510;Heel;D006365
A11.118.290.330.315.335;Heinz Bodies;D006366
A11.284.420.204.335;Heinz Bodies;D006366
A15.145.229.334.330.340.335;Heinz Bodies;D006366
A11.251.210.190.400;HeLa Cells;D006367
A11.251.860.180.400;HeLa Cells;D006367
A11.436.340;HeLa Cells;D006367
B01.650.940.800.575.100.100.400;Helianthus;D006368
J02.500.300.100.287;Helianthus;D006368
B01.050.500.500.294.700.775.400;Heligmosomatoidea;D006369
E02.774.430;Heliotherapy;D006370
D01.268.613.350;Helium;D006371
D01.362.641.352;Helium;D006371
B01.050.500.644.400.750.450;Helix (Snails);D006372
C03.335;Helminthiasis;D006373
C03.335.349;Helminthiasis, Animal;D006374
C03.701.377;Helminthiasis, Animal;D006374
C22.674.377;Helminthiasis, Animal;D006374
B01.300.381.420;Helminthosporium;D006375
B01.050.500.500;Helminths;D006376
A11.118.637.555.567.550.500.400;T-Lymphocytes, Helper-Inducer;D006377
A11.118.637.555.567.569.200.400;T-Lymphocytes, Helper-Inducer;D006377
A11.118.637.555.567.569.500.400;T-Lymphocytes, Helper-Inducer;D006377
A15.145.229.637.555.567.550.500.400;T-Lymphocytes, Helper-Inducer;D006377
A15.145.229.637.555.567.569.200.400;T-Lymphocytes, Helper-Inducer;D006377
A15.145.229.637.555.567.569.500.400;T-Lymphocytes, Helper-Inducer;D006377
A15.382.490.555.567.550.500.400;T-Lymphocytes, Helper-Inducer;D006377
A15.382.490.555.567.569.200.400;T-Lymphocytes, Helper-Inducer;D006377
A15.382.490.555.567.569.500.400;T-Lymphocytes, Helper-Inducer;D006377
B04.423;Helper Viruses;D006378
F01.145.813.225;Helping Behavior;D006379
F01.393.398;Helplessness, Learned;D006380
F02.463.425.420;Helplessness, Learned;D006380
K01.316.080.249;Helsinki Declaration;D006381
K01.316.366.400;Helsinki Declaration;D006381
N05.350.340.080.249;Helsinki Declaration;D006381
G06.590.360;Hemadsorption;D006382
E01.370.225.812.735.360;Hemadsorption Inhibition Tests;D006383
E05.200.812.735.360;Hemadsorption Inhibition Tests;D006383
E05.478.594.760.360;Hemadsorption Inhibition Tests;D006383
G02.111.087.026.500;Hemagglutination;D006384
G02.149.115.026.500;Hemagglutination;D006384
G12.425.143.100.200;Hemagglutination;D006384
E01.370.225.812.735.370;Hemagglutination Inhibition Tests;D006385
E05.200.812.735.370;Hemagglutination Inhibition Tests;D006385
E05.478.594.760.370;Hemagglutination Inhibition Tests;D006385
E01.370.225.812.735.050.375;Hemagglutination Tests;D006386
E05.200.812.735.050.375;Hemagglutination Tests;D006386
E05.478.594.760.050.375;Hemagglutination Tests;D006386
G02.111.087.026.500.500;Hemagglutination, Viral;D006387
G02.149.115.026.500.500;Hemagglutination, Viral;D006387
G06.590.875.380;Hemagglutination, Viral;D006387
G06.920.875.380;Hemagglutination, Viral;D006387
D27.505.696.477.136.377;Hemagglutinins;D006388
D12.776.964.970.880.345;Hemagglutinins, Viral;D006389
D23.050.327.461;Hemagglutinins, Viral;D006389
C04.557.645.375.370;Hemangioendothelioma;D006390
C04.557.645.375;Hemangioma;D006391
C04.557.645.375.385;Hemangioma, Cavernous;D006392
C14.907.454.385;Hemangioma, Cavernous;D006392
C15.378.463.515.385;Hemangioma, Cavernous;D006392
C04.557.645.380;Hemangiopericytoma;D006393
C04.557.450.795.390;Hemangiosarcoma;D006394
C04.557.645.390;Hemangiosarcoma;D006394
C05.550.459;Hemarthrosis;D006395
C23.550.414.794;Hemarthrosis;D006395
C06.405.227.400;Hematemesis;D006396
C23.550.414.788.400;Hematemesis;D006396
C23.888.821.937.019;Hematemesis;D006396
D27.505.954.502.543;Hematinics;D006397
C12.294.287;Hematocele;D006398
C23.550.414.817;Hematocele;D006398
C13.351.500.894.300;Hematocolpos;D006399
E01.370.225.625.400;Hematocrit;D006400
E05.200.625.400;Hematocrit;D006400
G09.188.370.374;Hematocrit;D006400
D27.505.954.502;Hematologic Agents;D006401
C15.378;Hematologic Diseases;D006402
E01.370.225.625;Hematologic Tests;D006403
E05.200.625;Hematologic Tests;D006403
H02.403.429.445;Hematology;D006405
C23.550.414.838;Hematoma;D006406
C10.228.140.300.535.450.300;Hematoma, Epidural, Cranial;D006407
C10.900.300.837.300;Hematoma, Epidural, Cranial;D006407
C14.907.253.573.400.400;Hematoma, Epidural, Cranial;D006407
C23.550.414.838.349;Hematoma, Epidural, Cranial;D006407
C23.550.414.913.400;Hematoma, Epidural, Cranial;D006407
C26.260.616.300;Hematoma, Epidural, Cranial;D006407
C26.915.300.490.400;Hematoma, Epidural, Cranial;D006407
C10.228.140.300.535.450.400;Hematoma, Subdural;D006408
C10.900.300.837.600;Hematoma, Subdural;D006408
C14.907.253.573.400.450;Hematoma, Subdural;D006408
C23.550.414.838.700;Hematoma, Subdural;D006408
C23.550.414.913.700;Hematoma, Subdural;D006408
C26.260.616.600;Hematoma, Subdural;D006408
C26.915.300.490.450;Hematoma, Subdural;D006408
C13.351.500.852.495;Hematometra;D006409
G04.299.151.825;Hematopoiesis;D006410
G09.188.124.544;Hematopoiesis;D006410
G04.299.151.825.463;Hematopoiesis, Extramedullary;D006411
G09.188.124.544.463;Hematopoiesis, Extramedullary;D006411
A11.148.378;Hematopoietic Stem Cells;D006412
A11.872.378;Hematopoietic Stem Cells;D006412
A15.378.316.378;Hematopoietic Stem Cells;D006412
A15.378;Hematopoietic System;D006413
E02.774.722.435;Hematoporphyrin Photoradiation;D006414
D03.383.129.578.840.500.462;Hematoporphyrins;D006415
D03.549.909.500.462;Hematoporphyrins;D006415
D04.345.783.500.462;Hematoporphyrins;D006415
D23.767.727.462;Hematoporphyrins;D006415
D03.438.150.600;Hematoxylin;D006416
D03.830.219.600;Hematoxylin;D006416
C12.777.934.442;Hematuria;D006417
C13.351.968.934.442;Hematuria;D006417
C23.550.414.849;Hematuria;D006417
D03.383.129.578.840.500.640.587;Heme;D006418
D03.549.909.500.640.587;Heme;D006418
D04.345.783.500.640.587;Heme;D006418
D23.767.727.640.587;Heme;D006418
D08.811.682.690.708.410;Heme Oxygenase (Decyclizing);D006419
D12.776.422;Hemeproteins;D006420
D12.776.157.427.374.187;Hemerythrin;D006422
D12.776.556.579.374.187;Hemerythrin;D006422
C10.597.751.941.512;Hemianopsia;D006423
C11.966.075.500;Hemianopsia;D006423
C23.888.592.763.941.512;Hemianopsia;D006423
A15;Hemic and Immune Systems;D006424
C15;Hemic and Lymphatic Diseases;D006425
D02.092.877.435;Hemicholinium 3;D006426
D02.675.276.435;Hemicholinium 3;D006426
D03.383.129.578.840.500.640.587.462;Hemin;D006427
D03.549.909.500.640.587.462;Hemin;D006427
D04.345.783.500.640.587.462;Hemin;D006427
D23.767.727.640.587.462;Hemin;D006427
E04.555.080.380;Hemipelvectomy;D006428
C10.597.622.295;Hemiplegia;D006429
C23.888.592.636.312;Hemiplegia;D006429
B01.050.500.131.617.412;Hemiptera;D006430
C23.550.414.864;Hemobilia;D006431
C16.320.565.618.337;Hemochromatosis;D006432
C18.452.565.500.480;Hemochromatosis;D006432
C18.452.648.618.337;Hemochromatosis;D006432
D12.776.124.337;Hemocyanin;D006433
D12.776.422.412;Hemocyanin;D006433
D12.776.556.462;Hemocyanin;D006433
D23.767.482;Hemocyanin;D006433
A11.118.480;Hemocytes;D006434
A15.145.229.480;Hemocytes;D006434
E02.870.300;Renal Dialysis;D006435
E02.912.800;Renal Dialysis;D006435
N02.278.388.200;Hemodialysis Units, Hospital;D006436
E02.870.300.300;Hemodialysis, Home;D006437
E02.912.800.300;Hemodialysis, Home;D006437
N02.421.143.524.337;Hemodialysis, Home;D006437
E02.514;Hemodilution;D006438
G09.330.190.400;Hemodynamics;D006439
G09.330.380;Hemodynamics;D006439
E02.870.350;Hemofiltration;D006440
E02.912.400;Hemofiltration;D006440
E04.292.471;Hemofiltration;D006440
E04.292.975.300;Hemofiltration;D006440
E05.196.454.807.300;Hemofiltration;D006440
D12.776.124.400.405;Hemoglobin A;D006441
D12.776.422.316.762.380;Hemoglobin A;D006441
D09.408.375;Hemoglobin A, Glycosylated;D006442
D12.776.124.400.405.440;Hemoglobin A, Glycosylated;D006442
D12.776.422.316.762.380.440;Hemoglobin A, Glycosylated;D006442
D12.776.124.400.405.450;Hemoglobin A2;D006443
D12.776.422.316.762.380.450;Hemoglobin A2;D006443
D12.776.124.400.463.338;Hemoglobin C;D006444
D12.776.422.316.762.426.338;Hemoglobin C;D006444
C15.378.071.141.150.490;Hemoglobin C Disease;D006445
C15.378.420.463;Hemoglobin C Disease;D006445
C16.320.070.490;Hemoglobin C Disease;D006445
C16.320.365.463;Hemoglobin C Disease;D006445
D12.776.124.400.463.375;Hemoglobin E;D006446
D12.776.422.316.762.426.375;Hemoglobin E;D006446
D12.776.124.400.463.463;Hemoglobin H;D006447
D12.776.422.316.762.426.463;Hemoglobin H;D006447
D12.776.124.400.463.480;Hemoglobin J;D006448
D12.776.422.316.762.426.480;Hemoglobin J;D006448
D12.776.124.400.463.510;Hemoglobin M;D006449
D12.776.422.316.762.426.510;Hemoglobin M;D006449
C15.378.071.141.150.150.440;Hemoglobin SC Disease;D006450
C15.378.420.155.440;Hemoglobin SC Disease;D006450
C16.320.070.150.440;Hemoglobin SC Disease;D006450
C16.320.365.155.440;Hemoglobin SC Disease;D006450
D12.776.124.400.463.588;Hemoglobin, Sickle;D006451
D12.776.422.316.762.426.588;Hemoglobin, Sickle;D006451
E01.370.225.625.410;Hemoglobinometry;D006452
E05.200.625.410;Hemoglobinometry;D006452
C15.378.420;Hemoglobinopathies;D006453
C16.320.365;Hemoglobinopathies;D006453
D12.776.124.400;Hemoglobins;D006454
D12.776.422.316.762;Hemoglobins;D006454
D12.776.124.400.463;Hemoglobins, Abnormal;D006455
D12.776.422.316.762.426;Hemoglobins, Abnormal;D006455
C12.777.934.734.634;Hemoglobinuria;D006456
C13.351.968.934.734.634;Hemoglobinuria;D006456
C23.888.942.750.634;Hemoglobinuria;D006456
C15.378.071.141.560;Hemoglobinuria, Paroxysmal;D006457
C15.378.190.625.460;Hemoglobinuria, Paroxysmal;D006457
A13.453;Hemolymph;D006458
G05.360.600.430;Hemolysin Factors;D006459
D12.776.543.695.444;Hemolysin Proteins;D006460
C23.550.403;Hemolysis;D006461
G12.425.143.545;Hemolysis;D006461
E01.370.225.812.375;Hemolytic Plaque Technique;D006462
E05.200.812.375;Hemolytic Plaque Technique;D006462
E05.478.594.375;Hemolytic Plaque Technique;D006462
C12.777.419.936.463;Hemolytic-Uremic Syndrome;D006463
C13.351.968.419.936.463;Hemolytic-Uremic Syndrome;D006463
C15.378.071.141.610;Hemolytic-Uremic Syndrome;D006463
C15.378.140.855.925.500;Hemolytic-Uremic Syndrome;D006463
E02.912.430;Hemoperfusion;D006464
E04.292.510;Hemoperfusion;D006464
C06.844.400;Hemoperitoneum;D006465
C23.550.414.888;Hemoperitoneum;D006465
D12.776.124.050.350;Hemopexin;D006466
D12.776.124.790.223.338;Hemopexin;D006466
D12.776.377.715.182.338;Hemopexin;D006466
D12.776.395.401;Hemopexin;D006466
C15.378.100.100.500;Hemophilia A;D006467
C15.378.100.141.500;Hemophilia A;D006467
C15.378.463.500;Hemophilia A;D006467
C16.320.099.500;Hemophilia A;D006467
C08.528.338;Hemopneumothorax;D006468
C23.550.414.904.500;Hemopneumothorax;D006468
C08.381.348;Hemoptysis;D006469
C23.550.414.896;Hemoptysis;D006469
C23.888.852.430;Hemoptysis;D006469
C23.550.414;Hemorrhage;D006470
C06.405.227;Gastrointestinal Hemorrhage;D006471
C23.550.414.788;Gastrointestinal Hemorrhage;D006471
C07.465.625;Oral Hemorrhage;D006472
C23.550.414.922;Oral Hemorrhage;D006472
C23.888.619.500;Oral Hemorrhage;D006472
C13.703.420.725;Postpartum Hemorrhage;D006473
C13.703.844.700;Postpartum Hemorrhage;D006473
C23.550.414.993.850;Postpartum Hemorrhage;D006473
C15.378.463;Hemorrhagic Disorders;D006474
C15.378.100.920.360;Vitamin K Deficiency Bleeding;D006475
C15.378.463.841.464;Vitamin K Deficiency Bleeding;D006475
C16.614.940;Vitamin K Deficiency Bleeding;D006475
C18.654.422.360;Vitamin K Deficiency Bleeding;D006475
C18.654.521.500.133.912.360;Vitamin K Deficiency Bleeding;D006475
B04.820.087.440;Hantavirus;D006476
B04.909.777.147.440;Hantavirus;D006476
B04.820.057.070.800;Arenaviruses, New World;D006477
B04.909.777.080.070.800;Arenaviruses, New World;D006477
C02.782.082.440;Hemorrhagic Fever, American;D006478
C02.782.417.400;Hemorrhagic Fever, American;D006478
C02.081.885.430;Hemorrhagic Fever, Crimean;D006479
C02.782.147.444;Hemorrhagic Fever, Crimean;D006479
C02.782.417.412;Hemorrhagic Fever, Crimean;D006479
C02.782.147.420.400;Hemorrhagic Fever with Renal Syndrome;D006480
C02.782.417.450;Hemorrhagic Fever with Renal Syndrome;D006480
C02.081.885.440;Hemorrhagic Fever, Omsk;D006481
C02.782.350.250.560;Hemorrhagic Fever, Omsk;D006481
C02.782.417.435;Hemorrhagic Fever, Omsk;D006481
C02.782.417;Hemorrhagic Fevers, Viral;D006482
C01.252.100.375;Hemorrhagic Septicemia;D006483
C01.252.400.700.662.297;Hemorrhagic Septicemia;D006483
C01.539.757.100.375;Hemorrhagic Septicemia;D006483
C23.550.470.790.500.100.375;Hemorrhagic Septicemia;D006483
C06.405.469.860.401;Hemorrhoids;D006484
C14.907.449;Hemorrhoids;D006484
D12.776.556.526;Hemosiderin;D006485
C18.452.565.500.500;Hemosiderosis;D006486
G09.188.124.560;Hemostasis;D006487
E02.520.490;Hemostasis, Surgical;D006488
E04.350;Hemostasis, Surgical;D006488
E02.520;Hemostatic Techniques;D006489
D27.505.954.502.270.463;Hemostatics;D006490
C08.528.380;Hemothorax;D006491
C23.550.414.904;Hemothorax;D006491
D02.705.672.249;Hempa;D006492
D09.698.373.400;Heparin;D006493
D27.505.519.452;Heparin Antagonists;D006494
D27.505.954.502.270.546;Heparin Antagonists;D006494
D09.698.373.400.300;Heparin, Low-Molecular-Weight;D006495
D09.698.373.400.320;Heparinoids;D006496
D09.698.373.425;Heparitin Sulfate;D006497
E04.210.556;Hepatectomy;D006498
A07.231.114.407;Hepatic Artery;D006499
A03.159.183.079.600;Hepatic Duct, Common;D006500
C06.552.308.500.356;Hepatic Encephalopathy;D006501
C10.228.140.163.360;Hepatic Encephalopathy;D006501
C18.452.132.360;Hepatic Encephalopathy;D006501
C06.552.347;Budd-Chiari Syndrome;D006502
C14.907.355.830.925.275;Budd-Chiari Syndrome;D006502
A07.231.908.380;Hepatic Veins;D006503
C06.552.360;Hepatic Veno-Occlusive Disease;D006504
C14.907.460;Hepatic Veno-Occlusive Disease;D006504
C06.552.380;Hepatitis;D006505
C02.440.420;Hepatitis A;D006506
C02.782.687.359.500;Hepatitis A;D006506
C06.552.380.705.422;Hepatitis A;D006506
B04.450.420;Hepatovirus;D006507
B04.820.565.400;Hepatovirus;D006507
B04.909.777.618.400;Hepatovirus;D006507
D12.776.124.486.485.114.254.450;Hepatitis Antibodies;D006508
D12.776.124.790.651.114.254.450;Hepatitis Antibodies;D006508
D12.776.377.715.548.114.254.450;Hepatitis Antibodies;D006508
C02.256.430.400;Hepatitis B;D006509
C02.440.435;Hepatitis B;D006509
C06.552.380.705.437;Hepatitis B;D006509
D12.776.124.486.485.114.254.450.504;Hepatitis B Antibodies;D006510
D12.776.124.790.651.114.254.450.504;Hepatitis B Antibodies;D006510
D12.776.377.715.548.114.254.450.504;Hepatitis B Antibodies;D006510
D23.050.327.495.500;Hepatitis B Antigens;D006511
D23.050.327.495.500.450;Hepatitis B Core Antigens;D006512
D23.050.327.495.500.469;Hepatitis B e Antigens;D006513
D23.050.327.495.500.475;Hepatitis B Surface Antigens;D006514
B04.280.375.650.425;Hepatitis B virus;D006515
B04.450.390.650.425;Hepatitis B virus;D006515
B04.909.204.340.650.425;Hepatitis B virus;D006515
B04.280.030.500.200;Adenoviruses, Canine;D006516
B04.450.100;Adenoviruses, Canine;D006516
B04.909.204.097.500.200;Adenoviruses, Canine;D006516
B04.450.580;Murine hepatitis virus;D006517
B04.820.504.540.150.580;Murine hepatitis virus;D006517
B04.909.777.500.540.150.580;Murine hepatitis virus;D006517
B04.450;Hepatitis Viruses;D006518
C06.552.380.290;Hepatitis, Alcoholic;D006519
C06.552.645.490;Hepatitis, Alcoholic;D006519
C25.100.087.645.490;Hepatitis, Alcoholic;D006519
C06.552.380.315;Hepatitis, Animal;D006520
C22.467;Hepatitis, Animal;D006520
C06.552.380.350;Hepatitis, Chronic;D006521
C02.256.076.381;Hepatitis, Infectious Canine;D006522
C02.407.432;Hepatitis, Infectious Canine;D006522
C06.552.380.315.430.440;Hepatitis, Infectious Canine;D006522
C22.268.465;Hepatitis, Infectious Canine;D006522
C22.467.435.442;Hepatitis, Infectious Canine;D006522
C02.407;Hepatitis, Viral, Animal;D006524
C06.552.380.315.430;Hepatitis, Viral, Animal;D006524
C22.467.435;Hepatitis, Viral, Animal;D006524
C02.440;Hepatitis, Viral, Human;D006525
C06.552.380.705;Hepatitis, Viral, Human;D006525
C02.440.440;Hepatitis C;D006526
C02.782.350.350;Hepatitis C;D006526
C06.552.380.705.440;Hepatitis C;D006526
C06.552.413;Hepatolenticular Degeneration;D006527
C10.228.140.079.493;Hepatolenticular Degeneration;D006527
C10.228.140.163.100.360;Hepatolenticular Degeneration;D006527
C10.228.662.400;Hepatolenticular Degeneration;D006527
C10.574.500.487;Hepatolenticular Degeneration;D006527
C16.320.400.361;Hepatolenticular Degeneration;D006527
C16.320.565.189.360;Hepatolenticular Degeneration;D006527
C16.320.565.618.403;Hepatolenticular Degeneration;D006527
C18.452.132.100.360;Hepatolenticular Degeneration;D006527
C18.452.648.189.360;Hepatolenticular Degeneration;D006527
C18.452.648.618.403;Hepatolenticular Degeneration;D006527
C04.557.470.200.025.255;Carcinoma, Hepatocellular;D006528
C04.588.274.623.160;Carcinoma, Hepatocellular;D006528
C06.301.623.160;Carcinoma, Hepatocellular;D006528
C06.552.697.160;Carcinoma, Hepatocellular;D006528
C06.552.416;Hepatomegaly;D006529
C23.300.775.525;Hepatomegaly;D006529
C06.552.465;Hepatorenal Syndrome;D006530
C12.777.419.291;Hepatorenal Syndrome;D006530
C13.351.968.419.291;Hepatorenal Syndrome;D006530
D02.455.326.146.100.250;HEPES;D006531
D02.886.645.600.055.250;HEPES;D006531
D03.383.606.500;HEPES;D006531
D02.455.526.439.516;Heptachlor;D006533
D02.455.526.439.516.350;Heptachlor Epoxide;D006534
D02.033.100.350;Heptaminol;D006535
D02.092.063.350;Heptaminol;D006535
D02.455.326.146.485;Heptanes;D006536
D10.251.450.400;Heptanoates;D006537
D10.251.450;Heptanoic Acids;D006538
D09.546.286;Heptoses;D006539
D27.720.031.700.366;Herbicides;D006540
D27.720.723.366;Herbicides;D006540
D27.888.723.366;Herbicides;D006540
C23.300.707;Hernia;D006547
C23.300.707.500;Hernia, Diaphragmatic;D006548
C23.300.707.500.233;Hernia, Diaphragmatic, Traumatic;D006549
C26.017.258;Hernia, Diaphragmatic, Traumatic;D006549
C23.300.707.374.750;Hernia, Femoral;D006550
C23.300.707.500.467;Hernia, Hiatal;D006551
C23.300.707.374.875;Hernia, Inguinal;D006552
C23.300.707.937;Hernia, Obturator;D006553
C16.614.378;Hernia, Umbilical;D006554
C23.300.707.374.937.500;Hernia, Umbilical;D006554
C23.300.707.374.937;Hernia, Ventral;D006555
C25.675.400;Heroin Dependence;D006556
F03.900.675.400;Heroin Dependence;D006556
C02.782.687.359.213.466;Herpangina;D006557
C02.256.466.382.290;Herpes Genitalis;D006558
C02.800.801.350;Herpes Genitalis;D006558
C12.294.329;Herpes Genitalis;D006558
C13.351.500.342;Herpes Genitalis;D006558
C13.703.570;Pemphigoid Gestationis;D006559
C17.800.865.700;Pemphigoid Gestationis;D006559
C02.256.466.382.316;Herpes Labialis;D006560
C02.825.320.320;Herpes Labialis;D006560
C07.465.409.466;Herpes Labialis;D006560
C17.800.838.790.320.320;Herpes Labialis;D006560
C02.256.466.382;Herpes Simplex;D006561
C02.825.320;Herpes Simplex;D006561
C17.800.838.790.320;Herpes Simplex;D006561
C02.256.466.423;Herpes Zoster;D006562
C02.256.466.423.466;Herpes Zoster Ophthalmicus;D006563
C02.325.450;Herpes Zoster Ophthalmicus;D006563
C11.294.800.450;Herpes Zoster Ophthalmicus;D006563
B04.280.382;Herpesviridae;D006564
B04.909.204.382;Herpesviridae;D006564
C02.256.466;Herpesviridae Infections;D006566
B04.280.382.400.700.400;Herpesvirus 2, Saimiriine;D006567
B04.909.204.210.400.700.400;Herpesvirus 2, Saimiriine;D006567
B04.909.204.382.400.700.400;Herpesvirus 2, Saimiriine;D006567
B04.909.574.204.500.700.400;Herpesvirus 2, Saimiriine;D006567
B04.280.382.100.750.350;Herpesvirus 1, Cercopithecine;D006568
B04.909.204.382.100.750.350;Herpesvirus 1, Cercopithecine;D006568
D03.438.150.266.450.252.500;Hesperidin;D006569
D03.830.219.266.450.252.500;Hesperidin;D006569
A11.284.430.106.279.345.190.160.180.383;Heterochromatin;D006570
D12.776.664.224.466;Heterochromatin;D006570
G05.360.160.180.383;Heterochromatin;D006570
D03;Heterocyclic Compounds;D006571
D03.605;Heterocyclic Compounds, Bridged-Ring;D006572
D03.383;Heterocyclic Compounds, 1-Ring;D006573
D03.438;Heterocyclic Compounds, 2-Ring;D006574
D03.494;Heterocyclic Compounds, 3-Ring;D006575
D03.549;Heterocyclic Compounds with 4 or More Rings;D006576
D03.661;Heterocyclic Oxides;D006577
B01.050.500.500.736.715.465;Heterophyidae;D006578
G05.380.383;Heterozygote;D006579
E05.393.450;Heterozygote Detection;D006580
D02.455.426.559.389.261.400;Hexachlorobenzene;D006581
D02.455.526.439.202.400;Hexachlorobenzene;D006581
D02.455.426.559.389.261.190.350;Hexachlorophene;D006582
D02.455.426.559.389.657.190.350;Hexachlorophene;D006582
D02.092.782.420;Hexadimethrine;D006583
D05.750.470;Hexadimethrine;D006583
D25.720.470;Hexadimethrine;D006583
J01.637.051.720.470;Hexadimethrine;D006583
D02.092.877.250.592;Hexamethonium Compounds;D006584
D02.675.276.558.592;Hexamethonium Compounds;D006584
D03.383.931.135;Altretamine;D006585
D02.455.326.146.500;Hexanes;D006586
D02.522.520;Hexanones;D006588
D02.455.426.559.389.150.700.175.450;Hexestrol;D006589
D03.383.742.279;Hexetidine;D006590
D03.383.742.698.253.317;Hexobarbital;D006591
D02.241.223.100.300.350.500;Hexobendine;D006592
D02.241.511.390.350.500;Hexobendine;D006592
D02.455.426.559.389.127.281.350.500;Hexobendine;D006592
D02.455.426.559.389.657.654.638.500;Hexobendine;D006592
D08.811.913.696.620.300;Hexokinase;D006593
D02.092.471.683.530;Hexoprenaline;D006594
D09.067.342;Hexosamines;D006595
D08.811.277.450.483;Hexosaminidases;D006596
D08.811.277.352.650.200;Fructose-Bisphosphatase;D006597
D09.894.417.592;Hexosediphosphates;D006598
D08.811.913.696.445.850;UDPglucose-Hexose-1-Phosphate Uridylyltransferase;D006599
D09.894.417;Hexosephosphates;D006600
D09.546.359;Hexoses;D006601
D08.811.913.400.450;Hexosyltransferases;D006602
D02.241.081.844.915.400;Hexuronic Acids;D006603
D02.241.152.811.400;Hexuronic Acids;D006603
D02.241.511.902.915.400;Hexuronic Acids;D006603
D09.811.922.400;Hexuronic Acids;D006603
D02.455.426.559.389.657.852.467;Hexylresorcinol;D006604
G07.110.232.450;Hibernation;D006605
G07.700.062.592;Hibernation;D006605
G07.700.100.450;Hibernation;D006605
G16.100.057.500.592;Hibernation;D006605
C23.888.821.578;Hiccup;D006606
C04.557.470.035.175;Adenoma, Sweat Gland;D006607
C04.557.470.550.175;Adenoma, Sweat Gland;D006607
I01.880.298;Hierarchy, Social;D006608
D12.776.660.235.400;High Mobility Group Proteins;D006609
D12.776.664.235.400;High Mobility Group Proteins;D006609
C10.228.470;High Pressure Neurological Syndrome;D006610
C24.410;High Pressure Neurological Syndrome;D006610
E02.041.625.508.510;High-Frequency Jet Ventilation;D006611
E02.880.820.508.510;High-Frequency Jet Ventilation;D006611
E02.041.625.508;High-Frequency Ventilation;D006612
E02.880.820.508;High-Frequency Ventilation;D006612
F02.463.247;Higher Nervous Activity;D006613
G11.561.600.370;Higher Nervous Activity;D006613
A13.473;Hindlimb;D006614
A01.378.610.400;Hip;D006615
C05.550.323.468;Hip Contracture;D006616
C05.651.197.468;Hip Contracture;D006616
C26.289.384;Hip Dislocation;D006617
C26.531.500;Hip Dislocation;D006617
C05.550.485;Hip Dislocation, Congenital;D006618
C05.660.449;Hip Dislocation, Congenital;D006618
C16.131.621.449;Hip Dislocation, Congenital;D006618
C22.268.485;Hip Dysplasia, Canine;D006619
C26.404.061.425;Hip Fractures;D006620
C26.404.484;Hip Fractures;D006620
C26.531.750;Hip Fractures;D006620
C26.558.276.425;Hip Fractures;D006620
A02.835.583.411;Hip Joint;D006621
E07.695.400.400;Hip Prosthesis;D006622
C10.562.925;von Hippel-Lindau Disease;D006623
C14.907.077.925;von Hippel-Lindau Disease;D006623
A08.186.211.464.405;Hippocampus;D006624
A08.186.211.730.885.287.500.345;Hippocampus;D006624
K01.316.080.400;Hippocratic Oath;D006625
K01.316.333.132.750.551;Hippocratic Oath;D006625
N05.350.340.080.400;Hippocratic Oath;D006625
D02.065.277.431;Hippurates;D006626
D02.241.223.100.100.400;Hippurates;D006626
D02.241.755.360;Hippurates;D006626
D02.455.426.559.389.127.085.460;Hippurates;D006626
C06.198.439;Hirschsprung Disease;D006627
C06.405.469.158.701.439;Hirschsprung Disease;D006627
C16.131.314.439;Hirschsprung Disease;D006627
C17.800.329.750;Hirsutism;D006628
C23.888.971.468;Hirsutism;D006628
D12.644.822.750.060.875;Hirudins;D006629
D12.644.861.060.875;Hirudins;D006629
D12.776.645.750.060.875;Hirudins;D006629
D12.776.872.060.875;Hirudins;D006629
M01.686.754.441;Hispanic Americans;D006630
D08.811.682.664.249;Amine Oxidase (Copper-Containing);D006631
D02.092.211.215.501;Histamine;D006632
D02.092.471.440;Histamine;D006632
D03.383.129.308.373;Histamine;D006632
D23.469.050.300;Histamine;D006632
D27.505.519.625.375.425;Histamine Antagonists;D006633
D27.505.696.577.375.425;Histamine Antagonists;D006633
D27.505.519.625.375.425.400;Histamine H1 Antagonists;D006634
D27.505.696.577.375.425.400;Histamine H1 Antagonists;D006634
D27.505.519.625.375.425.425;Histamine H2 Antagonists;D006635
D27.505.696.577.375.425.425;Histamine H2 Antagonists;D006635
G12.425.431;Histamine Release;D006636
D08.811.913.555.500.500;Histamine N-Methyltransferase;D006637
D08.811.520.232.400.500;Histidine Ammonia-Lyase;D006638
D12.125.072.329;Histidine;D006639
D12.125.142.308;Histidine;D006639
D08.811.520.224.125.300;Histidine Decarboxylase;D006640
D02.033.100.624.380;Histidinol;D006641
D02.033.755.624.380;Histidinol;D006641
D02.092.063.624.380;Histidinol;D006641
D03.383.129.308.385;Histidinol;D006641
D08.811.277.352.650.300;Histidinol-Phosphatase;D006642
D08.811.464.263.200.400;Histidine-tRNA Ligase;D006643
A11.329.372.385;Histiocytes;D006644
A11.627.482.385;Histiocytes;D006644
A11.733.397.385;Histiocytes;D006644
A15.382.680.397.385;Histiocytes;D006644
A15.382.812.522.385;Histiocytes;D006644
C08.381.483.375;Histiocytosis, Langerhans-Cell;D006646
C15.604.250.400;Histiocytosis, Langerhans-Cell;D006646
G12.425.901.519;Histocompatibility;D006648
D23.050.301.500;Histocompatibility Antigens;D006649
D23.050.705.552;Histocompatibility Antigens;D006649
E01.370.225.812.385;Histocompatibility Testing;D006650
E05.200.812.385;Histocompatibility Testing;D006650
E05.478.594.385;Histocompatibility Testing;D006650
E01.370.225.500.607;Histocytochemistry;D006651
E01.370.225.750.551;Histocytochemistry;D006651
E05.200.500.607;Histocytochemistry;D006651
E05.200.750.551;Histocytochemistry;D006651
H01.158.100.656.234;Histocytochemistry;D006651
H01.158.201.344;Histocytochemistry;D006651
H01.181.122.573;Histocytochemistry;D006651
E01.370.225.750;Histological Techniques;D006652
E05.200.750;Histological Techniques;D006652
H01.158.100.656;Histology;D006653
H01.158.100.656.469;Histology, Comparative;D006654
D08.811.277.087.520;Histone Deacetylases;D006655
D08.811.913.696.620.682.700.150.575;Protamine Kinase;D006656
D12.644.360.200.575;Protamine Kinase;D006656
D12.776.476.200.575;Protamine Kinase;D006656
D12.776.660.470;Histones;D006657
D12.776.664.469;Histones;D006657
B01.300.381.440;Histoplasma;D006658
D23.050.202.386;Histoplasmin;D006659
C01.703.450;Histoplasmosis;D006660
K01.400.441;Historiography;D006663
K01.400;History;D006664
K01.400.551;History of Dentistry;D006665
K01.400.552;History of Medicine;D006666
K01.400.608;History of Nursing;D006676
F03.675.400;Histrionic Personality Disorder;D006677
B04.820.650.589.650.350;HIV;D006678
B04.909.777.731.589.650.350;HIV;D006678
C02.782.815.616.400.500;HIV Seropositivity;D006679
C02.800.801.400.500;HIV Seropositivity;D006679
C20.673.480.500;HIV Seropositivity;D006679
D23.050.301.500.450;HLA Antigens;D006680
D23.050.705.552.450;HLA Antigens;D006680
D12.776.395.550.509.400;HLA-D Antigens;D006681
D12.776.543.550.423.400;HLA-D Antigens;D006681
D23.050.301.500.400.400;HLA-D Antigens;D006681
D23.050.301.500.450.400;HLA-D Antigens;D006681
D23.050.705.552.410.400;HLA-D Antigens;D006681
D23.050.705.552.450.400;HLA-D Antigens;D006681
D12.776.395.550.509.400.420;HLA-DP Antigens;D006682
D12.776.543.550.423.400.420;HLA-DP Antigens;D006682
D23.050.301.500.400.400.420;HLA-DP Antigens;D006682
D23.050.301.500.450.400.420;HLA-DP Antigens;D006682
D23.050.705.552.410.400.420;HLA-DP Antigens;D006682
D23.050.705.552.450.400.420;HLA-DP Antigens;D006682
D12.776.395.550.509.400.430;HLA-DQ Antigens;D006683
D12.776.543.550.423.400.430;HLA-DQ Antigens;D006683
D23.050.301.500.400.400.430;HLA-DQ Antigens;D006683
D23.050.301.500.450.400.430;HLA-DQ Antigens;D006683
D23.050.705.552.410.400.430;HLA-DQ Antigens;D006683
D23.050.705.552.450.400.430;HLA-DQ Antigens;D006683
D12.776.395.550.509.400.440;HLA-DR Antigens;D006684
D12.776.543.550.423.400.440;HLA-DR Antigens;D006684
D23.050.301.500.400.400.440;HLA-DR Antigens;D006684
D23.050.301.500.450.400.440;HLA-DR Antigens;D006684
D23.050.705.552.410.400.440;HLA-DR Antigens;D006684
D23.050.705.552.450.400.440;HLA-DR Antigens;D006684
C08.360.940.490;Hoarseness;D006685
C08.618.490;Hoarseness;D006685
C09.400.940.490;Hoarseness;D006685
C10.597.975.550;Hoarseness;D006685
C23.888.592.979.550;Hoarseness;D006685
C23.888.852.490;Hoarseness;D006685
I03.450.642.469;Hobbies;D006686
I03.450.642.845.475;Hockey;D006688
C04.557.386.355;Hodgkin Disease;D006689
C15.604.515.569.355;Hodgkin Disease;D006689
C20.683.515.761.355;Hodgkin Disease;D006689
D03.438.103.145;Bisbenzimidazole;D006690
C02.782.350.675.200;Classical Swine Fever;D006691
C22.905.170;Classical Swine Fever;D006691
B04.820.250.700.400;Classical swine fever virus;D006692
B04.909.777.310.700.400;Classical swine fever virus;D006692
I03.450.345;Holidays;D006693
E02.190.321;Holistic Health;D006694
K01.752.667.710;Holistic Health;D006694
N01.400.350;Holistic Health;D006694
D01.268.477.492;Holmium;D006695
D01.268.558.362.492;Holmium;D006695
D01.552.550.399.492;Holmium;D006695
E01.370.350.400.500;Holography;D006696
E01.370.350.600.300;Holography;D006696
D09.408.782.350;Holothurin;D006697
D23.946.580.450;Holothurin;D006697
F04.711.647.622.341.387;Holtzman Inkblot Test;D006698
N02.421.143.524;Home Care Services;D006699
N02.421.539.089;Home Care Services;D006699
G08.686.785.760.769.490.124;Home Childbirth;D006700
E02.760.611.470;Home Nursing;D006701
N02.421.143.524.470;Home Nursing;D006701
N02.421.533.320;Home Nursing;D006701
N02.421.585.611.470;Home Nursing;D006701
F01.145.113.646;Homing Behavior;D006702
M01.325;Homeless Persons;D006703
N02.421.143.524.595;Homemaker Services;D006704
E02.190.388;Homeopathy;D006705
E02.190.901.249;Homeopathy;D006705
G07.700.360;Homeostasis;D006706
N02.278.825.462;Homes for the Aged;D006707
I01.198.240.470;Homicide;D006708
I01.880.735.344;Homicide;D006708
D12.125.068.050.400;Homoarginine;D006709
D12.125.095.104.400;Homoarginine;D006709
D02.886.030.498;Homocysteine;D006710
D12.125.166.498;Homocysteine;D006710
D02.886.030.554;Homocystine;D006711
D12.125.095.533;Homocystine;D006711
D12.125.119.658;Homocystine;D006711
D12.125.166.554;Homocystine;D006711
C10.228.140.163.100.365;Homocystinuria;D006712
C16.320.565.100.480.500;Homocystinuria;D006712
C16.320.565.189.365;Homocystinuria;D006712
C17.300.428;Homocystinuria;D006712
C18.452.132.100.365;Homocystinuria;D006712
C18.452.648.100.480.500;Homocystinuria;D006712
C18.452.648.189.365;Homocystinuria;D006712
D02.241.223.601.421;Homogentisic Acid;D006713
D12.125.526;Homoserine;D006714
D08.811.682.047.370;Homoserine Dehydrogenase;D006715
F01.145.802.975.500;Homosexuality;D006716
G08.686.867.500;Homosexuality;D006716
D04.808.496;Homosteroids;D006718
D02.241.223.601.521;Homovanillic Acid;D006719
G05.380.554;Homozygote;D006720
Z01.107.169.534;Honduras;D006721
J02.500.581;Honey;D006722
Z01.252.474.164.450;Hong Kong;D006723
A13.491;Hoof and Claw;D006724
C03.335.508.700.775.455;Hookworm Infections;D006725
C01.252.354.400;Hordeolum;D006726
C01.539.375.354.400;Hordeolum;D006726
C11.294.354.400;Hordeolum;D006726
C11.338.648;Hordeolum;D006726
D06.347;Hormone Antagonists;D006727
D27.505.696.399.450;Hormone Antagonists;D006727
D06.472;Hormones;D006728
D27.505.696.399.472;Hormones;D006728
D06.472.397;Hormones, Ectopic;D006729
D23.101.840.375;Hormones, Ectopic;D006729
D06;Hormones, Hormone Substitutes, and Hormone Antagonists;D006730
D27.505.696.399;Hormones, Hormone Substitutes, and Hormone Antagonists;D006730
C10.177.350;Horner Syndrome;D006732
C10.597.690.362.500;Horner Syndrome;D006732
C11.710.528.500;Horner Syndrome;D006732
C23.888.592.708.362.500;Horner Syndrome;D006732
A13.507;Horns;D006733
C22.488;Horse Diseases;D006734
D08.811.682.732.512;Horseradish Peroxidase;D006735
B01.050.150.900.649.709.235.472;Horses;D006736
B01.050.500.131.450;Horseshoe Crabs;D006737
N02.278.421.556.185;Hospices;D006738
N02.421.143.550;Hospices;D006738
H02.309;Hospital Administration;D006739
N02.278.216.500;Hospital Administration;D006739
N02.278.354;Hospital Administration;D006739
N04.452.442;Hospital Administration;D006739
M01.526.070.490.490;Hospital Administrators;D006740
M01.526.485.430.490;Hospital Administrators;D006740
M01.526.485.740.380;Hospital Administrators;D006740
N02.360.430.490;Hospital Administrators;D006740
N02.360.740.380;Hospital Administrators;D006740
M01.526.485.740.400.375;Hospital Auxiliaries;D006741
M01.955.473.375;Hospital Auxiliaries;D006741
N02.360.740.400.375;Hospital Auxiliaries;D006741
N02.278.306.472;Hospital Bed Capacity;D006742
N02.278.306.472.080;Hospital Bed Capacity, under 100;D006743
N02.278.306.472.120;Hospital Bed Capacity, 100 to 299;D006744
N02.278.306.472.180;Hospital Bed Capacity, 300 to 499;D006745
N02.278.306.472.300;Hospital Bed Capacity, 500 and over;D006746
N02.278.354.322;Hospital Communication Systems;D006747
N04.452.442.322;Hospital Communication Systems;D006747
N02.278.354.422;Hospital Departments;D006748
N04.452.442.422;Hospital Departments;D006748
J01.086.339.250;Hospital Design and Construction;D006749
N02.278.200.403;Hospital Design and Construction;D006749
N02.278.354.446;Hospital Distribution Systems;D006750
N04.452.442.450;Hospital Distribution Systems;D006750
L01.700.508.300.408;Hospital Information Systems;D006751
L01.700.508.300.680.360;Hospital Information Systems;D006751
N04.452.442.452;Hospital Information Systems;D006751
N04.452.515.360;Hospital Information Systems;D006751
N03.349.650.250.200;Hospital Planning;D006752
E05.318.308.940.425;Hospital Records;D006753
L01.280.900.425;Hospital Records;D006753
N04.452.859.380;Hospital Records;D006753
N05.715.360.300.715.380;Hospital Records;D006753
N06.850.520.308.940.425;Hospital Records;D006753
N02.278.354.550;Hospital Restructuring;D006754
N04.452.442.550;Hospital Restructuring;D006754
N02.278.354.565;Hospital Shared Services;D006755
N04.452.442.565;Hospital Shared Services;D006755
N04.452.540.308;Hospital Shared Services;D006755
N02.278.354.580;Hospital Shops;D006756
N04.452.442.585;Hospital Shops;D006756
N02.278.388;Hospital Units;D006757
M01.526.485.740.400;Hospital Volunteers;D006758
M01.955.473;Hospital Volunteers;D006758
N02.360.740.400;Hospital Volunteers;D006758
N02.278.354.550.380;Hospital-Physician Joint Ventures;D006759
N04.452.442.550.380;Hospital-Physician Joint Ventures;D006759
E02.760.400;Hospitalization;D006760
N02.421.585.400;Hospitalization;D006760
N02.278.421;Hospitals;D006761
N02.278.421.280;Hospitals, Animal;D006762
N06.230.150.360.250.200;Hospitals, Animal;D006762
N02.278.421.556.200;Hospitals, Chronic Disease;D006763
N02.278.421.306;Hospitals, Community;D006764
N02.278.421.556.294;Hospitals, Convalescent;D006765
N02.278.421.510.100;Hospitals, County;D006766
N02.278.421.510.140;Hospitals, District;D006767
N02.278.421.510.180;Hospitals, Federal;D006768
N02.278.421.389;Hospitals, General;D006769
N02.278.421.395;Hospitals, Group Practice;D006770
N02.278.421.556.366;Hospitals, Maternity;D006771
J01.086.339.445.500;Hospitals, Military;D006772
N02.278.421.510.180.250;Hospitals, Military;D006772
N02.278.421.510.210;Hospitals, Municipal;D006773
N02.278.421.660.400;Hospitals, Municipal;D006773
N02.278.421.556.386;Hospitals, Osteopathic;D006774
E07.325.473;Hospitals, Packaged;D006775
N02.278.421.473;Hospitals, Packaged;D006775
N02.278.421.556.437;Hospitals, Pediatric;D006776
N02.278.215.110;Hospitals, Proprietary;D006777
N02.278.421.481.500;Hospitals, Proprietary;D006777
N02.278.421.556.508;Hospitals, Psychiatric;D006778
N02.278.421.510;Hospitals, Public;D006779
N02.278.421.518;Hospitals, Rural;D006780
N02.278.421.530;Hospitals, Satellite;D006781
N02.278.421.556;Hospitals, Special;D006782
N02.278.421.510.300;Hospitals, State;D006783
N02.278.020.300;Hospitals, Teaching;D006784
N02.278.421.639;Hospitals, Teaching;D006784
N02.278.020.300.310;Hospitals, University;D006785
N02.278.421.639.725;Hospitals, University;D006785
N02.278.421.660;Hospitals, Urban;D006786
N02.278.421.510.180.400;Hospitals, Veterans;D006787
N02.278.421.481.800;Hospitals, Voluntary;D006788
G12.425.901.545;Host vs Graft Reaction;D006789
G16.100.380.400;Host-Parasite Interactions;D006790
F01.470.596;Hostility;D006791
N04.452.758.307;House Calls;D006792
B01.050.500.131.617.289.642.470;Houseflies;D006793
J01.494;Household Articles;D006794
J01.516;Household Products;D006795
N02.508;Housekeeping;D006796
N02.278.354.422.412;Housekeeping, Hospital;D006797
N02.508.472;Housekeeping, Hospital;D006797
N04.452.442.422.412;Housekeeping, Hospital;D006797
N01.224.791.400;Housing;D006798
N06.230.150.360;Housing;D006798
N06.850.505.400.800.400;Housing;D006798
N06.230.150.360.250;Housing, Animal;D006799
C02.782.815.200;Deltaretrovirus Infections;D006800
C20.673.483;Deltaretrovirus Infections;D006800
B01.050.150.900.649.801.400.112.400.400;Humans;D006801
I03;Human Activities;D006802
F01.525;Human Development;D006803
G07.700.320.374;Human Development;D006803
F02.784.412;Human Engineering;D006804
J01.293.556;Human Engineering;D006804
E05.445;Human Experimentation;D006805
H01.770.644.145.365;Human Experimentation;D006805
H01.770.644.302;Human Experimentation;D006805
I01.880.604.473;Human Rights;D006806
N03.706.437;Human Rights;D006806
K01.316.400;Humanism;D006808
K01.752.256.120;Humanism;D006808
K01;Humanities;D006809
C26.088.390;Humeral Fractures;D006810
C26.404.500;Humeral Fractures;D006810
A02.835.232.087.090.400;Humerus;D006811
D02.241.444;Humic Substances;D006812
D02.455.426.559.389.657.377;Humic Substances;D006812
D20.721.500;Humic Substances;D006812
G16.500.275.063.725.310;Humidity;D006813
G16.500.750.775.310;Humidity;D006813
N06.230.150.372;Humidity;D006813
N06.230.300.100.725.310;Humidity;D006813
Z01.542.248.495;Hungary;D006814
F01.658.293.391;Hunger;D006815
G07.610.390;Hunger;D006815
G10.261.390;Hunger;D006815
C10.228.140.079.545;Huntington Disease;D006816
C10.228.140.380.278;Huntington Disease;D006816
C10.228.662.262.249.750;Huntington Disease;D006816
C10.574.500.497;Huntington Disease;D006816
C16.320.400.430;Huntington Disease;D006816
F03.087.250.400;Huntington Disease;D006816
F03.087.400.390;Huntington Disease;D006816
A12.580;Hyalin;D006818
C08.381.842.475;Hyaline Membrane Disease;D006819
C08.618.842.475;Hyaline Membrane Disease;D006819
C16.614.521.563.475;Hyaline Membrane Disease;D006819
D09.698.373.475;Hyaluronic Acid;D006820
D08.811.277.450.529;Hyaluronoglucosaminidase;D006821
D08.811.520.241.700.675;Hyaluronoglucosaminidase;D006821
A11.251.600;Hybrid Cells;D006822
G05.400;Hybrid Vigor;D006823
E05.820.150.390;Hybridization, Genetic;D006824
G05.355.090.390;Hybridization, Genetic;D006824
A11.251.353.485;Hybridomas;D006825
A11.251.600.485;Hybridomas;D006825
D02.886.952.450;Hycanthone;D006826
D03.494.953.704.450;Hycanthone;D006826
D03.383.129.308.432.555;Hydantoins;D006827
C04.557.465.955.416.812;Hydatidiform Mole;D006828
C04.850.908.416.750;Hydatidiform Mole;D006828
C13.703.720.949.416.875;Hydatidiform Mole;D006828
B01.050.500.308.485.400;Hydra;D006829
D03.383.710.605.500;Hydralazine;D006830
C13.703.610;Polyhydramnios;D006831
C10.500.450;Hydranencephaly;D006832
C16.131.666.450;Hydranencephaly;D006832
C05.550.509;Hydrarthrosis;D006833
D02.442;Hydrazines;D006834
D02.442.288;Hydrazones;D006835
D08.811.520.241.300;Hydro-Lyases;D006836
C17.800.600.425;Hydroa Vacciniforme;D006837
C17.800.865.575;Hydroa Vacciniforme;D006837
D02.455;Hydrocarbons;D006838
D02.455.326;Hydrocarbons, Acyclic;D006839
D02.455.426.392;Hydrocarbons, Alicyclic;D006840
D02.455.426.559;Hydrocarbons, Aromatic;D006841
D02.455.526.368;Hydrocarbons, Brominated;D006842
D02.455.526.439;Hydrocarbons, Chlorinated;D006843
D02.455.426;Hydrocarbons, Cyclic;D006844
D02.455.526.510;Hydrocarbons, Fluorinated;D006845
D02.455.526;Hydrocarbons, Halogenated;D006846
D02.455.526.581;Hydrocarbons, Iodinated;D006847
C12.294.882;Testicular Hydrocele;D006848
C10.228.140.602;Hydrocephalus;D006849
C10.228.140.631.450;Hydrocephalus;D006849
C10.228.140.602.559;Hydrocephalus, Normal Pressure;D006850
D01.029.260.326;Hydrochloric Acid;D006851
D01.210.450;Hydrochloric Acid;D006851
D02.886.590.700.135.261.476;Hydrochlorothiazide;D006852
D02.886.655.500.261.476;Hydrochlorothiazide;D006852
D03.438.174.261.476;Hydrochlorothiazide;D006852
D03.132.577.249.547.547.149.287;Hydrocodone;D006853
D03.549.686.575.547.204.540;Hydrocodone;D006853
D03.605.497.575.547.204.540;Hydrocodone;D006853
D04.615.723.795.547.547.149.287;Hydrocodone;D006853
D04.808.745.745.654.600;Hydrocortisone;D006854
D06.472.040.585.353.476;Hydrocortisone;D006854
D06.472.040.585.478.392;Hydrocortisone;D006854
D01.029.260.330;Hydrogen Cyanide;D006856
D01.625.400;Hydrogen Cyanide;D006856
D02.886.590.700.135.475;Hydroflumethiazide;D006857
D02.886.655.500.475;Hydroflumethiazide;D006857
D03.438.174.475;Hydroflumethiazide;D006857
D01.029.260.328;Hydrofluoric Acid;D006858
D01.303.350;Hydrofluoric Acid;D006858
D01.268.406;Hydrogen;D006859
D01.362.340;Hydrogen;D006859
D01.435;Hydrogen;D006859
G02.149.767.620;Hydrogen Bonding;D006860
G02.842.750.620;Hydrogen Bonding;D006860
D01.248.497.158.685.750.424;Hydrogen Peroxide;D006861
D01.339.431.374.424;Hydrogen Peroxide;D006861
D01.650.550.750.400;Hydrogen Peroxide;D006861
D01.029.260.340;Hydrogen Sulfide;D006862
D01.362.350;Hydrogen Sulfide;D006862
D01.875.350;Hydrogen Sulfide;D006862
G02.300;Hydrogen-Ion Concentration;D006863
D08.811.682.400;Hydrogenase;D006864
G02.111.087.497;Hydrogenation;D006865
G02.149.115.497;Hydrogenation;D006865
G02.149.465.400;Hydrogenation;D006865
G02.607.750.400;Hydrogenation;D006865
G03.495.506;Hydrogenation;D006865
D08.811.277;Hydrolases;D006867
G02.111.087.505;Hydrolysis;D006868
G02.149.115.505;Hydrolysis;D006868
G02.149.395;Hydrolysis;D006868
G03.495.508;Hydrolysis;D006868
C12.777.419.307;Hydronephrosis;D006869
C13.351.968.419.307;Hydronephrosis;D006869
C11.250.480;Hydrophthalmos;D006871
C11.525.381.407.480;Hydrophthalmos;D006871
C16.131.384.480;Hydrophthalmos;D006871
C16.614.438;Hydrophthalmos;D006871
C08.528.434;Hydropneumothorax;D006872
D02.455.426.559.389.657.393;Hydroquinones;D006873
G01.374.715.352;Hydrostatic Pressure;D006874
E02.533;Hydrotherapy;D006875
E02.779.492;Hydrotherapy;D006875
C08.528.476;Hydrothorax;D006876
D02.092.570.394;Hydroxamic Acids;D006877
D02.241.511.372;Hydroxamic Acids;D006877
D01.045.250;Hydroxides;D006878
D01.248.497.158.459;Hydroxides;D006878
D01.455;Hydroxides;D006878
D03.383.129.578.840.437.777.560;Hydroxocobalamin;D006879
D03.549.909.437.777.560;Hydroxocobalamin;D006879
D04.345.783.437.777.560;Hydroxocobalamin;D006879
D02.241.511;Hydroxy Acids;D006880
D02.065.064.150.400;Hydroxyacetylaminofluorene;D006881
D02.241.081.018.110.080.400;Hydroxyacetylaminofluorene;D006881
D02.455.426.559.847.389.050.400;Hydroxyacetylaminofluorene;D006881
D04.615.389.050.400;Hydroxyacetylaminofluorene;D006881
D01.146.360.050.300;Hydroxyapatites;D006882
D01.578.122.477;Hydroxyapatites;D006882
D01.695.625.675.650.075.025.300;Hydroxyapatites;D006882
D08.811.682.047.393;Hydroxybutyrate Dehydrogenase;D006884
D02.241.081.114.937;Hydroxybutyrates;D006885
D02.241.511.400.410;Hydroxybutyrates;D006885
D10.251.400.143.781;Hydroxybutyrates;D006885
D03.438.810.050.180.350;Hydroxychloroquine;D006886
D04.808.247.222.159.478;Hydroxycholecalciferols;D006887
D04.808.247.808.146.478;Hydroxycholecalciferols;D006887
D04.808.812.768.196.478;Hydroxycholecalciferols;D006887
D10.570.938.146.478;Hydroxycholecalciferols;D006887
D04.808.247.222.284.478;Hydroxycholesterols;D006888
D04.808.247.808.197.561;Hydroxycholesterols;D006888
D10.570.938.208.603;Hydroxycholesterols;D006888
D06.472.040.585;Hydroxycorticosteroids;D006889
D02.092.311.342.478;Hydroxydopamines;D006892
D10.251.355.096.450;Hydroxyeicosatetraenoic Acids;D006893
D10.251.355.255.100.300;Hydroxyeicosatetraenoic Acids;D006893
D02.455.426.559.389.657.166.350.350;Hydroxyestrones;D006894
D04.808.365.415.414.400;Hydroxyestrones;D006894
D04.808.578.502.497.400;Hydroxyestrones;D006894
D06.472.334.851.437.984.350;Hydroxyestrones;D006894
D09.698.365.855.500;Hetastarch;D006895
D03.438.150.266.450.284.888.500;Hydroxyethylrutoside;D006896
D03.830.219.266.450.284.888.500;Hydroxyethylrutoside;D006896
D03.066.288.478;Hydroxyindoleacetic Acid;D006897
D03.438.473.404.478;Hydroxyindoleacetic Acid;D006897
D02.092.570;Hydroxylamines;D006898
D08.811.682.690.708;Mixed Function Oxygenases;D006899
G02.111.087.512;Hydroxylation;D006900
G02.149.115.512;Hydroxylation;D006900
G02.149.465.410;Hydroxylation;D006900
G02.607.750.410;Hydroxylation;D006900
G03.495.510;Hydroxylation;D006900
D12.125.068.555.478;Hydroxylysine;D006901
D12.125.095.647.478;Hydroxylysine;D006901
D02.241.223.100.300.400;Hydroxymercuribenzoates;D006902
D02.241.223.100.500.450;Hydroxymercuribenzoates;D006902
D02.241.511.390.400;Hydroxymercuribenzoates;D006902
D02.455.426.559.389.127.281.400;Hydroxymercuribenzoates;D006902
D02.455.426.559.389.127.500.450;Hydroxymercuribenzoates;D006902
D02.455.426.559.389.657.410.400;Hydroxymercuribenzoates;D006902
D02.691.750.740.644.450;Hydroxymercuribenzoates;D006902
D08.811.682.047.385.415;Hydroxymethylglutaryl CoA Reductases;D006903
D08.811.913.050.612;Hydroxymethylglutaryl-CoA Synthase;D006904
D03.383.742.698.875.480;Hydroxyphenylazouracil;D006906
D04.808.745.745.725.395;17-alpha-Hydroxypregnenolone;D006907
D06.472.040.585.745.500;17-alpha-Hydroxypregnenolone;D006907
D06.472.334.851.687.500.500;17-alpha-Hydroxypregnenolone;D006907
D04.808.745.745.654.829.395;Hydroxyprogesterones;D006908
D06.472.334.851.687.750.478;Hydroxyprogesterones;D006908
D12.125.072.401.623.478;Hydroxyproline;D006909
D02.522.818.561;Hydroxypropiophenone;D006910
D08.811.682.047.428;Hydroxyprostaglandin Dehydrogenases;D006911
D03.438.810.350;Hydroxyquinolines;D006912
D08.811.682.047.436;Hydroxysteroid Dehydrogenases;D006913
D04.808.528;Hydroxysteroids;D006914
D04.808.054.079.429.824.375;Hydroxytestosterones;D006915
D12.125.072.050.850.479;5-Hydroxytryptophan;D006916
D03.438.473.385;Hydroxytryptophol;D006917
D02.948.395;Hydroxyurea;D006918
D03.383.606.515;Hydroxyzine;D006919
E02.547;Hygiene;D006920
N06.850.670;Hygiene;D006920
D09.408.051.420;Hygromycin B;D006921
B01.050.150.900.649.801.400.112.420.390;Hylobates;D006922
D03.438.150.446.912.531;Hymecromone;D006923
D03.830.219.446.912.531;Hymecromone;D006923
A05.360.319.779.479;Hymen;D006924
C03.335.190.519;Hymenolepiasis;D006925
B01.050.500.500.736.215.454;Hymenolepis;D006926
B01.050.500.131.617.479;Hymenoptera;D006927
A02.835.232.409;Hyoid Bone;D006928
C19.053.800.604;Hyperaldosteronism;D006929
C10.597.751.791.400;Hyperalgesia;D006930
C23.888.592.763.770.400;Hyperalgesia;D006930
E02.880.690.490;Hyperbaric Oxygenation;D006931
C23.550.429;Hyperbilirubinemia;D006932
C16.320.565.300;Hyperbilirubinemia, Hereditary;D006933
C18.452.648.300;Hyperbilirubinemia, Hereditary;D006933
C18.452.174.451;Hypercalcemia;D006934
C18.452.950.340;Hypercalcemia;D006934
C23.888.852.544;Hypercapnia;D006935
C07.793.422;Hypercementosis;D006936
C18.452.584.500.500.396;Hypercholesterolemia;D006937
C16.320.565.398.481;Hyperlipoproteinemia Type II;D006938
C18.452.584.500.500.644.475;Hyperlipoproteinemia Type II;D006938
C18.452.648.398.481;Hyperlipoproteinemia Type II;D006938
C13.703.407.500;Hyperemesis Gravidarum;D006939
C23.888.821.937.049.500;Hyperemesis Gravidarum;D006939
C14.907.474;Hyperemia;D006940
C10.597.751.791.450;Hyperesthesia;D006941
C23.888.592.763.770.450;Hyperesthesia;D006941
C15.378.147.542;Hypergammaglobulinemia;D006942
C20.683.460;Hypergammaglobulinemia;D006942
C23.888.512;Hypergammaglobulinemia;D006942
C18.452.394.952;Hyperglycemia;D006943
C19.246.099.750.490;Hyperglycemic Hyperosmolar Nonketotic Coma;D006944
C17.800.946.350;Hyperhidrosis;D006945
C18.452.394.968;Hyperinsulinism;D006946
C18.452.950.396;Hyperkalemia;D006947
C10.597.350.350;Hyperkinesis;D006948
C23.888.592.350.350;Hyperkinesis;D006948
C18.452.584.500.500;Hyperlipidemias;D006949
C16.320.565.398.450;Hyperlipidemia, Familial Combined;D006950
C18.452.584.500.500.438;Hyperlipidemia, Familial Combined;D006950
C18.452.648.398.450;Hyperlipidemia, Familial Combined;D006950
C18.452.584.500.500.644;Hyperlipoproteinemias;D006951
C16.320.565.398.483;Hyperlipoproteinemia Type III;D006952
C18.452.584.500.500.644.485;Hyperlipoproteinemia Type III;D006952
C18.452.648.398.483;Hyperlipoproteinemia Type III;D006952
C16.320.565.398.487;Hyperlipoproteinemia Type IV;D006953
C18.452.584.500.500.644.490;Hyperlipoproteinemia Type IV;D006953
C18.452.584.500.500.851.500;Hyperlipoproteinemia Type IV;D006953
C18.452.648.398.487;Hyperlipoproteinemia Type IV;D006953
C16.320.565.398.493;Hyperlipoproteinemia Type V;D006954
C18.452.584.500.500.644.495;Hyperlipoproteinemia Type V;D006954
C18.452.584.500.500.851.750;Hyperlipoproteinemia Type V;D006954
C18.452.648.398.493;Hyperlipoproteinemia Type V;D006954
C18.452.950.452;Hypernatremia;D006955
C11.744.479;Hyperopia;D006956
C05.116.099.708.486;Hyperostosis Frontalis Interna;D006957
C05.116.540.420;Hyperostosis Frontalis Interna;D006957
C05.116.099.708.479;Hyperostosis, Cortical, Congenital;D006958
C05.116.540.400;Hyperostosis, Cortical, Congenital;D006958
C16.614.465;Hyperostosis, Cortical, Congenital;D006958
C12.777.419.313;Hyperoxaluria;D006959
C13.351.968.419.313;Hyperoxaluria;D006959
C12.777.419.313.500;Hyperoxaluria, Primary;D006960
C13.351.968.419.313.500;Hyperoxaluria, Primary;D006960
C16.320.565.202.460;Hyperoxaluria, Primary;D006960
C18.452.648.202.460;Hyperoxaluria, Primary;D006960
C19.642.355;Hyperparathyroidism;D006961
C19.642.355.480;Hyperparathyroidism, Secondary;D006962
C23.888.821.645;Hyperphagia;D006963
C10.228.140.617.738.250;Hyperpituitarism;D006964
C19.700.355;Hyperpituitarism;D006964
C23.550.444;Hyperplasia;D006965
C10.228.140.617.738.250.450;Hyperprolactinemia;D006966
C19.700.355.600;Hyperprolactinemia;D006966
C20.543;Hypersensitivity;D006967
C20.543.418;Hypersensitivity, Delayed;D006968
C20.543.480;Hypersensitivity, Immediate;D006969
C10.886.425.800.200;Disorders of Excessive Somnolence;D006970
F03.870.400.800.200;Disorders of Excessive Somnolence;D006970
C15.604.744.293;Hypersplenism;D006971
C05.116.099.370.231.480;Hypertelorism;D006972
C05.660.207.231.480;Hypertelorism;D006972
C16.131.621.207.231.480;Hypertelorism;D006972
C14.907.489;Hypertension;D006973
C14.907.489.330;Hypertension, Malignant;D006974
C06.552.494;Hypertension, Portal;D006975
C08.381.423;Hypertension, Pulmonary;D006976
C12.777.419.331;Hypertension, Renal;D006977
C13.351.968.419.331;Hypertension, Renal;D006977
C14.907.489.631;Hypertension, Renal;D006977
C12.777.419.331.490;Hypertension, Renovascular;D006978
C13.351.968.419.331.490;Hypertension, Renovascular;D006978
C14.907.489.631.485;Hypertension, Renovascular;D006978
E02.565;Hyperthermia, Induced;D006979
E02.779.496;Hyperthermia, Induced;D006979
C19.874.397;Hyperthyroidism;D006980
C19.874.410;Hyperthyroxinemia;D006981
D26.776.314;Hypertonic Solutions;D006982
C17.800.329.875;Hypertrichosis;D006983
C23.300.775;Hypertrophy;D006984
C08.618.501;Hyperventilation;D006985
C23.888.852.591;Hyperventilation;D006985
C18.654.301;Hypervitaminosis A;D006986
C10.597.751.791.500;Hypesthesia;D006987
C23.888.592.763.770.500;Hypesthesia;D006987
C11.290.484;Hyphema;D006988
C23.550.414.756.550;Hyphema;D006988
E02.190.525.217;Hypnosis;D006990
F04.754.424;Hypnosis;D006990
E03.155.675;Hypnosis, Anesthetic;D006991
E03.155.141.481;Hypnosis, Dental;D006992
E03.155.675.481;Hypnosis, Dental;D006992
E06.045.481;Hypnosis, Dental;D006992
D27.505.696.277.350;Hypnotics and Sedatives;D006993
D27.505.696.410;Hypnotics and Sedatives;D006993
D27.505.954.427.210.350;Hypnotics and Sedatives;D006993
C19.053.500.480;Hypoaldosteronism;D006994
C16.320.565.398.500.440;Hypobetalipoproteinemias;D006995
C18.452.584.500.875.440;Hypobetalipoproteinemias;D006995
C18.452.648.398.500.440;Hypobetalipoproteinemias;D006995
C18.452.174.509;Hypocalcemia;D006996
C18.452.950.509;Hypocalcemia;D006996
D01.029.260.365;Hypochlorous Acid;D006997
D01.210.465;Hypochlorous Acid;D006997
D01.339.431.311;Hypochlorous Acid;D006997
D01.650.550.400;Hypochlorous Acid;D006997
F03.875.450;Hypochondriasis;D006998
B01.300.107.501;Hypocreales;D006999
C03.858.211.503.398;Hypodermyiasis;D007000
A08.800.050.050.400;Hypogastric Plexus;D007001
A08.800.800.060.400;Hypogastric Plexus;D007001
A08.800.800.120.330;Hypoglossal Nerve;D007002
C18.452.394.984;Hypoglycemia;D007003
D27.505.696.422;Hypoglycemic Agents;D007004
D02.455.426.392.368.533.450;Hypoglycins;D007005
D23.946.412;Hypoglycins;D007005
C19.391.482;Hypogonadism;D007006
C17.800.946.370;Hypohidrosis;D007007
C18.452.950.565;Hypokalemia;D007008
C16.320.565.398.500;Hypolipoproteinemias;D007009
C18.452.584.500.875;Hypolipoproteinemias;D007009
C18.452.648.398.500;Hypolipoproteinemias;D007009
C18.452.950.620;Hyponatremia;D007010
C19.642.482;Hypoparathyroidism;D007011
C04.588.443.665.710.485;Hypopharyngeal Neoplasms;D007012
C07.550.745.436;Hypopharyngeal Neoplasms;D007012
C09.647.710.485;Hypopharyngeal Neoplasms;D007012
C09.775.549.485;Hypopharyngeal Neoplasms;D007012
A04.623.490;Hypopharynx;D007013
A14.724.490;Hypopharynx;D007013
C16.320.565.618.482;Hypophosphatasia;D007014
C18.452.648.618.482;Hypophosphatasia;D007014
C12.777.419.815.647;Hypophosphatemia, Familial;D007015
C13.351.968.419.815.647;Hypophosphatemia, Familial;D007015
C16.320.565.618.544;Hypophosphatemia, Familial;D007015
C16.320.565.861.647;Hypophosphatemia, Familial;D007015
C18.452.648.618.544;Hypophosphatemia, Familial;D007015
C18.452.648.861.647;Hypophosphatemia, Familial;D007015
C18.452.750.400.500;Hypophosphatemia, Familial;D007015
E04.270.532;Hypophysectomy;D007016
E04.525.400;Hypophysectomy;D007016
E04.270.532.490;Hypophysectomy, Chemical;D007017
C10.228.140.617.738.300;Hypopituitarism;D007018
C19.700.482;Hypopituitarism;D007018
C15.378.147.607;Hypoproteinemia;D007019
C15.378.100.100.550;Hypoprothrombinemias;D007020
C15.378.100.141.550;Hypoprothrombinemias;D007020
C15.378.463.550;Hypoprothrombinemias;D007020
C16.320.099.550;Hypoprothrombinemias;D007020
C12.294.494.400;Hypospadias;D007021
C12.706.516;Hypospadias;D007021
C13.351.875.466;Hypospadias;D007021
C16.131.939.516;Hypospadias;D007021
C14.907.514;Hypotension;D007022
E03.545;Hypotension, Controlled;D007023
C10.177.575.600.450;Hypotension, Orthostatic;D007024
C14.907.514.482;Hypotension, Orthostatic;D007024
A08.186.211.730.317.357.342.063;Anterior Hypothalamic Nucleus;D007025
A08.186.211.730.317.357.300;Hypothalamic Area, Lateral;D007026
C10.228.140.617;Hypothalamic Diseases;D007027
D06.472.699.327;Hypothalamic Hormones;D007028
D12.644.400.400;Hypothalamic Hormones;D007028
D12.644.548.365;Hypothalamic Hormones;D007028
D12.776.641.650.405;Hypothalamic Hormones;D007028
C04.588.614.250.195.885.500;Hypothalamic Neoplasms;D007029
C10.228.140.211.885.500;Hypothalamic Neoplasms;D007029
C10.228.140.617.477;Hypothalamic Neoplasms;D007029
C10.551.240.250.700.500;Hypothalamic Neoplasms;D007029
A06.688.357;Hypothalamo-Hypophyseal System;D007030
A08.186.211.730.317.357.352.435;Hypothalamo-Hypophyseal System;D007030
A08.713.357;Hypothalamo-Hypophyseal System;D007030
A08.186.211.464.482;Hypothalamus;D007031
A08.186.211.730.317.357;Hypothalamus;D007031
A08.186.211.730.317.357.342;Hypothalamus, Anterior;D007032
A08.186.211.730.317.357.352;Hypothalamus, Middle;D007033
A08.186.211.730.317.357.362;Hypothalamus, Posterior;D007034
C23.888.119.565;Hypothermia;D007035
E02.258.750;Hypothermia, Induced;D007036
C19.874.482;Hypothyroidism;D007037
D26.776.399;Hypotonic Solutions;D007038
C17.800.329.937;Hypotrichosis;D007039
C08.618.846.565;Hypoventilation;D007040
C23.888.852.638;Hypoventilation;D007040
D08.811.913.400.725.450;Hypoxanthine Phosphoribosyltransferase;D007041
D03.438.759.758.399;Hypoxanthines;D007042
B01.050.150.900.649.400;Hyraxes;D007043
E04.950.300.399;Hysterectomy;D007044
E04.950.300.399.380;Hysterectomy, Vaginal;D007045
F03.675.400.500;Hysteria;D007046
E01.370.350.700.325;Hysterosalpingography;D007047
E01.370.378.325;Hysterosalpingography;D007047
D23.050.301.290.501;I Blood-Group System;D007048
D23.050.705.230.501;I Blood-Group System;D007048
C23.550.291.875;Iatrogenic Disease;D007049
D03.132.436.681.444;Ibogaine;D007050
D03.438.473.390;Ibogaine;D007050
D03.438.473.402.681.444;Ibogaine;D007050
D03.383.129.385.231;Ibotenic Acid;D007051
D23.946.587.475;Ibotenic Acid;D007051
D02.241.223.701.430;Ibuprofen;D007052
D01.455.900.400;Ice;D007053
D01.650.550.925.400;Ice;D007053
G16.500.275.410;Ice;D007053
G16.500.750.775.342;Ice;D007053
N06.230.291;Ice;D007053
J02.500.350.400;Ice Cream;D007054
Z01.542.433;Iceland;D007055
Z01.639.490;Iceland;D007055
C16.131.831.512;Ichthyosis;D007057
C16.614.492;Ichthyosis;D007057
C17.800.428.333;Ichthyosis;D007057
C17.800.804.512;Ichthyosis;D007057
B01.050.150.900.493.080.148;Ictaluridae;D007059
F01.752.747.347;Id;D007060
F02.739.794.371;Id;D007060
Z01.107.567.875.560.380;Idaho;D007061
F01.393.446;Identification (Psychology);D007062
F01.752.747.385;Identification (Psychology);D007062
F01.752.747.423;Identity Crisis;D007063
D08.811.682.047.150.700.475;L-Iditol 2-Dehydrogenase;D007064
D03.383.742.680.852.300.400;Idoxuridine;D007065
D13.570.230.430.609;Idoxuridine;D007065
D13.570.685.852.300.400;Idoxuridine;D007065
D08.811.277.352.827.500;Iduronate Sulfatase;D007066
D02.241.081.844.915.400.500;Iduronic Acid;D007067
D02.241.152.811.400.500;Iduronic Acid;D007067
D02.241.511.902.915.400.500;Iduronic Acid;D007067
D09.811.922.400.500;Iduronic Acid;D007067
D08.811.277.450.560;Iduronidase;D007068
D02.455.526.728.650.730.243.250;Ifosfamide;D007069
D02.705.672.500.243.250;Ifosfamide;D007069
D03.383.533.500;Ifosfamide;D007069
D12.776.124.486.485.114.619.026;Immunoglobulin A;D007070
D12.776.124.790.651.114.619.026;Immunoglobulin A;D007070
D12.776.377.715.548.114.619.026;Immunoglobulin A;D007070
D12.776.124.486.485.114.619.026.030;Immunoglobulin A, Secretory;D007071
D12.776.124.790.651.114.619.026.030;Immunoglobulin A, Secretory;D007071
D12.776.377.715.548.114.619.026.030;Immunoglobulin A, Secretory;D007071
D12.776.124.486.485.114.619.251;Immunoglobulin D;D007072
D12.776.124.790.651.114.619.251;Immunoglobulin D;D007072
D12.776.377.715.548.114.619.251;Immunoglobulin D;D007072
D12.776.124.486.485.114.619.312;Immunoglobulin E;D007073
D12.776.124.790.651.114.619.312;Immunoglobulin E;D007073
D12.776.377.715.548.114.619.312;Immunoglobulin E;D007073
D12.776.124.486.485.114.619.393;Immunoglobulin G;D007074
D12.776.124.790.651.114.619.393;Immunoglobulin G;D007074
D12.776.377.715.548.114.619.393;Immunoglobulin G;D007074
D12.776.124.486.485.114.619.574;Immunoglobulin M;D007075
D12.776.124.790.651.114.619.574;Immunoglobulin M;D007075
D12.776.377.715.548.114.619.574;Immunoglobulin M;D007075
B01.050.150.900.833.393.500;Iguanas;D007076
C06.405.469.420;Ileal Diseases;D007077
C04.588.274.476.411.501;Ileal Neoplasms;D007078
C06.301.371.411.501;Ileal Neoplasms;D007078
C06.405.249.411.501;Ileal Neoplasms;D007078
C06.405.469.420.501;Ileal Neoplasms;D007078
C06.405.469.491.501;Ileal Neoplasms;D007078
C06.405.205.462.624;Ileitis;D007079
C06.405.469.326.875;Ileitis;D007079
C06.405.469.420.520;Ileitis;D007079
A03.556.124.684.249.400;Ileocecal Valve;D007080
A03.556.249.124.400;Ileocecal Valve;D007080
E04.210.338.508;Ileostomy;D007081
E04.579.338.508;Ileostomy;D007081
A03.556.124.684.249;Ileum;D007082
A03.556.249.124;Ileum;D007082
A07.231.114.444;Iliac Artery;D007083
A07.231.908.427;Iliac Vein;D007084
A02.835.232.043.825.434;Ilium;D007085
I01.880.225.465;Illegitimacy;D007086
I01.880.735.424;Illegitimacy;D007086
Z01.107.567.875.350.350;Illinois;D007087
Z01.107.567.875.510.350;Illinois;D007087
C10.597.606.762.400;Illusions;D007088
C23.888.592.604.764.400;Illusions;D007088
F01.700.750.400;Illusions;D007088
F02.463.593.446;Illusions;D007088
E01.370.350.600.350;Image Enhancement;D007089
L01.224.308.380;Image Enhancement;D007089
E01.158.600;Image Interpretation, Computer-Assisted;D007090
E01.370.350.350;Image Interpretation, Computer-Assisted;D007090
L01.700.508.100.158.600;Image Interpretation, Computer-Assisted;D007090
L01.224.308;Image Processing, Computer-Assisted;D007091
F02.463.188.634;Imagination;D007092
D03.383.129.308;Imidazoles;D007093
D02.478;Imides;D007094
D02.065.199.326.400;Imidocarb;D007095
D02.948.684.202.400;Imidocarb;D007095
D02.478.400;Imidoesters;D007096
D02.491;Imines;D007097
D02.241.081.583;Imino Acids;D007098
D02.491.485;Imino Acids;D007098
D12.125.072.401;Imino Acids;D007098
D03.494.240.485;Imipramine;D007099
F01.145.510;Imitative Behavior;D007100
E05.466;Immersion;D007101
C17.800.321.500;Immersion Foot;D007102
E05.472;Immobilization;D007103
E01.370.225.812.400;Immune Adherence Reaction;D007104
E05.200.812.400;Immune Adherence Reaction;D007104
E05.478.594.400;Immune Adherence Reaction;D007104
C20.543.520;Immune Complex Diseases;D007105
A12.207.152.846.500;Immune Sera;D007106
D12.776.124.486.485.114.573;Immune Sera;D007106
D12.776.124.790.651.114.573;Immune Sera;D007106
D12.776.377.715.548.114.573;Immune Sera;D007106
D20.215.401;Immune Sera;D007106
A15.382;Immune System;D007107
G12.425.746.425;Immune Tolerance;D007108
G12.450;Immunity;D007109
G12.450.050.370;Immunity, Active;D007110
G12.450.050.400;Immunity, Cellular;D007111
G12.450.570;Immunity, Maternally-Acquired;D007112
G12.450.564;Immunity, Innate;D007113
E02.095.465.425.400;Immunization;D007114
E05.478.550;Immunization;D007114
N02.421.726.758.310;Immunization;D007114
N06.850.780.200.425;Immunization;D007114
N06.850.780.680.310;Immunization;D007114
E02.095.465.425.400.470;Immunization Schedule;D007115
E05.478.550.545;Immunization Schedule;D007115
E02.095.465.425.400.330;Immunization, Passive;D007116
E05.478.550.520;Immunization, Passive;D007116
E02.095.465.425.400.485;Immunization, Secondary;D007117
E05.478.550.550;Immunization, Secondary;D007117
E05.478.566;Immunoassay;D007118
E05.601.495;Immunoassay;D007118
C15.604.515.509;Immunoblastic Lymphadenopathy;D007119
C20.683.515.501;Immunoblastic Lymphadenopathy;D007119
H01.158.201.486;Immunochemistry;D007120
H01.181.122.605;Immunochemistry;D007120
H02.403.044.500;Immunochemistry;D007120
G12.460;Immunocompetence;D007121
E01.370.225.812.735.645.350.350;Immunoelectrophoresis;D007122
E05.196.401.568;Immunoelectrophoresis;D007122
E05.200.812.735.645.350.350;Immunoelectrophoresis;D007122
E05.301.300.568;Immunoelectrophoresis;D007122
E05.478.594.760.645.350.350;Immunoelectrophoresis;D007122
E05.478.605.492.350.350;Immunoelectrophoresis;D007122
E01.370.225.812.735.645.350.350.350;Immunoelectrophoresis, Two-Dimensional;D007123
E05.196.401.568.520;Immunoelectrophoresis, Two-Dimensional;D007123
E05.200.812.735.645.350.350.350;Immunoelectrophoresis, Two-Dimensional;D007123
E05.301.300.568.520;Immunoelectrophoresis, Two-Dimensional;D007123
E05.478.594.760.645.350.350.350;Immunoelectrophoresis, Two-Dimensional;D007123
E05.478.605.492.350.350.350;Immunoelectrophoresis, Two-Dimensional;D007123
E05.478.566.350;Immunoenzyme Techniques;D007124
E05.478.583.400;Immunoenzyme Techniques;D007124
E05.601.495.350;Immunoenzyme Techniques;D007124
H01.158.273.343.420;Immunogenetics;D007125
D12.776.124.486.485.114.606;Immunoglobulin Allotypes;D007126
D12.776.124.790.651.114.606;Immunoglobulin Allotypes;D007126
D12.776.377.715.548.114.606;Immunoglobulin Allotypes;D007126
G12.500.400;Immunoglobulin Allotypes;D007126
D12.776.124.486.485.538;Immunoglobulin Constant Regions;D007127
D12.776.124.790.651.538;Immunoglobulin Constant Regions;D007127
D12.776.377.715.548.538;Immunoglobulin Constant Regions;D007127
D12.644.541.500;Immunoglobulin Fragments;D007128
D12.776.124.486.485.680;Immunoglobulin Fragments;D007128
D12.776.124.790.651.680;Immunoglobulin Fragments;D007128
D12.776.377.715.548.680;Immunoglobulin Fragments;D007128
D12.776.124.486.485.114.606.586;Immunoglobulin Gm Allotypes;D007129
D12.776.124.486.485.114.619.393.522.400;Immunoglobulin Gm Allotypes;D007129
D12.776.124.486.485.705.500.380.500;Immunoglobulin Gm Allotypes;D007129
D12.776.124.790.651.114.606.586;Immunoglobulin Gm Allotypes;D007129
D12.776.124.790.651.114.619.393.522.400;Immunoglobulin Gm Allotypes;D007129
D12.776.124.790.651.705.500.380.500;Immunoglobulin Gm Allotypes;D007129
D12.776.377.715.548.114.606.586;Immunoglobulin Gm Allotypes;D007129
D12.776.377.715.548.114.619.393.522.400;Immunoglobulin Gm Allotypes;D007129
D12.776.377.715.548.705.500.380.500;Immunoglobulin Gm Allotypes;D007129
G12.500.400.586;Immunoglobulin Gm Allotypes;D007129
D12.644.541.500.745;Immunoglobulin Idiotypes;D007130
D12.776.124.486.485.680.745;Immunoglobulin Idiotypes;D007130
D12.776.124.790.651.680.745;Immunoglobulin Idiotypes;D007130
D12.776.377.715.548.680.745;Immunoglobulin Idiotypes;D007130
D23.050.550.750;Immunoglobulin Idiotypes;D007130
G02.111.570.060.425.580;Immunoglobulin Idiotypes;D007130
G12.500.450;Immunoglobulin Idiotypes;D007130
D12.776.124.486.485.114.606.587;Immunoglobulin Km Allotypes;D007131
D12.776.124.486.485.705.750.530.500;Immunoglobulin Km Allotypes;D007131
D12.776.124.790.651.114.606.587;Immunoglobulin Km Allotypes;D007131
D12.776.124.790.651.705.750.530.500;Immunoglobulin Km Allotypes;D007131
D12.776.377.715.548.114.606.587;Immunoglobulin Km Allotypes;D007131
D12.776.377.715.548.705.750.530.500;Immunoglobulin Km Allotypes;D007131
G12.500.400.587;Immunoglobulin Km Allotypes;D007131
D12.776.124.486.485.114.619;Immunoglobulin Isotypes;D007132
D12.776.124.790.651.114.619;Immunoglobulin Isotypes;D007132
D12.776.377.715.548.114.619;Immunoglobulin Isotypes;D007132
D12.644.541.500.650.500.590;Immunoglobulin Joining Region;D007133
D12.776.124.486.485.680.650.500.590;Immunoglobulin Joining Region;D007133
D12.776.124.486.485.797.590;Immunoglobulin Joining Region;D007133
D12.776.124.790.651.680.650.500.590;Immunoglobulin Joining Region;D007133
D12.776.124.790.651.797.590;Immunoglobulin Joining Region;D007133
D12.776.377.715.548.680.650.500.590;Immunoglobulin Joining Region;D007133
D12.776.377.715.548.797.590;Immunoglobulin Joining Region;D007133
G05.360.340.024.340.137.430;Immunoglobulin Switch Region;D007134
G05.360.340.024.340.335.300.500;Immunoglobulin Switch Region;D007134
D12.644.541.500.650.500;Immunoglobulin Variable Region;D007135
D12.776.124.486.485.680.650.500;Immunoglobulin Variable Region;D007135
D12.776.124.486.485.797;Immunoglobulin Variable Region;D007135
D12.776.124.790.651.680.650.500;Immunoglobulin Variable Region;D007135
D12.776.124.790.651.797;Immunoglobulin Variable Region;D007135
D12.776.377.715.548.680.650.500;Immunoglobulin Variable Region;D007135
D12.776.377.715.548.797;Immunoglobulin Variable Region;D007135
G02.111.570.060.425;Immunoglobulin Variable Region;D007135
D12.776.124.486.485;Immunoglobulins;D007136
D12.776.124.790.651;Immunoglobulins;D007136
D12.776.377.715.548;Immunoglobulins;D007136
D12.776.124.486.485.114.619.026.515;Immunoglobulin alpha-Chains;D007137
D12.776.124.486.485.705.500.350;Immunoglobulin alpha-Chains;D007137
D12.776.124.790.651.114.619.026.515;Immunoglobulin alpha-Chains;D007137
D12.776.124.790.651.705.500.350;Immunoglobulin alpha-Chains;D007137
D12.776.377.715.548.114.619.026.515;Immunoglobulin alpha-Chains;D007137
D12.776.377.715.548.705.500.350;Immunoglobulin alpha-Chains;D007137
D12.776.124.486.485.114.619.251.500;Immunoglobulin delta-Chains;D007138
D12.776.124.486.485.705.500.360;Immunoglobulin delta-Chains;D007138
D12.776.124.790.651.114.619.251.500;Immunoglobulin delta-Chains;D007138
D12.776.124.790.651.705.500.360;Immunoglobulin delta-Chains;D007138
D12.776.377.715.548.114.619.251.500;Immunoglobulin delta-Chains;D007138
D12.776.377.715.548.705.500.360;Immunoglobulin delta-Chains;D007138
D12.776.124.486.485.114.619.312.500;Immunoglobulin epsilon-Chains;D007139
D12.776.124.486.485.705.500.370;Immunoglobulin epsilon-Chains;D007139
D12.776.124.790.651.114.619.312.500;Immunoglobulin epsilon-Chains;D007139
D12.776.124.790.651.705.500.370;Immunoglobulin epsilon-Chains;D007139
D12.776.377.715.548.114.619.312.500;Immunoglobulin epsilon-Chains;D007139
D12.776.377.715.548.705.500.370;Immunoglobulin epsilon-Chains;D007139
D12.644.541.500.650;Immunoglobulin Fab Fragments;D007140
D12.776.124.486.485.680.650;Immunoglobulin Fab Fragments;D007140
D12.776.124.790.651.680.650;Immunoglobulin Fab Fragments;D007140
D12.776.377.715.548.680.650;Immunoglobulin Fab Fragments;D007140
D12.644.541.500.697;Immunoglobulin Fc Fragments;D007141
D12.776.124.486.485.538.500;Immunoglobulin Fc Fragments;D007141
D12.776.124.486.485.680.697;Immunoglobulin Fc Fragments;D007141
D12.776.124.790.651.538.500;Immunoglobulin Fc Fragments;D007141
D12.776.124.790.651.680.660;Immunoglobulin Fc Fragments;D007141
D12.776.377.715.548.538.500;Immunoglobulin Fc Fragments;D007141
D12.776.377.715.548.680.660;Immunoglobulin Fc Fragments;D007141
D12.776.124.486.485.114.619.393.522;Immunoglobulin gamma-Chains;D007142
D12.776.124.486.485.705.500.380;Immunoglobulin gamma-Chains;D007142
D12.776.124.790.651.114.619.393.522;Immunoglobulin gamma-Chains;D007142
D12.776.124.790.651.705.500.380;Immunoglobulin gamma-Chains;D007142
D12.776.377.715.548.114.619.393.522;Immunoglobulin gamma-Chains;D007142
D12.776.377.715.548.705.500.380;Immunoglobulin gamma-Chains;D007142
D12.776.124.486.485.705.500;Immunoglobulin Heavy Chains;D007143
D12.776.124.790.651.705.500;Immunoglobulin Heavy Chains;D007143
D12.776.377.715.548.705.500;Immunoglobulin Heavy Chains;D007143
D12.776.124.486.485.705.625;Immunoglobulin J-Chains;D007144
D12.776.124.790.651.705.625;Immunoglobulin J-Chains;D007144
D12.776.377.715.548.705.625;Immunoglobulin J-Chains;D007144
D12.776.124.486.485.705.750.530;Immunoglobulin kappa-Chains;D007145
D12.776.124.790.651.705.750.530;Immunoglobulin kappa-Chains;D007145
D12.776.377.715.548.705.750.530;Immunoglobulin kappa-Chains;D007145
D12.776.124.486.485.705.750.550;Immunoglobulin lambda-Chains;D007146
D12.776.124.790.651.705.750.550;Immunoglobulin lambda-Chains;D007146
D12.776.377.715.548.705.750.550;Immunoglobulin lambda-Chains;D007146
D12.776.124.486.485.705.750;Immunoglobulin Light Chains;D007147
D12.776.124.790.651.705.750;Immunoglobulin Light Chains;D007147
D12.776.377.715.548.705.750;Immunoglobulin Light Chains;D007147
D12.776.124.486.485.114.619.574.500;Immunoglobulin mu-Chains;D007148
D12.776.124.486.485.705.500.500;Immunoglobulin mu-Chains;D007148
D12.776.124.790.651.114.619.574.500;Immunoglobulin mu-Chains;D007148
D12.776.124.790.651.705.500.500;Immunoglobulin mu-Chains;D007148
D12.776.377.715.548.114.619.574.500;Immunoglobulin mu-Chains;D007148
D12.776.377.715.548.705.500.500;Immunoglobulin mu-Chains;D007148
E01.370.225.500.607.512;Immunohistochemistry;D007150
E01.370.225.750.551.512;Immunohistochemistry;D007150
E05.200.500.607.512;Immunohistochemistry;D007150
E05.200.750.551.512;Immunohistochemistry;D007150
E05.478.583;Immunohistochemistry;D007150
H01.158.100.656.234.512;Immunohistochemistry;D007150
H01.158.201.344.512;Immunohistochemistry;D007150
H01.158.201.486.512;Immunohistochemistry;D007150
H01.181.122.573.512;Immunohistochemistry;D007150
H01.181.122.605.512;Immunohistochemistry;D007150
G04.299.780.612;Immunologic Capping;D007152
G12.425.143.612;Immunologic Capping;D007152
C20.673;Immunologic Deficiency Syndromes;D007153
C20;Immune System Diseases;D007154
D27.505.696.477;Immunologic Factors;D007155
G12.450.050.500;Immunologic Memory;D007156
G12.425.745;Immunologic Surveillance;D007157
G12.450.050.400.412;Immunologic Surveillance;D007157
E05.478;Immunologic Techniques;D007158
E01.370.225.812;Immunologic Tests;D007159
E05.200.812;Immunologic Tests;D007159
E05.478.594;Immunologic Tests;D007159
C20.683;Immunoproliferative Disorders;D007160
C04.557.386.390;Immunoproliferative Small Intestinal Disease;D007161
C06.301.371.411.512;Immunoproliferative Small Intestinal Disease;D007161
C06.405.249.411.512;Immunoproliferative Small Intestinal Disease;D007161
C06.405.469.491.505;Immunoproliferative Small Intestinal Disease;D007161
C15.378.147.780.490.512;Immunoproliferative Small Intestinal Disease;D007161
C15.604.515.435.512;Immunoproliferative Small Intestinal Disease;D007161
C20.683.515.512;Immunoproliferative Small Intestinal Disease;D007161
C20.683.780.490.512;Immunoproliferative Small Intestinal Disease;D007161
D12.776.124.486;Immunoproteins;D007162
E05.478.566.380;Immunosorbent Techniques;D007163
E05.601.495.380;Immunosorbent Techniques;D007163
D27.720.877.501;Immunosorbents;D007164
E02.095.465.425.450;Immunosuppression;D007165
E05.478.610;Immunosuppression;D007165
D27.505.696.477.656;Immunosuppressive Agents;D007166
E02.095.465.425;Immunotherapy;D007167
D08.811.682.047.485;IMP Dehydrogenase;D007168
C01.252.410.868.820.504;Impetigo;D007169
C01.252.410.890.485;Impetigo;D007169
C01.252.825.770.360;Impetigo;D007169
C01.539.800.720.770.360;Impetigo;D007169
C17.800.838.765.770.360;Impetigo;D007169
F04.754.137.506.325;Implosive Therapy;D007171
C12.294.644.486;Erectile Dysfunction;D007172
F03.800.800.400;Erectile Dysfunction;D007172
F02.463.425.448;Imprinting (Psychology);D007173
F03.500;Impulse Control Disorders;D007174
F01.145.527;Impulsive Behavior;D007175
V03.500;In Vitro;D007176
C10.228.140.617.738.320;Inappropriate ADH Syndrome;D007177
C18.452.950.626;Inappropriate ADH Syndrome;D007177
C19.700.490;Inappropriate ADH Syndrome;D007177
E05.820.150.520;Inbreeding;D007178
G05.355.090.403;Inbreeding;D007178
I01.880.735.442;Incest;D007179
A14.549.167.860.425;Incisor;D007180
A11.284.420.390;Inclusion Bodies, Viral;D007181
G06.920.400;Inclusion Bodies, Viral;D007181
N01.824.417;Income;D007182
N03.219.900.250;Income Tax;D007183
C16.131.077.445;Incontinentia Pigmenti;D007184
C16.131.831.580;Incontinentia Pigmenti;D007184
C16.320.850.420;Incontinentia Pigmenti;D007184
C17.800.621.497;Incontinentia Pigmenti;D007184
C17.800.804.580;Incontinentia Pigmenti;D007184
C17.800.827.420;Incontinentia Pigmenti;D007184
E07.461;Incubators;D007185
E07.325.569;Incubators, Infant;D007186
E07.461.487;Incubators, Infant;D007186
L01.178.682.192.515;Incunabula as Topic;D007187
A09.246.397.247.362;Incus;D007188
D02.455.426.559.847.486.487;Indans;D007189
D04.615.486.487;Indans;D007189
D02.065.884.540;Indapamide;D007190
D02.886.590.700.540;Indapamide;D007190
D03.438.473.391;Indapamide;D007190
D03.383.129.539.487;Indazoles;D007191
D03.438.449;Indazoles;D007191
D02.455.426.559.847.486;Indenes;D007192
D04.615.486;Indenes;D007192
N03.219.521.576.343.800.450;Independent Practice Associations;D007193
N04.452.758.244.450;Independent Practice Associations;D007193
N04.452.758.745.450;Independent Practice Associations;D007193
N04.590.374.410.450;Independent Practice Associations;D007193
Z01.252.245.393;India;D007194
Z01.639.520;Indian Ocean Islands;D007195
Z01.107.567.875.350.360;Indiana;D007196
Z01.107.567.875.510.360;Indiana;D007196
M01.686.508.150.575;Indians, Central American;D007197
M01.686.508.150.600;Indians, North American;D007198
M01.686.508.150.625;Indians, South American;D007199
D03.438.473.393;Indican;D007200
E05.484;Indicator Dilution Techniques;D007201
D27.720.470.410;Indicators and Reagents;D007202
D03.438.473.396;Indigo Carmine;D007203
D01.268.556.381;Indium;D007204
D01.552.544.381;Indium;D007204
D01.496.749.460;Indium Radioisotopes;D007205
F01.752.488;Individuality;D007206
F01.752.747.466;Individuation;D007207
D03.438.473.400;Indocyanine Green;D007208
D08.811.520.224.125.350;Indole-3-Glycerol-Phosphate Synthase;D007209
D03.066.288;Indoleacetic Acids;D007210
D03.438.473.404;Indoleacetic Acids;D007210
D03.438.473;Indoles;D007211
D03.438.496;Indolizines;D007212
D03.438.473.420;Indomethacin;D007213
Z01.252.145.380;Indonesia;D007214
Z01.639.580;Indonesia;D007214
D02.455.426.559.389.657.446;Indophenol;D007215
D02.241.223.701.450;Indoprofen;D007216
D03.438.513.374;Indoprofen;D007216
D02.065.277.480;Indoramin;D007217
D02.241.223.100.100.470;Indoramin;D007217
D02.455.426.559.389.127.085.470;Indoramin;D007217
D03.383.621.320;Indoramin;D007217
D03.438.473.432;Indoramin;D007217
H01.158.273.540.460;Industrial Microbiology;D007218
J01.897.120.460;Industrial Microbiology;D007218
J01.637.450;Industrial Oils;D007219
D20.944.420;Industrial Waste;D007220
D27.888.284.404;Industrial Waste;D007220
N06.850.460.710.420;Industrial Waste;D007220
J01.576;Industry;D007221
C24.426;Inert Gas Narcosis;D007222
C25.723.455.571;Inert Gas Narcosis;D007222
M01.060.703;Infant;D007223
N02.421.088.120;Infant Care;D007224
J02.500.525.500;Infant Food;D007225
E05.318.308.985.550.475;Infant Mortality;D007226
L01.280.975.550.475;Infant Mortality;D007226
N01.224.935.698.489;Infant Mortality;D007226
N06.850.505.400.975.550.475;Infant Mortality;D007226
N06.850.520.308.985.550.475;Infant Mortality;D007226
G07.610.220.500;Infant Nutritional Physiological Phenomena;D007227
C18.654.422;Infant Nutrition Disorders;D007228
I01.880.787.539;Infant Welfare;D007229
M01.060.703.520.460;Infant, Low Birth Weight;D007230
M01.060.703.520;Infant, Newborn;D007231
C16.614;Infant, Newborn, Diseases;D007232
M01.060.703.520.500;Infant, Postmature;D007233
M01.060.703.520.520;Infant, Premature;D007234
C16.614.521;Infant, Premature, Diseases;D007235
M01.060.703.520.460.560;Infant, Small for Gestational Age;D007236
I01.198.240.470.572;Infanticide;D007237
C23.550.513.355;Infarction;D007238
C23.550.717.489;Infarction;D007238
C01.539;Infection;D007239
B04.820.504.080.100.100;Arteritis Virus, Equine;D007240
B04.909.777.500.080.500.100;Arteritis Virus, Equine;D007240
C02.256.466.488;Infectious Bovine Rhinotracheitis;D007241
C22.196.429;Infectious Bovine Rhinotracheitis;D007241
B04.280.382.100.900.400;Herpesvirus 1, Bovine;D007242
B04.909.204.382.100.900.400;Herpesvirus 1, Bovine;D007242
B04.820.075.060.400;Infectious bursal disease virus;D007243
B04.909.777.123.060.400;Infectious bursal disease virus;D007243
C02.256.466.313.400;Infectious Mononucleosis;D007244
C15.378.553.381;Infectious Mononucleosis;D007244
C15.604.515.516;Infectious Mononucleosis;D007244
C20.683.515.515;Infectious Mononucleosis;D007244
A08.186.211.132.659.727.407;Inferior Colliculi;D007245
A08.186.211.653.727.249;Inferior Colliculi;D007245
C12.294.365;Infertility;D007246
C13.351.500.365;Infertility;D007246
C13.351.500.365.700;Infertility, Female;D007247
C12.294.365.700;Infertility, Male;D007248
C23.550.470;Inflammation;D007249
N03.219.680;Inflation, Economic;D007250
C02.782.620.365;Influenza, Human;D007251
C08.730.310;Influenza, Human;D007251
D20.215.894.899.302;Influenza Vaccines;D007252
L01.346;Information Centers;D007253
L01;Information Science;D007254
L01.453;Information Services;D007255
L01.700.508.300;Information Systems;D007256
L01.488;Information Theory;D007257
I01.880.604.473.650.718;Informed Consent;D007258
I01.880.604.583.427;Informed Consent;D007258
N03.706.437.650.312;Informed Consent;D007258
N03.706.535.489;Informed Consent;D007258
G01.358.500.505.650.552;Infrared Rays;D007259
G01.590.540.552;Infrared Rays;D007259
G01.750.250.650.552;Infrared Rays;D007259
G01.750.770.578.552;Infrared Rays;D007259
G16.500.275.063.725.525.400;Infrared Rays;D007259
G16.500.750.775.525.400;Infrared Rays;D007259
N06.230.300.100.725.525.400;Infrared Rays;D007259
E07.505;Infusion Pumps;D007260
E07.858.082.505;Infusion Pumps;D007260
E02.319.267.510.520;Infusions, Intra-Arterial;D007261
E02.319.267.082.500;Infusions, Intravenous;D007262
E02.319.267.510.590;Infusions, Intravenous;D007262
E02.319.267.510;Infusions, Parenteral;D007263
A01.923.047.412;Inguinal Canal;D007264
D06.472.334.968;Inhibins;D007265
D06.472.699.337;Inhibins;D007265
D12.644.548.387;Inhibins;D007265
D12.776.395.439;Inhibins;D007265
F01.145.544;Inhibition (Psychology);D007266
F02.463.425.475;Inhibition (Psychology);D007266
F02.739.794.405;Inhibition (Psychology);D007266
E02.319.267.530;Injections;D007267
E02.319.267.530.580.300;Injections, Epidural;D007268
E02.319.267.530.370;Injections, Intra-Arterial;D007269
E02.319.267.530.380;Injections, Intra-Articular;D007270
E02.319.267.530.620.410;Injections, Intradermal;D007271
E02.319.267.530.440;Injections, Intralymphatic;D007272
E02.319.267.530.460;Injections, Intramuscular;D007273
E02.319.267.530.490;Injections, Intraperitoneal;D007274
E02.319.267.082.750;Injections, Intravenous;D007275
E02.319.267.530.540;Injections, Intravenous;D007275
E02.319.267.530.550;Injections, Intraventricular;D007276
E02.319.267.530.620.570;Injections, Jet;D007277
E02.319.267.530.580;Injections, Spinal;D007278
E02.319.267.530.620;Injections, Subcutaneous;D007279
C21;Disorders of Environmental Origin;D007280
J01.576.154.400;Ink;D007281
J01.637.500;Ink;D007281
F04.711.647.622.341;Ink Blot Tests;D007282
D25.339.334.574;Inlay Casting Wax;D007283
J01.637.051.339.334.574;Inlay Casting Wax;D007283
E06.323.428.275;Inlays;D007284
E06.780.345.737.500;Inlays;D007284
E06.780.345.817;Inlays;D007284
E07.695.190.190.350;Inlays;D007284
D01;Inorganic Chemicals;D007287
D03.438.759.590.616;Inosine;D007288
D13.570.583.616;Inosine;D007288
D13.570.800.573;Inosine;D007288
D03.438.759.646.616.300;Cyclic IMP;D007289
D13.695.462.300;Cyclic IMP;D007289
D13.695.667.616.300;Cyclic IMP;D007289
D13.695.827.519.300;Cyclic IMP;D007289
D03.438.759.646.616.400;Inosine Diphosphate;D007290
D13.695.667.616.400;Inosine Diphosphate;D007290
D13.695.827.519.400;Inosine Diphosphate;D007290
D03.438.759.646.616.500;Inosine Monophosphate;D007291
D13.695.667.616.500;Inosine Monophosphate;D007291
D13.695.827.519.500;Inosine Monophosphate;D007291
D03.438.759.646.616;Inosine Nucleotides;D007292
D13.695.667.616;Inosine Nucleotides;D007292
D13.695.827.519;Inosine Nucleotides;D007292
D03.438.759.646.616.800;Inosine Triphosphate;D007293
D13.695.667.616.800;Inosine Triphosphate;D007293
D13.695.827.519.800;Inosine Triphosphate;D007293
D02.033.800.519;Inositol;D007294
D09.853.519;Inositol;D007294
D02.033.800.519.400;Inositol Phosphates;D007295
D09.853.519.400;Inositol Phosphates;D007295
D09.894.480;Inositol Phosphates;D007295
D08.811.399.430.500;Myo-Inositol-1-Phosphate Synthase;D007296
M01.643.470;Inpatients;D007297
F04.096.544.335.528;Insanity Defense;D007298
I01.198.780.937.469.528;Insanity Defense;D007298
I01.880.604.583.310.528;Insanity Defense;D007298
N03.706.535.351.528;Insanity Defense;D007298
C25.723.127.441;Insect Bites and Stings;D007299
N06.850.780.200.650.425;Insect Control;D007300
D06.472.445.573;Insect Hormones;D007301
D27.720.031.700.441;Insect Repellents;D007302
D27.720.723.441;Insect Repellents;D007302
D27.888.723.441;Insect Repellents;D007302
N06.850.310.350.100.500;Insect Vectors;D007303
B04.525;Insect Viruses;D007304
G07.690.320.491;Insecticide Resistance;D007305
D27.720.031.700.491;Insecticides;D007306
D27.720.723.491;Insecticides;D007306
D27.888.723.491;Insecticides;D007306
B01.050.150.900.649.473;Insectivora;D007312
B01.050.500.131.617;Insects;D007313
G08.686.785.760.363;Insemination;D007314
E02.875.540;Insemination, Artificial;D007315
E02.875.800.937;Insemination, Artificial;D007315
E05.820.800.937;Insemination, Artificial;D007315
G08.686.785.760.363.492;Insemination, Artificial;D007315
E02.875.540.515;Insemination, Artificial, Heterologous;D007316
E02.875.800.937.515;Insemination, Artificial, Heterologous;D007316
E05.820.800.937.515;Insemination, Artificial, Heterologous;D007316
E02.875.540.525;Insemination, Artificial, Homologous;D007317
E02.875.800.937.525;Insemination, Artificial, Homologous;D007317
E05.820.800.937.525;Insemination, Artificial, Homologous;D007317
I02.574;Inservice Training;D007318
C10.886.425.800.800;Sleep Initiation and Maintenance Disorders;D007319
F03.870.400.800.800;Sleep Initiation and Maintenance Disorders;D007319
E01.370.386.700.485.750.900.350;Inspiratory Capacity;D007320
G09.772.850.970.500;Inspiratory Capacity;D007320
E01.370.386.700.485.750.900.350.350;Inspiratory Reserve Volume;D007321
G09.772.850.970.500.375;Inspiratory Reserve Volume;D007321
E02.319.267.641;Instillation, Drug;D007322
F01.658.642;Instinct;D007323
N04.452.460;Institutional Management Teams;D007324
N04.452.758.367;Institutional Practice;D007325
E02.760.415;Institutionalization;D007326
N02.421.585.415;Institutionalization;D007326
E01.370.450;Insufflation;D007327
E02.583;Insufflation;D007327
D06.472.699.587.200.500.625;Insulin;D007328
D12.644.548.586.200.500.625;Insulin;D007328
D06.347.420;Insulin Antagonists;D007329
D27.505.696.399.450.420;Insulin Antagonists;D007329
D12.776.124.486.485.114.656;Insulin Antibodies;D007330
D12.776.124.790.651.114.656;Insulin Antibodies;D007330
D12.776.377.715.548.114.656;Insulin Antibodies;D007330
C10.597.606.358.800.200.600;Insulin Coma;D007331
C18.452.394.984.492;Insulin Coma;D007331
E02.319.300.508;Insulin Infusion Systems;D007332
E07.505.508;Insulin Infusion Systems;D007332
E07.858.082.505.508;Insulin Infusion Systems;D007332
C18.452.394.968.500;Insulin Resistance;D007333
G07.690.320.617;Insulin Resistance;D007333
D12.644.276.937.400;Insulin-Like Growth Factor I;D007334
D12.776.124.862.400;Insulin-Like Growth Factor I;D007334
D12.776.467.937.400;Insulin-Like Growth Factor I;D007334
D23.529.937.400;Insulin-Like Growth Factor I;D007334
D12.644.276.937.420;Insulin-Like Growth Factor II;D007335
D12.776.124.862.425;Insulin-Like Growth Factor II;D007335
D12.776.467.937.420;Insulin-Like Growth Factor II;D007335
D23.529.937.420;Insulin-Like Growth Factor II;D007335
D06.472.699.587.200.300.200;Insulin, Isophane;D007336
D12.644.548.586.200.300.200;Insulin, Isophane;D007336
D08.811.277.656.300.480.300;Insulysin;D007339
D08.811.277.656.675.374.300;Insulysin;D007339
C04.557.470.035.100.852;Insulinoma;D007340
C04.588.274.761.249.500;Insulinoma;D007340
C04.588.322.475.249.500;Insulinoma;D007340
C06.301.761.249.500;Insulinoma;D007340
C06.689.667.249.500;Insulinoma;D007340
C19.344.421.249.500;Insulinoma;D007340
N03.219.521.576;Insurance;D007341
N03.219.521.576.130;Insurance Benefits;D007342
N03.219.521.576.160;Insurance Carriers;D007343
N03.219.521.576.210;Insurance Claim Reporting;D007344
N03.219.521.576.215;Insurance Claim Review;D007345
N03.219.521.576.343.409;Insurance, Accident;D007346
N03.219.521.576.343.450;Insurance, Dental;D007347
N03.219.521.576.343;Insurance, Health;D007348
N03.219.521.576.343.480;Insurance, Health, Reimbursement;D007349
N03.219.521.710;Insurance, Health, Reimbursement;D007349
N03.219.521.576.343.492;Insurance, Hospitalization;D007350
N03.219.521.576.443;Insurance, Liability;D007351
N03.219.521.576.543;Insurance, Life;D007352
N03.219.521.576.343.508;Insurance, Long-Term Care;D007353
N03.219.521.576.343.533;Insurance, Major Medical;D007354
N03.219.521.576.343.545;Insurance, Nursing Services;D007355
N03.219.521.576.343.575;Insurance, Pharmaceutical Services;D007356
N03.219.521.576.343.616;Insurance, Physician Services;D007357
N03.219.521.576.343.658;Insurance, Psychiatric;D007358
N03.219.521.576.343.700;Insurance, Surgical;D007359
F01.752.543;Intelligence;D007360
F04.711.141.493;Intelligence Tests;D007361
N02.278.388.493;Intensive Care Units;D007362
N02.278.388.493.390.380;Intensive Care Units, Neonatal;D007363
D27.720.470.410.360;Intercalating Agents;D007364
A11.284.149.165.420;Intercellular Junctions;D007365
A02.633.567.900.500;Intercostal Muscles;D007366
A08.800.800.720.800.350;Intercostal Nerves;D007367
E05.490;Interferometry;D007368
D27.505.696.477.828;Interferon Inducers;D007369
D12.644.276.374.440.890;Interferon Type I;D007370
D12.644.276.718.500;Interferon Type I;D007370
D12.776.467.374.440.890;Interferon Type I;D007370
D12.776.467.718.500;Interferon Type I;D007370
D23.529.374.440.890;Interferon Type I;D007370
D23.529.718.500;Interferon Type I;D007370
D12.644.276.374.440.893;Interferon-gamma;D007371
D12.644.276.374.480.350;Interferon-gamma;D007371
D12.644.276.374.480.615.350;Interferon-gamma;D007371
D12.644.276.718.550;Interferon-gamma;D007371
D12.776.467.374.440.893;Interferon-gamma;D007371
D12.776.467.374.480.350;Interferon-gamma;D007371
D12.776.467.374.480.615.350;Interferon-gamma;D007371
D12.776.467.718.550;Interferon-gamma;D007371
D23.529.374.440.893;Interferon-gamma;D007371
D23.529.374.480.350;Interferon-gamma;D007371
D23.529.374.480.615.350;Interferon-gamma;D007371
D23.529.718.550;Interferon-gamma;D007371
D12.644.276.374.440;Interferons;D007372
D12.644.276.718;Interferons;D007372
D12.776.467.374.440;Interferons;D007372
D12.776.467.718;Interferons;D007372
D23.529.374.440;Interferons;D007372
D23.529.718;Interferons;D007372
N04.452.822.400;Interinstitutional Relations;D007373
J01.086.339.290;Interior Design and Furnishings;D007374
D12.644.276.374.465.501;Interleukin-1;D007375
D12.644.276.374.500.400;Interleukin-1;D007375
D12.776.467.374.465.501;Interleukin-1;D007375
D12.776.467.374.500.400;Interleukin-1;D007375
D23.529.374.465.501;Interleukin-1;D007375
D23.529.374.500.400;Interleukin-1;D007375
D12.644.276.374.465.502;Interleukin-2;D007376
D12.644.276.374.480.372;Interleukin-2;D007376
D12.776.467.374.465.502;Interleukin-2;D007376
D12.776.467.374.480.372;Interleukin-2;D007376
D23.529.374.465.502;Interleukin-2;D007376
D23.529.374.480.372;Interleukin-2;D007376
D12.644.276.374.410.240.400;Interleukin-3;D007377
D12.644.276.374.465.503;Interleukin-3;D007377
D12.776.395.240.400;Interleukin-3;D007377
D12.776.467.374.410.240.400;Interleukin-3;D007377
D12.776.467.374.465.503;Interleukin-3;D007377
D23.529.374.410.240.400;Interleukin-3;D007377
D23.529.374.465.503;Interleukin-3;D007377
D12.644.276.374.465;Interleukins;D007378
D12.776.467.374.465;Interleukins;D007378
D23.529.374.465;Interleukins;D007378
L01.453.639.493;Interlibrary Loans;D007379
L01.583.464.493;Interlibrary Loans;D007379
N02.278.825.610.480;Intermediate Care Facilities;D007380
D05.750.078.593;Intermediate Filament Proteins;D007381
D12.776.220.475;Intermediate Filament Proteins;D007381
A11.284.430.214.190.750.410;Intermediate Filaments;D007382
C14.907.137.126.669;Intermittent Claudication;D007383
C23.888.531;Intermittent Claudication;D007383
E02.041.625.790.520;Intermittent Positive-Pressure Breathing;D007384
E02.880.820.790.520;Intermittent Positive-Pressure Breathing;D007384
E02.041.625.790.550;Intermittent Positive-Pressure Ventilation;D007385
E02.880.820.790.550;Intermittent Positive-Pressure Ventilation;D007385
E04.100.376.719.332.400;Internal Mammary-Coronary Artery Anastomosis;D007387
E04.100.814.868.750.400;Internal Mammary-Coronary Artery Anastomosis;D007387
E04.928.220.520.220.380;Internal Mammary-Coronary Artery Anastomosis;D007387
H02.403.429;Internal Medicine;D007388
F01.829.379;Internal-External Control;D007389
N03.540.514;International Agencies;D007390
I01.615.500;International Cooperation;D007391
N03.540.828.672.463;International Council of Nurses;D007392
I01.615.500.650;International Educational Exchange;D007393
I02.581;International Educational Exchange;D007393
E05.978.507;International System of Units;D007394
A08.663.358;Interneurons;D007395
A11.671.358;Interneurons;D007395
I02.358.399.644;Internship and Residency;D007396
I02.358.750;Internship, Nonmedical;D007397
F01.829.401;Interpersonal Relations;D007398
G04.299.134.500;Interphase;D007399
F01.829.401.205;Interprofessional Relations;D007400
A13.530;Interrenal Gland;D007401
C17.800.174.640;Intertrigo;D007402
C17.800.815.650;Intertrigo;D007402
A02.165.308.410;Intervertebral Disc;D007403
A02.835.232.834.432;Intervertebral Disc;D007403
E02.718.500;Intervertebral Disc Chemolysis;D007404
C05.116.900.307;Intervertebral Disc Displacement;D007405
C23.300.707.952;Intervertebral Disc Displacement;D007405
F04.669.599;Interview, Psychological;D007406
E05.318.308.420;Interviews as Topic;D007407
L01.280.520;Interviews as Topic;D007407
N05.715.360.300.400;Interviews as Topic;D007407
N06.850.520.308.420;Interviews as Topic;D007407
G03.495.023.500;Intestinal Absorption;D007408
G07.610.593.431;Intestinal Absorption;D007408
G07.700.620.431;Intestinal Absorption;D007408
G10.261.326.430;Intestinal Absorption;D007408
C06.198.719;Intestinal Atresia;D007409
C06.405.469.445;Intestinal Atresia;D007409
C16.131.314.466;Intestinal Atresia;D007409
C06.405.469;Intestinal Diseases;D007410
C03.432;Intestinal Diseases, Parasitic;D007411
C06.405.469.452;Intestinal Diseases, Parasitic;D007411
C06.267.550;Intestinal Fistula;D007412
C06.405.469.471;Intestinal Fistula;D007412
C23.300.575.185.550;Intestinal Fistula;D007412
A03.556.124.369;Intestinal Mucosa;D007413
A10.615.550.444;Intestinal Mucosa;D007413
C04.588.274.476.411;Intestinal Neoplasms;D007414
C06.301.371.411;Intestinal Neoplasms;D007414
C06.405.249.411;Intestinal Neoplasms;D007414
C06.405.469.491;Intestinal Neoplasms;D007414
C06.405.469.531;Intestinal Obstruction;D007415
C06.405.469.557;Intestinal Perforation;D007416
C23.300.825.411;Intestinal Polyps;D007417
C06.405.469.531.492.500;Intestinal Pseudo-Obstruction;D007418
A12.200.390;Intestinal Secretions;D007419
A03.556.124.526;Intestine, Large;D007420
A03.556.249.249;Intestine, Large;D007420
A03.556.124.684;Intestine, Small;D007421
A03.556.124;Intestines;D007422
E04.050.215.400;Intra-Aortic Balloon Pumping;D007423
A11.284.430.429;Intracellular Fluid;D007424
A11.284.835.450;Intracellular Fluid;D007424
A12.207.515;Intracellular Fluid;D007424
A11.284.149.450;Intracellular Membranes;D007425
A11.284.835.514;Intracellular Membranes;D007425
G02.111.570.080.708.330.800.200;Genes, Intracisternal A-Particle;D007426
G05.360.080.708.330.800.200;Genes, Intracisternal A-Particle;D007426
G05.360.340.024.340.490.360;Genes, Intracisternal A-Particle;D007426
G05.360.340.024.425.800.200;Genes, Intracisternal A-Particle;D007426
G05.360.340.400.500.360;Genes, Intracisternal A-Particle;D007426
G11.561.170.505;Intracranial Pressure;D007427
E01.370.225.812.871.300;Intradermal Tests;D007428
E05.200.812.871.300;Intradermal Tests;D007428
E05.478.594.890.300;Intradermal Tests;D007428
G14.440;Intraocular Pressure;D007429
E02.760.731.400;Intraoperative Care;D007430
E04.604.249;Intraoperative Care;D007430
N02.421.585.722.400;Intraoperative Care;D007430
C23.550.505;Intraoperative Complications;D007431
E04.614.374;Intraoperative Period;D007432
N02.421.585.753.374;Intraoperative Period;D007432
E05.325.578.500;Intrauterine Device Expulsion;D007433
E07.190.250.520;Intrauterine Devices;D007434
E07.190.250.520.520.300;Intrauterine Devices, Copper;D007435
E07.190.250.520.520;Intrauterine Devices, Medicated;D007436
D12.776.395.560.494;Intrinsic Factor;D007437
G05.360.340.024.220.400;Introns;D007438
G05.360.340.024.340.137.515;Introns;D007438
F01.752.747.511;Introversion (Psychology);D007439
F02.739.794.438;Introversion (Psychology);D007439
E02.585;Intubation;D007440
E05.497;Intubation;D007440
E02.585.412;Intubation, Gastrointestinal;D007441
E05.497.412;Intubation, Gastrointestinal;D007441
E02.041.500;Intubation, Intratracheal;D007442
E02.585.578;Intubation, Intratracheal;D007442
E05.497.578;Intubation, Intratracheal;D007442
C06.405.469.531.577;Intussusception;D007443
D05.750.078.562.855.750;Inulin;D007444
D09.698.350.500;Inulin;D007444
D09.698.365.855.750;Inulin;D007444
N02.278.354.650.300;Inventories, Hospital;D007445
N04.452.442.650.300;Inventories, Hospital;D007445
C23.550.210.190;Chromosome Inversion;D007446
G05.355.600.805.500;Chromosome Inversion;D007446
G05.365.590.175.190;Chromosome Inversion;D007446
G05.365.590.770.500;Chromosome Inversion;D007446
D06.472.445;Invertebrate Hormones;D007447
B01.050.500;Invertebrates;D007448
N03.219.702;Investments;D007449
D02.241.223.100.400.880.375;Iodamide;D007451
D02.455.426.559.389.127.375.880.375;Iodamide;D007451
D01.248.497.158.480;Iodates;D007452
D01.475.400;Iodates;D007452
D08.811.682.732.525;Iodide Peroxidase;D007453
D01.248.497.158.490;Iodides;D007454
D01.475.410;Iodides;D007454
D01.268.380.400;Iodine;D007455
D01.496.448;Iodine Isotopes;D007456
D01.496.448.496;Iodine Radioisotopes;D007457
D01.496.749.474;Iodine Radioisotopes;D007457
D02.241.223.100.400.880.380;Iodipamide;D007458
D02.455.426.559.389.127.375.880.380;Iodipamide;D007458
D10.627.700.550;Iodized Oil;D007459
D20.215.784.750.550;Iodized Oil;D007459
D02.065.064.400;Iodoacetamide;D007460
D02.241.081.018.110.400;Iodoacetamide;D007460
D02.241.081.018.487.249;Iodoacetamide;D007460
D02.455.526.581.247.249;Iodoacetamide;D007460
D02.241.081.018.487;Iodoacetates;D007461
D02.455.526.581.247;Iodoacetates;D007461
D02.455.426.559.389.454;Iodobenzenes;D007462
D02.455.526.581.496;Iodobenzenes;D007462
D02.241.223.100.400;Iodobenzoates;D007463
D02.455.426.559.389.127.375;Iodobenzoates;D007463
D03.438.810.350.625.400;Clioquinol;D007464
D02.065.277.431.579;Iodohippuric Acid;D007465
D02.241.223.100.100.400.500;Iodohippuric Acid;D007465
D02.241.755.360.579;Iodohippuric Acid;D007465
D02.455.426.559.389.127.085.460.500;Iodohippuric Acid;D007465
D01.475.557;Iodophors;D007466
D12.776.486;Iodoproteins;D007467
D03.383.725.791.496.371;Iodopyracet;D007468
D03.383.725.791.496;Iodopyridones;D007469
D06.472.931.388;Monoiodotyrosine;D007470
D12.125.072.050.875.496;Monoiodotyrosine;D007470
D02.241.223.100.400.880.390;Ioglycamic Acid;D007471
D02.455.426.559.389.127.375.880.390;Ioglycamic Acid;D007471
D02.241.223.100.400.880.400;Iohexol;D007472
D02.455.426.559.389.127.375.880.400;Iohexol;D007472
D12.776.157.530.400;Ion Channels;D007473
D12.776.543.550.425;Ion Channels;D007473
D12.776.543.585.400;Ion Channels;D007473
G02.149.767.640;Ion Exchange;D007474
G02.842.750.640;Ion Exchange;D007474
D27.720.470.420;Ion Exchange Resins;D007475
D27.505.519.562.374;Ionophores;D007476
D27.720.395;Ionophores;D007476
D01.248.497;Ions;D007477
E02.319.267.650;Iontophoresis;D007478
E05.301.300.575;Iontophoresis;D007478
D02.241.223.100.400.880.410;Iopamidol;D007479
D02.455.426.559.389.127.375.880.410;Iopamidol;D007479
D02.455.426.559.389.454.385;Iopanoic Acid;D007480
D02.455.526.581.496.385;Iopanoic Acid;D007480
D02.455.426.559.389.454.400;Iophendylate;D007481
D02.455.526.581.496.400;Iophendylate;D007481
D02.033.800.813.550.600;Iothalamate Meglumine;D007482
D02.241.223.100.400.880.430.500;Iothalamate Meglumine;D007482
D02.455.426.559.389.127.375.880.420;Iothalamate Meglumine;D007482
D09.067.342.600.600;Iothalamate Meglumine;D007482
D09.853.813.550.600;Iothalamate Meglumine;D007482
D02.241.223.100.400.880.430;Iothalamic Acid;D007483
D02.455.426.559.389.127.375.880.430;Iothalamic Acid;D007483
Z01.107.567.875.510.370;Iowa;D007484
D02.241.223.100.400.880.450;Ioxaglic Acid;D007485
D02.455.426.559.389.127.375.880.450;Ioxaglic Acid;D007485
D20.215.784.500.450;Ipecac;D007486
D02.455.426.559.389.454.450;Ipodate;D007487
D02.455.526.581.496.450;Ipodate;D007487
D02.455.426.392.368.408.333;Iprindole;D007488
D03.438.473.469;Iprindole;D007488
D02.442.372;Iproniazid;D007490
D03.066.349.390;Iproniazid;D007490
D03.383.725.394.414;Iproniazid;D007490
D02.640.672.400;Ipronidazole;D007491
D03.383.129.308.658.400;Ipronidazole;D007491
Z01.252.245.500.350;Iran;D007492
Z01.586.500.350;Iran;D007492
Z01.252.245.500.360;Iraq;D007493
Z01.586.500.360;Iraq;D007493
Z01.542.467;Ireland;D007494
Z01.639.587;Ireland;D007494
D01.268.556.401;Iridium;D007495
D01.268.956.280;Iridium;D007495
D01.552.544.401;Iridium;D007495
D01.496.749.500;Iridium Radioisotopes;D007496
B04.280.410;Iridoviridae;D007497
B04.909.204.490;Iridoviridae;D007497
A09.371.060.450;Iris;D007498
A09.371.894.513;Iris;D007498
C11.941.375;Iris Diseases;D007499
C11.941.375.385;Iritis;D007500
C11.941.879.780.880.448;Iritis;D007500
D01.268.556.412;Iron;D007501
D01.268.956.287;Iron;D007501
D01.552.544.412;Iron;D007501
D27.505.519.249.410;Iron Chelating Agents;D007502
D27.720.222.410;Iron Chelating Agents;D007502
D01.496.473;Iron Isotopes;D007503
D01.496.473.498;Iron Radioisotopes;D007504
D01.496.749.514;Iron Radioisotopes;D007504
D02.691.550.100.500;Iron-Dextran Complex;D007505
D09.698.365.272.400;Iron-Dextran Complex;D007505
D12.776.157.427.374.375;Iron-Sulfur Proteins;D007506
D12.776.556.579.374.375;Iron-Sulfur Proteins;D007506
E02.533.500;Therapeutic Irrigation;D007507
E05.927;Therapeutic Irrigation;D007507
F01.470.047.110;Irritable Mood;D007508
D27.720.400;Irritants;D007509
D27.720.821.498;Irritants;D007509
D27.888.569.300;Irritants;D007509
D27.888.569.734.498;Irritants;D007509
D03.438.473.525;Isatin;D007510
C23.550.513;Ischemia;D007511
A02.835.232.043.825.548;Ischium;D007512
D02.455.326.146.100.300;Isethionic Acid;D007513
D02.886.645.600.055.300;Isethionic Acid;D007513
K01.844.275;Islam;D007514
A03.734.414;Islets of Langerhans;D007515
A06.407.414;Islets of Langerhans;D007515
C04.557.470.035.100;Adenoma, Islet Cell;D007516
C04.588.274.761.249;Adenoma, Islet Cell;D007516
C04.588.322.475.249;Adenoma, Islet Cell;D007516
C06.301.761.249;Adenoma, Islet Cell;D007516
C06.689.667.249;Adenoma, Islet Cell;D007516
C19.344.421.249;Adenoma, Islet Cell;D007516
D08.811.277.450.585;Isoamylase;D007517
D12.776.124.486.485.114.664;Isoantibodies;D007518
D12.776.124.790.651.114.664;Isoantibodies;D007518
D12.776.377.715.548.114.664;Isoantibodies;D007518
D23.050.705;Isoantigens;D007519
D03.383.129.385.300;Isocarboxazid;D007520
D08.811.682.047.497;Isocitrate Dehydrogenase;D007521
D08.811.520.224.600.700;Isocitrate Lyase;D007522
D02.241.081.901.434.498;Isocitrates;D007523
D03.383.725.762.500;Isodesmosine;D007524
D12.125.072.415;Isodesmosine;D007524
E05.196.401.663;Isoelectric Focusing;D007525
E05.301.300.663;Isoelectric Focusing;D007525
E05.301.300.663.500;Isoelectric Point;D007526
G02.300.500;Isoelectric Point;D007526
D08.811.348;Isoenzymes;D007527
D12.776.800.300;Isoenzymes;D007527
D02.033.100.400;Isoetharine;D007528
D02.092.063.400;Isoetharine;D007528
D03.438.150.266.450.400;Isoflavones;D007529
D03.830.219.266.450.400;Isoflavones;D007529
D02.355.601.570;Isoflurane;D007530
D02.705.429.750.249;Isoflurophate;D007531
D12.125.070.577;Isoleucine;D007532
D12.125.142.383;Isoleucine;D007532
D08.811.464.263.200.450;Isoleucine-tRNA Ligase;D007533
D09.698.365.410;Isomaltose;D007534
D09.698.629.305.320;Isomaltose;D007534
D08.811.399;Isomerases;D007535
G02.575.249;Isomerism;D007536
G02.607.500;Isomerism;D007536
G11.427.590.540.472;Isometric Contraction;D007537
D02.442.436;Isoniazid;D007538
D03.066.349.410;Isoniazid;D007538
D03.383.725.394.582;Isoniazid;D007538
D03.066.349;Isonicotinic Acids;D007539
D03.383.725.394;Isonicotinic Acids;D007539
D03.066.399;Isonipecotic Acids;D007540
D03.383.621.349;Isonipecotic Acids;D007540
D03.438.759.138.525.350;Isopentenyladenosine;D007541
D03.438.759.590.138.500;Isopentenyladenosine;D007541
D13.570.583.138.500;Isopentenyladenosine;D007541
D13.570.800.096.500;Isopentenyladenosine;D007541
D02.065.199.092.450;Inosine Pranobex;D007542
D03.438.759.590.616.450;Inosine Pranobex;D007542
D13.570.583.616.450;Inosine Pranobex;D007542
D13.570.800.573.450;Inosine Pranobex;D007542
D02.886.740.600.500;Isopropyl Thiogalactoside;D007544
D09.408.320.820.500;Isopropyl Thiogalactoside;D007544
D09.408.903.600.500;Isopropyl Thiogalactoside;D007544
D02.033.100.291.439;Isoproterenol;D007545
D02.092.063.291.439;Isoproterenol;D007545
D02.092.311.649;Isoproterenol;D007545
D03.438.531;Isoquinolines;D007546
D02.033.800.813.480;Isosorbide;D007547
D09.853.813.480;Isosorbide;D007547
D02.033.800.813.480.500;Isosorbide Dinitrate;D007548
D09.853.813.480.500;Isosorbide Dinitrate;D007548
B01.043.075.189.250.250.400;Isospora;D007549
D02.886.904.390;Isothiuronium;D007550
D02.948.898.390;Isothiuronium;D007550
G11.427.590.540.493;Isotonic Contraction;D007551
D26.776.498;Isotonic Solutions;D007552
E05.522;Isotope Labeling;D007553
D01.496;Isotopes;D007554
D03.383.129.385;Isoxazoles;D007555
D02.033.100.624.427;Isoxsuprine;D007556
D02.033.755.624.427;Isoxsuprine;D007556
D02.092.471.683.560;Isoxsuprine;D007556
Z01.252.245.500.375;Israel;D007557
Z01.586.500.375;Israel;D007557
Z01.542.489;Italy;D007558
D02.540.505.330;Ivermectin;D007559
Z01.058.290.190.272;Cote d'Ivoire;D007560
C10.228.140.380.165;Creutzfeldt-Jakob Syndrome;D007562
C10.228.228.800.230;Creutzfeldt-Jakob Syndrome;D007562
F03.087.400.300;Creutzfeldt-Jakob Syndrome;D007562
Z01.107.084.900.525;Jamaica;D007563
Z01.639.880.525;Jamaica;D007563
Z01.252.474.463;Japan;D007564
Z01.639.595;Japan;D007564
C23.550.429.500;Jaundice;D007565
C23.888.885.375;Jaundice;D007565
C16.320.565.300.764;Jaundice, Chronic Idiopathic;D007566
C16.614.451.500.250;Jaundice, Chronic Idiopathic;D007566
C18.452.648.300.764;Jaundice, Chronic Idiopathic;D007566
C16.614.451.500;Jaundice, Neonatal;D007567
C23.550.429.249.500;Jaundice, Neonatal;D007567
A02.835.232.781.324.502;Jaw;D007568
A14.521;Jaw;D007568
C05.500.460;Jaw Abnormalities;D007569
C05.660.207.540.460;Jaw Abnormalities;D007569
C07.320.440;Jaw Abnormalities;D007569
C07.650.500.460;Jaw Abnormalities;D007569
C16.131.621.207.540.460;Jaw Abnormalities;D007569
C16.131.850.500.460;Jaw Abnormalities;D007569
C04.182.089.530;Jaw Cysts;D007570
C05.500.470;Jaw Cysts;D007570
C07.320.450;Jaw Cysts;D007570
C05.500;Jaw Diseases;D007571
C07.320;Jaw Diseases;D007571
C26.260.275.500.400;Jaw Fractures;D007572
C26.404.750.467;Jaw Fractures;D007572
C04.588.149.721.450;Jaw Neoplasms;D007573
C05.116.231.754.450;Jaw Neoplasms;D007573
C05.500.499;Jaw Neoplasms;D007573
C07.320.515;Jaw Neoplasms;D007573
E06.520;Jaw Relation Record;D007574
C05.500.480;Jaw, Edentulous;D007575
C07.320.480;Jaw, Edentulous;D007575
C07.465.550.425;Jaw, Edentulous;D007575
C07.793.597.425;Jaw, Edentulous;D007575
C05.500.480.450;Jaw, Edentulous, Partially;D007576
C07.320.480.450;Jaw, Edentulous, Partially;D007576
C07.465.550.425.450;Jaw, Edentulous, Partially;D007576
C07.793.597.425.450;Jaw, Edentulous, Partially;D007576
B04.280.640.615.400;JC Virus;D007577
B04.909.204.210.620.615.400;JC Virus;D007577
B04.909.574.204.670.615.400;JC Virus;D007577
B04.909.675.615.400;JC Virus;D007577
F01.470.653;Jealousy;D007578
C06.405.469.600;Jejunal Diseases;D007579
C04.588.274.476.411.523;Jejunal Neoplasms;D007580
C06.301.371.411.523;Jejunal Neoplasms;D007580
C06.405.249.411.523;Jejunal Neoplasms;D007580
C06.405.469.491.523;Jejunal Neoplasms;D007580
C06.405.469.600.523;Jejunal Neoplasms;D007580
E02.065.062.875;Jejunoileal Bypass;D007581
E04.035.415;Jejunoileal Bypass;D007581
E04.062.875;Jejunoileal Bypass;D007581
E04.210.626;Jejunoileal Bypass;D007581
E04.210.338.523;Jejunostomy;D007582
E04.579.338.523;Jejunostomy;D007582
A03.556.124.684.500;Jejunum;D007583
A03.556.249.750;Jejunum;D007583
M01.686.754.600;Jews;D007585
N04.452.677.400;Job Application;D007586
N04.452.677.410;Job Description;D007587
F02.784.692.425;Job Satisfaction;D007588
C15.378.553.774.600;Job's Syndrome;D007589
C20.673.774.600;Job's Syndrome;D007589
G11.427.590.530.568.610.320;Jogging;D007590
G11.427.590.530.698.277.750.320;Jogging;D007590
I03.450.642.845.610.320;Jogging;D007590
N03.706.110.070.410;Joint Commission on Accreditation of Healthcare Organizations;D007591
N05.700.200.100.420;Joint Commission on Accreditation of Healthcare Organizations;D007591
C05.550;Joint Diseases;D007592
C05.550.521;Joint Instability;D007593
C05.550.535;Joint Loose Bodies;D007594
E07.695.400;Joint Prosthesis;D007595
A02.835.583;Joints;D007596
Z01.252.245.500.400;Jordan;D007597
Z01.586.500.400;Jordan;D007597
L01.737.498.500;Journalism, Dental;D007598
K01.844.385;Judaism;D007599
F02.463.785.626;Judgment;D007600
A07.231.908.498;Jugular Veins;D007601
F02.739.794.471;Jungian Theory;D007602
I01.880.604.583;Jurisprudence;D007603
N03.706.535;Jurisprudence;D007603
I01.880.735.479;Juvenile Delinquency;D007604
D06.472.445.573.666;Juvenile Hormones;D007605
A05.810.453.324.359.520;Juxtaglomerular Apparatus;D007606
A05.810.453.736.520.520;Juxtaglomerular Apparatus;D007606
D03.383.773.400;Kainic Acid;D007608
D12.644.276.812.169.400;Kallidin;D007609
D12.644.456.193.400;Kallidin;D007609
D12.776.467.812.169.400;Kallidin;D007609
D23.469.050.375.110.400;Kallidin;D007609
D23.529.812.169.400;Kallidin;D007609
D08.811.277.656.300.760.442;Kallikreins;D007610
D08.811.277.656.959.350.442;Kallikreins;D007610
D12.776.124.125.597;Kallikreins;D007610
D23.119.597;Kallikreins;D007610
D12.776.083;Aprotinin;D007611
D09.408.051.476;Kanamycin;D007612
G06.099.225.875;Kanamycin Resistance;D007613
G06.225.347.875;Kanamycin Resistance;D007613
G07.690.320.269.347.875;Kanamycin Resistance;D007613
B01.050.150.900.649.573.500;Macropodidae;D007614
Z01.107.567.875.510.390;Kansas;D007615
D01.056.050.075.350;Kaolin;D007616
D01.578.725.025.350;Kaolin;D007616
D01.650.550.050.075.350;Kaolin;D007616
D01.837.725.700.760.050.400;Kaolin;D007616
C02.256.466.382.410;Kaposi Varicelliform Eruption;D007617
C02.825.320.410;Kaposi Varicelliform Eruption;D007617
C17.800.838.790.320.410;Kaposi Varicelliform Eruption;D007617
D05.750.078.739.625;Karaya Gum;D007618
D09.698.700.625;Karaya Gum;D007618
D20.215.721.249.625;Karaya Gum;D007618
C08.127.384.500;Kartagener Syndrome;D007619
C08.200.531;Kartagener Syndrome;D007619
C08.695.501;Kartagener Syndrome;D007619
C09.150.531;Kartagener Syndrome;D007619
C14.240.400.280.500;Kartagener Syndrome;D007619
C14.280.400.280.500;Kartagener Syndrome;D007619
C16.131.240.400.280.500;Kartagener Syndrome;D007619
C16.131.740.501;Kartagener Syndrome;D007619
C16.131.810.250.500;Kartagener Syndrome;D007619
C16.320.480;Kartagener Syndrome;D007619
E01.370.225.500.384.617;Karyometry;D007620
E05.200.500.384.467;Karyometry;D007620
E05.242.384.467;Karyometry;D007620
E01.370.225.500.385.315;Karyotyping;D007621
E05.200.500.385.315;Karyotyping;D007621
E05.242.385.315;Karyotyping;D007621
E05.393.285.475;Karyotyping;D007621
Z01.252.100.420;Kazakhstan;D007623
Z01.586.200.440;Kazakhstan;D007623
Z01.586.950.440;Kazakhstan;D007623
A11.251.210.190.400.500;KB Cells;D007624
A11.251.860.180.400.500;KB Cells;D007624
A11.436.340.500;KB Cells;D007624
C05.651.460.700.500;Kearns-Sayre Syndrome;D007625
C10.292.562.775.500;Kearns-Sayre Syndrome;D007625
C10.668.491.500.700.500;Kearns-Sayre Syndrome;D007625
C11.590.641.500;Kearns-Sayre Syndrome;D007625
C11.768.585.658.500.627;Kearns-Sayre Syndrome;D007625
C14.280.238.510;Kearns-Sayre Syndrome;D007625
C18.452.660.410;Kearns-Sayre Syndrome;D007625
C18.452.660.560.700.500;Kearns-Sayre Syndrome;D007625
D23.050.301.290.533;Kell Blood-Group System;D007626
D23.050.705.230.533;Kell Blood-Group System;D007626
A10.165.450.300.425;Keloid;D007627
C17.300.200.425;Keloid;D007627
C23.550.355.274.510;Keloid;D007627
Z01.107.567.875.075.400;Kentucky;D007629
Z01.107.567.875.510.400;Kentucky;D007629
Z01.058.290.120.400;Kenya;D007630
D02.455.526.439.190;Chlordecone;D007631
D09.698.373.550;Keratan Sulfate;D007632
D05.750.078.593.450;Keratins;D007633
D12.776.220.475.450;Keratins;D007633
D12.776.860.607;Keratins;D007633
C11.204.564;Keratitis;D007634
C02.256.466.382.465.450;Keratitis, Dendritic;D007635
C02.325.465.450;Keratitis, Dendritic;D007635
C11.204.564.425.450;Keratitis, Dendritic;D007635
C11.294.800.475.450;Keratitis, Dendritic;D007635
C17.800.417;Keratoacanthoma;D007636
C11.187.183.394;Keratoconjunctivitis;D007637
C11.204.564.585;Keratoconjunctivitis;D007637
C11.187.183.394.550;Keratoconjunctivitis Sicca;D007638
C11.204.564.585.630;Keratoconjunctivitis Sicca;D007638
C11.496.260.394;Keratoconjunctivitis Sicca;D007638
C01.252.354.450;Keratoconjunctivitis, Infectious;D007639
C01.539.375.354.450;Keratoconjunctivitis, Infectious;D007639
C11.187.183.394.520;Keratoconjunctivitis, Infectious;D007639
C11.204.564.585.500;Keratoconjunctivitis, Infectious;D007639
C11.294.354.450;Keratoconjunctivitis, Infectious;D007639
C22.500;Keratoconjunctivitis, Infectious;D007639
C11.204.627;Keratoconus;D007640
D27.505.954.444.400;Keratolytic Agents;D007641
C17.800.428;Keratosis;D007642
C16.320.850.190;Darier Disease;D007644
C17.800.428.275;Darier Disease;D007644
C17.800.827.190;Darier Disease;D007644
C16.320.850.475;Keratoderma, Palmoplantar;D007645
C17.800.428.435;Keratoderma, Palmoplantar;D007645
C17.800.827.475;Keratoderma, Palmoplantar;D007645
E04.540.825.550;Keratotomy, Radial;D007646
C10.228.140.163.480;Kernicterus;D007647
C15.378.120.413.502;Kernicterus;D007647
C16.614.304.502;Kernicterus;D007647
C18.452.132.480;Kernicterus;D007647
C20.188.413.502;Kernicterus;D007647
C23.550.429.750;Kernicterus;D007647
D20.345.630.600;Kerosene;D007648
N06.230.132.258.630.600;Kerosene;D007648
D02.455.426.392.368.367.652;Ketamine;D007649
D03.383.621.365;Ketanserin;D007650
D03.438.786.830.333;Ketanserin;D007650
D02.241.755;Keto Acids;D007651
D08.811.520.224.600;Oxo-Acid-Lyases;D007652
D04.808.247.222.265.450;Ketocholesterols;D007653
D04.808.247.222.284.600;Ketocholesterols;D007653
D04.808.247.808.197.600;Ketocholesterols;D007653
D10.570.938.208.650;Ketocholesterols;D007653
D03.383.606.560;Ketoconazole;D007654
D05.500.562.468;Ketoglutarate Dehydrogenase Complex;D007655
D08.811.600.465;Ketoglutarate Dehydrogenase Complex;D007655
D08.811.682.657.350.750;Ketoglutarate Dehydrogenase Complex;D007655
D02.241.081.337.351.502;Ketoglutaric Acids;D007656
D02.241.755.465;Ketoglutaric Acids;D007656
D02.522.585;Ketone Bodies;D007657
D08.811.682.657.350;Ketone Oxidoreductases;D007658
D02.522;Ketones;D007659
D02.241.223.701.480;Ketoprofen;D007660
D09.546.465;Ketoses;D007661
C18.452.076.176.652;Ketosis;D007662
D04.808.578;Ketosteroids;D007664
D02.886.778.370;Ketotifen;D007665
D03.383.621.370;Ketotifen;D007665
D03.383.903.370;Ketotifen;D007665
D03.438.150.446.794.300;Khellin;D007666
D03.494.770.300;Khellin;D007666
D03.830.219.446.794.300;Khellin;D007666
D23.050.301.290.538;Kidd Blood-Group System;D007667
D23.050.705.230.538;Kidd Blood-Group System;D007667
A05.810.453;Kidney;D007668
C12.777.419.600.500;Kidney Calculi;D007669
C12.777.967.249.500;Kidney Calculi;D007669
C12.777.967.500.503;Kidney Calculi;D007669
C13.351.968.419.600.500;Kidney Calculi;D007669
C13.351.968.967.249.500;Kidney Calculi;D007669
C13.351.968.967.500.503;Kidney Calculi;D007669
C23.300.175.850.550;Kidney Calculi;D007669
A05.810.453.537.503;Kidney Calices;D007670
G08.852.536;Kidney Concentrating Ability;D007671
A05.810.453.324;Kidney Cortex;D007672
C12.777.419.393;Kidney Cortex Necrosis;D007673
C13.351.968.419.393;Kidney Cortex Necrosis;D007673
C12.777.419;Kidney Diseases;D007674
C13.351.968.419;Kidney Diseases;D007674
C12.777.419.780.750.500;Kidney Failure, Chronic;D007676
C13.351.968.419.780.750.500;Kidney Failure, Chronic;D007676
E01.370.390.400;Kidney Function Tests;D007677
A05.810.453.324.359;Kidney Glomerulus;D007678
A05.810.453.736.520;Kidney Glomerulus;D007678
A05.810.453.466;Kidney Medulla;D007679
C04.588.945.947.535;Kidney Neoplasms;D007680
C12.758.820.750;Kidney Neoplasms;D007680
C12.777.419.473;Kidney Neoplasms;D007680
C13.351.937.820.535;Kidney Neoplasms;D007680
C13.351.968.419.473;Kidney Neoplasms;D007680
C12.777.419.493;Kidney Papillary Necrosis;D007681
C13.351.968.419.493;Kidney Papillary Necrosis;D007681
A05.810.453.537;Kidney Pelvis;D007682
C12.777.419.780.050.500;Kidney Tubular Necrosis, Acute;D007683
C13.351.968.419.780.050.500;Kidney Tubular Necrosis, Acute;D007683
A05.810.453.736.560;Kidney Tubules;D007684
A05.810.453.736.560.510;Kidney Tubules, Collecting;D007685
A05.810.453.736.560.540;Kidney Tubules, Distal;D007686
A05.810.453.736.560.570;Kidney Tubules, Proximal;D007687
E07.858.082.585;Kidneys, Artificial;D007688
C12.777.419.403.875;Polycystic Kidney Diseases;D007690
C13.351.968.419.403.875;Polycystic Kidney Diseases;D007690
C12.777.419.403.500;Medullary Sponge Kidney;D007691
C13.351.968.419.403.500;Medullary Sponge Kidney;D007691
D01.578.750.300;Diatomaceous Earth;D007692
D01.650.550.825.400;Diatomaceous Earth;D007692
D01.837.725.400;Diatomaceous Earth;D007692
A11.118.637.555.567.537;Killer Cells, Natural;D007694
A15.145.229.637.555.567.537;Killer Cells, Natural;D007694
A15.382.490.555.567.537;Killer Cells, Natural;D007694
B01.050.150.900.493.850.280.500;Killifishes;D007695
G11.561.600.480;Kindling, Neurologic;D007696
F01.145.209.530.538;Kinesics;D007697
F02.830.606.587;Kinesis;D007698
F02.830.816.541.504;Kinesthesis;D007699
G11.561.600.810.541.587;Kinesthesis;D007699
G01.374.661;Kinetics;D007700
G02.111.325;Kinetics;D007700
D03.438.759.138.525.400;Kinetin;D007701
E01.370.370.380.450;Kinetocardiography;D007702
D08.811.277.656.350.350.687;Peptidyl-Dipeptidase A;D007703
D23.050.301.264.035.585;Peptidyl-Dipeptidase A;D007703
D23.101.100.110.585;Peptidyl-Dipeptidase A;D007703
D12.644.276.812.654;Kininogens;D007704
D12.776.124.125.635;Kininogens;D007704
D12.776.467.812.654;Kininogens;D007704
D12.776.811.420;Kininogens;D007704
D23.119.630;Kininogens;D007704
D23.469.050.375.425;Kininogens;D007704
D23.529.812.654;Kininogens;D007704
D12.644.276.812;Kinins;D007705
D12.776.467.812;Kinins;D007705
D23.469.050.375;Kinins;D007705
D23.529.812;Kinins;D007705
C10.228.140.163.100.540;Menkes Kinky Hair Syndrome;D007706
C10.574.500.540;Menkes Kinky Hair Syndrome;D007706
C10.597.606.643.455.687;Menkes Kinky Hair Syndrome;D007706
C16.320.322.500.687;Menkes Kinky Hair Syndrome;D007706
C16.320.400.520;Menkes Kinky Hair Syndrome;D007706
C16.320.400.525.687;Menkes Kinky Hair Syndrome;D007706
C16.320.565.189.540;Menkes Kinky Hair Syndrome;D007706
C16.320.565.618.590;Menkes Kinky Hair Syndrome;D007706
C17.800.329.968;Menkes Kinky Hair Syndrome;D007706
C18.452.132.100.540;Menkes Kinky Hair Syndrome;D007706
C18.452.648.189.540;Menkes Kinky Hair Syndrome;D007706
C18.452.648.618.590;Menkes Kinky Hair Syndrome;D007706
Z01.252.100.450;Kyrgyzstan;D007707
Z01.586.200.450;Kyrgyzstan;D007707
Z01.586.950.450;Kyrgyzstan;D007707
B04.265.600.500;Kirsten murine sarcoma virus;D007708
B04.820.650.375.860.500;Kirsten murine sarcoma virus;D007708
B04.909.574.807.375.860.500;Kirsten murine sarcoma virus;D007708
B04.909.777.731.375.860.500;Kirsten murine sarcoma virus;D007708
B03.440.450.425.425;Klebsiella;D007709
B03.660.250.150.400;Klebsiella;D007709
C01.252.400.310.503;Klebsiella Infections;D007710
B03.440.450.425.425.600;Klebsiella pneumoniae;D007711
B03.660.250.150.400.590;Klebsiella pneumoniae;D007711
C12.706.316.795.500;Klinefelter Syndrome;D007713
C13.351.875.253.795.500;Klinefelter Syndrome;D007713
C16.131.260.830.835.500;Klinefelter Syndrome;D007713
C16.131.939.316.795.500;Klinefelter Syndrome;D007713
C16.320.180.830.835.500;Klinefelter Syndrome;D007713
C19.391.119.795.500;Klinefelter Syndrome;D007713
C19.391.482.629;Klinefelter Syndrome;D007713
C05.116.099.370.535;Klippel-Feil Syndrome;D007714
C05.660.551;Klippel-Feil Syndrome;D007714
C16.131.621.551;Klippel-Feil Syndrome;D007714
C14.907.077.410;Klippel-Trenaunay-Weber Syndrome;D007715
B01.300.107.795.536;Kluyveromyces;D007716
B01.300.930.536;Kluyveromyces;D007716
A01.378.610.450;Knee;D007717
C26.558.554;Knee Injuries;D007718
A02.835.583.475;Knee Joint;D007719
E07.695.400.410;Knee Prosthesis;D007720
F02.463.425.770.379;Knowledge of Results (Psychology);D007721
F01.100.150.500;Health Knowledge, Attitudes, Practice;D007722
N05.300.150.410;Health Knowledge, Attitudes, Practice;D007722
Z01.252.474.557;Korea;D007723
Z01.586.407;Korea;D007723
C13.351.500.944.815;Vulvar Lichen Sclerosus;D007724
C04.557.470.200.025.415.410;Krukenberg Tumor;D007725
C04.557.470.590.415.410;Krukenberg Tumor;D007725
D01.268.613.425;Krypton;D007726
D01.362.641.468;Krypton;D007726
D01.496.749.540;Krypton Radioisotopes;D007727
A11.329.372.588;Kupffer Cells;D007728
A11.627.482.588;Kupffer Cells;D007728
A11.733.397.588;Kupffer Cells;D007728
A15.382.680.397.588;Kupffer Cells;D007728
A15.382.812.522.588;Kupffer Cells;D007728
C10.228.228.800.435;Kuru;D007729
C10.574.843.625;Kuru;D007729
Z01.252.245.500.425;Kuwait;D007730
Z01.586.500.425;Kuwait;D007730
E01.370.225.812.871.300.540;Kveim Test;D007731
E05.200.812.871.300.540;Kveim Test;D007731
E05.478.594.890.300.540;Kveim Test;D007731
C18.654.521.500.708.626.505;Kwashiorkor;D007732
C02.081.885.475;Kyasanur Forest Disease;D007733
C02.782.350.250.635;Kyasanur Forest Disease;D007733
C02.782.417.475;Kyasanur Forest Disease;D007733
E01.370.475;Kymography;D007734
D02.522.818.600;Kynuramine;D007735
D03.066.942.505;Kynurenic Acid;D007736
D03.438.810.350.400;Kynurenic Acid;D007736
D12.125.608;Kynurenine;D007737
C05.116.900.800.500;Kyphosis;D007738
A11.251.210.505;L Cells (Cell Line);D007739
A11.329.228.505;L Cells (Cell Line);D007739
B03.110.422;L Forms;D007740
B05.110.422;L Forms;D007740
D02.033.100.291.460;Labetalol;D007741
D02.065.793.324;Labetalol;D007741
D02.092.063.291.460;Labetalol;D007741
A14.549.336.505;Labial Frenum;D007742
G08.686.785.760.769.326;Labor, Obstetric;D007743
C13.703.420;Obstetric Labor Complications;D007744
G08.686.785.760.769.326.500;Labor Onset;D007745
G08.686.520;Labor Presentation;D007746
G08.686.785.760.769.326.520;Labor Presentation;D007746
G08.686.785.760.769.326.500.080;Labor Stage, First;D007747
G08.686.785.760.769.326.500.090;Labor Stage, Second;D007748
G08.686.785.760.769.326.500.110;Labor Stage, Third;D007749
N03.540.571;Labor Unions;D007750
E04.520.252.968;Labor, Induced;D007751
C13.703.420.491;Obstetric Labor, Premature;D007752
N02.278.487;Laboratories;D007753
N02.278.192.631;Laboratories, Dental;D007754
N02.278.354.422.420;Laboratories, Hospital;D007755
N02.278.487.410;Laboratories, Hospital;D007755
N04.452.442.422.420;Laboratories, Hospital;D007755
H01.158.273.368;Laboratory Animal Science;D007756
C01.539.503;Laboratory Infection;D007757
C24.506;Laboratory Infection;D007757
A09.246.631;Ear, Inner;D007758
C09.218.568;Labyrinth Diseases;D007759
A09.246.631.246.577.543;Labyrinth Supporting Cells;D007760
A11.436.495;Labyrinth Supporting Cells;D007760
A12.207.270.517;Labyrinthine Fluids;D007761
C09.218.568.558;Labyrinthitis;D007762
C09.218.705.371;Labyrinthitis;D007762
G05.360.340.024.686.545;Lac Operon;D007763
G05.360.340.300.500.545;Lac Operon;D007763
J01.637.597.422;Lacquer;D007764
A09.371.463;Lacrimal Apparatus;D007765
A10.336.422;Lacrimal Apparatus;D007765
C11.496;Lacrimal Apparatus Diseases;D007766
C11.496.456;Lacrimal Duct Obstruction;D007767
D12.776.034.398;Lactalbumin;D007768
D12.776.256.626.506;Lactalbumin;D007768
D02.065.589;Lactams;D007769
D03.383.411;Lactams;D007769
D08.811.682.047.551.400;L-Lactate Dehydrogenase;D007770
B04.820.504.080.100.500;Lactate dehydrogenase-elevating virus;D007772
B04.909.777.500.080.500.500;Lactate dehydrogenase-elevating virus;D007772
D02.241.511.459;Lactates;D007773
G08.686.702.500;Lactation;D007774
G08.686.785.420;Lactation;D007774
C13.703.844.506;Lactation Disorders;D007775
C17.800.090.937;Lactation Disorders;D007775
B03.510.460.400.410.475;Lactobacillaceae;D007777
B03.510.550.450;Lactobacillaceae;D007777
B03.510.460.400.410.475.475;Lactobacillus;D007778
B03.510.550.450.475;Lactobacillus;D007778
B03.510.460.400.410.475.475.100;Lactobacillus acidophilus;D007779
B03.510.550.450.475.100;Lactobacillus acidophilus;D007779
B03.510.460.400.410.475.475.225;Lactobacillus casei;D007780
B03.510.550.450.475.225;Lactobacillus casei;D007780
D08.811.277.656.300.760.471;Lactoferrin;D007781
D08.811.277.656.959.350.471;Lactoferrin;D007781
D12.776.157.427.750.249;Lactoferrin;D007781
D12.776.256.626.632.507;Lactoferrin;D007781
D12.776.377.457.507;Lactoferrin;D007781
D12.776.395.507;Lactoferrin;D007781
D12.776.556.579.750.249;Lactoferrin;D007781
D12.776.256.626.632;Lactoglobulins;D007782
D12.776.377.457;Lactoglobulins;D007782
D02.540;Lactones;D007783
D08.811.682.732.550;Lactoperoxidase;D007784
D09.698.629.305.340;Lactose;D007785
G05.360.600.500;Lactose Factors;D007786
C06.405.469.637.506;Lactose Intolerance;D007787
C16.320.565.202.589;Lactose Intolerance;D007787
C18.452.603.506;Lactose Intolerance;D007787
C18.452.648.202.589;Lactose Intolerance;D007787
D08.811.600.541;Lactose Synthase;D007788
D08.811.913.400.450.400.500;Lactose Synthase;D007788
E01.370.225.124.100.450;Lactose Tolerance Test;D007789
E01.370.372.450;Lactose Tolerance Test;D007789
E05.200.124.100.450;Lactose Tolerance Test;D007789
D02.065.313.612;Lactosylceramides;D007790
D09.400.410.420.525.200.612;Lactosylceramides;D007790
D10.390.470.675.200.612;Lactosylceramides;D007790
D10.570.877.360.612.200.612;Lactosylceramides;D007790
D08.811.520.300.500;Lactoylglutathione Lyase;D007791
D09.698.629.305.423;Lactulose;D007792
B01.050.150.900.649.521;Lagomorpha;D007793
C22.510;Lameness, Animal;D007794
B01.750.600.450;Laminaria;D007795
E04.525.450;Laminectomy;D007796
D12.776.395.550.530;Laminin;D007797
D12.776.543.550.500;Laminin;D007797
D12.776.860.300.675;Laminin;D007797
B01.050.150.900.493.559;Lampreys;D007798
D04.808.155.580.130.500.657;Lanatosides;D007799
D09.408.180.261.657;Lanatosides;D007799
A11.066.270.500;Langerhans Cells;D007801
A11.436.270.545;Langerhans Cells;D007801
A15.382.066.270.500;Langerhans Cells;D007801
A15.382.812.260.500;Langerhans Cells;D007801
F01.145.209.399;Language;D007802
L01.143.506;Language;D007802
L01.143.506.423;Language Arts;D007803
F01.525.200.310;Language Development;D007804
C10.597.606.150.500.550;Language Development Disorders;D007805
C23.888.592.604.150.500.550;Language Development Disorders;D007805
C10.597.606.150.500;Language Disorders;D007806
C23.888.592.604.150.500;Language Disorders;D007806
F04.711.400;Language Tests;D007807
E02.831.727.344;Language Therapy;D007808
D10.945.507;Lanolin;D007809
D02.455.849.919.383;Lanosterol;D007810
D04.808.247.222.222.347.557;Lanosterol;D007810
D04.808.247.808.607;Lanosterol;D007810
D10.570.938.590;Lanosterol;D007810
D01.268.477.500;Lanthanum;D007811
D01.268.558.362.500;Lanthanum;D007811
D01.552.550.399.500;Lanthanum;D007811
Z01.252.145.435;Laos;D007812
E04.406;Laparotomy;D007813
B05.500.500;Larva;D007814
G07.700.320.500.550.500.500;Larva;D007814
C03.335.508.523;Larva Migrans;D007815
C03.858.424;Larva Migrans;D007815
C17.800.838.775.424;Larva Migrans;D007815
C03.335.508.523.780;Larva Migrans, Visceral;D007816
C03.335.508.700.100.868.420;Larva Migrans, Visceral;D007816
A02.165.257.625;Laryngeal Cartilages;D007817
A02.165.407.500;Laryngeal Cartilages;D007817
A04.329.591;Laryngeal Cartilages;D007817
C08.360;Laryngeal Diseases;D007818
C09.400;Laryngeal Diseases;D007818
C08.360.313;Laryngeal Edema;D007819
C09.400.313;Laryngeal Edema;D007819
A04.329.597;Laryngeal Mucosa;D007820
A04.760.520;Laryngeal Mucosa;D007820
A10.615.550.760.520;Laryngeal Mucosa;D007820
A02.633.567.500;Laryngeal Muscles;D007821
A04.329.604;Laryngeal Muscles;D007821
C04.588.443.665.481;Laryngeal Neoplasms;D007822
C08.360.369;Laryngeal Neoplasms;D007822
C08.785.481;Laryngeal Neoplasms;D007822
C09.400.369;Laryngeal Neoplasms;D007822
C09.647.481;Laryngeal Neoplasms;D007822
A08.800.050.050.925.450;Laryngeal Nerves;D007823
A08.800.050.600.825.450;Laryngeal Nerves;D007823
A08.800.800.060.920.450;Laryngeal Nerves;D007823
A08.800.800.120.900.450;Laryngeal Nerves;D007823
E04.580.369;Laryngectomy;D007825
C08.360.480;Laryngismus;D007826
C08.618.573;Laryngismus;D007826
C09.400.480;Laryngismus;D007826
C08.360.535;Laryngitis;D007827
C08.730.368;Laryngitis;D007827
C09.400.535;Laryngitis;D007827
E01.370.386.460;Laryngoscopy;D007828
E01.370.388.250.525;Laryngoscopy;D007828
E04.580.373;Laryngoscopy;D007828
E04.800.250.525;Laryngoscopy;D007828
C08.360.591;Laryngostenosis;D007829
C09.400.591;Laryngostenosis;D007829
C16.131.740.658;Laryngostenosis;D007829
A04.329;Larynx;D007830
E07.695.450;Larynx, Artificial;D007831
E07.858.082.595;Larynx, Artificial;D007831
D03.383.312.490;Lasalocid;D007832
E07.632.490;Lasers;D007834
E07.710.520;Lasers;D007834
C02.782.082.545;Lassa Fever;D007835
C02.782.417.505;Lassa Fever;D007835
C23.996.575;Lassa Fever;D007835
B04.820.057.070.100.500;Lassa virus;D007836
B04.909.777.080.070.100.500;Lassa virus;D007836
F01.752.747.722.458;Latency Period (Psychology);D007837
F02.739.794.793.458;Latency Period (Psychology);D007837
F02.830.297.425;Functional Laterality;D007839
G11.561.225.425;Functional Laterality;D007839
D05.750.078.625;Latex;D007840
D20.215.721.124;Latex;D007840
D25.720.099.625;Latex;D007840
D25.720.099.750.500;Latex;D007840
D25.720.327.840.239;Latex;D007840
J01.637.051.720.099.625;Latex;D007840
J01.637.051.720.540;Latex;D007840
E01.370.225.812.735.050.450;Latex Fixation Tests;D007841
E05.200.812.735.050.450;Latex Fixation Tests;D007841
E05.478.594.760.050.450;Latex Fixation Tests;D007841
C25.723.756.558;Lathyrism;D007842
Z01.107.424;Latin America;D007843
Z01.542.248.136.560;Latvia;D007844
Z01.586.950.140.560;Latvia;D007844
F01.145.209.530.614;Laughter;D007845
F01.470.693;Laughter;D007845
J01.576.549;Laundering;D007846
N02.278.354.422.428;Laundry Service, Hospital;D007847
N04.452.442.422.428;Laundry Service, Hospital;D007847
D10.251.500.410;Laurates;D007848
C10.228.140.617.500;Laurence-Moon Syndrome;D007849
C16.131.077.509;Laurence-Moon Syndrome;D007849
D10.251.500;Lauric Acids;D007850
D02.033.415.220;Dodecanol;D007851
D10.289.220;Dodecanol;D007851
D01.268.033.500;Lawrencium;D007852
D01.268.271.100.500;Lawrencium;D007852
D01.268.556.423;Lawrencium;D007852
D01.268.956.295;Lawrencium;D007852
D01.552.020.507;Lawrencium;D007852
D01.552.544.423;Lawrencium;D007852
D01.268.556.435;Lead;D007854
D01.552.544.435;Lead;D007854
C25.723.589;Lead Poisoning;D007855
D01.496.749.560;Lead Radioisotopes;D007856
F01.752.609;Leadership;D007857
F02.463.425;Learning;D007858
F02.784.629.529;Learning;D007858
C10.597.606.150.550;Learning Disorders;D007859
C23.888.592.604.150.550;Learning Disorders;D007859
F03.550.350.500;Learning Disorders;D007859
F03.550.450;Learning Disorders;D007859
N03.219.463.500;Leasing, Property;D007860
Z01.252.245.500.450;Lebanon;D007861
Z01.586.500.450;Lebanon;D007861
D08.811.913.050.625;Phosphatidylcholine-Sterol O-Acyltransferase;D007862
C16.320.565.398.500.330.500;Lecithin Acyltransferase Deficiency;D007863
C18.452.584.500.875.330.500;Lecithin Acyltransferase Deficiency;D007863
C18.452.648.398.500.330.500;Lecithin Acyltransferase Deficiency;D007863
B01.050.500.091.426;Leeches;D007865
A01.378.610.500;Leg;D007866
A02.835.232.043.650;Leg Bones;D007867
C17.800.446;Leg Dermatoses;D007868
C26.558;Leg Injuries;D007869
C05.116.099.655;Leg Length Inequality;D007870
C23.300.808;Leg Length Inequality;D007870
C17.800.893.592;Leg Ulcer;D007871
M01.380;Legal Guardians;D007872
C05.116.852.175.570;Legg-Calve-Perthes Disease;D007873
D12.776.422.316.881;Leghemoglobin;D007874
D12.776.765.500;Leghemoglobin;D007874
B03.440.400.425.450.450;Legionella;D007875
B03.660.250.460.460;Legionella;D007875
C01.252.400.500;Legionellosis;D007876
C08.730.382;Legionellosis;D007876
C01.252.400.500.501;Legionnaires' Disease;D007877
C08.730.382.380;Legionnaires' Disease;D007877
N03.706.615;Legislation as Topic;D007878
N03.706.615.331;Legislation, Dental;D007879
I01.880.604.605;Legislation, Drug;D007880
N03.706.615.402;Legislation, Drug;D007880
N03.706.615.412;Legislation, Food;D007881
N03.706.615.420;Legislation, Hospital;D007882
N03.706.615.473;Legislation, Medical;D007883
N03.706.615.544;Legislation, Nursing;D007884
N03.706.615.615;Legislation, Pharmacy;D007885
N03.706.615.686;Legislation, Veterinary;D007886
B01.650.940.800.575.100.401;Fabaceae;D007887
J02.500.850.500;Fabaceae;D007887
C10.228.140.163.100.412;Leigh Disease;D007888
C16.320.565.189.412;Leigh Disease;D007888
C16.320.565.202.810.444;Leigh Disease;D007888
C18.452.132.100.412;Leigh Disease;D007888
C18.452.648.189.412;Leigh Disease;D007888
C18.452.648.202.810.444;Leigh Disease;D007888
C18.452.660.520;Leigh Disease;D007888
C04.557.450.590.450;Leiomyoma;D007889
C04.557.450.590.455;Leiomyosarcoma;D007890
C04.557.450.795.455;Leiomyosarcoma;D007890
B01.268.475.868.488;Leishmania;D007891
B01.268.475.868.488.080;Leishmania braziliensis;D007892
B01.268.475.868.488.230;Leishmania donovani;D007893
B01.268.475.868.488.410;Leishmania mexicana;D007894
B01.268.475.868.488.680;Leishmania tropica;D007895
C03.752.300.500;Leishmaniasis;D007896
C03.858.560;Leishmaniasis;D007896
C17.800.838.775.560;Leishmaniasis;D007896
C23.996.600;Leishmaniasis;D007896
C03.752.300.500.400.385;Leishmaniasis, Mucocutaneous;D007897
C03.858.560.400.385;Leishmaniasis, Mucocutaneous;D007897
C17.800.838.775.560.400.385;Leishmaniasis, Mucocutaneous;D007897
C03.752.300.500.510;Leishmaniasis, Visceral;D007898
I03.450;Leisure Activities;D007899
B01.050.150.900.649.801.700.508.490;Lemur;D007900
B01.050.150.900.649.801.700.508;Lemuridae;D007901
E02.760.400.480;Length of Stay;D007902
N02.421.585.400.480;Length of Stay;D007902
A09.371.060.500.155;Lens Capsule, Crystalline;D007903
A09.371.060.500.225;Lens Cortex, Crystalline;D007904
C11.510;Lens Diseases;D007905
C11.510.598;Lens Subluxation;D007906
A09.371.060.500.670;Lens Nucleus, Crystalline;D007907
A09.371.060.500;Lens, Crystalline;D007908
E07.632.500;Lenses;D007909
E07.632.500.460;Lenses, Intraocular;D007910
E07.695.460;Lenses, Intraocular;D007910
C17.800.621.430.530.550;Lentigo;D007911
D09.698.365.089.500;Lentinan;D007912
B04.280.382.500;Herpesvirus 1, Ranid;D007913
B04.909.204.210.430;Herpesvirus 1, Ranid;D007913
B04.909.204.382.500;Herpesvirus 1, Ranid;D007913
B04.909.574.204.550;Herpesvirus 1, Ranid;D007913
N02.278.524;Leper Colonies;D007914
B01.050.500.131.617.561;Lepidoptera;D007915
D23.050.161.386;Lepromin;D007916
D27.505.954.122.085.777;Leprostatic Agents;D007917
C01.252.410.040.552.386;Leprosy;D007918
C23.996.620;Leprosy;D007918
B03.440.400.425.475.475;Leptospira;D007919
B03.851.475.475;Leptospira;D007919
B03.440.400.425.475.475.400;Leptospira interrogans;D007921
B03.851.475.475.400;Leptospira interrogans;D007921
C01.252.400.511;Leptospirosis;D007922
C01.252.847.511;Leptospirosis;D007922
C14.907.109.661;Leriche Syndrome;D007925
C14.907.137.427;Leriche Syndrome;D007925
C10.228.140.163.100.425;Lesch-Nyhan Syndrome;D007926
C10.574.500.536;Lesch-Nyhan Syndrome;D007926
C10.597.606.643.455.625;Lesch-Nyhan Syndrome;D007926
C16.320.322.500.625;Lesch-Nyhan Syndrome;D007926
C16.320.400.500;Lesch-Nyhan Syndrome;D007926
C16.320.400.525.625;Lesch-Nyhan Syndrome;D007926
C16.320.565.189.425;Lesch-Nyhan Syndrome;D007926
C16.320.565.798.594;Lesch-Nyhan Syndrome;D007926
C18.452.132.100.425;Lesch-Nyhan Syndrome;D007926
C18.452.648.189.425;Lesch-Nyhan Syndrome;D007926
C18.452.648.798.594;Lesch-Nyhan Syndrome;D007926
Z01.058.290.175.400;Lesotho;D007927
E05.940.402;Lethal Dose 50;D007928
G07.690.520;Lethal Dose 50;D007928
D12.125.070.637;Leucine;D007930
D12.125.142.441;Leucine;D007930
D08.811.277.656.350.100.511;Leucyl Aminopeptidase;D007931
D08.811.277.656.350.555.700;Leucyl Aminopeptidase;D007931
D08.811.277.656.675.555.700;Leucyl Aminopeptidase;D007931
D02.455.426.559.847.885.511;Leucogenenol;D007932
D04.615.885.511;Leucogenenol;D007932
D02.540.505.440;Leucomycins;D007933
B03.510.550.475.450;Leuconostoc;D007934
D08.811.464.263.200.500;Leucine-tRNA Ligase;D007935
E02.095.160.570;Leukapheresis;D007937
E02.120.285.570;Leukapheresis;D007937
E02.120.527.570;Leukapheresis;D007937
E05.242.363.285.570;Leukapheresis;D007937
C04.557.337;Leukemia;D007938
C04.557.337.372.594;Leukemia L1210;D007939
C04.619.531.594;Leukemia L1210;D007939
C04.557.337.372.602;Leukemia L5178;D007940
C04.619.531.602;Leukemia L5178;D007940
C04.557.337.372.782;Leukemia P388;D007941
C04.619.531.782;Leukemia P388;D007941
C04.557.337.372;Leukemia, Experimental;D007942
C04.619.531;Leukemia, Experimental;D007942
E05.598.500.496.500;Leukemia, Experimental;D007942
C04.557.337.415;Leukemia, Hairy Cell;D007943
C15.604.515.553;Leukemia, Hairy Cell;D007943
C20.683.515.517;Leukemia, Hairy Cell;D007943
C04.557.337.428;Leukemia, Lymphoid;D007945
C15.604.515.560;Leukemia, Lymphoid;D007945
C20.683.515.528;Leukemia, Lymphoid;D007945
C04.557.337.440;Leukemia, Mast-Cell;D007946
C04.557.337.539.275.440;Leukemia, Mast-Cell;D007946
C04.557.450.565.465.750.500;Leukemia, Mast-Cell;D007946
C04.557.337.539.275.450;Leukemia, Megakaryoblastic, Acute;D007947
C04.557.337.539.275.484;Leukemia, Monocytic, Acute;D007948
C04.557.337.539;Leukemia, Myeloid;D007951
C04.557.337.595;Leukemia, Plasma Cell;D007952
C04.557.595.500.500;Leukemia, Plasma Cell;D007952
C20.683.515.845.500;Leukemia, Plasma Cell;D007952
C04.557.337.650;Leukemia, Radiation-Induced;D007953
C04.682.512;Leukemia, Radiation-Induced;D007953
C26.733.345;Leukemia, Radiation-Induced;D007953
C15.378.190.636.484;Leukemoid Reaction;D007955
C15.378.553.475.428;Leukemoid Reaction;D007955
D12.776.543.695.750;Leukocidins;D007956
E01.370.225.812.460;Leukocyte Adherence Inhibition Test;D007957
E05.200.812.460;Leukocyte Adherence Inhibition Test;D007957
E05.478.594.500;Leukocyte Adherence Inhibition Test;D007957
E01.370.225.500.195.107.595;Leukocyte Count;D007958
E01.370.225.625.107.595;Leukocyte Count;D007958
E05.200.500.195.107.595;Leukocyte Count;D007958
E05.200.625.107.595;Leukocyte Count;D007958
E05.242.195.107.595;Leukocyte Count;D007958
G04.170.107.595;Leukocyte Count;D007958
G09.188.105.595;Leukocyte Count;D007958
E01.370.225.812.385.475;Lymphocyte Culture Test, Mixed;D007959
E05.200.812.385.475;Lymphocyte Culture Test, Mixed;D007959
E05.478.594.385.429;Lymphocyte Culture Test, Mixed;D007959
C15.378.553;Leukocyte Disorders;D007960
D12.644.276.374.480.428;Leukocyte Migration-Inhibitory Factors;D007961
D12.776.467.374.480.428;Leukocyte Migration-Inhibitory Factors;D007961
D23.125.477;Leukocyte Migration-Inhibitory Factors;D007961
D23.529.374.480.428;Leukocyte Migration-Inhibitory Factors;D007961
A11.118.637;Leukocytes;D007962
A15.145.229.637;Leukocytes;D007962
A15.382.490;Leukocytes;D007962
A11.118.637.555;Leukocytes, Mononuclear;D007963
A15.145.229.637.555;Leukocytes, Mononuclear;D007963
A15.382.490.555;Leukocytes, Mononuclear;D007963
C15.378.553.475;Leukocytosis;D007964
C23.550.526;Leukocytosis;D007964
C10.228.140.163.100.362.500;Leukodystrophy, Globoid Cell;D007965
C10.228.140.163.100.435.825.590;Leukodystrophy, Globoid Cell;D007965
C10.228.140.695.625.500;Leukodystrophy, Globoid Cell;D007965
C10.228.518.625.500;Leukodystrophy, Globoid Cell;D007965
C10.314.400.500;Leukodystrophy, Globoid Cell;D007965
C16.320.565.189.362.500;Leukodystrophy, Globoid Cell;D007965
C16.320.565.189.435.825.590;Leukodystrophy, Globoid Cell;D007965
C16.320.565.398.641.803.585;Leukodystrophy, Globoid Cell;D007965
C16.320.565.595.554.825.590;Leukodystrophy, Globoid Cell;D007965
C18.452.132.100.362.500;Leukodystrophy, Globoid Cell;D007965
C18.452.132.100.435.825.590;Leukodystrophy, Globoid Cell;D007965
C18.452.584.687.803.585;Leukodystrophy, Globoid Cell;D007965
C18.452.648.189.362.500;Leukodystrophy, Globoid Cell;D007965
C18.452.648.189.435.825.590;Leukodystrophy, Globoid Cell;D007965
C18.452.648.398.641.803.585;Leukodystrophy, Globoid Cell;D007965
C18.452.648.595.554.825.590;Leukodystrophy, Globoid Cell;D007965
C10.228.140.163.100.362.550;Leukodystrophy, Metachromatic;D007966
C10.228.140.163.100.435.825.850.500;Leukodystrophy, Metachromatic;D007966
C10.228.140.695.625.550;Leukodystrophy, Metachromatic;D007966
C10.228.518.625.550;Leukodystrophy, Metachromatic;D007966
C10.314.400.550;Leukodystrophy, Metachromatic;D007966
C16.320.565.189.362.550;Leukodystrophy, Metachromatic;D007966
C16.320.565.189.435.825.850.500;Leukodystrophy, Metachromatic;D007966
C16.320.565.398.641.803.925.500;Leukodystrophy, Metachromatic;D007966
C16.320.565.595.554.825.850.500;Leukodystrophy, Metachromatic;D007966
C18.452.132.100.362.550;Leukodystrophy, Metachromatic;D007966
C18.452.132.100.435.825.850.500;Leukodystrophy, Metachromatic;D007966
C18.452.584.687.803.925.500;Leukodystrophy, Metachromatic;D007966
C18.452.648.189.362.550;Leukodystrophy, Metachromatic;D007966
C18.452.648.189.435.825.850.500;Leukodystrophy, Metachromatic;D007966
C18.452.648.398.641.803.925.500;Leukodystrophy, Metachromatic;D007966
C18.452.648.595.554.825.850.500;Leukodystrophy, Metachromatic;D007966
C07.465.385;Leukoedema, Oral;D007967
C02.182.500.300.500;Leukoencephalopathy, Progressive Multifocal;D007968
C02.256.721.500;Leukoencephalopathy, Progressive Multifocal;D007968
C02.290.575;Leukoencephalopathy, Progressive Multifocal;D007968
C02.839.550;Leukoencephalopathy, Progressive Multifocal;D007968
C10.228.140.695.750;Leukoencephalopathy, Progressive Multifocal;D007968
C10.228.228.210.150.300.500;Leukoencephalopathy, Progressive Multifocal;D007968
C10.228.228.245.340.575;Leukoencephalopathy, Progressive Multifocal;D007968
C10.228.518.750;Leukoencephalopathy, Progressive Multifocal;D007968
C10.314.450;Leukoencephalopathy, Progressive Multifocal;D007968
C10.228.140.300.700;Leukomalacia, Periventricular;D007969
C10.228.140.461.550;Leukomalacia, Periventricular;D007969
C14.907.253.612;Leukomalacia, Periventricular;D007969
C16.614.521.450;Leukomalacia, Periventricular;D007969
C15.378.553.546;Leukopenia;D007970
C04.834.512;Leukoplakia;D007971
C23.300.816;Leukoplakia;D007971
C04.588.443.591.545;Leukoplakia, Oral;D007972
C04.834.512.513;Leukoplakia, Oral;D007972
C07.465.565.545;Leukoplakia, Oral;D007972
C23.300.816.513;Leukoplakia, Oral;D007972
C13.351.500.894.700.500;Leukorrhea;D007973
D10.251.355.255.100.450.411;Leukotriene B4;D007975
D23.469.050.175.450.415;Leukotriene B4;D007975
D12.644.456.580;Leupeptins;D007976
D03.132.577.249.413;Levallorphan;D007977
D03.549.686.429;Levallorphan;D007977
D03.605.497.429;Levallorphan;D007977
D04.615.723.795.413;Levallorphan;D007977
D02.886.675.346;Levamisole;D007978
D03.383.129.308.480;Levamisole;D007978
D03.383.129.708.346;Levamisole;D007978
C14.240.400.701;Levocardia;D007979
C14.280.400.701;Levocardia;D007979
C16.131.240.400.701;Levocardia;D007979
C16.131.810.700;Levocardia;D007979
D02.092.311.200.480;Levodopa;D007980
D12.125.072.050.685.400.500;Levodopa;D007980
D12.125.072.050.875.130.500;Levodopa;D007980
D03.132.577.249.463;Levorphanol;D007981
D03.549.686.485;Levorphanol;D007981
D03.605.497.485;Levorphanol;D007981
D04.615.723.795.463;Levorphanol;D007981
D02.241.755.547;Levulinic Acids;D007982
D23.050.301.290.544;Lewis Blood-Group System;D007983
D23.050.705.230.544;Lewis Blood-Group System;D007983
C04.557.475.750.847.249;Leydig Cell Tumor;D007984
C04.588.322.762.500.249;Leydig Cell Tumor;D007984
C04.588.945.440.915.500.249;Leydig Cell Tumor;D007984
C12.294.260.937.500.249;Leydig Cell Tumor;D007984
C12.758.409.937.500.249;Leydig Cell Tumor;D007984
C19.344.762.500.249;Leydig Cell Tumor;D007984
C19.391.829.782.500.249;Leydig Cell Tumor;D007984
A05.360.444.849.513;Leydig Cells;D007985
A06.407.312.782.513;Leydig Cells;D007985
A11.382.906;Leydig Cells;D007985
A11.436.513;Leydig Cells;D007985
D06.472.699.322.576.463;Luteinizing Hormone;D007986
D06.472.699.631.525.343.463;Luteinizing Hormone;D007986
D12.644.548.691.525.343.463;Luteinizing Hormone;D007986
D06.472.699.327.740.320;Gonadotropin-Releasing Hormone;D007987
D12.644.400.400.740.320;Gonadotropin-Releasing Hormone;D007987
D12.644.456.460;Gonadotropin-Releasing Hormone;D007987
D12.644.548.365.740.320;Gonadotropin-Releasing Hormone;D007987
D12.776.641.650.405.740.320;Gonadotropin-Releasing Hormone;D007987
Z01.058.290.190.425;Liberia;D007988
F02.739.794.511;Libido;D007989
L01.346.596;Libraries;D007990
L01.346.596.363;Libraries, Dental;D007991
L01.346.596.463;Libraries, Hospital;D007992
N02.278.354.600;Libraries, Hospital;D007992
N04.452.442.600;Libraries, Hospital;D007992
L01.346.596.563;Libraries, Medical;D007993
L01.346.596.663;Libraries, Nursing;D007994
L01.583.363;Library Administration;D007995
L01.583.390;Library Associations;D007996
I02.783.388;Library Schools;D007997
L01.583.430;Library Schools;D007997
L01.583;Library Science;D007998
L01.453.639;Library Services;D007999
L01.583.464;Library Services;D007999
L01.583.564;Library Surveys;D008000
L01.453.819;Library Technical Services;D008001
L01.583.782;Library Technical Services;D008001
Z01.058.266.513;Libya;D008002
Z01.586.500.460;Libya;D008002
B01.050.500.131.617.690;Phthiraptera;D008003
N03.706.110.510;Licensure;D008004
N05.700.200.450;Licensure;D008004
N03.706.110.510.180;Licensure, Dental;D008005
N05.700.200.450.300;Licensure, Dental;D008005
N03.706.110.510.290;Licensure, Hospital;D008006
N05.700.200.450.380;Licensure, Hospital;D008006
N03.706.110.510.410;Licensure, Medical;D008007
N05.700.200.450.500;Licensure, Medical;D008007
N03.706.110.510.490;Licensure, Nursing;D008008
N05.700.200.450.550;Licensure, Nursing;D008008
N03.706.110.510.560;Licensure, Pharmacy;D008009
N05.700.200.450.625;Licensure, Pharmacy;D008009
C17.800.859.475.560;Lichen Planus;D008010
B01.300.340;Lichens;D008011
B05.350;Lichens;D008011
D02.065.199.092.500;Lidocaine;D008012
D03.383.606.596;Lidoflazine;D008013
F02.784.240.514;Lie Detection;D008014
F02.830.512;Lie Detection;D008014
I01.198.780.937.619;Lie Detection;D008014
Z01.542.524;Liechtenstein;D008015
F01.829.458.410;Life Change Events;D008016
E05.318.308.985.450;Life Expectancy;D008017
L01.280.975.450;Life Expectancy;D008017
N01.224.935.464;Life Expectancy;D008017
N06.850.505.400.975.450;Life Expectancy;D008017
N06.850.520.308.985.450;Life Expectancy;D008017
B05.500;Life Cycle Stages;D008018
G07.700.320.500.550.500;Life Cycle Stages;D008018
F01.829.458;Life Style;D008019
E02.760.440;Life Support Care;D008020
N02.421.585.440;Life Support Care;D008020
N06.230.150.391;Life Support Systems;D008021
A02.513;Ligaments;D008022
A02.513.514;Ligaments, Articular;D008023
A02.835.583.512;Ligaments, Articular;D008023
D27.720.470.480;Ligands;D008024
D08.811.464;Ligases;D008025
E04.426;Ligation;D008026
G01.358.500.505.650;Light;D008027
G01.590.540;Light;D008027
G01.750.250.650;Light;D008027
G01.750.770.578;Light;D008027
E02.520.745;Light Coagulation;D008028
E04.350.750;Light Coagulation;D008028
E04.540.630;Light Coagulation;D008028
N06.230.150.410;Lighting;D008029
G16.500.240.135.843;Lightning;D008030
G16.500.750.775.375;Lightning;D008030
N06.230.300.100.725.375;Lightning;D008030
D05.750.078.562.180.515;Lignin;D008031
D05.750.078.687;Lignin;D008031
D20.538;Lignin;D008031
D25.720.099.687;Lignin;D008031
J01.637.051.720.099.687;Lignin;D008031
A08.186.211.464;Limbic System;D008032
E01.370.225.124.470;Limulus Test;D008033
E01.370.225.875.150.570;Limulus Test;D008033
E05.091.570;Limulus Test;D008033
E05.200.124.470;Limulus Test;D008033
E05.200.875.150.570;Limulus Test;D008033
D03.383.773.532.500;Lincomycin;D008034
D09.408.471.500;Lincomycin;D008034
A03.556.500.885.431;Lingual Frenum;D008035
A14.549.885.431;Lingual Frenum;D008035
A08.800.800.120.760.500.450;Lingual Nerve;D008036
L01.143.506.598;Linguistics;D008037
D26.255.480;Liniments;D008038
D27.720.280.480;Liniments;D008038
C04.557.470.200.025.095.410;Linitis Plastica;D008039
G05.540;Genetic Linkage;D008040
D10.251.355.310.515;Linoleic Acids;D008041
D10.251.355.343.500;Linoleic Acids;D008041
D10.251.355.310.640;Linolenic Acids;D008042
D10.251.355.450;Linolenic Acids;D008042
D10.212.507.550;Linseed Oil;D008043
D10.627.700.615;Linseed Oil;D008043
D20.215.784.750.615;Linseed Oil;D008043
D02.948.684.515;Linuron;D008044
B01.050.150.900.649.147.354.600.500;Lions;D008045
A01.456.505.631.515;Lip;D008046
A14.549.336;Lip;D008046
C07.465.409;Lip Diseases;D008047
C04.588.443.591.550;Lip Neoplasms;D008048
C07.465.409.640;Lip Neoplasms;D008048
C07.465.565.550;Lip Neoplasms;D008048
D08.811.277.352.100.400;Lipase;D008049
D09.698.718.450.500;Lipid A;D008050
D10.494.500;Lipid A;D008050
D23.050.161.616.525.500;Lipid A;D008050
D23.946.123.329.500.500;Lipid A;D008050
D10.570.510;Lipid Bilayers;D008051
J01.637.087.500.510;Lipid Bilayers;D008051
C16.320.565.398;Lipid Metabolism, Inborn Errors;D008052
C18.452.584.562;Lipid Metabolism, Inborn Errors;D008052
C18.452.648.398;Lipid Metabolism, Inborn Errors;D008052
G03.495.520.500.500;Lipid Mobilization;D008053
D02.389.338.450;Lipid Peroxides;D008054
D02.737.450;Lipid Peroxides;D008054
D10.440;Lipid Peroxides;D008054
D10;Lipids;D008055
D05.500.562.452.150;Dihydrolipoamide Dehydrogenase;D008058
D05.500.562.468.500;Dihydrolipoamide Dehydrogenase;D008058
D05.500.562.625.500;Dihydrolipoamide Dehydrogenase;D008058
D08.811.600.391.150;Dihydrolipoamide Dehydrogenase;D008058
D08.811.600.465.500;Dihydrolipoamide Dehydrogenase;D008058
D08.811.600.741.525;Dihydrolipoamide Dehydrogenase;D008058
D08.811.682.657.350.750.500;Dihydrolipoamide Dehydrogenase;D008058
D08.811.682.667.061;Dihydrolipoamide Dehydrogenase;D008058
D12.776.331.192;Dihydrolipoamide Dehydrogenase;D008058
C16.320.565.202.715.640;Mucopolysaccharidosis I;D008059
C16.320.565.595.600.640;Mucopolysaccharidosis I;D008059
C17.300.550.575.640;Mucopolysaccharidosis I;D008059
C18.452.648.202.715.640;Mucopolysaccharidosis I;D008059
C18.452.648.595.600.640;Mucopolysaccharidosis I;D008059
C17.800.849.391;Lipodystrophy;D008060
C18.452.584.625;Lipodystrophy;D008060
C18.452.880.391;Lipodystrophy;D008060
C01.252.410.040.137.631;Whipple Disease;D008061
C06.405.469.637.925;Whipple Disease;D008061
C18.452.603.925;Whipple Disease;D008061
D10.460;Lipofuscin;D008062
D23.767.550;Lipofuscin;D008062
D02.241.803;Thioctic Acid;D008063
D02.886.778.827;Thioctic Acid;D008063
D08.211.906;Thioctic Acid;D008063
D10.251.941;Thioctic Acid;D008063
C16.320.565.398.641;Lipidoses;D008064
C18.452.584.687;Lipidoses;D008064
C18.452.648.398.641;Lipidoses;D008064
C08.618.490.500;Lipoid Proteinosis of Urbach and Wiethe;D008065
C16.320.850.595;Lipoid Proteinosis of Urbach and Wiethe;D008065
G02.111.087.530;Lipolysis;D008066
G02.149.115.530;Lipolysis;D008066
G03.495.520.500;Lipolysis;D008066
C04.557.450.550.400;Lipoma;D008067
C17.800.463;Lipomatosis;D008068
C18.452.584.718;Lipomatosis;D008068
C17.800.463.500;Lipomatosis, Multiple Symmetrical;D008069
C18.452.584.718.750;Lipomatosis, Multiple Symmetrical;D008069
D09.400.500;Lipopolysaccharides;D008070
D09.698.718.450;Lipopolysaccharides;D008070
D10.494;Lipopolysaccharides;D008070
D23.050.161.616.525;Lipopolysaccharides;D008070
D23.946.123.329.500;Lipopolysaccharides;D008070
D08.811.277.352.100.430;Lipoprotein Lipase;D008071
C16.320.565.398.465;Hyperlipoproteinemia Type I;D008072
C18.452.584.500.500.644.237;Hyperlipoproteinemia Type I;D008072
C18.452.648.398.465;Hyperlipoproteinemia Type I;D008072
D10.532.400;Lipoprotein-X;D008073
D12.776.521.450;Lipoprotein-X;D008073
D10.532;Lipoproteins;D008074
D12.776.521;Lipoproteins;D008074
D10.532.432;Lipoproteins, HDL;D008075
D12.776.521.479;Lipoproteins, HDL;D008075
D10.532.432.400;Cholesterol, HDL;D008076
D10.570.938.208.270;Cholesterol, HDL;D008076
D12.776.521.479.470;Cholesterol, HDL;D008076
D10.532.515;Lipoproteins, LDL;D008077
D12.776.521.550;Lipoproteins, LDL;D008077
D10.532.515.500;Cholesterol, LDL;D008078
D10.570.938.208.275;Cholesterol, LDL;D008078
D12.776.521.550.500;Cholesterol, LDL;D008078
D10.532.599;Lipoproteins, VLDL;D008079
D12.776.521.622;Lipoproteins, VLDL;D008079
C04.557.450.550.420;Liposarcoma;D008080
C04.557.450.795.465;Liposarcoma;D008080
D25.479.517;Liposomes;D008081
D26.255.260.517;Liposomes;D008081
D27.720.280.260.517;Liposomes;D008081
J01.637.051.479.517;Liposomes;D008081
J01.637.087.500.517;Liposomes;D008081
D27.505.519.186.071.601;Lipotropic Agents;D008082
D27.505.954.483.680;Lipotropic Agents;D008082
D27.505.954.557.500.601;Lipotropic Agents;D008082
D06.472.699.327.935.480;beta-Lipotropin;D008083
D06.472.699.631.525.600.480;beta-Lipotropin;D008083
D12.644.400.400.935.480;beta-Lipotropin;D008083
D12.644.548.365.935.480;beta-Lipotropin;D008083
D12.644.548.691.525.690.480;beta-Lipotropin;D008083
D12.776.641.650.405.935.480;beta-Lipotropin;D008083
D08.811.682.690.416.583.625;Lipoxygenase;D008084
D12.776.556.579.374.568.750;Lipoxygenase;D008084
E02.831.671.432;Lipreading;D008085
L01.143.506.423.348;Lipreading;D008085
D02.092.877.475;Lissamine Green Dyes;D008086
D02.675.276.475;Lissamine Green Dyes;D008086
D02.886.645.600.080.050.550;Lissamine Green Dyes;D008086
B03.510.100.500;Listeria;D008087
B03.510.460.400.410.485;Listeria;D008087
C01.252.410.514;Listeriosis;D008088
B03.510.100.500.500;Listeria monocytogenes;D008089
B03.510.460.400.410.485.500;Listeria monocytogenes;D008089
D03.132.327.287.417;Lisuride;D008090
D03.549.439.560;Lisuride;D008090
K01.517;Literature;D008091
K01.517.495;Literature, Medieval;D008092
K01.517.533;Literature, Modern;D008093
D01.268.549.450;Lithium;D008094
D01.552.528.480;Lithium;D008094
D04.808.105.225.480;Lithocholic Acid;D008095
D04.808.221.430.622;Lithocholic Acid;D008095
E02.600;Lithotripsy;D008096
E04.943.500;Lithotripsy;D008096
Z01.542.248.136.580;Lithuania;D008097
Z01.586.950.140.580;Lithuania;D008097
G08.686.530;Litter Size;D008098
G08.686.785.760.769.498.300;Litter Size;D008098
A03.620;Liver;D008099
C01.539.830.025.020.455;Liver Abscess;D008100
C06.552.597;Liver Abscess;D008100
C01.539.830.025.020.455.460;Liver Abscess, Amebic;D008101
C03.518.600;Liver Abscess, Amebic;D008101
C03.752.049.703;Liver Abscess, Amebic;D008101
C06.552.597.517;Liver Abscess, Amebic;D008101
C06.552.664.642;Liver Abscess, Amebic;D008101
G09.330.190.163.881.552;Liver Circulation;D008102
C06.552.630;Liver Cirrhosis;D008103
C06.552.630.380;Liver Cirrhosis, Alcoholic;D008104
C06.552.645.590;Liver Cirrhosis, Alcoholic;D008104
C25.100.087.645.550;Liver Cirrhosis, Alcoholic;D008104
C06.130.120.135.250.250;Liver Cirrhosis, Biliary;D008105
C06.552.150.250;Liver Cirrhosis, Biliary;D008105
C06.552.630.400;Liver Cirrhosis, Biliary;D008105
C06.552.630.467;Liver Cirrhosis, Experimental;D008106
E05.598.500.468;Liver Cirrhosis, Experimental;D008106
C06.552;Liver Diseases;D008107
C06.552.645;Liver Diseases, Alcoholic;D008108
C25.100.087.645;Liver Diseases, Alcoholic;D008108
C03.518;Liver Diseases, Parasitic;D008109
C06.552.664;Liver Diseases, Parasitic;D008109
D20.777.351;Liver Extracts;D008110
E01.370.372.460;Liver Function Tests;D008111
D05.750.078.562.388.518;Liver Glycogen;D008112
D09.698.365.388.518;Liver Glycogen;D008112
C04.588.274.623;Liver Neoplasms;D008113
C06.301.623;Liver Neoplasms;D008113
C06.552.697;Liver Neoplasms;D008113
C04.588.274.623.460;Liver Neoplasms, Experimental;D008114
C04.619.540;Liver Neoplasms, Experimental;D008114
C06.301.623.460;Liver Neoplasms, Experimental;D008114
C06.552.697.580;Liver Neoplasms, Experimental;D008114
E05.598.500.496.750;Liver Neoplasms, Experimental;D008114
G10.261.326.520;Liver Regeneration;D008115
G16.100.856.468;Liver Regeneration;D008115
B01.050.150.900.833.393;Lizards;D008116
B01.050.500.500.294.700.750.700.300.410;Loa;D008117
C03.335.508.700.750.361.518;Loiasis;D008118
I01.738.610;Lobbying;D008119
D03.132.478;Lobeline;D008120
D03.383.621.418;Lobeline;D008120
B01.050.500.131.365.190.550;Nephropidae;D008121
L01.224.230.110.600;Local Area Networks;D008122
J01.086.339.400;Location Directories and Signs;D008123
G07.700.560.500;Locomotion;D008124
G11.427.590.530.568;Locomotion;D008124
A08.186.211.132.659.473;Locus Coeruleus;D008125
A08.186.211.132.810.428.600.500;Locus Coeruleus;D008125
A08.186.211.653.473;Locus Coeruleus;D008125
A08.186.211.865.428.600.500;Locus Coeruleus;D008125
G05.540.750;Lod Score;D008126
D03.494.240.520;Lofepramine;D008127
K01.752.448;Logic;D008128
B01.650.940.800.575.100.822.500;Lolium;D008129
J02.500.300.100.400;Lolium;D008129
D02.654.692.440;Lomustine;D008130
D02.948.594.440;Lomustine;D008130
Z01.433.553;London;D008131
Z01.542.363.300.553;London;D008131
F01.470.713;Loneliness;D008132
I01.880.683.435;Loneliness;D008132
C14.280.067.565;Long QT Syndrome;D008133
C16.131.240.400.715;Long QT Syndrome;D008133
C23.550.073.547;Long QT Syndrome;D008133
E02.760.476;Long-Term Care;D008134
N02.421.585.476;Long-Term Care;D008134
D12.776.124.486.485.114.323.480.500;Long-Acting Thyroid Stimulator;D008135
D12.776.124.486.485.114.619.393.550;Long-Acting Thyroid Stimulator;D008135
D12.776.124.790.651.114.323.480.500;Long-Acting Thyroid Stimulator;D008135
D12.776.124.790.651.114.619.393.550;Long-Acting Thyroid Stimulator;D008135
D12.776.377.715.548.114.323.480.500;Long-Acting Thyroid Stimulator;D008135
D12.776.377.715.548.114.619.393.550;Long-Acting Thyroid Stimulator;D008135
G07.540;Longevity;D008136
G07.700.320.124.519;Longevity;D008136
E05.318.760.500.750.500;Longitudinal Studies;D008137
N05.715.360.775.175.250.450;Longitudinal Studies;D008137
N06.850.520.450.500.750.500;Longitudinal Studies;D008137
A05.810.453.736.560.610;Loop of Henle;D008138
D03.383.621.440;Loperamide;D008139
D03.438.079.080.070.450;Lorazepam;D008140
C05.116.900.800.750;Lordosis;D008141
B01.050.150.900.649.801.700.572;Lorisidae;D008142
F02.463.593.071.576;Loudness Perception;D008144
Z01.107.567.875.750.480;Louisiana;D008145
C02.782.350.250.650;Louping Ill;D008146
C22.836.435;Louping Ill;D008146
D02.455.426.559.847.638.400;Lovastatin;D008148
D04.615.638.400;Lovastatin;D008148
F01.470.734;Love;D008149
E02.278.500;Lower Body Negative Pressure;D008150
C14.280.067.780.560;Lown-Ganong-Levine Syndrome;D008151
D03.494.347.500;Loxapine;D008152
E05.830.583;Lubrication;D008153
D02.886.952.500;Lucanthone;D008154
D03.494.953.704.500;Lucanthone;D008154
D03.494.953.852.388;Lucanthone;D008154
D02.540.505.450;Lucensomycin;D008155
D08.811.682.517;Luciferases;D008156
D12.776.532.510;Luciferases;D008156
C01.539.535;Ludwig's Angina;D008158
C07.465.433;Ludwig's Angina;D008158
A02.835.232.834.519;Lumbar Vertebrae;D008159
A08.800.800.720.450;Lumbosacral Plexus;D008160
A01.923.176.519;Lumbosacral Region;D008161
D03.132.225.500;Lumicolchicines;D008162
E05.196.712.516;Luminescent Measurements;D008163
D12.776.532;Luminescent Proteins;D008164
D03.383.710.350;Luminol;D008165
C02.256.743.494;Lumpy Skin Disease;D008166
C22.196.497;Lumpy Skin Disease;D008166
B04.280.650.160.150.500;Lumpy skin disease virus;D008167
B04.909.204.783.160.150.500;Lumpy skin disease virus;D008167
A04.411;Lung;D008168
C01.539.830.025.490;Lung Abscess;D008169
C08.381.450;Lung Abscess;D008169
C08.730.407;Lung Abscess;D008169
E01.370.386.700.475;Lung Compliance;D008170
G09.772.540;Lung Compliance;D008170
C08.381;Lung Diseases;D008171
C01.703.534;Lung Diseases, Fungal;D008172
C08.381.472;Lung Diseases, Fungal;D008172
C08.730.435;Lung Diseases, Fungal;D008172
C08.381.495;Lung Diseases, Obstructive;D008173
C03.582;Lung Diseases, Parasitic;D008174
C08.381.517;Lung Diseases, Parasitic;D008174
C08.730.450;Lung Diseases, Parasitic;D008174
C04.588.894.797.520;Lung Neoplasms;D008175
C08.381.540;Lung Neoplasms;D008175
C08.785.520;Lung Neoplasms;D008175
E01.370.386.700.485;Lung Volume Measurements;D008176
C01.252.410.040.552.846.583.470;Lupus Vulgaris;D008177
C01.252.825.820.470;Lupus Vulgaris;D008177
C01.539.800.720.820.470;Lupus Vulgaris;D008177
C17.800.838.765.820.470;Lupus Vulgaris;D008177
C17.300.475;Lupus Erythematosus, Cutaneous;D008178
C17.800.480;Lupus Erythematosus, Cutaneous;D008178
C17.300.475.479;Lupus Erythematosus, Discoid;D008179
C17.800.480.479;Lupus Erythematosus, Discoid;D008179
C17.300.480;Lupus Erythematosus, Systemic;D008180
C20.111.590;Lupus Erythematosus, Systemic;D008180
C12.777.419.570.363.680;Lupus Nephritis;D008181
C13.351.968.419.570.363.680;Lupus Nephritis;D008181
C17.300.480.680;Lupus Nephritis;D008181
C20.111.590.560;Lupus Nephritis;D008181
F04.711.513.300;Luria-Nebraska Neuropsychological Battery;D008182
G08.686.605.410;Luteal Phase;D008183
A05.360.319.114.630.278.400;Luteal Cells;D008184
A06.407.312.497.278.400;Luteal Cells;D008184
A11.382.921;Luteal Cells;D008184
A11.436.566;Luteal Cells;D008184
C14.240.400.560.375.518;Lutembacher Syndrome;D008185
C14.280.400.560.375.518;Lutembacher Syndrome;D008185
C16.131.240.400.560.375.518;Lutembacher Syndrome;D008185
D27.505.696.875.360.276.450;Luteolytic Agents;D008186
D27.505.696.875.610;Luteolytic Agents;D008186
D27.505.954.705.360.276.450;Luteolytic Agents;D008186
D27.505.954.705.610;Luteolytic Agents;D008186
D01.268.477.562;Lutetium;D008187
D01.268.558.362.562;Lutetium;D008187
D01.268.956.311;Lutetium;D008187
D01.552.550.399.562;Lutetium;D008187
D23.050.301.290.552;Lutheran Blood-Group System;D008188
D23.050.705.230.552;Lutheran Blood-Group System;D008188
Z01.542.550;Luxembourg;D008189
D08.811.520;Lyases;D008190
D01.045.250.400;Lye;D008191
D01.455.450;Lye;D008191
F01.145.813.157;Deception;D008192
C01.252.400.155.569;Lyme Disease;D008193
C01.252.400.825.480;Lyme Disease;D008193
C01.252.847.193.569;Lyme Disease;D008193
D02.455.426.559.847.562.900.450;Lymecycline;D008194
D04.615.562.900.450;Lymecycline;D008194
B01.050.500.644.400.750.645;Lymnaea;D008195
A12.207.270.606;Lymph;D008196
A15.382.520.150;Lymph;D008196
E04.446;Lymph Node Excision;D008197
A10.549.400;Lymph Nodes;D008198
A15.382.520.604.412;Lymph Nodes;D008198
C15.604.315;Lymphadenitis;D008199
C15.604.360;Lymphangiectasis;D008200
C15.604.360.500;Lymphangiectasis, Intestinal;D008201
C15.604.451.500;Lymphangiectasis, Intestinal;D008201
C16.131.482.500;Lymphangiectasis, Intestinal;D008201
C04.557.375.450;Lymphangioma;D008202
C04.557.375.460;Lymphangiomyoma;D008203
C15.604.515.562;Lymphangiomyoma;D008203
C20.683.515.710;Lymphangiomyoma;D008203
C04.557.375.480;Lymphangiosarcoma;D008204
C04.557.450.795.480;Lymphangiosarcoma;D008204
C15.604.406;Lymphangitis;D008205
C15.604;Lymphatic Diseases;D008206
C04.697.650.560;Lymphatic Metastasis;D008207
C23.550.727.650.560;Lymphatic Metastasis;D008207
A15.382.520;Lymphatic System;D008208
C15.604.496;Lymphedema;D008209
C04.182.430;Lymphocele;D008210
C15.604.510;Lymphocele;D008210
G04.299.540;Lymphocyte Cooperation;D008211
G12.425.749;Lymphocyte Cooperation;D008211
E02.095.465.425.450.521;Lymphocyte Depletion;D008212
E05.478.610.570;Lymphocyte Depletion;D008212
E01.370.225.812.482;Lymphocyte Activation;D008213
E05.200.812.482;Lymphocyte Activation;D008213
E05.478.594.530;Lymphocyte Activation;D008213
G12.425.747;Lymphocyte Activation;D008213
G12.450.050.400.545;Lymphocyte Activation;D008213
A11.118.637.555.567;Lymphocytes;D008214
A15.145.229.637.555.567;Lymphocytes;D008214
A15.382.490.555.567;Lymphocytes;D008214
A11.118.637.555.567.622;Lymphocytes, Null;D008215
A15.145.229.637.555.567.584;Lymphocytes, Null;D008215
A15.382.490.555.567.622;Lymphocytes, Null;D008215
C02.182.550.500;Lymphocytic Choriomeningitis;D008216
C02.587.580;Lymphocytic Choriomeningitis;D008216
C02.782.082.580;Lymphocytic Choriomeningitis;D008216
C10.228.228.210.500.500;Lymphocytic Choriomeningitis;D008216
C10.228.228.507.700.500;Lymphocytic Choriomeningitis;D008216
B04.820.057.070.100.550;Lymphocytic choriomeningitis virus;D008217
B04.909.777.080.070.100.550;Lymphocytic choriomeningitis virus;D008217
C15.378.553.475.604;Lymphocytosis;D008218
C01.252.400.210.210.490;Lymphogranuloma Venereum;D008219
C01.252.810.301.490;Lymphogranuloma Venereum;D008219
C01.539.778.281.301.490;Lymphogranuloma Venereum;D008219
C12.294.668.281.301.490;Lymphogranuloma Venereum;D008219
C13.351.500.711.281.301.490;Lymphogranuloma Venereum;D008219
E01.370.350.700.475;Lymphography;D008220
A10.549;Lymphoid Tissue;D008221
A15.382.520.604;Lymphoid Tissue;D008221
D12.644.276.374.480;Lymphokines;D008222
D12.776.467.374.480;Lymphokines;D008222
D23.529.374.480;Lymphokines;D008222
C04.557.386;Lymphoma;D008223
C15.604.515.569;Lymphoma;D008223
C20.683.515.761;Lymphoma;D008223
C04.557.386.480.350;Lymphoma, Follicular;D008224
C15.604.515.569.480.350;Lymphoma, Follicular;D008224
C20.683.515.761.480.350;Lymphoma, Follicular;D008224
C04.557.386.480;Lymphoma, Non-Hodgkin;D008228
C15.604.515.569.480;Lymphoma, Non-Hodgkin;D008228
C20.683.515.761.480;Lymphoma, Non-Hodgkin;D008228
C04.557.386.480.150.600;Lymphomatoid Granulomatosis;D008230
C04.834.567;Lymphomatoid Granulomatosis;D008230
C15.604.515.569.480.150.600;Lymphomatoid Granulomatosis;D008230
C20.683.515.761.480.150.600;Lymphomatoid Granulomatosis;D008230
C15.378.553.546.605;Lymphopenia;D008231
C20.673.627;Lymphopenia;D008231
C15.604.515;Lymphoproliferative Disorders;D008232
C20.683.515;Lymphoproliferative Disorders;D008232
D12.644.276.374.480.438;Lymphotoxin-alpha;D008233
D12.644.276.374.750.500;Lymphotoxin-alpha;D008233
D12.644.276.972.500;Lymphotoxin-alpha;D008233
D12.776.467.374.480.438;Lymphotoxin-alpha;D008233
D12.776.467.374.750.500;Lymphotoxin-alpha;D008233
D12.776.467.972.500;Lymphotoxin-alpha;D008233
D23.529.374.480.438;Lymphotoxin-alpha;D008233
D23.529.374.750.500;Lymphotoxin-alpha;D008233
D23.529.972.500;Lymphotoxin-alpha;D008233
D04.808.668.651.693.494;Lynestrenol;D008234
D03.438.473.402.511;Lyngbya Toxins;D008235
D23.946.580.565;Lyngbya Toxins;D008235
D06.472.699.631.692.781.400;Lypressin;D008236
D12.644.400.900.400;Lypressin;D008236
D12.644.456.925.480;Lypressin;D008236
D12.644.548.691.692.781.400;Lypressin;D008236
D12.776.641.650.937.400;Lypressin;D008236
D03.132.327.287.572;Lysergic Acid;D008237
D03.549.439.572;Lysergic Acid;D008237
D03.132.327.287.572.522;Lysergic Acid Diethylamide;D008238
D03.549.439.572.522;Lysergic Acid Diethylamide;D008238
D12.125.068.555;Lysine;D008239
D12.125.095.647;Lysine;D008239
D12.125.142.497;Lysine;D008239
D08.811.682.690.708.660;Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase;D008240
D12.125.042.475;Lysinoalanine;D008241
D12.125.068.555.575;Lysinoalanine;D008241
D12.125.095.647.575;Lysinoalanine;D008241
G05.355.930.500;Lysogeny;D008242
G06.590.875.750.500;Lysogeny;D008242
G06.920.875.750.500;Lysogeny;D008242
D08.811.913.050.175;1-Acylglycerophosphocholine O-Acyltransferase;D008243
D10.570.755.375.760.550.550;Lysophosphatidylcholines;D008244
D08.811.277.352.100.680.510;Lysophospholipase;D008245
D10.570.755.375.760.550;Lysophospholipids;D008246
A11.284.430.214.190.875.190.550;Lysosomes;D008247
D08.811.277.656.300.480.452;Lysostaphin;D008248
D08.811.277.656.675.374.452;Lysostaphin;D008248
D08.811.682.664.500.848;Protein-Lysine 6-Oxidase;D008249
D08.811.464.263.200.550;Lysine-tRNA Ligase;D008250
B01.050.150.900.649.801.400.112.199.120.510;Macaca;D008251
B01.050.150.900.649.801.400.112.199.120.510.520;Macaca fascicularis;D008252
B01.050.150.900.649.801.400.112.199.120.510.550;Macaca mulatta;D008253
B01.050.150.900.649.801.400.112.199.120.510.560;Macaca nemestrina;D008254
B01.050.150.900.649.801.400.112.199.120.510.570;Macaca radiata;D008255
Z01.252.474.164.675;Macau;D008256
Z01.639.610;Macau;D008256
F01.752.650;Machiavellianism;D008257
C04.557.595.925;Waldenstrom Macroglobulinemia;D008258
C14.907.454.960;Waldenstrom Macroglobulinemia;D008258
C15.378.147.780.925;Waldenstrom Macroglobulinemia;D008258
C15.378.463.515.960;Waldenstrom Macroglobulinemia;D008258
C15.604.515.925;Waldenstrom Macroglobulinemia;D008258
C20.683.780.925;Waldenstrom Macroglobulinemia;D008258
D12.776.124.790.720;Macroglobulins;D008259
D12.776.377.715.647;Macroglobulins;D008259
C07.465.910.460;Macroglossia;D008260
G12.425.270.500;Macrophage Activation;D008262
D12.644.276.374.480.625;Macrophage Migration-Inhibitory Factors;D008263
D12.776.467.374.480.625;Macrophage Migration-Inhibitory Factors;D008263
D23.125.477.500;Macrophage Migration-Inhibitory Factors;D008263
D23.529.374.480.625;Macrophage Migration-Inhibitory Factors;D008263
A11.329.372;Macrophages;D008264
A11.627.482;Macrophages;D008264
A11.733.397;Macrophages;D008264
A15.382.680.397;Macrophages;D008264
A15.382.812.522;Macrophages;D008264
C07.465.525.480;Macrostomia;D008265
C07.650.525.480;Macrostomia;D008265
C16.131.850.525.480;Macrostomia;D008265
A09.371.729.522;Macula Lutea;D008266
A09.246.631.909.625.125;Acoustic Maculae;D008267
C11.768.585.439;Macular Degeneration;D008268
C11.768.585.439.245;Macular Edema;D008269
Z01.639.520.500;Madagascar;D008270
C01.252.410.040.692.606;Mycetoma;D008271
C01.252.825.557;Mycetoma;D008271
C01.539.800.200.500;Mycetoma;D008271
C01.539.800.720.557;Mycetoma;D008271
C01.703.295.522;Mycetoma;D008271
C17.800.838.208.557;Mycetoma;D008271
C17.800.838.765.557;Mycetoma;D008271
D02.065.884.570;Mafenide;D008272
D02.886.590.700.570;Mafenide;D008272
E02.190.901.411;Magic;D008273
I01.076.201.450.897.439;Magic;D008273
D01.268.552.437;Magnesium;D008274
D01.268.557.500;Magnesium;D008274
D01.552.547.500;Magnesium;D008274
C18.654.521.500.439;Magnesium Deficiency;D008275
D01.455.550;Magnesium Hydroxide;D008276
D01.524.485;Magnesium Hydroxide;D008276
D01.524.490;Magnesium Oxide;D008277
D01.650.550.575;Magnesium Oxide;D008277
D01.524.550;Magnesium Sulfate;D008278
D01.875.800.800.850.500;Magnesium Sulfate;D008278
E01.370.350.500;Magnetic Resonance Imaging;D008279
E01.370.350.825.500;Magnetic Resonance Imaging;D008279
H01.671.493;Magnetics;D008280
Z01.107.567.875.550.500;Maine;D008281
I02.158.600;Mainstreaming (Education);D008282
I02.233.213.600;Mainstreaming (Education);D008282
N02.628;Maintenance;D008283
N02.278.354.422.450;Maintenance and Engineering, Hospital;D008284
N02.628.472;Maintenance and Engineering, Hospital;D008284
N04.452.442.422.450;Maintenance and Engineering, Hospital;D008284
G05.360.340.024.340.610;Major Histocompatibility Complex;D008285
G05.360.340.024.380.500;Major Histocompatibility Complex;D008285
G12.500.500;Major Histocompatibility Complex;D008285
C06.405.469.637;Malabsorption Syndromes;D008286
C18.452.603;Malabsorption Syndromes;D008286
C23.550.548;Malacoplakia;D008287
C03.752.530;Malaria;D008288
C23.996.660;Malaria;D008288
C03.752.530.606;Malaria, Avian;D008289
C22.131.498;Malaria, Avian;D008289
B01.300.381.522;Malassezia;D008290
B01.300.930.574;Malassezia;D008290
D08.811.682.047.605;Malate Dehydrogenase;D008291
D08.811.913.050.618;Malate Synthase;D008292
D02.241.081.337.463;Malates;D008293
D02.241.511.505;Malates;D008293
D02.705.400.625.500;Malathion;D008294
D02.705.539.345.500;Malathion;D008294
D02.886.300.692.500;Malathion;D008294
Z01.058.290.175.500;Malawi;D008295
Z01.252.145.487;Malaysia;D008296
D02.241.081.337.502;Maleates;D008298
D02.113.450;Maleic Anhydrides;D008299
D03.383.312.520;Maleic Anhydrides;D008299
D03.383.710.400;Maleic Hydrazide;D008300
D02.241.081.337.502.524;Maleimides;D008301
D02.478.440;Maleimides;D008301
D03.383.129.578.399;Maleimides;D008301
Z01.058.290.190.500;Mali;D008302
C04.557.465.625.650.200.500;Malignant Carcinoid Syndrome;D008303
C04.557.470.200.025.200.500;Malignant Carcinoid Syndrome;D008303
C04.557.580.625.650.200.500;Malignant Carcinoid Syndrome;D008303
C02.256.466.606;Malignant Catarrh;D008304
C22.196.540;Malignant Catarrh;D008304
C23.550.767.600;Malignant Hyperthermia;D008305
F01.145.126.925;Malingering;D008306
A09.246.397.247.524;Malleus;D008307
C06.405.117.468.524;Mallory-Weiss Syndrome;D008309
C07.793.494;Malocclusion;D008310
C07.793.494.610;Malocclusion, Angle Class I;D008311
C07.793.494.630;Malocclusion, Angle Class II;D008312
C07.793.494.650;Malocclusion, Angle Class III;D008313
D02.241.081.337.540;Malonates;D008314
D02.047.700;Malondialdehyde;D008315
D03.438.759.646.138.382.300.500;Malonyl Coenzyme A;D008316
D08.211.211.300.500;Malonyl Coenzyme A;D008316
D13.695.667.138.382.300.500;Malonyl Coenzyme A;D008316
D13.695.827.068.382.300.500;Malonyl Coenzyme A;D008316
A13.574;Malpighian Tubules;D008317
I01.880.604.583.524;Malpractice;D008318
N03.706.535.606;Malpractice;D008318
Z01.542.580.500.650;Malta;D008319
Z01.639.640.650;Malta;D008319
D09.698.365.450;Maltose;D008320
D09.698.629.305.523;Maltose;D008320
A10.336.482;Mammary Glands, Animal;D008321
A13.589;Mammary Glands, Animal;D008321
B01.050.150.900.649;Mammals;D008322
A07.231.114.891.525;Mammary Arteries;D008323
B04.820.650.124.500;Mammary Tumor Virus, Mouse;D008324
B04.909.574.807.124.500;Mammary Tumor Virus, Mouse;D008324
B04.909.777.731.124.500;Mammary Tumor Virus, Mouse;D008324
C04.588.531.500;Mammary Neoplasms, Experimental;D008325
C04.619.590;Mammary Neoplasms, Experimental;D008325
E05.598.500.496.843;Mammary Neoplasms, Experimental;D008325
A08.186.211.730.317.357.362.500;Mamillary Bodies;D008326
E01.370.350.700.500;Mammography;D008327
F02.784.412.575;Man-Machine Systems;D008328
J01.293.556.441;Man-Machine Systems;D008328
J01.897.441;Man-Machine Systems;D008328
N03.219.521.576.343.800;Managed Care Programs;D008329
N04.590.374.410;Managed Care Programs;D008329
N04.452.500;Management Audit;D008330
L01.700.508.300.680;Management Information Systems;D008331
N04.452.515;Management Information Systems;D008331
N04.452.677.420;Management Quality Circles;D008332
D02.241.223.475;Mandelic Acids;D008333
D02.241.511.536;Mandelic Acids;D008333
A02.835.232.781.324.502.632;Mandible;D008334
A14.521.632;Mandible;D008334
A02.835.232.781.324.502.632.600;Mandibular Condyle;D008335
A14.521.632.600;Mandibular Condyle;D008335
C05.500.607;Mandibular Diseases;D008336
C07.320.610;Mandibular Diseases;D008336
C26.260.275.500.400.255;Mandibular Fractures;D008337
C26.404.750.467.441;Mandibular Fractures;D008337
C26.260.275.500.500;Mandibular Injuries;D008338
C04.588.149.721.450.583;Mandibular Neoplasms;D008339
C05.116.231.754.450.583;Mandibular Neoplasms;D008339
C05.500.499.583;Mandibular Neoplasms;D008339
C05.500.607.442;Mandibular Neoplasms;D008339
C07.320.515.583;Mandibular Neoplasms;D008339
C07.320.610.583;Mandibular Neoplasms;D008339
A08.800.800.120.760.500;Mandibular Nerve;D008340
E07.695.510.500;Mandibular Prosthesis;D008341
C05.116.099.370.231.576;Mandibulofacial Dysostosis;D008342
C05.660.207.231.576;Mandibulofacial Dysostosis;D008342
C16.131.621.207.231.576;Mandibulofacial Dysostosis;D008342
D02.241.081.251.869.265.441;Maneb;D008344
D02.691.600;Maneb;D008344
D02.886.706.250.500;Maneb;D008344
D01.268.556.484;Manganese;D008345
D01.268.956.374;Manganese;D008345
D01.552.544.484;Manganese;D008345
F04.711.647.513.463;Manifest Anxiety Scale;D008347
J01.897.280.500.545.129.400;Manikins;D008348
L01.178.820.090.545.129.400;Manikins;D008348
E02.718.625;Manipulation, Orthopedic;D008349
E02.779.867.433;Manipulation, Orthopedic;D008349
Z01.107.567.176.410;Manitoba;D008350
D09.698.550;Mannans;D008351
D02.092.650;Mannich Bases;D008352
D02.522.650;Mannich Bases;D008352
D02.033.800.609;Mannitol;D008353
D09.853.609;Mannitol;D008353
D08.811.682.047.150.700.649;Mannitol Dehydrogenases;D008354
D02.033.800.609.450;Mannitol Phosphates;D008355
D09.853.609.450;Mannitol Phosphates;D008355
D09.894.500;Mannitol Phosphates;D008355
D09.546.286.500;Mannoheptulose;D008356
D09.546.465.500;Mannoheptulose;D008356
D02.455.526.728.650.463;Mannomustine;D008357
D09.546.359.588;Mannose;D008358
D08.811.399.475.200.550;Mannose-6-Phosphate Isomerase;D008359
D09.894.417.650;Mannosephosphates;D008360
D08.811.277.450.625;Mannosidases;D008361
D09.408.490;Mannosides;D008362
C16.320.565.202.607.500;alpha-Mannosidosis;D008363
C16.320.565.595.577.500;alpha-Mannosidosis;D008363
C18.452.648.202.607.500;alpha-Mannosidosis;D008363
C18.452.648.595.577.500;alpha-Mannosidosis;D008363
D08.811.913.400.450.560;Mannosyltransferases;D008364
E05.559;Manometry;D008365
B01.050.500.500.294.700.750.700.300.438;Mansonella;D008366
C03.335.508.700.750.361.588;Mansonelliasis;D008368
E02.831.671.609;Manual Communication;D008369
F01.145.209.530.702;Manual Communication;D008369
L01.143.649.526;Manual Communication;D008369
L01.178.682.192.609;Manuals as Topic;D008370
L01.178.820.500;Manuals as Topic;D008370
A02.835.232.904.766.442;Manubrium;D008371
D20.601;Manure;D008372
L01.178.682.608;Manuscripts as Topic;D008373
L01.178.682.608.526;Manuscripts, Medical;D008374
C10.228.140.163.100.520;Maple Syrup Urine Disease;D008375
C16.320.565.100.608;Maple Syrup Urine Disease;D008375
C16.320.565.189.520;Maple Syrup Urine Disease;D008375
C18.452.132.100.520;Maple Syrup Urine Disease;D008375
C18.452.648.100.608;Maple Syrup Urine Disease;D008375
C18.452.648.189.520;Maple Syrup Urine Disease;D008375
D02.455.426.559.847.117.600;Maprotiline;D008376
D04.615.117.600;Maprotiline;D008376
J01.897.280.500.426;Maps as Topic;D008377
L01.178.820.090.426;Maps as Topic;D008377
C02.782.417.560;Marburg Virus Disease;D008379
C02.782.580.250.500;Marburg Virus Disease;D008379
C22.735.500.500;Marburg Virus Disease;D008379
C02.256.466.650;Marek Disease;D008380
C02.928.489;Marek Disease;D008380
C04.619.935.489;Marek Disease;D008380
C04.925.489;Marek Disease;D008380
C15.604.515.700;Marek Disease;D008380
C20.683.515.840;Marek Disease;D008380
C22.131.546;Marek Disease;D008380
B04.280.382.100.562.400;Herpesvirus 2, Gallid;D008381
B04.909.204.382.100.562.400;Herpesvirus 2, Gallid;D008381
C05.116.099.674;Marfan Syndrome;D008382
C14.240.400.725;Marfan Syndrome;D008382
C14.280.400.725;Marfan Syndrome;D008382
C16.131.077.550;Marfan Syndrome;D008382
C16.131.240.400.720;Marfan Syndrome;D008382
C16.320.540;Marfan Syndrome;D008382
C17.300.500;Marfan Syndrome;D008382
D10.212.302.651;Margarine;D008383
J02.500.350.500;Margarine;D008383
J02.500.375.650;Margarine;D008383
F01.145.466.753.488;Marijuana Smoking;D008385
H01.158.273.248.750.500;Marine Biology;D008386
H01.277.249.750.500;Marine Biology;D008386
H01.277.750.500;Marine Biology;D008386
D23.946.580;Marine Toxins;D008387
F04.754.864.581.550;Marital Therapy;D008388
J01.219.687.550;Marketing of Health Services;D008389
N03.219.463.548;Marketing of Health Services;D008389
N05.300.430.500;Marketing of Health Services;D008389
E05.318.740.600.500;Markov Chains;D008390
E05.318.740.996.500;Markov Chains;D008390
G17.830.500;Markov Chains;D008390
N05.715.360.750.625.500;Markov Chains;D008390
N05.715.360.750.770.500;Markov Chains;D008390
N06.850.520.830.600.500;Markov Chains;D008390
N06.850.520.830.996.500;Markov Chains;D008390
B01.050.150.900.649.865.750.460;Marmota;D008392
F01.829.263.315.500.500;Marriage;D008393
I01.240.361.500.500;Marriage;D008393
I01.880.225.423.500.500;Marriage;D008393
N01.224.361.500.500;Marriage;D008393
N01.824.308.500.500;Marriage;D008393
B01.050.150.900.649.573;Marsupialia;D008394
Z01.107.084.900.600;Martinique;D008395
Z01.639.880.600;Martinique;D008395
Z01.107.567.875.075.418;Maryland;D008396
Z01.107.567.875.500.500;Maryland;D008396
E07.325.877.500;Masks;D008397
E07.700.500;Masks;D008397
E07.858.594.750;Masks;D008397
J01.637.708.500;Masks;D008397
F03.800.800.600.500;Masochism;D008398
F01.145.813.527;Mass Behavior;D008399
E01.370.350.700.730.500;Mass Chest X-Ray;D008400
E01.370.386.500;Mass Chest X-Ray;D008400
E01.370.500.500;Mass Chest X-Ray;D008400
E05.318.308.250.580.510;Mass Chest X-Ray;D008400
N02.421.143.827.233.443.443;Mass Chest X-Ray;D008400
N02.421.726.233.443.443;Mass Chest X-Ray;D008400
N05.715.360.300.375.500.500;Mass Chest X-Ray;D008400
N06.850.520.308.250.580.510;Mass Chest X-Ray;D008400
N06.850.780.500.500;Mass Chest X-Ray;D008400
E05.196.181.349.500;Gas Chromatography-Mass Spectrometry;D008401
E05.196.566.500;Gas Chromatography-Mass Spectrometry;D008401
L01.178.590;Mass Media;D008402
E01.370.500;Mass Screening;D008403
E05.318.308.250.580;Mass Screening;D008403
N02.421.143.827.233.443;Mass Screening;D008403
N02.421.726.233.443;Mass Screening;D008403
N05.715.360.300.375.500;Mass Screening;D008403
N06.850.520.308.250.580;Mass Screening;D008403
N06.850.780.500;Mass Screening;D008403
Z01.107.567.875.550.510;Massachusetts;D008404
E02.190.599.500;Massage;D008405
E02.779.867.522;Massage;D008405
A02.633.567.600.500;Masseter Muscle;D008406
A14.530.630;Masseter Muscle;D008406
A11.329.427;Mast Cells;D008407
A15.382.652;Mast Cells;D008407
E04.466;Mastectomy;D008408
G07.610.593.260.500;Mastication;D008409
G07.700.620.260.500;Mastication;D008409
G10.261.326.240.500;Mastication;D008409
A02.633.567.600;Masticatory Muscles;D008410
A14.530;Masticatory Muscles;D008410
B01.300.283;Chytridiomycota;D008411
C13.703.844.603;Mastitis;D008413
C17.800.090.968;Mastitis;D008413
C22.196.581;Mastitis, Bovine;D008414
C04.557.450.565.465;Mastocytosis;D008415
C17.800.508;Mastocytosis;D008415
A02.835.232.781.885.444;Mastoid;D008416
C01.539.160.495.500;Mastoiditis;D008417
C05.116.165.495.249;Mastoiditis;D008417
C09.218.705.663.652;Mastoiditis;D008417
F01.145.802.526;Masturbation;D008418
D26.526;Materia Medica;D008419
J01.637;Manufactured Materials;D008420
N02.278.354.650;Materials Management, Hospital;D008421
N04.452.442.650;Materials Management, Hospital;D008421
E05.570;Materials Testing;D008422
G08.686.560;Maternal Age;D008423
N05.715.350.075.550;Maternal Age;D008423
N06.850.490.250.550;Maternal Age;D008423
F01.829.263.370.215;Maternal Behavior;D008425
F01.829.263.370.240;Maternal Deprivation;D008426
N02.421.143.620;Maternal Health Services;D008427
N02.421.800.500;Maternal Health Services;D008427
E05.318.308.985.550.500;Maternal Mortality;D008428
L01.280.975.550.500;Maternal Mortality;D008428
N01.224.935.698.653;Maternal Mortality;D008428
N06.850.505.400.975.550.500;Maternal Mortality;D008428
N06.850.520.308.985.550.500;Maternal Mortality;D008428
I01.880.787.678;Maternal Welfare;D008429
N02.278.035.310;Maternal-Child Health Centers;D008430
G08.686.785.760.769.455;Maternal-Fetal Exchange;D008431
L01.224.680;Mathematical Computing;D008432
H01.548;Mathematics;D008433
E06.186.501.630;Matrix Bands;D008434
E07.222.501.630;Matrix Bands;D008434
Z01.058.290.190.520;Mauritania;D008435
Z01.639.520.520;Mauritius;D008436
A02.835.232.781.324.502.645;Maxilla;D008437
A14.521.645;Maxilla;D008437
A07.231.114.523;Maxillary Artery;D008438
C05.500.693;Maxillary Diseases;D008439
C07.320.660;Maxillary Diseases;D008439
C26.260.275.500.400.510;Maxillary Fractures;D008440
C26.404.750.467.611;Maxillary Fractures;D008440
C04.588.149.721.450.601;Maxillary Neoplasms;D008441
C05.116.231.754.450.601;Maxillary Neoplasms;D008441
C05.500.499.601;Maxillary Neoplasms;D008441
C05.500.693.528;Maxillary Neoplasms;D008441
C07.320.515.601;Maxillary Neoplasms;D008441
C07.320.660.601;Maxillary Neoplasms;D008441
A08.800.800.120.760.550;Maxillary Nerve;D008442
A04.531.621.578;Maxillary Sinus;D008443
C04.588.443.665.650.693.575;Maxillary Sinus Neoplasms;D008444
C08.460.669.693.575;Maxillary Sinus Neoplasms;D008444
C08.460.692.503.503;Maxillary Sinus Neoplasms;D008444
C08.785.600.693.575;Maxillary Sinus Neoplasms;D008444
C09.603.669.693.575;Maxillary Sinus Neoplasms;D008444
C09.603.692.503.503;Maxillary Sinus Neoplasms;D008444
C09.647.685.693.575;Maxillary Sinus Neoplasms;D008444
G07.700.320.500.325.377.625.100.478;Maxillofacial Development;D008445
G11.427.590.560.100.478;Maxillofacial Development;D008445
C26.260.275.500;Maxillofacial Injuries;D008446
E07.695.510;Maxillofacial Prosthesis;D008447
E01.370.386.700.660.225.500;Maximal Expiratory Flow Rate;D008448
G09.772.650.300.590;Maximal Expiratory Flow Rate;D008448
E01.370.386.700.660.225.505;Maximal Expiratory Flow-Volume Curves;D008449
G09.772.650.300.630;Maximal Expiratory Flow-Volume Curves;D008449
E01.370.386.700.660.225.510;Maximal Midexpiratory Flow Rate;D008450
G09.772.650.300.670;Maximal Midexpiratory Flow Rate;D008450
E01.370.386.700.660.500;Maximal Voluntary Ventilation;D008451
G09.772.650.630;Maximal Voluntary Ventilation;D008451
N06.850.460.350.210;Maximum Allowable Concentration;D008452
N06.850.460.350.600.615;Maximum Allowable Concentration;D008452
D02.540.505.495;Maytansine;D008453
D04.345.295.500;Maytansine;D008453
D03.438.513.500;Mazindol;D008454
D02.092.877.674.033;(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride;D008455
D02.455.326.397.325;(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride;D008455
D02.675.276.210;(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride;D008455
D02.241.081.018.386.682.500;2-Methyl-4-chlorophenoxyacetic Acid;D008456
D02.241.511.316.682.224;2-Methyl-4-chlorophenoxyacetic Acid;D008456
C02.782.580.600.500.500;Measles;D008457
D20.215.894.899.404;Measles Vaccine;D008458
B04.820.455.600.650.500.500;Measles virus;D008459
B04.909.777.455.600.650.500.500;Measles virus;D008459
J02.500.600;Meat;D008460
J02.500.600.500;Meat Products;D008461
J01.576.423.200.700;Meat-Packing Industry;D008462
D02.241.081.251.415;Mebendazole;D008463
D03.438.103.600;Mebendazole;D008463
D02.455.849.575.781.500;Mecamylamine;D008464
A08.663.650.915.750;Mechanoreceptors;D008465
A08.800.950.750;Mechanoreceptors;D008465
A11.671.650.915.750;Mechanoreceptors;D008465
D02.455.526.728.650.529;Mechlorethamine;D008466
A03.556.124.684.249.612;Meckel Diverticulum;D008467
A03.556.249.124.612;Meckel Diverticulum;D008467
C06.198.859;Meckel Diverticulum;D008467
C16.131.314.556;Meckel Diverticulum;D008467
C23.300.415.750;Meckel Diverticulum;D008467
D02.455.426.559.389.115.475;Meclizine;D008468
D03.383.606.650;Meclizine;D008468
D02.241.223.100.050.400.200.500;Meclofenamic Acid;D008469
D02.455.426.559.389.127.020.906.750.500;Meclofenamic Acid;D008469
A12.459.529;Meconium;D008470
A16.378.529;Meconium;D008470
C08.381.520.687;Meconium Aspiration Syndrome;D008471
C08.618.580;Meconium Aspiration Syndrome;D008471
C13.703.277.785;Meconium Aspiration Syndrome;D008471
C16.300.580;Meconium Aspiration Syndrome;D008471
C16.614.580;Meconium Aspiration Syndrome;D008471
D03.438.079.080.550;Medazepam;D008472
A06.688.357.500;Median Eminence;D008473
A08.186.211.730.317.357.352.435.249;Median Eminence;D008473
A08.713.357.500;Median Eminence;D008473
A08.612.492;Medial Forebrain Bundle;D008474
A08.800.800.720.050.500;Median Nerve;D008475
C04.182.444;Mediastinal Cyst;D008476
C08.846.187.145;Mediastinal Cyst;D008476
C08.846.187;Mediastinal Diseases;D008477
C08.846.187.290;Mediastinal Emphysema;D008478
C23.550.325.250;Mediastinal Emphysema;D008478
C04.588.894.479;Mediastinal Neoplasms;D008479
C08.846.187.580;Mediastinal Neoplasms;D008479
C08.846.187.790;Mediastinitis;D008480
E01.370.388.250.560;Mediastinoscopy;D008481
E04.800.250.560;Mediastinoscopy;D008481
E04.928.490;Mediastinoscopy;D008481
A01.923.761.800.500;Mediastinum;D008482
N03.219.521.346.506.564;Medical Assistance;D008483
N03.219.521.346.506.564.655;Medicaid;D008484
N03.706.615.693;Medicaid;D008484
N04.761.700.250.500;Medical Audit;D008485
N05.700.175.500;Medical Audit;D008485
M01.526.070.700;Physician Executives;D008486
M01.526.485.800;Physician Executives;D008486
N02.360.800;Physician Executives;D008486
E01.370.510;Medical History Taking;D008487
H02.385;Medical Illustration;D008488
J01.897.280.500.480;Medical Illustration;D008488
K01.093.410;Medical Illustration;D008488
L01.178.820.090.480;Medical Illustration;D008488
N01.824.460;Medical Indigency;D008489
N03.219.780;Medical Indigency;D008489
L01.313.500;Medical Informatics;D008490
L01.700;Medical Informatics;D008490
L01.700.508;Medical Informatics Applications;D008491
L01.700.568;Medical Informatics Computing;D008492
I01.615.500.750;Medical Missions, Official;D008493
N02.278.562;Medical Office Buildings;D008494
H02.403.429.515;Medical Oncology;D008495
M01.526.485.067.600.630;Medical Receptionists;D008496
N02.360.067.600.630;Medical Receptionists;D008496
M01.526.485.067.550;Medical Record Administrators;D008497
N02.360.067.550;Medical Record Administrators;D008497
E05.318.308.940.968.500;Medical Record Linkage;D008498
L01.280.900.968.500;Medical Record Linkage;D008498
N04.452.859.564.550;Medical Record Linkage;D008498
N05.715.360.300.715.500.500;Medical Record Linkage;D008498
N06.850.520.308.940.968.500;Medical Record Linkage;D008498
E05.318.308.940.968;Medical Records;D008499
L01.280.900.968;Medical Records;D008499
N04.452.859.564;Medical Records;D008499
N05.715.360.300.715.500;Medical Records;D008499
N06.850.520.308.940.968;Medical Records;D008499
N02.278.354.422.465;Medical Records Department, Hospital;D008500
N04.452.442.422.465;Medical Records Department, Hospital;D008500
E05.318.308.940.968.550;Medical Records, Problem-Oriented;D008501
L01.280.900.968.550;Medical Records, Problem-Oriented;D008501
N04.452.859.564.600;Medical Records, Problem-Oriented;D008501
N05.715.360.300.715.500.520;Medical Records, Problem-Oriented;D008501
N06.850.520.308.940.968.550;Medical Records, Problem-Oriented;D008501
M01.526.485.067.600;Medical Secretaries;D008502
N02.360.067.600;Medical Secretaries;D008502
M01.526.485.630;Medical Staff;D008503
N02.360.630;Medical Staff;D008503
N02.278.354.458.500;Medical Staff Privileges;D008504
N04.452.442.530.500;Medical Staff Privileges;D008504
N04.452.758.275.500;Medical Staff Privileges;D008504
M01.526.485.630.490;Medical Staff, Hospital;D008505
M01.526.485.740.422;Medical Staff, Hospital;D008505
N02.360.630.490;Medical Staff, Hospital;D008505
N02.360.740.422;Medical Staff, Hospital;D008505
D20.944.460;Medical Waste;D008506
N06.850.460.710.460;Medical Waste;D008506
N03.349.650.340;Medically Underserved Area;D008507
N05.300.450.520;Medically Underserved Area;D008507
E02.319.529;Medication Errors;D008508
N02.421.450.500;Medication Errors;D008508
N04.452.528;Medication Systems;D008509
N02.278.354.675;Medication Systems, Hospital;D008510
N04.452.442.675;Medication Systems, Hospital;D008510
N04.452.528.473;Medication Systems, Hospital;D008510
H02.403;Medicine;D008511
K01.093.530;Medicine in Art;D008512
K01.517.584;Medicine in Literature;D008513
E02.190.488.510;Medicine, Arabic;D008514
I01.076.201.450.654.510;Medicine, Arabic;D008514
K01.400.552.643;Medicine, Arabic;D008514
E02.190.488.515;Medicine, Ayurvedic;D008515
I01.076.201.450.654.515;Medicine, Ayurvedic;D008515
E02.190.488.585.520;Medicine, Chinese Traditional;D008516
I01.076.201.450.654.558.520;Medicine, Chinese Traditional;D008516
E02.190.755;Phytotherapy;D008517
E02.190.488.585;Medicine, East Asian Traditional;D008518
I01.076.201.450.654.558;Medicine, East Asian Traditional;D008518
E02.190.488;Medicine, Traditional;D008519
I01.076.201.450.654;Medicine, Traditional;D008519
D04.808.155.160.349.500;Medigoxin;D008520
D04.808.155.580.130.500.436.500;Medigoxin;D008520
D09.408.180.261.436.500;Medigoxin;D008520
Z01.542.580.500;Mediterranean Islands;D008521
Z01.639.640;Mediterranean Islands;D008521
Z01.756.592;Mediterranean Sea;D008522
L01.700.508.280.710;MEDLARS;D008523
L01.700.508.300.710;MEDLARS;D008523
D04.808.745.432.481;Medrogestone;D008524
D04.808.745.745.654.829.614;Medroxyprogesterone;D008525
A08.186.211.132.810.406;Medulla Oblongata;D008526
A08.186.211.865.467.500;Medulla Oblongata;D008526
C04.557.465.625.600.380.515;Medulloblastoma;D008527
C04.557.465.625.600.590.500;Medulloblastoma;D008527
C04.557.470.670.380.515;Medulloblastoma;D008527
C04.557.470.670.590.500;Medulloblastoma;D008527
C04.557.580.625.600.380.515;Medulloblastoma;D008527
C04.557.580.625.600.590.500;Medulloblastoma;D008527
D02.241.223.100.050.400.200.555;Mefenamic Acid;D008528
D02.455.426.559.389.127.020.906.750.555;Mefenamic Acid;D008528
D02.065.884.575;Mefruside;D008529
D02.886.590.700.575;Mefruside;D008529
D12.776.097.151.615;Megacins;D008530
C06.405.469.158.701;Megacolon;D008531
C06.405.469.158.701.591;Megacolon, Toxic;D008532
A11.148.479;Megakaryocytes;D008533
A15.378.316.479;Megakaryocytes;D008533
A11.118.290.330.531;Megaloblasts;D008534
A11.148.378.590.837.250.200.500;Megaloblasts;D008534
A11.443.240.330.531;Megaloblasts;D008534
A11.443.240.497.200.500;Megaloblasts;D008534
A15.145.229.334.330.531;Megaloblasts;D008534
A15.378.316.378.590.837.250.200.500;Megaloblasts;D008534
D04.808.745.432.531;Megestrol;D008535
D02.033.800.813.550;Meglumine;D008536
D09.067.342.600;Meglumine;D008536
D09.853.813.550;Meglumine;D008536
A09.371.337.614;Meibomian Glands;D008537
A10.336.827.600;Meibomian Glands;D008537
C10.228.140.079.590;Meige Syndrome;D008538
C10.228.662.300.500;Meige Syndrome;D008538
C04.588.322.455.531;Meigs Syndrome;D008539
C13.351.500.056.630.705.531;Meigs Syndrome;D008539
C13.351.937.418.685.531;Meigs Syndrome;D008539
C19.344.410.531;Meigs Syndrome;D008539
C19.391.630.705.531;Meigs Syndrome;D008539
G04.299.134.220.220.687;Meiosis;D008540
G05.355.105.220.687;Meiosis;D008540
Z01.252.145.530;Mekong Valley;D008541
Z01.639.760.590;Melanesia;D008542
D12.125.072.050.875.379;Melanins;D008543
D23.767.620;Melanins;D008543
A11.436.613;Melanocytes;D008544
C04.557.465.625.650.510;Melanoma;D008545
C04.557.580.625.650.510;Melanoma;D008545
C04.557.665.510;Melanoma;D008545
C04.557.465.625.650.510.525;Melanoma, Experimental;D008546
C04.557.580.625.650.510.525;Melanoma, Experimental;D008546
C04.557.665.510.525;Melanoma, Experimental;D008546
C04.619.600;Melanoma, Experimental;D008546
E05.598.500.496.937;Melanoma, Experimental;D008546
A11.436.265.531;Melanophores;D008547
C17.800.621.430.530;Melanosis;D008548
D02.691.088.500;Melarsoprol;D008549
D03.438.473.914.481;Melatonin;D008550
D06.472.506;Melatonin;D008550
A12.459.764;Melena;D008551
C06.405.227.600;Melena;D008551
C23.550.414.788.600;Melena;D008551
D04.808.745.432.581;Melengestrol Acetate;D008552
D09.698.629.305.540;Melibiose;D008553
C01.252.400.170.531;Melioidosis;D008554
D12.644.050.550;Melitten;D008555
D12.776.543.695.054.550;Melitten;D008555
D20.888.065.115.580;Melitten;D008555
D23.946.833.065.115.580;Melitten;D008555
C07.465.466;Melkersson-Rosenthal Syndrome;D008556
C10.292.300.800;Melkersson-Rosenthal Syndrome;D008556
C05.116.099.708.702.593;Melorheostosis;D008557
D02.455.526.728.650.594;Melphalan;D008558
D12.125.072.050.685.500;Melphalan;D008558
D02.455.426.100.050.035.500;Memantine;D008559
G01.154.500;Membrane Fluidity;D008560
G02.111.550;Membrane Fluidity;D008560
G04.570;Membrane Fluidity;D008560
G04.299.570;Membrane Fusion;D008561
D12.776.395.550;Membrane Glycoproteins;D008562
D12.776.543.550;Membrane Glycoproteins;D008562
D10.570;Membrane Lipids;D008563
G01.154.535;Membrane Potentials;D008564
G04.580;Membrane Potentials;D008564
G07.265.750;Membrane Potentials;D008564
G11.561.570;Membrane Potentials;D008564
D12.776.543;Membrane Proteins;D008565
A10.615;Membranes;D008566
D25.479;Membranes, Artificial;D008567
J01.637.051.479;Membranes, Artificial;D008567
J01.637.087.500;Membranes, Artificial;D008567
F02.463.425.540;Memory;D008568
C10.597.606.525;Memory Disorders;D008569
C23.888.592.604.529;Memory Disorders;D008569
F01.700.625;Memory Disorders;D008569
F02.463.425.540.407;Memory, Short-Term;D008570
M01.390;Men;D008571
G08.686.760.410;Menarche;D008572
G08.686.785.880.374.410;Menarche;D008572
D01.268.033.525;Mendelevium;D008573
D01.268.271.100.525;Mendelevium;D008573
D01.268.556.494;Mendelevium;D008573
D01.552.020.561;Mendelevium;D008573
D01.552.544.494;Mendelevium;D008573
B04.820.565.170.200.500;Mengovirus;D008574
B04.909.777.618.170.200.500;Mengovirus;D008574
C09.218.568.217.500;Meniere Disease;D008575
A07.231.114.545;Meningeal Arteries;D008576
C04.588.614.250.580;Meningeal Neoplasms;D008577
C10.551.240.500;Meningeal Neoplasms;D008577
A08.186.566;Meninges;D008578
C04.557.580.520;Meningioma;D008579
C04.557.645.520;Meningioma;D008579
C04.588.614.250.580.500;Meningioma;D008579
C10.551.240.500.500;Meningioma;D008579
C10.597.544;Meningism;D008580
C23.888.592.544;Meningism;D008580
C10.228.228.507;Meningitis;D008581
C10.228.566;Meningitis;D008581
C02.182.550.600;Meningitis, Aseptic;D008582
C02.587.600;Meningitis, Aseptic;D008582
C10.228.228.210.500.600;Meningitis, Aseptic;D008582
C10.228.228.507.220;Meningitis, Aseptic;D008582
C10.228.228.507.700.600;Meningitis, Aseptic;D008582
C01.252.200.500.450;Meningitis, Haemophilus;D008583
C01.252.400.700.433.615;Meningitis, Haemophilus;D008583
C10.228.228.180.500.425;Meningitis, Haemophilus;D008583
C10.228.228.507.280.393;Meningitis, Haemophilus;D008583
C01.252.200.500.500;Meningitis, Listeria;D008584
C01.252.410.514.533;Meningitis, Listeria;D008584
C10.228.228.180.500.500;Meningitis, Listeria;D008584
C10.228.228.507.280.449;Meningitis, Listeria;D008584
C01.252.200.500.550;Meningitis, Meningococcal;D008585
C01.252.400.625.549.449;Meningitis, Meningococcal;D008585
C10.228.228.180.500.750;Meningitis, Meningococcal;D008585
C10.228.228.507.280.505;Meningitis, Meningococcal;D008585
C01.252.200.500.600;Meningitis, Pneumococcal;D008586
C01.252.410.890.670.595;Meningitis, Pneumococcal;D008586
C10.228.228.180.500.875;Meningitis, Pneumococcal;D008586
C10.228.228.507.280.560;Meningitis, Pneumococcal;D008586
C02.182.550;Meningitis, Viral;D008587
C02.587;Meningitis, Viral;D008587
C10.228.228.210.500;Meningitis, Viral;D008587
C10.228.228.507.700;Meningitis, Viral;D008587
C10.500.680.598;Meningocele;D008588
C16.131.666.680.598;Meningocele;D008588
C23.300.707.968;Meningocele;D008588
C01.252.400.625.549;Meningococcal Infections;D008589
C10.228.140.430.550;Meningoencephalitis;D008590
C10.228.228.245.550;Meningoencephalitis;D008590
C10.228.228.507.850;Meningoencephalitis;D008590
C10.228.228.553;Meningoencephalitis;D008590
C10.228.566.500;Meningoencephalitis;D008590
C10.500.680.610;Meningomyelocele;D008591
C16.131.666.680.610;Meningomyelocele;D008591
A02.165.308.500;Menisci, Tibial;D008592
A02.835.583.475.590;Menisci, Tibial;D008592
G08.686.157.500;Menopause;D008593
G08.686.785.880.249.500;Menopause;D008593
C13.351.500.056.630.250;Menopause, Premature;D008594
G08.686.157.500.500;Menopause, Premature;D008594
G08.686.785.880.249.500.500;Menopause, Premature;D008594
C13.351.500.852.691.449;Menorrhagia;D008595
C23.550.568.875;Menorrhagia;D008595
D06.472.699.322.576.583;Menotropins;D008596
D06.472.699.631.525.343.583;Menotropins;D008596
D12.644.548.691.525.343.583;Menotropins;D008596
D20.215.535;Menotropins;D008596
G08.686.605;Menstrual Cycle;D008597
G08.686.605.428;Menstruation;D008598
G08.686.785.560;Menstruation;D008598
C23.550.568;Menstruation Disturbances;D008599
D27.505.696.875.360.276.500;Menstruation-Inducing Agents;D008600
D27.505.696.875.650;Menstruation-Inducing Agents;D008600
D27.505.954.705.360.276.500;Menstruation-Inducing Agents;D008600
D27.505.954.705.650;Menstruation-Inducing Agents;D008600
E02.190.525.500;Mental Healing;D008602
E02.190.901.500;Mental Healing;D008602
F02.418;Mental Health;D008603
N01.400.500;Mental Health;D008603
N03.540.630.780.500;Mental Health Associations;D008604
F04.408;Mental Health Services;D008605
N02.421.461;Mental Health Services;D008605
F02.463;Mental Processes;D008606
C10.597.606.643;Intellectual Disability;D008607
C23.888.592.604.646;Intellectual Disability;D008607
F01.700.687;Intellectual Disability;D008607
F03.550.600;Intellectual Disability;D008607
F04.586.574;Mental Status Schedule;D008609
D02.033.480.300.605;Menthol;D008610
D02.455.849.575.750;Menthol;D008610
I02.588;Mentors;D008611
M01.395;Mentors;D008611
J01.576.423.500.500;Menu Planning;D008612
N02.421.242.472.310;Menu Planning;D008612
D02.455.326.271.665.400;Mepartricin;D008613
D02.540.505.497;Mepartricin;D008613
D03.066.399.450;Meperidine;D008614
D03.383.621.349.450;Meperidine;D008614
D02.033.455.706.517;Mephenesin;D008615
D02.092.471.683.152.766.617;Mephentermine;D008616
D03.383.129.308.432.555.620;Mephenytoin;D008617
D03.383.742.698.253.434;Mephobarbital;D008618
D03.383.621.450;Mepivacaine;D008619
D02.241.081.251.510;Meprobamate;D008620
D03.383.066.400;Meptazinol;D008621
D02.691.750.575;Merbromin;D008622
D02.033.375.534;Mercaptoethanol;D008623
D02.886.489.409;Mercaptoethanol;D008623
D02.092.471.562;Mercaptoethylamines;D008624
D02.886.489.472;Mercaptoethylamines;D008624
D02.886.030.896;Tiopronin;D008625
D12.125.166.896;Tiopronin;D008625
D12.125.481.700.760;Tiopronin;D008625
D02.241.223.100.500;Mercuribenzoates;D008626
D02.455.426.559.389.127.500;Mercuribenzoates;D008626
D02.691.750.740.644;Mercuribenzoates;D008626
D01.210.450.150.525;Mercuric Chloride;D008627
D01.538.500;Mercuric Chloride;D008627
D01.268.556.504;Mercury;D008628
D01.268.956.437;Mercury;D008628
D01.552.544.504;Mercury;D008628
D01.496.532;Mercury Isotopes;D008629
C25.723.647;Mercury Poisoning;D008630
D01.496.532.500;Mercury Radioisotopes;D008631
D01.496.749.590;Mercury Radioisotopes;D008631
B01.050.500.500.294.100.275.570;Mermithoidea;D008632
D02.691.750.100.710;Mersalyl;D008634
D02.092.471.683.635;Mescaline;D008635
D03.132.524;Mescaline;D008635
A08.186.211.132.659;Mesencephalon;D008636
A08.186.211.653;Mesencephalon;D008636
C04.557.435.500;Mesenchymoma;D008637
A07.231.114.565;Mesenteric Arteries;D008638
C04.182.473;Mesenteric Cyst;D008639
C06.844.620.500;Mesenteric Cyst;D008639
C06.844.520;Mesenteric Lymphadenitis;D008640
C15.604.315.618;Mesenteric Lymphadenitis;D008640
C06.405.469.675;Mesenteric Vascular Occlusion;D008641
C06.844.550;Mesenteric Vascular Occlusion;D008641
C14.907.137.534;Mesenteric Vascular Occlusion;D008641
A07.231.908.670.385;Mesenteric Veins;D008642
A01.923.047.025.600.451;Mesentery;D008643
C07.465.714.836.535;Mesial Movement of Teeth;D008644
G10.549.235.803.535;Mesial Movement of Teeth;D008644
B01.050.500.500.736.215.520;Mesocestoides;D008645
A01.923.047.025.600.451.535;Mesocolon;D008646
B01.050.150.900.649.865.635.150.500;Mesocricetus;D008647
A16.504.660;Mesoderm;D008648
C04.557.465.510;Mesonephroma;D008649
A16.599;Mesonephros;D008650
G01.249.600;Mesons;D008651
D03.383.129.578.840.500.620;Mesoporphyrins;D008652
D03.549.909.500.620;Mesoporphyrins;D008652
D04.345.783.500.620;Mesoporphyrins;D008652
D23.767.727.620;Mesoporphyrins;D008652
D02.886.369.470;Mesoridazine;D008653
D03.494.741.470;Mesoridazine;D008653
C04.557.470.035.510;Mesothelioma;D008654
C04.557.470.660.510;Mesothelioma;D008654
D04.808.054.040.248.450;Mesterolone;D008655
D04.808.668.651.568.291.500;Mestranol;D008656
D06.472.334.851.437.968.500.500;Mestranol;D008656
E01.370.225.843;Metabolic Clearance Rate;D008657
E05.200.843;Metabolic Clearance Rate;D008657
G03.490;Metabolic Clearance Rate;D008657
G03.495.244.640;Metabolic Clearance Rate;D008657
G07.690.595;Metabolic Clearance Rate;D008657
G07.690.725.513;Metabolic Clearance Rate;D008657
G07.690.812.097.595;Metabolic Clearance Rate;D008657
G07.700.680.097.595;Metabolic Clearance Rate;D008657
G03.495.244.820;Metabolic Detoxication, Drug;D008658
G07.690.812.097.600;Metabolic Detoxication, Drug;D008658
G07.700.680.097.600;Metabolic Detoxication, Drug;D008658
C18.452;Metabolic Diseases;D008659
G03.495;Metabolism;D008660
C16.320.565;Metabolism, Inborn Errors;D008661
C18.452.648;Metabolism, Inborn Errors;D008661
A02.835.583.405.500;Metacarpophalangeal Joint;D008662
A01.378.800.667.572;Metacarpus;D008663
C16.320.565.618;Metal Metabolism, Inborn Errors;D008664
C18.452.648.618;Metal Metabolism, Inborn Errors;D008664
D03.383.129.578.840.500.640;Metalloporphyrins;D008665
D03.549.909.500.640;Metalloporphyrins;D008665
D04.345.783.500.640;Metalloporphyrins;D008665
D23.767.727.640;Metalloporphyrins;D008665
D08.811.277.656.300.480;Metalloendopeptidases;D008666
D08.811.277.656.675.374;Metalloendopeptidases;D008666
D12.776.556;Metalloproteins;D008667
D12.776.556.670;Metallothionein;D008668
J01.576.370.400;Metallurgy;D008669
D01.552;Metals;D008670
D01.268.033;Actinoid Series Elements;D008671
D01.268.271.100;Actinoid Series Elements;D008671
D01.552.020;Actinoid Series Elements;D008671
D01.268.549;Metals, Alkali;D008672
D01.552.528;Metals, Alkali;D008672
D01.268.552;Metals, Alkaline Earth;D008673
D01.552.539;Metals, Alkaline Earth;D008673
D01.268.558;Metals, Rare Earth;D008674
D01.552.550;Metals, Rare Earth;D008674
G07.700.320.500.550;Metamorphosis, Biological;D008675
D02.092.211.215.311.461.400;Metanephrine;D008676
D02.092.311.461.400;Metanephrine;D008676
G04.299.134.220.220.750;Metaphase;D008677
G04.299.134.220.220.781.625;Metaphase;D008677
G05.355.105.220.750;Metaphase;D008677
G05.355.105.220.781.625;Metaphase;D008677
K01.752.511;Metaphysics;D008678
C23.550.589;Metaplasia;D008679
D02.033.100.624.706.500;Metaraminol;D008680
D02.033.755.624.706.500;Metaraminol;D008680
D02.092.063.624.706.500;Metaraminol;D008680
B01.050.500.500.294.700.775.588;Metastrongyloidea;D008681
A02.835.232.043.300.492;Metatarsal Bones;D008682
A02.835.583.378.531;Metatarsophalangeal Joint;D008683
A01.378.610.250.300.480;Metatarsus;D008684
G16.500.750;Meteorological Concepts;D008685
N06.230.300;Meteorological Concepts;D008685
G08.686.195.750;Metestrus;D008686
D02.078.370.141.450;Metformin;D008687
D02.092.877.883.555;Methacholine Compounds;D008688
D02.675.276.534;Methacholine Compounds;D008688
D02.241.081.069.600;Methacrylates;D008689
D02.455.426.559.847.562.900.525;Methacycline;D008690
D04.615.562.900.525;Methacycline;D008690
D02.522.675;Methadone;D008691
D02.522.675.500;Methadyl Acetate;D008692
D02.886.904.425;Methallibure;D008693
D02.948.898.425;Methallibure;D008693
D02.092.471.683.152.619;Methamphetamine;D008694
D04.808.054.079.429.154.600;Methandriol;D008695
D04.808.054.079.129.453;Methandrostenolone;D008696
D02.455.326.146.571;Methane;D008697
D02.455.326.146.100.050.500;Mesylates;D008698
D02.886.645.600.055.050.510;Mesylates;D008698
D02.092.782.258.368.500;Methapyrilene;D008701
D03.383.725.050.440;Methapyrilene;D008701
D03.438.786.830.666;Methaqualone;D008702
D02.886.675.867.537;Methazolamide;D008704
D03.383.129.708.867.537;Methazolamide;D008704
D12.776.034.841.350;Methemalbumin;D008705
D12.776.124.727.350;Methemalbumin;D008705
D12.776.422.680;Methemalbumin;D008705
D12.776.124.400.599;Methemoglobin;D008706
D12.776.422.316.762.571;Methemoglobin;D008706
C15.378.619;Methemoglobinemia;D008708
D02.092.782.500;Methenamine;D008709
D02.455.426.100.050.392;Methenamine;D008709
D04.808.054.079.429.824.537;Methenolone;D008710
D03.132.327.287.630;Metergoline;D008711
D03.549.439.630;Metergoline;D008711
D02.065.589.099.750.500;Methicillin;D008712
D02.886.108.750.500;Methicillin;D008712
D03.438.260.825.500;Methicillin;D008712
D03.605.084.737.500;Methicillin;D008712
D04.075.080.875.099.221.750.500;Methicillin;D008712
D02.886.489.600;Methimazole;D008713
D03.383.129.308.535;Methimazole;D008713
D02.241.081.251.583.555;Methiocarb;D008714
D02.886.030.676;Methionine;D008715
D12.125.142.557;Methionine;D008715
D12.125.154.549;Methionine;D008715
D12.125.166.676;Methionine;D008715
D08.811.913.225.650;Methionine Adenosyltransferase;D008716
D02.886.030.676.620;Methionine Sulfoximine;D008717
D12.125.166.676.620;Methionine Sulfoximine;D008717
D08.811.464.263.200.600;Methionine-tRNA Ligase;D008718
D02.886.680.350.520;Methiothepin;D008719
D03.494.311.520;Methiothepin;D008719
D02.845.746.703.450;Methisazone;D008720
D02.886.803.450;Methisazone;D008720
D03.438.473.615;Methisazone;D008720
D02.241.081.251.515;Methocarbamol;D008721
D02.241.081.251.583.577;Methocarbamol;D008721
D02.355.601.536.400.500;Methocarbamol;D008721
D02.355.726.453.400.500;Methocarbamol;D008721
D02.455.426.559.389.657.654.453.400.500;Methocarbamol;D008721
E05.581;Methods;D008722
D03.383.742.698.253.488;Methohexital;D008723
D02.241.081.251.525;Methomyl;D008724
D02.886.706.537;Methomyl;D008724
D02.092.877.250;Bis-Trimethylammonium Compounds;D008725
D02.675.276.558;Bis-Trimethylammonium Compounds;D008725
D06.472.445.573.666.500;Methoprene;D008726
D03.438.733.631.192.500;Methotrexate;D008727
D02.886.369.513;Methotrimeprazine;D008728
D03.494.741.513;Methotrimeprazine;D008728
D02.033.100.624.536;Methoxamine;D008729
D02.033.755.624.536;Methoxamine;D008729
D02.092.063.624.536;Methoxamine;D008729
D02.092.471.683.661;Methoxamine;D008729
D03.438.150.446.794.500;Methoxsalen;D008730
D03.494.770.500;Methoxsalen;D008730
D03.830.219.446.794.500;Methoxsalen;D008730
D02.455.526.439.610;Methoxychlor;D008731
D02.092.211.215.801.451.601;Methoxydimethyltryptamines;D008732
D03.438.473.914.237.150.500;Methoxydimethyltryptamines;D008732
D03.438.473.914.814.150.500;Methoxydimethyltryptamines;D008732
D02.355.417.600;Methoxyflurane;D008733
D02.355.601.620;Methoxyflurane;D008733
D02.033.455.250.610;Methoxyhydroxyphenylglycol;D008734
D02.092.211.215.801.852.611;5-Methoxytryptamine;D008735
D03.438.473.914.814.400;5-Methoxytryptamine;D008735
D02.886.590.700.135.620;Methyclothiazide;D008736
D02.886.655.500.620;Methyclothiazide;D008736
D03.438.174.620;Methyclothiazide;D008736
D02.455.526.439.632;Methyl Chloride;D008737
D02.355.601;Methyl Ethers;D008738
D02.092.146.475;Methyl Green;D008739
D02.455.326.146.100.050.500.500;Methyl Methanesulfonate;D008741
D02.886.645.600.055.050.510.500;Methyl Methanesulfonate;D008741
D02.522.520.500;Methyl n-Butyl Ketone;D008742
D02.705.400.625.600.500;Methyl Parathion;D008743
D02.705.539.345.600.500;Methyl Parathion;D008743
D02.886.300.692.600.500;Methyl Parathion;D008743
D02.092.668;Methylamines;D008744
G02.111.087.029.538;Methylation;D008745
G02.149.115.029.538;Methylation;D008745
G02.149.465.040.538;Methylation;D008745
G02.607.750.040.538;Methylation;D008745
G03.495.130.538;Methylation;D008745
D02.172.080.600;Methylazoxymethanol Acetate;D008746
D09.698.365.180.663;Methylcellulose;D008747
D02.455.426.559.847.149.500;Methylcholanthrene;D008748
D04.615.149.500;Methylcholanthrene;D008748
D02.092.146.325.500;Methyldimethylaminoazobenzene;D008749
D02.092.311.200.538;Methyldopa;D008750
D12.125.072.050.685.400.600;Methyldopa;D008750
D12.125.072.050.875.130.600;Methyldopa;D008750
D02.886.369.517;Methylene Blue;D008751
D03.494.741.517;Methylene Blue;D008751
D02.455.526.439.642;Methylene Chloride;D008752
D02.092.146.500;Methylenebis(chloroaniline);D008753
D02.455.426.559.389.115.500;Methylenebis(chloroaniline);D008753
D08.811.682.662.253;Methylenetetrahydrofolate Dehydrogenase (NADP);D008754
D03.132.327.287.262.455;Methylergonovine;D008755
D03.549.439.262.538;Methylergonovine;D008755
D09.408.320.500;Methylgalactosides;D008756
D09.408.514.455;Methylgalactosides;D008756
D09.408.348.500;Methylglucosides;D008757
D09.408.514.622;Methylglucosides;D008757
D09.408.514;Methylglycosides;D008759
D02.078.370.570;Methylguanidine;D008760
D02.092.211.215.501.621;Methylhistamines;D008761
D02.092.471.440.500;Methylhistamines;D008761
D03.383.129.308.373.500;Methylhistamines;D008761
D12.125.072.329.539;Methylhistidines;D008762
D02.442.600;Methylhydrazines;D008763
D02.241.081.337.540.500;Methylmalonic Acid;D008764
D08.811.399.520.625;Methylmalonyl-CoA Mutase;D008765
D09.408.490.500;Methylmannosides;D008766
D09.408.514.700;Methylmannosides;D008766
D02.691.750.100.738;Methylmercury Compounds;D008767
D02.241.081.069.800.550;Methylmethacrylates;D008768
D05.750.716.822.111.650.605;Methylmethacrylates;D008768
D25.720.716.822.111.650.605;Methylmethacrylates;D008768
J01.637.051.720.716.822.111.650.605;Methylmethacrylates;D008768
D02.078.370.649.400;Methylnitronitrosoguanidine;D008769
D02.654.567.400;Methylnitronitrosoguanidine;D008769
D02.654.692.480;Methylnitrosourea;D008770
D02.948.594.490;Methylnitrosourea;D008770
D02.092.311.461.484.400;Nordefrin;D008771
B03.440.400.425.500;Methylococcaceae;D008772
B03.660.250.500;Methylococcaceae;D008772
D03.494.704.550;Methylphenazonium Methosulfate;D008773
D02.241.223.601.600;Methylphenidate;D008774
D03.383.621.460;Methylphenidate;D008774
D04.808.745.432.769.795.539;Methylprednisolone;D008775
D04.808.745.432.769.795.539.500;Methylprednisolone Hemisuccinate;D008776
D04.808.054.079.429.824.664;Methyltestosterone;D008777
D02.886.759.800.500;Methylthioinosine;D008778
D03.438.759.590.616.900.500;Methylthioinosine;D008778
D13.570.583.616.900.500;Methylthioinosine;D008778
D13.570.800.573.900.500;Methylthioinosine;D008778
D13.570.900.800.500;Methylthioinosine;D008778
D03.383.742.698.875.842.455;Methylthiouracil;D008779
D08.811.913.555.500;Methyltransferases;D008780
D12.125.072.050.875.485;Methyltyrosines;D008781
D02.948.511;Methylurea Compounds;D008782
D03.132.327.287.689;Methysergide;D008784
D03.549.439.689;Methysergide;D008784
D02.886.904.455;Metiamide;D008785
D02.948.898.455;Metiamide;D008785
D12.776.422.316.940.500;Metmyoglobin;D008786
D02.065.277.573;Metoclopramide;D008787
D02.241.223.100.050.500.647;Metoclopramide;D008787
D02.241.223.100.100.510;Metoclopramide;D008787
D02.241.223.100.200.750;Metoclopramide;D008787
D02.241.223.100.300.350.625;Metoclopramide;D008787
D02.241.511.390.350.625;Metoclopramide;D008787
D02.455.426.559.389.127.020.937.647;Metoclopramide;D008787
D02.455.426.559.389.127.085.510;Metoclopramide;D008787
D02.455.426.559.389.127.250.750;Metoclopramide;D008787
D02.455.426.559.389.127.281.350.625;Metoclopramide;D008787
D02.455.426.559.389.657.654.638.625;Metoclopramide;D008787
D02.065.884.600;Metolazone;D008788
D02.886.590.700.600;Metolazone;D008788
D03.438.786.830.688;Metolazone;D008788
D02.033.100.624.550;Metoprolol;D008790
D02.033.100.624.698.573;Metoprolol;D008790
D02.033.755.624.550;Metoprolol;D008790
D02.033.755.624.698.573;Metoprolol;D008790
D02.092.063.624.698.573;Metoprolol;D008790
A13.600;Metrial Gland;D008791
E05.978.539;Metric System;D008792
D02.241.223.100.400.880.520;Metrizamide;D008793
D02.455.426.559.389.127.375.880.520;Metrizamide;D008793
D09.408.051.545;Metrizamide;D008793
D02.241.223.100.400.880.530;Metrizoate;D008794
D02.455.426.559.389.127.375.880.530;Metrizoate;D008794
D02.640.672.500;Metronidazole;D008795
D03.383.129.308.658.500;Metronidazole;D008795
C13.351.500.852.691.622;Metrorrhagia;D008796
C23.550.414.993.700;Metrorrhagia;D008796
D03.383.725.463;Metyrapone;D008797
D02.241.511.579;Mevalonic Acid;D008798
D02.705.400.501;Mevinphos;D008799
Z01.107.567.589;Mexico;D008800
D02.092.831.500;Mexiletine;D008801
D02.455.426.559.389.657.654.675;Mexiletine;D008801
D02.065.589.099.750.750.050.500;Mezlocillin;D008802
D02.886.108.750.750.050.500;Mezlocillin;D008802
D03.438.260.825.750.050.500;Mezlocillin;D008802
D03.605.084.737.750.050.500;Mezlocillin;D008802
D04.075.080.875.099.221.750.750.050.500;Mezlocillin;D008802
D03.494.240.550;Mianserin;D008803
B01.050.050.157.520.300;Mice, Inbred A;D008805
B01.050.050.199.520.520.300;Mice, Inbred A;D008805
B01.050.150.900.649.865.635.505.500.400.300;Mice, Inbred A;D008805
B01.050.050.157.520.318;Mice, Inbred AKR;D008806
B01.050.050.199.520.520.318;Mice, Inbred AKR;D008806
B01.050.150.900.649.865.635.505.500.400.318;Mice, Inbred AKR;D008806
B01.050.050.157.520.338;Mice, Inbred BALB C;D008807
B01.050.050.199.520.520.338;Mice, Inbred BALB C;D008807
B01.050.150.900.649.865.635.505.500.400.338;Mice, Inbred BALB C;D008807
B01.050.050.157.520.440;Mice, Inbred CBA;D008808
B01.050.050.199.520.520.440;Mice, Inbred CBA;D008808
B01.050.150.900.649.865.635.505.500.400.440;Mice, Inbred CBA;D008808
B01.050.050.157.520.388;Mice, Inbred C3H;D008809
B01.050.050.199.520.520.388;Mice, Inbred C3H;D008809
B01.050.150.900.649.865.635.505.500.400.388;Mice, Inbred C3H;D008809
B01.050.050.157.520.420;Mice, Inbred C57BL;D008810
B01.050.050.199.520.520.420;Mice, Inbred C57BL;D008810
B01.050.150.900.649.865.635.505.500.400.420;Mice, Inbred C57BL;D008810
B01.050.050.157.520.500;Mice, Inbred DBA;D008811
B01.050.050.199.520.520.500;Mice, Inbred DBA;D008811
B01.050.150.900.649.865.635.505.500.400.500;Mice, Inbred DBA;D008811
B01.050.050.157.520.480;Mice, Hairless;D008812
B01.050.050.199.520.520.480;Mice, Hairless;D008812
B01.050.150.900.649.865.635.505.500.400.480;Mice, Hairless;D008812
B01.050.150.900.649.865.635.505.500.550.230;Mice, Hairless;D008812
B01.050.050.157.520.510;Mice, Inbred ICR;D008813
B01.050.050.199.520.520.510;Mice, Inbred ICR;D008813
B01.050.150.900.649.865.635.505.500.400.510;Mice, Inbred ICR;D008813
B01.050.050.157.520.580;Mice, Inbred NZB;D008814
B01.050.050.199.520.520.580;Mice, Inbred NZB;D008814
B01.050.150.900.649.865.635.505.500.400.580;Mice, Inbred NZB;D008814
B01.050.050.157.520;Mice, Inbred Strains;D008815
B01.050.050.199.520.520;Mice, Inbred Strains;D008815
B01.050.150.900.649.865.635.505.500.400;Mice, Inbred Strains;D008815
B01.050.150.900.649.865.635.505.500.550.430;Mice, Jimpy;D008816
B01.050.150.900.649.865.635.505.500.550;Mice, Mutant Strains;D008817
B01.050.150.900.649.865.635.505.500.550.480;Mice, Neurologic Mutants;D008818
B01.050.150.900.649.865.635.505.500.550.500;Mice, Nude;D008819
B01.050.150.900.649.865.635.505.500.550.530;Mice, Obese;D008820
B01.050.150.900.649.865.635.505.500.550.560;Mice, Quaking;D008821
B01.050.050.136.500;Mice, Transgenic;D008822
B01.050.150.900.649.865.635.505.500.800;Mice, Transgenic;D008822
D05.374;Micelles;D008823
D26.255.560;Micelles;D008823
D27.720.280.560;Micelles;D008823
Z01.107.567.875.350.500;Michigan;D008824
Z01.107.567.875.510.500;Michigan;D008824
D03.383.129.308.550;Miconazole;D008825
E01.370.225.875.595;Microbial Sensitivity Tests;D008826
E05.200.875.595;Microbial Sensitivity Tests;D008826
E05.337.550.400;Microbial Sensitivity Tests;D008826
G06;Microbiological Phenomena;D008827
E01.370.225.875;Microbiological Techniques;D008828
E05.200.875;Microbiological Techniques;D008828
H01.158.273.540;Microbiology;D008829
A11.284.430.214.190.500.585;Microbodies;D008830
A11.284.430.214.190.875.190.190.755;Microbodies;D008830
C05.660.207.620;Microcephaly;D008831
C10.500.507.500;Microcephaly;D008831
C16.131.621.207.620;Microcephaly;D008831
C16.131.666.507.500;Microcephaly;D008831
E05.196.620;Microchemistry;D008832
H01.181.650;Microchemistry;D008832
G09.330.190.163.645;Microcirculation;D008833
G16.500.275.071.450;Microclimate;D008834
N06.230.300.100.250.450;Microclimate;D008834
B03.510.024.049.475;Micrococcaceae;D008835
B03.510.400.500;Micrococcaceae;D008835
D08.811.277.352.335.350.500;Micrococcal Nuclease;D008836
D08.811.277.352.355.325.500;Micrococcal Nuclease;D008836
D08.811.277.352.355.350.500;Micrococcal Nuclease;D008836
D08.811.277.352.700.350.500;Micrococcal Nuclease;D008836
B03.510.024.049.475.500;Micrococcus;D008837
B03.510.400.500.500;Micrococcus;D008837
L01.224.230.260.550;Microcomputers;D008838
E07.305.250.500;Microelectrodes;D008839
D05.750.078.730;Microfilament Proteins;D008840
D12.776.220.525;Microfilament Proteins;D008840
A11.284.430.214.190.750.050;Actin Cytoskeleton;D008841
B01.050.500.500.294.700.750.700.300.470;Microfilaria;D008842
L01.240.630;Microfilming;D008843
C05.500.460.457;Micrognathism;D008844
C05.660.207.540.460.457;Micrognathism;D008844
C07.320.440.457;Micrognathism;D008844
C07.650.500.460.457;Micrognathism;D008844
C16.131.621.207.540.460.457;Micrognathism;D008844
C16.131.850.500.460.457;Micrognathism;D008844
E02.319.267.530.690;Microinjections;D008845
E05.591.570;Microinjections;D008845
E05.591;Micromanipulation;D008846
B03.300.390.400.500.500;Micromonospora;D008847
B03.510.024.049.500.500;Micromonospora;D008847
B03.510.415.400.500.500;Micromonospora;D008847
B03.510.460.410.500.500;Micromonospora;D008847
B03.300.390.400.500;Micromonosporaceae;D008848
B03.510.024.049.500;Micromonosporaceae;D008848
B03.510.415.400.500;Micromonosporaceae;D008848
B03.510.460.410.500;Micromonosporaceae;D008848
Z01.639.760.680;Micronesia;D008849
C11.250.566;Microphthalmos;D008850
C16.131.384.666;Microphthalmos;D008850
E05.196.454.403;Micropore Filters;D008851
E07.560;Micropore Filters;D008851
E01.370.350.700.510;Microradiography;D008852
E01.370.350.515;Microscopy;D008853
E05.595;Microscopy;D008853
H01.671.617.562;Microscopy;D008853
E01.370.350.515.402;Microscopy, Electron;D008854
E05.595.402;Microscopy, Electron;D008854
E01.370.350.515.402.541;Microscopy, Electron, Scanning;D008855
E05.595.402.541;Microscopy, Electron, Scanning;D008855
E01.370.350.515.458;Microscopy, Fluorescence;D008856
E05.595.458;Microscopy, Fluorescence;D008856
E01.370.350.515.513;Microscopy, Interference;D008857
E05.490.630;Microscopy, Interference;D008857
E05.595.513;Microscopy, Interference;D008857
E01.370.350.515.513.569;Microscopy, Phase-Contrast;D008858
E05.490.630.569;Microscopy, Phase-Contrast;D008858
E05.595.513.569;Microscopy, Phase-Contrast;D008858
E01.370.350.515.624;Microscopy, Polarization;D008859
E05.595.624;Microscopy, Polarization;D008859
E01.370.350.515.680;Microscopy, Ultraviolet;D008860
E05.595.680;Microscopy, Ultraviolet;D008860
A11.284.835.540;Microsomes;D008861
A11.284.835.540.541;Microsomes, Liver;D008862
E07.565;Microspheres;D008863
B01.300.381.560;Microsporum;D008864
C07.465.525.520;Microstomia;D008865
C07.650.525.520;Microstomia;D008865
C16.131.850.525.520;Microstomia;D008865
E04.494;Microsurgery;D008866
E05.591.580;Microsurgery;D008866
E01.370.225.500.620.530;Microtomy;D008867
E01.370.225.750.600.530;Microtomy;D008867
E05.200.500.620.530;Microtomy;D008867
E05.200.750.600.530;Microtomy;D008867
D05.750.078.734;Microtubule Proteins;D008868
D12.776.220.600;Microtubule Proteins;D008868
D12.776.220.600.450;Microtubule-Associated Proteins;D008869
D12.776.641.560;Microtubule-Associated Proteins;D008869
A11.284.430.214.190.750.602;Microtubules;D008870
A11.284.180.565;Microvilli;D008871
G01.358.500.505.810.500;Microwaves;D008872
G01.750.250.810.500;Microwaves;D008872
G01.750.770.721.500;Microwaves;D008872
Z01.107.567.875.500;Mid-Atlantic Region;D008873
D03.438.079.080.575;Midazolam;D008874
M01.060.116.630;Middle Aged;D008875
E04.579.592;Middle Ear Ventilation;D008876
E04.580.450.472;Middle Ear Ventilation;D008876
Z01.252.245.500;Middle East;D008877
Z01.586.500;Middle East;D008877
C08.381.730.542;Middle Lobe Syndrome;D008878
D02.033.100.291.480;Midodrine;D008879
D02.092.063.291.480;Midodrine;D008879
H02.478.676.416;Midwifery;D008880
C10.228.140.546.399.750;Migraine Disorders;D008881
C07.465.815.355;Mikulicz' Disease;D008882
C17.800.946.492;Miliaria;D008883
F04.754.864.392;Milieu Therapy;D008884
H02.163.592;Military Dentistry;D008885
N06.850.670.300;Military Hygiene;D008886
H02.403.500;Military Medicine;D008887
H02.478.676.458;Military Nursing;D008888
M01.526.625;Military Personnel;D008889
F04.096.544.480;Military Psychiatry;D008890
H02.403.690.508;Military Psychiatry;D008890
J01.675;Military Science;D008891
A12.200.455;Milk;D008892
J02.200.700;Milk;D008892
J02.500.350.525;Milk;D008892
G08.686.702.500.460;Milk Ejection;D008893
G08.686.785.420.460;Milk Ejection;D008893
D12.776.256.626;Milk Proteins;D008894
J02.500.350.525.520;Milk Proteins;D008894
J02.500.428.626;Milk Proteins;D008894
A12.200.467;Milk, Human;D008895
J02.200.700.500;Milk, Human;D008895
J02.500.350.525.500;Milk, Human;D008895
B01.650.940.800.575.100.822.680;Panicum;D008897
J02.500.200.733;Panicum;D008897
J02.500.300.100.606;Panicum;D008897
D03.383.725.791.550;Mimosine;D008898
D12.125.042.500;Mimosine;D008898
D02.455.699.500;Mineral Oil;D008899
D01.455.900.600;Mineral Waters;D008900
D01.650.550.925.600;Mineral Waters;D008900
D27.505.696.399.472.673;Mineralocorticoids;D008901
D01.578;Minerals;D008903
J01.897.520;Miniaturization;D008904
L01.224.230.260.580;Minicomputers;D008905
J01.576.370.500;Mining;D008906
B01.050.150.900.649.147.550.500;Mink;D008907
B04.820.650.375.525.580;Mink Cell Focus-Inducing Viruses;D008908
B04.909.574.807.375.525.580;Mink Cell Focus-Inducing Viruses;D008908
B04.909.777.731.375.525.580;Mink Cell Focus-Inducing Viruses;D008908
Z01.107.567.875.350.510;Minnesota;D008910
Z01.107.567.875.510.510;Minnesota;D008910
D02.455.426.559.847.562.900.550;Minocycline;D008911
D04.615.562.900.550;Minocycline;D008911
G05.360.340.024.380.625;Minor Histocompatibility Loci;D008912
G12.500.530;Minor Histocompatibility Loci;D008912
I01.880.371;Minority Groups;D008913
D03.383.621.493;Minoxidil;D008914
D03.383.742.418;Minoxidil;D008914
B04.280.580.650.600.550;Minute virus of mice;D008915
B04.909.204.671.650.600.550;Minute virus of mice;D008915
D27.505.696.663.050.495;Miotics;D008916
D02.455.526.439.659;Mirex;D008917
E05;Investigative Techniques;D008919
D02.640.672.530;Misonidazole;D008920
D03.383.129.308.658.530;Misonidazole;D008920
M01.526.682;Missions and Missionaries;D008921
N02.720;Missions and Missionaries;D008921
Z01.107.567.875.750.500;Mississippi;D008922
Z01.107.567.875.510.515;Missouri;D008923
C03.858.211.480;Mite Infestations;D008924
B01.050.500.131.166.132.419;Mites;D008925
D02.455.426.559.847.562.050.650;Plicamycin;D008926
D04.615.562.050.650;Plicamycin;D008926
D09.408.051.059.650;Plicamycin;D008926
D02.033.800.609.500;Mitobronitol;D008927
D09.853.609.500;Mitobronitol;D008927
A11.284.430.214.190.875.564;Mitochondria;D008928
A11.284.835.626;Mitochondria;D008928
A11.284.430.214.190.875.564.627.603;Mitochondria, Heart;D008929
A11.284.835.626.627.603;Mitochondria, Heart;D008929
A11.284.430.214.190.875.564.461;Mitochondria, Liver;D008930
A11.284.835.626.461;Mitochondria, Liver;D008930
A11.284.430.214.190.875.564.627;Mitochondria, Muscle;D008931
A11.284.835.626.627;Mitochondria, Muscle;D008931
G04.299.580;Mitochondrial Swelling;D008933
D27.505.519.593.624;Mitogens;D008934
D02.078.370.600;Mitoguazone;D008935
D02.033.800.400.500;Mitolactol;D008936
D09.853.400.500;Mitolactol;D008936
D02.806.400.249;Mitomycins;D008937
D03.383.097.500;Mitomycins;D008937
D03.438.473.412.249;Mitomycins;D008937
G04.299.134.220.220.781;Mitosis;D008938
G05.355.105.220.781;Mitosis;D008938
D02.455.526.439.681;Mitotane;D008939
E01.370.225.500.385.500;Mitotic Index;D008940
E05.200.500.385.500;Mitotic Index;D008940
E05.242.385.500;Mitotic Index;D008940
A11.284.430.214.190.750.610;Mitotic Spindle Apparatus;D008941
D02.455.426.559.847.117.159.500;Mitoxantrone;D008942
D02.806.100.500;Mitoxantrone;D008942
D04.615.117.159.500;Mitoxantrone;D008942
A07.541.510.507;Mitral Valve;D008943
C14.280.484.461;Mitral Valve Insufficiency;D008944
C14.280.484.400.500;Mitral Valve Prolapse;D008945
C14.280.484.517;Mitral Valve Stenosis;D008946
C17.300.540;Mixed Connective Tissue Disease;D008947
C04.557.435.090;Adenoma, Pleomorphic;D008949
C04.557.470.035.155;Adenoma, Pleomorphic;D008949
F04.711.647.513.607;MMPI;D008950
D23.050.301.290.606;MNSs Blood-Group System;D008951
D23.050.705.230.606;MNSs Blood-Group System;D008951
N02.421.143.827.233.628;Mobile Health Units;D008952
N02.421.726.233.628;Mobile Health Units;D008952
J01.897.280.500.545.129;Models, Anatomic;D008953
L01.178.820.090.545.129;Models, Anatomic;D008953
E05.599.395;Models, Biological;D008954
E05.599.395.161;Models, Cardiovascular;D008955
E05.599.495;Models, Chemical;D008956
E05.599.395.397;Models, Genetic;D008957
E05.599.595;Models, Molecular;D008958
E05.599.395.642;Models, Neurological;D008959
E05.599.695;Models, Psychological;D008960
J01.897.280.500.545;Models, Structural;D008961
L01.178.820.090.545;Models, Structural;D008961
E05.599;Models, Theoretical;D008962
A14.549.167.860.525;Molar;D008963
A14.549.167.860.525.500;Molar, Third;D008964
J02.500.662;Molasses;D008965
Z01.542.248.540;Moldova;D008966
Z01.586.200.540;Moldova;D008966
Z01.586.950.540;Moldova;D008966
H01.158.201.636;Molecular Biology;D008967
H01.158.273.343.595;Molecular Biology;D008967
H01.181.122.650;Molecular Biology;D008967
G02.111.570.790;Molecular Conformation;D008968
G02.575.500;Molecular Conformation;D008968
G02.842.575.500;Molecular Conformation;D008968
L01.453.245.667;Molecular Sequence Data;D008969
G02.842.580;Molecular Weight;D008970
B01.050.150.900.649.473.450;Moles;D008971
D03.438.473.629;Molindone;D008972
B03.440.860;Tenericutes;D008973
B01.050.500.644;Mollusca;D008974
D27.720.031.700.596;Molluscacides;D008975
D27.720.723.596;Molluscacides;D008975
D27.888.723.596;Molluscacides;D008975
C02.256.743.611;Molluscum Contagiosum;D008976
C02.825.550;Molluscum Contagiosum;D008976
C17.800.838.790.550;Molluscum Contagiosum;D008976
B04.280.650.160.550.500;Molluscum contagiosum virus;D008977
B04.909.204.783.160.550.500;Molluscum contagiosum virus;D008977
D20.888.590;Mollusk Venoms;D008978
D23.946.580.590;Mollusk Venoms;D008978
D23.946.833.590;Mollusk Venoms;D008978
B04.820.650.375.525.596;Moloney murine leukemia virus;D008979
B04.909.574.807.375.525.596;Moloney murine leukemia virus;D008979
B04.909.777.731.375.525.596;Moloney murine leukemia virus;D008979
B04.265.600.600;Moloney murine sarcoma virus;D008980
B04.820.650.375.860.600;Moloney murine sarcoma virus;D008980
B04.909.574.807.375.860.600;Moloney murine sarcoma virus;D008980
B04.909.777.731.375.860.600;Moloney murine sarcoma virus;D008980
D03.383.129.462.580.693.450;Molsidomine;D008981
D03.383.533.640.362;Molsidomine;D008981
D01.268.556.555;Molybdenum;D008982
D01.268.956.500;Molybdenum;D008982
D01.552.544.555;Molybdenum;D008982
D08.811.682.647.550;Molybdoferredoxin;D008983
D12.776.097.350.450;Molybdoferredoxin;D008983
D12.776.157.427.374.375.275.450;Molybdoferredoxin;D008983
D12.776.556.579.374.375.275.450;Molybdoferredoxin;D008983
Z01.542.616;Monaco;D008984
D03.383.312.600;Monensin;D008985
Z01.252.474.651;Mongolia;D008986
B01.050.150.900.649.147.400;Herpestidae;D008988
C03.335.190.628;Monieziasis;D008989
C03.335.349.656;Monieziasis;D008989
C03.701.377.656;Monieziasis;D008989
C22.674.377.656;Monieziasis;D008989
B01.050.500.500.132.546;Moniliformis;D008990
E01.370.520;Monitoring, Physiologic;D008991
C22.735.500;Monkey Diseases;D008992
B04.280.650.160.650.500;Monkeypox virus;D008993
B04.909.204.783.160.650.500;Monkeypox virus;D008993
D08.811.277.352.100.500;Monoacylglycerol Lipases;D008994
D08.811.682.664.750;Monoamine Oxidase;D008995
D27.505.519.389.616;Monoamine Oxidase Inhibitors;D008996
D02.065.589.099.500;Monobactams;D008997
D02.886.108.500;Monobactams;D008997
D03.383.411.350;Monobactams;D008997
D04.075.080.875.099.221.500;Monobactams;D008997
C15.378.147.542.640;Monoclonal Gammopathy of Undetermined Significance;D008998
C20.683.460.640;Monoclonal Gammopathy of Undetermined Significance;D008998
C20.683.780.640;Monoclonal Gammopathy of Undetermined Significance;D008998
D02.705.400.550;Monocrotophos;D008999
A11.118.637.555.652;Monocytes;D009000
A11.148.580;Monocytes;D009000
A11.627.624;Monocytes;D009000
A11.733.547;Monocytes;D009000
A15.145.229.637.555.652;Monocytes;D009000
A15.378.316.580;Monocytes;D009000
A15.382.490.555.652;Monocytes;D009000
A15.382.680.547;Monocytes;D009000
A15.382.812.547;Monocytes;D009000
D02.442.600.601;Monomethylhydrazine;D009002
D12.776.157.530.500;Monosaccharide Transport Proteins;D009004
D12.776.543.585.500;Monosaccharide Transport Proteins;D009004
D09.546;Monosaccharides;D009005
C23.550.210.050.500;Monosomy;D009006
G05.365.590.175.050.500;Monosomy;D009006
G05.700.131.500;Monosomy;D009006
B01.050.150.900.649.627;Monotremata;D009007
C16.131.085;Abnormalities, Severe Teratoid;D009008
Z01.107.567.875.560.500;Montana;D009009
E05.318.740.525;Monte Carlo Method;D009010
L01.906.575.422;Monte Carlo Method;D009010
N05.715.360.750.540;Monte Carlo Method;D009010
N06.850.520.830.525;Monte Carlo Method;D009010
C26.404.937.547;Monteggia's Fracture;D009011
D03.383.742.430;Mopidamol;D009012
F01.829.477;Morale;D009013
F01.829.500;Morals;D009014
K01.316.630;Morals;D009014
K01.752.256.547;Morals;D009014
D02.886.778.440;Morantel;D009015
D03.383.742.440;Morantel;D009015
D03.383.903.440;Morantel;D009015
B03.440.400.425.537.525;Moraxella;D009016
B03.660.250.530.525;Moraxella;D009016
E05.318.308.985.525;Morbidity;D009017
L01.280.975.525;Morbidity;D009017
N01.224.935.597;Morbidity;D009017
N06.850.505.400.975.525;Morbidity;D009017
N06.850.520.308.985.525;Morbidity;D009017
Z01.058.266.629;Morocco;D009018
D03.132.577.249;Morphinans;D009019
D03.549.686;Morphinans;D009019
D03.605.497;Morphinans;D009019
D04.615.723.795;Morphinans;D009019
D03.132.577.249.547;Morphine;D009020
D03.549.686.575;Morphine;D009020
D03.605.497.575;Morphine;D009020
D04.615.723.795.547;Morphine;D009020
C25.675.600;Morphine Dependence;D009021
F03.900.675.600;Morphine Dependence;D009021
D03.132.577.249.547.547;Morphine Derivatives;D009022
D03.549.686.575.547;Morphine Derivatives;D009022
D03.605.497.575.547;Morphine Derivatives;D009022
D04.615.723.795.547.547;Morphine Derivatives;D009022
G07.700.320.500;Morphogenesis;D009024
D03.383.533.640;Morpholines;D009025
E05.318.308.985.550;Mortality;D009026
L01.280.975.550;Mortality;D009026
N01.224.935.698;Mortality;D009026
N06.850.505.400.975.550;Mortality;D009026
N06.850.520.308.985.550;Mortality;D009026
H02.438;Mortuary Practice;D009027
A16.615;Morula;D009028
B04.715.464;Mosaic Viruses;D009029
B04.820.464;Mosaic Viruses;D009029
G05.365.590.175.595;Mosaicism;D009030
Z01.433.653;Moscow;D009031
Z01.542.248.775.510;Moscow;D009031
Z01.586.200.775.510;Moscow;D009031
Z01.586.950.775.510;Moscow;D009031
N06.850.780.200.650.425.500;Mosquito Control;D009032
B01.050.500.131.617.289.275;Culicidae;D009033
F01.829.263.370.290.170;Mother-Child Relations;D009034
F01.829.263.500.320.200;Mothers;D009035
I01.880.225.500.340.270;Mothers;D009035
M01.620.630;Mothers;D009035
B01.050.500.131.617.561.650;Moths;D009036
D06.472.317.525;Motilin;D009037
D06.472.699.500;Motilin;D009037
D12.644.400.470;Motilin;D009037
D12.644.548.500;Motilin;D009037
D12.776.641.650.463;Motilin;D009037
G01.595.560;Motion;D009038
F02.463.593.932.567;Motion Perception;D009039
J01.897.280.500.598;Motion Pictures as Topic;D009040
L01.178.590.500;Motion Pictures as Topic;D009040
L01.178.820.090.598;Motion Pictures as Topic;D009040
C23.888.571;Motion Sickness;D009041
F01.658;Motivation;D009042
F01.752.543.500.750;Motivation;D009042
F01.145.632;Motor Activity;D009043
G11.427.590.530.698;Motor Activity;D009043
A08.186.211.730.885.287.500.270.548;Motor Cortex;D009044
A08.800.550.550.550.500;Motor Endplate;D009045
A08.850.550.550.500;Motor Endplate;D009045
A11.284.149.165.420.780.550.550.500;Motor Endplate;D009045
A08.663.655.500;Motor Neurons;D009046
A11.671.655.500;Motor Neurons;D009046
A08.663.655.500.525;Motor Neurons, Gamma;D009047
A11.671.655.500.525;Motor Neurons, Gamma;D009047
F02.808.260;Motor Skills;D009048
J01.937.500.500;Motorcycles;D009049
C07.793.330;Fluorosis, Dental;D009050
I03.450.642.845.582;Mountaineering;D009051
B04.820.650.375.525;Leukemia Virus, Murine;D009052
B04.909.574.807.375.525;Leukemia Virus, Murine;D009052
B04.909.777.731.375.525;Leukemia Virus, Murine;D009052
B04.265.600;Sarcoma Viruses, Murine;D009053
B04.820.650.375.860;Sarcoma Viruses, Murine;D009053
B04.909.574.807.375.860;Sarcoma Viruses, Murine;D009053
B04.909.777.731.375.860;Sarcoma Viruses, Murine;D009053
A01.456.505.631;Mouth;D009055
A03.556.500;Mouth;D009055
A14.549;Mouth;D009055
C07.465.525;Mouth Abnormalities;D009056
C07.650.525;Mouth Abnormalities;D009056
C16.131.850.525;Mouth Abnormalities;D009056
C07;Stomatognathic Diseases;D009057
C08.618.659;Mouth Breathing;D009058
C23.888.852.761;Mouth Breathing;D009058
C07.465;Mouth Diseases;D009059
A14.549.441;Mouth Floor;D009060
A10.615.550.599;Mouth Mucosa;D009061
A14.549.512;Mouth Mucosa;D009061
C04.588.443.591;Mouth Neoplasms;D009062
C07.465.565;Mouth Neoplasms;D009062
G10.549;Dental Physiological Phenomena;D009063
E06.761.599;Mouth Protectors;D009064
E07.700.520;Mouth Protectors;D009064
J01.637.708.520;Mouth Protectors;D009064
E06.584;Mouth Rehabilitation;D009065
C07.465.550;Mouth, Edentulous;D009066
C07.793.597;Mouth, Edentulous;D009066
D25.583;Mouthwashes;D009067
D27.720.102.583;Mouthwashes;D009067
D27.720.269.583;Mouthwashes;D009067
J01.637.051.583;Mouthwashes;D009067
G07.700.560;Movement;D009068
G11.427.590.530;Movement;D009068
C10.228.662;Movement Disorders;D009069
D02.065.589.099.625;Moxalactam;D009070
D02.886.520.575;Moxalactam;D009070
D04.075.080.875.099.221.625;Moxalactam;D009070
E02.190.044.588;Moxibustion;D009071
C10.228.140.300.200.600;Moyamoya Disease;D009072
C10.228.140.300.510.200.737;Moyamoya Disease;D009072
C14.907.137.615;Moyamoya Disease;D009072
C14.907.253.123.620;Moyamoya Disease;D009072
C14.907.253.560.200.737;Moyamoya Disease;D009072
Z01.058.290.175.545;Mozambique;D009073
D06.472.699.327.935.531.750;Melanocyte-Stimulating Hormones;D009074
D06.472.699.631.525.600.531.750;Melanocyte-Stimulating Hormones;D009074
D12.644.400.400.935.531.750;Melanocyte-Stimulating Hormones;D009074
D12.644.400.460;Melanocyte-Stimulating Hormones;D009074
D12.644.548.365.935.531.750;Melanocyte-Stimulating Hormones;D009074
D12.644.548.691.525.690.531.750;Melanocyte-Stimulating Hormones;D009074
D12.776.641.650.405.935.531.750;Melanocyte-Stimulating Hormones;D009074
D12.776.641.650.460;Melanocyte-Stimulating Hormones;D009074
D06.472.699.327.700.500;MSH Release-Inhibiting Hormone;D009075
D12.644.400.400.700.500;MSH Release-Inhibiting Hormone;D009075
D12.644.548.365.700.500;MSH Release-Inhibiting Hormone;D009075
D12.776.641.650.405.700.500;MSH Release-Inhibiting Hormone;D009075
D12.776.395.560.631;Mucins;D009077
C04.182.511;Mucocele;D009078
E01.370.386.520;Mucociliary Clearance;D009079
G09.772.770.580;Mucociliary Clearance;D009079
C14.907.940.560;Mucocutaneous Lymph Node Syndrome;D009080
C15.604.560;Mucocutaneous Lymph Node Syndrome;D009080
C17.800.862.560;Mucocutaneous Lymph Node Syndrome;D009080
C05.116.198.371;Mucolipidoses;D009081
C10.228.140.163.100.435.590;Mucolipidoses;D009081
C16.320.565.189.435.590;Mucolipidoses;D009081
C16.320.565.202.670;Mucolipidoses;D009081
C16.320.565.595.554.590;Mucolipidoses;D009081
C18.452.132.100.435.590;Mucolipidoses;D009081
C18.452.648.189.435.590;Mucolipidoses;D009081
C18.452.648.202.670;Mucolipidoses;D009081
C18.452.648.595.554.590;Mucolipidoses;D009081
C16.320.565.202.715;Mucopolysaccharidoses;D009083
C16.320.565.595.600;Mucopolysaccharidoses;D009083
C17.300.550.575;Mucopolysaccharidoses;D009083
C18.452.648.202.715;Mucopolysaccharidoses;D009083
C18.452.648.595.600;Mucopolysaccharidoses;D009083
C16.320.565.202.715.650;Mucopolysaccharidosis III;D009084
C16.320.565.595.600.650;Mucopolysaccharidosis III;D009084
C17.300.550.575.650;Mucopolysaccharidosis III;D009084
C18.452.648.202.715.650;Mucopolysaccharidosis III;D009084
C18.452.648.595.600.650;Mucopolysaccharidosis III;D009084
C16.320.565.202.715.655;Mucopolysaccharidosis IV;D009085
C16.320.565.595.600.655;Mucopolysaccharidosis IV;D009085
C17.300.550.575.655;Mucopolysaccharidosis IV;D009085
C18.452.648.202.715.655;Mucopolysaccharidosis IV;D009085
C18.452.648.595.600.655;Mucopolysaccharidosis IV;D009085
C16.320.565.202.715.670;Mucopolysaccharidosis VI;D009087
C16.320.565.595.600.670;Mucopolysaccharidosis VI;D009087
C17.300.550.575.670;Mucopolysaccharidosis VI;D009087
C18.452.648.202.715.670;Mucopolysaccharidosis VI;D009087
C18.452.648.595.600.670;Mucopolysaccharidosis VI;D009087
D12.776.395.560;Mucoproteins;D009088
B01.300.300.500.500;Mucor;D009089
B01.300.300.500;Mucorales;D009090
C01.703.980.600;Mucormycosis;D009091
A10.615.550;Mucous Membrane;D009092
A12.200.503;Mucus;D009093
E02.056.610;Mud Therapy;D009094
E02.779.249.610;Mud Therapy;D009094
A16.623;Mullerian Ducts;D009095
N04.452.540;Multi-Institutional Systems;D009096
D05.500.562;Multienzyme Complexes;D009097
D08.811.600;Multienzyme Complexes;D009097
E01.370.500.540;Multiphasic Screening;D009098
E05.318.308.250.580.560;Multiphasic Screening;D009098
N02.421.143.827.233.443.633;Multiphasic Screening;D009098
N02.421.726.233.443.633;Multiphasic Screening;D009098
N05.715.360.300.375.500.540;Multiphasic Screening;D009098
N06.850.520.308.250.580.560;Multiphasic Screening;D009098
N06.850.780.500.560;Multiphasic Screening;D009098
M01.438;Multiple Birth Offspring;D009099
C16.320.565.100.620;Multiple Carboxylase Deficiency;D009100
C16.320.565.202.720;Multiple Carboxylase Deficiency;D009100
C18.452.648.100.620;Multiple Carboxylase Deficiency;D009100
C18.452.648.202.720;Multiple Carboxylase Deficiency;D009100
C04.557.595.500;Multiple Myeloma;D009101
C14.907.454.460;Multiple Myeloma;D009101
C15.378.147.780.650;Multiple Myeloma;D009101
C15.378.463.515.460;Multiple Myeloma;D009101
C20.683.515.845;Multiple Myeloma;D009101
C20.683.780.650;Multiple Myeloma;D009101
C23.550.835.525;Multiple Organ Failure;D009102
C10.114.375.500;Multiple Sclerosis;D009103
C10.314.350.500;Multiple Sclerosis;D009103
C20.111.258.250.500;Multiple Sclerosis;D009103
C26.640;Multiple Trauma;D009104
F03.300.500;Multiple Personality Disorder;D009105
I01.076.368.584.500;Mummies;D009106
C02.782.580.600.680.500;Mumps;D009107
C07.465.815.470.800.630;Mumps;D009107
D20.215.894.899.488;Mumps Vaccine;D009108
B04.820.455.600.650.750.550;Mumps virus;D009109
B04.909.777.455.600.650.750.550;Mumps virus;D009109
F03.400.600;Munchausen Syndrome;D009110
I01.409.700;Local Government;D009111
N03.540.348.750;Local Government;D009111
D02.241.081.844.520;Muramic Acids;D009112
D02.241.511.902.522;Muramic Acids;D009112
D09.067.550;Muramic Acids;D009112
D09.811.522;Muramic Acids;D009112
D08.811.277.450.642;Muramidase;D009113
D03.383.742.698.253.500;Murexide;D009114
B01.050.150.900.649.865.635;Muridae;D009115
D02.092.877.883.777;Muscarine;D009116
D02.675.276.580;Muscarine;D009116
D03.132.545;Muscarine;D009116
B01.050.500.131.617.289.642;Muscidae;D009117
D03.383.129.462.470;Muscimol;D009118
D23.946.587.587;Muscimol;D009118
G11.427.590.540;Muscle Contraction;D009119
C05.651.475;Muscle Cramp;D009120
C10.597.613.500;Muscle Cramp;D009120
C23.888.592.608.500;Muscle Cramp;D009120
E04.525.210.500;Muscle Denervation;D009121
C10.597.613.550;Muscle Hypertonia;D009122
C23.888.592.608.550;Muscle Hypertonia;D009122
C10.597.613.575;Muscle Hypotonia;D009123
C23.888.592.608.575;Muscle Hypotonia;D009123
D12.776.210.500;Muscle Proteins;D009124
D27.505.696.510;Muscle Relaxants, Central;D009125
D27.505.696.663.700.600;Muscle Relaxants, Central;D009125
D27.505.954.427.525;Muscle Relaxants, Central;D009125
G11.427.590.540.554;Muscle Relaxation;D009126
C05.651.504;Muscle Rigidity;D009127
C10.597.613.550.500;Muscle Rigidity;D009127
C23.888.592.608.550.500;Muscle Rigidity;D009127
C05.651.512;Muscle Spasticity;D009128
C10.597.613.550.550;Muscle Spasticity;D009128
C23.888.592.608.550.550;Muscle Spasticity;D009128
G11.427.565;Muscle Tonus;D009129
A02.633.570;Muscle, Smooth;D009130
A10.690.467;Muscle, Smooth;D009130
A02.633.570.491;Muscle, Smooth, Vascular;D009131
A07.231.491;Muscle, Smooth, Vascular;D009131
A10.690.467.491;Muscle, Smooth, Vascular;D009131
A02.633;Muscles;D009132
A10.690;Muscles;D009132
C10.597.613.612;Muscular Atrophy;D009133
C23.300.070.500;Muscular Atrophy;D009133
C23.888.592.608.612;Muscular Atrophy;D009133
C10.228.854.468;Muscular Atrophy, Spinal;D009134
C10.574.562.500;Muscular Atrophy, Spinal;D009134
C10.668.467.500;Muscular Atrophy, Spinal;D009134
C10.668.475;Muscular Atrophy, Spinal;D009134
C05.651;Muscular Diseases;D009135
C10.668.491;Muscular Diseases;D009135
C05.651.534.500;Muscular Dystrophies;D009136
C10.668.491.175.500;Muscular Dystrophies;D009136
C16.320.577;Muscular Dystrophies;D009136
C22.595;Muscular Dystrophy, Animal;D009137
A08.800.800.720.050.540;Musculocutaneous Nerve;D009138
C05.660;Musculoskeletal Abnormalities;D009139
C16.131.621;Musculoskeletal Abnormalities;D009139
C05;Musculoskeletal Diseases;D009140
A02;Musculoskeletal System;D009141
G11.427;Musculoskeletal Physiological Phenomena;D009142
K01.400.152.552;Museums;D009144
C25.723.415.551;Mushroom Poisoning;D009145
C25.723.680.551;Mushroom Poisoning;D009145
K01.602;Music;D009146
E02.190.888.500;Music Therapy;D009147
E02.831.440;Music Therapy;D009147
F04.754.549;Music Therapy;D009147
B01.650.940.800.575.100.157.200.500;Mustard Plant;D009149
J02.500.300.100.575;Mustard Plant;D009149
J02.500.850.537;Mustard Plant;D009149
D02.455.526.728;Mustard Compounds;D009150
D02.455.526.728.468;Mustard Gas;D009151
E05.393.560;Mutagenicity Tests;D009152
E05.940.560;Mutagenicity Tests;D009152
D27.888.569.468;Mutagens;D009153
G05.365.590;Mutation;D009154
C10.597.606.150.500.800.500;Mutism;D009155
C23.888.592.604.150.500.800.500;Mutism;D009155
F03.550.700;Mutism;D009155
D03.383.129.539.550;Muzolimine;D009156
C10.114.656;Myasthenia Gravis;D009157
C10.668.758.725;Myasthenia Gravis;D009157
C20.111.258.500;Myasthenia Gravis;D009157
D04.345.566.515;Mycobacillin;D009158
D12.644.641.515;Mycobacillin;D009158
B03.510.024.049.525;Mycobacteriaceae;D009159
B03.510.460.400.410.552;Mycobacteriaceae;D009159
B04.123.502;Mycobacteriophages;D009160
B03.510.024.049.525.500;Mycobacterium;D009161
B03.510.460.400.410.552.552;Mycobacterium;D009161
B03.510.024.049.525.500.300;Mycobacterium avium;D009162
B03.510.460.400.410.552.552.300;Mycobacterium avium;D009162
B03.510.024.049.525.500.402;Mycobacterium bovis;D009163
B03.510.460.400.410.552.552.402;Mycobacterium bovis;D009163
C01.252.410.040.552;Mycobacterium Infections;D009164
C01.252.410.040.552.475;Mycobacterium Infections, Nontuberculous;D009165
B03.510.024.049.525.500.502;Mycobacterium leprae;D009166
B03.510.460.400.410.552.552.502;Mycobacterium leprae;D009166
B03.510.024.049.525.500.602;Mycobacterium lepraemurium;D009167
B03.510.460.400.410.552.552.602;Mycobacterium lepraemurium;D009167
B03.510.024.049.525.500.640;Mycobacterium phlei;D009168
B03.510.460.400.410.552.552.640;Mycobacterium phlei;D009168
B03.510.024.049.525.500.702;Mycobacterium tuberculosis;D009169
B03.510.460.400.410.552.552.702;Mycobacterium tuberculosis;D009169
B03.510.024.049.525.500.720;Nontuberculous Mycobacteria;D009170
B03.510.460.400.410.552.552.720;Nontuberculous Mycobacteria;D009170
D02.241.511.621;Mycolic Acids;D009171
D10.251.572;Mycolic Acids;D009171
H01.158.273.540.553;Mycology;D009172
D02.241.081.193.678;Mycophenolic Acid;D009173
D10.251.618;Mycophenolic Acid;D009173
B03.440.860.580.553.553;Mycoplasma;D009174
C01.252.400.610.610;Mycoplasma Infections;D009175
B03.440.860.580.553.553.585;Mycoplasma mycoides;D009176
B03.440.860.580.553.553.650;Mycoplasma pneumoniae;D009177
B03.440.860.580.553;Mycoplasmataceae;D009178
B03.440.860.580;Mycoplasmatales;D009179
C01.252.400.610;Mycoplasmatales Infections;D009180
C01.703;Mycoses;D009181
C04.557.386.480.750.800.550;Mycosis Fungoides;D009182
C15.604.515.569.480.750.800.550;Mycosis Fungoides;D009182
C20.683.515.761.480.750.800.550;Mycosis Fungoides;D009182
D23.946.587;Mycotoxins;D009183
D27.505.696.663.050.500;Mydriatics;D009184
D12.776.543.620;Myelin Proteins;D009185
D12.776.641.580;Myelin Proteins;D009185
A08.637.600.500;Myelin Sheath;D009186
A08.637.800.500;Myelin Sheath;D009186
A08.663.542.512.560;Myelin Sheath;D009186
A08.800.800.690.500;Myelin Sheath;D009186
A10.755.503;Myelin Sheath;D009186
A11.284.149.165.600;Myelin Sheath;D009186
A11.650.600.500;Myelin Sheath;D009186
A11.650.800.500;Myelin Sheath;D009186
A11.671.514.553;Myelin Sheath;D009186
C02.182.600;Myelitis;D009187
C10.228.228.210.575;Myelitis;D009187
C10.228.228.618;Myelitis;D009187
C10.228.854.525;Myelitis;D009187
C04.588.614.550.550;Myelitis, Transverse;D009188
C04.730.856.543;Myelitis, Transverse;D009188
C10.114.375.600;Myelitis, Transverse;D009188
C10.228.854.525.553;Myelitis, Transverse;D009188
C10.314.350.600;Myelitis, Transverse;D009188
C10.574.781.625;Myelitis, Transverse;D009188
C20.111.258.250.550;Myelitis, Transverse;D009188
B04.820.650.070.110;Avian myeloblastosis virus;D009189
B04.909.574.807.070.110;Avian myeloblastosis virus;D009189
B04.909.777.731.070.110;Avian myeloblastosis virus;D009189
C15.378.190.625;Myelodysplastic Syndromes;D009190
E01.370.350.578.937.505;Myelography;D009192
E01.370.350.700.560.505;Myelography;D009192
E01.370.376.537.750.505;Myelography;D009192
E05.629.937.505;Myelography;D009192
D12.776.124.486.485.900.500;Myeloma Proteins;D009194
D12.776.124.790.651.900.500;Myeloma Proteins;D009194
D12.776.377.715.548.900.500;Myeloma Proteins;D009194
D12.776.624.553;Myeloma Proteins;D009194
D08.811.682.732.700;Peroxidase;D009195
C15.378.190.636;Myeloproliferative Disorders;D009196
A08.800.050.050.500;Myenteric Plexus;D009197
A08.800.050.150.500;Myenteric Plexus;D009197
A08.800.800.060.500;Myenteric Plexus;D009197
C03.858.211.503;Myiasis;D009198
G09.330.190.541;Myocardial Contraction;D009200
G11.427.590.540.570;Myocardial Contraction;D009200
D12.644.370;Myocardial Depressant Factor;D009201
C14.280.238;Cardiomyopathies;D009202
C14.280.647.500;Myocardial Infarction;D009203
C14.907.585.500;Myocardial Infarction;D009203
E04.100.376.719;Myocardial Revascularization;D009204
E04.928.220.520;Myocardial Revascularization;D009204
C14.280.238.625;Myocarditis;D009205
A02.633.580;Myocardium;D009206
A07.541.704;Myocardium;D009206
A10.690.552.750;Myocardium;D009206
C10.597.350.500;Myoclonus;D009207
C23.888.592.350.500;Myoclonus;D009207
C04.557.435.585;Myoepithelioma;D009208
C05.651.550;Myofascial Pain Syndromes;D009209
A10.690.552.875;Myofibrils;D009210
A11.284.430.214.190.750.620;Myofibrils;D009210
A11.620.249.850;Myofibrils;D009210
A11.620.500.500;Myofibrils;D009210
D12.776.210.500.588;Myoglobin;D009211
D12.776.422.316.940;Myoglobin;D009211
C05.651.807.628;Myoglobinuria;D009212
E01.370.530;Myography;D009213
C04.557.450.590.540;Myoma;D009214
A02.633.570.500;Myometrium;D009215
A05.360.319.679.690;Myometrium;D009215
A10.690.467.500;Myometrium;D009215
C11.744.636;Myopia;D009216
C04.557.450.590.550;Myosarcoma;D009217
C04.557.450.795.550;Myosarcoma;D009217
D05.750.078.730.475;Myosins;D009218
D08.811.277.040.025.193.750;Myosins;D009218
D12.776.210.500.600;Myosins;D009218
D12.776.220.525.475;Myosins;D009218
D08.811.913.696.620.682.700.125.500;Myosin-Light-Chain Kinase;D009219
D12.644.360.100.500;Myosin-Light-Chain Kinase;D009219
D12.776.476.100.500;Myosin-Light-Chain Kinase;D009219
C05.651.594;Myositis;D009220
C10.668.491.562;Myositis;D009220
C05.651.594.638;Myositis Ossificans;D009221
C10.597.613.700;Myotonia;D009222
C23.888.592.608.700;Myotonia;D009222
C05.651.534.500.500;Myotonic Dystrophy;D009223
C05.651.662.750;Myotonic Dystrophy;D009223
C10.574.500.547;Myotonic Dystrophy;D009223
C10.668.491.175.500.500;Myotonic Dystrophy;D009223
C10.668.491.606.750;Myotonic Dystrophy;D009223
C16.320.400.542;Myotonic Dystrophy;D009223
C16.320.577.500;Myotonic Dystrophy;D009223
C05.651.662.500;Myotonia Congenita;D009224
C10.574.500.545;Myotonia Congenita;D009224
C10.668.491.606.500;Myotonia Congenita;D009224
C16.320.400.540;Myotonia Congenita;D009224
E04.580.450.505;Myringoplasty;D009225
D10.251.640.610;Myristates;D009226
D10.251.640;Myristic Acids;D009227
K01.844.799.430;Mysticism;D009228
K01.517.647;Mythology;D009229
C17.300.550.590;Myxedema;D009230
C19.874.482.638;Myxedema;D009230
B03.660.125.500;Myxococcales;D009231
C04.557.450.565.550;Myxoma;D009232
B04.280.650.160.500.550;Myxoma virus;D009233
B04.909.204.210.600.550;Myxoma virus;D009233
B04.909.204.783.160.500.550;Myxoma virus;D009233
B04.909.574.204.600.550;Myxoma virus;D009233
C02.256.743.665;Myxomatosis, Infectious;D009234
C22.627;Myxomatosis, Infectious;D009234
B01.046.550.550;Myxomycetes;D009235
C04.557.450.565.560;Myxosarcoma;D009236
C04.557.450.795.560;Myxosarcoma;D009236
D08.811.913.400.450.400.500.100;N-Acetyllactosamine Synthase;D009237
D08.811.277.087.030;N-Acetylmuramoyl-L-alanine Amidase;D009238
D02.886.030.676.450;N-Formylmethionine;D009239
D12.125.166.676.450;N-Formylmethionine;D009239
D02.886.030.676.450.440;N-Formylmethionine Leucyl-Phenylalanine;D009240
D12.125.166.676.450.440;N-Formylmethionine Leucyl-Phenylalanine;D009240
D12.644.456.400;N-Formylmethionine Leucyl-Phenylalanine;D009240
D23.125.320.685;N-Formylmethionine Leucyl-Phenylalanine;D009240
D23.125.685;N-Formylmethionine Leucyl-Phenylalanine;D009240
D02.145.074.722.189.297.400;Ipratropium;D009241
D03.132.889.180.297.297.400;Ipratropium;D009241
D03.605.869.189.297.400;Ipratropium;D009241
D04.075.080.875.099.722.189.297.400;Ipratropium;D009241
D02.654.442.550;N-Nitrosopyrrolidine;D009242
D03.383.773.630;N-Nitrosopyrrolidine;D009242
D03.438.759.646.138.694;NAD;D009243
D08.211.589;NAD;D009243
D13.695.667.138.694;NAD;D009243
D13.695.827.068.694;NAD;D009243
D08.811.277.450.430.400;NAD+ Nucleosidase;D009244
D08.811.913.400.725.115.660;NAD+ Nucleosidase;D009244
D08.811.682.608.504.500;NADH Dehydrogenase;D009245
D12.776.157.427.374.375.863.500;NADH Dehydrogenase;D009245
D12.776.331.887;NADH Dehydrogenase;D009245
D12.776.556.579.374.375.140.500;NADH Dehydrogenase;D009245
D08.811.682.608.530;NADH Tetrazolium Reductase;D009246
D08.811.682.608;NADH, NADPH Oxidoreductases;D009247
D02.033.100.624.580;Nadolol;D009248
D02.033.100.624.698.601;Nadolol;D009248
D02.033.755.624.580;Nadolol;D009248
D02.033.755.624.698.601;Nadolol;D009248
D02.092.063.624.698.601;Nadolol;D009248
D03.438.759.646.138.749;NADP;D009249
D08.211.625;NADP;D009249
D13.695.667.138.749;NADP;D009249
D13.695.827.068.749;NADP;D009249
D08.811.682.608.540;NADP Transhydrogenases;D009250
D08.811.682.608.191.500;NADPH-Ferrihemoprotein Reductase;D009251
D08.811.682.608.550;NADPH Dehydrogenase;D009252
B01.046.500.700.710;Naegleria;D009253
D02.065.589.099.750.562;Nafcillin;D009254
D02.886.108.750.562;Nafcillin;D009254
D03.438.260.825.562;Nafcillin;D009254
D03.605.084.737.562;Nafcillin;D009254
D04.075.080.875.099.221.750.562;Nafcillin;D009254
D02.241.081.751.512;Nafenopin;D009255
D03.383.773.589;Nafoxidine;D009256
D03.383.312.620;Nafronyl;D009257
F01.145.466.554;Nail Biting;D009259
C17.800.529;Nail Diseases;D009260
C05.550.629;Nail-Patella Syndrome;D009261
C16.131.077.606;Nail-Patella Syndrome;D009261
C16.320.600;Nail-Patella Syndrome;D009261
C17.800.529.400;Nail-Patella Syndrome;D009261
A17.600;Nails;D009262
C17.800.529.406;Nails, Ingrown;D009263
C23.300.820;Nails, Malformed;D009264
C02.081.885.550;Nairobi Sheep Disease;D009265
C02.782.147.633;Nairobi Sheep Disease;D009265
C22.836.583;Nairobi Sheep Disease;D009265
D03.132.577.249.606;Nalbuphine;D009266
D03.549.686.639;Nalbuphine;D009266
D03.605.497.639;Nalbuphine;D009266
D04.615.723.795.606;Nalbuphine;D009266
D02.705.400.600;Naled;D009267
D03.438.612.500;Nalidixic Acid;D009268
D03.438.810.835.055.500;Nalidixic Acid;D009268
D03.132.577.249.656;Nalorphine;D009269
D03.549.686.694;Nalorphine;D009269
D03.605.497.694;Nalorphine;D009269
D04.615.723.795.656;Nalorphine;D009269
D03.132.577.249.706;Naloxone;D009270
D03.549.686.750;Naloxone;D009270
D03.605.497.750;Naloxone;D009270
D04.615.723.795.706;Naloxone;D009270
D03.132.577.249.706.550;Naltrexone;D009271
D03.549.686.750.550;Naltrexone;D009271
D03.605.497.750.550;Naltrexone;D009271
D04.615.723.795.706.550;Naltrexone;D009271
M01;Persons;D009272
M01.060;Age Groups;D009273
M01.526;Occupational Groups;D009274
L01.143.506.598.400.556;Names;D009275
Z01.058.290.175.580;Namibia;D009276
D04.808.365.415.638;Nandrolone;D009277
D06.472.334.851.968.976;Nandrolone;D009277
D03.383.129.308.585;Naphazoline;D009278
D02.455.426.559.847.562;Naphthacenes;D009279
D04.615.562;Naphthacenes;D009279
D02.455.426.559.847.638.472;Naphthaleneacetic Acids;D009280
D04.615.638.472;Naphthaleneacetic Acids;D009280
D02.455.426.559.847.638;Naphthalenes;D009281
D04.615.638;Naphthalenes;D009281
D02.455.426.559.847.638.555;Naphthalenesulfonates;D009282
D02.886.645.600.080.050.650;Naphthalenesulfonates;D009282
D04.615.638.555;Naphthalenesulfonates;D009282
D08.811.277.352.100.550;Naphthol AS D Esterase;D009283
D02.455.426.559.847.638.638;Naphthols;D009284
D04.615.638.638;Naphthols;D009284
D02.455.426.559.847.638.721;Naphthoquinones;D009285
D02.806.550;Naphthoquinones;D009285
D04.615.638.721;Naphthoquinones;D009285
D02.455.426.559.847.638.900;Naphthylvinylpyridine;D009286
D03.383.725.495;Naphthylvinylpyridine;D009286
D04.615.638.900;Naphthylvinylpyridine;D009286
D03.438.612;Naphthyridines;D009287
D02.455.426.559.847.638.472.500;Naproxen;D009288
D04.615.638.472.450;Naproxen;D009288
F02.739.794.582;Narcissism;D009289
C10.886.425.800.200.750;Narcolepsy;D009290
F03.870.400.800.200.750;Narcolepsy;D009290
F04.570.505.557;Narcotherapy;D009291
D27.505.696.543;Narcotic Antagonists;D009292
D27.505.696.663.850.512;Narcotic Antagonists;D009292
D27.505.954.427.550;Narcotic Antagonists;D009292
C25.675;Opioid-Related Disorders;D009293
F03.900.675;Opioid-Related Disorders;D009293
D27.505.696.277.600;Narcotics;D009294
D27.505.696.663.850.014.760;Narcotics;D009294
D27.505.954.427.040.550;Narcotics;D009294
D27.505.954.427.210.600;Narcotics;D009294
A02.835.232.781.324.665;Nasal Bone;D009295
A04.531.378;Nasal Bone;D009295
A04.531.449;Nasal Cavity;D009296
A04.531.520;Nasal Mucosa;D009297
A04.760.600;Nasal Mucosa;D009297
A10.615.550.760.600;Nasal Mucosa;D009297
C08.460.572;Nasal Polyps;D009298
C09.603.557;Nasal Polyps;D009298
C23.300.825.557;Nasal Polyps;D009298
E01.370.386.550;Nasal Provocation Tests;D009299
A04.531.591;Nasal Septum;D009300
A09.371.463.640;Nasolacrimal Duct;D009301
C07.550.350;Nasopharyngeal Diseases;D009302
C09.775.350;Nasopharyngeal Diseases;D009302
C04.588.443.665.710.650;Nasopharyngeal Neoplasms;D009303
C07.550.350.650;Nasopharyngeal Neoplasms;D009303
C07.550.745.650;Nasopharyngeal Neoplasms;D009303
C09.647.710.650;Nasopharyngeal Neoplasms;D009303
C09.775.350.650;Nasopharyngeal Neoplasms;D009303
C09.775.549.650;Nasopharyngeal Neoplasms;D009303
C07.550.350.700;Nasopharyngitis;D009304
C07.550.781.500;Nasopharyngitis;D009304
C08.730.561.500;Nasopharyngitis;D009304
C09.775.350.700;Nasopharyngitis;D009304
C09.775.649.500;Nasopharyngitis;D009304
A04.623.557;Nasopharynx;D009305
A14.724.557;Nasopharynx;D009305
A14.549.167.860.700.500;Natal Teeth;D009306
N03.540.608;National Academy of Sciences (U.S.);D009307
I01.409.137.500.600.650.400;National Center for Health Care Technology (U.S.);D009308
N03.540.348.500.500.600.650.400;National Center for Health Care Technology (U.S.);D009308
I01.409.137.500.600.650.425;National Center for Health Statistics (U.S.);D009309
N03.540.348.500.500.600.650.425;National Center for Health Statistics (U.S.);D009309
N03.219.521.576.343.900;National Health Insurance, United States;D009310
N03.349.550.610;National Health Insurance, United States;D009310
I01.409.137.500.600.650.790.525;National Health Planning Information Center (U.S.);D009312
N03.540.348.500.500.600.650.790.525;National Health Planning Information Center (U.S.);D009312
N03.349.550;National Health Programs;D009313
I01.409.137.500.600.650.225.520;National Institute for Occupational Safety and Health (U.S.);D009314
N03.540.348.500.500.600.650.225.520;National Institute for Occupational Safety and Health (U.S.);D009314
I01.409.137.500.600.480.460;National Institute of Mental Health (U.S.);D009315
N03.540.348.500.500.600.480.460;National Institute of Mental Health (U.S.);D009315
I01.409.137.500.600.480;National Institutes of Health (U.S.);D009316
N03.540.348.500.500.600.480;National Institutes of Health (U.S.);D009316
I01.409.137.500.600.480.490;National Library of Medicine (U.S.);D009317
L01.346.596.563.725;National Library of Medicine (U.S.);D009317
N03.540.348.500.500.600.480.490;National Library of Medicine (U.S.);D009317
G08.852.796.241.557;Natriuresis;D009318
D06.472.699.584.500;Atrial Natriuretic Factor;D009320
D12.644.548.585.500;Atrial Natriuretic Factor;D009320
G08.686.785.760.769.490.249;Natural Childbirth;D009321
L01.224.065.580;Natural Language Processing;D009323
E02.190.655;Naturopathy;D009324
C23.888.821.712;Nausea;D009325
H02.403.560;Naval Medicine;D009326
D03.383.129.462.580.400;4-Chloro-7-nitrobenzofurazan;D009327
D09.408.051.476.600;Nebramycin;D009328
Z01.107.567.875.510.520;Nebraska;D009329
E07.605;Nebulizers and Vaporizers;D009330
E07.858.400;Nebulizers and Vaporizers;D009330
B01.050.500.500.294.700.775.100.550;Necator;D009331
C03.335.508.700.775.455.683;Necatoriasis;D009332
A01.598;Neck;D009333
A02.633.567.650;Neck Muscles;D009334
C17.300.200.495.545;Necrobiosis Lipoidica;D009335
C17.800.550.545;Necrobiosis Lipoidica;D009335
C17.800.849.495;Necrobiosis Lipoidica;D009335
C18.452.880.495;Necrobiosis Lipoidica;D009335
C23.550.717;Necrosis;D009336
G04.299.139.638;Necrosis;D009336
B01.050.150.900.090.608.630.510;Necturus;D009337
B01.050.150.900.090.608.630.510.508;Necturus maculosus;D009338
E07.612;Needles;D009339
D03.383.113.767.500;Nefopam;D009340
F01.752.698;Negativism;D009341
B03.440.400.425.550.550;Neisseria;D009343
B03.660.075.525.520;Neisseria;D009343
B03.440.400.425.550.550.474;Neisseria gonorrhoeae;D009344
B03.660.075.525.520.400;Neisseria gonorrhoeae;D009344
B03.440.400.425.550.550.641;Neisseria meningitidis;D009345
B03.660.075.525.520.500;Neisseria meningitidis;D009345
B03.440.400.425.550;Neisseriaceae;D009346
B03.660.075.525;Neisseriaceae;D009346
C04.588.322.609.145.500;Nelson Syndrome;D009347
C10.228.140.617.738.675.149.500;Nelson Syndrome;D009347
C19.344.609.145.500;Nelson Syndrome;D009347
C19.700.734.145.500;Nelson Syndrome;D009347
B01.050.500.500.294;Nematoda;D009348
C03.335.508;Nematode Infections;D009349
B01.050.500.500.294.700.775.400.550.275;Nematospiroides dubius;D009351
D02.455.326.271.244.500;Zinostatin;D009353
D02.455.326.397.662.500.500.500;Zinostatin;D009353
D01.268.477.625;Neodymium;D009354
D01.268.558.362.625;Neodymium;D009354
D01.552.550.399.625;Neodymium;D009354
D09.408.051.623;Neomycin;D009355
D01.268.613.600;Neon;D009356
D01.362.641.592;Neon;D009356
C16.614.610;Neonatal Abstinence Syndrome;D009357
C25.650;Neonatal Abstinence Syndrome;D009357
F03.900.650;Neonatal Abstinence Syndrome;D009357
C16;Congenital, Hereditary, and Neonatal Diseases and Abnormalities;D009358
H02.403.670.400;Neonatology;D009359
A11.642;Neoplastic Cells, Circulating;D009360
C04.697.650.900;Neoplastic Cells, Circulating;D009360
C23.550.727.650.900;Neoplastic Cells, Circulating;D009360
C04.697.645;Neoplasm Invasiveness;D009361
C23.550.727.645;Neoplasm Invasiveness;D009361
C04.697.650;Neoplasm Metastasis;D009362
C23.550.727.650;Neoplasm Metastasis;D009362
D12.776.624;Neoplasm Proteins;D009363
C04.697.655;Neoplasm Recurrence, Local;D009364
C23.550.727.655;Neoplasm Recurrence, Local;D009364
C04.697.670;Neoplasm Regression, Spontaneous;D009365
C23.550.727.670;Neoplasm Regression, Spontaneous;D009365
G16.100.870.500;Neoplasm Regression, Spontaneous;D009365
C04.697.650.830;Neoplasm Seeding;D009366
C23.550.727.650.830;Neoplasm Seeding;D009366
E01.789.625;Neoplasm Staging;D009367
E05.624;Neoplasm Transplantation;D009368
C04;Neoplasms;D009369
C04.557;Neoplasms by Histologic Type;D009370
C04.588;Neoplasms by Site;D009371
C04.557.450.565;Neoplasms, Connective Tissue;D009372
C17.300.680;Neoplasms, Connective Tissue;D009372
C04.557.465;Neoplasms, Germ Cell and Embryonal;D009373
C04.619;Neoplasms, Experimental;D009374
E05.598.500.496;Neoplasms, Experimental;D009374
C04.557.470;Neoplasms, Glandular and Epithelial;D009375
C04.626;Neoplasms, Hormone-Dependent;D009376
C04.588.322.400;Multiple Endocrine Neoplasia;D009377
C04.651.600;Multiple Endocrine Neoplasia;D009377
C04.700.630;Multiple Endocrine Neoplasia;D009377
C16.320.700.630;Multiple Endocrine Neoplasia;D009377
C19.344.400;Multiple Endocrine Neoplasia;D009377
C04.651;Neoplasms, Multiple Primary;D009378
C04.557.450.590;Neoplasms, Muscle Tissue;D009379
C04.557.580;Neoplasms, Nerve Tissue;D009380
C04.682;Neoplasms, Radiation-Induced;D009381
C26.733.476;Neoplasms, Radiation-Induced;D009381
C04.697.650.895;Neoplasms, Unknown Primary;D009382
C23.550.727.650.895;Neoplasms, Unknown Primary;D009382
C04.557.645;Neoplasms, Vascular Tissue;D009383
C04.588.322.490;Paraneoplastic Endocrine Syndromes;D009384
C04.730.713;Paraneoplastic Endocrine Syndromes;D009384
C19.344.473;Paraneoplastic Endocrine Syndromes;D009384
C04.697;Neoplastic Processes;D009385
C23.550.727;Neoplastic Processes;D009385
C04.700;Neoplastic Syndromes, Hereditary;D009386
C16.320.700;Neoplastic Syndromes, Hereditary;D009386
D02.455.326.271.665.480;Neoprene;D009387
D25.720.327.390;Neoprene;D009387
J01.637.051.720.327.840.480;Neoprene;D009387
J01.637.412.767.480;Neoprene;D009387
D02.092.877.674.666;Neostigmine;D009388
D02.675.276.602;Neostigmine;D009388
C23.550.589.500;Neovascularization, Pathologic;D009389
Z01.252.245.674;Nepal;D009390
E05.196.712.650;Nephelometry and Turbidimetry;D009391
E04.950.774.435;Nephrectomy;D009392
C12.777.419.570;Nephritis;D009393
C13.351.968.419.570;Nephritis;D009393
C12.706.742;Nephritis, Hereditary;D009394
C12.777.419.570.620;Nephritis, Hereditary;D009394
C13.351.875.742;Nephritis, Hereditary;D009394
C13.351.968.419.570.620;Nephritis, Hereditary;D009394
C16.131.939.742;Nephritis, Hereditary;D009394
C17.300.200.517;Nephritis, Hereditary;D009394
C12.777.419.570.643;Nephritis, Interstitial;D009395
C13.351.968.419.570.643;Nephritis, Interstitial;D009395
C04.557.435.595;Wilms Tumor;D009396
C04.588.945.947.535.585;Wilms Tumor;D009396
C04.700.635;Wilms Tumor;D009396
C12.758.820.750.585;Wilms Tumor;D009396
C12.777.419.473.585;Wilms Tumor;D009396
C13.351.937.820.535.585;Wilms Tumor;D009396
C13.351.968.419.473.585;Wilms Tumor;D009396
C16.320.700.642;Wilms Tumor;D009396
C12.777.419.590;Nephrocalcinosis;D009397
C13.351.968.419.590;Nephrocalcinosis;D009397
C18.452.174.130.560;Nephrocalcinosis;D009397
H02.403.429.580;Nephrology;D009398
A05.810.453.736;Nephrons;D009399
C12.777.419.610;Nephrosclerosis;D009400
C13.351.968.419.610;Nephrosclerosis;D009400
C12.777.419.630;Nephrosis;D009401
C13.351.968.419.630;Nephrosis;D009401
C12.777.419.630.477;Nephrosis, Lipoid;D009402
C13.351.968.419.630.477;Nephrosis, Lipoid;D009402
E01.370.390.550;Nephrostomy, Percutaneous;D009403
E04.579.642;Nephrostomy, Percutaneous;D009403
E04.950.774.852.642;Nephrostomy, Percutaneous;D009403
C12.777.419.630.643;Nephrotic Syndrome;D009404
C13.351.968.419.630.643;Nephrotic Syndrome;D009404
D01.268.033.550;Neptunium;D009405
D01.268.271.100.550;Neptunium;D009405
D01.268.556.600;Neptunium;D009405
D01.552.020.621;Neptunium;D009405
D01.552.544.600;Neptunium;D009405
E03.155.086.711;Nerve Block;D009407
E04.525.210.550;Nerve Block;D009407
C10.668.829.550;Nerve Compression Syndromes;D009408
E04.525.210.560;Nerve Crush;D009409
C23.550.737;Nerve Degeneration;D009410
A08.800.550;Nerve Endings;D009411
A08.663.542;Nerve Fibers;D009412
A08.663.542.512;Nerve Fibers, Myelinated;D009413
A11.671.514;Nerve Fibers, Myelinated;D009413
D12.644.276.860;Nerve Growth Factors;D009414
D12.776.467.860;Nerve Growth Factors;D009414
D12.776.641.600;Nerve Growth Factors;D009414
D23.529.850;Nerve Growth Factors;D009414
A08.511;Nerve Net;D009415
G11.561.600.615;Nerve Regeneration;D009416
G16.100.856.611;Nerve Regeneration;D009416
A08.561;Nerve Tissue;D009417
A10.755;Nerve Tissue;D009417
D12.776.157.125.750;S100 Proteins;D009418
D12.776.641.655;S100 Proteins;D009418
D12.776.641;Nerve Tissue Proteins;D009419
A08;Nervous System;D009420
C10.500;Nervous System Malformations;D009421
C16.131.666;Nervous System Malformations;D009421
C10;Nervous System Diseases;D009422
C04.588.614;Nervous System Neoplasms;D009423
C10.551;Nervous System Neoplasms;D009423
G11.561;Nervous System Physiological Phenomena;D009424
F01.145.113.252.478;Nesting Behavior;D009425
Z01.542.651;Netherlands;D009426
Z01.107.084.900.645;Netherlands Antilles;D009427
Z01.639.880.645;Netherlands Antilles;D009427
D09.408.051.374.785.525;Netilmicin;D009428
D12.644.456.650;Netropsin;D009429
A08.663.575;Neural Analyzers;D009430
G07.265.337.600;Neural Conduction;D009431
G07.700.240.600;Neural Conduction;D009431
G11.561.600.620;Neural Conduction;D009431
A16.627;Neural Crest;D009432
G07.265.337.615;Neural Inhibition;D009433
G07.700.240.615;Neural Inhibition;D009433
G11.561.600.625;Neural Inhibition;D009433
A08.612;Neural Pathways;D009434
G02.111.087.800.850;Synaptic Transmission;D009435
G02.149.115.800.850;Synaptic Transmission;D009435
G04.299.880.850;Synaptic Transmission;D009435
G07.265.337.900;Synaptic Transmission;D009435
G07.700.240.900;Synaptic Transmission;D009435
G11.561.600.835;Synaptic Transmission;D009435
C10.500.680;Neural Tube Defects;D009436
C16.131.666.680;Neural Tube Defects;D009436
C10.597.617.682;Neuralgia;D009437
C10.668.829.600;Neuralgia;D009437
C23.888.592.612.664;Neuralgia;D009437
C23.888.646.508;Neuralgia;D009437
D02.241.081.844.562;Neuraminic Acids;D009438
D02.241.511.902.562;Neuraminic Acids;D009438
D09.067.687;Neuraminic Acids;D009438
D09.811.589;Neuraminic Acids;D009438
D08.811.277.450.692;Neuraminidase;D009439
F03.875.600;Neurasthenia;D009440
A08.561.600;Neurilemma;D009441
A08.637.800.500.550;Neurilemma;D009441
A08.663.542.512.560.550;Neurilemma;D009441
A08.800.800.690.500.550;Neurilemma;D009441
A10.755.503.550;Neurilemma;D009441
A10.755.612;Neurilemma;D009441
A11.650.800.500.550;Neurilemma;D009441
A11.671.514.553.550;Neurilemma;D009441
C04.557.465.625.650.595;Neurilemmoma;D009442
C04.557.580.600.290;Neurilemmoma;D009442
C04.557.580.600.610.595;Neurilemmoma;D009442
C04.557.580.625.650.595;Neurilemmoma;D009442
C10.551.775.500.500;Neurilemmoma;D009442
C10.668.829.725.500.500;Neurilemmoma;D009442
C10.668.829.650;Neuritis;D009443
C10.114.703.700;Neuritis, Autoimmune, Experimental;D009444
C10.668.829.650.500;Neuritis, Autoimmune, Experimental;D009444
C20.111.258.625.700;Neuritis, Autoimmune, Experimental;D009444
E05.598.500.500.875;Neuritis, Autoimmune, Experimental;D009444
H01.158.100.700;Neuroanatomy;D009445
H01.158.610.060;Neuroanatomy;D009445
H01.158.273.610;Neurobiology;D009446
H01.158.610.080;Neurobiology;D009446
C04.557.465.625.600.590.650.550;Neuroblastoma;D009447
C04.557.470.670.590.650.550;Neuroblastoma;D009447
C04.557.580.625.600.590.650.550;Neuroblastoma;D009447
H01.158.201.687;Neurochemistry;D009448
H01.158.610.110;Neurochemistry;D009448
H01.181.122.709;Neurochemistry;D009448
F03.080.500;Neurocirculatory Asthenia;D009449
C17.800.174.660;Neurodermatitis;D009450
C17.800.815.660;Neurodermatitis;D009450
A08.800.550.550;Neuroeffector Junction;D009451
A08.850.550;Neuroeffector Junction;D009451
A11.284.149.165.420.780.550;Neuroeffector Junction;D009451
H01.158.610.160;Neuroendocrinology;D009452
H01.158.782.323.200;Neuroendocrinology;D009452
A08.663.609;Neurofibrils;D009454
A11.284.430.214.190.750.640;Neurofibrils;D009454
A11.671.573;Neurofibrils;D009454
C04.557.580.600.580;Neurofibroma;D009455
C10.551.775.500.750;Neurofibroma;D009455
C10.668.829.725.500.600;Neurofibroma;D009455
C04.557.580.600.580.590.650;Neurofibromatosis 1;D009456
C04.700.645.650;Neurofibromatosis 1;D009456
C10.562.600.500;Neurofibromatosis 1;D009456
C10.574.500.549.400;Neurofibromatosis 1;D009456
C10.668.829.675;Neurofibromatosis 1;D009456
C16.320.400.560.400;Neurofibromatosis 1;D009456
C16.320.700.645.650;Neurofibromatosis 1;D009456
A08.637;Neuroglia;D009457
A11.650;Neuroglia;D009457
E03.091.646;Neuroleptanalgesia;D009458
C10.228.140.079.737;Neuroleptic Malignant Syndrome;D009459
C10.720.737;Neuroleptic Malignant Syndrome;D009459
C25.723.705.600;Neuroleptic Malignant Syndrome;D009459
E01.370.376.550;Neurologic Examination;D009460
E01.370.600.550;Neurologic Examination;D009460
C10.597;Neurologic Manifestations;D009461
C23.888.592;Neurologic Manifestations;D009461
H02.403.600;Neurology;D009462
C04.557.580.600.610;Neuroma;D009463
C04.557.465.625.650.595.610;Neuroma, Acoustic;D009464
C04.557.580.600.610.595.610;Neuroma, Acoustic;D009464
C04.557.580.625.650.595.610;Neuroma, Acoustic;D009464
C04.588.614.596.240.015;Neuroma, Acoustic;D009464
C09.218.807.800.675;Neuroma, Acoustic;D009464
C09.647.675;Neuroma, Acoustic;D009464
C10.292.225.750;Neuroma, Acoustic;D009464
C10.292.910.600;Neuroma, Acoustic;D009464
D27.505.696.663.700;Neuromuscular Agents;D009465
D27.505.696.663.700.710;Neuromuscular Blocking Agents;D009466
D27.505.696.663.700.710.550;Neuromuscular Depolarizing Agents;D009467
C10.668;Neuromuscular Diseases;D009468
A08.800.550.550.550;Neuromuscular Junction;D009469
A08.850.550.550;Neuromuscular Junction;D009469
A11.284.149.165.420.780.550.550;Neuromuscular Junction;D009469
A08.663.650.915.750.500;Muscle Spindles;D009470
A08.800.950.750.500;Muscle Spindles;D009470
A10.690.552.500.750;Muscle Spindles;D009470
A11.671.650.915.750.500;Muscle Spindles;D009470
C10.114.375.500.650;Neuromyelitis Optica;D009471
C10.114.375.600.500;Neuromyelitis Optica;D009471
C10.114.375.650;Neuromyelitis Optica;D009471
C10.292.700.550.500;Neuromyelitis Optica;D009471
C10.314.350.500.650;Neuromyelitis Optica;D009471
C10.314.350.600.500;Neuromyelitis Optica;D009471
C10.314.350.650;Neuromyelitis Optica;D009471
C11.640.576.695;Neuromyelitis Optica;D009471
C20.111.258.250.500.650;Neuromyelitis Optica;D009471
C20.111.258.250.550.500;Neuromyelitis Optica;D009471
C20.111.258.250.600;Neuromyelitis Optica;D009471
C10.574.500.550;Neuronal Ceroid-Lipofuscinoses;D009472
C16.320.400.600;Neuronal Ceroid-Lipofuscinoses;D009472
C16.320.565.398.641.509;Neuronal Ceroid-Lipofuscinoses;D009472
C18.452.584.687.509;Neuronal Ceroid-Lipofuscinoses;D009472
C18.452.648.398.641.509;Neuronal Ceroid-Lipofuscinoses;D009472
G11.561.600.635;Neuronal Plasticity;D009473
A08.663;Neurons;D009474
A11.671;Neurons;D009474
A08.663.650;Neurons, Afferent;D009475
A11.671.650;Neurons, Afferent;D009475
A08.663.655;Neurons, Efferent;D009476
A11.671.655;Neurons, Efferent;D009476
C10.114.750.137;Hereditary Sensory and Autonomic Neuropathies;D009477
C10.314.750.600;Hereditary Sensory and Autonomic Neuropathies;D009477
C10.500.310;Hereditary Sensory and Autonomic Neuropathies;D009477
C10.574.500.496;Hereditary Sensory and Autonomic Neuropathies;D009477
C10.668.829.800.625;Hereditary Sensory and Autonomic Neuropathies;D009477
C10.668.829.800.750.450;Hereditary Sensory and Autonomic Neuropathies;D009477
C16.131.666.310;Hereditary Sensory and Autonomic Neuropathies;D009477
C16.320.400.415;Hereditary Sensory and Autonomic Neuropathies;D009477
C20.111.258.750.600;Hereditary Sensory and Autonomic Neuropathies;D009477
D12.644.400.500;Neuropeptide Y;D009478
D12.776.641.650.500;Neuropeptide Y;D009478
D12.644.400;Neuropeptides;D009479
D12.776.641.650;Neuropeptides;D009479
H01.158.610.208;Neuropharmacology;D009480
H01.158.703.030;Neuropharmacology;D009480
H02.628.280;Neuropharmacology;D009480
D12.644.400.525;Neurophysins;D009481
D12.776.157.597;Neurophysins;D009481
D12.776.641.650.525;Neurophysins;D009481
H01.158.610.268;Neurophysiology;D009482
H01.158.782.562;Neurophysiology;D009482
F04.711.513;Neuropsychological Tests;D009483
F04.096.795.600;Neuropsychology;D009484
H01.158.782.795.110;Neuropsychology;D009484
E01.370.350.578.937;Neuroradiography;D009485
E01.370.350.700.560;Neuroradiography;D009485
E01.370.376.537.750;Neuroradiography;D009485
E05.629.937;Neuroradiography;D009485
H01.158.610;Neurosciences;D009488
G11.561.600.640;Neurosecretion;D009489
A06.688;Neurosecretory Systems;D009490
A08.713;Neurosecretory Systems;D009490
B01.300.107.800.629;Neurospora;D009491
B01.300.107.800.629.564;Neurospora crassa;D009492
H02.403.810.425;Neurosurgery;D009493
C01.252.200.750;Neurosyphilis;D009494
C01.252.400.840.744.456;Neurosyphilis;D009494
C01.252.847.840.744.456;Neurosyphilis;D009494
C10.228.228.180.600;Neurosyphilis;D009494
D12.644.400.550;Neurotensin;D009496
D12.776.641.650.550;Neurotensin;D009496
F03.650;Neurotic Disorders;D009497
D27.888.569.504;Neurotoxins;D009498
D03.494.704.600;Neutral Red;D009499
E01.370.225.812.735.550;Neutralization Tests;D009500
E05.200.812.735.550;Neutralization Tests;D009500
E05.478.594.760.550;Neutralization Tests;D009500
E05.196.039.564;Neutron Activation Analysis;D009501
G01.249.645;Neutrons;D009502
C15.378.553.546.184.564;Neutropenia;D009503
A11.118.637.415.583;Neutrophils;D009504
A11.627.340.583;Neutrophils;D009504
A11.733.689;Neutrophils;D009504
A15.145.229.637.415.583;Neutrophils;D009504
A15.382.490.315.583;Neutrophils;D009504
A15.382.680.689;Neutrophils;D009504
Z01.107.567.875.760.550;Nevada;D009505
C04.557.665.560;Nevus;D009506
C04.557.665.560.615.585;Nevus of Ota;D009507
C04.557.665.560.615;Nevus, Pigmented;D009508
Z01.107.567.176.494;New Brunswick;D009509
Z01.639.760.590.620;New Caledonia;D009510
Z01.107.567.875.550;New England;D009511
Z01.586.650;New Guinea;D009512
Z01.107.567.875.550.580;New Hampshire;D009513
Z01.639.760.590.736;Vanuatu;D009514
Z01.107.567.875.500.525;New Jersey;D009515
Z01.107.567.875.760.560;New Mexico;D009516
Z01.338.480;New South Wales;D009517
Z01.107.567.875.075.437;New York;D009518
Z01.107.567.875.350.530;New York;D009518
Z01.107.567.875.500.530;New York;D009518
Z01.107.567.875.350.530.530;New York City;D009519
Z01.107.567.875.500.530.530;New York City;D009519
Z01.433.741;New York City;D009519
Z01.639.760.747;New Zealand;D009520
Z01.678.100.747;New Zealand;D009520
C02.782.580.600.080.600;Newcastle Disease;D009521
C22.131.630;Newcastle Disease;D009521
B04.820.455.600.650.070.600;Newcastle disease virus;D009522
B04.909.777.455.600.650.070.600;Newcastle disease virus;D009522
Z01.107.567.176.540;Newfoundland and Labrador;D009523
L01.178.682.829.481;Newspapers;D009524
D03.066.515.475;Niacin;D009525
D03.383.725.547.475;Niacin;D009525
D03.066.349.490;Nialamide;D009526
D03.383.725.394.628;Nialamide;D009526
Z01.107.169.690;Nicaragua;D009527
D02.065.199.326.550;Nicarbazin;D009528
D02.948.684.202.550;Nicarbazin;D009528
D03.383.742.470;Nicarbazin;D009528
D03.383.725.203.510;Nicardipine;D009529
D03.132.327.287.730;Nicergoline;D009530
D03.549.439.730;Nicergoline;D009530
D03.066.515.540;Niceritrol;D009531
D03.383.725.547.540;Niceritrol;D009531
D01.268.556.607;Nickel;D009532
D01.268.956.625;Nickel;D009532
D01.552.544.607;Nickel;D009532
D02.455.426.559.389.185.600;Niclofolan;D009533
D02.455.426.559.389.657.566.600;Niclofolan;D009533
D02.640.743.600;Niclofolan;D009533
D02.065.199.860.470;Niclosamide;D009534
D02.065.793.650.470;Niclosamide;D009534
D08.811.277.087.610;Nicotinamidase;D009535
D03.066.515.530;Niacinamide;D009536
D03.383.725.547.530;Niacinamide;D009536
D13.695.827.648;Nicotinamide Mononucleotide;D009537
D03.132.760.570;Nicotine;D009538
D03.383.725.518;Nicotine;D009538
D03.066.515;Nicotinic Acids;D009539
D03.383.725.547;Nicotinic Acids;D009539
D03.383.725.565;Nicotinyl Alcohol;D009540
A13.660;Nictitating Membrane;D009541
C10.228.140.163.100.435.825.700;Niemann-Pick Diseases;D009542
C15.604.250.410.625;Niemann-Pick Diseases;D009542
C16.320.565.189.435.825.700;Niemann-Pick Diseases;D009542
C16.320.565.398.641.803.730;Niemann-Pick Diseases;D009542
C16.320.565.595.554.825.700;Niemann-Pick Diseases;D009542
C18.452.132.100.435.825.700;Niemann-Pick Diseases;D009542
C18.452.584.687.803.730;Niemann-Pick Diseases;D009542
C18.452.648.189.435.825.700;Niemann-Pick Diseases;D009542
C18.452.648.398.641.803.730;Niemann-Pick Diseases;D009542
C18.452.648.595.554.825.700;Niemann-Pick Diseases;D009542
D03.383.725.203.540;Nifedipine;D009543
D02.241.223.100.050.400.200.777;Niflumic Acid;D009544
D02.455.426.559.389.127.020.906.750.777;Niflumic Acid;D009544
D03.066.515.550;Niflumic Acid;D009544
D03.383.725.547.550;Niflumic Acid;D009544
D02.640.600.410;Nifuratel;D009545
D03.383.129.462.600.600;Nifuratel;D009545
D03.383.312.649.410;Nifuratel;D009545
D02.640.600.480;Nifurtimox;D009547
D02.886.665.400;Nifurtimox;D009547
D03.383.312.649.480;Nifurtimox;D009547
D03.383.855.400;Nifurtimox;D009547
Z01.058.290.190.560;Niger;D009548
Z01.058.290.190.565;Nigeria;D009549
D03.383.312.634;Nigericin;D009550
D03.383.663.620;Nigericin;D009550
D03.830.620;Nigericin;D009550
E02.760.564;Night Care;D009551
N02.421.585.564;Night Care;D009551
D03.066.515.530.500;Nikethamide;D009552
D03.383.725.547.530.500;Nikethamide;D009552
D03.383.725.203.570;Nimodipine;D009553
D03.383.725.547.570;Nimodipine;D009553
D02.640.672.580;Nimorazole;D009554
D03.383.129.308.658.580;Nimorazole;D009554
D02.455.426.559.847.486.487.500;Ninhydrin;D009555
D04.615.486.487.500;Ninhydrin;D009555
D01.268.556.615;Niobium;D009556
D01.268.956.687;Niobium;D009556
D01.552.544.615;Niobium;D009556
D03.066.566;Nipecotic Acids;D009557
D03.383.621.566;Nipecotic Acids;D009557
A01.236.500;Nipples;D009558
B01.050.500.500.294.700.775.400.575;Nippostrongylus;D009559
D02.886.675.482;Niridazole;D009560
D03.383.129.308.626;Niridazole;D009560
D03.383.129.708.482;Niridazole;D009560
D04.345.566.582;Nisin;D009561
D12.644.641.582;Nisin;D009561
D12.776.097.151.700;Nisin;D009561
D12.776.543.695.110.700;Nisin;D009561
A08.663.712;Nissl Bodies;D009562
A11.284.430.214.190.500.610;Nissl Bodies;D009562
A11.284.430.214.190.875.248.300.610;Nissl Bodies;D009562
A11.284.430.214.190.875.811.740.300.610;Nissl Bodies;D009562
A11.671.693;Nissl Bodies;D009562
D03.494.046.250.650;Nitracrine;D009564
D08.811.682.655.500;Nitrate Reductases;D009565
D01.248.497.158.606;Nitrates;D009566
D01.625.525.550;Nitrates;D009566
D02.583;Nitrates;D009566
D03.438.079.080.070.565;Nitrazepam;D009567
D03.383.725.203.590;Nitrendipine;D009568
D01.339.387;Nitric Oxide;D009569
D01.625.550.500;Nitric Oxide;D009569
D01.625.700.500;Nitric Oxide;D009569
D01.650.550.587.600;Nitric Oxide;D009569
D02.626;Nitriles;D009570
D02.241.081.018.588;Nitrilotriacetic Acid;D009571
D08.811.682.655.750;Nitrite Reductases;D009572
D01.248.497.158.635;Nitrites;D009573
D01.625.600.600;Nitrites;D009573
D02.633;Nitrites;D009573
D02.640;Nitro Compounds;D009574
D08.811.682.670.550;Nitroanisole O-Demethylase;D009575
B03.440.400.425.200.520;Nitrobacter;D009576
B03.660.050.035.520;Nitrobacter;D009576
D02.455.426.559.389.565;Nitrobenzenes;D009578
D02.640.529;Nitrobenzenes;D009578
D02.241.223.100.600;Nitrobenzoates;D009579
D02.455.426.559.389.127.650;Nitrobenzoates;D009579
D03.383.129.617.700.500;Nitroblue Tetrazolium;D009580
D02.640.600;Nitrofurans;D009581
D03.383.312.649;Nitrofurans;D009581
D02.640.600.566;Nitrofurantoin;D009582
D03.383.312.649.566;Nitrofurantoin;D009582
D02.640.600.691;Nitrofurazone;D009583
D03.383.312.649.691;Nitrofurazone;D009583
D01.268.604;Nitrogen;D009584
D01.362.625;Nitrogen;D009584
D01.362.635.600;Nitrogen Dioxide;D009585
D01.625.550.525;Nitrogen Dioxide;D009585
D01.650.550.587.625;Nitrogen Dioxide;D009585
G02.111.087.070.630;Nitrogen Fixation;D009586
G02.149.115.070.630;Nitrogen Fixation;D009586
G03.495.153.630;Nitrogen Fixation;D009586
G06.099.112.610;Nitrogen Fixation;D009586
G06.590.110.610;Nitrogen Fixation;D009586
G06.590.620;Nitrogen Fixation;D009586
D01.496.586;Nitrogen Isotopes;D009587
D02.455.526.728.650;Nitrogen Mustard Compounds;D009588
D01.362.635;Nitrogen Oxides;D009589
D01.625.550;Nitrogen Oxides;D009589
D01.650.550.587;Nitrogen Oxides;D009589
D01.496.586.520;Nitrogen Radioisotopes;D009590
D01.496.749.615;Nitrogen Radioisotopes;D009590
D08.811.682.647;Nitrogenase;D009591
D02.455.426.559.389.657.566.610;Nitrohydroxyiodophenylacetate;D009592
D02.640.743.610;Nitrohydroxyiodophenylacetate;D009592
D23.050.550.480.641;Nitrohydroxyiodophenylacetate;D009592
D02.640.672;Nitroimidazoles;D009593
D03.383.129.308.658;Nitroimidazoles;D009593
D03.383.773.610;Nitromifene;D009594
D02.455.326.146.672;Nitroparaffins;D009595
D02.640.720;Nitroparaffins;D009595
D02.455.426.559.389.657.566;Nitrophenols;D009596
D02.640.743;Nitrophenols;D009596
D08.811.277.352.650.575;4-Nitrophenylphosphatase;D009597
D09.408.320.550;Nitrophenylgalactosides;D009598
D01.248.497.158.291.350.550;Nitroprusside;D009599
D01.490.100.300.550;Nitroprusside;D009599
D01.625.400.100.325.550;Nitroprusside;D009599
D02.640.820;Nitroquinolines;D009600
D03.438.810.470;Nitroquinolines;D009600
D08.811.682.655;Nitroreductases;D009601
D02.654.442;Nitrosamines;D009602
D02.654;Nitroso Compounds;D009603
D02.078.370.649;Nitrosoguanidines;D009604
D02.654.567;Nitrosoguanidines;D009604
D02.241.081.251.944.500;Nitrosomethylurethane;D009605
D02.654.585;Nitrosomethylurethane;D009605
B03.440.400.425.562.500;Nitrosomonas;D009606
B03.660.075.550.500;Nitrosomonas;D009606
D02.654.692;Nitrosourea Compounds;D009607
D02.948.594;Nitrosourea Compounds;D009607
D01.029.260.575;Nitrous Acid;D009608
D01.625.600;Nitrous Acid;D009608
D01.362.635.625;Nitrous Oxide;D009609
D01.625.550.550;Nitrous Oxide;D009609
D01.650.550.587.650;Nitrous Oxide;D009609
D02.640.600.750;Nitrovin;D009610
D03.383.312.649.750;Nitrovin;D009610
D02.455.426.559.389.657.566.620;Nitroxinil;D009611
D02.640.743.620;Nitroxinil;D009611
D08.811.913.696.445.600;Nicotinamide-Nucleotide Adenylyltransferase;D009612
K01.150.567;Nobel Prize;D009613
D01.268.033.575;Nobelium;D009614
D01.268.271.100.575;Nobelium;D009614
D01.268.556.620;Nobelium;D009614
D01.552.020.659;Nobelium;D009614
D01.552.544.620;Nobelium;D009614
B03.510.024.049.537.550;Nocardia;D009615
B03.510.024.049.537.550.550;Nocardia asteroides;D009616
C01.252.410.040.692;Nocardia Infections;D009617
B03.510.024.049.537;Nocardiaceae;D009618
A08.663.650.915.875;Nociceptors;D009619
A08.800.950.875;Nociceptors;D009619
A11.671.650.915.875;Nociceptors;D009619
A08.340.390.550;Nodose Ganglion;D009620
A08.800.050.050.925.550;Nodose Ganglion;D009620
A08.800.050.600.825.550;Nodose Ganglion;D009620
A08.800.350.550;Nodose Ganglion;D009620
A08.800.800.060.920.550;Nodose Ganglion;D009620
A08.800.800.120.900.550;Nodose Ganglion;D009620
D02.455.426.559.847.562.050.200.650;Nogalamycin;D009621
D04.615.562.050.200.650;Nogalamycin;D009621
D09.408.051.059.200.650;Nogalamycin;D009621
G01.750.770.776.567;Noise;D009622
G16.500.275.600;Noise;D009622
N06.230.400;Noise;D009622
N06.850.460.610;Noise;D009622
N06.230.400.500;Noise, Occupational;D009623
N06.850.460.610.526;Noise, Occupational;D009623
N06.230.400.550;Noise, Transportation;D009624
N06.850.460.610.680;Noise, Transportation;D009624
C07.465.604;Noma;D009625
L01.143.506.598.400;Terminology as Topic;D009626
D03.438.531.535;Nomifensine;D009627
D02.886.369.550;Nonachlazine;D009628
D03.494.741.550;Nonachlazine;D009628
F04.754.592;Nondirective Therapy;D009629
C23.550.210.645;Nondisjunction, Genetic;D009630
G05.355.105.220.625.620;Nondisjunction, Genetic;D009630
G05.355.600.620;Nondisjunction, Genetic;D009630
C04.182.089.530.660;Nonodontogenic Cysts;D009631
C05.500.470.660;Nonodontogenic Cysts;D009631
C07.320.450.640;Nonodontogenic Cysts;D009631
D12.776.124.862.575;Nonsuppressible Insulin-Like Activity;D009632
F01.145.209.530;Nonverbal Communication;D009633
L01.143.649;Nonverbal Communication;D009633
C05.660.207.690;Noonan Syndrome;D009634
C14.240.400.787;Noonan Syndrome;D009634
C14.280.400.787;Noonan Syndrome;D009634
C16.131.240.400.784;Noonan Syndrome;D009634
C16.131.621.207.690;Noonan Syndrome;D009634
C17.300.690;Noonan Syndrome;D009634
D04.808.668.100;Norandrostanes;D009635
D02.455.849.575.781;Norbornanes;D009636
D02.455.426.559.389.140.450.582;Nordihydroguaiaretic Acid;D009637
D02.455.426.559.389.657.166.550;Nordihydroguaiaretic Acid;D009637
D02.033.100.291.502;Norepinephrine;D009638
D02.092.063.480;Norepinephrine;D009638
D02.092.211.215.311.560;Norepinephrine;D009638
D02.092.311.461.484;Norepinephrine;D009638
D04.808.668.651.693.595;Norethandrolone;D009639
D04.808.668.651.693.651;Norethindrone;D009640
D04.808.668.651.693.706;Norethynodrel;D009641
D02.092.471.683.467.500;Norfenfluramine;D009642
D03.438.810.835.322.374;Norfloxacin;D009643
D04.808.668.651.693.762;Norgestrel;D009644
D04.808.668.651.568.620;Norgestrienone;D009645
D12.125.213.568;Norleucine;D009646
D02.033.100.291.502.651;Normetanephrine;D009647
D02.092.063.480.651;Normetanephrine;D009647
D02.092.211.215.311.560.651;Normetanephrine;D009647
D02.092.311.461.651;Normetanephrine;D009647
D23.101.840.540;Normetanephrine;D009647
D04.808.668.651.443;Norpregnadienes;D009649
D04.808.668.651;Norpregnanes;D009650
D04.808.668.651.568;Norpregnatrienes;D009651
D04.808.668.651.693;Norpregnenes;D009652
D04.808.668.651.693.820;Norprogesterones;D009653
D04.808.668;Norsteroids;D009654
D02.033.100.291.525;Octopamine;D009655
D02.092.063.291.525;Octopamine;D009655
D02.092.211.215.811.651;Octopamine;D009655
D02.092.471.683.725;Octopamine;D009655
Z01.107.567;North America;D009656
Z01.107.567.875.075.475;North Carolina;D009657
Z01.107.567.875.750.530;North Carolina;D009657
Z01.107.567.875.510.525;North Dakota;D009658
Z01.756.092.650;North Sea;D009659
Z01.542.363.602;Northern Ireland;D009660
Z01.639.280.602;Northern Ireland;D009660
D02.455.426.559.847.181.384.535;Nortriptyline;D009661
D04.615.181.384.535;Nortriptyline;D009661
D02.145.074.722.744;Nortropanes;D009662
D03.605.869.744;Nortropanes;D009662
D04.075.080.875.099.722.744;Nortropanes;D009662
B04.820.095.550.500;Norwalk virus;D009663
B04.909.777.162.550.500;Norwalk virus;D009663
Z01.542.808.618;Norway;D009664
D03.132.577.500;Noscapine;D009665
D03.438.531.567;Noscapine;D009665
A01.456.505.733;Nose;D009666
A04.531;Nose;D009666
A09.531;Nose;D009666
C08.460.619;Nose Deformities, Acquired;D009667
C09.603.619;Nose Deformities, Acquired;D009667
C08.460;Nose Diseases;D009668
C09.603;Nose Diseases;D009668
C04.588.149.721.600;Nose Neoplasms;D009669
C04.588.443.665.650;Nose Neoplasms;D009669
C05.116.231.754.600;Nose Neoplasms;D009669
C08.460.669;Nose Neoplasms;D009669
C08.785.600;Nose Neoplasms;D009669
C09.603.669;Nose Neoplasms;D009669
C09.647.685;Nose Neoplasms;D009669
B01.300.360.500.500.100.175.175;Encephalitozoon cuniculi;D009670
D26.593;Nostrums;D009671
A16.660;Notochord;D009672
B01.050.150.900.090.608.700.500.480;Notophthalmus viridescens;D009673
Z01.107.567.176.589;Nova Scotia;D009674
D03.438.150.446.139.500;Novobiocin;D009675
D03.830.219.446.139.500;Novobiocin;D009675
D09.408.554;Novobiocin;D009675
D27.888.569;Noxae;D009676
D02.886.904.500;Noxythiolin;D009677
D02.948.898.500;Noxythiolin;D009677
G01.595.630;Nuclear Energy;D009678
N06.230.132.580;Nuclear Energy;D009678
F01.829.263.500;Nuclear Family;D009679
I01.880.225.500;Nuclear Family;D009679
G01.595.630.485;Nuclear Fission;D009680
N06.230.132.580.500;Nuclear Fission;D009680
G01.595.630.652;Nuclear Fusion;D009681
N06.230.132.580.520;Nuclear Fusion;D009681
E05.196.867.519;Magnetic Resonance Spectroscopy;D009682
H02.403.740.500;Nuclear Medicine;D009683
N02.278.354.422.472;Nuclear Medicine Department, Hospital;D009684
N04.452.442.422.472;Nuclear Medicine Department, Hospital;D009684
A11.284.149.165.630;Nuclear Envelope;D009685
A11.284.149.450.700;Nuclear Envelope;D009685
A11.284.430.106.279.692;Nuclear Envelope;D009685
A11.284.835.514.700;Nuclear Envelope;D009685
H01.671.579;Nuclear Physics;D009686
D12.776.660;Nuclear Proteins;D009687
E07.710.600;Nuclear Reactors;D009688
I01.880.735.944.600;Nuclear Warfare;D009689
G02.111.570.790.486;Nucleic Acid Conformation;D009690
G05.360.580;Nucleic Acid Conformation;D009690
E05.393.640;Nucleic Acid Denaturation;D009691
G02.111.087.615;Nucleic Acid Denaturation;D009691
G02.149.115.615;Nucleic Acid Denaturation;D009691
G05.355.720;Nucleic Acid Denaturation;D009691
D13.444.500;Nucleic Acid Heteroduplexes;D009692
E05.393.661;Nucleic Acid Hybridization;D009693
G02.111.087.620;Nucleic Acid Hybridization;D009693
G02.149.115.620;Nucleic Acid Hybridization;D009693
D13.400;Nucleic Acid Precursors;D009694
G02.111.087.625;Nucleic Acid Renaturation;D009695
G02.149.115.625;Nucleic Acid Renaturation;D009695
D13.444;Nucleic Acids;D009696
A11.284.430.106.279.345.190.160.650;Nucleolus Organizer Region;D009697
G05.360.160.650;Nucleolus Organizer Region;D009697
G05.360.340.024.380.875;Nucleolus Organizer Region;D009697
D12.776.664;Nucleoproteins;D009698
D08.811.277.450.430;N-Glycosyl Hydrolases;D009699
D08.811.277.151.486;Nucleoside Deaminases;D009700
D08.811.913.696.650.550;Nucleoside-Diphosphate Kinase;D009701
D09.408.620.569;Nucleoside Diphosphate Sugars;D009702
D13.695.201.486;Nucleoside Diphosphate Sugars;D009702
D13.695.827.708;Nucleoside Diphosphate Sugars;D009702
D08.811.913.696.650.575;Nucleoside-Phosphate Kinase;D009703
D03.438.759.590.454.500;Nucleoside Q;D009704
D13.570.583.454.500;Nucleoside Q;D009704
D13.570.800.453.500;Nucleoside Q;D009704
D09.408.595;Nucleosides;D009705
D13.570;Nucleosides;D009705
D13;Nucleic Acids, Nucleotides, and Nucleosides;D009706
A11.284.430.106.279.345.190.160.180.625;Nucleosomes;D009707
D12.776.664.224.550;Nucleosomes;D009707
G05.360.160.180.625;Nucleosomes;D009707
D08.811.277.352.650.600;Nucleotidases;D009708
D08.811.277.151.653;Nucleotide Deaminases;D009709
E05.196.181.400.454.655;Nucleotide Mapping;D009710
E05.196.401.319.670;Nucleotide Mapping;D009710
E05.196.680;Nucleotide Mapping;D009710
D09.408.620;Nucleotides;D009711
D13.695;Nucleotides;D009711
D13.695.462;Nucleotides, Cyclic;D009712
D08.811.913.696.445;Nucleotidyltransferases;D009713
A08.186.211.730.885.287.249.683;Nucleus Accumbens;D009714
I03.548;Nudism;D009715
L01.224.680.700;Numerical Analysis, Computer-Assisted;D009716
K01.093.560;Numismatics;D009717
M01.526.070.670;Nurse Administrators;D009718
M01.526.485.650.580;Nurse Administrators;D009718
N02.360.650.580;Nurse Administrators;D009718
M01.526.485.650.600;Nurse Anesthetists;D009719
N02.360.650.600;Nurse Anesthetists;D009719
M01.526.485.650.610;Nurse Clinicians;D009720
N02.360.650.610;Nurse Clinicians;D009720
M01.526.485.650.620;Nurse Midwives;D009721
N02.360.650.620;Nurse Midwives;D009721
M01.526.485.650.640;Nurse Practitioners;D009722
N02.360.650.640;Nurse Practitioners;D009722
F01.829.401.650.600;Nurse-Patient Relations;D009723
N05.300.660.560;Nurse-Patient Relations;D009723
N02.278.617;Nurseries;D009724
N02.278.388.540;Nurseries, Hospital;D009725
N02.278.617.473;Nurseries, Hospital;D009725
M01.526.485.650;Nurses;D009726
N02.360.650;Nurses;D009726
M01.390.660;Nurses, Male;D009727
M01.526.485.650.670;Nurses, Male;D009727
N02.360.650.670;Nurses, Male;D009727
M01.526.485.067.652;Nurses' Aides;D009728
N02.360.067.652;Nurses' Aides;D009728
H02.478;Nursing;D009729
N04.452.758.377;Nursing;D009729
N04.590.233.508.480;Nursing Assessment;D009730
N04.761.700.250.520;Nursing Audit;D009731
N05.700.175.520;Nursing Audit;D009731
E02.760.611;Nursing Care;D009732
N02.421.533;Nursing Care;D009732
N02.421.585.611;Nursing Care;D009732
N04.590.233.508.480.110;Nursing Diagnosis;D009733
N04.452.758.388;Nursing Faculty Practice;D009734
N02.278.825.610;Nursing Homes;D009735
N04.590.233.508;Nursing Process;D009736
E05.318.308.940.984;Nursing Records;D009737
L01.280.900.984;Nursing Records;D009737
N04.452.859.675;Nursing Records;D009737
N05.715.360.300.715.550;Nursing Records;D009737
N06.850.520.308.940.984;Nursing Records;D009737
N02.278.354.422.489;Nursing Service, Hospital;D009738
N02.421.539.180;Nursing Service, Hospital;D009738
N04.452.442.422.489;Nursing Service, Hospital;D009738
N02.421.539;Nursing Services;D009739
M01.526.485.680;Nursing Staff;D009740
N02.360.680;Nursing Staff;D009740
M01.526.485.680.490;Nursing Staff, Hospital;D009741
M01.526.485.740.523;Nursing Staff, Hospital;D009741
N02.360.680.490;Nursing Staff, Hospital;D009741
N02.360.740.523;Nursing Staff, Hospital;D009741
H02.478.408;Nursing Theory;D009742
H02.495;Nursing, Practical;D009743
N02.421.533.520;Nursing, Practical;D009743
N04.452.758.377.500;Nursing, Private Duty;D009744
N04.452.758.377.750;Nursing, Supervisory;D009745
N04.590.715.571;Nursing, Team;D009746
G07.610;Nutritional Physiological Phenomena;D009747
C18.654;Nutrition Disorders;D009748
E05.318.308.250.600;Nutrition Surveys;D009749
E05.318.308.585.550;Nutrition Surveys;D009749
N05.715.360.300.375.560;Nutrition Surveys;D009749
N05.715.360.300.560.565;Nutrition Surveys;D009749
N06.850.520.308.250.600;Nutrition Surveys;D009749
N06.850.520.308.585.550;Nutrition Surveys;D009749
C18;Nutritional and Metabolic Diseases;D009750
G07.610.620;Nutritional Requirements;D009751
G07.610.650;Nutritional Status;D009752
N01.224.425.525;Nutritional Status;D009752
G07.610.660;Nutritive Value;D009753
J01.576.423.850.730.750;Nutritive Value;D009753
N06.850.601.750;Nutritive Value;D009753
A18.024.500.500;Nuts;D009754
J02.500.700;Nuts;D009754
C11.966.671;Night Blindness;D009755
D02.033.100.624.605;Nylidrin;D009756
D02.033.755.624.605;Nylidrin;D009756
D02.092.063.624.706.550;Nylidrin;D009756
D02.092.471.683.715;Nylidrin;D009756
D05.750.716.392;Nylons;D009757
D25.720.716.392;Nylons;D009757
J01.576.885.800.600;Nylons;D009757
J01.637.051.720.716.392;Nylons;D009757
J01.637.548;Nylons;D009757
B05.500.650;Nymph;D009758
G07.700.320.500.550.500.650;Nymph;D009758
C10.292.562.675;Nystagmus, Pathologic;D009759
C11.590.400;Nystagmus, Pathologic;D009759
G14.640.260.378;Nystagmus, Physiologic;D009760
D02.540.505.575;Nystatin;D009761
D02.172.037;o-Aminoazotoluene;D009762
D02.626.310;o-Chlorobenzylidenemalonitrile;D009763
D02.047.750;o-Phthalaldehyde;D009764
D02.241.223.805.780;o-Phthalaldehyde;D009764
C18.654.726.500;Obesity;D009765
C23.888.144.699.500;Obesity;D009765
E01.370.600.115.100.160.120.699.500;Obesity;D009765
G07.100.100.160.120.699.500;Obesity;D009765
C18.654.726.500.700;Obesity, Morbid;D009767
C23.888.144.699.500.500;Obesity, Morbid;D009767
E01.370.600.115.100.160.120.699.500.500;Obesity, Morbid;D009767
G07.100.100.160.120.699.500.500;Obesity, Morbid;D009767
D02.092.570.665.500;Obidoxime Chloride;D009768
D03.383.725.762.600;Obidoxime Chloride;D009768
F02.739.794.624;Object Attachment;D009769
F01.145.126.950;Obsessive Behavior;D009770
F03.080.600;Obsessive-Compulsive Disorder;D009771
E07.858.700.650;Obstetrical Forceps;D009772
H02.478.676.570;Obstetrical Nursing;D009773
N02.421.533.571;Obstetrical Nursing;D009773
H02.403.810.450;Obstetrics;D009774
N02.278.354.422.495;Obstetrics and Gynecology Department, Hospital;D009775
N04.452.442.422.495;Obstetrics and Gynecology Department, Hospital;D009775
A08.800.800.720.450.600;Obturator Nerve;D009776
A02.835.232.781.572;Occipital Bone;D009777
A08.186.211.730.885.287.500.571;Occipital Lobe;D009778
E07.101.650;Occlusive Dressings;D009779
E01.370.225.925;Occult Blood;D009780
E05.200.925;Occult Blood;D009780
E02.190.901.650;Occultism;D009781
K01.672;Occultism;D009781
H02.163.640;Occupational Dentistry;D009782
C17.800.174.255.700;Dermatitis, Occupational;D009783
C17.800.815.255.700;Dermatitis, Occupational;D009783
C24.270;Dermatitis, Occupational;D009783
C24;Occupational Diseases;D009784
H02.478.676.590;Occupational Health Nursing;D009785
N02.421.533.585;Occupational Health Nursing;D009785
N02.421.143.740;Occupational Health Services;D009786
H02.403.720.750.510;Occupational Medicine;D009787
E02.831.489;Occupational Therapy;D009788
H02.010.500;Occupational Therapy;D009788
N02.278.354.422.500;Occupational Therapy Department, Hospital;D009789
N04.452.442.422.500;Occupational Therapy Department, Hospital;D009789
N01.824.547;Occupations;D009790
H01.277.500.392;Oceanography;D009791
H01.277.750;Oceanography;D009791
G01.311.625;Oceans and Seas;D009792
G16.500.275.810.650;Oceans and Seas;D009792
Z01.756;Oceans and Seas;D009792
D03.438.150.446.598.500;Ochratoxins;D009793
D03.830.219.446.598.500;Ochratoxins;D009793
D23.946.587.697;Ochratoxins;D009793
C23.550.744;Ochronosis;D009794
D02.455.326.146.720;Octanes;D009795
C11.525;Ocular Hypertension;D009798
G14;Ocular Physiological Phenomena;D009799
C10.228.140.163.100.640;Oculocerebrorenal Syndrome;D009800
C12.777.419.815.720;Oculocerebrorenal Syndrome;D009800
C13.351.968.419.815.720;Oculocerebrorenal Syndrome;D009800
C16.131.077.661;Oculocerebrorenal Syndrome;D009800
C16.320.322.750;Oculocerebrorenal Syndrome;D009800
C16.320.565.151.600;Oculocerebrorenal Syndrome;D009800
C16.320.565.189.640;Oculocerebrorenal Syndrome;D009800
C16.320.565.861.750;Oculocerebrorenal Syndrome;D009800
C18.452.132.100.640;Oculocerebrorenal Syndrome;D009800
C18.452.648.151.600;Oculocerebrorenal Syndrome;D009800
C18.452.648.189.640;Oculocerebrorenal Syndrome;D009800
C18.452.648.861.750;Oculocerebrorenal Syndrome;D009800
A02.633.567.700;Oculomotor Muscles;D009801
A09.371.613;Oculomotor Muscles;D009801
A08.800.050.050.650;Oculomotor Nerve;D009802
A08.800.050.600.475;Oculomotor Nerve;D009802
A08.800.800.060.650;Oculomotor Nerve;D009802
A08.800.800.120.600;Oculomotor Nerve;D009802
A03.159.183.079.300.950.600;Sphincter of Oddi;D009803
A03.556.124.684.124.236.572;Sphincter of Oddi;D009803
A03.556.875.249.160.572;Sphincter of Oddi;D009803
A11.329.522;Odontoblasts;D009804
G07.700.320.500.325.377.750;Odontogenesis;D009805
C04.182.089.530.690;Odontogenic Cysts;D009807
C05.500.470.690;Odontogenic Cysts;D009807
C07.320.450.670;Odontogenic Cysts;D009807
C04.557.695;Odontogenic Tumors;D009808
A02.835.232.834.151.383.668;Odontoid Process;D009809
C04.557.695.610;Odontoma;D009810
E01.370.600.024.650;Odontometry;D009811
E05.041.650;Odontometry;D009811
E06.623;Odontometry;D009811
G16.500.275.640;Odors;D009812
N06.230.480;Odors;D009812
F02.739.794.653;Oedipus Complex;D009813
C03.335.508.700.775.583;Oesophagostomiasis;D009814
B01.050.500.500.294.700.775.710.600;Oesophagostomum;D009815
N04.452.515.708;Office Automation;D009816
N04.452.758.572;Office Management;D009817
N04.452.758.708.200;Office Management;D009817
N04.452.758.377.875;Office Nursing;D009818
N04.452.758.635;Office Visits;D009819
Z01.107.567.875.075.512;Ohio;D009820
Z01.107.567.875.350.540;Ohio;D009820
Z01.107.567.875.510.540;Ohio;D009820
D10.627;Oils;D009821
D10.627.675;Oils, Volatile;D009822
D26.650.523;Ointment Bases;D009823
D27.720.744.523;Ointment Bases;D009823
D26.255.640;Ointments;D009824
D27.720.280.640;Ointments;D009824
Z01.107.567.875.510.550;Oklahoma;D009825
N03.219.521.346.506.678;Old Age Assistance;D009826
D02.540.505.600;Oleandomycin;D009827
D02.455.849.919.530.733;Oleanolic Acid;D009828
D02.455.849.919.650.600;Oleanolic Acid;D009828
D10.251.355.325.600;Oleic Acids;D009829
A08.186.211.464.699.573;Olfactory Bulb;D009830
A08.186.211.730.885.600.573;Olfactory Bulb;D009830
A04.531.520.573;Olfactory Mucosa;D009831
A04.760.600.640;Olfactory Mucosa;D009831
A09.531.623;Olfactory Mucosa;D009831
A10.615.550.760.600.640;Olfactory Mucosa;D009831
A08.800.800.120.640;Olfactory Nerve;D009832
A08.186.211.464.699;Olfactory Pathways;D009833
A08.186.211.730.885.600;Olfactory Pathways;D009833
A08.612.220.640;Olfactory Pathways;D009833
D08.811.277.450.770;Oligo-1,6-Glucosidase;D009834
B01.050.500.091.657;Oligochaeta;D009835
A08.637.600;Oligodendroglia;D009836
A11.650.600;Oligodendroglia;D009836
C04.557.465.625.600.380.590;Oligodendroglioma;D009837
C04.557.470.670.380.590;Oligodendroglioma;D009837
C04.557.580.625.600.380.590;Oligodendroglioma;D009837
D13.695.578.424.450;Oligodeoxyribonucleotides;D009838
C23.550.568.937;Oligomenorrhea;D009839
D02.540.505.620;Oligomycins;D009840
D13.695.578.424;Oligonucleotides;D009841
D12.644.456;Oligopeptides;D009842
D13.695.578.424.500;Oligoribonucleotides;D009843
D09.698.629;Oligosaccharides;D009844
C12.294.365.700.508;Oligospermia;D009845
C12.777.934.600;Oliguria;D009846
C13.351.968.934.600;Oliguria;D009846
C23.888.942.400;Oliguria;D009846
A08.186.211.132.810.406.574;Olivary Nucleus;D009847
A08.186.211.865.467.500.574;Olivary Nucleus;D009847
D09.408.661;Olivomycins;D009848
C10.228.140.079.612.600;Olivopontocerebellar Atrophies;D009849
C10.228.140.252.700.650;Olivopontocerebellar Atrophies;D009849
C10.228.662.550.600;Olivopontocerebellar Atrophies;D009849
C10.228.854.787.750;Olivopontocerebellar Atrophies;D009849
C10.574.500.825.650;Olivopontocerebellar Atrophies;D009849
C10.574.625.600;Olivopontocerebellar Atrophies;D009849
C10.574.750;Olivopontocerebellar Atrophies;D009849
C16.320.400.780.750;Olivopontocerebellar Atrophies;D009849
Z01.252.245.500.600;Oman;D009850
Z01.586.500.600;Oman;D009850
A13.869.524;Omasum;D009851
A01.923.047.025.600.573;Omentum;D009852
D02.886.640.074.500;Omeprazole;D009853
D03.383.725.024.500;Omeprazole;D009853
D03.438.103.034.500;Omeprazole;D009853
B01.050.500.500.294.700.750.700.300.510;Onchocerca;D009854
C03.335.508.700.750.361.699;Onchocerciasis;D009855
C03.858.650;Onchocerciasis;D009855
C17.800.838.775.690;Onchocerciasis;D009855
C23.996.700;Onchocerciasis;D009855
D12.776.624.664.520;Oncogene Proteins, Viral;D009856
D12.776.964.700;Oncogene Proteins, Viral;D009856
G05.360.340.024.340.375.500;Oncogenes;D009857
B04.909.574;Oncogenic Viruses;D009858
H02.478.676.605;Oncologic Nursing;D009859
N02.421.533.600;Oncologic Nursing;D009859
D02.675;Onium Compounds;D009861
L01.700.508.300.742;Online Systems;D009862
F01.829.263.500.280;Only Child;D009863
I01.880.225.500.280;Only Child;D009863
Z01.107.567.176.639;Ontario;D009864
A05.360.490.690.680;Oocytes;D009865
A11.497.497.600;Oocytes;D009865
G04.299.151.650.249;Oogenesis;D009866
G08.686.785.760.310.500;Oogenesis;D009866
A05.360.490.690.700;Oogonia;D009867
A11.497.497.650;Oogonia;D009867
B01.750.937;Oomycetes;D009868
C13.351.500.056.630.450;Oophoritis;D009869
C13.351.500.056.750.500;Oophoritis;D009869
C19.391.630.450;Oophoritis;D009869
L01.700.508.300.680.360.500;Operating Room Information Systems;D009870
N04.452.442.452.600;Operating Room Information Systems;D009870
N04.452.515.360.555;Operating Room Information Systems;D009870
H02.478.676.650.625;Operating Room Nursing;D009871
N02.421.533.710.625;Operating Room Nursing;D009871
M01.526.485.067.700;Operating Room Technicians;D009872
N02.360.067.700;Operating Room Technicians;D009872
N02.278.388.700;Operating Rooms;D009873
H01.770.644.333;Operations Research;D009874
L01.906.575;Operations Research;D009874
G02.111.570.080.689.650;Operator Regions, Genetic;D009875
G05.360.080.689.650;Operator Regions, Genetic;D009875
G05.360.340.024.686.645;Operator Regions, Genetic;D009875
G05.360.340.300.500.645;Operator Regions, Genetic;D009875
G05.360.340.024.686;Operon;D009876
G05.360.340.300.500;Operon;D009876
C01.539.375.265;Endophthalmitis;D009877
C11.294.265;Endophthalmitis;D009877
C01.252.354.225.625;Ophthalmia Neonatorum;D009878
C01.252.400.625.391.658;Ophthalmia Neonatorum;D009878
C01.539.375.354.220.625;Ophthalmia Neonatorum;D009878
C11.187.183.220.538;Ophthalmia Neonatorum;D009878
C11.294.354.220.625;Ophthalmia Neonatorum;D009878
C16.614.677;Ophthalmia Neonatorum;D009878
C11.941.879.780.500;Ophthalmia, Sympathetic;D009879
C20.111.709;Ophthalmia, Sympathetic;D009879
A07.231.114.622;Ophthalmic Artery;D009880
M01.526.485.067.740.690;Ophthalmic Assistants;D009881
N02.360.067.740.690;Ophthalmic Assistants;D009881
A08.800.800.120.760.650;Ophthalmic Nerve;D009882
D26.255.775.645;Ophthalmic Solutions;D009883
D26.776.708.645;Ophthalmic Solutions;D009883
D27.720.280.775.645;Ophthalmic Solutions;D009883
E01.370.380.550;Ophthalmodynamometry;D009884
H02.403.810.468;Ophthalmology;D009885
C10.292.562.750;Ophthalmoplegia;D009886
C10.597.622.447;Ophthalmoplegia;D009886
C11.590.472;Ophthalmoplegia;D009886
C23.888.592.636.447;Ophthalmoplegia;D009886
E01.370.380.560;Ophthalmoscopy;D009887
D03.494.240.625;Opipramol;D009888
C03.335.865.685;Opisthorchiasis;D009889
B01.050.500.500.736.715.520;Opisthorchidae;D009890
B01.050.500.500.736.715.520.700;Opisthorchis;D009891
D20.215.784.500.534;Opium;D009892
B01.050.150.900.649.573.575;Opossums;D009893
C01.539.597;Opportunistic Infections;D009894
C02.597;Opportunistic Infections;D009894
C03.684;Opportunistic Infections;D009894
D12.776.124.486.485.114.767;Opsonin Proteins;D009895
D12.776.124.486.657;Opsonin Proteins;D009895
D12.776.124.790.651.114.767;Opsonin Proteins;D009895
D12.776.377.715.548.114.767;Opsonin Proteins;D009895
C10.292.700.225;Optic Atrophy;D009896
C11.640.451;Optic Atrophy;D009896
A08.800.800.120.680.600;Optic Chiasm;D009897
A08.800.800.120.680.660;Optic Disk;D009898
A09.371.729.690;Optic Disk;D009898
A13.686;Optic Lobe, Nonmammalian;D009899
A08.800.800.120.680;Optic Nerve;D009900
C10.292.700;Optic Nerve Diseases;D009901
C11.640;Optic Nerve Diseases;D009901
C10.292.700.550;Optic Neuritis;D009902
C11.640.576;Optic Neuritis;D009902
F02.463.593.446.659;Optical Illusions;D009903
G01.590.770.640;Optical Rotation;D009904
G01.595.640.640;Optical Rotation;D009904
E05.196.867.576;Optical Rotatory Dispersion;D009905
H02.553;Optometry;D009907
N01.400.535;Oral Health;D009909
E02.547.600;Oral Hygiene;D009910
E06.761.726;Oral Hygiene;D009910
E05.318.308.250.300.675;Oral Hygiene Index;D009911
E06.208.576;Oral Hygiene Index;D009911
N05.715.360.300.375.300.670;Oral Hygiene Index;D009911
N06.850.520.308.250.300.675;Oral Hygiene Index;D009911
N06.890.160.168;Oral Hygiene Index;D009911
C07.465.634;Oral Manifestations;D009912
C23.888.619;Oral Manifestations;D009912
F01.752.747.722.626;Oral Stage;D009913
F02.739.794.793.626;Oral Stage;D009913
C07.465.654;Oral Submucous Fibrosis;D009914
A02.835.232.781.324.690;Orbit;D009915
C11.675;Orbital Diseases;D009916
C26.260.275.500.550;Orbital Fractures;D009917
C26.404.750.684;Orbital Fractures;D009917
C04.588.149.721.656;Orbital Neoplasms;D009918
C04.588.364.659;Orbital Neoplasms;D009918
C05.116.231.754.659;Orbital Neoplasms;D009918
C11.319.457;Orbital Neoplasms;D009918
C11.675.659;Orbital Neoplasms;D009918
E04.270.282.679;Orchiectomy;D009919
E04.950.165.679;Orchiectomy;D009919
E04.950.774.860.618;Orchiectomy;D009919
C12.294.829.493;Orchitis;D009920
C19.391.829.493;Orchitis;D009920
D02.033.100.291.465;Metaproterenol;D009921
D02.092.063.291.465;Metaproterenol;D009921
D02.092.211.215.311.465;Metaproterenol;D009921
D02.092.311.660;Metaproterenol;D009921
Z01.107.567.875.560.550;Oregon;D009922
Z01.107.567.875.580.550;Oregon;D009922
B04.280.650.160.670.600;Orf virus;D009923
B04.909.204.783.160.670.600;Orf virus;D009923
E05.240.484;Organ Culture Techniques;D009924
A09.246.631.246.577;Organ of Corti;D009925
E02.792.833.660;Organ Preservation;D009926
E05.760.833.660;Organ Preservation;D009926
N02.421.911;Tissue and Organ Procurement;D009927
G07.650;Organ Specificity;D009928
E01.370.600.115.100.660;Organ Size;D009929
E05.041.124.715;Organ Size;D009929
G07.100.100.660;Organ Size;D009929
G07.700.320.249.690;Organ Size;D009929
D02;Organic Chemicals;D009930
N04.452;Organization and Administration;D009934
N04.452.602;Organizational Affiliation;D009935
N04.452.610;Organizational Innovation;D009936
N04.452.615;Organizational Objectives;D009937
N03.540;Organizations;D009938
N03.540.630;Organizations, Nonprofit;D009939
A10.802;Organoids;D009940
D02.691.750;Organomercury Compounds;D009941
D02.691;Organometallic Compounds;D009942
D02.705;Organophosphorus Compounds;D009943
D02.691.800;Organoplatinum Compounds;D009944
E02.095.682;Organotherapy;D009945
E02.190.701;Organotherapy;D009945
D02.705.539;Organothiophosphorus Compounds;D009946
D02.886.300;Organothiophosphorus Compounds;D009946
D02.691.850;Organotin Compounds;D009947
G08.686.785.760.460;Orgasm;D009948
F01.058.577;Orientation;D009949
F02.830.606;Orientation;D009949
D02.640.672.700;Ornidazole;D009950
D03.383.129.308.658.700;Ornidazole;D009950
D06.472.699.631.692.781.700;Ornipressin;D009951
D12.644.400.900.700;Ornipressin;D009951
D12.644.456.925.700;Ornipressin;D009951
D12.644.548.691.692.781.700;Ornipressin;D009951
D12.776.641.650.937.700;Ornipressin;D009951
D12.125.068.665;Ornithine;D009952
D12.125.095.765;Ornithine;D009952
D08.811.913.477.700.700;Ornithine-Oxo-Acid Transaminase;D009953
D08.811.913.555.275.600;Ornithine Carbamoyltransferase;D009954
D08.811.520.224.125.425;Ornithine Decarboxylase;D009955
C01.252.400.210.250.600;Psittacosis;D009956
C07.465.614.421;Oroantral Fistula;D009957
C23.300.575.500.550;Oroantral Fistula;D009957
C05.116.099.370.652;Orofaciodigital Syndromes;D009958
C05.660.207.700;Orofaciodigital Syndromes;D009958
C16.131.077.677;Orofaciodigital Syndromes;D009958
C16.131.260.830.670;Orofaciodigital Syndromes;D009958
C16.131.621.207.700;Orofaciodigital Syndromes;D009958
C16.320.180.830.670;Orofaciodigital Syndromes;D009958
C04.588.443.665.710.684;Oropharyngeal Neoplasms;D009959
C07.550.745.671;Oropharyngeal Neoplasms;D009959
C09.647.710.685;Oropharyngeal Neoplasms;D009959
C09.775.549.685;Oropharyngeal Neoplasms;D009959
A04.623.603;Oropharynx;D009960
A14.724.603;Oropharynx;D009960
D12.776.124.050.600;Orosomucoid;D009961
D12.776.124.790.106.640;Orosomucoid;D009961
D12.776.377.715.085.640;Orosomucoid;D009961
D12.776.395.560.742;Orosomucoid;D009961
D08.811.913.400.725.700;Orotate Phosphoribosyltransferase;D009962
D03.066.627;Orotic Acid;D009963
D03.383.742.698.875.660;Orotic Acid;D009963
D08.811.520.224.125.450;Orotidine-5'-Phosphate Decarboxylase;D009964
J01.576.318.600;Orphan Drug Production;D009965
D02.092.471.600;Orphenadrine;D009966
D02.455.426.559.389.115.600;Orphenadrine;D009966
E06.658.453;Orthodontic Appliances;D009967
E06.658.453.578;Orthodontic Appliances, Removable;D009968
E06.658.453.684;Orthodontic Wires;D009969
E06.658;Orthodontics;D009970
H02.163.876.439;Orthodontics;D009970
E06.658.578;Orthodontics, Corrective;D009971
E06.658.641;Orthodontics, Interceptive;D009972
E06.658.703;Orthodontics, Preventive;D009973
E02.319.630;Orthomolecular Therapy;D009974
F04.570.400;Orthomolecular Therapy;D009974
B04.820.545;Orthomyxoviridae;D009975
B04.909.777.545;Orthomyxoviridae;D009975
C02.782.620;Orthomyxoviridae Infections;D009976
B04.820.545.405.400;Influenza A virus;D009980
B04.909.777.545.405.400;Influenza A virus;D009980
B04.820.545.407.410;Influenza B virus;D009981
B04.909.777.545.407.410;Influenza B virus;D009981
B04.820.545.410;Influenzavirus C;D009982
B04.909.777.545.410;Influenzavirus C;D009982
E07.858.442;Orthopedic Equipment;D009983
E07.858.442.660;Orthopedic Fixation Devices;D009984
E07.858.690.650;Orthopedic Fixation Devices;D009984
H02.403.810.494;Orthopedics;D009985
F04.096.544.528;Orthopsychiatry;D009986
B01.050.500.131.617.678;Orthoptera;D009987
E02.730;Orthoptics;D009988
H02.573;Orthoptics;D009988
E07.858.442.743;Orthotic Devices;D009989
B01.050.150.900.493.850.139.650;Oryzias;D009990
E05.654;Oscillometry;D009991
D01.268.556.660;Osmium;D009992
D01.268.956.702;Osmium;D009992
D01.552.544.660;Osmium;D009992
D01.640.500;Osmium Tetroxide;D009993
D01.650.550.600;Osmium Tetroxide;D009993
G02.640;Osmolar Concentration;D009994
G02.842.640;Osmolar Concentration;D009994
G01.154.100.600;Osmosis;D009995
G01.595.100.600;Osmosis;D009995
G02.111.087.640;Osmosis;D009995
G02.149.115.640;Osmosis;D009995
G02.149.535;Osmosis;D009995
G02.149.767.645;Osmosis;D009995
G02.685.495;Osmosis;D009995
G02.842.700.495;Osmosis;D009995
G02.842.750.645;Osmosis;D009995
E01.370.225.625.550;Osmotic Fragility;D009996
E05.200.625.550;Osmotic Fragility;D009996
G09.188.640;Osmotic Fragility;D009996
G01.374.715.578;Osmotic Pressure;D009997
G02.640.249;Osmotic Pressure;D009997
G02.685.661;Osmotic Pressure;D009997
G02.842.640.249;Osmotic Pressure;D009997
G02.842.700.661;Osmotic Pressure;D009997
E07.695.550;Ossicular Prosthesis;D009998
C23.550.751;Ossification, Heterotopic;D009999
C01.539.160.412;Osteitis;D010000
C05.116.165.412;Osteitis;D010000
C05.116.680;Osteitis;D010000
C05.116.692;Osteitis Deformans;D010001
C05.116.132.684;Osteitis Fibrosa Cystica;D010002
C05.550.114.606;Osteoarthritis;D010003
C05.799.613;Osteoarthritis;D010003
C05.116.725;Osteoarthropathy, Primary Hypertrophic;D010004
C05.550.648;Osteoarthropathy, Primary Hypertrophic;D010004
C05.116.758;Osteoarthropathy, Secondary Hypertrophic;D010005
C05.550.684;Osteoarthropathy, Secondary Hypertrophic;D010005
A11.329.629;Osteoblasts;D010006
C05.116.791;Osteochondritis;D010007
C05.182.520;Osteochondritis;D010007
C17.300.182.520;Osteochondritis;D010007
C05.116.791.668;Osteochondritis Dissecans;D010008
C05.116.099.708;Osteochondrodysplasias;D010009
A11.329.372.700;Osteoclasts;D010010
A11.627.482.700;Osteoclasts;D010010
A11.329.629.500;Osteocytes;D010011
G07.700.320.500.325.377.625.100.729;Osteogenesis;D010012
G11.427.590.560.100.729;Osteogenesis;D010012
C05.116.099.708.685;Osteogenesis Imperfecta;D010013
C16.320.737;Osteogenesis Imperfecta;D010013
C17.300.200.540;Osteogenesis Imperfecta;D010013
C05.116.264.579;Osteolysis;D010014
G11.427.590.195.150.570;Osteolysis;D010014
C05.116.099.736;Osteolysis, Essential;D010015
C05.116.264.579.704;Osteolysis, Essential;D010015
C04.557.450.565.575.625;Osteoma;D010016
C04.557.450.565.575.625.625;Osteoma, Osteoid;D010017
C05.116.198.495;Osteomalacia;D010018
C18.452.174.662;Osteomalacia;D010018
C18.654.521.500.133.770.496;Osteomalacia;D010018
C01.539.160.495;Osteomyelitis;D010019
C05.116.165.495;Osteomyelitis;D010019
C05.116.852;Osteonecrosis;D010020
C23.550.717.732;Osteonecrosis;D010020
H02.403.640;Osteopathic Medicine;D010021
C05.116.099.708.702.678;Osteopetrosis;D010022
C05.116.099.708.702.685;Osteopoikilosis;D010023
C17.300.705;Osteopoikilosis;D010023
C05.116.198.579;Osteoporosis;D010024
C26.733.579;Osteoradionecrosis;D010025
C05.116.099.708.702;Osteosclerosis;D010026
E04.555.580;Osteotomy;D010027
B01.050.500.500.294.700.775.746.432;Ostertagia;D010028
C03.335.508.700.775.825.580;Ostertagiasis;D010029
E04.579;Ostomy;D010030
C09.218.705;Otitis;D010031
C09.218.705.496;Otitis Externa;D010032
C09.218.705.663;Otitis Media;D010033
C09.218.705.663.683;Otitis Media with Effusion;D010034
C01.539.830.694;Otitis Media, Suppurative;D010035
C09.218.705.663.680;Otitis Media, Suppurative;D010035
H02.403.810.526;Otolaryngology;D010036
A09.246.631.909.625.125.680;Otolithic Membrane;D010037
C09;Otorhinolaryngologic Diseases;D010038
C04.588.443.665;Otorhinolaryngologic Neoplasms;D010039
C09.647;Otorhinolaryngologic Neoplasms;D010039
C09.218.768;Otosclerosis;D010040
B01.050.150.900.649.147.550.600;Otters;D010041
D04.808.155.160.861.600;Ouabain;D010042
D04.808.155.580.130.750.600;Ouabain;D010042
D09.408.180.810.600;Ouabain;D010042
N04.761.559;Outcome and Process Assessment (Health Care);D010043
N05.715.360.575;Outcome and Process Assessment (Health Care);D010043
N02.278.035.380;Outpatient Clinics, Hospital;D010044
N02.278.354.422.527;Outpatient Clinics, Hospital;D010044
N04.452.442.422.527;Outpatient Clinics, Hospital;D010044
M01.643.630;Outpatients;D010045
A09.246.631.909.551;Oval Window, Ear;D010046
D12.644.861.560;Ovalbumin;D010047
D12.776.034.614;Ovalbumin;D010047
D12.776.256.317.663;Ovalbumin;D010047
D12.776.290.663;Ovalbumin;D010047
D12.776.872.560;Ovalbumin;D010047
C04.182.612;Ovarian Cysts;D010048
C13.351.500.056.630.580;Ovarian Cysts;D010048
C19.391.630.580;Ovarian Cysts;D010048
C13.351.500.056.630;Ovarian Diseases;D010049
C19.391.630;Ovarian Diseases;D010049
E01.370.374.530;Ovarian Function Tests;D010050
E01.370.378.530;Ovarian Function Tests;D010050
C04.588.322.455;Ovarian Neoplasms;D010051
C13.351.500.056.630.705;Ovarian Neoplasms;D010051
C13.351.937.418.685;Ovarian Neoplasms;D010051
C19.344.410;Ovarian Neoplasms;D010051
C19.391.630.705;Ovarian Neoplasms;D010051
E04.270.282.685;Ovariectomy;D010052
E04.950.165.685;Ovariectomy;D010052
E04.950.300.680;Ovariectomy;D010052
A05.360.319.114.630;Ovary;D010053
A05.360.576.497;Ovary;D010053
A06.407.312.497;Ovary;D010053
F04.586.083;Brief Psychiatric Rating Scale;D010054
F02.463.425.612;Overlearning;D010056
A13.706;Oviducts;D010057
G08.686.785.760.480;Oviposition;D010058
D12.776.256.317.675;Ovomucin;D010059
D12.776.290.675;Ovomucin;D010059
D12.776.395.560.760;Ovomucin;D010059
G08.686.785.760.690;Ovulation;D010060
E01.370.378.530.550;Ovulation Detection;D010061
E02.875.690;Ovulation Detection;D010061
E05.820.690;Ovulation Detection;D010061
E02.875.800.984;Ovulation Induction;D010062
E05.820.800.984;Ovulation Induction;D010062
A05.360.490.690;Ovum;D010063
A11.497.497;Ovum;D010063
A16.690;Ovum;D010063
G08.686.785.760.170.104.500;Embryo Implantation;D010064
G08.686.785.760.170.104.500.100;Embryo Implantation, Delayed;D010065
G04.299.283.700;Ovum Transport;D010066
G08.686.785.760.277.360;Ovum Transport;D010066
I01.880.604.583.594;Ownership;D010067
N04.452.633;Ownership;D010067
D02.065.589.099.750.625;Oxacillin;D010068
D02.886.108.750.625;Oxacillin;D010068
D03.438.260.825.625;Oxacillin;D010068
D03.605.084.737.625;Oxacillin;D010068
D04.075.080.875.099.221.750.625;Oxacillin;D010068
D03.383.129.462.580;Oxadiazoles;D010069
D02.241.081.337.593;Oxalates;D010070
D02.241.081.337.593.812;Oxaloacetates;D010071
D02.241.755.648;Oxaloacetates;D010071
D02.241.152.367.600;Oxamic Acid;D010072
D12.125.730;Oxamic Acid;D010072
D03.438.810.350.600;Oxamniquine;D010073
D03.438.810.470.600;Oxamniquine;D010073
D04.808.054.040.581;Oxandrolone;D010074
D03.383.517;Oxathiins;D010075
D03.438.079.080.070.663;Oxazepam;D010076
D03.383.066.498;Oxazepines;D010077
D03.383.533;Oxazines;D010078
D03.383.113.767;Oxazocines;D010079
D03.383.129.462;Oxazoles;D010080
D03.383.129.462.620;Oxazolone;D010081
D02.355.291.852;Oxepins;D010082
D03.383.564;Oxepins;D010082
D27.720.642.631;Oxidants, Photochemical;D010083
D27.888.284.101.696;Oxidants, Photochemical;D010083
D27.888.569.540.631;Oxidants, Photochemical;D010083
G02.149.767.650;Oxidation-Reduction;D010084
G02.842.750.650;Oxidation-Reduction;D010084
G03.495.335.531;Oxidation-Reduction;D010084
G02.111.087.677.550;Oxidative Phosphorylation;D010085
G02.149.115.677.550;Oxidative Phosphorylation;D010085
G03.495.335.631;Oxidative Phosphorylation;D010085
G03.495.790.550;Oxidative Phosphorylation;D010085
D12.776.691;Oxidative Phosphorylation Coupling Factors;D010086
D01.248.497.158.685;Oxides;D010087
D01.650.550;Oxides;D010087
D08.811.682;Oxidoreductases;D010088
D08.811.682.662.582;Oxidoreductases, N-Demethylating;D010089
D08.811.682.670;Oxidoreductases, O-Demethylating;D010090
D02.092.570.665;Oximes;D010091
E01.370.225.124.100.100.600;Oximetry;D010092
E01.370.370.380.600;Oximetry;D010092
E01.370.386.700.100.600;Oximetry;D010092
E05.200.124.100.100.600;Oximetry;D010092
D03.438.810.835.055.580;Oxolinic Acid;D010093
D03.383.931.640;Oxonic Acid;D010094
D03.383.773.812.498;Oxotremorine;D010095
D02.033.100.624.651;Oxprenolol;D010096
D02.033.100.624.698.633;Oxprenolol;D010096
D02.033.755.624.651;Oxprenolol;D010096
D02.033.755.624.698.633;Oxprenolol;D010096
D02.092.063.624.698.633;Oxprenolol;D010096
D02.065.199.860.500;Oxyclozanide;D010097
D02.065.793.650.500;Oxyclozanide;D010097
D03.132.577.249.547.547.149.575;Oxycodone;D010098
D03.549.686.575.547.204.650;Oxycodone;D010098
D03.605.497.575.547.204.650;Oxycodone;D010098
D04.615.723.795.547.547.149.575;Oxycodone;D010098
D02.033.100.624.675;Oxyfedrine;D010099
D02.033.755.624.675;Oxyfedrine;D010099
D02.092.063.624.706.600;Oxyfedrine;D010099
D02.092.471.683.775;Oxyfedrine;D010099
D02.522.818.800;Oxyfedrine;D010099
D01.268.185.550;Oxygen;D010100
D01.362.670;Oxygen;D010100
G03.730;Oxygen Consumption;D010101
E02.880.690;Oxygen Inhalation Therapy;D010102
D01.496.625;Oxygen Isotopes;D010103
D01.496.625.600;Oxygen Radioisotopes;D010104
D01.496.749.635;Oxygen Radioisotopes;D010104
D08.811.682.690;Oxygenases;D010105
E07.652;Oxygenators;D010106
E07.652.582;Oxygenators, Membrane;D010107
D12.776.124.400.707;Oxyhemoglobins;D010108
D12.776.422.316.762.687;Oxyhemoglobins;D010108
D03.383.129.308.704;Oxymetazoline;D010109
D04.808.054.040.632;Oxymetholone;D010110
D03.132.577.249.547.547.692;Oxymorphone;D010111
D03.549.686.575.547.675;Oxymorphone;D010111
D03.605.497.575.547.675;Oxymorphone;D010111
D04.615.723.795.547.547.692;Oxymorphone;D010111
D03.383.129.539.850.777.700;Oxyphenbutazone;D010113
D03.438.473.725;Oxyphenisatin Acetate;D010114
D02.092.877.648;Oxyphenonium;D010115
D02.675.276.648;Oxyphenonium;D010115
D03.383.129.539.650;Oxypurinol;D010117
D03.383.742.550;Oxypurinol;D010117
D02.455.426.559.847.562.900.600;Oxytetracycline;D010118
D04.615.562.900.600;Oxytetracycline;D010118
D02.886.675.540;Oxythiamine;D010119
D03.383.129.708.540;Oxythiamine;D010119
D27.505.696.875.737;Oxytocics;D010120
D27.505.954.705.737;Oxytocics;D010120
D06.472.699.631.692.433;Oxytocin;D010121
D12.644.548.691.692.433;Oxytocin;D010121
D08.811.277.656.350.100.235;Cystinyl Aminopeptidase;D010122
D08.811.277.656.350.555.400;Cystinyl Aminopeptidase;D010122
D08.811.277.656.675.555.400;Cystinyl Aminopeptidase;D010122
C03.335.508.700.550.550;Oxyuriasis;D010123
B01.050.500.500.294.700.500.500;Oxyuroidea;D010124
B01.050.500.644.080.643;Ostreidae;D010125
D01.362.670.600;Ozone;D010126
D23.050.301.290.691;P Blood-Group System;D010127
D23.050.705.230.691;P Blood-Group System;D010127
D02.172.032;p-Aminoazobenzene;D010128
D02.241.223.100.050.500.640;4-Aminobenzoic Acid;D010129
D02.455.426.559.389.127.020.937.640;4-Aminobenzoic Acid;D010129
D02.065.277.431.192.100;p-Aminohippuric Acid;D010130
D02.241.223.100.050.500.650;p-Aminohippuric Acid;D010130
D02.241.223.100.100.100.100;p-Aminohippuric Acid;D010130
D02.241.755.360.192.100;p-Aminohippuric Acid;D010130
D02.455.426.559.389.127.020.937.650;p-Aminohippuric Acid;D010130
D02.455.426.559.389.127.085.067.100;p-Aminohippuric Acid;D010130
D02.241.223.100.050.500.642;Aminosalicylic Acid;D010131
D02.241.223.100.300.595.100.060;Aminosalicylic Acid;D010131
D02.241.511.390.595.100.060;Aminosalicylic Acid;D010131
D02.455.426.559.389.127.020.937.642;Aminosalicylic Acid;D010131
D02.455.426.559.389.127.281.595.100.060;Aminosalicylic Acid;D010131
D02.455.426.559.389.657.410.595.100.060;Aminosalicylic Acid;D010131
D02.172.045;p-Azobenzenearsonate;D010132
D02.691.088.060;p-Azobenzenearsonate;D010132
D23.050.550.480.097;p-Azobenzenearsonate;D010132
D02.092.471.683.152.200;p-Chloroamphetamine;D010133
D12.125.072.050.685.440;Fenclonine;D010134
D12.125.072.050.685.450;p-Fluorophenylalanine;D010135
D02.092.471.683.152.500;p-Hydroxyamphetamine;D010136
D02.033.100.624.706.400;p-Hydroxynorephedrine;D010137
D02.033.755.624.706.400;p-Hydroxynorephedrine;D010137
D02.092.063.624.706.400;p-Hydroxynorephedrine;D010137
E07.305.250.750;Pacemaker, Artificial;D010138
Z01.639.760;Pacific Islands;D010139
Z01.678.100.873;Pacific Islands;D010139
Z01.756.700;Pacific Ocean;D010140
A08.663.650.915.750.700;Pacinian Corpuscles;D010141
A08.800.950.750.700;Pacinian Corpuscles;D010141
A11.671.650.915.750.700;Pacinian Corpuscles;D010141
D02.241.223.100.300.450;Pactamycin;D010142
D02.241.511.390.450;Pactamycin;D010142
D02.455.426.559.389.127.281.450;Pactamycin;D010142
D02.455.426.559.389.657.410.450;Pactamycin;D010142
B01.300.381.640;Paecilomyces;D010143
C04.557.470.200.025.275.625;Paget's Disease, Mammary;D010144
C04.557.470.615.275.625;Paget's Disease, Mammary;D010144
C04.557.470.200.025.660;Paget Disease, Extramammary;D010145
C04.557.470.615.660;Paget Disease, Extramammary;D010145
C10.597.617;Pain;D010146
C23.888.592.612;Pain;D010146
C23.888.646;Pain;D010146
F02.830.816.444;Pain;D010146
G11.561.600.810.444;Pain;D010146
E01.370.376.550.600;Pain Measurement;D010147
C10.597.617.788;Pain, Intractable;D010148
C23.888.592.612.776;Pain, Intractable;D010148
C23.888.646.515;Pain, Intractable;D010148
C23.550.767.700;Pain, Postoperative;D010149
C23.888.646.530;Pain, Postoperative;D010149
J01.637.597;Paint;D010150
K01.093.646;Paintings;D010151
F01.145.113.252.748.400;Pair Bond;D010152
F02.463.425.952.500;Paired-Associate Learning;D010153
Z01.252.245.723;Pakistan;D010154
E06.658.578.458;Palatal Expansion Technique;D010155
A02.633.567.750;Palatal Muscles;D010156
A14.549.617.623;Palatal Muscles;D010156
C04.588.149.721.450.692;Palatal Neoplasms;D010157
C04.588.443.591.692;Palatal Neoplasms;D010157
C05.116.231.754.450.692;Palatal Neoplasms;D010157
C05.500.499.692;Palatal Neoplasms;D010157
C07.320.515.692;Palatal Neoplasms;D010157
C07.465.565.692;Palatal Neoplasms;D010157
E06.780.345.850;Palatal Obturators;D010158
E07.695.190.600;Palatal Obturators;D010158
A14.521.658;Palate;D010159
A14.549.617;Palate;D010159
A14.549.617.780;Palate, Soft;D010160
I01.076.368.584.583;Paleodontology;D010161
L01.143.506.423.906.539.500;Paleography;D010162
H01.277.875;Paleontology;D010163
I01.076.368.584;Paleontology;D010163
I01.076.368.584.709;Paleopathology;D010164
D01.268.556.680;Palladium;D010165
D01.268.956.718;Palladium;D010165
D01.552.544.680;Palladium;D010165
E02.760.666;Palliative Care;D010166
N02.421.585.666;Palliative Care;D010166
C23.888.885.500;Pallor;D010167
D10.251.694.600;Palmitates;D010168
D10.251.694;Palmitic Acids;D010169
D08.811.277.352.897.700;Palmitoyl-CoA Hydrolase;D010170
D03.438.759.646.138.382.300.700;Palmitoyl Coenzyme A;D010171
D08.211.211.300.700;Palmitoyl Coenzyme A;D010171
D10.251.694.600.500;Palmitoyl Coenzyme A;D010171
D13.695.667.138.382.300.700;Palmitoyl Coenzyme A;D010171
D13.695.827.068.382.300.700;Palmitoyl Coenzyme A;D010171
D02.092.877.883.099.700;Palmitoylcarnitine;D010172
E01.370.600.600;Palpation;D010173
L01.178.682.707;Pamphlets;D010174
N03.540.514.718.800.628;Pan American Health Organization;D010175
Z01.107.169.772;Panama;D010176
Z01.107.169.772.584;Panama Canal Zone;D010177
C04.588.894.797.520.734;Pancoast Syndrome;D010178
C08.381.540.734;Pancoast Syndrome;D010178
C08.785.520.734;Pancoast Syndrome;D010178
A03.734;Pancreas;D010179
E04.210.752;Pancreatectomy;D010180
C04.182.640;Pancreatic Cyst;D010181
C06.689.500;Pancreatic Cyst;D010181
C06.689;Pancreatic Diseases;D010182
A03.734.667;Pancreatic Ducts;D010183
D20.777.500;Pancreatic Extracts;D010184
C06.267.775;Pancreatic Fistula;D010185
C06.689.583;Pancreatic Fistula;D010185
C23.300.575.185.775;Pancreatic Fistula;D010185
E01.370.372.600;Pancreatic Function Tests;D010186
D06.472.699.587;Pancreatic Hormones;D010187
D12.644.548.586;Pancreatic Hormones;D010187
C06.689.276;Exocrine Pancreatic Insufficiency;D010188
A12.200.567;Pancreatic Juice;D010189
C04.588.274.761;Pancreatic Neoplasms;D010190
C04.588.322.475;Pancreatic Neoplasms;D010190
C06.301.761;Pancreatic Neoplasms;D010190
C06.689.667;Pancreatic Neoplasms;D010190
C19.344.421;Pancreatic Neoplasms;D010190
D06.472.699.587.700;Pancreatic Polypeptide;D010191
D12.644.400.600;Pancreatic Polypeptide;D010191
D12.644.548.586.700;Pancreatic Polypeptide;D010191
D12.776.641.650.600;Pancreatic Polypeptide;D010191
C04.182.640.692;Pancreatic Pseudocyst;D010192
C06.689.500.692;Pancreatic Pseudocyst;D010192
E04.035.703;Pancreaticojejunostomy;D010193
E04.210.762;Pancreaticojejunostomy;D010193
D08.811.277.610;Pancreatin;D010194
D20.777.500.720;Pancreatin;D010194
C06.689.750;Pancreatitis;D010195
D08.811.277.656.300.760.560;Pancreatic Elastase;D010196
D08.811.277.656.959.350.560;Pancreatic Elastase;D010196
D04.808.054.040.685;Pancuronium;D010197
C15.378.700;Pancytopenia;D010198
F01.470.361.585;Panic;D010200
C17.300.710.500;Panniculitis, Nodular Nonsuppurative;D010201
C17.800.566.500;Panniculitis, Nodular Nonsuppurative;D010201
C01.252.354.900.675;Panophthalmitis;D010202
C01.539.375.354.900.675;Panophthalmitis;D010202
C01.539.375.450.900.675;Panophthalmitis;D010202
C01.703.343.900.675;Panophthalmitis;D010202
C11.294.354.900.675;Panophthalmitis;D010202
C11.294.450.900.675;Panophthalmitis;D010202
C11.941.879.960.580;Panophthalmitis;D010202
B01.050.500.131.617.412.420.700.850.600;Panstrongylus;D010203
D02.886.489.700;Pantetheine;D010204
D02.478.520;Pantothenic Acid;D010205
D12.125.042.070.500;Pantothenic Acid;D010205
D08.811.277.656.262.500.585;Papain;D010206
D08.811.277.656.300.200.585;Papain;D010206
B01.650.940.800.575.100.795.500;Papaver;D010207
D03.132.098.666;Papaverine;D010208
D03.132.577.750;Papaverine;D010208
D03.438.531.085.666;Papaverine;D010208
J01.576.154.600;Paper;D010209
J01.637.650;Paper;D010209
A02.633.580.680;Papillary Muscles;D010210
A07.541.510.619;Papillary Muscles;D010210
A07.541.704.750;Papillary Muscles;D010210
A07.541.749;Papillary Muscles;D010210
C10.292.700.900;Papilledema;D010211
C11.640.710;Papilledema;D010211
C04.557.470.700.600;Papilloma;D010212
C16.320.850.475.600;Papillon-Lefevre Disease;D010214
C17.800.428.435.600;Papillon-Lefevre Disease;D010214
C17.800.827.475.600;Papillon-Lefevre Disease;D010214
B01.050.150.900.649.801.400.112.199.120.610;Papio;D010215
C02.081.700;Phlebotomus Fever;D010217
C02.782.147.700;Phlebotomus Fever;D010217
Z01.639.760.590.715;Papua New Guinea;D010219
A06.224.636;Para-Aortic Bodies;D010220
B04.820.455.600.650.700.715;Parainfluenza Virus 1, Human;D010222
B04.909.777.455.600.650.700.715;Parainfluenza Virus 1, Human;D010222
B04.820.455.600.650.750.715;Parainfluenza Virus 2, Human;D010223
B04.909.777.455.600.650.750.715;Parainfluenza Virus 2, Human;D010223
B04.820.455.600.650.700.735;Parainfluenza Virus 3, Human;D010224
B04.909.777.455.600.650.700.735;Parainfluenza Virus 3, Human;D010224
D02.241.223.100.300.460;Parabens;D010226
D02.241.511.390.460;Parabens;D010226
D02.455.426.559.389.127.281.460;Parabens;D010226
D02.455.426.559.389.657.410.460;Parabens;D010226
E05.660;Parabiosis;D010227
B01.300.381.648;Paracoccidioides;D010228
C01.539.800.200.600;Paracoccidioidomycosis;D010229
C01.703.295.600;Paracoccidioidomycosis;D010229
C01.703.700;Paracoccidioidomycosis;D010229
C17.800.838.208.600;Paracoccidioidomycosis;D010229
B03.440.400.425.600;Paracoccus;D010230
B03.660.050.750.600;Paracoccus;D010230
B03.440.400.425.600.380;Paracoccus denitrificans;D010231
B03.660.050.750.600.125;Paracoccus denitrificans;D010231
D02.455.612;Paraffin;D010232
A06.224.736;Paraganglia, Chromaffin;D010233
A08.663.650.915.500.600;Paraganglia, Nonchromaffin;D010234
A08.800.950.500.600;Paraganglia, Nonchromaffin;D010234
A11.671.650.915.500.600;Paraganglia, Nonchromaffin;D010234
C04.557.465.625.650.700;Paraganglioma;D010235
C04.557.580.625.650.700;Paraganglioma;D010235
C04.557.465.625.650.700.705;Paraganglioma, Extra-Adrenal;D010236
C04.557.580.625.650.700.705;Paraganglioma, Extra-Adrenal;D010236
C03.335.865.741;Paragonimiasis;D010237
B01.050.500.500.736.715.800.610;Paragonimus;D010238
Z01.107.757.656;Paraguay;D010239
B01.050.150.900.248.710.672.650;Parakeets;D010240
C17.800.428.736;Parakeratosis;D010241
D02.047.064.586;Paraldehyde;D010242
C10.597.622;Paralysis;D010243
C23.888.592.636;Paralysis;D010243
C10.574.562.300;Bulbar Palsy, Progressive;D010244
C10.668.467.300;Bulbar Palsy, Progressive;D010244
C05.651.701;Paralyses, Familial Periodic;D010245
C10.668.491.650;Paralyses, Familial Periodic;D010245
C16.320.565.618.711;Paralyses, Familial Periodic;D010245
C18.452.648.618.711;Paralyses, Familial Periodic;D010245
C16.614.131.587;Paralysis, Obstetric;D010246
C26.141.587;Paralysis, Obstetric;D010246
B01.043.185.650.375.550.637;Paramecium;D010247
D04.808.745.432.769.692;Paramethasone;D010248
D04.808.908.727;Paramethasone;D010248
C13.351.500.056.750.750;Parametritis;D010249
B01.050.500.500.736.715.600;Paramphistomatidae;D010250
B04.820.455.600;Paramyxoviridae;D010252
B04.909.777.455.600;Paramyxoviridae;D010252
C02.782.580.600.600;Respirovirus Infections;D010253
C08.460.692;Paranasal Sinus Diseases;D010254
C09.603.692;Paranasal Sinus Diseases;D010254
C04.588.443.665.650.693;Paranasal Sinus Neoplasms;D010255
C08.460.669.693;Paranasal Sinus Neoplasms;D010255
C08.460.692.503;Paranasal Sinus Neoplasms;D010255
C08.785.600.693;Paranasal Sinus Neoplasms;D010255
C09.603.669.693;Paranasal Sinus Neoplasms;D010255
C09.603.692.503;Paranasal Sinus Neoplasms;D010255
C09.647.685.693;Paranasal Sinus Neoplasms;D010255
A04.531.621;Paranasal Sinuses;D010256
C04.730;Paraneoplastic Syndromes;D010257
F01.145.126.962;Paranoid Behavior;D010258
F03.700.450;Paranoid Disorders;D010259
F03.675.600;Paranoid Personality Disorder;D010260
D02.705.400.650;Paraoxon;D010261
F03.800.800.600;Paraphilias;D010262
C12.294.494.684.587;Paraphimosis;D010263
C10.597.622.669;Paraplegia;D010264
C23.888.592.636.637;Paraplegia;D010264
C15.378.147.780;Paraproteinemias;D010265
C20.683.780;Paraproteinemias;D010265
D12.776.124.486.485.900;Paraproteins;D010266
D12.776.124.790.651.900;Paraproteins;D010266
D12.776.377.715.548.900;Paraproteins;D010266
C17.800.859.575;Parapsoriasis;D010267
F02.550;Parapsychology;D010268
F04.096.462;Parapsychology;D010268
H01.770.644.364;Parapsychology;D010268
D03.383.725.762.621;Paraquat;D010269
E01.370.225.932.600;Parasite Egg Count;D010270
E05.200.932.600;Parasite Egg Count;D010270
B01.050.500.714;Parasites;D010271
C03;Parasitic Diseases;D010272
C03.701;Parasitic Diseases, Animal;D010273
C22.674;Parasitic Diseases, Animal;D010273
H01.158.273.688;Parasitology;D010274
A08.800.050.600;Parasympathetic Nervous System;D010275
D27.505.696.663.050.650;Parasympatholytics;D010276
D27.505.696.663.050.675;Parasympathomimetics;D010277
D02.705.400.625.600;Parathion;D010278
D02.705.539.345.600;Parathion;D010278
D02.886.300.692.600;Parathion;D010278
C19.642;Parathyroid Diseases;D010279
A06.407.560;Parathyroid Glands;D010280
D06.472.699.590;Parathyroid Hormone;D010281
D12.644.548.587;Parathyroid Hormone;D010281
C04.588.322.525;Parathyroid Neoplasms;D010282
C04.588.443.680;Parathyroid Neoplasms;D010282
C19.344.525;Parathyroid Neoplasms;D010282
C19.642.713;Parathyroid Neoplasms;D010282
C01.252.410.040.552.588;Paratuberculosis;D010283
C22.688;Paratuberculosis;D010283
C01.252.400.310.821.438;Paratyphoid Fever;D010284
B04.280.650.160.670.650;Pseudocowpox virus;D010285
B04.909.204.783.160.670.650;Pseudocowpox virus;D010285
A08.186.211.730.317.357.342.400;Paraventricular Hypothalamic Nucleus;D010286
F01.829.263.370.290;Parent-Child Relations;D010287
E02.421.505;Parenteral Nutrition;D010288
E02.642.500.505;Parenteral Nutrition;D010288
E02.421.505.575;Parenteral Nutrition, Total;D010289
E02.642.500.505.750;Parenteral Nutrition, Total;D010289
F01.829.263.500.320;Parents;D010290
I01.880.225.500.340;Parents;D010290
M01.620;Parents;D010290
C10.597.636;Paresis;D010291
C23.888.592.643;Paresis;D010291
C10.597.751.791.875;Paresthesia;D010292
C23.888.592.763.770.875;Paresthesia;D010292
D02.092.200.650;Pargyline;D010293
D02.455.426.559.389.140.210.650;Pargyline;D010293
A02.835.232.781.651;Parietal Bone;D010294
A03.556.875.875.440.708;Parietal Cells, Gastric;D010295
A10.615.550.291.650;Parietal Cells, Gastric;D010295
A11.436.708;Parietal Cells, Gastric;D010295
A08.186.211.730.885.287.500.670;Parietal Lobe;D010296
Z01.433.800;Paris;D010297
Z01.542.286.588;Paris;D010297
G08.686.677;Parity;D010298
G08.686.785.760.769.472;Parity;D010298
N06.850.490.812.600;Parity;D010298
J01.086.339.490;Parking Facilities;D010299
C10.228.140.079.862.500;Parkinson Disease;D010300
C10.228.662.600.400;Parkinson Disease;D010300
C10.574.812;Parkinson Disease;D010300
C10.228.140.079.862.800.600;Parkinson Disease, Postencephalitic;D010301
C10.228.662.600.700.500;Parkinson Disease, Postencephalitic;D010301
C10.228.140.079.862.800;Parkinson Disease, Secondary;D010302
C10.228.662.600.700;Parkinson Disease, Secondary;D010302
D09.408.051.623.635;Paromomycin;D010303
C01.539.800.460;Paronychia;D010304
C17.800.529.639;Paronychia;D010304
C17.800.838.486;Paronychia;D010304
C07.465.815.470;Parotid Diseases;D010305
A03.556.500.760.464;Parotid Gland;D010306
A10.336.779.464;Parotid Gland;D010306
A14.549.760.464;Parotid Gland;D010306
C04.588.443.591.824.695;Parotid Neoplasms;D010307
C07.465.565.824.695;Parotid Neoplasms;D010307
C07.465.815.470.770;Parotid Neoplasms;D010307
C07.465.815.718.589;Parotid Neoplasms;D010307
C07.465.815.470.800;Parotitis;D010309
C07.465.815.793.500;Parotitis;D010309
C04.182.668;Parovarian Cyst;D010310
C23.300.306.500;Parovarian Cyst;D010310
B01.050.150.900.248.710.672;Parrots;D010311
G08.686.785.760.830.500;Parthenogenesis;D010312
G01.374.715.714;Partial Pressure;D010313
E01.370.225.625.115.600;Partial Thromboplastin Time;D010314
E05.200.625.115.600;Partial Thromboplastin Time;D010314
G09.188.660;Partial Thromboplastin Time;D010314
E07.710.680;Particle Accelerators;D010315
G02.842.680;Particle Size;D010316
N04.452.758.671;Partnership Practice;D010317
N04.452.758.671.589;Partnership Practice, Dental;D010318
C22.695;Parturient Paresis;D010319
D12.776.034.700;Parvalbumins;D010320
D12.776.210.500.750;Parvalbumins;D010320
B04.280.580;Parvoviridae;D010321
B04.909.204.671;Parvoviridae;D010321
C02.256.700;Parvoviridae Infections;D010322
E01.370.225.812.871.600;Passive Cutaneous Anaphylaxis;D010323
E05.200.812.871.600;Passive Cutaneous Anaphylaxis;D010323
E05.478.594.890.600;Passive Cutaneous Anaphylaxis;D010323
G12.425.143.754;Passive Cutaneous Anaphylaxis;D010323
F03.675.625;Passive-Aggressive Personality Disorder;D010324
B03.440.450.600.600;Pasteurella;D010325
B03.660.250.550.590;Pasteurella;D010325
C01.252.400.700.662;Pasteurella Infections;D010326
F02.784.176.560;Pastoral Care;D010327
F02.880.410;Pastoral Care;D010327
E01.370.225.812.871.610;Patch Tests;D010328
E05.200.812.871.610;Patch Tests;D010328
E05.478.594.890.610;Patch Tests;D010328
A02.835.232.043.650.624;Patella;D010329
I01.880.604.583.458.650;Patents as Topic;D010330
N03.706.535.518.650;Patents as Topic;D010330
G08.686.700;Paternal Age;D010331
F01.829.263.370.330;Paternal Behavior;D010332
F01.829.263.370.380;Paternal Deprivation;D010333
I01.198.780.937.766;Paternity;D010334
C23.550;Pathologic Processes;D010335
H02.403.650;Pathology;D010336
N02.278.354.422.535;Pathology Department, Hospital;D010337
N04.452.442.422.535;Pathology Department, Hospital;D010337
H02.403.650.500;Pathology, Clinical;D010338
E06.685;Pathology, Oral;D010339
H02.163.876.506;Pathology, Oral;D010339
H02.403.650.510;Pathology, Surgical;D010340
H02.956.465;Pathology, Veterinary;D010341
N05.300.150.600;Patient Acceptance of Health Care;D010342
E02.760.400.600;Patient Admission;D010343
N02.421.585.400.600;Patient Admission;D010343
I01.880.604.631;Patient Advocacy;D010344
N03.706.678;Patient Advocacy;D010344
N04.590;Patient Care Management;D010346
N04.590.233.624;Patient Care Planning;D010347
N04.590.715;Patient Care Team;D010348
F01.145.488.500;Patient Compliance;D010349
N05.300.150.600.600;Patient Compliance;D010349
N03.219.463.030.320;Patient Credit and Collection;D010350
E02.760.400.610;Patient Discharge;D010351
N02.421.585.400.610;Patient Discharge;D010351
M01.643.673;Patient Dropouts;D010352
I02.233.332.500;Patient Education as Topic;D010353
N02.421.143.827.407.680;Patient Education as Topic;D010353
N02.421.726.407.680;Patient Education as Topic;D010353
N02.360.740.400.650;Patient Escort Service;D010354
N04.452.653;Patient Identification Systems;D010355
E02.770;Patient Isolation;D010356
N06.850.780.200.450.650;Patient Isolation;D010356
E07.325.755;Patient Isolators;D010357
N02.421.143.262.300;Patient Participation;D010358
N03.540.245.360.300;Patient Participation;D010358
N05.300.150.600.620;Patient Participation;D010358
E02.760.400.620;Patient Readmission;D010359
N02.421.585.400.620;Patient Readmission;D010359
E02.760.400.630;Patient Transfer;D010360
N02.421.585.400.630;Patient Transfer;D010360
M01.643;Patients;D010361
N02.278.220.640;Patients' Rooms;D010362
L01.725;Pattern Recognition, Automated;D010363
F02.463.593.524.500;Pattern Recognition, Visual;D010364
F02.463.593.932.622;Pattern Recognition, Visual;D010364
F02.463.593.932.869.435.673;Pattern Recognition, Visual;D010364
D03.830.670;Patulin;D010365
D23.946.587.725;Patulin;D010365
E01.370.386.700.660.225.600;Peak Expiratory Flow Rate;D010366
G09.772.650.300.790;Peak Expiratory Flow Rate;D010366
B01.650.940.800.575.100.401.077;Arachis hypogaea;D010367
J02.500.850.500.077;Arachis hypogaea;D010367
D05.750.078.738;Pectins;D010368
D09.698.670;Pectins;D010368
D20.215.784.500.618;Pectins;D010368
A02.633.567.775;Pectoralis Muscles;D010369
M01.526.485.067.740.750;Pediatric Assistants;D010370
N02.360.067.740.750;Pediatric Assistants;D010370
H02.478.676.631;Pediatric Nursing;D010371
N02.421.533.691;Pediatric Nursing;D010371
H02.403.670;Pediatrics;D010372
C03.858.211.465;Lice Infestations;D010373
C17.800.838.775.580;Lice Infestations;D010373
B01.050.500.131.617.690.060.716;Pediculus;D010374
E05.393.673;Pedigree;D010375
B03.510.550.450.737;Pediococcus;D010376
H02.163.700;Pediatric Dentistry;D010377
H02.163.876.600;Pediatric Dentistry;D010377
F03.800.800.600.600;Pedophilia;D010378
F01.829.316.483;Peer Group;D010379
F01.829.316.549;Peer Review;D010380
I01.880.604.640;Peer Review;D010380
N03.706.700;Peer Review;D010380
C15.378.553.696;Pelger-Huet Anomaly;D010381
C16.320.784;Pelger-Huet Anomaly;D010381
C06.552.802;Peliosis Hepatis;D010382
C18.654.521.500.133.699.529;Pellagra;D010383
A02.835.232.043.825;Pelvic Bones;D010384
E04.584;Pelvic Exenteration;D010385
C04.588.699;Pelvic Neoplasms;D010386
E01.370.378.605;Pelvimetry;D010387
E01.370.600.024.690;Pelvimetry;D010387
E05.041.690;Pelvimetry;D010387
A01.923.600;Pelvis;D010388
D03.383.129.462.673;Pemoline;D010389
C11.187.482;Pemphigoid, Benign Mucous Membrane;D010390
C17.800.865.670;Pemphigoid, Benign Mucous Membrane;D010390
C17.800.865.690;Pemphigoid, Bullous;D010391
C20.111.730;Pemphigoid, Bullous;D010391
C17.800.865.716;Pemphigus;D010392
C20.111.736;Pemphigus;D010392
D03.383.621.610;Pempidine;D010393
D02.033.100.624.690;Penbutolol;D010394
D02.033.100.624.698.688;Penbutolol;D010394
D02.033.755.624.690;Penbutolol;D010394
D02.033.755.624.698.688;Penbutolol;D010394
D02.092.063.624.698.688;Penbutolol;D010394
D03.383.621.620;Penfluridol;D010395
D02.886.030.786;Penicillamine;D010396
D12.125.166.786;Penicillamine;D010396
D02.065.589.099.750.687;Penicillanic Acid;D010397
D02.886.108.750.687;Penicillanic Acid;D010397
D03.438.260.825.687;Penicillanic Acid;D010397
D03.605.084.737.687;Penicillanic Acid;D010397
D04.075.080.875.099.221.750.687;Penicillanic Acid;D010397
D02.241.081.193.839;Penicillic Acid;D010398
D23.946.587.735;Penicillic Acid;D010398
D08.811.277.087.690;Penicillin Amidase;D010399
D02.065.589.099.750.750;Penicillin G;D010400
D02.886.108.750.750;Penicillin G;D010400
D03.438.260.825.750;Penicillin G;D010400
D03.605.084.737.750;Penicillin G;D010400
D04.075.080.875.099.221.750.750;Penicillin G;D010400
D02.065.589.099.750.750.685;Penicillin G Benzathine;D010401
D02.886.108.750.750.685;Penicillin G Benzathine;D010401
D03.438.260.825.750.685;Penicillin G Benzathine;D010401
D03.605.084.737.750.685;Penicillin G Benzathine;D010401
D04.075.080.875.099.221.750.750.685;Penicillin G Benzathine;D010401
D02.065.589.099.750.750.695;Penicillin G Procaine;D010402
D02.241.223.100.050.500.906.666;Penicillin G Procaine;D010402
D02.455.426.559.389.127.020.937.906.666;Penicillin G Procaine;D010402
D02.886.108.750.750.695;Penicillin G Procaine;D010402
D03.438.260.825.750.695;Penicillin G Procaine;D010402
D03.605.084.737.750.695;Penicillin G Procaine;D010402
D04.075.080.875.099.221.750.750.695;Penicillin G Procaine;D010402
G06.099.225.500.600;Penicillin Resistance;D010403
G06.225.347.500.600;Penicillin Resistance;D010403
G07.690.320.269.347.500.600;Penicillin Resistance;D010403
D02.065.589.099.750.781;Penicillin V;D010404
D02.886.108.750.781;Penicillin V;D010404
D03.438.260.825.781;Penicillin V;D010404
D03.605.084.737.781;Penicillin V;D010404
D04.075.080.875.099.221.750.781;Penicillin V;D010404
D08.811.277.087.180.697;Penicillinase;D010405
D02.065.589.099.750;Penicillins;D010406
D02.886.108.750;Penicillins;D010406
D03.438.260.825;Penicillins;D010406
D03.605.084.737;Penicillins;D010406
D04.075.080.875.099.221.750;Penicillins;D010406
B01.300.381.662;Penicillium;D010407
B01.300.381.662.592;Penicillium chrysogenum;D010408
C12.294.494;Penile Diseases;D010409
G08.686.785.760.717;Penile Erection;D010410
C12.294.494.508;Penile Induration;D010411
C17.300.715;Penile Induration;D010411
C04.588.945.440.715;Penile Neoplasms;D010412
C12.294.260.500;Penile Neoplasms;D010412
C12.294.494.591;Penile Neoplasms;D010412
C12.758.409.500;Penile Neoplasms;D010412
A05.360.444.492;Penis;D010413
Z01.107.567.875.075.550;Pennsylvania;D010414
Z01.107.567.875.350.550;Pennsylvania;D010414
Z01.107.567.875.500.550;Pennsylvania;D010414
N01.824.417.510;Pensions;D010415
D02.455.426.559.389.657.190.633;Pentachlorophenol;D010416
D02.033.455.706.690;Pentaerythritol Tetranitrate;D010417
D06.472.317.413.593;Pentagastrin;D010418
D12.644.456.716;Pentagastrin;D010418
D02.078.100.700;Pentamidine;D010419
D02.455.326.146.770;Pentanes;D010420
D02.241.081.944.509;Pentanoic Acids;D010421
D10.251.400.895.593;Pentanoic Acids;D010421
D02.522.720;Pentanones;D010422
D03.132.577.249.106.700;Pentazocine;D010423
D04.615.723.795.106.700;Pentazocine;D010423
D03.383.742.698.253.593;Pentobarbital;D010424
D03.383.773.700;Pentolinium Tartrate;D010425
D02.886.645.655.424;Pentosan Sulfuric Polyester;D010426
D09.698.682;Pentosan Sulfuric Polyester;D010426
G02.111.087.160.875;Pentose Phosphate Pathway;D010427
G02.149.115.160.875;Pentose Phosphate Pathway;D010427
G03.495.256.875;Pentose Phosphate Pathway;D010427
G03.495.335.693;Pentose Phosphate Pathway;D010427
G03.495.553.695;Pentose Phosphate Pathway;D010427
D09.894.643;Pentosephosphates;D010428
D09.546.627;Pentoses;D010429
D08.811.913.400.725;Pentosyltransferases;D010430
D03.438.759.758.824.651.700;Pentoxifylline;D010431
D03.383.742.698.875.700;Pentoxyl;D010432
D03.383.066.600;Pentylenetetrazole;D010433
D08.811.277.656.074.500.700;Pepsin A;D010434
D08.811.277.656.300.048.700;Pepsin A;D010434
D08.622.509;Pepsinogens;D010435
D12.644.456.724;Pepstatins;D010436
C06.405.469.275.800;Peptic Ulcer;D010437
C06.405.608;Peptic Ulcer;D010437
C06.405.748.586;Peptic Ulcer;D010437
C06.405.227.700;Peptic Ulcer Hemorrhage;D010438
C23.550.414.788.700;Peptic Ulcer Hemorrhage;D010438
C06.405.469.275.800.698;Peptic Ulcer Perforation;D010439
C06.405.608.698;Peptic Ulcer Perforation;D010439
C06.405.748.586.698;Peptic Ulcer Perforation;D010439
D02.455.526.728.650.594.690;Peptichemio;D010440
D12.644.456.726;Peptichemio;D010440
G02.111.087.675.871.640;Peptide Chain Elongation, Translational;D010441
G02.149.115.675.871.640;Peptide Chain Elongation, Translational;D010441
G03.495.770.871.640;Peptide Chain Elongation, Translational;D010441
G02.111.087.675.871.650;Peptide Chain Initiation, Translational;D010442
G02.149.115.675.871.650;Peptide Chain Initiation, Translational;D010442
G03.495.770.871.650;Peptide Chain Initiation, Translational;D010442
G02.111.087.675.871.720;Peptide Chain Termination, Translational;D010443
G02.149.115.675.871.720;Peptide Chain Termination, Translational;D010443
G03.495.770.871.720;Peptide Chain Termination, Translational;D010443
D08.811.277.040.330.300.100.700;Peptide Elongation Factor Tu;D010444
D12.776.157.325.150.700;Peptide Elongation Factor Tu;D010444
D12.776.835.700.350.700;Peptide Elongation Factor Tu;D010444
D12.776.835.700;Peptide Elongation Factors;D010445
D12.644.541;Peptide Fragments;D010446
D08.811.277.656;Peptide Hydrolases;D010447
D12.776.835.725;Peptide Initiation Factors;D010448
E05.196.181.400.454.720;Peptide Mapping;D010449
E05.196.401.319.720;Peptide Mapping;D010449
E05.196.700;Peptide Mapping;D010449
E05.393.760.705.685;Peptide Mapping;D010449
D08.811.277.656.300;Endopeptidases;D010450
D06.472.699.592;Peptide PHI;D010451
D12.644.400.610;Peptide PHI;D010451
D12.644.548.592;Peptide PHI;D010451
D12.776.641.650.610;Peptide PHI;D010451
G02.111.087.675;Peptide Biosynthesis;D010452
G02.149.115.675;Peptide Biosynthesis;D010452
G03.495.770;Peptide Biosynthesis;D010452
D08.811.464.259.850;Peptide Synthases;D010453
D12.776.835.862;Peptide Termination Factors;D010454
D12.644;Peptides;D010455
D04.345.566;Peptides, Cyclic;D010456
D12.644.641;Peptides, Cyclic;D010456
D09.400.420.700;Peptidoglycan;D010457
D09.698.718.594;Peptidoglycan;D010457
D12.644.233.594;Peptidoglycan;D010457
D12.776.395.560.800;Peptidoglycan;D010457
D23.050.161.616.594;Peptidoglycan;D010457
D08.811.913.050.200.700;Peptidyl Transferases;D010458
B03.510.400.562;Peptococcaceae;D010459
B03.510.400.562.593;Peptococcus;D010460
D12.776.719;Peptones;D010461
B03.510.400.625;Peptostreptococcus;D010462
D02.241.081.018.664;Peracetic Acid;D010463
D02.886.369.575;Perazine;D010464
D03.494.741.575;Perazine;D010464
F02.463.593;Perception;D010465
F02.463.593.932.677;Perceptual Closure;D010466
F01.393.628;Perceptual Defense;D010467
C10.597.606.762;Perceptual Disorders;D010468
C23.888.592.604.764;Perceptual Disorders;D010468
F01.700.750;Perceptual Disorders;D010468
F02.463.593.603;Perceptual Distortion;D010469
F02.463.593.071.594;Perceptual Masking;D010470
F02.463.593.932.733;Perceptual Masking;D010470
B01.050.150.900.493.602.600;Perches;D010471
D01.029.260.650;Perchloric Acid;D010472
D01.210.675;Perchloric Acid;D010472
B01.050.150.900.493.602;Perciformes;D010473
E01.370.600.610;Percussion;D010474
D27.720.269.700;Perfume;D010476
E05.680;Perfusion;D010477
E02.319.267.200;Chemotherapy, Cancer, Regional Perfusion;D010478
E04.292.425;Chemotherapy, Cancer, Regional Perfusion;D010478
D03.132.327.287.800;Pergolide;D010479
D03.549.439.800;Pergolide;D010479
D03.383.621.644;Perhexiline;D010480
A13.734;Perianal Glands;D010481
C01.539.830.025.650;Periapical Abscess;D010482
C07.320.830.700.700;Periapical Abscess;D010482
C07.465.714.306.700.700;Periapical Abscess;D010482
C07.465.714.533.487.700;Periapical Abscess;D010482
C07.320.830;Periapical Diseases;D010483
C07.465.714.306;Periapical Diseases;D010483
C07.320.830.700.740;Periapical Granuloma;D010484
C07.465.714.306.700.740;Periapical Granuloma;D010484
C07.465.714.533.487.740;Periapical Granuloma;D010484
C07.320.830.700;Periapical Periodontitis;D010485
C07.465.714.306.700;Periapical Periodontitis;D010485
C07.465.714.533.487;Periapical Periodontitis;D010485
A14.549.167.646.700;Periapical Tissue;D010486
A08.186.211.132.659.822.595;Periaqueductal Gray;D010487
A08.186.211.653.822.595;Periaqueductal Gray;D010487
C14.907.184.595;Polyarteritis Nodosa;D010488
C14.907.940.090.720;Polyarteritis Nodosa;D010488
C14.907.940.897.500;Polyarteritis Nodosa;D010488
C17.800.862.625;Polyarteritis Nodosa;D010488
C05.550.114.678;Periarthritis;D010489
C05.550.251.595;Periarthritis;D010489
C14.280.695;Pericardial Effusion;D010490
E04.035.720;Pericardial Window Techniques;D010491
E04.100.376.730;Pericardial Window Techniques;D010491
E04.928.220.600;Pericardial Window Techniques;D010491
E04.100.376.735;Pericardiectomy;D010492
E04.928.220.605;Pericardiectomy;D010492
C14.280.720;Pericarditis;D010493
C14.280.720.595;Pericarditis, Constrictive;D010494
C01.252.410.040.552.846.561.595;Pericarditis, Tuberculous;D010495
C01.539.190.750.595;Pericarditis, Tuberculous;D010495
C14.260.750.595;Pericarditis, Tuberculous;D010495
C14.280.720.801;Pericarditis, Tuberculous;D010495
A07.541.795;Pericardium;D010496
A10.615.789.470;Pericardium;D010496
C07.465.714.258.771;Pericoronitis;D010497
A12.207.270.517.678;Perilymph;D010498
H02.403.670.500;Perinatology;D010500
C12.777.419.685;Perinephritis;D010501
C13.351.968.419.685;Perinephritis;D010501
A01.719;Perineum;D010502
E01.370.225.500.607.790;Periodic Acid-Schiff Reaction;D010503
E01.370.225.750.551.790;Periodic Acid-Schiff Reaction;D010503
E05.200.500.607.790;Periodic Acid-Schiff Reaction;D010503
E05.200.500.620.670.620;Periodic Acid-Schiff Reaction;D010503
E05.200.750.551.790;Periodic Acid-Schiff Reaction;D010503
D01.029.260.675;Periodic Acid;D010504
D01.475.705;Periodic Acid;D010504
C16.320.382.625;Familial Mediterranean Fever;D010505
L01.178.682.829.678;Periodicals as Topic;D010506
G01.910.645;Periodicity;D010507
G07.180.562;Periodicity;D010507
C01.539.830.025.665;Periodontal Abscess;D010508
C07.465.714.533.650;Periodontal Abscess;D010508
C04.182.089.530.690.790;Periodontal Cyst;D010509
C05.500.470.690.790;Periodontal Cyst;D010509
C07.320.450.670.513;Periodontal Cyst;D010509
C07.465.714.470;Periodontal Cyst;D010509
C07.465.714;Periodontal Diseases;D010510
E06.721.595;Periodontal Dressings;D010511
E05.318.308.250.300.725;Periodontal Index;D010512
E06.208.720;Periodontal Index;D010512
E06.721.658;Periodontal Index;D010512
N05.715.360.300.375.300.690;Periodontal Index;D010512
N06.850.520.308.250.300.725;Periodontal Index;D010512
N06.890.160.215;Periodontal Index;D010512
A14.549.167.646.771;Periodontal Ligament;D010513
C07.465.714.533.750;Periodontal Pocket;D010514
E06.721.721;Periodontal Prosthesis;D010515
E07.695.190.610;Periodontal Prosthesis;D010515
E06.721.721.680;Periodontal Splints;D010516
E06.721;Periodontics;D010517
H02.163.876.623;Periodontics;D010517
C07.465.714.533;Periodontitis;D010518
A14.549.167.646;Periodontium;D010519
C07.465.714.533.161;Aggressive Periodontitis;D010520
A10.165.265.746;Periosteum;D010521
C01.539.160.595;Periostitis;D010522
C05.116.165.595;Periostitis;D010522
C10.668.829;Peripheral Nervous System Diseases;D010523
C04.588.614.596;Peripheral Nervous System Neoplasms;D010524
C10.551.775;Peripheral Nervous System Neoplasms;D010524
C10.668.829.725;Peripheral Nervous System Neoplasms;D010524
A08.800.800;Peripheral Nerves;D010525
B01.050.500.131.617.140.580;Periplaneta;D010526
B01.050.150.900.649.709;Perissodactyla;D010527
G10.261.326.310.596;Peristalsis;D010528
A01.923.047.025.600.678;Peritoneal Cavity;D010529
E02.870.300.650;Peritoneal Dialysis;D010530
E02.912.800.650;Peritoneal Dialysis;D010530
E02.760.106.500;Peritoneal Dialysis, Continuous Ambulatory;D010531
E02.870.300.650.500;Peritoneal Dialysis, Continuous Ambulatory;D010531
E02.912.800.650.500;Peritoneal Dialysis, Continuous Ambulatory;D010531
N02.421.585.106.500;Peritoneal Dialysis, Continuous Ambulatory;D010531
C06.844;Peritoneal Diseases;D010532
E05.927.705;Peritoneal Lavage;D010533
C04.588.033.513;Peritoneal Neoplasms;D010534
C04.588.274.780;Peritoneal Neoplasms;D010534
C06.301.780;Peritoneal Neoplasms;D010534
C06.844.620;Peritoneal Neoplasms;D010534
E01.370.388.250.520;Laparoscopy;D010535
E04.800.250.520;Laparoscopy;D010535
E04.035.735;Peritoneovenous Shunt;D010536
E04.100.814.750;Peritoneovenous Shunt;D010536
E04.210.790;Peritoneovenous Shunt;D010536
A01.923.047.025.600;Peritoneum;D010537
A10.615.789.596;Peritoneum;D010537
C01.539.463.600;Peritonitis;D010538
C06.844.640;Peritonitis;D010538
G02.685;Permeability;D010539
G02.842.700;Permeability;D010539
F01.145.813.546;Permissiveness;D010541
B01.050.150.900.649.865.635.680.510;Peromyscus;D010542
A08.800.800.720.450.760.640;Peroneal Nerve;D010543
D08.811.682.732;Peroxidases;D010544
D01.248.497.158.685.750;Peroxides;D010545
D01.339.431.374;Peroxides;D010545
D01.650.550.750;Peroxides;D010545
D02.389.338;Peroxides;D010545
D02.737;Peroxides;D010545
D02.886.369.593;Perphenazine;D010546
D03.494.741.593;Perphenazine;D010546
C08.381.423.694;Persistent Fetal Circulation Syndrome;D010547
C16.614.694;Persistent Fetal Circulation Syndrome;D010547
N02.421.631;Personal Health Services;D010548
F01.145.677;Personal Satisfaction;D010549
F01.145.875.596;Personal Space;D010550
F01.752;Personality;D010551
F04.513;Personality Assessment;D010552
F01.752.747;Personality Development;D010553
F03.675;Personality Disorders;D010554
F04.711.647.513;Personality Inventory;D010555
F04.711.647;Personality Tests;D010556
N02.278.354.422.565;Personnel Administration, Hospital;D010557
N04.452.442.422.565;Personnel Administration, Hospital;D010557
N04.452.677.440;Personnel Administration, Hospital;D010557
N04.452.677.460;Personnel Loyalty;D010558
N04.452.677;Personnel Management;D010559
N04.452.677.500;Personnel Selection;D010560
N04.452.677.650;Personnel Staffing and Scheduling;D010561
L01.700.508.300.680.800;Personnel Staffing and Scheduling Information Systems;D010562
N04.452.515.800;Personnel Staffing and Scheduling Information Systems;D010562
N04.452.677.680;Personnel Turnover;D010563
M01.526.485.740;Personnel, Hospital;D010564
N02.360.740;Personnel, Hospital;D010564
L01.143.762;Persuasive Communication;D010565
D23.946.123.946;Virulence Factors, Bordetella;D010566
D23.946.896.980;Virulence Factors, Bordetella;D010566
D20.215.894.135.535;Pertussis Vaccine;D010567
Z01.107.757.702;Peru;D010568
D02.455.426.559.847.149.700;Perylene;D010569
D02.455.426.559.847.680.500;Perylene;D010569
D04.615.149.700;Perylene;D010569
D04.615.680.500;Perylene;D010569
E07.858.499;Pessaries;D010570
N06.850.780.200.650;Pest Control;D010571
N06.850.780.200.650.650;Pest Control, Biological;D010572
D27.888.723.697;Pesticide Residues;D010573
N06.850.460.200.700;Pesticide Residues;D010573
D27.720.031.700.748;Pesticide Synergists;D010574
D27.720.723.748;Pesticide Synergists;D010574
D27.888.723.748;Pesticide Synergists;D010574
D27.720.031.700;Pesticides;D010575
D27.720.723;Pesticides;D010575
D27.888.723;Pesticides;D010575
B04.820.250.700;Pestivirus;D010576
B04.909.777.310.700;Pestivirus;D010576
D02.455.699;Petrolatum;D010577
D20.345.630;Petroleum;D010578
N06.230.132.258.630;Petroleum;D010578
A02.835.232.781.885.681;Petrous Bone;D010579
C04.700.705;Peutz-Jeghers Syndrome;D010580
C06.405.469.578.750;Peutz-Jeghers Syndrome;D010580
C16.320.700.705;Peutz-Jeghers Syndrome;D010580
C17.800.621.430.530.550.625;Peutz-Jeghers Syndrome;D010580
A10.549.600;Peyer's Patches;D010581
A15.382.520.604.600;Peyer's Patches;D010581
B04.123.150.800.230;Bacteriophage lambda;D010582
B04.123.205.230;Bacteriophage lambda;D010582
B04.280.090.800.230;Bacteriophage lambda;D010582
B04.123.150.500.260;Bacteriophage mu;D010583
B04.123.205.260;Bacteriophage mu;D010583
B04.280.090.500.260;Bacteriophage mu;D010583
B04.123.205.320;Bacteriophage phi X 174;D010584
B04.123.470.500.320;Bacteriophage phi X 174;D010584
B04.280.470.500.320;Bacteriophage phi X 174;D010584
C15.378.553.774;Phagocyte Bactericidal Dysfunction;D010585
C20.673.774;Phagocyte Bactericidal Dysfunction;D010585
A11.733;Phagocytes;D010586
A15.382.680;Phagocytes;D010586
G04.299.482.350;Phagocytosis;D010587
G09.188.124.780;Phagocytosis;D010587
G12.425.899;Phagocytosis;D010587
G12.450.564.809;Phagocytosis;D010587
A11.284.430.214.190.875.190.700;Phagosomes;D010588
D04.345.566.735;Phalloidine;D010590
D12.644.456.735;Phalloidine;D010590
D12.644.641.735;Phalloidine;D010590
D23.946.587.755;Phalloidine;D010590
C10.597.606.762.700;Phantom Limb;D010591
C23.550.767.700.500;Phantom Limb;D010591
C23.888.592.604.764.700;Phantom Limb;D010591
C23.888.646.530.500;Phantom Limb;D010591
F01.700.750.700;Phantom Limb;D010591
D26.650;Pharmaceutic Aids;D010592
D27.720.744;Pharmaceutic Aids;D010592
N02.421.668;Pharmaceutical Services;D010593
N02.278.678;Pharmacies;D010594
M01.526.485.780;Pharmacists;D010595
N02.360.780;Pharmacists;D010595
M01.526.485.067.735;Pharmacists' Aides;D010596
N02.360.067.730;Pharmacists' Aides;D010596
H01.158.273.343.750;Pharmacogenetics;D010597
H01.158.703.052;Pharmacogenetics;D010597
H02.628.479;Pharmacogenetics;D010597
H01.158.273.118.598;Pharmacognosy;D010598
H01.158.703.060;Pharmacognosy;D010598
G02.111.325.500;Pharmacokinetics;D010599
G03.787;Pharmacokinetics;D010599
G07.690.725;Pharmacokinetics;D010599
H01.158.703;Pharmacology;D010600
H02.628;Pharmacology;D010600
H01.158.703.152;Pharmacology, Clinical;D010601
H02.628.512;Pharmacology, Clinical;D010601
L01.178.682.192.836.749;Pharmacopoeias as Topic;D010602
L01.178.682.192.836.749.599;Pharmacopoeias, Homeopathic;D010603
H02.646;Pharmacy;D010604
N04.452.706;Pharmacy Administration;D010605
N04.452.758.788.682;Pharmacy and Therapeutics Committee;D010606
N05.700.685.625;Pharmacy and Therapeutics Committee;D010606
N02.278.354.422.603;Pharmacy Service, Hospital;D010607
N02.421.668.556;Pharmacy Service, Hospital;D010607
N04.452.442.422.603;Pharmacy Service, Hospital;D010607
C07.550;Pharyngeal Diseases;D010608
C09.775;Pharyngeal Diseases;D010608
A02.633.567.800;Pharyngeal Muscles;D010609
A04.623.617;Pharyngeal Muscles;D010609
A14.724.617;Pharyngeal Muscles;D010609
C04.588.443.665.710;Pharyngeal Neoplasms;D010610
C07.550.745;Pharyngeal Neoplasms;D010610
C09.647.710;Pharyngeal Neoplasms;D010610
C09.775.549;Pharyngeal Neoplasms;D010610
E04.580.515;Pharyngectomy;D010611
C07.550.781;Pharyngitis;D010612
C08.730.561;Pharyngitis;D010612
C09.775.649;Pharyngitis;D010612
E04.579.740;Pharyngostomy;D010613
E04.580.540;Pharyngostomy;D010613
A03.556.750;Pharynx;D010614
A04.623;Pharynx;D010614
A14.724;Pharynx;D010614
D02.065.199.092.700;Phenacetin;D010615
D02.455.426.559.847.723;Phenanthrenes;D010616
D04.615.723;Phenanthrenes;D010616
D03.494.633;Phenanthridines;D010617
D03.494.669;Phenanthrolines;D010618
D03.494.704;Phenazines;D010619
D03.132.577.249.106.715;Phenazocine;D010620
D04.615.723.795.106.715;Phenazocine;D010620
D03.383.725.050.610;Phenazopyridine;D010621
D03.383.621.699;Phencyclidine;D010622
C25.700;Phencyclidine Abuse;D010623
F03.900.700;Phencyclidine Abuse;D010623
D02.442.700;Phenelzine;D010624
D08.811.913.555.500.700;Phenylethanolamine N-Methyltransferase;D010625
D02.033.375.650;Phenylethyl Alcohol;D010626
D02.092.471.683;Phenethylamines;D010627
D02.092.146.100.700;Phenetidine;D010628
D02.355.417.650;Phenetidine;D010628
D02.355.726.750;Phenetidine;D010628
D02.455.426.559.389.657.654.750;Phenetidine;D010628
D02.078.370.141.700;Phenformin;D010629
D02.455.426.559.847.486.487.750;Phenindione;D010630
D04.615.486.487.750;Phenindione;D010630
D03.383.725.620;Pheniramine;D010632
D03.383.533.640.650;Phenmetrazine;D010633
D03.383.742.698.253.650;Phenobarbital;D010634
D02.455.426.559.389.657.625;Phenolphthaleins;D010635
D02.455.426.559.389.657;Phenols;D010636
D02.455.426.559.389.657.625.560;Phenolsulfonphthalein;D010637
D03.066.399.600;Phenoperidine;D010638
D03.383.621.349.683;Phenoperidine;D010638
D02.886.369;Phenothiazines;D010640
D03.494.741;Phenothiazines;D010640
G05.695;Phenotype;D010641
D02.241.081.018.386.682;Phenoxyacetates;D010642
D02.241.511.316.682;Phenoxyacetates;D010642
D02.092.471.739;Phenoxybenzamine;D010643
D03.438.150.446.520.750;Phenprocoumon;D010644
D03.830.219.446.520.750;Phenprocoumon;D010644
D02.092.471.683.152.766;Phentermine;D010645
D03.383.129.308.754;Phentolamine;D010646
D02.355.726;Phenyl Ethers;D010647
D02.455.426.559.389.657.654;Phenyl Ethers;D010647
D02.241.223.601;Phenylacetates;D010648
D12.125.072.050.685;Phenylalanine;D010649
D12.125.142.666;Phenylalanine;D010649
D08.811.520.232.400.700;Phenylalanine Ammonia-Lyase;D010650
D08.811.682.690.708.601;Phenylalanine Hydroxylase;D010651
D08.811.464.263.200.650;Phenylalanine-tRNA Ligase;D010652
D03.383.129.539.850.777;Phenylbutazone;D010653
D02.241.223.651;Phenylbutyrates;D010654
D02.092.146.651;Phenylenediamines;D010655
D02.092.782.258.651;Phenylenediamines;D010655
D02.033.100.291.617;Phenylephrine;D010656
D02.092.063.291.617;Phenylephrine;D010656
D02.241.081.337.540.700;Phenylethylmalonamide;D010657
D02.047.644.620;Phenylglyoxal;D010658
D02.442.726;Phenylhydrazines;D010659
D03.438.759.590.138.630;Phenylisopropyladenosine;D010660
D13.570.583.138.630;Phenylisopropyladenosine;D010660
D13.570.800.096.630;Phenylisopropyladenosine;D010660
C10.228.140.163.100.687;Phenylketonurias;D010661
C16.320.565.100.766;Phenylketonurias;D010661
C16.320.565.189.687;Phenylketonurias;D010661
C18.452.132.100.687;Phenylketonurias;D010661
C18.452.648.100.766;Phenylketonurias;D010661
C18.452.648.189.687;Phenylketonurias;D010661
D02.691.750.740.760;Phenylmercuric Acetate;D010662
D02.691.750.740;Phenylmercury Compounds;D010663
D02.886.590.625;Phenylmethylsulfonyl Fluoride;D010664
D02.033.100.624.706;Phenylpropanolamine;D010665
D02.033.755.624.706;Phenylpropanolamine;D010665
D02.092.063.624.706;Phenylpropanolamine;D010665
D02.241.223.701;Phenylpropionates;D010666
D02.241.223.751;Phenylpyruvic Acids;D010667
D02.241.755.812.601;Phenylpyruvic Acids;D010667
D02.886.904.601.600;Phenylthiazolylthiourea;D010668
D02.948.898.601.600;Phenylthiazolylthiourea;D010668
D03.383.129.308.432.555.868.650;Phenylthiohydantoin;D010669
D02.886.904.601;Phenylthiourea;D010670
D02.948.898.601;Phenylthiourea;D010670
D02.948.684;Phenylurea Compounds;D010671
D03.383.129.308.432.555.730;Phenytoin;D010672
C04.557.465.625.650.700.725;Pheochromocytoma;D010673
C04.557.580.625.650.700.725;Pheochromocytoma;D010673
D03.383.129.578.840.374.700;Pheophytins;D010674
D03.549.909.374.700;Pheophytins;D010674
D04.345.783.374.700;Pheophytins;D010674
D23.767.727.220.700;Pheophytins;D010674
D23.641;Pheromones;D010675
B01.300.381.706;Phialophora;D010676
A11.284.187.520.300.325.345.500;Philadelphia Chromosome;D010677
A11.284.187.520.300.505.515.500;Philadelphia Chromosome;D010677
C23.550.210.870.680;Philadelphia Chromosome;D010677
G05.360.162.520.300.325.345.700;Philadelphia Chromosome;D010677
G05.360.162.520.300.505.515.700;Philadelphia Chromosome;D010677
G05.365.590.175.870.680;Philadelphia Chromosome;D010677
K01.093.660;Philately;D010678
Z01.252.145.671;Philippines;D010679
Z01.639.790;Philippines;D010679
K01.517.732;Philology;D010680
K01.517.732.477;Philology, Classical;D010681
K01.517.732.602;Philology, Oriental;D010682
K01.517.732.727;Philology, Romance;D010683
K01.752;Philosophy;D010684
K01.752.622;Philosophy, Dental;D010685
K01.752.667;Philosophy, Medical;D010686
K01.752.712;Philosophy, Nursing;D010687
C12.294.494.684;Phimosis;D010688
C14.907.617.718;Phlebitis;D010689
C14.907.940.740;Phlebitis;D010689
E01.370.350.700.060.600;Phlebography;D010690
E01.370.370.050.600;Phlebography;D010690
B01.050.500.131.617.289.781.602;Phlebotomus;D010691
D09.400.420.110.710;Phleomycins;D010692
D12.644.233.110.710;Phleomycins;D010692
D02.455.426.559.389.657.684.602;Phloretin;D010693
D02.522.818.561.602;Phloretin;D010693
D08.811.277.450.420.475;Glycosylceramidase;D010694
D09.408.702;Phlorhizin;D010695
D02.455.426.559.389.657.684;Phloroglucinol;D010696
D02.455.426.559.847.885.347.300;Eosine I Bluish;D010697
D03.494.953.275.300;Eosine I Bluish;D010697
D04.615.885.347.300;Eosine I Bluish;D010697
F03.080.725;Phobic Disorders;D010698
G09.772.770.680;Phonation;D010699
L01.143.506.598.518;Phonetics;D010700
E01.370.370.380.400.500;Phonocardiography;D010701
D02.705.400.625.650;Phorate;D010702
D02.705.539.345.650;Phorate;D010702
D02.886.300.692.650;Phorate;D010702
D02.455.849.291.500.510;Phorbol Esters;D010703
D02.455.849.291.500;Phorbols;D010704
D02.522.741;Phosgene;D010705
D02.705.400.625.670;Phosmet;D010706
D02.705.539.345.670;Phosmet;D010706
D02.886.300.692.670;Phosmet;D010706
D03.438.513.750.625;Phosmet;D010706
D02.705.400.700;Phosphamidon;D010707
D08.811.913.050.134.700;Phosphate Acetyltransferase;D010709
D01.248.497.158.730;Phosphates;D010710
D01.695.625.675.650;Phosphates;D010710
D08.811.277.352.650.620;Phosphatidate Phosphatase;D010711
D10.570.755.375.760;Phosphatidic Acids;D010712
D10.570.755.375.760.400.800;Phosphatidylcholines;D010713
D10.570.755.375.760.400.840;Phosphatidylethanolamines;D010714
D10.570.755.375.760.400.885;Phosphatidylglycerols;D010715
D10.570.755.375.760.400.942;Phosphatidylinositols;D010716
D08.811.913.696.900.150;CDPdiacylglycerol-Serine O-Phosphatidyltransferase;D010717
D10.570.755.375.760.400.971;Phosphatidylserines;D010718
F02.830.816.964.500;Phosphenes;D010719
G11.561.600.810.964.500;Phosphenes;D010719
G14.640.816.500;Phosphenes;D010719
D01.695.525;Phosphines;D010720
D02.705.621;Phosphines;D010720
D01.029.260.700.600;Phosphinic Acids;D010721
D01.695.625.600;Phosphinic Acids;D010721
D02.705.629;Phosphinic Acids;D010721
D08.811.913.225.250;3-Deoxy-7-Phosphoheptulonate Synthase;D010723
D03.438.759.646.138.850;Phosphoadenosine Phosphosulfate;D010724
D13.695.667.138.850;Phosphoadenosine Phosphosulfate;D010724
D13.695.827.068.850;Phosphoadenosine Phosphosulfate;D010724
D12.125.373.603;Phosphocreatine;D010725
D12.125.740.675;Phosphocreatine;D010725
D27.505.519.389.735;Phosphodiesterase Inhibitors;D010726
D08.811.277.352.640;Phosphoric Diester Hydrolases;D010727
D02.241.511.701;Phosphoenolpyruvate;D010728
D08.811.520.224.125.550;Phosphoenolpyruvate Carboxykinase (GTP);D010729
D08.811.520.224.125.650;Phosphoenolpyruvate Carboxylase;D010730
D05.500.562.484;Phosphoenolpyruvate Sugar Phosphotransferase System;D010731
D08.811.600.700;Phosphoenolpyruvate Sugar Phosphotransferase System;D010731
D08.811.913.696.620.650;Phosphoenolpyruvate Sugar Phosphotransferase System;D010731
D08.811.913.696.620.225.850.500;Phosphofructokinase-1;D010732
D08.811.399.520.750.625;Phosphoglucomutase;D010733
D08.811.682.047.150.600;Phosphogluconate Dehydrogenase;D010734
D08.811.913.696.630.700;Phosphoglycerate Kinase;D010735
D08.811.399.520.750.700;Phosphoglycerate Mutase;D010736
D08.811.277.352.640.700.700;Type C Phospholipases;D010738
D08.811.277.352.640.700.710;Phospholipase D;D010739
D08.811.277.352.100.680;Phospholipases;D010740
D08.811.277.352.640.700;Phospholipases;D010740
D08.811.277.352.100.680.750;Phospholipases A;D010741
D02.033.800.421.400.750;Phospholipid Ethers;D010742
D02.355.460.750;Phospholipid Ethers;D010742
D10.570.755.375.760.400.985;Phospholipid Ethers;D010742
D10.570.755;Phospholipids;D010743
D10.695;Phospholipids;D010743
D08.811.277.352.650;Phosphoric Monoester Hydrolases;D010744
D02.241.081.018.677;Phosphonoacetic Acid;D010746
D02.705.429.875;Phosphonoacetic Acid;D010746
D12.644.717;Phosphopeptides;D010748
D08.811.277.352.650.625;Phosphoprotein Phosphatases;D010749
D12.776.744;Phosphoproteins;D010750
D08.811.520.241.300.500;Phosphopyruvate Hydratase;D010751
D02.455.526.728.650.730;Phosphoramide Mustards;D010752
D02.705.672.500;Phosphoramide Mustards;D010752
D01.695.550;Phosphoranes;D010753
D02.705.675;Phosphoranes;D010753
D09.894.643.650;Phosphoribosyl Pyrophosphate;D010754
D02.705.400;Organophosphates;D010755
D01.029.260.700.675;Phosphoric Acids;D010756
D01.695.625.675;Phosphoric Acids;D010756
D01.029.260.700.700;Phosphorous Acids;D010757
D01.695.625.700;Phosphorous Acids;D010757
D01.268.666;Phosphorus;D010758
D01.496.669;Phosphorus Isotopes;D010759
C18.452.750;Phosphorus Metabolism Disorders;D010760
D01.496.669.604;Phosphorus Radioisotopes;D010761
D01.496.749.658;Phosphorus Radioisotopes;D010761
D08.811.913.400.450.460.400.280;Phosphorylase a;D010762
D08.811.913.400.450.460.400.327;Phosphorylase b;D010763
D08.811.913.696.620.682.650;Phosphorylase Kinase;D010764
D08.811.277.352.650.625.650;Phosphorylase Phosphatase;D010765
G02.111.087.677;Phosphorylation;D010766
G02.149.115.677;Phosphorylation;D010766
G02.149.465.700;Phosphorylation;D010766
G02.607.750.700;Phosphorylation;D010766
G03.495.790;Phosphorylation;D010766
D02.092.877.883.333.700;Phosphorylcholine;D010767
D02.675.276.232.700;Phosphorylcholine;D010767
D12.125.740.700;Phosphoserine;D010768
D12.125.837.800;Phosphoserine;D010768
D12.125.740.725;Phosphothreonine;D010769
D12.125.901.800;Phosphothreonine;D010769
D08.811.913.696;Phosphotransferases;D010770
D01.029.260.700.675.750;Phosphotungstic Acid;D010772
D01.695.625.675.750;Phosphotungstic Acid;D010772
D01.940.700;Phosphotungstic Acid;D010772
D02.705.429.812.500;Leptophos;D010773
D02.705.539.692.500;Leptophos;D010773
D02.886.300.846.500;Leptophos;D010773
D12.776.256.317.700;Phosvitin;D010774
D12.776.290.700;Phosvitin;D010774
D12.776.744.700;Phosvitin;D010774
E05.723.729;Photic Stimulation;D010775
B03.440.450.900.604;Photobacterium;D010776
B03.660.250.830.590;Photobacterium;D010776
H01.181.529.711;Photochemistry;D010777
E02.186.500;Photochemotherapy;D010778
E02.319.685;Photochemotherapy;D010778
E02.774.722;Photochemotherapy;D010778
E01.370.350.600.625;Photofluorography;D010779
E01.370.350.700.225.625;Photofluorography;D010779
E01.370.350.600.630;Photogrammetry;D010780
E01.370.350.600;Photography;D010781
E05.712;Photography;D010781
G02.149.767.690.685;Photolysis;D010782
G02.842.750.690.685;Photolysis;D010782
E05.196.712;Photometry;D010783
E01.370.350.515.799;Photomicrography;D010784
E01.370.350.600.635;Photomicrography;D010784
E05.595.799;Photomicrography;D010784
G02.111.087.160.937.700;Photophosphorylation;D010785
G02.111.087.677.605;Photophosphorylation;D010785
G02.111.087.678.700.700;Photophosphorylation;D010785
G02.149.115.160.937.700;Photophosphorylation;D010785
G02.149.115.677.605;Photophosphorylation;D010785
G02.149.115.678.700.700;Photophosphorylation;D010785
G02.149.767.690.842;Photophosphorylation;D010785
G02.842.750.690.842;Photophosphorylation;D010785
G03.495.256.937.700;Photophosphorylation;D010785
G03.495.335.724;Photophosphorylation;D010785
G03.495.790.605;Photophosphorylation;D010785
G03.495.795.700.700;Photophosphorylation;D010785
A08.663.650.850.625;Photoreceptor Cells;D010786
A08.663.650.915.937;Photoreceptor Cells;D010786
A08.800.950.937;Photoreceptor Cells;D010786
A09.371.729.831.625;Photoreceptor Cells;D010786
A11.671.650.850.625;Photoreceptor Cells;D010786
A11.671.650.915.937;Photoreceptor Cells;D010786
C17.800.600;Photosensitivity Disorders;D010787
G02.111.087.160.937;Photosynthesis;D010788
G02.111.087.678.700;Photosynthesis;D010788
G02.149.115.160.937;Photosynthesis;D010788
G02.149.115.678.700;Photosynthesis;D010788
G02.149.767.690.921;Photosynthesis;D010788
G02.842.750.690.921;Photosynthesis;D010788
G03.495.256.937;Photosynthesis;D010788
G03.495.553.700;Photosynthesis;D010788
G03.495.795.700;Photosynthesis;D010788
G15.744.700;Photosynthesis;D010788
E02.774;Phototherapy;D010789
A08.800.800.720.150.700;Phrenic Nerve;D010791
K01.400.799;Phrenology;D010792
D03.383.710.605;Phthalazines;D010793
D02.241.223.805;Phthalic Acids;D010795
D02.113.600;Phthalic Anhydrides;D010796
D02.241.223.805.800;Phthalic Anhydrides;D010796
D02.241.223.805.810;Phthalimides;D010797
D02.478.600;Phthalimides;D010797
D03.438.513.750;Phthalimides;D010797
D05.500.562.488.490.500.500.755;Phycocyanin;D010798
D08.811.600.710.490.500.500.755;Phycocyanin;D010798
D12.776.765.650;Phycocyanin;D010798
D23.767.690;Phycocyanin;D010798
D05.500.562.488.490.500.500.777;Phycoerythrin;D010799
D08.811.600.710.490.500.500.777;Phycoerythrin;D010799
D12.776.765.665;Phycoerythrin;D010799
D23.767.705;Phycoerythrin;D010799
B01.300.300.500.750;Phycomyces;D010800
G05.697;Phylogeny;D010802
G16.100.178.605;Phylogeny;D010802
L01.100.697;Phylogeny;D010802
D12.644.276.812.900.800;Physalaemin;D010803
D12.644.400.800.625;Physalaemin;D010803
D12.644.456.800.745;Physalaemin;D010803
D12.776.467.812.900.800;Physalaemin;D010803
D12.776.641.650.800.625;Physalaemin;D010803
D20.888.033.728;Physalaemin;D010803
D23.469.050.375.850.780;Physalaemin;D010803
D23.529.812.900.800;Physalaemin;D010803
D23.946.833.033.728;Physalaemin;D010803
B01.046.550.550.600.700;Physarum;D010804
E05.718;Physical Conditioning, Animal;D010805
I02.233.543;Physical Education and Training;D010806
G11.427.680;Physical Endurance;D010807
I03.450.642.845.054.600;Physical Endurance;D010807
E01.370.600;Physical Examination;D010808
I03.621;Physical Fitness;D010809
N01.400.545;Physical Fitness;D010809
H02.403.680;Physical and Rehabilitation Medicine;D010810
H01;Natural Science Disciplines;D010811
E05.723;Physical Stimulation;D010812
N02.278.354.422.615;Physical Therapy Department, Hospital;D010814
N04.452.442.422.615;Physical Therapy Department, Hospital;D010814
I01.880.604.583.524.528.500;Physician Impairment;D010815
N03.706.535.606.528.500;Physician Impairment;D010815
N04.452.677.740;Physician Incentive Plans;D010816
F01.829.401.650.675;Physician-Patient Relations;D010817
N05.300.660.625;Physician-Patient Relations;D010817
N04.590.748;Physician's Practice Patterns;D010818
N05.300.625;Physician's Practice Patterns;D010818
F01.829.316.616.625.600;Physician's Role;D010819
M01.526.485.810;Physicians;D010820
N02.360.810;Physicians;D010820
M01.526.485.810.770;Physicians, Family;D010821
N02.360.810.770;Physicians, Family;D010821
M01.526.485.810.820;Physicians, Women;D010822
M01.975.790;Physicians, Women;D010822
N02.360.810.820;Physicians, Women;D010822
M01.526.485.067.740;Physician Assistants;D010823
N02.360.067.740;Physician Assistants;D010823
N02.278.692;Physicians' Offices;D010824
H01.671;Physics;D010825
E05.734;Physiognomy;D010826
H01.158.782;Physiology;D010827
H01.158.782.688;Physiology, Comparative;D010828
G07;Physiological Phenomena;D010829
D02.241.081.251.583.682;Physostigmine;D010830
D03.132.436.545;Physostigmine;D010830
D03.438.473.402.545;Physostigmine;D010830
D02.455.849.291.515;Phytanic Acid;D010831
D08.811.277.352.650.700;6-Phytase;D010832
D02.033.800.519.400.700;Phytic Acid;D010833
D09.853.519.400.700;Phytic Acid;D010833
D09.894.480.700;Phytic Acid;D010833
D12.776.765.675;Phytochrome;D010834
D23.767.712;Phytochrome;D010834
D12.776.395.560.825;Phytohemagglutinins;D010835
D12.776.503.499.750;Phytohemagglutinins;D010835
D12.776.765.678.750;Phytohemagglutinins;D010835
D02.455.849.291.523;Phytol;D010836
D02.455.426.559.847.638.721.374.689;Vitamin K 1;D010837
D02.455.849.291.523.500.689;Vitamin K 1;D010837
D02.806.550.625;Vitamin K 1;D010837
D04.615.638.721.374.689;Vitamin K 1;D010837
B01.750.937.715;Phytophthora;D010838
B05.080.500.600;Phytoplankton;D010839
D04.808.247.808.756;Phytosterols;D010840
A08.186.566.731;Pia Mater;D010841
F03.375.600;Pica;D010842
F03.550.400.600;Pica;D010842
B01.300.107.795.700;Pichia;D010843
B01.300.930.600;Pichia;D010843
D20.215.659;Picibanil;D010844
C08.618.085.852.850.500;Obesity Hypoventilation Syndrome;D010845
C08.618.846.565.500;Obesity Hypoventilation Syndrome;D010845
C10.886.425.800.750.850.500;Obesity Hypoventilation Syndrome;D010845
C18.654.726.500.695;Obesity Hypoventilation Syndrome;D010845
D03.066.707.523;Picloram;D010846
D03.383.725.705.523;Picloram;D010846
D03.383.725.676;Picolines;D010847
D03.066.707;Picolinic Acids;D010848
D03.383.725.705;Picolinic Acids;D010848
B04.820.565;Picornaviridae;D010849
B04.909.777.618;Picornaviridae;D010849
C02.782.687;Picornaviridae Infections;D010850
D02.455.426.559.389.657.566.690;Picrates;D010851
D02.640.743.690;Picrates;D010851
D02.455.426.392.368.367.800;Picrotoxin;D010852
D02.540.552;Picrotoxin;D010852
D02.455.526.439.750;Picryl Chloride;D010853
D02.640.529.880.607;Picryl Chloride;D010853
D23.050.550.480.820;Picryl Chloride;D010853
C01.703.753;Piedra;D010854
C17.800.329.992;Piedra;D010854
C05.500.460.606;Pierre Robin Syndrome;D010855
C05.660.207.540.460.606;Pierre Robin Syndrome;D010855
C07.320.440.606;Pierre Robin Syndrome;D010855
C07.650.500.460.606;Pierre Robin Syndrome;D010855
C16.131.621.207.540.460.606;Pierre Robin Syndrome;D010855
C16.131.850.500.460.606;Pierre Robin Syndrome;D010855
B01.050.150.900.248.165.150;Columbidae;D010856
A09.371.670;Pigment Epithelium of Eye;D010857
A10.272.640;Pigment Epithelium of Eye;D010857
E01.370.600.620;Pigmentation;D010858
G16.690;Pigmentation;D010858
C17.800.621;Pigmentation Disorders;D010859
D23.767;Pigments, Biological;D010860
A11.284.180.285;Fimbriae, Bacterial;D010861
A20.843;Fimbriae, Bacterial;D010861
D03.132.672;Pilocarpine;D010862
F02.830.702.607;Piloerection;D010863
G11.561.600.765.482;Piloerection;D010863
G13.750.829.690;Piloerection;D010863
C04.182.710;Pilonidal Sinus;D010864
E05.318.760.750;Pilot Projects;D010865
E05.337.737;Pilot Projects;D010865
N05.715.360.775.625;Pilot Projects;D010865
N06.850.520.450.720;Pilot Projects;D010865
D02.540.505.550;Natamycin;D010866
D02.241.081.337.699;Pimelic Acids;D010867
D03.438.103.732;Pimozide;D010868
D02.033.100.624.698.699;Pindolol;D010869
D02.033.100.624.748;Pindolol;D010869
D02.033.755.624.698.699;Pindolol;D010869
D02.033.755.624.748;Pindolol;D010869
D02.092.063.624.698.699;Pindolol;D010869
A06.407.635;Pineal Gland;D010870
A06.688.733;Pineal Gland;D010870
A08.186.211.730.317.200.620;Pineal Gland;D010870
A08.713.733;Pineal Gland;D010870
C04.557.465.625.600.657;Pinealoma;D010871
C04.557.470.670.657;Pinealoma;D010871
C04.557.580.625.600.657;Pinealoma;D010871
C04.588.614.250.195.766;Pinealoma;D010871
C10.228.140.211.788;Pinealoma;D010871
C10.551.240.250.625;Pinealoma;D010871
B01.050.150.900.649.147.600;Pinnipedia;D010872
G04.299.482.370;Pinocytosis;D010873
C01.252.400.840.558;Pinta;D010874
C01.252.825.630;Pinta;D010874
C01.252.847.840.558;Pinta;D010874
C01.539.800.720.630;Pinta;D010874
C17.800.838.765.630;Pinta;D010874
D03.066.758;Pipecolic Acids;D010875
D03.383.621.758;Pipecolic Acids;D010875
D03.066.515.635;Pipemidic Acid;D010876
D03.383.606.765;Pipemidic Acid;D010876
D03.383.725.547.635;Pipemidic Acid;D010876
D02.065.589.099.750.750.050.650;Piperacillin;D010878
D02.886.108.750.750.050.650;Piperacillin;D010878
D03.438.260.825.750.050.650;Piperacillin;D010878
D03.605.084.737.750.050.650;Piperacillin;D010878
D04.075.080.875.099.221.750.750.050.650;Piperacillin;D010878
D03.383.606;Piperazines;D010879
D03.383.621;Piperidines;D010880
D03.383.621.808;Piperidones;D010881
D03.383.246.118.600;Piperonyl Butoxide;D010882
D03.438.115.600;Piperonyl Butoxide;D010882
D03.383.231.388.568;Piperoxan;D010883
D03.383.621.815;Piperoxan;D010883
B01.050.150.900.090.180.610;Pipidae;D010884
D03.383.606.773;Pipobroman;D010885
D02.065.064.650;Piracetam;D010889
D02.241.081.018.110.650;Piracetam;D010889
D03.383.773.812.555;Piracetam;D010889
D03.438.079.080.070.750;Pirenzepine;D010890
D03.383.606.790;Piribedil;D010891
D03.066.399.650;Pirinitramide;D010892
D03.383.621.349.700;Pirinitramide;D010892
D03.066.515.650;Piromidic Acid;D010893
D03.383.725.547.650;Piromidic Acid;D010893
D02.886.665.500;Piroxicam;D010894
D03.383.855.500;Piroxicam;D010894
D25.339.773;Pit and Fissure Sealants;D010895
J01.637.051.339.773;Pit and Fissure Sealants;D010895
Z01.639.760.815.700;Pitcairn Island;D010896
F02.463.593.071.700.408;Pitch Discrimination;D010897
F02.463.593.071.700;Pitch Perception;D010898
C10.228.140.300.535.625;Pituitary Apoplexy;D010899
C10.228.140.617.738.350;Pituitary Apoplexy;D010899
C14.907.253.573.600;Pituitary Apoplexy;D010899
C19.700.725;Pituitary Apoplexy;D010899
C10.228.140.617.738;Pituitary Diseases;D010900
C19.700;Pituitary Diseases;D010900
E01.370.374.605;Pituitary Function Tests;D010901
A06.407.747;Pituitary Gland;D010902
A06.688.357.750;Pituitary Gland;D010902
A08.186.211.730.317.357.352.435.500;Pituitary Gland;D010902
A08.713.357.750;Pituitary Gland;D010902
A06.407.747.500;Pituitary Gland, Anterior;D010903
A06.688.357.750.500;Pituitary Gland, Anterior;D010903
A08.186.211.730.317.357.352.435.500.500;Pituitary Gland, Anterior;D010903
A08.713.357.750.500;Pituitary Gland, Anterior;D010903
A06.407.747.875;Pituitary Gland, Posterior;D010904
A06.688.357.750.875;Pituitary Gland, Posterior;D010904
A08.186.211.730.317.357.352.435.500.875;Pituitary Gland, Posterior;D010904
A08.713.357.750.875;Pituitary Gland, Posterior;D010904
D06.472.699.327.700;Pituitary Hormone Release Inhibiting Hormones;D010905
D12.644.400.400.700;Pituitary Hormone Release Inhibiting Hormones;D010905
D12.644.548.365.700;Pituitary Hormone Release Inhibiting Hormones;D010905
D12.776.641.650.405.700;Pituitary Hormone Release Inhibiting Hormones;D010905
D06.472.699.327.740;Pituitary Hormone-Releasing Hormones;D010906
D12.644.400.400.740;Pituitary Hormone-Releasing Hormones;D010906
D12.644.548.365.740;Pituitary Hormone-Releasing Hormones;D010906
D12.776.641.650.405.740;Pituitary Hormone-Releasing Hormones;D010906
D06.472.699.631;Pituitary Hormones;D010907
D12.644.548.691;Pituitary Hormones;D010907
D06.472.699.631.525;Pituitary Hormones, Anterior;D010908
D12.644.548.691.525;Pituitary Hormones, Anterior;D010908
D06.472.699.631.692;Pituitary Hormones, Posterior;D010909
D12.644.548.691.692;Pituitary Hormones, Posterior;D010909
E02.815.190.600;Pituitary Irradiation;D010910
C04.588.322.609;Pituitary Neoplasms;D010911
C04.588.614.250.195.885.500.600;Pituitary Neoplasms;D010911
C10.228.140.211.885.500.600;Pituitary Neoplasms;D010911
C10.228.140.617.477.600;Pituitary Neoplasms;D010911
C10.228.140.617.738.675;Pituitary Neoplasms;D010911
C10.551.240.250.700.500.500;Pituitary Neoplasms;D010911
C19.344.609;Pituitary Neoplasms;D010911
C19.700.734;Pituitary Neoplasms;D010911
E01.370.374.600;Pituitary-Adrenal Function Tests;D010912
A06.407.691;Pituitary-Adrenal System;D010913
C17.800.859.600;Pityriasis;D010915
C17.800.859.600.685;Pityriasis Rubra Pilaris;D010916
D02.065.589.099.750.750.050.700;Pivampicillin;D010917
D02.886.108.750.750.050.700;Pivampicillin;D010917
D03.438.260.825.750.050.700;Pivampicillin;D010917
D03.605.084.737.750.050.700;Pivampicillin;D010917
D04.075.080.875.099.221.750.750.050.700;Pivampicillin;D010917
D02.886.778.580;Pizotyline;D010918
D03.383.903.580;Pizotyline;D010918
D26.660;Placebos;D010919
E02.785;Placebos;D010919
A16.710;Placenta;D010920
C13.703.420.643;Placenta Accreta;D010921
C13.703.590.609;Placenta Accreta;D010921
C13.703.590;Placenta Diseases;D010922
C13.703.420.714;Placenta Previa;D010923
C13.703.590.734;Placenta Previa;D010923
D20.777.608;Placental Extracts;D010924
E01.370.378.610;Placental Function Tests;D010925
D06.472.699.649;Placental Hormones;D010926
D12.644.548.726;Placental Hormones;D010926
C13.703.590.800;Placental Insufficiency;D010927
D06.472.699.649.692;Placental Lactogen;D010928
D12.644.548.726.692;Placental Lactogen;D010928
D12.776.780.650;Placental Lactogen;D010928
G08.686.785.760.769.491;Placentation;D010929
C01.252.400.310.980.745;Plague;D010930
D20.215.894.135.609;Plague Vaccine;D010931
B01.050.500.500.736.847.610;Planarians;D010932
B05.080.500;Plankton;D010933
N04.452.718;Planning Techniques;D010934
G15.556;Plant Diseases;D010935
D20.215.784.500;Plant Extracts;D010936
D26.667;Plant Extracts;D010936
D27.505.696.377.760;Plant Growth Regulators;D010937
D10.627.700;Plant Oils;D010938
D20.215.784.750;Plant Oils;D010938
C25.723.756;Plant Poisoning;D010939
D12.776.765;Plant Proteins;D010940
G15.556.700;Plant Tumors;D010941
B04.715;Plant Viruses;D010942
B01.650.940.800.575.100.818;Plantago;D010943
B01.650;Plants;D010944
B01.650.510;Plants, Edible;D010945
B01.650.560;Plants, Medicinal;D010946
B01.650.660;Plants, Toxic;D010947
E01.370.225.875.970.790;Viral Plaque Assay;D010948
E05.200.875.970.790;Viral Plaque Assay;D010948
A12.207.152.693;Plasma;D010949
A12.207.270.695;Plasma;D010949
A15.145.693;Plasma;D010949
A11.063.438.725;Plasma Cells;D010950
A11.118.637.555.567.562.725;Plasma Cells;D010950
A15.145.229.637.555.567.562.725;Plasma Cells;D010950
A15.382.032.438.725;Plasma Cells;D010950
A15.382.490.555.567.562.725;Plasma Cells;D010950
E02.095.135.750;Plasma Exchange;D010951
D27.505.954.502.140.500;Plasma Substitutes;D010952
G09.188.130.610;Plasma Volume;D010953
G09.330.380.092.610;Plasma Volume;D010953
C04.557.595.600;Plasmacytoma;D010954
C20.683.515.880;Plasmacytoma;D010954
D10.570.755.375.760.400.985.820;Plasmalogens;D010955
E02.120.770;Plasmapheresis;D010956
E02.912.715;Plasmapheresis;D010956
G05.360.600;Plasmids;D010957
D08.622.610;Plasminogen;D010958
D12.776.124.790.223.580;Plasminogen;D010958
D12.776.377.715.182.580;Plasminogen;D010958
D08.811.277.656.300.760.875;Tissue Plasminogen Activator;D010959
D08.811.277.656.959.350.875;Tissue Plasminogen Activator;D010959
D12.776.124.125.662.768;Tissue Plasminogen Activator;D010959
D23.119.970;Tissue Plasminogen Activator;D010959
D08.811.277.656.300.760.635;Plasminogen Activators;D010960
D08.811.277.656.959.350.635;Plasminogen Activators;D010960
D12.776.124.125.662;Plasminogen Activators;D010960
B01.043.075.380.611;Plasmodium;D010961
B01.043.075.380.611.461;Plasmodium berghei;D010962
B01.043.075.380.611.561;Plasmodium falciparum;D010963
B01.043.075.380.611.576;Plasmodium gallinaceum;D010964
B01.043.075.380.611.661;Plasmodium malariae;D010965
B01.043.075.380.611.761;Plasmodium vivax;D010966
B01.043.075.380.611.780;Plasmodium yoelii;D010967
D27.720.760;Plasticizers;D010968
D05.750.716;Plastics;D010969
D25.720.716;Plastics;D010969
J01.637.051.720.716;Plastics;D010969
D12.776.556.760;Plastocyanin;D010970
D12.776.765.680;Plastocyanin;D010970
D02.806.250.700;Plastoquinone;D010971
D02.033.100.291.211.500;Platelet Activating Factor;D010972
D02.092.063.291.211.500;Platelet Activating Factor;D010972
D02.092.877.883.333.710;Platelet Activating Factor;D010972
D02.675.276.232.710;Platelet Activating Factor;D010972
D10.570.755.375.760.400.985.910;Platelet Activating Factor;D010972
D23.119.865;Platelet Activating Factor;D010972
D23.469.050.600;Platelet Activating Factor;D010972
G09.188.124.560.600.500;Platelet Adhesiveness;D010973
G09.188.670;Platelet Adhesiveness;D010973
G09.188.124.552.624;Platelet Aggregation;D010974
G09.188.124.560.600.640;Platelet Aggregation;D010974
D27.505.954.502.780;Platelet Aggregation Inhibitors;D010975
E01.370.225.500.195.107.740;Platelet Count;D010976
E01.370.225.625.107.700;Platelet Count;D010976
E01.370.225.625.625.625;Platelet Count;D010976
E05.200.500.195.107.740;Platelet Count;D010976
E05.200.625.107.700;Platelet Count;D010976
E05.200.625.625.625;Platelet Count;D010976
E05.242.195.107.740;Platelet Count;D010976
G04.170.107.740;Platelet Count;D010976
G09.188.105.700;Platelet Count;D010976
D12.776.124.125.691;Platelet Factor 3;D010977
D23.119.932;Platelet Factor 3;D010977
D12.644.276.374.200.120.900;Platelet Factor 4;D010978
D12.776.124.125.720;Platelet Factor 4;D010978
D12.776.467.374.200.120.900;Platelet Factor 4;D010978
D23.119.940;Platelet Factor 4;D010978
D23.125.300.120.900;Platelet Factor 4;D010978
D23.469.200.120.900;Platelet Factor 4;D010978
D23.529.374.200.120.900;Platelet Factor 4;D010978
E01.370.225.625.625;Platelet Function Tests;D010979
E05.200.625.625;Platelet Function Tests;D010979
D12.776.395.550.625;Platelet Membrane Glycoproteins;D010980
D12.776.543.550.625;Platelet Membrane Glycoproteins;D010980
D12.776.543.750.705.675;Platelet Membrane Glycoproteins;D010980
C15.378.100.685;Platelet Storage Pool Deficiency;D010981
C15.378.140.735;Platelet Storage Pool Deficiency;D010981
C15.378.463.735;Platelet Storage Pool Deficiency;D010981
D12.644.276.910;Platelet-Derived Growth Factor;D010982
D12.776.124.625;Platelet-Derived Growth Factor;D010982
D12.776.467.910;Platelet-Derived Growth Factor;D010982
D23.529.910;Platelet-Derived Growth Factor;D010982
E02.095.160.790;Plateletpheresis;D010983
E02.120.285.790;Plateletpheresis;D010983
E05.242.363.285.790;Plateletpheresis;D010983
D01.268.556.690;Platinum;D010984
D01.268.956.734;Platinum;D010984
D01.552.544.690;Platinum;D010984
C05.116.099.742;Platybasia;D010985
C05.116.900.540;Platybasia;D010985
C05.660.207.720;Platybasia;D010985
C16.131.621.207.720;Platybasia;D010985
B01.050.500.500.736;Platyhelminths;D010986
B01.050.150.900.649.627.600;Platypus;D010987
I03.450.642.693;Play and Playthings;D010988
E02.190.888.625;Play Therapy;D010989
F04.754.664;Play Therapy;D010989
F02.739.794.746;Pleasure-Pain Principle;D010990
E01.370.370.610;Plethysmography;D010991
E01.370.610;Plethysmography;D010991
E01.370.370.610.610;Plethysmography, Impedance;D010992
E01.370.405.610;Plethysmography, Impedance;D010992
E01.370.610.610;Plethysmography, Impedance;D010992
E01.370.386.700.615;Plethysmography, Whole Body;D010993
E01.370.610.615;Plethysmography, Whole Body;D010993
A04.716;Pleura;D010994
A10.615.789.736;Pleura;D010994
C08.528;Pleural Diseases;D010995
C08.528.652;Pleural Effusion;D010996
C04.588.894.797.640;Pleural Neoplasms;D010997
C08.528.694;Pleural Neoplasms;D010997
C08.785.640;Pleural Neoplasms;D010997
C08.528.735;Pleurisy;D010998
C08.730.582;Pleurisy;D010998
B01.050.150.900.090.608.700.540;Pleurodeles;D010999
C02.782.687.359.213.737;Pleurodynia, Epidemic;D011000
C08.381.677.473;Pleuropneumonia;D011001
C08.528.735.473;Pleuropneumonia;D011001
C08.730.582.473;Pleuropneumonia;D011001
C08.730.610.473;Pleuropneumonia;D011001
C01.252.400.610.610.717;Pleuropneumonia, Contagious;D011002
C22.717;Pleuropneumonia, Contagious;D011002
G05.700;Ploidies;D011003
C06.405.117.119.500.742;Plummer-Vinson Syndrome;D011004
D01.268.033.700;Plutonium;D011005
D01.268.271.100.700;Plutonium;D011005
D01.268.556.700;Plutonium;D011005
D01.552.020.734;Plutonium;D011005
D01.552.544.700;Plutonium;D011005
C06.405.469.778;Pneumatosis Cystoides Intestinalis;D011006
C10.228.140.199.700;Pneumocephalus;D011007
C10.228.806;Pneumocephalus;D011007
C10.900.300.087.700;Pneumocephalus;D011007
C26.260.118.650;Pneumocephalus;D011007
C26.915.300.200.650;Pneumocephalus;D011007
C01.252.410.890.670;Pneumococcal Infections;D011008
C08.381.483.581;Pneumoconiosis;D011009
C08.381.520.702;Pneumoconiosis;D011009
C24.800;Pneumoconiosis;D011009
B01.300.107.730;Pneumocystis;D011010
E01.370.350.578.937.620;Pneumoencephalography;D011011
E01.370.350.700.560.620;Pneumoencephalography;D011011
E01.370.350.700.625.620;Pneumoencephalography;D011011
E01.370.376.537.750.620;Pneumoencephalography;D011011
E05.629.937.620;Pneumoencephalography;D011011
E01.370.388.600;Pneumomediastinum, Diagnostic;D011012
E04.928.600.600;Pneumonectomy;D011013
C08.381.677;Pneumonia;D011014
C08.730.610;Pneumonia;D011014
C08.381.677.529;Pneumonia, Aspiration;D011015
C08.730.610.529;Pneumonia, Aspiration;D011015
C08.730.085.660;Pneumonia, Atypical Interstitial, of Cattle;D011016
C22.196.090.660;Pneumonia, Atypical Interstitial, of Cattle;D011016
C08.381.677.529.612;Pneumonia, Lipid;D011017
C08.730.610.529.612;Pneumonia, Lipid;D011017
C01.252.410.890.670.750;Pneumonia, Pneumococcal;D011018
C01.252.620.550;Pneumonia, Pneumococcal;D011018
C08.381.677.540.550;Pneumonia, Pneumococcal;D011018
C08.730.610.540.550;Pneumonia, Pneumococcal;D011018
C01.252.400.610.610.760;Pneumonia, Mycoplasma;D011019
C01.252.620.500;Pneumonia, Mycoplasma;D011019
C08.381.677.540.500;Pneumonia, Mycoplasma;D011019
C08.730.610.540.500;Pneumonia, Mycoplasma;D011019
C01.703.534.700;Pneumonia, Pneumocystis;D011020
C01.703.770.700;Pneumonia, Pneumocystis;D011020
C08.381.472.700;Pneumonia, Pneumocystis;D011020
C08.381.677.675;Pneumonia, Pneumocystis;D011020
C08.730.435.700;Pneumonia, Pneumocystis;D011020
C08.730.610.675;Pneumonia, Pneumocystis;D011020
C02.782.815.616.660;Pneumonia, Progressive Interstitial, of Sheep;D011021
C02.839.660;Pneumonia, Progressive Interstitial, of Sheep;D011021
C22.836.660;Pneumonia, Progressive Interstitial, of Sheep;D011021
C01.252.400.780.600;Pneumonia, Rickettsial;D011022
C01.252.620.600;Pneumonia, Rickettsial;D011022
C08.381.677.540.600;Pneumonia, Rickettsial;D011022
C08.730.610.540.600;Pneumonia, Rickettsial;D011022
C01.252.410.868.675;Pneumonia, Staphylococcal;D011023
C01.252.620.620;Pneumonia, Staphylococcal;D011023
C08.381.677.540.620;Pneumonia, Staphylococcal;D011023
C08.730.610.540.620;Pneumonia, Staphylococcal;D011023
C02.705;Pneumonia, Viral;D011024
C08.381.677.807;Pneumonia, Viral;D011024
C08.730.610.763;Pneumonia, Viral;D011024
E04.928.600.220.610;Pneumonolysis;D011025
E04.928.600.610;Pneumonolysis;D011025
C14.280.763;Pneumopericardium;D011026
C06.844.670;Pneumoperitoneum;D011027
E01.370.388.605;Pneumoperitoneum, Artificial;D011028
E01.370.350.700.625;Pneumoradiography;D011029
C08.528.778;Pneumothorax;D011030
E04.928.600.220.620;Pneumothorax, Artificial;D011031
H02.696;Podiatry;D011032
D20.215.784.500.675;Podophyllin;D011033
D02.455.426.559.389.140.450.777;Podophyllotoxin;D011034
D02.455.426.559.847.638.960.675;Podophyllotoxin;D011034
D04.615.638.960.675;Podophyllotoxin;D011034
B01.650.940.800.575.100.125.500;Podophyllum;D011035
B01.050.150.900.493.850.280.680;Poecilia;D011036
K01.517.781;Poetry as Topic;D011037
C16.131.831.775;Rothmund-Thomson Syndrome;D011038
C16.320.850.765;Rothmund-Thomson Syndrome;D011038
C16.614.760;Rothmund-Thomson Syndrome;D011038
C17.800.804.775;Rothmund-Thomson Syndrome;D011038
C17.800.827.775;Rothmund-Thomson Syndrome;D011038
C18.452.284.760;Rothmund-Thomson Syndrome;D011038
N02.278.726;Poison Control Centers;D011039
N02.421.297.695;Poison Control Centers;D011039
C17.800.174.255.100.700;Dermatitis, Toxicodendron;D011040
C17.800.815.255.100.700;Dermatitis, Toxicodendron;D011040
C20.543.418.150.700;Dermatitis, Toxicodendron;D011040
C25.723;Poisoning;D011041
D27.720.777;Poisons;D011042
D27.888.569.612;Poisons;D011042
D12.776.503.499.875;Pokeweed Mitogens;D011043
D12.776.765.678.875;Pokeweed Mitogens;D011043
Z01.542.248.679;Poland;D011044
C05.116.099.370.894.819.756;Poland Syndrome;D011045
C05.660.585.800.756;Poland Syndrome;D011045
C05.660.906.819.756;Poland Syndrome;D011045
C16.131.621.585.800.756;Poland Syndrome;D011045
C16.131.621.906.819.756;Poland Syndrome;D011045
E05.196.749;Polarography;D011048
E05.301.700;Polarography;D011048
I01.655.500;Social Control Policies;D011049
I01.880.604.825;Social Control Policies;D011049
N03.623.500;Social Control Policies;D011049
N03.706.742;Policy Making;D011050
C02.182.600.700;Poliomyelitis;D011051
C02.182.700;Poliomyelitis;D011051
C02.782.687.359.764;Poliomyelitis;D011051
C10.228.228.210.575.750;Poliomyelitis;D011051
C10.228.228.210.650;Poliomyelitis;D011051
C10.228.228.618.850;Poliomyelitis;D011051
C10.228.854.525.850;Poliomyelitis;D011051
C10.228.854.641;Poliomyelitis;D011051
C10.668.864;Poliomyelitis;D011051
C02.182.600.700.600;Poliomyelitis, Bulbar;D011052
C02.782.687.359.764.614;Poliomyelitis, Bulbar;D011052
C10.228.228.210.650.600;Poliomyelitis, Bulbar;D011052
D20.215.894.830.614;Poliovirus Vaccine, Inactivated;D011054
D20.215.894.899.623.500;Poliovirus Vaccine, Inactivated;D011054
D20.215.894.899.623.750;Poliovirus Vaccine, Oral;D011055
I01.696;Political Systems;D011056
I01.738;Politics;D011057
A18.024.249.500.249.500;Pollen;D011058
D01.268.185.600;Polonium;D011059
D01.268.271.680;Polonium;D011059
D01.268.513.875;Polonium;D011059
D02.033.455.250.700.680;Poloxalene;D011060
D05.750.741.650;Poloxalene;D011060
D25.720.741.650;Poloxalene;D011060
J01.637.051.720.741.650;Poloxalene;D011060
D13.695.578.550.500;Poly A;D011061
D08.811.913.696.445.650;Polynucleotide Adenylyltransferase;D011062
D13.695.578.550.500.510;Poly A-U;D011063
D13.695.578.550.750.510;Poly A-U;D011063
D09.408.620.569.070.125.600;Poly Adenosine Diphosphate Ribose;D011064
D13.695.578.550.530;Poly Adenosine Diphosphate Ribose;D011064
D13.695.827.708.070.125.600;Poly Adenosine Diphosphate Ribose;D011064
D08.811.913.400.725.115.690;Poly(ADP-ribose) Polymerases;D011065
D13.695.578.550.560;Poly C;D011066
D13.695.578.500.300;Poly dA-dT;D011067
D13.695.578.550.600;Poly G;D011068
D13.695.578.550.650;Poly I;D011069
D13.695.578.550.560.600;Poly I-C;D011070
D13.695.578.550.650.600;Poly I-C;D011070
D13.695.578.500.600;Poly T;D011071
D13.695.578.550.750;Poly U;D011072
D02.092.782;Polyamines;D011073
D02.455.426.559.389.097.675;Polyanetholesulfonate;D011074
D02.886.645.600.080.050.100.600;Polyanetholesulfonate;D011074
D05.750.722;Polyanetholesulfonate;D011074
D25.720.722;Polyanetholesulfonate;D011074
J01.637.051.720.722;Polyanetholesulfonate;D011074
D02.455.426.559.389.185.680;Polybrominated Biphenyls;D011075
D02.455.526.368.700;Polybrominated Biphenyls;D011075
D25.339.291.700;Polycarboxylate Cement;D011076
J01.637.051.339.291.700;Polycarboxylate Cement;D011076
B01.050.500.091.700;Polychaeta;D011077
D02.455.426.559.389.185.698;Polychlorinated Biphenyls;D011078
D02.455.526.439.773;Polychlorinated Biphenyls;D011078
D02.455.426.559.389.805.700;Polychloroterphenyl Compounds;D011080
D02.455.526.439.785;Polychloroterphenyl Compounds;D011080
C05.182.531;Polychondritis, Relapsing;D011081
C17.300.182.531;Polychondritis, Relapsing;D011081
D04;Polycyclic Compounds;D011083
D02.455.426.559.847;Polycyclic Hydrocarbons, Aromatic;D011084
D04.615;Polycyclic Hydrocarbons, Aromatic;D011084
C04.182.612.765;Polycystic Ovary Syndrome;D011085
C13.351.500.056.630.580.765;Polycystic Ovary Syndrome;D011085
C19.391.630.580.765;Polycystic Ovary Syndrome;D011085
C15.378.738;Polycythemia;D011086
C15.378.190.636.753;Polycythemia Vera;D011087
D08.811.074.500;DNA Ligases;D011088
D08.811.464.754.600;DNA Ligases;D011088
D13.695.578.500;Polydeoxyribonucleotides;D011089
D02.455.326.271.665;Polyenes;D011090
D05.750.728;Polyesters;D011091
D25.720.728;Polyesters;D011091
J01.637.051.720.728;Polyesters;D011091
D02.033.455.250.700;Polyethylene Glycols;D011092
D05.750.741;Polyethylene Glycols;D011092
D25.720.741;Polyethylene Glycols;D011092
J01.637.051.720.741;Polyethylene Glycols;D011092
D05.750.728.764;Polyethylene Terephthalates;D011093
D25.720.728.764;Polyethylene Terephthalates;D011093
J01.637.051.720.728.764;Polyethylene Terephthalates;D011093
D02.455.326.271.665.550.600;Polyethyleneimine;D011094
D02.491.650;Polyethyleneimine;D011094
D05.750.716.507.600;Polyethyleneimine;D011094
D25.720.716.507.600;Polyethyleneimine;D011094
J01.637.051.720.716.507.600;Polyethyleneimine;D011094
D02.455.326.271.665.550;Polyethylenes;D011095
D05.750.716.507;Polyethylenes;D011095
D25.720.716.507;Polyethylenes;D011095
J01.637.051.720.716.507;Polyethylenes;D011095
D08.811.277.450.800;Polygalacturonase;D011096
D05.750.780;Polygeline;D011097
D12.644.740;Polygeline;D011097
D25.720.780;Polygeline;D011097
J01.637.051.720.780;Polygeline;D011097
D05.750.728.772;Polyglactin 910;D011098
D25.720.728.772;Polyglactin 910;D011098
J01.637.051.720.728.772;Polyglactin 910;D011098
D12.125.067.750.400.700;Polyglutamic Acid;D011099
D12.125.119.450.400.700;Polyglutamic Acid;D011099
D12.644.748;Polyglutamic Acid;D011099
D05.750.728.780;Polyglycolic Acid;D011100
D25.720.728.780;Polyglycolic Acid;D011100
J01.637.051.720.728.780;Polyglycolic Acid;D011100
D02.033.455.250.700.685;Polyhydroxyethyl Methacrylate;D011102
D02.241.081.069.800.700;Polyhydroxyethyl Methacrylate;D011102
D05.750.716.822.111.650.750;Polyhydroxyethyl Methacrylate;D011102
D05.750.741.685;Polyhydroxyethyl Methacrylate;D011102
D25.720.716.822.111.650.750;Polyhydroxyethyl Methacrylate;D011102
D25.720.741.685;Polyhydroxyethyl Methacrylate;D011102
J01.637.051.720.716.822.111.650.750;Polyhydroxyethyl Methacrylate;D011102
J01.637.051.720.741.685;Polyhydroxyethyl Methacrylate;D011102
D02.455.849.690.700.700;Polyisoprenyl Phosphate Monosaccharides;D011103
D09.894.680.700;Polyisoprenyl Phosphate Monosaccharides;D011103
D10.390.700.700;Polyisoprenyl Phosphate Monosaccharides;D011103
D02.455.849.690.700.710;Polyisoprenyl Phosphate Oligosaccharides;D011104
D09.894.680.710;Polyisoprenyl Phosphate Oligosaccharides;D011104
D10.390.700.710;Polyisoprenyl Phosphate Oligosaccharides;D011104
D02.455.849.690.700;Polyisoprenyl Phosphate Sugars;D011105
D09.894.680;Polyisoprenyl Phosphate Sugars;D011105
D10.390.700;Polyisoprenyl Phosphate Sugars;D011105
D02.455.849.690;Polyisoprenyl Phosphates;D011106
D02.705.400.725;Polyisoprenyl Phosphates;D011106
D12.125.068.555.750;Polylysine;D011107
D12.125.095.647.750;Polylysine;D011107
D12.644.760;Polylysine;D011107
D05.750;Polymers;D011108
D25.720;Polymers;D011108
J01.637.051.720;Polymers;D011108
D02.241.081.069.800;Polymethacrylic Acids;D011109
D05.750.716.822.111.650;Polymethacrylic Acids;D011109
D25.720.716.822.111.650;Polymethacrylic Acids;D011109
J01.637.051.720.716.822.111.650;Polymethacrylic Acids;D011109
G05.365.795;Polymorphism, Genetic;D011110
C05.651.742;Polymyalgia Rheumatica;D011111
C05.799.720;Polymyalgia Rheumatica;D011111
C17.300.775.720;Polymyalgia Rheumatica;D011111
D04.345.566.780.750;Polymyxin B;D011112
D10.477.750.750;Polymyxin B;D011112
D12.644.050.600.750;Polymyxin B;D011112
D12.644.641.780.750;Polymyxin B;D011112
D12.776.543.695.054.600.750;Polymyxin B;D011112
D04.345.566.780;Polymyxins;D011113
D10.477.750;Polymyxins;D011113
D12.644.050.600;Polymyxins;D011113
D12.644.641.780;Polymyxins;D011113
D12.776.543.695.054.600;Polymyxins;D011113
Z01.639.760.815;Polynesia;D011114
C10.668.829.800;Polyneuropathies;D011115
D08.811.074.875;Polynucleotide 5'-Hydroxyl-Kinase;D011116
D08.811.913.696.620.680;Polynucleotide 5'-Hydroxyl-Kinase;D011116
D08.811.913.696.445.735.532;Polyribonucleotide Nucleotidyltransferase;D011117
D08.811.464.754;Polynucleotide Ligases;D011118
D13.695.578;Polynucleotides;D011119
B04.280.640.615;Polyomavirus;D011120
B04.909.204.210.620.615;Polyomavirus;D011120
B04.909.574.204.670.615;Polyomavirus;D011120
B04.909.675.615;Polyomavirus;D011120
D02.455.426.559.389.657.684.602.615;Polyphloretin Phosphate;D011121
D02.522.818.561.602.615;Polyphloretin Phosphate;D011121
D05.750.795;Polyphloretin Phosphate;D011121
D25.720.795;Polyphloretin Phosphate;D011121
J01.637.051.720.795;Polyphloretin Phosphate;D011121
D01.248.497.158.730.650;Polyphosphates;D011122
D01.695.625.675.650.775;Polyphosphates;D011122
C23.550.210.702;Polyploidy;D011123
G05.365.590.175.677;Polyploidy;D011123
G05.700.740;Polyploidy;D011123
B01.300.179.120.760;Polyporaceae;D011124
C04.557.470.035.215.100;Adenomatous Polyposis Coli;D011125
C04.588.274.476.411.307.089;Adenomatous Polyposis Coli;D011125
C04.588.274.476.411.307.180.089;Adenomatous Polyposis Coli;D011125
C04.700.100;Adenomatous Polyposis Coli;D011125
C06.301.371.411.307.180.089;Adenomatous Polyposis Coli;D011125
C06.405.249.411.307.180.089;Adenomatous Polyposis Coli;D011125
C06.405.469.158.356.180.089;Adenomatous Polyposis Coli;D011125
C06.405.469.491.307.180.089;Adenomatous Polyposis Coli;D011125
C06.405.469.578.249;Adenomatous Polyposis Coli;D011125
C16.320.700.100;Adenomatous Polyposis Coli;D011125
D02.455.326.271.665.590;Polypropylenes;D011126
D05.750.716.550;Polypropylenes;D011126
D25.720.716.550;Polypropylenes;D011126
J01.637.051.720.716.550;Polypropylenes;D011126
C23.300.825;Polyps;D011127
C10.668.829.800.750.700;Polyradiculopathy;D011128
C10.114.750;Polyradiculoneuropathy;D011129
C10.314.750;Polyradiculoneuropathy;D011129
C10.668.829.800.750;Polyradiculoneuropathy;D011129
C20.111.258.750;Polyradiculoneuropathy;D011129
D08.811.464.754.720;RNA Ligase (ATP);D011130
D13.695.578.550;Polyribonucleotides;D011131
A11.284.430.214.190.875.811.740;Polyribosomes;D011132
D08.811.520.241.700;Polysaccharide-Lyases;D011133
D09.698;Polysaccharides;D011134
D09.698.718;Polysaccharides, Bacterial;D011135
D23.050.161.616;Polysaccharides, Bacterial;D011135
D02.033.455.250.700.690;Polysorbates;D011136
D05.750.741.700;Polysorbates;D011136
D25.720.741.700;Polysorbates;D011136
J01.637.051.720.741.700;Polysorbates;D011136
D02.455.426.559.389.150.750.800.830;Polystyrenes;D011137
D05.750.716.579;Polystyrenes;D011137
D25.720.716.579;Polystyrenes;D011137
J01.637.051.720.716.579;Polystyrenes;D011137
D05.750.395.616;Polytetrafluoroethylene;D011138
D25.720.395.616;Polytetrafluoroethylene;D011138
J01.637.051.720.395.616;Polytetrafluoroethylene;D011138
D02.886.590.700.135.781;Polythiazide;D011139
D02.886.655.500.781;Polythiazide;D011139
D03.438.174.781;Polythiazide;D011139
D02.241.081.251.944.750;Polyurethanes;D011140
D05.750.716.650;Polyurethanes;D011140
D25.720.327.782;Polyurethanes;D011140
D25.720.716.650;Polyurethanes;D011140
J01.637.051.720.327.782;Polyurethanes;D011140
J01.637.051.720.716.650;Polyurethanes;D011140
J01.637.412.700;Polyurethanes;D011140
C12.777.934.616;Polyuria;D011141
C13.351.968.934.616;Polyuria;D011141
C23.888.942.600;Polyuria;D011141
D02.033.750;Polyvinyl Alcohol;D011142
D02.455.326.271.884.533.532;Polyvinyl Alcohol;D011142
D05.750.716.721.616;Polyvinyl Alcohol;D011142
D25.720.716.721.616;Polyvinyl Alcohol;D011142
J01.637.051.720.716.721.616;Polyvinyl Alcohol;D011142
D02.455.326.271.884.533.565;Polyvinyl Chloride;D011143
D05.750.716.721.812;Polyvinyl Chloride;D011143
D25.720.327.811;Polyvinyl Chloride;D011143
D25.720.716.721.812;Polyvinyl Chloride;D011143
J01.637.051.720.716.721.812;Polyvinyl Chloride;D011143
D02.455.326.271.884.533.660;Polyvinylpyridine N-Oxide;D011144
D03.383.725.740;Polyvinylpyridine N-Oxide;D011144
D02.455.326.271.665.616;Polyvinyls;D011145
D02.455.326.271.884.533;Polyvinyls;D011145
D05.750.716.721;Polyvinyls;D011145
D25.720.716.721;Polyvinyls;D011145
J01.637.051.720.716.721;Polyvinyls;D011145
C17.800.174.620.300;Eczema, Dyshidrotic;D011146
C17.800.815.620.300;Eczema, Dyshidrotic;D011146
C17.800.865.385;Eczema, Dyshidrotic;D011146
B01.050.150.900.649.801.400.112.400.635.650;Pongo pygmaeus;D011148
A08.186.211.132.810.428.600;Pons;D011149
A08.186.211.865.428.600;Pons;D011149
A07.231.114.681;Popliteal Artery;D011150
C04.182.867.500;Popliteal Cyst;D011151
A07.231.908.641;Popliteal Vein;D011152
N01.600;Population;D011153
N01;Population Characteristics;D011154
I01.240.600.650;Population Control;D011155
N01.224.625.650;Population Control;D011155
N06.850.505.400.700.650;Population Control;D011155
N01.224.600;Population Density;D011156
N06.850.505.400.600;Population Density;D011156
I01.240.600;Population Dynamics;D011157
N01.224.625;Population Dynamics;D011157
N06.850.505.400.700;Population Dynamics;D011157
I01.240.600.660;Population Growth;D011158
N01.224.625.660;Population Growth;D011158
N06.850.505.400.700.660;Population Growth;D011158
E05.318.308.250.700;Population Surveillance;D011159
N05.715.360.300.375.625;Population Surveillance;D011159
N06.850.520.308.250.700;Population Surveillance;D011159
N06.850.780.675;Population Surveillance;D011159
D02.806.400.249.700;Porfiromycin;D011160
D03.383.097.500.700;Porfiromycin;D011160
D03.438.473.412.249.700;Porfiromycin;D011160
B01.050.500.802;Porifera;D011161
D03.383.129.578.617;Porphobilinogen;D011162
D08.811.913.225.575;Hydroxymethylbilane Synthase;D011163
C16.320.565.708;Porphyrias;D011164
C17.800.849.617;Porphyrias;D011164
C18.452.648.708;Porphyrias;D011164
C18.452.811;Porphyrias;D011164
C18.452.880.617;Porphyrias;D011164
D03.383.129.578.840.500.700;Porphyrinogens;D011165
D03.549.909.500.700;Porphyrinogens;D011165
D04.345.783.500.700;Porphyrinogens;D011165
D03.383.129.578.840.500;Porphyrins;D011166
D03.549.909.500;Porphyrins;D011166
D04.345.783.500;Porphyrins;D011166
D23.767.727;Porphyrins;D011166
E04.035.760.755;Portacaval Shunt, Surgical;D011167
E04.100.814.868.937.790;Portacaval Shunt, Surgical;D011167
A07.231.908.670;Portal System;D011168
A07.231.908.670.567;Portal Vein;D011169
E04.035.760;Portasystemic Shunt, Surgical;D011170
E04.100.814.868.937;Portasystemic Shunt, Surgical;D011170
E04.035.775;Portoenterostomy, Hepatic;D011171
E04.210.120.775;Portoenterostomy, Hepatic;D011171
E01.370.350.700.060.610;Portography;D011172
E01.370.350.700.715.610;Portography;D011172
E01.370.370.050.610;Portography;D011172
E01.370.372.610;Portography;D011172
K01.093.742;Portraits as Topic;D011173
Z01.542.727;Portugal;D011174
E02.041.625.790;Positive-Pressure Respiration;D011175
E02.880.820.790;Positive-Pressure Respiration;D011175
E06.323.428.100.500;Post and Core Technique;D011176
E06.323.528.250.500;Post and Core Technique;D011176
E06.780.345.250.500;Post and Core Technique;D011176
E06.780.345.737.100.500;Post and Core Technique;D011176
I01.451.617;Postal Service;D011177
C06.405.748.630;Postgastrectomy Syndromes;D011178
C23.550.767.812;Postgastrectomy Syndromes;D011178
C23.550.260.224.617;Postmortem Changes;D011180
E02.760.703.500;Postnatal Care;D011181
N02.421.143.620.550.500;Postnatal Care;D011181
N02.421.585.703.500;Postnatal Care;D011181
E02.760.731.700;Postoperative Care;D011182
E04.604.500;Postoperative Care;D011182
N02.421.585.722.700;Postoperative Care;D011182
C23.550.767;Postoperative Complications;D011183
E04.614.750;Postoperative Period;D011184
N02.421.585.753.750;Postoperative Period;D011184
C14.280.793;Postpericardiotomy Syndrome;D011185
C23.550.767.863;Postpericardiotomy Syndrome;D011185
C14.907.617.718.760;Postphlebitic Syndrome;D011186
C14.907.952.760;Postphlebitic Syndrome;D011186
G11.427.695;Posture;D011187
D01.268.549.550;Potassium;D011188
D01.552.528.652;Potassium;D011188
D01.210.450.150.750;Potassium Chloride;D011189
D01.745.625;Potassium Chloride;D011189
D01.625.400.100.750;Potassium Cyanide;D011190
D01.745.635;Potassium Cyanide;D011190
C18.654.521.500.617;Potassium Deficiency;D011191
D01.220.150.650;Potassium Dichromate;D011192
D01.745.650;Potassium Dichromate;D011192
D01.475.410.700;Potassium Iodide;D011193
D01.745.680;Potassium Iodide;D011193
D01.496.705;Potassium Isotopes;D011194
D12.125.067.500.700;Potassium Magnesium Aspartate;D011195
D12.125.119.170.700;Potassium Magnesium Aspartate;D011195
D01.530.700;Potassium Permanganate;D011196
D01.745.750;Potassium Permanganate;D011196
D01.496.705.700;Potassium Radioisotopes;D011197
D01.496.749.690;Potassium Radioisotopes;D011197
B01.650.940.800.575.100.905.725.777;Solanum tuberosum;D011198
J02.500.850.790;Solanum tuberosum;D011198
E05.196.922.750;Potentiometry;D011199
E05.301.710;Potentiometry;D011199
B01.050.050.116.625;Poultry;D011200
B01.050.150.900.248.617;Poultry;D011200
J02.500.600.750;Poultry;D011200
C22.131.728;Poultry Diseases;D011201
J02.500.600.750.500;Poultry Products;D011202
I01.880.735.634;Poverty;D011203
I01.880.840.535;Poverty;D011203
N01.824.600;Poverty;D011203
I01.880.840.535.550;Poverty Areas;D011204
N01.824.600.550;Poverty Areas;D011204
D02.455.326.271.884.533.699;Povidone;D011205
D03.383.773.812.615;Povidone;D011205
D05.750.716.721.838;Povidone;D011205
D25.720.716.721.838;Povidone;D011205
J01.637.051.720.716.721.838;Povidone;D011205
D01.475.557.500;Povidone-Iodine;D011206
D02.455.326.271.884.533.710;Povidone-Iodine;D011206
D03.383.773.812.615.630;Povidone-Iodine;D011206
D05.750.716.721.838.745;Povidone-Iodine;D011206
D25.720.716.721.838.745;Povidone-Iodine;D011206
J01.637.051.720.716.721.838.745;Povidone-Iodine;D011206
D26.255.779;Powders;D011208
D27.720.280.779;Powders;D011208
F01.658.780;Power (Psychology);D011209
E07.305.437;Power Plants;D011210
J01.780;Power Plants;D011210
E07.305.124;Electric Power Supplies;D011211
B04.280.650;Poxviridae;D011212
B04.909.204.783;Poxviridae;D011212
C02.256.743;Poxviridae Infections;D011213
F02.463.425.674;Practice (Psychology);D011214
N04.452.758.708.300;Practice Management, Dental;D011215
N04.452.758.708.450;Practice Management, Medical;D011216
D02.033.100.624.698.705;Practolol;D011217
D02.033.100.624.795;Practolol;D011217
D02.033.755.624.698.705;Practolol;D011217
D02.033.755.624.795;Practolol;D011217
D02.065.199.092.800;Practolol;D011217
D02.092.063.624.698.705;Practolol;D011217
C10.597.606.643.690;Prader-Willi Syndrome;D011218
C16.131.077.730;Prader-Willi Syndrome;D011218
C16.131.260.700;Prader-Willi Syndrome;D011218
C16.320.180.700;Prader-Willi Syndrome;D011218
C18.654.726.500.740;Prader-Willi Syndrome;D011218
D03.132.436.681.077.650;Prajmaline;D011219
D03.438.473.402.681.077.650;Prajmaline;D011219
D02.092.570.665.535;Pralidoxime Compounds;D011220
D01.268.477.750;Praseodymium;D011221
D01.268.558.362.750;Praseodymium;D011221
D01.552.550.399.750;Praseodymium;D011221
D03.438.079.080.070.784;Prazepam;D011222
D03.438.531.690;Praziquantel;D011223
D03.438.786.750;Prazosin;D011224
C13.703.395.249;Pre-Eclampsia;D011225
C14.280.067.780;Pre-Excitation Syndromes;D011226
C14.280.067.780.770;Pre-Excitation, Mahaim-Type;D011227
D12.776.034.841.450;Prealbumin;D011228
D12.776.124.727.450;Prealbumin;D011228
E03.806;Preanesthetic Medication;D011229
E04.604.750.619;Preanesthetic Medication;D011229
C04.834;Precancerous Conditions;D011230
I02.600;Preceptorship;D011231
E05.196.150;Chemical Precipitation;D011232
G02.149.767.502;Chemical Precipitation;D011232
G02.842.750.502;Chemical Precipitation;D011232
E01.370.225.812.735.645;Precipitin Tests;D011233
E05.196.150.639.500;Precipitin Tests;D011233
E05.200.812.735.645;Precipitin Tests;D011233
E05.478.594.760.645;Precipitin Tests;D011233
E05.478.605.492;Precipitin Tests;D011233
D12.776.124.486.485.114.837;Precipitins;D011234
D12.776.124.790.651.114.837;Precipitins;D011234
D12.776.377.715.548.114.837;Precipitins;D011234
F01.145.113.111.600;Predatory Behavior;D011235
F01.145.113.252.520;Predatory Behavior;D011235
C18.452.394.750.774;Prediabetic State;D011236
C19.246.774;Prediabetic State;D011236
E05.318.780.800.650;Predictive Value of Tests;D011237
N05.715.360.780.700.640;Predictive Value of Tests;D011237
N06.850.520.445.800.650;Predictive Value of Tests;D011237
D02.455.526.728.650.156.700;Prednimustine;D011238
D04.808.745.432.769.795.700;Prednimustine;D011238
D04.808.745.432.769.795;Prednisolone;D011239
D04.808.745.432.719.702;Prednisone;D011241
N03.219.521.576.343.800.750;Preferred Provider Organizations;D011243
N04.590.374.410.750;Preferred Provider Organizations;D011243
D04.808.745.432.719;Pregnadienediols;D011244
D04.808.745.432;Pregnadienes;D011245
D04.808.745.432.769;Pregnadienetriols;D011246
G08.686.785.760.769;Pregnancy;D011247
C13.703;Pregnancy Complications;D011248
C13.703.634;Pregnancy Complications, Cardiovascular;D011249
C14.583;Pregnancy Complications, Cardiovascular;D011249
C13.703.667;Pregnancy Complications, Hematologic;D011250
C15.378.785;Pregnancy Complications, Hematologic;D011250
C01.539.674;Pregnancy Complications, Infectious;D011251
C13.703.700;Pregnancy Complications, Infectious;D011251
C04.850;Pregnancy Complications, Neoplastic;D011252
C13.703.720;Pregnancy Complications, Neoplastic;D011252
G08.686.785.760.769.494;Pregnancy in Adolescence;D011253
C13.703.726;Pregnancy in Diabetics;D011254
G08.686.785.760.769.520;Pregnancy Maintenance;D011255
E01.789.700;Pregnancy Outcome;D011256
G08.686.785.760.769.530;Pregnancy Outcome;D011256
D12.776.780;Pregnancy Proteins;D011257
E01.370.225.970;Pregnancy Tests;D011258
E01.370.378.620;Pregnancy Tests;D011258
E05.200.970;Pregnancy Tests;D011258
E01.370.225.812.620;Pregnancy Tests, Immunologic;D011259
E01.370.225.970.620;Pregnancy Tests, Immunologic;D011259
E01.370.378.620.620;Pregnancy Tests, Immunologic;D011259
E05.200.812.620;Pregnancy Tests, Immunologic;D011259
E05.200.970.620;Pregnancy Tests, Immunologic;D011259
E05.478.594.662;Pregnancy Tests, Immunologic;D011259
G08.686.707.408;Pregnancy Trimester, First;D011261
G08.686.707.490;Pregnancy Trimester, Second;D011262
G08.686.707.520;Pregnancy Trimester, Third;D011263
G08.686.707;Pregnancy Trimesters;D011264
D08.811.277.656.300.480.632;Pregnancy-Associated Plasma Protein-A;D011266
D08.811.277.656.675.374.632;Pregnancy-Associated Plasma Protein-A;D011266
D12.776.780.700;Pregnancy-Associated Plasma Protein-A;D011266
D12.776.780.730;Pregnancy-Specific beta 1-Glycoproteins;D011268
C13.703.733.536;Pregnancy, Abdominal;D011269
G08.686.785.760.769.498;Pregnancy, Animal;D011270
C13.703.733;Pregnancy, Ectopic;D011271
G08.686.710;Pregnancy, Multiple;D011272
G08.686.785.760.769.525;Pregnancy, Multiple;D011272
C13.703.805;Pregnancy, Prolonged;D011273
C13.703.733.703;Pregnancy, Tubal;D011274
G08.686.785.760.769.580;Pregnancy, Unwanted;D011275
D04.808.745.495;Pregnanediol;D011276
D06.472.334.851.687.750.739;Pregnanediol;D011276
D04.808.745.558;Pregnanediones;D011277
D04.808.745;Pregnanes;D011278
D04.808.745.620;Pregnanetriol;D011279
D06.472.334.851.687.750.478.400.500;Pregnanetriol;D011279
D04.808.745.640;Pregnanolone;D011280
D04.808.745.683;Pregnatrienes;D011281
D04.808.745.745.654;Pregnenediones;D011282
D04.808.745.745;Pregnenes;D011283
D04.808.745.745.725;Pregnenolone;D011284
D06.472.040.585.745;Pregnenolone;D011284
D06.472.334.851.687.500;Pregnenolone;D011284
D02.626.745;Pregnenolone Carbonitrile;D011285
D04.808.745.745.725.703;Pregnenolone Carbonitrile;D011285
F01.145.813.550;Prejudice;D011287
F01.829.595;Prejudice;D011287
D08.811.277.656.300.760.442.725;Prekallikrein;D011288
D08.811.277.656.959.350.442.725;Prekallikrein;D011288
D12.776.124.125.597.712;Prekallikrein;D011288
D23.119.597.712;Prekallikrein;D011288
C04.834.770;Preleukemia;D011289
C15.378.800;Preleukemia;D011289
E01.370.620;Premarital Examinations;D011291
E02.319.703;Premedication;D011292
C23.550.568.968;Premenstrual Syndrome;D011293
D02.033.100.624.698.708;Prenalterol;D011294
D02.033.100.624.800;Prenalterol;D011294
D02.033.755.624.698.708;Prenalterol;D011294
D02.033.755.624.800;Prenalterol;D011294
D02.092.063.624.698.708;Prenalterol;D011294
E02.760.786;Prenatal Care;D011295
N02.421.143.620.704;Prenatal Care;D011295
N02.421.585.786;Prenatal Care;D011295
E01.370.378.630;Prenatal Diagnosis;D011296
C13.703.824.500;Prenatal Exposure Delayed Effects;D011297
D03.383.129.539.850.777.670;Feprazone;D011298
D02.092.471.683.825;Prenylamine;D011299
E02.760.795;Preoperative Care;D011300
E04.604.750;Preoperative Care;D011300
N02.421.585.795;Preoperative Care;D011300
A08.186.211.730.317.357.342.450;Preoptic Area;D011301
D08.811.399.520.250.500;Prephenate Dehydratase;D011302
D08.811.520.241.300.600;Prephenate Dehydratase;D011302
D08.811.399.520.250.750;Prephenate Dehydrogenase;D011303
D08.811.682.660.500;Prephenate Dehydrogenase;D011303
C09.218.458.341.887.772;Presbycusis;D011304
C10.597.751.418.341.887.772;Presbycusis;D011304
C23.888.592.763.393.341.887.772;Presbycusis;D011304
C11.744.786;Presbyopia;D011305
N03.219.442.551.621;Prescription Fees;D011306
N03.219.442.675;Prescription Fees;D011306
E02.319.307;Drug Prescriptions;D011307
N02.421.668.778.500;Drug Prescriptions;D011307
E02.792;Preservation, Biological;D011309
E05.760;Preservation, Biological;D011309
D26.650.702;Preservatives, Pharmaceutical;D011310
D27.720.744.771;Preservatives, Pharmaceutical;D011310
A08.663.650.915.750.750;Pressoreceptors;D011311
A08.800.050.800.900.700;Pressoreceptors;D011311
A08.800.950.750.750;Pressoreceptors;D011311
A11.671.650.915.750.750;Pressoreceptors;D011311
G01.374.715;Pressure;D011312
E06.761;Preventive Dentistry;D011313
H02.163.721;Preventive Dentistry;D011313
N02.421.143.827;Preventive Health Services;D011314
N02.421.726;Preventive Health Services;D011314
H02.403.720.750;Preventive Medicine;D011315
F04.096.544.215.508;Preventive Psychiatry;D011316
H02.403.690.150.580;Preventive Psychiatry;D011316
H02.403.720.750.550;Preventive Psychiatry;D011316
C12.294.494.786;Priapism;D011317
D02.065.199.750;Prilocaine;D011318
D03.438.810.050.650;Primaquine;D011319
N04.590.233.727;Primary Health Care;D011320
N02.421.533.760;Primary Nursing;D011321
N02.421.726.758;Primary Prevention;D011322
N06.850.780.680;Primary Prevention;D011322
B01.050.150.900.649.801;Primates;D011323
D03.383.742.698.253.650.700;Primidone;D011324
Z01.107.567.176.732;Prince Edward Island;D011325
Z01.639.820;Prince Edward Island;D011325
L01.178.682.192.122.622;Printers' Marks;D011326
L01.737.787;Printing;D011327
D12.776.785;Prions;D011328
M01.729;Prisoners;D011329
I01.880.604.787;Prisons;D011330
N04.452.758.745;Private Practice;D011331
N04.452.633.780;Privatization;D011332
D06.472.699.327.935;Pro-Opiomelanocortin;D011333
D06.472.699.631.525.600;Pro-Opiomelanocortin;D011333
D12.644.400.400.935;Pro-Opiomelanocortin;D011333
D12.644.548.365.935;Pro-Opiomelanocortin;D011333
D12.644.548.691.525.690;Pro-Opiomelanocortin;D011333
D12.776.641.650.405.935;Pro-Opiomelanocortin;D011333
D12.776.811.800;Pro-Opiomelanocortin;D011333
F01.145.544.538;Proactive Inhibition;D011334
F02.463.425.475.538;Proactive Inhibition;D011334
D02.241.081.944.550;Proadifen;D011335
E05.318.740.600;Probability;D011336
G17.680;Probability;D011336
N05.715.360.750.625;Probability;D011336
N06.850.520.830.600;Probability;D011336
F02.463.425.701;Probability Learning;D011337
L01.906.575.622;Probability Theory;D011338
D02.065.884.625;Probenecid;D011339
D02.886.590.700.625;Probenecid;D011339
F02.463.425.725;Problem Solving;D011340
F02.463.785.810;Problem Solving;D011340
D02.455.426.559.389.657.746;Probucol;D011341
D02.065.277.650;Procainamide;D011342
D02.241.223.100.050.500.875;Procainamide;D011342
D02.241.223.100.100.650;Procainamide;D011342
D02.455.426.559.389.127.020.937.875;Procainamide;D011342
D02.455.426.559.389.127.085.650;Procainamide;D011342
D02.241.223.100.050.500.906;Procaine;D011343
D02.455.426.559.389.127.020.937.906;Procaine;D011343
D02.065.277.727;Procarbazine;D011344
D02.241.223.100.100.655;Procarbazine;D011344
D02.455.426.559.389.127.085.655;Procarbazine;D011344
D02.241.081.114.968.500.625;Fenofibrate;D011345
D02.355.726.305.625;Fenofibrate;D011345
D02.455.426.559.389.115.124.750;Fenofibrate;D011345
D02.455.426.559.389.657.654.305.625;Fenofibrate;D011345
D02.522.223.750;Fenofibrate;D011345
D02.886.369.639;Prochlorperazine;D011346
D03.494.741.639;Prochlorperazine;D011346
D12.776.811.690;Procollagen;D011347
D12.776.860.300.250.600;Procollagen;D011347
D08.811.277.656.300.480.664;Procollagen N-Endopeptidase;D011348
D08.811.277.656.675.374.664;Procollagen N-Endopeptidase;D011348
C06.405.205.865;Proctitis;D011349
C06.405.469.860.622;Proctitis;D011349
C06.405.205.265.767;Proctocolitis;D011350
C06.405.205.865.790;Proctocolitis;D011350
C06.405.469.158.188.767;Proctocolitis;D011350
C06.405.469.158.850.790;Proctocolitis;D011350
C06.405.469.860.622.790;Proctocolitis;D011350
E01.370.372.250.250.600;Proctoscopy;D011351
E01.370.388.250.250.250.680;Proctoscopy;D011351
E04.210.240.250.680;Proctoscopy;D011351
E04.800.250.250.250.680;Proctoscopy;D011351
D03.383.773.728;Procyclidine;D011352
D03.383.129.578.748;Prodigiosin;D011353
D23.767.778;Prodigiosin;D011353
D09.698.718.650;Prodigiozan;D011354
D26.675;Prodrugs;D011355
J01.576.761.700;Product Labeling;D011356
N02.278.354.700;Product Line Management;D011357
N04.452.442.700;Product Line Management;D011357
N04.590.374.600;Product Line Management;D011357
E05.337.800;Product Surveillance, Postmarketing;D011358
G08.686.195.875;Proestrus;D011359
I02.399.630;Professional Competence;D011361
N04.452.758.760;Professional Corporations;D011362
I01.880.604.583.524.528;Professional Impairment;D011363
N03.706.535.606.528;Professional Impairment;D011363
N04.452.758;Professional Practice;D011364
N04.452.758.772;Professional Practice Location;D011365
N04.761.673;Professional Review Organizations;D011366
N05.700.675;Professional Review Organizations;D011366
N04.452.758.788;Professional Staff Committees;D011367
N05.700.685;Professional Staff Committees;D011367
F01.829.401.550;Professional-Family Relations;D011368
F01.829.401.650;Professional-Patient Relations;D011369
N05.300.660;Professional-Patient Relations;D011369
D03.494.046.250.720;Proflavine;D011370
C16.320.565.753;Progeria;D011371
C18.452.648.753;Progeria;D011371
D27.505.696.399.472.858;Progestins;D011372
D04.808.745.745.654.829;Progesterone;D011374
D06.472.334.734.623;Progesterone;D011374
D06.472.334.851.687.750;Progesterone;D011374
D08.811.682.047.436.350.700;Progesterone Reductase;D011375
D12.776.124.790.106.740;Progesterone-Binding Globulin;D011376
D12.776.377.715.085.740;Progesterone-Binding Globulin;D011376
D12.125.068.330.700;Proglumide;D011377
D12.125.095.461.700;Proglumide;D011377
C05.500.460.655;Prognathism;D011378
C05.500.607.655;Prognathism;D011378
C05.660.207.540.460.655;Prognathism;D011378
C07.320.440.655;Prognathism;D011378
C07.320.610.655;Prognathism;D011378
C07.650.500.460.655;Prognathism;D011378
C16.131.621.207.540.460.655;Prognathism;D011378
C16.131.850.500.460.655;Prognathism;D011378
E01.789;Prognosis;D011379
I02.903.573;Programmed Instruction as Topic;D011380
L01.224.900.780;Programming Languages;D011381
L01.906.575.748;Programming, Linear;D011382
N04.590.233.799;Progressive Patient Care;D011383
D06.472.699.587.200.500;Proinsulin;D011384
D12.644.548.586.200.500;Proinsulin;D011384
D12.776.811.706;Proinsulin;D011384
F01.393.693;Projection;D011385
F04.711.647.622;Projective Techniques;D011386
A11.760;Prokaryotic Cells;D011387
D06.472.699.322.576.773;Prolactin;D011388
D06.472.699.631.525.525;Prolactin;D011388
D12.644.548.691.525.525;Prolactin;D011388
D06.472.699.327.700.750;Prolactin Release-Inhibiting Factors;D011389
D12.644.400.400.700.750;Prolactin Release-Inhibiting Factors;D011389
D12.644.548.365.700.750;Prolactin Release-Inhibiting Factors;D011389
D12.776.641.650.405.700.750;Prolactin Release-Inhibiting Factors;D011389
C23.300.842;Prolapse;D011391
D12.125.072.401.623;Proline;D011392
D08.811.682.690.708.673;Procollagen-Proline Dioxygenase;D011393
D08.811.682.662.640;Proline Oxidase;D011394
D08.811.682.664.500.810;Proline Oxidase;D011394
D02.886.369.661;Promazine;D011395
D03.494.741.661;Promazine;D011395
D03.066.399.450.700;Promedol;D011396
D03.383.621.349.450.700;Promedol;D011396
D04.808.668.651.443.680;Promegestone;D011397
D02.092.831.690;Promethazine;D011398
D02.886.369.670;Promethazine;D011398
D03.494.741.670;Promethazine;D011398
D01.268.271.720;Promethium;D011399
D01.268.477.875;Promethium;D011399
D01.268.558.362.875;Promethium;D011399
D01.552.550.399.875;Promethium;D011399
D03.383.931.674;Prometryne;D011400
G02.111.570.080.689.675;Promoter Regions, Genetic;D011401
G05.360.080.689.675;Promoter Regions, Genetic;D011401
G05.360.340.024.340.137.750.680;Promoter Regions, Genetic;D011401
D08.811.277.656.300.480.680;Pronase;D011402
D08.811.277.656.300.760.638;Pronase;D011402
D08.811.277.656.675.374.680;Pronase;D011402
D08.811.277.656.959.350.638;Pronase;D011402
G11.427.590.530.698.840;Pronation;D011403
D02.522.818.830;Propafenone;D011405
L01.143.790;Propaganda;D011406
D02.455.326.146.800;Propane;D011407
D08.811.520.241.300.650;Propanediol Dehydratase;D011408
D02.033.455.706;Propylene Glycols;D011409
D02.092.471.302.500;Propanidid;D011410
D02.241.223.601.774;Propanidid;D011410
D02.065.199.789;Propanil;D011411
D02.033.100.624;Propanolamines;D011412
D02.033.755.624;Propanolamines;D011412
D02.092.063.624;Propanolamines;D011412
D02.092.877.700;Propantheline;D011413
D02.675.276.700;Propantheline;D011413
D03.494.953.558;Propantheline;D011413
D12.776.124.486.274.965;Properdin;D011414
D12.776.124.486.789;Properdin;D011414
D12.776.124.790.223.624;Properdin;D011414
D12.776.377.715.182.624;Properdin;D011414
D08.622.200;Complement Factor B;D011415
D08.811.277.656.300.760.198;Complement Factor B;D011415
D08.811.277.656.959.350.198;Complement Factor B;D011415
D12.776.124.486.274.900;Complement Factor B;D011415
D08.811.277.300.450;Complement Factor D;D011416
D08.811.277.656.300.760.200;Complement Factor D;D011416
D08.811.277.656.959.350.200;Complement Factor D;D011416
D12.776.124.486.274.045.450;Complement Factor D;D011416
G04.299.134.220.220.781.906;Prophase;D011418
G04.299.134.220.220.875;Prophase;D011418
G05.355.105.220.781.906;Prophase;D011418
G05.355.105.220.875;Prophase;D011418
D03.494.633.700;Propidium;D011419
D02.540.600;Propiolactone;D011420
D02.241.081.751;Propionates;D011422
D10.251.400.706;Propionates;D011422
B03.510.024.049.600;Propionibacteriaceae;D011423
B03.510.460.400.400.600;Propionibacteriaceae;D011423
B03.510.024.049.600.600;Propionibacterium;D011424
B03.510.460.400.400.600.600;Propionibacterium;D011424
B03.510.024.049.600.600.600;Propionibacterium acnes;D011425
B03.510.460.400.400.600.600.600;Propionibacterium acnes;D011425
D02.522.818;Propiophenones;D011427
D05.750.395.616.755;Proplast;D011428
D25.720.395.616.755;Proplast;D011428
J01.637.051.720.395.616.755;Proplast;D011428
D05.750.078.840.762;Propolis;D011429
D20.215.721.500.762;Propolis;D011429
D02.241.223.100.050.500.937;Propoxycaine;D011430
D02.241.223.100.300.350.687;Propoxycaine;D011430
D02.241.511.390.350.687;Propoxycaine;D011430
D02.455.426.559.389.127.020.937.937;Propoxycaine;D011430
D02.455.426.559.389.127.281.350.687;Propoxycaine;D011430
D02.241.081.751.120;Dextropropoxyphene;D011431
D02.033.100.624.698.711;Propranolol;D011433
D02.033.100.624.836;Propranolol;D011433
D02.033.755.624.698.711;Propranolol;D011433
D02.033.755.624.836;Propranolol;D011433
D02.092.063.624.698.711;Propranolol;D011433
D02.455.426.559.847.638.945;Propranolol;D011433
D04.615.638.945;Propranolol;D011433
F02.830.816.541;Proprioception;D011434
G11.561.600.810.541;Proprioception;D011434
D02.241.223.100.300.200.600;Propyl Gallate;D011435
D02.241.511.390.200.600;Propyl Gallate;D011435
D02.455.426.559.389.127.281.200.600;Propyl Gallate;D011435
D02.455.426.559.389.657.410.200.600;Propyl Gallate;D011435
D08.811.913.225.825;Spermidine Synthase;D011436
D02.092.831;Propylamines;D011437
D02.092.877.883.333.720;Propylbenzilylcholine Mustard;D011438
D02.455.526.728.650.740;Propylbenzilylcholine Mustard;D011438
D02.675.276.232.720;Propylbenzilylcholine Mustard;D011438
D03.383.725.791.496.750;Propyliodone;D011440
D03.383.742.698.875.842.708;Propylthiouracil;D011441
D04.808.155.580.064.580;Proscillaridin;D011442
D09.408.180.660;Proscillaridin;D011442
B01.050.150.900.649.801.700;Strepsirhini;D011443
N03.219.521.710.305.200.605;Prospective Payment Assessment Commission;D011444
N03.219.521.710.305.200;Prospective Payment System;D011445
E05.318.760.500.750.500.650;Prospective Studies;D011446
N05.715.360.775.175.250.630;Prospective Studies;D011446
N06.850.520.450.500.750.650;Prospective Studies;D011446
D02.455.426.559.847.885.700;Prospidium;D011447
D03.383.606.810;Prospidium;D011447
D04.615.885.700;Prospidium;D011447
D06.347.710;Prostaglandin Antagonists;D011448
D27.505.696.399.450.710;Prostaglandin Antagonists;D011448
D02.737.637;Prostaglandin Endoperoxides;D011449
D10.251.355.255.100.637.025;Prostaglandin Endoperoxides;D011449
D10.251.355.255.550.025;Prostaglandin Endoperoxides;D011449
D23.469.050.175.725.720;Prostaglandin Endoperoxides;D011449
D10.251.355.255.550.700.250;Prostaglandin Endoperoxides, Synthetic;D011450
D23.469.700.630;Prostaglandin Endoperoxides, Synthetic;D011450
D08.811.600.720;Prostaglandin-Endoperoxide Synthases;D011451
D08.811.682.690.708.715;Prostaglandin-Endoperoxide Synthases;D011451
D08.811.682.660.490;15-Oxoprostaglandin 13-Reductase;D011452
D10.251.355.255.100.637;Prostaglandins;D011453
D10.251.355.255.550;Prostaglandins;D011453
D23.469.050.175.725;Prostaglandins;D011453
D10.251.355.255.100.637.100;Prostaglandins A;D011454
D10.251.355.255.550.100;Prostaglandins A;D011454
D23.469.050.175.725.740;Prostaglandins A;D011454
D10.251.355.255.550.700.350;Prostaglandins A, Synthetic;D011455
D23.469.700.645;Prostaglandins A, Synthetic;D011455
D10.251.355.255.100.637.150;Prostaglandins B;D011456
D10.251.355.255.550.150;Prostaglandins B;D011456
D23.469.050.175.725.750;Prostaglandins B;D011456
D10.251.355.255.100.637.200;Prostaglandins D;D011457
D10.251.355.255.550.200;Prostaglandins D;D011457
D23.469.050.175.725.770;Prostaglandins D;D011457
D10.251.355.255.100.637.250;Prostaglandins E;D011458
D10.251.355.255.550.250;Prostaglandins E;D011458
D23.469.050.175.725.780;Prostaglandins E;D011458
D10.251.355.255.550.700.450;Prostaglandins E, Synthetic;D011459
D23.469.700.660;Prostaglandins E, Synthetic;D011459
D10.251.355.255.100.637.400;Prostaglandins F;D011460
D10.251.355.255.550.400;Prostaglandins F;D011460
D23.469.050.175.725.790;Prostaglandins F;D011460
D10.251.355.255.550.700.500;Prostaglandins F, Synthetic;D011461
D23.469.700.670;Prostaglandins F, Synthetic;D011461
D02.737.637.600;Prostaglandins G;D011462
D10.251.355.255.100.637.025.600;Prostaglandins G;D011462
D10.251.355.255.550.025.600;Prostaglandins G;D011462
D23.469.050.175.725.720.700;Prostaglandins G;D011462
D02.737.637.650;Prostaglandins H;D011463
D10.251.355.255.100.637.025.650;Prostaglandins H;D011463
D10.251.355.255.550.025.650;Prostaglandins H;D011463
D23.469.050.175.725.720.720;Prostaglandins H;D011463
D10.251.355.255.100.637.550.500;Epoprostenol;D011464
D10.251.355.255.550.550.500;Epoprostenol;D011464
D23.469.050.175.725.895.500;Epoprostenol;D011464
D10.251.355.255.550.700;Prostaglandins, Synthetic;D011465
D23.469.700;Prostaglandins, Synthetic;D011465
D10.251.740;Prostanoic Acids;D011466
A05.360.444.575;Prostate;D011467
A10.336.707;Prostate;D011467
E04.950.774.860.625;Prostatectomy;D011468
C12.294.565;Prostatic Diseases;D011469
C12.294.565.500;Prostatic Hyperplasia;D011470
C04.588.945.440.770;Prostatic Neoplasms;D011471
C12.294.260.750;Prostatic Neoplasms;D011471
C12.294.565.625;Prostatic Neoplasms;D011471
C12.758.409.750;Prostatic Neoplasms;D011471
C12.294.565.750;Prostatitis;D011472
E05.320.550;Prosthesis Design;D011474
E07.695.680;Prosthesis Design;D011474
C23.550.767.865;Prosthesis Failure;D011475
E05.325.771;Prosthesis Failure;D011475
E06.780;Prosthodontics;D011476
H02.163.876.708;Prosthodontics;D011476
F01.145.802.790;Prostitution;D011477
I01.880.735.679;Prostitution;D011477
D01.268.033.725;Protactinium;D011478
D01.268.271.100.725;Protactinium;D011478
D01.268.556.750;Protactinium;D011478
D01.552.020.778;Protactinium;D011478
D01.552.544.750;Protactinium;D011478
D12.776.660.750;Protamines;D011479
D12.776.664.750;Protamines;D011479
D27.505.519.389.745;Protease Inhibitors;D011480
E07.700.600;Protective Clothing;D011481
J01.637.215.600;Protective Clothing;D011481
J01.637.708.600;Protective Clothing;D011481
E07.700;Protective Devices;D011482
J01.637.708;Protective Devices;D011482
B01.050.150.900.090.608.630;Proteidae;D011483
D08.811.913.555.500.800.750;Protein-Arginine N-Methyltransferases;D011484
G02.111.087.680;Protein Binding;D011485
G02.149.115.680;Protein Binding;D011485
G03.495.800;Protein Binding;D011485
D08.622.705;Protein C;D011486
D12.776.124.650;Protein C;D011486
D12.776.395.635;Protein C;D011486
D23.113.700;Protein C;D011486
G02.111.570.790.709;Protein Conformation;D011487
C18.654.521.500.708;Protein Deficiency;D011488
E05.793.500;Protein Denaturation;D011489
G01.154.100.640.750.500;Protein Denaturation;D011489
G01.595.100.640.750.500;Protein Denaturation;D011489
G02.111.087.690.750.500;Protein Denaturation;D011489
G02.149.115.690.750.500;Protein Denaturation;D011489
D08.811.682.667.186;Protein Disulfide Reductase (Glutathione);D011490
D12.776.796;Protein Hydrolysates;D011492
D08.811.913.696.620.682.700.725;Protein Kinase C;D011493
D08.811.913.696.620.682;Protein Kinases;D011494
D08.811.913.555.500.800.400;Histone-Lysine N-Methyltransferase;D011495
D08.811.913.555.500.800;Protein Methyltransferases;D011496
D08.811.913.555.500.800.800;Protein O-Methyltransferase;D011497
D12.776.811;Protein Precursors;D011498
G02.111.087.675.871.790.600;Protein Processing, Post-Translational;D011499
G02.111.087.693.600;Protein Processing, Post-Translational;D011499
G02.149.115.675.871.790.600;Protein Processing, Post-Translational;D011499
G02.149.115.693.600;Protein Processing, Post-Translational;D011499
G03.495.770.871.790.600;Protein Processing, Post-Translational;D011499
G05.355.315.670.600;Protein Processing, Post-Translational;D011499
D27.505.519.389.760;Protein Synthesis Inhibitors;D011500
C18.654.521.500.708.626;Protein-Energy Malnutrition;D011502
D08.811.913.050.200.800;Transglutaminases;D011503
C06.405.469.818;Protein-Losing Enteropathies;D011504
D08.811.913.696.620.682.725;Protein-Tyrosine Kinases;D011505
D12.776;Proteins;D011506
C12.777.934.734;Proteinuria;D011507
C13.351.968.934.734;Proteinuria;D011507
C23.888.942.750;Proteinuria;D011507
D09.698.735.200;Chondroitin Sulfate Proteoglycans;D011508
D12.776.395.650.750;Chondroitin Sulfate Proteoglycans;D011508
D09.698.735;Proteoglycans;D011509
D12.776.395.650;Proteoglycans;D011509
D10.570.780;Proteolipids;D011510
D12.776.816;Proteolipids;D011510
B03.440.450.425.600;Proteus;D011511
B03.660.250.150.590;Proteus;D011511
C01.252.400.310.708;Proteus Infections;D011512
B03.440.450.425.600.501;Proteus mirabilis;D011513
B03.660.250.150.590.500;Proteus mirabilis;D011513
B03.440.450.425.600.800;Proteus vulgaris;D011514
B03.660.250.150.590.840;Proteus vulgaris;D011514
D03.066.349.570;Prothionamide;D011515
D03.383.725.394.675;Prothionamide;D011515
D08.622.709;Prothrombin;D011516
D12.776.124.125.800;Prothrombin;D011516
D23.119.945;Prothrombin;D011516
E01.370.225.625.115.610;Prothrombin Time;D011517
E05.200.625.115.610;Prothrombin Time;D011517
G09.188.680;Prothrombin Time;D011517
D12.776.624.664.700;Proto-Oncogene Proteins;D011518
G05.360.340.024.340.375.500.791;Proto-Oncogenes;D011519
D08.811.682.690.416.652;Protocatechuate-3,4-Dioxygenase;D011520
D03.383.129.578.840.374.725;Protochlorophyllide;D011521
D03.383.129.578.840.500.640.220.725;Protochlorophyllide;D011521
D03.549.909.374.725;Protochlorophyllide;D011521
D03.549.909.500.640.220.725;Protochlorophyllide;D011521
D04.345.783.374.725;Protochlorophyllide;D011521
D04.345.783.500.640.220.725;Protochlorophyllide;D011521
D23.767.727.220.725;Protochlorophyllide;D011521
D23.767.727.640.220.725;Protochlorophyllide;D011521
D01.248.497.300.459.700;Protons;D011522
D01.435.550;Protons;D011522
G01.249.765;Protons;D011522
A11.789;Protoplasts;D011523
D03.383.129.578.840.500.725;Protoporphyrins;D011524
D03.549.909.500.725;Protoporphyrins;D011524
D04.345.783.500.725;Protoporphyrins;D011524
D23.767.727.725;Protoporphyrins;D011524
B01.650.940.150.634;Prototheca;D011525
D03.132.920.256.543;Protoveratrines;D011526
D03.549.256.543;Protoveratrines;D011526
C03.752;Protozoan Infections;D011528
C03.701.688;Protozoan Infections, Animal;D011529
C03.752.625;Protozoan Infections, Animal;D011529
C22.674.710;Protozoan Infections, Animal;D011529
D02.455.426.559.847.181.384.650;Protriptyline;D011530
D04.615.181.384.650;Protriptyline;D011530
A13.853.710;Proventriculus;D011531
B03.440.450.425.670;Providencia;D011532
B03.660.250.150.600;Providencia;D011532
B04.725;Proviruses;D011533
C16.131.077.745;Prune Belly Syndrome;D011535
C17.800.674;Prurigo;D011536
C17.800.685;Pruritus;D011537
C23.888.885.625;Pruritus;D011537
C06.405.469.860.101.752;Pruritus Ani;D011538
C17.800.685.544;Pruritus Ani;D011538
C13.351.500.944.626;Pruritus Vulvae;D011539
C17.800.685.710;Pruritus Vulvae;D011539
E01.370.225.500.607.810;Prussian Blue Reaction;D011540
E01.370.225.500.620.670.660;Prussian Blue Reaction;D011540
E01.370.225.750.551.810;Prussian Blue Reaction;D011540
E01.370.225.750.600.670.660;Prussian Blue Reaction;D011540
E05.200.500.607.810;Prussian Blue Reaction;D011540
E05.200.500.620.670.660;Prussian Blue Reaction;D011540
E05.200.750.551.810;Prussian Blue Reaction;D011540
E05.200.750.600.670.660;Prussian Blue Reaction;D011540
B01.300.107.780;Pseudallescheria;D011541
C26.404.468.627;Pseudarthrosis;D011542
D08.811.277.352.100.170.710;Pseudocholinesterase;D011543
G05.360.340.024.340.700;Pseudogenes;D011544
C12.777.419.815.770;Pseudohypoaldosteronism;D011546
C13.351.968.419.815.770;Pseudohypoaldosteronism;D011546
C16.320.565.861.770;Pseudohypoaldosteronism;D011546
C18.452.648.861.770;Pseudohypoaldosteronism;D011546
C05.116.198.709;Pseudohypoparathyroidism;D011547
C16.320.565.618.815;Pseudohypoparathyroidism;D011547
C18.452.174.766;Pseudohypoparathyroidism;D011547
C18.452.648.618.815;Pseudohypoparathyroidism;D011547
B03.440.400.425.625;Pseudomonadaceae;D011548
B03.660.250.580;Pseudomonadaceae;D011548
B03.440.400.425.625.625;Pseudomonas;D011549
B03.660.250.580.590;Pseudomonas;D011549
B03.440.400.425.625.625.100;Pseudomonas aeruginosa;D011550
B03.660.250.580.590.050;Pseudomonas aeruginosa;D011550
B03.440.400.425.625.625.325;Pseudomonas fluorescens;D011551
B03.660.250.580.590.210;Pseudomonas fluorescens;D011551
C01.252.400.739;Pseudomonas Infections;D011552
C04.557.470.590.782;Pseudomyxoma Peritonei;D011553
A11.284.180.700;Pseudopodia;D011554
G08.686.785.760.769.887;Pseudopregnancy;D011555
C05.116.198.709.628;Pseudopseudohypoparathyroidism;D011556
C16.320.565.618.815.815;Pseudopseudohypoparathyroidism;D011556
C18.452.174.766.815;Pseudopseudohypoparathyroidism;D011556
C18.452.648.618.815.815;Pseudopseudohypoparathyroidism;D011556
C02.182.710;Pseudorabies;D011557
C02.256.466.793;Pseudorabies;D011557
C10.228.228.210.710;Pseudorabies;D011557
C22.742;Pseudorabies;D011557
B04.280.382.100.900.510;Herpesvirus 1, Suid;D011558
B04.909.204.382.100.900.510;Herpesvirus 1, Suid;D011558
C10.228.140.631.750;Pseudotumor Cerebri;D011559
D03.383.742.680.852.628;Pseudouridine;D011560
D13.570.685.852.628;Pseudouridine;D011560
D13.570.800.892.628;Pseudouridine;D011560
C14.907.454.530;Pseudoxanthoma Elasticum;D011561
C15.378.463.515.530;Pseudoxanthoma Elasticum;D011561
C16.131.831.766;Pseudoxanthoma Elasticum;D011561
C16.320.850.750;Pseudoxanthoma Elasticum;D011561
C17.300.766;Pseudoxanthoma Elasticum;D011561
C17.800.804.766;Pseudoxanthoma Elasticum;D011561
C17.800.827.750;Pseudoxanthoma Elasticum;D011561
D03.132.436.613;Psilocybine;D011562
D03.438.473.402.613;Psilocybine;D011562
D03.438.473.914.700;Psilocybine;D011562
B01.050.150.900.248.710;Psittaciformes;D011563
D03.438.150.446.794;Psoralens;D011564
D03.494.770;Psoralens;D011564
D03.830.219.446.794;Psoralens;D011564
C17.800.859.675;Psoriasis;D011565
M01.526.485.067.652.628;Psychiatric Aides;D011566
N02.360.067.652.628;Psychiatric Aides;D011566
N02.278.354.422.641;Psychiatric Department, Hospital;D011567
N04.452.442.422.641;Psychiatric Department, Hospital;D011567
H02.478.676.710;Psychiatric Nursing;D011568
N02.421.533.778;Psychiatric Nursing;D011568
F04.586;Psychiatric Status Rating Scales;D011569
F04.096.544;Psychiatry;D011570
H02.403.690;Psychiatry;D011570
E01.370.382.375.060.530;Psychoacoustics;D011571
E01.370.685.628;Psychoacoustics;D011571
F04.096.753.628;Psychoacoustics;D011571
F04.732.628;Psychoacoustics;D011571
F04.096.544.779;Psychoanalysis;D011572
F04.628;Psychoanalytic Interpretation;D011573
F02.739.794;Psychoanalytic Theory;D011574
F04.754.709;Psychoanalytic Therapy;D011575
B01.050.500.131.617.289.781;Psychodidae;D011576
E02.190.525.781;Psychodrama;D011577
F04.754.864.581.679;Psychodrama;D011577
F02.694;Psycholinguistics;D011578
F04.096.586;Psycholinguistics;D011578
L01.143.506.598.628;Psycholinguistics;D011578
F02;Psychological Phenomena and Processes;D011579
F04.669;Psychological Techniques;D011580
F04.711;Psychological Tests;D011581
F02.739;Psychological Theory;D011582
I01.880.735.944.711;Psychological Warfare;D011583
F04.096.628;Psychology;D011584
F02.784;Psychology, Applied;D011585
F04.096.628.579;Psychology, Clinical;D011586
F04.096.628.629;Psychology, Comparative;D011587
F02.784.629;Psychology, Educational;D011588
F04.096.628.679;Psychology, Educational;D011588
F04.096.628.729;Psychology, Experimental;D011589
F02.784.692;Psychology, Industrial;D011590
F04.096.628.779;Psychology, Industrial;D011590
F04.096.628.808;Psychology, Medical;D011591
H02.720;Psychology, Medical;D011591
F02.784.754;Psychology, Military;D011592
F01.829;Psychology, Social;D011593
F04.096.628.829;Psychology, Social;D011593
F04.711.780;Psychometrics;D011594
C10.597.350.600;Psychomotor Agitation;D011595
C10.597.606.881.700;Psychomotor Agitation;D011595
C23.888.592.350.600;Psychomotor Agitation;D011595
C23.888.592.604.882.700;Psychomotor Agitation;D011595
F01.700.875.700;Psychomotor Agitation;D011595
C10.597.606.881;Psychomotor Disorders;D011596
C23.888.592.604.882;Psychomotor Disorders;D011596
F01.700.875;Psychomotor Disorders;D011596
F02.808;Psychomotor Performance;D011597
G11.427.700;Psychomotor Performance;D011597
G11.561.623;Psychomotor Performance;D011597
F04.096.795.650;Psychoneuroimmunology;D011598
H01.158.782.795.180;Psychoneuroimmunology;D011598
F04.096.670;Psychopathology;D011599
F04.096.712;Psychopharmacology;D011600
F04.570.505;Psychopharmacology;D011600
H01.158.703.546;Psychopharmacology;D011600
H02.628.546;Psychopharmacology;D011600
E01.370.685;Psychophysics;D011601
F04.096.753;Psychophysics;D011601
F04.732;Psychophysics;D011601
C23.888.592.700;Psychophysiologic Disorders;D011602
E02.190.525.812;Psychophysiology;D011603
F02.830;Psychophysiology;D011603
F04.096.795;Psychophysiology;D011603
H01.158.782.795;Psychophysiology;D011603
C25.100.087.750;Psychoses, Alcoholic;D011604
C25.723.809.750;Psychoses, Alcoholic;D011604
F03.700.675.600.750;Psychoses, Alcoholic;D011604
F03.900.100.750;Psychoses, Alcoholic;D011604
C25.723.809;Psychoses, Substance-Induced;D011605
C25.746;Psychoses, Substance-Induced;D011605
F03.700.675.600;Psychoses, Substance-Induced;D011605
F03.900.746;Psychoses, Substance-Induced;D011605
F01.752.747.722;Psychosexual Development;D011606
F02.739.794.793;Psychosexual Development;D011606
D02.033.100.700.700;Psychosine;D011609
D02.092.063.700.700;Psychosine;D011609
D09.400.410.420.806;Psychosine;D011609
D10.390.470.806;Psychosine;D011609
D10.570.877.360.806;Psychosine;D011609
F01.829.628;Psychosocial Deprivation;D011610
I01.880.143.806;Psychosocial Deprivation;D011610
F04.096.544.830;Psychosomatic Medicine;D011611
E04.525.600;Psychosurgery;D011612
F04.570.630;Psychosurgery;D011612
F04.754;Psychotherapy;D011613
F04.754.738;Psychotherapy, Brief;D011614
F04.754.864.581;Psychotherapy, Group;D011615
F04.754.766;Psychotherapy, Multiple;D011616
F04.754.785;Psychotherapy, Rational-Emotive;D011617
F03.700.675;Psychotic Disorders;D011618
D27.505.954.427.700;Psychotropic Drugs;D011619
D20.215.784.500.720;Psyllium;D011620
D03.438.733;Pteridines;D011621
D03.438.733.631;Pterins;D011622
D23.767.831;Pterins;D011622
D08.811.277.656.350.245.280;gamma-Glutamyl Hydrolase;D011623
D03.438.733.631.400.600;Pteroylpolyglutamic Acids;D011624
C11.187.781;Pterygium;D011625
A02.633.567.600.700;Pterygoid Muscles;D011626
A14.530.790;Pterygoid Muscles;D011626
G08.686.760;Puberty;D011627
G08.686.785.880.374;Puberty;D011627
C19.391.690;Puberty, Delayed;D011628
C19.391.693;Puberty, Precocious;D011629
A02.835.232.043.825.781;Pubic Bone;D011630
A02.835.583.656;Pubic Symphysis;D011631
N03.219.521.346.506;Public Assistance;D011632
N06.850.860.410;Public Facilities;D011633
H02.403.720;Public Health;D011634
N01.400.550;Public Health;D011634
N06.850;Public Health;D011634
N04.452.794;Public Health Administration;D011635
H02.163.876.770;Public Health Dentistry;D011636
N06.890;Public Health Dentistry;D011636
H02.478.676.755;Public Health Nursing;D011637
N01.224.791.400.650;Public Housing;D011638
N06.230.150.360.650;Public Housing;D011638
I01.880.630.548;Public Opinion;D011639
I01.655.500.608;Public Policy;D011640
I01.880.604.825.608;Public Policy;D011640
N03.623.500.608;Public Policy;D011640
N04.452.822;Public Relations;D011641
L01.178.682;Publications;D011642
L01.737;Publishing;D011643
C13.703.844;Puerperal Disorders;D011644
C01.539.674.715;Puerperal Infection;D011645
C13.703.700.715;Puerperal Infection;D011645
C13.703.844.757;Puerperal Infection;D011645
Z01.107.084.900.750;Puerto Rico;D011647
Z01.639.880.750;Puerto Rico;D011647
C02.782.815.725;Pulmonary Adenomatosis, Ovine;D011648
C02.928.740;Pulmonary Adenomatosis, Ovine;D011648
C04.557.470.200.025.715;Pulmonary Adenomatosis, Ovine;D011648
C22.836.715;Pulmonary Adenomatosis, Ovine;D011648
C08.381.719;Pulmonary Alveolar Proteinosis;D011649
A04.411.715;Pulmonary Alveoli;D011650
A07.231.114.715;Pulmonary Artery;D011651
G09.330.190.163.770;Pulmonary Circulation;D011652
G09.772.770.690;Pulmonary Circulation;D011652
E01.370.386.700.650.650;Pulmonary Diffusing Capacity;D011653
G09.772.600;Pulmonary Diffusing Capacity;D011653
C08.381.742;Pulmonary Edema;D011654
C08.381.746;Pulmonary Embolism;D011655
C14.907.355.350.700;Pulmonary Embolism;D011655
C08.381.748;Pulmonary Emphysema;D011656
C08.381.750;Pulmonary Eosinophilia;D011657
C15.378.553.231.549.750;Pulmonary Eosinophilia;D011657
C08.381.765;Pulmonary Fibrosis;D011658
E01.370.386.700.650;Pulmonary Gas Exchange;D011659
G03.495.166.775.602;Pulmonary Gas Exchange;D011659
G09.772.770.755.760.602;Pulmonary Gas Exchange;D011659
C14.280.832;Pulmonary Heart Disease;D011660
A08.663.650.915.750.780;Pulmonary Stretch Receptors;D011661
A08.800.950.750.780;Pulmonary Stretch Receptors;D011661
A11.671.650.915.750.780;Pulmonary Stretch Receptors;D011661
C14.280.484.716.762;Pulmonary Subvalvular Stenosis;D011662
C14.280.955.750.762;Pulmonary Subvalvular Stenosis;D011662
D27.505.954.796.600;Pulmonary Surfactants;D011663
A07.541.510.738;Pulmonary Valve;D011664
C14.280.484.660;Pulmonary Valve Insufficiency;D011665
C14.280.484.716;Pulmonary Valve Stenosis;D011666
C14.280.955.750;Pulmonary Valve Stenosis;D011666
A07.231.908.713;Pulmonary Veins;D011667
C08.381.780;Pulmonary Veno-Occlusive Disease;D011668
C14.907.690;Pulmonary Veno-Occlusive Disease;D011668
G09.330.380.076.695;Pulmonary Wedge Pressure;D011669
E06.397.633;Pulpectomy;D011670
C07.793.237.820;Pulpitis;D011671
E06.397.695;Pulpotomy;D011672
G01.595.560.620;Pulsatile Flow;D011673
G09.330.190.400.295.750;Pulsatile Flow;D011673
E01.370.370.380.650;Pulse;D011674
E01.370.600.650;Pulse;D011674
G09.330.380.750;Pulse;D011674
E05.196.867.660;Pulse Radiolysis;D011675
L01.224.085.800;Punched-Card Systems;D011676
E02.800;Punctures;D011677
E04.665;Punctures;D011677
F02.463.425.770.571;Punishment;D011678
I01.880.630.716;Punishment;D011678
B05.500.700;Pupa;D011679
G07.700.320.500.550.500.700;Pupa;D011679
A09.371.060.450.780;Pupil;D011680
A09.371.894.513.780;Pupil;D011680
C10.597.690;Pupil Disorders;D011681
C11.710;Pupil Disorders;D011681
C23.888.592.708;Pupil Disorders;D011681
N02.278.354.422.679;Purchasing, Hospital;D011682
N04.452.442.422.679;Purchasing, Hospital;D011682
D08.811.913.400.725.800;Purine-Nucleoside Phosphorylase;D011683
D03.438.759.590;Purine Nucleosides;D011684
D13.570.583;Purine Nucleosides;D011684
D03.438.759.646;Purine Nucleotides;D011685
D13.695.667;Purine Nucleotides;D011685
C16.320.565.798;Purine-Pyrimidine Metabolism, Inborn Errors;D011686
C18.452.648.798;Purine-Pyrimidine Metabolism, Inborn Errors;D011686
D03.438.759;Purines;D011687
D03.438.759.758;Purinones;D011688
A08.186.211.132.810.428.200.212.600;Purkinje Cells;D011689
A08.186.211.865.428.200.212.600;Purkinje Cells;D011689
A08.663.784;Purkinje Cells;D011689
A11.671.784;Purkinje Cells;D011689
A07.541.409.683;Purkinje Fibers;D011690
D02.241.223.200.380;Puromycin;D011691
D03.438.759.590.138.711;Puromycin;D011691
D09.408.051.788;Puromycin;D011691
D13.570.583.138.711;Puromycin;D011691
D02.241.223.200.380.650;Puromycin Aminonucleoside;D011692
D03.438.759.590.138.325.800;Puromycin Aminonucleoside;D011692
D03.438.759.590.138.711.650;Puromycin Aminonucleoside;D011692
D09.408.051.788.650;Puromycin Aminonucleoside;D011692
D13.570.230.229.650;Puromycin Aminonucleoside;D011692
D13.570.583.138.325.800;Puromycin Aminonucleoside;D011692
D13.570.583.138.711.650;Puromycin Aminonucleoside;D011692
C15.378.100.802;Purpura;D011693
C23.550.414.950;Purpura;D011693
C23.888.885.687;Purpura;D011693
C14.907.454.550;Purpura, Hyperglobulinemic;D011694
C15.378.100.802.250;Purpura, Hyperglobulinemic;D011694
C15.378.463.515.550;Purpura, Hyperglobulinemic;D011694
C23.550.414.950.250;Purpura, Hyperglobulinemic;D011694
C23.888.885.687.250;Purpura, Hyperglobulinemic;D011694
C14.907.940.777;Purpura, Schoenlein-Henoch;D011695
C15.378.100.802.375;Purpura, Schoenlein-Henoch;D011695
C15.378.463.515.580;Purpura, Schoenlein-Henoch;D011695
C20.543.520.600;Purpura, Schoenlein-Henoch;D011695
C23.550.414.950.375;Purpura, Schoenlein-Henoch;D011695
C23.888.885.687.375;Purpura, Schoenlein-Henoch;D011695
C15.378.100.802.687;Purpura, Thrombocytopenic;D011696
C15.378.140.855.925.750;Purpura, Thrombocytopenic;D011696
C20.841;Purpura, Thrombocytopenic;D011696
C23.550.414.950.687;Purpura, Thrombocytopenic;D011696
C23.888.885.687.687;Purpura, Thrombocytopenic;D011696
C15.378.100.802.687.680;Purpura, Thrombotic Thrombocytopenic;D011697
C15.378.140.855.925.750.680;Purpura, Thrombotic Thrombocytopenic;D011697
C15.378.925.850;Purpura, Thrombotic Thrombocytopenic;D011697
C23.550.414.950.687.680;Purpura, Thrombotic Thrombocytopenic;D011697
C23.888.885.687.687.680;Purpura, Thrombotic Thrombocytopenic;D011697
G14.640.260.453;Pursuit, Smooth;D011698
A08.186.211.730.885.287.249.487.550.784;Putamen;D011699
D02.092.211.415.701;Putrescine;D011700
D02.092.782.258.784;Putrescine;D011700
E02.774.945.500;PUVA Therapy;D011701
C12.777.419.570.821;Pyelitis;D011702
C13.351.968.419.570.821;Pyelitis;D011702
C12.777.419.570.643.790;Pyelonephritis;D011704
C12.777.419.570.821.717;Pyelonephritis;D011704
C13.351.968.419.570.643.790;Pyelonephritis;D011704
C13.351.968.419.570.821.717;Pyelonephritis;D011704
C12.777.419.570.643.790.810;Pyelonephritis, Xanthogranulomatous;D011705
C12.777.419.570.821.717.810;Pyelonephritis, Xanthogranulomatous;D011705
C13.351.968.419.570.643.790.810;Pyelonephritis, Xanthogranulomatous;D011705
C13.351.968.419.570.821.717.810;Pyelonephritis, Xanthogranulomatous;D011705
A03.556.875.875.716;Pyloric Antrum;D011706
C06.405.748.340.690;Pyloric Stenosis;D011707
A03.556.875.875.799;Pylorus;D011708
D12.776.097.151.785;Pyocins;D011709
D03.494.704.700;Pyocyanine;D011710
D23.767.860;Pyocyanine;D011710
C17.800.695;Pyoderma;D011711
A08.186.854.633;Pyramidal Tracts;D011712
A08.612.380.730;Pyramidal Tracts;D011712
D03.383.663.705;Pyran Copolymer;D011713
D03.830.705;Pyran Copolymer;D011713
D05.750.830;Pyran Copolymer;D011713
D25.720.830;Pyran Copolymer;D011713
J01.637.051.720.830;Pyran Copolymer;D011713
D03.383.663;Pyrans;D011714
D03.830;Pyrans;D011714
D02.886.778.634;Pyrantel;D011715
D03.383.742.634;Pyrantel;D011715
D03.383.903.634;Pyrantel;D011715
D02.886.778.634.600;Pyrantel Pamoate;D011716
D03.383.742.634.600;Pyrantel Pamoate;D011716
D03.383.903.634.600;Pyrantel Pamoate;D011716
D02.886.778.634.670;Pyrantel Tartrate;D011717
D03.383.742.634.670;Pyrantel Tartrate;D011717
D03.383.903.634.670;Pyrantel Tartrate;D011717
D03.383.679.750;Pyrazinamide;D011718
D03.383.679;Pyrazines;D011719
D03.383.129.539;Pyrazoles;D011720
D02.455.426.559.847.799;Pyrenes;D011721
D04.615.799;Pyrenes;D011721
D02.455.849.575.812;Pyrethrins;D011722
B01.650.940.800.575.100.100.206.222;Chrysanthemum cinerariifolium;D011723
D03.383.710;Pyridazines;D011724
D03.383.725;Pyridines;D011725
D03.383.725.762;Pyridinium Compounds;D011726
D02.241.081.251.583.799;Pyridinolcarbamate;D011727
D03.383.725.791;Pyridones;D011728
D03.383.725.762.740;Pyridostigmine Bromide;D011729
D03.383.725.676.925.500;Pyridoxal;D011730
D08.811.913.696.620.685;Pyridoxal Kinase;D011731
D03.383.725.676.925.500.500;Pyridoxal Phosphate;D011732
D08.211.740;Pyridoxal Phosphate;D011732
D03.383.725.676.925.750;Pyridoxamine;D011733
D08.811.682.662.680;Pyridoxaminephosphate Oxidase;D011734
D03.066.349.600;Pyridoxic Acid;D011735
D03.383.725.394.700;Pyridoxic Acid;D011735
D03.383.725.705.645;Pyridoxic Acid;D011735
D03.383.725.676.925.875;Pyridoxine;D011736
D03.383.725.050.805;Pyrilamine;D011738
D03.383.742.675;Pyrimethamine;D011739
D03.383.742.686.600;Pyrimidine Dimers;D011740
D13.695.578.424.600;Pyrimidine Dimers;D011740
D13.695.740.600;Pyrimidine Dimers;D011740
D03.383.742.680;Pyrimidine Nucleosides;D011741
D13.570.685;Pyrimidine Nucleosides;D011741
D03.383.742.686;Pyrimidine Nucleotides;D011742
D13.695.740;Pyrimidine Nucleotides;D011742
D03.383.742;Pyrimidines;D011743
D03.383.742.698;Pyrimidinones;D011744
D03.383.725.762.760;Pyrithiamine;D011745
D03.383.742.715;Pyrithiamine;D011745
D03.383.725.812;Pyrithioxin;D011746
D02.455.426.559.389.657.800;Pyrogallol;D011748
D27.888.569.673;Pyrogens;D011749
D12.776.124.486.485.900.700;Pyroglobulins;D011750
D12.776.124.790.651.900.700;Pyroglobulins;D011750
D12.776.377.715.548.900.700;Pyroglobulins;D011750
D08.811.277.656.350.100.755;Pyroglutamyl-Peptidase I;D011751
D08.811.277.087.760;Pyroglutamate Hydrolase;D011752
D03.383.663.718;Pyrones;D011753
D03.830.718;Pyrones;D011753
D03.494.953.570;Pyronine;D011754
D08.811.277.040.600;Pyrophosphatases;D011755
D01.248.497.158.730.650.200;Diphosphates;D011756
D01.695.625.675.650.775.150;Diphosphates;D011756
D03.383.129.578;Pyrroles;D011758
D03.383.773;Pyrrolidines;D011759
D03.383.773.812;Pyrrolidinones;D011760
D03.383.773.812.718;Pyrrolidonecarboxylic Acid;D011761
D12.125.067.750.700;Pyrrolidonecarboxylic Acid;D011761
D12.125.072.401.761;Pyrrolidonecarboxylic Acid;D011761
D08.811.682.662.695;Pyrroline Carboxylate Reductases;D011762
D03.132.716;Pyrrolizidine Alkaloids;D011763
D03.438.772;Pyrrolizidine Alkaloids;D011763
D03.383.129.578.770;Pyrrolnitrin;D011764
D02.047.644.650;Pyruvaldehyde;D011765
D08.811.464.257.500;Pyruvate Carboxylase;D011766
D08.811.520.224.125.750;Pyruvate Decarboxylase;D011767
D05.500.562.625;Pyruvate Dehydrogenase Complex;D011768
D08.811.600.741;Pyruvate Dehydrogenase Complex;D011768
D08.811.277.352.650.625.725;Pyruvate Dehydrogenase (Lipoamide)-Phosphatase;D011769
D08.811.913.696.620.695;Pyruvate Kinase;D011770
D08.811.682.657.350.937;Pyruvate Oxidase;D011771
D08.811.913.696.645.700;Pyruvate, Orthophosphate Dikinase;D011772
D02.241.755.812;Pyruvates;D011773
D03.438.810.824.700;Pyrvinium Compounds;D011774
B01.750.937.750;Pythium;D011775
C01.539.895.719;Pyuria;D011776
C12.777.892.719;Pyuria;D011776
C13.351.968.892.719;Pyuria;D011776
D08.811.913.696.445.735.630;Q beta Replicase;D011777
C01.252.400.755;Q Fever;D011778
F04.513.636;Q-Sort;D011779
Z01.252.245.500.690;Qatar;D011780
Z01.586.500.690;Qatar;D011780
I01.880.735.728;Quackery;D011781
C10.597.622.760;Quadriplegia;D011782
C23.888.592.636.786;Quadriplegia;D011782
M01.438.486;Quadruplets;D011783
B01.050.150.900.248.350.650;Quail;D011784
N04.761.700;Quality Assurance, Health Care;D011785
N05.700;Quality Assurance, Health Care;D011785
J01.897.608;Quality Control;D011786
N04.761;Quality of Health Care;D011787
N05.715;Quality of Health Care;D011787
I01.800;Quality of Life;D011788
K01.752.400.750;Quality of Life;D011788
H01.671.579.800;Quantum Theory;D011789
N06.850.780.200.450.700;Quarantine;D011790
D01.578.750.600;Quartz;D011791
D01.650.550.825.600;Quartz;D011791
D01.837.725.600;Quartz;D011791
Z01.107.567.176.791;Quebec;D011792
Z01.338.520;Queensland;D011793
D03.438.150.266.450.284.777;Quercetin;D011794
D03.830.219.266.450.284.777;Quercetin;D011794
E05.318.308.750;Questionnaires;D011795
L01.280.800;Questionnaires;D011795
N05.715.360.300.695;Questionnaires;D011795
N06.850.520.308.750;Questionnaires;D011795
D03.494.046.250.760;Quinacrine;D011796
D02.455.526.728.650.760;Quinacrine Mustard;D011797
D03.494.046.250.760.750;Quinacrine Mustard;D011797
D03.438.810.637;Quinaldines;D011798
D03.438.786;Quinazolines;D011799
D04.808.668.651.568.291.750;Quinestrol;D011800
D06.472.334.851.437.968.500.750;Quinestrol;D011800
D02.241.223.268.637;Quinic Acid;D011801
D02.241.511.764;Quinic Acid;D011801
D03.132.206.636;Quinidine;D011802
D03.438.810.699;Quinidine;D011802
D03.605.687.637;Quinidine;D011802
D03.132.206.719;Quinine;D011803
D03.438.810.762;Quinine;D011803
D03.605.687.762;Quinine;D011803
D03.438.810;Quinolines;D011804
D03.383.725.822;Quinolinic Acids;D011805
D03.438.810.824;Quinolinium Compounds;D011806
D03.438.834;Quinolizines;D011807
D08.811.682.608.800;Quinone Reductases;D011808
D02.806;Quinones;D011809
D03.438.857;Quinoxalines;D011810
M01.438.587;Quintuplets;D011811
D03.605.687;Quinuclidines;D011812
D02.241.223.601.238.306.740;Quinuclidinyl Benzilate;D011813
D02.241.511.085.740;Quinuclidinyl Benzilate;D011813
D03.605.687.800;Quinuclidinyl Benzilate;D011813
D03.383.606.827;Quipazine;D011814
D03.438.810.850;Quipazine;D011814
G05.360.600.600;R Factors;D011815
B01.050.150.900.649.521.700;Rabbits;D011817
C02.782.580.830.750;Rabies;D011818
D20.215.894.899.700;Rabies Vaccines;D011819
B04.820.455.750.500.700;Rabies virus;D011820
B04.909.777.455.750.500.700;Rabies virus;D011820
B01.050.150.900.649.147.650.700;Raccoons;D011821
I01.880.735.768;Race Relations;D011822
L01.178.847.500;Radar;D011825
A08.800.800.720.050.700;Radial Nerve;D011826
G01.750;Radiation;D011827
B05.200.750.760;Radiation Chimera;D011828
B05.825.760;Radiation Chimera;D011828
G12.470.500;Radiation Chimera;D011828
E05.799.513;Radiation Dosage;D011829
G01.750.740;Radiation Dosage;D011829
N06.850.810.250;Radiation Dosage;D011829
G01.750.745;Radiation Effects;D011830
N06.850.810.300;Radiation Effects;D011830
H01.158.273.343.800;Radiation Genetics;D011831
N06.850.810.335;Radiation Genetics;D011831
C26.733;Radiation Injuries;D011832
N06.850.810.300.360;Radiation Injuries;D011832
C26.733.720;Radiation Injuries, Experimental;D011833
E05.598.500.750;Radiation Injuries, Experimental;D011833
N06.850.810.300.360.285;Radiation Injuries, Experimental;D011833
E05.799.638;Radiation Monitoring;D011834
N06.850.780.375.700;Radiation Monitoring;D011834
N06.850.810.370;Radiation Monitoring;D011834
N06.850.810.425;Radiation Protection;D011835
G04.299.680;Radiation Tolerance;D011836
G07.700.760;Radiation Tolerance;D011836
D27.505.696.706.776;Radiation-Protective Agents;D011837
D27.720.799.763;Radiation-Protective Agents;D011837
D27.505.954.600;Radiation-Sensitizing Agents;D011838
G01.750.750;Radiation, Ionizing;D011839
G01.750.770;Radiation, Nonionizing;D011840
C04.182.089.530.690.790.820;Radicular Cyst;D011842
C05.500.470.690.790.820;Radicular Cyst;D011842
C07.320.450.670.513.811;Radicular Cyst;D011842
C07.320.830.820;Radicular Cyst;D011842
C07.465.714.306.820;Radicular Cyst;D011842
C10.668.829.820;Radiculopathy;D011843
E02.190.901.740;Radiesthesia;D011844
J01.897.280.500.739;Radio;D011845
L01.178.590.700;Radio;D011845
L01.178.820.090.739;Radio;D011845
L01.178.847.514;Radio;D011845
G01.358.500.505.810;Radio Waves;D011846
G01.750.250.810;Radio Waves;D011846
G01.750.770.721;Radio Waves;D011846
D20.693.555;Radioactive Fallout;D011847
N06.850.810.460;Radioactive Fallout;D011847
D20.693;Radioactive Pollutants;D011848
D01.496.749.731;Radioactive Tracers;D011849
D20.693.638;Radioactive Waste;D011850
D20.944.380.638;Radioactive Waste;D011850
N06.850.460.710.380.638;Radioactive Waste;D011850
N06.850.810.485;Radioactive Waste;D011850
G01.595.815;Radioactivity;D011851
E01.370.225.812.735.830;Radioallergosorbent Test;D011852
E05.200.812.735.830;Radioallergosorbent Test;D011852
E05.478.566.380.810;Radioallergosorbent Test;D011852
E05.478.566.639.810;Radioallergosorbent Test;D011852
E05.478.594.760.830;Radioallergosorbent Test;D011852
E05.601.495.380.810;Radioallergosorbent Test;D011852
E05.601.495.639.810;Radioallergosorbent Test;D011852
H01.158.273.789;Radiobiology;D011853
H01.181.529.776;Radiochemistry;D011854
C17.800.174.826;Radiodermatitis;D011855
C26.733.804;Radiodermatitis;D011855
E01.370.350.600.350.700;Radiographic Image Enhancement;D011856
E01.370.350.700.700;Radiographic Image Enhancement;D011856
L01.224.308.380.600;Radiographic Image Enhancement;D011856
E01.158.600.680;Radiographic Image Interpretation, Computer-Assisted;D011857
E01.370.350.350.700;Radiographic Image Interpretation, Computer-Assisted;D011857
E01.370.350.700.705;Radiographic Image Interpretation, Computer-Assisted;D011857
L01.700.508.100.158.600.680;Radiographic Image Interpretation, Computer-Assisted;D011857
E01.370.350.700.710;Radiographic Magnification;D011858
E01.370.350.700;Radiography;D011859
E01.370.350.700.715;Radiography, Abdominal;D011860
E01.370.350.700.720;Radiography, Dental;D011861
E06.342.764;Radiography, Dental;D011861
E01.370.350.700.720.750;Radiography, Panoramic;D011862
E06.342.764.750;Radiography, Panoramic;D011862
E01.370.384.700;Radioimmunoassay;D011863
E05.478.566.639;Radioimmunoassay;D011863
E05.601.495.639;Radioimmunoassay;D011863
E05.478.566.380.830;Radioimmunosorbent Test;D011864
E05.478.566.639.830;Radioimmunosorbent Test;D011864
E05.601.495.380.830;Radioimmunosorbent Test;D011864
E05.601.495.639.830;Radioimmunosorbent Test;D011864
E01.370.384.710;Radioisotope Dilution Technique;D011865
E05.484.650;Radioisotope Dilution Technique;D011865
E01.370.350.710.715.700;Radioisotope Renography;D011866
E01.370.384.730.715.700;Radioisotope Renography;D011866
E01.370.390.400.700;Radioisotope Renography;D011866
E02.815.722.820;Radioisotope Teletherapy;D011867
D01.496.749;Radioisotopes;D011868
E01.370.225.985;Radioligand Assay;D011869
E01.370.374.650;Radioligand Assay;D011869
E01.370.384.720;Radioligand Assay;D011869
E05.200.985;Radioligand Assay;D011869
N06.850.810;Radiologic Health;D011870
H02.403.740;Radiology;D011871
N02.278.354.422.695;Radiology Department, Hospital;D011872
N04.452.442.422.695;Radiology Department, Hospital;D011872
L01.700.508.300.680.850;Radiology Information Systems;D011873
L01.700.508.300.780;Radiology Information Systems;D011873
N04.452.442.452.760;Radiology Information Systems;D011873
N04.452.515.360.750;Radiology Information Systems;D011873
N04.452.515.825;Radiology Information Systems;D011873
E05.799;Radiometry;D011874
E01.370.350.710.715;Radionuclide Angiography;D011875
E01.370.370.050.650;Radionuclide Angiography;D011875
E01.370.384.730.715;Radionuclide Angiography;D011875
E07.710.770;Radionuclide Generators;D011876
E01.370.350.710;Radionuclide Imaging;D011877
E01.370.384.730;Radionuclide Imaging;D011877
E02.815;Radiotherapy;D011878
E02.815.639;Radiotherapy Dosage;D011879
E02.950.825;Radiotherapy Planning, Computer-Assisted;D011880
L01.700.508.100.710.600.608;Radiotherapy Planning, Computer-Assisted;D011880
E02.815.635;Radiotherapy, Computer-Assisted;D011881
L01.700.508.100.710.600;Radiotherapy, Computer-Assisted;D011881
E02.815.722;Radiotherapy, High-Energy;D011882
D01.268.271.770;Radium;D011883
D01.268.552.775;Radium;D011883
D01.268.556.775;Radium;D011883
D01.552.539.745;Radium;D011883
D01.552.544.775;Radium;D011883
A02.835.232.087.090.700;Radius;D011884
C26.088.268.556;Radius Fractures;D011885
C26.404.562;Radius Fractures;D011885
D01.268.271.800;Radon;D011886
D01.268.613.700;Radon;D011886
D01.362.641.745;Radon;D011886
D09.698.629.802.700;Raffinose;D011887
D02.065.199.860.600;Rafoxanide;D011888
D02.065.793.650.600;Rafoxanide;D011888
F01.470.093.640;Rage;D011889
J01.937.690;Railroads;D011890
G16.500.240.135.859;Rain;D011891
G16.500.275.063.725.395;Rain;D011891
G16.500.750.775.450;Rain;D011891
N06.230.300.100.725.450;Rain;D011891
N06.230.520;Rain;D011891
B01.050.150.900.090.180.708.180;Rana catesbeiana;D011892
B01.050.150.900.090.180.708.240;Rana esculenta;D011893
B01.050.150.900.090.180.708.310;Rana pipiens;D011894
B01.050.150.900.090.180.708.360;Rana ridibunda;D011895
B01.050.150.900.090.180.708.420;Rana temporaria;D011896
E05.318.780.700;Random Allocation;D011897
E05.581.500.805;Random Allocation;D011897
N05.715.360.780.675;Random Allocation;D011897
N06.850.520.445.700;Random Allocation;D011897
B01.050.150.900.090.180.708;Ranidae;D011898
D03.383.312.750;Ranitidine;D011899
C04.182.766;Ranula;D011900
C07.465.780;Ranula;D011900
A08.637.800.500.700;Ranvier's Nodes;D011901
A08.663.542.512.560.700;Ranvier's Nodes;D011901
A08.800.800.690.500.700;Ranvier's Nodes;D011901
A10.755.503.700;Ranvier's Nodes;D011901
A11.284.149.165.760;Ranvier's Nodes;D011901
A11.650.800.500.700;Ranvier's Nodes;D011901
A11.671.514.553.640;Ranvier's Nodes;D011901
I01.198.240.748.640;Rape;D011902
A08.186.211.132.659.632;Raphe Nuclei;D011903
A08.186.211.132.810.507;Raphe Nuclei;D011903
A08.186.211.653.632;Raphe Nuclei;D011903
A08.186.211.865.507;Raphe Nuclei;D011903
L01.178.682.192.779;Rare Books;D011904
G05.360.340.024.340.375.500.791.550;Genes, ras;D011905
C01.252.400.388.750;Rat-Bite Fever;D011906
C01.252.400.771;Rat-Bite Fever;D011906
N03.219.442.800;Rate Setting and Review;D011907
N03.219.463.060.800;Rate Setting and Review;D011907
F01.393.746;Rationalization;D011908
B01.050.150.900.649.865.635.505.700.550.110;Rats, Brattleboro;D011910
B01.050.150.900.649.865.635.505.700.550.308;Rats, Gunn;D011911
B01.050.050.157.760.080;Rats, Inbred ACI;D011912
B01.050.050.199.520.760.080;Rats, Inbred ACI;D011912
B01.050.150.900.649.865.635.505.700.400.080;Rats, Inbred ACI;D011912
B01.050.050.157.760.090;Rats, Inbred BB;D011913
B01.050.050.199.520.760.090;Rats, Inbred BB;D011913
B01.050.150.900.649.865.635.505.700.400.090;Rats, Inbred BB;D011913
B01.050.050.157.760.110;Rats, Inbred BN;D011914
B01.050.050.199.520.760.110;Rats, Inbred BN;D011914
B01.050.150.900.649.865.635.505.700.400.110;Rats, Inbred BN;D011914
B01.050.050.157.760.130;Rats, Inbred BUF;D011915
B01.050.050.199.520.760.130;Rats, Inbred BUF;D011915
B01.050.150.900.649.865.635.505.700.400.130;Rats, Inbred BUF;D011915
B01.050.050.157.760.200;Rats, Inbred F344;D011916
B01.050.050.199.520.760.200;Rats, Inbred F344;D011916
B01.050.150.900.649.865.635.505.700.400.200;Rats, Inbred F344;D011916
B01.050.050.157.760.280;Rats, Inbred Lew;D011917
B01.050.050.199.520.760.280;Rats, Inbred Lew;D011917
B01.050.150.900.649.865.635.505.700.400.280;Rats, Inbred Lew;D011917
B01.050.050.157.760.300;Rats, Inbred SHR;D011918
B01.050.050.199.520.760.300;Rats, Inbred SHR;D011918
B01.050.150.900.649.865.635.505.700.400.300;Rats, Inbred SHR;D011918
B01.050.050.157.760;Rats, Inbred Strains;D011919
B01.050.050.199.520.760;Rats, Inbred Strains;D011919
B01.050.150.900.649.865.635.505.700.400;Rats, Inbred Strains;D011919
B01.050.050.157.760.360;Rats, Inbred WF;D011920
B01.050.050.199.520.760.360;Rats, Inbred WF;D011920
B01.050.150.900.649.865.635.505.700.400.360;Rats, Inbred WF;D011920
B01.050.050.157.760.390;Rats, Inbred WKY;D011921
B01.050.050.199.520.760.390;Rats, Inbred WKY;D011921
B01.050.150.900.649.865.635.505.700.400.390;Rats, Inbred WKY;D011921
B01.050.150.900.649.865.635.505.700.550;Rats, Mutant Strains;D011922
B01.050.150.900.649.865.635.505.700.550.508;Rats, Nude;D011923
B01.050.150.900.649.865.635.505.700.550.700;Rats, Zucker;D011924
B04.820.650.375.525.770;Rauscher Virus;D011925
B04.909.574.807.375.525.770;Rauscher Virus;D011925
B04.909.777.731.375.525.770;Rauscher Virus;D011925
B01.650.940.800.575.100.081.777;Rauwolfia;D011926
C14.907.617.812;Raynaud Disease;D011928
D03.383.606.385.500;Razoxane;D011929
F02.830.650;Reaction Time;D011930
F04.669.817;Reaction Time;D011930
G11.561.677;Reaction Time;D011930
F01.145.544.724;Reactive Inhibition;D011931
F02.463.425.475.724;Reactive Inhibition;D011931
L01.143.506.423.557;Reading;D011932
D27.720.470.410.680;Reagent Kits, Diagnostic;D011933
E07.720;Reagent Kits, Diagnostic;D011933
D27.720.470.410.680.680;Reagent Strips;D011934
E07.720.720;Reagent Strips;D011934
D12.776.124.486.485.114.890;Reagins;D011935
D12.776.124.790.651.114.890;Reagins;D011935
D12.776.377.715.548.114.890;Reagins;D011935
F01.752.747.189.508;Reality Testing;D011936
F02.739.794.206.508;Reality Testing;D011936
F04.754.804;Reality Therapy;D011937
D08.811.739.650;Rec A Recombinases;D011938
D08.811.913.696.445.692;Rec A Recombinases;D011938
F02.463.425.540.641;Mental Recall;D011939
G04.299.780;Receptor Aggregation;D011940
D12.776.543.750.070.300.300;Receptors, Adrenergic;D011941
D12.776.543.750.100.150.300;Receptors, Adrenergic;D011941
D12.776.543.750.720.300.300.300;Receptors, Adrenergic;D011941
D12.776.543.750.070.300.300.300;Receptors, Adrenergic, alpha;D011942
D12.776.543.750.100.150.300.300;Receptors, Adrenergic, alpha;D011942
D12.776.543.750.720.300.300.300.300;Receptors, Adrenergic, alpha;D011942
D12.776.543.750.070.300.300.340;Receptors, Adrenergic, beta;D011943
D12.776.543.750.100.150.300.340;Receptors, Adrenergic, beta;D011943
D12.776.543.750.720.300.300.300.340;Receptors, Adrenergic, beta;D011943
D12.776.260.698.750.150;Receptors, Androgen;D011944
D12.776.826.750.150;Receptors, Androgen;D011944
D12.776.930.669.750.150;Receptors, Androgen;D011944
D12.776.543.750.100.047;Receptors, Angiotensin;D011945
D12.776.543.750.720.600.150;Receptors, Angiotensin;D011945
D12.776.543.750.750.130;Receptors, Angiotensin;D011945
D12.776.543.750.750.555.150;Receptors, Angiotensin;D011945
D12.776.543.750.705.816;Receptors, Antigen;D011946
D12.776.124.486.485.950;Receptors, Antigen, B-Cell;D011947
D12.776.124.790.651.950;Receptors, Antigen, B-Cell;D011947
D12.776.377.715.548.950;Receptors, Antigen, B-Cell;D011947
D12.776.543.750.705.816.821;Receptors, Antigen, B-Cell;D011947
D12.776.543.750.705.816.824;Receptors, Antigen, T-Cell;D011948
D12.776.543.750.100.170;Receptors, Cholecystokinin;D011949
D12.776.543.750.720.600.270;Receptors, Cholecystokinin;D011949
D12.776.543.750.750.360.200;Receptors, Cholecystokinin;D011949
D12.776.543.750.750.555.270;Receptors, Cholecystokinin;D011949
D12.776.543.750.720.360;Receptors, Cholinergic;D011950
D12.776.543.750.705.833;Receptors, Complement;D011951
D12.776.543.750.705.880.600;Receptors, Concanavalin A;D011952
D12.776.543.750.100.700.150;Receptors, Cyclic AMP;D011953
D12.776.543.750.720.700.150;Receptors, Cyclic AMP;D011953
D12.776.543.750.810.150;Receptors, Cyclic AMP;D011953
D12.776.543.750.070.300.400;Receptors, Dopamine;D011954
D12.776.543.750.100.150.400;Receptors, Dopamine;D011954
D12.776.543.750.720.300.300.400;Receptors, Dopamine;D011954
D12.776.827;Receptors, Drug;D011955
D12.776.543.750;Receptors, Cell Surface;D011956
D12.776.543.750.100.620;Receptors, Opioid;D011957
D12.776.543.750.720.600.610;Receptors, Opioid;D011957
D12.776.543.750.750.555.610;Receptors, Opioid;D011957
D08.811.913.696.620.682.725.400.100;Receptor, Epidermal Growth Factor;D011958
D12.776.543.750.060.249;Receptor, Epidermal Growth Factor;D011958
D12.776.543.750.750.360.300;Receptor, Epidermal Growth Factor;D011958
D12.776.543.750.750.400.340;Receptor, Epidermal Growth Factor;D011958
D12.776.260.698.750.350.350;Receptors, Estradiol;D011959
D12.776.826.750.350.350;Receptors, Estradiol;D011959
D12.776.930.669.750.350.350;Receptors, Estradiol;D011959
D12.776.260.698.750.350;Receptors, Estrogen;D011960
D12.776.826.750.350;Receptors, Estrogen;D011960
D12.776.930.669.750.350;Receptors, Estrogen;D011960
D12.776.543.750.705.871;Receptors, Fc;D011961
D12.776.543.750.100.250;Receptors, FSH;D011962
D12.776.543.750.720.600.370;Receptors, FSH;D011962
D12.776.543.750.750.555.370;Receptors, FSH;D011962
D12.776.543.750.750.660.350.300;Receptors, FSH;D011962
D12.776.157.530.400.175.562;Receptors, GABA-A;D011963
D12.776.157.530.400.400.100.100;Receptors, GABA-A;D011963
D12.776.543.550.425.175.562;Receptors, GABA-A;D011963
D12.776.543.550.425.500.100.100;Receptors, GABA-A;D011963
D12.776.543.585.400.175.562;Receptors, GABA-A;D011963
D12.776.543.585.400.500.100.100;Receptors, GABA-A;D011963
D12.776.543.750.051.500;Receptors, GABA-A;D011963
D12.776.543.750.720.200.300.300;Receptors, GABA-A;D011963
D12.776.543.750.750.360;Receptors, Gastrointestinal Hormone;D011964
D12.776.260.698.750.430;Receptors, Glucocorticoid;D011965
D12.776.826.750.430;Receptors, Glucocorticoid;D011965
D12.776.930.669.750.430;Receptors, Glucocorticoid;D011965
D12.776.543.750.100.410;Receptors, LHRH;D011966
D12.776.543.750.720.600.460;Receptors, LHRH;D011966
D12.776.543.750.750.555.460;Receptors, LHRH;D011966
D12.776.543.750.750.700.460;Receptors, LHRH;D011966
D12.776.543.750.750.660.350;Receptors, Gonadotropin;D011967
D12.776.543.750.070.450;Receptors, Histamine;D011968
D12.776.543.750.720.300.450;Receptors, Histamine;D011968
D12.776.543.750.070.450.100;Receptors, Histamine H1;D011969
D12.776.543.750.100.350;Receptors, Histamine H1;D011969
D12.776.543.750.720.300.450.300;Receptors, Histamine H1;D011969
D12.776.543.750.070.450.400;Receptors, Histamine H2;D011970
D12.776.543.750.100.355;Receptors, Histamine H2;D011970
D12.776.543.750.720.300.450.400;Receptors, Histamine H2;D011970
D12.776.543.750.705;Receptors, Immunologic;D011971
D08.811.913.696.620.682.725.400.200;Receptor, Insulin;D011972
D12.776.543.750.060.484;Receptor, Insulin;D011972
D12.776.543.750.750.580.300;Receptor, Insulin;D011972
D12.776.543.750.710.450;Receptors, LDL;D011973
D12.776.543.750.100.400;Receptors, LH;D011974
D12.776.543.750.720.600.450;Receptors, LH;D011974
D12.776.543.750.750.555.450;Receptors, LH;D011974
D12.776.543.750.750.660.350.450;Receptors, LH;D011974
D12.776.543.750.705.880;Receptors, Mitogen;D011975
D12.776.543.750.100.475;Receptors, Muscarinic;D011976
D12.776.543.750.720.360.500;Receptors, Muscarinic;D011976
D12.776.157.530.400.400.100.500;Receptors, Nicotinic;D011978
D12.776.543.550.425.500.100.500;Receptors, Nicotinic;D011978
D12.776.543.585.400.500.100.500;Receptors, Nicotinic;D011978
D12.776.543.750.051.687;Receptors, Nicotinic;D011978
D12.776.543.750.720.360.550;Receptors, Nicotinic;D011978
D12.776.543.750.750.660;Receptors, Pituitary Hormone;D011979
D12.776.260.698.750.765;Receptors, Progesterone;D011980
D12.776.826.750.765;Receptors, Progesterone;D011980
D12.776.930.669.750.765;Receptors, Progesterone;D011980
D12.776.543.750.720.600.710;Receptors, Prolactin;D011981
D12.776.543.750.750.555.710;Receptors, Prolactin;D011981
D12.776.543.750.750.660.350.725;Receptors, Prolactin;D011981
D12.776.543.750.075.700;Receptors, Prostaglandin;D011982
D12.776.543.750.100.200.700;Receptors, Prostaglandin;D011982
D12.776.543.750.100.700;Receptors, Purinergic;D011983
D12.776.543.750.720.700;Receptors, Purinergic;D011983
D12.776.543.750.810;Receptors, Purinergic;D011983
A08.663.650.915;Sensory Receptor Cells;D011984
A08.800.950;Sensory Receptor Cells;D011984
A11.671.650.915;Sensory Receptor Cells;D011984
D12.776.543.750.070.800;Receptors, Serotonin;D011985
D12.776.543.750.100.800;Receptors, Serotonin;D011985
D12.776.543.750.720.300.800;Receptors, Serotonin;D011985
D12.776.543.750.750.555.770;Receptors, Somatotropin;D011986
D12.776.543.750.750.660.750;Receptors, Somatotropin;D011986
D12.776.260.698.750;Receptors, Steroid;D011987
D12.776.826.750;Receptors, Steroid;D011987
D12.776.930.669.750;Receptors, Steroid;D011987
D12.776.260.698.850;Receptors, Thyroid Hormone;D011988
D12.776.624.664.700.830;Receptors, Thyroid Hormone;D011988
D12.776.826.850;Receptors, Thyroid Hormone;D011988
D12.776.930.669.850;Receptors, Thyroid Hormone;D011988
D12.776.543.750.720.600.850;Receptors, Thyrotropin;D011989
D12.776.543.750.750.555.850;Receptors, Thyrotropin;D011989
D12.776.543.750.750.660.825;Receptors, Thyrotropin;D011989
D12.776.157.905.500;Receptors, Transferrin;D011990
D12.776.543.750.850;Receptors, Transferrin;D011990
D12.776.543.750.925;Receptors, Virus;D011991
A11.284.430.214.190.875.190.880.337;Endosomes;D011992
D12.776.828.300;Recombinant Fusion Proteins;D011993
D12.776.828;Recombinant Proteins;D011994
G05.355.760;Recombination, Genetic;D011995
E05.318.308.940;Records as Topic;D011996
L01.280.900;Records as Topic;D011996
N04.452.859;Records as Topic;D011996
N05.715.360.300.715;Records as Topic;D011996
N06.850.520.308.940;Records as Topic;D011996
N02.278.388.493.592;Recovery Room;D011997
I03.450.642;Recreation;D011998
G07.265.337.600.760;Recruitment, Neurophysiological;D011999
G07.700.240.600.760;Recruitment, Neurophysiological;D011999
G11.561.600.620.760;Recruitment, Neurophysiological;D011999
E01.370.382.375.650;Recruitment Detection, Audiologic;D012000
C09.218.458.505;Hyperacusis;D012001
C10.597.751.418.505;Hyperacusis;D012001
C23.888.592.763.393.505;Hyperacusis;D012001
C06.405.469.860;Rectal Diseases;D012002
C06.267.550.600;Rectal Fistula;D012003
C06.405.469.471.600;Rectal Fistula;D012003
C06.405.469.860.752;Rectal Fistula;D012003
C23.300.575.185.550.600;Rectal Fistula;D012003
C04.588.274.476.411.307.790;Rectal Neoplasms;D012004
C06.301.371.411.307.790;Rectal Neoplasms;D012004
C06.405.249.411.307.790;Rectal Neoplasms;D012004
C06.405.469.491.307.790;Rectal Neoplasms;D012004
C06.405.469.860.180.500;Rectal Neoplasms;D012004
C06.405.469.860.800;Rectal Prolapse;D012005
C23.300.842.624.500;Rectal Prolapse;D012005
C06.267.550.600.650;Rectovaginal Fistula;D012006
C06.405.469.471.600.650;Rectovaginal Fistula;D012006
C06.405.469.860.752.650;Rectovaginal Fistula;D012006
C23.300.575.185.550.600.650;Rectovaginal Fistula;D012006
C23.300.575.925.558;Rectovaginal Fistula;D012006
A03.556.124.526.767;Rectum;D012007
A03.556.249.249.767;Rectum;D012007
C23.550.291.937;Recurrence;D012008
A08.800.050.050.925.450.700;Recurrent Laryngeal Nerve;D012009
A08.800.050.600.825.450.700;Recurrent Laryngeal Nerve;D012009
A08.800.800.060.920.450.700;Recurrent Laryngeal Nerve;D012009
A08.800.800.120.900.450.700;Recurrent Laryngeal Nerve;D012009
C15.378.071.750;Red-Cell Aplasia, Pure;D012010
N03.540.514.642;Red Cross;D012011
N03.540.630.780.608;Red Cross;D012011
A08.186.211.132.659.822.642;Red Nucleus;D012012
A08.186.211.653.822.642;Red Nucleus;D012012
L01.178.682.192.836;Reference Books;D012013
L01.178.682.192.836.842;Reference Books, Medical;D012014
E05.978.808;Reference Standards;D012015
E05.978.810;Reference Values;D012016
N04.452.758.849;Referral and Consultation;D012017
E01.370.376.550.650;Reflex;D012018
E01.370.600.550.650;Reflex;D012018
F02.830.702;Reflex;D012018
G11.561.600.765;Reflex;D012018
C10.177.195.800;Reflex Sympathetic Dystrophy;D012019
C10.668.829.250.800;Reflex Sympathetic Dystrophy;D012019
E01.370.376.550.650.650;Reflex, Abdominal;D012020
E01.370.600.550.650.650;Reflex, Abdominal;D012020
G11.561.600.765.580;Reflex, Abdominal;D012020
C10.597.704;Reflex, Abnormal;D012021
C23.888.592.717;Reflex, Abnormal;D012021
E01.370.376.550.650.655;Reflex, Abnormal;D012021
E01.370.600.550.650.655;Reflex, Abnormal;D012021
G11.561.600.765.587;Reflex, Abnormal;D012021
E01.370.376.550.650.670;Reflex, Acoustic;D012022
E01.370.600.550.650.670;Reflex, Acoustic;D012022
G11.561.600.765.594;Reflex, Acoustic;D012022
G11.561.600.765.643;Reflex, Monosynaptic;D012023
G11.561.600.765.685;Reflex, Oculocardiac;D012024
E01.370.376.550.650.690;Reflex, Pupillary;D012025
E01.370.600.550.650.690;Reflex, Pupillary;D012025
G11.561.600.765.705;Reflex, Pupillary;D012025
E01.370.376.550.650.700;Reflex, Stretch;D012026
E01.370.600.550.650.700;Reflex, Stretch;D012026
G11.561.600.765.768;Reflex, Stretch;D012026
G11.561.600.765.795;Reflex, Vestibulo-Ocular;D012027
E02.190.799;Reflexotherapy;D012028
E01.370.380.850.700;Refraction, Ocular;D012029
G01.590.770.760;Refraction, Ocular;D012029
G01.595.640.760;Refraction, Ocular;D012029
G14.760;Refraction, Ocular;D012029
C11.744;Refractive Errors;D012030
E05.196.808;Refractometry;D012031
H01.671.617.755;Refractometry;D012031
G07.265.337.600.770;Refractory Period, Electrophysiological;D012032
G07.265.760;Refractory Period, Electrophysiological;D012032
G07.700.240.600.770;Refractory Period, Electrophysiological;D012032
G11.561.600.620.770;Refractory Period, Electrophysiological;D012032
G11.561.785;Refractory Period, Electrophysiological;D012032
F02.830.650.400;Refractory Period, Psychological;D012033
F04.669.817.559;Refractory Period, Psychological;D012033
E02.792.643;Refrigeration;D012034
E05.760.643;Refrigeration;D012034
C10.228.140.163.100.680.760;Refsum Disease;D012035
C10.500.300.780;Refsum Disease;D012035
C10.574.500.495.780;Refsum Disease;D012035
C10.668.829.800.300.780;Refsum Disease;D012035
C16.131.666.300.780;Refsum Disease;D012035
C16.320.400.375.780;Refsum Disease;D012035
C16.320.565.189.680.760;Refsum Disease;D012035
C16.320.565.663.760;Refsum Disease;D012035
C18.452.132.100.680.760;Refsum Disease;D012035
C18.452.648.189.680.760;Refsum Disease;D012035
C18.452.648.663.760;Refsum Disease;D012035
M01.755;Refugees;D012036
N06.850.780.200.800.800.700;Refuse Disposal;D012037
N06.850.860.510.900.600;Refuse Disposal;D012037
G16.100.856;Regeneration;D012038
G09.330.190.163.780;Regional Blood Flow;D012039
N03.349.650;Regional Health Planning;D012040
N03.349.650.400;Regional Medical Programs;D012041
E05.318.308.970;Registries;D012042
L01.280.950;Registries;D012042
N04.452.859.819;Registries;D012042
N05.715.360.300.715.700;Registries;D012042
N06.850.520.308.970;Registries;D012042
F01.393.784;Regression (Psychology);D012043
E05.318.740.750;Regression Analysis;D012044
N05.715.360.750.695;Regression Analysis;D012044
N06.850.520.830.750;Regression Analysis;D012044
G02.111.570.080.689;Regulatory Sequences, Nucleic Acid;D012045
G05.360.080.689;Regulatory Sequences, Nucleic Acid;D012045
E02.831;Rehabilitation;D012046
H02.403.680.600;Rehabilitation;D012046
N02.421.784;Rehabilitation;D012046
N02.278.808;Rehabilitation Centers;D012047
E02.831.671;Correction of Hearing Impairment;D012048
H02.403.680.600.500;Correction of Hearing Impairment;D012048
N02.421.784.377;Correction of Hearing Impairment;D012048
E02.831.727;Rehabilitation of Speech and Language Disorders;D012049
E02.831.782;Rehabilitation, Vocational;D012050
N02.421.784.644;Rehabilitation, Vocational;D012050
N03.219.521.710.305;Reimbursement Mechanisms;D012051
N03.219.521.710.305.380;Reimbursement, Incentive;D012052
B01.050.150.900.649.077.380.373.644;Reindeer;D012053
F02.463.425.770;Reinforcement (Psychology);D012054
F02.463.425.770.644;Reinforcement Schedule;D012055
F02.463.425.770.706;Reinforcement, Social;D012056
F02.463.425.770.769;Reinforcement, Verbal;D012057
F01.145.813.565;Rejection (Psychology);D012059
E02.190.822;Rejuvenation;D012060
E02.849;Rejuvenation;D012060
C01.252.400.155.644;Relapsing Fever;D012061
C01.252.400.825.750;Relapsing Fever;D012061
C01.252.847.193.644;Relapsing Fever;D012061
N06.850.810.250.275;Relative Biological Effectiveness;D012062
I03.450.769;Relaxation;D012063
E02.190.525.875;Relaxation Therapy;D012064
F04.754.137.750;Relaxation Therapy;D012064
D06.472.334.734.769;Relaxin;D012065
D06.472.699.715;Relaxin;D012065
D12.644.548.762;Relaxin;D012065
I01.880.787.839;Relief Work;D012066
N06.230.100.300;Relief Work;D012066
K01.844;Religion;D012067
K01.844.619;Religion and Medicine;D012068
F02.880;Religion and Psychology;D012069
K01.844.664;Religion and Psychology;D012069
K01.844.709;Religion and Science;D012070
K01.844.754;Religion and Sex;D012071
K01.844.799;Religious Philosophies;D012072
F02.784.629.709;Remedial Teaching;D012073
I02.903.694;Remedial Teaching;D012073
E02.860;Remission Induction;D012074
C23.550.291.656.700;Remission, Spontaneous;D012075
G16.100.870;Remission, Spontaneous;D012075
D27.505.954.613;Renal Agents;D012076
A07.231.114.745;Renal Artery;D012077
C12.777.419.775;Renal Artery Obstruction;D012078
C13.351.968.419.775;Renal Artery Obstruction;D012078
C14.907.137.727;Renal Artery Obstruction;D012078
G08.852.796.700;Renal Circulation;D012079
G09.330.190.163.812;Renal Circulation;D012079
C05.116.198.762;Renal Osteodystrophy;D012080
C05.116.198.816.750;Renal Osteodystrophy;D012080
C12.777.419.795;Renal Osteodystrophy;D012080
C13.351.968.419.795;Renal Osteodystrophy;D012080
C18.452.174.845.750;Renal Osteodystrophy;D012080
C18.654.521.500.133.770.734.750;Renal Osteodystrophy;D012080
C19.642.355.480.500;Renal Osteodystrophy;D012080
A07.231.908.752;Renal Veins;D012082
D08.811.277.656.074.500.780;Renin;D012083
D08.811.277.656.300.048.780;Renin;D012083
D08.811.277.656.837.750;Renin;D012083
G03.495.805;Renin-Angiotensin System;D012084
G09.330.190.400.750;Renin-Angiotensin System;D012084
D08.811.277.656.074.500.200;Chymosin;D012085
D08.811.277.656.300.048.200;Chymosin;D012085
E04.690;Reoperation;D012086
B04.820.630;Reoviridae;D012087
B04.909.777.714;Reoviridae;D012087
C02.782.791;Reoviridae Infections;D012088
B04.820.630.590.550.700;Mammalian orthoreovirus 3;D012089
B04.909.777.714.590.550.700;Mammalian orthoreovirus 3;D012089
C26.844.150;Cumulative Trauma Disorders;D012090
G02.111.570.080.708;Repetitive Sequences, Nucleic Acid;D012091
G05.360.080.708;Repetitive Sequences, Nucleic Acid;D012091
E04.936.494;Replantation;D012092
G05.360.340.024.745;Replicon;D012093
F01.393.821;Repression, Psychology;D012094
F01.393.821.645;Repression-Sensitization;D012095
D12.776.260.703;Repressor Proteins;D012097
D12.776.930.700;Repressor Proteins;D012097
G08.686.785.760;Reproduction;D012098
E02.875;Reproductive Techniques;D012099
E05.820;Reproductive Techniques;D012099
G08.686.785.760.830;Reproduction, Asexual;D012100
G08;Reproductive and Urinary Physiological Phenomena;D012101
D27.505.696.875;Reproductive Control Agents;D012102
D27.505.954.705;Reproductive Control Agents;D012102
D08.811.277.656.300.760.955.135;Batroxobin;D012103
D08.811.277.656.959.350.955.135;Batroxobin;D012103
D20.888.850.960.200.105;Batroxobin;D012103
D23.946.833.850.960.200.105;Batroxobin;D012103
B01.050.150.900.833;Reptiles;D012104
H01.770.644;Research;D012106
E05.581.500;Research Design;D012107
H01.770.644.728;Research Design;D012107
M01.526.839;Research Personnel;D012108
M01.770;Research Personnel;D012108
N03.219.483.645;Research Support as Topic;D012109
D03.132.436.681.933.500;Reserpine;D012110
D03.438.473.402.681.933.500;Reserpine;D012110
N01.224.791;Residence Characteristics;D012111
N06.850.505.400.800;Residence Characteristics;D012111
N02.278.825;Residential Facilities;D012112
F04.754.864.696;Residential Treatment;D012114
E01.370.386.700.485.750.275.650;Residual Volume;D012115
G09.772.850.390.820;Residual Volume;D012115
D05.750.078.840;Resins, Plant;D012116
D20.215.721.500;Resins, Plant;D012116
D05.750.716.822;Resins, Synthetic;D012117
D25.339.816;Resins, Synthetic;D012117
D25.720.716.822;Resins, Synthetic;D012117
J01.637.051.339.816;Resins, Synthetic;D012117
J01.637.051.720.716.822;Resins, Synthetic;D012117
D02.455.426.559.389.657.852;Resorcinols;D012118
G09.772.770.755;Respiration;D012119
C08.618;Respiration Disorders;D012120
E02.041.625;Respiration, Artificial;D012121
E02.365.647.729;Respiration, Artificial;D012121
E02.880.820;Respiration, Artificial;D012121
E07.950;Ventilators, Mechanical;D012122
E01.370.386.700.660;Pulmonary Ventilation;D012123
G09.772.650;Pulmonary Ventilation;D012123
N02.278.388.493.696;Respiratory Care Units;D012124
A08.186.211.132.772.646;Respiratory Center;D012125
G09.772.760;Respiratory Dead Space;D012126
C08.381.842;Respiratory Distress Syndrome, Newborn;D012127
C08.618.842;Respiratory Distress Syndrome, Newborn;D012127
C16.614.521.563;Respiratory Distress Syndrome, Newborn;D012127
C08.381.840;Respiratory Distress Syndrome, Adult;D012128
C08.618.840;Respiratory Distress Syndrome, Adult;D012128
E01.370.386.700;Respiratory Function Tests;D012129
C08.674;Respiratory Hypersensitivity;D012130
C20.543.480.680;Respiratory Hypersensitivity;D012130
C08.618.846;Respiratory Insufficiency;D012131
A02.633.567.900;Respiratory Muscles;D012132
C08.618.846.812;Respiratory Paralysis;D012133
C10.597.622.812;Respiratory Paralysis;D012133
C23.888.592.636.812;Respiratory Paralysis;D012133
E07.700.700;Respiratory Protective Devices;D012134
J01.637.708.700;Respiratory Protective Devices;D012134
C23.888.852.779;Respiratory Sounds;D012135
E01.370.386.720;Respiratory Sounds;D012135
G09.772.775;Respiratory Sounds;D012135
B04.820.455.600.670.600.750;Respiratory Syncytial Viruses;D012136
B04.909.777.455.600.670.600.750;Respiratory Syncytial Viruses;D012136
A04;Respiratory System;D012137
E02.880;Respiratory Therapy;D012138
N02.278.354.422.712;Respiratory Therapy Department, Hospital;D012139
N04.452.442.422.712;Respiratory Therapy Department, Hospital;D012139
C08;Respiratory Tract Diseases;D012140
C01.539.739;Respiratory Tract Infections;D012141
C08.730;Respiratory Tract Infections;D012141
C04.588.894.797;Respiratory Tract Neoplasms;D012142
C08.785;Respiratory Tract Neoplasms;D012142
G09.772;Respiratory Physiological Phenomena;D012143
E02.760.611.470.610;Respite Care;D012144
N02.421.143.524.470.610;Respite Care;D012144
N02.421.533.320.610;Respite Care;D012144
N02.421.585.611.470.610;Respite Care;D012144
I03.450.769.647;Rest;D012146
J01.576.423.500.700;Restaurants;D012147
C10.886.425.800.700;Restless Legs Syndrome;D012148
C10.886.659.634;Restless Legs Syndrome;D012148
F03.870.400.800.700;Restless Legs Syndrome;D012148
F03.870.664.634;Restless Legs Syndrome;D012148
E02.085.700;Restraint, Physical;D012149
E05.472.760;Restraint, Physical;D012149
G05.365.795.595;Polymorphism, Restriction Fragment Length;D012150
E02.365.647;Resuscitation;D012151
A05.360.444.849.600;Rete Testis;D012152
F02.463.425.540.772;Retention (Psychology);D012153
A08.186.211.132.772;Reticular Formation;D012154
D05.750.078.850;Reticulin;D012155
D12.776.860.823;Reticulin;D012155
A11.118.290.760;Reticulocytes;D012156
A11.148.790;Reticulocytes;D012156
A11.443.240.665;Reticulocytes;D012156
A15.145.229.334.760;Reticulocytes;D012156
A15.378.316.790;Reticulocytes;D012156
A15.382.812;Mononuclear Phagocyte System;D012157
A13.869.697;Reticulum;D012159
A09.371.729;Retina;D012160
A07.231.114.765;Retinal Artery;D012161
A07.231.611.647;Retinal Artery;D012161
C11.768.585;Retinal Degeneration;D012162
C11.768.648;Retinal Detachment;D012163
C11.768;Retinal Diseases;D012164
A08.663.650.850.875;Retinal Ganglion Cells;D012165
A09.371.729.831.875;Retinal Ganglion Cells;D012165
A11.671.650.850.875;Retinal Ganglion Cells;D012165
C11.290.807;Retinal Hemorrhage;D012166
C11.768.710;Retinal Hemorrhage;D012166
C23.550.414.756.775;Retinal Hemorrhage;D012166
C11.768.740;Retinal Perforations;D012167
D23.767.930;Retinal Pigments;D012168
A07.231.611.773;Retinal Vein;D012169
A07.231.908.783;Retinal Vein;D012169
C11.768.760;Retinal Vein Occlusion;D012170
C14.907.355.830.925.650;Retinal Vein Occlusion;D012170
C14.907.760;Retinal Vein Occlusion;D012170
A07.231.611;Retinal Vessels;D012171
D02.047.850;Retinaldehyde;D012172
D02.455.326.271.665.202.495.690;Retinaldehyde;D012172
D02.455.426.392.368.367.379.249.700.690;Retinaldehyde;D012172
D02.455.849.131.495.690;Retinaldehyde;D012172
D23.767.261.700.690;Retinaldehyde;D012172
C11.768.773;Retinitis;D012173
C11.270.684;Retinitis Pigmentosa;D012174
C11.768.585.658.500;Retinitis Pigmentosa;D012174
C16.320.290.684;Retinitis Pigmentosa;D012174
C04.557.465.625.600.725;Retinoblastoma;D012175
C04.557.470.670.725;Retinoblastoma;D012175
C04.557.580.625.600.725;Retinoblastoma;D012175
C04.588.364.818.760;Retinoblastoma;D012175
C11.319.475.760;Retinoblastoma;D012175
C11.768.717.760;Retinoblastoma;D012175
D02.455.326.271.665.202.495;Retinoids;D012176
D02.455.426.392.368.367.379.249.700;Retinoids;D012176
D02.455.849.131.495;Retinoids;D012176
D23.767.261.700;Retinoids;D012176
D12.776.157.700;Retinol-Binding Proteins;D012177
C11.768.836;Retinopathy of Prematurity;D012178
C16.614.521.731;Retinopathy of Prematurity;D012178
I03.702;Retirement;D012179
L01.737.840;Retraction of Publication as Topic;D012180
C09.218.807;Retrocochlear Diseases;D012181
C23.550.737.500;Retrograde Degeneration;D012183
E06.397.778.778.648;Retrograde Obturation;D012184
C23.550.355.700;Retroperitoneal Fibrosis;D012185
C04.588.033.731;Retroperitoneal Neoplasms;D012186
A01.923.047.025.750;Retroperitoneal Space;D012187
C23.550.794;Retropneumoperitoneum;D012188
C26.748;Retropneumoperitoneum;D012188
E05.318.760.500.500.500;Retrospective Studies;D012189
E05.318.760.500.750.750;Retrospective Studies;D012189
N05.715.360.775.175.200.710;Retrospective Studies;D012189
N05.715.360.775.175.250.815;Retrospective Studies;D012189
N06.850.520.450.500.500.500;Retrospective Studies;D012189
N06.850.520.450.500.750.825;Retrospective Studies;D012189
B04.820.650;Retroviridae;D012190
B04.909.574.807;Retroviridae;D012190
B04.909.777.731;Retroviridae;D012190
D12.776.964.775;Retroviridae Proteins;D012191
C02.782.815;Retroviridae Infections;D012192
F02.463.425.798;Reversal Learning;D012193
D08.811.913.696.445.308.300.750;RNA-Directed DNA Polymerase;D012194
D12.776.964.775.375.750;RNA-Directed DNA Polymerase;D012194
D12.776.964.970.600.850.375.750;RNA-Directed DNA Polymerase;D012194
L01.178.682.759;Review Literature as Topic;D012196
F02.463.425.770.836;Reward;D012201
C06.552.241.649;Reye Syndrome;D012202
C10.228.140.163.780;Reye Syndrome;D012202
C18.452.132.780;Reye Syndrome;D012202
C15.378.120.780;Rh Isoimmunization;D012203
C20.188.780;Rh Isoimmunization;D012203
G12.425.143.780;Rh Isoimmunization;D012203
D23.050.301.290.775;Rh-Hr Blood-Group System;D012204
D23.050.705.230.775;Rh-Hr Blood-Group System;D012204
B01.050.500.500.294.700.700.640;Rhabdiasoidea;D012205
C05.651.807;Rhabdomyolysis;D012206
C04.557.450.590.540.700;Rhabdomyoma;D012207
C04.557.450.590.550.660;Rhabdomyosarcoma;D012208
C04.557.450.795.550.660;Rhabdomyosarcoma;D012208
B04.820.455.750;Rhabdoviridae;D012209
B04.909.777.455.750;Rhabdoviridae;D012209
D09.254.799;Rhamnose;D012210
D09.546.359.774;Rhamnose;D012210
D01.268.556.787;Rhenium;D012211
D01.268.956.750;Rhenium;D012211
D01.552.544.787;Rhenium;D012211
E05.830;Rheology;D012212
H01.671.808;Rheology;D012212
C01.252.410.890.731;Rheumatic Fever;D012213
C05.550.114.843;Rheumatic Fever;D012213
C05.799.825;Rheumatic Fever;D012213
C01.252.410.890.731.649;Rheumatic Heart Disease;D012214
C14.280.874;Rheumatic Heart Disease;D012214
C05.550.114.843.566;Rheumatic Nodule;D012215
C05.799.825.566;Rheumatic Nodule;D012215
C05.799;Rheumatic Diseases;D012216
C17.300.775;Rheumatic Diseases;D012216
D12.776.124.486.485.114.323.732;Rheumatoid Factor;D012217
D12.776.124.790.651.114.323.732;Rheumatoid Factor;D012217
D12.776.377.715.548.114.323.732;Rheumatoid Factor;D012217
C05.550.114.154.683;Rheumatoid Nodule;D012218
C05.799.114.683;Rheumatoid Nodule;D012218
C17.300.775.099.683;Rheumatoid Nodule;D012218
H02.403.429.730;Rheumatology;D012219
C08.460.799;Rhinitis;D012220
C08.730.674;Rhinitis;D012220
C09.603.799;Rhinitis;D012220
C08.460.799.631;Rhinitis, Allergic, Perennial;D012221
C08.674.810;Rhinitis, Allergic, Perennial;D012221
C09.603.799.631;Rhinitis, Allergic, Perennial;D012221
C20.543.480.680.791;Rhinitis, Allergic, Perennial;D012221
C08.460.799.649;Rhinitis, Atrophic;D012222
C09.603.799.649;Rhinitis, Atrophic;D012222
C08.460.799.910;Rhinitis, Vasomotor;D012223
C09.603.799.910;Rhinitis, Vasomotor;D012223
C17.800.716.500;Rhinophyma;D012224
C17.800.794.650;Rhinophyma;D012224
E02.218.755;Rhinoplasty;D012225
E04.580.392.500;Rhinoplasty;D012225
E04.680.650;Rhinoplasty;D012225
C01.252.400.310.503.650;Rhinoscleroma;D012226
C01.252.825.705;Rhinoscleroma;D012226
C01.539.800.720.705;Rhinoscleroma;D012226
C08.460.850;Rhinoscleroma;D012226
C08.730.702;Rhinoscleroma;D012226
C09.603.850;Rhinoscleroma;D012226
C17.800.838.765.705;Rhinoscleroma;D012226
C03.600.700;Rhinosporidiosis;D012227
B01.500.700;Rhinosporidium;D012228
B04.820.565.775;Rhinovirus;D012229
B04.909.777.618.775;Rhinovirus;D012229
B03.440.400.425.700;Rhizobiaceae;D012230
B03.660.050.730;Rhizobiaceae;D012230
B03.440.400.425.700.800;Rhizobium;D012231
B03.660.050.730.670;Rhizobium;D012231
B01.300.381.740;Rhizoctonia;D012232
B01.300.300.500.800;Rhizopus;D012233
D12.776.930.750;Rho Factor;D012234
D03.494.953.600;Rhodamines;D012235
D02.886.675.649;Rhodanine;D012236
D03.383.129.708.649;Rhodanine;D012236
Z01.107.567.875.550.680;Rhode Island;D012237
D01.268.556.793;Rhodium;D012238
D01.268.956.781;Rhodium;D012238
D01.552.544.793;Rhodium;D012238
B01.050.500.131.617.412.420.700.850.700;Rhodnius;D012239
B03.510.024.049.537.775;Rhodococcus;D012240
B03.440.400.425.200.700;Rhodopseudomonas;D012241
B03.660.050.035.700;Rhodopseudomonas;D012241
B03.440.623.700;Rhodobacter sphaeroides;D012242
B03.660.050.750.700.700;Rhodobacter sphaeroides;D012242
D12.776.543.750.100.955;Rhodopsin;D012243
D23.767.930.750.500.500;Rhodopsin;D012243
B03.440.400.425.708;Rhodospirillaceae;D012244
B03.660.050.663.750;Rhodospirillaceae;D012244
B03.660.050.663;Rhodospirillales;D012245
B03.440.400.425.708.733;Rhodospirillum;D012246
B03.660.050.663.750.733;Rhodospirillum;D012246
B03.440.400.425.708.733.650;Rhodospirillum rubrum;D012247
B03.660.050.663.750.733.650;Rhodospirillum rubrum;D012247
B01.300.381.750;Rhodotorula;D012248
B01.300.930.650;Rhodotorula;D012248
A08.186.211.132.810;Rhombencephalon;D012249
A08.186.211.865;Rhombencephalon;D012249
B01.650.940.800.575.100.825.700;Rheum;D012250
J02.500.850.700;Rheum;D012250
B01.650.940.800.575.100.044.744;Toxicodendron;D012251
E02.875.194.605;Natural Family Planning Methods;D012252
C26.404.593;Rib Fractures;D012253
C26.891.733;Rib Fractures;D012253
D13.570.800.790;Ribavirin;D012254
D02.033.800.780;Ribitol;D012255
D09.853.780;Ribitol;D012255
D03.438.733.315.650;Riboflavin;D012256
D03.494.507.650;Riboflavin;D012256
D08.211.474.650;Riboflavin;D012256
D23.767.405.650;Riboflavin;D012256
C18.654.521.500.133.699.713;Riboflavin Deficiency;D012257
D08.811.913.225.750;Riboflavin Synthase;D012258
D08.811.277.352.355.350.715;Ribonuclease, Pancreatic;D012259
D08.811.277.352.700.350.715;Ribonuclease, Pancreatic;D012259
D08.811.277.352.700;Ribonucleases;D012260
D12.776.157.725.500;Ribonucleoproteins;D012261
D12.776.664.962.500;Ribonucleoproteins;D012261
D08.811.682.810.567;Ribonucleoside Diphosphate Reductase;D012262
D13.570.800;Ribonucleosides;D012263
D08.811.682.810;Ribonucleotide Reductases;D012264
D13.695.827;Ribonucleotides;D012265
D09.546.627.651;Ribose;D012266
D09.894.643.700;Ribosemonophosphates;D012267
D08.811.913.696.175.650;Ribose-Phosphate Pyrophosphokinase;D012268
D12.776.835;Ribosomal Proteins;D012269
A11.284.430.214.190.875.811;Ribosomes;D012270
D09.408.051.623.800;Ribostamycin;D012271
A02.835.232.904.567;Ribs;D012272
D08.811.520.224.125.800;Ribulose-Bisphosphate Carboxylase;D012273
D12.776.183.499;Ribulose-Bisphosphate Carboxylase;D012273
D12.776.765.199.499;Ribulose-Bisphosphate Carboxylase;D012273
D09.894.643.720;Ribulosephosphates;D012274
B01.650.940.800.575.100.822.616;Oryza sativa;D012275
J02.500.200.700;Oryza sativa;D012275
D08.811.277.450.430.700.750.666;Ricin;D012276
D12.776.034.756;Ricin;D012276
D12.776.503.499.937;Ricin;D012276
D12.776.765.678.906.750;Ricin;D012276
D10.212.507.300.500;Ricinoleic Acids;D012277
D10.251.355.325.600.780;Ricinoleic Acids;D012277
B01.650.940.800.575.100.350.650;Ricinus;D012278
C05.116.198.816;Rickets;D012279
C18.452.174.845;Rickets;D012279
C18.654.521.500.133.770.734;Rickets;D012279
B03.440.647.650.650;Rickettsia;D012281
B03.660.050.765.650.650;Rickettsia;D012281
C01.252.400.780.790;Rickettsia Infections;D012282
B03.440.647.650.650.600;Rickettsia prowazekii;D012283
B03.660.050.765.650.650.600;Rickettsia prowazekii;D012283
B03.440.647.650.650.650;Rickettsia rickettsii;D012284
B03.660.050.765.650.650.650;Rickettsia rickettsii;D012284
B03.440.647.650.550;Orientia tsutsugamushi;D012285
B03.660.050.765.650.600;Orientia tsutsugamushi;D012285
B03.440.647.650.650.810;Rickettsia typhi;D012286
B03.660.050.765.650.650.810;Rickettsia typhi;D012286
B03.440.647;Rickettsiaceae;D012287
B03.660.050.765;Rickettsiaceae;D012287
C01.252.400.780;Rickettsiaceae Infections;D012288
D20.215.894.135.650;Rickettsial Vaccines;D012290
D03.549.811.700;Rifampin;D012293
D04.345.295.750.700;Rifampin;D012293
D03.549.811;Rifamycins;D012294
D04.345.295.750;Rifamycins;D012294
C02.081.810;Rift Valley Fever;D012295
C02.407.810;Rift Valley Fever;D012295
C02.782.147.810;Rift Valley Fever;D012295
C02.782.417.762;Rift Valley Fever;D012295
C06.552.380.315.430.812;Rift Valley Fever;D012295
C22.467.435.812;Rift Valley Fever;D012295
B04.820.087.710.700;Rift Valley fever virus;D012296
B04.909.777.147.710.700;Rift Valley fever virus;D012296
I01.880.604.473.650.952;Right to Die;D012297
N03.706.437.650.750;Right to Die;D012297
C23.550.260.224.617.839;Rigor Mortis;D012298
D02.455.426.100.050.750;Rimantadine;D012299
D02.455.426.392.368.075.750;Rimantadine;D012299
C02.782.580.600.500.700;Rinderpest;D012301
C22.780;Rinderpest;D012301
B04.820.455.600.650.500.675;Rinderpest virus;D012302
B04.909.777.455.600.650.500.675;Rinderpest virus;D012302
A11.284.187.788;Ring Chromosomes;D012303
C23.550.210.760;Ring Chromosomes;D012303
G05.360.162.788;Ring Chromosomes;D012303
G05.365.590.175.760;Ring Chromosomes;D012303
D27.720.821;Riot Control Agents, Chemical;D012304
D27.888.569.734;Riot Control Agents, Chemical;D012304
I01.880.735.140.652;Riots;D012305
E05.318.740.600.800;Risk;D012306
G17.680.750;Risk;D012306
N05.715.360.750.625.700;Risk;D012306
N06.850.520.830.600.800;Risk;D012306
E05.318.740.600.800.725;Risk Factors;D012307
N05.715.350.200.700;Risk Factors;D012307
N05.715.360.750.625.700.700;Risk Factors;D012307
N06.850.490.625.750;Risk Factors;D012307
N06.850.520.830.600.800.725;Risk Factors;D012307
N03.219.463.800;Risk Management;D012308
N04.452.871;Risk Management;D012308
F01.145.722;Risk-Taking;D012309
D09.400.420.800;Ristocetin;D012310
D12.644.233.697;Ristocetin;D012310
D02.033.100.624.870;Ritodrine;D012312
D02.033.755.624.870;Ritodrine;D012312
D02.092.063.624.870;Ritodrine;D012312
D02.092.471.683.870;Ritodrine;D012312
D13.444.735;RNA;D012313
D03.438.759.646.454.700.710;RNA Cap Analogs;D012314
D13.444.735.544.500.710;RNA Cap Analogs;D012314
D13.695.667.454.700.710;RNA Cap Analogs;D012314
D13.695.827.426.700.710;RNA Cap Analogs;D012314
D03.438.759.646.454.700;RNA Caps;D012315
D13.444.735.544.500;RNA Caps;D012315
D13.695.667.454.700;RNA Caps;D012315
D13.695.827.426.700;RNA Caps;D012315
D08.811.913.696.445.735;RNA Nucleotidyltransferases;D012316
B04.123.691;RNA Phages;D012317
D08.811.913.696.445.735.270.750;RNA Polymerase I;D012318
D08.811.913.696.445.735.270.762;RNA Polymerase II;D012319
D08.811.913.696.445.735.270.775;RNA Polymerase III;D012320
D08.811.913.696.445.735.270;DNA-Directed RNA Polymerases;D012321
D13.400.730;RNA Precursors;D012322
D13.444.735.640;RNA Precursors;D012322
G02.111.087.750;RNA Processing, Post-Transcriptional;D012323
G02.149.115.750;RNA Processing, Post-Transcriptional;D012323
G03.495.839;RNA Processing, Post-Transcriptional;D012323
G05.355.315.700;RNA Processing, Post-Transcriptional;D012323
D08.811.913.696.445.735.780;RNA Replicase;D012324
G02.111.087.750.700;RNA Splicing;D012326
G02.149.115.750.700;RNA Splicing;D012326
G03.495.839.700;RNA Splicing;D012326
G05.355.315.700.700;RNA Splicing;D012326
C02.782;RNA Virus Infections;D012327
B04.820;RNA Viruses;D012328
B04.909.777;RNA Viruses;D012328
D13.444.735.473;RNA, Bacterial;D012329
D13.444.735.490;RNA, Double-Stranded;D012330
G02.111.570.790.486.775;RNA, Double-Stranded;D012330
G05.360.580.775;RNA, Double-Stranded;D012330
D13.444.735.500;RNA, Fungal;D012331
D13.444.735.628.806;RNA, Heterogeneous Nuclear;D012332
D13.444.735.544;RNA, Messenger;D012333
D13.444.735.615;RNA, Neoplasm;D012334
D13.444.735.686;RNA, Ribosomal;D012335
D13.444.735.686.670;RNA, Ribosomal, 16S;D012336
D13.444.735.686.675;RNA, Ribosomal, 18S;D012337
D13.444.735.686.680;RNA, Ribosomal, 23S;D012338
D13.444.735.686.690;RNA, Ribosomal, 28S;D012339
D13.444.735.686.660;RNA, Ribosomal, 5.8S;D012340
D13.444.735.686.650;RNA, Ribosomal, 5S;D012341
D13.444.735.628.818;RNA, Small Nuclear;D012342
D13.444.735.790.552.937;RNA, Small Nuclear;D012342
D13.444.735.757;RNA, Transfer;D012343
D13.444.735.757.700.050;RNA, Transfer, Ala;D012344
D13.444.735.757.700;RNA, Transfer, Amino Acid-Specific;D012345
D12.125.780;RNA, Transfer, Amino Acyl;D012346
D13.444.735.757.715;RNA, Transfer, Amino Acyl;D012346
D13.444.735.757.700.075;RNA, Transfer, Arg;D012347
D13.444.735.757.700.085;RNA, Transfer, Asn;D012348
D13.444.735.757.700.090;RNA, Transfer, Asp;D012349
D13.444.735.757.700.200;RNA, Transfer, Cys;D012350
D13.444.735.757.700.400;RNA, Transfer, Gln;D012351
D13.444.735.757.700.410;RNA, Transfer, Glu;D012352
D13.444.735.757.700.420;RNA, Transfer, Gly;D012353
D13.444.735.757.700.450;RNA, Transfer, His;D012354
D13.444.735.757.700.480;RNA, Transfer, Ile;D012355
D13.444.735.757.700.500;RNA, Transfer, Leu;D012356
D13.444.735.757.700.510;RNA, Transfer, Lys;D012357
D13.444.735.757.700.525;RNA, Transfer, Met;D012358
D08.811.913.555.500.925;tRNA Methyltransferases;D012359
D13.444.735.757.700.650;RNA, Transfer, Phe;D012360
D13.444.735.757.700.660;RNA, Transfer, Pro;D012361
D13.444.735.757.700.700;RNA, Transfer, Ser;D012362
D13.444.735.757.700.725;RNA, Transfer, Thr;D012363
D13.444.735.757.700.740;RNA, Transfer, Trp;D012364
D13.444.735.757.700.750;RNA, Transfer, Tyr;D012365
D13.444.735.757.700.900;RNA, Transfer, Val;D012366
D13.444.735.828;RNA, Viral;D012367
D03.383.129.308.100;4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;D012368
D03.438.834.700;2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-;D012369
D02.078.370.810;Robenidine;D012370
H01.671.293.643;Robotics;D012371
J01.897.104.834;Robotics;D012371
L01.224.065.630;Robotics;D012371
E05.318.740.872.750;ROC Curve;D012372
E05.318.780.800.750;ROC Curve;D012372
N05.715.360.780.700.680;ROC Curve;D012372
N06.850.520.445.800.750;ROC Curve;D012372
C01.252.400.780.790.700;Rocky Mountain Spotted Fever;D012373
C01.252.400.825.775;Rocky Mountain Spotted Fever;D012373
A08.663.650.850.625.670.375.500;Rod Cell Outer Segment;D012374
A08.663.650.850.625.670.650.650;Rod Cell Outer Segment;D012374
A08.663.650.915.937.670.375.500;Rod Cell Outer Segment;D012374
A08.663.650.915.937.670.650.650;Rod Cell Outer Segment;D012374
A08.800.950.937.670.375.500;Rod Cell Outer Segment;D012374
A08.800.950.937.670.650.650;Rod Cell Outer Segment;D012374
A09.371.729.831.625.670.375.500;Rod Cell Outer Segment;D012374
A09.371.729.831.625.670.650.650;Rod Cell Outer Segment;D012374
A11.671.650.850.625.670.375.500;Rod Cell Outer Segment;D012374
A11.671.650.850.625.670.650.650;Rod Cell Outer Segment;D012374
A11.671.650.915.937.670.375.500;Rod Cell Outer Segment;D012374
A11.671.650.915.937.670.650.650;Rod Cell Outer Segment;D012374
N06.850.780.200.650.700;Rodent Control;D012375
C22.795;Rodent Diseases;D012376
B01.050.150.900.649.865;Rodentia;D012377
D27.720.031.700.853;Rodenticides;D012378
D27.720.723.853;Rodenticides;D012378
D27.888.723.853;Rodenticides;D012378
F01.829.316.616;Role;D012380
E02.190.525.781.653;Role Playing;D012381
F04.754.864.581.679.653;Role Playing;D012381
D02.455.426.559.847.562.900.720;Rolitetracycline;D012382
D04.615.562.900.720;Rolitetracycline;D012382
Z01.542.248.764;Romania;D012383
Z01.433.850;Rome;D012384
Z01.542.489.569;Rome;D012384
D02.640.672.730;Ronidazole;D012385
D03.383.129.308.658.730;Ronidazole;D012385
N02.421.088.120.240;Rooming-in Care;D012386
D25.339.859;Root Canal Filling Materials;D012387
J01.637.051.339.859;Root Canal Filling Materials;D012387
D25.800;Root Canal Irrigants;D012388
D27.505.954.122.425.300.500;Root Canal Irrigants;D012388
D27.720.274.300.500;Root Canal Irrigants;D012388
J01.637.051.800;Root Canal Irrigants;D012388
E06.397.778.778;Root Canal Obturation;D012389
E06.397.778;Root Canal Therapy;D012390
C07.793.901.653;Root Resorption;D012391
G10.549.235.917.653;Root Resorption;D012391
F04.711.647.622.341.736;Rorschach Test;D012392
C17.800.716;Rosacea;D012393
D02.092.146.755;Rosaniline Dyes;D012394
D02.455.426.559.847.885.347.700;Rose Bengal;D012395
D03.494.953.275.700;Rose Bengal;D012395
D04.615.885.347.700;Rose Bengal;D012395
E01.370.225.812.706;Rosette Formation;D012397
E05.200.812.706;Rosette Formation;D012397
E05.478.594.730;Rosette Formation;D012397
B04.820.850.054.813;Ross River virus;D012398
B04.909.777.923.054.813;Ross River virus;D012398
G01.595.560.703;Rotation;D012399
C02.782.791.814;Rotavirus Infections;D012400
B04.820.630.790;Rotavirus;D012401
B04.909.777.714.790;Rotavirus;D012401
D03.438.150.266.450.400.843;Rotenone;D012402
D03.549.825;Rotenone;D012402
D03.830.219.266.450.400.843;Rotenone;D012402
B01.050.500.500.770;Rotifera;D012403
A02.513.803;Round Ligament;D012404
A05.360.319.114.803;Round Ligament;D012404
A09.246.631.246.814;Round Window, Ear;D012405
D02.691.088.700;Roxarsone;D012406
G05.360.340.024.686.817;rRNA Operon;D012407
G05.360.340.300.500.817;rRNA Operon;D012407
D25.720.099.750;Rubber;D012408
D25.720.327.840;Rubber;D012408
J01.637.051.720.099.750;Rubber;D012408
J01.637.051.720.327.840;Rubber;D012408
J01.637.412.767;Rubber;D012408
C02.782.930.700.700;Rubella;D012409
C02.782.930.700.700.700;Rubella Syndrome, Congenital;D012410
C16.131.077.790;Rubella Syndrome, Congenital;D012410
D20.215.894.899.779;Rubella Vaccine;D012411
B04.820.850.700.700;Rubella virus;D012412
B04.909.777.923.700.700;Rubella virus;D012412
D01.268.549.650;Rubidium;D012413
D01.268.556.800;Rubidium;D012413
D01.552.528.759;Rubidium;D012413
D01.552.544.800;Rubidium;D012413
D01.496.749.740;Rubidium Radioisotopes;D012414
C05.116.099.370.797;Rubinstein-Taybi Syndrome;D012415
C05.660.207.850;Rubinstein-Taybi Syndrome;D012415
C10.597.606.643.700;Rubinstein-Taybi Syndrome;D012415
C16.131.077.804;Rubinstein-Taybi Syndrome;D012415
C16.131.260.790;Rubinstein-Taybi Syndrome;D012415
C16.131.621.207.850;Rubinstein-Taybi Syndrome;D012415
C16.320.180.790;Rubinstein-Taybi Syndrome;D012415
D12.776.097.350.650;Rubredoxins;D012416
D12.776.157.427.374.375.275.725;Rubredoxins;D012416
D12.776.556.579.374.375.275.725;Rubredoxins;D012416
A13.869.804;Rumen;D012417
B01.050.150.900.649.077.380;Ruminants;D012418
I01.880.735.779;Runaway Behavior;D012419
G11.427.590.530.568.610;Running;D012420
G11.427.590.530.698.277.750;Running;D012420
I03.450.642.845.610;Running;D012420
C26.761;Rupture;D012421
C23.300.909;Rupture, Spontaneous;D012422
N01.400.650;Rural Health;D012423
N01.600.725;Rural Population;D012424
Z01.586.800;Russia (Pre-1917);D012425
Z01.542.248.775;Russia;D012426
Z01.586.200.775;Russia;D012426
Z01.586.950.775;Russia;D012426
D02.540.505.620.750;Rutamycin;D012427
D01.268.556.805;Ruthenium;D012428
D01.268.956.812;Ruthenium;D012428
D01.552.544.805;Ruthenium;D012428
D01.496.749.745;Ruthenium Radioisotopes;D012429
D01.210.837;Ruthenium Red;D012430
D01.625.800;Ruthenium Red;D012430
D01.765.765;Ruthenium Red;D012430
D03.438.150.266.450.284.888;Rutin;D012431
D03.830.219.266.450.284.888;Rutin;D012431
Z01.058.290.120.680;Rwanda;D012432
D02.455.849.291.686;Ryanodine;D012433
D03.132.740;Ryanodine;D012433
D03.383.129.578.805;Ryanodine;D012433
B01.650.940.800.575.100.822.857;Secale cereale;D012434
J02.500.200.750;Secale cereale;D012434
J02.500.300.100.750;Secale cereale;D012434
D02.886.030.498.050;S-Adenosylhomocysteine;D012435
D03.438.759.590.138.240;S-Adenosylhomocysteine;D012435
D12.125.166.498.050;S-Adenosylhomocysteine;D012435
D13.570.583.138.240;S-Adenosylhomocysteine;D012435
D13.570.800.096.262;S-Adenosylhomocysteine;D012435
D02.886.030.676.180;S-Adenosylmethionine;D012436
D03.438.759.590.138.264;S-Adenosylmethionine;D012436
D12.125.166.676.180;S-Adenosylmethionine;D012436
D13.570.583.138.264;S-Adenosylmethionine;D012436
D13.570.800.096.264;S-Adenosylmethionine;D012436
D08.811.520.224.125.050;Adenosylmethionine Decarboxylase;D012437
G14.640.260.500;Saccades;D012438
D02.886.675.687;Saccharin;D012439
D03.383.129.708.089.708;Saccharin;D012439
D03.438.185.708;Saccharin;D012439
B01.300.107.795.785;Saccharomyces;D012440
B01.300.930.705;Saccharomyces;D012440
B01.300.107.795.785.800;Saccharomyces cerevisiae;D012441
B01.300.930.705.655;Saccharomyces cerevisiae;D012441
B01.300.107.795.815;Saccharomycopsis;D012442
B01.300.930.710;Saccharomycopsis;D012442
D08.811.682.662.750;Saccharopine Dehydrogenases;D012443
A09.246.631.909.625;Saccule and Utricle;D012444
A01.923.176.780;Sacrococcygeal Region;D012445
A02.835.583.707;Sacroiliac Joint;D012446
A02.835.232.834.717;Sacrum;D012447
F03.800.800.600.700;Sadism;D012448
N06.850.135.060.075;Safety;D012449
D10.212.302.380.750;Safflower Oil;D012450
D10.212.507.750;Safflower Oil;D012450
D10.627.700.840;Safflower Oil;D012450
D20.215.784.750.840;Safflower Oil;D012450
J02.500.375.400.700;Safflower Oil;D012450
D03.383.246.118.750;Safrole;D012451
D03.438.115.750;Safrole;D012451
J02.500.512.400.587;Safrole;D012451
B01.050.150.900.649.801.400.600.150.150.710;Saguinus;D012452
B01.050.150.900.649.801.400.600.150.710.710;Saimiri;D012453
B01.050.150.900.090.608.700.610;Salamandra;D012454
B01.050.150.900.090.608.700;Salamandridae;D012455
N01.824.417.700;Salaries and Fringe Benefits;D012456
N04.452.677.800;Salaries and Fringe Benefits;D012456
D02.065.793;Salicylamides;D012457
D02.065.199.860;Salicylanilides;D012458
D02.065.793.650;Salicylanilides;D012458
D02.241.223.100.300.595;Salicylates;D012459
D02.241.511.390.595;Salicylates;D012459
D02.455.426.559.389.127.281.595;Salicylates;D012459
D02.455.426.559.389.657.410.595;Salicylates;D012459
D02.065.884.730;Sulfasalazine;D012460
D02.886.590.700.730;Sulfasalazine;D012460
D26.776.314.890;Saline Solution, Hypertonic;D012462
A12.200.666;Saliva;D012463
D25.583.820;Saliva, Artificial;D012464
J01.637.051.583.820;Saliva, Artificial;D012464
C07.465.815.497.325;Salivary Duct Calculi;D012465
C23.300.175.700.325;Salivary Duct Calculi;D012465
C07.465.815;Salivary Gland Diseases;D012466
C07.465.614.655;Salivary Gland Fistula;D012467
C07.465.815.655;Salivary Gland Fistula;D012467
C23.300.575.500.775;Salivary Gland Fistula;D012467
C04.588.443.591.824;Salivary Gland Neoplasms;D012468
C07.465.565.824;Salivary Gland Neoplasms;D012468
C07.465.815.718;Salivary Gland Neoplasms;D012468
A03.556.500.760;Salivary Glands;D012469
A10.336.779;Salivary Glands;D012469
A14.549.760;Salivary Glands;D012469
A03.556.500.760.650;Salivary Glands, Minor;D012470
A10.336.779.650;Salivary Glands, Minor;D012470
A14.549.760.650;Salivary Glands, Minor;D012470
D12.644.848;Salivary Proteins and Peptides;D012471
D12.776.850;Salivary Proteins and Peptides;D012471
G07.610.593.220.800;Salivation;D012472
G07.700.620.220.800;Salivation;D012472
G10.261.326.222.800;Salivation;D012472
D12.776.660.750.740;Salmine;D012473
D12.776.664.750.739;Salmine;D012473
B01.050.150.900.493.817.750.705;Salmon;D012474
B03.440.450.425.800;Salmonella;D012475
B03.660.250.150.710;Salmonella;D012475
B03.440.450.425.800.100;Salmonella arizonae;D012476
B03.660.250.150.710.050;Salmonella arizonae;D012476
B03.440.450.425.800.200.300;Salmonella enteritidis;D012477
B03.660.250.150.710.160.160;Salmonella enteritidis;D012477
C01.252.400.310.821.606;Salmonella Food Poisoning;D012478
C25.723.415.738;Salmonella Food Poisoning;D012478
B03.440.450.425.800.200.750;Salmonella paratyphi C;D012479
B03.660.250.150.710.160.711;Salmonella paratyphi C;D012479
C01.252.400.310.821;Salmonella Infections;D012480
C01.252.400.310.821.706;Salmonella Infections, Animal;D012481
C22.812;Salmonella Infections, Animal;D012481
B03.440.450.425.800.200.600;Salmonella paratyphi A;D012482
B03.660.250.150.710.160.580;Salmonella paratyphi A;D012482
B04.123.706;Salmonella Phages;D012483
B03.440.450.425.800.200.700;Salmonella paratyphi B;D012484
B03.660.250.150.710.160.710;Salmonella paratyphi B;D012484
B03.440.450.425.800.200.800;Salmonella typhi;D012485
B03.660.250.150.710.160.750;Salmonella typhi;D012485
B03.440.450.425.800.200.825;Salmonella typhimurium;D012486
B03.660.250.150.710.160.760;Salmonella typhimurium;D012486
B01.050.150.900.493.817.750;Salmonidae;D012487
C13.351.500.056.390.890;Salpingitis;D012488
C13.351.500.056.750.875;Salpingitis;D012488
E04.035.832;Salpingostomy;D012489
E04.950.300.750;Salpingostomy;D012489
D03.132.750;Salsoline Alkaloids;D012490
D03.438.531.820.500;Salsoline Alkaloids;D012490
A13.811;Salt Gland;D012491
D01.786;Salts;D012492
D01.268.477.937;Samarium;D012493
D01.268.558.362.937;Samarium;D012493
D01.552.550.399.937;Samarium;D012493
E05.318.760.875;Sampling Studies;D012494
N05.715.360.775.700;Sampling Studies;D012494
N06.850.520.450.875;Sampling Studies;D012494
Z01.107.567.875.580.200.700;San Francisco;D012495
Z01.107.567.875.760.200.700;San Francisco;D012495
Z01.433.875;San Francisco;D012495
Z01.542.786;San Marino;D012496
C10.228.140.163.100.435.825.300.300.249;Sandhoff Disease;D012497
C10.228.140.163.100.435.825.300.700;Sandhoff Disease;D012497
C16.320.565.189.435.825.300.300.249;Sandhoff Disease;D012497
C16.320.565.189.435.825.300.700;Sandhoff Disease;D012497
C16.320.565.398.641.803.350.300.700;Sandhoff Disease;D012497
C16.320.565.595.554.825.300.300.800;Sandhoff Disease;D012497
C18.452.132.100.435.825.300.300.249;Sandhoff Disease;D012497
C18.452.132.100.435.825.300.700;Sandhoff Disease;D012497
C18.452.584.687.803.350.300.700;Sandhoff Disease;D012497
C18.452.648.189.435.825.300.300.249;Sandhoff Disease;D012497
C18.452.648.189.435.825.300.700;Sandhoff Disease;D012497
C18.452.648.398.641.803.350.300.700;Sandhoff Disease;D012497
C18.452.648.595.554.825.300.300.800;Sandhoff Disease;D012497
H02.229.656;Sanitary Engineering;D012498
J01.293.821;Sanitary Engineering;D012498
N06.850.780.200.800.800;Sanitary Engineering;D012498
N06.850.860.510;Sanitary Engineering;D012498
H02.229.782;Sanitation;D012499
N06.850.780.200.800;Sanitation;D012499
N06.850.860;Sanitation;D012499
D02.455.849.765.750;Santonin;D012500
A07.231.908.819;Saphenous Vein;D012501
D02.455.849.919.650;Sapogenins;D012502
D04.808.795;Sapogenins;D012502
D09.408.782;Saponins;D012503
D12.644.456.073.041.800;Saralasin;D012504
D23.469.050.050.050.700;Saralasin;D012504
B03.510.400.750;Sarcina;D012505
C15.604.515.827;Sarcoidosis;D012507
A11.284.149.707;Sarcolemma;D012508
C04.557.450.795;Sarcoma;D012509
C04.557.450.795.830.780;Sarcoma 180;D012510
C04.619.857.656;Sarcoma 180;D012510
C04.557.450.795.830.760;Sarcoma 37;D012511
C04.619.857.573;Sarcoma 37;D012511
C04.557.450.565.575.650.800;Sarcoma, Ewing;D012512
C04.557.450.795.620.800;Sarcoma, Ewing;D012512
C04.557.450.795.830;Sarcoma, Experimental;D012513
C04.619.857;Sarcoma, Experimental;D012513
E05.598.500.496.968;Sarcoma, Experimental;D012513
C02.256.466.860;Sarcoma, Kaposi;D012514
C04.557.450.795.850;Sarcoma, Kaposi;D012514
C04.557.645.750;Sarcoma, Kaposi;D012514
C04.557.450.565.465.124;Mast-Cell Sarcoma;D012515
C04.557.450.565.575.650;Osteosarcoma;D012516
C04.557.450.795.620;Osteosarcoma;D012516
C04.557.450.795.830.850;Sarcoma, Yoshida;D012517
C04.619.857.822;Sarcoma, Yoshida;D012517
A10.690.552.875.700;Sarcomeres;D012518
A11.284.430.214.190.875.820;Sarcomeres;D012518
A11.620.249.850.700;Sarcomeres;D012518
A11.620.500.500.700;Sarcomeres;D012518
A10.690.552.500.500.850;Sarcoplasmic Reticulum;D012519
A11.284.430.214.190.875.248.310.800;Sarcoplasmic Reticulum;D012519
B01.050.500.131.166.132.419.750.800;Sarcoptes scabiei;D012520
D12.125.481.700.374;Sarcosine;D012521
B01.043.075.189.250.750.750;Sarcocystis;D012522
C03.752.250.634;Sarcocystosis;D012523
D02.705.429.750.500;Sarin;D012524
Z01.107.567.176.858;Saskatchewan;D012525
B04.265.658;Satellite Viruses;D012526
F02.830.749;Satiation;D012527
F02.830.749.658;Satiety Response;D012528
Z01.252.245.500.750;Saudi Arabia;D012529
Z01.586.500.750;Saudi Arabia;D012529
D03.438.759.794;Saxitoxin;D012530
D23.946.580.830;Saxitoxin;D012530
D03.494.347.200;Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide;D012531
C03.858.211.480.708;Scabies;D012532
C17.800.838.775.800;Scabies;D012532
A09.246.631.246.848;Scala Tympani;D012533
E06.721.189.350;Dental Scaling;D012534
E06.761.227.350;Dental Scaling;D012534
A01.456.810;Scalp;D012535
C17.800.738;Scalp Dermatoses;D012536
Z01.542.808;Scandinavia;D012537
D01.268.558.800;Scandium;D012538
D01.268.956.827;Scandium;D012538
D01.552.550.800;Scandium;D012538
F01.145.813.572;Scapegoating;D012539
F01.393.246.500;Scapegoating;D012539
F01.393.693.500;Scapegoating;D012539
A02.835.232.087.783;Scapula;D012540
C01.252.410.890.823;Scarlet Fever;D012541
E05.196.822;Scattering, Radiation;D012542
G01.595.861;Scattering, Radiation;D012542
A13.820;Scent Glands;D012543
C05.116.821.500.500;Scheuermann Disease;D012544
C05.116.900.800.500.500;Scheuermann Disease;D012544
C05.116.900.808.500;Scheuermann Disease;D012544
D02.491.784;Schiff Bases;D012545
E01.370.225.625.750;Schilling Test;D012546
E01.370.384.750;Schilling Test;D012546
E05.200.625.750;Schilling Test;D012546
B01.050.500.500.736.715.770.680;Schistosoma;D012547
B01.050.500.500.736.715.770.680.510;Schistosoma haematobium;D012548
B01.050.500.500.736.715.770.680.570;Schistosoma japonicum;D012549
B01.050.500.500.736.715.770.680.700;Schistosoma mansoni;D012550
B01.050.500.500.736.715.770;Schistosomatidae;D012551
C03.335.865.859;Schistosomiasis;D012552
C23.996.800;Schistosomiasis;D012552
C01.539.895.775;Schistosomiasis haematobia;D012553
C03.335.865.859.427;Schistosomiasis haematobia;D012553
C12.777.892.775;Schistosomiasis haematobia;D012553
C13.351.968.892.775;Schistosomiasis haematobia;D012553
C03.335.865.859.521;Schistosomiasis japonica;D012554
C03.335.865.859.576;Schistosomiasis mansoni;D012555
D27.505.954.122.250.075.100.750;Schistosomicides;D012556
F03.675.700;Schizoid Personality Disorder;D012557
F03.700.750;Schizophrenia;D012559
F03.700.750.300;Schizophrenia, Catatonic;D012560
F03.550.768;Schizophrenia, Childhood;D012561
F03.700.750.350;Schizophrenia, Disorganized;D012562
F03.700.750.600;Schizophrenia, Paranoid;D012563
F01.145.126.975;Schizophrenic Language;D012564
F04.824;Schizophrenic Psychology;D012565
D09.698.365.089.625;Sizofiran;D012566
B01.300.179.100.750;Schizophyllum;D012567
B01.300.107.797;Schizosaccharomyces;D012568
B01.300.930.720;Schizosaccharomyces;D012568
F03.675.725;Schizotypal Personality Disorder;D012569
I02.399.750;School Admission Criteria;D012570
H02.163.809;School Dentistry;D012571
N02.421.143.827.809.576;School Dentistry;D012571
N02.421.726.809.576;School Dentistry;D012571
N02.421.143.827.809;School Health Services;D012572
N02.421.726.809;School Health Services;D012572
H02.478.676.824;School Nursing;D012573
N02.421.143.827.809.742;School Nursing;D012573
N02.421.726.809.742;School Nursing;D012573
I02.233.659;Schools;D012574
I02.783;Schools;D012574
I02.783.660.481;Schools, Dental;D012575
I02.783.660;Schools, Health Occupations;D012576
I02.783.660.552;Schools, Medical;D012577
N02.278.020.578;Schools, Medical;D012577
I02.233.659.660;Schools, Nursery;D012578
I02.783.660.623;Schools, Nursing;D012579
I02.783.660.694;Schools, Pharmacy;D012580
I02.783.660.765;Schools, Public Health;D012581
I02.783.660.836;Schools, Veterinary;D012582
A08.637.800;Schwann Cells;D012583
A08.800.800.690;Schwann Cells;D012583
A11.650.800;Schwann Cells;D012583
A08.800.800.720.450.760;Sciatic Nerve;D012584
C10.597.617.682.800;Sciatica;D012585
C10.668.829.500.675.800;Sciatica;D012585
C10.668.829.600.800;Sciatica;D012585
C23.888.592.612.664.800;Sciatica;D012585
C23.888.646.508.800;Sciatica;D012585
H01.770;Science;D012586
C08.381.844;Scimitar Syndrome;D012587
C08.695.815;Scimitar Syndrome;D012587
C14.240.850.968;Scimitar Syndrome;D012587
C14.907.780;Scimitar Syndrome;D012587
C16.131.240.850.937;Scimitar Syndrome;D012587
C16.131.740.815;Scimitar Syndrome;D012587
E05.799.700;Scintillation Counting;D012588
B01.050.150.900.649.865.750;Sciuridae;D012589
A09.371.784;Sclera;D012590
E04.540.890;Scleral Buckling;D012591
C17.300.550.750;Scleredema Adultorum;D012592
C17.800.751;Scleredema Adultorum;D012592
C16.131.831.812;Sclerema Neonatorum;D012593
C16.614.810;Sclerema Neonatorum;D012593
C17.800.804.812;Sclerema Neonatorum;D012593
C17.300.787;Scleroderma, Localized;D012594
C17.800.767;Scleroderma, Localized;D012594
C17.300.799;Scleroderma, Systemic;D012595
C17.800.784;Scleroderma, Systemic;D012595
D12.776.860;Scleroproteins;D012596
D26.776.708.822;Sclerosing Solutions;D012597
D27.505.954.411.700;Sclerosing Solutions;D012597
D27.720.280.775.822;Sclerosing Solutions;D012597
C23.550.823;Sclerosis;D012598
E04.540.450.600;Sclerostomy;D012599
E04.579.895;Sclerostomy;D012599
C05.116.900.800.875;Scoliosis;D012600
D02.145.074.722.900;Scopolamine Hydrobromide;D012601
D03.132.760.180.848;Scopolamine Hydrobromide;D012601
D03.132.889.848;Scopolamine Hydrobromide;D012601
D03.605.869.900;Scopolamine Hydrobromide;D012601
D04.075.080.875.099.722.900;Scopolamine Hydrobromide;D012601
D02.145.074.722.900.700;Scopolamine Derivatives;D012602
D03.132.889.848.661;Scopolamine Derivatives;D012602
D03.605.869.900.700;Scopolamine Derivatives;D012602
D04.075.080.875.099.722.900.700;Scopolamine Derivatives;D012602
D03.438.150.446.912.850;Scopoletin;D012603
D03.830.219.446.912.850;Scopoletin;D012603
D20.888.065.830;Scorpion Venoms;D012604
D23.946.833.065.830;Scorpion Venoms;D012604
B01.050.500.131.166.661;Scorpions;D012605
Z01.542.363.766;Scotland;D012606
Z01.639.280.766;Scotland;D012606
C10.597.751.941.811;Scotoma;D012607
C11.966.811;Scotoma;D012607
C23.888.592.763.941.811;Scotoma;D012607
C10.228.228.800.717;Scrapie;D012608
C10.574.843.850;Scrapie;D012608
C22.836.799;Scrapie;D012608
C03.858.211.503.744;Screw Worm Infection;D012610
A05.360.444.661;Scrotum;D012611
C01.252.400.780.850;Scrub Typhus;D012612
K01.093.849;Sculpture;D012613
C14.907.454.800;Scurvy;D012614
C15.378.463.515.800;Scurvy;D012614
C18.654.521.500.133.115.661;Scurvy;D012614
B01.050.500.308.237.750;Sea Anemones;D012615
B01.050.500.408.560;Sea Cucumbers;D012616
B01.050.500.408.578;Sea Urchins;D012617
C10.228.140.163.100.435.825.775;Sea-Blue Histiocyte Syndrome;D012618
C15.604.250.410.800;Sea-Blue Histiocyte Syndrome;D012618
C16.320.565.189.435.825.775;Sea-Blue Histiocyte Syndrome;D012618
C16.320.565.398.641.803.850;Sea-Blue Histiocyte Syndrome;D012618
C16.320.565.595.554.825.775;Sea-Blue Histiocyte Syndrome;D012618
C18.452.132.100.435.825.775;Sea-Blue Histiocyte Syndrome;D012618
C18.452.584.687.803.850;Sea-Blue Histiocyte Syndrome;D012618
C18.452.648.189.435.825.775;Sea-Blue Histiocyte Syndrome;D012618
C18.452.648.398.641.803.850;Sea-Blue Histiocyte Syndrome;D012618
C18.452.648.595.554.825.775;Sea-Blue Histiocyte Syndrome;D012618
G01.910.645.661;Seasons;D012621
G16.500.275.071.590;Seasons;D012621
N06.230.300.100.250.525;Seasons;D012621
E07.700.800;Seat Belts;D012622
J01.637.708.800;Seat Belts;D012622
G16.500.275.810;Seawater;D012623
N06.230.580;Seawater;D012623
B05.080.750;Seaweed;D012624
C17.800.794;Sebaceous Gland Diseases;D012625
C04.588.805.578;Sebaceous Gland Neoplasms;D012626
C17.800.794.712;Sebaceous Gland Neoplasms;D012626
C17.800.882.712;Sebaceous Gland Neoplasms;D012626
A10.336.827;Sebaceous Glands;D012627
A17.815.805;Sebaceous Glands;D012627
C17.800.174.580;Dermatitis, Seborrheic;D012628
C17.800.794.230;Dermatitis, Seborrheic;D012628
C17.800.815.580;Dermatitis, Seborrheic;D012628
C17.800.859.350;Dermatitis, Seborrheic;D012628
A12.200.702;Sebum;D012629
D03.383.742.698.253.762;Secobarbital;D012631
D04.808.812;Secosteroids;D012632
D06.472.317.800;Secretin;D012633
D06.472.699.810;Secretin;D012633
D12.644.400.705;Secretin;D012633
D12.644.548.810;Secretin;D012633
D12.776.641.650.705;Secretin;D012633
A12.200;Bodily Secretions;D012634
D12.776.124.486.485.114.619.026.030.500;Secretory Component;D012635
D12.776.124.486.485.705.875;Secretory Component;D012635
D12.776.124.790.651.114.619.026.030.500;Secretory Component;D012635
D12.776.124.790.651.705.875;Secretory Component;D012635
D12.776.377.715.548.114.619.026.030.500;Secretory Component;D012635
D12.776.377.715.548.705.875;Secretory Component;D012635
G03.495.873;Secretory Rate;D012636
N04.452.910;Security Measures;D012637
A18.024.500.750;Seeds;D012639
J02.500.775;Seeds;D012639
C10.228.140.490.631;Seizures;D012640
C10.597.742;Seizures;D012640
C23.888.592.742;Seizures;D012640
G05.355.800;Selection, Genetic;D012641
D02.092.471.683.915;Selegiline;D012642
D01.268.185.850;Selenium;D012643
D01.578.700;Selenium;D012643
D01.496.749.780;Selenium Radioisotopes;D012644
D02.712.700;Selenomethionine;D012645
D02.886.030.676.900;Selenomethionine;D012645
D12.125.166.676.900;Selenomethionine;D012645
E02.319.890;Self Administration;D012646
E02.900.890;Self Administration;D012646
F01.752.747.792.537;Self-Assessment;D012647
E02.900;Self Care;D012648
N02.421.784.680;Self Care;D012648
F01.752.747.792;Self Concept;D012649
F01.752.747.792.662;Self Disclosure;D012650
E02.319.900;Self Medication;D012651
E02.900.900;Self Medication;D012651
C26.780;Self Mutilation;D012652
F01.145.126.980.750;Self Mutilation;D012652
F01.145.775;Self Stimulation;D012653
F02.830.784;Self Stimulation;D012653
N02.278.388.740;Self-Care Units;D012654
I02.399.780;Self-Evaluation Programs;D012655
E07.796;Self-Help Devices;D012656
N03.540.782;Self-Help Groups;D012657
A02.835.232.781.802.662;Sella Turcica;D012658
F02.694.663;Semantic Differential;D012659
F04.711.647.745;Semantic Differential;D012659
L01.143.506.598.745;Semantics;D012660
A12.200.732;Semen;D012661
E02.792.833.890;Semen Preservation;D012662
E05.760.833.890;Semen Preservation;D012662
D02.845;Semicarbazides;D012663
D02.845.746;Semicarbazones;D012664
A09.246.631.663;Semicircular Canals;D012665
E07.305.625;Semiconductors;D012666
A02.835.232.087.319.150.500;Lunate Bone;D012667
A08.340.390.850;Trigeminal Ganglion;D012668
A08.800.350.850;Trigeminal Ganglion;D012668
A08.800.800.120.760.825;Trigeminal Ganglion;D012668
A05.360.444.713;Seminal Vesicles;D012669
A05.360.444.849.700.700;Seminiferous Epithelium;D012670
A10.272.700;Seminiferous Epithelium;D012670
A05.360.444.849.700;Seminiferous Tubules;D012671
B04.820.850.054.840;Semliki forest virus;D012672
B04.909.777.923.054.840;Semliki forest virus;D012672
D02.654.692.440.700;Semustine;D012673
D02.948.594.440.700;Semustine;D012673
B01.650.940.800.575.100.100.800;Senecio;D012674
Z01.058.290.190.710;Senegal;D012675
D02.455.426.559.847.117.159.750;Senna Extract;D012676
D02.806.100.750;Senna Extract;D012676
D20.215.784.500.860;Senna Extract;D012676
F02.830.816;Sensation;D012677
G11.561.600.810;Sensation;D012677
C10.597.751;Sensation Disorders;D012678
C23.888.592.763;Sensation Disorders;D012678
A09;Sense Organs;D012679
E05.318.740.872;Sensitivity and Specificity;D012680
E05.318.780.800;Sensitivity and Specificity;D012680
G17.800;Sensitivity and Specificity;D012680
N05.715.360.750.725;Sensitivity and Specificity;D012680
N05.715.360.780.700;Sensitivity and Specificity;D012680
N06.850.520.445.800;Sensitivity and Specificity;D012680
N06.850.520.830.872;Sensitivity and Specificity;D012680
F01.829.316.697;Sensitivity Training Groups;D012681
F04.754.864.581.813;Sensitivity Training Groups;D012681
E07.814;Sensory Aids;D012682
F02.463.593.696;Sensory Deprivation;D012683
F02.463.593.710;Sensory Thresholds;D012684
D09.698.813;Sepharose;D012685
A08.186.211.464.750.800;Septal Nuclei;D012686
A08.186.211.730.885.750.800;Septal Nuclei;D012686
A08.186.211.276.814;Septum Pellucidum;D012688
A08.186.211.730.885.750.814;Septum Pellucidum;D012688
G02.111.810.550;Sequence Homology, Nucleic Acid;D012689
G05.810.550;Sequence Homology, Nucleic Acid;D012689
E04.545.700.680;Serial Extraction;D012690
E06.645.700.680;Serial Extraction;D012690
E06.658.641.890;Serial Extraction;D012690
F02.463.425.952.747;Serial Learning;D012691
E01.370.225.875.837;Serial Passage;D012692
E05.200.875.837;Serial Passage;D012692
L01.178.682.829;Serial Publications;D012693
D12.125.154.800;Serine;D012694
D12.125.837;Serine;D012694
D08.811.520.232.400.600;L-Serine Dehydratase;D012695
D08.811.913.555.400.500;Glycine Hydroxymethyltransferase;D012696
D08.811.277.656.300.760;Serine Endopeptidases;D012697
D08.811.277.656.959.350;Serine Endopeptidases;D012697
E01.370.225.812.735;Serologic Tests;D012698
E05.200.812.735;Serologic Tests;D012698
E05.478.594.760;Serologic Tests;D012698
H02.781;Serology;D012699
C23.550.470.646;Serositis;D012700
D02.092.211.215.801.852;Serotonin;D012701
D03.438.473.914.814;Serotonin;D012701
D23.469.050.650;Serotonin;D012701
D27.505.519.625.850.850;Serotonin Antagonists;D012702
D27.505.696.577.850.850;Serotonin Antagonists;D012702
E01.370.225.812.742;Serotyping;D012703
E01.370.225.875.150.125.890;Serotyping;D012703
E05.200.812.742;Serotyping;D012703
E05.200.875.150.125.890;Serotyping;D012703
E05.478.594.780;Serotyping;D012703
A10.615.789;Serous Membrane;D012704
B03.440.450.425.814;Serratia;D012705
B03.660.250.150.720;Serratia;D012705
B03.440.450.425.814.664;Serratia marcescens;D012706
B03.660.250.150.720.500;Serratia marcescens;D012706
C04.557.475.750.847.500;Sertoli Cell Tumor;D012707
C04.588.322.762.500.500;Sertoli Cell Tumor;D012707
C04.588.945.440.915.500.500;Sertoli Cell Tumor;D012707
C12.294.260.937.500.500;Sertoli Cell Tumor;D012707
C12.758.409.937.500.500;Sertoli Cell Tumor;D012707
C19.344.762.500.500;Sertoli Cell Tumor;D012707
C19.391.829.782.500.500;Sertoli Cell Tumor;D012707
A05.360.444.849.789;Sertoli Cells;D012708
A11.382.952;Sertoli Cells;D012708
A11.436.837;Sertoli Cells;D012708
D12.776.034.841;Serum Albumin;D012709
D12.776.124.050.700;Serum Albumin;D012709
D12.776.124.727;Serum Albumin;D012709
D12.776.034.841.540;Serum Albumin, Bovine;D012710
D12.776.124.727.540;Serum Albumin, Bovine;D012710
D01.496.448.496.665;Serum Albumin, Radio-Iodinated;D012711
D01.496.749.474.665;Serum Albumin, Radio-Iodinated;D012711
D12.776.034.841.665;Serum Albumin, Radio-Iodinated;D012711
D12.776.124.727.665;Serum Albumin, Radio-Iodinated;D012711
D12.776.124.790;Serum Globulins;D012712
D12.776.377.715;Serum Globulins;D012712
C17.800.174.600.800;Serum Sickness;D012713
C20.543.206.380.800;Serum Sickness;D012713
C20.543.520.770;Serum Sickness;D012713
C25.723.276.505.800;Serum Sickness;D012713
D08.811.464.263.200.750;Serine-tRNA Ligase;D012714
D10.212.302.380.775;Sesame Oil;D012715
D10.212.507.775;Sesame Oil;D012715
D10.627.700.865;Sesame Oil;D012715
D20.215.784.750.865;Sesame Oil;D012715
J02.500.375.400.725;Sesame Oil;D012715
A02.835.232.730;Sesamoid Bones;D012716
D02.455.849.765;Sesquiterpenes;D012717
F02.463.425.838;Set (Psychology);D012718
C03.335.349.820;Setariasis;D012719
C03.335.508.700.750.361.852;Setariasis;D012719
C03.701.377.820;Setariasis;D012719
C22.674.377.820;Setariasis;D012719
E05.318.308.250.475.456.500;Severity of Illness Index;D012720
N05.715.360.300.375.375.364.500;Severity of Illness Index;D012720
N06.850.520.308.250.475.364.500;Severity of Illness Index;D012720
D02.241.081.251.150;Carbaryl;D012721
D02.455.426.559.847.638.162;Carbaryl;D012721
D04.615.638.162;Carbaryl;D012721
D20.944.932.500;Sewage;D012722
G08.686.810;Sex;D012723
D23.641.800;Sex Attractants;D012724
F01.145.802;Sexual Behavior;D012725
F01.145.113.252.748;Sexual Behavior, Animal;D012726
G08.686.815;Sex Characteristics;D012727
A11.284.187.865.800;Sex Chromatin;D012728
A11.284.430.106.279.345.190.160.180.383.800;Sex Chromatin;D012728
G05.360.160.180.383.800;Sex Chromatin;D012728
G05.360.162.865.800;Sex Chromatin;D012728
C23.550.210.815;Sex Chromosome Aberrations;D012729
G05.365.590.175.815;Sex Chromosome Aberrations;D012729
A11.284.187.865;Sex Chromosomes;D012730
G05.360.162.865;Sex Chromosomes;D012730
F02.784.176.700;Sex Counseling;D012731
F04.096.837.249;Sex Counseling;D012731
F04.408.413.700;Sex Counseling;D012731
N02.421.143.303.700;Sex Counseling;D012731
N02.421.461.363.700;Sex Counseling;D012731
E01.370.225.996;Sex Determination Analysis;D012732
E01.370.701;Sex Determination Analysis;D012732
E05.200.996;Sex Determination Analysis;D012732
E05.393.285.830;Sex Determination Analysis;D012732
G07.700.320.500.325.377.843;Sex Differentiation;D012733
G07.700.320.750.500;Sex Differentiation;D012733
G08.686.785.880.500;Sex Differentiation;D012733
C12.706.316;Disorders of Sex Development;D012734
C13.351.875.253;Disorders of Sex Development;D012734
C16.131.939.316;Disorders of Sex Development;D012734
C19.391.119;Disorders of Sex Development;D012734
F03.800.399;Disorders of Sex Development;D012734
C12.294.644;Sexual Dysfunction, Physiological;D012735
C13.351.500.665;Sexual Dysfunction, Physiological;D012735
F04.096.837.500;Sex Education;D012736
I02.233.332.749;Sex Education;D012736
N05.715.350.675;Sex Factors;D012737
N06.850.490.875;Sex Factors;D012737
D12.776.124.790.223.800;Sex Hormone-Binding Globulin;D012738
D12.776.157.762;Sex Hormone-Binding Globulin;D012738
D12.776.377.715.182.800;Sex Hormone-Binding Globulin;D012738
D06.472.334.851;Gonadal Steroid Hormones;D012739
L01.178.682.192.609.666;Sex Manuals;D012740
L01.178.820.500.666;Sex Manuals;D012740
G07.700.320.750.750;Sexual Maturation;D012741
G08.686.785.880.750;Sexual Maturation;D012741
I01.198.240.748;Sex Offenses;D012742
E05.393.420.890;Sex Preselection;D012743
G05.815;Sex Ratio;D012744
I01.240.800.815;Sex Ratio;D012744
N01.224.803.815;Sex Ratio;D012744
N06.850.505.400.850.815;Sex Ratio;D012744
F01.145.802.900;Sexual Abstinence;D012746
M01.778;Sexual Partners;D012747
C01.539.778;Sexually Transmitted Diseases;D012749
C02.800;Sexually Transmitted Diseases;D012749
C12.294.668;Sexually Transmitted Diseases;D012749
C13.351.500.711;Sexually Transmitted Diseases;D012749
Z01.639.520.750;Seychelles;D012750
C04.557.386.480.750.800.775;Sezary Syndrome;D012751
C15.604.515.569.480.750.800.775;Sezary Syndrome;D012751
C15.604.515.841;Sezary Syndrome;D012751
C20.683.515.761.480.750.800.775;Sezary Syndrome;D012751
C20.683.515.920;Sezary Syndrome;D012751
F01.470.483.666;Shame;D012752
F03.700.750.700;Shared Paranoid Disorder;D012753
B01.050.150.900.493.370.853;Sharks;D012754
B01.050.150.900.649.077.380.791;Sheep;D012756
C22.836;Sheep Diseases;D012757
J02.500.600.875.700;Shellfish;D012758
N02.278.808.860;Sheltered Workshops;D012759
B03.440.450.425.850;Shigella;D012760
B03.660.250.150.730;Shigella;D012760
B03.440.450.425.850.175;Shigella boydii;D012761
B03.660.250.150.730.050;Shigella boydii;D012761
B03.440.450.425.850.350;Shigella dysenteriae;D012762
B03.660.250.150.730.125;Shigella dysenteriae;D012762
B03.440.450.425.850.450;Shigella flexneri;D012763
B03.660.250.150.730.210;Shigella flexneri;D012763
B03.440.450.425.850.800;Shigella sonnei;D012764
B03.660.250.150.730.710;Shigella sonnei;D012764
D02.241.223.268.792;Shikimic Acid;D012765
D02.241.511.852;Shikimic Acid;D012765
D02.455.426.392.368.367.379.750;Shikimic Acid;D012765
C01.252.400.700.675;Pasteurellosis, Pneumonic;D012766
C02.782.580.600.600.648;Pasteurellosis, Pneumonic;D012766
C08.730.085.600;Pasteurellosis, Pneumonic;D012766
C22.196.090.600;Pasteurellosis, Pneumonic;D012766
J01.937.817;Ships;D012767
G07.110.232.778.500;Shivering;D012768
G07.700.100.778.500;Shivering;D012768
C23.550.835;Shock;D012769
C14.280.647.500.750;Shock, Cardiogenic;D012770
C14.907.585.500.750;Shock, Cardiogenic;D012770
C23.550.835.550;Shock, Cardiogenic;D012770
C23.550.414.980;Shock, Hemorrhagic;D012771
C23.550.835.650;Shock, Hemorrhagic;D012771
C01.539.757.800;Shock, Septic;D012772
C23.550.470.790.500.800;Shock, Septic;D012772
C23.550.835.900.712;Shock, Septic;D012772
C23.550.767.879;Shock, Surgical;D012773
C23.550.835.775;Shock, Surgical;D012773
C23.550.835.888;Shock, Traumatic;D012774
C26.797;Shock, Traumatic;D012774
J01.637.215.800;Shoes;D012775
B04.280.650.160.500.250;Fibroma Virus, Rabbit;D012776
B04.909.204.210.600.250;Fibroma Virus, Rabbit;D012776
B04.909.204.783.160.500.250;Fibroma Virus, Rabbit;D012776
B04.909.574.204.600.250;Fibroma Virus, Rabbit;D012776
B04.280.535.500.150;Cottontail rabbit papillomavirus;D012777
B04.909.204.210.655.500.150;Cottontail rabbit papillomavirus;D012777
B04.909.574.204.655.500.150;Cottontail rabbit papillomavirus;D012777
B04.909.624.500.150;Cottontail rabbit papillomavirus;D012777
C06.405.469.637.832;Short Bowel Syndrome;D012778
C23.550.767.882;Short Bowel Syndrome;D012778
C05.116.099.708.857;Short Rib-Polydactyly Syndrome;D012779
C05.660.585.600.750;Short Rib-Polydactyly Syndrome;D012779
C16.131.077.850;Short Rib-Polydactyly Syndrome;D012779
C16.131.621.585.600.750;Short Rib-Polydactyly Syndrome;D012779
E02.565.280.853;Short-Wave Therapy;D012780
E02.779.496.280.853;Short-Wave Therapy;D012780
L01.143.506.423.906.539.750;Shorthand;D012781
A01.378.800.750;Shoulder;D012782
C26.088.666;Shoulder Dislocation;D012783
C26.289.750;Shoulder Dislocation;D012783
C26.088.749;Shoulder Fractures;D012784
C26.404.625;Shoulder Fractures;D012784
A02.835.583.748;Shoulder Joint;D012785
D13.570.800.810;Showdomycin;D012787
B01.050.150.900.649.473.751;Shrews;D012788
C14.907.454.810;Shwartzman Phenomenon;D012790
C14.907.940.890;Shwartzman Phenomenon;D012790
C15.378.463.515.810;Shwartzman Phenomenon;D012790
C10.177.575.550.750;Shy-Drager Syndrome;D012791
C10.228.140.079.612.700;Shy-Drager Syndrome;D012791
C10.228.662.550.700;Shy-Drager Syndrome;D012791
C10.574.625.700;Shy-Drager Syndrome;D012791
C10.574.875;Shy-Drager Syndrome;D012791
C14.907.514.741;Shy-Drager Syndrome;D012791
F01.145.813.617;Shyness;D012792
C07.465.815.793;Sialadenitis;D012793
D02.241.081.844.562.668;Sialic Acids;D012794
D02.241.511.902.562.668;Sialic Acids;D012794
D09.067.687.668;Sialic Acids;D012794
D09.811.589.668;Sialic Acids;D012794
D12.644.233.800;Sialoglycoproteins;D012795
D12.776.395.700;Sialoglycoproteins;D012795
E01.370.350.700.720.793;Sialography;D012796
E01.370.372.700;Sialography;D012796
E06.342.764.793;Sialography;D012796
C07.465.815.802;Sialometaplasia, Necrotizing;D012797
C07.465.815.815;Sialorrhea;D012798
D08.811.913.400.800;Sialyltransferases;D012799
Z01.542.248.775.800;Siberia;D012800
Z01.586.200.775.800;Siberia;D012800
Z01.586.950.775.800;Siberia;D012800
F01.829.263.370.450;Sibling Relations;D012801
Z01.542.489.751;Sicily;D012802
Z01.542.580.500.751;Sicily;D012802
Z01.639.640.751;Sicily;D012802
F01.829.316.616.751;Sick Role;D012803
C14.280.067.093.249;Sick Sinus Syndrome;D012804
C14.280.067.558.536;Sick Sinus Syndrome;D012804
C23.550.073.093.249;Sick Sinus Syndrome;D012804
C23.550.073.425.440;Sick Sinus Syndrome;D012804
C15.378.071.141.150.150.670;Sickle Cell Trait;D012805
C15.378.420.155.668;Sickle Cell Trait;D012805
C16.320.070.150.670;Sickle Cell Trait;D012805
C16.320.365.155.668;Sickle Cell Trait;D012805
C08.381.483.581.750;Siderosis;D012806
C08.381.520.702.750;Siderosis;D012806
C24.800.773;Siderosis;D012806
Z01.058.290.190.725;Sierra Leone;D012807
D12.776.930.800;Sigma Factor;D012808
A03.556.124.526.356.668;Colon, Sigmoid;D012809
A03.556.249.249.356.668;Colon, Sigmoid;D012809
C06.405.469.158.850;Sigmoid Diseases;D012810
C04.588.274.476.411.307.180.800;Sigmoid Neoplasms;D012811
C06.301.371.411.307.180.800;Sigmoid Neoplasms;D012811
C06.405.249.411.307.180.800;Sigmoid Neoplasms;D012811
C06.405.469.158.356.180.800;Sigmoid Neoplasms;D012811
C06.405.469.158.850.850;Sigmoid Neoplasms;D012811
C06.405.469.491.307.180.800;Sigmoid Neoplasms;D012811
E01.370.372.250.250.200.700;Sigmoidoscopy;D012812
E01.370.388.250.250.250.160.800;Sigmoidoscopy;D012812
E04.210.240.250.160.800;Sigmoidoscopy;D012812
E04.800.250.250.250.160.800;Sigmoidoscopy;D012812
E02.831.671.609.668;Sign Language;D012813
F01.145.209.530.702.668;Sign Language;D012813
L01.143.649.526.668;Sign Language;D012813
L01.224.800;Signal Processing, Computer-Assisted;D012815
C23.888;Signs and Symptoms;D012816
C23.888.821;Signs and Symptoms, Digestive;D012817
C23.888.852;Signs and Symptoms, Respiratory;D012818
Z01.252.245.393.750;Sikkim;D012819
J02.500.300.100.800;Silage;D012820
D01.837.700;Silanes;D012821
D02.715.625;Silanes;D012821
D01.578.750;Silicon Dioxide;D012822
D01.650.550.825;Silicon Dioxide;D012822
D01.837.725;Silicon Dioxide;D012822
D25.339.291.800;Silicate Cement;D012823
J01.637.051.339.291.800;Silicate Cement;D012823
D01.029.260.863;Silicic Acid;D012824
D01.837.725.700;Silicic Acid;D012824
D01.268.513.937;Silicon;D012825
D05.750.900.850.900;Silicone Elastomers;D012826
D25.720.327.900;Silicone Elastomers;D012826
D25.720.900.850.900;Silicone Elastomers;D012826
J01.637.051.720.327.900;Silicone Elastomers;D012826
J01.637.051.720.900.850.900;Silicone Elastomers;D012826
J01.637.412.900;Silicone Elastomers;D012826
D02.715.650.700.800;Silicone Oils;D012827
D05.750.900.850.950;Silicone Oils;D012827
D25.720.900.850.950;Silicone Oils;D012827
J01.637.051.720.900.850.950;Silicone Oils;D012827
D02.715.650.700;Silicones;D012828
D05.750.900.850;Silicones;D012828
D25.720.900.850;Silicones;D012828
J01.637.051.720.900.850;Silicones;D012828
C08.381.483.581.760;Silicosis;D012829
C08.381.520.702.760;Silicosis;D012829
C24.800.834;Silicosis;D012829
C01.252.410.040.552.846.899.669;Silicotuberculosis;D012830
C08.381.483.581.760.750;Silicotuberculosis;D012830
C08.381.520.702.760.750;Silicotuberculosis;D012830
C08.381.922.669;Silicotuberculosis;D012830
C08.730.939.669;Silicotuberculosis;D012830
C24.800.834.752;Silicotuberculosis;D012830
B01.050.500.131.617.561.650.100;Bombyx;D012831
C08.381.483.125.682;Silo Filler's Disease;D012832
C24.080.752;Silo Filler's Disease;D012832
D01.837.800;Siloxanes;D012833
D02.715.650;Siloxanes;D012833
D05.750.900;Siloxanes;D012833
D25.720.900;Siloxanes;D012833
J01.637.051.720.900;Siloxanes;D012833
D01.268.556.812;Silver;D012834
D01.268.956.843;Silver;D012834
D01.552.544.812;Silver;D012834
D01.625.525.550.850;Silver Nitrate;D012835
D01.847.900;Silver Nitrate;D012835
D12.776.884;Silver Proteins;D012836
D02.065.884.725.755.800;Silver Sulfadiazine;D012837
D02.092.146.807.755.800;Silver Sulfadiazine;D012837
D02.886.590.700.725.755.800;Silver Sulfadiazine;D012837
D03.438.150.266.450.268.777;Silymarin;D012838
D03.830.219.266.450.268.777;Silymarin;D012838
D03.383.931.819;Simazine;D012839
B04.820.087.640.855;Simbu virus;D012840
B04.909.777.147.640.855;Simbu virus;D012840
D02.715.650.700.150.750;Simethicone;D012841
D05.750.900.850.150.750;Simethicone;D012841
D25.720.900.850.150.750;Simethicone;D012841
J01.637.051.720.900.850.150.750;Simethicone;D012841
B04.820.650.375.770;Sarcoma Virus, Woolly Monkey;D012842
B04.820.650.805.601;Sarcoma Virus, Woolly Monkey;D012842
B04.909.574.807.375.770;Sarcoma Virus, Woolly Monkey;D012842
B04.909.574.807.805.601;Sarcoma Virus, Woolly Monkey;D012842
B04.909.777.731.375.770;Sarcoma Virus, Woolly Monkey;D012842
B04.909.777.731.805.601;Sarcoma Virus, Woolly Monkey;D012842
B01.050.500.131.617.289.800;Simuliidae;D012843
D06.472.317.152.700;Sincalide;D012844
D12.644.120.700;Sincalide;D012844
B04.820.850.054.860;Sindbis Virus;D012845
B04.909.777.923.054.860;Sindbis Virus;D012845
Z01.252.145.774;Singapore;D012846
F01.829.263.315.500.725;Single Person;D012847
I01.240.361.500.725;Single Person;D012847
I01.880.225.423.500.725;Single Person;D012847
M01.785;Single Person;D012847
N01.224.361.500.725;Single Person;D012847
N01.824.308.500.725;Single Person;D012847
C14.280.067.558.750;Sinoatrial Block;D012848
C23.550.073.425.780;Sinoatrial Block;D012848
A07.541.409.819;Sinoatrial Node;D012849
A07.231.114.056.847;Sinus of Valsalva;D012850
C10.228.140.300.525.425.500;Sinus Thrombosis, Intracranial;D012851
C14.907.253.566.350.500;Sinus Thrombosis, Intracranial;D012851
C14.907.355.590.213.350.500;Sinus Thrombosis, Intracranial;D012851
C14.907.355.830.850.213.350.500;Sinus Thrombosis, Intracranial;D012851
C08.460.692.752;Sinusitis;D012852
C08.730.749;Sinusitis;D012852
C09.603.692.752;Sinusitis;D012852
D09.408.051.374.785;Sisomicin;D012853
G05.355.760.615.750;Sister Chromatid Exchange;D012854
D04.808.247.222.857;Sitosterols;D012855
D04.808.247.808.756.669;Sitosterols;D012855
D02.455.426.559.389.150.700.050;4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid;D012856
D02.500.375.050;4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid;D012856
D02.886.250.050;4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid;D012856
C16.131.810;Situs Inversus;D012857
F02.463.593.725;Size Perception;D012858
F02.463.593.932.869.794;Size Perception;D012858
C05.550.114.154.774;Sjogren's Syndrome;D012859
C05.799.114.774;Sjogren's Syndrome;D012859
C07.465.815.929.669;Sjogren's Syndrome;D012859
C11.496.260.719;Sjogren's Syndrome;D012859
C17.300.775.099.774;Sjogren's Syndrome;D012859
C20.111.199.774;Sjogren's Syndrome;D012859
B01.050.150.900.493.370.870;Skates (Fish);D012860
B01.050.150.900.493.378.682;Skates (Fish);D012860
I03.450.642.845.700;Skating;D012861
D03.438.473.808;Skatole;D012862
A02.835;Skeleton;D012863
I03.450.642.845.787.500;Skiing;D012865
N02.278.825.610.770;Skilled Nursing Facilities;D012866
A17.815;Skin;D012867
C16.131.831;Skin Abnormalities;D012868
C17.800.804;Skin Abnormalities;D012868
G03.495.023.750;Skin Absorption;D012869
G13.750.829.820;Skin Absorption;D012869
C17.800;Skin Diseases;D012871
C17.800.865;Skin Diseases, Vesiculobullous;D012872
C16.320.850;Skin Diseases, Genetic;D012873
C17.800.827;Skin Diseases, Genetic;D012873
C01.539.800;Skin Diseases, Infectious;D012874
C17.800.838;Skin Diseases, Infectious;D012874
C17.800.849;Skin Diseases, Metabolic;D012875
C18.452.880;Skin Diseases, Metabolic;D012875
C03.858;Skin Diseases, Parasitic;D012876
C17.800.838.775;Skin Diseases, Parasitic;D012876
C23.888.885;Skin Manifestations;D012877
C04.588.805;Skin Neoplasms;D012878
C17.800.882;Skin Neoplasms;D012878
G13.750;Skin Physiological Phenomena;D012879
E01.370.600.620.750;Skin Pigmentation;D012880
G13.750.829.833;Skin Pigmentation;D012880
G16.690.890;Skin Pigmentation;D012880
G07.110.753;Skin Temperature;D012881
G13.750.844;Skin Temperature;D012881
E01.370.225.812.871;Skin Tests;D012882
E05.200.812.871;Skin Tests;D012882
E05.478.594.890;Skin Tests;D012882
C17.800.893;Skin Ulcer;D012883
E01.370.225.500.335.875;Skin Window Technique;D012884
E01.370.225.812.125.875;Skin Window Technique;D012884
E01.370.225.812.871.705;Skin Window Technique;D012884
E05.200.500.335.875;Skin Window Technique;D012884
E05.200.812.125.875;Skin Window Technique;D012884
E05.200.812.871.705;Skin Window Technique;D012884
E05.242.335.875;Skin Window Technique;D012884
E05.478.594.122.875;Skin Window Technique;D012884
E05.478.594.890.705;Skin Window Technique;D012884
E01.370.600.115.100.803;Skinfold Thickness;D012885
E05.041.124.803;Skinfold Thickness;D012885
G07.100.100.803;Skinfold Thickness;D012885
A02.835.232.781;Skull;D012886
C10.900.300.918;Skull Fractures;D012887
C26.260.836;Skull Fractures;D012887
C26.404.750;Skull Fractures;D012887
C26.915.300.745;Skull Fractures;D012887
C04.588.149.721;Skull Neoplasms;D012888
C05.116.231.754;Skull Neoplasms;D012888
B01.050.150.900.649.147.500;Mephitidae;D012889
F02.830.855;Sleep;D012890
G11.561.600.815;Sleep;D012890
C08.618.085.852;Sleep Apnea Syndromes;D012891
C10.886.425.800.750;Sleep Apnea Syndromes;D012891
C10.886.425.175;Sleep Deprivation;D012892
C23.888.592.796.772;Sleep Deprivation;D012892
F02.830.855.671;Sleep Deprivation;D012892
F03.870.400.099;Sleep Deprivation;D012892
G11.561.600.815.587;Sleep Deprivation;D012892
C10.886;Sleep Disorders;D012893
C23.888.592.796;Sleep Disorders;D012893
F03.870;Sleep Disorders;D012893
F02.830.855.796;Sleep Stages;D012894
G11.561.600.815.754;Sleep Stages;D012894
F02.830.855.796.671;Sleep, REM;D012895
G11.561.600.815.754.671;Sleep, REM;D012895
B01.050.150.900.649.900.750;Sloths;D012896
C02.839;Slow Virus Diseases;D012897
D23.469.050;Autacoids;D012898
C02.256.743.826;Smallpox;D012899
D20.215.894.899.859;Smallpox Vaccine;D012900
B04.280.650.160.650.930;Variola virus;D012901
B04.909.204.783.160.650.930;Variola virus;D012901
A12.200.769;Smegma;D012902
F02.830.816.643;Smell;D012903
G11.561.600.810.643;Smell;D012903
F01.145.209.530.385.671;Smiling;D012904
D20.633.875;Smog;D012905
D20.633.937;Smoke;D012906
F01.145.466.753;Smoking;D012907
B01.050.500.644.400.750;Snails;D012908
C25.723.127.722;Snake Bites;D012909
D20.888.850;Snake Venoms;D012910
D23.946.833.850;Snake Venoms;D012910
B01.050.150.900.833.672;Snakes;D012911
C23.888.852.889;Sneezing;D012912
G09.772.770.820;Sneezing;D012912
C23.888.852.779.850;Snoring;D012913
G16.500.240.135.867;Snow;D012914
G16.500.275.063.725.480;Snow;D012914
G16.500.750.775.480;Snow;D012914
N06.230.300.100.725.480;Snow;D012914
D27.720.877.265.861;Soaps;D012915
J01.516.872;Soaps;D012915
I03.450.642.845.800;Soccer;D012916
F01.145.813.621;Social Adjustment;D012917
I01.880.683.755;Social Alienation;D012918
F01.145.813;Social Behavior;D012919
I01.880.735.784;Social Behavior Disorders;D012920
I01.880.526;Social Change;D012922
N01.824.737;Social Change;D012922
I01.880.552;Social Class;D012923
I01.880.840.755;Social Class;D012923
N01.824.782;Social Class;D012923
I01.880.578;Social Conditions;D012924
N01.824.827;Social Conditions;D012924
F01.145.813.625;Social Conformity;D012925
I01.880.604;Social Control, Formal;D012926
N03.706;Social Control, Formal;D012926
I01.880.630;Social Control, Informal;D012927
F01.145.813.628;Social Desirability;D012928
F01.145.813.630;Social Distance;D012929
F01.829.316.777;Social Distance;D012929
F01.145.813.650;Social Dominance;D012930
I01.880.656;Social Environment;D012931
F01.145.813.655;Social Facilitation;D012932
F01.145.813.708;Social Identification;D012933
F01.145.813.781;Social Isolation;D012934
I01.880.683;Social Isolation;D012934
I01.880.604.473.700;Social Justice;D012935
K01.316.756.750;Social Justice;D012935
K01.752.256.830.750;Social Justice;D012935
N03.706.437.700;Social Justice;D012935
H02.403.800;Social Medicine;D012936
I01.880.552.673;Social Mobility;D012937
I01.880.840.755.673;Social Mobility;D012937
N01.824.782.673;Social Mobility;D012937
F02.463.593.752;Social Perception;D012938
I01.880.709;Social Planning;D012939
I01.880.735;Social Problems;D012940
K01.316.630.595;Social Responsibility;D012941
K01.752.256.547.599;Social Responsibility;D012941
F04.096.879;Social Sciences;D012942
I01;Social Sciences;D012942
N03.219.521.346.506.849;Social Security;D012943
N03.219.521.576.823;Social Security;D012943
I01.880.656.600;Social Support;D012944
F01.829.873;Social Values;D012945
I01.880.787;Social Welfare;D012946
I01.880.792;Social Work;D012947
N02.421.849;Social Work;D012947
N02.278.354.422.730;Social Work Department, Hospital;D012948
N04.452.442.422.730;Social Work Department, Hospital;D012948
F04.408.823;Social Work, Psychiatric;D012949
I01.880.792.410;Social Work, Psychiatric;D012949
N02.421.461.798;Social Work, Psychiatric;D012949
N02.421.849.673;Social Work, Psychiatric;D012949
I01.696.798;Socialism;D012950
I01.880.813;Socialization;D012951
N03.540.828;Societies;D012952
N03.540.828.506;Societies, Dental;D012953
N03.540.828.540;Societies, Hospital;D012954
N03.540.828.589;Societies, Medical;D012955
N03.540.828.672;Societies, Nursing;D012956
N03.540.828.755;Societies, Pharmaceutical;D012957
N03.540.828.838;Societies, Scientific;D012958
I01.880.840;Socioeconomic Factors;D012959
N01.824;Socioeconomic Factors;D012959
F04.754.864;Socioenvironmental Therapy;D012960
F04.096.879.757;Sociology;D012961
I01.880;Sociology;D012961
F04.096.879.757.400;Sociology, Medical;D012962
H02.790;Sociology, Medical;D012962
I01.880.866;Sociometric Techniques;D012963
D01.268.549.750;Sodium;D012964
D01.552.528.850;Sodium;D012964
D01.210.450.150.875;Sodium Chloride;D012965
D01.857.650;Sodium Chloride;D012965
D01.625.400.100.875;Sodium Cyanide;D012966
D01.857.660;Sodium Cyanide;D012966
D02.033.415.220.720;Sodium Dodecyl Sulfate;D012967
D02.886.645.600.055.050.632;Sodium Dodecyl Sulfate;D012967
D10.289.220.720;Sodium Dodecyl Sulfate;D012967
D02.705.429.500.830;Etidronic Acid;D012968
D01.303.350.300.875;Sodium Fluoride;D012969
D01.857.725;Sodium Fluoride;D012969
D25.223.716;Sodium Fluoride;D012969
J01.637.051.223.716;Sodium Fluoride;D012969
D12.125.067.750.400.800;Sodium Glutamate;D012970
D12.125.119.450.400.800;Sodium Glutamate;D012970
D01.379.425;Gold Sodium Thiosulfate;D012971
D01.857.300;Gold Sodium Thiosulfate;D012971
D01.875.800.800.850.900.250;Gold Sodium Thiosulfate;D012971
D01.045.250.750;Sodium Hydroxide;D012972
D01.455.824;Sodium Hydroxide;D012972
D01.857.745;Sodium Hydroxide;D012972
D01.210.465.800;Sodium Hypochlorite;D012973
D01.650.550.400.800;Sodium Hypochlorite;D012973
D01.857.750;Sodium Hypochlorite;D012973
D01.475.410.800;Sodium Iodide;D012974
D01.857.760;Sodium Iodide;D012974
D01.496.807;Sodium Isotopes;D012975
D10.251.860;Sodium Morrhuate;D012976
D01.625.600.600.800;Sodium Nitrite;D012977
D01.857.775;Sodium Nitrite;D012977
D02.241.081.114.937.700;Sodium Oxybate;D012978
D02.241.511.400.410.700;Sodium Oxybate;D012978
D01.496.749.795;Sodium Radioisotopes;D012979
D01.496.807.800;Sodium Radioisotopes;D012979
D02.241.223.100.300.595.608.500;Sodium Salicylate;D012980
D02.241.511.390.595.608.500;Sodium Salicylate;D012980
D02.455.426.559.389.127.281.595.608.500;Sodium Salicylate;D012980
D02.455.426.559.389.657.410.595.608.500;Sodium Salicylate;D012980
D02.033.415.900;Sodium Tetradecyl Sulfate;D012981
D02.886.645.600.055.050.755;Sodium Tetradecyl Sulfate;D012981
D10.289.900;Sodium Tetradecyl Sulfate;D012981
D01.857.700;Sodium, Dietary;D012982
C04.588.839;Soft Tissue Neoplasms;D012983
L01.224.900;Software;D012984
L01.224.900.820;Software Design;D012985
L01.224.900.868;Software Validation;D012986
D20.721;Soil;D012987
G01.311.820;Soil;D012987
G16.500.275.815;Soil;D012987
N06.230.600;Soil;D012987
H01.158.273.540.274.555;Soil Microbiology;D012988
N06.850.425.300;Soil Microbiology;D012988
D27.888.284.756;Soil Pollutants;D012989
D20.693.756;Soil Pollutants, Radioactive;D012990
D27.888.284.756.674;Soil Pollutants, Radioactive;D012990
D03.132.760;Solanaceous Alkaloids;D012991
D03.132.760.769;Solanine;D012992
D04.808.247.515.500.500;Solanine;D012992
D04.808.247.808.874;Solanine;D012992
D09.408.782.674;Solanine;D012992
G01.750.897;Solar Energy;D012993
N06.230.132.644.500;Solar Energy;D012993
E06.912.190;Dental Soldering;D012994
G02.842.800;Solubility;D012995
D26.776;Solutions;D012996
D27.720.844;Solvents;D012997
Z01.058.290.120.730;Somalia;D012998
D02.705.429.750.750;Soman;D012999
F04.570;Psychiatric Somatic Therapies;D013000
F03.875;Somatoform Disorders;D013001
D12.644.276.937;Somatomedins;D013002
D12.776.124.862;Somatomedins;D013002
D12.776.467.937;Somatomedins;D013002
D23.529.937;Somatomedins;D013002
A08.186.211.730.885.287.500.670.675;Somatosensory Cortex;D013003
D06.472.699.327.700.875;Somatostatin;D013004
D06.472.699.587.780;Somatostatin;D013004
D12.644.400.400.700.875;Somatostatin;D013004
D12.644.548.365.700.875;Somatostatin;D013004
D12.644.548.586.780;Somatostatin;D013004
D12.776.641.650.405.700.875;Somatostatin;D013004
C04.557.465.625.650.240.695;Somatostatinoma;D013005
C04.557.470.200.025.370.695;Somatostatinoma;D013005
C04.588.274.761.500.500;Somatostatinoma;D013005
C04.588.322.475.500.500;Somatostatinoma;D013005
C06.301.761.500.500;Somatostatinoma;D013005
C06.689.667.500.500;Somatostatinoma;D013005
C19.344.421.500.500;Somatostatinoma;D013005
D06.472.699.631.525.425;Growth Hormone;D013006
D12.644.548.691.525.425;Growth Hormone;D013006
D06.472.699.327.740.860;Growth Hormone-Releasing Hormone;D013007
D12.644.400.400.740.860;Growth Hormone-Releasing Hormone;D013007
D12.644.548.365.740.860;Growth Hormone-Releasing Hormone;D013007
D12.776.641.650.405.740.860;Growth Hormone-Releasing Hormone;D013007
E01.370.600.115.800;Somatotypes;D013008
G07.100.800;Somatotypes;D013008
C10.886.659.635.700;Somnambulism;D013009
F03.870.664.635.700;Somnambulism;D013009
E05.848;Sonication;D013010
D10.251.355.840;Sorbic Acid;D013011
D02.033.800.813;Sorbitol;D013012
D09.853.813;Sorbitol;D013012
D09.546.359.862;Sorbose;D013013
D09.546.465.758;Sorbose;D013013
G02.111.087.219.830;SOS Response (Genetics);D013014
G02.149.115.219.830;SOS Response (Genetics);D013014
G05.355.195.830;SOS Response (Genetics);D013014
D02.033.100.291.805;Sotalol;D013015
D02.092.063.291.805;Sotalol;D013015
G01.750.770.776;Sound;D013016
F02.463.593.071.869;Sound Localization;D013017
E05.855;Sound Spectrography;D013018
Z01.058.290.175.735;South Africa;D013019
Z01.107.757;South America;D013020
Z01.338.600;South Australia;D013021
Z01.107.567.875.075.662;South Carolina;D013022
Z01.107.567.875.750.700;South Carolina;D013022
Z01.107.567.875.510.700;South Dakota;D013023
D10.212.302.380.800;Soybean Oil;D013024
D10.212.507.800;Soybean Oil;D013024
D10.627.700.880;Soybean Oil;D013024
D20.215.784.750.880;Soybean Oil;D013024
J02.500.375.400.750;Soybean Oil;D013024
B01.650.940.800.575.100.401.750;Soybeans;D013025
J02.500.300.100.900;Soybeans;D013025
J02.500.850.500.700;Soybeans;D013025
J01.937.285.850;Space Flight;D013026
E06.658.703.675;Space Maintenance;D013027
F02.463.593.778;Space Perception;D013028
F02.463.593.932.869;Space Perception;D013028
E05.318.740.250.700;Space-Time Clustering;D013029
N05.715.360.750.200.775;Space-Time Clustering;D013029
N06.850.520.830.250.700;Space-Time Clustering;D013029
Z01.542.846;Spain;D013030
C03.335.190.304.780;Sparganosis;D013031
B01.050.500.500.736.215.228.831;Sparganum;D013032
B01.050.500.500.736.215.800.810;Sparganum;D013032
D03.383.742.698.715;Sparsomycin;D013033
D03.132.786;Sparteine;D013034
D03.438.834.737.500;Sparteine;D013034
C10.597.613.750;Spasm;D013035
C23.888.592.608.750;Spasm;D013035
C10.228.140.490.375.760;Spasms, Infantile;D013036
F01.145.875;Spatial Behavior;D013037
I01.880.894;Spatial Behavior;D013037
H02.811;Specialization;D013038
H02.163.876;Specialties, Dental;D013039
H02.478.676;Specialties, Nursing;D013041
H02.403.810;Specialties, Surgical;D013043
N03.706.110.120.580;Specialty Boards;D013044
N05.700.200.190.750;Specialty Boards;D013044
G16.824;Species Specificity;D013045
G02.842.810;Specific Gravity;D013046
G06.320.676;Specific Pathogen-Free Organisms;D013047
E01.370.225.998;Specimen Handling;D013048
E05.200.998;Specimen Handling;D013048
D12.776.124.875;Spectrin;D013049
D12.776.220.980;Spectrin;D013049
D12.776.543.980;Spectrin;D013049
E05.196.712.516.600.676;Spectrometry, Fluorescence;D013050
E05.196.867.726;Spectrometry, Fluorescence;D013050
E05.196.867.776;Spectrometry, Gamma;D013051
E05.799.801;Spectrometry, Gamma;D013051
E05.196.867.800;Spectrometry, X-Ray Emission;D013052
E05.799.830;Spectrometry, X-Ray Emission;D013052
E05.196.712.726;Spectrophotometry;D013053
E05.196.867.826;Spectrophotometry;D013053
E05.196.712.726.551;Spectrophotometry, Atomic;D013054
E05.196.867.826.551;Spectrophotometry, Atomic;D013054
E05.196.712.726.676;Spectrophotometry, Infrared;D013055
E05.196.867.826.676;Spectrophotometry, Infrared;D013055
E05.196.712.726.802;Spectrophotometry, Ultraviolet;D013056
E05.196.867.826.802;Spectrophotometry, Ultraviolet;D013056
E05.196.867;Spectrum Analysis;D013057
E05.196.566;Mass Spectrometry;D013058
E05.196.822.860;Spectrum Analysis, Raman;D013059
E05.196.867.890;Spectrum Analysis, Raman;D013059
F01.145.209.908.677;Speech;D013060
G11.561.600.825;Speech;D013060
L01.143.506.423.676;Speech;D013060
G11.561.600.825.650;Speech Acoustics;D013061
G11.561.820;Speech Acoustics;D013061
E01.370.760.760;Speech Articulation Tests;D013062
E01.370.382.375.060.060.750;Speech Discrimination Tests;D013063
C10.597.606.150.500.800;Speech Disorders;D013064
C23.888.592.604.150.500.800;Speech Disorders;D013064
F01.145.209.908.677.610;Speech Intelligibility;D013065
G11.561.600.825.686;Speech Intelligibility;D013065
H02.010.750;Speech-Language Pathology;D013066
F02.463.593.071.875;Speech Perception;D013067
E01.370.760;Speech Production Measurement;D013068
E01.370.382.375.060.060.760;Speech Reception Threshold Test;D013069
E02.831.727.552;Speech Therapy;D013070
E02.831.727.541;Speech, Alaryngeal;D013071
E02.831.727.541.677;Speech, Esophageal;D013072
G12.425.143.100.700;Sperm Agglutination;D013073
N02.278.065.700;Sperm Banks;D013074
G08.686.785.760.277.760;Sperm Capacitation;D013075
E01.370.225.500.195.870;Sperm Count;D013076
E01.370.225.992.624;Sperm Count;D013076
E05.200.500.195.870;Sperm Count;D013076
E05.200.992.624;Sperm Count;D013076
E05.242.195.870;Sperm Count;D013076
G04.170.870;Sperm Count;D013076
A05.360.490.890.820;Sperm Head;D013077
A11.497.760.400;Sperm Head;D013077
D27.505.696.138.379;Sperm Immobilizing Agents;D013078
D27.505.696.875.360.276.727;Sperm Immobilizing Agents;D013078
D27.505.954.705.360.276.727;Sperm Immobilizing Agents;D013078
D27.888.569.071.379;Sperm Immobilizing Agents;D013078
G04.299.151.650.624.700;Sperm Maturation;D013079
G08.686.785.760.310.760.700;Sperm Maturation;D013079
E01.370.225.992.812;Sperm Motility;D013081
E05.200.992.812;Sperm Motility;D013081
G04.299.283.750;Sperm Motility;D013081
A05.360.490.890.840;Sperm Tail;D013082
A11.284.180.290.835;Sperm Tail;D013082
A11.497.760.500;Sperm Tail;D013082
G04.299.283.800;Sperm Transport;D013083
G08.686.785.760.277.820;Sperm Transport;D013083
G08.686.785.760.277.800;Sperm-Ovum Interactions;D013084
A05.360.444.777;Spermatic Cord;D013085
C12.294.693;Spermatic Cord Torsion;D013086
A05.360.490.890.860;Spermatids;D013087
A11.497.760.600;Spermatids;D013087
C12.294.731;Spermatocele;D013088
C23.300.306.750;Spermatocele;D013088
D27.505.696.138.569;Spermatocidal Agents;D013089
D27.505.696.875.360.276.827;Spermatocidal Agents;D013089
D27.505.954.705.360.276.827;Spermatocidal Agents;D013089
D27.888.569.071.569;Spermatocidal Agents;D013089
A05.360.490.890.880;Spermatocytes;D013090
A11.497.760.700;Spermatocytes;D013090
G04.299.151.650.624;Spermatogenesis;D013091
G08.686.785.760.310.760;Spermatogenesis;D013091
D27.505.696.138.760;Spermatogenesis-Blocking Agents;D013092
D27.505.696.875.360.443.068.760;Spermatogenesis-Blocking Agents;D013092
D27.505.954.705.360.443.068.760;Spermatogenesis-Blocking Agents;D013092
D27.888.569.071.760;Spermatogenesis-Blocking Agents;D013092
A05.360.490.890.900;Spermatogonia;D013093
A11.497.760.800;Spermatogonia;D013093
A05.360.490.890;Spermatozoa;D013094
A11.497.760;Spermatozoa;D013094
D02.092.211.415.701.801;Spermidine;D013095
D02.092.782.677;Spermidine;D013095
D02.092.211.415.701.801.821;Spermine;D013096
D02.092.782.802;Spermine;D013096
D08.811.913.225.912;Spermine Synthase;D013097
B01.300.107.950;Xylariales;D013098
A02.835.232.781.802;Sphenoid Bone;D013100
A04.531.621.827;Sphenoid Sinus;D013101
A11.118.290.330.802;Spherocytes;D013102
A11.443.240.330.802;Spherocytes;D013102
A15.145.229.334.330.802;Spherocytes;D013102
C15.378.071.141.150.785;Spherocytosis, Hereditary;D013103
C16.320.070.785;Spherocytosis, Hereditary;D013103
A11.868;Spheroplasts;D013104
B03.110.761;Spheroplasts;D013104
B05.110.761;Spheroplasts;D013104
E04.210.120.860;Sphincterotomy, Transhepatic;D013105
C10.228.140.163.100.435.825;Sphingolipidoses;D013106
C16.320.565.189.435.825;Sphingolipidoses;D013106
C16.320.565.398.641.803;Sphingolipidoses;D013106
C16.320.565.595.554.825;Sphingolipidoses;D013106
C18.452.132.100.435.825;Sphingolipidoses;D013106
C18.452.584.687.803;Sphingolipidoses;D013106
C18.452.648.189.435.825;Sphingolipidoses;D013106
C18.452.648.398.641.803;Sphingolipidoses;D013106
C18.452.648.595.554.825;Sphingolipidoses;D013106
D10.570.877;Sphingolipids;D013107
D10.808;Sphingolipids;D013107
D08.811.277.352.640.750;Sphingomyelin Phosphodiesterase;D013108
D09.400.410.420.525.870;Sphingomyelins;D013109
D10.390.470.675.870;Sphingomyelins;D013109
D10.570.755.893;Sphingomyelins;D013109
D10.570.877.360.612.870;Sphingomyelins;D013109
D02.033.100.700;Sphingosine;D013110
D02.033.455.843;Sphingosine;D013110
D02.092.063.700;Sphingosine;D013110
D20.888.065.870;Spider Venoms;D013111
D23.946.833.065.870;Spider Venoms;D013111
B01.050.500.131.166.803;Spiders;D013112
D02.389.678;Spin Labels;D013113
A02.835.232.834.803;Spinal Canal;D013115
A08.186.854;Spinal Cord;D013116
C10.228.854.761;Spinal Cord Compression;D013117
C26.819.678;Spinal Cord Compression;D013117
C10.228.854;Spinal Cord Diseases;D013118
C10.228.854.770;Spinal Cord Injuries;D013119
C10.900.850;Spinal Cord Injuries;D013119
C26.819;Spinal Cord Injuries;D013119
C04.588.614.250.803;Spinal Cord Neoplasms;D013120
C10.228.854.765;Spinal Cord Neoplasms;D013120
C10.551.240.750;Spinal Cord Neoplasms;D013120
C05.116.900.800;Spinal Curvatures;D013121
C05.116.900;Spinal Diseases;D013122
E04.555.100.700;Spinal Fusion;D013123
C26.117.500;Spinal Injuries;D013124
C26.831;Spinal Injuries;D013124
C04.588.149.828;Spinal Neoplasms;D013125
C05.116.231.828;Spinal Neoplasms;D013125
C05.116.900.801;Spinal Neoplasms;D013125
A08.800.800.720.725;Spinal Nerve Roots;D013126
A08.800.800.720;Spinal Nerves;D013127
C05.116.900.815;Spinal Osteophytosis;D013128
E01.370.225.998.054.790;Spinal Puncture;D013129
E01.370.376.700;Spinal Puncture;D013129
E04.074.790;Spinal Puncture;D013129
E04.665.700;Spinal Puncture;D013129
E05.200.998.054.790;Spinal Puncture;D013129
E05.200.998.683;Spinal Puncture;D013129
C05.116.900.825;Spinal Stenosis;D013130
A02.835.232.834;Spine;D013131
C10.228.140.252.700;Spinocerebellar Degenerations;D013132
C10.228.854.787;Spinocerebellar Degenerations;D013132
C10.574.500.825;Spinocerebellar Degenerations;D013132
C16.320.400.780;Spinocerebellar Degenerations;D013132
A08.186.854.761;Spinothalamic Tracts;D013133
A08.612.220.735;Spinothalamic Tracts;D013133
D02.455.426.559.847.885.800;Spiperone;D013134
D02.522.352.800;Spiperone;D013134
D04.615.885.800;Spiperone;D013134
A08.340.390.800;Spiral Ganglion;D013136
A08.800.350.800;Spiral Ganglion;D013136
A08.800.800.120.910.120.800;Spiral Ganglion;D013136
A09.246.631.246.900;Spiral Ganglion;D013136
A09.246.631.246.930;Spiral Lamina;D013137
B03.440.840.750;Spirillum;D013139
B03.660.075.710.750;Spirillum;D013139
K01.844.799.679;Spiritualism;D013140
D02.455.426.559.847.885;Spiro Compounds;D013141
D04.615.885;Spiro Compounds;D013141
B03.440.425.410.711.679;Spirochaeta;D013142
B03.851.595.679;Spirochaeta;D013142
B03.440.425.410.711;Spirochaetaceae;D013143
B03.851.595;Spirochaetaceae;D013143
B03.851;Spirochaetales;D013144
C01.252.847;Spirochaetales Infections;D013145
B01.050.500.500.736.215.800;Spirometra;D013146
E01.370.386.700.750;Spirometry;D013147
D02.540.679;Spironolactone;D013148
D04.808.745.745.855;Spironolactone;D013148
B03.440.860.300.750.625;Spiroplasma;D013149
D04.808.247.515;Spirostans;D013150
B01.050.500.500.294.700.750.700.680;Spiruroidea;D013151
G09.330.190.163.881;Splanchnic Circulation;D013152
A08.800.050.050.800;Splanchnic Nerves;D013153
A08.800.050.800.800;Splanchnic Nerves;D013153
A08.800.800.060.800;Splanchnic Nerves;D013153
A10.549.700;Spleen;D013154
A15.382.520.604.700;Spleen;D013154
B04.820.650.375.525.850;Spleen Focus-Forming Viruses;D013155
B04.909.574.807.375.525.850;Spleen Focus-Forming Viruses;D013155
B04.909.777.731.375.525.850;Spleen Focus-Forming Viruses;D013155
E04.726;Splenectomy;D013156
A07.231.114.814;Splenic Artery;D013157
C15.604.744;Splenic Diseases;D013158
C14.907.795;Splenic Infarction;D013159
C15.604.744.617;Splenic Infarction;D013159
C04.588.842;Splenic Neoplasms;D013160
C15.604.744.680;Splenic Neoplasms;D013160
C15.604.744.742;Splenic Rupture;D013161
C26.017.680;Splenic Rupture;D013161
C26.761.555;Splenic Rupture;D013161
A07.231.908.670.730;Splenic Vein;D013162
C23.300.775.750;Splenomegaly;D013163
E04.035.760.835;Splenorenal Shunt, Surgical;D013164
E04.100.814.868.937.870;Splenorenal Shunt, Surgical;D013164
E07.858.442.660.845;Splints;D013165
E07.858.690.650.845;Splints;D013165
C01.539.160.762;Spondylitis;D013166
C05.116.165.762;Spondylitis;D013166
C05.116.900.853;Spondylitis;D013166
C05.116.900.853.625.800.850;Spondylitis, Ankylosing;D013167
C05.550.069.680;Spondylitis, Ankylosing;D013167
C05.550.114.865.800.850;Spondylitis, Ankylosing;D013167
C05.116.900.938.500.500;Spondylolisthesis;D013168
C05.116.900.938.500;Spondylolysis;D013169
A11.870;Spores;D013170
B05.775;Spores;D013170
A11.870.700;Spores, Bacterial;D013171
B05.775.700;Spores, Bacterial;D013171
A11.870.710;Spores, Fungal;D013172
A19.374.500;Spores, Fungal;D013172
B05.775.710;Spores, Fungal;D013172
D03.438.473.840;Sporidesmins;D013173
D23.946.587.800;Sporidesmins;D013173
C01.539.800.200.675;Sporotrichosis;D013174
C01.703.295.675;Sporotrichosis;D013174
C17.800.838.208.675;Sporotrichosis;D013174
B01.300.381.820;Sporothrix;D013175
I03.450.642.845;Sports;D013177
H02.403.830;Sports Medicine;D013178
I01.198.240.856.350.750;Spouse Abuse;D013179
I01.880.735.900.350.750;Spouse Abuse;D013179
C26.844;Sprains and Strains;D013180
G11.561.270.300;Cortical Spreading Depression;D013181
C06.405.469.637.850;Sprue, Tropical;D013182
C18.452.603.850;Sprue, Tropical;D013182
C23.996.820;Sprue, Tropical;D013182
A12.200.808;Sputum;D013183
D02.640.600.200;5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole;D013184
D03.383.129.462.580.200;5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole;D013184
D03.383.312.649.200;5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole;D013184
D02.455.326.271.665.806;Squalene;D013185
D02.455.849.919.681;Squalene;D013185
D08.811.913.225.431;Farnesyl-Diphosphate Farnesyltransferase;D013186
Z01.252.245.840;Sri Lanka;D013188
Z01.639.520.875;Sri Lanka;D013188
D10.251.355.255.100.450.855;SRS-A;D013189
D23.469.050.175.450.725;SRS-A;D013189
B04.265.700;SSPE Virus;D013190
B04.820.455.600.650.500.500.890;SSPE Virus;D013190
B04.909.777.455.600.650.500.500.890;SSPE Virus;D013190
B01.300.381.840;Stachybotrys;D013191
I02.574.700;Staff Development;D013192
N04.452.677.822;Staff Development;D013192
D01.490.800.900;Stainless Steel;D013193
D01.552.033.847.681;Stainless Steel;D013193
D25.058.807.681;Stainless Steel;D013193
J01.637.051.058.807.681;Stainless Steel;D013193
E01.370.225.500.620.670;Staining and Labeling;D013194
E01.370.225.750.600.670;Staining and Labeling;D013194
E05.200.500.620.670;Staining and Labeling;D013194
E05.200.750.600.670;Staining and Labeling;D013194
F04.711.141.493.225;Stanford-Binet Test;D013195
D04.808.054.040.248;Dihydrotestosterone;D013196
D06.472.334.851.968.964;Dihydrotestosterone;D013196
D04.808.054.040.881;Stanozolol;D013197
A02.633.567.950;Stapedius;D013198
A09.246.397.727;Stapedius;D013198
A09.246.397.247.806;Stapes;D013199
E04.580.450.731.681;Stapes Mobilization;D013200
E04.580.450.731;Stapes Surgery;D013201
C01.252.410.868.806;Staphylococcal Food Poisoning;D013202
C25.723.415.846;Staphylococcal Food Poisoning;D013202
C01.252.410.868;Staphylococcal Infections;D013203
B04.123.831;Staphylococcus Phages;D013204
D12.776.097.820;Staphylococcal Protein A;D013205
D23.050.161.821;Staphylococcal Protein A;D013205
C01.252.410.868.820.770;Staphylococcal Scalded Skin Syndrome;D013206
C01.252.825.770.770;Staphylococcal Scalded Skin Syndrome;D013206
C01.539.800.720.770.770;Staphylococcal Scalded Skin Syndrome;D013206
C17.800.838.765.770.770;Staphylococcal Scalded Skin Syndrome;D013206
C01.252.410.868.820;Staphylococcal Skin Infections;D013207
C01.252.825.770;Staphylococcal Skin Infections;D013207
C01.539.800.720.770;Staphylococcal Skin Infections;D013207
C17.800.838.765.770;Staphylococcal Skin Infections;D013207
D20.215.894.691.681;Staphylococcal Toxoid;D013208
D20.215.894.135.744;Staphylococcal Vaccines;D013209
B03.300.390.400.800.750;Staphylococcus;D013210
B03.510.100.750.750;Staphylococcus;D013210
B03.510.400.790.750;Staphylococcus;D013210
B03.300.390.400.800.750.100;Staphylococcus aureus;D013211
B03.510.100.750.750.100;Staphylococcus aureus;D013211
B03.510.400.790.750.100;Staphylococcus aureus;D013211
B03.300.390.400.800.750.343;Staphylococcus epidermidis;D013212
B03.510.100.750.750.343;Staphylococcus epidermidis;D013212
B03.510.400.790.750.343;Staphylococcus epidermidis;D013212
D05.750.078.562.855;Starch;D013213
D09.698.365.855;Starch;D013213
D08.811.913.400.450.460.750;Starch Synthase;D013214
B01.050.500.408.765;Starfish;D013215
E01.370.376.550.650.800;Startle Reaction;D013216
E01.370.600.550.650.800;Startle Reaction;D013216
F02.830.702.807;Startle Reaction;D013216
G11.561.600.765.869;Startle Reaction;D013216
C18.654.521.750;Starvation;D013217
N03.787;State Dentistry;D013218
I01.409.775;State Government;D013219
N03.540.348.875;State Government;D013219
N03.540.452.508;State Health Planning and Development Agencies;D013220
N03.349.650.480;State Health Plans;D013221
N03.349.550.902;State Medicine;D013222
N03.858;State Medicine;D013222
E05.318.740;Statistics as Topic;D013223
H01.548.832;Statistics as Topic;D013223
N05.715.360.750;Statistics as Topic;D013223
N06.850.520.830;Statistics as Topic;D013223
C08.127.108.880;Status Asthmaticus;D013224
C08.674.095.880;Status Asthmaticus;D013224
C20.543.480.680.095.880;Status Asthmaticus;D013224
C10.228.140.490.690;Status Epilepticus;D013226
D01.455.900.800;Steam;D013227
D01.650.550.925.800;Steam;D013227
G16.500.887;Steam;D013227
N06.230.650;Steam;D013227
D10.251.882.800;Stearates;D013228
D10.251.882;Stearic Acids;D013229
D08.811.682.690.708.392.625;Stearoyl-CoA Desaturase;D013230
C18.654.521.500.133.841.682;Steatitis;D013231
C22.880;Steatitis;D013231
D01.490.800;Steel;D013232
D01.552.033.847;Steel;D013232
D25.058.807;Steel;D013232
J01.637.051.058.807;Steel;D013232
A08.340.315.350.800;Stellate Ganglion;D013233
A08.800.050.300.300.800;Stellate Ganglion;D013233
A08.800.050.800.300.800;Stellate Ganglion;D013233
A11.872;Stem Cells;D013234
F02.463.593.373.765;Stereognosis;D013236
F02.463.593.894.500;Stereognosis;D013236
G02.607.500.682;Stereoisomerism;D013237
E04.525.800;Stereotaxic Techniques;D013238
E05.873;Stereotaxic Techniques;D013238
F01.145.896;Stereotyped Behavior;D013239
F01.145.813.854;Stereotyping;D013240
D03.494.953.852.777;Sterigmatocystin;D013241
D23.946.587.850;Sterigmatocystin;D013241
N06.850.780.200.450.850;Sterilization;D013242
E04.950.599.500;Sterilization Reversal;D013243
E04.950.599.450;Sterilization, Involuntary;D013244
E02.875.194.910;Sterilization, Reproductive;D013245
E04.950.599;Sterilization, Reproductive;D013245
E04.950.300.766;Sterilization, Tubal;D013246
E04.950.599.683;Sterilization, Tubal;D013246
A02.835.583.781;Sternoclavicular Joint;D013247
A02.835.583.790;Sternocostal Joints;D013248
A02.835.232.904.766;Sternum;D013249
D08.244.453.915;Steroid Hydroxylases;D013250
D08.811.682.690.708.170.915;Steroid Hydroxylases;D013250
D08.811.682.690.708.783;Steroid Hydroxylases;D013250
D12.776.422.220.453.915;Steroid Hydroxylases;D013250
D08.811.399.475.400.700;Steroid Isomerases;D013251
D08.244.453.915.750;Steroid 11-beta-Hydroxylase;D013252
D08.811.682.690.708.170.915.750;Steroid 11-beta-Hydroxylase;D013252
D08.811.682.690.708.783.750;Steroid 11-beta-Hydroxylase;D013252
D12.776.422.220.453.915.750;Steroid 11-beta-Hydroxylase;D013252
D08.244.453.915.730;Steroid 12-alpha-Hydroxylase;D013253
D08.811.682.690.708.170.915.730;Steroid 12-alpha-Hydroxylase;D013253
D08.811.682.690.708.783.730;Steroid 12-alpha-Hydroxylase;D013253
D12.776.422.220.453.915.730;Steroid 12-alpha-Hydroxylase;D013253
D08.244.453.915.748;Steroid 17-alpha-Hydroxylase;D013254
D08.811.682.690.708.170.915.748;Steroid 17-alpha-Hydroxylase;D013254
D08.811.682.690.708.783.745;Steroid 17-alpha-Hydroxylase;D013254
D12.776.422.220.453.915.748;Steroid 17-alpha-Hydroxylase;D013254
D08.244.453.915.760;Steroid 21-Hydroxylase;D013255
D08.811.682.690.708.170.915.760;Steroid 21-Hydroxylase;D013255
D08.811.682.690.708.783.760;Steroid 21-Hydroxylase;D013255
D12.776.422.220.453.915.760;Steroid 21-Hydroxylase;D013255
D04.808;Steroids;D013256
D04.808.875;Steroids, Brominated;D013257
D04.808.883;Steroids, Chlorinated;D013258
D04.808.908;Steroids, Fluorinated;D013259
D04.808.925;Steroids, Heterocyclic;D013260
D04.808.247.808;Sterols;D013261
D10.570.938;Sterols;D013261
D10.851;Sterols;D013261
C07.465.864.500;Stevens-Johnson Syndrome;D013262
C17.800.229.400.683;Stevens-Johnson Syndrome;D013262
C17.800.865.475.683;Stevens-Johnson Syndrome;D013262
A13.473.683;Stifle;D013264
D04.808.247.222.222.347.833;Stigmasterol;D013265
D04.808.247.808.756.808;Stigmasterol;D013265
D02.078.766;Stilbamidines;D013266
D02.455.426.559.389.150.700.550;Stilbamidines;D013266
D02.455.426.559.389.150.700;Stilbenes;D013267
G07.690.812.850;Stimulation, Chemical;D013268
G07.700.680.850;Stimulation, Chemical;D013268
E05.318.740.996;Stochastic Processes;D013269
G17.830;Stochastic Processes;D013269
N05.715.360.750.770;Stochastic Processes;D013269
N06.850.520.830.996;Stochastic Processes;D013269
A03.556.875.875;Stomach;D013270
C06.405.748.300;Gastric Dilatation;D013271
C06.405.748;Stomach Diseases;D013272
C23.300.415.687;Diverticulum, Stomach;D013273
C04.588.274.476.767;Stomach Neoplasms;D013274
C06.301.371.767;Stomach Neoplasms;D013274
C06.405.249.767;Stomach Neoplasms;D013274
C06.405.748.789;Stomach Neoplasms;D013274
C06.405.748.824;Stomach Rupture;D013275
C26.017.809;Stomach Rupture;D013275
C26.761.684;Stomach Rupture;D013275
C06.405.608.849;Stomach Ulcer;D013276
C06.405.748.586.849;Stomach Ulcer;D013276
C06.405.748.895;Stomach Volvulus;D013277
A13.853;Stomach, Avian;D013278
A13.869;Stomach, Ruminant;D013279
C07.465.864;Stomatitis;D013280
C07.465.864.750;Stomatitis, Aphthous;D013281
C07.465.864.875;Stomatitis, Denture;D013282
C02.256.466.382.834;Stomatitis, Herpetic;D013283
C07.465.864.937;Stomatitis, Herpetic;D013283
A14;Stomatognathic System;D013284
C10.292.562.887;Strabismus;D013285
C11.590.810;Strabismus;D013285
B01.650.940.800.575.100.905.188.800;Datura stramonium;D013286
D26.878;Street Drugs;D013287
B03.370.700;Streptobacillus;D013288
B03.440.450.700;Streptobacillus;D013288
B03.510.400.800;Streptococcaceae;D013289
B03.510.550.737;Streptococcaceae;D013289
C01.252.410.890;Streptococcal Infections;D013290
B03.510.400.800.872;Streptococcus;D013291
B03.510.550.737.872;Streptococcus;D013291
B03.510.400.800.872.100;Streptococcus agalactiae;D013292
B03.510.550.737.872.100;Streptococcus agalactiae;D013292
B03.510.550.250.250.280;Enterococcus faecalis;D013293
B03.510.400.800.500.400;Lactococcus lactis;D013294
B03.510.550.737.500.400;Lactococcus lactis;D013294
B03.510.400.800.872.875.520;Streptococcus mutans;D013295
B03.510.550.737.872.875.520;Streptococcus mutans;D013295
B03.510.400.800.872.550;Streptococcus pneumoniae;D013296
B03.510.550.737.872.550;Streptococcus pneumoniae;D013296
B03.510.400.800.872.575;Streptococcus pyogenes;D013297
B03.510.550.737.872.575;Streptococcus pyogenes;D013297
B03.510.400.800.872.875.700;Streptococcus sanguis;D013298
B03.510.550.737.872.875.700;Streptococcus sanguis;D013298
D08.811.277.352.335.350.250.900;Streptodornase and Streptokinase;D013299
D08.811.277.656.300.775.900;Streptodornase and Streptokinase;D013299
D12.776.124.125.662.537.900;Streptodornase and Streptokinase;D013299
D08.811.277.656.300.775;Streptokinase;D013300
D12.776.124.125.662.537;Streptokinase;D013300
D12.776.543.695.937;Streptolysins;D013301
D23.946.123.868;Streptolysins;D013301
D23.946.350.750;Streptolysins;D013301
B03.300.390.400.810.768;Streptomyces;D013302
B03.510.024.049.775.775;Streptomyces;D013302
B03.510.415.400.810.768;Streptomyces;D013302
B03.510.460.410.810.768;Streptomyces;D013302
B03.300.390.400.810.768.100;Streptomyces antibioticus;D013303
B03.510.024.049.775.775.100;Streptomyces antibioticus;D013303
B03.510.415.400.810.768.100;Streptomyces antibioticus;D013303
B03.510.460.410.810.768.100;Streptomyces antibioticus;D013303
B03.300.390.400.810.768.125;Streptomyces aureofaciens;D013304
B03.510.024.049.775.775.125;Streptomyces aureofaciens;D013304
B03.510.415.400.810.768.125;Streptomyces aureofaciens;D013304
B03.510.460.410.810.768.125;Streptomyces aureofaciens;D013304
B03.300.390.400.810.768.375;Streptomyces griseus;D013305
B03.510.024.049.775.775.375;Streptomyces griseus;D013305
B03.510.415.400.810.768.375;Streptomyces griseus;D013305
B03.510.460.410.810.768.375;Streptomyces griseus;D013305
B03.300.390.400.810;Streptomycetaceae;D013306
B03.510.024.049.775;Streptomycetaceae;D013306
B03.510.415.400.810;Streptomycetaceae;D013306
B03.510.460.410.810;Streptomycetaceae;D013306
D09.408.051.885;Streptomycin;D013307
D03.066.707.768;Streptonigrin;D013308
D03.383.725.705.768;Streptonigrin;D013308
D09.408.051.892;Streptothricins;D013309
D03.549.811.650.700;Streptovaricin;D013310
D04.345.295.750.650.700;Streptovaricin;D013310
D02.654.692.768;Streptozocin;D013311
D02.948.594.768;Streptozocin;D013311
D09.408.051.900;Streptozocin;D013311
G07.700.830;Stress, Physiological;D013312
F03.080.931.500;Stress Disorders, Post-Traumatic;D013313
G01.374.676.830;Stress, Mechanical;D013314
G01.595.540.830;Stress, Mechanical;D013314
F01.145.126.990;Stress, Psychological;D013315
F02.830.900;Stress, Psychological;D013315
A09.246.631.246.292.876;Stria Vascularis;D013316
N03.540.571.608;Strikes, Employee;D013317
N04.452.677.842;Strikes, Employee;D013317
E01.370.370.380.150.700;Stroke Volume;D013318
G09.330.380.124.882;Stroke Volume;D013318
C03.335.349.840;Strongyle Infections, Equine;D013319
C03.335.508.700.775.773;Strongyle Infections, Equine;D013319
C03.701.377.840;Strongyle Infections, Equine;D013319
C22.488.861;Strongyle Infections, Equine;D013319
C22.674.377.840;Strongyle Infections, Equine;D013319
B01.050.500.500.294.700.775.710;Strongyloidea;D013320
B01.050.500.500.294.700.700.640.680;Strongyloides;D013321
C03.335.508.700.700.799;Strongyloidiasis;D013322
B01.050.500.500.294.700.775.710.700;Strongylus;D013323
D01.268.552.850;Strontium;D013324
D01.268.556.825;Strontium;D013324
D01.552.539.861;Strontium;D013324
D01.552.544.825;Strontium;D013324
D01.496.840;Strontium Isotopes;D013325
D01.496.749.815;Strontium Radioisotopes;D013326
D01.496.840.685;Strontium Radioisotopes;D013326
D04.808.155.160.861.700;Strophanthidin;D013327
D04.808.155.160.861;Strophanthins;D013328
D04.808.155.580.130.750;Strophanthins;D013328
D09.408.180.810;Strophanthins;D013328
G02.111.830;Structure-Activity Relationship;D013329
G07.690.830;Structure-Activity Relationship;D013329
C04.557.465.910.850;Struma Ovarii;D013330
D03.132.436.681.722;Strychnine;D013331
D03.438.473.402.681.722;Strychnine;D013331
F02.784.629.796;Student Dropouts;D013332
I02.233.748.686;Student Dropouts;D013332
M01.848.602;Student Dropouts;D013332
N02.421.897;Student Health Services;D013333
I02.233.748;Students;D013334
I02.851;Students;D013334
M01.848;Students;D013334
I02.851.686.519;Students, Dental;D013335
M01.848.769.519;Students, Dental;D013335
I02.851.686;Students, Health Occupations;D013336
M01.848.769;Students, Health Occupations;D013336
I02.851.686.602;Students, Medical;D013337
M01.848.769.602;Students, Medical;D013337
I02.851.686.685;Students, Nursing;D013338
M01.848.769.685;Students, Nursing;D013338
I02.851.686.768;Students, Pharmacy;D013339
M01.848.769.768;Students, Pharmacy;D013339
I02.851.686.851;Students, Premedical;D013340
M01.848.769.851;Students, Premedical;D013340
C04.557.645.375.850;Sturge-Weber Syndrome;D013341
C10.562.800;Sturge-Weber Syndrome;D013341
C14.907.077.850;Sturge-Weber Syndrome;D013341
C10.597.606.150.500.800.750;Stuttering;D013342
C23.888.592.604.150.500.800.750;Stuttering;D013342
D02.455.426.559.389.150.750;Styrenes;D013343
C02.182.500.300.600;Subacute Sclerosing Panencephalitis;D013344
C02.290.700;Subacute Sclerosing Panencephalitis;D013344
C02.782.580.600.500.500.800;Subacute Sclerosing Panencephalitis;D013344
C02.839.862;Subacute Sclerosing Panencephalitis;D013344
C10.228.228.210.150.300.600;Subacute Sclerosing Panencephalitis;D013344
C10.228.228.245.340.700;Subacute Sclerosing Panencephalitis;D013344
C10.228.140.300.535.800;Subarachnoid Hemorrhage;D013345
C14.907.253.573.800;Subarachnoid Hemorrhage;D013345
C23.550.414.913.850;Subarachnoid Hemorrhage;D013345
A08.186.566.166.686;Subarachnoid Space;D013346
A11.284.835;Subcellular Fractions;D013347
A07.231.114.839;Subclavian Artery;D013348
C10.228.140.300.150.956.700;Subclavian Steal Syndrome;D013349
C14.907.253.092.956.700;Subclavian Steal Syndrome;D013349
C14.907.253.956.700;Subclavian Steal Syndrome;D013349
A07.231.908.877;Subclavian Vein;D013350
A08.713.810;Subcommissural Organ;D013351
C23.550.325.500;Subcutaneous Emphysema;D013352
C10.228.140.870;Subdural Effusion;D013353
C10.228.228.709.675;Subdural Effusion;D013353
C01.252.200.200;Empyema, Subdural;D013354
C01.395.750;Empyema, Subdural;D013354
C01.539.830.305.330;Empyema, Subdural;D013354
C10.228.228.180.350;Empyema, Subdural;D013354
C10.228.228.227;Empyema, Subdural;D013354
C10.228.228.709.300;Empyema, Subdural;D013354
A08.186.566.395.687;Subdural Space;D013355
A08.713.840;Subfornical Organ;D013356
E06.721.874;Subgingival Curettage;D013357
L01.453.245.945.700;Subject Headings;D013358
F01.393.898;Sublimation;D013359
F02.463.593.710.750;Subliminal Stimulation;D013360
A03.556.500.760.687;Sublingual Gland;D013361
A10.336.779.687;Sublingual Gland;D013361
A14.549.760.687;Sublingual Gland;D013361
C04.588.443.591.824.882;Sublingual Gland Neoplasms;D013362
C07.465.565.824.882;Sublingual Gland Neoplasms;D013362
C07.465.815.718.870;Sublingual Gland Neoplasms;D013362
A03.556.500.760.812;Submandibular Gland;D013363
A10.336.779.812;Submandibular Gland;D013363
A14.549.760.812;Submandibular Gland;D013363
C07.465.815.882;Submandibular Gland Diseases;D013364
C04.588.443.591.824.885;Submandibular Gland Neoplasms;D013365
C07.465.565.824.885;Submandibular Gland Neoplasms;D013365
C07.465.815.718.885;Submandibular Gland Neoplasms;D013365
C07.465.815.882.500;Submandibular Gland Neoplasms;D013365
H02.403.560.508;Submarine Medicine;D013366
A11.284.430.214.190.875.564.882;Submitochondrial Particles;D013367
A11.284.835.626.882;Submitochondrial Particles;D013367
A08.800.050.050.850;Submucous Plexus;D013368
A08.800.050.150.750;Submucous Plexus;D013368
A08.800.800.060.840;Submucous Plexus;D013368
C01.539.463.600.500;Subphrenic Abscess;D013369
C01.539.830.025.020.810;Subphrenic Abscess;D013369
C06.844.640.500;Subphrenic Abscess;D013369
E05.337.550.200.900.830;Subrenal Capsule Assay;D013370
E05.624.850.830;Subrenal Capsule Assay;D013370
D12.644.276.812.900.866;Substance P;D013373
D12.644.400.800.750;Substance P;D013373
D12.644.456.800.866;Substance P;D013373
D12.776.467.812.900.866;Substance P;D013373
D12.776.641.650.800.750;Substance P;D013373
D23.469.050.375.850.890;Substance P;D013373
D23.529.812.900.866;Substance P;D013373
C25.835;Substance Withdrawal Syndrome;D013375
F03.900.825;Substance Withdrawal Syndrome;D013375
A08.186.854.610.800;Substantia Gelatinosa;D013376
A08.663.650.675.800;Substantia Gelatinosa;D013376
A11.671.650.675.800;Substantia Gelatinosa;D013376
A08.186.211.464.820;Substantia Innominata;D013377
A08.186.211.730.885.287.249.880;Substantia Innominata;D013377
A08.186.211.132.659.822.731;Substantia Nigra;D013378
A08.186.211.653.822.731;Substantia Nigra;D013378
G02.111.835;Substrate Specificity;D013379
A02.835.583.378.831.780;Subtalar Joint;D013380
D08.811.277.656.300.760.787;Subtilisins;D013381
D08.811.277.656.959.350.787;Subtilisins;D013381
E01.370.350.760;Subtraction Technique;D013382
N01.600.775;Suburban Population;D013383
D05.500.562.750;Succinate Cytochrome c Oxidoreductase;D013384
D08.811.600.250.875;Succinate Cytochrome c Oxidoreductase;D013384
D08.811.682.830;Succinate Cytochrome c Oxidoreductase;D013384
D12.776.543.277.875;Succinate Cytochrome c Oxidoreductase;D013384
D05.500.562.750.249.500;Succinate Dehydrogenase;D013385
D08.811.600.250.500.750.500;Succinate Dehydrogenase;D013385
D08.811.600.250.875.249.500;Succinate Dehydrogenase;D013385
D08.811.682.660.385.500;Succinate Dehydrogenase;D013385
D08.811.682.660.750;Succinate Dehydrogenase;D013385
D08.811.682.830.249.500;Succinate Dehydrogenase;D013385
D12.776.157.427.374.375.909.500;Succinate Dehydrogenase;D013385
D12.776.331.199.750.500;Succinate Dehydrogenase;D013385
D12.776.543.277.500.750.500;Succinate Dehydrogenase;D013385
D12.776.543.277.875.249.500;Succinate Dehydrogenase;D013385
D12.776.556.579.374.375.141.500;Succinate Dehydrogenase;D013385
D02.241.081.337.759;Succinates;D013386
D02.113.700;Succinic Anhydrides;D013387
D02.241.081.337.759.750;Succinic Anhydrides;D013387
D02.478.770;Succinimides;D013388
D03.383.773.812.852;Succinimides;D013388
D08.811.464.267.500.600;Succinate-CoA Ligases;D013389
D02.092.877.883.333.780;Succinylcholine;D013390
D02.241.081.337.759.875;Succinylcholine;D013390
D02.675.276.232.780;Succinylcholine;D013390
F01.145.916;Sucking Behavior;D013391
D02.691.925;Sucralfate;D013392
D02.886.740.299;Sucralfate;D013392
D09.698.629.305.770.850;Sucralfate;D013392
D08.811.277.450.329.738;Sucrase;D013393
D05.500.562.875;Sucrase-Isomaltase Complex;D013394
D08.811.277.450.329.738.700;Sucrase-Isomaltase Complex;D013394
D08.811.277.450.770.800;Sucrase-Isomaltase Complex;D013394
D08.811.600.850;Sucrase-Isomaltase Complex;D013394
D09.698.629.305.770;Sucrose;D013395
E04.237.890;Suction;D013396
Z01.058.290.120.760;Sudan;D013397
C23.550.260.322.400;Sudden Infant Death;D013398
D02.241.081.844;Sugar Acids;D013400
D02.241.511.902;Sugar Acids;D013400
D09.811;Sugar Acids;D013400
D08.811.682.047.150.700;Sugar Alcohol Dehydrogenases;D013401
D02.033.800;Sugar Alcohols;D013402
D09.853;Sugar Alcohols;D013402
D09.894;Sugar Phosphates;D013403
E02.190.525.217.771;Suggestion;D013404
F04.754.424.771;Suggestion;D013404
F01.145.126.980.875;Suicide;D013405
I01.880.735.856;Suicide;D013405
F01.145.126.980.875.600;Suicide, Attempted;D013406
I01.880.735.856.600;Suicide, Attempted;D013406
D02.065.589.099.750.812;Sulbactam;D013407
D02.886.108.750.812;Sulbactam;D013407
D03.438.260.825.812;Sulbactam;D013407
D03.605.084.737.812;Sulbactam;D013407
D04.075.080.875.099.221.750.812;Sulbactam;D013407
D02.065.589.099.750.750.875;Sulbenicillin;D013408
D02.886.108.750.750.875;Sulbenicillin;D013408
D03.438.260.825.750.875;Sulbenicillin;D013408
D03.605.084.737.750.875;Sulbenicillin;D013408
D04.075.080.875.099.221.750.750.875;Sulbenicillin;D013408
D02.065.884.725.650;Sulfacetamide;D013409
D02.092.146.807.650;Sulfacetamide;D013409
D02.886.590.700.725.650;Sulfacetamide;D013409
D02.065.884.725.700;Sulfachlorpyridazine;D013410
D02.092.146.807.700;Sulfachlorpyridazine;D013410
D02.886.590.700.725.700;Sulfachlorpyridazine;D013410
D02.065.884.725.755;Sulfadiazine;D013411
D02.092.146.807.755;Sulfadiazine;D013411
D02.886.590.700.725.755;Sulfadiazine;D013411
D02.065.884.725.760;Sulfadimethoxine;D013412
D02.092.146.807.760;Sulfadimethoxine;D013412
D02.886.590.700.725.760;Sulfadimethoxine;D013412
D02.065.884.725.765;Sulfadoxine;D013413
D02.092.146.807.765;Sulfadoxine;D013413
D02.886.590.700.725.765;Sulfadoxine;D013413
D02.065.884.725.810;Sulfaguanidine;D013414
D02.078.370.853;Sulfaguanidine;D013414
D02.092.146.807.810;Sulfaguanidine;D013414
D02.886.590.700.725.810;Sulfaguanidine;D013414
D02.065.884.725.850;Sulfalene;D013415
D02.092.146.807.850;Sulfalene;D013415
D02.886.590.700.725.850;Sulfalene;D013415
D02.065.884.725.853;Sulfamerazine;D013416
D02.092.146.807.853;Sulfamerazine;D013416
D02.886.590.700.725.853;Sulfamerazine;D013416
D02.065.884.725.857;Sulfameter;D013417
D02.092.146.807.857;Sulfameter;D013417
D02.886.590.700.725.857;Sulfameter;D013417
D02.065.884.725.862;Sulfamethazine;D013418
D02.092.146.807.862;Sulfamethazine;D013418
D02.886.590.700.725.862;Sulfamethazine;D013418
D02.065.884.725.935.813;Sulfamethizole;D013419
D02.092.146.807.935.813;Sulfamethizole;D013419
D02.886.590.700.725.935.813;Sulfamethizole;D013419
D02.065.884.725.867;Sulfamethoxazole;D013420
D02.092.146.807.867;Sulfamethoxazole;D013420
D02.886.590.700.725.867;Sulfamethoxazole;D013420
D02.065.884.725.872;Sulfamethoxypyridazine;D013421
D02.092.146.807.872;Sulfamethoxypyridazine;D013421
D02.886.590.700.725.872;Sulfamethoxypyridazine;D013421
D02.065.884.725.877;Sulfamonomethoxine;D013422
D02.092.146.807.877;Sulfamonomethoxine;D013422
D02.886.590.700.725.877;Sulfamonomethoxine;D013422
D02.065.884.725.882;Sulfamoxole;D013423
D02.092.146.807.882;Sulfamoxole;D013423
D02.886.590.700.725.882;Sulfamoxole;D013423
D02.065.884.725;Sulfanilamides;D013424
D02.092.146.807;Sulfanilamides;D013424
D02.886.590.700.725;Sulfanilamides;D013424
D02.455.426.559.389.750;Sulfanilic Acids;D013425
D02.886.645.600.080.850;Sulfanilic Acids;D013425
D02.065.884.725.887;Sulfaphenazole;D013426
D02.092.146.807.887;Sulfaphenazole;D013426
D02.886.590.700.725.887;Sulfaphenazole;D013426
D03.383.129.539.925;Sulfaphenazole;D013426
D02.065.884.725.900;Sulfapyridine;D013427
D02.092.146.807.900;Sulfapyridine;D013427
D02.886.590.700.725.900;Sulfapyridine;D013427
D02.065.884.725.925;Sulfaquinoxaline;D013428
D02.092.146.807.925;Sulfaquinoxaline;D013428
D02.886.590.700.725.925;Sulfaquinoxaline;D013428
D08.811.277.352.827;Sulfatases;D013429
D08.811.913.696.445.800;Sulfate Adenylyltransferase;D013430
D01.248.497.158.845;Sulfates;D013431
D01.875.800.800.850;Sulfates;D013431
D02.065.884.725.935;Sulfathiazoles;D013432
D02.092.146.807.935;Sulfathiazoles;D013432
D02.886.590.700.725.935;Sulfathiazoles;D013432
D02.886.675.725;Sulfathiazoles;D013432
D03.383.129.708.725;Sulfathiazoles;D013432
D09.400.410.420.025.837;Sulfoglycosphingolipids;D013433
D10.390.470.025.837;Sulfoglycosphingolipids;D013433
D10.570.877.360.025.837;Sulfoglycosphingolipids;D013433
D02.886.645.575;Sulfenic Acids;D013434
D12.776.124.400.877;Sulfhemoglobin;D013435
D12.776.422.316.762.865;Sulfhemoglobin;D013435
C15.378.896;Sulfhemoglobinemia;D013436
D08.811.520.300;Carbon-Sulfur Lyases;D013437
D02.886.489;Sulfhydryl Compounds;D013438
D27.720.470.410.700;Sulfhydryl Reagents;D013439
D01.248.497.158.874;Sulfides;D013440
D01.875.350.850;Sulfides;D013440
D02.886.520;Sulfides;D013440
D01.029.260.877.700;Sulfinic Acids;D013441
D01.875.800.700;Sulfinic Acids;D013441
D02.886.645.585;Sulfinic Acids;D013441
D03.383.129.539.850.777.800;Sulfinpyrazone;D013442
D02.065.884.725.940;Sulfisomidine;D013443
D02.092.146.807.940;Sulfisomidine;D013443
D02.886.590.700.725.940;Sulfisomidine;D013443
D02.065.884.725.945;Sulfisoxazole;D013444
D02.092.146.807.945;Sulfisoxazole;D013444
D02.886.590.700.725.945;Sulfisoxazole;D013444
D01.248.497.158.904;Sulfites;D013447
D01.875.750;Sulfites;D013447
D02.455.426.559.389.657.625.617;Sulfobromophthalein;D013448
D02.065.884;Sulfonamides;D013449
D02.886.590.700;Sulfonamides;D013449
D02.886.590;Sulfones;D013450
D01.029.260.877.740;Sulfonic Acids;D013451
D01.875.800.740;Sulfonic Acids;D013451
D02.886.645.600;Sulfonic Acids;D013451
D02.675.800;Sulfonium Compounds;D013452
D02.886.620;Sulfonium Compounds;D013452
D02.886.590.795;Sulfonylurea Compounds;D013453
D02.948.828;Sulfonylurea Compounds;D013453
D02.886.640;Sulfoxides;D013454
D01.268.185.900;Sulfur;D013455
D01.029.260.877;Sulfur Acids;D013456
D01.875.800;Sulfur Acids;D013456
D02.886.645;Sulfur Acids;D013456
D01.875;Sulfur Compounds;D013457
D02.886;Sulfur Compounds;D013457
D01.362.810;Sulfur Dioxide;D013458
D01.650.550.850.925;Sulfur Dioxide;D013458
D01.875.825.925;Sulfur Dioxide;D013458
D01.303.350.300.900;Sulfur Hexafluoride;D013459
D01.362.820;Sulfur Hexafluoride;D013459
D01.875.812;Sulfur Hexafluoride;D013459
D01.496.868;Sulfur Isotopes;D013460
D01.650.550.850;Sulfur Oxides;D013461
D01.875.825;Sulfur Oxides;D013461
D01.496.749.858;Sulfur Radioisotopes;D013462
D01.496.868.690;Sulfur Radioisotopes;D013462
D02.886.645.655.850;Sulfuric Acid Esters;D013463
D01.029.260.877.800;Sulfuric Acids;D013464
D01.875.800.800;Sulfuric Acids;D013464
D02.886.645.655;Sulfuric Acids;D013464
D08.811.913.817.500;Sulfurtransferases;D013466
D02.455.426.559.847.486.875;Sulindac;D013467
D04.615.486.875;Sulindac;D013467
D02.033.100.624.890;Suloctidil;D013468
D02.033.755.624.890;Suloctidil;D013468
D02.092.063.624.890;Suloctidil;D013468
D02.092.471.683.934;Suloctidil;D013468
D02.065.277.866;Sulpiride;D013469
D02.241.223.100.100.866;Sulpiride;D013469
D02.455.426.559.389.127.085.866;Sulpiride;D013469
C17.800.600.725;Sunburn;D013471
C26.200.855;Sunburn;D013471
G01.358.500.505.650.836;Sunlight;D013472
G01.750.250.650.836;Sunlight;D013472
G01.750.770.578.836;Sunlight;D013472
G16.500.275.063.725.525;Sunlight;D013472
G16.500.750.775.525;Sunlight;D013472
N06.230.300.100.725.525;Sunlight;D013472
D27.505.696.706.776.800;Sunscreening Agents;D013473
D27.505.954.444.695;Sunscreening Agents;D013473
D27.720.269.800;Sunscreening Agents;D013473
D27.720.799.763.764;Sunscreening Agents;D013473
C26.522.500.500;Sunstroke;D013474
F01.752.747.859;Superego;D013475
F02.739.794.881;Superego;D013475
G08.686.710.608;Superfetation;D013476
G08.686.785.760.769.525.608;Superfetation;D013476
A08.186.211.132.659.727.816;Superior Colliculi;D013477
A08.186.211.653.727.500;Superior Colliculi;D013477
C06.405.469.275.395.890;Superior Mesenteric Artery Syndrome;D013478
C14.907.800;Superior Vena Cava Syndrome;D013479
E02.875.800.984.500;Superovulation;D013480
E05.820.800.984.500;Superovulation;D013480
G08.686.785.760.690.768;Superovulation;D013480
D01.248.497.158.685.750.850;Superoxides;D013481
D01.339.431.374.850;Superoxides;D013481
D01.339.431.750;Superoxides;D013481
D01.650.550.750.800;Superoxides;D013481
D08.811.682.881;Superoxide Dismutase;D013482
I01.076.201.450.897;Superstitions;D013483
G11.427.590.530.698.920;Supination;D013484
V04.124;Research Support, Non-U.S. Gov't;D013485
V04.750.249;Research Support, U.S. Gov't, Non-P.H.S.;D013486
V04.750.500;Research Support, U.S. Gov't, P.H.S.;D013487
D26.255.785;Suppositories;D013488
D27.720.280.785;Suppositories;D013488
G05.355.600.835;Suppression, Genetic;D013489
G05.365.590.835;Suppression, Genetic;D013489
D12.644.276.374.480.700;Suppressor Factors, Immunologic;D013491
D12.776.467.374.480.700;Suppressor Factors, Immunologic;D013491
D23.529.374.480.700;Suppressor Factors, Immunologic;D013491
C01.539.830;Suppuration;D013492
C23.550.470.756;Suppuration;D013492
A08.186.211.730.317.357.342.625;Suprachiasmatic Nucleus;D013493
C10.228.140.079.882;Supranuclear Palsy, Progressive;D013494
C10.228.662.700;Supranuclear Palsy, Progressive;D013494
C10.292.562.750.500;Supranuclear Palsy, Progressive;D013494
C10.574.945.500;Supranuclear Palsy, Progressive;D013494
C10.597.622.447.690;Supranuclear Palsy, Progressive;D013494
C11.590.472.500;Supranuclear Palsy, Progressive;D013494
C23.888.592.636.447.690;Supranuclear Palsy, Progressive;D013494
A08.186.211.730.317.357.342.650;Supraoptic Nucleus;D013495
D02.241.223.701.700;Suprofen;D013496
A08.800.800.720.450.760.820.820;Sural Nerve;D013497
D02.455.426.559.847.638.555.750;Suramin;D013498
D02.886.645.600.080.050.650.750;Suramin;D013498
D04.615.638.555.750;Suramin;D013498
G02.842.850;Surface Properties;D013499
G02.842.850.816;Surface Tension;D013500
D27.720.877;Surface-Active Agents;D013501
H02.403.810.300;General Surgery;D013502
N02.278.354.422.750;Surgery Department, Hospital;D013503
N04.452.442.422.750;Surgery Department, Hospital;D013503
E04.100;Cardiovascular Surgical Procedures;D013504
E04.210;Digestive System Surgical Procedures;D013505
E04.580.450;Otologic Surgical Procedures;D013506
E04.270;Endocrine Surgical Procedures;D013507
E04.540;Ophthalmologic Surgical Procedures;D013508
E04.950.300;Gynecologic Surgical Procedures;D013509
E04.928.600;Pulmonary Surgical Procedures;D013510
E04.806;Surgical Procedures, Minor;D013511
E04.520;Obstetric Surgical Procedures;D013513
E04;Surgical Procedures, Operative;D013514
E06.892;Surgery, Oral;D013515
H02.163.876.886;Surgery, Oral;D013515
E04.545.550;Oral Surgical Procedures, Preprosthetic;D013516
E06.645.550;Oral Surgical Procedures, Preprosthetic;D013516
E04.580;Otorhinolaryngologic Surgical Procedures;D013517
H02.403.810.788;Surgery, Plastic;D013518
E04.950;Urogenital Surgical Procedures;D013519
E04.950.774;Urologic Surgical Procedures;D013520
E04.950.774.860;Urologic Surgical Procedures, Male;D013521
H02.956.692;Surgery, Veterinary;D013522
E07.858;Surgical Equipment;D013523
A10.850.710;Surgical Flaps;D013524
E07.862.710;Surgical Flaps;D013524
E07.858.700;Surgical Instruments;D013525
E07.858.708;Surgical Mesh;D013526
E02.760.731.500;Perioperative Nursing;D013527
H02.478.676.650;Perioperative Nursing;D013527
N02.421.533.710;Perioperative Nursing;D013527
N02.421.585.722.500;Perioperative Nursing;D013527
E07.858.700.750;Surgical Staplers;D013528
C23.550.767.887;Surgical Wound Dehiscence;D013529
C01.539.947.692;Surgical Wound Infection;D013530
C23.550.767.925;Surgical Wound Infection;D013530
N02.278.035.652;Surgicenters;D013531
N02.278.421.556.868;Surgicenters;D013531
Z01.107.757.833;Suriname;D013532
F01.829.263.500.320.892;Surrogate Mothers;D013533
I01.880.225.500.340.892;Surrogate Mothers;D013533
M01.620.892;Surrogate Mothers;D013533
I03.784;Survival;D013534
D20.280.810;Suspensions;D013535
D26.255.165.810;Suspensions;D013535
D27.720.280.165.810;Suspensions;D013535
E04.987.775;Suture Techniques;D013536
E07.858.690.820;Sutures;D013537
Z01.542.808.618.650;Svalbard;D013538
Z01.639.835;Svalbard;D013538
B04.280.640.615.700;Simian virus 40;D013539
B04.909.204.210.620.615.700;Simian virus 40;D013539
B04.909.574.204.670.615.700;Simian virus 40;D013539
B04.909.675.615.700;Simian virus 40;D013539
C18.654.521.500.857;Swayback;D013540
C22.836.886;Swayback;D013540
Z01.058.290.175.795;Swaziland;D013541
A12.200.849;Sweat;D013542
C17.800.946;Sweat Gland Diseases;D013543
C04.588.805.776;Sweat Gland Neoplasms;D013544
C17.800.882.743;Sweat Gland Neoplasms;D013544
C17.800.946.743;Sweat Gland Neoplasms;D013544
A10.336.899;Sweat Glands;D013545
A17.815.830;Sweat Glands;D013545
G07.110.232.693;Sweating;D013546
G07.700.100.693;Sweating;D013546
G13.750.829.855;Sweating;D013546
C10.177.825;Sweating, Gustatory;D013547
C17.800.946.350.843;Sweating, Gustatory;D013547
Z01.542.808.843;Sweden;D013548
D27.720.364.609;Sweetening Agents;D013549
D27.720.888;Sweetening Agents;D013549
J02.500.512.400.700;Sweetening Agents;D013549
G11.427.590.530.568.800;Swimming;D013550
G11.427.590.530.698.277.875;Swimming;D013550
I03.450.642.845.869;Swimming;D013550
N06.850.860.410.500;Swimming Pools;D013551
B01.050.150.900.649.077.880;Swine;D013552
C22.905;Swine Diseases;D013553
C01.252.410.334.776;Swine Erysipelas;D013554
C22.331.693;Swine Erysipelas;D013554
C22.905.832;Swine Erysipelas;D013554
C02.782.687.359.855;Swine Vesicular Disease;D013555
C22.905.850;Swine Vesicular Disease;D013555
B01.050.150.900.649.077.880.399.800;Swine, Miniature;D013556
Z01.542.883;Switzerland;D013557
D03.383.129.462.580.693;Sydnones;D013558
G06.590.580.800;Symbiosis;D013559
G16.100.900;Symbiosis;D013559
K01.400.899;Symbolism;D013561
K01.752.798;Symbolism;D013561
E04.525.210.080.800;Sympathectomy;D013562
E04.525.210.080.800.800;Sympathectomy, Chemical;D013563
A08.800.050.800;Sympathetic Nervous System;D013564
D27.505.696.663.050.850;Sympatholytics;D013565
D27.505.696.663.050.870;Sympathomimetics;D013566
E04.910;Symphysiotomy;D013567
C23;Pathological Conditions, Signs and Symptoms;D013568
A08.850;Synapses;D013569
A11.284.149.165.420.780;Synapses;D013569
A08.850.800;Synaptic Membranes;D013570
A11.284.149.165.420.780.800;Synaptic Membranes;D013570
A11.284.149.844;Synaptic Membranes;D013570
A08.850.840;Synaptic Vesicles;D013572
A11.284.430.214.190.875.190.880.830;Synaptic Vesicles;D013572
A11.284.430.106.279.345.190.160.830;Synaptonemal Complex;D013573
G04.299.134.220.220.687.444.299.500;Synaptonemal Complex;D013573
G04.299.134.220.220.875.500.299.500;Synaptonemal Complex;D013573
G05.355.105.220.687.500.299.500;Synaptonemal Complex;D013573
G05.355.105.220.875.500.299.500;Synaptonemal Complex;D013573
G05.360.160.830;Synaptonemal Complex;D013573
A11.284.835.859;Synaptosomes;D013574
C10.597.606.358.800.600;Syncope;D013575
C23.888.592.604.359.800.600;Syncope;D013575
C05.116.099.370.894.819;Syndactyly;D013576
C05.660.585.800;Syndactyly;D013576
C05.660.906.819;Syndactyly;D013576
C16.131.621.585.800;Syndactyly;D013576
C16.131.621.906.819;Syndactyly;D013576
C23.550.288.500;Syndrome;D013577
D02.033.100.291.870;Synephrine;D013578
D02.092.063.291.870;Synephrine;D013578
D02.092.211.215.811.875;Synephrine;D013578
C05.116.099.370.894;Synostosis;D013580
C05.660.906;Synostosis;D013580
C16.131.621.906;Synostosis;D013580
C04.182.867;Synovial Cyst;D013581
A02.835.583.443.800.800;Synovial Fluid;D013582
A12.207.270.847;Synovial Fluid;D013582
A02.835.583.443.800;Synovial Membrane;D013583
C04.557.450.565.835;Sarcoma, Synovial;D013584
C04.557.450.795.875;Sarcoma, Synovial;D013584
C05.550.870;Synovitis;D013585
C05.550.870.890;Synovitis, Pigmented Villonodular;D013586
C01.252.400.840.744;Syphilis;D013587
C01.252.810.859;Syphilis;D013587
C01.252.847.840.744;Syphilis;D013587
C01.539.778.281.859;Syphilis;D013587
C12.294.668.281.859;Syphilis;D013587
C13.351.500.711.281.859;Syphilis;D013587
E01.370.225.812.735.850;Syphilis Serodiagnosis;D013588
E05.200.812.735.850;Syphilis Serodiagnosis;D013588
E05.478.594.760.850;Syphilis Serodiagnosis;D013588
C01.252.400.840.744.657;Syphilis, Cardiovascular;D013589
C01.252.847.840.744.657;Syphilis, Cardiovascular;D013589
C01.539.190.500;Syphilis, Cardiovascular;D013589
C14.260.500;Syphilis, Cardiovascular;D013589
C01.252.400.840.744.725;Syphilis, Congenital;D013590
C01.252.847.840.744.725;Syphilis, Congenital;D013590
C16.614.868;Syphilis, Congenital;D013590
C01.252.400.840.744.800;Syphilis, Cutaneous;D013591
C01.252.825.790;Syphilis, Cutaneous;D013591
C01.252.847.840.744.800;Syphilis, Cutaneous;D013591
C01.539.800.720.790;Syphilis, Cutaneous;D013591
C17.800.838.765.790;Syphilis, Cutaneous;D013591
C01.252.400.840.744.871;Syphilis, Latent;D013592
C01.252.847.840.744.871;Syphilis, Latent;D013592
Z01.252.245.500.795;Syria;D013593
Z01.586.500.795;Syria;D013593
E07.877;Syringes;D013594
C10.228.854.833;Syringomyelia;D013595
L01.906;Systems Analysis;D013597
H01.770.808;Systems Theory;D013598
G09.330.190.541.880;Systole;D013599
G11.427.590.540.570.880;Systole;D013599
A11.118.637.555.567.569;T-Lymphocytes;D013601
A15.145.229.637.555.567.569;T-Lymphocytes;D013601
A15.382.490.555.567.569;T-Lymphocytes;D013601
A11.118.637.555.283.875;T-Lymphocytes, Cytotoxic;D013602
A11.118.637.555.567.550.500.200;T-Lymphocytes, Cytotoxic;D013602
A11.118.637.555.567.569.220.200;T-Lymphocytes, Cytotoxic;D013602
A11.118.637.555.567.569.500.200;T-Lymphocytes, Cytotoxic;D013602
A15.145.229.637.555.283.875;T-Lymphocytes, Cytotoxic;D013602
A15.145.229.637.555.567.550.500.200;T-Lymphocytes, Cytotoxic;D013602
A15.145.229.637.555.567.569.220.200;T-Lymphocytes, Cytotoxic;D013602
A15.145.229.637.555.567.569.500.200;T-Lymphocytes, Cytotoxic;D013602
A15.382.490.555.283.875;T-Lymphocytes, Cytotoxic;D013602
A15.382.490.555.567.550.500.200;T-Lymphocytes, Cytotoxic;D013602
A15.382.490.555.567.569.220.200;T-Lymphocytes, Cytotoxic;D013602
A15.382.490.555.567.569.500.200;T-Lymphocytes, Cytotoxic;D013602
B04.123.205.891;T-Phages;D013604
D02.455.849.765.850.870;T-2 Toxin;D013605
D04.345.891.870;T-2 Toxin;D013605
D23.946.587.933.870;T-2 Toxin;D013605
C01.252.400.840.744.456.778;Tabes Dorsalis;D013606
C01.252.847.840.744.456.778;Tabes Dorsalis;D013606
C10.228.228.180.600.800;Tabes Dorsalis;D013606
C10.228.854.889;Tabes Dorsalis;D013606
D26.255.830;Tablets;D013607
D27.720.280.830;Tablets;D013607
D26.255.210.860;Tablets, Enteric-Coated;D013608
D26.255.830.860;Tablets, Enteric-Coated;D013608
D27.720.280.210.860;Tablets, Enteric-Coated;D013608
D27.720.280.830.860;Tablets, Enteric-Coated;D013608
I01.076.201.450.948;Taboo;D013609
C14.280.067.845;Tachycardia;D013610
C23.550.073.845;Tachycardia;D013610
C14.280.067.845.787.249;Tachycardia, Atrioventricular Nodal Reentry;D013611
C23.550.073.845.787.500;Tachycardia, Atrioventricular Nodal Reentry;D013611
C14.280.067.845.880.315;Tachycardia, Ectopic Atrial;D013612
C23.550.073.845.880.315;Tachycardia, Ectopic Atrial;D013612
C14.280.067.845.880.320;Tachycardia, Ectopic Junctional;D013613
C23.550.073.845.880.320;Tachycardia, Ectopic Junctional;D013613
C14.280.067.845.695;Tachycardia, Paroxysmal;D013614
C23.550.073.845.695;Tachycardia, Paroxysmal;D013614
C14.280.067.845.787.500;Tachycardia, Sinoatrial Nodal Reentry;D013615
C23.550.073.845.787.750;Tachycardia, Sinoatrial Nodal Reentry;D013615
C14.280.067.845.880.845;Tachycardia, Sinus;D013616
C23.550.073.845.880.845;Tachycardia, Sinus;D013616
C14.280.067.845.880;Tachycardia, Supraventricular;D013617
C23.550.073.845.880;Tachycardia, Supraventricular;D013617
G07.690.812.260.910;Tachyphylaxis;D013618
G07.700.680.260.910;Tachyphylaxis;D013618
G12.425.746.425.910;Tachyphylaxis;D013618
D03.494.046.250.900;Tacrine;D013619
Z01.252.100.900;Tajikistan;D013620
Z01.586.200.900;Tajikistan;D013620
Z01.586.950.900;Tajikistan;D013620
B01.050.500.500.736.215.895;Taenia;D013621
C03.335.190.902;Taeniasis;D013622
A13.895;Tail;D013623
Z01.252.474.872;Taiwan;D013624
Z01.639.850;Taiwan;D013624
C14.907.109.239.650;Takayasu Arteritis;D013625
C14.907.184.800;Takayasu Arteritis;D013625
C14.907.940.090.800;Takayasu Arteritis;D013625
C17.800.862.875;Takayasu Arteritis;D013625
D02.065.589.099.750.750.050.900;Talampicillin;D013626
D02.886.108.750.750.050.900;Talampicillin;D013626
D03.438.260.825.750.050.900;Talampicillin;D013626
D03.605.084.737.750.050.900;Talampicillin;D013626
D04.075.080.875.099.221.750.750.050.900;Talampicillin;D013626
D01.524.500.850;Talc;D013627
D01.578.725.500.800;Talc;D013627
D01.837.725.700.760.535.800;Talc;D013627
A02.835.232.043.300.710.780;Talus;D013628
D02.455.426.559.389.150.700.900;Tamoxifen;D013629
E07.858.826;Tampons, Surgical;D013630
C10.668.829.800.875;Tangier Disease;D013631
C16.320.565.398.500.330.750;Tangier Disease;D013631
C18.452.584.500.875.330.750;Tangier Disease;D013631
C18.452.648.398.500.330.750;Tangier Disease;D013631
J01.576.852;Tanning;D013633
D05.750.078.937;Tannins;D013634
D01.268.556.837;Tantalum;D013635
D01.268.956.859;Tantalum;D013635
D01.552.544.837;Tantalum;D013635
Z01.058.290.120.840;Tanzania;D013636
J01.897.280.500.846;Tape Recording;D013637
L01.178.820.090.846;Tape Recording;D013637
L01.240.940;Tape Recording;D013637
D20.749;Tars;D013638
A02.835.232.043.300.710;Tarsal Bones;D013639
A02.835.583.378.831;Tarsal Joints;D013640
C10.668.829.500.700.800;Tarsal Tunnel Syndrome;D013641
C10.668.829.550.800;Tarsal Tunnel Syndrome;D013641
A13.473.821;Tarsus, Animal;D013643
D02.241.081.337.864;Tartrates;D013644
D02.241.081.844.759;Tartrates;D013644
D02.241.511.902.759;Tartrates;D013644
D09.811.779;Tartrates;D013644
D02.172.950;Tartrazine;D013645
D02.241.081.337.902;Tartronates;D013646
D02.241.081.844.821;Tartronates;D013646
D02.241.511.902.821;Tartronates;D013646
D09.811.835;Tartronates;D013646
F02.784.412.846;Task Performance and Analysis;D013647
F02.784.692.746;Task Performance and Analysis;D013647
F02.808.600;Task Performance and Analysis;D013647
Z01.338.680;Tasmania;D013648
Z01.639.100.680;Tasmania;D013648
F02.830.816.724;Taste;D013649
G11.561.600.810.724;Taste;D013649
A03.556.500.885.779;Taste Buds;D013650
A08.663.650.915.500.800;Taste Buds;D013650
A08.800.950.500.800;Taste Buds;D013650
A09.846;Taste Buds;D013650
A11.671.650.915.500.800;Taste Buds;D013650
A14.549.885.779;Taste Buds;D013650
C10.597.751.861;Taste Disorders;D013651
C23.888.592.763.861;Taste Disorders;D013651
F02.463.593.710.790;Taste Threshold;D013652
G11.561.600.810.724.880;Taste Threshold;D013652
G11.561.840;Taste Threshold;D013652
E02.218.085.840;Tattooing;D013653
E04.085.840;Tattooing;D013653
D02.455.326.146.100.850;Taurine;D013654
D02.886.645.600.055.850;Taurine;D013654
D02.455.326.146.100.850.875.900.875;Taurochenodeoxycholic Acid;D013655
D02.886.645.600.055.850.800.900.875;Taurochenodeoxycholic Acid;D013655
D04.808.105.225.272.150.850;Taurochenodeoxycholic Acid;D013655
D04.808.105.225.272.925.875;Taurochenodeoxycholic Acid;D013655
D04.808.105.225.900.900.870;Taurochenodeoxycholic Acid;D013655
D04.808.221.430.342.300.900;Taurochenodeoxycholic Acid;D013655
D04.808.221.430.342.900.910;Taurochenodeoxycholic Acid;D013655
D04.808.221.430.873.920.900;Taurochenodeoxycholic Acid;D013655
D02.455.326.146.100.850.875;Taurocholic Acid;D013656
D02.886.645.600.055.850.800;Taurocholic Acid;D013656
D04.808.105.225.900;Taurocholic Acid;D013656
D04.808.221.430.873;Taurocholic Acid;D013656
D02.455.326.146.100.850.875.900;Taurodeoxycholic Acid;D013657
D02.886.645.600.055.850.800.900;Taurodeoxycholic Acid;D013657
D04.808.105.225.272.925;Taurodeoxycholic Acid;D013657
D04.808.105.225.900.900;Taurodeoxycholic Acid;D013657
D04.808.221.430.342.900;Taurodeoxycholic Acid;D013657
D04.808.221.430.873.920;Taurodeoxycholic Acid;D013657
D02.455.326.146.100.850.875.925;Taurolithocholic Acid;D013658
D02.886.645.600.055.850.800.925;Taurolithocholic Acid;D013658
D04.808.105.225.480.880;Taurolithocholic Acid;D013658
D04.808.105.225.900.920;Taurolithocholic Acid;D013658
D04.808.221.430.622.900;Taurolithocholic Acid;D013658
D04.808.221.430.873.940;Taurolithocholic Acid;D013658
N03.219.900.880;Tax Equity and Fiscal Responsibility Act;D013659
N03.706.615.889;Tax Equity and Fiscal Responsibility Act;D013659
N03.219.900;Taxes;D013660
C10.228.140.163.100.435.825.300.300.500;Tay-Sachs Disease;D013661
C16.320.565.189.435.825.300.300.500;Tay-Sachs Disease;D013661
C16.320.565.398.641.803.350.300.850;Tay-Sachs Disease;D013661
C16.320.565.595.554.825.300.300.840;Tay-Sachs Disease;D013661
C18.452.132.100.435.825.300.300.500;Tay-Sachs Disease;D013661
C18.452.584.687.803.350.300.850;Tay-Sachs Disease;D013661
C18.452.648.189.435.825.300.300.500;Tay-Sachs Disease;D013661
C18.452.648.398.641.803.350.300.850;Tay-Sachs Disease;D013661
C18.452.648.595.554.825.300.300.840;Tay-Sachs Disease;D013661
D20.215.784.875;Tea;D013662
J02.200.900;Tea;D013662
I02.903;Teaching;D013663
L01.178.820;Teaching Materials;D013664
D27.720.400.800;Tear Gases;D013665
D27.720.821.498.697;Tear Gases;D013665
D27.888.569.300.800;Tear Gases;D013665
D27.888.569.734.498.697;Tear Gases;D013665
J01.637.870.800;Tear Gases;D013665
A12.200.882;Tears;D013666
D01.268.271.870;Technetium;D013667
D01.268.556.843;Technetium;D013667
D01.268.956.875;Technetium;D013667
D01.552.544.843;Technetium;D013667
D02.691.825.375;Technetium Tc 99m Aggregated Albumin;D013668
D12.776.034.900;Technetium Tc 99m Aggregated Albumin;D013668
D02.691.825.750;Technetium Tc 99m Medronate;D013669
D02.705.429.500.885;Technetium Tc 99m Medronate;D013669
D01.925.800;Sodium Pertechnetate Tc 99m;D013670
D01.875.900;Technetium Tc 99m Sulfur Colloid;D013671
D01.925.950;Technetium Tc 99m Sulfur Colloid;D013671
J01.897;Technology;D013672
N03.880;Technology Assessment, Biomedical;D013673
N05.715.360.825;Technology Assessment, Biomedical;D013673
E06.912;Technology, Dental;D013674
H02.010.800;Technology, Dental;D013674
J01.897.724;Technology, Dental;D013674
N03.880.502;Technology, High-Cost;D013675
J01;Technology, Industry, and Agriculture;D013676
H02.010.450;Medical Laboratory Science;D013677
J01.897.480;Medical Laboratory Science;D013677
E05.916;Technology, Pharmaceutical;D013678
H02.646.500;Technology, Pharmaceutical;D013678
J01.897.836;Technology, Pharmaceutical;D013678
E05.920;Technology, Radiologic;D013679
H02.010.850;Technology, Radiologic;D013679
J01.897.891;Technology, Radiologic;D013679
A09.246.631.246.292.938;Tectorial Membrane;D013680
A08.186.211.132.659.822;Tegmentum Mesencephali;D013681
A08.186.211.653.822;Tegmentum Mesencephali;D013681
D09.408.872;Teichoic Acids;D013682
D09.698.718.825;Teichoic Acids;D013682
D09.894.847;Teichoic Acids;D013682
D23.050.161.616.797;Teichoic Acids;D013682
C14.907.454.900;Telangiectasia, Hereditary Hemorrhagic;D013683
C14.907.823.780;Telangiectasia, Hereditary Hemorrhagic;D013683
C15.378.463.515.900;Telangiectasia, Hereditary Hemorrhagic;D013683
C16.131.240.850.968;Telangiectasia, Hereditary Hemorrhagic;D013683
C14.907.823;Telangiectasis;D013684
L01.178.847;Telecommunications;D013685
E01.370.520.750;Telemetry;D013686
E05.925;Telemetry;D013686
L01.178.847.675;Telemetry;D013686
A08.186.211.730.885;Telencephalon;D013687
F02.550.847;Telepathy;D013688
L01.178.847.698;Telephone;D013689
J01.897.280.500.898;Television;D013690
L01.178.590.875;Television;D013690
L01.178.820.090.898;Television;D013690
L01.178.847.823;Television;D013690
D01.268.185.950;Tellurium;D013691
D01.268.513.968;Tellurium;D013691
G04.299.134.220.220.781.953;Telophase;D013692
G04.299.134.220.220.937;Telophase;D013692
G05.355.105.220.781.953;Telophase;D013692
G05.355.105.220.937;Telophase;D013692
D03.438.079.080.070.880;Temazepam;D013693
F01.752.898;Temperament;D013694
I03.828;Temperance;D013695
G01.906.595;Temperature;D013696
G16.500.275.063.725.710;Temperature;D013696
G16.500.750.775.710;Temperature;D013696
N06.230.150.450;Temperature;D013696
N06.230.300.100.725.710;Temperature;D013696
F02.830.816.781;Thermosensing;D013697
G07.700.850;Thermosensing;D013697
G11.561.600.810.781;Thermosensing;D013697
G05.360.840;Templates, Genetic;D013698
A07.231.114.228.868;Temporal Arteries;D013699
C10.114.875.700;Giant Cell Arteritis;D013700
C10.228.140.300.850.500;Giant Cell Arteritis;D013700
C14.907.184.438;Giant Cell Arteritis;D013700
C14.907.253.946.700;Giant Cell Arteritis;D013700
C14.907.940.090.530;Giant Cell Arteritis;D013700
C14.907.940.907.700;Giant Cell Arteritis;D013700
C17.800.862.252;Giant Cell Arteritis;D013700
C20.111.258.962.800;Giant Cell Arteritis;D013700
A02.835.232.781.885;Temporal Bone;D013701
A08.186.211.730.885.287.500.863;Temporal Lobe;D013702
A02.633.567.600.850;Temporal Muscle;D013703
A14.530.940;Temporal Muscle;D013703
A02.835.583.861;Temporomandibular Joint;D013704
A14.907;Temporomandibular Joint;D013704
C05.500.607.221.897;Temporomandibular Joint Disorders;D013705
C05.550.905;Temporomandibular Joint Disorders;D013705
C05.651.243.897;Temporomandibular Joint Disorders;D013705
C07.320.610.291.897;Temporomandibular Joint Disorders;D013705
C07.678;Temporomandibular Joint Disorders;D013705
C05.500.607.221.897.897;Temporomandibular Joint Dysfunction Syndrome;D013706
C05.550.905.905;Temporomandibular Joint Dysfunction Syndrome;D013706
C05.651.243.897.897;Temporomandibular Joint Dysfunction Syndrome;D013706
C05.651.550.905;Temporomandibular Joint Dysfunction Syndrome;D013706
C07.320.610.291.897.897;Temporomandibular Joint Dysfunction Syndrome;D013706
C07.678.949;Temporomandibular Joint Dysfunction Syndrome;D013706
C26.874;Tendon Injuries;D013708
E04.555.700;Tendon Transfer;D013709
A02.880;Tendons;D013710
B01.050.500.131.617.069.615;Tenebrio;D013712
D09.408.348.800;Teniposide;D013713
Z01.107.567.875.075.775;Tennessee;D013714
I03.450.642.845.600.900;Tennis;D013715
C05.906;Tennis Elbow;D013716
C26.088.890;Tennis Elbow;D013716
C05.651.869.870;Tenosynovitis;D013717
G01.374.850;Tensile Strength;D013718
A02.633.567.975;Tensor Tympani;D013719
A09.246.397.749;Tensor Tympani;D013719
D03.383.773.812.900;Tenuazonic Acid;D013720
D23.946.587.915;Tenuazonic Acid;D013720
D03.383.097.217.935;Triethylenephosphoramide;D013721
D12.644.456.810;Teprotide;D013722
D27.888.569.864;Teratogens;D013723
C04.557.465.910;Teratoma;D013724
D01.268.477.968;Terbium;D013725
D01.268.558.362.968;Terbium;D013725
D01.552.550.399.968;Terbium;D013725
D02.033.100.291.905;Terbutaline;D013726
D02.092.063.291.905;Terbutaline;D013726
E02.760.905;Terminal Care;D013727
N02.421.585.905;Terminal Care;D013727
G02.111.570.080.689.810;Terminator Regions, Genetic;D013728
G05.360.080.689.810;Terminator Regions, Genetic;D013728
G05.360.340.024.340.137.750.830;Terminator Regions, Genetic;D013728
D02.455.849;Terpenes;D013729
D02.455.426.559.389.805;Terphenyl Compounds;D013730
F01.145.875.864;Territoriality;D013731
F04.711.647.513.886;Test Anxiety Scale;D013732
C12.294.829;Testicular Diseases;D013733
C19.391.829;Testicular Diseases;D013733
C12.706.316.096.500;Androgen-Insensitivity Syndrome;D013734
C13.351.875.253.096.500;Androgen-Insensitivity Syndrome;D013734
C16.131.939.316.096.500;Androgen-Insensitivity Syndrome;D013734
C16.320.322.061;Androgen-Insensitivity Syndrome;D013734
C19.391.119.096.500;Androgen-Insensitivity Syndrome;D013734
D06.472.334.984;Testicular Hormones;D013735
C04.588.322.762;Testicular Neoplasms;D013736
C04.588.945.440.915;Testicular Neoplasms;D013736
C12.294.260.937;Testicular Neoplasms;D013736
C12.758.409.937;Testicular Neoplasms;D013736
C19.344.762;Testicular Neoplasms;D013736
C19.391.829.782;Testicular Neoplasms;D013736
A05.360.444.849;Testis;D013737
A05.360.576.782;Testis;D013737
A06.407.312.782;Testis;D013737
D04.808.054.079.129.782;Testolactone;D013738
D04.808.496.699;Testolactone;D013738
D04.808.054.079.429.824;Testosterone;D013739
D06.472.334.851.968.984;Testosterone;D013739
D08.811.682.660.465;3-Oxo-5-alpha-Steroid 4-Dehydrogenase;D013741
C01.252.410.222.864;Tetanus;D013742
D12.776.124.486.485.114.301.849;Tetanus Antitoxin;D013743
D12.776.124.486.485.114.573.601.849;Tetanus Antitoxin;D013743
D12.776.124.790.651.114.301.849;Tetanus Antitoxin;D013743
D12.776.377.715.548.114.301.849;Tetanus Antitoxin;D013743
D20.215.121.824;Tetanus Antitoxin;D013743
D12.776.097.872;Tetanus Toxin;D013744
D23.946.123.893;Tetanus Toxin;D013744
D20.215.894.691.824;Tetanus Toxoid;D013745
C10.597.613.875;Tetany;D013746
C18.452.174.509.700;Tetany;D013746
C23.888.592.608.875;Tetany;D013746
D03.438.834.850;Tetrabenazine;D013747
D02.241.223.100.050.500.968;Tetracaine;D013748
D02.455.426.559.389.127.020.937.968;Tetracaine;D013748
D03.383.231.900;Tetrachlorodibenzodioxin;D013749
D02.455.526.439.880;Tetrachloroethylene;D013750
D02.705.400.750;Tetrachlorvinphos;D013751
D02.455.426.559.847.562.900.875;Tetracycline;D013752
D04.615.562.900.875;Tetracycline;D013752
G06.099.225.937;Tetracycline Resistance;D013753
G06.225.347.937;Tetracycline Resistance;D013753
G07.690.320.269.347.937;Tetracycline Resistance;D013753
D02.455.426.559.847.562.900;Tetracyclines;D013754
D04.615.562.900;Tetracyclines;D013754
D02.455.849.291.500.510.850;Tetradecanoylphorbol Acetate;D013755
D02.691.950;Tetraethyl Lead;D013756
D02.092.877.787;Tetraethylammonium Compounds;D013757
D02.675.276.787;Tetraethylammonium Compounds;D013757
D06.472.317.413.800;Tetragastrin;D013758
D12.644.456.830;Tetragastrin;D013758
D02.455.849.090.810;Tetrahydrocannabinol;D013759
D04.808.745.887;Tetrahydrocortisol;D013760
D06.472.040.585.353.825;Tetrahydrocortisol;D013760
D06.472.040.585.478.782;Tetrahydrocortisol;D013760
D04.808.745.558.783;Tetrahydrocortisone;D013761
D06.472.040.585.478.865;Tetrahydrocortisone;D013761
D08.811.682.662.825;Tetrahydrofolate Dehydrogenase;D013762
D03.438.733.631.400.800;Tetrahydrofolates;D013763
D08.211.840;Tetrahydrofolates;D013763
D02.455.426.559.847.638.960;Tetrahydronaphthalenes;D013764
D04.615.638.960;Tetrahydronaphthalenes;D013764
D03.132.098.666.850;Tetrahydropapaveroline;D013765
D03.132.577.750.850;Tetrahydropapaveroline;D013765
D03.438.531.085.666.850;Tetrahydropapaveroline;D013765
D08.811.913.555.500.645;5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase;D013766
D03.383.742.680.852.800;Tetrahydrouridine;D013767
D13.570.685.852.800;Tetrahydrouridine;D013767
D13.570.800.892.800;Tetrahydrouridine;D013767
B01.043.185.650.375.750.850;Tetrahymena;D013768
B01.043.185.650.375.750.850.700;Tetrahymena pyriformis;D013769
D02.705.672.750;Tetraisopropylpyrophosphamide;D013770
C14.240.400.849;Tetralogy of Fallot;D013771
C14.280.400.849;Tetralogy of Fallot;D013771
C16.131.240.400.849;Tetralogy of Fallot;D013771
D02.092.146.651.900;Tetramethylphenylenediamine;D013772
D02.092.782.258.651.900;Tetramethylphenylenediamine;D013772
D02.886.675.782;Tetramisole;D013773
D03.383.129.308.884;Tetramisole;D013773
D03.383.129.708.782;Tetramisole;D013773
D02.455.326.146.571.850;Tetranitromethane;D013774
D02.455.326.146.672.800;Tetranitromethane;D013774
D02.640.720.800;Tetranitromethane;D013774
D02.203.087.050.750;Tetraphenylborate;D013775
D01.029.260.877.800.900;Tetrathionic Acid;D013776
D01.875.800.800.900;Tetrathionic Acid;D013776
D03.383.129.617;Tetrazoles;D013777
D03.383.129.617.700;Tetrazolium Salts;D013778
D03.438.786.910;Tetrodotoxin;D013779
D23.946.580.910;Tetrodotoxin;D013779
D09.546.805;Tetroses;D013780
Z01.107.567.875.760.750;Texas;D013781
L01.178.682.192.900;Textbooks as Topic;D013782
L01.178.820.900;Textbooks as Topic;D013782
J01.576.885;Textile Industry;D013783
J01.576.885.800;Textiles;D013784
Z01.252.145.841;Thailand;D013785
C10.228.140.915;Thalamic Diseases;D013786
A08.186.211.730.317.826.701;Thalamic Nuclei;D013787
A08.186.211.730.317.826;Thalamus;D013788
C15.378.071.141.150.875;Thalassemia;D013789
C15.378.420.826;Thalassemia;D013789
C16.320.070.875;Thalassemia;D013789
C16.320.365.826;Thalassemia;D013789
E02.921;Climatotherapy;D013790
D02.241.223.805.810.800;Thalidomide;D013792
D03.383.621.808.800;Thalidomide;D013792
D03.438.513.750.750;Thalidomide;D013792
D01.268.556.847;Thallium;D013793
D01.552.544.847;Thallium;D013793
D01.496.749.900;Thallium Radioisotopes;D013794
K01.752.827;Thanatology;D013795
C05.116.099.343.110.500;Thanatophoric Dysplasia;D013796
C05.116.099.708.017.500;Thanatophoric Dysplasia;D013796
C05.660.585.984;Thanatophoric Dysplasia;D013796
C16.131.621.585.984;Thanatophoric Dysplasia;D013796
C16.320.240.500.500;Thanatophoric Dysplasia;D013796
C16.614.890;Thanatophoric Dysplasia;D013796
D03.132.577.249.547.547.856;Thebaine;D013797
D03.549.686.575.547.851;Thebaine;D013797
D03.605.497.575.547.851;Thebaine;D013797
D04.615.723.795.547.547.856;Thebaine;D013797
C04.557.475.750.875;Thecoma;D013798
C04.588.322.455.765;Thecoma;D013798
C13.351.500.056.630.705.765;Thecoma;D013798
C13.351.937.418.685.765;Thecoma;D013798
C19.344.410.765;Thecoma;D013798
C19.391.630.705.765;Thecoma;D013798
A05.360.319.114.630.535.400;Theca Cells;D013799
A06.407.312.497.535.600;Theca Cells;D013799
A11.329.850;Theca Cells;D013799
I01.198.240.810;Theft;D013800
I01.880.735.191.410;Theft;D013800
C03.701.688.735;Theileriasis;D013801
C03.752.625.735;Theileriasis;D013801
C03.752.875.850;Theileriasis;D013801
C22.196.831;Theileriasis;D013801
C22.674.710.735;Theileriasis;D013801
B01.050.500.500.294.700.750.700.722;Thelazioidea;D013802
F04.711.647.622.851;Thematic Apperception Test;D013803
D02.522.296.900;Thenoyltrifluoroacetone;D013804
D02.886.778.820;Thenoyltrifluoroacetone;D013804
D03.383.903.820;Thenoyltrifluoroacetone;D013804
D03.132.960.651;Theobromine;D013805
D03.438.759.758.824.651;Theobromine;D013805
D03.132.960.751;Theophylline;D013806
D03.438.759.758.824.751;Theophylline;D013806
F04.754.864.392.701;Therapeutic Community;D013808
G03.787.559;Therapeutic Equivalency;D013810
G07.690.725.898;Therapeutic Equivalency;D013810
F04.754.720;Psychotherapeutic Processes;D013811
E02;Therapeutics;D013812
E02.950;Therapy, Computer-Assisted;D013813
L01.700.508.100.710;Therapy, Computer-Assisted;D013813
G01.906.730;Thermal Conductivity;D013814
E05.484.750;Thermodilution;D013815
G01.906;Thermodynamics;D013816
E01.370.350.800;Thermography;D013817
E05.933.500;Thermography;D013817
E05.196.904;Thermogravimetry;D013818
E05.799.638.785;Thermoluminescent Dosimetry;D013819
N06.850.810.370.420;Thermoluminescent Dosimetry;D013819
D08.811.277.656.300.480.827;Thermolysin;D013820
D08.811.277.656.675.374.827;Thermolysin;D013820
E07.900;Thermometers;D013821
B02.200.850.800;Thermoplasma;D013822
A08.663.650.915.968;Thermoreceptors;D013823
A08.800.950.968;Thermoreceptors;D013823
A11.671.650.915.968;Thermoreceptors;D013823
B03.440.400.425.875;Thermus;D013824
E01.370.376.300.150.937;Theta Rhythm;D013826
E01.370.405.245.287.937;Theta Rhythm;D013826
G07.265.087.937;Theta Rhythm;D013826
G11.561.127.937;Theta Rhythm;D013826
D02.886.675.840;Thiabendazole;D013827
D03.383.129.708.824;Thiabendazole;D013827
D03.438.103.850;Thiabendazole;D013827
D02.845.746.703.702;Thioacetazone;D013828
D02.886.803.702;Thioacetazone;D013828
D02.886.665.785;Thiadiazines;D013829
D03.383.855.785;Thiadiazines;D013829
D02.886.675.867;Thiadiazoles;D013830
D03.383.129.708.867;Thiadiazoles;D013830
D02.886.675.900;Thiamine;D013831
D03.383.129.708.900;Thiamine;D013831
D03.383.742.795;Thiamine;D013831
C18.654.521.500.133.699.827;Thiamine Deficiency;D013832
D02.886.675.900.600;Thiamine Monophosphate;D013833
D03.383.129.708.900.600;Thiamine Monophosphate;D013833
D03.383.742.795.600;Thiamine Monophosphate;D013833
D08.811.277.040.600.800;Thiamine Pyrophosphatase;D013834
D02.886.675.900.702;Thiamine Pyrophosphate;D013835
D03.383.129.708.900.702;Thiamine Pyrophosphate;D013835
D03.383.742.795.702;Thiamine Pyrophosphate;D013835
D08.211.878;Thiamine Pyrophosphate;D013835
D08.811.913.696.175.825;Thiamin Pyrophosphokinase;D013836
D08.811.277.040.850;Thiamin-Triphosphatase;D013837
D02.886.675.900.900;Thiamine Triphosphate;D013838
D03.383.129.708.900.900;Thiamine Triphosphate;D013838
D03.383.742.795.900;Thiamine Triphosphate;D013838
D02.033.455.706.300.850;Thiamphenicol;D013839
D02.455.426.559.389.565.175.850;Thiamphenicol;D013839
D02.640.529.175.850;Thiamphenicol;D013839
D03.383.742.698.253.800.750;Thiamylal;D013840
D02.886.680.702;Thiazepines;D013841
D03.383.066.785;Thiazepines;D013841
D03.383.886.702;Thiazepines;D013841
D02.886.665;Thiazines;D013843
D03.383.855;Thiazines;D013843
D02.886.675;Thiazoles;D013844
D03.383.129.708;Thiazoles;D013844
D02.065.589.099.124.300;Thienamycins;D013845
D04.075.080.875.099.221.124.300;Thienamycins;D013845
D02.886.680;Thiepins;D013846
D03.383.886;Thiepins;D013846
D02.886.369.780;Thiethylperazine;D013847
D03.383.606.880;Thiethylperazine;D013847
D03.494.741.780;Thiethylperazine;D013847
A01.378.610.750;Thigh;D013848
D02.691.750.100.347.850;Thimerosal;D013849
F02.463.785;Thinking;D013850
C23.888.144.828;Thinness;D013851
E01.370.600.115.100.160.120.828;Thinness;D013851
G07.100.100.160.120.828;Thinness;D013851
D02.705.672.875;Thiotepa;D013852
D03.383.097.217.935.960;Thiotepa;D013852
D02.065.064.786;Thioacetamide;D013853
D02.065.900.890;Thioacetamide;D013853
D02.241.081.018.110.786;Thioacetamide;D013853
D02.886.685.800;Thioacetamide;D013853
D02.065.900;Thioamides;D013854
D02.886.685;Thioamides;D013854
B03.440.400.450.800;Thiobacillus;D013855
B03.660.075.400.800;Thiobacillus;D013855
B03.440.400.425.103.800;Acidithiobacillus thiooxidans;D013856
B03.660.250.015.800;Acidithiobacillus thiooxidans;D013856
D03.383.742.698.253.800;Thiobarbiturates;D013858
D02.241.081.251.869;Thiocarbamates;D013859
D02.886.706;Thiocarbamates;D013859
D02.092.877.883.333.800;Thiocholine;D013860
D02.675.276.232.800;Thiocholine;D013860
D02.886.489.789;Thiocholine;D013860
D02.262.775;Thiocyanates;D013861
D02.886.728;Thiocyanates;D013861
D02.886.740.600;Thiogalactosides;D013862
D09.408.320.820;Thiogalactosides;D013862
D09.408.903.600;Thiogalactosides;D013862
D02.886.740.703;Thioglucosides;D013863
D09.408.348.820;Thioglucosides;D013863
D09.408.903.703;Thioglucosides;D013863
D02.241.081.018.900;Thioglycolates;D013864
D02.886.489.828;Thioglycolates;D013864
D02.886.740;Thioglycosides;D013865
D09.408.903;Thioglycosides;D013865
D03.438.759.854;Thioguanine;D013866
D03.383.129.308.432.555.868;Thiohydantoins;D013867
D02.886.759.800;Thioinosine;D013868
D03.438.759.590.616.900;Thioinosine;D013868
D13.570.583.616.900;Thioinosine;D013868
D13.570.800.573.900;Thioinosine;D013868
D13.570.900.800;Thioinosine;D013868
D08.811.277.352.897;Thiolester Hydrolases;D013869
D02.241.081.337.463.703;Thiomalates;D013870
D02.886.489.891;Thiomalates;D013870
D02.886.753;Thiones;D013871
D02.886.759;Thionucleosides;D013872
D13.570.900;Thionucleosides;D013872
D02.886.765;Thionucleotides;D013873
D13.695.900;Thionucleotides;D013873
D03.383.742.698.253.800.810;Thiopental;D013874
D02.241.081.251.890;Thiophanate;D013875
D02.886.904.601.900;Thiophanate;D013875
D02.948.898.601.900;Thiophanate;D013875
D02.886.778;Thiophenes;D013876
D03.383.903;Thiophenes;D013876
D12.776.915;Thioredoxins;D013879
D08.811.682.667.750;Thioredoxin-Disulfide Reductase;D013880
D12.776.331.971;Thioredoxin-Disulfide Reductase;D013880
D02.886.369.843;Thioridazine;D013881
D03.494.741.843;Thioridazine;D013881
D02.845.746.703;Thiosemicarbazones;D013882
D02.886.803;Thiosemicarbazones;D013882
D04.345.566.825;Thiostrepton;D013883
D12.644.641.825;Thiostrepton;D013883
D08.811.913.817.500.500;Thiosulfate Sulfurtransferase;D013884
D01.248.497.158.845.703;Thiosulfates;D013885
D01.875.800.800.850.900;Thiosulfates;D013885
D01.029.260.877.740.900;Thiosulfonic Acids;D013886
D01.875.800.740.900;Thiosulfonic Acids;D013886
D02.886.645.600.925;Thiosulfonic Acids;D013886
D02.886.952.787;Thiothixene;D013888
D03.494.953.704.787;Thiothixene;D013888
D03.383.742.698.875.842;Thiouracil;D013889
D02.886.904;Thiourea;D013890
D02.948.898;Thiourea;D013890
D02.886.759.829;Thiouridine;D013891
D03.383.742.680.852.829;Thiouridine;D013891
D13.570.685.852.829;Thiouridine;D013891
D13.570.800.892.829;Thiouridine;D013891
D13.570.900.829;Thiouridine;D013891
D02.886.952;Thioxanthenes;D013892
D03.494.953.704;Thioxanthenes;D013892
D02.241.081.251.869.210.800;Thiram;D013893
D02.886.706.175.900;Thiram;D013893
F01.658.293.787;Thirst;D013894
A07.231.114.891;Thoracic Arteries;D013895
C08.846;Thoracic Diseases;D013896
A15.382.520.301.750;Thoracic Duct;D013897
C26.891;Thoracic Injuries;D013898
C04.588.894;Thoracic Neoplasms;D013899
A08.800.800.720.800;Thoracic Nerves;D013900
C10.668.829.550.850;Thoracic Outlet Syndrome;D013901
C14.907.863;Thoracic Outlet Syndrome;D013901
E01.370.350.700.730;Radiography, Thoracic;D013902
H02.403.810.803;Thoracic Surgery;D013903
A02.835.232.834.892;Thoracic Vertebrae;D013904
E04.928.750;Thoracoplasty;D013905
E01.370.388.250.840;Thoracoscopy;D013906
E04.800.250.840;Thoracoscopy;D013906
E04.928.752;Thoracoscopy;D013906
E04.579.918;Thoracostomy;D013907
E04.928.755;Thoracostomy;D013907
E04.928.760;Thoracotomy;D013908
A01.923.761;Thorax;D013909
A02.835.232.904;Thorax;D013909
D01.268.033.900;Thorium;D013910
D01.268.271.100.900;Thorium;D013910
D01.268.556.850;Thorium;D013910
D01.552.020.889;Thorium;D013910
D01.552.544.850;Thorium;D013910
D01.650.550.875;Thorium Dioxide;D013911
D01.930.930;Thorium Dioxide;D013911
D12.125.142.815;Threonine;D013912
D12.125.154.900;Threonine;D013912
D12.125.901;Threonine;D013912
D08.811.520.232.400.850;Threonine Dehydratase;D013913
D08.811.464.263.200.800;Threonine-tRNA Ligase;D013914
C15.378.100.100.820;Thrombasthenia;D013915
C15.378.140.810;Thrombasthenia;D013915
C15.378.463.810;Thrombasthenia;D013915
C16.320.099.820;Thrombasthenia;D013915
E01.370.225.625.115.830;Thrombelastography;D013916
E05.200.625.115.830;Thrombelastography;D013916
D08.811.277.656.300.760.855;Thrombin;D013917
D08.811.277.656.959.350.855;Thrombin;D013917
D12.776.124.125.890;Thrombin;D013917
D23.119.960;Thrombin;D013917
E01.370.225.625.115.870;Thrombin Time;D013918
E05.200.625.115.870;Thrombin Time;D013918
G09.188.840;Thrombin Time;D013918
C14.907.137.870;Thromboangiitis Obliterans;D013919
C14.907.940.905;Thromboangiitis Obliterans;D013919
C15.378.100.832;Thrombocythemia, Essential;D013920
C15.378.140.860.800;Thrombocythemia, Essential;D013920
C15.378.190.636.860.800;Thrombocythemia, Essential;D013920
C15.378.463.825;Thrombocythemia, Essential;D013920
C15.378.140.855;Thrombocytopenia;D013921
C15.378.140.860;Thrombocytosis;D013922
C15.378.190.636.860;Thrombocytosis;D013922
C14.907.355.590;Thromboembolism;D013923
C14.907.355.830.850;Thromboembolism;D013923
C14.907.355.830.925.770;Thrombophlebitis;D013924
C14.907.617.718.788;Thrombophlebitis;D013924
C14.907.940.740.910;Thrombophlebitis;D013924
D12.776.124.125.900;Thromboplastin;D013925
D23.119.965;Thromboplastin;D013925
D12.644.276.374.410.240.750;Thrombopoietin;D013926
D12.776.395.240.750;Thrombopoietin;D013926
D12.776.395.720;Thrombopoietin;D013926
D12.776.467.374.410.240.750;Thrombopoietin;D013926
D23.529.374.410.240.750;Thrombopoietin;D013926
C14.907.355.830;Thrombosis;D013927
D10.251.355.255.100.825.800;Thromboxane A2;D013928
D23.469.050.175.800.800;Thromboxane A2;D013928
D10.251.355.255.100.825.810;Thromboxane B2;D013929
D23.469.050.175.800.810;Thromboxane B2;D013929
D08.811.399.475.900;Thromboxane-A Synthase;D013930
D10.251.355.255.100.825;Thromboxanes;D013931
D10.251.355.255.775;Thromboxanes;D013931
D23.469.050.175.800;Thromboxanes;D013931
D01.268.477.984;Thulium;D013932
D01.268.558.362.984;Thulium;D013932
D01.552.550.399.984;Thulium;D013932
A01.378.800.667.430.705;Thumb;D013933
E04.928.770;Thymectomy;D013934
D06.472.910.750;Thymic Factor, Circulating;D013935
D12.644.456.835;Thymic Factor, Circulating;D013935
D03.383.742.680.705;Thymidine;D013936
D13.570.230.855;Thymidine;D013936
D13.570.685.705;Thymidine;D013936
D08.811.913.696.620.750;Thymidine Kinase;D013937
D03.383.742.686.706.788;Thymidine Monophosphate;D013938
D13.695.201.789.788;Thymidine Monophosphate;D013938
D13.695.740.706.788;Thymidine Monophosphate;D013938
D08.811.913.400.725.850.500;Thymidine Phosphorylase;D013939
D08.811.913.555.500.862;Thymidylate Synthase;D013940
D03.383.742.698.875.899;Thymine;D013941
D03.383.742.686.706;Thymine Nucleotides;D013942
D13.695.201.789;Thymine Nucleotides;D013942
D13.695.740.706;Thymine Nucleotides;D013942
D02.455.849.575.875;Thymol;D013943
D02.455.426.559.389.657.625.808;Thymolphthalein;D013944
C04.557.435.850;Thymoma;D013945
C04.588.894.949.500;Thymoma;D013945
C15.604.861.800;Thymoma;D013945
D06.472.910.800;Thymopoietins;D013946
D06.472.910.850;Thymosin;D013947
D12.644.548.869;Thymosin;D013947
D12.776.922;Thymosin;D013947
D02.092.668.387.500;Moxisylyte;D013948
D20.777.871;Thymus Extracts;D013949
A10.549.750;Thymus Gland;D013950
A15.382.520.604.750;Thymus Gland;D013950
D06.472.910;Thymus Hormones;D013951
C15.604.816;Thymus Hyperplasia;D013952
C04.588.894.949;Thymus Neoplasms;D013953
C15.604.861;Thymus Neoplasms;D013953
D12.776.377.856;Thyroglobulin;D013954
D12.776.395.768;Thyroglobulin;D013954
D12.776.486.706;Thyroglobulin;D013954
C04.182.902;Thyroglossal Cyst;D013955
D06.347.100;Antithyroid Agents;D013956
D27.505.696.399.450.100;Antithyroid Agents;D013956
A02.165.257.625.870;Thyroid Cartilage;D013957
A02.165.407.500.870;Thyroid Cartilage;D013957
A04.329.591.870;Thyroid Cartilage;D013957
C19.874.397.685.905;Thyroid Crisis;D013958
C19.874.902.905;Thyroid Crisis;D013958
C19.874;Thyroid Diseases;D013959
E01.370.374.750;Thyroid Function Tests;D013960
A06.407.900;Thyroid Gland;D013961
D06.472.931.669;Thyroid (USP);D013962
D06.472.931;Thyroid Hormones;D013963
C04.588.322.894;Thyroid Neoplasms;D013964
C04.588.443.915;Thyroid Neoplasms;D013964
C19.344.894;Thyroid Neoplasms;D013964
C19.874.788;Thyroid Neoplasms;D013964
E04.270.856;Thyroidectomy;D013965
C19.874.871;Thyroiditis;D013966
C19.874.871.102;Thyroiditis, Autoimmune;D013967
C20.111.809;Thyroiditis, Autoimmune;D013967
C19.874.871.900;Thyroiditis, Subacute;D013968
C01.539.830.840;Thyroiditis, Suppurative;D013969
C19.874.871.910;Thyroiditis, Suppurative;D013969
D06.472.931.740;Thyronines;D013970
D12.125.072.050.767.741;Thyronines;D013970
C19.874.397.685;Thyrotoxicosis;D013971
C19.874.902;Thyrotoxicosis;D013971
D06.472.699.631.525.883;Thyrotropin;D013972
D12.644.548.691.525.883;Thyrotropin;D013972
D06.472.699.327.740.880;Thyrotropin-Releasing Hormone;D013973
D12.644.400.400.740.880;Thyrotropin-Releasing Hormone;D013973
D12.644.456.837;Thyrotropin-Releasing Hormone;D013973
D12.644.548.365.740.880;Thyrotropin-Releasing Hormone;D013973
D12.776.641.650.405.740.880;Thyrotropin-Releasing Hormone;D013973
D12.776.641.650.810;Thyrotropin-Releasing Hormone;D013973
D06.472.931.812;Thyroxine;D013974
D12.125.072.050.767;Thyroxine;D013974
D12.776.124.885;Thyroxine-Binding Proteins;D013975
D12.776.157.785;Thyroxine-Binding Proteins;D013975
D12.776.395.832;Thyroxine-Binding Proteins;D013975
D02.092.471.683.943;Tiapamil Hydrochloride;D013976
D02.355.726.825;Tiapamil Hydrochloride;D013976
A02.835.232.043.650.883;Tibia;D013977
C26.404.875;Tibial Fractures;D013978
C26.558.857;Tibial Fractures;D013978
A08.800.800.720.450.760.820;Tibial Nerve;D013979
C10.228.662.825;Tic Disorders;D013981
F03.550.825;Tic Disorders;D013981
D02.065.589.099.750.875;Ticarcillin;D013982
D02.886.108.750.875;Ticarcillin;D013982
D03.438.260.825.875;Ticarcillin;D013982
D03.605.084.737.875;Ticarcillin;D013982
D04.075.080.875.099.221.750.875;Ticarcillin;D013982
N06.850.780.200.650.850;Tick Control;D013983
C03.858.211.857;Tick Infestations;D013984
C25.723.127.857.707;Tick Paralysis;D013985
C25.723.127.857;Tick Toxicoses;D013986
B01.050.500.131.166.132.832;Ticks;D013987
D02.886.778.823.500;Ticlopidine;D013988
D03.383.725.849.500;Ticlopidine;D013988
D03.383.903.830.500;Ticlopidine;D013988
D03.438.928.500;Ticlopidine;D013988
D02.241.081.018.386.682.900;Ticrynafen;D013989
D02.241.511.316.682.900;Ticrynafen;D013989
D02.886.778.840;Ticrynafen;D013989
D03.383.903.840;Ticrynafen;D013989
E01.370.386.700.485.750.900.350.750;Tidal Volume;D013990
G09.772.850.970.500.700;Tidal Volume;D013990
C05.182.790;Tietze's Syndrome;D013991
C17.300.182.790;Tietze's Syndrome;D013991
D02.455.426.392.368.367.850;Tiletamine;D013992
D02.522.400.850;Tiletamine;D013992
D02.886.778.850;Tiletamine;D013992
D03.383.903.850;Tiletamine;D013992
D02.241.223.268.825;Tilidine;D013993
D02.455.426.559.847.389.850;Tilorone;D013994
D04.615.389.850;Tilorone;D013994
G01.910;Time;D013995
F02.784.412.846.707;Time and Motion Studies;D013996
F02.784.692.746.707;Time and Motion Studies;D013996
G01.910.857;Time Factors;D013997
F02.463.593.857;Time Perception;D013998
D02.033.100.624.915;Timolol;D013999
D02.033.755.624.915;Timolol;D013999
D02.092.063.624.915;Timolol;D013999
D02.886.675.867.768;Timolol;D013999
D03.383.129.708.867.768;Timolol;D013999
D03.383.533.640.775;Timolol;D013999
D01.268.556.875;Tin;D014001
D01.552.544.875;Tin;D014001
D01.303.350.300.950;Tin Fluorides;D014002
D01.935.925;Tin Fluorides;D014002
D25.223.800;Tin Fluorides;D014002
J01.637.051.223.800;Tin Fluorides;D014002
D01.695.625.675.650.775.950;Tin Polyphosphates;D014003
D01.935.950;Tin Polyphosphates;D014003
D01.496.749.910;Tin Radioisotopes;D014004
C01.539.800.200.720;Tinea;D014005
C01.703.295.872;Tinea;D014005
C17.800.838.208.883;Tinea;D014005
C01.539.800.200.720.730;Tinea Capitis;D014006
C01.703.295.872.541;Tinea Capitis;D014006
C17.800.738.708;Tinea Capitis;D014006
C17.800.838.208.883.558;Tinea Capitis;D014006
C01.539.800.200.720.730.740;Tinea Favosa;D014007
C01.703.295.872.541.500;Tinea Favosa;D014007
C17.800.738.708.708;Tinea Favosa;D014007
C17.800.838.208.883.558.708;Tinea Favosa;D014007
C01.539.800.200.720.760;Tinea Pedis;D014008
C01.703.295.872.707;Tinea Pedis;D014008
C17.800.321.125.500;Tinea Pedis;D014008
C17.800.838.208.883.658;Tinea Pedis;D014008
C23.888.885.625.500;Tinea Pedis;D014008
C01.539.800.200.720.550;Onychomycosis;D014009
C01.703.295.872.458;Onychomycosis;D014009
C17.800.529.550;Onychomycosis;D014009
C17.800.838.208.883.458;Onychomycosis;D014009
C01.539.800.200.860;Tinea Versicolor;D014010
C01.703.295.936;Tinea Versicolor;D014010
C17.800.838.208.941;Tinea Versicolor;D014010
D02.640.672.900;Tinidazole;D014011
D03.383.129.308.658.900;Tinidazole;D014011
C09.218.458.670;Tinnitus;D014012
C10.597.751.418.670;Tinnitus;D014012
C23.888.592.763.393.670;Tinnitus;D014012
D02.455.426.559.389.097.175;1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt;D014013
D02.455.426.559.389.657.166.210;1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt;D014013
D02.886.645.600.080.050.100.150;1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt;D014013
D25.919;Tissue Adhesives;D014014
D27.720.102.919;Tissue Adhesives;D014014
E07.858.690.860;Tissue Adhesives;D014014
J01.637.051.919;Tissue Adhesives;D014014
N02.278.065.900;Tissue Banks;D014015
E06.780.895;Tissue Conditioning (Dental);D014016
G03.787.917;Tissue Distribution;D014018
G07.690.725.949;Tissue Distribution;D014018
M01.898;Tissue Donors;D014019
D20.777;Tissue Extracts;D014020
E01.370.225.500.620.760;Tissue Preservation;D014021
E01.370.225.750.600.760;Tissue Preservation;D014021
E02.792.833;Tissue Preservation;D014021
E05.200.500.620.760;Tissue Preservation;D014021
E05.200.750.600.760;Tissue Preservation;D014021
E05.760.833;Tissue Preservation;D014021
G16.920;Tissue Survival;D014022
E02.095.682.884;Tissue Therapy;D014023
E02.190.701.884;Tissue Therapy;D014023
A10;Tissues;D014024
D01.268.557.800;Titanium;D014025
D01.268.956.878;Titanium;D014025
D01.552.547.800;Titanium;D014025
B01.650.940.800.575.100.905.900;Tobacco;D014026
B04.715.464.725.800;Tobacco Mosaic Virus;D014027
B04.820.464.725.800;Tobacco Mosaic Virus;D014027
D20.633.937.680;Tobacco Smoke Pollution;D014028
N06.850.460.100.555;Tobacco Smoke Pollution;D014028
C25.912;Tobacco Use Disorder;D014029
F03.900.912;Tobacco Use Disorder;D014029
J01.637.836.500;Tobacco, Smokeless;D014030
D09.408.051.476.600.800;Tobramycin;D014031
D02.442.925;Todralazine;D014032
D03.383.710.605.925;Todralazine;D014032
A02.835.583.378.900;Toe Joint;D014033
A01.378.610.250.300.792;Toes;D014034
B04.820.850;Togaviridae;D014035
B04.909.777.923;Togaviridae;D014035
C02.782.930;Togaviridae Infections;D014036
Z01.058.290.190.800;Togo;D014037
N06.850.860.410.560;Toilet Facilities;D014038
N06.850.860.510.490;Toilet Facilities;D014038
F01.318.709;Toilet Training;D014039
F02.463.425.770.836.500;Token Economy;D014040
Z01.252.474.463.709;Tokyo;D014041
Z01.433.900;Tokyo;D014041
D02.886.590.795.834;Tolazamide;D014042
D02.948.828.834;Tolazamide;D014042
D03.383.129.308.436.750;Tolazoline;D014043
D02.886.590.795.896;Tolbutamide;D014044
D02.948.828.896;Tolbutamide;D014044
D03.383.129.578.910;Tolmetin;D014046
D02.241.081.251.869.791;Tolnaftate;D014047
D02.455.426.559.847.638.975;Tolnaftate;D014047
D02.886.706.825;Tolnaftate;D014047
D04.615.638.975;Tolnaftate;D014047
D02.886.369.869;Tolonium Chloride;D014048
D03.494.741.869;Tolonium Chloride;D014048
D02.522.818.950;Tolperisone;D014049
D03.383.725.877;Tolperisone;D014049
D02.455.426.559.389.832;Toluene;D014050
D02.455.426.559.389.832.500;Toluene 2,4-Diisocyanate;D014051
D02.500.800;Toluene 2,4-Diisocyanate;D014051
D02.092.146.859;Toluidines;D014052
D02.455.426.559.389.832.559;Toluidines;D014052
D03.132.760.864;Tomatine;D014053
D09.408.934;Tomatine;D014053
E01.370.350.825;Tomography;D014054
E01.370.350.350.800;Tomography, Emission-Computed;D014055
E01.370.350.600.350.800;Tomography, Emission-Computed;D014055
E01.370.350.710.800;Tomography, Emission-Computed;D014055
E01.370.350.825.800;Tomography, Emission-Computed;D014055
E01.370.384.730.800;Tomography, Emission-Computed;D014055
E01.370.350.700.810;Tomography, X-Ray;D014056
E01.370.350.825.810;Tomography, X-Ray;D014056
E01.370.350.350.810;Tomography, X-Ray Computed;D014057
E01.370.350.600.350.700.810;Tomography, X-Ray Computed;D014057
E01.370.350.700.700.810;Tomography, X-Ray Computed;D014057
E01.370.350.700.810.810;Tomography, X-Ray Computed;D014057
E01.370.350.825.810.810;Tomography, X-Ray Computed;D014057
Z01.639.760.815.890;Tonga;D014058
A03.556.500.885;Tongue;D014059
A14.549.885;Tongue;D014059
C07.465.910;Tongue Diseases;D014060
F01.145.466.874;Tongue Habits;D014061
C04.588.443.591.925;Tongue Neoplasms;D014062
C07.465.565.925;Tongue Neoplasms;D014062
C07.465.910.874;Tongue Neoplasms;D014062
C07.465.910.708;Tongue, Fissured;D014063
C07.465.910.791;Tongue, Hairy;D014064
E01.370.380.750;Tonometry, Ocular;D014065
A04.623.603.925;Palatine Tonsil;D014066
A10.549.580;Palatine Tonsil;D014066
A14.724.603.925;Palatine Tonsil;D014066
A15.382.520.604.580;Palatine Tonsil;D014066
C04.588.443.665.710.684.800;Tonsillar Neoplasms;D014067
C07.550.745.671.800;Tonsillar Neoplasms;D014067
C09.647.710.685.800;Tonsillar Neoplasms;D014067
C09.775.549.685.800;Tonsillar Neoplasms;D014067
E04.580.848;Tonsillectomy;D014068
C07.550.781.750;Tonsillitis;D014069
C08.730.561.750;Tonsillitis;D014069
C09.775.649.750;Tonsillitis;D014069
A14.549.167.860;Tooth;D014070
C07.650.800;Tooth Abnormalities;D014071
C07.793.700;Tooth Abnormalities;D014071
C16.131.850.800;Tooth Abnormalities;D014071
C07.793.818.124;Tooth Abrasion;D014072
E06.420.750;Tooth Bleaching;D014073
G07.700.320.186.710;Tooth Calcification;D014074
G10.549.235.688;Tooth Calcification;D014074
C07.793.735;Tooth Discoloration;D014075
C07.793;Tooth Diseases;D014076
C07.793.818.500;Tooth Erosion;D014077
G10.549.235.726;Tooth Eruption;D014078
C07.793.790;Tooth Eruption, Ectopic;D014079
G10.549.235.764;Tooth Exfoliation;D014080
E04.545.700;Tooth Extraction;D014081
E06.645.700;Tooth Extraction;D014081
C07.793.850.750;Tooth Fractures;D014082
C26.900.750;Tooth Fractures;D014082
A14.549.167.900.720;Tooth Germ;D014083
C07.793.850.725;Tooth Avulsion;D014084
C26.900.725;Tooth Avulsion;D014084
C07.465.714.836;Tooth Migration;D014085
G10.549.235.803;Tooth Migration;D014085
C07.465.714.898;Tooth Mobility;D014086
G10.549.840;Tooth Mobility;D014086
E06.658.578.836;Tooth Movement;D014087
G10.549.845;Tooth Permeability;D014088
E06.950;Tooth Remineralization;D014089
E04.545.710;Tooth Replantation;D014090
E04.936.494.711;Tooth Replantation;D014090
E06.397.898;Tooth Replantation;D014090
E06.645.710;Tooth Replantation;D014090
C07.793.901;Tooth Resorption;D014091
G10.549.235.917;Tooth Resorption;D014091
A14.549.167.900.750;Tooth Root;D014092
E06.780.345.875;Tooth, Artificial;D014093
E07.695.190.800;Tooth, Artificial;D014093
A14.549.167.860.700;Tooth, Deciduous;D014094
C07.793.846;Tooth, Impacted;D014095
C07.650.800.850;Tooth, Supernumerary;D014096
C07.793.700.850;Tooth, Supernumerary;D014096
C16.131.850.800.850;Tooth, Supernumerary;D014096
A14.549.167.860.715;Tooth, Unerupted;D014097
C07.793.915;Tooth, Unerupted;D014097
C07.793.929;Toothache;D014098
C23.888.646.429.800;Toothache;D014098
E06.761.726.794;Toothbrushing;D014099
D25.376.711;Toothpastes;D014100
J01.637.051.376.711;Toothpastes;D014100
B01.050.150.900.493.370.935;Torpedo;D014101
B01.050.150.900.493.378.722;Torpedo;D014101
C23.300.970;Torsion Abnormality;D014102
C10.228.662.300.750;Torticollis;D014103
C10.597.350.300.800;Torticollis;D014103
C23.888.592.350.300.800;Torticollis;D014103
I01.198.240.856.825;Torture;D014104
I01.880.735.900.825;Torture;D014104
D02.455.426.559.389.832.661;Tosyl Compounds;D014105
D02.886.590.887;Tosyl Compounds;D014105
D02.455.426.559.389.832.670;Tosylarginine Methyl Ester;D014106
D02.886.590.887.570;Tosylarginine Methyl Ester;D014106
D12.125.068.050.900;Tosylarginine Methyl Ester;D014106
D12.125.095.104.900;Tosylarginine Methyl Ester;D014106
D02.455.426.559.389.832.690;Tosyllysine Chloromethyl Ketone;D014107
D02.886.590.887.600;Tosyllysine Chloromethyl Ketone;D014107
D12.125.065.850;Tosyllysine Chloromethyl Ketone;D014107
D02.455.426.559.389.832.710;Tosylphenylalanyl Chloromethyl Ketone;D014108
D02.886.590.887.660;Tosylphenylalanyl Chloromethyl Ketone;D014108
D12.125.065.930;Tosylphenylalanyl Chloromethyl Ketone;D014108
E01.370.386.700.485.750;Total Lung Capacity;D014109
G09.772.850;Total Lung Capacity;D014109
F02.830.816.850;Touch;D014110
G11.561.600.810.850;Touch;D014110
E07.926;Tourniquets;D014111
D02.455.526.439.913;Toxaphene;D014112
D02.455.849.575.781.795;Toxaphene;D014112
B01.050.500.500.294.700.100.100.700;Toxascaris;D014114
C01.539.861;Toxemia;D014115
H01.158.703.795;Toxicology;D014116
H02.628.795;Toxicology;D014116
D02.092.877.844;Toxiferine;D014117
D02.675.276.844;Toxiferine;D014117
D03.132.098.833;Toxiferine;D014117
D03.438.531.085.777;Toxiferine;D014117
D03.438.531.820.687;Toxiferine;D014117
D23.946;Toxins, Biological;D014118
B01.050.500.500.294.700.100.100.780;Toxocara;D014119
C03.335.349.868;Toxocariasis;D014120
C03.335.508.700.100.868;Toxocariasis;D014120
C03.701.377.868;Toxocariasis;D014120
C22.674.377.868;Toxocariasis;D014120
D20.215.894.691;Toxoids;D014121
B01.043.075.189.250.750.800;Toxoplasma;D014122
C03.752.250.800;Toxoplasmosis;D014123
C03.701.688.817;Toxoplasmosis, Animal;D014124
C03.752.250.800.110;Toxoplasmosis, Animal;D014124
C03.752.625.817;Toxoplasmosis, Animal;D014124
C22.674.710.817;Toxoplasmosis, Animal;D014124
C03.752.250.800.445;Toxoplasmosis, Congenital;D014125
C10.228.228.205.300.900;Toxoplasmosis, Congenital;D014125
C16.614.909;Toxoplasmosis, Congenital;D014125
C03.300.781;Toxoplasmosis, Ocular;D014126
C03.752.250.800.640;Toxoplasmosis, Ocular;D014126
C11.294.725.781;Toxoplasmosis, Ocular;D014126
D13.570.800.840;Toyocamycin;D014127
D09.408.210.209;Chromomycin A3;D014128
A09.371.060.932;Trabecular Meshwork;D014129
E04.540.450.700;Trabeculectomy;D014130
D27.505.696.377.605.555;Trace Elements;D014131
J02.500.631.555;Trace Elements;D014131
A04.889;Trachea;D014132
C08.907;Tracheal Diseases;D014133
C04.588.443.925;Tracheal Neoplasms;D014134
C04.588.894.797.760;Tracheal Neoplasms;D014134
C08.785.760;Tracheal Neoplasms;D014134
C08.907.563;Tracheal Neoplasms;D014134
C08.907.663;Tracheal Stenosis;D014135
C08.730.848;Tracheitis;D014136
C08.907.763;Tracheitis;D014136
C08.127.930;Tracheobronchomegaly;D014137
C08.695.830;Tracheobronchomegaly;D014137
C08.907.830;Tracheobronchomegaly;D014137
C16.131.740.830;Tracheobronchomegaly;D014137
C06.267.250.725;Tracheoesophageal Fistula;D014138
C06.405.117.367.725;Tracheoesophageal Fistula;D014138
C08.702.750;Tracheoesophageal Fistula;D014138
C08.907.863;Tracheoesophageal Fistula;D014138
C23.300.575.185.250.725;Tracheoesophageal Fistula;D014138
E02.041.750;Tracheostomy;D014139
E04.579.935;Tracheostomy;D014139
E04.580.900;Tracheostomy;D014139
E04.928.780;Tracheostomy;D014139
E04.580.907;Tracheotomy;D014140
E04.928.790;Tracheotomy;D014140
C01.252.354.225.800;Trachoma;D014141
C01.252.400.210.210.800;Trachoma;D014141
C01.539.375.354.220.800;Trachoma;D014141
C11.187.183.220.889;Trachoma;D014141
C11.204.813;Trachoma;D014141
C11.294.354.220.800;Trachoma;D014141
C23.996.850;Trachoma;D014141
I03.450.642.845.925;Track and Field;D014142
E04.555.720;Traction;D014143
D05.750.078.739.750;Tragacanth;D014144
D09.698.700.750;Tragacanth;D014144
D20.215.721.249.750;Tragacanth;D014144
F04.711.513.838;Trail Making Test;D014145
N03.219.483.838;Training Support;D014146
D02.033.480.300.802;Tramadol;D014147
D02.092.668.387.750;Tramadol;D014147
D02.241.223.268.860;Tranexamic Acid;D014148
D27.505.696.277.950;Tranquilizing Agents;D014149
D27.505.954.427.210.950;Tranquilizing Agents;D014149
D27.505.954.427.700.872;Tranquilizing Agents;D014149
D27.505.696.277.950.040;Antipsychotic Agents;D014150
D27.505.954.427.210.950.040;Antipsychotic Agents;D014150
D27.505.954.427.700.872.331;Antipsychotic Agents;D014150
D27.505.696.277.950.015;Anti-Anxiety Agents;D014151
D27.505.954.427.210.950.015;Anti-Anxiety Agents;D014151
D27.505.954.427.700.872.015;Anti-Anxiety Agents;D014151
F04.754.709.838;Transactional Analysis;D014152
D08.811.913.200.650;Transaldolase;D014153
Z01.542.900;Transcaucasia;D014154
D12.776.124.790.900;Transcobalamins;D014155
D12.776.157.800;Transcobalamins;D014155
D12.776.377.715.900;Transcobalamins;D014155
D12.644.861.915;Transcortin;D014156
D12.776.124.790.106.901;Transcortin;D014156
D12.776.157.818;Transcortin;D014156
D12.776.377.715.085.901;Transcortin;D014156
D12.776.395.901;Transcortin;D014156
D12.776.872.915;Transcortin;D014156
D12.776.930;Transcription Factors;D014157
G02.111.087.847;Transcription, Genetic;D014158
G02.149.115.847;Transcription, Genetic;D014158
G05.355.310.700;Transcription, Genetic;D014158
E07.305.812;Transducers;D014159
E07.305.812.901;Transducers, Pressure;D014160
E05.393.350.800;Transduction, Genetic;D014161
G05.355.760.850;Transduction, Genetic;D014161
E05.393.350.810;Transfection;D014162
G05.355.760.860;Transfection;D014162
F02.463.425.910;Transfer (Psychology);D014163
N04.452.602.713;Transfer Agreement;D014164
D12.644.276.374.480.750;Transfer Factor;D014165
D12.776.467.374.480.750;Transfer Factor;D014165
D23.529.374.480.750;Transfer Factor;D014165
D08.811.913;Transferases;D014166
F04.754.720.864;Transference (Psychology);D014167
D12.776.124.050.800;Transferrin;D014168
D12.776.124.790.223.839;Transferrin;D014168
D12.776.157.427.750.500;Transferrin;D014168
D12.776.377.715.182.839;Transferrin;D014168
D12.776.556.579.750.500;Transferrin;D014168
E05.393.350.810.500;Transformation, Bacterial;D014169
G05.355.760.860.500;Transformation, Bacterial;D014169
G05.355.760.865.820;Transformation, Bacterial;D014169
G06.099.112.805;Transformation, Bacterial;D014169
G06.590.110.805;Transformation, Bacterial;D014169
G05.355.760.865;Transformation, Genetic;D014170
M01.920;Transients and Migrants;D014171
E01.370.350.589.500;Transillumination;D014172
E05.642.500;Transillumination;D014172
E07.305.625.714;Transistors, Electronic;D014173
D08.811.913.200.825;Transketolase;D014174
L01.143.506.423.796;Translating;D014175
G02.111.087.675.871;Protein Biosynthesis;D014176
G02.149.115.675.871;Protein Biosynthesis;D014176
G03.495.770.871;Protein Biosynthesis;D014176
G05.355.310.670;Protein Biosynthesis;D014176
L01.178.682.920;Translations;D014177
C23.550.210.870;Translocation, Genetic;D014178
G05.355.600.860;Translocation, Genetic;D014178
G05.365.590.175.870;Translocation, Genetic;D014178
D27.505.519.625.600;Neurotransmitter Uptake Inhibitors;D014179
D27.505.696.577.600;Neurotransmitter Uptake Inhibitors;D014179
E04.936;Transplantation;D014180
G12.425.901;Transplantation Immunology;D014181
E04.936.664;Transplantation, Autologous;D014182
E04.936.764;Transplantation, Heterologous;D014183
E04.936.864;Transplantation, Homologous;D014184
E04.936.864.700;Transplantation, Isogeneic;D014185
J01.937;Transportation;D014186
E02.365.839;Transportation of Patients;D014187
N02.421.297.879;Transportation of Patients;D014187
C14.240.400.915;Transposition of Great Vessels;D014188
C14.280.400.915;Transposition of Great Vessels;D014188
C16.131.240.400.915;Transposition of Great Vessels;D014188
F03.800.800.800;Transsexualism;D014189
F03.800.800.600.800;Transvestism;D014190
D02.092.831.845;Tranylcypromine;D014191
D03.383.129.799.900;Trapidil;D014192
D03.383.742.875;Trapidil;D014192
N02.278.354.422.336.500;Trauma Centers;D014193
N02.421.297.195.480;Trauma Centers;D014193
N04.452.442.422.336.400;Trauma Centers;D014193
H02.403.810.850;Traumatology;D014194
I03.883;Travel;D014195
D03.383.606.900;Trazodone;D014196
D03.383.725.791.900;Trazodone;D014196
B01.650.915;Trees;D014197
D08.811.277.450.329.865;Trehalase;D014198
D09.698.365.900;Trehalose;D014199
D09.698.629.305.880;Trehalose;D014199
B01.050.500.500.736.715;Trematoda;D014200
C03.335.865;Trematode Infections;D014201
C10.597.350.850;Tremor;D014202
C23.888.592.350.850;Tremor;D014202
D03.383.773.906;Tremorine;D014203
D04.808.365.415.930;Trenbolone Acetate;D014204
C01.252.400.126.100.800;Trench Fever;D014205
E04.525.850;Trephining;D014207
B03.440.425.410.711.795;Treponema;D014208
B03.851.595.795;Treponema;D014208
E01.370.225.812.735.850.800;Treponema Immobilization Test;D014209
E05.200.812.735.850.800;Treponema Immobilization Test;D014209
E05.478.594.760.850.800;Treponema Immobilization Test;D014209
B03.440.425.410.711.795.840;Treponema pallidum;D014210
B03.851.595.795.840;Treponema pallidum;D014210
C01.252.400.840;Treponemal Infections;D014211
C01.252.847.840;Treponemal Infections;D014211
D02.455.326.271.665.202.495.818.500;Tretinoin;D014212
D02.455.426.392.368.367.379.249.700.860.500;Tretinoin;D014212
D02.455.849.131.495.818.800;Tretinoin;D014212
D23.767.261.700.780;Tretinoin;D014212
D03.438.531.085.888;Tretoquinol;D014213
D02.241.081.251.869.820;Triallate;D014214
D02.886.706.850;Triallate;D014214
D10.351.801.632;Triacetin;D014215
D02.389.678.900;Triacetoneamine-N-Oxyl;D014216
D03.383.621.808.930;Triacetoneamine-N-Oxyl;D014216
D03.661.243.930;Triacetoneamine-N-Oxyl;D014216
D02.540.505.600.800;Troleandomycin;D014217
N02.421.297.900;Triage;D014218
G08.686.785.760.769.326.660;Trial of Labor;D014219
D02.691.850.900;Trialkyltin Compounds;D014220
D04.808.745.432.915;Triamcinolone;D014221
D04.808.908.891;Triamcinolone;D014221
D04.808.745.432.915.715;Triamcinolone Acetonide;D014222
D04.808.908.891.927;Triamcinolone Acetonide;D014222
D03.438.733.900;Triamterene;D014223
B01.050.500.131.617.412.420.700.850.800;Triatoma;D014224
B01.050.500.131.617.412.420.700.850;Triatominae;D014225
D02.925;Triazenes;D014226
D03.383.931;Triazines;D014227
D03.383.097.217.900;Triaziquone;D014228
D03.438.079.080.900;Triazolam;D014229
D03.383.129.799;Triazoles;D014230
B01.050.500.131.617.069.799;Tribolium;D014231
D02.241.081.901;Tricarboxylic Acids;D014233
B01.050.500.500.294.100.275.780.608;Trichinella;D014234
C03.335.508.100.275.882;Trichinellosis;D014235
D02.705.429.937;Trichlorfon;D014236
D02.886.590.700.135.261.476.716;Trichlormethiazide;D014237
D02.886.655.500.261.476.716;Trichlormethiazide;D014237
D03.438.174.261.476.716;Trichlormethiazide;D014237
D02.241.081.018.214.750;Trichloroacetic Acid;D014238
D02.455.526.439.196.750;Trichloroacetic Acid;D014238
D02.355.291.411.900;Trichloroepoxypropane;D014239
D02.455.526.439.920;Trichloroepoxypropane;D014239
D02.455.526.439.927;Trichloroethanes;D014240
D02.455.526.439.939;Trichloroethylene;D014241
B01.300.381.910;Trichoderma;D014242
D02.455.849.765.850.900;Trichodermin;D014243
D04.345.891.900;Trichodermin;D014243
D23.946.587.933.900;Trichodermin;D014243
B01.630.800.808;Trichomonas;D014244
C03.752.890;Trichomonas Infections;D014245
B01.630.800.808.717;Trichomonas vaginalis;D014246
C03.752.890.633;Trichomonas Vaginitis;D014247
C13.351.500.894.906.633;Trichomonas Vaginitis;D014247
D23.050.202.800;Trichophytin;D014248
B01.300.381.928;Trichophyton;D014249
B01.300.381.940;Trichosporon;D014250
B01.300.930.930;Trichosporon;D014250
B01.050.500.500.294.700.775.746;Trichostrongyloidea;D014251
C03.335.508.700.775.825;Trichostrongyloidiasis;D014252
C03.335.508.700.775.825.842;Trichostrongylosis;D014253
B01.050.500.500.294.700.775.746.610;Trichostrongylus;D014254
D02.455.849.765.850;Trichothecenes;D014255
D04.345.891;Trichothecenes;D014255
D23.946.587.933;Trichothecenes;D014255
F03.500.800;Trichotillomania;D014256
C03.335.508.100.275.895;Trichuriasis;D014257
B01.050.500.500.294.100.275.780.628;Trichuris;D014258
B01.050.500.500.294.100.275.780;Trichuroidea;D014259
D02.355.726.900;Triclosan;D014260
D02.455.426.559.389.657.654.900;Triclosan;D014260
A07.541.510.893;Tricuspid Valve;D014261
C14.280.484.856;Tricuspid Valve Insufficiency;D014262
C14.280.484.400.875;Tricuspid Valve Prolapse;D014263
C14.280.484.911;Tricuspid Valve Stenosis;D014264
D03.383.097.217.924;Triethylenemelamine;D014265
D03.383.931.915;Triethylenemelamine;D014265
D02.092.782.258.368.880;Trientine;D014266
D02.691.850.900.910;Triethyltin Compounds;D014267
D02.886.369.898;Trifluoperazine;D014268
D03.494.741.898;Trifluoperazine;D014268
D02.241.081.018.285.500;Trifluoroacetic Acid;D014269
D02.455.526.510.286.500;Trifluoroacetic Acid;D014269
D02.033.375.880;Trifluoroethanol;D014270
D03.383.742.680.705.900;Trifluridine;D014271
D13.570.230.855.900;Trifluridine;D014271
D13.570.685.705.900;Trifluridine;D014271
D02.522.352.867;Trifluperidol;D014272
D02.886.369.918;Triflupromazine;D014273
D03.494.741.918;Triflupromazine;D014273
D02.092.146.859.717;Trifluralin;D014274
D02.455.426.559.389.832.767;Trifluralin;D014274
A08.186.211.132.931.920.927;Trigeminal Caudal Nucleus;D014275
A08.800.800.120.760;Trigeminal Nerve;D014276
C10.292.775.700;Trigeminal Neuralgia;D014277
A08.186.211.132.931;Trigeminal Nuclei;D014278
A08.186.211.132.931.920;Trigeminal Nucleus, Spinal;D014279
D10.351.801;Triglycerides;D014280
D02.065.313.906;Trihexosylceramides;D014281
D09.400.410.420.525.200.906;Trihexosylceramides;D014281
D10.390.470.675.200.906;Trihexosylceramides;D014281
D10.570.877.360.612.200.906;Trihexosylceramides;D014281
D03.383.621.900;Trihexyphenidyl;D014282
D02.241.223.100.400.880;Triiodobenzoic Acids;D014283
D02.455.426.559.389.127.375.880;Triiodobenzoic Acids;D014283
D06.472.931.740.385;Triiodothyronine;D014284
D12.125.072.050.767.741.894;Triiodothyronine;D014284
D06.472.931.740.590;Triiodothyronine, Reverse;D014285
D12.125.072.050.767.741.947;Triiodothyronine, Reverse;D014285
C14.240.400.960;Trilogy of Fallot;D014286
C14.280.400.960;Trilogy of Fallot;D014286
C16.131.240.400.960;Trilogy of Fallot;D014286
D02.241.223.100.300.350.750;Trimebutine;D014287
D02.241.511.390.350.750;Trimebutine;D014287
D02.455.426.559.389.127.281.350.750;Trimebutine;D014287
D02.455.426.559.389.657.654.638.750;Trimebutine;D014287
D02.065.199.092.900;Trimecaine;D014288
D02.092.570.665.850;Trimedoxime;D014289
D03.383.725.762.900;Trimedoxime;D014289
D02.033.100.624.545;Metipranolol;D014290
D02.033.100.624.698.542;Metipranolol;D014290
D02.033.755.624.545;Metipranolol;D014290
D02.033.755.624.698.542;Metipranolol;D014290
D02.092.063.624.698.542;Metipranolol;D014290
D02.886.369.939;Trimeprazine;D014291
D03.494.741.939;Trimeprazine;D014291
D03.383.606.920;Trimetazidine;D014292
D03.383.129.462.883;Trimethadione;D014293
D03.383.129.308.935;Trimethaphan;D014294
D03.383.742.906;Trimethoprim;D014295
G06.099.225.968;Trimethoprim Resistance;D014296
G06.225.347.968;Trimethoprim Resistance;D014296
G07.690.320.269.347.968;Trimethoprim Resistance;D014296
D02.715.715;Trimethylsilyl Compounds;D014297
D02.691.850.900.950;Trimethyltin Compounds;D014298
D03.494.240.918;Trimipramine;D014299
Z01.107.084.900.900;Trinidad and Tobago;D014300
Z01.639.880.900;Trinidad and Tobago;D014300
D02.455.426.559.389.565.880;Trinitrobenzenes;D014301
D02.640.529.880;Trinitrobenzenes;D014301
D02.455.426.559.389.565.880.880;Trinitrobenzenesulfonic Acid;D014302
D02.640.529.880.900;Trinitrobenzenesulfonic Acid;D014302
D02.886.645.600.080.900;Trinitrobenzenesulfonic Acid;D014302
D02.455.426.559.389.832.868;Trinitrotoluene;D014303
D10.212.507.850;Triolein;D014304
D10.351.801.801;Triolein;D014304
D08.811.399.475.200.775;Triose-Phosphate Isomerase;D014305
D09.546.894;Trioses;D014306
D03.438.150.446.794.875;Trioxsalen;D014307
D03.494.770.875;Trioxsalen;D014307
D03.830.219.446.794.875;Trioxsalen;D014307
D02.455.426.559.389.875;Triparanol;D014308
D02.092.782.258.368.900;Tripelennamine;D014309
D03.383.725.050.920;Tripelennamine;D014309
M01.438.768;Triplets;D014310
D03.383.725.932;Triprolidine;D014311
D09.698.629.802;Trisaccharides;D014312
C10.597.613.750.700;Trismus;D014313
C23.888.592.608.750.700;Trismus;D014313
C23.550.210.050.750;Trisomy;D014314
C23.550.210.182.500;Trisomy;D014314
G05.365.590.175.050.750;Trisomy;D014314
G05.365.590.175.183.500;Trisomy;D014314
G05.700.131.750;Trisomy;D014314
D02.455.849.919;Triterpenes;D014315
D01.435.719;Tritium;D014316
D01.496.749.925;Tritium;D014316
D02.455.426.559.389.657.239.900;Tritolyl Phosphates;D014317
D02.705.400.875;Tritolyl Phosphates;D014317
B01.630.800.849;Tritrichomonas;D014318
B01.050.150.900.090.608.700.670;Triturus;D014319
D02.455.426.559.389.884;Trityl Compounds;D014320
A08.800.800.120.800;Trochlear Nerve;D014321
B01.050.500.500.736.715.800;Troglotrematidae;D014322
C03.858.211.480.869;Trombiculiasis;D014323
B01.050.500.131.166.132.419.875;Trombiculidae;D014324
D02.033.455.706.900;Tromethamine;D014325
D02.145.074.722;Tropanes;D014326
D03.132.889;Tropanes;D014326
D03.605.869;Tropanes;D014326
D04.075.080.875.099.722;Tropanes;D014326
A11.382.992;Trophoblasts;D014327
A16.254.500.766;Trophoblasts;D014327
A16.710.802;Trophoblasts;D014327
C04.557.465.955;Trophoblastic Neoplasms;D014328
C04.850.908;Trophoblastic Neoplasms;D014328
C13.703.720.949;Trophoblastic Neoplasms;D014328
G16.500.275.071.600;Tropical Climate;D014329
N06.230.300.100.250.600;Tropical Climate;D014329
C01.539.878;Tropical Medicine;D014330
D03.383.725.942;Tropicamide;D014331
D12.776.860.300.250.700;Tropocollagen;D014332
D12.776.811.850;Tropoelastin;D014333
D12.776.860.300.350.700;Tropoelastin;D014333
D02.455.426.392.368.284.900;Tropolone;D014334
D05.750.078.730.800;Tropomyosin;D014335
D12.776.210.500.895;Tropomyosin;D014335
D12.776.220.525.800;Tropomyosin;D014335
D05.750.078.730.825;Troponin;D014336
D12.776.210.500.910;Troponin;D014336
D12.776.220.525.825;Troponin;D014336
B01.050.150.900.493.817.750.825;Trout;D014337
A07.541.278.930;Truncus Arteriosus;D014338
A16.378.303.930;Truncus Arteriosus;D014338
C14.240.400.560.098.500;Truncus Arteriosus, Persistent;D014339
C14.280.400.560.098.500;Truncus Arteriosus, Persistent;D014339
C16.131.240.400.560.098.500;Truncus Arteriosus, Persistent;D014339
E07.858.925;Trusses;D014340
M01.526.070.940;Trustees;D014341
N04.452.394.600;Trustees;D014341
F01.829.401.046.800;Truth Disclosure;D014342
I01.880.604.583.080.134.800;Truth Disclosure;D014342
D02.172.975;Trypan Blue;D014343
D02.455.426.559.847.638.555.875;Trypan Blue;D014343
D02.886.645.600.080.050.650.875;Trypan Blue;D014343
D04.615.638.555.875;Trypan Blue;D014343
D27.505.954.122.250.100.875;Trypanocidal Agents;D014344
B01.268.475.868.887;Trypanosoma;D014345
B01.268.475.868.887.080;Trypanosoma brucei brucei;D014346
B01.268.475.868.887.110;Trypanosoma brucei gambiense;D014347
B01.268.475.868.887.128;Trypanosoma congolense;D014348
B01.268.475.868.887.140;Trypanosoma cruzi;D014349
B01.268.475.868.887.410;Trypanosoma lewisi;D014350
B01.268.475.868;Trypanosomatina;D014351
C03.752.300.900;Trypanosomiasis;D014352
C23.996.860;Trypanosomiasis;D014352
C03.752.300.900.719;Trypanosomiasis, African;D014353
C23.996.860.870;Trypanosomiasis, African;D014353
C03.701.688.896;Trypanosomiasis, Bovine;D014354
C03.752.300.900.802;Trypanosomiasis, Bovine;D014354
C03.752.625.896;Trypanosomiasis, Bovine;D014354
C22.196.888;Trypanosomiasis, Bovine;D014354
C22.674.710.896;Trypanosomiasis, Bovine;D014354
C03.752.300.900.200;Chagas Disease;D014355
C23.996.200;Chagas Disease;D014355
D08.811.277.656.300.760.895;Trypsin;D014357
D08.811.277.656.959.350.895;Trypsin;D014357
D12.776.765.741.500;Trypsin Inhibitor, Bowman-Birk Soybean;D014358
D12.776.124.050.850;Trypsin Inhibitor, Kazal Pancreatic;D014359
D12.776.765.741.750;Trypsin Inhibitor, Kunitz Soybean;D014360
D27.505.519.389.745.800.900;Trypsin Inhibitors;D014361
D08.622.885;Trypsinogen;D014362
D02.092.211.215.801;Tryptamines;D014363
D03.438.473.914;Tryptamines;D014363
D12.125.072.050.850;Tryptophan;D014364
D12.125.142.875;Tryptophan;D014364
D08.811.682.690.708.870;Tryptophan Hydroxylase;D014365
D08.811.682.690.416.722;Tryptophan Oxygenase;D014366
D08.811.520.241.300.850;Tryptophan Synthase;D014367
D08.811.600.896;Tryptophan Synthase;D014367
D08.811.520.224.800;Tryptophanase;D014368
D08.811.464.263.200.850;Tryptophan-tRNA Ligase;D014369
B01.050.500.131.617.289.400.700;Tsetse Flies;D014370
A08.186.211.730.317.357.352.870;Tuber Cinereum;D014371
D03.438.759.590.910;Tubercidin;D014372
D13.570.583.910;Tubercidin;D014372
D13.570.800.850;Tubercidin;D014372
D23.050.161.845;Tuberculin;D014373
E01.370.225.812.871.800;Tuberculin Test;D014374
E05.200.812.871.800;Tuberculin Test;D014374
E05.478.594.890.800;Tuberculin Test;D014374
C01.252.410.040.552.846.493;Tuberculoma;D014375
C01.252.410.040.552.846;Tuberculosis;D014376
N03.540.630.780.850;Tuberculosis Societies;D014378
C01.252.410.040.552.846.516;Tuberculosis, Avian;D014379
C22.131.921;Tuberculosis, Avian;D014379
C01.252.410.040.552.846.538;Tuberculosis, Bovine;D014380
C22.196.927;Tuberculosis, Bovine;D014380
C01.252.410.040.552.846.561;Tuberculosis, Cardiovascular;D014381
C01.539.190.750;Tuberculosis, Cardiovascular;D014381
C14.260.750;Tuberculosis, Cardiovascular;D014381
C01.252.410.040.552.846.583;Tuberculosis, Cutaneous;D014382
C01.252.825.820;Tuberculosis, Cutaneous;D014382
C01.539.800.720.820;Tuberculosis, Cutaneous;D014382
C17.800.838.765.820;Tuberculosis, Cutaneous;D014382
C01.252.410.040.552.846.606;Tuberculosis, Endocrine;D014383
C19.927;Tuberculosis, Endocrine;D014383
C01.252.410.040.552.846.944.596;Tuberculosis, Female Genital;D014384
C13.351.500.758;Tuberculosis, Female Genital;D014384
C13.351.750.940;Tuberculosis, Female Genital;D014384
C01.252.410.040.552.846.628;Tuberculosis, Gastrointestinal;D014385
C06.405.874;Tuberculosis, Gastrointestinal;D014385
C01.252.410.040.552.846.651;Tuberculosis, Hepatic;D014386
C06.552.933;Tuberculosis, Hepatic;D014386
C01.252.410.040.552.846.696;Tuberculosis, Laryngeal;D014387
C08.360.860;Tuberculosis, Laryngeal;D014387
C08.730.860;Tuberculosis, Laryngeal;D014387
C09.400.860;Tuberculosis, Laryngeal;D014387
C01.252.410.040.552.846.719;Tuberculosis, Lymph Node;D014388
C15.604.315.809;Tuberculosis, Lymph Node;D014388
C15.604.921;Tuberculosis, Lymph Node;D014388
C01.252.410.040.552.846.944.721;Tuberculosis, Male Genital;D014389
C12.294.909;Tuberculosis, Male Genital;D014389
C12.672.721;Tuberculosis, Male Genital;D014389
C01.252.200.500.800;Tuberculosis, Meningeal;D014390
C01.252.410.040.552.846.570.600;Tuberculosis, Meningeal;D014390
C10.228.228.180.500.937;Tuberculosis, Meningeal;D014390
C10.228.228.180.850.800;Tuberculosis, Meningeal;D014390
C10.228.228.507.280.915;Tuberculosis, Meningeal;D014390
C01.252.410.040.552.846.764;Tuberculosis, Miliary;D014391
C01.252.354.800;Tuberculosis, Ocular;D014392
C01.252.410.040.552.846.786;Tuberculosis, Ocular;D014392
C01.539.375.354.800;Tuberculosis, Ocular;D014392
C11.294.354.800;Tuberculosis, Ocular;D014392
C01.252.410.040.552.846.809;Tuberculosis, Oral;D014393
C07.465.943;Tuberculosis, Oral;D014393
C01.252.410.040.552.846.831;Tuberculosis, Osteoarticular;D014394
C01.539.160.886;Tuberculosis, Osteoarticular;D014394
C05.116.165.886;Tuberculosis, Osteoarticular;D014394
C01.252.410.040.552.846.246;Peritonitis, Tuberculous;D014395
C01.539.463.600.249;Peritonitis, Tuberculous;D014395
C06.844.640.249;Peritonitis, Tuberculous;D014395
C01.252.410.040.552.846.877;Tuberculosis, Pleural;D014396
C08.528.928;Tuberculosis, Pleural;D014396
C08.730.912;Tuberculosis, Pleural;D014396
C01.252.410.040.552.846.899;Tuberculosis, Pulmonary;D014397
C08.381.922;Tuberculosis, Pulmonary;D014397
C08.730.939;Tuberculosis, Pulmonary;D014397
C01.252.410.040.552.846.944.847;Tuberculosis, Renal;D014398
C12.672.847;Tuberculosis, Renal;D014398
C12.777.419.912;Tuberculosis, Renal;D014398
C13.351.750.970;Tuberculosis, Renal;D014398
C13.351.968.419.912;Tuberculosis, Renal;D014398
C01.252.410.040.552.846.831.722;Tuberculosis, Spinal;D014399
C01.539.160.886.722;Tuberculosis, Spinal;D014399
C05.116.165.886.722;Tuberculosis, Spinal;D014399
C05.116.900.853.850;Tuberculosis, Spinal;D014399
C01.252.410.040.552.846.922;Tuberculosis, Splenic;D014400
C15.604.744.909;Tuberculosis, Splenic;D014400
C01.252.410.040.552.846.944;Tuberculosis, Urogenital;D014401
C12.672;Tuberculosis, Urogenital;D014401
C13.351.750;Tuberculosis, Urogenital;D014401
C04.445.810;Tuberous Sclerosis;D014402
C04.651.800;Tuberous Sclerosis;D014402
C04.700.632;Tuberous Sclerosis;D014402
C10.500.507.875;Tuberous Sclerosis;D014402
C10.562.850;Tuberous Sclerosis;D014402
C10.574.500.865;Tuberous Sclerosis;D014402
C16.131.666.507.875;Tuberous Sclerosis;D014402
C16.320.400.880;Tuberous Sclerosis;D014402
C16.320.700.636;Tuberous Sclerosis;D014402
D02.092.877.922;Tubocurarine;D014403
D02.675.276.922;Tubocurarine;D014403
D03.132.098.916;Tubocurarine;D014403
D03.438.531.085.944;Tubocurarine;D014403
D03.438.531.820.875;Tubocurarine;D014403
D05.750.078.734.800;Tubulin;D014404
D12.776.220.600.800;Tubulin;D014404
D12.776.641.920;Tubulin;D014404
D12.644.456.840;Tuftsin;D014405
D12.644.541.500.650.750;Tuftsin;D014405
D12.776.124.486.485.397.500;Tuftsin;D014405
D12.776.124.486.485.680.650.750;Tuftsin;D014405
D12.776.124.790.651.397.500;Tuftsin;D014405
D12.776.124.790.651.680.650.750;Tuftsin;D014405
D12.776.377.715.548.397.500;Tuftsin;D014405
D12.776.377.715.548.680.650.750;Tuftsin;D014405
C01.252.400.825.900;Tularemia;D014406
C01.252.400.939;Tularemia;D014406
A11.251.860;Tumor Cells, Cultured;D014407
D23.101.840;Tumor Markers, Biological;D014408
D12.644.276.374.500.800;Tumor Necrosis Factor-alpha;D014409
D12.644.276.374.750.626;Tumor Necrosis Factor-alpha;D014409
D12.644.276.972.626;Tumor Necrosis Factor-alpha;D014409
D12.776.124.900;Tumor Necrosis Factor-alpha;D014409
D12.776.395.930;Tumor Necrosis Factor-alpha;D014409
D12.776.467.374.500.800;Tumor Necrosis Factor-alpha;D014409
D12.776.467.374.750.626;Tumor Necrosis Factor-alpha;D014409
D12.776.467.972.626;Tumor Necrosis Factor-alpha;D014409
D23.529.374.500.800;Tumor Necrosis Factor-alpha;D014409
D23.529.374.750.626;Tumor Necrosis Factor-alpha;D014409
D23.529.972.626;Tumor Necrosis Factor-alpha;D014409
E01.370.225.500.383.910;Tumor Stem Cell Assay;D014410
E01.370.225.500.388.930;Tumor Stem Cell Assay;D014410
E05.200.500.383.910;Tumor Stem Cell Assay;D014410
E05.200.500.388.930;Tumor Stem Cell Assay;D014410
E05.242.383.910;Tumor Stem Cell Assay;D014410
E05.242.388.930;Tumor Stem Cell Assay;D014410
E05.337.550.200.800;Tumor Stem Cell Assay;D014410
A11.872.650;Neoplastic Stem Cells;D014411
C02.928;Tumor Virus Infections;D014412
C04.619.935;Tumor Virus Infections;D014412
C04.925;Tumor Virus Infections;D014412
B01.050.150.900.493.602.825;Tuna;D014413
D01.268.556.887;Tungsten;D014414
D01.268.956.882;Tungsten;D014414
D01.552.544.887;Tungsten;D014414
D03.383.742.680.725;Tunicamycin;D014415
D13.570.685.725;Tunicamycin;D014415
Z01.058.266.887;Tunisia;D014416
B01.050.150.900.649.875.770.770;Tupaia;D014417
B01.050.150.900.649.875.770;Tupaiidae;D014418
B01.050.500.500.736.847;Turbellaria;D014419
A02.835.232.781.324.948;Turbinates;D014420
A04.531.898;Turbinates;D014420
Z01.252.245.500.850;Turkey;D014421
Z01.586.500.850;Turkey;D014421
B01.050.150.900.248.350.800;Turkeys;D014422
B01.050.150.900.248.617.800;Turkeys;D014422
Z01.252.100.940;Turkmenistan;D014423
Z01.586.200.940;Turkmenistan;D014423
Z01.586.950.940;Turkmenistan;D014423
C12.706.316.309.872;Turner Syndrome;D014424
C12.706.316.795.750;Turner Syndrome;D014424
C13.351.875.253.309.872;Turner Syndrome;D014424
C13.351.875.253.795.750;Turner Syndrome;D014424
C14.240.400.980;Turner Syndrome;D014424
C14.280.400.980;Turner Syndrome;D014424
C16.131.240.400.970;Turner Syndrome;D014424
C16.131.260.830.835.750;Turner Syndrome;D014424
C16.131.939.316.309.872;Turner Syndrome;D014424
C16.131.939.316.795.750;Turner Syndrome;D014424
C16.320.180.830.835.750;Turner Syndrome;D014424
C19.391.119.309.872;Turner Syndrome;D014424
C19.391.119.795.750;Turner Syndrome;D014424
D10.627.675.800;Turpentine;D014425
D20.215.721.500.881;Turpentine;D014425
B01.050.150.900.833.848;Turtles;D014426
M01.438.873;Twins;D014427
C16.131.085.806;Twins, Conjoined;D014428
M01.438.873.920;Twins, Dizygotic;D014429
M01.438.873.940;Twins, Monozygotic;D014430
B01.050.500.500.294.700.825.825;Tylenchoidea;D014431
A09.246.272.702;Tympanic Membrane;D014432
E04.580.450.873;Tympanoplasty;D014433
F01.752.747.880;Type A Personality;D014434
C01.252.400.310.821.873;Typhoid Fever;D014435
D20.215.894.135.685.910;Typhoid-Paratyphoid Vaccines;D014436
C01.252.400.780.790.800;Typhus, Endemic Flea-Borne;D014437
C01.252.400.780.790.805;Typhus, Epidemic Louse-Borne;D014438
D02.092.211.215.811;Tyramine;D014439
D04.345.566.850.920;Tyrocidine;D014440
D12.644.641.850.920;Tyrocidine;D014440
D12.644.905.920;Tyrocidine;D014440
D02.455.426.559.389.454.950;Tyropanoate;D014441
D02.455.526.581.496.950;Tyropanoate;D014441
D08.811.682.690.708.125.500;Monophenol Monooxygenase;D014442
D12.125.072.050.875;Tyrosine;D014443
D08.811.913.477.700.900;Tyrosine Transaminase;D014444
D08.811.520.224.125.875;Tyrosine Decarboxylase;D014445
D08.811.682.690.708.923;Tyrosine 3-Monooxygenase;D014446
D12.776.556.579.374.925;Tyrosine 3-Monooxygenase;D014446
D08.811.520.224.900;Tyrosine Phenol-Lyase;D014447
D08.811.464.263.200.900;Tyrosine-tRNA Ligase;D014448
D04.345.566.850;Tyrothricin;D014449
D12.644.641.850;Tyrothricin;D014449
D12.644.905;Tyrothricin;D014449
D05.500.562.750.500;Electron Transport Complex III;D014450
D08.811.600.250.875.500;Electron Transport Complex III;D014450
D08.811.682.830.500;Electron Transport Complex III;D014450
D12.776.157.427.374.375.954;Electron Transport Complex III;D014450
D12.776.157.530.450.250.875.303;Electron Transport Complex III;D014450
D12.776.543.277.875.500;Electron Transport Complex III;D014450
D12.776.543.585.450.250.875.468;Electron Transport Complex III;D014450
D12.776.556.579.374.375.142;Electron Transport Complex III;D014450
D02.806.250.900;Ubiquinone;D014451
D08.211.935;Ubiquinone;D014451
D12.776.947;Ubiquitins;D014452
D08.811.913.400.450.480;Glucuronosyltransferase;D014453
Z01.058.290.120.880;Uganda;D014454
Z01.542.248.960;Ukraine;D014455
Z01.586.200.960;Ukraine;D014455
Z01.586.950.960;Ukraine;D014455
C23.550.891;Ulcer;D014456
A02.835.232.087.090.850;Ulna;D014457
C26.088.268.807;Ulna Fractures;D014458
C26.404.937;Ulna Fractures;D014458
A08.800.800.720.050.850;Ulnar Nerve;D014459
A13.939;Ultimobranchial Body;D014460
E05.181.724;Ultracentrifugation;D014461
E05.196.941;Ultracentrifugation;D014461
E04.292.975;Ultrafiltration;D014462
E05.196.454.807;Ultrafiltration;D014462
G01.595.280.807;Ultrafiltration;D014462
G02.149.767.600.807;Ultrafiltration;D014462
G02.842.750.600.807;Ultrafiltration;D014462
E01.370.350.850;Ultrasonography;D014463
E02.565.280.945;Ultrasonic Therapy;D014464
E02.779.496.280.945;Ultrasonic Therapy;D014464
H01.671.031.849;Ultrasonics;D014465
G01.358.500.505.650.891;Ultraviolet Rays;D014466
G01.590.540.891;Ultraviolet Rays;D014466
G01.750.250.650.891;Ultraviolet Rays;D014466
G01.750.750.659;Ultraviolet Rays;D014466
G01.750.770.578.891;Ultraviolet Rays;D014466
G16.500.275.063.725.525.600;Ultraviolet Rays;D014466
G16.500.750.775.525.600;Ultraviolet Rays;D014466
N06.230.300.100.725.525.600;Ultraviolet Rays;D014466
E02.774.945;Ultraviolet Therapy;D014467
D03.438.150.446.912;Umbelliferones;D014468
D03.830.219.446.912;Umbelliferones;D014468
A07.231.114.929;Umbilical Arteries;D014469
A16.378.693.641;Umbilical Arteries;D014469
A16.378.693;Umbilical Cord;D014470
A07.231.908.670.874;Umbilical Veins;D014471
A16.378.693.807;Umbilical Veins;D014471
A01.923.047.849;Umbilicus;D014472
F01.752.747.930;Unconscious (Psychology);D014473
F02.739.794.942;Unconscious (Psychology);D014473
C10.597.606.358.800;Unconsciousness;D014474
C23.888.592.604.359.800;Unconsciousness;D014474
D27.505.519.389.936;Uncoupling Agents;D014475
D10.251.355.325.919;Undecylenic Acids;D014476
F02.784.629.880;Underachievement;D014477
N01.824.245.850;Unemployment;D014478
Z01.252.245.500.900;United Arab Emirates;D014479
Z01.586.500.900;United Arab Emirates;D014479
N03.540.514.718;United Nations;D014480
Z01.107.567.875;United States;D014481
I01.409.137.500.600.650.920;United States Substance Abuse and Mental Health Services Administration;D014482
N03.540.348.500.500.600.650.920;United States Substance Abuse and Mental Health Services Administration;D014482
I01.409.137.500.600;United States Dept. of Health and Human Services;D014483
N03.540.348.500.500.600;United States Dept. of Health and Human Services;D014483
I01.409.137.500.937;United States Environmental Protection Agency;D014484
N03.540.348.500.500.937;United States Environmental Protection Agency;D014484
I01.409.137.500.968;United States Federal Trade Commission;D014485
N03.540.348.500.500.968;United States Federal Trade Commission;D014485
I01.409.137.500.600.650.760;United States Food and Drug Administration;D014486
N03.540.348.500.500.600.650.760;United States Food and Drug Administration;D014486
I01.409.137.500.600.310;Centers for Medicare and Medicaid Services (U.S.);D014487
N03.540.348.500.500.600.310;Centers for Medicare and Medicaid Services (U.S.);D014487
I01.409.137.500.600.650.790;United States Health Resources and Services Administration;D014488
N03.540.348.500.500.600.650.790;United States Health Resources and Services Administration;D014488
I01.409.137.500.992;United States Occupational Safety and Health Administration;D014489
N03.540.348.500.500.992;United States Occupational Safety and Health Administration;D014489
I01.409.137.500.996;United States Office of Economic Opportunity;D014490
N03.540.348.500.500.996;United States Office of Economic Opportunity;D014490
I01.409.137.500.998;United States Office of Technology Assessment;D014491
N03.540.348.500.500.998;United States Office of Technology Assessment;D014491
I01.409.137.500.600.650;United States Public Health Service;D014492
N03.540.348.500.500.600.650;United States Public Health Service;D014492
I01.409.137.500.700;United States Department of Veterans Affairs;D014493
N03.540.348.500.500.700;United States Department of Veterans Affairs;D014493
D02.886.489.180.900;Unithiol;D014494
I02.783.850;Universities;D014495
C04.182.946;Urachal Cyst;D014496
A16.890;Urachus;D014497
D03.383.742.698.875;Uracil;D014498
D02.455.526.728.650.913;Uracil Mustard;D014499
D03.383.742.698.875.949;Uracil Mustard;D014499
D03.383.742.686.850;Uracil Nucleotides;D014500
D13.695.740.850;Uracil Nucleotides;D014500
D13.695.827.919;Uracil Nucleotides;D014500
D01.268.033.950;Uranium;D014501
D01.268.271.100.950;Uranium;D014501
D01.268.556.900;Uranium;D014501
D01.552.020.940;Uranium;D014501
D01.552.544.900;Uranium;D014501
D01.625.525.550.950;Uranyl Nitrate;D014502
D01.950.950;Uranyl Nitrate;D014502
D08.811.682.943;Urate Oxidase;D014503
N01.400.800;Urban Health;D014504
N01.600.900;Urban Population;D014505
I01.880.709.876;Urban Renewal;D014506
I01.880.526.726;Urbanization;D014507
D02.948;Urea;D014508
B03.440.860.580.553.900;Ureaplasma;D014509
D08.811.277.087.902;Urease;D014510
C12.777.419.936;Uremia;D014511
C13.351.968.419.936;Uremia;D014511
D08.811.277.913;Ureohydrolases;D014512
A05.810.776;Ureter;D014513
C12.777.725.938.500;Ureteral Calculi;D014514
C12.777.967.374.500;Ureteral Calculi;D014514
C12.777.967.500.851;Ureteral Calculi;D014514
C13.351.968.725.938.500;Ureteral Calculi;D014514
C13.351.968.967.374.500;Ureteral Calculi;D014514
C13.351.968.967.500.851;Ureteral Calculi;D014514
C23.300.175.850.750;Ureteral Calculi;D014514
C12.777.725;Ureteral Diseases;D014515
C13.351.968.725;Ureteral Diseases;D014515
C04.588.945.947.940;Ureteral Neoplasms;D014516
C12.758.820.875;Ureteral Neoplasms;D014516
C12.777.725.676;Ureteral Neoplasms;D014516
C13.351.937.820.875;Ureteral Neoplasms;D014516
C13.351.968.725.676;Ureteral Neoplasms;D014516
C12.777.725.776;Ureteral Obstruction;D014517
C13.351.968.725.776;Ureteral Obstruction;D014517
C12.777.725.876;Ureterocele;D014518
C13.351.968.725.876;Ureterocele;D014518
E04.579.947;Ureterostomy;D014519
E04.950.774.852.947;Ureterostomy;D014519
D02.241.081.251.944;Urethane;D014520
A05.360.444.492.726;Urethra;D014521
A05.810.876;Urethra;D014521
C12.777.767;Urethral Diseases;D014522
C13.351.968.767;Urethral Diseases;D014522
C04.588.945.947.945;Urethral Neoplasms;D014523
C12.758.820.937;Urethral Neoplasms;D014523
C12.777.767.601;Urethral Neoplasms;D014523
C13.351.937.820.890;Urethral Neoplasms;D014523
C13.351.968.767.601;Urethral Neoplasms;D014523
C12.777.767.700;Urethral Obstruction;D014524
C13.351.968.767.700;Urethral Obstruction;D014524
C12.777.767.700.700;Urethral Stricture;D014525
C13.351.968.767.700.700;Urethral Stricture;D014525
C12.777.767.851;Urethritis;D014526
C13.351.968.767.851;Urethritis;D014526
D03.132.960.877;Uric Acid;D014527
D03.438.759.758.824.877;Uric Acid;D014527
D27.505.954.329.337.900;Uricosuric Agents;D014528
D27.505.954.613.860;Uricosuric Agents;D014528
D03.383.742.680.852;Uridine;D014529
D13.570.685.852;Uridine;D014529
D13.570.800.892;Uridine;D014529
D03.383.742.686.850.600;Uridine Diphosphate;D014530
D13.695.740.850.600;Uridine Diphosphate;D014530
D13.695.827.919.600;Uridine Diphosphate;D014530
D03.383.742.686.850.600.677.300;Uridine Diphosphate Galactose;D014531
D09.408.620.569.727.300;Uridine Diphosphate Galactose;D014531
D13.695.740.850.600.677.300;Uridine Diphosphate Galactose;D014531
D13.695.827.708.727.300;Uridine Diphosphate Galactose;D014531
D13.695.827.919.600.677.300;Uridine Diphosphate Galactose;D014531
D03.383.742.686.850.600.677.350;Uridine Diphosphate Glucose;D014532
D09.408.620.569.727.350;Uridine Diphosphate Glucose;D014532
D13.695.740.850.600.677.350;Uridine Diphosphate Glucose;D014532
D13.695.827.708.727.350;Uridine Diphosphate Glucose;D014532
D13.695.827.919.600.677.350;Uridine Diphosphate Glucose;D014532
D08.811.682.047.150.900;Uridine Diphosphate Glucose Dehydrogenase;D014533
D08.811.399.894.500.700;UDPglucose 4-Epimerase;D014534
D03.383.742.686.850.600.677.375;Uridine Diphosphate Glucuronic Acid;D014535
D09.408.620.569.727.375;Uridine Diphosphate Glucuronic Acid;D014535
D13.695.740.850.600.677.375;Uridine Diphosphate Glucuronic Acid;D014535
D13.695.827.708.727.375;Uridine Diphosphate Glucuronic Acid;D014535
D13.695.827.919.600.677.375;Uridine Diphosphate Glucuronic Acid;D014535
D03.383.742.686.850.600.677.100;Uridine Diphosphate N-Acetylgalactosamine;D014536
D09.408.620.569.727.100;Uridine Diphosphate N-Acetylgalactosamine;D014536
D13.695.740.850.600.677.100;Uridine Diphosphate N-Acetylgalactosamine;D014536
D13.695.827.708.727.100;Uridine Diphosphate N-Acetylgalactosamine;D014536
D13.695.827.919.600.677.100;Uridine Diphosphate N-Acetylgalactosamine;D014536
D03.383.742.686.850.600.677.120;Uridine Diphosphate N-Acetylglucosamine;D014537
D09.408.620.569.727.120;Uridine Diphosphate N-Acetylglucosamine;D014537
D13.695.740.850.600.677.120;Uridine Diphosphate N-Acetylglucosamine;D014537
D13.695.827.708.727.120;Uridine Diphosphate N-Acetylglucosamine;D014537
D13.695.827.919.600.677.120;Uridine Diphosphate N-Acetylglucosamine;D014537
D03.383.742.686.850.600.677.150;Uridine Diphosphate N-Acetylmuramic Acid;D014538
D09.408.620.569.727.150;Uridine Diphosphate N-Acetylmuramic Acid;D014538
D13.695.740.850.600.677.150;Uridine Diphosphate N-Acetylmuramic Acid;D014538
D13.695.827.708.727.150;Uridine Diphosphate N-Acetylmuramic Acid;D014538
D13.695.827.919.600.677.150;Uridine Diphosphate N-Acetylmuramic Acid;D014538
D03.383.742.686.850.600.677;Uridine Diphosphate Sugars;D014539
D09.408.620.569.727;Uridine Diphosphate Sugars;D014539
D13.695.740.850.600.677;Uridine Diphosphate Sugars;D014539
D13.695.827.708.727;Uridine Diphosphate Sugars;D014539
D13.695.827.919.600.677;Uridine Diphosphate Sugars;D014539
D03.383.742.686.850.600.677.800;Uridine Diphosphate Xylose;D014540
D09.408.620.569.727.800;Uridine Diphosphate Xylose;D014540
D13.695.740.850.600.677.800;Uridine Diphosphate Xylose;D014540
D13.695.827.708.727.800;Uridine Diphosphate Xylose;D014540
D13.695.827.919.600.677.800;Uridine Diphosphate Xylose;D014540
D08.811.913.696.620.800;Uridine Kinase;D014541
D03.383.742.686.850.877;Uridine Monophosphate;D014542
D13.695.740.850.877;Uridine Monophosphate;D014542
D13.695.827.919.877;Uridine Monophosphate;D014542
D08.811.913.400.725.850.750;Uridine Phosphorylase;D014543
D03.383.742.686.850.950;Uridine Triphosphate;D014544
D13.695.740.850.950;Uridine Triphosphate;D014544
D13.695.827.919.950;Uridine Triphosphate;D014544
C12.777.967.500;Urinary Calculi;D014545
C13.351.968.967.500;Urinary Calculi;D014545
C23.300.175.850;Urinary Calculi;D014545
E01.370.390.820;Urinary Catheterization;D014546
E02.148.947;Urinary Catheterization;D014546
E04.950.774.852;Urinary Diversion;D014547
C12.706.881;Urinary Fistula;D014548
C13.351.875.881;Urinary Fistula;D014548
C23.300.575.825;Urinary Fistula;D014548
C12.777.934.852;Urinary Incontinence;D014549
C13.351.968.934.814;Urinary Incontinence;D014549
C23.888.942.343.800;Urinary Incontinence;D014549
C12.777.934.852.249;Urinary Incontinence, Stress;D014550
C13.351.968.934.814.500;Urinary Incontinence, Stress;D014550
C23.888.942.343.800.500;Urinary Incontinence, Stress;D014550
A05.810;Urinary Tract;D014551
C01.539.895;Urinary Tract Infections;D014552
C12.777.892;Urinary Tract Infections;D014552
C13.351.968.892;Urinary Tract Infections;D014552
G08.852;Urinary Tract Physiological Phenomena;D014553
G08.852.796.877;Urination;D014554
C12.777.934;Urination Disorders;D014555
C13.351.968.934;Urination Disorders;D014555
A12.207.927;Urine;D014556
D03.383.129.578.840.249.727;Urobilin;D014557
D03.549.909.249.727;Urobilin;D014557
D04.345.783.249.727;Urobilin;D014557
D23.767.193.727;Urobilin;D014557
D03.383.129.578.840.249.852;Urobilinogen;D014558
D03.549.909.249.852;Urobilinogen;D014558
D04.345.783.249.852;Urobilinogen;D014558
D23.767.193.852;Urobilinogen;D014558
D08.811.520.241.300.900;Urocanate Hydratase;D014559
D02.241.081.069.920;Urocanic Acid;D014560
D03.383.129.308.960;Urocanic Acid;D014560
B01.050.150.200.727;Urochordata;D014561
B01.050.500.272.727;Urochordata;D014561
B01.050.150.900.090.608;Urodela;D014562
G08.852.898;Urodynamics;D014563
C12.706;Urogenital Abnormalities;D014564
C13.351.875;Urogenital Abnormalities;D014564
C16.131.939;Urogenital Abnormalities;D014564
C04.588.945;Urogenital Neoplasms;D014565
C12.758;Urogenital Neoplasms;D014565
C13.351.937;Urogenital Neoplasms;D014565
A05;Urogenital System;D014566
E01.370.350.700.830;Urography;D014567
E01.370.390.830;Urography;D014567
D08.811.277.656.300.760.910;Urokinase-Type Plasminogen Activator;D014568
D08.811.277.656.959.350.910;Urokinase-Type Plasminogen Activator;D014568
D12.776.124.125.662.884;Urokinase-Type Plasminogen Activator;D014568
C12.777;Urologic Diseases;D014570
C13.351.968;Urologic Diseases;D014570
C04.588.945.947;Urologic Neoplasms;D014571
C12.758.820;Urologic Neoplasms;D014571
C13.351.937.820;Urologic Neoplasms;D014571
H02.403.810.860;Urology;D014572
N02.278.354.422.790;Urology Department, Hospital;D014573
N04.452.442.422.790;Urology Department, Hospital;D014573
D02.241.081.844.915;Uronic Acids;D014574
D02.241.152.811;Uronic Acids;D014574
D02.241.511.902.915;Uronic Acids;D014574
D09.811.922;Uronic Acids;D014574
D08.811.520.224.125.900;Uroporphyrinogen Decarboxylase;D014575
D08.811.520.241.300.950;Uroporphyrinogen III Synthetase;D014576
D03.383.129.578.840.500.700.900;Uroporphyrinogens;D014577
D03.549.909.500.700.900;Uroporphyrinogens;D014577
D04.345.783.500.700.900;Uroporphyrinogens;D014577
D03.383.129.578.840.500.880;Uroporphyrins;D014578
D03.549.909.500.880;Uroporphyrins;D014578
D04.345.783.500.880;Uroporphyrins;D014578
D23.767.727.880;Uroporphyrins;D014578
D06.472.699.905;Urotensins;D014579
D12.644.548.905;Urotensins;D014579
D23.469.050.375.925;Urotensins;D014579
D04.808.105.225.272.962;Ursodeoxycholic Acid;D014580
D04.808.221.430.342.925;Ursodeoxycholic Acid;D014580
C17.800.862.945;Urticaria;D014581
C20.543.480.904;Urticaria;D014581
C04.557.450.565.465.500.850;Urticaria Pigmentosa;D014582
C17.800.508.473.850;Urticaria Pigmentosa;D014582
C17.800.621.893;Urticaria Pigmentosa;D014582
Z01.107.757.904;Uruguay;D014583
L01.224.900.910;User-Computer Interface;D014584
Z01.586.950;USSR;D014586
B01.300.179.853;Ustilaginales;D014587
B01.300.179.853.800;Ustilago;D014588
Z01.107.567.875.760.800;Utah;D014589
G08.686.785.760.769.326.700;Uterine Contraction;D014590
G11.427.590.540.890;Uterine Contraction;D014590
C13.351.500.852;Uterine Diseases;D014591
C13.351.500.852.691;Uterine Hemorrhage;D014592
C23.550.414.993;Uterine Hemorrhage;D014592
C13.703.420.288.728;Uterine Inertia;D014593
C04.588.945.418.948;Uterine Neoplasms;D014594
C13.351.500.852.762;Uterine Neoplasms;D014594
C13.351.937.418.875;Uterine Neoplasms;D014594
C13.351.500.852.904.500;Uterine Perforation;D014595
C26.761.853.500;Uterine Perforation;D014595
C13.351.500.852.833;Uterine Prolapse;D014596
C23.300.842.624.750;Uterine Prolapse;D014596
C13.351.500.852.904;Uterine Rupture;D014597
C13.703.420.904;Uterine Rupture;D014597
C26.761.853;Uterine Rupture;D014597
D12.776.861.500;Uteroglobin;D014598
A05.360.319.679;Uterus;D014599
N04.761.879;Utilization Review;D014600
N05.700.900;Utilization Review;D014600
K01.752.884;Utopias;D014601
A09.371.894;Uvea;D014602
C11.941;Uveal Diseases;D014603
C04.588.364.978;Uveal Neoplasms;D014604
C11.319.494;Uveal Neoplasms;D014604
C11.941.855;Uveal Neoplasms;D014604
C11.941.879;Uveitis;D014605
C11.941.879.780.880;Uveitis, Anterior;D014606
C10.114.843;Uveomeningoencephalitic Syndrome;D014607
C10.228.228.553.900;Uveomeningoencephalitic Syndrome;D014607
C11.941.879.980;Uveomeningoencephalitic Syndrome;D014607
C20.111.258.925;Uveomeningoencephalitic Syndrome;D014607
C15.604.515.827.865;Uveoparotid Fever;D014608
A14.549.617.780.729;Uvula;D014609
Z01.252.100.975;Uzbekistan;D014610
Z01.586.200.975;Uzbekistan;D014610
Z01.586.950.975;Uzbekistan;D014610
E02.095.465.425.400.530.890;Vaccination;D014611
E05.478.550.600.890;Vaccination;D014611
N02.421.726.758.310.890;Vaccination;D014611
N06.850.780.200.425.900;Vaccination;D014611
N06.850.780.680.310.890;Vaccination;D014611
D20.215.894;Vaccines;D014612
D20.215.894.811;Vaccines, Attenuated;D014613
D12.776.828.868;Vaccines, Synthetic;D014614
D20.215.894.865;Vaccines, Synthetic;D014614
D23.050.865;Vaccines, Synthetic;D014614
C02.256.743.929;Vaccinia;D014615
B04.280.650.160.650.900;Vaccinia virus;D014616
B04.909.204.783.160.650.900;Vaccinia virus;D014616
A11.284.430.214.190.875.190.920;Vacuoles;D014617
G01.374.715.902;Vacuum;D014618
G16.500.750.274.902;Vacuum;D014618
N06.230.300.100.185.902;Vacuum;D014618
E04.157.310.970;Vacuum Curettage;D014619
E04.950.300.299.970;Vacuum Curettage;D014619
E04.520.252.875.970;Vacuum Extraction, Obstetrical;D014620
A05.360.319.779;Vagina;D014621
D26.255.955;Vaginal Creams, Foams, and Jellies;D014622
D26.908;Vaginal Creams, Foams, and Jellies;D014622
D27.720.280.955;Vaginal Creams, Foams, and Jellies;D014622
E07.357.750;Vaginal Creams, Foams, and Jellies;D014622
C13.351.500.894;Vaginal Diseases;D014623
C13.351.500.894.767;Vaginal Fistula;D014624
C23.300.575.925;Vaginal Fistula;D014624
C04.588.945.418.955;Vaginal Neoplasms;D014625
C13.351.500.894.834;Vaginal Neoplasms;D014625
C13.351.937.418.937;Vaginal Neoplasms;D014625
E01.370.225.500.384.100.895;Vaginal Smears;D014626
E01.370.225.998.054.895;Vaginal Smears;D014626
E01.370.378.900;Vaginal Smears;D014626
E04.074.895;Vaginal Smears;D014626
E05.200.500.384.100.895;Vaginal Smears;D014626
E05.200.998.054.895;Vaginal Smears;D014626
E05.200.998.841;Vaginal Smears;D014626
E05.242.384.100.895;Vaginal Smears;D014626
C13.351.500.894.906;Vaginitis;D014627
E04.525.210.080.600.850;Vagotomy;D014628
E04.525.210.850;Vagotomy;D014628
E04.525.210.080.600.850.850;Vagotomy, Proximal Gastric;D014629
E04.525.210.850.850;Vagotomy, Proximal Gastric;D014629
A08.800.050.050.925;Vagus Nerve;D014630
A08.800.050.600.825;Vagus Nerve;D014630
A08.800.800.060.920;Vagus Nerve;D014630
A08.800.800.120.900;Vagus Nerve;D014630
D02.241.081.944;Valerates;D014631
D10.251.400.895;Valerates;D014631
B01.650.940.800.575.100.955.888;Valerian;D014632
D12.125.070.950;Valine;D014633
D12.125.142.930;Valine;D014633
D04.345.566.297.500;Valinomycin;D014634
D12.644.641.297.500;Valinomycin;D014634
D02.241.081.944.509.900;Valproic Acid;D014635
D10.251.400.895.593.900;Valproic Acid;D014635
E01.370.370.380.950;Valsalva Maneuver;D014636
E01.370.386.700.950;Valsalva Maneuver;D014636
G09.330.380.875;Valsalva Maneuver;D014636
G09.772.910;Valsalva Maneuver;D014636
D08.811.464.263.200.950;Valine-tRNA Ligase;D014637
D01.248.497.158.952;Vanadates;D014638
D01.960.960;Vanadates;D014638
D01.268.556.920;Vanadium;D014639
D01.268.956.886;Vanadium;D014639
D01.552.544.920;Vanadium;D014639
D09.400.420.925;Vancomycin;D014640
D12.644.233.925;Vancomycin;D014640
D02.241.223.100.300.350.875;Vanillic Acid;D014641
D02.241.511.390.350.875;Vanillic Acid;D014641
D02.241.511.390.932;Vanillic Acid;D014641
D02.455.426.559.389.127.281.350.875;Vanillic Acid;D014641
D02.455.426.559.389.657.410.932;Vanillic Acid;D014641
D02.455.426.559.389.657.654.638.875;Vanillic Acid;D014641
D02.241.223.475.730;Vanilmandelic Acid;D014642
D02.241.511.536.730;Vanilmandelic Acid;D014642
D12.776.395.550.990;Variant Surface Glycoproteins, Trypanosoma;D014643
D12.776.543.550.990;Variant Surface Glycoproteins, Trypanosoma;D014643
D23.050.293.900;Variant Surface Glycoproteins, Trypanosoma;D014643
D23.050.301.900;Variant Surface Glycoproteins, Trypanosoma;D014643
G05.365;Genetic Variation;D014644
B04.280.382.100.900.460;Herpesvirus 3, Human;D014645
B04.909.204.382.100.900.460;Herpesvirus 3, Human;D014645
C12.294.936;Varicocele;D014646
C14.907.903;Varicocele;D014646
C14.907.927.730;Varicose Ulcer;D014647
C17.800.893.592.730;Varicose Ulcer;D014647
C14.907.927;Varicose Veins;D014648
A05.360.444.930;Vas Deferens;D014649
A07.231.765;Vasa Nervorum;D014650
A07.231.836;Vasa Vasorum;D014651
C14.907;Vascular Diseases;D014652
C10.228.140.300.800;Vascular Headaches;D014653
C10.228.140.546.699.500;Vascular Headaches;D014653
C14.907.253.937;Vascular Headaches;D014653
G09.330.920;Vascular Patency;D014654
G09.330.380.921;Vascular Resistance;D014655
E04.100.814;Vascular Surgical Procedures;D014656
C14.907.940;Vasculitis;D014657
E04.950.599.900;Vasectomy;D014659
E04.950.774.860.856;Vasectomy;D014659
D06.472.317.950;Vasoactive Intestinal Peptide;D014660
D06.472.699.952;Vasoactive Intestinal Peptide;D014660
D12.644.400.875;Vasoactive Intestinal Peptide;D014660
D12.644.548.952;Vasoactive Intestinal Peptide;D014660
D12.776.641.650.875;Vasoactive Intestinal Peptide;D014660
G09.330.190.400.920;Vasoconstriction;D014661
D27.505.954.411.793;Vasoconstrictor Agents;D014662
D27.505.954.411.793.610;Nasal Decongestants;D014663
D27.505.954.796.560;Nasal Decongestants;D014663
G09.330.190.400.925;Vasodilation;D014664
D27.505.954.411.918;Vasodilator Agents;D014665
A08.800.050.800.900;Vasomotor System;D014666
D06.472.699.631.692.781;Vasopressins;D014667
D12.644.400.900;Vasopressins;D014667
D12.644.456.925;Vasopressins;D014667
D12.644.548.691.692.781;Vasopressins;D014667
D12.776.641.650.937;Vasopressins;D014667
D06.472.699.631.692.881;Vasotocin;D014668
D12.644.548.691.692.881;Vasotocin;D014668
E04.035.956;Vasovasostomy;D014669
E04.950.599.500.800;Vasovasostomy;D014669
E04.950.774.860.956;Vasovasostomy;D014669
A03.159.183.079.300.950;Ampulla of Vater;D014670
A03.556.124.684.124.236;Ampulla of Vater;D014670
A03.556.875.249.160;Ampulla of Vater;D014670
Z01.542.961;Vatican City;D014671
E01.370.370.380.240.850;Vectorcardiography;D014672
E01.370.405.240.850;Vectorcardiography;D014672
D04.808.054.040.920;Vecuronium Bromide;D014673
D12.776.256.920;Vegetable Proteins;D014674
D12.776.765.836;Vegetable Proteins;D014674
J02.500.428.920;Vegetable Proteins;D014674
J02.500.850.900;Vegetable Proteins;D014674
B01.650.510.956;Vegetables;D014675
J02.500.850;Vegetables;D014675
E02.642.249.300;Diet, Vegetarian;D014676
G07.610.240.300;Diet, Vegetarian;D014676
D26.650.700;Pharmaceutical Vehicles;D014677
D27.720.744.770;Pharmaceutical Vehicles;D014677
E02.319.300.754;Pharmaceutical Vehicles;D014677
B03.440.425.410.096.938;Veillonella;D014678
A07.231.908;Veins;D014680
C07.465.525.955;Velopharyngeal Insufficiency;D014681
C07.550.966;Velopharyngeal Insufficiency;D014681
C07.650.525.955;Velopharyngeal Insufficiency;D014681
C09.775.955;Velopharyngeal Insufficiency;D014681
C16.131.850.525.955;Velopharyngeal Insufficiency;D014681
A07.231.908.949.648;Vena Cava, Inferior;D014682
A07.231.908.949.815;Vena Cava, Superior;D014683
A07.231.908.949;Venae Cavae;D014684
C04.588.945.956;Venereal Tumors, Veterinary;D014685
C22.950;Venereal Tumors, Veterinary;D014685
H02.403.909;Venereology;D014686
Z01.107.757.943;Venezuela;D014687
A12.200.935;Venoms;D014688
D20.888;Venoms;D014688
D23.946.833;Venoms;D014688
C14.907.952;Venous Insufficiency;D014689
G09.330.380.076.732;Venous Pressure;D014690
N06.230.150.520;Ventilation;D014691
E01.370.386.700.650.900;Ventilation-Perfusion Ratio;D014692
G09.772.920;Ventilation-Perfusion Ratio;D014692
C14.280.067.922;Ventricular Fibrillation;D014693
C23.550.073.922;Ventricular Fibrillation;D014693
C14.280.955;Ventricular Outflow Obstruction;D014694
E01.370.350.578.937.190;Cerebral Ventriculography;D014695
E01.370.350.700.560.190;Cerebral Ventriculography;D014695
E01.370.376.537.750.190;Cerebral Ventriculography;D014695
E05.629.937.190;Cerebral Ventriculography;D014695
E04.035.188.957;Ventriculostomy;D014696
E04.525.170.860;Ventriculostomy;D014696
A08.186.211.730.317.357.352.953;Ventromedial Hypothalamic Nucleus;D014697
D02.540.800;Venturicidins;D014698
A07.231.461.920;Venules;D014699
A07.231.908.952;Venules;D014699
D02.092.471.683.953;Verapamil;D014700
D03.132.920.256.679;Veratridine;D014701
D03.549.256.679;Veratridine;D014701
D03.132.920.256.815;Veratrine;D014702
D03.549.256.815;Veratrine;D014702
B01.650.940.800.575.100.610.800;Veratrum;D014703
D03.132.920;Veratrum Alkaloids;D014704
F01.145.209.908;Verbal Behavior;D014705
F02.463.425.952;Verbal Learning;D014706
Z01.107.567.875.550.880;Vermont;D014707
A12.200.946;Vernix Caseosa;D014708
A16.378.857;Vernix Caseosa;D014708
A11.251.210.955;Vero Cells;D014709
A11.436.955;Vero Cells;D014709
E04.520.252.996;Version, Fetal;D014710
A07.231.114.955;Vertebral Artery;D014711
B04.909;Vertebrate Viruses;D014712
B04.970;Viruses, Unclassified;D014713
B01.050.150.900;Vertebrates;D014714
C10.228.140.300.150.956;Vertebrobasilar Insufficiency;D014715
C14.907.253.092.956;Vertebrobasilar Insufficiency;D014715
C14.907.253.956;Vertebrobasilar Insufficiency;D014715
E06.276.459.733;Vertical Dimension;D014716
C09.218.568.900.883;Vertigo;D014717
C10.597.951;Vertigo;D014717
C23.888.592.958;Vertigo;D014717
C12.777.829.920;Vesico-Ureteral Reflux;D014718
C13.351.968.829.920;Vesico-Ureteral Reflux;D014718
C13.351.875.881.312.733;Vesicovaginal Fistula;D014719
C13.351.968.829.548.733;Vesicovaginal Fistula;D014719
C23.300.575.825.250.775;Vesicovaginal Fistula;D014719
C23.300.575.925.816;Vesicovaginal Fistula;D014719
C02.782.160.927;Vesicular Exanthema of Swine;D014720
C22.905.927;Vesicular Exanthema of Swine;D014720
B04.820.455.750.900.900;Vesicular stomatitis Indiana virus;D014721
B04.909.777.455.750.900.900;Vesicular stomatitis Indiana virus;D014721
A09.246.631.909;Vestibule, Labyrinth;D014722
A09.246.631.909.957;Vestibular Aqueduct;D014723
E01.370.382.900;Vestibular Function Tests;D014724
A08.800.800.120.910.900;Vestibular Nerve;D014725
A08.186.211.132.810.428.600.800;Vestibular Nuclei;D014726
A08.186.211.865.428.600.800;Vestibular Nuclei;D014726
E04.545.550.800;Vestibuloplasty;D014727
E06.645.550.800;Vestibuloplasty;D014727
M01.930;Veterans;D014728
N03.219.521.346.733;Veterans Disability Claims;D014729
H02.956;Veterinary Medicine;D014730
H02.956.858;Veterinary Service, Military;D014731
G01.374.676.930;Vibration;D014732
G01.595.540.930;Vibration;D014732
B03.440.450.900.859;Vibrio;D014733
B03.660.250.830.830;Vibrio;D014733
B03.440.450.900.859.225;Vibrio cholerae;D014734
B03.660.250.830.830.100;Vibrio cholerae;D014734
C01.252.400.959;Vibrio Infections;D014735
B03.440.450.900.859.550;Vibrio parahaemolyticus;D014736
B03.660.250.830.830.590;Vibrio parahaemolyticus;D014736
B03.440.450.900;Vibrionaceae;D014737
B03.660.250.830;Vibrionaceae;D014737
A13.950;Vibrissae;D014738
Z01.338.740;Victoria;D014739
D03.438.759.590.138.900;Vidarabine;D014740
D13.570.065.950;Vidarabine;D014740
D13.570.583.138.900;Vidarabine;D014740
L01.240.960;Video Recording;D014741
J01.897.280.500.668.800;Videodisc Recording;D014742
J01.897.280.500.898.800;Videodisc Recording;D014742
L01.178.590.875.800;Videodisc Recording;D014742
L01.178.820.090.668.800;Videodisc Recording;D014742
L01.178.820.090.898.800;Videodisc Recording;D014742
L01.240.960.800;Videodisc Recording;D014742
J01.897.280.500.846.734;Videotape Recording;D014743
J01.897.280.500.898.840;Videotape Recording;D014743
L01.178.590.875.840;Videotape Recording;D014743
L01.178.820.090.846.734;Videotape Recording;D014743
L01.178.820.090.898.840;Videotape Recording;D014743
L01.240.940.840;Videotape Recording;D014743
L01.240.960.880;Videotape Recording;D014743
Z01.252.145.945;Vietnam;D014744
D03.383.533.640.900;Viloxazine;D014745
D05.750.078.593.900;Vimentin;D014746
D12.776.220.475.900;Vimentin;D014746
D03.132.436.681.827.650;Vinblastine;D014747
D03.438.473.402.681.827.650;Vinblastine;D014747
D03.132.436.681.827;Vinca Alkaloids;D014748
D03.438.473.402.681.827;Vinca Alkaloids;D014748
D03.132.436.681.827.750;Vincamine;D014749
D03.438.473.402.681.827.750;Vincamine;D014749
D03.132.436.681.827.817;Vincristine;D014750
D03.438.473.402.681.827.817;Vincristine;D014750
D03.132.436.681.827.830;Vindesine;D014751
D03.438.473.402.681.827.830;Vindesine;D014751
D02.455.326.271.884.750;Vinyl Chloride;D014752
D02.455.526.439.975;Vinyl Chloride;D014752
D02.455.326.271.884;Vinyl Compounds;D014753
I01.198.240.856;Violence;D014754
I01.880.735.900;Violence;D014754
D03.383.725.762.925;Viologens;D014755
D04.345.566.875;Viomycin;D014756
D12.644.641.875;Viomycin;D014756
D20.888.850.960;Viper Venoms;D014757
D23.946.833.850.960;Viper Venoms;D014757
D12.776.964.970.600.850;Viral Core Proteins;D014758
D12.776.964.970.880;Viral Envelope Proteins;D014759
D12.776.543.512.500;Viral Fusion Proteins;D014760
D12.776.964.970.880.910;Viral Fusion Proteins;D014760
D20.215.894.899.955;Viral Hepatitis Vaccines;D014761
G06.590.875.710;Viral Interference;D014762
G06.920.875.710;Viral Interference;D014762
D12.776.964.970.880.940;Viral Matrix Proteins;D014763
D12.776.964;Viral Proteins;D014764
D20.215.894.899;Viral Vaccines;D014765
C02.937;Viremia;D014766
C23.550.470.790.500.900;Viremia;D014766
Z01.107.084.900.970;Virgin Islands of the United States;D014767
Z01.639.880.970;Virgin Islands of the United States;D014767
Z01.107.567.875.075.837;Virginia;D014768
Z01.107.567.875.750.870;Virginia;D014768
D04.345.566.802.875;Virginiamycin;D014769
D12.644.641.802.875;Virginiamycin;D014769
C23.888.971;Virilism;D014770
A21.249;Virion;D014771
B04.950;Virion;D014771
B04.956;Viroids;D014772
H01.158.273.540.859;Virology;D014773
G06.930;Virulence;D014774
G06.590.875.780.940;Virus Activation;D014775
G06.920.875.780.940;Virus Activation;D014775
E01.370.225.875.970;Virus Cultivation;D014776
E05.200.875.970;Virus Cultivation;D014776
C02;Virus Diseases;D014777
G06.590.875.780;Virus Replication;D014779
G06.920.875.780;Virus Replication;D014779
B04;Viruses;D014780
A01.960;Viscera;D014781
C06.405.937;Visceral Prolapse;D014782
C23.300.842.624.875;Visceral Prolapse;D014782
G02.842.925;Viscosity;D014783
B01.650.940.800.575.100.735;Mistletoe;D014784
F02.830.816.964;Vision, Ocular;D014785
G02.111.087.800.480.900;Vision, Ocular;D014785
G02.149.115.800.480.900;Vision, Ocular;D014785
G04.299.880.480.900;Vision, Ocular;D014785
G11.561.600.810.964;Vision, Ocular;D014785
G14.640.816;Vision, Ocular;D014785
C10.597.751.941;Vision Disorders;D014786
C11.966;Vision Disorders;D014786
C23.888.592.763.941;Vision Disorders;D014786
E01.370.380.850;Vision Tests;D014787
F02.830.816.964.730;Vision, Entoptic;D014788
G11.561.600.810.964.730;Vision, Entoptic;D014788
G14.640.816.730;Vision, Entoptic;D014788
M01.935;Visitors to Patients;D014789
B04.820.650.589.600.900;Visna-maedi virus;D014790
B04.909.777.731.589.600.900;Visna-maedi virus;D014790
E01.370.380.850.950;Visual Acuity;D014792
F02.463.593.932.901;Visual Acuity;D014792
G14.940;Visual Acuity;D014792
A08.186.211.730.885.287.500.571.735;Visual Cortex;D014793
F02.463.593.932.934;Visual Fields;D014794
G14.950;Visual Fields;D014794
A08.612.220.860;Visual Pathways;D014795
F02.463.593.932;Visual Perception;D014796
E01.370.386.700.485.750.900;Vital Capacity;D014797
G09.772.850.970;Vital Capacity;D014797
E05.318.308.985;Vital Statistics;D014798
L01.280.975;Vital Statistics;D014798
N01.224.935;Vital Statistics;D014798
N06.850.505.400.975;Vital Statistics;D014798
N06.850.520.308.985;Vital Statistics;D014798
K01.752.935;Vitalism;D014799
D01.220.175.950;Vitallium;D014800
D01.552.033.182.900;Vitallium;D014800
D25.058.224.735;Vitallium;D014800
D25.339.208.224.959;Vitallium;D014800
J01.637.051.058.224.735;Vitallium;D014800
J01.637.051.339.208.224.959;Vitallium;D014800
D02.455.326.271.665.202.495.818;Vitamin A;D014801
D02.455.426.392.368.367.379.249.700.860;Vitamin A;D014801
D02.455.849.131.495.818;Vitamin A;D014801
D23.767.261.700.860;Vitamin A;D014801
C18.654.521.500.133.628;Vitamin A Deficiency;D014802
D27.505.696.377.605.600.708;Vitamin B Complex;D014803
C18.654.521.500.133.699;Vitamin B Deficiency;D014804
D03.383.129.578.840.437.777;Vitamin B 12;D014805
D03.549.909.437.777;Vitamin B 12;D014805
D04.345.783.437.777;Vitamin B 12;D014805
C18.654.521.500.133.699.923;Vitamin B 12 Deficiency;D014806
D04.808.812.768;Vitamin D;D014807
C18.654.521.500.133.770;Vitamin D Deficiency;D014808
D12.776.157.920;Vitamin D-Binding Protein;D014809
D03.438.150.909;Vitamin E;D014810
D03.830.219.909;Vitamin E;D014810
C18.654.521.500.133.841;Vitamin E Deficiency;D014811
D02.455.426.559.847.638.721.374;Vitamin K;D014812
D02.455.849.291.523.500;Vitamin K;D014812
D04.615.638.721.374;Vitamin K;D014812
C15.378.100.920;Vitamin K Deficiency;D014813
C15.378.463.841;Vitamin K Deficiency;D014813
C18.654.521.500.133.912;Vitamin K Deficiency;D014813
D02.886.030.676.950;Vitamin U;D014814
D12.125.166.676.950;Vitamin U;D014814
D27.505.696.377.605.600;Vitamins;D014815
J02.500.631.600;Vitamins;D014815
A16.920;Vitelline Duct;D014816
A16.690.886;Vitelline Membrane;D014817
G04.299.151.650.249.880;Vitellogenesis;D014818
G08.686.785.760.310.500.880;Vitellogenesis;D014818
D12.776.092.500.925;Vitellogenins;D014819
D12.776.290.812.500;Vitellogenins;D014819
D12.776.744.925;Vitellogenins;D014819
C17.800.621.440.895;Vitiligo;D014820
E04.540.960;Vitrectomy;D014821
A09.371.714.500;Vitreous Body;D014822
C11.290.960;Vitreous Hemorrhage;D014823
C23.550.414.756.887;Vitreous Hemorrhage;D014823
E05.017.900;Vivisection;D014824
L01.143.506.598.901;Vocabulary;D014825
C08.360.931;Vocal Cord Paralysis;D014826
C09.400.931;Vocal Cord Paralysis;D014826
C10.292.887.800;Vocal Cord Paralysis;D014826
C10.597.622.943;Vocal Cord Paralysis;D014826
C23.888.592.636.943;Vocal Cord Paralysis;D014826
A04.329.364.737;Vocal Cords;D014827
F01.145.113.055.800;Vocalization, Animal;D014828
I02.233.862;Vocational Education;D014829
F02.784.629.937;Vocational Guidance;D014830
F02.784.692.887;Vocational Guidance;D014830
G09.772.925;Voice;D014831
C08.360.940;Voice Disorders;D014832
C09.400.940;Voice Disorders;D014832
C10.597.975;Voice Disorders;D014832
C23.888.592.979;Voice Disorders;D014832
G09.772.925.960;Voice Quality;D014833
E02.831.727.862;Voice Training;D014834
G01.595.680.750;Volatilization;D014835
G02.149.767.680.933;Volatilization;D014835
G02.842.750.680.933;Volatilization;D014835
F02.463.902;Volition;D014836
N03.540.630.780;Voluntary Health Agencies;D014837
M01.955;Voluntary Workers;D014838
C23.888.821.937;Vomiting;D014839
C23.888.821.937.080;Vomiting, Anticipatory;D014840
D12.776.124.125.920;von Willebrand Factor;D014841
D23.119.985;von Willebrand Factor;D014841
C15.378.100.100.900;von Willebrand Diseases;D014842
C15.378.100.141.900;von Willebrand Diseases;D014842
C15.378.140.900;von Willebrand Diseases;D014842
C15.378.463.920;von Willebrand Diseases;D014842
C16.320.099.920;von Willebrand Diseases;D014842
F03.800.800.600.900;Voyeurism;D014843
A05.360.319.887;Vulva;D014844
C13.351.500.944;Vulvar Diseases;D014845
C04.588.945.418.968;Vulvar Neoplasms;D014846
C13.351.500.944.819;Vulvar Neoplasms;D014846
C13.351.937.418.968;Vulvar Neoplasms;D014846
C13.351.500.944.902;Vulvitis;D014847
C13.351.500.894.906.820;Vulvovaginitis;D014848
C13.351.500.944.902.737;Vulvovaginitis;D014848
C16.131.077.938;Waardenburg Syndrome;D014849
N04.452.095.738;Waiting Lists;D014850
F02.830.104.821;Wakefulness;D014851
G11.561.600.042.738;Wakefulness;D014851
Z01.542.363.914;Wales;D014852
Z01.639.280.914;Wales;D014852
E07.858.442.980;Walkers;D014853
C10.228.140.300.150.477.100.500;Lateral Medullary Syndrome;D014854
C10.228.140.300.775.200.100.500;Lateral Medullary Syndrome;D014854
C14.907.253.092.477.100.500;Lateral Medullary Syndrome;D014854
C14.907.253.855.200.100.500;Lateral Medullary Syndrome;D014854
C23.550.737.750;Wallerian Degeneration;D014855
B01.050.150.900.649.147.600.821;Walruses;D014856
I01.880.735.944;War;D014857
I01.198.240.903;War Crimes;D014858
I01.880.735.944.903;War Crimes;D014858
D03.438.150.446.520.914;Warfarin;D014859
D03.830.219.446.520.914;Warfarin;D014859
C02.256.650.810;Warts;D014860
C02.825.810;Warts;D014860
C02.928.914;Warts;D014860
C04.925.744;Warts;D014860
C17.800.838.790.810;Warts;D014860
Z01.107.567.875.560.900;Washington;D014861
Z01.107.567.875.580.900;Washington;D014861
D20.888.065.970;Wasp Venoms;D014862
D23.946.833.065.970;Wasp Venoms;D014862
B01.050.500.131.617.479.900;Wasps;D014863
N06.850.780.200.800.800.890;Waste Disposal, Fluid;D014865
N06.850.860.510.900.600.900;Waste Disposal, Fluid;D014865
N06.850.860.510.900.800;Waste Disposal, Fluid;D014865
D20.944;Waste Products;D014866
N06.850.460.710;Waste Products;D014866
D01.455.900;Water;D014867
D01.650.550.925;Water;D014867
F01.658.938;Water Deprivation;D014868
C18.452.950.932;Water Intoxication;D014869
C25.723.932;Water Intoxication;D014869
G02.111.917.750;Water Loss, Insensible;D014870
G07.700.360.888.750;Water Loss, Insensible;D014870
H01.158.273.540.274.777;Water Microbiology;D014871
N06.850.425.450;Water Microbiology;D014871
G16.500.240.960;Water Movements;D014872
N06.230.132.644.750;Water Movements;D014872
N06.230.850;Water Movements;D014872
D27.888.284.903;Water Pollutants;D014873
D27.888.284.903.655;Water Pollutants, Chemical;D014874
D20.693.903;Water Pollutants, Radioactive;D014875
D27.888.284.903.821;Water Pollutants, Radioactive;D014875
N06.850.460.790;Water Pollution;D014876
N06.850.460.790.410;Water Pollution, Chemical;D014877
N06.850.460.790.460;Water Pollution, Radioactive;D014878
N06.850.810.530;Water Pollution, Radioactive;D014878
N06.850.860.510.910;Water Softening;D014880
H01.158.273.248.875.500;Water Supply;D014881
G02.111.917;Water-Electrolyte Balance;D014882
G03.960;Water-Electrolyte Balance;D014882
G07.700.360.888;Water-Electrolyte Balance;D014882
C18.452.950;Water-Electrolyte Imbalance;D014883
C01.252.200.500.550.800;Waterhouse-Friderichsen Syndrome;D014884
C01.252.400.625.549.449.800;Waterhouse-Friderichsen Syndrome;D014884
C10.228.228.180.500.750.500;Waterhouse-Friderichsen Syndrome;D014884
C10.228.228.507.280.505.904;Waterhouse-Friderichsen Syndrome;D014884
C15.378.100.802.843;Waterhouse-Friderichsen Syndrome;D014884
C15.378.463.950;Waterhouse-Friderichsen Syndrome;D014884
C19.053.500.740;Waterhouse-Friderichsen Syndrome;D014884
C23.550.414.950.843;Waterhouse-Friderichsen Syndrome;D014884
C23.888.885.687.843;Waterhouse-Friderichsen Syndrome;D014884
D10.945;Waxes;D014885
G07.610.220.500.750;Weaning;D014886
G07.610.593.762;Weaning;D014886
G07.700.620.762;Weaning;D014886
G16.500.275.063.725;Weather;D014887
G16.500.750.775;Weather;D014887
N06.230.300.100.725;Weather;D014887
F04.711.141.493.822;Wechsler Scales;D014888
C08.381.483.950;Wegener Granulomatosis;D014890
C14.907.940.897.249.750;Wegener Granulomatosis;D014890
C20.111.193.875;Wegener Granulomatosis;D014890
I03.450.642.845.950;Weight Lifting;D014891
F02.463.593.959;Weight Perception;D014892
G01.595.060.535.369.400.900;Weightlessness;D014893
E05.978;Weights and Measures;D014894
C01.252.400.511.739;Weil Disease;D014895
C01.252.847.511.739;Weil Disease;D014895
J01.576.370.400.900;Welding;D014896
C10.228.854.468.800;Spinal Muscular Atrophies of Childhood;D014897
C10.574.500.812;Spinal Muscular Atrophies of Childhood;D014897
C10.574.562.500.750;Spinal Muscular Atrophies of Childhood;D014897
C10.668.467.500.750;Spinal Muscular Atrophies of Childhood;D014897
C10.668.475.500;Spinal Muscular Atrophies of Childhood;D014897
C16.320.400.765;Spinal Muscular Atrophies of Childhood;D014897
C16.320.925;Werner Syndrome;D014898
C18.452.284.960;Werner Syndrome;D014898
C10.228.140.163.960;Wernicke Encephalopathy;D014899
C18.452.132.960;Wernicke Encephalopathy;D014899
C18.654.521.500.133.699.827.822;Wernicke Encephalopathy;D014899
C25.100.625;Wernicke Encephalopathy;D014899
F03.900.100.875;Wernicke Encephalopathy;D014899
Z01.107.084.900;West Indies;D014900
Z01.639.880;West Indies;D014900
C02.081.343.950;West Nile Fever;D014901
C02.182.500.300.300.850;West Nile Fever;D014901
C02.290.310.950;West Nile Fever;D014901
C02.782.310.950;West Nile Fever;D014901
C02.782.350.250.900;West Nile Fever;D014901
C10.228.228.210.150.300.300.887;West Nile Fever;D014901
C10.228.228.245.340.310.950;West Nile Fever;D014901
B04.820.250.350.300.950;West Nile virus;D014902
B04.909.777.270.475.950;West Nile virus;D014902
B04.909.777.310.350.300.950;West Nile virus;D014902
Z01.107.567.875.075.900;West Virginia;D014903
Z01.107.567.875.750.900;West Virginia;D014903
Z01.338.800;Western Australia;D014904
Z01.639.760.815.800.400;Independent State of Samoa;D014905
D27.720.877.974;Wetting Agents;D014906
B01.050.150.900.649.189.865;Whales;D014907
B01.650.940.800.575.100.822.918;Triticum;D014908
J02.500.200.875;Triticum;D014908
D12.776.503.499.968;Wheat Germ Agglutinins;D014909
D12.776.765.678.968;Wheat Germ Agglutinins;D014909
E07.796.980;Wheelchairs;D014910
C26.700.500;Whiplash Injuries;D014911
C22.595.740;White Muscle Disease;D014912
E01.370.225.625.115.950;Whole Blood Coagulation Time;D014914
E05.200.625.115.950;Whole Blood Coagulation Time;D014914
G09.188.960;Whole Blood Coagulation Time;D014914
E05.799.950;Whole-Body Counting;D014915
E02.815.814;Whole-Body Irradiation;D014916
E05.980;Whole-Body Irradiation;D014916
C01.252.400.143.740;Whooping Cough;D014917
C01.539.739.969;Whooping Cough;D014917
C08.730.969;Whooping Cough;D014917
I01.880.604.583.927;Wills;D014918
G16.500.240.135.249.200;Wind;D014919
G16.500.275.063.725.154.200;Wind;D014919
G16.500.750.775.780;Wind;D014919
N06.230.132.644.875;Wind;D014919
N06.230.300.100.150.185.200;Wind;D014919
N06.230.300.100.725.780;Wind;D014919
J02.200.100.900;Wine;D014920
A13.395.823;Wing;D014921
Z01.107.567.875.350.900;Wisconsin;D014922
Z01.107.567.875.510.900;Wisconsin;D014922
C15.378.100.100.970;Wiskott-Aldrich Syndrome;D014923
C15.378.463.960;Wiskott-Aldrich Syndrome;D014923
C15.378.553.546.605.900;Wiskott-Aldrich Syndrome;D014923
C16.320.099.970;Wiskott-Aldrich Syndrome;D014923
C16.320.322.937;Wiskott-Aldrich Syndrome;D014923
C20.673.627.900;Wiskott-Aldrich Syndrome;D014923
C20.673.972;Wiskott-Aldrich Syndrome;D014923
C05.550.114.843.823;Wissler's Syndrome;D014924
C05.799.825.823;Wissler's Syndrome;D014924
C20.543.928;Wissler's Syndrome;D014924
K01.517.946;Wit and Humor as Topic;D014925
C14.280.067.780.977;Wolff-Parkinson-White Syndrome;D014927
C16.131.240.400.980;Wolff-Parkinson-White Syndrome;D014927
A16.935;Wolffian Ducts;D014928
C09.218.458.341.186.500.750;Wolfram Syndrome;D014929
C10.292.700.225.500.980;Wolfram Syndrome;D014929
C10.574.500.662.980;Wolfram Syndrome;D014929
C10.597.751.418.341.186.500.750;Wolfram Syndrome;D014929
C10.597.751.941.162.625.750;Wolfram Syndrome;D014929
C11.270.564.980;Wolfram Syndrome;D014929
C11.640.451.451.980;Wolfram Syndrome;D014929
C11.966.075.375.750;Wolfram Syndrome;D014929
C12.777.419.135.875;Wolfram Syndrome;D014929
C13.351.968.419.135.875;Wolfram Syndrome;D014929
C16.131.077.299.750;Wolfram Syndrome;D014929
C16.131.077.951;Wolfram Syndrome;D014929
C16.320.290.564.980;Wolfram Syndrome;D014929
C16.320.400.630.980;Wolfram Syndrome;D014929
C18.452.394.750.124.960;Wolfram Syndrome;D014929
C19.246.267.960;Wolfram Syndrome;D014929
C19.700.159.875;Wolfram Syndrome;D014929
M01.975;Women;D014930
M01.975.825;Women, Working;D014931
N02.421.920;Women's Health Services;D014932
I01.880.604.473.850;Women's Rights;D014933
N03.706.437.850;Women's Rights;D014933
A18.700.888;Wood;D014934
J01.637.241.900;Wood;D014934
A13.970;Wool;D014935
A17.360.855;Wool;D014935
J01.576.885.800.800;Wool;D014935
J01.637.883;Wool;D014935
F04.711.647.905;Word Association Tests;D014936
I03.946;Work;D014937
E01.370.400.925;Work Capacity Evaluation;D014938
E01.370.386.700.975;Work of Breathing;D014939
G09.772.965;Work of Breathing;D014939
I03.946.900;Work Schedule Tolerance;D014940
F02.784.412.846.853;Work Simplification;D014941
F02.784.692.746.853;Work Simplification;D014941
N03.219.521.346.866;Workers' Compensation;D014942
N03.219.521.576.300.900;Workers' Compensation;D014942
N01.400.910;World Health;D014943
N03.540.514.718.800;World Health Organization;D014944
G16.100.856.891;Wound Healing;D014945
C01.539.947;Wound Infection;D014946
C26.951;Wound Infection;D014946
C26;Wounds and Injuries;D014947
C26.986.900;Wounds, Gunshot;D014948
C26.974;Wounds, Nonpenetrating;D014949
C26.986;Wounds, Penetrating;D014950
C26.986.950;Wounds, Stab;D014951
I03.450.642.845.975;Wrestling;D014952
A01.378.800.667.715;Wrist;D014953
C26.088.906;Wrist Injuries;D014954
A02.835.583.405.930;Wrist Joint;D014955
L01.143.506.423.906;Writing;D014956
B01.050.500.500.294.700.750.700.300.708;Wuchereria;D014957
B01.050.500.500.294.700.750.700.300.708.150;Wuchereria bancrofti;D014958
Z01.107.567.875.560.925;Wyoming;D014959
A11.284.187.865.982;X Chromosome;D014960
G05.360.162.865.982;X Chromosome;D014960
E05.196.309.742;X-Ray Diffraction;D014961
E05.196.822.950;X-Ray Diffraction;D014961
G01.595.861.950;X-Ray Diffraction;D014961
G02.149.767.915;X-Ray Diffraction;D014961
G02.842.750.915;X-Ray Diffraction;D014961
E07.960;X-Ray Film;D014962
E07.970;X-Ray Intensifying Screens;D014963
E02.815.907;X-Ray Therapy;D014964
G01.358.500.505.970;X-Rays;D014965
G01.750.250.970;X-Rays;D014965
G01.750.750.918;X-Rays;D014965
D03.494.953;Xanthenes;D014966
D08.811.682.047.892;Xanthine Dehydrogenase;D014968
D08.811.682.047.928;Xanthine Oxidase;D014969
D03.132.960;Xanthines;D014970
D03.438.759.758.824;Xanthines;D014970
D03.066.515.950;Xanthinol Niacinate;D014971
D03.383.725.547.950;Xanthinol Niacinate;D014971
D03.438.759.758.824.751.950;Xanthinol Niacinate;D014971
C15.604.250.410.900;Xanthogranuloma, Juvenile;D014972
C17.800.973;Xanthogranuloma, Juvenile;D014972
C18.452.584.750;Xanthomatosis;D014973
B03.440.400.425.967.930;Xanthomonas;D014974
B03.660.250.915.930;Xanthomonas;D014974
D02.455.326.271.665.202.868.500;Lutein;D014975
D02.455.426.392.368.367.379.249.887.500;Lutein;D014975
D02.455.849.131.868.500;Lutein;D014975
D23.767.261.887.500;Lutein;D014975
D03.438.733.631.825;Xanthopterin;D014976
D23.767.831.742;Xanthopterin;D014976
D03.066.942;Xanthurenates;D014977
D01.268.613.900;Xenon;D014978
D01.362.641.918;Xenon;D014978
D01.496.920;Xenon Isotopes;D014979
D01.496.749.945;Xenon Radioisotopes;D014980
D01.496.920.700;Xenon Radioisotopes;D014980
B01.050.150.900.090.180.610.500;Xenopus;D014981
B01.050.150.900.090.180.610.500.562;Xenopus laevis;D014982
C04.834.867;Xeroderma Pigmentosum;D014983
C16.131.831.936;Xeroderma Pigmentosum;D014983
C16.320.850.970;Xeroderma Pigmentosum;D014983
C17.800.600.925;Xeroderma Pigmentosum;D014983
C17.800.621.936;Xeroderma Pigmentosum;D014983
C17.800.804.936;Xeroderma Pigmentosum;D014983
C17.800.827.970;Xeroderma Pigmentosum;D014983
C18.452.284.975;Xeroderma Pigmentosum;D014983
E01.370.350.700.500.975;Xeromammography;D014984
E01.370.350.700.975.975;Xeromammography;D014984
C11.187.810;Xerophthalmia;D014985
C11.496.260.892;Xerophthalmia;D014985
E01.370.350.700.975;Xeroradiography;D014986
C07.465.815.929;Xerostomia;D014987
D02.065.884.975;Xipamide;D014988
D02.886.590.700.975;Xipamide;D014988
A02.835.232.904.766.825;Xiphoid Bone;D014989
D09.698.925;Xylans;D014990
D02.886.665.985;Xylazine;D014991
D03.383.855.985;Xylazine;D014991
D02.455.426.559.389.948;Xylenes;D014992
D02.033.800.936;Xylitol;D014993
D09.853.936;Xylitol;D014993
D09.546.627.867;Xylose;D014994
D08.811.277.450.950;Xylosidases;D014995
D09.546.465.920;Xylulose;D014996
D09.546.627.885;Xylulose;D014996
C23.550.210.024.500;XYY Karyotype;D014997
C23.550.210.815.970;XYY Karyotype;D014997
G05.360.162.679.500.500;XYY Karyotype;D014997
G05.365.590.175.024.500;XYY Karyotype;D014997
G05.365.590.175.815.970;XYY Karyotype;D014997
A11.284.187.865.983;Y Chromosome;D014998
G05.360.162.865.983;Y Chromosome;D014998
B04.280.650.160.980.950;Yaba monkey tumor virus;D014999
B04.909.204.210.950.950;Yaba monkey tumor virus;D014999
B04.909.204.783.160.980.950;Yaba monkey tumor virus;D014999
B04.909.574.204.950.950;Yaba monkey tumor virus;D014999
G09.772.770.980;Yawning;D015000
C01.252.400.840.892;Yaws;D015001
C01.252.825.910;Yaws;D015001
C01.252.847.840.892;Yaws;D015001
C01.539.800.720.910;Yaws;D015001
C17.800.838.765.910;Yaws;D015001
C23.996.900;Yaws;D015001
J02.500.456.933;Yeast, Dried;D015002
B01.300.930;Yeasts;D015003
C02.081.980;Yellow Fever;D015004
C02.782.350.250.980;Yellow Fever;D015004
C23.996.950;Yellow Fever;D015004
B04.820.250.350.990;Yellow fever virus;D015005
B04.909.777.310.350.990;Yellow fever virus;D015005
Z01.252.245.500.950;Yemen;D015006
Z01.586.500.950;Yemen;D015006
B03.440.450.425.900;Yersinia;D015007
B03.660.250.150.950;Yersinia;D015007
B03.440.450.425.900.300;Yersinia enterocolitica;D015008
B03.660.250.150.950.160;Yersinia enterocolitica;D015008
C01.252.400.310.980;Yersinia Infections;D015009
B03.440.450.425.900.600;Yersinia pestis;D015010
B03.660.250.150.950.580;Yersinia pestis;D015010
B03.440.450.425.900.615;Yersinia pseudotuberculosis;D015011
B03.660.250.150.950.590;Yersinia pseudotuberculosis;D015011
C01.252.400.310.980.780;Yersinia pseudotuberculosis Infections;D015012
E02.190.525.937;Yoga;D015013
E02.190.901.984;Yoga;D015013
E02.779.474.937;Yoga;D015013
K01.844.799.867;Yoga;D015013
J02.500.350.525.221.888;Yogurt;D015014
D03.132.436.681.933;Yohimbine;D015016
D03.438.473.402.681.933;Yohimbine;D015016
A10.615.284.981;Yolk Sac;D015017
A16.254.750.981;Yolk Sac;D015017
A16.331.800;Yolk Sac;D015017
D01.268.477.992;Ytterbium;D015018
D01.268.558.362.992;Ytterbium;D015018
D01.552.550.399.992;Ytterbium;D015018
D01.268.558.975;Yttrium;D015019
D01.268.956.890;Yttrium;D015019
D01.552.550.975;Yttrium;D015019
D01.496.943;Yttrium Isotopes;D015020
D01.496.749.960;Yttrium Radioisotopes;D015021
D01.496.943.800;Yttrium Radioisotopes;D015021
Z01.542.248.980;Yugoslavia;D015022
Z01.586.980;Yugoslavia;D015022
Z01.058.290.100.220;Democratic Republic of the Congo;D015023
Z01.058.290.175.920;Zambia;D015024
D02.455.426.559.389.657.852.900;Zearalenone;D015025
D02.540.950;Zearalenone;D015025
D23.946.587.989;Zearalenone;D015025
D03.438.759.138.525.700;Zeatin;D015026
B01.050.150.900.493.200.244.828;Zebrafish;D015027
D12.776.765.725.500.750;Zein;D015028
D02.455.426.559.389.657.852.900.975;Zeranol;D015029
D02.540.950.975;Zeranol;D015029
Z01.058.290.175.960;Zimbabwe;D015030
D03.383.725.620.129.960;Zimeldine;D015031
D01.268.556.940;Zinc;D015032
D01.268.956.906;Zinc;D015032
D01.552.544.940;Zinc;D015032
D01.496.966;Zinc Isotopes;D015033
D01.650.550.975;Zinc Oxide;D015034
D01.975.975;Zinc Oxide;D015034
D25.339.291.925;Zinc Oxide-Eugenol Cement;D015035
J01.637.051.339.291.925;Zinc Oxide-Eugenol Cement;D015035
D25.339.291.950;Zinc Phosphate Cement;D015036
J01.637.051.339.291.950;Zinc Phosphate Cement;D015036
D01.496.749.980;Zinc Radioisotopes;D015037
D01.496.966.800;Zinc Radioisotopes;D015037
D02.241.081.251.869.265.908;Zineb;D015038
D02.691.975;Zineb;D015038
D02.886.706.250.950;Zineb;D015038
D02.241.081.251.869.210.925;Ziram;D015039
D02.886.706.175.950;Ziram;D015039
D01.268.556.950;Zirconium;D015040
D01.268.956.937;Zirconium;D015040
D01.552.544.950;Zirconium;D015040
D03.383.066.985;Zolazepam;D015041
C04.730.713.988;Zollinger-Ellison Syndrome;D015043
C06.301.371.883;Zollinger-Ellison Syndrome;D015043
C06.405.249.883;Zollinger-Ellison Syndrome;D015043
C06.405.469.965;Zollinger-Ellison Syndrome;D015043
C06.405.608.924;Zollinger-Ellison Syndrome;D015043
C06.405.748.947;Zollinger-Ellison Syndrome;D015043
A05.360.490.690.950;Zona Pellucida;D015044
A11.284.295.310.990;Zona Pellucida;D015044
A11.497.497.900;Zona Pellucida;D015044
A16.690.900;Zona Pellucida;D015044
B03.440.400.425.983;Zoogloea;D015045
B03.660.075.655.975;Zoogloea;D015045
H01.158.273.943;Zoology;D015046
C01.908;Zoonoses;D015047
C02.968;Zoonoses;D015047
C03.908;Zoonoses;D015047
C22.969;Zoonoses;D015047
B05.080.500.980;Zooplankton;D015048
D03.438.221.950;Zoxazolamine;D015049
A02.835.232.781.324.995;Zygoma;D015050
C26.260.275.500.950;Zygomatic Fractures;D015051
C26.404.750.959;Zygomatic Fractures;D015051
A05.360.490.690.970;Zygote;D015053
A11.497.497.950;Zygote;D015053
A16.950;Zygote;D015053
D09.698.365.089.750;Zymosan;D015054
D02.241.081.901.400;1-Carboxyglutamic Acid;D015055
D12.125.067.750.150;1-Carboxyglutamic Acid;D015055
D12.125.119.450.150;1-Carboxyglutamic Acid;D015055
D03.438.759.758.824.751.500;1-Methyl-3-isobutylxanthine;D015056
D02.092.705;1-Naphthylamine;D015057
D02.455.426.559.847.638.845;1-Naphthylamine;D015057
D04.615.638.845;1-Naphthylamine;D015057
D02.455.426.559.847.638.870;1-Naphthylisothiocyanate;D015058
D02.500.375.625;1-Naphthylisothiocyanate;D015058
D02.886.250.625;1-Naphthylisothiocyanate;D015058
D04.615.638.870;1-Naphthylisothiocyanate;D015058
D12.644.456.073.041.815;1-Sarcosine-8-Isoleucine Angiotensin II;D015059
D23.469.050.050.050.725;1-Sarcosine-8-Isoleucine Angiotensin II;D015059
D10.570.755.375.760.400.800.224;1,2-Dipalmitoylphosphatidylcholine;D015060
D08.811.913.400.450.460.100;1,4-alpha-Glucan Branching Enzyme;D015061
D06.472.040.585.353;11-Hydroxycorticosteroids;D015062
D10.251.355.255.550.700.450.300;16,16-Dimethylprostaglandin E2;D015064
D23.469.700.660.200;16,16-Dimethylprostaglandin E2;D015064
D06.472.040.585.478;17-Hydroxycorticosteroids;D015065
D08.811.682.047.436.375;17-Hydroxysteroid Dehydrogenases;D015067
D04.808.578.502;17-Ketosteroids;D015068
D06.472.040.502;17-Ketosteroids;D015068
D04.808.745.745.654.237.400;18-Hydroxycorticosterone;D015069
D06.472.040.585.353.500;18-Hydroxycorticosterone;D015069
D04.808.745.745.654.339.400;18-Hydroxydesoxycorticosterone;D015070
D06.472.040.585.611.400;18-Hydroxydesoxycorticosterone;D015070
D04.808.247.222.284.510;19-Iodocholesterol;D015071
D04.808.247.808.197.580;19-Iodocholesterol;D015071
D08.811.399.520.100;2-Acetolactate Mutase;D015072
D02.065.064.150;2-Acetylaminofluorene;D015073
D02.241.081.018.110.080;2-Acetylaminofluorene;D015073
D02.455.426.559.847.389.050;2-Acetylaminofluorene;D015073
D04.615.389.050;2-Acetylaminofluorene;D015073
D02.241.081.337.052.075;2-Aminoadipic Acid;D015074
D12.125.119.075;2-Aminoadipic Acid;D015074
D03.438.759.138.050;2-Aminopurine;D015075
D02.455.426.559.389.140.400;2-Hydroxy-5-nitrobenzyl Bromide;D015077
D02.455.426.559.389.657.566.400;2-Hydroxy-5-nitrobenzyl Bromide;D015077
D02.640.743.400;2-Hydroxy-5-nitrobenzyl Bromide;D015077
D02.033.100.291.410;2-Hydroxyphenethylamine;D015078
D02.092.063.291.410;2-Hydroxyphenethylamine;D015078
D02.092.211.215.581;2-Hydroxyphenethylamine;D015078
D02.092.471.683.545;2-Hydroxyphenethylamine;D015078
D08.811.913.050.614;2-Isopropylmalate Synthase;D015079
D02.455.326.146.100.050.490;Mesna;D015080
D02.886.489.590;Mesna;D015080
D02.886.645.600.055.050.500;Mesna;D015080
D02.092.710;2-Naphthylamine;D015081
D02.455.426.559.847.638.850;2-Naphthylamine;D015081
D04.615.638.850;2-Naphthylamine;D015081
D03.383.725.220;2,2'-Dipyridyl;D015082
D02.241.081.844.200;2,3-Diketogulonic Acid;D015083
D02.241.511.902.200;2,3-Diketogulonic Acid;D015083
D09.811.200;2,3-Diketogulonic Acid;D015083
D02.241.081.018.386.682.224;2,4-Dichlorophenoxyacetic Acid;D015084
D02.241.511.316.682.149;2,4-Dichlorophenoxyacetic Acid;D015084
D02.241.081.018.386.682.800;2,4,5-Trichlorophenoxyacetic Acid;D015085
D02.241.511.316.682.800;2,4,5-Trichlorophenoxyacetic Acid;D015085
D02.455.426.559.389.657.446.250;2,6-Dichloroindophenol;D015086
D08.811.277.352.640.160;2',3'-Cyclic-Nucleotide Phosphodiesterases;D015087
D08.811.913.696.445.625;2',5'-Oligoadenylate Synthetase;D015088
D08.811.682.047.436.400;20-Hydroxysteroid Dehydrogenases;D015089
D08.244.453.915.400;25-Hydroxyvitamin D3 1-alpha-Hydroxylase;D015090
D08.811.682.690.708.170.915.400;25-Hydroxyvitamin D3 1-alpha-Hydroxylase;D015090
D08.811.682.690.708.783.400;25-Hydroxyvitamin D3 1-alpha-Hydroxylase;D015090
D12.776.422.220.453.915.400;25-Hydroxyvitamin D3 1-alpha-Hydroxylase;D015090
D12.125.042.070;beta-Alanine;D015091
D03.383.742.680.852.250;3-Deazauridine;D015092
D13.570.685.852.250;3-Deazauridine;D015092
D13.570.800.892.250;3-Deazauridine;D015092
D02.241.081.337.351.550;Meglutol;D015093
D08.811.682.047.385;3-Hydroxyacyl CoA Dehydrogenases;D015094
D02.241.223.100.050.400.400;3-Hydroxyanthranilic Acid;D015095
D02.241.223.100.300.300;3-Hydroxyanthranilic Acid;D015095
D02.241.511.390.300;3-Hydroxyanthranilic Acid;D015095
D02.455.426.559.389.127.020.906.249;3-Hydroxyanthranilic Acid;D015095
D08.811.682.047.436.350;3-Hydroxysteroid Dehydrogenases;D015096
D02.241.081.751.080;3-Mercaptopropionic Acid;D015097
D02.886.489.520;3-Mercaptopropionic Acid;D015097
D02.455.426.559.389.657.166.500;3-Methoxy-4-hydroxyphenylethanol;D015098
D08.811.913.050.622;3-Oxoacyl-(Acyl-Carrier-Protein) Synthase;D015099
D02.455.426.559.389.185.200;3,3'-Diaminobenzidine;D015100
D02.455.426.559.389.185.226;3,3'-Dichlorobenzidine;D015101
D02.241.223.601.220;3,4-Dihydroxyphenylacetic Acid;D015102
D02.092.211.215.311.560.220;Droxidopa;D015103
D02.092.311.461.484.220;Droxidopa;D015103
D12.125.837.225;Droxidopa;D015103
D02.092.471.683.152.660;3,4-Methylenedioxyamphetamine;D015104
D08.811.277.352.640.150;3',5'-Cyclic-AMP Phosphodiesterases;D015105
D12.644.360.008;3',5'-Cyclic-AMP Phosphodiesterases;D015105
D12.776.476.008;3',5'-Cyclic-AMP Phosphodiesterases;D015105
D08.811.277.352.640.155;3',5'-Cyclic-GMP Phosphodiesterases;D015106
D12.644.360.009;3',5'-Cyclic-GMP Phosphodiesterases;D015106
D12.776.476.009;3',5'-Cyclic-GMP Phosphodiesterases;D015106
D02.540.150;4-Butyrolactone;D015107
D03.383.312.150;4-Butyrolactone;D015107
D02.092.570.450;4-Hydroxyaminoquinoline-1-oxide;D015108
D03.438.810.050.440;4-Hydroxyaminoquinoline-1-oxide;D015108
D03.661.243.320;4-Hydroxyaminoquinoline-1-oxide;D015108
D08.811.682.690.708.425;4-Hydroxybenzoate-3-Monooxygenase;D015109
D03.438.150.446.520;4-Hydroxycoumarins;D015110
D03.830.219.446.520;4-Hydroxycoumarins;D015110
D08.811.682.690.416.330;4-Hydroxyphenylpyruvate Dioxygenase;D015111
D02.640.820.600;4-Nitroquinoline-1-oxide;D015112
D03.438.810.470.450;4-Nitroquinoline-1-oxide;D015112
D03.661.243.500;4-Nitroquinoline-1-oxide;D015112
D04.808.054.040.080;Androstane-3,17-diol;D015113
D06.472.334.851.968.500;Androstane-3,17-diol;D015113
D04.808.054.079.429.154.050;Androstenediol;D015114
D06.472.334.851.968.750;Androstenediol;D015114
D03.438.473.914.201.259;5,6-Dihydroxytryptamine;D015115
D03.438.473.914.201.263;5,7-Dihydroxytryptamine;D015116
D10.251.355.255.205;5,8,11,14-Eicosatetraynoic Acid;D015117
D10.212.302.380.410.385;Eicosapentaenoic Acid;D015118
D10.251.355.255.200;Eicosapentaenoic Acid;D015118
D10.251.355.337.290;Eicosapentaenoic Acid;D015118
D10.627.430.450.390;Eicosapentaenoic Acid;D015118
D02.241.081.193.150.075;6-Aminocaproic Acid;D015119
D12.125.213.075;6-Aminocaproic Acid;D015119
D03.066.515.530.248;6-Aminonicotinamide;D015120
D03.383.725.547.530.248;6-Aminonicotinamide;D015120
D10.251.355.255.100.637.400.350;6-Ketoprostaglandin F1 alpha;D015121
D10.251.355.255.550.400.350;6-Ketoprostaglandin F1 alpha;D015121
D10.251.355.325.450;6-Ketoprostaglandin F1 alpha;D015121
D23.469.050.175.725.790.450;6-Ketoprostaglandin F1 alpha;D015121
D02.886.489.534;6-Mercaptopurine;D015122
D03.438.759.534;6-Mercaptopurine;D015122
D02.455.426.559.847.799.306.400.350;7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide;D015123
D04.615.799.306.400.350;7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide;D015123
D03.438.759.646.138.395.225;8-Bromo Cyclic Adenosine Monophosphate;D015124
D13.695.462.200.225;8-Bromo Cyclic Adenosine Monophosphate;D015124
D13.695.667.138.395.225;8-Bromo Cyclic Adenosine Monophosphate;D015124
D13.695.827.068.395.225;8-Bromo Cyclic Adenosine Monophosphate;D015124
D03.438.810.350.625;Oxyquinoline;D015125
D10.251.355.255.207;8,11,14-Eicosatrienoic Acid;D015126
D02.455.426.559.847.149.301;9,10-Dimethyl-1,2-benzanthracene;D015127
D04.615.149.301;9,10-Dimethyl-1,2-benzanthracene;D015127
D13.444.735.628;RNA, Nuclear;D015138
E05.196.401.114;Blotting, Southern;D015139
E05.301.300.087;Blotting, Southern;D015139
E05.393.525.150;Blotting, Southern;D015139
E05.601.150;Blotting, Southern;D015139
C10.228.140.300.400;Dementia, Vascular;D015140
C10.228.140.300.510.800.500;Dementia, Vascular;D015140
C10.228.140.380.230;Dementia, Vascular;D015140
C10.228.140.695.500;Dementia, Vascular;D015140
C10.228.518.500;Dementia, Vascular;D015140
C14.907.137.126.372.500;Dementia, Vascular;D015140
C14.907.253.560.350.500;Dementia, Vascular;D015140
F03.087.400.350;Dementia, Vascular;D015140
Z01.107.567.875.580.200.450;Los Angeles;D015141
Z01.107.567.875.760.200.450;Los Angeles;D015141
Z01.433.565;Los Angeles;D015141
Z01.107.567.875.500.500.100;Baltimore;D015142
Z01.433.100;Baltimore;D015142
Z01.107.567.875.500.550.525;Philadelphia;D015143
Z01.433.820;Philadelphia;D015143
Z01.107.567.875.750;Southeastern United States;D015144
E02.875.900;Tocolysis;D015145
Z01.107.567.875.510;Midwestern United States;D015146
E01.370.370.380.170;Cardiotocography;D015148
E01.370.378.230.150;Cardiotocography;D015148
E01.370.520.230.150;Cardiotocography;D015148
D27.505.696.875.825;Tocolytic Agents;D015149
D27.505.954.705.825;Tocolytic Agents;D015149
E01.370.350.130.750.220;Echocardiography, Doppler;D015150
E01.370.350.850.220.220;Echocardiography, Doppler;D015150
E01.370.350.850.850.220;Echocardiography, Doppler;D015150
E01.370.370.380.220.220;Echocardiography, Doppler;D015150
E05.478.566.320;Immunoblotting;D015151
E05.601.495.320;Immunoblotting;D015151
E05.196.401.095;Blotting, Northern;D015152
E05.301.300.074;Blotting, Northern;D015152
E05.393.525.100;Blotting, Northern;D015152
E05.601.140;Blotting, Northern;D015152
E05.196.401.143;Blotting, Western;D015153
E05.301.300.096;Blotting, Western;D015153
E05.393.525.262;Blotting, Western;D015153
E05.478.566.320.200;Blotting, Western;D015153
E05.601.495.320.200;Blotting, Western;D015153
C06.405.117.119.500;Esophageal Motility Disorders;D015154
C06.405.117.119.500.450;Esophageal Spasm, Diffuse;D015155
C13.703.277.060.480;Hydrops Fetalis;D015160
C15.378.120.413.480;Hydrops Fetalis;D015160
C15.378.420.826.100.350;Hydrops Fetalis;D015160
C16.300.060.480;Hydrops Fetalis;D015160
C16.320.365.826.100.350;Hydrops Fetalis;D015160
C20.188.413.480;Hydrops Fetalis;D015160
C23.888.277.395;Hydrops Fetalis;D015160
C10.228.140.300.150.477.200.199;Dementia, Multi-Infarct;D015161
C10.228.140.300.400.408;Dementia, Multi-Infarct;D015161
C10.228.140.300.775.200.200.199;Dementia, Multi-Infarct;D015161
C10.228.140.380.230.250;Dementia, Multi-Infarct;D015161
C14.907.253.092.477.200.199;Dementia, Multi-Infarct;D015161
C14.907.253.855.200.200.199;Dementia, Multi-Infarct;D015161
F03.087.400.350.400;Dementia, Multi-Infarct;D015161
E05.393.560.598;Micronucleus Tests;D015162
C01.539.597.880;Superinfection;D015163
C02.597.880;Superinfection;D015163
C03.684.880;Superinfection;D015163
D20.215.894.830;Vaccines, Inactivated;D015164
E01.370.225.812.505;Monitoring, Immunologic;D015166
E01.370.520.505;Monitoring, Immunologic;D015166
E05.200.812.505;Monitoring, Immunologic;D015166
E05.478.594.550;Monitoring, Immunologic;D015166
E04.525.210.080.600.850.860;Vagotomy, Truncal;D015167
E04.525.210.850.860;Vagotomy, Truncal;D015167
C26.324.550;Lightning Injuries;D015168
E01.370.225.875.220;Colony Count, Microbial;D015169
E05.200.875.220;Colony Count, Microbial;D015169
G11.561.170;Cerebrospinal Fluid Pressure;D015170
E04.525.210.080.800.380;Ganglionectomy;D015171
E04.525.210.380;Ganglionectomy;D015171
C04.588.614.250.195.885;Supratentorial Neoplasms;D015173
C10.228.140.211.885;Supratentorial Neoplasms;D015173
C10.551.240.250.700;Supratentorial Neoplasms;D015173
C04.588.614.250.803.342;Epidural Neoplasms;D015174
C10.228.854.765.342;Epidural Neoplasms;D015174
C10.551.240.750.200;Epidural Neoplasms;D015174
C04.557.470.035.625;Prolactinoma;D015175
C04.588.322.609.792;Prolactinoma;D015175
C10.228.140.617.738.675.800;Prolactinoma;D015175
C19.344.609.792;Prolactinoma;D015175
C19.700.734.792;Prolactinoma;D015175
C04.588.274.476.411.307;Colorectal Neoplasms;D015179
C06.301.371.411.307;Colorectal Neoplasms;D015179
C06.405.249.411.307;Colorectal Neoplasms;D015179
C06.405.469.158.356;Colorectal Neoplasms;D015179
C06.405.469.491.307;Colorectal Neoplasms;D015179
C06.405.469.860.180;Colorectal Neoplasms;D015179
E05.196.401.250;Electrophoresis, Gel, Two-Dimensional;D015180
E05.196.401.402.250;Electrophoresis, Gel, Two-Dimensional;D015180
E05.301.300.230;Electrophoresis, Gel, Two-Dimensional;D015180
E05.301.300.319.450;Electrophoresis, Gel, Two-Dimensional;D015180
E02.875.800.875;Gamete Intrafallopian Transfer;D015181
E05.820.800.875;Gamete Intrafallopian Transfer;D015181
E02.815.350;Lymphatic Irradiation;D015182
E05.393.183.620.650;Restriction Mapping;D015183
E05.393.712;Restriction Mapping;D015183
B01.050.150.900.649.801.400.112.400;Hominidae;D015186
E02.065.062.937;Lipectomy;D015187
E02.218.530;Lipectomy;D015187
E04.062.937;Lipectomy;D015187
E04.680.450;Lipectomy;D015187
E01.370.225.124.100.105;Blood Glucose Self-Monitoring;D015190
E01.370.374.100;Blood Glucose Self-Monitoring;D015190
E01.370.520.100;Blood Glucose Self-Monitoring;D015190
E02.900.100;Blood Glucose Self-Monitoring;D015190
E05.200.124.100.105;Blood Glucose Self-Monitoring;D015190
C04.588.614.250.195.411;Infratentorial Neoplasms;D015192
C10.228.140.211.500;Infratentorial Neoplasms;D015192
C10.551.240.250.400;Infratentorial Neoplasms;D015192
E01.370.225.500.384.100.149;Chorionic Villi Sampling;D015193
E01.370.225.500.384.150;Chorionic Villi Sampling;D015193
E01.370.225.998.054.149;Chorionic Villi Sampling;D015193
E01.370.378.630.150;Chorionic Villi Sampling;D015193
E01.370.388.100.150;Chorionic Villi Sampling;D015193
E04.074.149;Chorionic Villi Sampling;D015193
E04.665.160;Chorionic Villi Sampling;D015193
E05.200.500.384.100.149;Chorionic Villi Sampling;D015193
E05.200.500.384.150;Chorionic Villi Sampling;D015193
E05.200.998.054.149;Chorionic Villi Sampling;D015193
E05.200.998.165;Chorionic Villi Sampling;D015193
E05.242.384.100.149;Chorionic Villi Sampling;D015193
E05.242.384.150;Chorionic Villi Sampling;D015193
E07.241;Diffusion Chambers, Culture;D015194
E05.295.500;Drug Design;D015195
H01.158.703.007.675.500;Drug Design;D015195
H01.181.466.675.500;Drug Design;D015195
E05.940.150;Carcinogenicity Tests;D015197
D26.200;Designer Drugs;D015198
E02.880.301;Extracorporeal Membrane Oxygenation;D015199
E04.292.451;Extracorporeal Membrane Oxygenation;D015199
E05.478.412.341;Fluoroimmunoassay;D015200
E05.478.566.159;Fluoroimmunoassay;D015200
E05.318.780.500;Meta-Analysis as Topic;D015201
E05.581.500.501;Meta-Analysis as Topic;D015201
N05.715.360.780.515;Meta-Analysis as Topic;D015201
N06.850.520.445.500;Meta-Analysis as Topic;D015201
E05.393.420.601;Protein Engineering;D015202
E05.318.780.725;Reproducibility of Results;D015203
E05.337.851;Reproducibility of Results;D015203
N05.715.360.780.685;Reproducibility of Results;D015203
N06.850.520.445.725;Reproducibility of Results;D015203
E05.196.867.776.751;Spectroscopy, Mossbauer;D015204
Z01.107.567.875.560;Northwestern United States;D015205
Z01.107.567.875.760;Southwestern United States;D015206
C05.550.114.606.400;Osteoarthritis, Hip;D015207
C05.799.613.400;Osteoarthritis, Hip;D015207
C26.200.322.800;Smoke Inhalation Injury;D015208
C06.130.120.200.110;Cholangitis, Sclerosing;D015209
C05.550.114.423.410;Arthritis, Gouty;D015210
C05.799.414.410;Arthritis, Gouty;D015210
C16.320.565.798.368.410;Arthritis, Gouty;D015210
C18.452.648.798.368.410;Arthritis, Gouty;D015210
C06.552.970;Zellweger Syndrome;D015211
C10.228.140.163.100.680.970;Zellweger Syndrome;D015211
C12.777.419.978;Zellweger Syndrome;D015211
C13.351.968.419.978;Zellweger Syndrome;D015211
C16.131.077.970;Zellweger Syndrome;D015211
C16.320.565.189.680.970;Zellweger Syndrome;D015211
C16.320.565.663.970;Zellweger Syndrome;D015211
C18.452.132.100.680.970;Zellweger Syndrome;D015211
C18.452.648.189.680.970;Zellweger Syndrome;D015211
C18.452.648.663.970;Zellweger Syndrome;D015211
C06.405.205.731;Inflammatory Bowel Diseases;D015212
C06.405.469.432;Inflammatory Bowel Diseases;D015212
G07.265.337.620;Neuroimmunomodulation;D015213
G07.700.240.620;Neuroimmunomodulation;D015213
G11.561.600.630;Neuroimmunomodulation;D015213
G12.425.746.575;Neuroimmunomodulation;D015213
D23.050.301.264.900;Antigens, Differentiation, Myelomonocytic;D015214
D23.101.100.900;Antigens, Differentiation, Myelomonocytic;D015214
D03.383.742.680.705.950;Zidovudine;D015215
D13.570.230.500.950;Zidovudine;D015215
D13.570.230.855.950;Zidovudine;D015215
D13.570.685.705.950;Zidovudine;D015215
C16.320.565.398.641.201;Cholesterol Ester Storage Disease;D015217
C16.320.565.595.201;Cholesterol Ester Storage Disease;D015217
C18.452.584.687.201;Cholesterol Ester Storage Disease;D015217
C18.452.648.398.641.201;Cholesterol Ester Storage Disease;D015217
C18.452.648.595.201;Cholesterol Ester Storage Disease;D015217
C05.116.540.600;Hyperostosis, Sternocostoclavicular;D015218
C05.799.440;Hyperostosis, Sternocostoclavicular;D015218
C17.300.775.440;Hyperostosis, Sternocostoclavicular;D015218
G02.111.087.820;Substrate Cycling;D015219
G02.149.115.820;Substrate Cycling;D015219
G03.495.335.835;Substrate Cycling;D015219
D12.776.157.530.400.150;Calcium Channels;D015220
D12.776.543.550.425.150;Calcium Channels;D015220
D12.776.543.585.400.150;Calcium Channels;D015220
D12.776.157.530.400.600;Potassium Channels;D015221
D12.776.543.550.425.750;Potassium Channels;D015221
D12.776.543.585.400.750;Potassium Channels;D015221
D12.776.157.530.400.875;Sodium Channels;D015222
D12.776.543.550.425.875;Sodium Channels;D015222
D12.776.543.585.400.875;Sodium Channels;D015222
C16.320.565.398.641.201.500;Wolman Disease;D015223
C16.320.565.595.201.500;Wolman Disease;D015223
C16.614.947;Wolman Disease;D015223
C18.452.584.687.201.500;Wolman Disease;D015223
C18.452.648.398.641.201.500;Wolman Disease;D015223
C18.452.648.595.201.500;Wolman Disease;D015223
D13.570.230.500;Dideoxynucleosides;D015224
E01.370.376.500;Magnetoencephalography;D015225
E01.370.405.440;Magnetoencephalography;D015225
E05.540.500;Magnetoencephalography;D015225
D13.695.250;Dinucleoside Phosphates;D015226
G02.111.087.520;Lipid Peroxidation;D015227
G02.149.115.520;Lipid Peroxidation;D015227
G03.495.335.531.587;Lipid Peroxidation;D015227
C18.452.584.500.500.851;Hypertriglyceridemia;D015228
C02.800.801;Sexually Transmitted Diseases, Viral;D015229
D10.251.355.255.100.637.200.200;Prostaglandin D2;D015230
D10.251.355.255.550.200.200;Prostaglandin D2;D015230
D23.469.050.175.725.770.720;Prostaglandin D2;D015230
C01.252.810;Sexually Transmitted Diseases, Bacterial;D015231
C01.539.778.281;Sexually Transmitted Diseases, Bacterial;D015231
C12.294.668.281;Sexually Transmitted Diseases, Bacterial;D015231
C13.351.500.711.281;Sexually Transmitted Diseases, Bacterial;D015231
D10.251.355.255.100.637.250.200;Dinoprostone;D015232
D10.251.355.255.550.250.200;Dinoprostone;D015232
D23.469.050.175.725.780.200;Dinoprostone;D015232
E05.318.740.500;Models, Statistical;D015233
E05.599.835;Models, Statistical;D015233
N05.715.360.750.530;Models, Statistical;D015233
N06.850.520.830.500;Models, Statistical;D015233
D12.776.395.550.489.400;HLA-A Antigens;D015234
D12.776.543.550.421.400;HLA-A Antigens;D015234
D23.050.301.500.100.400;HLA-A Antigens;D015234
D23.050.301.500.450.370;HLA-A Antigens;D015234
D23.050.705.552.100.400;HLA-A Antigens;D015234
D23.050.705.552.450.370;HLA-A Antigens;D015234
D12.776.395.550.489.500;HLA-B Antigens;D015235
D12.776.543.550.421.500;HLA-B Antigens;D015235
D23.050.301.500.100.500;HLA-B Antigens;D015235
D23.050.301.500.450.380;HLA-B Antigens;D015235
D23.050.705.552.100.500;HLA-B Antigens;D015235
D23.050.705.552.450.380;HLA-B Antigens;D015235
D12.776.395.550.489.600;HLA-C Antigens;D015236
D12.776.543.550.421.600;HLA-C Antigens;D015236
D23.050.301.500.100.600;HLA-C Antigens;D015236
D23.050.301.500.450.390;HLA-C Antigens;D015236
D23.050.705.552.100.600;HLA-C Antigens;D015236
D23.050.705.552.450.390;HLA-C Antigens;D015236
D10.251.355.255.100.637.400.200;Dinoprost;D015237
D10.251.355.255.550.400.200;Dinoprost;D015237
D23.469.050.175.725.790.185;Dinoprost;D015237
D08.811.913.817.400;Sulfotransferases;D015238
D08.811.913.817.400.300;Arylsulfotransferase;D015239
D02.455.849.291.500.510.700;Phorbol 12,13-Dibutyrate;D015240
D12.776.124.050.250.265;Fibrinogens, Abnormal;D015241
D12.776.124.125.500.265;Fibrinogens, Abnormal;D015241
D23.119.490.265;Fibrinogens, Abnormal;D015241
D03.438.810.835.322.500;Ofloxacin;D015242
D10.532.599.700;Cholesterol, VLDL;D015243
D10.570.938.208.285;Cholesterol, VLDL;D015243
D12.776.521.622.700;Cholesterol, VLDL;D015243
D02.886.030.893;Thiorphan;D015244
D12.125.166.893;Thiorphan;D015244
D12.125.481.700.750;Thiorphan;D015244
D08.811.150.280.260.240;Deoxyribonuclease BamHI;D015245
D08.811.277.352.335.350.300.260.240;Deoxyribonuclease BamHI;D015245
D08.811.277.352.355.325.300.260.240;Deoxyribonuclease BamHI;D015245
D08.811.150.280.260.300;Deoxyribonuclease EcoRI;D015246
D08.811.277.352.335.350.300.260.250;Deoxyribonuclease EcoRI;D015246
D08.811.277.352.355.325.300.260.250;Deoxyribonuclease EcoRI;D015246
D08.811.150.280.260.400;Deoxyribonuclease HindIII;D015247
D08.811.277.352.335.350.300.260.260;Deoxyribonuclease HindIII;D015247
D08.811.277.352.355.325.300.260.260;Deoxyribonuclease HindIII;D015247
D02.241.081.114.968.500.750;Gemfibrozil;D015248
D02.241.081.944.509.350;Gemfibrozil;D015248
D02.355.726.305.750;Gemfibrozil;D015248
D02.455.426.559.389.657.654.305.750;Gemfibrozil;D015248
D10.251.400.895.593.350;Gemfibrozil;D015248
D02.455.426.559.847.562.050.050;Aclarubicin;D015250
D04.615.562.050.050;Aclarubicin;D015250
D09.408.051.059.050;Aclarubicin;D015250
D02.455.426.559.847.562.050.200.175.200;Epirubicin;D015251
D04.615.562.050.200.175.200;Epirubicin;D015251
D09.408.051.059.200.175.200;Epirubicin;D015251
D08.811.150.280.260;Deoxyribonucleases, Type II Site-Specific;D015252
D08.811.277.352.335.350.300.260;Deoxyribonucleases, Type II Site-Specific;D015252
D08.811.277.352.355.325.300.260;Deoxyribonucleases, Type II Site-Specific;D015252
D08.811.150.280.250;Deoxyribonucleases, Type I Site-Specific;D015253
D08.811.277.352.335.350.300.250;Deoxyribonucleases, Type I Site-Specific;D015253
D08.811.277.352.355.325.300.250;Deoxyribonucleases, Type I Site-Specific;D015253
D08.811.150.240;DNA Modification Methylases;D015254
D08.811.913.555.500.350;DNA Modification Methylases;D015254
D02.455.426.559.847.562.050.200.300;Idarubicin;D015255
D04.615.562.050.200.300;Idarubicin;D015255
D09.408.051.059.200.300;Idarubicin;D015255
D08.811.913.817.200;Coenzyme A-Transferases;D015256
D08.811.913.555.500.350.100;DNA-Cytosine Methylases;D015257
D20.050;Acid Rain;D015258
G16.500.240.135.859.050;Acid Rain;D015258
G16.500.275.063.725.395.050;Acid Rain;D015258
G16.500.750.775.450.050;Acid Rain;D015258
N06.230.300.100.725.450.050;Acid Rain;D015258
N06.230.520.050;Acid Rain;D015258
N06.850.460.790.410.050;Acid Rain;D015258
D27.505.519.625.150;Dopamine Agents;D015259
D27.505.696.577.150;Dopamine Agents;D015259
D08.811.277.656.300.480.600;Neprilysin;D015260
D08.811.277.656.675.374.600;Neprilysin;D015260
D23.050.285.550;Neprilysin;D015260
D23.050.301.264.035.550;Neprilysin;D015260
D23.101.100.110.550;Neprilysin;D015260
D23.101.840.500;Neprilysin;D015260
D26.969;Xenobiotics;D015262
D08.811.150.280.270;Deoxyribonucleases, Type III Site-Specific;D015263
D08.811.277.352.335.350.300.270;Deoxyribonucleases, Type III Site-Specific;D015263
D08.811.277.352.355.325.300.270;Deoxyribonucleases, Type III Site-Specific;D015263
D08.811.913.555.500.350.700;Site-Specific DNA-Methyltransferase (Adenine-Specific);D015265
C02.256.721.150;Carcinoma, Merkel Cell;D015266
C02.928.216;Carcinoma, Merkel Cell;D015266
C04.557.465.625.650.240.325;Carcinoma, Merkel Cell;D015266
C04.557.470.200.025.370.325;Carcinoma, Merkel Cell;D015266
C04.557.580.625.650.240.325;Carcinoma, Merkel Cell;D015266
C04.925.216;Carcinoma, Merkel Cell;D015266
C14.907.940.897.249.249;Churg-Strauss Syndrome;D015267
C15.604.515.292.015;Churg-Strauss Syndrome;D015267
C20.111.193.500;Churg-Strauss Syndrome;D015267
B03.510.024.049.525.500.720.100;Mycobacterium avium Complex;D015269
B03.510.460.400.410.552.552.720.100;Mycobacterium avium Complex;D015269
C01.252.410.040.552.475.495;Mycobacterium avium-intracellulare Infection;D015270
N03.219.521.576.570;Insurance Pools;D015271
H02.403.429.675;Pulmonary Medicine;D015272
N03.219.521.576.585;Insurance Selection Bias;D015273
N04.452.822.388;Interdepartmental Relations;D015274
C15.604.515.880;Tumor Lysis Syndrome;D015275
C20.683.515.950;Tumor Lysis Syndrome;D015275
I01.261.750.500;Health Care Rationing;D015276
N03.349.270;Health Care Rationing;D015276
N05.300.430.375;Health Care Rationing;D015276
L01.143.380;Hotlines;D015277
N02.278.388.493.390;Intensive Care Units, Pediatric;D015278
N04.452.606;Organizational Culture;D015279
D08.811.150;DNA Restriction-Modification Enzymes;D015280
D02.065.589.099.249.190.190.125;Cefmenoxime;D015281
D02.886.665.074.190.190.125;Cefmenoxime;D015281
D04.075.080.875.099.221.249.190.190.125;Cefmenoxime;D015281
D04.345.566.650;Octreotide;D015282
D12.644.641.650;Octreotide;D015282
D02.092.831.170;Citalopram;D015283
D02.626.320;Citalopram;D015283
D03.438.127.187;Citalopram;D015283
N03.219.521.710.305.180;Physician Payment Review Commission;D015284
N02.278.354.455;Hospital-Patient Relations;D015285
N04.452.442.510;Hospital-Patient Relations;D015285
N04.452.822.370;Hospital-Patient Relations;D015285
D12.644.276.812.900.475;Kassinin;D015286
D12.644.400.800.475;Kassinin;D015286
D12.644.456.800.475;Kassinin;D015286
D12.776.467.812.900.475;Kassinin;D015286
D12.776.641.650.800.475;Kassinin;D015286
D23.469.050.375.850.400;Kassinin;D015286
D23.529.812.900.475;Kassinin;D015286
D12.644.276.812.900.550;Neurokinin B;D015287
D12.644.400.800.550;Neurokinin B;D015287
D12.644.456.800.550;Neurokinin B;D015287
D12.776.467.812.900.550;Neurokinin B;D015287
D12.776.641.650.800.550;Neurokinin B;D015287
D23.469.050.375.850.570;Neurokinin B;D015287
D23.529.812.900.550;Neurokinin B;D015287
D12.644.276.812.900.500;Neurokinin A;D015288
D12.644.400.800.500;Neurokinin A;D015288
D12.644.456.800.500;Neurokinin A;D015288
D12.776.467.812.900.500;Neurokinin A;D015288
D12.776.641.650.800.500;Neurokinin A;D015288
D23.469.050.375.850.550;Neurokinin A;D015288
D23.529.812.900.500;Neurokinin A;D015288
D10.251.355.255.100.450;Leukotrienes;D015289
D23.469.050.175.450;Leukotrienes;D015289
G02.111.087.800.800;Second Messenger Systems;D015290
G02.149.115.800.800;Second Messenger Systems;D015290
G04.299.880.800;Second Messenger Systems;D015290
D12.644.276.954.800;Transforming Growth Factors;D015291
D12.644.276.963;Transforming Growth Factors;D015291
D12.776.467.942.800;Transforming Growth Factors;D015291
D12.776.467.960;Transforming Growth Factors;D015291
D23.529.942.800;Transforming Growth Factors;D015291
D23.529.960;Transforming Growth Factors;D015291
D06.472.699.322.326.562;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.322.576.288.750;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.322.576.463.249;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.631.525.343.288.750;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.631.525.343.463.249;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.631.525.883.249;Glycoprotein Hormones, alpha Subunit;D015292
D06.472.699.649.367.562;Glycoprotein Hormones, alpha Subunit;D015292
D12.644.548.691.525.343.288.750;Glycoprotein Hormones, alpha Subunit;D015292
D12.644.548.691.525.343.463.249;Glycoprotein Hormones, alpha Subunit;D015292
D12.644.548.691.525.883.249;Glycoprotein Hormones, alpha Subunit;D015292
D12.644.548.726.367.562;Glycoprotein Hormones, alpha Subunit;D015292
D08.811.277.040.330.300.200.800;Transducin;D015293
D12.644.360.375.940;Transducin;D015293
D12.776.157.325.332.940;Transducin;D015293
D12.776.476.375.940;Transducin;D015293
D12.776.543.325.800;Transducin;D015293
D23.050.285.050;Antigens, Tumor-Associated, Carbohydrate;D015295
D23.050.550.325;Antigens, Tumor-Associated, Carbohydrate;D015295
D23.101.840.075;Antigens, Tumor-Associated, Carbohydrate;D015295
D02.065.589.099.249.190.190.145;Ceftizoxime;D015296
D02.886.665.074.190.190.145;Ceftizoxime;D015296
D04.075.080.875.099.221.249.190.190.145;Ceftizoxime;D015296
C01.539.160.762.301;Discitis;D015299
C05.116.165.762.301;Discitis;D015299
C05.116.900.853.500;Discitis;D015299
E02.041.625.950;Ventilator Weaning;D015300
E02.880.820.950;Ventilator Weaning;D015300
B04.820.650.805;Retroviruses, Simian;D015301
B04.909.574.807.805;Retroviruses, Simian;D015301
B04.909.777.731.805;Retroviruses, Simian;D015301
B04.820.650.589.650.800;Simian immunodeficiency virus;D015302
B04.820.650.805.700;Simian immunodeficiency virus;D015302
B04.909.777.731.589.650.800;Simian immunodeficiency virus;D015302
B04.909.777.731.805.700;Simian immunodeficiency virus;D015302
B04.820.650.200.725.755;Simian T-lymphotropic virus 1;D015303
B04.820.650.805.851;Simian T-lymphotropic virus 1;D015303
B04.909.574.807.200.725.750;Simian T-lymphotropic virus 1;D015303
B04.909.574.807.805.851;Simian T-lymphotropic virus 1;D015303
B04.909.777.731.200.725.755;Simian T-lymphotropic virus 1;D015303
B04.909.777.731.805.851;Simian T-lymphotropic virus 1;D015303
D02.092.211.215;Biogenic Monoamines;D015306
G03.730.110;Anaerobic Threshold;D015308
G11.427.680.134;Anaerobic Threshold;D015308
E01.370.225.124.100.350;Glucose Clamp Technique;D015309
E05.196.500;Glucose Clamp Technique;D015309
E05.200.124.100.350;Glucose Clamp Technique;D015309
D02.065.589.099.249.190.190.135;Cefotiam;D015310
D02.886.665.074.190.190.135;Cefotiam;D015310
D04.075.080.875.099.221.249.190.190.135;Cefotiam;D015310
D02.065.589.099.249.250.177;Cefmetazole;D015311
D02.886.665.074.250.177;Cefmetazole;D015311
D04.075.080.875.099.221.249.250.177;Cefmetazole;D015311
D26.776.708.322.651;Hemodialysis Solutions;D015312
D27.720.280.775.483.651;Hemodialysis Solutions;D015312
D02.065.589.099.249.250.199;Cefotetan;D015313
D02.886.665.074.250.199;Cefotetan;D015313
D03.383.129.617.235;Cefotetan;D015313
D04.075.080.875.099.221.249.250.199;Cefotetan;D015313
D26.776.708.322;Dialysis Solutions;D015314
D27.720.280.775.483;Dialysis Solutions;D015314
E02.095.301;Genetic Therapy;D015316
E05.393.420.301;Genetic Therapy;D015316
D02.092.211.415;Biogenic Polyamines;D015317
C16.320.565.202.251;Fructose Metabolism, Inborn Errors;D015318
C18.452.648.202.251;Fructose Metabolism, Inborn Errors;D015318
C16.320.565.202.251.221;Fructose-1,6-Diphosphatase Deficiency;D015319
C18.452.648.202.251.221;Fructose-1,6-Diphosphatase Deficiency;D015319
D12.644.276.812.900;Tachykinins;D015320
D12.644.400.800;Tachykinins;D015320
D12.644.456.800;Tachykinins;D015320
D12.776.467.812.900;Tachykinins;D015320
D12.776.641.650.800;Tachykinins;D015320
D23.469.050.375.850;Tachykinins;D015320
D23.529.812.900;Tachykinins;D015320
G05.355.330;Gene Rearrangement;D015321
G05.355.330.401;Gene Rearrangement, B-Lymphocyte;D015322
G12.425.742.500;Gene Rearrangement, B-Lymphocyte;D015322
G12.500.349.500;Gene Rearrangement, B-Lymphocyte;D015322
C16.320.565.202.810;Pyruvate Metabolism, Inborn Errors;D015323
C18.452.648.202.810;Pyruvate Metabolism, Inborn Errors;D015323
C10.228.140.163.100.725;Pyruvate Carboxylase Deficiency Disease;D015324
C16.320.565.189.725;Pyruvate Carboxylase Deficiency Disease;D015324
C16.320.565.202.810.666;Pyruvate Carboxylase Deficiency Disease;D015324
C18.452.132.100.725;Pyruvate Carboxylase Deficiency Disease;D015324
C18.452.648.189.725;Pyruvate Carboxylase Deficiency Disease;D015324
C18.452.648.202.810.666;Pyruvate Carboxylase Deficiency Disease;D015324
C18.452.660.705;Pyruvate Carboxylase Deficiency Disease;D015324
C10.228.140.163.100.750;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C10.597.606.643.455.875;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C16.320.322.500.875;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C16.320.400.525.875;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C16.320.565.189.750;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C16.320.565.202.810.766;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C18.452.132.100.750;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C18.452.648.189.750;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C18.452.648.202.810.766;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
C18.452.660.710;Pyruvate Dehydrogenase Complex Deficiency Disease;D015325
G05.355.330.401.501;Gene Rearrangement, B-Lymphocyte, Heavy Chain;D015326
G12.425.742.500.501;Gene Rearrangement, B-Lymphocyte, Heavy Chain;D015326
G12.500.349.500.501;Gene Rearrangement, B-Lymphocyte, Heavy Chain;D015326
G05.355.330.401.601;Gene Rearrangement, B-Lymphocyte, Light Chain;D015328
G12.425.742.500.601;Gene Rearrangement, B-Lymphocyte, Light Chain;D015328
G12.500.349.500.601;Gene Rearrangement, B-Lymphocyte, Light Chain;D015328
G05.355.330.801;Gene Rearrangement, T-Lymphocyte;D015329
G12.425.742.530;Gene Rearrangement, T-Lymphocyte;D015329
G12.500.349.530;Gene Rearrangement, T-Lymphocyte;D015329
E05.318.760.500.750;Cohort Studies;D015331
N05.715.360.775.175.250;Cohort Studies;D015331
N06.850.520.450.500.750;Cohort Studies;D015331
G05.355.330.801.111;Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor;D015332
G12.425.742.530.111;Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor;D015332
G12.500.349.530.111;Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor;D015332
G05.355.330.801.211;Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;D015333
G12.425.742.530.211;Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;D015333
G12.500.349.530.211;Gene Rearrangement, beta-Chain T-Cell Antigen Receptor;D015333
G05.355.330.801.311;Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor;D015334
G12.425.742.530.311;Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor;D015334
G12.500.349.530.311;Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor;D015334
D27.720.470.530;Molecular Probes;D015335
E05.393.525;Molecular Probe Techniques;D015336
E05.601;Molecular Probe Techniques;D015336
E05.318.760.535.500;Multicenter Studies as Topic;D015337
E05.337.250.500;Multicenter Studies as Topic;D015337
N05.715.360.775.235.545;Multicenter Studies as Topic;D015337
N06.850.520.450.535.500;Multicenter Studies as Topic;D015337
E05.318.780;Epidemiologic Research Design;D015340
N05.715.360.780;Epidemiologic Research Design;D015340
N06.850.520.445;Epidemiologic Research Design;D015340
D13.444.600;Nucleic Acid Probes;D015341
D27.720.470.530.600;Nucleic Acid Probes;D015341
D13.444.600.223;DNA Probes;D015342
D27.720.470.530.600.223;DNA Probes;D015342
D13.444.600.223.550;DNA Probes, HLA;D015343
D27.720.470.530.600.223.615;DNA Probes, HLA;D015343
D13.444.600.223.555;DNA Probes, HPV;D015344
D27.720.470.530.600.223.620;DNA Probes, HPV;D015344
D13.444.600.601;Oligonucleotide Probes;D015345
D27.720.470.530.600.650;Oligonucleotide Probes;D015345
D13.444.600.723;RNA Probes;D015347
D27.720.470.530.600.825;RNA Probes;D015347
F02.463.593.932.885;Vision, Binocular;D015348
F02.463.593.932.893;Vision, Monocular;D015349
E01.370.380.850.950.500;Contrast Sensitivity;D015350
F02.463.593.932.869.435.110;Contrast Sensitivity;D015350
F02.463.593.932.901.500;Contrast Sensitivity;D015350
G14.940.500;Contrast Sensitivity;D015350
E01.370.380.850.900;Vision Screening;D015351
E05.318.308.250.580.925;Vision Screening;D015351
N05.715.360.300.375.500.825;Vision Screening;D015351
N06.850.520.308.250.580.925;Vision Screening;D015351
N06.850.780.500.950;Vision Screening;D015351
C11.496.260;Dry Eye Syndromes;D015352
E04.540.429;Eye Enucleation;D015353
C10.597.751.941.905;Vision, Low;D015354
C11.966.905;Vision, Low;D015354
C23.888.592.763.941.848;Vision, Low;D015354
C11.525.381.348;Glaucoma, Neovascular;D015355
C11.768.400;Retinal Artery Occlusion;D015356
C14.907.137.780;Retinal Artery Occlusion;D015356
F02.463.593.932.869.255.780;Vision Disparity;D015357
G14.930;Vision Disparity;D015357
B03.510.024.049.525.500.720.625;Mycobacterium scrofulaceum;D015359
B03.510.460.400.410.552.552.720.625;Mycobacterium scrofulaceum;D015359
E03.091.080;Analgesia, Epidural;D015360
E02.218.765;Rhytidoplasty;D015361
E04.680.275.700;Rhytidoplasty;D015361
C18.654.180;Child Nutrition Disorders;D015362
D03.438.810.835;Quinolones;D015363
D03.438.810.835.322.280;Enoxacin;D015365
D03.438.810.835.322.750;Pefloxacin;D015366
B04.820.650.200.730.404;Human T-lymphotropic virus 2;D015367
B04.909.574.807.200.730.399;Human T-lymphotropic virus 2;D015367
B04.909.777.731.200.730.404;Human T-lymphotropic virus 2;D015367
B04.820.650.200.725.400;Human T-lymphotropic virus 1;D015368
B04.909.574.807.200.725.400;Human T-lymphotropic virus 1;D015368
B04.909.777.731.200.725.400;Human T-lymphotropic virus 1;D015368
E07.490;Infant Equipment;D015370
E01.370.225.875.150.125;Bacterial Typing Techniques;D015373
E05.200.875.150.125;Bacterial Typing Techniques;D015373
E05.601.123;Biosensing Techniques;D015374
D12.776.543.750.705.852.420.320;Receptors, Interleukin-2;D015375
D02.654.692.550;Nimustine;D015376
D02.948.594.550;Nimustine;D015376
D02.455.426.392.368.533.200;Cilastatin;D015377
D10.251.355.325.200;Cilastatin;D015377
D02.065.589.099.124.300.500;Imipenem;D015378
D04.075.080.875.099.221.124.300.500;Imipenem;D015378
A06.407.071.140.950;Zona Fasciculata;D015383
A06.407.071.140.960;Zona Glomerulosa;D015384
A06.407.071.140.970;Zona Reticularis;D015385
D27.888.284.360;Hazardous Substances;D015386
D12.776.256.317;Egg Proteins, Dietary;D015387
D12.776.290.300;Egg Proteins, Dietary;D015387
J02.500.428.317;Egg Proteins, Dietary;D015387
J02.500.470.349;Egg Proteins, Dietary;D015387
A11.284.430.214.190.875;Organelles;D015388
E02.065.062.249;Gastric Bypass;D015390
E04.035.398.385;Gastric Bypass;D015390
E04.062.249;Gastric Bypass;D015390
E04.210.457.430;Gastric Bypass;D015390
E02.065.062.750;Gastroplasty;D015391
E04.062.750;Gastroplasty;D015391
E04.210.485;Gastroplasty;D015391
H01.181.370;Chemistry, Inorganic;D015392
H01.158.201.214;Chemistry, Bioinorganic;D015393
H01.181.122.253;Chemistry, Bioinorganic;D015393
H01.181.370.310;Chemistry, Bioinorganic;D015393
G02.111.570;Molecular Structure;D015394
G02.575;Molecular Structure;D015394
G02.842.575;Molecular Structure;D015394
D12.776.395.550.489;Histocompatibility Antigens Class I;D015395
D12.776.543.550.421;Histocompatibility Antigens Class I;D015395
D23.050.301.500.100;Histocompatibility Antigens Class I;D015395
D23.050.705.552.100;Histocompatibility Antigens Class I;D015395
E05.337.820;Program Evaluation;D015397
N04.761.685;Program Evaluation;D015397
N05.715.360.650;Program Evaluation;D015397
G02.111.087.800;Signal Transduction;D015398
G02.149.115.800;Signal Transduction;D015398
G04.299.880;Signal Transduction;D015398
H01.770.644.145.390;Nursing Research;D015399
H02.478.395;Nursing Research;D015399
N04.590.233.508.613;Nursing Research;D015399
H01.770.644.145.390.234;Clinical Nursing Research;D015400
H02.478.395.234;Clinical Nursing Research;D015400
N04.590.233.508.613.234;Clinical Nursing Research;D015400
H01.770.644.145.390.385;Nursing Administration Research;D015401
H02.478.395.385;Nursing Administration Research;D015401
N04.590.233.508.613.385;Nursing Administration Research;D015401
H01.770.644.145.390.413;Nursing Education Research;D015402
H02.478.395.413;Nursing Education Research;D015402
I02.358.462.612;Nursing Education Research;D015402
N04.590.233.508.613.413;Nursing Education Research;D015402
H01.770.644.145.390.432;Nursing Evaluation Research;D015403
H02.478.395.432;Nursing Evaluation Research;D015403
N04.590.233.508.613.432;Nursing Evaluation Research;D015403
H01.770.644.145.390.634;Nursing Methodology Research;D015404
H02.478.395.634;Nursing Methodology Research;D015404
N04.590.233.508.613.634;Nursing Methodology Research;D015404
F01.829.263.315.500.725.700;Single Parent;D015406
F01.829.263.500.320.785;Single Parent;D015406
I01.240.361.500.725.700;Single Parent;D015406
I01.880.225.423.500.725.700;Single Parent;D015406
I01.880.225.500.340.785;Single Parent;D015406
M01.620.785;Single Parent;D015406
N01.224.361.500.725.700;Single Parent;D015406
N01.824.308.500.725.700;Single Parent;D015406
C04.557.470.200.025.290.500;Gastrinoma;D015408
C04.588.274.761.500.124;Gastrinoma;D015408
C04.588.322.475.500.124;Gastrinoma;D015408
C06.301.761.500.124;Gastrinoma;D015408
C06.689.667.500.124;Gastrinoma;D015408
C19.344.421.500.124;Gastrinoma;D015408
E04.466.678;Mastectomy, Radical;D015409
E04.466.678.354;Mastectomy, Extended Radical;D015410
E04.466.678.476;Mastectomy, Modified Radical;D015411
E04.466.701;Mastectomy, Segmental;D015412
E04.466.754;Mastectomy, Simple;D015413
E04.466.823;Mastectomy, Subcutaneous;D015414
D23.101;Biological Markers;D015415
G02.149.465.500;Maillard Reaction;D015416
G02.607.750.500;Maillard Reaction;D015416
C10.500.300;Hereditary Sensory and Motor Neuropathy;D015417
C10.574.500.495;Hereditary Sensory and Motor Neuropathy;D015417
C10.668.829.800.300;Hereditary Sensory and Motor Neuropathy;D015417
C16.131.666.300;Hereditary Sensory and Motor Neuropathy;D015417
C16.320.400.375;Hereditary Sensory and Motor Neuropathy;D015417
C10.292.700.225.500;Optic Atrophies, Hereditary;D015418
C10.574.500.662;Optic Atrophies, Hereditary;D015418
C11.270.564;Optic Atrophies, Hereditary;D015418
C11.640.451.451;Optic Atrophies, Hereditary;D015418
C16.320.290.564;Optic Atrophies, Hereditary;D015418
C16.320.400.630;Optic Atrophies, Hereditary;D015418
C10.500.300.820;Spastic Paraplegia, Hereditary;D015419
C10.574.500.495.820;Spastic Paraplegia, Hereditary;D015419
C10.668.829.800.300.820;Spastic Paraplegia, Hereditary;D015419
C16.131.666.300.820;Spastic Paraplegia, Hereditary;D015419
C16.320.400.375.820;Spastic Paraplegia, Hereditary;D015419
C11.790;Scleral Diseases;D015422
C11.790.500;Scleritis;D015423
E04.100.700;Reperfusion;D015424
E05.680.730;Reperfusion;D015424
E04.100.700.600;Myocardial Reperfusion;D015425
E05.680.730.600;Myocardial Reperfusion;D015425
C14.907.725;Reperfusion Injury;D015427
C23.550.767.877;Reperfusion Injury;D015427
C14.280.238.615;Myocardial Reperfusion Injury;D015428
C14.280.647.625;Myocardial Reperfusion Injury;D015428
C14.907.585.625;Myocardial Reperfusion Injury;D015428
C14.907.725.600;Myocardial Reperfusion Injury;D015428
C23.550.767.877.500;Myocardial Reperfusion Injury;D015428
C23.888.144.243.926;Weight Gain;D015430
G07.700.320.249.314.120.200.926;Weight Gain;D015430
C23.888.144.243.963;Weight Loss;D015431
G07.700.320.249.314.120.200.963;Weight Loss;D015431
C12.777.419.570.363.615;Glomerulonephritis, Membranoproliferative;D015432
C13.351.968.419.570.363.615;Glomerulonephritis, Membranoproliferative;D015432
C20.425;Glomerulonephritis, Membranoproliferative;D015432
C12.777.419.570.363.625;Glomerulonephritis, Membranous;D015433
C13.351.968.419.570.363.625;Glomerulonephritis, Membranous;D015433
C20.111.535;Glomerulonephritis, Membranous;D015433
C17.300.710;Panniculitis;D015434
C17.800.566;Panniculitis;D015434
C17.300.475.479.400;Panniculitis, Lupus Erythematosus;D015435
C17.300.710.400;Panniculitis, Lupus Erythematosus;D015435
C17.800.480.479.400;Panniculitis, Lupus Erythematosus;D015435
C17.800.566.400;Panniculitis, Lupus Erythematosus;D015435
C06.844.600;Panniculitis, Peritoneal;D015436
C17.300.710.600;Panniculitis, Peritoneal;D015436
F01.145.488;Health Behavior;D015438
C01.252.410.040.552.386.850.249;Leprosy, Borderline;D015439
C01.252.410.040.552.386.775.500;Leprosy, Lepromatous;D015440
C01.252.410.040.552.386.850.500;Leprosy, Tuberculoid;D015441
N03.219.521.576.343.616.508;Medicare Assignment;D015442
N03.219.521.576.343.840.508;Medicare Assignment;D015442
L01.224.900.950;Word Processing;D015443
N04.452.515.708.950;Word Processing;D015443
G11.427.590.530.698.277;Exercise;D015444
I03.350;Exercise;D015444
C04.557.337.428.080;Leukemia, B-Cell;D015448
C15.604.515.560.080;Leukemia, B-Cell;D015448
C20.683.515.528.080;Leukemia, B-Cell;D015448
C04.557.337.428.080.125;Leukemia, Lymphocytic, Chronic, B-Cell;D015451
C15.604.515.560.080.125;Leukemia, Lymphocytic, Chronic, B-Cell;D015451
C20.683.515.528.080.125;Leukemia, Lymphocytic, Chronic, B-Cell;D015451
C04.557.337.428.600.600;Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;D015452
C15.604.515.560.600.600;Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;D015452
C20.683.515.528.600.600;Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;D015452
C04.557.337.428.100;Leukemia, Biphenotypic, Acute;D015456
C15.604.515.560.100;Leukemia, Biphenotypic, Acute;D015456
C20.683.515.528.100;Leukemia, Biphenotypic, Acute;D015456
C04.557.337.428.580;Leukemia, T-Cell;D015458
C15.604.515.560.575;Leukemia, T-Cell;D015458
C20.683.515.528.582;Leukemia, T-Cell;D015458
C04.557.337.428.580.100;Leukemia-Lymphoma, Adult T-Cell;D015459
C15.604.515.560.575.100;Leukemia-Lymphoma, Adult T-Cell;D015459
C20.683.515.528.582.100;Leukemia-Lymphoma, Adult T-Cell;D015459
C04.557.337.428.565.750;Leukemia, Prolymphocytic, T-Cell;D015461
C04.557.337.428.580.125;Leukemia, Prolymphocytic, T-Cell;D015461
C15.604.515.560.550.750;Leukemia, Prolymphocytic, T-Cell;D015461
C15.604.515.560.575.125;Leukemia, Prolymphocytic, T-Cell;D015461
C20.683.515.528.565.750;Leukemia, Prolymphocytic, T-Cell;D015461
C20.683.515.528.582.125;Leukemia, Prolymphocytic, T-Cell;D015461
C04.557.337.428.565;Leukemia, Prolymphocytic;D015463
C15.604.515.560.550;Leukemia, Prolymphocytic;D015463
C20.683.515.528.565;Leukemia, Prolymphocytic;D015463
C04.557.337.539.250;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;D015464
C15.378.190.636.370;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;D015464
C04.557.337.539.250.300;Leukemia, Myeloid, Accelerated Phase;D015465
C15.378.190.636.370.300;Leukemia, Myeloid, Accelerated Phase;D015465
C04.557.337.539.250.400;Leukemia, Myeloid, Chronic-Phase;D015466
C15.378.190.636.370.400;Leukemia, Myeloid, Chronic-Phase;D015466
C15.378.190.636.380;Leukemia, Neutrophilic, Chronic;D015467
C04.557.337.539.275;Leukemia, Myeloid, Acute;D015470
C04.557.337.539.275.125;Leukemia, Basophilic, Acute;D015471
C04.557.337.539.275.300;Leukemia, Eosinophilic, Acute;D015472
C04.557.337.539.275.700;Leukemia, Promyelocytic, Acute;D015473
D02.455.326.271.665.202.495.325;Isotretinoin;D015474
D02.455.426.392.368.367.379.249.700.325;Isotretinoin;D015474
D02.455.849.131.495.325;Isotretinoin;D015474
D23.767.261.700.325;Isotretinoin;D015474
C04.557.337.539.522;Leukemia, Myelomonocytic, Chronic;D015477
C15.378.190.615.510;Leukemia, Myelomonocytic, Chronic;D015477
D23.050.244;Antigens, Heterophile;D015478
C04.557.337.539.520;Leukemia, Myelomonocytic, Acute;D015479
D12.776.124.486.485.114.254.150;Deltaretrovirus Antibodies;D015480
D12.776.124.790.651.114.254.150;Deltaretrovirus Antibodies;D015480
D12.776.377.715.548.114.254.150;Deltaretrovirus Antibodies;D015480
D12.776.124.486.485.114.254.150.500;HTLV-I Antibodies;D015481
D12.776.124.790.651.114.254.150.500;HTLV-I Antibodies;D015481
D12.776.377.715.548.114.254.150.500;HTLV-I Antibodies;D015481
D12.776.124.486.485.114.254.150.510;HTLV-II Antibodies;D015482
D12.776.124.790.651.114.254.150.510;HTLV-II Antibodies;D015482
D12.776.377.715.548.114.254.150.510;HTLV-II Antibodies;D015482
D12.776.124.486.485.114.254.150.440;HIV Antibodies;D015483
D12.776.124.790.651.114.254.150.440;HIV Antibodies;D015483
D12.776.377.715.548.114.254.150.440;HIV Antibodies;D015483
D23.050.327.150;Deltaretrovirus Antigens;D015485
D23.050.327.150.500;HTLV-I Antigens;D015486
D23.050.327.150.510;HTLV-II Antigens;D015487
D23.050.327.520;HIV Antigens;D015488
C02.782.815.200.470;HTLV-I Infections;D015490
C20.673.483.470;HTLV-I Infections;D015490
C02.782.815.200.480;HTLV-II Infections;D015491
C20.673.483.480;HTLV-II Infections;D015491
E01.370.225.812.735.060;AIDS Serodiagnosis;D015492
E05.200.812.735.060;AIDS Serodiagnosis;D015492
E05.478.594.760.060;AIDS Serodiagnosis;D015492
C02.182.600.600;Paraparesis, Tropical Spastic;D015493
C02.782.815.200.470.710;Paraparesis, Tropical Spastic;D015493
C10.228.228.210.575.500;Paraparesis, Tropical Spastic;D015493
C10.228.228.618.700;Paraparesis, Tropical Spastic;D015493
C10.228.854.525.700;Paraparesis, Tropical Spastic;D015493
C23.996.750;Paraparesis, Tropical Spastic;D015493
C07.465.815.497.500;Salivary Gland Calculi;D015494
C23.300.175.700.500;Salivary Gland Calculi;D015494
A11.118.637.555.567.569.200;CD4-Positive T-Lymphocytes;D015496
A15.145.229.637.555.567.569.200;CD4-Positive T-Lymphocytes;D015496
A15.382.490.555.567.569.200;CD4-Positive T-Lymphocytes;D015496
B04.820.650.589.650.350.400;HIV-1;D015497
B04.909.777.731.589.650.350.400;HIV-1;D015497
B04.820.650.589.650.350.410;HIV-2;D015498
B04.909.777.731.589.650.350.410;HIV-2;D015498
C12.777.419.815;Renal Tubular Transport, Inborn Errors;D015499
C13.351.968.419.815;Renal Tubular Transport, Inborn Errors;D015499
C16.320.565.861;Renal Tubular Transport, Inborn Errors;D015499
C18.452.648.861;Renal Tubular Transport, Inborn Errors;D015499
D08.811.913.050.134.170;Chloramphenicol O-Acetyltransferase;D015500
E01.370.350.700.024;Absorptiometry, Photon;D015502
E05.196.712.224.187;Absorptiometry, Photon;D015502
E07.858.740;Surgical Sponges;D015503
E07.858.150;Chest Tubes;D015505
D26.371;Drugs, Investigational;D015507
C08.460.525;Nasal Obstruction;D015508
C08.618.846.185.525;Nasal Obstruction;D015508
C09.603.525;Nasal Obstruction;D015508
H01.158.273.200;Developmental Biology;D015509
H02.403.200;Clinical Medicine;D015510
C22.405;Goat Diseases;D015511
D12.776.624.664;Oncogene Proteins;D015513
D12.776.602.500.500;Oncogene Proteins, Fusion;D015514
D12.776.624.664.500;Oncogene Proteins, Fusion;D015514
C10.574.500.775;Rett Syndrome;D015518
C10.597.606.643.455.937;Rett Syndrome;D015518
C16.320.322.500.937;Rett Syndrome;D015518
C16.320.400.525.937;Rett Syndrome;D015518
C16.320.400.700;Rett Syndrome;D015518
G11.427.100;Bone Density;D015519
C08.460.692.752.267;Ethmoid Sinusitis;D015521
C08.730.749.267;Ethmoid Sinusitis;D015521
C09.603.692.752.267;Ethmoid Sinusitis;D015521
C08.460.692.752.387;Frontal Sinusitis;D015522
C08.730.749.387;Frontal Sinusitis;D015522
C09.603.692.752.387;Frontal Sinusitis;D015522
C08.460.692.752.578;Maxillary Sinusitis;D015523
C08.730.749.578;Maxillary Sinusitis;D015523
C09.603.692.752.578;Maxillary Sinusitis;D015523
C08.460.692.752.827;Sphenoid Sinusitis;D015524
C08.730.749.827;Sphenoid Sinusitis;D015524
C09.603.692.752.827;Sphenoid Sinusitis;D015524
D10.212.302.380.410;Fatty Acids, Omega-3;D015525
D10.251.355.337;Fatty Acids, Omega-3;D015525
D10.627.430.450;Fatty Acids, Omega-3;D015525
C02.782.815.616.400.070;AIDS Dementia Complex;D015526
C02.800.801.400.070;AIDS Dementia Complex;D015526
C10.228.140.380.070;AIDS Dementia Complex;D015526
C20.673.480.070;AIDS Dementia Complex;D015526
F03.087.400.050;AIDS Dementia Complex;D015526
E05.318.760.500.950.375;HIV Seroprevalence;D015528
N05.715.360.775.175.800.375;HIV Seroprevalence;D015528
N06.850.520.450.500.950.375;HIV Seroprevalence;D015528
C04.182.198;Choledochal Cyst;D015529
C06.130.120.127;Choledochal Cyst;D015529
C06.198.184;Choledochal Cyst;D015529
C16.131.314.184;Choledochal Cyst;D015529
A11.284.430.106.279.345.700;Nuclear Matrix;D015530
E01.370.225.812.735.840;Radioimmunoprecipitation Assay;D015531
E05.200.812.735.840;Radioimmunoprecipitation Assay;D015531
E05.478.566.380.825;Radioimmunoprecipitation Assay;D015531
E05.478.566.639.825;Radioimmunoprecipitation Assay;D015531
E05.478.594.760.840;Radioimmunoprecipitation Assay;D015531
E05.478.605.825;Radioimmunoprecipitation Assay;D015531
E05.601.495.380.825;Radioimmunoprecipitation Assay;D015531
E05.601.495.639.825;Radioimmunoprecipitation Assay;D015531
D26.776.741;Rehydration Solutions;D015532
G05.355.315.800;Transcriptional Activation;D015533
D12.776.260.755;Trans-Activators;D015534
D12.776.930.900;Trans-Activators;D015534
D12.776.964.925.984;Trans-Activators;D015534
C05.116.900.853.625.800.424;Arthritis, Psoriatic;D015535
C05.550.114.145;Arthritis, Psoriatic;D015535
C05.550.114.865.800.424;Arthritis, Psoriatic;D015535
C17.800.859.675.175;Arthritis, Psoriatic;D015535
G02.111.087.225;Down-Regulation;D015536
G02.149.115.225;Down-Regulation;D015536
G05.355.315.200;Down-Regulation;D015536
G07.690.812.230;Down-Regulation;D015536
G07.700.680.230;Down-Regulation;D015536
G02.111.087.612;Nitrosation;D015538
G02.149.115.612;Nitrosation;D015538
G02.149.465.620;Nitrosation;D015538
G02.607.750.620;Nitrosation;D015538
G03.495.655;Nitrosation;D015538
G09.188.124.560.600;Platelet Activation;D015539
J01.937.500.600;Off-Road Motor Vehicles;D015541
D02.033.800.519.400.350;Inositol 1,4,5-Trisphosphate;D015544
D09.853.519.400.350;Inositol 1,4,5-Trisphosphate;D015544
D09.894.480.350;Inositol 1,4,5-Trisphosphate;D015544
E01.370.225.812.100;Basophil Degranulation Test;D015549
E05.200.812.100;Basophil Degranulation Test;D015549
E05.478.594.100;Basophil Degranulation Test;D015549
G04.299.490.160;Cell Degranulation;D015550
G12.450.192;Autoimmunity;D015551
E02.319.267.530.430;Injections, Intralesional;D015552
D02.540.505.410;Josamycin;D015570
A05.360.319.114.630.535.150;Follicular Fluid;D015571
A06.407.312.497.535.150;Follicular Fluid;D015571
A12.207.270.340;Follicular Fluid;D015571
D02.540.505.440.725;Spiramycin;D015572
D02.540.505.250.630;Roxithromycin;D015575
C05.116.540;Hyperostosis;D015576
E05.318.308.225;Geriatric Assessment;D015577
I01.240.425.350;Geriatric Assessment;D015577
L01.280.360;Geriatric Assessment;D015577
N01.224.425.350;Geriatric Assessment;D015577
N05.715.360.300.360;Geriatric Assessment;D015577
N06.850.505.400.425.350;Geriatric Assessment;D015577
N06.850.520.308.225;Geriatric Assessment;D015577
E04.494.575;Mohs Surgery;D015580
E04.680.275.580;Mohs Surgery;D015580
E01.354.753;Observer Variation;D015588
N02.421.450.600;Observer Variation;D015588
N05.715.350.150.675;Observer Variation;D015588
N06.850.490.500.250;Observer Variation;D015588
N06.850.490.750;Observer Variation;D015588
E01.370.380.255;Fluorophotometry;D015590
E05.196.712.516.600.410;Fluorophotometry;D015590
E05.196.712.726.300;Microspectrophotometry;D015591
E05.196.867.826.300;Microspectrophotometry;D015591
E05.478.566.639.405;Immunoradiometric Assay;D015592
E05.601.495.639.405;Immunoradiometric Assay;D015592
C11.768.585.585;Retinal Drusen;D015593
C10.292.700.450;Optic Disk Drusen;D015594
C11.640.513;Optic Disk Drusen;D015594
G13.750.829.826;Skin Aging;D015595
E05.318.308.585;Nutrition Assessment;D015596
N05.715.360.300.560;Nutrition Assessment;D015596
N06.850.505.557;Nutrition Assessment;D015596
N06.850.520.308.585;Nutrition Assessment;D015596
C03.718;Pregnancy Complications, Parasitic;D015597
C13.703.700.680;Pregnancy Complications, Parasitic;D015597
E05.318.308.940.968.875;Trauma Severity Indices;D015599
E05.944;Trauma Severity Indices;D015599
L01.280.900.968.875;Trauma Severity Indices;D015599
N04.452.859.564.800;Trauma Severity Indices;D015599
N05.715.360.300.715.500.800;Trauma Severity Indices;D015599
N06.850.520.308.940.968.875;Trauma Severity Indices;D015599
E05.318.308.940.968.875.250;Glasgow Coma Scale;D015600
E05.944.500;Glasgow Coma Scale;D015600
L01.280.900.968.875.250;Glasgow Coma Scale;D015600
N04.452.859.564.800.250;Glasgow Coma Scale;D015600
N05.715.360.300.715.500.800.325;Glasgow Coma Scale;D015600
E05.318.308.940.968.875.500;Injury Severity Score;D015601
E05.944.600;Injury Severity Score;D015601
L01.280.900.968.875.500;Injury Severity Score;D015601
N04.452.859.564.800.500;Injury Severity Score;D015601
N05.715.360.300.715.500.800.400;Injury Severity Score;D015601
A11.436.397;Keratinocytes;D015603
C02.256.743.175;Cowpox;D015605
E07.695.750;Stents;D015607
B04.280.650.160.650.150;Cowpox virus;D015608
B04.909.204.783.160.650.150;Cowpox virus;D015608
D02.691.825;Organotechnetium Compounds;D015609
E01.370.225.875.595.800;Serum Bactericidal Test;D015610
E05.200.875.595.800;Serum Bactericidal Test;D015610
E05.337.550.400.800;Serum Bactericidal Test;D015610
B04.280.375.100.450;Hepatitis B Virus, Duck;D015611
B04.450.390.100.450;Hepatitis B Virus, Duck;D015611
B04.909.204.340.100.450;Hepatitis B Virus, Duck;D015611
E02.319.267.700;Phonophoresis;D015612
B04.280.375;Hepadnaviridae;D015613
B04.450.390;Hepadnaviridae;D015613
B04.909.204.340;Hepadnaviridae;D015613
C15.604.250;Histiocytosis;D015614
C08.381.150;Cystic Adenomatoid Malformation of Lung, Congenital;D015615
C08.695.290;Cystic Adenomatoid Malformation of Lung, Congenital;D015615
C16.131.740.290;Cystic Adenomatoid Malformation of Lung, Congenital;D015615
C15.604.250.410;Histiocytosis, Non-Langerhans-Cell;D015616
C15.604.250.410.450;Histiocytosis, Sinus;D015618
C08.695;Respiratory System Abnormalities;D015619
C16.131.740;Respiratory System Abnormalities;D015619
C04.557.227;Histiocytic Disorders, Malignant;D015620
C15.604.250.390;Histiocytic Disorders, Malignant;D015620
A11.329.372.300;Epithelioid Cells;D015622
A11.627.482.300;Epithelioid Cells;D015622
A11.733.397.300;Epithelioid Cells;D015622
A15.382.680.397.300;Epithelioid Cells;D015622
A15.382.812.522.300;Epithelioid Cells;D015622
E02.642.249.300.500;Diet, Macrobiotic;D015623
G07.610.240.300.500;Diet, Macrobiotic;D015623
C04.588.614.550.225;Lambert-Eaton Myasthenic Syndrome;D015624
C04.730.856.225;Lambert-Eaton Myasthenic Syndrome;D015624
C10.114.468;Lambert-Eaton Myasthenic Syndrome;D015624
C10.574.781.500;Lambert-Eaton Myasthenic Syndrome;D015624
C10.668.758.450;Lambert-Eaton Myasthenic Syndrome;D015624
C20.111.258.350;Lambert-Eaton Myasthenic Syndrome;D015624
C20.111.580;Lambert-Eaton Myasthenic Syndrome;D015624
E07.695.800;Tissue Expansion Devices;D015625
E07.858.886;Tissue Expansion Devices;D015625
E04.680.800;Tissue Expansion;D015626
D03.383.725.450;1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine;D015632
A12.207.270.300;Extravascular Lung Water;D015633
E01.370.350.130.937;Radionuclide Ventriculography;D015635
E01.370.350.710.715.710;Radionuclide Ventriculography;D015635
E01.370.370.050.650.650;Radionuclide Ventriculography;D015635
E01.370.370.380.710;Radionuclide Ventriculography;D015635
E01.370.384.730.715.710;Radionuclide Ventriculography;D015635
D01.210.450.150.500;Magnesium Chloride;D015636
D01.524.475;Magnesium Chloride;D015636
E01.370.350.130.500.750;Gated Blood-Pool Imaging;D015637
E01.370.350.130.937.350;Gated Blood-Pool Imaging;D015637
E01.370.350.710.715.710.350;Gated Blood-Pool Imaging;D015637
E01.370.370.050.650.650.350;Gated Blood-Pool Imaging;D015637
E01.370.370.380.710.350;Gated Blood-Pool Imaging;D015637
E01.370.384.730.715.710.350;Gated Blood-Pool Imaging;D015637
D03.438.473.231.450;Cytochalasin D;D015638
D23.946.587.370.450;Cytochalasin D;D015638
G02.111.087.800.400;Ion Channel Gating;D015640
G02.149.115.800.400;Ion Channel Gating;D015640
G04.299.500;Ion Channel Gating;D015640
G04.299.880.400;Ion Channel Gating;D015640
G07.265.337.500;Ion Channel Gating;D015640
G07.700.240.500;Ion Channel Gating;D015640
E01.370.350.700.725;Radiography, Interventional;D015641
E04.800.780;Radiography, Interventional;D015641
H02.403.740.675;Radiology, Interventional;D015642
D02.540.505.250.260;Erythromycin Ethylsuccinate;D015643
D02.540.505.500;Miocamycin;D015644
D02.540.505.905;Tylosin;D015645
E01.370.350.130.937.950;Ventriculography, First-Pass;D015646
E01.370.350.710.715.710.950;Ventriculography, First-Pass;D015646
E01.370.370.050.650.650.950;Ventriculography, First-Pass;D015646
E01.370.370.380.710.950;Ventriculography, First-Pass;D015646
E01.370.384.730.715.710.950;Ventriculography, First-Pass;D015646
D03.438.079.800;2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine;D015647
D03.383.742.680.350.200.700;Pentostatin;D015649
D13.570.230.677;Pentostatin;D015649
D13.570.685.350.200.700;Pentostatin;D015649
D04.808.247.222.159.478.387.400;24,25-Dihydroxyvitamin D 3;D015650
D04.808.247.808.146.478.387.400;24,25-Dihydroxyvitamin D 3;D015650
D04.808.812.768.196.478.387.400;24,25-Dihydroxyvitamin D 3;D015650
D10.570.938.146.478.387.400;24,25-Dihydroxyvitamin D 3;D015650
C25.723.680;Mycotoxicosis;D015651
D04.808.247.222.474.400;25-Hydroxyvitamin D 2;D015652
D04.808.247.808.412.400;25-Hydroxyvitamin D 2;D015652
D04.808.812.768.462.400;25-Hydroxyvitamin D 2;D015652
D10.570.938.439.500;25-Hydroxyvitamin D 2;D015652
E04.950.774.150;Cystectomy;D015653
B04.280.382.150.750.400;Herpesvirus 6, Human;D015654
B04.909.204.382.150.750.400;Herpesvirus 6, Human;D015654
D03.383.725.762.550;1-Methyl-4-phenylpyridinium;D015655
G09.772.770.755.700;Respiratory Mechanics;D015656
G03.495.166.775;Respiratory Transport;D015657
G09.772.770.755.760;Respiratory Transport;D015657
C02.782.815.616.400;HIV Infections;D015658
C02.800.801.400;HIV Infections;D015658
C20.673.480;HIV Infections;D015658
D08.811.682.690.708.170.040.024;7-Alkoxycoumarin O-Dealkylase;D015660
B03.440.450.600;Pasteurellaceae;D015661
B03.660.250.550;Pasteurellaceae;D015661
D02.065.884.725.867.500;Trimethoprim-Sulfamethoxazole Combination;D015662
D02.092.146.807.867.500;Trimethoprim-Sulfamethoxazole Combination;D015662
D02.886.590.700.725.867.500;Trimethoprim-Sulfamethoxazole Combination;D015662
D03.383.742.906.500;Trimethoprim-Sulfamethoxazole Combination;D015662
C05.116.198.579.610;Osteoporosis, Postmenopausal;D015663
E02.190.044.105;Acupuncture Analgesia;D015667
E03.091.048;Acupuncture Analgesia;D015667
E02.190.044.555.035;Acupuncture Points;D015669
E02.190.044;Acupuncture Therapy;D015670
E02.186.250;Electroacupuncture;D015671
E02.190.044.244;Electroacupuncture;D015671
E02.342.543;Electroacupuncture;D015671
E02.779.468.399;Electroacupuncture;D015671
E03.091.823.500;Electroacupuncture;D015671
E03.155.519;Electroacupuncture;D015671
A11.148.378.590.837.250;Erythroid Precursor Cells;D015672
A11.443.240.497;Erythroid Precursor Cells;D015672
A11.872.378.590.817.250;Erythroid Precursor Cells;D015672
A15.378.316.378.590.837.250;Erythroid Precursor Cells;D015672
C02.330;Fatigue Syndrome, Chronic;D015673
C05.651.310;Fatigue Syndrome, Chronic;D015673
C10.228.440.600;Fatigue Syndrome, Chronic;D015673
C10.668.364;Fatigue Syndrome, Chronic;D015673
C04.588.531;Mammary Neoplasms, Animal;D015674
C22.520;Mammary Neoplasms, Animal;D015674
D12.776.157.125.700;Osteocalcin;D015675
D12.776.157.125.715;Osteonectin;D015676
D12.776.395.600;Osteonectin;D015676
D12.776.964.970;Viral Structural Proteins;D015678
D12.776.602.500.500.320;Fusion Proteins, gag-onc;D015681
D12.776.624.664.500.320;Fusion Proteins, gag-onc;D015681
D12.776.624.664.520.750.320;Fusion Proteins, gag-onc;D015681
D12.776.964.700.750.320;Fusion Proteins, gag-onc;D015681
D12.776.964.775.350.320;Fusion Proteins, gag-onc;D015681
D12.776.964.775.750.320;Fusion Proteins, gag-onc;D015681
D12.776.624.664.520.750;Retroviridae Proteins, Oncogenic;D015682
D12.776.964.700.750;Retroviridae Proteins, Oncogenic;D015682
D12.776.964.775.750;Retroviridae Proteins, Oncogenic;D015682
D12.776.775.330;Gene Products, gag;D015683
D12.776.964.775.350;Gene Products, gag;D015683
D12.776.964.970.600.850.350;Gene Products, gag;D015683
D12.776.775.360;Gene Products, pol;D015684
D12.776.964.775.375;Gene Products, pol;D015684
D12.776.964.970.600.850.375;Gene Products, pol;D015684
D12.776.775.330.300;Fusion Proteins, gag-pol;D015685
D12.776.775.360.300;Fusion Proteins, gag-pol;D015685
D12.776.964.775.350.325;Fusion Proteins, gag-pol;D015685
D12.776.964.775.375.325;Fusion Proteins, gag-pol;D015685
D12.776.964.970.600.850.350.325;Fusion Proteins, gag-pol;D015685
D12.776.964.970.600.850.375.325;Fusion Proteins, gag-pol;D015685
D12.776.775.320;Gene Products, env;D015686
D12.776.964.775.325;Gene Products, env;D015686
D12.776.964.970.880.325;Gene Products, env;D015686
G03.495.278.300;Cell Hypoxia;D015687
G04.299.305.300;Cell Hypoxia;D015687
D08.811.913.696.620.682.725.800.472;Oncogene Protein pp60(v-src);D015688
D12.776.624.664.520.750.760;Oncogene Protein pp60(v-src);D015688
D12.776.964.700.750.760;Oncogene Protein pp60(v-src);D015688
D12.776.964.775.750.760;Oncogene Protein pp60(v-src);D015688
D08.811.277.040.330.300.400.500.300;Oncogene Protein p21(ras);D015689
D12.644.360.525.500.300;Oncogene Protein p21(ras);D015689
D12.776.157.325.515.500.300;Oncogene Protein p21(ras);D015689
D12.776.476.525.500.300;Oncogene Protein p21(ras);D015689
D12.776.624.664.520.750.710;Oncogene Protein p21(ras);D015689
D12.776.964.700.750.710;Oncogene Protein p21(ras);D015689
D12.776.964.775.750.710;Oncogene Protein p21(ras);D015689
D12.776.964.775.362;Gene Products, nef;D015693
D12.776.964.925.500;Gene Products, nef;D015693
D12.776.157.725.076;Gene Products, rev;D015694
D12.776.664.962.186;Gene Products, rev;D015694
D12.776.964.925.984.385;Gene Products, rev;D015694
D12.776.260.755.199;Gene Products, tat;D015696
D12.776.930.900.199;Gene Products, tat;D015696
D12.776.964.925.984.400;Gene Products, tat;D015696
G05.360.325.425;Genomic Library;D015698
G05.360.340.425;Genomic Library;D015698
D12.776.964.775.325.164.249;HIV Envelope Protein gp120;D015699
D12.776.964.775.562.500.500;HIV Envelope Protein gp120;D015699
D12.776.964.970.880.325.164.249;HIV Envelope Protein gp120;D015699
D23.050.327.520.350;HIV Envelope Protein gp120;D015699
D12.776.543.512.500.330;HIV Envelope Protein gp41;D015700
D12.776.964.775.325.164.200;HIV Envelope Protein gp41;D015700
D12.776.964.775.562.500.200;HIV Envelope Protein gp41;D015700
D12.776.964.970.880.325.164.200;HIV Envelope Protein gp41;D015700
D12.776.964.970.880.910.330;HIV Envelope Protein gp41;D015700
D23.050.327.520.330;HIV Envelope Protein gp41;D015700
C26.304.500;Near Drowning;D015701
N06.850.135.696.500;Near Drowning;D015701
D23.050.301.264.035;Antigens, CD;D015703
D23.101.100.110;Antigens, CD;D015703
D12.776.543.750.705.852.420.810.500;Antigens, CD4;D015704
D12.776.543.750.925.700.025;Antigens, CD4;D015704
D23.050.301.264.035.104;Antigens, CD4;D015704
D23.050.301.264.894.100;Antigens, CD4;D015704
D23.101.100.110.104;Antigens, CD4;D015704
D23.101.100.894.100;Antigens, CD4;D015704
L01.178.682.099.325;Bibliometrics;D015706
L01.453.183.291;Bibliometrics;D015706
D12.776.964.970.880.350;HN Protein;D015707
D23.050.327.461.350;HN Protein;D015707
L01.143.506.423.906.377;Correspondence as Topic;D015709
L01.737.471;Duplicate Publication as Topic;D015713
L01.737.684;Plagiarism;D015714
C11.204.267;Corneal Edema;D015715
E01.370.370.380.240.230;Electrocardiography, Ambulatory;D015716
E01.370.405.240.230;Electrocardiography, Ambulatory;D015716
E01.370.520.500.230;Electrocardiography, Ambulatory;D015716
D12.644.456.729;Peptide T;D015717
D12.776.124.270.305;Fibrin Tissue Adhesive;D015718
D08.811.277.352.335.350.700;Single-Strand Specific DNA and RNA Endonucleases;D015719
D08.811.277.352.355.325.700;Single-Strand Specific DNA and RNA Endonucleases;D015719
D08.811.277.352.355.350.820;Single-Strand Specific DNA and RNA Endonucleases;D015719
D08.811.277.352.700.350.850;Single-Strand Specific DNA and RNA Endonucleases;D015719
D08.811.277.352.650.600.600;5'-Nucleotidase;D015720
D23.050.301.264.035.570;5'-Nucleotidase;D015720
D23.101.100.110.570;5'-Nucleotidase;D015720
D20.215.894.135.300;Diphtheria-Tetanus-Pertussis Vaccine;D015721
D20.215.894.135.535.300;Diphtheria-Tetanus-Pertussis Vaccine;D015721
D20.215.894.691.263.300;Diphtheria-Tetanus-Pertussis Vaccine;D015721
D20.215.894.691.824.300;Diphtheria-Tetanus-Pertussis Vaccine;D015721
D20.215.894.815.300;Diphtheria-Tetanus-Pertussis Vaccine;D015721
G05.360.325;Gene Library;D015723
D03.383.129.799.450;Fluconazole;D015725
A11.500;Giant Cells;D015726
D12.776.543.750.925.700;Receptors, HIV;D015728
Z01.058.290.120.275;Djibouti;D015730
D04.808.365.415.580;Mifepristone;D015735
D03.383.725.203.250;Felodipine;D015736
D03.383.725.203.580;Nisoldipine;D015737
D02.886.675.215;Famotidine;D015738
D03.383.129.708.215;Famotidine;D015738
D03.438.103.637;Nocodazole;D015739
D12.644.400.097;Calcitonin Gene-Related Peptide;D015740
D12.776.641.650.097;Calcitonin Gene-Related Peptide;D015740
D04.808.365.415.550;Metribolone;D015741
D02.455.426.559.389.657.773;Propofol;D015742
A11.329.372.376;Giant Cells, Foreign-Body;D015743
A11.500.376;Giant Cells, Foreign-Body;D015743
A11.627.482.376;Giant Cells, Foreign-Body;D015743
A11.733.397.376;Giant Cells, Foreign-Body;D015743
A15.382.680.397.376;Giant Cells, Foreign-Body;D015743
A15.382.812.522.376;Giant Cells, Foreign-Body;D015743
A11.329.372.380;Giant Cells, Langhans;D015744
A11.500.380;Giant Cells, Langhans;D015744
A11.627.482.380;Giant Cells, Langhans;D015744
A11.733.397.380;Giant Cells, Langhans;D015744
A15.382.680.397.380;Giant Cells, Langhans;D015744
A15.382.812.522.380;Giant Cells, Langhans;D015744
C23.550.382.437;Granuloma, Foreign-Body;D015745
C26.392.560.325;Granuloma, Foreign-Body;D015745
C23.888.646.100;Abdominal Pain;D015746
C23.888.821.030;Abdominal Pain;D015746
B03.440.425.410.711.193.150;Borrelia burgdorferi Group;D015748
B03.851.595.193.150;Borrelia burgdorferi Group;D015748
G05.360.340.024.340.490.258;Genes, gag;D015750
G05.360.340.400.500.258;Genes, gag;D015750
G05.360.340.024.340.490.667;Genes, pol;D015751
G05.360.340.400.500.667;Genes, pol;D015751
G05.360.340.024.340.490.172;Genes, env;D015752
G05.360.340.400.500.172;Genes, env;D015752
G05.360.340.024.340.425.413;Genes, nef;D015754
G05.360.340.024.340.490.600;Genes, nef;D015754
G05.360.340.400.500.600;Genes, nef;D015754
G05.360.340.024.340.425.560;Genes, tat;D015756
G05.360.340.024.340.490.850;Genes, tat;D015756
G05.360.340.400.500.850;Genes, tat;D015756
G05.360.340.024.340.425.418;Genes, rev;D015757
G05.360.340.024.340.490.775;Genes, rev;D015757
G05.360.340.400.500.775;Genes, rev;D015757
D10.251.355.391;Ionomycin;D015759
D03.383.621.265.100;Alfentanil;D015760
D02.092.080.060;4-Aminopyridine;D015761
D03.383.725.050.060;4-Aminopyridine;D015761
D03.438.759.590.138.300;2-Chloroadenosine;D015762
D13.570.583.138.300;2-Chloroadenosine;D015762
D13.570.800.096.300;2-Chloroadenosine;D015762
D12.125.070.950.100;2-Amino-5-phosphonovalerate;D015763
D12.125.740.025;2-Amino-5-phosphonovalerate;D015763
D03.383.773.107;Bepridil;D015764
D03.383.606.130;Almitrine;D015765
D03.383.931.095;Almitrine;D015765
D02.241.081.251.022;Albendazole;D015766
D03.438.103.070;Albendazole;D015766
D03.438.810.410;Mefloquine;D015767
C08.280;Granuloma, Respiratory Tract;D015769
C23.550.382.968;Granuloma, Respiratory Tract;D015769
D03.383.129.539.120;4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine;D015772
D12.644.456.345.360.300;Enalaprilat;D015773
D03.438.759.758.399.454.250.300;Ganciclovir;D015774
C26.404.437;Fractures, Stress;D015775
C16.320.850.475.440;Keratoderma, Palmoplantar, Diffuse;D015776
C17.800.428.435.440;Keratoderma, Palmoplantar, Diffuse;D015776
C17.800.827.475.440;Keratoderma, Palmoplantar, Diffuse;D015776
D10.251.355.255;Eicosanoids;D015777
D23.469.050.175;Eicosanoids;D015777
D23.050.301.500.600;Minor Histocompatibility Antigens;D015778
D23.050.705.552.600;Minor Histocompatibility Antigens;D015778
D02.065.589.099.124;Carbapenems;D015780
D04.075.080.875.099.221.124;Carbapenems;D015780
C11.250.060;Aniridia;D015783
C11.270.060;Aniridia;D015783
C11.941.375.060;Aniridia;D015783
C16.131.384.079;Aniridia;D015783
C16.320.290.078;Aniridia;D015783
D02.033.100.624.102;Betaxolol;D015784
D02.033.100.624.698.077;Betaxolol;D015784
D02.033.755.624.102;Betaxolol;D015784
D02.033.755.624.698.077;Betaxolol;D015784
D02.092.063.624.698.077;Betaxolol;D015784
C11.270;Eye Diseases, Hereditary;D015785
C16.320.290;Eye Diseases, Hereditary;D015785
D08.244.187.500;Cytochromes b5;D015786
D12.776.422.220.187.500;Cytochromes b5;D015786
C01.252.400.155.569.200;Erythema Chronicum Migrans;D015787
C01.252.400.825.480.400;Erythema Chronicum Migrans;D015787
C01.252.825.310;Erythema Chronicum Migrans;D015787
C01.252.847.193.569.200;Erythema Chronicum Migrans;D015787
C01.539.800.720.310;Erythema Chronicum Migrans;D015787
C17.800.229.200;Erythema Chronicum Migrans;D015787
C17.800.838.765.310;Erythema Chronicum Migrans;D015787
D12.776.395.550.489.400.010;HLA-A1 Antigen;D015788
D12.776.543.550.421.400.010;HLA-A1 Antigen;D015788
D23.050.301.500.100.400.010;HLA-A1 Antigen;D015788
D23.050.301.500.450.370.010;HLA-A1 Antigen;D015788
D23.050.705.552.100.400.010;HLA-A1 Antigen;D015788
D23.050.705.552.450.370.372;HLA-A1 Antigen;D015788
D12.776.395.550.489.400.020;HLA-A2 Antigen;D015789
D12.776.543.550.421.400.020;HLA-A2 Antigen;D015789
D23.050.301.500.100.400.020;HLA-A2 Antigen;D015789
D23.050.301.500.450.370.020;HLA-A2 Antigen;D015789
D23.050.705.552.100.400.020;HLA-A2 Antigen;D015789
D23.050.705.552.450.370.374;HLA-A2 Antigen;D015789
D02.065.589.099.249.177;Cefonicid;D015790
D02.886.665.074.177;Cefonicid;D015790
D04.075.080.875.099.221.249.177;Cefonicid;D015790
D12.776.395.550.489.400.030;HLA-A3 Antigen;D015791
D12.776.543.550.421.400.030;HLA-A3 Antigen;D015791
D23.050.301.500.100.400.030;HLA-A3 Antigen;D015791
D23.050.301.500.450.370.030;HLA-A3 Antigen;D015791
D23.050.705.552.100.400.030;HLA-A3 Antigen;D015791
D23.050.705.552.450.370.376;HLA-A3 Antigen;D015791
C11.250.666;Retinal Dysplasia;D015792
C11.270.660;Retinal Dysplasia;D015792
C11.768.660;Retinal Dysplasia;D015792
C16.131.384.784;Retinal Dysplasia;D015792
C16.320.290.660;Retinal Dysplasia;D015792
D12.776.395.550.489.500.070;HLA-B7 Antigen;D015793
D12.776.543.550.421.500.070;HLA-B7 Antigen;D015793
D23.050.301.500.100.500.070;HLA-B7 Antigen;D015793
D23.050.301.500.450.380.070;HLA-B7 Antigen;D015793
D23.050.705.552.100.500.070;HLA-B7 Antigen;D015793
D23.050.705.552.450.380.070;HLA-B7 Antigen;D015793
C11.270.142;Choroideremia;D015794
C11.941.160.300;Choroideremia;D015794
C16.320.290.142;Choroideremia;D015794
C16.320.322.092;Choroideremia;D015794
D12.776.395.550.489.500.080;HLA-B8 Antigen;D015795
D12.776.543.550.421.500.080;HLA-B8 Antigen;D015795
D23.050.301.500.100.500.080;HLA-B8 Antigen;D015795
D23.050.301.500.450.380.080;HLA-B8 Antigen;D015795
D23.050.705.552.100.500.080;HLA-B8 Antigen;D015795
D23.050.705.552.450.380.080;HLA-B8 Antigen;D015795
D12.776.395.550.489.500.270;HLA-B27 Antigen;D015796
D12.776.543.550.421.500.270;HLA-B27 Antigen;D015796
D23.050.301.500.100.500.270;HLA-B27 Antigen;D015796
D23.050.301.500.450.380.270;HLA-B27 Antigen;D015796
D23.050.705.552.100.500.270;HLA-B27 Antigen;D015796
D23.050.705.552.450.380.270;HLA-B27 Antigen;D015796
D12.776.395.550.489.500.350;HLA-B35 Antigen;D015797
D12.776.543.550.421.500.350;HLA-B35 Antigen;D015797
D23.050.301.500.100.500.350;HLA-B35 Antigen;D015797
D23.050.301.500.450.380.350;HLA-B35 Antigen;D015797
D23.050.705.552.100.500.350;HLA-B35 Antigen;D015797
D23.050.705.552.450.380.350;HLA-B35 Antigen;D015797
D12.776.395.550.509.400.440.400.010;HLA-DR1 Antigen;D015798
D12.776.543.550.423.400.440.400.010;HLA-DR1 Antigen;D015798
D23.050.301.500.400.400.440.400.010;HLA-DR1 Antigen;D015798
D23.050.301.500.450.400.440.389.500;HLA-DR1 Antigen;D015798
D23.050.705.552.410.400.440.389.010;HLA-DR1 Antigen;D015798
D23.050.705.552.450.400.440.389.500;HLA-DR1 Antigen;D015798
C11.270.468;Gyrate Atrophy;D015799
C11.941.160.578;Gyrate Atrophy;D015799
C16.320.290.468;Gyrate Atrophy;D015799
D12.776.820;Protozoan Proteins;D015800
D12.776.419;Helminth Proteins;D015801
D12.776.395.550.509.400.440.400.020;HLA-DR2 Antigen;D015802
D12.776.543.550.423.400.440.400.020;HLA-DR2 Antigen;D015802
D23.050.301.500.400.400.440.400.020;HLA-DR2 Antigen;D015802
D23.050.301.500.450.400.440.389.750;HLA-DR2 Antigen;D015802
D23.050.705.552.410.400.440.389.020;HLA-DR2 Antigen;D015802
D23.050.705.552.450.400.440.389.750;HLA-DR2 Antigen;D015802
D12.776.395.550.509.400.440.400.030;HLA-DR3 Antigen;D015803
D12.776.543.550.423.400.440.400.030;HLA-DR3 Antigen;D015803
D23.050.301.500.400.400.440.400.030;HLA-DR3 Antigen;D015803
D23.050.301.500.450.400.440.389.875;HLA-DR3 Antigen;D015803
D23.050.705.552.410.400.440.389.030;HLA-DR3 Antigen;D015803
D23.050.705.552.450.400.440.389.875;HLA-DR3 Antigen;D015803
D12.776.395.550.509.400.440.400.040;HLA-DR4 Antigen;D015804
D12.776.543.550.423.400.440.400.040;HLA-DR4 Antigen;D015804
D23.050.301.500.400.400.440.400.040;HLA-DR4 Antigen;D015804
D23.050.301.500.450.400.440.389.937;HLA-DR4 Antigen;D015804
D23.050.705.552.410.400.440.389.040;HLA-DR4 Antigen;D015804
D23.050.705.552.450.400.440.389.937;HLA-DR4 Antigen;D015804
D12.776.395.550.509.400.440.400.050;HLA-DR5 Antigen;D015805
D12.776.543.550.423.400.440.400.050;HLA-DR5 Antigen;D015805
D23.050.301.500.400.400.440.400.050;HLA-DR5 Antigen;D015805
D23.050.301.500.450.400.440.389.968;HLA-DR5 Antigen;D015805
D23.050.705.552.410.400.440.389.050;HLA-DR5 Antigen;D015805
D23.050.705.552.450.400.440.389.968;HLA-DR5 Antigen;D015805
B03.440.400.425.708.100.020;Azospirillum brasilense;D015806
B03.660.050.663.750.100.020;Azospirillum brasilense;D015806
C26.260.275.250.270;Eye Injuries, Penetrating;D015807
C26.986.450;Eye Injuries, Penetrating;D015807
D12.776.395.550.509.400.440.400.060;HLA-DR6 Antigen;D015808
D12.776.543.550.423.400.440.400.060;HLA-DR6 Antigen;D015808
D23.050.301.500.400.400.440.400.060;HLA-DR6 Antigen;D015808
D23.050.301.500.450.400.440.389.984;HLA-DR6 Antigen;D015808
D23.050.705.552.410.400.440.389.060;HLA-DR6 Antigen;D015808
D23.050.705.552.450.400.440.389.984;HLA-DR6 Antigen;D015808
D12.776.395.550.509.400.440.400.070;HLA-DR7 Antigen;D015809
D12.776.543.550.423.400.440.400.070;HLA-DR7 Antigen;D015809
D23.050.301.500.400.400.440.400.070;HLA-DR7 Antigen;D015809
D23.050.301.500.450.400.440.389.992;HLA-DR7 Antigen;D015809
D23.050.705.552.410.400.440.389.070;HLA-DR7 Antigen;D015809
D23.050.705.552.450.400.440.389.992;HLA-DR7 Antigen;D015809
G05.540.500;Linkage Disequilibrium;D015810
C04.588.364.978.400;Iris Neoplasms;D015811
C11.319.494.400;Iris Neoplasms;D015811
C11.941.375.375;Iris Neoplasms;D015811
C11.941.855.400;Iris Neoplasms;D015811
C11.525.381.056;Glaucoma, Angle-Closure;D015812
E05.885;Substance Abuse Detection;D015813
N06.850.780.500.765;Substance Abuse Detection;D015813
C11.540;Ocular Hypotension;D015814
D12.776.395.550.200;Cell Adhesion Molecules;D015815
D12.776.543.550.200;Cell Adhesion Molecules;D015815
D23.050.301.350;Cell Adhesion Molecules;D015815
D12.776.395.550.200.250;Cell Adhesion Molecules, Neuronal;D015816
D12.776.543.550.200.250;Cell Adhesion Molecules, Neuronal;D015816
D23.050.301.350.250;Cell Adhesion Molecules, Neuronal;D015816
C01.539.375;Eye Infections;D015817
C11.294;Eye Infections;D015817
C01.252.354;Eye Infections, Bacterial;D015818
C01.539.375.354;Eye Infections, Bacterial;D015818
C11.294.354;Eye Infections, Bacterial;D015818
C25.793;Substance Abuse, Intravenous;D015819
F03.900.793;Substance Abuse, Intravenous;D015819
D12.776.395.550.200.200;Cadherins;D015820
D12.776.543.550.200.200;Cadherins;D015820
D23.050.301.350.200;Cadherins;D015820
C01.539.375.450;Eye Infections, Fungal;D015821
C01.703.343;Eye Infections, Fungal;D015821
C11.294.450;Eye Infections, Fungal;D015821
C03.300;Eye Infections, Parasitic;D015822
C11.294.725;Eye Infections, Parasitic;D015822
C03.300.125;Acanthamoeba Keratitis;D015823
C03.752.049.203;Acanthamoeba Keratitis;D015823
C11.204.564.112;Acanthamoeba Keratitis;D015823
C11.294.725.125;Acanthamoeba Keratitis;D015823
A04.411.715.025;Blood-Air Barrier;D015824
A07.025;Blood-Air Barrier;D015824
A11.284.187.360;Chromosomes, Fungal;D015825
A19.311;Chromosomes, Fungal;D015825
G05.360.162.360;Chromosomes, Fungal;D015825
C05.116.099.708.582;Langer-Giedion Syndrome;D015826
C03.300.562;Onchocerciasis, Ocular;D015827
C03.335.508.700.750.361.699.500;Onchocerciasis, Ocular;D015827
C11.294.725.562;Onchocerciasis, Ocular;D015827
C02.325;Eye Infections, Viral;D015828
C11.294.800;Eye Infections, Viral;D015828
C01.252.354.900;Uveitis, Suppurative;D015829
C01.539.375.265.500;Uveitis, Suppurative;D015829
C01.539.375.354.900;Uveitis, Suppurative;D015829
C01.539.375.450.900;Uveitis, Suppurative;D015829
C01.539.830.900;Uveitis, Suppurative;D015829
C01.703.343.900;Uveitis, Suppurative;D015829
C11.294.265.500;Uveitis, Suppurative;D015829
C11.294.354.900;Uveitis, Suppurative;D015829
C11.294.450.900;Uveitis, Suppurative;D015829
C11.941.879.960;Uveitis, Suppurative;D015829
C04.557.450.565.575.610;Osteochondroma;D015831
C05.116.099.708.670;Osteochondroma;D015831
C09.218.568.120;Cochlear Diseases;D015834
C10.228.758;Ocular Motility Disorders;D015835
C10.292.562;Ocular Motility Disorders;D015835
C11.590;Ocular Motility Disorders;D015835
C09.218.568.900;Vestibular Diseases;D015837
C05.550.287;Chondromatosis, Synovial;D015838
C10.292.562.700;Oculomotor Nerve Diseases;D015840
C10.292.600;Oculomotor Nerve Diseases;D015840
C11.590.436;Oculomotor Nerve Diseases;D015840
C11.675.319;Enophthalmos;D015841
D27.505.519.389.745.800;Serine Proteinase Inhibitors;D015842
D12.644.822.750;Serpins;D015843
D12.644.861;Serpins;D015843
D12.776.645.750;Serpins;D015843
D12.776.872;Serpins;D015843
D12.644.822.750.060.750;Heparin Cofactor II;D015844
D12.644.861.060.750;Heparin Cofactor II;D015844
D12.776.124.790.106.450;Heparin Cofactor II;D015844
D12.776.377.715.085.450;Heparin Cofactor II;D015844
D12.776.645.750.060.750;Heparin Cofactor II;D015844
D12.776.872.060.750;Heparin Cofactor II;D015844
C10.597.690.575;Tonic Pupil;D015845
C11.710.800;Tonic Pupil;D015845
C23.888.592.708.575;Tonic Pupil;D015845
D12.644.276.374.500;Monokines;D015846
D12.776.467.374.500;Monokines;D015846
D23.529.374.500;Monokines;D015846
D12.644.276.374.465.504;Interleukin-4;D015847
D12.776.467.374.465.504;Interleukin-4;D015847
D23.529.374.465.504;Interleukin-4;D015847
D12.644.276.374.465.505;Interleukin-5;D015848
D12.776.467.374.465.505;Interleukin-5;D015848
D23.529.374.465.505;Interleukin-5;D015848
D12.644.822.750.695;Plasminogen Inactivators;D015849
D12.644.861.695;Plasminogen Inactivators;D015849
D12.776.645.750.695;Plasminogen Inactivators;D015849
D12.776.872.695;Plasminogen Inactivators;D015849
D23.119.832;Plasminogen Inactivators;D015849
D12.644.276.374.465.506;Interleukin-6;D015850
D12.776.467.374.465.506;Interleukin-6;D015850
D23.529.374.465.506;Interleukin-6;D015850
D12.644.276.374.465.507;Interleukin-7;D015851
D12.776.467.374.465.507;Interleukin-7;D015851
D23.529.374.465.507;Interleukin-7;D015851
D12.776.835.725.868.249;Eukaryotic Initiation Factor-2;D015852
D27.505.519.389.745.325;Cysteine Proteinase Inhibitors;D015853
G02.111.087.880;Up-Regulation;D015854
G02.149.115.880;Up-Regulation;D015854
G05.355.315.850;Up-Regulation;D015854
G07.690.812.925;Up-Regulation;D015854
G07.700.680.925;Up-Regulation;D015854
C11.744.126;Anisometropia;D015858
C11.768.725;Retinal Neovascularization;D015861
C23.550.589.500.725;Retinal Neovascularization;D015861
C11.941.160;Choroid Diseases;D015862
C11.941.375.360;Iridocyclitis;D015863
C11.941.879.780.880.400;Iridocyclitis;D015863
C11.941.879.780;Panuveitis;D015864
I03.450.642.845.600;Racquet Sports;D015865
C11.941.879.780.900;Uveitis, Posterior;D015866
C11.941.879.900;Uveitis, Intermediate;D015867
C11.941.160.478.700;Pars Planitis;D015868
C11.941.879.780.900.300.659;Pars Planitis;D015868
C11.941.879.900.500;Pars Planitis;D015868
G05.355.310;Gene Expression;D015870
K01.316.768.500;Scientific Misconduct;D015871
Z01.107.567.176.564;Northwest Territories;D015873
Z01.107.567.176.929;Yukon Territory;D015874
C10.597.690.150;Anisocoria;D015875
C11.710.090;Anisocoria;D015875
C23.888.592.708.150;Anisocoria;D015875
Z01.338.500;Northern Territory;D015876
C10.597.690.362;Miosis;D015877
C11.710.528;Miosis;D015877
C23.888.592.708.362;Miosis;D015877
C11.710.570;Mydriasis;D015878
D05.750.078.730.475.300;Myosin Subfragments;D015879
D12.776.210.500.600.300;Myosin Subfragments;D015879
D12.776.220.525.475.300;Myosin Subfragments;D015879
C11.768.773.674;Retinal Necrosis Syndrome, Acute;D015882
D12.776.215;Cystatins;D015891
G05.360.340.350;Genome, Human;D015894
N03.219.521.710.305.500;Relative Value Scales;D015895
N04.452.313.500;Relative Value Scales;D015895
N05.715.350.225;Comorbidity;D015897
N06.850.490.687;Comorbidity;D015897
E07.913;Tomography Scanners, X-Ray Computed;D015898
E01.370.350.350.800.800;Tomography, Emission-Computed, Single-Photon;D015899
E01.370.350.600.350.800.800;Tomography, Emission-Computed, Single-Photon;D015899
E01.370.350.710.800.800;Tomography, Emission-Computed, Single-Photon;D015899
E01.370.350.825.800.800;Tomography, Emission-Computed, Single-Photon;D015899
E01.370.384.730.800.800;Tomography, Emission-Computed, Single-Photon;D015899
E01.370.350.600.350.700.700;Radiography, Dual-Energy Scanned Projection;D015900
E01.370.350.700.700.700;Radiography, Dual-Energy Scanned Projection;D015900
E01.370.350.760.700;Radiography, Dual-Energy Scanned Projection;D015900
L01.224.308.380.800;Radiography, Dual-Energy Scanned Projection;D015900
E01.370.350.600.350.700.060;Angiography, Digital Subtraction;D015901
E01.370.350.700.060.060;Angiography, Digital Subtraction;D015901
E01.370.350.700.700.060;Angiography, Digital Subtraction;D015901
E01.370.350.760.060;Angiography, Digital Subtraction;D015901
E01.370.370.050.060;Angiography, Digital Subtraction;D015901
E07.420;Gamma Cameras;D015902
E01.370.350.600.630.500;Moire Topography;D015903
E05.490.815;Moire Topography;D015903
E04.210.120.086;Biliopancreatic Diversion;D015904
E04.210.169;Biliopancreatic Diversion;D015904
E07.430;Gastric Balloon;D015905
E02.148.050.060.100;Angioplasty, Balloon, Coronary;D015906
E04.100.376.719.100;Angioplasty, Balloon, Coronary;D015906
E04.100.814.529.124.060.100;Angioplasty, Balloon, Coronary;D015906
E04.100.814.529.968.050;Angioplasty, Balloon, Coronary;D015906
E04.800.382.124.060.100;Angioplasty, Balloon, Coronary;D015906
E04.800.382.968.050;Angioplasty, Balloon, Coronary;D015906
E04.928.220.520.100;Angioplasty, Balloon, Coronary;D015906
E01.370.378.330;Hysteroscopy;D015907
E01.370.388.250.360;Hysteroscopy;D015907
E04.520.360;Hysteroscopy;D015907
E04.800.250.360;Hysteroscopy;D015907
E04.950.300.539;Hysteroscopy;D015907
E04.050.215;Counterpulsation;D015908
E02.319.805;Sclerotherapy;D015911
E02.319.913;Thrombolytic Therapy;D015912
E02.319.155;Chelation Therapy;D015913
E02.319.452.150;Estrogen Replacement Therapy;D015914
E02.779.483.500;Motion Therapy, Continuous Passive;D015915
E02.779.867.761;Motion Therapy, Continuous Passive;D015915
E02.831.387.500;Motion Therapy, Continuous Passive;D015915
E02.309.221;Drainage, Postural;D015916
E02.779.358;Drainage, Postural;D015916
E02.880.150;Drainage, Postural;D015916
E07.695.610;Penile Prosthesis;D015917
E07.505.254;Infusion Pumps, Implantable;D015918
E07.858.082.505.254;Infusion Pumps, Implantable;D015918
E07.950.500;Ventilators, Negative-Pressure;D015919
E07.427;Gas Scavengers;D015920
D25.339.312;Dental Implants;D015921
E06.780.345.593;Dental Implants;D015921
E07.695.185;Dental Implants;D015921
J01.637.051.339.312;Dental Implants;D015921
D12.776.124.486.274.050.270;Complement C1q;D015922
D08.811.277.300.280;Complement C1r;D015923
D12.776.124.486.274.045.280;Complement C1r;D015923
D12.776.124.486.274.050.280;Complement C1r;D015923
E07.230.740.100;Blood Pressure Monitors;D015924
E01.370.225.500.620.760.160;Cryopreservation;D015925
E01.370.225.750.600.760.160;Cryopreservation;D015925
E02.792.156;Cryopreservation;D015925
E05.200.500.620.760.160;Cryopreservation;D015925
E05.200.750.600.760.160;Cryopreservation;D015925
E05.760.156;Cryopreservation;D015925
D12.776.124.486.274.024.250;Complement C3a;D015926
D12.776.124.486.274.250.250;Complement C3a;D015926
E01.370.225.812.871.300.750;Skin Test End-Point Titration;D015927
E05.200.812.871.300.750;Skin Test End-Point Titration;D015927
E05.478.594.890.300.750;Skin Test End-Point Titration;D015927
F04.754.137.428;Cognitive Therapy;D015928
N04.452.859.360;Diet Records;D015930
E02.760.190.400.405;Intensive Care, Neonatal;D015931
N02.421.088.120.120;Intensive Care, Neonatal;D015931
N02.421.585.190.400.405;Intensive Care, Neonatal;D015931
D12.776.124.486.274.250.260.500;Complement C3c;D015932
D12.776.124.486.274.250.260.750;Complement C3d;D015933
D12.776.124.486.274.024.260;Complement C4a;D015934
D12.776.124.486.274.350.250;Complement C4a;D015934
D12.776.124.486.274.350.260;Complement C4b;D015935
D12.776.124.486.274.024.270;Complement C5a;D015936
D12.776.124.486.274.450.250;Complement C5a;D015936
D12.776.124.486.274.024.270.255;Complement C5a, des-Arginine;D015937
D12.776.124.486.274.450.250.255;Complement C5a, des-Arginine;D015937
D12.776.124.486.274.930;Complement Membrane Attack Complex;D015938
D02.540.505.440.450;Kitasamycin;D015939
E01.370.225.812.160.155;Complement Hemolytic Activity Assay;D015941
E01.370.225.812.735.155;Complement Hemolytic Activity Assay;D015941
E05.200.812.160.155;Complement Hemolytic Activity Assay;D015941
E05.200.812.735.155;Complement Hemolytic Activity Assay;D015941
E05.478.594.160.150;Complement Hemolytic Activity Assay;D015941
E05.478.594.760.155;Complement Hemolytic Activity Assay;D015941
D08.811.277.656.300.760.300;Factor VIIa;D015942
D08.811.277.656.959.350.300;Factor VIIa;D015942
D12.776.124.125.325.300;Factor VIIa;D015942
D23.119.325.300;Factor VIIa;D015942
D12.776.124.125.300.300;Factor Va;D015943
D23.119.300.300;Factor Va;D015943
D12.776.124.125.350.300;Factor VIIIa;D015944
D23.119.350.300;Factor VIIIa;D015944
D08.811.277.656.300.760.320;Factor XIa;D015945
D08.811.277.656.959.350.320;Factor XIa;D015945
D12.776.124.125.425.320;Factor XIa;D015945
D23.119.425.320;Factor XIa;D015945
D02.455.526.368.225;Ethylene Dibromide;D015946
E04.540.825.374.350;Keratoplasty, Penetrating;D015948
E04.936.580.225.350;Keratoplasty, Penetrating;D015948
D08.811.277.656.300.760.310;Factor IXa;D015949
D08.811.277.656.959.350.310;Factor IXa;D015949
D12.776.124.125.375.310;Factor IXa;D015949
D23.119.375.310;Factor IXa;D015949
D08.811.277.656.300.760.315;Factor Xa;D015951
D08.811.277.656.959.350.315;Factor Xa;D015951
D12.776.124.125.400.315;Factor Xa;D015951
D23.119.400.315;Factor Xa;D015951
D08.811.277.656.300.760.324;Factor XIIa;D015956
D08.811.277.656.959.350.324;Factor XIIa;D015956
D12.776.124.125.450.324;Factor XIIa;D015956
D23.119.450.324;Factor XIIa;D015956
G05.355.315.300;Gene Expression Regulation, Bacterial;D015964
G05.355.315.330;Gene Expression Regulation, Fungal;D015966
G05.355.315.385;Gene Expression Regulation, Viral;D015967
N03.540.608.500;Institute of Medicine (U.S.);D015969
G05.355.315.320;Gene Expression Regulation, Enzymologic;D015971
G05.355.315.370;Gene Expression Regulation, Neoplastic;D015972
G05.355.315.370.500;Gene Expression Regulation, Leukemic;D015973
I01.880.604.583.963;Wrongful Life;D015974
N03.706.535.803;Wrongful Life;D015974
L01.178.682.759.150.500;Consensus Development Conferences, NIH as Topic;D015975
N03.540.199.205.500;Consensus Development Conferences, NIH as Topic;D015975
D12.776.835.725.868.124;Eukaryotic Initiation Factor-1;D015977
D12.776.765.710.500.500;Trichosanthin;D015978
A11.118.637.555.283.500;Killer Cells, Lymphokine-Activated;D015979
A11.118.637.555.567.537.500;Killer Cells, Lymphokine-Activated;D015979
A15.145.229.637.555.283.500;Killer Cells, Lymphokine-Activated;D015979
A15.145.229.637.555.567.537.500;Killer Cells, Lymphokine-Activated;D015979
A15.382.490.555.283.500;Killer Cells, Lymphokine-Activated;D015979
A15.382.490.555.567.537.500;Killer Cells, Lymphokine-Activated;D015979
N06.850.780;Public Health Practice;D015980
N05.715.350;Epidemiologic Factors;D015981
N06.850.490;Epidemiologic Factors;D015981
N05.715.350.150;Bias (Epidemiology);D015982
N06.850.490.500;Bias (Epidemiology);D015982
N05.715.350.150.775;Selection Bias;D015983
N06.850.490.500.500;Selection Bias;D015983
N05.715.350.200;Causality;D015984
N06.850.490.625;Causality;D015984
N05.715.350.200.650;Precipitating Factors;D015985
N06.850.490.625.500;Precipitating Factors;D015985
N05.715.350.240;Confounding Factors (Epidemiology);D015986
N06.850.490.718;Confounding Factors (Epidemiology);D015986
N05.715.350.350;Effect Modifier, Epidemiologic;D015987
N06.850.490.734;Effect Modifier, Epidemiologic;D015987
N05.715.350.350.225;Cohort Effect;D015988
N06.850.490.734.500;Cohort Effect;D015988
N05.715.350.350.375;Healthy Worker Effect;D015989
N06.850.490.734.750;Healthy Worker Effect;D015989
N05.715.350.350.625;Placebo Effect;D015990
N06.850.490.734.875;Placebo Effect;D015990
N06.850.505;Epidemiologic Measurements;D015991
E01.370.600.115.100.125;Body Mass Index;D015992
E05.041.124.125;Body Mass Index;D015992
G07.100.100.125;Body Mass Index;D015992
N06.850.505.200.100.175;Body Mass Index;D015992
E05.318.308.985.475;Life Tables;D015993
E05.318.740.100.500;Life Tables;D015993
L01.280.975.475;Life Tables;D015993
N01.224.935.530;Life Tables;D015993
N06.850.505.400.975.475;Life Tables;D015993
N06.850.520.308.985.475;Life Tables;D015993
E05.318.308.985.525.375;Incidence;D015994
L01.280.975.525.375;Incidence;D015994
N01.224.935.597.500;Incidence;D015994
N06.850.505.400.975.525.375;Incidence;D015994
N06.850.520.308.985.525.375;Incidence;D015994
E05.318.308.985.525.750;Prevalence;D015995
L01.280.975.525.750;Prevalence;D015995
N01.224.935.597.750;Prevalence;D015995
N06.850.505.400.975.525.750;Prevalence;D015995
N06.850.520.308.985.525.750;Prevalence;D015995
E05.318.308.985.550.900;Survival Rate;D015996
L01.280.975.550.900;Survival Rate;D015996
N01.224.935.698.826;Survival Rate;D015996
N06.850.505.400.975.550.900;Survival Rate;D015996
N06.850.520.308.985.550.900;Survival Rate;D015996
E01.370.225.910;Neonatal Screening;D015997
E01.370.500.580;Neonatal Screening;D015997
E05.200.910;Neonatal Screening;D015997
E05.318.308.250.580.580;Neonatal Screening;D015997
N02.421.143.827.233.443.816;Neonatal Screening;D015997
N05.715.360.300.375.500.575;Neonatal Screening;D015997
N06.850.520.308.250.580.580;Neonatal Screening;D015997
N06.850.780.500.580;Neonatal Screening;D015997
E05.318.308.940.968.875.125;Abbreviated Injury Scale;D015998
E05.944.250;Abbreviated Injury Scale;D015998
L01.280.900.968.875.125;Abbreviated Injury Scale;D015998
N04.452.859.564.800.125;Abbreviated Injury Scale;D015998
N05.715.360.300.715.500.800.100;Abbreviated Injury Scale;D015998
E05.318.740.150.500;Multivariate Analysis;D015999
N05.715.360.750.125.500;Multivariate Analysis;D015999
N06.850.520.830.150.500;Multivariate Analysis;D015999
E05.318.740.250;Cluster Analysis;D016000
N05.715.360.750.200;Cluster Analysis;D016000
N06.850.520.830.250;Cluster Analysis;D016000
E05.318.740.275;Confidence Intervals;D016001
N05.715.360.750.220;Confidence Intervals;D016001
N06.850.520.830.275;Confidence Intervals;D016001
E05.318.740.350;Discriminant Analysis;D016002
N05.715.360.750.325;Discriminant Analysis;D016002
N06.850.520.830.350;Discriminant Analysis;D016002
E05.318.740.994;Statistical Distributions;D016008
G17.820;Statistical Distributions;D016008
N05.715.360.750.750;Statistical Distributions;D016008
N06.850.520.830.994;Statistical Distributions;D016008
E05.318.740.994.300;Chi-Square Distribution;D016009
G17.820.300;Chi-Square Distribution;D016009
N05.715.360.750.750.200;Chi-Square Distribution;D016009
N06.850.520.830.994.300;Chi-Square Distribution;D016009
E05.318.740.994.250;Binomial Distribution;D016010
G17.820.250;Binomial Distribution;D016010
N05.715.360.750.750.150;Binomial Distribution;D016010
N06.850.520.830.994.250;Binomial Distribution;D016010
E05.318.740.994.500;Normal Distribution;D016011
G17.820.500;Normal Distribution;D016011
N05.715.360.750.750.565;Normal Distribution;D016011
N06.850.520.830.994.500;Normal Distribution;D016011
E05.318.740.994.750;Poisson Distribution;D016012
G17.820.750;Poisson Distribution;D016012
N05.715.360.750.750.620;Poisson Distribution;D016012
N06.850.520.830.994.750;Poisson Distribution;D016012
E05.318.740.500.475;Likelihood Functions;D016013
E05.318.740.600.400;Likelihood Functions;D016013
E05.599.835.500;Likelihood Functions;D016013
N05.715.360.750.530.450;Likelihood Functions;D016013
N05.715.360.750.625.450;Likelihood Functions;D016013
N06.850.520.830.500.475;Likelihood Functions;D016013
N06.850.520.830.600.400;Likelihood Functions;D016013
E05.318.740.500.500;Linear Models;D016014
E05.318.740.750.425;Linear Models;D016014
E05.599.835.750;Linear Models;D016014
N05.715.360.750.530.460;Linear Models;D016014
N05.715.360.750.695.460;Linear Models;D016014
N06.850.520.830.500.500;Linear Models;D016014
N06.850.520.830.750.425;Linear Models;D016014
E05.318.740.500.525;Logistic Models;D016015
E05.318.740.600.800.450;Logistic Models;D016015
E05.318.740.750.450;Logistic Models;D016015
E05.599.835.875;Logistic Models;D016015
N05.715.360.750.530.480;Logistic Models;D016015
N05.715.360.750.625.700.450;Logistic Models;D016015
N05.715.360.750.695.470;Logistic Models;D016015
N06.850.520.830.500.525;Logistic Models;D016015
N06.850.520.830.600.800.450;Logistic Models;D016015
N06.850.520.830.750.450;Logistic Models;D016015
E05.318.740.500.700;Proportional Hazards Models;D016016
E05.318.740.600.700;Proportional Hazards Models;D016016
E05.318.740.750.725;Proportional Hazards Models;D016016
E05.318.740.998.825;Proportional Hazards Models;D016016
E05.599.835.900;Proportional Hazards Models;D016016
N05.715.360.750.530.650;Proportional Hazards Models;D016016
N05.715.360.750.625.650;Proportional Hazards Models;D016016
N05.715.360.750.695.650;Proportional Hazards Models;D016016
N05.715.360.750.795.825;Proportional Hazards Models;D016016
N06.850.520.830.500.700;Proportional Hazards Models;D016016
N06.850.520.830.600.700;Proportional Hazards Models;D016016
N06.850.520.830.750.725;Proportional Hazards Models;D016016
E05.318.740.600.600;Odds Ratio;D016017
G17.680.500;Odds Ratio;D016017
N05.715.360.750.625.590;Odds Ratio;D016017
N06.850.520.830.600.600;Odds Ratio;D016017
E05.318.740.750.400;Least-Squares Analysis;D016018
N05.715.360.750.695.440;Least-Squares Analysis;D016018
N06.850.520.830.750.400;Least-Squares Analysis;D016018
E05.318.740.998;Survival Analysis;D016019
N05.715.360.750.795;Survival Analysis;D016019
N06.850.520.830.998;Survival Analysis;D016019
E05.318.760;Epidemiologic Study Characteristics as Topic;D016020
N05.715.360.775;Epidemiologic Study Characteristics as Topic;D016020
N06.850.520.450;Epidemiologic Study Characteristics as Topic;D016020
E05.318.760.500;Epidemiologic Studies;D016021
N05.715.360.775.175;Epidemiologic Studies;D016021
N06.850.520.450.500;Epidemiologic Studies;D016021
E05.318.760.500.500;Case-Control Studies;D016022
N05.715.360.775.175.200;Case-Control Studies;D016022
N06.850.520.450.500.500;Case-Control Studies;D016022
D12.776.543.750.705.408;Integrins;D016023
D12.776.543.750.705.408.460;Receptors, Cytoadhesin;D016024
E04.555.130;Bone Transplantation;D016025
E04.936.450.050;Bone Transplantation;D016025
E04.936.580.040;Bone Marrow Transplantation;D016026
E04.100.376.475;Heart Transplantation;D016027
E04.928.220.390;Heart Transplantation;D016027
E04.936.450.475;Heart Transplantation;D016027
D12.776.543.750.705.408.600;Receptors, Leukocyte-Adhesion;D016028
D12.776.543.750.705.408.850;Receptors, Very Late Antigen;D016029
E02.870.500;Kidney Transplantation;D016030
E04.936.450.485;Kidney Transplantation;D016030
E04.950.774.400;Kidney Transplantation;D016030
E04.210.650;Liver Transplantation;D016031
E04.936.450.490;Liver Transplantation;D016031
E04.936.580.490;Liver Transplantation;D016031
E05.318.760.535.365.500;Randomized Controlled Trials as Topic;D016032
E05.337.250.365.500;Randomized Controlled Trials as Topic;D016032
N05.715.360.775.235.387.500;Randomized Controlled Trials as Topic;D016032
N06.850.520.450.535.365.500;Randomized Controlled Trials as Topic;D016032
E05.318.760.565;Intervention Studies;D016033
N05.715.360.775.390;Intervention Studies;D016033
N06.850.520.450.565;Intervention Studies;D016033
E04.210.725;Pancreas Transplantation;D016035
E04.936.450.650;Pancreas Transplantation;D016035
E05.318.760.500.950;Seroepidemiologic Studies;D016036
N05.715.360.775.175.800;Seroepidemiologic Studies;D016036
N06.850.520.450.500.950;Seroepidemiologic Studies;D016036
E05.318.780.850;Single-Blind Method;D016037
N05.715.360.780.730;Single-Blind Method;D016037
N06.850.520.445.850;Single-Blind Method;D016037
E04.680.275.850;Skin Transplantation;D016038
E04.936.580.700;Skin Transplantation;D016038
E04.540.825.374;Corneal Transplantation;D016039
E04.936.580.225;Corneal Transplantation;D016039
E04.928.600.495;Lung Transplantation;D016040
E04.936.450.495;Lung Transplantation;D016040
E04.100.376.475.450;Heart-Lung Transplantation;D016041
E04.928.220.390.450;Heart-Lung Transplantation;D016041
E04.928.600.495.450;Heart-Lung Transplantation;D016041
E04.936.450.475.450;Heart-Lung Transplantation;D016041
E04.936.450.495.450;Heart-Lung Transplantation;D016041
E04.936.800;Transplantation, Heterotopic;D016042
D08.811.913.696.620.682.725.500.500;Fusion Proteins, bcr-abl;D016044
D12.776.602.500.500.100;Fusion Proteins, bcr-abl;D016044
D12.776.624.664.500.100;Fusion Proteins, bcr-abl;D016044
D12.776.624.664.700.171.500;Fusion Proteins, bcr-abl;D016044
H01.158.273.180.350.174;Human Genome Project;D016045
H01.158.273.343.249.400;Human Genome Project;D016045
H01.158.273.343.350.174;Human Genome Project;D016045
H01.770.644.145.350.500;Human Genome Project;D016045
L01.453.450;Human Genome Project;D016045
D03.383.742.680.245.500.950;Zalcitabine;D016047
D13.570.230.329.950;Zalcitabine;D016047
D13.570.230.500.925;Zalcitabine;D016047
D13.570.685.245.500.950;Zalcitabine;D016047
D03.438.759.590.138.325.105;Dideoxyadenosine;D016048
D13.570.230.229.105;Dideoxyadenosine;D016048
D13.570.230.500.105;Dideoxyadenosine;D016048
D13.570.583.138.325.105;Dideoxyadenosine;D016048
D03.438.759.590.616.130;Didanosine;D016049
D13.570.230.500.090;Didanosine;D016049
D13.570.583.616.130;Didanosine;D016049
D13.570.800.573.130;Didanosine;D016049
D20.215.894.582;Protozoan Vaccines;D016052
D13.444.735.650;RNA, Protozoan;D016053
D13.444.308.442;DNA, Protozoan;D016054
C12.777.934.880;Urinary Retention;D016055
C13.351.968.934.880;Urinary Retention;D016055
D23.050.550.500;Immunodominant Epitopes;D016056
G07.265.500.370.300;Evoked Potentials, Auditory, Brain Stem;D016057
G11.561.270.370.300;Evoked Potentials, Auditory, Brain Stem;D016057
E03.091.120;Analgesia, Patient-Controlled;D016058
E01.370.600.700;Range of Motion, Articular;D016059
G11.427.760;Range of Motion, Articular;D016059
E02.912;Sorption Detoxification;D016060
E02.912.300;Enterosorption;D016061
G01.374.710;Porosity;D016062
C23.550.414.300;Blood Loss, Surgical;D016063
C23.550.505.300;Blood Loss, Surgical;D016063
E04.520.252.992;Vaginal Birth after Cesarean;D016064
G07.265.750.775;Myoelectric Complex, Migrating;D016065
G10.261.326.310.570;Myoelectric Complex, Migrating;D016065
G11.427.590.540.730;Myoelectric Complex, Migrating;D016065
G11.561.570.837;Myoelectric Complex, Migrating;D016065
C04.588.894.797.640.700;Pleural Effusion, Malignant;D016066
C08.528.652.700;Pleural Effusion, Malignant;D016066
C08.528.694.700;Pleural Effusion, Malignant;D016066
C08.785.640.700;Pleural Effusion, Malignant;D016066
E04.525.550;Nerve Transfer;D016067
N04.590.233.727.605;Refusal to Treat;D016079
N05.300.100.675;Refusal to Treat;D016079
C04.182.044;Arachnoid Cysts;D016080
C04.588.614.250.387.100;Arachnoid Cysts;D016080
C10.500.142.100;Arachnoid Cysts;D016080
C10.551.240.375.100;Arachnoid Cysts;D016080
C16.131.666.142.100;Arachnoid Cysts;D016080
G01.060.249.730.700.200.500;Moon;D016081
G01.060.249.730;Solar System;D016082
G01.060.249.680;Planets;D016083
G01.060.249.730.700;Planets;D016083
G09.772.770.755.700.080;Bronchoconstriction;D016084
D27.505.696.663.050.100;Bronchoconstrictor Agents;D016085
D27.505.954.796.170;Bronchoconstrictor Agents;D016085
B04.820.650.589;Lentivirus;D016086
B04.909.777.731.589;Lentivirus;D016086
B04.820.650.589.500.400;Immunodeficiency Virus, Bovine;D016087
B04.909.777.731.589.500.400;Immunodeficiency Virus, Bovine;D016087
B04.820.650.589.600.070;Arthritis-Encephalitis Virus, Caprine;D016088
B04.909.777.731.589.600.070;Arthritis-Encephalitis Virus, Caprine;D016088
B04.820.650.589.530.400;Immunodeficiency Virus, Feline;D016089
B04.909.777.731.589.530.400;Immunodeficiency Virus, Feline;D016089
B04.820.650.850;Spumavirus;D016092
B04.909.777.731.850;Spumavirus;D016092
B04.820.650.124.520;Mason-Pfizer monkey virus;D016093
B04.820.650.805.550;Mason-Pfizer monkey virus;D016093
B04.909.574.807.124.520;Mason-Pfizer monkey virus;D016093
B04.909.574.807.805.550;Mason-Pfizer monkey virus;D016093
B04.909.777.731.124.520;Mason-Pfizer monkey virus;D016093
B04.909.777.731.805.550;Mason-Pfizer monkey virus;D016093
C02.782.815.616.850;Simian Acquired Immunodeficiency Syndrome;D016097
C02.839.850;Simian Acquired Immunodeficiency Syndrome;D016097
C22.735.500.850;Simian Acquired Immunodeficiency Syndrome;D016097
C10.228.228.800.350;Gerstmann-Straussler-Scheinker Disease;D016098
C10.574.500.425;Gerstmann-Straussler-Scheinker Disease;D016098
C10.574.843.400;Gerstmann-Straussler-Scheinker Disease;D016098
C16.320.400.350;Gerstmann-Straussler-Scheinker Disease;D016098
E01.370.372.250.250;Endoscopy, Gastrointestinal;D016099
E01.370.388.250.250.250;Endoscopy, Gastrointestinal;D016099
E04.210.240.250;Endoscopy, Gastrointestinal;D016099
E04.800.250.250.250;Endoscopy, Gastrointestinal;D016099
C26.117.500.500;Spinal Fractures;D016103
C26.404.812;Spinal Fractures;D016103
C26.831.600;Spinal Fractures;D016103
C13.703.560;Oligohydramnios;D016104
E04.270.694;Parathyroidectomy;D016105
G06.099.225.500.600.525;Methicillin Resistance;D016106
G06.225.347.500.600.525;Methicillin Resistance;D016106
G07.690.320.269.347.500.600.525;Methicillin Resistance;D016106
C16.131.831.493.080;Epidermolysis Bullosa Acquisita;D016107
C17.800.804.493.080;Epidermolysis Bullosa Acquisita;D016107
C17.800.827.275.080;Epidermolysis Bullosa Acquisita;D016107
C17.800.865.410.080;Epidermolysis Bullosa Acquisita;D016107
C16.131.831.493.160;Epidermolysis Bullosa Dystrophica;D016108
C16.320.850.275.160;Epidermolysis Bullosa Dystrophica;D016108
C17.300.200.367;Epidermolysis Bullosa Dystrophica;D016108
C17.800.804.493.160;Epidermolysis Bullosa Dystrophica;D016108
C17.800.827.275.160;Epidermolysis Bullosa Dystrophica;D016108
C17.800.865.410.160;Epidermolysis Bullosa Dystrophica;D016108
C16.131.831.493.170;Epidermolysis Bullosa, Junctional;D016109
C16.320.850.275.170;Epidermolysis Bullosa, Junctional;D016109
C17.800.804.493.170;Epidermolysis Bullosa, Junctional;D016109
C17.800.827.275.170;Epidermolysis Bullosa, Junctional;D016109
C17.800.865.410.170;Epidermolysis Bullosa, Junctional;D016109
C16.131.831.493.180;Epidermolysis Bullosa Simplex;D016110
C16.320.850.275.180;Epidermolysis Bullosa Simplex;D016110
C17.800.804.493.180;Epidermolysis Bullosa Simplex;D016110
C17.800.827.275.180;Epidermolysis Bullosa Simplex;D016110
C17.800.865.410.180;Epidermolysis Bullosa Simplex;D016110
C16.131.831.512.723;Sjogren-Larsson Syndrome;D016111
C16.320.565.398.641.723;Sjogren-Larsson Syndrome;D016111
C16.320.850.820;Sjogren-Larsson Syndrome;D016111
C16.614.492.723;Sjogren-Larsson Syndrome;D016111
C17.800.428.333.723;Sjogren-Larsson Syndrome;D016111
C17.800.804.512.723;Sjogren-Larsson Syndrome;D016111
C17.800.827.820;Sjogren-Larsson Syndrome;D016111
C18.452.584.687.723;Sjogren-Larsson Syndrome;D016111
C18.452.648.398.641.723;Sjogren-Larsson Syndrome;D016111
C16.131.831.512.410;Ichthyosis Vulgaris;D016112
C16.320.850.405;Ichthyosis Vulgaris;D016112
C17.800.428.333.410;Ichthyosis Vulgaris;D016112
C17.800.804.512.410;Ichthyosis Vulgaris;D016112
C17.800.827.405;Ichthyosis Vulgaris;D016112
C16.131.831.512.400;Ichthyosiform Erythroderma, Congenital;D016113
C16.320.850.400;Ichthyosiform Erythroderma, Congenital;D016113
C16.614.492.400;Ichthyosiform Erythroderma, Congenital;D016113
C17.800.428.333.250;Ichthyosiform Erythroderma, Congenital;D016113
C17.800.804.512.400;Ichthyosiform Erythroderma, Congenital;D016113
C17.800.827.400;Ichthyosiform Erythroderma, Congenital;D016113
C16.131.831.512.420;Ichthyosis, X-Linked;D016114
C16.320.322.241;Ichthyosis, X-Linked;D016114
C16.320.565.925.400;Ichthyosis, X-Linked;D016114
C16.320.850.408;Ichthyosis, X-Linked;D016114
C16.614.492.420;Ichthyosis, X-Linked;D016114
C17.800.428.333.420;Ichthyosis, X-Linked;D016114
C17.800.804.512.420;Ichthyosis, X-Linked;D016114
C17.800.827.408;Ichthyosis, X-Linked;D016114
C18.452.648.925.400;Ichthyosis, X-Linked;D016114
C11.270.040.545;Albinism, Oculocutaneous;D016115
C16.320.290.040.100;Albinism, Oculocutaneous;D016115
C16.320.565.100.102.100;Albinism, Oculocutaneous;D016115
C16.320.850.080.100;Albinism, Oculocutaneous;D016115
C17.800.621.440.102.100;Albinism, Oculocutaneous;D016115
C17.800.827.080.100;Albinism, Oculocutaneous;D016115
C18.452.648.100.102.100;Albinism, Oculocutaneous;D016115
C16.320.290.040.600;Piebaldism;D016116
C16.320.565.100.102.600;Piebaldism;D016116
C16.320.850.080.600;Piebaldism;D016116
C17.800.621.440.102.600;Piebaldism;D016116
C17.800.827.080.600;Piebaldism;D016116
C18.452.648.100.102.600;Piebaldism;D016116
C11.270.040.090;Albinism, Ocular;D016117
C16.320.290.040.090;Albinism, Ocular;D016117
C16.320.565.100.102.090;Albinism, Ocular;D016117
C16.320.850.080.090;Albinism, Ocular;D016117
C17.800.621.440.102.090;Albinism, Ocular;D016117
C17.800.827.080.090;Albinism, Ocular;D016117
C18.452.648.100.102.090;Albinism, Ocular;D016117
A02.513.514.100;Anterior Cruciate Ligament;D016118
A02.835.583.512.100;Anterior Cruciate Ligament;D016118
A02.513.514.600;Posterior Cruciate Ligament;D016119
A02.835.583.512.600;Posterior Cruciate Ligament;D016119
A07.231.908.130;Brachiocephalic Veins;D016121
A07.231.114.145;Brachiocephalic Trunk;D016122
B03.440.180.425;Campylobacter jejuni;D016123
B03.660.150.100.375;Campylobacter jejuni;D016123
B03.440.450.400.275;Eikenella corrodens;D016124
B03.660.075.525.170.100;Eikenella corrodens;D016124
C14.280.484.400;Heart Valve Prolapse;D016127
E01.370.225.812.447;Immunophenotyping;D016130
E05.200.812.447;Immunophenotyping;D016130
E05.478.594.450;Immunophenotyping;D016130
A11.118.637.555.567.550;Lymphocyte Subsets;D016131
A15.145.229.637.555.567.550;Lymphocyte Subsets;D016131
A15.382.490.555.567.550;Lymphocyte Subsets;D016131
E05.393.620.500;Polymerase Chain Reaction;D016133
I01.655.500.550;Organizational Policy;D016134
I01.880.604.825.550;Organizational Policy;D016134
N03.623.500.550;Organizational Policy;D016134
C10.500.680.800;Spinal Dysraphism;D016135
C16.131.666.680.800;Spinal Dysraphism;D016135
C10.500.680.800.750;Spina Bifida Occulta;D016136
C16.131.666.680.800.750;Spina Bifida Occulta;D016136
C10.500.680.800.730;Spina Bifida Cystica;D016137
C16.131.666.680.800.730;Spina Bifida Cystica;D016137
G11.427.590.530.568.900;Walking;D016138
G11.427.590.530.698.277.937;Walking;D016138
I03.450.642.845.940;Walking;D016138
I03.450.642.845.560;Martial Arts;D016139
C05.660.207.410;Holoprosencephaly;D016142
C10.500.034.875;Holoprosencephaly;D016142
C16.131.077.410;Holoprosencephaly;D016142
C16.131.260.380;Holoprosencephaly;D016142
C16.131.621.207.410;Holoprosencephaly;D016142
C16.131.666.034.875;Holoprosencephaly;D016142
C16.131.666.410;Holoprosencephaly;D016142
C16.320.180.380;Holoprosencephaly;D016142
E01.370.372.250;Endoscopy, Digestive System;D016145
E01.370.388.250.250;Endoscopy, Digestive System;D016145
E04.210.240;Endoscopy, Digestive System;D016145
E04.800.250.250;Endoscopy, Digestive System;D016145
G05.360.340.024.340.375.249;Genes, Tumor Suppressor;D016147
G05.360.340.024.340.415.400;Genes, Tumor Suppressor;D016147
G05.360.340.024.340.460;Genes, Suppressor;D016153
C06.267;Digestive System Fistula;D016154
C23.300.575.185;Digestive System Fistula;D016154
C07.465.614;Oral Fistula;D016155
C23.300.575.500;Oral Fistula;D016155
C08.702;Respiratory Tract Fistula;D016156
C23.300.575.687;Respiratory Tract Fistula;D016156
C14.240.850.984;Vascular Fistula;D016157
C14.907.933;Vascular Fistula;D016157
C23.300.575.950;Vascular Fistula;D016157
G05.360.340.024.340.375.249.385;Genes, p53;D016158
G05.360.340.024.340.415.400.385;Genes, p53;D016158
D12.776.260.820;Tumor Suppressor Protein p53;D016159
D12.776.624.776.775;Tumor Suppressor Protein p53;D016159
D12.776.660.825;Tumor Suppressor Protein p53;D016159
D12.776.744.845;Tumor Suppressor Protein p53;D016159
D12.776.260.704;Retinoblastoma Protein;D016160
D12.776.624.776.745;Retinoblastoma Protein;D016160
D12.776.660.807;Retinoblastoma Protein;D016160
D12.776.744.770;Retinoblastoma Protein;D016160
G05.360.340.024.340.375.249.400;Genes, Retinoblastoma;D016161
G05.360.340.024.340.415.400.400;Genes, Retinoblastoma;D016161
G05.360.340.024.340.375.249.420;Genes, Wilms Tumor;D016162
G05.360.340.024.340.415.400.420;Genes, Wilms Tumor;D016162
G05.360.340.024.340.375.249.200;Genes, DCC;D016163
G05.360.340.024.340.415.400.200;Genes, DCC;D016163
B01.050.150.900.649.077.380.120;Bison;D016164
D27.505.519.217.500;Free Radical Scavengers;D016166
D12.776.395.550.200.275;Integrin alphaXbeta2;D016167
D12.776.543.550.200.275;Integrin alphaXbeta2;D016167
D12.776.543.750.705.408.600.100;Integrin alphaXbeta2;D016167
D12.776.543.750.705.833.249;Integrin alphaXbeta2;D016167
D23.050.301.350.275;Integrin alphaXbeta2;D016167
D12.776.395.550.200.625.550;Lymphocyte Function-Associated Antigen-1;D016169
D12.776.543.550.200.625.550;Lymphocyte Function-Associated Antigen-1;D016169
D12.776.543.750.705.408.600.400;Lymphocyte Function-Associated Antigen-1;D016169
D12.776.543.750.705.877.550;Lymphocyte Function-Associated Antigen-1;D016169
D23.050.301.264.035.111.400;Lymphocyte Function-Associated Antigen-1;D016169
D23.050.301.264.035.850.550;Lymphocyte Function-Associated Antigen-1;D016169
D23.050.301.350.625.550;Lymphocyte Function-Associated Antigen-1;D016169
D23.101.100.110.111.400;Lymphocyte Function-Associated Antigen-1;D016169
D23.101.100.110.850.550;Lymphocyte Function-Associated Antigen-1;D016169
C14.280.067.845.940.349;Accelerated Idioventricular Rhythm;D016170
C23.550.073.845.940.349;Accelerated Idioventricular Rhythm;D016170
C14.280.067.845.940.700;Torsades de Pointes;D016171
C23.550.073.845.940.700;Torsades de Pointes;D016171
E05.318.740.225.500.500;DNA Fingerprinting;D016172
E05.393.290;DNA Fingerprinting;D016172
I01.198.780.937.375;DNA Fingerprinting;D016172
D12.644.276.374.410.240.500;Macrophage Colony-Stimulating Factor;D016173
D12.776.395.240.500;Macrophage Colony-Stimulating Factor;D016173
D12.776.467.374.410.240.500;Macrophage Colony-Stimulating Factor;D016173
D23.529.374.410.240.500;Macrophage Colony-Stimulating Factor;D016173
B04.450.410;Hepacivirus;D016174
B04.820.250.475;Hepacivirus;D016174
B04.909.777.310.475;Hepacivirus;D016174
A11.063.438.450;B-Lymphocyte Subsets;D016175
A11.118.637.555.567.550.450;B-Lymphocyte Subsets;D016175
A11.118.637.555.567.562.450;B-Lymphocyte Subsets;D016175
A15.145.229.637.555.567.550.450;B-Lymphocyte Subsets;D016175
A15.145.229.637.555.567.562.450;B-Lymphocyte Subsets;D016175
A15.382.032.438.450;B-Lymphocyte Subsets;D016175
A15.382.490.555.567.550.300;B-Lymphocyte Subsets;D016175
A15.382.490.555.567.562.450;B-Lymphocyte Subsets;D016175
A11.118.637.555.567.550.500;T-Lymphocyte Subsets;D016176
A11.118.637.555.567.569.500;T-Lymphocyte Subsets;D016176
A15.145.229.637.555.567.550.500;T-Lymphocyte Subsets;D016176
A15.145.229.637.555.567.569.500;T-Lymphocyte Subsets;D016176
A15.382.490.555.567.550.500;T-Lymphocyte Subsets;D016176
A15.382.490.555.567.569.500;T-Lymphocyte Subsets;D016176
D12.776.543.750.705.408.495.500;Macrophage-1 Antigen;D016177
D12.776.543.750.705.408.600.500;Macrophage-1 Antigen;D016177
D12.776.543.750.705.833.500;Macrophage-1 Antigen;D016177
D12.644.276.374.410.240.375;Granulocyte-Macrophage Colony-Stimulating Factor;D016178
D12.776.395.240.300;Granulocyte-Macrophage Colony-Stimulating Factor;D016178
D12.776.467.374.410.240.375;Granulocyte-Macrophage Colony-Stimulating Factor;D016178
D23.529.374.410.240.375;Granulocyte-Macrophage Colony-Stimulating Factor;D016178
D12.644.276.374.410.240.350;Granulocyte Colony-Stimulating Factor;D016179
D12.776.395.240.200;Granulocyte Colony-Stimulating Factor;D016179
D12.776.467.374.410.240.350;Granulocyte Colony-Stimulating Factor;D016179
D23.529.374.410.240.350;Granulocyte Colony-Stimulating Factor;D016179
C02.782.815.616;Lentivirus Infections;D016180
C02.782.815.616.350;Feline Acquired Immunodeficiency Syndrome;D016181
C02.839.400;Feline Acquired Immunodeficiency Syndrome;D016181
C22.180.350;Feline Acquired Immunodeficiency Syndrome;D016181
C02.782.815.616.900;Visna;D016182
C02.839.900;Visna;D016182
C22.836.900;Visna;D016182
C02.782.815.650;Murine Acquired Immunodeficiency Syndrome;D016183
C02.928.650;Murine Acquired Immunodeficiency Syndrome;D016183
C22.795.650;Murine Acquired Immunodeficiency Syndrome;D016183
D12.776.543.750.705.852.150;Receptors, Colony-Stimulating Factor;D016184
D12.776.543.750.750.400.200;Receptors, Colony-Stimulating Factor;D016184
D12.776.543.750.705.852.150.360;Receptors, Interleukin-3;D016185
D12.776.543.750.705.852.420.340;Receptors, Interleukin-3;D016185
D12.776.543.750.750.400.200.480;Receptors, Interleukin-3;D016185
D08.811.913.696.620.682.725.400.500;Receptor, Macrophage Colony-Stimulating Factor;D016186
D12.776.543.750.060.492;Receptor, Macrophage Colony-Stimulating Factor;D016186
D12.776.543.750.705.852.150.150;Receptor, Macrophage Colony-Stimulating Factor;D016186
D12.776.543.750.750.400.200.200;Receptor, Macrophage Colony-Stimulating Factor;D016186
D12.776.624.664.700.800;Receptor, Macrophage Colony-Stimulating Factor;D016186
D23.050.301.264.035.597;Receptor, Macrophage Colony-Stimulating Factor;D016186
D23.101.100.110.597;Receptor, Macrophage Colony-Stimulating Factor;D016186
D12.776.543.750.705.852.150.310;Receptors, Granulocyte-Macrophage Colony-Stimulating Factor;D016187
D12.776.543.750.750.400.200.420;Receptors, Granulocyte-Macrophage Colony-Stimulating Factor;D016187
D12.776.543.750.705.852.150.280;Receptors, Granulocyte Colony-Stimulating Factor;D016188
D12.776.543.750.750.400.200.400;Receptors, Granulocyte Colony-Stimulating Factor;D016188
D12.776.210.500.250;Dystrophin;D016189
D12.776.220.250;Dystrophin;D016189
D12.776.543.250;Dystrophin;D016189
D02.691.800.338;Carboplatin;D016190
G04.299.134.500.300;G0 Phase;D016192
G04.299.134.500.320;G1 Phase;D016193
D12.776.157.530.400.400.500.500;Receptors, N-Methyl-D-Aspartate;D016194
D12.776.543.550.425.500.200.500;Receptors, N-Methyl-D-Aspartate;D016194
D12.776.543.585.400.500.200.500;Receptors, N-Methyl-D-Aspartate;D016194
D12.776.543.750.720.200.450.400.500;Receptors, N-Methyl-D-Aspartate;D016194
G04.299.134.500.340;G2 Phase;D016195
G02.111.087.222.880;S Phase;D016196
G02.149.115.222.880;S Phase;D016196
G04.299.134.500.800;S Phase;D016196
G05.355.200.880;S Phase;D016196
B04.280.382.150.750.420;Herpesvirus 7, Human;D016199
B04.909.204.382.150.750.420;Herpesvirus 7, Human;D016199
D08.811.913.696.620.682.700.200.580;Maturation-Promoting Factor;D016200
D12.644.360.250.580;Maturation-Promoting Factor;D016200
D12.776.167.200.580;Maturation-Promoting Factor;D016200
D12.776.476.250.580;Maturation-Promoting Factor;D016200
D12.776.395.550.200.625;Receptors, Lymphocyte Homing;D016201
D12.776.543.550.200.625;Receptors, Lymphocyte Homing;D016201
D12.776.543.750.705.877;Receptors, Lymphocyte Homing;D016201
D23.050.301.264.035.850;Receptors, Lymphocyte Homing;D016201
D23.050.301.350.625;Receptors, Lymphocyte Homing;D016201
D23.101.100.110.850;Receptors, Lymphocyte Homing;D016201
D12.125.067.500.400;N-Methylaspartate;D016202
D12.125.119.170.400;N-Methylaspartate;D016202
D08.811.913.696.620.682.700.200.067.249;CDC2 Protein Kinase;D016203
D08.811.913.696.620.682.700.200.580.500;CDC2 Protein Kinase;D016203
D12.644.360.250.067.249;CDC2 Protein Kinase;D016203
D12.644.360.250.580.500;CDC2 Protein Kinase;D016203
D12.776.167.200.067.249;CDC2 Protein Kinase;D016203
D12.776.167.200.580.500;CDC2 Protein Kinase;D016203
D12.776.476.250.067.249;CDC2 Protein Kinase;D016203
D12.776.476.250.580.500;CDC2 Protein Kinase;D016203
D12.776.744.360;CDC2 Protein Kinase;D016203
B01.050.150.900.649.865.635.680;Sigmodontinae;D016205
L01.470.750.500;Databases, Bibliographic;D016206
L01.700.508.300.188.300;Databases, Bibliographic;D016206
D12.644.276.374;Cytokines;D016207
D12.776.467.374;Cytokines;D016207
D23.529.374;Cytokines;D016207
L01.470.750.750;Databases, Factual;D016208
L01.700.508.300.188.400;Databases, Factual;D016208
D12.644.276.374.200.120.800;Interleukin-8;D016209
D12.644.276.374.465.508;Interleukin-8;D016209
D12.776.467.374.200.120.800;Interleukin-8;D016209
D12.776.467.374.465.508;Interleukin-8;D016209
D23.125.300.120.800;Interleukin-8;D016209
D23.469.200.120.800;Interleukin-8;D016209
D23.529.374.200.120.800;Interleukin-8;D016209
D23.529.374.465.508;Interleukin-8;D016209
D02.092.877.883.555.500;Methacholine Chloride;D016210
D02.675.276.534.500;Methacholine Chloride;D016210
D12.644.276.963.700;Transforming Growth Factor alpha;D016211
D12.776.467.960.700;Transforming Growth Factor alpha;D016211
D23.529.960.700;Transforming Growth Factor alpha;D016211
D12.644.276.374.687;Transforming Growth Factor beta;D016212
D12.644.276.954.800.720;Transforming Growth Factor beta;D016212
D12.644.276.963.720;Transforming Growth Factor beta;D016212
D12.776.467.374.687;Transforming Growth Factor beta;D016212
D12.776.467.942.800.720;Transforming Growth Factor beta;D016212
D12.776.467.960.720;Transforming Growth Factor beta;D016212
D23.529.374.687;Transforming Growth Factor beta;D016212
D23.529.942.800.720;Transforming Growth Factor beta;D016212
D23.529.960.720;Transforming Growth Factor beta;D016212
D12.644.360.262;Cyclins;D016213
D12.776.167.218;Cyclins;D016213
D12.776.476.262;Cyclins;D016213
D12.644.276.374.480.615;Macrophage-Activating Factors;D016215
D12.776.467.374.480.615;Macrophage-Activating Factors;D016215
D23.529.374.480.615;Macrophage-Activating Factors;D016215
E01.370.350.850.865;Ultrasonography, Prenatal;D016216
E01.370.378.630.865;Ultrasonography, Prenatal;D016216
E01.370.350.850.860;Ultrasonography, Mammary;D016217
E01.370.378.850;Ultrasonography, Mammary;D016217
E02.095.465.425.400.330.050.400;Immunotherapy, Adoptive;D016219
E05.478.550.520.050.400;Immunotherapy, Adoptive;D016219
D12.644.276.624.110;Fibroblast Growth Factor 1;D016220
D12.776.467.624.110;Fibroblast Growth Factor 1;D016220
D23.529.624.110;Fibroblast Growth Factor 1;D016220
V02.260.400;Festschrift;D016221
V02.530.400;Festschrift;D016221
V02.672.500;Festschrift;D016221
D12.644.276.624.120;Fibroblast Growth Factor 2;D016222
D12.776.467.624.120;Fibroblast Growth Factor 2;D016222
D23.529.624.120;Fibroblast Growth Factor 2;D016222
I01.880.604.583.020;Advance Directives;D016223
N03.706.535.020;Advance Directives;D016223
N04.590.233.624.124.050;Advance Directives;D016223
I01.880.604.583.020.500;Living Wills;D016224
I01.880.604.583.927.500;Living Wills;D016224
N03.706.535.020.500;Living Wills;D016224
N04.590.233.624.124.050.500;Living Wills;D016224
D01.695.635;Phosphorus, Dietary;D016226
D02.806.250;Benzoquinones;D016227
D12.644.276.390;Endothelial Growth Factors;D016228
D12.776.467.390;Endothelial Growth Factors;D016228
D23.529.390;Endothelial Growth Factors;D016228
D12.644.024;Amyloid beta-Peptides;D016229
D12.776.049.407.249.500;Amyloid beta-Peptides;D016229
D12.776.543.039.500;Amyloid beta-Peptides;D016229
E05.196.712.516.600.390.350;Fluorescence Polarization Immunoassay;D016231
E05.478.412.341.350;Fluorescence Polarization Immunoassay;D016231
E05.478.566.159.350;Fluorescence Polarization Immunoassay;D016231
D12.644.276.400;Endothelins;D016232
D12.776.467.400;Endothelins;D016232
D23.529.400;Endothelins;D016232
E02.095.465.425.400.530;Immunotherapy, Active;D016233
E05.478.550.600;Immunotherapy, Active;D016233
G02.111.917.500;Kallikrein-Kinin System;D016234
G03.495.553.485;Kallikrein-Kinin System;D016234
G03.960.500;Kallikrein-Kinin System;D016234
G07.700.360.888.500;Kallikrein-Kinin System;D016234
G09.330.190.400.500;Kallikrein-Kinin System;D016234
N03.540.828.105;American Speech-Language-Hearing Association;D016235
G05.360.340.024.340.375.500.791.325;Genes, fms;D016236
E02.095.160;Cytapheresis;D016238
E02.120.285;Cytapheresis;D016238
E05.242.363.285;Cytapheresis;D016238
L01.470.750.500.650.500;MEDLINE;D016239
L01.700.508.280.710.500;MEDLINE;D016239
L01.700.508.280.750.500;MEDLINE;D016239
L01.700.508.300.188.300.650.500;MEDLINE;D016239
L01.700.508.300.710.500;MEDLINE;D016239
L01.700.508.300.742.650.500;MEDLINE;D016239
L01.224.900.400;Grateful Med;D016240
L01.700.508.280.400;Grateful Med;D016240
M01.106;Child of Impaired Parents;D016241
L01.583.400;Library Automation;D016242
L01.583.410;Library Collection Development;D016243
D02.886.765.380;Guanosine 5'-O-(3-Thiotriphosphate);D016244
D13.695.667.454.504.380;Guanosine 5'-O-(3-Thiotriphosphate);D016244
D13.695.827.426.504.380;Guanosine 5'-O-(3-Thiotriphosphate);D016244
D13.695.900.380;Guanosine 5'-O-(3-Thiotriphosphate);D016244
M01.526.555;Librarians;D016245
A11.118.637.555.567.650;Lymphocytes, Tumor-Infiltrating;D016246
A15.145.229.637.555.567.650;Lymphocytes, Tumor-Infiltrating;D016246
A15.382.490.555.567.650;Lymphocytes, Tumor-Infiltrating;D016246
L01.470;Information Storage and Retrieval;D016247
L01.700.508.280;Information Storage and Retrieval;D016247
L01.224.230.260.115.475;Computer Storage Devices;D016248
J01.897.280.500.668;Optical Storage Devices;D016249
L01.178.820.090.668;Optical Storage Devices;D016249
L01.224.230.260.115.475.600;Optical Storage Devices;D016249
J01.897.280.500.668.800.250;Compact Disks;D016250
J01.897.280.500.898.800.250;Compact Disks;D016250
L01.178.590.875.800.250;Compact Disks;D016250
L01.178.820.090.668.800.250;Compact Disks;D016250
L01.178.820.090.898.800.250;Compact Disks;D016250
L01.224.230.260.115.475.600.325;Compact Disks;D016250
L01.240.960.800.250;Compact Disks;D016250
J01.897.280.500.668.800.250.200;CD-ROM;D016251
J01.897.280.500.898.800.250.200;CD-ROM;D016251
L01.178.590.875.800.250.200;CD-ROM;D016251
L01.178.820.090.668.800.250.200;CD-ROM;D016251
L01.178.820.090.898.800.250.200;CD-ROM;D016251
L01.224.230.260.115.475.600.325.750;CD-ROM;D016251
L01.240.960.800.250.200;CD-ROM;D016251
E01.370.350.515.666.500;Microscopy, Scanning Tunneling;D016252
E05.595.666.500;Microscopy, Scanning Tunneling;D016252
E01.370.350.515.402.625;Microscopy, Immunoelectron;D016253
E05.595.402.625;Microscopy, Immunoelectron;D016253
E05.393.420.601.550;Mutagenesis, Insertional;D016254
G05.355.600.550;Mutagenesis, Insertional;D016254
G05.365.590.575;Mutagenesis, Insertional;D016254
D08.811.277.656.300.760.635.075;Anistreplase;D016255
D08.811.277.656.300.775.075;Anistreplase;D016255
D08.811.277.656.959.350.635.075;Anistreplase;D016255
D12.776.124.125.662.537.075;Anistreplase;D016255
D23.050.285.050.050;Antigens, CD15;D016256
D23.050.301.264.035.115;Antigens, CD15;D016256
D23.050.301.264.900.050;Antigens, CD15;D016256
D23.050.301.264.965.500;Antigens, CD15;D016256
D23.050.301.290.544.059;Antigens, CD15;D016256
D23.050.550.325.050;Antigens, CD15;D016256
D23.050.705.230.544.059;Antigens, CD15;D016256
D23.101.100.110.115;Antigens, CD15;D016256
D23.101.100.900.050;Antigens, CD15;D016256
D23.101.840.075.050;Antigens, CD15;D016256
D03.383.129.462.285;Fura-2;D016257
D03.438.127.250;Fura-2;D016257
G05.360.340.024.340.375.500.791.400;Genes, mos;D016258
G05.360.340.024.340.375.500.791.420;Genes, myc;D016259
A11.118.637.555.283.750;Monocytes, Activated Killer;D016260
A11.118.637.555.652.500;Monocytes, Activated Killer;D016260
A11.627.624.500;Monocytes, Activated Killer;D016260
A11.733.547.500;Monocytes, Activated Killer;D016260
A15.145.229.637.555.283.750;Monocytes, Activated Killer;D016260
A15.145.229.637.555.652.500;Monocytes, Activated Killer;D016260
A15.382.490.555.283.750;Monocytes, Activated Killer;D016260
A15.382.490.555.652.500;Monocytes, Activated Killer;D016260
A15.382.680.547.500;Monocytes, Activated Killer;D016260
A15.382.812.547.500;Monocytes, Activated Killer;D016260
C02.182.600.700.800;Postpoliomyelitis Syndrome;D016262
C02.782.687.359.764.650;Postpoliomyelitis Syndrome;D016262
C05.651.534.750;Postpoliomyelitis Syndrome;D016262
C10.228.228.210.650.800;Postpoliomyelitis Syndrome;D016262
C10.228.854.641.650;Postpoliomyelitis Syndrome;D016262
C10.574.827;Postpoliomyelitis Syndrome;D016262
C10.668.491.175.750;Postpoliomyelitis Syndrome;D016262
C10.668.550.500;Postpoliomyelitis Syndrome;D016262
C10.668.864.500;Postpoliomyelitis Syndrome;D016262
C02.782.815.616.400.050;AIDS-Associated Nephropathy;D016263
C02.800.801.400.050;AIDS-Associated Nephropathy;D016263
C12.777.419.050;AIDS-Associated Nephropathy;D016263
C13.351.968.419.050;AIDS-Associated Nephropathy;D016263
C20.673.480.050;AIDS-Associated Nephropathy;D016263
D09.698.365.272.300;Dextran Sulfate;D016264
K01.316.130;Conflict of Interest;D016265
N05.350.225;Conflict of Interest;D016265
H01.158.273.688.500;Food Parasitology;D016266
J01.576.423.850.730.500.249.650;Food Parasitology;D016266
N06.850.460.400.650;Food Parasitology;D016266
N06.850.601.500.249.650;Food Parasitology;D016266
E07.858.442.660.430;External Fixators;D016267
E07.858.690.650.430;External Fixators;D016267
E07.695.350;Internal Fixators;D016268
E07.858.442.660.460;Internal Fixators;D016268
E07.858.690.650.460;Internal Fixators;D016268
C20.543.480.370.500;Milk Hypersensitivity;D016269
I01.409.137.500.600.650.592;United States Agency for Healthcare Research and Quality;D016270
N03.540.348.500.500.600.650.592;United States Agency for Healthcare Research and Quality;D016270
D12.776.260.676;Proto-Oncogene Proteins c-myc;D016271
D12.776.624.664.700.189;Proto-Oncogene Proteins c-myc;D016271
D12.776.660.765;Proto-Oncogene Proteins c-myc;D016271
N01.400.525;Occupational Health;D016272
N06.850.460.350.600;Occupational Exposure;D016273
D12.776.260.630;Oncogene Protein p55(v-myc);D016274
D12.776.624.664.520.750.750;Oncogene Protein p55(v-myc);D016274
D12.776.660.700;Oncogene Protein p55(v-myc);D016274
D12.776.964.700.750.750;Oncogene Protein p55(v-myc);D016274
D12.776.964.775.750.750;Oncogene Protein p55(v-myc);D016274
G09.330.190.075;Atrial Function;D016275
G09.330.190.962;Ventricular Function;D016276
G09.330.190.962.800;Ventricular Function, Left;D016277
G09.330.190.962.900;Ventricular Function, Right;D016278
G09.330.190.075.100;Atrial Function, Left;D016279
G09.330.190.075.200;Atrial Function, Right;D016280
D12.776.624.664.520.750.650;Oncogene Protein gp140(v-fms);D016281
D12.776.964.700.750.650;Oncogene Protein gp140(v-fms);D016281
D12.776.964.775.750.650;Oncogene Protein gp140(v-fms);D016281
D08.811.277.656.074.500;Aspartic Acid Endopeptidases;D016282
D08.811.277.656.300.048;Aspartic Acid Endopeptidases;D016282
D08.811.277.040.330.300.400.500.600;Proto-Oncogene Proteins p21(ras);D016283
D12.644.360.525.500.600;Proto-Oncogene Proteins p21(ras);D016283
D12.776.157.325.515.500.600;Proto-Oncogene Proteins p21(ras);D016283
D12.776.476.525.500.600;Proto-Oncogene Proteins p21(ras);D016283
D12.776.624.664.700.200;Proto-Oncogene Proteins p21(ras);D016283
D02.092.782.590.883;Technetium Tc 99m Pentetate;D016284
D02.241.081.018.639.883;Technetium Tc 99m Pentetate;D016284
D02.691.825.875;Technetium Tc 99m Pentetate;D016284
D10.251.355.255.550.700.125;Iloprost;D016285
D23.469.700.275;Iloprost;D016285
L01.224.230.260.115;Computer Peripherals;D016287
L01.224.230.260.115.500;Computer Terminals;D016288
D02.455.426.559.847.181.384.380;Dizocilpine Maleate;D016291
D04.615.181.384.380;Dizocilpine Maleate;D016291
E03.250;Conscious Sedation;D016292
D02.886.369.533;Moricizine;D016293
D03.383.533.640.475;Moricizine;D016293
D03.494.741.533;Moricizine;D016293
E05.599.645;Models, Nursing;D016294
G05.355.600;Mutagenesis;D016296
E05.393.420.601.575;Mutagenesis, Site-Directed;D016297
D12.644.276.374.410;Hematopoietic Cell Growth Factors;D016298
D12.776.467.374.410;Hematopoietic Cell Growth Factors;D016298
D23.529.374.410;Hematopoietic Cell Growth Factors;D016298
E04.545.550.280.290;Dental Implantation, Subperiosteal;D016299
E06.231.482;Dental Implantation, Subperiosteal;D016299
E06.645.550.280.290;Dental Implantation, Subperiosteal;D016299
E06.780.314.482;Dental Implantation, Subperiosteal;D016299
E01.370.350.700.720.700;Radiography, Bitewing;D016300
E06.342.764.600;Radiography, Bitewing;D016300
C05.116.264.150;Alveolar Bone Loss;D016301
C07.465.714.354.500;Alveolar Bone Loss;D016301
E06.520.200;Centric Relation;D016302
L01.453.270.200;Clinical Pharmacy Information Systems;D016303
L01.700.508.300.680.085;Clinical Pharmacy Information Systems;D016303
N02.421.668.320.200;Clinical Pharmacy Information Systems;D016303
N04.452.442.452.200;Clinical Pharmacy Information Systems;D016303
N04.452.515.095;Clinical Pharmacy Information Systems;D016303
N04.452.515.360.250;Clinical Pharmacy Information Systems;D016303
N02.278.421.481;Hospitals, Private;D016304
D06.472.910.800.850;Thymopentin;D016305
E07.695.207.500;Vena Cava Filters;D016306
D12.644.468.281.231.300;Enkephalin, Leucine-2-Alanine;D016308
N03.219.521.710.305.200.080.550;Outliers, DRG;D016311
F01.145.488.800;Treatment Refusal;D016312
I01.880.604.473.650.968;Treatment Refusal;D016312
N03.706.437.650.875;Treatment Refusal;D016312
N05.300.150.600.800;Treatment Refusal;D016312
G05.360.340.024.340.375.500.791.100;Genes, abl;D016313
D03.383.113.367.350;Ethylketocyclazocine;D016314
D03.605.168.350;Ethylketocyclazocine;D016314
D08.811.913.696.620.682.725.500;Proto-Oncogene Proteins c-abl;D016315
D12.776.624.664.700.167;Proto-Oncogene Proteins c-abl;D016315
D02.078.370.465;Guanfacine;D016316
D02.241.223.601.329;Guanfacine;D016316
D03.383.129.462.580.600;Quisqualic Acid;D016318
D12.125.755;Quisqualic Acid;D016318
E01.370.225.500.620.620.150;Corrosion Casting;D016319
E01.370.225.750.600.620.150;Corrosion Casting;D016319
E05.200.500.620.620.150;Corrosion Casting;D016319
E05.200.750.600.620.150;Corrosion Casting;D016319
N02.278.035.128.800;Substance Abuse Treatment Centers;D016320
N02.278.808.930;Substance Abuse Treatment Centers;D016320
E06.170.100;Dental Care for Aged;D016321
N02.421.240.190.210;Dental Care for Aged;D016321
G02.111.570.080.689.330.400;HIV Enhancer;D016322
G02.111.570.080.708.850.400.400;HIV Enhancer;D016322
G05.360.080.689.330.400;HIV Enhancer;D016322
G05.360.080.708.850.400.400;HIV Enhancer;D016322
G05.360.340.024.340.137.750.249.400;HIV Enhancer;D016322
A14.549.167.245;Dentition, Primary;D016323
G05.360.340.024.810;Sequence Tagged Sites;D016324
G02.111.570.080.708.850.400;HIV Long Terminal Repeat;D016325
G05.360.080.708.850.400;HIV Long Terminal Repeat;D016325
D12.776.860.300;Extracellular Matrix Proteins;D016326
D12.776.260.600;NF-kappa B;D016328
D12.776.660.600;NF-kappa B;D016328
D12.776.930.600;NF-kappa B;D016328
D12.776.260.522.750.249;Sp1 Transcription Factor;D016329
D12.776.930.375.750.249;Sp1 Transcription Factor;D016329
M01.060.116.100.540;Frail Elderly;D016330
E02.421.505.550;Parenteral Nutrition, Home;D016331
E02.642.500.505.550;Parenteral Nutrition, Home;D016331
N02.421.143.524.650;Parenteral Nutrition, Home;D016331
E04.936.580.300;Fetal Tissue Transplantation;D016332
D08.811.277.656.074.500.340;HIV Protease;D016333
D08.811.277.656.300.048.340;HIV Protease;D016333
D12.776.964.775.375.545.750;HIV Protease;D016333
G05.360.340.024.340.425.578;Genes, vpr;D016334
G05.360.340.024.340.490.897;Genes, vpr;D016334
G05.360.340.400.500.897;Genes, vpr;D016334
G02.111.570.790.709.600.040.985;Zinc Fingers;D016335
D12.776.964.925.984.430;Gene Products, vpr;D016336
D08.811.797;RNA, Catalytic;D016337
D13.444.735.790.199;RNA, Catalytic;D016337
G05.360.340.024.340.425.580;Genes, vpu;D016338
G05.360.340.024.340.490.900;Genes, vpu;D016338
G05.360.340.400.500.900;Genes, vpu;D016338
E05.196.566.750;Spectrometry, Mass, Fast Atom Bombardment;D016339
G05.360.340.024.340.425.575;Genes, vif;D016341
G05.360.340.024.340.490.890;Genes, vif;D016341
G05.360.340.400.500.890;Genes, vif;D016341
E02.148.050.075;Angioplasty, Laser;D016342
E02.594.060;Angioplasty, Laser;D016342
E04.014.520.060;Angioplasty, Laser;D016342
E04.100.814.529.124.075;Angioplasty, Laser;D016342
E04.800.382.124.075;Angioplasty, Laser;D016342
E01.370.520.510;Monitoring, Intraoperative;D016343
E04.510;Monitoring, Intraoperative;D016343
N03.219.521.346.506.564.663.500;Medicare Part A;D016344
N03.219.521.576.343.840.725;Medicare Part A;D016344
N03.706.615.698;Medicare Part A;D016344
N03.219.521.346.506.564.663.515;Medicare Part B;D016345
N03.219.521.576.343.840.754;Medicare Part B;D016345
N03.706.615.699;Medicare Part B;D016345
D12.776.964.775.468;Gene Products, vif;D016346
D12.776.964.925.875;Gene Products, vif;D016346
E05.318.308.940.968.625;Medical Records Systems, Computerized;D016347
L01.280.900.968.775;Medical Records Systems, Computerized;D016347
L01.700.508.300.695;Medical Records Systems, Computerized;D016347
N04.452.859.564.650;Medical Records Systems, Computerized;D016347
N05.715.360.300.715.500.530;Medical Records Systems, Computerized;D016347
N06.850.520.308.940.968.625;Medical Records Systems, Computerized;D016347
G11.427.590.195.140.570;Osseointegration;D016348
G16.100.856.150.150.570;Osseointegration;D016348
G02.111.570.790.709.600.040.520;Leucine Zippers;D016350
N02.278.825.375;Group Homes;D016352
E01.370.600.750;Self-Examination;D016353
F01.145.488.700;Self-Examination;D016353
B03.440.623.225;Rhodobacter capsulatus;D016354
B03.660.050.750.700.225;Rhodobacter capsulatus;D016354
G05.360.340.024.340.425.416;Genes, pX;D016355
G05.360.340.024.340.490.735;Genes, pX;D016355
G05.360.340.400.500.735;Genes, pX;D016355
D12.776.624.664.520.750.480;Gene Products, tax;D016356
D12.776.964.700.750.480;Gene Products, tax;D016356
D12.776.964.775.750.480;Gene Products, tax;D016356
D12.776.964.925.984.410;Gene Products, tax;D016356
M01.526.485.490;Infection Control Practitioners;D016357
N02.360.490;Infection Control Practitioners;D016357
E05.318.270;Contact Tracing;D016358
N06.850.520.270;Contact Tracing;D016358
N06.850.780.200.225;Contact Tracing;D016358
B03.300.390.400.200.250;Clostridium difficile;D016360
B03.510.415.400.200.250;Clostridium difficile;D016360
N03.219.463.045;Bankruptcy;D016361
E03.091.110;Analgesia, Obstetrical;D016362
N03.706.615.100;Antitrust Laws;D016363
G05.360.335.760;Reading Frames;D016364
I01.880.604.583.490;Liability, Legal;D016365
N03.706.535.547;Liability, Legal;D016365
G05.360.335.760.640;Open Reading Frames;D016366
G05.360.340.024.340.137.650;Open Reading Frames;D016366
B04.280.065;Baculoviridae;D016367
B04.525.100;Baculoviridae;D016367
G05.365.590.265;Frameshift Mutation;D016368
C07.793.208.688;Smear Layer;D016369
D12.776.624.664.520.750.470;Gene Products, rex;D016370
D12.776.964.700.750.470;Gene Products, rex;D016370
D12.776.964.775.750.470;Gene Products, rex;D016370
D12.776.964.925.750;Gene Products, rex;D016370
E02.815.190;Cranial Irradiation;D016371
D13.150.650;RNA, Antisense;D016372
D13.444.600.150.760;RNA, Antisense;D016372
D13.444.735.150;RNA, Antisense;D016372
D27.720.470.530.600.150.760;RNA, Antisense;D016372
D13.150.200;DNA, Antisense;D016373
D13.444.308.150;DNA, Antisense;D016373
D13.444.600.150.200;DNA, Antisense;D016373
D27.720.470.530.600.150.200;DNA, Antisense;D016373
D12.776.624.664.520.750.875;Oncogene Proteins v-abl;D016374
D12.776.964.700.750.875;Oncogene Proteins v-abl;D016374
D12.776.964.775.750.875;Oncogene Proteins v-abl;D016374
D13.150;Antisense Elements (Genetics);D016375
D13.444.600.150;Antisense Elements (Genetics);D016375
D27.720.470.530.600.150;Antisense Elements (Genetics);D016375
D13.150.480;Oligonucleotides, Antisense;D016376
D13.444.600.150.640;Oligonucleotides, Antisense;D016376
D13.695.578.424.480;Oligonucleotides, Antisense;D016376
D27.720.470.530.600.150.640;Oligonucleotides, Antisense;D016376
E04.936.450;Organ Transplantation;D016377
E04.936.580;Tissue Transplantation;D016378
E06.780.345.760.433.271.260;Denture, Partial, Fixed, Resin-Bonded;D016379
E07.695.190.200.220.220.220;Denture, Partial, Fixed, Resin-Bonded;D016379
E04.525.090;Brain Tissue Transplantation;D016380
E04.936.580.090;Brain Tissue Transplantation;D016380
E04.270.550;Islets of Langerhans Transplantation;D016381
E04.936.225.375;Islets of Langerhans Transplantation;D016381
E05.320.274;Orthodontic Appliance Design;D016382
E06.658.450;Orthodontic Appliance Design;D016382
E06.912.675;Orthodontic Appliance Design;D016382
G02.111.570.580.175;Consensus Sequence;D016384
G02.111.570.080.689.675.850;TATA Box;D016385
G05.360.080.689.675.850;TATA Box;D016385
G05.360.340.024.340.137.750.680.850;TATA Box;D016385
E05.393.183.250;Chromosome Walking;D016386
N01.400.900;Women's Health;D016387
C07.465.714.804;Tooth Loss;D016388
C07.793.870;Tooth Loss;D016388
H02.478.676.390;Maternal-Child Nursing;D016389
N02.421.533.460;Maternal-Child Nursing;D016389
H02.010;Allied Health Occupations;D016390
G05.360.340.024.340.375.500.791.570;Genes, src;D016391
D08.811.913.696.620.682.725.800.630;Proto-Oncogene Proteins pp60(c-src);D016392
D12.776.624.664.700.202;Proto-Oncogene Proteins pp60(c-src);D016392
C04.557.386.480.150;Lymphoma, B-Cell;D016393
C15.604.515.569.480.150;Lymphoma, B-Cell;D016393
C20.683.515.761.480.150;Lymphoma, B-Cell;D016393
C04.557.386.480.750;Lymphoma, T-Cell;D016399
C15.604.515.569.480.750;Lymphoma, T-Cell;D016399
C20.683.515.761.480.750;Lymphoma, T-Cell;D016399
C04.557.386.480.493;Lymphoma, Large-Cell, Immunoblastic;D016400
C15.604.515.569.480.493;Lymphoma, Large-Cell, Immunoblastic;D016400
C20.683.515.761.480.487;Lymphoma, Large-Cell, Immunoblastic;D016400
C04.557.386.480.150.585;Lymphoma, Large B-Cell, Diffuse;D016403
C15.604.515.569.480.150.585;Lymphoma, Large B-Cell, Diffuse;D016403
C20.683.515.761.480.150.585;Lymphoma, Large B-Cell, Diffuse;D016403
C04.557.386.480.750.800;Lymphoma, T-Cell, Cutaneous;D016410
C15.604.515.569.480.750.800;Lymphoma, T-Cell, Cutaneous;D016410
C20.683.515.761.480.750.800;Lymphoma, T-Cell, Cutaneous;D016410
C04.557.386.480.750.825;Lymphoma, T-Cell, Peripheral;D016411
C15.604.515.569.480.750.825;Lymphoma, T-Cell, Peripheral;D016411
C20.683.515.761.480.750.825;Lymphoma, T-Cell, Peripheral;D016411
E02.365.647.740;Resuscitation Orders;D016414
E02.760.905.700;Resuscitation Orders;D016414
I01.880.604.583.789;Resuscitation Orders;D016414
N02.421.585.905.700;Resuscitation Orders;D016414
N03.706.535.704;Resuscitation Orders;D016414
E05.393.751;Sequence Alignment;D016415
V02.650;Meeting Abstracts;D016416
V01.165;Bibliography;D016417
V02.165;Bibliography;D016417
V02.610;Legal Cases;D016418
V02.255;Classical Article;D016419
V02.530.250;Classical Article;D016419
V01.205;Comment;D016420
V02.267;Comment;D016420
V01.250;Editorial;D016421
V02.335;Editorial;D016421
V01.550;Letter;D016422
V02.355.374;Letter;D016422
V02.625;Letter;D016422
V02.270;Congresses;D016423
V02.270.500;Overall;D016424
V02.672;Overall;D016424
V01.700;Published Erratum;D016425
V02.737;Published Erratum;D016425
V03.800;Scientific Integrity Review;D016426
V02.935;Technical Report;D016427
V02.600;Journal Article;D016428
V03.150;Clinical Conference;D016429
V03.200;Clinical Trial;D016430
V02.515;Guideline;D016431
V01.630;News;D016433
V02.665;News;D016433
V02.312;Directory;D016435
V02.310;Dictionary;D016437
V02.320;Duplicate Publication;D016438
V02.275;Corrected and Republished Article;D016439
V01.775;Retraction of Publication;D016440
V02.825;Retraction of Publication;D016440
V02.800;Retracted Publication;D016441
V02.912.500;Consensus Development Conference;D016446
V03.300;Consensus Development Conference;D016446
V02.912.500.500;Consensus Development Conference, NIH;D016447
V03.300.300;Consensus Development Conference, NIH;D016447
V03.200.600;Multicenter Study;D016448
V03.650;Multicenter Study;D016448
V03.200.700;Randomized Controlled Trial;D016449
V02.682;Periodical Index;D016453
V02.600.500;Review;D016454
V02.912;Review;D016454
V02.530;Historical Article;D016456
C01.539.685;Prosthesis-Related Infections;D016459
C23.550.767.868;Prosthesis-Related Infections;D016459
C17.300.200.495.380;Granuloma Annulare;D016460
C17.800.550.380;Granuloma Annulare;D016460
C23.550.382.375;Granuloma Annulare;D016460
E02.520.360.150;Chemoembolization, Therapeutic;D016461
E02.926.500.150;Chemoembolization, Therapeutic;D016461
E02.218.565;Mammaplasty;D016462
E04.680.500;Mammaplasty;D016462
C17.800.229.800;Sweet Syndrome;D016463
C16.320.565.595;Lysosomal Storage Diseases;D016464
C18.452.648.595;Lysosomal Storage Diseases;D016464
E02.120.142;Bone Marrow Purging;D016465
A11.251.210.200;CHO Cells;D016466
A11.436.155;CHO Cells;D016466
V02.660;Monograph;D016467
J01.576.430;Forestry;D016468
C01.539.757.360;Fungemia;D016469
C01.703.360;Fungemia;D016469
C23.550.470.790.500.360;Fungemia;D016469
C01.252.100;Bacteremia;D016470
C01.539.757.100;Bacteremia;D016470
C23.550.470.790.500.100;Bacteremia;D016470
C13.351.500.056.630.642;Ovarian Hyperstimulation Syndrome;D016471
C19.391.630.642;Ovarian Hyperstimulation Syndrome;D016471
C10.574.562;Motor Neuron Disease;D016472
C10.668.467;Motor Neuron Disease;D016472
G10.261.326.300;Gallbladder Emptying;D016473
G01.374.676.965;Weight-Bearing;D016474
G01.595.540.965;Weight-Bearing;D016474
A11.251.210.700;3T3 Cells;D016475
A11.329.228.900;3T3 Cells;D016475
A10.850.750;Urinary Reservoirs, Continent;D016476
E07.862.750;Urinary Reservoirs, Continent;D016476
E05.047;Artifacts;D016477
B03.440.500.550;Helicobacter pylori;D016480
B03.660.150.280.550;Helicobacter pylori;D016480
C01.252.400.466;Helicobacter Infections;D016481
E01.370.225.124.810;Urinalysis;D016482
E01.370.390.810;Urinalysis;D016482
E05.200.124.810;Urinalysis;D016482
C04.557.386.480.150.450;Lymphoma, AIDS-Related;D016483
C15.604.515.569.480.150.450;Lymphoma, AIDS-Related;D016483
C20.683.515.761.480.150.450;Lymphoma, AIDS-Related;D016483
I01.880.735.580;Needle Sharing;D016485
F01.829.263.370.310;Parenting;D016487
E02.190.488.505;Medicine, African Traditional;D016488
E02.190.901.433;Medicine, African Traditional;D016488
I01.076.201.450.654.505;Medicine, African Traditional;D016488
C10.900.300.350;Head Injuries, Closed;D016489
C26.260.382;Head Injuries, Closed;D016489
C26.915.300.450;Head Injuries, Closed;D016489
C26.974.382;Head Injuries, Closed;D016489
L01.700.508.300.420;Integrated Advanced Information Management Systems;D016490
C14.907.617;Peripheral Vascular Diseases;D016491
L01.209;Computer Security;D016494
N04.452.910.200;Computer Security;D016494
I01.880.604.646;Police;D016495
M01.526.373.750;Police;D016495
M01.526.760;Police;D016495
E07.325.068.500;Incontinence Pads;D016496
N02.421.044;Adolescent Health Services;D016497
E02.095.465.425.750;Radioimmunotherapy;D016499
E02.186.750;Radioimmunotherapy;D016499
E02.815.520;Radioimmunotherapy;D016499
E02.190.888.249;Color Therapy;D016500
E02.774.215;Color Therapy;D016500
F04.754.215;Color Therapy;D016500
A08.663.256.500;Neurites;D016501
A08.663.542.145.500;Neurites;D016501
A11.284.180.610;Neurites;D016501
A11.671.543;Neurites;D016501
E02.319.300;Drug Delivery Systems;D016503
E01.370.600.750.100;Breast Self-Examination;D016504
F01.145.488.700.100;Breast Self-Examination;D016504
C16.320.850.700;Pemphigus, Benign Familial;D016506
C17.800.827.700;Pemphigus, Benign Familial;D016506
C17.800.865.858;Pemphigus, Benign Familial;D016506
N02.278.354.422.215;Cardiology Service, Hospital;D016507
N04.452.442.422.215;Cardiology Service, Hospital;D016507
E01.370.225.812.735.850.200;Fluorescent Treponemal Antibody-Absorption Test;D016508
E05.200.812.735.850.200;Fluorescent Treponemal Antibody-Absorption Test;D016508
E05.478.594.760.850.200;Fluorescent Treponemal Antibody-Absorption Test;D016508
C11.204.290;Corneal Neovascularization;D016510
C16.614.815;Severe Combined Immunodeficiency;D016511
C18.452.284.800;Severe Combined Immunodeficiency;D016511
C20.673.815;Severe Combined Immunodeficiency;D016511
C26.558.100;Ankle Injuries;D016512
B01.050.150.900.649.865.635.505.500.550.780;Mice, SCID;D016513
G05.360.340.024.340.375.249.340;Genes, Neurofibromatosis 1;D016514
G05.360.340.024.340.415.400.340;Genes, Neurofibromatosis 1;D016514
G05.360.340.024.340.375.249.345;Genes, Neurofibromatosis 2;D016515
G05.360.340.024.340.415.400.345;Genes, Neurofibromatosis 2;D016515
E01.370.225.500.195.107.595.500.150.160;CD4-CD8 Ratio;D016516
E01.370.225.625.107.595.500.150.160;CD4-CD8 Ratio;D016516
E05.200.500.195.107.595.500.150.160;CD4-CD8 Ratio;D016516
E05.200.625.107.595.500.150.160;CD4-CD8 Ratio;D016516
E05.242.195.107.595.500.150.160;CD4-CD8 Ratio;D016516
G04.170.107.595.500.150.160;CD4-CD8 Ratio;D016516
G09.188.105.595.500.150.160;CD4-CD8 Ratio;D016516
G12.248;CD4-CD8 Ratio;D016516
C04.557.465.625.650.595.610.500;Neurofibromatosis 2;D016518
C04.557.580.600.580.590.655;Neurofibromatosis 2;D016518
C04.557.580.600.610.595.610.500;Neurofibromatosis 2;D016518
C04.700.645.655;Neurofibromatosis 2;D016518
C09.218.807.800.675.500;Neurofibromatosis 2;D016518
C09.647.675.500;Neurofibromatosis 2;D016518
C10.292.225.750.500;Neurofibromatosis 2;D016518
C10.292.910.600.500;Neurofibromatosis 2;D016518
C10.562.600.750;Neurofibromatosis 2;D016518
C10.574.500.549.700;Neurofibromatosis 2;D016518
C16.320.400.560.700;Neurofibromatosis 2;D016518
C16.320.700.645.655;Neurofibromatosis 2;D016518
N02.278.421.481.600;Hospitals, Religious;D016519
J01.219.375;Entrepreneurship;D016520
N04.452.610.250;Entrepreneurship;D016520
E05.196.401.220;Electrophoresis, Gel, Pulsed-Field;D016521
E05.301.300.220;Electrophoresis, Gel, Pulsed-Field;D016521
N02.278.354.422.513;Oncology Service, Hospital;D016522
N04.452.442.422.513;Oncology Service, Hospital;D016522
C17.800.321.250;Foot Ulcer;D016523
C17.800.893.592.450;Foot Ulcer;D016523
N01.824.417.700.162.500;Parental Leave;D016524
N04.452.677.800.162.500;Parental Leave;D016524
G12.425.143.140;Antigenic Modulation;D016525
N04.452.677.950;Workload;D016526
N03.219.151.400.350;Drug Costs;D016527
N05.300.375.300;Drug Costs;D016527
H02.478.676.650.650;Postanesthesia Nursing;D016528
N02.421.533.710.650;Postanesthesia Nursing;D016528
H02.478.676.200;Emergency Nursing;D016529
N02.421.533.200;Emergency Nursing;D016529
H02.478.676.615;Orthopedic Nursing;D016530
N02.421.533.635;Orthopedic Nursing;D016530
C10.597.606.643.455.750;Mucopolysaccharidosis II;D016532
C16.320.322.500.750;Mucopolysaccharidosis II;D016532
C16.320.400.525.750;Mucopolysaccharidosis II;D016532
C16.320.565.202.715.645;Mucopolysaccharidosis II;D016532
C16.320.565.595.600.645;Mucopolysaccharidosis II;D016532
C17.300.550.575.645;Mucopolysaccharidosis II;D016532
C18.452.648.202.715.645;Mucopolysaccharidosis II;D016532
C18.452.648.595.600.645;Mucopolysaccharidosis II;D016532
E01.370.225.875.610;Mycological Typing Techniques;D016533
E05.200.875.610;Mycological Typing Techniques;D016533
C14.280.142;Cardiac Output, High;D016534
C23.888.176;Cardiac Output, High;D016534
C08.127.210;Bronchial Hyperreactivity;D016535
N03.219.521.576.343.800.175;Competitive Medical Plans;D016536
N04.590.374.410.175;Competitive Medical Plans;D016536
C10.228.140.163.100.435.825.300.400;Gangliosidosis, GM1;D016537
C16.320.565.189.435.825.300.400;Gangliosidosis, GM1;D016537
C16.320.565.398.641.803.350.360;Gangliosidosis, GM1;D016537
C16.320.565.595.554.825.300.400;Gangliosidosis, GM1;D016537
C18.452.132.100.435.825.300.400;Gangliosidosis, GM1;D016537
C18.452.584.687.803.350.360;Gangliosidosis, GM1;D016537
C18.452.648.189.435.825.300.400;Gangliosidosis, GM1;D016537
C18.452.648.398.641.803.350.360;Gangliosidosis, GM1;D016537
C18.452.648.595.554.825.300.400;Gangliosidosis, GM1;D016537
C16.320.565.202.715.675;Mucopolysaccharidosis VII;D016538
C16.320.565.595.600.675;Mucopolysaccharidosis VII;D016538
C17.300.550.575.675;Mucopolysaccharidosis VII;D016538
C18.452.648.202.715.675;Mucopolysaccharidosis VII;D016538
C18.452.648.595.600.675;Mucopolysaccharidosis VII;D016538
A11.828;Reed-Sternberg Cells;D016539
F01.145.940.700;Smoking Cessation;D016540
M01.526.070.490.490.100;Chief Executive Officers, Hospital;D016542
M01.526.485.430.490.100;Chief Executive Officers, Hospital;D016542
M01.526.485.740.380.100;Chief Executive Officers, Hospital;D016542
N02.360.430.490.100;Chief Executive Officers, Hospital;D016542
N02.360.740.380.100;Chief Executive Officers, Hospital;D016542
C04.588.614.250;Central Nervous System Neoplasms;D016543
C10.551.240;Central Nervous System Neoplasms;D016543
I02.903.525;Patient Simulation;D016544
C04.588.614.250.195.205.200;Choroid Plexus Neoplasms;D016545
C10.228.140.211.280.300;Choroid Plexus Neoplasms;D016545
C10.551.240.250.200.200;Choroid Plexus Neoplasms;D016545
D08.811.277.040.025.193.500;Kinesin;D016547
D12.776.220.600.450.450;Kinesin;D016547
D12.776.641.560.450;Kinesin;D016547
A08.186.211.730;Prosencephalon;D016548
I01.409.137.500.600.650.825;United States Indian Health Service;D016549
N03.540.348.500.500.600.650.825;United States Indian Health Service;D016549
N02.278.080;Birthing Centers;D016550
E05.333;Ergometry;D016552
C15.378.100.802.687.600;Purpura, Thrombocytopenic, Idiopathic;D016553
C15.378.140.855.925.750.600;Purpura, Thrombocytopenic, Idiopathic;D016553
C15.378.463.740;Purpura, Thrombocytopenic, Idiopathic;D016553
C20.111.759;Purpura, Thrombocytopenic, Idiopathic;D016553
C20.841.600;Purpura, Thrombocytopenic, Idiopathic;D016553
C23.550.414.950.687.600;Purpura, Thrombocytopenic, Idiopathic;D016553
C23.888.885.687.687.600;Purpura, Thrombocytopenic, Idiopathic;D016553
E05.318.740.475;Matched-Pair Analysis;D016555
E05.318.780.485;Matched-Pair Analysis;D016555
N05.715.360.750.500;Matched-Pair Analysis;D016555
N05.715.360.780.500;Matched-Pair Analysis;D016555
N06.850.520.445.485;Matched-Pair Analysis;D016555
N06.850.520.830.475;Matched-Pair Analysis;D016555
E06.323.115;Crown Lengthening;D016556
E06.658.578.099;Crown Lengthening;D016556
E04.680.300.500;Guided Tissue Regeneration, Periodontal;D016557
E06.645.410;Guided Tissue Regeneration, Periodontal;D016557
E06.721.485;Guided Tissue Regeneration, Periodontal;D016557
E02.520.425;Hemostasis, Endoscopic;D016558
D02.540.505.810;Tacrolimus;D016559
E02.421.505.550.565;Parenteral Nutrition, Home Total;D016562
E02.421.505.575.565;Parenteral Nutrition, Home Total;D016562
E02.642.500.505.550.565;Parenteral Nutrition, Home Total;D016562
E02.642.500.505.750.565;Parenteral Nutrition, Home Total;D016562
N02.421.143.524.650.565;Parenteral Nutrition, Home Total;D016562
B04.820.455.300;Filoviridae;D016563
B04.909.777.455.300;Filoviridae;D016563
D12.776.049.407.249;Amyloid beta-Protein Precursor;D016564
D12.776.543.039;Amyloid beta-Protein Precursor;D016564
D12.776.645.468.500;Amyloid beta-Protein Precursor;D016564
D12.776.811.050;Amyloid beta-Protein Precursor;D016564
B01.050.150.900.649.801.700.200;Cheirogaleidae;D016565
D02.712;Organoselenium Compounds;D016566
D02.886.675.500;Nizatidine;D016567
D03.383.129.708.500;Nizatidine;D016567
D26.360;Drugs, Generic;D016568
C11.250.090;Blepharophimosis;D016569
C11.338.190;Blepharophimosis;D016569
C16.131.384.190;Blepharophimosis;D016569
A09.371.894.223.250;Bruch Membrane;D016570
A10.272.220.250;Bruch Membrane;D016570
A10.615.179.250;Bruch Membrane;D016570
G17.485;Neural Networks (Computer);D016571
L01.224.065.605;Neural Networks (Computer);D016571
L01.725.500;Neural Networks (Computer);D016571
D04.345.566.235.300;Cyclosporine;D016572
D12.644.641.235.300;Cyclosporine;D016572
D27.720.031;Agrochemicals;D016573
F03.600.300.700;Seasonal Affective Disorder;D016574
C17.800.946.315;Hidradenitis;D016575
D03.438.810.835.322.186.400;Fleroxacin;D016576
E04.210.760;Pancreaticoduodenectomy;D016577
D02.145.074.722.388.250;Crack Cocaine;D016578
D03.132.889.354.250;Crack Cocaine;D016578
D03.605.869.388.250;Crack Cocaine;D016578
D04.075.080.875.099.722.388.250;Crack Cocaine;D016578
D26.878.250;Crack Cocaine;D016578
C02.782.815.622;Leukemia, Feline;D016582
C04.557.337.385;Leukemia, Feline;D016582
C22.180.500;Leukemia, Feline;D016582
C02.782.815.200.260;Enzootic Bovine Leukosis;D016583
C04.557.337.100;Enzootic Bovine Leukosis;D016583
C20.673.483.260;Enzootic Bovine Leukosis;D016583
C22.196.260;Enzootic Bovine Leukosis;D016583
F03.080.700;Panic Disorder;D016584
C01.252.954;Vaginosis, Bacterial;D016585
C13.351.500.894.906.800;Vaginosis, Bacterial;D016585
C04.557.450.590.350;Granular Cell Tumor;D016586
D27.505.696.706.080;Antimutagenic Agents;D016587
D27.720.799.042;Antimutagenic Agents;D016587
D27.505.696.706.018;Anticarcinogenic Agents;D016588
D27.505.954.248.125;Anticarcinogenic Agents;D016588
D27.720.799.018;Anticarcinogenic Agents;D016588
D03.438.103.105;Astemizole;D016589
D02.455.849.291.075;Aphidicolin;D016590
E01.370.225.500.620;Histocytological Preparation Techniques;D016591
E01.370.225.750.600;Histocytological Preparation Techniques;D016591
E05.200.500.620;Histocytological Preparation Techniques;D016591
E05.200.750.600;Histocytological Preparation Techniques;D016591
D02.455.426.559.389.115.800;Terfenadine;D016593
D03.383.621.855;Terfenadine;D016593
D10.251.355.255.550.700.450.500;Misoprostol;D016595
D23.469.700.660.500;Misoprostol;D016595
D12.776.220.990;Vinculin;D016596
D03.438.786.925;Trimetrexate;D016597
D12.776.157.725;RNA-Binding Proteins;D016601
D12.776.664.962;RNA-Binding Proteins;D016601
C26.986.950.500;Needlestick Injuries;D016602
C05.651.290;Eosinophilia-Myalgia Syndrome;D016603
C10.668.491.387;Eosinophilia-Myalgia Syndrome;D016603
C15.378.553.231.335;Eosinophilia-Myalgia Syndrome;D016603
D03.438.150.119.075;Aflatoxin B1;D016604
D03.830.219.119.075;Aflatoxin B1;D016604
D23.946.587.142.075;Aflatoxin B1;D016604
C04.588.322.894.800;Thyroid Nodule;D016606
C04.588.443.915.800;Thyroid Nodule;D016606
C19.344.894.800;Thyroid Nodule;D016606
C19.874.788.800;Thyroid Nodule;D016606
D03.438.150.119.100;Aflatoxin M1;D016607
D03.830.219.119.100;Aflatoxin M1;D016607
D23.946.587.142.100;Aflatoxin M1;D016607
D12.776.220.985;Talin;D016608
C04.692;Neoplasms, Second Primary;D016609
E01.370.225.500.620.720;Tissue Embedding;D016610
E01.370.225.750.600.720;Tissue Embedding;D016610
E05.200.500.620.720;Tissue Embedding;D016610
E05.200.750.600.720;Tissue Embedding;D016610
E01.370.225.500.620.720.610;Paraffin Embedding;D016612
E01.370.225.750.600.720.610;Paraffin Embedding;D016612
E05.200.500.620.720.610;Paraffin Embedding;D016612
E05.200.750.600.720.610;Paraffin Embedding;D016612
E01.370.225.500.620.720.640;Plastic Embedding;D016613
E01.370.225.750.600.720.640;Plastic Embedding;D016613
E05.200.500.620.720.640;Plastic Embedding;D016613
E05.200.750.600.720.640;Plastic Embedding;D016613
A11.284.430.106.279.345.190.160.845;Telomere;D016615
G05.360.160.845;Telomere;D016615
E01.370.225.500.620.530.160;Cryoultramicrotomy;D016616
E01.370.225.750.600.530.160;Cryoultramicrotomy;D016616
E05.200.500.620.530.160;Cryoultramicrotomy;D016616
E05.200.750.600.530.160;Cryoultramicrotomy;D016616
D10.251.355.255.550.700.450.350;Enprostil;D016620
D23.469.700.660.250;Enprostil;D016620
E01.370.225.500.620.670.780;Silver Staining;D016622
E01.370.225.750.600.670.780;Silver Staining;D016622
E05.200.500.620.670.780;Silver Staining;D016622
E05.200.750.600.670.780;Silver Staining;D016622
D12.776.157.530.450;Ion Pumps;D016623
D12.776.543.585.450;Ion Pumps;D016623
E01.370.225.500.620.670.520;Negative Staining;D016624
E01.370.225.750.600.670.520;Negative Staining;D016624
E05.200.500.620.670.520;Negative Staining;D016624
E05.200.750.600.670.520;Negative Staining;D016624
E01.370.225.500.620.670.770;Shadowing (Histology);D016626
E01.370.225.750.600.670.770;Shadowing (Histology);D016626
E05.200.500.620.670.770;Shadowing (Histology);D016626
E05.200.750.600.670.770;Shadowing (Histology);D016626
D02.092.311.342.478.650;Oxidopamine;D016627
E01.370.225.500.620.620;Replica Techniques;D016628
E01.370.225.750.600.620;Replica Techniques;D016628
E05.200.500.620.620;Replica Techniques;D016628
E05.200.750.600.620;Replica Techniques;D016628
E04.210.346;Esophagectomy;D016629
D10.251.355.255.550.700.450.750;Rioprostil;D016630
D23.469.700.660.750;Rioprostil;D016630
A08.663.460;Lewy Bodies;D016631
A11.284.420.460;Lewy Bodies;D016631
A11.671.460;Lewy Bodies;D016631
D10.532.091.200.100;Apolipoprotein A-I;D016632
D12.776.070.400.200.100;Apolipoprotein A-I;D016632
D12.776.521.120.200.100;Apolipoprotein A-I;D016632
D10.532.091.200.150;Apolipoprotein A-II;D016633
D12.776.070.400.200.150;Apolipoprotein A-II;D016633
D12.776.521.120.200.150;Apolipoprotein A-II;D016633
E02.815.530;Radiosurgery;D016634
E04.525.800.650;Radiosurgery;D016634
E05.873.500;Radiosurgery;D016634
N06.850.780.200.925;Universal Precautions;D016635
L01.178.847.606;Telefacsimile;D016636
L01.240.950;Telefacsimile;D016636
C23.550.291.625;Critical Illness;D016638
E04.540.825.968;Scleroplasty;D016639
E04.680.700;Scleroplasty;D016639
C13.703.170;Diabetes, Gestational;D016640
C18.452.394.750.448;Diabetes, Gestational;D016640
C19.246.200;Diabetes, Gestational;D016640
D02.522.818.110;Bupropion;D016642
C10.228.228.800.260;Encephalopathy, Bovine Spongiform;D016643
C10.574.843.300;Encephalopathy, Bovine Spongiform;D016643
C22.196.250;Encephalopathy, Bovine Spongiform;D016643
D02.455.326.271.665.202.868.249;Canthaxanthin;D016644
D02.455.426.392.368.367.379.249.887.249;Canthaxanthin;D016644
D02.455.849.131.868.249;Canthaxanthin;D016644
D23.767.261.887.249;Canthaxanthin;D016644
B01.050.150.900.649.801.400.600.037;Aotidae;D016645
B01.050.150.900.649.801.400.600.150.120;Cebinae;D016646
B01.050.150.900.649.801.400.600.150.150.105;Callimico;D016647
B01.050.150.900.649.801.400.600.150.710;Saimirinae;D016648
C13.351.500.056.630.750;Primary Ovarian Insufficiency;D016649
C19.391.630.750;Primary Ovarian Insufficiency;D016649
D02.455.426.559.847.885.347.400;Fluorescein-5-isothiocyanate;D016650
D02.500.375.250;Fluorescein-5-isothiocyanate;D016650
D02.886.250.250;Fluorescein-5-isothiocyanate;D016650
D03.494.953.275.400;Fluorescein-5-isothiocyanate;D016650
D04.615.885.347.400;Fluorescein-5-isothiocyanate;D016650
D01.045.125.500;Lithium Carbonate;D016651
D01.200.275.150.550;Lithium Carbonate;D016651
D01.510.475;Lithium Carbonate;D016651
G05.360.340.024.340.400;Genes, RAG-1;D016654
D12.776.964.775.350.362.500;HIV Core Protein p24;D016655
D12.776.964.775.562.750.500;HIV Core Protein p24;D016655
D12.776.964.970.600.850.350.362.500;HIV Core Protein p24;D016655
D23.050.327.520.300;HIV Core Protein p24;D016655
I01.655.500.608.200;Family Planning Policy;D016656
I01.880.604.825.608.200;Family Planning Policy;D016656
N03.623.500.608.214;Family Planning Policy;D016656
C10.228.140.300.510.200.200;Cerebral Amyloid Angiopathy;D016657
C14.907.253.560.200.200;Cerebral Amyloid Angiopathy;D016657
C18.452.845.500.100;Cerebral Amyloid Angiopathy;D016657
A02.633.567.825;Psoas Muscles;D016658
C01.539.830.025.700;Psoas Abscess;D016659
D08.811.682.608.800.500;NAD(P)H Dehydrogenase (Quinone);D016660
B01.050.150.900.649.801.400.600.075.050;Alouattinae;D016661
G05.355.930;Virus Integration;D016662
G06.590.875.750;Virus Integration;D016662
G06.920.875.750;Virus Integration;D016662
B01.050.150.900.649.801.400.112.199.120;Cercopithecinae;D016663
B01.050.150.900.649.801.400.112.199.120.120;Cercocebus;D016664
B01.050.150.900.649.801.400.112.199.120.120.110;Cercocebus atys;D016665
D02.092.570.665.250;Fluvoxamine;D016666
A20.186;Bacterial Capsules;D016667
B01.050.150.900.649.801.400.112.199.120.260;Erythrocebus;D016669
D02.078.370.380;Gabexate;D016670
B01.050.150.900.649.801.400.112.199.120.730;Theropithecus;D016671
C23.300.415.625.900;Zenker Diverticulum;D016672
B01.050.150.900.649.801.400.112.199.150;Colobinae;D016673
B01.050.150.900.649.801.400.112.420;Hylobatidae;D016674
B01.050.150.900.649.875;Scandentia;D016675
A11.329.372.600;Macrophages, Alveolar;D016676
A11.627.482.600;Macrophages, Alveolar;D016676
A11.733.397.600;Macrophages, Alveolar;D016676
A15.382.680.397.600;Macrophages, Alveolar;D016676
A15.382.812.522.600;Macrophages, Alveolar;D016676
D02.065.199.920;Tocainide;D016677
G05.360.340;Genome;D016678
G05.360.340.400;Genome, Viral;D016679
G05.360.340.300;Genome, Bacterial;D016680
G05.360.340.325;Genome, Fungal;D016681
D12.776.124.486.485.114.323.210.600;Lupus Coagulation Inhibitor;D016682
D12.776.124.790.651.114.323.210.600;Lupus Coagulation Inhibitor;D016682
D12.776.377.715.548.114.323.210.600;Lupus Coagulation Inhibitor;D016682
D23.113.475;Lupus Coagulation Inhibitor;D016682
G11.427.695.625;Supine Position;D016683
G11.427.695.525;Prone Position;D016684
D02.806.400.249.350;Mitomycin;D016685
D03.383.097.500.350;Mitomycin;D016685
D03.438.473.412.249.350;Mitomycin;D016685
D03.132.716.500;Monocrotaline;D016686
D03.438.772.500;Monocrotaline;D016686
D05.750.728.700;Polydioxanone;D016687
D25.130.650;Polydioxanone;D016687
D25.720.728.700;Polydioxanone;D016687
J01.637.051.130.650;Polydioxanone;D016687
J01.637.051.720.728.700;Polydioxanone;D016687
B01.050.050.157.520.565;Mice, Inbred NOD;D016688
B01.050.050.199.520.520.565;Mice, Inbred NOD;D016688
B01.050.150.900.649.865.635.505.500.400.565;Mice, Inbred NOD;D016688
B01.268.475.868.887.850;Trypanosoma vivax;D016689
D12.776.543.750.705.816.824.830;Receptors, Antigen, T-Cell, gamma-delta;D016692
D12.776.543.750.705.816.824.825;Receptors, Antigen, T-Cell, alpha-beta;D016693
G05.355.330.801.261;Gene Rearrangement, delta-Chain T-Cell Antigen Receptor;D016694
G12.425.742.530.261;Gene Rearrangement, delta-Chain T-Cell Antigen Receptor;D016694
G12.500.349.530.261;Gene Rearrangement, delta-Chain T-Cell Antigen Receptor;D016694
D08.811.913.400;Glycosyltransferases;D016695
C02.256.466.423.733;Herpes Zoster Oticus;D016697
C09.218.513;Herpes Zoster Oticus;D016697
C10.292.300.750;Herpes Zoster Oticus;D016697
D01.695.625.675.650.775.150.900;Technetium Tc 99m Pyrophosphate;D016698
D01.925.925;Technetium Tc 99m Pyrophosphate;D016698
B01.050.150.900.649.801.400.800.500;Tarsiidae;D016699
D02.065.199.385;Encainide;D016700
Z01.058.290.190.375;Guinea;D016701
Z01.058.290.100.300;Equatorial Guinea;D016703
D12.776.641.750;Synapsins;D016704
D12.776.744.840;Synapsins;D016704
C05.550.114.154.870;Still's Disease, Adult-Onset;D016706
C05.799.114.870;Still's Disease, Adult-Onset;D016706
C17.300.775.099.870;Still's Disease, Adult-Onset;D016706
C20.111.199.870;Still's Disease, Adult-Onset;D016706
E01.370.225.500.620.760.720;Tissue Fixation;D016707
E01.370.225.750.600.760.720;Tissue Fixation;D016707
E05.200.500.620.760.720;Tissue Fixation;D016707
E05.200.750.600.760.720;Tissue Fixation;D016707
D12.776.543.488.875;Synaptophysin;D016708
D12.776.543.990.840;Synaptophysin;D016708
D12.776.641.800;Synaptophysin;D016708
D23.101.840.800;Synaptophysin;D016708
I01.076.201.450.654.558.520.967;Yin-Yang;D016709
K01.752.967;Yin-Yang;D016709
C23.550.972;Yin Deficiency;D016710
C23.550.945;Yang Deficiency;D016711
D02.355.291.411.658;Mupirocin;D016712
D03.383.663.555;Mupirocin;D016712
D03.830.555;Mupirocin;D016712
D10.251.536;Mupirocin;D016712
D03.383.621.840;Ritanserin;D016713
D03.383.742.698.700;Ritanserin;D016713
C04.445.435.500;Proteus Syndrome;D016715
C04.651.435.500;Proteus Syndrome;D016715
C05.116.099.750;Proteus Syndrome;D016715
C05.660.585.620;Proteus Syndrome;D016715
C16.131.077.740;Proteus Syndrome;D016715
C16.131.621.585.620;Proteus Syndrome;D016715
A11.251.210.190.750;PC12 Cells;D016716
A11.251.860.180.750;PC12 Cells;D016716
A11.299.500;PC12 Cells;D016716
E04.210.120.850;Sphincterotomy, Endoscopic;D016717
E04.210.240.250.840;Sphincterotomy, Endoscopic;D016717
E04.800.250.250.250.840;Sphincterotomy, Endoscopic;D016717
D10.251.355.096.100;Arachidonic Acid;D016718
D10.251.355.255.100.100;Arachidonic Acid;D016718
D10.251.355.310.166.100;Arachidonic Acid;D016718
E01.370.350.710.710;Radioimmunodetection;D016719
E01.370.384.730.710;Radioimmunodetection;D016719
E05.478.805;Radioimmunodetection;D016719
C01.703.770;Pneumocystis Infections;D016720
B04.820.650.375.525.750;Radiation Leukemia Virus;D016721
B04.909.574.807.375.525.750;Radiation Leukemia Virus;D016721
B04.909.777.731.375.525.750;Radiation Leukemia Virus;D016721
D01.552.033.690.250;Cermet Cements;D016722
D25.058.520.250;Cermet Cements;D016722
D25.339.208.720.250;Cermet Cements;D016722
D25.339.291.402.120;Cermet Cements;D016722
J01.637.051.058.520.250;Cermet Cements;D016722
J01.637.051.339.208.720.250;Cermet Cements;D016722
J01.637.051.339.291.402.120;Cermet Cements;D016722
G11.427.590.195;Bone Remodeling;D016723
G16.100.856.150;Bone Remodeling;D016723
C01.539.739.484;Empyema, Pleural;D016724
C01.539.830.305.310;Empyema, Pleural;D016724
C08.528.240;Empyema, Pleural;D016724
C08.730.265;Empyema, Pleural;D016724
C08.381.600;Plasma Cell Granuloma, Pulmonary;D016726
C11.675.679;Orbital Pseudotumor;D016727
F01.145.126.980;Self-Injurious Behavior;D016728
D06.472.699.327.740.320.400;Leuprolide;D016729
D12.644.400.400.740.320.400;Leuprolide;D016729
D12.644.456.460.480;Leuprolide;D016729
D12.644.548.365.740.320.400;Leuprolide;D016729
D12.776.641.650.405.740.320.400;Leuprolide;D016729
N04.452.760;Program Development;D016730
C02.256.700.300;Erythema Infectiosum;D016731
C02.825.260;Erythema Infectiosum;D016731
C17.800.229.335;Erythema Infectiosum;D016731
C17.800.838.790.260;Erythema Infectiosum;D016731
B04.280.580.650.200.650;Parvovirus B19, Human;D016732
B04.909.204.671.650.200.650;Parvovirus B19, Human;D016732
E06.186.670;Rubber Dams;D016733
E07.222.670;Rubber Dams;D016733
E06.780.345.562;Dental Clasps;D016734
E07.695.190.180;Dental Clasps;D016734
I01.198.240.856.350.250.525;Munchausen Syndrome by Proxy;D016735
I01.880.735.900.350.250.525;Munchausen Syndrome by Proxy;D016735
I01.880.787.293.292.525;Munchausen Syndrome by Proxy;D016735
C20.111.197;Antiphospholipid Syndrome;D016736
E04.210.219.620;Proctocolectomy, Restorative;D016737
C06.130.120.135.250.125;Alagille Syndrome;D016738
C06.552.150.125;Alagille Syndrome;D016738
C14.240.400.044;Alagille Syndrome;D016738
C16.131.077.065;Alagille Syndrome;D016738
C16.131.240.400.044;Alagille Syndrome;D016738
C16.320.051;Alagille Syndrome;D016738
F01.145.527.100.120;Behavior, Addictive;D016739
E02.190.044.555;Meridians;D016740
I01.076.201.450.654.558.520.300.500;Meridians;D016740
E07.695.850;Urinary Sphincter, Artificial;D016741
E07.858.082.900;Urinary Sphincter, Artificial;D016741
E02.760.775;Preconception Care;D016742
N02.421.143.620.620;Preconception Care;D016742
N02.421.585.775;Preconception Care;D016742
N02.421.920.660;Preconception Care;D016742
F01.590;Mental Competency;D016743
F02.410;Mental Competency;D016743
I01.880.604.583.530;Mental Competency;D016743
N03.706.535.625;Mental Competency;D016743
G05.360.340.024.380.750;Minor Lymphocyte Stimulatory Loci;D016744
G12.500.560;Minor Lymphocyte Stimulatory Loci;D016744
E06.721.189.350.650;Root Planing;D016745
E06.721.874.650;Root Planing;D016745
E06.761.227.350.650;Root Planing;D016745
H02.478.676.920;Transcultural Nursing;D016746
D23.050.301.625;Minor Lymphocyte Stimulatory Antigens;D016747
D23.050.820.625;Minor Lymphocyte Stimulatory Antigens;D016747
E04.100.814.895;Venous Cutdown;D016748
L01.470.750.750.600;National Practitioner Data Bank;D016749
L01.700.508.300.188.400.600;National Practitioner Data Bank;D016749
C10.114.812;Stiff-Person Syndrome;D016750
C10.228.854.790;Stiff-Person Syndrome;D016750
C10.668.900;Stiff-Person Syndrome;D016750
C20.111.258.850;Stiff-Person Syndrome;D016750
C02.440.470;Hepatitis E;D016751
C02.782.455;Hepatitis E;D016751
C06.552.380.705.470;Hepatitis E;D016751
B04.450.412;Hepatitis E virus;D016752
B04.820.340.400;Hepatitis E virus;D016752
B04.909.777.420.400;Hepatitis E virus;D016752
D12.644.276.374.465.510;Interleukin-10;D016753
D12.776.467.374.465.510;Interleukin-10;D016753
D23.529.374.465.510;Interleukin-10;D016753
E02.815.722.500.100;Boron Neutron Capture Therapy;D016754
D12.776.260.108.820;Proto-Oncogene Proteins c-jun;D016755
D12.776.624.664.700.182;Proto-Oncogene Proteins c-jun;D016755
D12.776.660.763;Proto-Oncogene Proteins c-jun;D016755
D12.776.930.127.820;Proto-Oncogene Proteins c-jun;D016755
D12.776.124.486.485.114.619.393.536;Immunoglobulins, Intravenous;D016756
D12.776.124.486.485.114.632;Immunoglobulins, Intravenous;D016756
D12.776.124.790.651.114.632;Immunoglobulins, Intravenous;D016756
D12.776.377.715.548.114.632;Immunoglobulins, Intravenous;D016756
C14.280.383.220;Death, Sudden, Cardiac;D016757
C23.550.260.322.250;Death, Sudden, Cardiac;D016757
G05.360.340.024.340.375.500.791.365;Genes, jun;D016758
D12.776.602.500.500.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.624.664.500.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.624.664.520.750.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.964.700.750.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.964.775.350.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.964.775.750.320.700;Oncogene Protein p65(gag-jun);D016759
D12.776.260.108.765;Proto-Oncogene Proteins c-fos;D016760
D12.776.624.664.700.179;Proto-Oncogene Proteins c-fos;D016760
D12.776.660.760;Proto-Oncogene Proteins c-fos;D016760
D12.776.930.127.765;Proto-Oncogene Proteins c-fos;D016760
D12.776.624.664.520.750.887;Oncogene Proteins v-fos;D016761
D12.776.964.700.750.887;Oncogene Proteins v-fos;D016761
D12.776.964.775.750.887;Oncogene Proteins v-fos;D016761
G05.360.340.024.340.375.500.791.330;Genes, fos;D016762
G04.310;Cell Polarity;D016764
B04.820.504.540.150.190;Coronavirus, Feline;D016765
B04.909.777.500.540.150.190;Coronavirus, Feline;D016765
C02.782.600.550.200.360;Feline Infectious Peritonitis;D016766
C22.180.440;Feline Infectious Peritonitis;D016766
C06.130.120.127.500;Caroli Disease;D016767
C06.198.184.500;Caroli Disease;D016767
C16.131.314.184.500;Caroli Disease;D016767
C14.907.355;Embolism and Thrombosis;D016769
C03.752.200;Ciliophora Infections;D016770
C03.752.300.500.400;Leishmaniasis, Cutaneous;D016773
C03.858.560.400;Leishmaniasis, Cutaneous;D016773
C17.800.838.775.560.400;Leishmaniasis, Cutaneous;D016773
C23.996.600.522;Leishmaniasis, Cutaneous;D016773
C03.752.300.500.400.350;Leishmaniasis, Diffuse Cutaneous;D016774
C03.858.560.400.350;Leishmaniasis, Diffuse Cutaneous;D016774
C17.800.838.775.560.400.350;Leishmaniasis, Diffuse Cutaneous;D016774
C03.432.250;Blastocystis Infections;D016776
C03.752.049.250;Blastocystis Infections;D016776
C06.405.469.452.250;Blastocystis Infections;D016776
C03.752.530.650;Malaria, Falciparum;D016778
C03.105.300.500;Malaria, Cerebral;D016779
C03.752.530.620;Malaria, Cerebral;D016779
C03.752.530.650.675;Malaria, Cerebral;D016779
C10.228.228.205.300.500;Malaria, Cerebral;D016779
C03.752.530.700;Malaria, Vivax;D016780
C01.323.800;Toxoplasmosis, Cerebral;D016781
C01.539.830.025.160.800;Toxoplasmosis, Cerebral;D016781
C03.105.300.800;Toxoplasmosis, Cerebral;D016781
C03.752.250.800.250;Toxoplasmosis, Cerebral;D016781
C10.228.140.116.800;Toxoplasmosis, Cerebral;D016781
C10.228.228.090.800;Toxoplasmosis, Cerebral;D016781
C10.228.228.205.300.800;Toxoplasmosis, Cerebral;D016781
B01.043.075;Apicomplexa;D016782
B01.043.075.189.275;Eucoccidiida;D016783
B01.043.075.189.250.150.160.170;Cryptosporidium parvum;D016785
B01.043.075.189.250.250.250.250;Eimeria tenella;D016786
B01.043.075.380;Haemosporida;D016787
B01.043.075.380.611.490;Plasmodium chabaudi;D016788
B01.043.075.380.611.505;Plasmodium cynomolgi;D016789
B01.043.075.380.611.610;Plasmodium knowlesi;D016790
B01.043.075.600;Piroplasmia;D016791
B01.043.075.600.580;Piroplasmida;D016792
B01.043.075.600.580.070.100;Babesia bovis;D016793
B01.043.075.600.580.700;Theileria;D016794
B01.043.075.600.580.700.100;Theileria annulata;D016796
B01.043.075.600.580.700.500;Theileria parva;D016797
B01.043.185;Ciliophora;D016798
B01.043.185.375;Kinetofragminophorea;D016799
B01.043.185.375.650;Trichostomatida;D016800
B01.043.185.375.650.650;Trichostomatina;D016801
B01.043.185.650;Oligohymenophorea;D016802
B01.043.185.650.375;Hymenostomatida;D016803
B01.043.185.650.375.550;Peniculina;D016804
B01.043.185.650.375.550.637.700;Paramecium tetraurelia;D016805
B01.043.185.650.375.750;Tetrahymenina;D016806
B01.043.185.650.375.750.850.875;Tetrahymena thermophila;D016808
B01.043.185.700;Polymenophorea;D016809
B01.043.185.700.400;Hypotrichida;D016810
B01.043.185.700.400.750;Sporadotrichina;D016811
B01.043.185.700.400.750.375;Euplotes;D016812
B01.043.185.700.400.750.600;Oxytricha;D016813
B01.300.360;Microsporidia;D016814
B01.300.360.500;Microsporea;D016815
B01.300.360.500.500;Microsporida;D016816
B01.300.360.500.500.100;Apansporoblastina;D016817
B01.300.360.500.500.100.400;Nosema;D016818
B01.300.360.500.500.100.175;Encephalitozoon;D016819
B01.268.250;Euglenida;D016822
B01.650.940.150.925;Volvocida;D016823
D23.050.705.115;Antigens, Human Platelet;D016824
B01.650.940.150.925.344.650;Chlamydomonas reinhardtii;D016825
D23.050.301.264.035.108;Antigens, CD8;D016827
D23.050.301.264.894.108;Antigens, CD8;D016827
D23.101.100.110.109;Antigens, CD8;D016827
D23.101.100.894.108;Antigens, CD8;D016827
B01.237;Diplomonadida;D016828
B01.237.385.400;Giardia lamblia;D016829
B01.268.475;Kinetoplastida;D016830
B01.268.475.868.110.350;Crithidia fasciculata;D016831
N01.824.245.350;Employment, Supported;D016832
N02.421.784.644.350;Employment, Supported;D016832
B01.268.475.868.887.115;Trypanosoma brucei rhodesiense;D016833
B01.630.800;Trichomonadida;D016834
B01.630.800.849.325;Tritrichomonas foetus;D016835
B01.046.550.200;Dictyosteliida;D016837
B01.046.550.550.600;Physarida;D016838
B01.046.550.550.600.700.550;Physarum polycephalum;D016839
B01.046.500;Lobosea;D016840
B01.046.500.100;Amoebida;D016841
B01.046.500.100.075;Acanthopodina;D016842
B01.046.500.100.200;Blastocystina;D016843
B01.046.500.100.200.200;Blastocystis;D016844
B01.046.500.100.200.200.375;Blastocystis hominis;D016845
B01.046.500.100.700;Tubulina;D016846
B01.046.500.700;Schizopyrenida;D016847
B01.046.500.700.710.375;Naegleria fowleri;D016848
C02.256.466.382.465;Keratitis, Herpetic;D016849
C02.325.465;Keratitis, Herpetic;D016849
C11.204.564.425;Keratitis, Herpetic;D016849
C11.294.800.475;Keratitis, Herpetic;D016849
A09.371.060.217.659;Limbus Corneae;D016850
B04.820.087.640;Orthobunyavirus;D016851
B04.909.777.147.640;Orthobunyavirus;D016851
N01.224.791.400.410;Housing for the Elderly;D016852
N06.230.150.360.260;Housing for the Elderly;D016852
D12.776.124.486.485.114.224.075.570;Muromonab-CD3;D016853
D12.776.124.486.485.114.619.393.570;Muromonab-CD3;D016853
D12.776.124.790.651.114.224.075.570;Muromonab-CD3;D016853
D12.776.124.790.651.114.619.393.570;Muromonab-CD3;D016853
D12.776.377.715.548.114.224.284.570;Muromonab-CD3;D016853
D12.776.377.715.548.114.619.393.570;Muromonab-CD3;D016853
F01.470.132.300;Dental Anxiety;D016854
F01.470.361.300;Dental Anxiety;D016854
B04.820.087.565;Nairovirus;D016855
B04.909.777.147.565;Nairovirus;D016855
B04.820.087.710;Phlebovirus;D016856
B04.909.777.147.710;Phlebovirus;D016856
C23.888.852.614;Hypocapnia;D016857
B03.440.860.580.553.553.315;Mycoplasma fermentans;D016858
D27.505.519.389.480;Lipoxygenase Inhibitors;D016859
D12.644.541.500.697.249;CD4 Immunoadhesins;D016860
D12.776.124.486.485.538.500.249;CD4 Immunoadhesins;D016860
D12.776.124.486.485.680.697.249;CD4 Immunoadhesins;D016860
D12.776.124.790.651.538.500.249;CD4 Immunoadhesins;D016860
D12.776.124.790.651.680.660.249;CD4 Immunoadhesins;D016860
D12.776.377.715.548.538.500.249;CD4 Immunoadhesins;D016860
D12.776.377.715.548.680.660.249;CD4 Immunoadhesins;D016860
D12.776.395.550.200.230;CD4 Immunoadhesins;D016860
D12.776.543.550.200.230;CD4 Immunoadhesins;D016860
D12.776.828.300.200;CD4 Immunoadhesins;D016860
D23.050.301.350.230;CD4 Immunoadhesins;D016860
D27.505.519.389.310;Cyclooxygenase Inhibitors;D016861
D27.505.696.663.850.014.040.500.500;Cyclooxygenase Inhibitors;D016861
D27.505.954.158.030.500;Cyclooxygenase Inhibitors;D016861
C01.252.410.040.552.846.493.400;Tuberculoma, Intracranial;D016862
C01.252.410.040.552.846.570.300;Tuberculoma, Intracranial;D016862
C10.228.228.180.850.400;Tuberculoma, Intracranial;D016862
C01.252.410.090;Bacillaceae Infections;D016863
C04.700.600;Li-Fraumeni Syndrome;D016864
C16.320.700.600;Li-Fraumeni Syndrome;D016864
C18.452.284.520;Li-Fraumeni Syndrome;D016864
B04.800;Reassortant Viruses;D016865
C01.252.400.110;Bacteroidaceae Infections;D016866
G12.470;Immunocompromised Host;D016867
C01.252.400.310.850;Serratia Infections;D016868
C01.252.400.610.850;Ureaplasma Infections;D016869
C01.252.400.625;Neisseriaceae Infections;D016870
C01.252.400.700;Pasteurellaceae Infections;D016871
C01.252.400.054.160;Ehrlichiosis;D016873
C01.252.400.825.200;Ehrlichiosis;D016873
A08.663.609.520;Neurofibrillary Tangles;D016874
A11.284.430.214.190.750.640.520;Neurofibrillary Tangles;D016874
A11.671.573.520;Neurofibrillary Tangles;D016874
D12.776.220.600.450.510;tau Proteins;D016875
D12.776.641.560.510;tau Proteins;D016875
D01.552.033.690;Metal Ceramic Alloys;D016876
D25.058.520;Metal Ceramic Alloys;D016876
D25.339.208.720;Metal Ceramic Alloys;D016876
J01.637.051.058.520;Metal Ceramic Alloys;D016876
J01.637.051.339.208.720;Metal Ceramic Alloys;D016876
D27.720.642;Oxidants;D016877
D27.888.569.540;Oxidants;D016877
C10.668.829.800.700;POEMS Syndrome;D016878
C15.378.147.780.750;POEMS Syndrome;D016878
C16.131.077.703;POEMS Syndrome;D016878
C20.683.780.750;POEMS Syndrome;D016878
E02.186.800;Salvage Therapy;D016879
E02.895;Salvage Therapy;D016879
G01.590.040;Anisotropy;D016880
G02.842.050;Anisotropy;D016880
C01.703.617;Microsporidiosis;D016881
D20.215.894.860.449;ISCOMs;D016882
C18.452.076.176.652.500;Diabetic Ketoacidosis;D016883
C18.452.394.750.535;Diabetic Ketoacidosis;D016883
C19.246.099.812;Diabetic Ketoacidosis;D016883
C19.787;Polyendocrinopathies, Autoimmune;D016884
C20.111.750;Polyendocrinopathies, Autoimmune;D016884
I01.409.137.500.400;United States Department of Agriculture;D016885
N03.540.348.500.500.400;United States Department of Agriculture;D016885
E02.365.647.110;Cardiopulmonary Resuscitation;D016887
C14.907.075;Angiodysplasia;D016888
C04.588.945.418.948.585;Endometrial Neoplasms;D016889
C13.351.500.852.762.200;Endometrial Neoplasms;D016889
C13.351.937.418.875.200;Endometrial Neoplasms;D016889
C01.703.617.300;Encephalitozoonosis;D016890
C12.777.419.403.875.500;Polycystic Kidney, Autosomal Dominant;D016891
C13.351.968.419.403.875.500;Polycystic Kidney, Autosomal Dominant;D016891
C10.228.140.300.200.360;Carotid Stenosis;D016893
C14.907.137.230;Carotid Stenosis;D016893
C14.907.253.123.360;Carotid Stenosis;D016893
E04.100.814.456.250;Endarterectomy, Carotid;D016894
D27.720.470.305.255;Culture Media, Serum-Free;D016895
E07.206.255;Culture Media, Serum-Free;D016895
E01.789.800;Treatment Outcome;D016896
N04.761.559.590.800;Treatment Outcome;D016896
N05.715.360.575.575.800;Treatment Outcome;D016896
G03.495.278.620;Respiratory Burst;D016897
G04.299.305.620;Respiratory Burst;D016897
D12.644.276.374.440.890.250;Interferon-alpha;D016898
D12.644.276.718.500.250;Interferon-alpha;D016898
D12.776.467.374.440.890.250;Interferon-alpha;D016898
D12.776.467.718.500.250;Interferon-alpha;D016898
D23.529.374.440.890.250;Interferon-alpha;D016898
D23.529.718.500.250;Interferon-alpha;D016898
D12.644.276.374.440.890.275;Interferon-beta;D016899
D12.644.276.718.500.275;Interferon-beta;D016899
D12.776.467.374.440.890.275;Interferon-beta;D016899
D12.776.467.718.500.275;Interferon-beta;D016899
D23.529.374.440.890.275;Interferon-beta;D016899
D23.529.718.500.275;Interferon-beta;D016899
D05.750.078.593.630;Neurofilament Proteins;D016900
D12.776.220.475.630;Neurofilament Proteins;D016900
D12.776.641.630;Neurofilament Proteins;D016900
F01.829.263.370.110;Intergenerational Relations;D016901
F01.829.401.190;Intergenerational Relations;D016901
N06.850.460.100.080;Air Pollution, Indoor;D016902
E01.370.520.200;Drug Monitoring;D016903
C01.252.400;Gram-Negative Bacterial Infections;D016905
D12.644.276.374.465.509;Interleukin-9;D016906
D12.776.467.374.465.509;Interleukin-9;D016906
D23.529.374.465.509;Interleukin-9;D016906
E05.337.800.120;Adverse Drug Reaction Reporting Systems;D016907
L01.453.270.120;Adverse Drug Reaction Reporting Systems;D016907
N02.421.668.320.120;Adverse Drug Reaction Reporting Systems;D016907
C01.252.410;Gram-Positive Bacterial Infections;D016908
A07.231.114.895;Tibial Arteries;D016909
E06.658.453.590;Orthodontic Brackets;D016910
F01.470.132.150.500;Koro;D016911
D04.808.668.651.693.762.450;Levonorgestrel;D016912
E02.095.135.140;Blood Component Transfusion;D016913
D08.811.277.352.355.350.700;Ribonuclease H;D016914
D08.811.277.352.700.350.700;Ribonuclease H;D016914
D20.215.894.899.050;AIDS Vaccines;D016915
C05.550.515;Joint Deformities, Acquired;D016916
C01.252.400.126.100.050;Angiomatosis, Bacillary;D016917
C01.252.825.150;Angiomatosis, Bacillary;D016917
C01.539.800.720.150;Angiomatosis, Bacillary;D016917
C14.907.077.060;Angiomatosis, Bacillary;D016917
C17.800.838.765.150;Angiomatosis, Bacillary;D016917
C17.800.862.060;Angiomatosis, Bacillary;D016917
C01.539.100.500;Arthritis, Reactive;D016918
C05.116.900.853.625.800.637;Arthritis, Reactive;D016918
C05.550.114.099.500;Arthritis, Reactive;D016918
C05.550.114.865.800.637;Arthritis, Reactive;D016918
C01.703.181.500.500;Meningitis, Cryptococcal;D016919
C01.703.248.290;Meningitis, Cryptococcal;D016919
C10.228.228.198.500.500;Meningitis, Cryptococcal;D016919
C10.228.228.507.400.500;Meningitis, Cryptococcal;D016919
C01.252.200.500;Meningitis, Bacterial;D016920
C10.228.228.180.500;Meningitis, Bacterial;D016920
C10.228.228.507.280;Meningitis, Bacterial;D016920
C01.703.181.500;Meningitis, Fungal;D016921
C10.228.228.198.500;Meningitis, Fungal;D016921
C10.228.228.507.400;Meningitis, Fungal;D016921
G04.299.119;Cell Aging;D016922
G04.299.139;Cell Death;D016923
B03.510.024.049.050.050.050;Actinomyces viscosus;D016924
B03.510.460.400.400.049.049.178.800;Actinomyces viscosus;D016924
B03.510.024.049.180.600;Corynebacterium pseudotuberculosis;D016925
B03.510.460.400.400.200.600;Corynebacterium pseudotuberculosis;D016925
B03.510.024.049.525.500.720.225;Mycobacterium chelonae;D016926
B03.510.460.400.410.552.552.720.225;Mycobacterium chelonae;D016926
B03.510.024.049.525.500.300.600;Mycobacterium avium subsp. paratuberculosis;D016927
B03.510.460.400.410.552.552.300.600;Mycobacterium avium subsp. paratuberculosis;D016927
B03.510.024.049.537.775.700;Rhodococcus equi;D016929
B03.300.390.400.790;Saccharopolyspora;D016930
B03.510.024.049.750;Saccharopolyspora;D016930
B03.510.415.400.790;Saccharopolyspora;D016930
B03.510.460.410.790;Saccharopolyspora;D016930
B02.200.400;Halobacteriales;D016931
B03.440.400.280;Caulobacter;D016934
B03.440.400.425.288.100;Caulobacter;D016934
B03.660.050.090.100;Caulobacter;D016934
B03.440.400.280.280;Caulobacter crescentus;D016935
B03.440.400.425.288.100.100;Caulobacter crescentus;D016935
B03.660.050.090.100.100;Caulobacter crescentus;D016935
B03.300.390;Gram-Positive Endospore-Forming Bacteria;D016936
B03.510.415;Gram-Positive Endospore-Forming Bacteria;D016936
B03.300.390.400;Gram-Positive Endospore-Forming Rods;D016937
B03.510.415.400;Gram-Positive Endospore-Forming Rods;D016937
B03.510.460.410;Gram-Positive Endospore-Forming Rods;D016937
B03.660.125.500.605;Myxococcus;D016940
B03.660.125.500.605.900;Myxococcus xanthus;D016941
B02.075.725;Sulfolobales;D016942
B02.075.725.725;Sulfolobaceae;D016943
B02.075.725.725.725;Sulfolobus;D016944
B02.075.725.725.725.070;Sulfolobus acidocaldarius;D016945
B03.440.400.425;Gram-Negative Aerobic Rods and Cocci;D016946
B03.440.400.425.100;Acetobacteraceae;D016947
B03.660.050.663.050;Acetobacteraceae;D016947
B03.440.400.425.625.050.850;Azotobacter vinelandii;D016948
B03.660.250.580.022.820;Azotobacter vinelandii;D016948
B03.440.400.425.708.100;Azospirillum;D016949
B03.660.050.663.750.100;Azospirillum;D016949
B03.440.400.425.117.075.200;Bordetella bronchiseptica;D016950
B03.660.075.027.075.050;Bordetella bronchiseptica;D016950
B03.440.400.425.450;Legionellaceae;D016951
B03.660.250.460;Legionellaceae;D016951
B03.440.400.425.450.450.500;Legionella pneumophila;D016952
B03.660.250.460.460.580;Legionella pneumophila;D016952
B03.440.400.425.475;Leptospiraceae;D016953
B03.851.475;Leptospiraceae;D016953
B03.440.400.425.537.050.200;Acinetobacter calcoaceticus;D016954
B03.660.250.530.050.200;Acinetobacter calcoaceticus;D016954
B03.440.400.425.537.525.500;Moraxella (Moraxella) bovis;D016955
B03.660.250.530.525.500;Moraxella (Moraxella) bovis;D016955
B03.440.400.425.251.100.110.500;Burkholderia cepacia;D016956
B03.660.075.077.100.110.500;Burkholderia cepacia;D016956
B03.440.400.425.251.100.600;Burkholderia pseudomallei;D016957
B03.660.075.077.100.600;Burkholderia pseudomallei;D016957
B03.440.400.425.625.625.675;Pseudomonas putida;D016958
B03.660.250.580.590.580;Pseudomonas putida;D016958
B03.440.400.425.967.930.100;Xanthomonas campestris;D016959
B03.660.250.915.930.100;Xanthomonas campestris;D016959
B03.440.400.425.700.024.050;Agrobacterium tumefaciens;D016960
B03.660.050.730.024.500;Agrobacterium tumefaciens;D016960
B03.440.400.425.700.800.450;Rhizobium leguminosarum;D016961
B03.660.050.730.670.450;Rhizobium leguminosarum;D016961
B03.440.400.425.700.887.500;Sinorhizobium meliloti;D016962
B03.660.050.730.835.800;Sinorhizobium meliloti;D016962
B03.440.400.425.875.875;Thermus thermophilus;D016963
B03.440.425.400;Gram-Negative Anaerobic Cocci;D016964
B03.440.425.410;Gram-Negative Anaerobic Straight, Curved, and Helical Rods;D016965
B03.140.094.625.515;Porphyromonas gingivalis;D016966
B03.440.425.410.194.625.515;Porphyromonas gingivalis;D016966
B03.370.250.500;Fusobacterium nucleatum;D016967
B03.440.425.410.420.500;Fusobacterium nucleatum;D016967
B03.440.425.410.875;Wolinella;D016968
B03.660.150.920;Wolinella;D016968
B03.440.425.410.350.875;Desulfovibrio vulgaris;D016969
B03.660.125.125.875;Desulfovibrio vulgaris;D016969
B03.900.350.875;Desulfovibrio vulgaris;D016969
B03.440.450.400;Eikenella;D016970
B03.660.075.525.170;Eikenella;D016970
B03.440.450.425.200.275;Citrobacter freundii;D016971
B03.660.250.150.100.210;Citrobacter freundii;D016971
B03.440.450.425.275.200;Enterobacter cloacae;D016972
B03.660.250.150.170.100;Enterobacter cloacae;D016972
B03.440.450.425.585.120;Pectobacterium carotovorum;D016973
B03.660.250.150.542.120;Pectobacterium carotovorum;D016973
B03.440.450.425.585.150;Pectobacterium chrysanthemi;D016974
B03.660.250.150.542.150;Pectobacterium chrysanthemi;D016974
B03.440.450.467;Gardnerella;D016975
B03.510.024.400;Gardnerella;D016975
B03.440.450.009.050;Actinobacillus actinomycetemcomitans;D016976
B03.660.250.550.050.050;Actinobacillus actinomycetemcomitans;D016976
B03.440.450.009.580;Actinobacillus pleuropneumoniae;D016977
B03.660.250.550.050.580;Actinobacillus pleuropneumoniae;D016977
B03.440.450.600.500.500;Mannheimia haemolytica;D016978
B03.660.250.550.500.500;Mannheimia haemolytica;D016978
B03.440.450.600.600.500;Pasteurella multocida;D016979
B03.660.250.550.590.500;Pasteurella multocida;D016979
B03.440.450.019.025.380;Aeromonas hydrophila;D016980
B03.660.250.017.025.380;Aeromonas hydrophila;D016980
B03.440.450.425.595;Plesiomonas;D016981
B03.660.250.150.550;Plesiomonas;D016981
B03.510.024.049.475.500.500;Micrococcus luteus;D016982
B03.510.400.500.500.400;Micrococcus luteus;D016982
B03.510.550.250.250;Enterococcus;D016983
B03.510.550.250.250.300;Enterococcus faecium;D016984
B03.510.400.800.872.150;Streptococcus bovis;D016985
B03.510.550.737.872.150;Streptococcus bovis;D016985
B03.510.400.800.872.875.750;Streptococcus sobrinus;D016986
B03.510.550.737.872.875.750;Streptococcus sobrinus;D016986
B03.510.460;Gram-Positive Rods;D016987
B03.510.460.400.400;Gram-Positive Asporogenous Rods, Irregular;D016988
B03.510.460.400.410;Gram-Positive Asporogenous Rods, Regular;D016989
B03.440.860.580.553.900.800;Ureaplasma urealyticum;D016990
B03.440.860.300.750;Spiroplasmataceae;D016991
B03.440.623;Rhodobacter;D016992
B03.660.050.750.700;Rhodobacter;D016992
B03.440.190.190.230.249;Chlamydophila pneumoniae;D016993
B03.440.040.287.700;Ehrlichia ruminantium;D016995
B03.660.050.020.287.700;Ehrlichia ruminantium;D016995
B03.440.647.650;Rickettsieae;D016996
B03.660.050.765.650;Rickettsieae;D016996
B03.440.400.425.297.150.100;Coxiella burnetii;D016997
B03.660.250.132.150.100;Coxiella burnetii;D016997
B03.440.500;Helicobacter;D016998
B03.660.150.280;Helicobacter;D016998
B03.900;Sulfur-Reducing Bacteria;D016999
B03.440.180.200;Campylobacter coli;D017000
B03.660.150.100.100;Campylobacter coli;D017000
C07.793.720;Tooth Demineralization;D017001
B04.820.504.540.800;Torovirus;D017003
B04.909.777.500.540.800;Torovirus;D017003
F01.145.194;Codependency (Psychology);D017004
E06.178;Dental Debonding;D017005
A02.633.567.912;Rotator Cuff;D017006
A02.880.700;Rotator Cuff;D017006
F01.829.401.046.800.200;Duty to Warn;D017007
F04.096.544.335.240.270;Duty to Warn;D017007
I01.880.604.583.080.134.800.200;Duty to Warn;D017007
I01.880.604.583.080.270;Duty to Warn;D017007
N03.706.535.230.270;Duty to Warn;D017007
F01.145.209.520;Negotiating;D017008
F01.829.401.520;Negotiating;D017008
F02.463.785.373.520;Negotiating;D017008
L01.143.620;Negotiating;D017008
N04.452.677.430;Negotiating;D017008
N04.452.758.752;Professional Autonomy;D017009
L01.143.820;Reminder Systems;D017010
L01.700.508.300.790;Reminder Systems;D017010
B03.510.400.800.872.750;Streptococcus suis;D017011
B03.510.550.737.872.750;Streptococcus suis;D017011
B02.200.492;Methanobacteriales;D017012
B02.200.492.500;Methanobacteriaceae;D017013
B02.200.492.500.500;Methanobacterium;D017014
B02.200.538;Methanococcales;D017015
B02.200.538.525;Methanococcaceae;D017016
B02.200.538.525.500;Methanococcus;D017017
B02.200.705;Methanomicrobiales;D017018
B02.200.765.550;Methanosarcinaceae;D017019
B02.200.765.550.550;Methanosarcina;D017020
B02.200.765.550.550.200;Methanosarcina barkeri;D017021
E05.196.460;Flow Injection Analysis;D017022
E01.370.350.130.625;Coronary Angiography;D017023
E01.370.350.700.060.200;Coronary Angiography;D017023
E01.370.370.050.200;Coronary Angiography;D017023
E01.370.370.380.200;Coronary Angiography;D017023
E02.186.170;Chemotherapy, Adjuvant;D017024
E02.319.170;Chemotherapy, Adjuvant;D017024
D03.132.830;Swainsonine;D017026
D08.811.277.352.650.775;Protein Tyrosine Phosphatases;D017027
M01.085;Caregivers;D017028
M01.526.485.200;Caregivers;D017028
N02.360.200;Caregivers;D017028
C10.228.140.490.360.260;Epilepsy, Complex Partial;D017029
B03.280.100;Anabaena;D017033
B03.440.475.100.100;Anabaena;D017033
C10.228.140.490.360.270;Epilepsy, Frontal Lobe;D017034
D02.455.426.559.847.638.930;Pravastatin;D017035
D04.615.638.930;Pravastatin;D017035
C10.228.140.490.690.260;Epilepsia Partialis Continua;D017036
D08.811.682.647.200;Dinitrogenase Reductase;D017037
D08.811.277.450.483.765;Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase;D017038
K01.316.173;Ethics Committees;D017041
N04.452.758.788.300;Ethics Committees;D017041
N05.350.268;Ethics Committees;D017041
N05.700.685.300;Ethics Committees;D017041
C10.228.140.163.100.687.500;Phenylketonuria, Maternal;D017042
C13.703.575;Phenylketonuria, Maternal;D017042
C16.320.565.100.766.500;Phenylketonuria, Maternal;D017042
C16.320.565.189.687.500;Phenylketonuria, Maternal;D017042
C18.452.132.100.687.500;Phenylketonuria, Maternal;D017042
C18.452.648.100.766.500;Phenylketonuria, Maternal;D017042
C18.452.648.189.687.500;Phenylketonuria, Maternal;D017042
C04.182.197;Chalazion;D017043
C11.338.300;Chalazion;D017043
C12.777.419.403.875.510;Polycystic Kidney, Autosomal Recessive;D017044
C13.351.968.419.403.875.510;Polycystic Kidney, Autosomal Recessive;D017044
C16.320.793;Polycystic Kidney, Autosomal Recessive;D017044
B03.510.400.800.500;Lactococcus;D017045
B03.510.550.737.500;Lactococcus;D017045
N03.219.151.160.200;Cost Savings;D017046
N03.219.151.170;Cost Sharing;D017047
N03.219.521.576.090;Cost Sharing;D017047
N03.219.151.400;Health Care Costs;D017048
N05.300.375;Health Care Costs;D017048
N03.219.151.400.375;Employer Health Costs;D017049
N05.300.375.350;Employer Health Costs;D017049
E02.760.300;Episode of Care;D017050
N02.421.585.300;Episode of Care;D017050
E02.760.905.400;Hospice Care;D017051
N02.421.585.905.400;Hospice Care;D017051
E05.318.308.985.550.400;Hospital Mortality;D017052
L01.280.975.550.400;Hospital Mortality;D017052
N01.224.935.698.400;Hospital Mortality;D017052
N06.850.505.400.975.550.400;Hospital Mortality;D017052
N06.850.520.308.985.550.400;Hospital Mortality;D017052
N06.850.780.200.450;Infection Control;D017053
N03.219.521.576.343.539;Insurance, Medigap;D017054
E02.760.190.400;Intensive Care;D017055
N02.421.585.190.400;Intensive Care;D017055
M01.526.485.510;Medical Laboratory Personnel;D017056
M01.526.502.500;Medical Laboratory Personnel;D017056
N02.360.510;Medical Laboratory Personnel;D017056
M01.385;Medically Uninsured;D017057
M01.686.754.441.500;Mexican Americans;D017058
E05.318.740.500.600.500;Models, Econometric;D017059
E05.599.835.890.500;Models, Econometric;D017059
N05.715.360.750.530.500.500;Models, Econometric;D017059
N06.850.520.830.500.600.500;Models, Econometric;D017059
N04.452.822.360.600;Patient Satisfaction;D017060
N05.300.150.600.630;Patient Satisfaction;D017060
N05.715.360.600;Patient Satisfaction;D017060
N03.219.521.576.343.925;Prepaid Health Plans;D017061
E05.318.740.250.675;Small-Area Analysis;D017062
N05.715.360.750.200.750;Small-Area Analysis;D017062
N06.850.520.830.250.675;Small-Area Analysis;D017062
H01.770.644.145.431;Outcome Assessment (Health Care);D017063
N04.761.559.590;Outcome Assessment (Health Care);D017063
N05.715.360.575.575;Outcome Assessment (Health Care);D017063
N04.761.559.650;Process Assessment (Health Care);D017064
N05.715.360.575.625;Process Assessment (Health Care);D017064
V02.515.500;Practice Guideline;D017065
A08.186.211.730.885.287.249.487.550;Neostriatum;D017072
E02.148.050.120;Atherectomy;D017073
E04.100.814.529.124.120;Atherectomy;D017073
E04.800.382.124.120;Atherectomy;D017073
C20.673.330;Common Variable Immunodeficiency;D017074
E02.520.745.410;Laser Coagulation;D017075
E02.594.530;Laser Coagulation;D017075
E04.014.520.530;Laser Coagulation;D017075
E04.350.750.410;Laser Coagulation;D017075
E04.540.630.410;Laser Coagulation;D017075
L01.224.108.150;Computer-Aided Design;D017076
L01.296.110.150;Computer-Aided Design;D017076
D27.720.470.305.250;Culture Media, Conditioned;D017077
E07.206.250;Culture Media, Conditioned;D017077
E01.370.370.475;Laser-Doppler Flowmetry;D017078
E05.830.500;Laser-Doppler Flowmetry;D017078
G11.427.680.270;Exercise Tolerance;D017079
E04.210.120.172.140;Cholecystectomy, Laparoscopic;D017081
E04.800.250.520.160;Cholecystectomy, Laparoscopic;D017081
G09.330.380.076.732.650;Portal Pressure;D017082
G11.561.600.810.263.570;Otoacoustic Emissions, Spontaneous;D017084
C15.378.071.141.150.875.100;alpha-Thalassemia;D017085
C15.378.420.826.100;alpha-Thalassemia;D017085
C16.320.070.875.100;alpha-Thalassemia;D017085
C16.320.365.826.100;alpha-Thalassemia;D017085
C15.378.071.141.150.875.150;beta-Thalassemia;D017086
C15.378.420.826.150;beta-Thalassemia;D017086
C16.320.070.875.150;beta-Thalassemia;D017086
C16.320.365.826.150;beta-Thalassemia;D017086
I01.880.604.100.100;Animal Rights;D017087
C01.539.597.050;AIDS-Related Opportunistic Infections;D017088
C02.597.050;AIDS-Related Opportunistic Infections;D017088
C02.782.815.616.400.100;AIDS-Related Opportunistic Infections;D017088
C03.684.050;AIDS-Related Opportunistic Infections;D017088
C20.673.480.100;AIDS-Related Opportunistic Infections;D017088
G02.111.570.060.720.030;Ankyrin Repeat;D017089
G02.111.570.790.709.600.040.030;Ankyrin Repeat;D017089
G02.111.570.790.709.610.640.080;Ankyrin Repeat;D017089
E06.658.453.510;Occlusal Splints;D017090
C06.405.205.265.115;Colitis, Ischemic;D017091
C06.405.469.158.188.115;Colitis, Ischemic;D017091
C14.907.286;Colitis, Ischemic;D017091
C16.320.565.708.250;Porphyria, Erythropoietic;D017092
C16.320.850.738;Porphyria, Erythropoietic;D017092
C17.800.827.738;Porphyria, Erythropoietic;D017092
C17.800.849.617.250;Porphyria, Erythropoietic;D017092
C18.452.648.708.250;Porphyria, Erythropoietic;D017092
C18.452.811.250;Porphyria, Erythropoietic;D017092
C18.452.880.617.250;Porphyria, Erythropoietic;D017092
C06.552.308.500;Liver Failure;D017093
C06.552.830;Porphyrias, Hepatic;D017094
C16.320.565.708.400;Porphyrias, Hepatic;D017094
C16.320.850.742;Porphyrias, Hepatic;D017094
C17.800.827.742;Porphyrias, Hepatic;D017094
C17.800.849.617.400;Porphyrias, Hepatic;D017094
C18.452.648.708.400;Porphyrias, Hepatic;D017094
C18.452.811.400;Porphyrias, Hepatic;D017094
C18.452.880.617.400;Porphyrias, Hepatic;D017094
C10.228.228.800;Prion Diseases;D017096
C10.574.843;Prion Diseases;D017096
G01.358.500.249.277.350;Electric Impedance;D017097
C15.378.147.333.500;IgA Deficiency;D017098
C20.673.430.500;IgA Deficiency;D017098
C15.378.147.333.750;IgG Deficiency;D017099
C20.673.430.750;IgG Deficiency;D017099
B04.123.150.700.070;Bacteriophage P22;D017100
B04.123.706.070;Bacteriophage P22;D017100
B04.280.090.700.070;Bacteriophage P22;D017100
B04.123.150.500.300;Bacteriophage P1;D017101
B04.123.205.300;Bacteriophage P1;D017101
B04.280.090.500.300;Bacteriophage P1;D017101
G16.100.856.891.500;Fracture Healing;D017102
B04.123.100;Bacillus Phages;D017103
B04.123.205.250;Bacteriophage M13;D017104
B04.123.370.400.250;Bacteriophage M13;D017104
B04.280.400.400.250;Bacteriophage M13;D017104
B04.123.660;Pseudomonas Phages;D017105
B04.123.850;Streptococcus Phages;D017108
C10.228.662.037;Akathisia, Drug-Induced;D017109
C10.720.075;Akathisia, Drug-Induced;D017109
C23.888.592.350.600.500;Akathisia, Drug-Induced;D017109
C25.723.276.252;Akathisia, Drug-Induced;D017109
C25.723.705.100;Akathisia, Drug-Induced;D017109
E01.370.225.500.620.760.160.260.270;Freeze Substitution;D017110
E01.370.225.750.600.760.160.260.270;Freeze Substitution;D017110
E02.792.156.260.270;Freeze Substitution;D017110
E05.200.500.620.760.160.260.270;Freeze Substitution;D017110
E05.200.750.600.760.160.260.270;Freeze Substitution;D017110
E05.760.156.260.270;Freeze Substitution;D017110
B01.050.150.900.649.865.635.150.630;Phodopus;D017111
C06.552.308.500.750;Liver Failure, Acute;D017114
E02.148.110;Catheter Ablation;D017115
E02.148.442.110;Catheter Ablation;D017115
E02.154.402.110;Catheter Ablation;D017115
E04.014.170.402.110;Catheter Ablation;D017115
C10.597.617.232.400;Low Back Pain;D017116
C23.888.592.612.107.400;Low Back Pain;D017116
C23.888.646.172.500;Low Back Pain;D017116
C06.552.830.150;Porphyria, Acute Intermittent;D017118
C16.320.565.708.400.150;Porphyria, Acute Intermittent;D017118
C16.320.850.742.150;Porphyria, Acute Intermittent;D017118
C17.800.827.742.150;Porphyria, Acute Intermittent;D017118
C17.800.849.617.400.150;Porphyria, Acute Intermittent;D017118
C18.452.648.708.400.150;Porphyria, Acute Intermittent;D017118
C18.452.811.400.150;Porphyria, Acute Intermittent;D017118
C18.452.880.617.400.150;Porphyria, Acute Intermittent;D017118
C06.552.830.250;Porphyria Cutanea Tarda;D017119
C16.320.565.708.400.250;Porphyria Cutanea Tarda;D017119
C16.320.850.742.250;Porphyria Cutanea Tarda;D017119
C17.800.827.742.250;Porphyria Cutanea Tarda;D017119
C17.800.849.617.400.250;Porphyria Cutanea Tarda;D017119
C18.452.648.708.400.250;Porphyria Cutanea Tarda;D017119
C18.452.811.400.250;Porphyria Cutanea Tarda;D017119
C18.452.880.617.400.250;Porphyria Cutanea Tarda;D017119
G14.640.260.378.500;Nystagmus, Optokinetic;D017120
C06.552.830.437;Porphyria, Hepatoerythropoietic;D017121
C16.320.565.708.400.437;Porphyria, Hepatoerythropoietic;D017121
C16.320.850.742.437;Porphyria, Hepatoerythropoietic;D017121
C17.800.827.742.437;Porphyria, Hepatoerythropoietic;D017121
C17.800.849.617.400.437;Porphyria, Hepatoerythropoietic;D017121
C18.452.648.708.400.437;Porphyria, Hepatoerythropoietic;D017121
C18.452.811.400.437;Porphyria, Hepatoerythropoietic;D017121
C18.452.880.617.400.437;Porphyria, Hepatoerythropoietic;D017121
B04.123.150.500.350;Bacteriophage T4;D017122
B04.123.205.891.200;Bacteriophage T4;D017122
B04.280.090.500.350;Bacteriophage T4;D017122
B04.123.150.700.230;Bacteriophage T7;D017123
B04.123.205.891.230;Bacteriophage T7;D017123
B04.280.090.700.230;Bacteriophage T7;D017123
G02.111.570.580;Conserved Sequence;D017124
G05.360.340.024.340.395;Genes, Protozoan;D017125
G05.360.340.375.500;Genes, Protozoan;D017125
B04.123.230.070;Bacteriophage phi 6;D017126
B04.123.660.550;Bacteriophage phi 6;D017126
B04.123.691.230.070;Bacteriophage phi 6;D017126
B04.820.180.070;Bacteriophage phi 6;D017126
D12.776.643.500;Glycosylation End Products, Advanced;D017127
E04.100.814.445;Embolectomy;D017128
C03.335.508.700.100.060;Anisakiasis;D017129
C03.432.060;Anisakiasis;D017129
C06.405.469.452.060;Anisakiasis;D017129
E02.148.050;Angioplasty;D017130
E04.100.814.529.124;Angioplasty;D017130
E04.800.382.124;Angioplasty;D017130
E04.100.814.842;Thrombectomy;D017131
N01.824.245.925;Workplace;D017132
N04.452.677.975;Workplace;D017132
D04.808.668.651.693.175;Desogestrel;D017135
G03.495.166.500;Ion Transport;D017136
D02.033.455.250.700.620;Nonoxynol;D017137
D05.750.741.575;Nonoxynol;D017137
D25.720.741.575;Nonoxynol;D017137
J01.637.051.720.741.575;Nonoxynol;D017137
E05.599.250;Fuzzy Logic;D017143
K01.752.448.250;Fuzzy Logic;D017143
L01.224.065.250;Fuzzy Logic;D017143
E05.318.308.420.200;Focus Groups;D017144
F01.829.316.137;Focus Groups;D017144
L01.280.520.200;Focus Groups;D017144
N05.715.360.300.400.350;Focus Groups;D017144
N06.850.520.308.420.200;Focus Groups;D017144
E05.599.545;Models, Educational;D017145
I02.903.302;Models, Educational;D017145
E05.599.670;Models, Organizational;D017146
N04.452.534;Models, Organizational;D017146
E07.305.250.159.175;Defibrillators, Implantable;D017147
E07.305.250.319.175;Defibrillators, Implantable;D017147
E07.695.175;Defibrillators, Implantable;D017147
E07.695.202.175;Defibrillators, Implantable;D017147
E02.319.267.510.560;Infusions, Intraosseous;D017148
I01.791;Private Sector;D017149
N04.452.633.390;Private Sector;D017149
I01.795;Public Sector;D017150
N04.452.633.890;Public Sector;D017150
D12.776.124.486.485.114.167;Antibodies, Catalytic;D017151
D12.776.124.790.651.114.167;Antibodies, Catalytic;D017151
D12.776.377.715.548.114.167;Antibodies, Catalytic;D017151
D12.776.124.486.485.114.323.210;Antibodies, Antiphospholipid;D017152
D12.776.124.790.651.114.323.210;Antibodies, Antiphospholipid;D017152
D12.776.377.715.548.114.323.210;Antibodies, Antiphospholipid;D017152
D12.776.124.486.485.114.323.210.100;Antibodies, Anticardiolipin;D017153
D12.776.124.790.651.114.323.210.100;Antibodies, Anticardiolipin;D017153
D12.776.377.715.548.114.323.210.100;Antibodies, Anticardiolipin;D017153
A11.329.830;Stromal Cells;D017154
G02.842.312.500;Wettability;D017155
G02.842.850.908;Wettability;D017155
E01.370.370.610.600;Photoplethysmography;D017156
E01.370.610.600;Photoplethysmography;D017156
B01.050.500.500.294.100;Adenophorea;D017157
B01.050.500.500.294.100.275;Enoplida;D017158
B01.050.500.500.294.100.275.200;Dioctophymatoidea;D017159
B01.050.500.500.294.100.275.780.608.700;Trichinella spiralis;D017160
B01.050.500.500.294.700;Secernentea;D017161
B01.050.500.500.294.700.100;Ascaridida;D017162
B01.050.500.500.294.700.100.100.075;Anisakis;D017163
B01.050.500.500.294.700.100.100.108.425;Ascaris lumbricoides;D017164
B01.050.500.500.294.700.100.100.108.700;Ascaris suum;D017165
B01.050.500.500.294.700.100.100.780.225;Toxocara canis;D017166
B01.050.500.500.294.700.500;Oxyurida;D017167
B01.050.500.500.294.700.700;Rhabditida;D017168
C04.666;Neoplasms, Post-Traumatic;D017169
B01.050.500.500.294.700.700.640.680.600;Strongyloides ratti;D017170
B01.050.500.500.294.700.700.640.680.700;Strongyloides stercoralis;D017171
B01.050.500.500.294.700.700.660;Rhabditoidea;D017172
B01.050.500.500.294.700.700.660.250.250;Caenorhabditis elegans;D017173
B01.050.500.500.294.700.750;Spirurida;D017174
B01.050.500.500.294.700.750.225;Camallanina;D017175
B01.050.500.500.294.700.750.225.250;Dracunculoidea;D017176
B01.050.500.500.294.700.750.700;Spirurina;D017177
B01.050.500.500.294.700.750.700.300.088.500;Brugia malayi;D017178
B01.050.500.500.294.700.750.700.300.088.550;Brugia pahangi;D017179
C14.280.067.845.940;Tachycardia, Ventricular;D017180
C23.550.073.845.940;Tachycardia, Ventricular;D017180
B01.050.500.500.294.700.750.700.300.510.850;Onchocerca volvulus;D017181
B01.050.500.500.294.700.750.700.300.700;Setaria Nematode;D017182
B01.050.500.500.294.700.775;Strongylida;D017183
B01.050.500.500.294.700.775.400.550;Nematospiroides;D017184
B01.050.500.500.294.700.775.588.080.225;Angiostrongylus cantonensis;D017185
E05.196.922;Titrimetry;D017186
B01.050.500.500.294.700.825;Tylenchida;D017187
C03.335.508.100;Adenophorea Infections;D017188
C03.335.508.100.275;Enoplida Infections;D017189
C03.335.508.700;Secernentea Infections;D017190
C03.335.508.700.100;Ascaridida Infections;D017191
C01.252.825;Skin Diseases, Bacterial;D017192
C01.539.800.720;Skin Diseases, Bacterial;D017192
C17.800.838.765;Skin Diseases, Bacterial;D017192
C02.825;Skin Diseases, Viral;D017193
C17.800.838.790;Skin Diseases, Viral;D017193
C03.335.508.700.550;Oxyurida Infections;D017194
G07.610.220.060;Adolescent Nutritional Physiological Phenomena;D017195
C03.335.508.700.700;Rhabditida Infections;D017196
G07.700.915;Virus Shedding;D017201
C14.280.647;Myocardial Ischemia;D017202
C14.907.585;Myocardial Ischemia;D017202
V02.170.500;Interview;D017203
C10.228.662.075;Angelman Syndrome;D017204
C16.131.077.095;Angelman Syndrome;D017204
C16.131.260.040;Angelman Syndrome;D017204
C16.320.180.040;Angelman Syndrome;D017204
C03.335.508.700.750;Spirurida Infections;D017205
C03.335.508.700.775;Strongylida Infections;D017206
B01.050.150.900.649.865.635.505.700.750;Rats, Sprague-Dawley;D017207
B01.050.150.900.649.865.635.505.700.900;Rats, Wistar;D017208
G04.299.139.160;Apoptosis;D017209
B01.050.150.900.493.602.200.800;Tilapia;D017210
E01.789.800.760;Treatment Failure;D017211
N04.761.559.590.800.760;Treatment Failure;D017211
N05.715.360.575.575.800.760;Treatment Failure;D017211
C07.793.720.210.650;Root Caries;D017213
E02.041.500.475;Laryngeal Masks;D017214
E02.585.578.475;Laryngeal Masks;D017214
E05.497.578.475;Laryngeal Masks;D017214
E07.700.500.450;Laryngeal Masks;D017214
J01.637.708.500.450;Laryngeal Masks;D017214
L01.178.847.550;Satellite Communications;D017215
H02.403.840;Telemedicine;D017216
L01.178.847.652;Telemedicine;D017216
N04.590.374.800;Telemedicine;D017216
E02.095.125;Blood Patch, Epidural;D017217
E02.319.267.530.580.300.145;Blood Patch, Epidural;D017217
E01.370.225.998.110.150;Cordocentesis;D017218
E04.665.150.150;Cordocentesis;D017218
E05.200.998.110.150;Cordocentesis;D017218
C06.405.748.340;Gastric Outlet Obstruction;D017219
D25.339.291.300;Dentin-Bonding Agents;D017220
J01.637.051.339.291.300;Dentin-Bonding Agents;D017220
B01.050.500.500.294.700.775.100.550.100;Necator americanus;D017221
E02.148.050.060.105;Angioplasty, Balloon, Laser-Assisted;D017222
E02.148.050.075.080;Angioplasty, Balloon, Laser-Assisted;D017222
E02.594.060.080;Angioplasty, Balloon, Laser-Assisted;D017222
E04.014.520.060.080;Angioplasty, Balloon, Laser-Assisted;D017222
E04.100.814.529.124.060.105;Angioplasty, Balloon, Laser-Assisted;D017222
E04.100.814.529.124.075.080;Angioplasty, Balloon, Laser-Assisted;D017222
E04.800.382.124.060.105;Angioplasty, Balloon, Laser-Assisted;D017222
E04.800.382.124.075.080;Angioplasty, Balloon, Laser-Assisted;D017222
E02.148.050.120.125;Atherectomy, Coronary;D017225
E04.100.376.719.125;Atherectomy, Coronary;D017225
E04.100.814.529.124.120.125;Atherectomy, Coronary;D017225
E04.100.814.529.968.060;Atherectomy, Coronary;D017225
E04.800.382.124.120.125;Atherectomy, Coronary;D017225
E04.800.382.968.060;Atherectomy, Coronary;D017225
E04.928.220.520.110;Atherectomy, Coronary;D017225
C03.335.508.700.100.850;Toxascariasis;D017227
D12.644.276.374.420;Hepatocyte Growth Factor;D017228
D12.776.467.374.420;Hepatocyte Growth Factor;D017228
D23.529.374.420;Hepatocyte Growth Factor;D017228
C03.335.508.700.550.550.375;Enterobiasis;D017229
D08.811.913.696.620.682.700.559.800;Proto-Oncogene Proteins c-mos;D017231
D12.644.360.400.800;Proto-Oncogene Proteins c-mos;D017231
D12.776.476.400.800;Proto-Oncogene Proteins c-mos;D017231
D12.776.624.664.700.187;Proto-Oncogene Proteins c-mos;D017231
D12.776.624.664.520.750.900;Oncogene Proteins v-mos;D017232
D12.776.964.700.750.900;Oncogene Proteins v-mos;D017232
D12.776.964.775.750.900;Oncogene Proteins v-mos;D017232
E04.540.760;Orbit Evisceration;D017233
E04.540.431;Eye Evisceration;D017234
E02.760.905.850;Suicide, Assisted;D017236
F01.145.126.980.875.300;Suicide, Assisted;D017236
I01.880.735.856.300;Suicide, Assisted;D017236
N02.421.585.905.850;Suicide, Assisted;D017236
C05.651.460.620;Mitochondrial Encephalomyopathies;D017237
C10.228.140.163.540;Mitochondrial Encephalomyopathies;D017237
C10.668.491.500.500;Mitochondrial Encephalomyopathies;D017237
C18.452.132.540;Mitochondrial Encephalomyopathies;D017237
C18.452.660.560.620;Mitochondrial Encephalomyopathies;D017237
G05.360.340.024.340.310;Genes, Helminth;D017238
G05.360.340.337.500;Genes, Helminth;D017238
D02.455.426.392.368.242.888.777;Paclitaxel;D017239
D02.455.849.291.850.777;Paclitaxel;D017239
C05.651.460;Mitochondrial Myopathies;D017240
C10.668.491.500;Mitochondrial Myopathies;D017240
C18.452.660.560;Mitochondrial Myopathies;D017240
C05.651.460.620.520;MELAS Syndrome;D017241
C10.228.140.163.100.535;MELAS Syndrome;D017241
C10.228.140.300.275.500;MELAS Syndrome;D017241
C10.668.491.500.500.500;MELAS Syndrome;D017241
C14.907.253.329.500;MELAS Syndrome;D017241
C16.320.565.189.535;MELAS Syndrome;D017241
C18.452.132.100.535;MELAS Syndrome;D017241
C18.452.648.189.535;MELAS Syndrome;D017241
C18.452.660.560.620.520;MELAS Syndrome;D017241
D12.776.124.486.274.920.325.200;Complement Factor H;D017242
D12.776.124.790.223.200;Complement Factor H;D017242
D12.776.377.715.182.200;Complement Factor H;D017242
C05.651.460.620.530;MERRF Syndrome;D017243
C10.228.140.163.100.545;MERRF Syndrome;D017243
C10.228.140.490.250.650.700;MERRF Syndrome;D017243
C10.668.491.500.500.550;MERRF Syndrome;D017243
C16.320.565.189.545;MERRF Syndrome;D017243
C18.452.132.100.545;MERRF Syndrome;D017243
C18.452.648.189.545;MERRF Syndrome;D017243
C18.452.660.560.620.530;MERRF Syndrome;D017243
D08.811.277.656.300.760.210;Complement Factor I;D017244
D08.811.277.656.959.350.210;Complement Factor I;D017244
D12.776.124.486.274.920.325.210;Complement Factor I;D017244
D02.241.081.018.677.250;Foscarnet;D017245
D02.705.429.875.500;Foscarnet;D017245
C05.651.460.700;Ophthalmoplegia, Chronic Progressive External;D017246
C10.292.562.750.250;Ophthalmoplegia, Chronic Progressive External;D017246
C10.292.562.775;Ophthalmoplegia, Chronic Progressive External;D017246
C10.597.622.447.511;Ophthalmoplegia, Chronic Progressive External;D017246
C10.668.491.500.700;Ophthalmoplegia, Chronic Progressive External;D017246
C11.590.472.250;Ophthalmoplegia, Chronic Progressive External;D017246
C11.590.641;Ophthalmoplegia, Chronic Progressive External;D017246
C18.452.660.560.700;Ophthalmoplegia, Chronic Progressive External;D017246
C23.888.592.636.447.511;Ophthalmoplegia, Chronic Progressive External;D017246
E02.815.722.500;Neutron Capture Therapy;D017247
E05.478.566.350.180;Enzyme Multiplied Immunoassay Technique;D017248
E05.478.583.400.180;Enzyme Multiplied Immunoassay Technique;D017248
E05.601.495.350.180;Enzyme Multiplied Immunoassay Technique;D017248
C02.782.160;Caliciviridae Infections;D017250
D23.050.301.264.035.103;Antigens, CD3;D017252
D23.050.301.264.894.095;Antigens, CD3;D017252
D23.101.100.110.103;Antigens, CD3;D017252
D23.101.100.894.095;Antigens, CD3;D017252
C04.557.580.600.580.590;Neurofibromatoses;D017253
C04.700.645;Neurofibromatoses;D017253
C10.562.600;Neurofibromatoses;D017253
C10.574.500.549;Neurofibromatoses;D017253
C16.320.400.560;Neurofibromatoses;D017253
C16.320.700.645;Neurofibromatoses;D017253
C04.697.645.500;Leukemic Infiltration;D017254
C23.550.727.645.500;Leukemic Infiltration;D017254
D02.455.326.271.665.202.495.050;Acitretin;D017255
D02.455.849.131.495.050;Acitretin;D017255
D23.767.261.700.050;Acitretin;D017255
D02.626.872;Technetium Tc 99m Sestamibi;D017256
D02.691.825.937;Technetium Tc 99m Sestamibi;D017256
D03.605.084.750;Ramipril;D017257
D04.808.745.745.654.829.614.500;Medroxyprogesterone Acetate;D017258
D02.886.904.282;Dimaprit;D017259
D02.948.898.282;Dimaprit;D017259
D12.776.543.750.705.816.824.800;Receptor-CD3 Complex, Antigen, T-Cell;D017260
D23.050.301.264.035.103.800;Receptor-CD3 Complex, Antigen, T-Cell;D017260
D23.050.301.264.894.095.800;Receptor-CD3 Complex, Antigen, T-Cell;D017260
D23.101.100.110.103.800;Receptor-CD3 Complex, Antigen, T-Cell;D017260
D23.101.100.894.095.800;Receptor-CD3 Complex, Antigen, T-Cell;D017260
D09.400.410.475;Glycosylphosphatidylinositols;D017261
D10.390.475;Glycosylphosphatidylinositols;D017261
D10.570.755.375.760.400.942.250;Glycosylphosphatidylinositols;D017261
D27.505.519.249.410.750;Siderophores;D017262
D02.691.825.775;Technetium Tc 99m Mertiatide;D017263
D12.644.456.805;Technetium Tc 99m Mertiatide;D017263
D02.033.100.291.630;Procaterol;D017265
D02.092.063.291.647;Procaterol;D017265
D03.438.810.350.700;Procaterol;D017265
E06.780.345;Dental Prosthesis;D017266
E07.695.190;Dental Prosthesis;D017266
E06.780.345.625;Dental Prosthesis Design;D017267
E06.912.145;Dental Prosthesis Design;D017267
E06.780.345.687;Dental Prosthesis Retention;D017268
E06.780.345.656;Dental Prosthesis Repair;D017269
E06.912.160;Dental Prosthesis Repair;D017269
D10.532.350;Lipoprotein(a);D017270
D12.776.521.400;Lipoprotein(a);D017270
C05.500.607.221;Craniomandibular Disorders;D017271
C05.651.243;Craniomandibular Disorders;D017271
C07.320.610.291;Craniomandibular Disorders;D017271
D02.033.100.624.240;Celiprolol;D017272
D02.033.100.624.698.268;Celiprolol;D017272
D02.033.755.624.240;Celiprolol;D017272
D02.033.755.624.698.268;Celiprolol;D017272
D02.092.063.624.698.268;Celiprolol;D017272
D02.948.684.241;Celiprolol;D017272
D06.472.699.327.740.320.340;Goserelin;D017273
D12.644.400.400.740.320.340;Goserelin;D017273
D12.644.456.460.315;Goserelin;D017273
D12.644.548.365.740.320.340;Goserelin;D017273
D12.776.641.650.405.740.320.340;Goserelin;D017273
D06.472.699.327.740.320.580;Nafarelin;D017274
D12.644.400.400.740.320.580;Nafarelin;D017274
D12.644.456.460.600;Nafarelin;D017274
D12.644.548.365.740.320.580;Nafarelin;D017274
D12.776.641.650.405.740.320.580;Nafarelin;D017274
D03.383.725.203.310;Isradipine;D017275
G01.374.618;Friction;D017276
E05.337.300;Drug Approval;D017277
I01.880.604.605.250.250;Drug Approval;D017277
E07.700.100;Air Bags;D017278
J01.637.708.100;Air Bags;D017278
D02.712.600;Selenocysteine;D017279
D02.886.030.230.700;Selenocysteine;D017279
D12.125.166.230.700;Selenocysteine;D017279
E07.190.270.150;Condoms;D017280
I01.137;Cost of Illness;D017281
N03.219.151.165;Cost of Illness;D017281
C01.252.400.825;Tick-Borne Diseases;D017282
C02.081.885;Tick-Borne Diseases;D017282
C03.752.875;Tick-Borne Diseases;D017282
H02.478.676.390.600;Neonatal Nursing;D017283
H02.478.676.631.600;Neonatal Nursing;D017283
N02.421.533.460.600;Neonatal Nursing;D017283
N02.421.533.691.600;Neonatal Nursing;D017283
C05.651.594.819;Polymyositis;D017285
C10.668.491.562.575;Polymyositis;D017285
E01.370.520.625;Polysomnography;D017286
E04.035.188.850;Ventriculoperitoneal Shunt;D017287
E04.525.170.850;Ventriculoperitoneal Shunt;D017287
F02.463.593.710.560;Pain Threshold;D017288
F02.830.816.444.700;Pain Threshold;D017288
G11.561.600.810.444.700;Pain Threshold;D017288
E06.658.453.560;Orthodontic Appliances, Functional;D017289
D02.455.426.559.847.562.050.200.650.500;Menogaril;D017290
D04.615.562.050.200.650.500;Menogaril;D017290
D09.408.051.059.200.650.500;Menogaril;D017290
D02.540.505.250.100;Clarithromycin;D017291
D03.438.786.750.200;Doxazosin;D017292
D12.776.124.670;Protein S;D017293
D12.776.395.642;Protein S;D017293
D23.113.725;Protein S;D017293
D03.383.129.308.690;Ondansetron;D017294
D03.438.473.144.500;Ondansetron;D017294
D03.494.148.500;Ondansetron;D017294
D02.033.100.624.111;Bisoprolol;D017298
D02.033.100.624.698.085;Bisoprolol;D017298
D02.033.755.624.111;Bisoprolol;D017298
D02.033.755.624.698.085;Bisoprolol;D017298
D02.092.063.624.698.085;Bisoprolol;D017298
D12.776.306.466.500;Rod Opsins;D017299
D23.767.930.750.500;Rod Opsins;D017299
D03.383.606.760;Pipecuronium;D017300
D08.811.277.040.025.095;Ca(2+) Mg(2+)-ATPase;D017301
D12.776.157.125.050;Annexins;D017302
D12.776.157.125.050.100;Annexin A5;D017304
D12.776.157.125.050.050;Annexin A1;D017305
D12.776.157.125.050.060;Annexin A2;D017306
D02.033.100.624.698.855;Xamoterol;D017307
D02.033.100.624.972;Xamoterol;D017307
D02.033.755.624.698.855;Xamoterol;D017307
D02.033.755.624.972;Xamoterol;D017307
D02.092.063.624.698.855;Xamoterol;D017307
D03.383.533.640.950;Xamoterol;D017307
D03.066.288.200;Etodolac;D017308
D03.438.473.404.200;Etodolac;D017308
D12.776.157.125.050.120;Annexin A7;D017310
D03.383.725.203.065;Amlodipine;D017311
D02.455.426.559.389.150.700.900.900;Toremifene;D017312
D02.455.326.271.665.202.495.270;Fenretinide;D017313
D02.455.426.392.368.367.379.249.700.270;Fenretinide;D017313
D02.455.849.131.495.270;Fenretinide;D017313
D23.767.261.700.270;Fenretinide;D017313
D12.776.157.125.050.080;Annexin A4;D017314
D03.383.710.100;Cilazapril;D017315
D02.626.400;Fadrozole;D017316
D03.383.129.308.270;Fadrozole;D017316
D12.776.157.125.050.110;Annexin A6;D017317
D08.811.277.352.640.050;Annexin A3;D017318
D12.776.157.125.050.070;Annexin A3;D017318
D27.505.954.444.600;Photosensitizing Agents;D017319
D27.505.954.600.710;Photosensitizing Agents;D017319
D27.505.519.389.745.420;HIV Protease Inhibitors;D017320
D27.505.954.122.388.077.088.420;HIV Protease Inhibitors;D017320
E05.318.760.535.200;Clinical Trials, Phase I as Topic;D017321
E05.337.250.200;Clinical Trials, Phase I as Topic;D017321
N05.715.360.775.235.200;Clinical Trials, Phase I as Topic;D017321
N06.850.520.450.535.200;Clinical Trials, Phase I as Topic;D017321
E05.318.760.535.210;Clinical Trials, Phase II as Topic;D017322
E05.337.250.210;Clinical Trials, Phase II as Topic;D017322
N05.715.360.775.235.210;Clinical Trials, Phase II as Topic;D017322
N06.850.520.450.535.210;Clinical Trials, Phase II as Topic;D017322
D03.383.129.578.840.500.462.400.200;Dihematoporphyrin Ether;D017323
D03.549.909.500.462.400.200;Dihematoporphyrin Ether;D017323
D04.345.783.500.462.400.200;Dihematoporphyrin Ether;D017323
D23.767.727.462.400.200;Dihematoporphyrin Ether;D017323
D03.383.129.578.840.500.462.400;Hematoporphyrin Derivative;D017324
D03.549.909.500.462.400;Hematoporphyrin Derivative;D017324
D04.345.783.500.462.400;Hematoporphyrin Derivative;D017324
D23.767.727.462.400;Hematoporphyrin Derivative;D017324
D20.215.894.899.955.400;Hepatitis B Vaccines;D017325
E05.318.760.535.220;Clinical Trials, Phase III as Topic;D017326
E05.337.250.220;Clinical Trials, Phase III as Topic;D017326
N05.715.360.775.235.220;Clinical Trials, Phase III as Topic;D017326
N06.850.520.450.535.220;Clinical Trials, Phase III as Topic;D017326
E05.318.760.535.230;Clinical Trials, Phase IV as Topic;D017327
E05.337.250.230;Clinical Trials, Phase IV as Topic;D017327
E05.337.800.200;Clinical Trials, Phase IV as Topic;D017327
N05.715.360.775.235.230;Clinical Trials, Phase IV as Topic;D017327
N06.850.520.450.535.230;Clinical Trials, Phase IV as Topic;D017327
D02.705.629.500;Fosinopril;D017328
D12.125.072.401.623.374;Fosinopril;D017328
D06.472.699.327.740.320.790;Triptorelin Pamoate;D017329
D12.644.400.400.740.320.790;Triptorelin Pamoate;D017329
D12.644.456.460.800;Triptorelin Pamoate;D017329
D12.644.548.365.740.320.790;Triptorelin Pamoate;D017329
D12.776.641.650.405.740.320.790;Triptorelin Pamoate;D017329
D02.065.277.796;Remoxipride;D017330
D02.241.223.100.100.796;Remoxipride;D017330
D02.241.223.100.150.500;Remoxipride;D017330
D02.455.426.559.389.127.085.796;Remoxipride;D017330
D02.455.426.559.389.127.150.500;Remoxipride;D017330
D03.383.606.515.200;Cetirizine;D017332
D09.400.420.900;Teicoplanin;D017334
D12.644.233.900;Teicoplanin;D017334
D03.383.129.308.253;Enoximone;D017335
D02.455.426.559.847.181.384.340.500;Loratadine;D017336
D03.383.621.160.500;Loratadine;D017336
D04.615.181.384.340.500;Loratadine;D017336
D06.472.699.327.740.860.780;Sermorelin;D017337
D12.644.400.400.740.860.780;Sermorelin;D017337
D12.644.548.365.740.860.780;Sermorelin;D017337
D12.776.641.650.405.740.860.780;Sermorelin;D017337
D03.438.759.590.138.300.200;Cladribine;D017338
D03.438.759.590.138.325.075;Cladribine;D017338
D13.570.230.229.075;Cladribine;D017338
D13.570.583.138.300.200;Cladribine;D017338
D13.570.583.138.325.075;Cladribine;D017338
D13.570.800.096.300.200;Cladribine;D017338
D02.640.672.250;Etanidazole;D017341
D03.383.129.308.658.250;Etanidazole;D017341
G05.360.340.024.340.393;Genes, Plant;D017343
G05.360.340.365.500;Genes, Plant;D017343
G05.360.340.024.340.340;Genes, Insect;D017344
G05.360.340.357.500;Genes, Insect;D017344
D08.811.913.696.620.682.700;Protein-Serine-Threonine Kinases;D017346
B03.440.400.425.215.500.500;Brucella melitensis;D017347
B03.660.050.070.100.500;Brucella melitensis;D017347
E01.370.350.515.402.580.480;Microscopy, Electron, Scanning Transmission;D017348
E05.595.402.580.480;Microscopy, Electron, Scanning Transmission;D017348
D08.811.913.400.100;N-Acetylhexosaminyltransferases;D017349
D08.811.913.400.100.200;N-Acetylgalactosaminyltransferases;D017350
D08.811.913.400.100.250;N-Acetylglucosaminyltransferases;D017351
E01.370.350.500.200;Echo-Planar Imaging;D017352
E01.370.350.825.500.200;Echo-Planar Imaging;D017352
G05.355.600.800.320;Gene Deletion;D017353
G05.365.590.762.320;Gene Deletion;D017353
G05.365.590.675;Point Mutation;D017354
B03.440.450.980;Zymomonas;D017355
B03.660.050.800.990;Zymomonas;D017355
E07.710.680.700;Synchrotrons;D017356
E07.710.680.250;Cyclotrons;D017357
A11.284.183.200;Cell Wall Skeleton;D017358
D12.776.097.162;Cell Wall Skeleton;D017358
D12.776.395.560.186;Cell Wall Skeleton;D017358
C13.703.395.186;HELLP Syndrome;D017359
B01.650.940.800.575.100.157.100;Arabidopsis;D017360
D12.776.964.900;Viral Nonstructural Proteins;D017361
D12.776.260.108.184;Cyclic AMP Response Element-Binding Protein;D017362
D12.776.930.127.184;Cyclic AMP Response Element-Binding Protein;D017362
D08.811.277.656.300.480.205;Collagenases;D017364
D08.811.277.656.675.374.205;Collagenases;D017364
J02.500.250.725;Spices;D017365
D27.505.519.625.850.800;Serotonin Receptor Agonists;D017366
D27.505.696.577.850.800;Serotonin Receptor Agonists;D017366
D27.505.519.625.600.850;Serotonin Uptake Inhibitors;D017367
D27.505.519.625.850.900;Serotonin Uptake Inhibitors;D017367
D27.505.696.577.600.850;Serotonin Uptake Inhibitors;D017367
D27.505.696.577.850.900;Serotonin Uptake Inhibitors;D017367
G02.111.087.675.871.790.600.400;Protein Prenylation;D017368
G02.111.087.679.500;Protein Prenylation;D017368
G02.111.087.693.600.400;Protein Prenylation;D017368
G02.149.115.675.871.790.600.400;Protein Prenylation;D017368
G02.149.115.679.500;Protein Prenylation;D017368
G02.149.115.693.600.400;Protein Prenylation;D017368
G03.495.770.871.790.600.400;Protein Prenylation;D017368
G03.495.797.500;Protein Prenylation;D017368
G05.355.315.670.600.400;Protein Prenylation;D017368
D12.644.276.374.465.511;Interleukin-11;D017370
D12.776.467.374.465.511;Interleukin-11;D017370
D23.529.374.465.511;Interleukin-11;D017370
D02.455.426.559.847.638.960.400;8-Hydroxy-2-(di-n-propylamino)tetralin;D017371
D04.615.638.960.400;8-Hydroxy-2-(di-n-propylamino)tetralin;D017371
D04.808.745.432.219.150;Cyproterone Acetate;D017373
D04.808.883.419.150;Cyproterone Acetate;D017373
D03.383.621.600;Paroxetine;D017374
D12.776.964.970.910;Viral Tail Proteins;D017376
B01.750.875;Diatoms;D017377
D03.383.725.822.700;Quinolinic Acid;D017378
C14.280.195.400;Hypertrophy, Left Ventricular;D017379
C23.300.775.250.400;Hypertrophy, Left Ventricular;D017379
C14.280.195.410;Hypertrophy, Right Ventricular;D017380
C23.300.775.250.401;Hypertrophy, Right Ventricular;D017380
A11.284.430.106.279.345.850;Spliceosomes;D017381
D01.339.431;Reactive Oxygen Species;D017382
D01.650.775;Reactive Oxygen Species;D017382
G05.355.600.800;Sequence Deletion;D017384
G05.365.590.762;Sequence Deletion;D017384
G02.111.810;Sequence Homology;D017385
G05.810;Sequence Homology;D017385
G02.111.810.200;Sequence Homology, Amino Acid;D017386
G05.810.200;Sequence Homology, Amino Acid;D017386
E05.337.300.400;Investigational New Drug Application;D017387
E02.875.800.992;Zygote Intrafallopian Transfer;D017388
E05.820.800.992;Zygote Intrafallopian Transfer;D017388
E04.540.825.374.225;Epikeratophakia;D017391
E04.936.580.225.225;Epikeratophakia;D017391
D02.047.700.700;Thiobarbituric Acid Reactive Substances;D017392
D27.720.470.410.750;Thiobarbituric Acid Reactive Substances;D017392
G02.111.087.750.250;RNA Editing;D017393
G02.149.115.750.250;RNA Editing;D017393
G03.495.839.250;RNA Editing;D017393
G05.355.315.700.250;RNA Editing;D017393
D13.444.735.790.552.625;RNA, Guide;D017394
D12.644.822.750.695.500;Plasminogen Activator Inhibitor 1;D017395
D12.644.861.695.500;Plasminogen Activator Inhibitor 1;D017395
D12.776.124.125.640;Plasminogen Activator Inhibitor 1;D017395
D12.776.645.750.695.500;Plasminogen Activator Inhibitor 1;D017395
D12.776.872.695.500;Plasminogen Activator Inhibitor 1;D017395
D23.119.832.500;Plasminogen Activator Inhibitor 1;D017395
D12.644.822.750.695.520;Plasminogen Activator Inhibitor 2;D017396
D12.644.861.695.520;Plasminogen Activator Inhibitor 2;D017396
D12.776.124.125.645;Plasminogen Activator Inhibitor 2;D017396
D12.776.645.750.695.520;Plasminogen Activator Inhibitor 2;D017396
D12.776.872.695.520;Plasminogen Activator Inhibitor 2;D017396
D23.119.832.750;Plasminogen Activator Inhibitor 2;D017396
A08.186.211.730.885.287.500.270.700;Prefrontal Cortex;D017397
G02.111.087.750.700.100;Alternative Splicing;D017398
G02.149.115.750.700.100;Alternative Splicing;D017398
G03.495.839.700.100;Alternative Splicing;D017398
G05.355.315.700.700.100;Alternative Splicing;D017398
B03.440.097;Brachyspira;D017400
B03.440.425.410.220;Brachyspira;D017400
B03.440.097.100;Brachyspira hyodysenteriae;D017401
B03.440.425.410.220.100;Brachyspira hyodysenteriae;D017401
D02.455.526.439.220;Chlorofluorocarbons;D017402
D02.455.526.510.140;Chlorofluorocarbons;D017402
E01.370.225.500.620.670.325;In Situ Hybridization;D017403
E01.370.225.750.600.670.325;In Situ Hybridization;D017403
E05.200.500.620.670.325;In Situ Hybridization;D017403
E05.200.750.600.670.325;In Situ Hybridization;D017403
E05.393.661.475;In Situ Hybridization;D017403
E01.370.225.500.620.670.325.350;In Situ Hybridization, Fluorescence;D017404
E01.370.225.750.600.670.325.350;In Situ Hybridization, Fluorescence;D017404
E05.200.500.620.670.325.350;In Situ Hybridization, Fluorescence;D017404
E05.200.750.600.670.325.350;In Situ Hybridization, Fluorescence;D017404
E05.393.285.350;In Situ Hybridization, Fluorescence;D017404
E05.393.661.475.350;In Situ Hybridization, Fluorescence;D017404
D12.776.260.755.400;Herpes Simplex Virus Protein Vmw65;D017405
D12.776.930.900.400;Herpes Simplex Virus Protein Vmw65;D017405
D12.776.964.925.984.445;Herpes Simplex Virus Protein Vmw65;D017405
F01.145.802.950;Sexual Harassment;D017406
N01.824.417.700.162;Family Leave;D017407
N04.452.677.800.162;Family Leave;D017407
N04.761.700.350;Guidelines as Topic;D017408
N05.700.350;Guidelines as Topic;D017408
D03.383.621.265.900;Sufentanil;D017409
N04.761.700.350.650;Practice Guidelines as Topic;D017410
N05.700.350.650;Practice Guidelines as Topic;D017410
D12.776.157.725.500.875;Ribonucleoproteins, Small Nuclear;D017411
D12.776.664.962.500.875;Ribonucleoproteins, Small Nuclear;D017411
D12.776.157.725.500.875.600;Ribonucleoprotein, U1 Small Nuclear;D017412
D12.776.664.962.500.875.600;Ribonucleoprotein, U1 Small Nuclear;D017412
D12.776.157.725.500.875.605;Ribonucleoprotein, U2 Small Nuclear;D017413
D12.776.664.962.500.875.605;Ribonucleoprotein, U2 Small Nuclear;D017413
D12.776.157.725.500.875.615;Ribonucleoprotein, U4-U6 Small Nuclear;D017414
D12.776.664.962.500.875.615;Ribonucleoprotein, U4-U6 Small Nuclear;D017414
D12.776.157.725.500.875.620;Ribonucleoprotein, U5 Small Nuclear;D017415
D12.776.664.962.500.875.620;Ribonucleoprotein, U5 Small Nuclear;D017415
V03.600;Meta-Analysis;D017418
D01.745.660;Potassium, Dietary;D017419
E05.393.760;Sequence Analysis;D017421
E05.393.760.700;Sequence Analysis, DNA;D017422
E05.393.760.710;Sequence Analysis, RNA;D017423
V03.200.100;Clinical Trial, Phase I;D017426
V03.200.200;Clinical Trial, Phase II;D017427
V03.200.300;Clinical Trial, Phase III;D017428
V03.200.400;Clinical Trial, Phase IV;D017429
D08.811.277.656.300.760.442.750;Prostate-Specific Antigen;D017430
D08.811.277.656.959.350.442.750;Prostate-Specific Antigen;D017430
D12.776.866.249.500;Prostate-Specific Antigen;D017430
D23.050.285.625;Prostate-Specific Antigen;D017430
D23.101.840.625;Prostate-Specific Antigen;D017430
G05.360.340.024.340.375.249.320;Genes, MCC;D017431
G05.360.340.024.340.415.400.320;Genes, MCC;D017431
L01.453.245.945.800;Unified Medical Language System;D017432
G02.111.570.790.709.600;Protein Structure, Secondary;D017433
G02.111.570.790.709.610;Protein Structure, Tertiary;D017434
C12.706.316.096.750;Kallmann Syndrome;D017436
C13.351.875.253.096.750;Kallmann Syndrome;D017436
C16.131.939.316.096.750;Kallmann Syndrome;D017436
C16.320.467;Kallmann Syndrome;D017436
C19.391.119.096.750;Kallmann Syndrome;D017436
C19.391.482.600;Kallmann Syndrome;D017436
C17;Skin and Connective Tissue Diseases;D017437
D02.241.081.069.600.150;Bisphenol A-Glycidyl Methacrylate;D017438
D02.455.426.559.389.657.100;Bisphenol A-Glycidyl Methacrylate;D017438
D05.750.716.822.308.200;Bisphenol A-Glycidyl Methacrylate;D017438
D25.339.816.500.200;Bisphenol A-Glycidyl Methacrylate;D017438
D25.720.716.822.308.200;Bisphenol A-Glycidyl Methacrylate;D017438
J01.637.051.339.816.500.200;Bisphenol A-Glycidyl Methacrylate;D017438
J01.637.051.720.716.822.308.200;Bisphenol A-Glycidyl Methacrylate;D017438
A10.165.450.300.125;Cicatrix, Hypertrophic;D017439
C23.550.355.274.505;Cicatrix, Hypertrophic;D017439
G01.910.675;Photoperiod;D017440
C17.300.200.495;Necrobiotic Disorders;D017441
C17.800.550;Necrobiotic Disorders;D017441
D27.505.519.625.375.400;Histamine Agonists;D017442
D27.505.696.577.375.400;Histamine Agonists;D017442
C17.800.815;Skin Diseases, Eczematous;D017443
C17.800.859;Skin Diseases, Papulosquamous;D017444
C17.800.862;Skin Diseases, Vascular;D017445
D02.078.370.500;Impromidine;D017446
D03.383.129.308.445;Impromidine;D017446
D12.776.543.750.070.300.400.400;Receptors, Dopamine D1;D017447
D12.776.543.750.100.150.400.400;Receptors, Dopamine D1;D017447
D12.776.543.750.720.300.300.400.400;Receptors, Dopamine D1;D017447
D12.776.543.750.070.300.400.500;Receptors, Dopamine D2;D017448
D12.776.543.750.100.150.400.500;Receptors, Dopamine D2;D017448
D12.776.543.750.720.300.300.400.500;Receptors, Dopamine D2;D017448
C17.800.174.255.100;Dermatitis, Allergic Contact;D017449
C17.800.815.255.100;Dermatitis, Allergic Contact;D017449
C20.543.418.150;Dermatitis, Allergic Contact;D017449
D12.776.543.750.100.620.550;Receptors, Opioid, mu;D017450
D12.776.543.750.720.600.610.550;Receptors, Opioid, mu;D017450
D12.776.543.750.750.555.610.550;Receptors, Opioid, mu;D017450
D12.776.543.750.750.400.780;Receptors, Somatomedin;D017451
D12.776.543.750.705.871.300;Receptors, IgG;D017452
D23.050.301.264.035.695;Receptors, IgG;D017452
D23.101.100.110.695;Receptors, IgG;D017452
C17.800.174.255.400;Dermatitis, Irritant;D017453
C17.800.815.255.400;Dermatitis, Irritant;D017453
C17.800.174.255.100.600;Dermatitis, Photoallergic;D017454
C17.800.600.325;Dermatitis, Photoallergic;D017454
C17.800.815.255.100.600;Dermatitis, Photoallergic;D017454
C20.543.418.150.600;Dermatitis, Photoallergic;D017454
D12.776.543.750.705.871.280;Receptors, IgE;D017455
D23.050.301.264.035.690;Receptors, IgE;D017455
D23.101.100.110.690;Receptors, IgE;D017455
D12.776.624.664.520.045;Adenovirus Early Proteins;D017456
D12.776.964.700.045;Adenovirus Early Proteins;D017456
D23.050.327.045;Adenovirus Early Proteins;D017456
D12.776.543.750.750.100;Receptors, Albumin;D017457
D12.776.543.750.720.200;Receptors, Amino Acid;D017459
D08.811.520.650.600.500.500;Receptors, Atrial Natriuretic Factor;D017461
D12.776.543.750.120.500;Receptors, Atrial Natriuretic Factor;D017461
D12.776.543.750.720.600.170;Receptors, Atrial Natriuretic Factor;D017461
D12.776.543.750.750.160;Receptors, Atrial Natriuretic Factor;D017461
D12.776.543.750.750.555.170;Receptors, Atrial Natriuretic Factor;D017461
D12.776.543.750.705.833.600;Receptors, Complement 3b;D017463
D23.050.301.264.035.608;Receptors, Complement 3b;D017463
D23.101.100.110.608;Receptors, Complement 3b;D017463
D12.776.543.750.705.833.610;Receptors, Complement 3d;D017464
D12.776.543.750.925.250;Receptors, Complement 3d;D017464
D23.050.301.264.035.610;Receptors, Complement 3d;D017464
D23.101.100.110.610;Receptors, Complement 3d;D017464
D12.776.543.750.100.620.200;Receptors, Opioid, delta;D017465
D12.776.543.750.720.600.610.200;Receptors, Opioid, delta;D017465
D12.776.543.750.750.555.610.200;Receptors, Opioid, delta;D017465
D12.776.543.750.100.220;Receptors, Endothelin;D017466
D12.776.543.750.750.320;Receptors, Endothelin;D017466
D12.776.543.750.705.852.150.200;Receptors, Erythropoietin;D017467
D12.776.543.750.750.400.200.340;Receptors, Erythropoietin;D017467
D12.776.543.750.750.400.370;Receptors, Fibroblast Growth Factor;D017468
D12.776.543.750.705.408.530;Receptors, Fibronectin;D017469
D12.776.543.750.720.200.450;Receptors, Glutamate;D017470
D12.776.543.750.705.852.400;Receptors, Interferon;D017471
D12.776.543.750.705.852.420.300;Receptors, Interleukin-1;D017472
D12.776.543.750.100.620.400;Receptors, Opioid, kappa;D017473
D12.776.543.750.720.600.610.400;Receptors, Opioid, kappa;D017473
D12.776.543.750.750.555.610.400;Receptors, Opioid, kappa;D017473
D12.776.543.750.705.876;Receptors, Laminin;D017474
D12.776.543.750.750.400.550;Receptors, Nerve Growth Factor;D017475
D12.776.543.750.100.500;Receptors, Neuropeptide Y;D017476
D12.776.543.750.720.600.540;Receptors, Neuropeptide Y;D017476
D12.776.543.750.750.555.540;Receptors, Neuropeptide Y;D017476
D12.776.827.550;Receptors, Phencyclidine;D017478
D08.811.913.696.620.682.725.400.900;Receptors, Platelet-Derived Growth Factor;D017479
D12.776.543.750.060.625;Receptors, Platelet-Derived Growth Factor;D017479
D12.776.543.750.750.400.630;Receptors, Platelet-Derived Growth Factor;D017479
D12.776.543.750.100.620.775;Receptors, sigma;D017480
D12.776.543.750.720.600.610.775;Receptors, sigma;D017480
D12.776.543.750.750.555.610.775;Receptors, sigma;D017480
D12.776.543.750.100.850;Receptors, Somatostatin;D017481
D12.776.543.750.720.600.760;Receptors, Somatostatin;D017481
D12.776.543.750.750.555.760;Receptors, Somatostatin;D017481
D12.776.543.750.750.580.720;Receptors, Somatostatin;D017481
D12.776.543.750.750.700.800;Receptors, Somatostatin;D017481
D12.776.543.750.075.800;Receptors, Thromboxane;D017482
D12.776.543.750.100.200.800;Receptors, Thromboxane;D017482
D12.776.543.750.100.910;Receptors, Vasopressin;D017483
D12.776.543.750.720.600.925;Receptors, Vasopressin;D017483
D12.776.543.750.750.555.925;Receptors, Vasopressin;D017483
D12.776.543.750.750.660.900;Receptors, Vasopressin;D017483
C17.800.174.255.400.225;Dermatitis, Phototoxic;D017484
C17.800.600.335;Dermatitis, Phototoxic;D017484
C17.800.815.255.400.225;Dermatitis, Phototoxic;D017484
D02.491.567.500.033;1-Deoxynojirimycin;D017485
D03.132.014;1-Deoxynojirimycin;D017485
D03.383.621.300.033;1-Deoxynojirimycin;D017485
D09.546.412.500.033;1-Deoxynojirimycin;D017485
C17.800.030;Acneiform Eruptions;D017486
C17.800.271.125;Acneiform Eruptions;D017486
D12.776.124.080;Ankyrins;D017487
D12.776.543.080;Ankyrins;D017487
C16.131.831.512.400.375;Hyperkeratosis, Epidermolytic;D017488
C16.320.850.400.375;Hyperkeratosis, Epidermolytic;D017488
C16.614.492.400.375;Hyperkeratosis, Epidermolytic;D017488
C17.800.428.333.250.375;Hyperkeratosis, Epidermolytic;D017488
C17.800.804.512.400.375;Hyperkeratosis, Epidermolytic;D017488
C17.800.827.400.375;Hyperkeratosis, Epidermolytic;D017488
D08.811.913.696.620.682.700.200.067.500;CDC28 Protein Kinase, S cerevisiae;D017489
D12.644.360.250.067.500;CDC28 Protein Kinase, S cerevisiae;D017489
D12.776.167.200.067.500;CDC28 Protein Kinase, S cerevisiae;D017489
D12.776.354.750.124;CDC28 Protein Kinase, S cerevisiae;D017489
D12.776.476.250.067.500;CDC28 Protein Kinase, S cerevisiae;D017489
C16.131.831.512.400.410;Ichthyosis, Lamellar;D017490
C16.320.850.400.410;Ichthyosis, Lamellar;D017490
C16.614.492.400.410;Ichthyosis, Lamellar;D017490
C17.800.428.333.250.410;Ichthyosis, Lamellar;D017490
C17.800.804.512.400.410;Ichthyosis, Lamellar;D017490
C17.800.827.400.410;Ichthyosis, Lamellar;D017490
G05.360.340.024.340.375.249.050;Genes, APC;D017491
G05.360.340.024.340.415.400.050;Genes, APC;D017491
C17.800.428.580;Keratosis, Seborrheic;D017492
D08.811.277.352.650.775.400.100.500;Antigens, CD45;D017493
D12.644.360.587.100.500;Antigens, CD45;D017493
D12.776.476.592.100.500;Antigens, CD45;D017493
D12.776.543.733.937.500;Antigens, CD45;D017493
D23.050.301.264.035.145;Antigens, CD45;D017493
D23.101.100.110.145;Antigens, CD45;D017493
D12.776.157.530.450.250.875;Proton Pumps;D017494
D12.776.543.585.450.250.875;Proton Pumps;D017494
C17.800.621.430;Hyperpigmentation;D017495
C17.800.621.440;Hypopigmentation;D017496
C01.252.825.420;Hidradenitis Suppurativa;D017497
C01.539.800.720.420;Hidradenitis Suppurativa;D017497
C01.539.830.499;Hidradenitis Suppurativa;D017497
C17.800.838.765.420;Hidradenitis Suppurativa;D017497
C17.800.946.315.320;Hidradenitis Suppurativa;D017497
D12.776.460.050;Adenovirus E1 Proteins;D017498
D12.776.624.664.520.045.050;Adenovirus E1 Proteins;D017498
D12.776.964.700.045.050;Adenovirus E1 Proteins;D017498
D23.050.327.045.050;Adenovirus E1 Proteins;D017498
C16.320.850.730;Porokeratosis;D017499
C17.800.428.750;Porokeratosis;D017499
C17.800.827.730;Porokeratosis;D017499
D12.776.460.050.100;Adenovirus E1A Proteins;D017500
D12.776.624.664.520.045.050.100;Adenovirus E1A Proteins;D017500
D12.776.930.100;Adenovirus E1A Proteins;D017500
D12.776.964.700.045.050.100;Adenovirus E1A Proteins;D017500
D23.050.285.062.045;Adenovirus E1A Proteins;D017500
D23.050.327.062.045;Adenovirus E1A Proteins;D017500
D12.776.460.050.110;Adenovirus E1B Proteins;D017501
D12.776.624.664.520.045.050.110;Adenovirus E1B Proteins;D017501
D12.776.930.110;Adenovirus E1B Proteins;D017501
D12.776.964.700.045.050.110;Adenovirus E1B Proteins;D017501
D23.050.285.062.050;Adenovirus E1B Proteins;D017501
D23.050.327.062.050;Adenovirus E1B Proteins;D017501
D12.776.260.060;Adenovirus E2 Proteins;D017502
D12.776.624.664.520.045.060;Adenovirus E2 Proteins;D017502
D12.776.964.700.045.060;Adenovirus E2 Proteins;D017502
D23.050.327.045.060;Adenovirus E2 Proteins;D017502
D12.776.624.664.520.045.070;Adenovirus E3 Proteins;D017503
D12.776.964.700.045.070;Adenovirus E3 Proteins;D017503
D23.050.327.045.070;Adenovirus E3 Proteins;D017503
D12.776.624.664.520.045.080;Adenovirus E4 Proteins;D017504
D12.776.964.700.045.080;Adenovirus E4 Proteins;D017504
D23.050.327.045.080;Adenovirus E4 Proteins;D017504
D08.811.277.040.025.325.625;H(+)-K(+)-Exchanging ATPase;D017506
D12.776.157.530.450.250.875.500.625;H(+)-K(+)-Exchanging ATPase;D017506
D12.776.543.585.450.250.875.500.625;H(+)-K(+)-Exchanging ATPase;D017506
Z01.639.520.200;Comoros;D017507
Z01.639.520.700;Reunion;D017508
G01.154.100.640;Protein Folding;D017510
G01.595.100.640;Protein Folding;D017510
G02.111.087.690;Protein Folding;D017510
G02.149.115.690;Protein Folding;D017510
C17.800.695.675;Pyoderma Gangrenosum;D017511
C17.800.862.675;Pyoderma Gangrenosum;D017511
C17.800.893.675;Pyoderma Gangrenosum;D017511
C17.800.859.475;Lichenoid Eruptions;D017512
C17.800.859.475.545;Lichen Nitidus;D017513
C17.800.859.475.650;Pityriasis Lichenoides;D017514
C17.800.859.575.650;Pityriasis Lichenoides;D017514
C17.800.859.600.650;Pityriasis Lichenoides;D017514
C17.800.859.600.675;Pityriasis Rosea;D017515
Z01.586;Historical Geographic Locations;D017516
Z01.586.200;Commonwealth of Independent States;D017517
C17.300.550;Mucinoses;D017520
Z01.542.248.160;Bosnia-Herzegovina;D017522
Z01.586.980.160;Bosnia-Herzegovina;D017522
Z01.542.248.295;Croatia;D017523
Z01.586.980.295;Croatia;D017523
Z01.542.248.820;Slovenia;D017524
Z01.586.980.820;Slovenia;D017524
D08.811.913.696.620.682.725.400.185;Receptor, IGF Type 1;D017526
D12.776.543.750.060.468;Receptor, IGF Type 1;D017526
D12.776.543.750.750.400.780.400;Receptor, IGF Type 1;D017526
D12.776.543.750.750.400.780.410;Receptor, IGF Type 2;D017527
N05;Health Care Quality, Access, and Evaluation;D017530
N05.715.360;Health Care Evaluation Mechanisms;D017531
F01.829.263.315.500;Marital Status;D017533
I01.240.361.500;Marital Status;D017533
I01.880.225.423.500;Marital Status;D017533
N01.224.361.500;Marital Status;D017533
N01.824.308.500;Marital Status;D017533
A07.231.114.740;Radial Artery;D017534
A07.231.114.920;Ulnar Artery;D017535
A07.231.114.186.200;Carotid Artery, Common;D017536
A07.231.114.565.510;Mesenteric Artery, Inferior;D017537
A07.231.114.565.755;Mesenteric Artery, Superior;D017538
A07.231.330.800;Tunica Intima;D017539
A07.231.700;Tunica Intima;D017539
A10.272.491.355.800;Tunica Intima;D017539
A02.633.570.491.800;Tunica Media;D017540
A07.231.491.800;Tunica Media;D017540
A10.690.467.491.800;Tunica Media;D017540
C14.907.055.090;Aneurysm, False;D017541
C14.907.055.185;Aneurysm, Ruptured;D017542
C14.907.055.625;Iliac Aneurysm;D017543
C14.907.055.239.075;Aortic Aneurysm, Abdominal;D017544
C14.907.109.139.075;Aortic Aneurysm, Abdominal;D017544
C14.907.055.239.125;Aortic Aneurysm, Thoracic;D017545
C14.907.109.139.125;Aortic Aneurysm, Thoracic;D017545
E01.370.370.065;Angioscopy;D017546
E01.370.388.250.035;Angioscopy;D017546
E04.100.814.529.500;Angioscopy;D017546
E04.800.250.035;Angioscopy;D017546
E04.800.382.500;Angioscopy;D017546
E01.370.350.130.750.235;Echocardiography, Transesophageal;D017548
E01.370.350.850.220.235;Echocardiography, Transesophageal;D017548
E01.370.370.380.220.235;Echocardiography, Transesophageal;D017548
E05.196.712.726.676.700;Spectroscopy, Fourier Transform Infrared;D017550
E05.196.867.826.676.700;Spectroscopy, Fourier Transform Infrared;D017550
E05.196.353.500;Microdialysis;D017551
A08.186.211.132.810.406.750;Solitary Nucleus;D017552
A08.186.211.865.467.500.750;Solitary Nucleus;D017552
D01.695;Phosphorus Compounds;D017553
D01.200;Carbon Compounds, Inorganic;D017554
D01.925;Technetium Compounds;D017556
A08.186.211.132.659.822.820;Ventral Tegmental Area;D017557
A08.186.211.653.822.820;Ventral Tegmental Area;D017557
E04.772;Surgical Procedures, Elective;D017558
C06.130.825;Postcholecystectomy Syndrome;D017562
C23.550.767.775;Postcholecystectomy Syndrome;D017562
C08.381.483;Lung Diseases, Interstitial;D017563
C08.381.483.675;Radiation Pneumonitis;D017564
C08.381.520.734;Radiation Pneumonitis;D017564
C26.733.762;Radiation Pneumonitis;D017564
C08.381.483.725;Sarcoidosis, Pulmonary;D017565
C15.604.515.827.725;Sarcoidosis, Pulmonary;D017565
C14.280.647.187.575;Microvascular Angina;D017566
C14.907.585.187.575;Microvascular Angina;D017566
E05.318.308.250.475.456.500.500;Karnofsky Performance Status;D017567
N05.715.360.300.375.375.364.500.500;Karnofsky Performance Status;D017567
N06.850.520.308.250.475.364.500.500;Karnofsky Performance Status;D017567
A02.633.567.050.800;Rectus Abdominis;D017568
D12.776.210.500.570.590;MyoD Protein;D017570
D12.776.260.103.750.590;MyoD Protein;D017570
D12.776.930.125.750.590;MyoD Protein;D017570
D10.251.355.255.100.450.405;Leukotriene A4;D017572
D23.469.050.175.450.400;Leukotriene A4;D017572
C07.465.342;Focal Epithelial Hyperplasia;D017573
C14.280.067.672;Parasystole;D017574
C23.550.073.670;Parasystole;D017574
E07.700.600.400;Gloves, Protective;D017575
J01.637.215.600.400;Gloves, Protective;D017575
J01.637.708.600.400;Gloves, Protective;D017575
D04.345.566.270;Daptomycin;D017576
D10.477.500;Daptomycin;D017576
D12.644.365.500;Daptomycin;D017576
D12.644.641.270;Daptomycin;D017576
C17.800.135;Cutaneous Fistula;D017577
C23.300.575.150;Cutaneous Fistula;D017577
G05.355.330.401.501.450;Immunoglobulin Class Switching;D017578
G12.425.742.500.501.450;Immunoglobulin Class Switching;D017578
G12.500.349.500.501.450;Immunoglobulin Class Switching;D017578
I01.198.240.856.350;Domestic Violence;D017579
I01.880.735.900.350;Domestic Violence;D017579
E02.870;Renal Replacement Therapy;D017582
E02.870.300.200;Hemodiafiltration;D017583
E02.870.350.300;Hemodiafiltration;D017583
E02.912.400.300;Hemodiafiltration;D017583
E02.912.800.200;Hemodiafiltration;D017583
E04.292.471.350;Hemodiafiltration;D017583
E04.292.975.300.300;Hemodiafiltration;D017583
E05.196.454.807.300.300;Hemodiafiltration;D017583
E01.370.510.700;Reproductive History;D017584
N05.715.350.575;Reproductive History;D017584
N06.850.490.812;Reproductive History;D017584
E01.370.350.578.937.260.850;Ultrasonography, Doppler, Transcranial;D017585
E01.370.350.700.560.260.850;Ultrasonography, Doppler, Transcranial;D017585
E01.370.350.850.260.850;Ultrasonography, Doppler, Transcranial;D017585
E01.370.350.850.850.870;Ultrasonography, Doppler, Transcranial;D017585
E01.370.376.537.750.260.850;Ultrasonography, Doppler, Transcranial;D017585
E05.629.937.260.850;Ultrasonography, Doppler, Transcranial;D017585
E04.555.200;Diskectomy;D017586
E04.555.200.200;Diskectomy, Percutaneous;D017587
C12.706.316.064.500;Hyperandrogenism;D017588
C12.706.316.129.750;Hyperandrogenism;D017588
C13.351.875.253.064.500;Hyperandrogenism;D017588
C13.351.875.253.129.750;Hyperandrogenism;D017588
C16.131.939.316.064.500;Hyperandrogenism;D017588
C16.131.939.316.129.750;Hyperandrogenism;D017588
C19.391.119.064.500;Hyperandrogenism;D017588
C19.391.119.129.750;Hyperandrogenism;D017588
N02.421.143.827.608;Immunization Programs;D017589
N02.421.726.608;Immunization Programs;D017589
C10.228.140.163.560;Myelinolysis, Central Pontine;D017590
C10.314.500;Myelinolysis, Central Pontine;D017590
C18.452.132.560;Myelinolysis, Central Pontine;D017590
E01.370.225.124.100.600;Petrosal Sinus Sampling;D017591
E01.370.225.998.110.600;Petrosal Sinus Sampling;D017591
E04.665.150.600;Petrosal Sinus Sampling;D017591
E05.200.124.100.600;Petrosal Sinus Sampling;D017591
E05.200.998.110.600;Petrosal Sinus Sampling;D017591
E02.547.800;Skin Care;D017592
C10.886.425.800.200.500;Kleine-Levin Syndrome;D017593
F03.870.400.800.200.500;Kleine-Levin Syndrome;D017593
L01.737.813;Publication Bias;D017594
G08.852.796.700.740;Renal Plasma Flow;D017595
G09.330.190.163.812.740;Renal Plasma Flow;D017595
G08.852.796.700.750;Renal Plasma Flow, Effective;D017596
G09.330.190.163.812.750;Renal Plasma Flow, Effective;D017596
G08.852.796.700.700;Renal Blood Flow, Effective;D017597
G09.330.190.163.812.700;Renal Blood Flow, Effective;D017597
N04.452.227;Efficiency, Organizational;D017598
C04.557.465.625;Neuroectodermal Tumors;D017599
C04.557.580.625;Neuroectodermal Tumors;D017599
C04.557.465.625.630;Neuroectodermal Tumor, Melanotic;D017600
C04.557.580.625.630;Neuroectodermal Tumor, Melanotic;D017600
D01.650;Oxygen Compounds;D017601
E02.594.550;Lithotripsy, Laser;D017602
E02.600.500;Lithotripsy, Laser;D017602
E04.014.520.550;Lithotripsy, Laser;D017602
E04.943.500.500;Lithotripsy, Laser;D017602
E01.370.685.814;Signal Detection, Psychological;D017603
F02.463.593.257.800;Signal Detection, Psychological;D017603
F02.463.593.710.725;Signal Detection, Psychological;D017603
F04.096.753.814;Signal Detection, Psychological;D017603
F04.669.908;Signal Detection, Psychological;D017603
E04.520.252.500.150;Cesarean Section, Repeat;D017604
D01.139;Bromine Compounds;D017605
D01.210;Chlorine Compounds;D017606
D01.056;Aluminum Compounds;D017607
D01.220;Chromium Compounds;D017608
D01.103;Barium Compounds;D017609
D01.146;Calcium Compounds;D017610
D01.303;Fluorine Compounds;D017611
D01.379;Gold Compounds;D017612
D01.475;Iodine Compounds;D017613
A08.800.050.150;Enteric Nervous System;D017615
D01.524;Magnesium Compounds;D017616
E02.815.270;Hemibody Irradiation;D017619
C07.465.714.354.750;Periodontal Attachment Loss;D017622
C04.557.435.595.950;WAGR Syndrome;D017624
C04.588.945.947.535.585.950;WAGR Syndrome;D017624
C04.700.635.950;WAGR Syndrome;D017624
C10.597.606.643.969;WAGR Syndrome;D017624
C11.250.060.950;WAGR Syndrome;D017624
C11.270.060.950;WAGR Syndrome;D017624
C11.941.375.060.950;WAGR Syndrome;D017624
C12.706.316.096.875;WAGR Syndrome;D017624
C12.758.820.750.585.950;WAGR Syndrome;D017624
C12.777.419.473.585.950;WAGR Syndrome;D017624
C13.351.875.253.096.875;WAGR Syndrome;D017624
C13.351.937.820.535.585.950;WAGR Syndrome;D017624
C13.351.968.419.473.585.950;WAGR Syndrome;D017624
C16.131.260.940;WAGR Syndrome;D017624
C16.131.384.079.950;WAGR Syndrome;D017624
C16.131.939.316.096.875;WAGR Syndrome;D017624
C16.320.180.940;WAGR Syndrome;D017624
C16.320.290.078.950;WAGR Syndrome;D017624
C16.320.700.642.950;WAGR Syndrome;D017624
C19.391.119.096.875;WAGR Syndrome;D017624
A08.186.211.132.810.428.600.135;Cochlear Nucleus;D017626
A08.186.211.865.428.600.135;Cochlear Nucleus;D017626
A08.637.400;Microglia;D017628
A11.650.400;Microglia;D017628
A11.284.149.165.420.471;Gap Junctions;D017629
D12.776.543.585.250;Connexins;D017630
D01.524.500.050;Asbestos, Serpentine;D017632
D01.578.725.050.075;Asbestos, Serpentine;D017632
D01.578.725.500.050;Asbestos, Serpentine;D017632
D01.837.725.700.760.070.110;Asbestos, Serpentine;D017632
D01.837.725.700.760.535.400;Asbestos, Serpentine;D017632
D01.524.500;Magnesium Silicates;D017633
D01.578.725.500;Magnesium Silicates;D017633
D01.837.725.700.760.535;Magnesium Silicates;D017633
G12.425.746.425.800;Self Tolerance;D017634
G12.425.746.425.100;Clonal Anergy;D017635
D01.578.725.050.050;Asbestos, Amphibole;D017636
D01.837.725.700.760.070.050;Asbestos, Amphibole;D017636
G12.425.746.425.120;Clonal Deletion;D017637
D01.578.725.050.050.100;Asbestos, Crocidolite;D017638
D01.837.725.700.760.070.050.090;Asbestos, Crocidolite;D017638
D01.524.500.040;Asbestos, Amosite;D017639
D01.578.725.050.050.050;Asbestos, Amosite;D017639
D01.578.725.500.040;Asbestos, Amosite;D017639
D01.837.725.700.760.070.050.060;Asbestos, Amosite;D017639
D01.837.725.700.760.535.040;Asbestos, Amosite;D017639
D01.578.725;Silicates;D017640
D01.837.725.700.760;Silicates;D017640
D01.056.050.075.975;Zeolites;D017641
D01.578.725.025.975;Zeolites;D017641
D01.650.550.050.075.975;Zeolites;D017641
D01.837.725.700.760.050.950;Zeolites;D017641
D02.715;Organosilicon Compounds;D017646
D01.837;Silicon Compounds;D017655
D12.776.543.750.050;Autoreceptors;D017660
D12.776.543.750.720.670.100;Autoreceptors;D017660
D12.776.543.750.720.670;Receptors, Presynaptic;D017661
D09.400.420.110.690;Peplomycin;D017663
D12.644.233.110.690;Peplomycin;D017663
N04.590.374.900;Uncompensated Care;D017664
N05.300.830;Uncompensated Care;D017664
D01.248.497.158.459.300;Hydroxyl Radical;D017665
D01.339.431.249;Hydroxyl Radical;D017665
D01.455.432;Hydroxyl Radical;D017665
D01.435.256.250;Deuterium Oxide;D017666
D01.455.900.200;Deuterium Oxide;D017666
A11.329.114;Adipocytes;D017667
N05.715.350.075.100;Age of Onset;D017668
N06.850.490.250.100;Age of Onset;D017668
D01.538;Mercury Compounds;D017669
D01.857;Sodium Compounds;D017670
D01.710;Platinum Compounds;D017671
D01.625;Nitrogen Compounds;D017672
D01.857.650.705;Sodium Chloride, Dietary;D017673
D01.857.700.705;Sodium Chloride, Dietary;D017673
C18.452.750.400;Hypophosphatemia;D017674
C06.405.117.119.500.204;CREST Syndrome;D017675
C14.907.617.812.500;CREST Syndrome;D017675
C14.907.823.225;CREST Syndrome;D017675
C17.300.799.801.500;CREST Syndrome;D017675
C17.800.784.801.500;CREST Syndrome;D017675
C18.452.174.130.204;CREST Syndrome;D017675
C07.465.397;Lichen Planus, Oral;D017676
C17.800.859.475.560.397;Lichen Planus, Oral;D017676
I01.240.050;Age Distribution;D017677
N01.224.033;Age Distribution;D017677
N06.850.505.400.050;Age Distribution;D017677
I01.240.800;Sex Distribution;D017678
N01.224.803;Sex Distribution;D017678
N06.850.505.400.850;Sex Distribution;D017678
E02.258;Cryotherapy;D017679
D01.745;Potassium Compounds;D017680
C15.378.553.231.549;Hypereosinophilic Syndrome;D017681
C14.280.647.500.375;Myocardial Stunning;D017682
C14.280.647.750;Myocardial Stunning;D017682
C14.907.585.500.375;Myocardial Stunning;D017682
C14.907.585.750;Myocardial Stunning;D017682
B01.050.150.900.493.817.750.705.580;Oncorhynchus;D017683
B01.050.150.900.493.817.750.825.580;Oncorhynchus;D017683
B01.050.150.900.493.817.750.705.580.410;Oncorhynchus kisutch;D017684
B01.050.150.900.493.817.750.705.580.400;Oncorhynchus keta;D017685
B01.050.150.900.493.817.750.825.580.600;Oncorhynchus mykiss;D017686
D01.268.271.800.800;Radon Daughters;D017687
D01.362.641.745.800;Radon Daughters;D017687
C06.405.205.200;Cholera Morbus;D017688
C05.660.585.600;Polydactyly;D017689
C16.131.621.585.600;Polydactyly;D017689
E04.936.225;Cell Transplantation;D017690
Z01.107.084;Caribbean Region;D017691
D01.200.275.150.100.800;Sodium Bicarbonate;D017693
D01.857.625;Sodium Bicarbonate;D017693
E02.891;Rewarming;D017694
C26.808;Soft Tissue Injuries;D017695
C05.651.575.290;Myopathies, Nemaline;D017696
C10.668.491.550.290;Myopathies, Nemaline;D017696
G08.686.157.500.812;Premenopause;D017697
G08.686.785.880.249.500.812;Premenopause;D017697
G08.686.157.500.625;Postmenopause;D017698
G08.686.785.880.249.500.625;Postmenopause;D017698
C23.888.646.587;Pelvic Pain;D017699
C14.907.355.350.454.500;Embolism, Cholesterol;D017700
E01.370.225.500.195.107.330.725;Reticulocyte Count;D017701
E01.370.225.625.107.330.725;Reticulocyte Count;D017701
E05.200.500.195.107.330.725;Reticulocyte Count;D017701
E05.200.625.107.330.725;Reticulocyte Count;D017701
E05.242.195.107.330.725;Reticulocyte Count;D017701
G04.170.107.330.725;Reticulocyte Count;D017701
G09.188.105.330.725;Reticulocyte Count;D017701
C01.539.830.025.780;Retropharyngeal Abscess;D017703
C07.550.781.625;Retropharyngeal Abscess;D017703
C08.730.561.625;Retropharyngeal Abscess;D017703
C09.775.649.625;Retropharyngeal Abscess;D017703
G09.330.190.400.090;Baroreflex;D017704
G11.561.600.765.063;Baroreflex;D017704
D02.455.426.559.389.140.450;Lignans;D017705
D12.644.456.345.600;Lisinopril;D017706
E02.095.135.140.275;Erythrocyte Transfusion;D017707
E02.095.135.140.425;Leukocyte Transfusion;D017708
E05.599.125;Fractals;D017709
G17.290;Fractals;D017709
E02.095.135.140.425.445;Lymphocyte Transfusion;D017710
E05.599.850;Nonlinear Dynamics;D017711
H01.548.675;Nonlinear Dynamics;D017711
F01.829.316.549.700;Peer Review, Research;D017712
H01.770.644.487;Peer Review, Research;D017712
I01.880.604.640.700;Peer Review, Research;D017712
L01.737.640;Peer Review, Research;D017712
N03.706.700.700;Peer Review, Research;D017712
E02.095.135.140.650;Platelet Transfusion;D017713
C01.539.234;Community-Acquired Infections;D017714
C14.907.320.191;Diabetic Foot;D017719
C17.800.893.592.450.200;Diabetic Foot;D017719
C19.246.099.500.191;Diabetic Foot;D017719
C19.246.099.937.250;Diabetic Foot;D017719
E05.318.416;Molecular Epidemiology;D017720
E05.393.522;Molecular Epidemiology;D017720
H01.158.201.636.475.500;Molecular Epidemiology;D017720
H01.158.273.343.595.475.500;Molecular Epidemiology;D017720
H01.181.122.650.475.550;Molecular Epidemiology;D017720
H02.403.720.500.300;Molecular Epidemiology;D017720
N06.850.520.470;Molecular Epidemiology;D017720
N03.219.151.400.687;Hospital Costs;D017721
N03.219.262.500;Hospital Costs;D017721
N05.300.375.500;Hospital Costs;D017721
N03.219.262.300;Hospital Charges;D017722
N03.219.442.613;Hospital Charges;D017722
N04.452.706.477.400;Drug Utilization Review;D017723
N04.761.879.300;Drug Utilization Review;D017723
N05.700.900.300;Drug Utilization Review;D017723
G09.330.190.962.950;Ventricular Pressure;D017725
G09.330.380.937;Ventricular Pressure;D017725
C02.256.466.245.150;Cytomegalovirus Retinitis;D017726
C02.325.270;Cytomegalovirus Retinitis;D017726
C11.294.800.270;Cytomegalovirus Retinitis;D017726
C11.768.773.360;Cytomegalovirus Retinitis;D017726
B04.280.120.400.150;Chicken anemia virus;D017727
B04.909.204.120.400.150;Chicken anemia virus;D017727
C04.557.386.480.487;Lymphoma, Large-Cell, Anaplastic;D017728
C04.557.386.480.750.399;Lymphoma, Large-Cell, Anaplastic;D017728
C15.604.515.569.480.487;Lymphoma, Large-Cell, Anaplastic;D017728
C20.683.515.761.480.750.399;Lymphoma, Large-Cell, Anaplastic;D017728
A08.663.542.145.750;Presynaptic Terminals;D017729
A08.850.700;Presynaptic Terminals;D017729
A11.284.149.165.420.780.700;Presynaptic Terminals;D017729
A11.671.137.750;Presynaptic Terminals;D017729
D12.776.543.750.705.852.760.072;Antigens, CD30;D017730
D23.050.285.025;Antigens, CD30;D017730
D23.050.301.264.035.130;Antigens, CD30;D017730
D23.101.100.110.130;Antigens, CD30;D017730
D23.101.840.055;Antigens, CD30;D017730
C04.557.386.480.750.800.528;Lymphomatoid Papulosis;D017731
C15.604.515.569.480.750.800.528;Lymphomatoid Papulosis;D017731
C20.683.515.761.480.750.800.528;Lymphomatoid Papulosis;D017731
J01.937.285.100.100;Air Ambulances;D017732
N02.421.297.879.100.100;Air Ambulances;D017732
C02.256.466.313.500;Leukoplakia, Hairy;D017733
C04.588.443.591.545.500;Leukoplakia, Hairy;D017733
C04.834.512.513.500;Leukoplakia, Hairy;D017733
C07.465.565.545.500;Leukoplakia, Hairy;D017733
C23.300.816.513.500;Leukoplakia, Hairy;D017733
A03.159.183.079;Bile Ducts, Extrahepatic;D017734
G06.920.900;Virus Latency;D017735
E07.305.250.471;Ion-Selective Electrodes;D017736
A11.329.372.630;Macrophages, Peritoneal;D017737
A11.627.482.630;Macrophages, Peritoneal;D017737
A11.733.397.630;Macrophages, Peritoneal;D017737
A15.382.680.397.630;Macrophages, Peritoneal;D017737
A15.382.812.522.630;Macrophages, Peritoneal;D017737
D02.455.326.146.100;Alkanesulfonic Acids;D017738
D02.886.645.600.055;Alkanesulfonic Acids;D017738
D02.886.645.600.080;Arylsulfonic Acids;D017739
M01.643.836;Survivors;D017741
M01.860;Survivors;D017741
E06.170.205;Dental Care for Chronically Ill;D017742
N02.421.240.190.220;Dental Care for Chronically Ill;D017742
E05.328;Equipment Reuse;D017743
N06.850.585;Equipment Reuse;D017743
D20.944.460.300;Medical Waste Disposal;D017744
N06.850.460.710.460.300;Medical Waste Disposal;D017744
N06.850.860.510.900.600.600;Medical Waste Disposal;D017744
N06.850.860.510.900.600.500;Incineration;D017745
A02.835.583.443;Joint Capsule;D017746
J02.500.600.875;Seafood;D017747
F02.784.412.923;Time Management;D017748
F02.784.692.816;Time Management;D017748
F04.096.628.779.900;Time Management;D017748
N04.452.932;Time Management;D017748
N04.452.955;Total Quality Management;D017749
N04.761.700.675;Total Quality Management;D017749
N05.700.792;Total Quality Management;D017749
M01.526.485.067.040;Animal Technicians;D017750
N02.360.067.040;Animal Technicians;D017750
N04.452.871.900;Safety Management;D017751
N04.452.884;Safety Management;D017751
N06.850.135.060.075.800;Safety Management;D017751
G16.500.240.135.374.750;Greenhouse Effect;D017752
G16.500.240.135.827;Greenhouse Effect;D017752
N06.230.265;Greenhouse Effect;D017752
G16.500.275.157;Ecosystem;D017753
N06.230.124;Ecosystem;D017753
N02.278.354.422.679.375;Group Purchasing;D017754
N03.219.463.430;Group Purchasing;D017754
N04.452.442.422.679.375;Group Purchasing;D017754
E02.794;Prosthesis Fitting;D017755
J01.040.168;Aquaculture;D017756
N06.850.310.415;Infectious Disease Transmission, Professional-to-Patient;D017757
N06.850.310.410;Infectious Disease Transmission, Patient-to-Professional;D017758
C26.404.249;Fractures, Malunited;D017759
C05.116.214;Bone Malalignment;D017760
D09.698.373.400.300.600;Nadroparin;D017762
E04.525.210.080;Autonomic Denervation;D017763
E04.525.210.080.600;Parasympathectomy;D017764
D08.811.277.040;Acid Anhydride Hydrolases;D017766
I01.198.240.903.149.500;Holocaust;D017767
I01.880.735.944.903.149.500;Holocaust;D017767
E07.858.082.800;Skin, Artificial;D017768
C10.668.829.500.850.600;Ulnar Nerve Compression Syndromes;D017769
C10.668.829.550.925;Ulnar Nerve Compression Syndromes;D017769
C26.844.150.957;Ulnar Nerve Compression Syndromes;D017769
G01.374.676.530;Lifting;D017770
G01.595.540.530;Lifting;D017770
C10.668.829.050;Amyloid Neuropathies;D017772
C18.452.845.500.050;Amyloid Neuropathies;D017772
A01.923.600.600;Pelvic Floor;D017773
A02.633.567.050.750;Pelvic Floor;D017773
G11.561.600.635.350;Long-Term Potentiation;D017774
A08.800.050.050;Autonomic Pathways;D017776
A08.800.800.060;Autonomic Pathways;D017776
A08.663.542.100.700;Parasympathetic Fibers, Postganglionic;D017777
A08.663.542.234.700;Parasympathetic Fibers, Postganglionic;D017777
A08.800.050.050.050.700;Parasympathetic Fibers, Postganglionic;D017777
A08.800.050.600.650;Parasympathetic Fibers, Postganglionic;D017777
A08.800.800.060.050.700;Parasympathetic Fibers, Postganglionic;D017777
A11.671.078.700;Parasympathetic Fibers, Postganglionic;D017777
D20.215.894.815;Vaccines, Combined;D017778
A08.663.542.075.800;Sympathetic Fibers, Postganglionic;D017779
A08.663.542.100.800;Sympathetic Fibers, Postganglionic;D017779
A08.800.050.050.050.800;Sympathetic Fibers, Postganglionic;D017779
A08.800.800.060.050.800;Sympathetic Fibers, Postganglionic;D017779
A11.671.078.800;Sympathetic Fibers, Postganglionic;D017779
D20.215.894.582.500;Malaria Vaccines;D017780
G05.360.340.024.340.330;Genes, Immediate-Early;D017781
G05.360.340.024.340.490.345;Genes, Immediate-Early;D017781
G05.360.340.400.500.345;Genes, Immediate-Early;D017781
A08.340.315.350.850;Superior Cervical Ganglion;D017783
A08.800.050.300.300.850;Superior Cervical Ganglion;D017783
A08.800.050.800.300.850;Superior Cervical Ganglion;D017783
N02.278.065.600;Milk Banks;D017784
G01.249.705;Photons;D017785
G01.358.500.505.650.782;Photons;D017785
G01.590.540.782;Photons;D017785
G01.750.250.650.782;Photons;D017785
G01.750.770.578.782;Photons;D017785
B04.715.260.150;Carlavirus;D017788
B04.820.260.150;Carlavirus;D017788
C23.550.382.937;Granuloma, Pyogenic;D017789
B04.715.110.150;Closterovirus;D017790
B04.820.110.150;Closterovirus;D017790
B04.280.350;Geminiviridae;D017791
B04.715.270;Geminiviridae;D017791
E04.987.775.800;Surgical Stapling;D017792
B04.715.435.500;Luteovirus;D017793
B04.820.420.500;Luteovirus;D017793
B04.715.081.050.050;Alfalfa mosaic virus;D017794
B04.715.464.040.050;Alfalfa mosaic virus;D017794
B04.820.081.050.050;Alfalfa mosaic virus;D017794
B04.820.464.040.050;Alfalfa mosaic virus;D017794
B04.715.081.080;Bromovirus;D017795
B04.715.464.080;Bromovirus;D017795
B04.820.081.080;Bromovirus;D017795
B04.820.464.080;Bromovirus;D017795
B04.280.092.150;Caulimovirus;D017796
B04.715.102.150;Caulimovirus;D017796
B04.715.464.100;Caulimovirus;D017796
E05.320.550.550;Prosthesis Coloring;D017797
E07.695.680.550;Prosthesis Coloring;D017797
B04.715.150.150;Comovirus;D017798
B04.715.464.150;Comovirus;D017798
B04.820.150.150;Comovirus;D017798
B04.820.464.150;Comovirus;D017798
B04.715.081.180;Cucumovirus;D017799
B04.715.464.180;Cucumovirus;D017799
B04.820.081.180;Cucumovirus;D017799
B04.820.464.180;Cucumovirus;D017799
B04.715.464.600;Potyvirus;D017800
B04.715.635.600;Potyvirus;D017800
B04.820.464.600;Potyvirus;D017800
B04.820.590.600;Potyvirus;D017800
B04.715.464.600.600;Plum Pox Virus;D017801
B04.715.635.600.600;Plum Pox Virus;D017801
B04.820.464.600.600;Plum Pox Virus;D017801
B04.820.590.600.600;Plum Pox Virus;D017801
F01.829.263.315.500.862;Widowhood;D017805
I01.240.361.500.862;Widowhood;D017805
I01.880.225.423.500.862;Widowhood;D017805
N01.224.361.500.862;Widowhood;D017805
N01.824.308.500.862;Widowhood;D017805
B04.715.464.750;Tymovirus;D017806
B04.715.850.860;Tymovirus;D017806
B04.820.464.750;Tymovirus;D017806
B04.820.900.850;Tymovirus;D017806
E05.318.308.985.550.325;Fatal Outcome;D017809
L01.280.975.550.325;Fatal Outcome;D017809
N01.224.935.698.201;Fatal Outcome;D017809
N06.850.505.400.975.550.325;Fatal Outcome;D017809
N06.850.520.308.985.550.325;Fatal Outcome;D017809
B01.050.150.900.833.672.280;Colubridae;D017812
B01.050.150.900.833.672.350;Elapidae;D017815
E05.927.573.500;Nasal Lavage Fluid;D017817
B01.050.150.900.833.672.875;Viperidae;D017819
B01.050.150.900.833.672.250;Boidae;D017821
C07.465.714.204;Furcation Defects;D017823
C04.182.089.265;Bone Cysts, Aneurysmal;D017824
C05.116.070.265;Bone Cysts, Aneurysmal;D017824
C10.228.140.163.100.362.375;Canavan Disease;D017825
C10.228.140.695.625.375;Canavan Disease;D017825
C10.228.518.625.375;Canavan Disease;D017825
C10.314.400.375;Canavan Disease;D017825
C10.574.500.300;Canavan Disease;D017825
C16.320.400.150;Canavan Disease;D017825
C16.320.565.189.362.375;Canavan Disease;D017825
C18.452.132.100.362.375;Canavan Disease;D017825
C18.452.648.189.362.375;Canavan Disease;D017825
C10.228.140.252.190.530.530;Machado-Joseph Disease;D017827
C10.228.140.252.700.700.500;Machado-Joseph Disease;D017827
C10.228.854.787.875.500;Machado-Joseph Disease;D017827
C10.574.500.825.700.500;Machado-Joseph Disease;D017827
C10.597.350.090.500.530.530;Machado-Joseph Disease;D017827
C16.320.400.780.875.500;Machado-Joseph Disease;D017827
D03.549.811.650;Rifabutin;D017828
D04.345.295.750.650;Rifabutin;D017828
D02.145.074.444;Granisetron;D017829
D03.383.129.539.487.350;Granisetron;D017829
D03.438.449.350;Granisetron;D017829
D04.075.080.875.099.444;Granisetron;D017829
D02.033.455.250.700.660;Octoxynol;D017830
D05.750.741.610;Octoxynol;D017830
D25.720.741.610;Octoxynol;D017830
J01.637.051.720.741.610;Octoxynol;D017830
E01.190;Diagnosis, Dual (Psychiatry);D017831
A08.612.220.830;Visceral Afferents;D017833
D03.438.810.835.055.550;Nedocromil;D017835
B01.050.150.900.833.672.875.120;Agkistrodon;D017836
B01.050.150.900.833.672.875.200;Bothrops;D017837
B01.050.150.900.833.672.350.225;Bungarus;D017838
B01.050.150.900.833.672.875.280;Crotalus;D017839
B01.050.150.900.833.672.875.750;Russell's Viper;D017840
B01.050.150.900.833.672.875.875;Trimeresurus;D017841
A02.513.514.287;Ligamentum Flavum;D017843
A02.835.583.512.287;Ligamentum Flavum;D017843
A02.513.514.162.500;Lateral Ligament, Ankle;D017844
A02.835.583.512.162.500;Lateral Ligament, Ankle;D017844
A02.513.514.350;Longitudinal Ligaments;D017846
A02.835.583.512.350;Longitudinal Ligaments;D017846
A02.513.514.475;Patellar Ligament;D017847
A02.835.583.512.475;Patellar Ligament;D017847
A02.880.438;Patellar Ligament;D017847
B01.300.248;Blood-Borne Pathogens;D017848
B02.050;Blood-Borne Pathogens;D017848
B03.165;Blood-Borne Pathogens;D017848
B04.909.142;Blood-Borne Pathogens;D017848
B01.050.050.157;Animals, Inbred Strains;D017849
B01.050.050.199.520;Animals, Inbred Strains;D017849
N03.219.390;Economics, Pharmaceutical;D017850
D08.811.913.696.630;Phosphotransferases (Carboxyl Group Acceptor);D017851
D08.811.913.696.640;Phosphotransferases (Nitrogenous Group Acceptor);D017852
D08.811.913.696.620;Phosphotransferases (Alcohol Group Acceptor);D017853
D08.811.913.696.175;Diphosphotransferases;D017854
D08.811.913.696.900;Transferases (Other Substituted Phosphate Groups);D017855
D08.811.913.696.650;Phosphotransferases (Phosphate Group Acceptor);D017856
B01.050.150.900.493.817;Salmoniformes;D017858
B01.050.150.900.493.385.300;Esocidae;D017859
B04.715.150.500;Nepovirus;D017860
B04.820.150.500;Nepovirus;D017860
B03.140.094.625;Porphyromonas;D017861
B03.440.425.410.194.625;Porphyromonas;D017861
B04.280.600;Phycodnaviridae;D017862
B04.715.600;Phycodnaviridae;D017862
B04.715.260.575;Potexvirus;D017863
B04.820.260.575;Potexvirus;D017863
B04.715.810.870;Tombusvirus;D017864
B04.820.860.870;Tombusvirus;D017864
B04.715.820;Tospovirus;D017865
B04.820.087.730;Tospovirus;D017865
D08.811.913.696.645;Phosphotransferases (Paired Acceptors);D017866
D08.811.913.696.620.682.700.150;Cyclic Nucleotide-Regulated Protein Kinases;D017867
D12.644.360.200;Cyclic Nucleotide-Regulated Protein Kinases;D017867
D12.776.476.200;Cyclic Nucleotide-Regulated Protein Kinases;D017867
D08.811.913.696.620.682.700.150.125;Cyclic AMP-Dependent Protein Kinases;D017868
D12.644.360.200.125;Cyclic AMP-Dependent Protein Kinases;D017868
D12.776.476.200.125;Cyclic AMP-Dependent Protein Kinases;D017868
D08.811.913.696.620.682.700.150.150;Cyclic GMP-Dependent Protein Kinases;D017869
D12.644.360.200.150;Cyclic GMP-Dependent Protein Kinases;D017869
D12.776.476.200.150;Cyclic GMP-Dependent Protein Kinases;D017869
D08.811.913.696.620.682.700.125;Calcium-Calmodulin-Dependent Protein Kinases;D017871
D12.644.360.100;Calcium-Calmodulin-Dependent Protein Kinases;D017871
D12.776.476.100;Calcium-Calmodulin-Dependent Protein Kinases;D017871
D12.776.460;Immediate-Early Proteins;D017874
D12.776.964.925.968;Immediate-Early Proteins;D017874
D08.811.399.520.750;Phosphotransferases (Phosphomutases);D017875
B01.050.150.900.493.385.850;Umbridae;D017877
D02.455.426.559.389.150.700.200;4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid;D017878
D02.500.375.125;4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid;D017878
D02.886.250.125;4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid;D017878
D02.500.375;Isothiocyanates;D017879
D02.886.250;Isothiocyanates;D017879
C05.660.585;Limb Deformities, Congenital;D017880
C16.131.621.585;Limb Deformities, Congenital;D017880
B03.440.400.425.550.400;Kingella;D017881
B03.660.075.525.410;Kingella;D017881
B03.440.400.425.550.400.375;Kingella kingae;D017882
B03.660.075.525.410.410;Kingella kingae;D017882
A02.513.514.162;Collateral Ligaments;D017885
A02.835.583.512.162;Collateral Ligaments;D017885
D01.146.360.050.300.200;Durapatite;D017886
D01.578.122.477.300;Durapatite;D017886
D01.695.625.675.650.075.025.300.150;Durapatite;D017886
C05.116.900.480;Ossification of Posterior Longitudinal Ligament;D017887
C23.550.751.500;Ossification of Posterior Longitudinal Ligament;D017887
A02.513.514.162.600;Medial Collateral Ligament, Knee;D017888
A02.835.583.512.162.600;Medial Collateral Ligament, Knee;D017888
C11.941.375.285;Exfoliation Syndrome;D017889
C15.604.744.742.500;Splenosis;D017890
C26.017.680.500;Splenosis;D017890
C26.761.555.500;Splenosis;D017890
H01.158.703.045;Pharmacoepidemiology;D017891
H02.403.720.500.650;Pharmacoepidemiology;D017891
H02.628.413;Pharmacoepidemiology;D017891
D01.640;Osmium Compounds;D017892
E02.774.945.500.500;Photopheresis;D017893
E04.292.762;Photopheresis;D017893
D01.530;Manganese Compounds;D017895
B04.715.464.725;Tobamovirus;D017898
B04.820.464.725;Tobamovirus;D017898
B04.123.150;Caudovirales;D017899
B04.280.090;Caudovirales;D017899
B04.100.500;Myoviridae;D017900
B04.123.150.500;Myoviridae;D017900
B04.280.090.500;Myoviridae;D017900
B04.123.150.500.305;Bacteriophage P2;D017901
B04.123.205.305;Bacteriophage P2;D017901
B04.280.090.500.305;Bacteriophage P2;D017901
B04.123.150.700;Podoviridae;D017902
B04.280.090.700;Podoviridae;D017902
B04.123.150.700.100;Bacteriophage T3;D017903
B04.123.205.891.100;Bacteriophage T3;D017903
B04.280.090.700.100;Bacteriophage T3;D017903
B03.510.024.049.050.525;Mobiluncus;D017904
B03.510.460.400.400.049.049.589;Mobiluncus;D017904
D01.248.497.158.750;Phosphites;D017905
D01.695.625.700.675;Phosphites;D017905
B04.100.750;Siphoviridae;D017906
B04.123.150.800;Siphoviridae;D017906
B04.280.090.800;Siphoviridae;D017906
B04.123.205.600;Leviviridae;D017907
B04.123.450;Leviviridae;D017907
B04.123.691.600;Leviviridae;D017907
B04.820.410;Leviviridae;D017907
B04.123.205.600.050;Allolevivirus;D017908
B04.123.450.050;Allolevivirus;D017908
B04.123.691.600.050;Allolevivirus;D017908
B04.820.410.050;Allolevivirus;D017908
B04.123.205.600.500;Levivirus;D017909
B04.123.450.500;Levivirus;D017909
B04.123.691.600.500;Levivirus;D017909
B04.820.410.500;Levivirus;D017909
B04.123.230;Cystoviridae;D017910
B04.123.691.230;Cystoviridae;D017910
B04.820.180;Cystoviridae;D017910
B04.123.370;Inoviridae;D017911
B04.280.400;Inoviridae;D017911
B04.123.370.400;Inovirus;D017912
B04.280.400.400;Inovirus;D017912
B04.123.370.600;Plectrovirus;D017913
B04.280.400.600;Plectrovirus;D017913
B04.123.470;Microviridae;D017914
B04.280.470;Microviridae;D017914
B04.123.470.500;Microvirus;D017915
B04.280.470.500;Microvirus;D017915
B04.123.900;Tectiviridae;D017916
B04.280.900;Tectiviridae;D017916
B04.280.375.100;Avihepadnavirus;D017917
B04.450.390.100;Avihepadnavirus;D017917
B04.909.204.340.100;Avihepadnavirus;D017917
B04.280.375.650;Orthohepadnavirus;D017918
B04.450.390.650;Orthohepadnavirus;D017918
B04.909.204.340.650;Orthohepadnavirus;D017918
B04.280.375.650.460;Hepatitis B Virus, Woodchuck;D017919
B04.450.390.650.460;Hepatitis B Virus, Woodchuck;D017919
B04.909.204.340.650.460;Hepatitis B Virus, Woodchuck;D017919
D12.776.157.530.450.162;Antiporters;D017920
D12.776.543.550.190;Antiporters;D017920
D12.776.543.585.450.162;Antiporters;D017920
B04.280.030.500;Mastadenovirus;D017921
B04.909.204.097.500;Mastadenovirus;D017921
D12.776.157.530.450.162.775;Sodium-Hydrogen Antiporter;D017923
D12.776.543.550.190.775;Sodium-Hydrogen Antiporter;D017923
D12.776.543.585.450.162.775;Sodium-Hydrogen Antiporter;D017923
B04.280.065.500;Nucleopolyhedrovirus;D017924
B04.525.100.500;Nucleopolyhedrovirus;D017924
B04.280.120.150;Circovirus;D017925
B04.909.204.120.150;Circovirus;D017925
B04.820.095.887.150;Calicivirus, Feline;D017927
B04.909.777.162.887.150;Calicivirus, Feline;D017927
B04.820.095.887.900;Vesicular exanthema of swine virus;D017928
B04.909.777.162.887.900;Vesicular exanthema of swine virus;D017928
B04.820.095.500.380;Hemorrhagic Disease Virus, Rabbit;D017929
B04.909.777.162.500.380;Hemorrhagic Disease Virus, Rabbit;D017929
G05.360.340.024.340.435;Genes, Reporter;D017930
D13.695.578.424.450.275;DNA Primers;D017931
D27.720.470.530.600.223.600;DNA Primers;D017931
A08.800;Peripheral Nervous System;D017933
B04.820.504.540.150;Coronavirus;D017934
B04.909.777.500.540.150;Coronavirus;D017934
D08.244.175;Cytochrome a Group;D017936
D12.776.422.220.175;Cytochrome a Group;D017936
D08.244.300;Cytochrome d Group;D017937
D12.776.422.220.300;Cytochrome d Group;D017937
B04.820.504.540.150.150;Coronavirus, Bovine;D017938
B04.909.777.500.540.150.150;Coronavirus, Bovine;D017938
B04.820.504.540.150.160;Coronavirus, Canine;D017939
B04.909.777.500.540.150.160;Coronavirus, Canine;D017939
B04.820.504.540.150.260;Coronavirus, Rat;D017941
B04.909.777.500.540.150.260;Coronavirus, Rat;D017941
D01.029.260.550;Nitric Acid;D017942
D01.625.525;Nitric Acid;D017942
B04.820.565.170;Cardiovirus;D017943
B04.909.777.618.170;Cardiovirus;D017943
B04.820.565.170.200.150;Columbia SK virus;D017944
B04.909.777.618.170.200.150;Columbia SK virus;D017944
B04.820.565.170.800;Theilovirus;D017945
B04.909.777.618.170.800;Theilovirus;D017945
A08.663.650.850.625.670.650;Retinal Rod Photoreceptor Cells;D017948
A08.663.650.915.937.670.650;Retinal Rod Photoreceptor Cells;D017948
A08.800.950.937.670.650;Retinal Rod Photoreceptor Cells;D017948
A09.371.729.831.625.670.650;Retinal Rod Photoreceptor Cells;D017948
A11.671.650.850.625.670.650;Retinal Rod Photoreceptor Cells;D017948
A11.671.650.915.937.670.650;Retinal Rod Photoreceptor Cells;D017948
A08.663.650.850.625.670.100;Retinal Cone Photoreceptor Cells;D017949
A08.663.650.915.937.670.100;Retinal Cone Photoreceptor Cells;D017949
A08.800.950.937.670.100;Retinal Cone Photoreceptor Cells;D017949
A09.371.729.831.625.670.100;Retinal Cone Photoreceptor Cells;D017949
A11.671.650.850.625.670.100;Retinal Cone Photoreceptor Cells;D017949
A11.671.650.915.937.670.100;Retinal Cone Photoreceptor Cells;D017949
A08.340.390;Ganglia, Sensory;D017950
A08.800.350;Ganglia, Sensory;D017950
G12.425.107;Antigen Presentation;D017951
G12.450.050.400.070;Antigen Presentation;D017951
A08.340.352;Ganglia, Invertebrate;D017952
A13.408;Ganglia, Invertebrate;D017952
D02.500;Isocyanates;D017953
Z01.058.290;Africa South of the Sahara;D017954
B04.820.565.284.664;Poliovirus;D017955
B04.909.777.618.284.689;Poliovirus;D017955
A08.663.650.850.625.660;Photoreceptor Cells, Invertebrate;D017956
A08.663.650.915.937.650;Photoreceptor Cells, Invertebrate;D017956
A08.800.950.937.650;Photoreceptor Cells, Invertebrate;D017956
A09.371.729.831.625.660;Photoreceptor Cells, Invertebrate;D017956
A11.671.650.850.625.660;Photoreceptor Cells, Invertebrate;D017956
A11.671.650.915.937.650;Photoreceptor Cells, Invertebrate;D017956
A13.750;Photoreceptor Cells, Invertebrate;D017956
B04.450.420.410.500;Hepatitis A Virus, Human;D017957
B04.820.565.400.410.500;Hepatitis A Virus, Human;D017957
B04.909.777.618.400.410.500;Hepatitis A Virus, Human;D017957
B04.820.650.589.650;Lentiviruses, Primate;D017958
B04.909.777.731.589.650;Lentiviruses, Primate;D017958
B04.820.650.589.500;Lentiviruses, Bovine;D017960
B04.909.777.731.589.500;Lentiviruses, Bovine;D017960
B04.820.650.589.520;Lentiviruses, Equine;D017961
B04.909.777.731.589.520;Lentiviruses, Equine;D017961
D10.212.302.380.410.100;alpha-Linolenic Acid;D017962
D10.251.355.310.640.400;alpha-Linolenic Acid;D017962
D10.251.355.337.100;alpha-Linolenic Acid;D017962
D10.251.355.450.400;alpha-Linolenic Acid;D017962
D02.540.505.250.050;Azithromycin;D017963
D03.383.129.799.550;Itraconazole;D017964
D03.383.606.530;Itraconazole;D017964
D10.251.355.310.640.425;gamma-Linolenic Acid;D017965
D10.251.355.343.249;gamma-Linolenic Acid;D017965
D10.251.355.450.450;gamma-Linolenic Acid;D017965
A08.186.211.464.405.700;Pyramidal Cells;D017966
A08.186.211.730.885.287.500.345.700;Pyramidal Cells;D017966
A08.186.211.730.885.287.500.766;Pyramidal Cells;D017966
A08.663.790;Pyramidal Cells;D017966
A11.671.790;Pyramidal Cells;D017966
D01.975;Zinc Compounds;D017967
D01.960;Vanadium Compounds;D017968
B04.820.650.589.530;Lentiviruses, Feline;D017969
B04.909.777.731.589.530;Lentiviruses, Feline;D017969
D01.930;Thorium Compounds;D017970
D01.935;Tin Compounds;D017971
B04.820.650.589.600;Lentiviruses, Ovine-Caprine;D017972
B04.909.777.731.589.600;Lentiviruses, Ovine-Caprine;D017972
D01.940;Tungsten Compounds;D017973
D01.950;Uranium Compounds;D017974
D01.765;Ruthenium Compounds;D017975
D01.029.260.700;Phosphorus Acids;D017976
D01.695.625;Phosphorus Acids;D017976
B04.820.650.200;Deltaretrovirus;D017977
B04.909.574.807.200;Deltaretrovirus;D017977
B04.909.777.731.200;Deltaretrovirus;D017977
D12.776.543.750.750.400;Receptors, Growth Factor;D017978
D01.379.400;Gold Colloid;D017979
D12.776.543.750.720;Receptors, Neurotransmitter;D017981
D12.776.543.750.070;Receptors, Biogenic Amine;D017982
D12.776.543.750.720.300;Receptors, Biogenic Amine;D017982
D12.776.543.750.070.300;Receptors, Catecholamine;D017983
D12.776.543.750.100.150;Receptors, Catecholamine;D017983
D12.776.543.750.720.300.300;Receptors, Catecholamine;D017983
D09.698.373.400.300.200;Enoxaparin;D017984
D09.698.373.400.300.150;Dalteparin;D017985
B04.820.650.375.700;Reticuloendotheliosis Viruses, Avian;D017986
B04.909.574.807.375.700;Reticuloendotheliosis Viruses, Avian;D017986
B04.909.777.731.375.700;Reticuloendotheliosis Viruses, Avian;D017986
B04.820.650.375;Gammaretrovirus;D017988
B04.909.574.807.375;Gammaretrovirus;D017988
B04.909.777.731.375;Gammaretrovirus;D017988
B04.820.650.375.510;Leukemia Virus, Gibbon Ape;D017989
B04.820.650.805.510;Leukemia Virus, Gibbon Ape;D017989
B04.909.574.807.375.510;Leukemia Virus, Gibbon Ape;D017989
B04.909.574.807.805.510;Leukemia Virus, Gibbon Ape;D017989
B04.909.777.731.375.510;Leukemia Virus, Gibbon Ape;D017989
B04.909.777.731.805.510;Leukemia Virus, Gibbon Ape;D017989
B04.280.580.150.200;Densovirus;D017990
B04.525.150.150;Densovirus;D017990
B04.280.580.650.600;Parvovirus;D017992
B04.909.204.671.650.600;Parvovirus;D017992
B04.280.580.650.600.325.660;Parvovirus, Canine;D017993
B04.909.204.671.650.600.325.660;Parvovirus, Canine;D017993
B04.280.410.400;Iridovirus;D017994
B04.525.400;Iridovirus;D017994
B04.280.410.700;Ranavirus;D017995
B04.909.204.490.700;Ranavirus;D017995
B04.280.650.250;Entomopoxvirinae;D017996
B04.525.250;Entomopoxvirinae;D017996
D10.251.355.255.100.450.855.455;Leukotriene C4;D017997
D23.469.050.175.450.725.400;Leukotriene C4;D017997
D10.251.355.255.100.450.855.461;Leukotriene D4;D017998
D23.469.050.175.450.725.415;Leukotriene D4;D017998
D10.251.355.255.100.450.855.470;Leukotriene E4;D017999
D23.469.050.175.450.725.425;Leukotriene E4;D017999
D12.776.543.750.750;Receptors, Peptide;D018000
D12.776.543.750.100.080;Receptors, Bradykinin;D018002
D12.776.543.750.720.600.220;Receptors, Bradykinin;D018002
D12.776.543.750.750.555.220;Receptors, Bradykinin;D018002
D12.776.543.750.100.100;Receptors, Calcitonin;D018003
D12.776.543.750.720.600.250;Receptors, Calcitonin;D018003
D12.776.543.750.750.200;Receptors, Calcitonin;D018003
D12.776.543.750.750.555.250;Receptors, Calcitonin;D018003
D12.776.543.750.100.070;Receptors, Bombesin;D018004
D12.776.543.750.720.600.200;Receptors, Bombesin;D018004
D12.776.543.750.750.555.200;Receptors, Bombesin;D018004
D12.776.543.750.100.900;Receptors, Vasoactive Intestinal Peptide;D018005
D12.776.543.750.720.600.915;Receptors, Vasoactive Intestinal Peptide;D018005
D12.776.543.750.750.360.900;Receptors, Vasoactive Intestinal Peptide;D018005
D12.776.543.750.750.555.915;Receptors, Vasoactive Intestinal Peptide;D018005
D12.776.210.500.570;Myogenic Regulatory Factors;D018006
D12.776.260.103.750;Myogenic Regulatory Factors;D018006
D12.776.930.125.750;Myogenic Regulatory Factors;D018006
D12.776.210.500.570.600;Myogenin;D018008
D12.776.260.103.750.600;Myogenin;D018008
D12.776.930.125.750.600;Myogenin;D018008
D12.776.157.530.400.175.781;Receptors, Glycine;D018009
D12.776.157.530.400.400.100.200;Receptors, Glycine;D018009
D12.776.543.550.425.175.781;Receptors, Glycine;D018009
D12.776.543.550.425.500.100.200;Receptors, Glycine;D018009
D12.776.543.585.400.175.781;Receptors, Glycine;D018009
D12.776.543.585.400.500.100.200;Receptors, Glycine;D018009
D12.776.543.750.051.625;Receptors, Glycine;D018009
D12.776.543.750.720.200.470;Receptors, Glycine;D018009
D12.776.543.750.750.460;Receptors, Invertebrate Peptide;D018010
D01.268.185;Chalcogens;D018011
D12.776.543.750.720.600;Receptors, Neuropeptide;D018013
D12.776.543.750.750.555;Receptors, Neuropeptide;D018013
E05.393.350;Gene Transfer Techniques;D018014
D12.776.543.750.100.105;Receptors, Calcitonin Gene-Related Peptide;D018015
D12.776.543.750.720.600.260;Receptors, Calcitonin Gene-Related Peptide;D018015
D12.776.543.750.750.555.260;Receptors, Calcitonin Gene-Related Peptide;D018015
D12.776.543.750.100.650;Receptors, Parathyroid Hormone;D018016
D12.776.543.750.750.600;Receptors, Parathyroid Hormone;D018016
D12.776.543.750.750.700;Receptors, Pituitary Hormone-Regulating Hormone;D018017
B04.820.504.080.100;Arterivirus;D018018
B04.909.777.500.080.500;Arterivirus;D018018
D12.776.543.750.100.180;Receptors, Corticotropin-Releasing Hormone;D018019
D12.776.543.750.720.600.290;Receptors, Corticotropin-Releasing Hormone;D018019
D12.776.543.750.750.555.290;Receptors, Corticotropin-Releasing Hormone;D018019
D12.776.543.750.750.700.150;Receptors, Corticotropin-Releasing Hormone;D018019
D01.510;Lithium Compounds;D018020
D01.210.450.150.450;Lithium Chloride;D018021
D01.510.500;Lithium Chloride;D018021
G12.400;HIV Seronegativity;D018023
F01.829.316.549.690;Peer Review, Health Care;D018024
I01.880.604.640.690;Peer Review, Health Care;D018024
N03.706.700.690;Peer Review, Health Care;D018024
N04.761.616;Peer Review, Health Care;D018024
N05.715.680;Peer Review, Health Care;D018024
D12.776.543.750.720.600.860;Receptors, Thyrotropin-Releasing Hormone;D018025
D12.776.543.750.750.555.860;Receptors, Thyrotropin-Releasing Hormone;D018025
D12.776.543.750.750.700.840;Receptors, Thyrotropin-Releasing Hormone;D018025
D12.776.543.750.750.580;Receptors, Pancreatic Hormone;D018026
D12.776.543.750.100.330;Receptors, Glucagon;D018027
D12.776.543.750.750.580.350;Receptors, Glucagon;D018027
D12.776.543.750.100.550;Receptors, Neurotensin;D018028
D12.776.543.750.720.600.560;Receptors, Neurotensin;D018028
D12.776.543.750.750.555.560;Receptors, Neurotensin;D018028
D12.776.124.486.485.114.619.393.700;Rho(D) Immune Globulin;D018029
D12.776.124.790.651.114.619.393.700;Rho(D) Immune Globulin;D018029
D12.776.377.715.548.114.619.393.700;Rho(D) Immune Globulin;D018029
D01.847;Silver Compounds;D018030
D12.776.543.585.250.200;Connexin 43;D018031
D12.776.124.486.485.114.125;Antibodies, Bispecific;D018033
D12.776.124.790.651.114.134;Antibodies, Bispecific;D018033
D12.776.377.715.548.114.134;Antibodies, Bispecific;D018033
A04.531.520.573.580;Olfactory Receptor Neurons;D018034
A04.760.600.640.640;Olfactory Receptor Neurons;D018034
A08.663.650.915.500.540;Olfactory Receptor Neurons;D018034
A08.800.950.500.540;Olfactory Receptor Neurons;D018034
A09.531.623.580;Olfactory Receptor Neurons;D018034
A10.615.550.760.600.640.640;Olfactory Receptor Neurons;D018034
A11.671.650.915.500.540;Olfactory Receptor Neurons;D018034
D12.776.543.750.100.600;Receptors, Odorant;D018035
D12.776.543.750.735;Receptors, Odorant;D018035
D01.810;Selenium Compounds;D018036
D01.810.950;Sodium Selenite;D018038
D01.857.850;Sodium Selenite;D018038
D12.776.543.750.720.600.830;Receptors, Tachykinin;D018039
D12.776.543.750.750.555.830;Receptors, Tachykinin;D018039
D12.776.543.750.720.600.830.500;Receptors, Neurokinin-1;D018040
D12.776.543.750.750.555.830.500;Receptors, Neurokinin-1;D018040
D12.776.543.750.720.600.830.540;Receptors, Neurokinin-2;D018041
D12.776.543.750.750.555.830.540;Receptors, Neurokinin-2;D018041
D12.776.543.750.720.600.830.580;Receptors, Neurokinin-3;D018042
D12.776.543.750.750.555.830.580;Receptors, Neurokinin-3;D018042
D12.776.543.750.720.600.285;Receptors, Corticotropin;D018043
D12.776.543.750.750.555.285;Receptors, Corticotropin;D018043
D12.776.543.750.750.660.285;Receptors, Corticotropin;D018043
D12.776.543.750.100.630;Receptors, Oxytocin;D018045
D12.776.543.750.720.600.630;Receptors, Oxytocin;D018045
D12.776.543.750.750.555.630;Receptors, Oxytocin;D018045
D12.776.543.750.750.660.600;Receptors, Oxytocin;D018045
D12.644.822.750.695.700;Protein C Inhibitor;D018046
D12.644.861.695.700;Protein C Inhibitor;D018046
D12.776.645.750.695.700;Protein C Inhibitor;D018046
D12.776.872.695.700;Protein C Inhibitor;D018046
D12.776.543.750.100.700.700;Receptors, Purinergic P1;D018047
D12.776.543.750.720.700.700;Receptors, Purinergic P1;D018047
D12.776.543.750.810.700;Receptors, Purinergic P1;D018047
D12.776.543.750.100.700.720;Receptors, Purinergic P2;D018048
D12.776.543.750.720.700.720;Receptors, Purinergic P2;D018048
D12.776.543.750.810.720;Receptors, Purinergic P2;D018048
B04.820.057.070.100;Arenaviruses, Old World;D018049
B04.909.777.080.070.100;Arenaviruses, Old World;D018049
B04.820.057.070;Arenavirus;D018050
B04.909.777.080.070;Arenavirus;D018050
B04.820.057.070.800.450;Junin virus;D018051
B04.909.777.080.070.800.450;Junin virus;D018051
B04.820.057.070.800.650;Pichinde virus;D018052
B04.909.777.080.070.800.650;Pichinde virus;D018052
D01.075.050;Arsenites;D018053
D01.248.497.158.055;Arsenites;D018053
D02.691.088.047;Arsenites;D018053
D01.029.260.300;Hydrobromic Acid;D018054
D01.139.300;Hydrobromic Acid;D018054
D12.776.543.750.075;Receptors, Eicosanoid;D018055
D12.776.543.750.100.200;Receptors, Eicosanoid;D018055
E05.830.250;Hemorheology;D018056
G09.188.124.552;Hemorheology;D018056
G09.188.370;Hemorheology;D018056
G09.330.190.400.295;Hemorheology;D018056
G09.330.380.630;Hemorheology;D018056
D20.944.460.150;Dental Waste;D018057
N06.850.460.710.460.150;Dental Waste;D018057
C09.218.903;Tympanic Membrane Perforation;D018058
C26.930;Tympanic Membrane Perforation;D018058
B04.820.075;Birnaviridae;D018059
B04.909.777.123;Birnaviridae;D018059
B04.820.075.050.430;Infectious pancreatic necrosis virus;D018061
B04.909.777.123.050.430;Infectious pancreatic necrosis virus;D018061
B04.820.087.640.300.500;La Crosse virus;D018062
B04.909.777.147.640.300.500;La Crosse virus;D018062
B04.909.777.270.100.500;La Crosse virus;D018062
B04.820.087.440.400;Hantaan virus;D018063
B04.909.777.147.440.400;Hantaan virus;D018063
B04.820.087.710.900;Uukuniemi virus;D018066
B04.909.777.147.710.900;Uukuniemi virus;D018066
B04.820.250;Flaviviridae;D018067
B04.909.777.310;Flaviviridae;D018067
B04.820.250.350.300.300;Encephalitis Virus, Murray Valley;D018068
B04.909.777.270.475.300;Encephalitis Virus, Murray Valley;D018068
B04.909.777.310.350.300.300;Encephalitis Virus, Murray Valley;D018068
A08.663.650.395;Hair Cells, Vestibular;D018069
A08.663.650.915.750.600.675;Hair Cells, Vestibular;D018069
A08.800.950.750.600.675;Hair Cells, Vestibular;D018069
A09.246.631.909.625.125.340;Hair Cells, Vestibular;D018069
A11.671.650.395;Hair Cells, Vestibular;D018069
A11.671.650.915.750.600.675;Hair Cells, Vestibular;D018069
N02.278.065;Biological Specimen Banks;D018070
B04.280.630;Polydnaviridae;D018071
B04.525.630;Polydnaviridae;D018071
A08.663.650.250.315;Hair Cells, Auditory, Outer;D018072
A08.663.650.915.750.600.350.365;Hair Cells, Auditory, Outer;D018072
A08.800.950.750.600.350.365;Hair Cells, Auditory, Outer;D018072
A09.246.631.246.577.325.380;Hair Cells, Auditory, Outer;D018072
A11.671.650.250.315;Hair Cells, Auditory, Outer;D018072
A11.671.650.915.750.600.350.365;Hair Cells, Auditory, Outer;D018072
D20.215.894.135.450;Haemophilus Vaccines;D018073
D20.215.894.865.900;Vaccines, Conjugate;D018074
D23.050.865.900;Vaccines, Conjugate;D018074
D13.444.600.723.480;RNA, Complementary;D018075
D13.444.735.480;RNA, Complementary;D018075
D27.720.470.530.600.825.840;RNA, Complementary;D018075
D13.444.308.497.220;DNA, Complementary;D018076
D13.444.600.223.500;DNA, Complementary;D018076
D27.720.470.530.600.223.260;DNA, Complementary;D018076
D12.776.543.750.075.450;Receptors, Leukotriene;D018077
D12.776.543.750.100.200.450;Receptors, Leukotriene;D018077
D12.776.543.750.075.700.600;Receptors, Prostaglandin E;D018078
D12.776.543.750.100.200.700.600;Receptors, Prostaglandin E;D018078
D12.776.543.750.720.200.300;Receptors, GABA;D018079
D12.776.543.750.100.300;Receptors, GABA-B;D018080
D12.776.543.750.720.200.300.320;Receptors, GABA-B;D018080
G02.111.570.790.709.610.480;Kringles;D018082
B04.820.250.700.100;Border disease virus;D018083
B04.909.777.310.700.100;Border disease virus;D018083
E01.370.350.850.855;Ultrasonography, Interventional;D018084
E04.800.890;Ultrasonography, Interventional;D018084
G05.360.340.024.742;Regulon;D018085
D08.811.682.664.500.410;Glutamate Dehydrogenase (NADP+);D018086
A11.284.430.214.190.875.700;Plastids;D018087
C01.252.410.040.552.846.775;Tuberculosis, Multidrug-Resistant;D018088
D23.050.820;Superantigens;D018089
D12.776.157.530.400.400.500.100;Receptors, AMPA;D018091
D12.776.543.550.425.500.200.100;Receptors, AMPA;D018091
D12.776.543.585.400.500.200.100;Receptors, AMPA;D018091
D12.776.543.750.720.200.450.400.100;Receptors, AMPA;D018091
D12.776.157.530.400.400.500.200;Receptors, Kainic Acid;D018092
D12.776.543.550.425.500.200.200;Receptors, Kainic Acid;D018092
D12.776.543.585.400.500.200.200;Receptors, Kainic Acid;D018092
D12.776.543.750.720.200.450.400.200;Receptors, Kainic Acid;D018092
D08.811.277.656.300.480.252;Gelatinases;D018093
D08.811.277.656.675.374.252;Gelatinases;D018093
D12.776.543.750.100.450;Receptors, Metabotropic Glutamate;D018094
D12.776.543.750.720.200.450.500;Receptors, Metabotropic Glutamate;D018094
G05.365.590.350;Germ-Line Mutation;D018095
B04.820.455;Mononegavirales;D018096
B04.909.777.455;Mononegavirales;D018096
B04.820.455.600.650;Paramyxovirinae;D018098
B04.909.777.455.600.650;Paramyxovirinae;D018098
B04.820.455.600.670;Pneumovirinae;D018099
B04.909.777.455.600.670;Pneumovirinae;D018099
D12.776.543.750.070.450.500;Receptors, Histamine H3;D018100
D12.776.543.750.720.300.450.500;Receptors, Histamine H3;D018100
B01.050.050.157.520.420.500;Mice, Inbred mdx;D018101
B01.050.050.199.520.520.420.500;Mice, Inbred mdx;D018101
B01.050.150.900.649.865.635.505.500.400.420.500;Mice, Inbred mdx;D018101
B01.050.150.900.649.865.635.505.500.550.265;Mice, Inbred mdx;D018101
D12.776.543.750.075.450.300;Receptors, Leukotriene B4;D018102
D12.776.543.750.100.200.450.300;Receptors, Leukotriene B4;D018102
B04.820.455.600.650.500;Morbillivirus;D018103
B04.909.777.455.600.650.500;Morbillivirus;D018103
B04.820.455.600.650.500.320;Distemper Virus, Phocine;D018104
B04.909.777.455.600.650.500.320;Distemper Virus, Phocine;D018104
D13.444.308.283.225.200;DNA, Kinetoplast;D018105
D13.444.308.442.200;DNA, Kinetoplast;D018105
D12.776.543.750.705.222.500;Antigens, CD28;D018106
D23.050.301.264.035.128;Antigens, CD28;D018106
D23.050.301.264.894.128;Antigens, CD28;D018106
D23.101.100.110.128;Antigens, CD28;D018106
D23.101.100.894.128;Antigens, CD28;D018106
B04.820.455.600.650.500.650;Peste-des-petits-ruminants virus;D018107
B04.909.777.455.600.650.500.650;Peste-des-petits-ruminants virus;D018107
B04.820.455.600.650.700;Respirovirus;D018108
B04.909.777.455.600.650.700;Respirovirus;D018108
B04.820.455.600.650.070;Avulavirus;D018109
B04.909.777.455.600.650.070;Avulavirus;D018109
D12.776.543.750.710;Receptors, Lipoprotein;D018110
B04.820.455.600.670.600;Pneumovirus;D018111
B04.909.777.455.600.670.600;Pneumovirus;D018111
B04.820.455.600.670.600.750.700;Respiratory Syncytial Virus, Bovine;D018112
B04.909.777.455.600.670.600.750.700;Respiratory Syncytial Virus, Bovine;D018112
B04.820.455.600.670.600.750.730;Respiratory Syncytial Virus, Human;D018113
B04.909.777.455.600.670.600.750.730;Respiratory Syncytial Virus, Human;D018113
B04.820.455.750.500;Lyssavirus;D018114
B04.909.777.455.750.500;Lyssavirus;D018114
B04.820.455.750.250.200;Ephemeral Fever Virus, Bovine;D018115
B04.909.777.455.750.250.200;Ephemeral Fever Virus, Bovine;D018115
B04.820.455.750.900;Vesiculovirus;D018116
B04.909.777.455.750.900;Vesiculovirus;D018116
B04.820.545.850;Thogotovirus;D018117
B04.909.777.545.850;Thogotovirus;D018117
D12.776.157.530.400.175;Chloride Channels;D018118
D12.776.543.550.425.175;Chloride Channels;D018118
D12.776.543.585.400.175;Chloride Channels;D018118
D03.383.742.680.705.875;Stavudine;D018119
D13.570.230.500.850;Stavudine;D018119
D13.570.230.855.875;Stavudine;D018119
D13.570.685.705.875;Stavudine;D018119
D04.808.054.079.500;Finasteride;D018120
D04.808.925.100.250;Finasteride;D018120
D12.776.543.750.705.852;Receptors, Cytokine;D018121
D12.776.467.150.100;Antigens, CD80;D018122
D12.776.543.095.100;Antigens, CD80;D018122
D23.050.301.264.035.276.100;Antigens, CD80;D018122
D23.050.301.285.100;Antigens, CD80;D018122
D23.101.100.110.276.100;Antigens, CD80;D018122
D23.529.168.100;Antigens, CD80;D018122
D12.776.543.750.705.852.420;Receptors, Interleukin;D018123
D12.776.543.750.705.852.760;Receptors, Tumor Necrosis Factor;D018124
D12.776.543.750.705.852.720;Receptors, Transforming Growth Factor beta;D018125
D12.776.543.750.750.400.820;Receptors, Transforming Growth Factor beta;D018125
C07.650.800.600;Odontodysplasia;D018126
C07.793.700.600;Odontodysplasia;D018126
C16.131.850.800.600;Odontodysplasia;D018126
D12.776.543.750.705.852.760.048;Antigens, CD27;D018127
D23.050.301.264.035.127;Antigens, CD27;D018127
D23.050.301.264.894.127;Antigens, CD27;D018127
D23.101.100.110.127;Antigens, CD27;D018127
D23.101.100.894.127;Antigens, CD27;D018127
D10.570.755.375.760.400.942.625;Phosphatidylinositol Phosphates;D018129
D01.268.150.200;Diamond;D018130
B04.820.850.700;Rubivirus;D018132
B04.909.777.923.700;Rubivirus;D018132
B04.280.120;Circoviridae;D018136
B04.909.204.120;Circoviridae;D018136
B04.280.382.100;Alphaherpesvirinae;D018138
B04.909.204.382.100;Alphaherpesvirinae;D018138
B04.280.382.100.750;Simplexvirus;D018139
B04.909.204.382.100.750;Simplexvirus;D018139
B04.280.382.100.900;Varicellovirus;D018140
B04.909.204.382.100.900;Varicellovirus;D018140
B04.280.382.150;Betaherpesvirinae;D018141
B04.909.204.382.150;Betaherpesvirinae;D018141
B04.280.382.400;Gammaherpesvirinae;D018142
B04.909.204.210.400;Gammaherpesvirinae;D018142
B04.909.204.382.400;Gammaherpesvirinae;D018142
B04.909.574.204.500;Gammaherpesvirinae;D018142
B04.280.382.400.500;Lymphocryptovirus;D018143
B04.909.204.210.400.500;Lymphocryptovirus;D018143
B04.909.204.382.400.500;Lymphocryptovirus;D018143
B04.909.574.204.500.500;Lymphocryptovirus;D018143
B04.280.382.400.700;Rhadinovirus;D018144
B04.909.204.210.400.700;Rhadinovirus;D018144
B04.909.204.382.400.700;Rhadinovirus;D018144
B04.909.574.204.500.700;Rhadinovirus;D018144
B04.280.382.150.500;Muromegalovirus;D018146
B04.909.204.382.150.500;Muromegalovirus;D018146
B04.280.650.160;Chordopoxvirinae;D018147
B04.909.204.783.160;Chordopoxvirinae;D018147
B04.280.650.160.800;Suipoxvirus;D018148
B04.909.204.783.160.800;Suipoxvirus;D018148
C18.452.394.952.500;Glucose Intolerance;D018149
B04.280.650.160.100;Avipoxvirus;D018150
B04.909.204.783.160.100;Avipoxvirus;D018150
B04.280.650.160.150;Capripoxvirus;D018151
B04.909.204.783.160.150;Capripoxvirus;D018151
B04.280.650.160.500;Leporipoxvirus;D018152
B04.909.204.210.600;Leporipoxvirus;D018152
B04.909.204.783.160.500;Leporipoxvirus;D018152
B04.909.574.204.600;Leporipoxvirus;D018152
Z01.542.248.395;Czech Republic;D018153
Z01.586.250.395;Czech Republic;D018153
Z01.542.248.797;Slovakia;D018154
Z01.586.250.750;Slovakia;D018154
B04.280.650.160.650;Orthopoxvirus;D018155
B04.909.204.783.160.650;Orthopoxvirus;D018155
L01.737.498.550;Journalism, Medical;D018156
B04.280.650.160.670;Parapoxvirus;D018157
B04.909.204.783.160.670;Parapoxvirus;D018157
B04.280.650.160.980;Yatapoxvirus;D018158
B04.909.204.210.950;Yatapoxvirus;D018158
B04.909.204.783.160.980;Yatapoxvirus;D018158
B04.909.574.204.950;Yatapoxvirus;D018158
C09.218.568.217;Endolymphatic Hydrops;D018159
D12.776.260.698;Receptors, Cytoplasmic and Nuclear;D018160
D12.776.826;Receptors, Cytoplasmic and Nuclear;D018160
D12.776.930.669;Receptors, Cytoplasmic and Nuclear;D018160
D12.776.260.698.750.530;Receptors, Mineralocorticoid;D018161
D12.776.826.750.530;Receptors, Mineralocorticoid;D018161
D12.776.930.669.750.530;Receptors, Mineralocorticoid;D018161
B04.820.630.160;Coltivirus;D018162
B04.909.777.714.160;Coltivirus;D018162
B04.820.630.550;Orbivirus;D018163
B04.909.777.714.550;Orbivirus;D018163
B04.820.630.550.400;Hemorrhagic Disease Virus, Epizootic;D018164
B04.909.777.714.550.400;Hemorrhagic Disease Virus, Epizootic;D018164
B04.820.630.590;Orthoreovirus;D018165
B04.909.777.714.590;Orthoreovirus;D018165
I01.655.500.608.400.285;Health Care Reform;D018166
I01.880.604.825.608.400.285;Health Care Reform;D018166
N03.349.285;Health Care Reform;D018166
N03.623.500.608.428.285;Health Care Reform;D018166
N04.590.374.285;Health Care Reform;D018166
N05.300.380;Health Care Reform;D018166
D12.776.260.698.535;Receptors, Calcitriol;D018167
D12.776.826.535;Receptors, Calcitriol;D018167
D12.776.930.669.535;Receptors, Calcitriol;D018167
D12.776.260.698.701;Receptors, Retinoic Acid;D018168
D12.776.826.701;Receptors, Retinoic Acid;D018168
D12.776.930.669.701;Receptors, Retinoic Acid;D018168
B04.280.650.160.550;Molluscipoxvirus;D018169
B04.909.204.783.160.550;Molluscipoxvirus;D018169
D02.065.884.750;Sumatriptan;D018170
D02.886.590.700.750;Sumatriptan;D018170
D03.438.473.914.907;Sumatriptan;D018170
D12.776.641.050;Agrin;D018171
I01.409.137.500.600.650.912;United States Office of Research Integrity;D018172
N03.540.348.500.500.600.650.912;United States Office of Research Integrity;D018172
C02.256.200;Circoviridae Infections;D018173
C02.782.600.100;Arterivirus Infections;D018174
C02.782.123;Birnaviridae Infections;D018175
C02.782.600.550.800;Torovirus Infections;D018176
C02.782.350.250;Flavivirus Infections;D018177
C02.782.350;Flaviviridae Infections;D018178
D12.776.395.550.625.800;Receptors, Thrombin;D018179
D12.776.543.550.625.800;Receptors, Thrombin;D018179
D12.776.543.750.100.875;Receptors, Thrombin;D018179
D12.776.543.750.750.850;Receptors, Thrombin;D018179
D12.776.543.750.792.500;Receptors, Thrombin;D018179
D12.776.395.550.625.800.800;Thrombomodulin;D018180
D12.776.543.550.625.800.800;Thrombomodulin;D018180
D12.776.543.750.750.850.800;Thrombomodulin;D018180
B01.050.050.157.520.445;Mice, Inbred CFTR;D018181
B01.050.050.199.520.520.445;Mice, Inbred CFTR;D018181
B01.050.150.900.649.865.635.505.500.400.445;Mice, Inbred CFTR;D018181
C02.782.350.675;Pestivirus Infections;D018182
B05.200.750;Transplantation Chimera;D018183
B05.825;Transplantation Chimera;D018183
C02.782.580.600;Paramyxoviridae Infections;D018184
C02.782.580.600.500;Morbillivirus Infections;D018185
C02.782.580.600.620;Pneumovirus Infections;D018186
F02.739.660;Personal Construct Theory;D018187
C02.782.687.150;Cardiovirus Infections;D018188
E02.095.437;Immunomagnetic Separation;D018189
E05.242.363.441;Immunomagnetic Separation;D018189
C04.557.375;Lymphatic Vessel Tumors;D018190
C04.557.375.450.450;Lymphangioma, Cystic;D018191
C04.557.375.460.465;Lymphangioleiomyomatosis;D018192
C04.557.450.692.500;Lymphangioleiomyomatosis;D018192
C15.604.515.562.465;Lymphangioleiomyomatosis;D018192
C20.683.515.710.465;Lymphangioleiomyomatosis;D018192
C04.557.435;Neoplasms, Complex and Mixed;D018193
C04.557.435.110;Adenomyoma;D018194
C04.557.435.135;Adenosarcoma;D018195
C04.557.450.795.135;Adenosarcoma;D018195
C04.557.435.250;Carcinoma, Adenosquamous;D018196
C04.557.470.200.150;Carcinoma, Adenosquamous;D018196
C04.557.435.380;Hepatoblastoma;D018197
C04.557.435.525;Mixed Tumor, Malignant;D018198
C04.557.435.530;Mixed Tumor, Mesodermal;D018199
C04.557.450.795.530;Mixed Tumor, Mesodermal;D018199
C04.557.435.540;Mixed Tumor, Mullerian;D018200
C04.557.435.600;Nephroma, Mesoblastic;D018201
C04.588.945.947.535.790;Nephroma, Mesoblastic;D018201
C12.758.820.750.372;Nephroma, Mesoblastic;D018201
C12.777.419.473.372;Nephroma, Mesoblastic;D018201
C13.351.937.820.535.790;Nephroma, Mesoblastic;D018201
C13.351.968.419.473.372;Nephroma, Mesoblastic;D018201
C04.557.435.675;Pulmonary Blastoma;D018202
C04.588.894.797.520.867;Pulmonary Blastoma;D018202
C04.557.435.775;Sarcoma, Endometrial Stromal;D018203
C04.557.450.795.332.500;Sarcoma, Endometrial Stromal;D018203
C13.351.500.852.762.200.500.500;Sarcoma, Endometrial Stromal;D018203
C13.351.937.418.875.200.374.500;Sarcoma, Endometrial Stromal;D018203
C04.557.450;Neoplasms, Connective and Soft Tissue;D018204
C04.557.450.550;Neoplasms, Adipose Tissue;D018205
C04.557.450.550.100;Angiolipoma;D018206
C04.557.450.550.125;Angiomyolipoma;D018207
C04.557.450.692.249;Angiomyolipoma;D018207
C04.557.450.550.420.425;Liposarcoma, Myxoid;D018208
C04.557.450.795.465.425;Liposarcoma, Myxoid;D018208
C04.557.450.550.710;Myelolipoma;D018209
C04.557.450.565.265.270;Chondromatosis;D018210
C04.557.450.565.280.280;Chondrosarcoma, Mesenchymal;D018211
C04.557.450.795.300.280;Chondrosarcoma, Mesenchymal;D018211
C04.557.450.565.380.380;Giant Cell Tumor of Bone;D018212
C04.557.450.565.575.420;Giant Cell Tumor of Bone;D018212
C04.557.450.565.575;Neoplasms, Bone Tissue;D018213
C04.557.450.565.575.400;Fibroma, Ossifying;D018214
C04.557.450.565.590.340.360;Fibroma, Ossifying;D018214
C04.557.450.565.575.600;Osteoblastoma;D018215
C04.557.450.565.575.610.615;Osteochondromatosis;D018216
C05.116.099.708.670.615;Osteochondromatosis;D018216
C04.557.450.565.575.650.655;Osteosarcoma, Juxtacortical;D018217
C04.557.450.795.620.655;Osteosarcoma, Juxtacortical;D018217
C04.557.450.565.590;Neoplasms, Fibrous Tissue;D018218
C04.557.450.565.590.425.350;Histiocytoma, Benign Fibrous;D018219
C04.557.450.565.590.340.345;Fibroma, Desmoplastic;D018220
C04.557.450.565.590.340.400;Fibromatosis, Abdominal;D018221
C04.557.450.565.590.340.410;Fibromatosis, Aggressive;D018222
C04.557.450.565.590.350.320;Dermatofibrosarcoma;D018223
C04.557.450.795.350.320;Dermatofibrosarcoma;D018223
C04.557.450.565.590.550;Myofibromatosis;D018224
C04.557.450.565.590.595;Neoplasms, Fibroepithelial;D018225
C04.557.470.625;Neoplasms, Fibroepithelial;D018225
C04.557.450.565.590.595.350;Fibroadenoma;D018226
C04.557.470.625.350;Fibroadenoma;D018226
C04.557.450.565.800;Sarcoma, Clear Cell;D018227
C04.557.450.795.800;Sarcoma, Clear Cell;D018227
C04.557.450.565.825;Sarcoma, Small Cell;D018228
C04.557.450.795.870;Sarcoma, Small Cell;D018228
C04.557.450.590.450.125;Angiomyoma;D018229
C04.557.450.590.450.455;Leiomyoma, Epithelioid;D018230
C04.557.450.590.450.465;Leiomyomatosis;D018231
C04.557.450.590.550.660.665;Rhabdomyosarcoma, Alveolar;D018232
C04.557.450.795.550.660.665;Rhabdomyosarcoma, Alveolar;D018232
C04.557.450.590.550.660.675;Rhabdomyosarcoma, Embryonal;D018233
C04.557.450.795.550.660.675;Rhabdomyosarcoma, Embryonal;D018233
C04.557.450.590.775;Sarcoma, Alveolar Soft Part;D018234
C04.557.450.795.775;Sarcoma, Alveolar Soft Part;D018234
C04.557.450.590.800;Smooth Muscle Tumor;D018235
C04.557.465.200;Carcinoma, Embryonal;D018236
C04.557.465.330;Germinoma;D018237
C04.557.465.420;Gonadoblastoma;D018238
C04.557.475.395;Gonadoblastoma;D018238
C12.706.316.096.687.500;Gonadoblastoma;D018238
C12.706.316.309.388.500;Gonadoblastoma;D018238
C13.351.875.253.096.687.500;Gonadoblastoma;D018238
C13.351.875.253.309.388.500;Gonadoblastoma;D018238
C16.131.939.316.096.687.500;Gonadoblastoma;D018238
C16.131.939.316.309.388.500;Gonadoblastoma;D018238
C19.391.119.096.687.500;Gonadoblastoma;D018238
C19.391.119.309.388.500;Gonadoblastoma;D018238
C04.557.465.330.800;Seminoma;D018239
C04.557.465.510.350;Endodermal Sinus Tumor;D018240
C04.557.465.625.600.590.650;Neuroectodermal Tumors, Primitive, Peripheral;D018241
C04.557.470.670.590.650;Neuroectodermal Tumors, Primitive, Peripheral;D018241
C04.557.580.625.600.590.650;Neuroectodermal Tumors, Primitive, Peripheral;D018241
C04.557.465.625.600.590;Neuroectodermal Tumors, Primitive;D018242
C04.557.470.670.590;Neuroectodermal Tumors, Primitive;D018242
C04.557.580.625.600.590;Neuroectodermal Tumors, Primitive;D018242
C04.557.465.900;Teratocarcinoma;D018243
A11.284.187.178.200;Chromosomes, Artificial, Yeast;D018244
A11.284.187.360.800;Chromosomes, Artificial, Yeast;D018244
A19.311.800;Chromosomes, Artificial, Yeast;D018244
G05.360.162.178.200;Chromosomes, Artificial, Yeast;D018244
G05.360.162.360.800;Chromosomes, Artificial, Yeast;D018244
G05.360.337.249.200;Chromosomes, Artificial, Yeast;D018244
C04.557.465.955.207.875;Trophoblastic Tumor, Placental Site;D018245
C04.557.465.955.416.202.875;Trophoblastic Tumor, Placental Site;D018245
C04.557.470.200.025.455.875;Trophoblastic Tumor, Placental Site;D018245
C04.850.908.416.186.875;Trophoblastic Tumor, Placental Site;D018245
C13.703.720.949.416.218.875;Trophoblastic Tumor, Placental Site;D018245
C04.588.322.078.265.500;Adrenocortical Adenoma;D018246
C19.053.098.265.500;Adrenocortical Adenoma;D018246
C19.053.347.500.500;Adrenocortical Adenoma;D018246
C19.344.078.265.500;Adrenocortical Adenoma;D018246
B03.440.500.350;Helicobacter heilmannii;D018247
B03.660.150.280.400;Helicobacter heilmannii;D018247
C04.557.470.035.120;Adenoma, Liver Cell;D018248
C04.588.274.623.040;Adenoma, Liver Cell;D018248
C06.301.623.040;Adenoma, Liver Cell;D018248
C06.552.697.040;Adenoma, Liver Cell;D018248
C04.557.470.035.140;Adenoma, Oxyphilic;D018249
C04.557.470.035.175.125;Acrospiroma;D018250
C04.557.470.550.175.125;Acrospiroma;D018250
C04.557.470.035.175.375;Hidrocystoma;D018251
C04.557.470.550.175.375;Hidrocystoma;D018251
C04.557.470.035.175.800;Syringoma;D018252
C04.557.470.550.175.800;Syringoma;D018252
C04.557.470.035.185;Adenoma, Villous;D018253
C04.557.470.035.200;Adenomatoid Tumor;D018254
C04.557.470.660.200;Adenomatoid Tumor;D018254
C04.557.470.035.210;Adenomatosis, Pulmonary;D018255
C04.557.470.035.215;Adenomatous Polyps;D018256
G02.111.570.790.709.600.040.360;Helix-Loop-Helix Motifs;D018257
B04.280.382.100.750.440;Herpesvirus 2, Human;D018258
B04.909.204.382.100.750.440;Herpesvirus 2, Human;D018258
B04.280.382.100.750.390;Herpesvirus 1, Human;D018259
B04.909.204.382.100.750.390;Herpesvirus 1, Human;D018259
D05.750.078.730.350;Gelsolin;D018260
D12.644.360.381.437;Gelsolin;D018260
D12.776.157.125.412.437;Gelsolin;D018260
D12.776.220.525.350;Gelsolin;D018260
D12.776.476.387.437;Gelsolin;D018260
C04.557.470.035.510.515;Mesothelioma, Cystic;D018261
C04.557.470.660.510.515;Mesothelioma, Cystic;D018261
C04.557.470.200.025.045;Adenocarcinoma, Clear Cell;D018262
C04.557.470.200.025.060;Adenocarcinoma, Follicular;D018263
C04.557.470.200.025.060.225;Carcinoma, Papillary, Follicular;D018265
C04.557.470.200.025.085.225;Carcinoma, Papillary, Follicular;D018265
C04.557.470.200.025.105;Adenocarcinoma, Sebaceous;D018266
C04.557.470.550.105;Adenocarcinoma, Sebaceous;D018266
C04.557.470.200.025.215;Carcinoma, Acinar Cell;D018267
C04.557.470.200.025.152;Adrenocortical Carcinoma;D018268
C04.588.322.078.265.750;Adrenocortical Carcinoma;D018268
C19.053.098.265.750;Adrenocortical Carcinoma;D018268
C19.053.347.500.750;Adrenocortical Carcinoma;D018268
C19.344.078.265.750;Adrenocortical Carcinoma;D018268
C04.557.470.200.025.240;Carcinoma, Endometrioid;D018269
C04.588.945.418.948.585.124;Carcinoma, Endometrioid;D018269
C13.351.500.056.630.705.331;Carcinoma, Endometrioid;D018269
C13.351.937.418.685.331;Carcinoma, Endometrioid;D018269
C13.351.937.418.875.200.124;Carcinoma, Endometrioid;D018269
C19.391.630.705.331;Carcinoma, Endometrioid;D018269
C04.557.470.200.025.232.500;Carcinoma, Ductal, Breast;D018270
C04.557.470.615.132.500;Carcinoma, Ductal, Breast;D018270
C04.588.180.390;Carcinoma, Ductal, Breast;D018270
C17.800.090.500.390;Carcinoma, Ductal, Breast;D018270
D12.776.157.725.500.750.800;Signal Recognition Particle;D018271
D12.776.664.962.500.750.800;Signal Recognition Particle;D018271
D12.776.157.530.400.500;Porins;D018272
D12.776.543.550.425.730;Porins;D018272
D12.776.543.585.400.730;Porins;D018272
C04.557.470.200.025.290;Carcinoma, Islet Cell;D018273
C04.588.274.761.500;Carcinoma, Islet Cell;D018273
C04.588.322.475.500;Carcinoma, Islet Cell;D018273
C06.301.761.500;Carcinoma, Islet Cell;D018273
C06.689.667.500;Carcinoma, Islet Cell;D018273
C19.344.421.500;Carcinoma, Islet Cell;D018273
E05.242.448;Electroporation;D018274
E05.301.500;Electroporation;D018274
C04.557.470.200.025.305;Carcinoma, Lobular;D018275
C04.557.470.615.305;Carcinoma, Lobular;D018275
C04.557.465.625.650.240.315;Carcinoma, Medullary;D018276
C04.557.470.200.025.370.315;Carcinoma, Medullary;D018276
C04.557.470.615.315;Carcinoma, Medullary;D018276
C04.557.580.625.650.240.315;Carcinoma, Medullary;D018276
C04.557.470.200.025.340;Carcinoma, Mucoepidermoid;D018277
C04.557.470.590.340;Carcinoma, Mucoepidermoid;D018277
C04.557.465.625.650.240;Carcinoma, Neuroendocrine;D018278
C04.557.470.200.025.370;Carcinoma, Neuroendocrine;D018278
C04.557.580.625.650.240;Carcinoma, Neuroendocrine;D018278
C04.557.470.200.025.415;Carcinoma, Signet Ring Cell;D018279
C04.557.470.590.415;Carcinoma, Signet Ring Cell;D018279
C04.557.470.200.025.420;Carcinoma, Skin Appendage;D018280
C04.557.470.550.420;Carcinoma, Skin Appendage;D018280
C04.557.470.200.025.450;Cholangiocarcinoma;D018281
C04.557.470.200.025.480.225;Cystadenocarcinoma, Mucinous;D018282
C04.557.470.590.480.225;Cystadenocarcinoma, Mucinous;D018282
C04.557.470.200.025.480.230;Cystadenocarcinoma, Papillary;D018283
C04.557.470.590.480.230;Cystadenocarcinoma, Papillary;D018283
C04.557.470.200.025.480.240;Cystadenocarcinoma, Serous;D018284
C04.557.470.590.480.240;Cystadenocarcinoma, Serous;D018284
C04.557.470.200.025.540;Klatskin's Tumor;D018285
C04.557.470.200.220;Carcinoma, Giant Cell;D018286
C04.557.470.200.260;Carcinoma, Large Cell;D018287
C04.557.470.200.380;Carcinoma, Small Cell;D018288
C04.557.470.200.450;Carcinoma, Verrucous;D018289
C04.557.470.700.450;Carcinoma, Verrucous;D018289
C04.557.470.200.240.250;Cervical Intraepithelial Neoplasia;D018290
C04.557.470.035.320.225;Cystadenoma, Mucinous;D018291
C04.557.470.590.485.225;Cystadenoma, Mucinous;D018291
C04.557.470.035.320.230;Cystadenoma, Papillary;D018292
C04.557.470.590.485.230;Cystadenoma, Papillary;D018292
C04.557.470.035.320.240;Cystadenoma, Serous;D018293
C04.557.470.590.485.240;Cystadenoma, Serous;D018293
C04.557.470.550;Neoplasms, Adnexal and Skin Appendage;D018294
C04.557.470.565;Neoplasms, Basal Cell;D018295
C04.557.470.565.625;Pilomatrixoma;D018296
C04.557.470.590;Neoplasms, Cystic, Mucinous, and Serous;D018297
C04.557.470.590.580;Mucoepidermoid Tumor;D018298
C04.557.470.615;Neoplasms, Ductal, Lobular, and Medullary;D018299
C04.557.470.615.670;Papilloma, Intraductal;D018300
C04.557.470.660;Neoplasms, Mesothelial;D018301
C04.557.465.625.600;Neoplasms, Neuroepithelial;D018302
C04.557.470.670;Neoplasms, Neuroepithelial;D018302
C04.557.580.625.600;Neoplasms, Neuroepithelial;D018302
C04.557.465.625.600.380.350;Ganglioglioma;D018303
C04.557.470.670.380.350;Ganglioglioma;D018303
C04.557.580.625.600.380.350;Ganglioglioma;D018303
C04.557.465.625.600.590.650.550.150;Esthesioneuroblastoma, Olfactory;D018304
C04.557.470.670.590.650.550.150;Esthesioneuroblastoma, Olfactory;D018304
C04.557.580.625.600.590.650.550.150;Esthesioneuroblastoma, Olfactory;D018304
C10.292.650.200;Esthesioneuroblastoma, Olfactory;D018304
C04.557.465.625.600.590.650.550.300;Ganglioneuroblastoma;D018305
C04.557.470.670.590.650.550.300;Ganglioneuroblastoma;D018305
C04.557.580.625.600.590.650.550.300;Ganglioneuroblastoma;D018305
C04.557.465.625.600.580;Neurocytoma;D018306
C04.557.470.670.580;Neurocytoma;D018306
C04.557.580.625.600.580;Neurocytoma;D018306
C04.588.614.250.195.648;Neurocytoma;D018306
C10.228.140.211.692;Neurocytoma;D018306
C10.551.240.250.550;Neurocytoma;D018306
C04.557.470.700;Neoplasms, Squamous Cell;D018307
C04.557.470.700.600.610;Papilloma, Inverted;D018308
C04.557.475;Neoplasms, Gonadal Tissue;D018309
C04.557.475.750.847;Sertoli-Leydig Cell Tumor;D018310
C04.588.322.455.648;Sertoli-Leydig Cell Tumor;D018310
C04.588.322.762.500;Sertoli-Leydig Cell Tumor;D018310
C04.588.945.440.915.500;Sertoli-Leydig Cell Tumor;D018310
C12.294.260.937.500;Sertoli-Leydig Cell Tumor;D018310
C12.758.409.937.500;Sertoli-Leydig Cell Tumor;D018310
C13.351.500.056.630.705.648;Sertoli-Leydig Cell Tumor;D018310
C13.351.937.418.685.648;Sertoli-Leydig Cell Tumor;D018310
C19.344.410.648;Sertoli-Leydig Cell Tumor;D018310
C19.344.762.500;Sertoli-Leydig Cell Tumor;D018310
C19.391.630.705.648;Sertoli-Leydig Cell Tumor;D018310
C19.391.829.782.500;Sertoli-Leydig Cell Tumor;D018310
C04.557.475.750.751;Luteoma;D018311
C04.588.322.455.464;Luteoma;D018311
C13.351.500.056.630.705.464;Luteoma;D018311
C13.351.937.418.685.464;Luteoma;D018311
C19.344.410.464;Luteoma;D018311
C19.391.630.705.464;Luteoma;D018311
C04.557.475.750;Sex Cord-Gonadal Stromal Tumors;D018312
B01.268.475.868.488.240;Leishmania enriettii;D018313
B01.268.475.868.488.325;Leishmania infantum;D018314
C04.557.465.625.600.380.290.390;Glioma, Subependymal;D018315
C04.557.470.670.380.290.390;Glioma, Subependymal;D018315
C04.557.580.625.600.380.290.390;Glioma, Subependymal;D018315
C04.557.465.625.600.380.400;Gliosarcoma;D018316
C04.557.470.670.380.400;Gliosarcoma;D018316
C04.557.580.625.600.380.400;Gliosarcoma;D018316
C04.557.580.600;Nerve Sheath Neoplasms;D018317
C10.551.775.500;Nerve Sheath Neoplasms;D018317
C10.668.829.725.500;Nerve Sheath Neoplasms;D018317
C04.557.580.600.580.585;Neurofibroma, Plexiform;D018318
C10.551.775.500.750.500;Neurofibroma, Plexiform;D018318
C10.668.829.725.500.600.500;Neurofibroma, Plexiform;D018318
C04.557.450.565.590.350.590;Neurofibrosarcoma;D018319
C04.557.450.795.350.590;Neurofibrosarcoma;D018319
C04.557.580.600.580.795;Neurofibrosarcoma;D018319
C04.557.580.600.590;Neurofibrosarcoma;D018319
C10.551.775.500.750.750;Neurofibrosarcoma;D018319
C10.668.829.725.500.600.600;Neurofibrosarcoma;D018319
B01.268.475.868.488.405;Leishmania major;D018320
C04.557.450.565.550.625;Neurothekeoma;D018321
C04.557.580.600.625;Neurothekeoma;D018321
C04.557.645.100;Angiofibroma;D018322
C04.557.645.375.370.380;Hemangioendothelioma, Epithelioid;D018323
C04.557.645.375.380;Hemangioma, Capillary;D018324
C04.557.645.375.380.370;Hemangioblastoma;D018325
C04.557.665;Nevi and Melanomas;D018326
C04.557.465.625.650.510.385;Hutchinson's Melanotic Freckle;D018327
C04.557.580.625.650.510.385;Hutchinson's Melanotic Freckle;D018327
C04.557.665.510.385;Hutchinson's Melanotic Freckle;D018327
C04.557.465.625.650.510.515;Melanoma, Amelanotic;D018328
C04.557.580.625.650.510.515;Melanoma, Amelanotic;D018328
C04.557.665.510.515;Melanoma, Amelanotic;D018328
C04.557.665.560.615.550;Nevus, Blue;D018329
C04.557.665.560.590;Nevus, Intradermal;D018330
C04.557.665.560.615.625;Nevus, Spindle Cell;D018331
C04.557.665.560.615.625.585;Nevus, Epithelioid and Spindle Cell;D018332
C04.182.089.530.690.605;Odontogenic Cyst, Calcifying;D018333
C04.557.695.605;Odontogenic Cyst, Calcifying;D018333
C05.500.470.690.605;Odontogenic Cyst, Calcifying;D018333
C07.320.450.670.495;Odontogenic Cyst, Calcifying;D018333
B01.268.475.868.488.285;Leishmania guyanensis;D018334
C04.557.435.710;Rhabdoid Tumor;D018335
D12.776.260.698.209.715;Receptors, Aryl Hydrocarbon;D018336
D12.776.826.209.715;Receptors, Aryl Hydrocarbon;D018336
D12.776.930.662;Receptors, Aryl Hydrocarbon;D018336
D12.776.930.669.209.715;Receptors, Aryl Hydrocarbon;D018336
D12.776.543.750.070.300.300.300.700;Receptors, Adrenergic, alpha-1;D018340
D12.776.543.750.100.150.300.300.700;Receptors, Adrenergic, alpha-1;D018340
D12.776.543.750.720.300.300.300.300.100;Receptors, Adrenergic, alpha-1;D018340
D12.776.543.750.070.300.300.300.725;Receptors, Adrenergic, alpha-2;D018341
D12.776.543.750.100.150.300.300.725;Receptors, Adrenergic, alpha-2;D018341
D12.776.543.750.720.300.300.300.300.200;Receptors, Adrenergic, alpha-2;D018341
D12.776.543.750.070.300.300.340.700;Receptors, Adrenergic, beta-1;D018342
D12.776.543.750.100.150.300.340.700;Receptors, Adrenergic, beta-1;D018342
D12.776.543.750.720.300.300.300.340.100;Receptors, Adrenergic, beta-1;D018342
D12.776.543.750.070.300.300.340.725;Receptors, Adrenergic, beta-2;D018343
D12.776.543.750.100.150.300.340.725;Receptors, Adrenergic, beta-2;D018343
D12.776.543.750.720.300.300.300.340.200;Receptors, Adrenergic, beta-2;D018343
C15.378.553.546.605.800;T-Lymphocytopenia, Idiopathic CD4-Positive;D018344
C20.673.627.800;T-Lymphocytopenia, Idiopathic CD4-Positive;D018344
B01.050.050.136.500.500;Mice, Knockout;D018345
B01.050.150.900.649.865.635.505.500.550.455;Mice, Knockout;D018345
B01.050.150.900.649.865.635.505.500.800.500;Mice, Knockout;D018345
C02.256.430;Hepadnaviridae Infections;D018347
B04.820.250.350.300;Encephalitis Viruses, Japanese;D018349
B04.909.777.270.475;Encephalitis Viruses, Japanese;D018349
B04.909.777.310.350.300;Encephalitis Viruses, Japanese;D018349
D03.383.129.385.025;alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid;D018350
C02.782.600.550.200;Coronavirus Infections;D018352
C02.782.580.830;Rhabdoviridae Infections;D018353
C02.782.930.100;Alphavirus Infections;D018354
C02.782.930.700;Rubivirus Infections;D018355
C02.782.580.600.620.750;Respiratory Syncytial Virus Infections;D018357
C04.557.465.625.650;Neuroendocrine Tumors;D018358
C04.557.580.625.650;Neuroendocrine Tumors;D018358
E05.196.309.742.225;Crystallography, X-Ray;D018360
C04.697.700;Neoplasm, Residual;D018365
C23.550.727.700;Neoplasm, Residual;D018365
C14.907.940.910;Vasculitis, Leukocytoclastic, Cutaneous;D018366
C20.543.520.910;Vasculitis, Leukocytoclastic, Cutaneous;D018366
C20.673.600;Leukocyte-Adhesion Deficiency Syndrome;D018370
D27.505.696.663;Peripheral Nervous System Agents;D018373
A11.251.210.520;LLC-PK1 Cells;D018374
A11.436.520;LLC-PK1 Cells;D018374
G12.425.897;Neutrophil Activation;D018375
C14.240;Cardiovascular Abnormalities;D018376
C16.131.240;Cardiovascular Abnormalities;D018376
D27.505.519.625;Neurotransmitter Agents;D018377
D27.505.696.577;Neurotransmitter Agents;D018377
E04.936.225.687.500;Hematopoietic Stem Cell Transplantation;D018380
C19.874.410.500;Thyroid Hormone Resistance Syndrome;D018382
G02.111.570.120.290;Bay-Region, Polycyclic Aromatic Hydrocarbon;D018383
G02.111.570.790.117;Bay-Region, Polycyclic Aromatic Hydrocarbon;D018383
G03.495.710;Oxidative Stress;D018384
G07.700.830.750;Oxidative Stress;D018384
A11.284.430.214.190.750.585.160;Centrosome;D018385
A11.284.430.106.279.345.190.160.165.500;Kinetochores;D018386
G05.360.160.165.500;Kinetochores;D018386
D13.444.735.544.355.225;Codon, Initiator;D018387
G05.360.335.355.225;Codon, Initiator;D018387
G05.360.340.024.340.137.190.225;Codon, Initiator;D018387
D13.444.735.544.355.250;Codon, Terminator;D018388
G05.360.335.355.250;Codon, Terminator;D018388
G05.360.340.024.340.137.190.250;Codon, Terminator;D018388
D13.444.735.544.355.250.235;Codon, Nonsense;D018389
G05.360.335.355.250.235;Codon, Nonsense;D018389
G05.365.590.195;Codon, Nonsense;D018389
E05.393.335;Gene Targeting;D018390
G05.355.315.203.500;Genomic Imprinting;D018392
B03.510.024.049.525.500.480;Mycobacterium haemophilum;D018393
B03.510.460.400.410.552.552.480;Mycobacterium haemophilum;D018393
D23.050.285.050.225;CA-125 Antigen;D018394
D23.050.550.325.225;CA-125 Antigen;D018394
D23.101.840.075.225;CA-125 Antigen;D018394
D23.050.285.050.119;CA-19-9 Antigen;D018395
D23.050.301.290.544.119;CA-19-9 Antigen;D018395
D23.050.550.325.119;CA-19-9 Antigen;D018395
D23.050.705.230.544.119;CA-19-9 Antigen;D018395
D23.101.840.075.119;CA-19-9 Antigen;D018395
D12.776.395.550.560;Mucin-1;D018396
D12.776.395.560.631.115;Mucin-1;D018396
D12.776.543.550.530;Mucin-1;D018396
D23.050.285.050.300;Mucin-1;D018396
D23.050.301.264.035.535;Mucin-1;D018396
D23.050.550.325.300;Mucin-1;D018396
D23.101.100.110.535;Mucin-1;D018396
D23.101.840.075.300;Mucin-1;D018396
B01.050.150.900.649.709.235;Equidae;D018397
D12.776.260.400;Homeodomain Proteins;D018398
E05.318.780.762;Sample Size;D018401
E05.581.500.902;Sample Size;D018401
N05.715.360.780.692;Sample Size;D018401
N06.850.520.445.762;Sample Size;D018401
B01.050.500.131.617.561.650.525;Manduca;D018402
A11.284.187.570;Isochromosomes;D018404
C23.550.210.430;Isochromosomes;D018404
G05.360.162.570;Isochromosomes;D018404
G05.365.590.175.430;Isochromosomes;D018404
G06.920;Virus Physiological Phenomena;D018406
G06.099;Bacterial Physiological Phenomena;D018407
E05.242.800;Patch-Clamp Techniques;D018408
C26.558.300;Foot Injuries;D018409
C01.252.620;Pneumonia, Bacterial;D018410
C08.381.677.540;Pneumonia, Bacterial;D018410
C08.730.610.540;Pneumonia, Bacterial;D018410
B01.050.500.131.617.561.650.700;Spodoptera;D018411
B03.440.090.100.650;Bartonella quintana;D018413
B03.660.050.030.040.650;Bartonella quintana;D018413
A11.118.637.555.567.569.220;CD8-Positive T-Lymphocytes;D018414
A15.145.229.637.555.567.569.220;CD8-Positive T-Lymphocytes;D018414
A15.382.490.555.567.569.220;CD8-Positive T-Lymphocytes;D018414
B03.440.090.100.350;Bartonella henselae;D018416
B03.660.050.030.040.350;Bartonella henselae;D018416
A11.118.637.555.567.550.500.400.900;Th1 Cells;D018417
A11.118.637.555.567.569.200.400.900;Th1 Cells;D018417
A11.118.637.555.567.569.500.400.900;Th1 Cells;D018417
A15.145.229.637.555.567.550.500.400.500;Th1 Cells;D018417
A15.145.229.637.555.567.569.200.400.500;Th1 Cells;D018417
A15.145.229.637.555.567.569.500.400.500;Th1 Cells;D018417
A15.382.490.555.567.550.500.400.900;Th1 Cells;D018417
A15.382.490.555.567.569.200.400.900;Th1 Cells;D018417
A15.382.490.555.567.569.500.400.900;Th1 Cells;D018417
A11.118.637.555.567.550.500.400.905;Th2 Cells;D018418
A11.118.637.555.567.569.200.400.905;Th2 Cells;D018418
A11.118.637.555.567.569.500.400.905;Th2 Cells;D018418
A15.145.229.637.555.567.550.500.400.750;Th2 Cells;D018418
A15.145.229.637.555.567.569.200.400.750;Th2 Cells;D018418
A15.145.229.637.555.567.569.500.400.750;Th2 Cells;D018418
A15.382.490.555.567.550.500.400.905;Th2 Cells;D018418
A15.382.490.555.567.569.200.400.905;Th2 Cells;D018418
A15.382.490.555.567.569.500.400.905;Th2 Cells;D018418
C22.735;Primate Diseases;D018419
C22.735.050;Ape Diseases;D018420
E04.100.376.125;Cardiomyoplasty;D018421
E04.928.220.220;Cardiomyoplasty;D018421
C09.218.200;Cholesteatoma, Middle Ear;D018424
C17.800.428.260.300;Cholesteatoma, Middle Ear;D018424
E05.318.308.970.725;SEER Program;D018426
L01.280.950.725;SEER Program;D018426
N04.452.859.819.725;SEER Program;D018426
N05.715.360.300.715.700.725;SEER Program;D018426
N06.850.520.308.970.725;SEER Program;D018426
E07.695.140;Breast Implants;D018427
B01.050.500.131.617.289.310;Drosophilidae;D018428
B01.050.500.131.617.289.400;Glossinidae;D018429
V02.667;Newspaper Article;D018431
G07.690.320.300;Drug Resistance, Multiple;D018432
E05.318.760.900;Twin Studies as Topic;D018433
N05.715.360.775.750;Twin Studies as Topic;D018433
N06.850.520.450.900;Twin Studies as Topic;D018433
E05.318.308.250.475.730;Sickness Impact Profile;D018434
N05.715.360.300.375.375.730;Sickness Impact Profile;D018434
N06.850.520.308.250.475.730;Sickness Impact Profile;D018434
D12.776.157.530.100.652;P-Glycoproteins;D018435
D12.776.157.530.450.074.500.500.875;P-Glycoproteins;D018435
D12.776.395.550.020.610;P-Glycoproteins;D018435
D12.776.543.550.192.610;P-Glycoproteins;D018435
D12.776.543.585.100.610;P-Glycoproteins;D018435
D12.776.543.585.450.074.500.500.875;P-Glycoproteins;D018435
Z01.586.035;Ancient Lands;D018436
C10.597.622.669.300;Brown-Sequard Syndrome;D018437
C23.888.592.636.637.300;Brown-Sequard Syndrome;D018437
C14.907.355.350.454.500.200;Blue Toe Syndrome;D018438
C14.907.617.249;Blue Toe Syndrome;D018438
G06.099.225.500;beta-Lactam Resistance;D018440
G06.225.347.500;beta-Lactam Resistance;D018440
G07.690.320.269.347.500;beta-Lactam Resistance;D018440
G06.120;Biofilms;D018441
C04.557.386.480.150.570;Lymphoma, B-Cell, Marginal Zone;D018442
C15.604.515.569.480.150.570;Lymphoma, B-Cell, Marginal Zone;D018442
C20.683.515.761.480.150.570;Lymphoma, B-Cell, Marginal Zone;D018442
N06.850.310.425;Infectious Disease Transmission, Vertical;D018445
E01.789.600;Medical Futility;D018447
E05.599.395.500;Models, Immunological;D018448
D20.215.894.899.790;SAIDS Vaccines;D018449
C23.550.291.656;Disease Progression;D018450
F01.145.802.975.500.600;Homosexuality, Male;D018451
G08.686.867.500.600;Homosexuality, Male;D018451
F01.145.802.975.500.400;Homosexuality, Female;D018452
G08.686.867.500.400;Homosexuality, Female;D018452
M01.325.400;Homeless Youth;D018453
F01.829.263.500.660;Spouses;D018454
I01.880.225.500.670;Spouses;D018454
M01.816;Spouses;D018454
C15.378.100.800;Protein S Deficiency;D018455
C15.378.147.890;Protein S Deficiency;D018455
C15.378.925.800;Protein S Deficiency;D018455
H02.403.763;Reproductive Medicine;D018456
C13.703.590.767;Placenta, Retained;D018457
C10.228.140.140.627;Persistent Vegetative State;D018458
C10.597.606.358.800.400;Persistent Vegetative State;D018458
C23.888.592.604.359.800.400;Persistent Vegetative State;D018458
C17.800.859.475.605;Lichen Sclerosus et Atrophicus;D018459
C26.404.186;Fractures, Comminuted;D018460
C01.539.820;Soft Tissue Infections;D018461
H01.158.273.738;Photobiology;D018462
E04.540.450;Filtering Surgery;D018463
E07.695.250.500;Molteno Implants;D018465
G11.561.600.810.255;Gravity Sensing;D018466
G15.744.450;Gravity Sensing;D018466
C08.618.846.688;Positive-Pressure Respiration, Intrinsic;D018467
B03.440.040.287.150;Ehrlichia chaffeensis;D018469
B03.660.050.020.287.100;Ehrlichia chaffeensis;D018469
G01.595.060.535.369;Gravity, Altered;D018470
G01.595.060.535.369.300;Hypergravity;D018471
G01.595.060.535.369.400;Hypogravity;D018472
E05.977;Weightlessness Simulation;D018474
N06.230.150.440.950;Weightlessness Simulation;D018474
G11.427.695.300;Head-Down Tilt;D018475
C10.597.350.400;Hypokinesia;D018476
C23.888.592.350.400;Hypokinesia;D018476
J01.937.285.850.400;Extravehicular Activity;D018478
N02.421.143.130.320;Early Intervention (Education);D018479
N02.421.143.827.320;Early Intervention (Education);D018479
N02.421.726.320;Early Intervention (Education);D018479
M01.770.100;Astronauts;D018480
G01.906.230;Convection;D018481
A02.633.567;Muscle, Skeletal;D018482
A10.690.552.500;Muscle, Skeletal;D018482
A02.835.232.169;Diaphyses;D018483
A10.690.552.500.500;Muscle Fibers, Skeletal;D018485
A11.620.249;Muscle Fibers, Skeletal;D018485
V03.900;Twin Study;D018486
C14.280.945.900;Ventricular Dysfunction, Left;D018487
C05.116.198.247;Bone Demineralization, Pathologic;D018488
C23.888.571.800;Space Motion Sickness;D018489
D27.505.519.625.850;Serotonin Agents;D018490
D27.505.696.577.850;Serotonin Agents;D018490
D27.505.519.625.150.151;Dopamine Agonists;D018491
D27.505.696.577.150.151;Dopamine Agonists;D018491
D27.505.519.625.150.175;Dopamine Antagonists;D018492
D27.505.696.577.150.175;Dopamine Antagonists;D018492
G09.330.175;Cardiovascular Deconditioning;D018493
D27.505.519.625.375;Histamine Agents;D018494
D27.505.696.577.375;Histamine Agents;D018494
G07.700.280;Fluid Shifts;D018495
C23.888.852.567;Hyperoxia;D018496
C14.280.945.910;Ventricular Dysfunction, Right;D018497
G01.154.100.240.400;Linear Energy Transfer;D018499
G01.595.100.240.400;Linear Energy Transfer;D018499
G02.111.087.242.400;Linear Energy Transfer;D018499
G02.149.115.242.400;Linear Energy Transfer;D018499
G02.149.767.580.400;Linear Energy Transfer;D018499
G02.842.750.580.400;Linear Energy Transfer;D018499
C12.777.419.135.500;Diabetes Insipidus, Nephrogenic;D018500
C13.351.968.419.135.500;Diabetes Insipidus, Nephrogenic;D018500
D27.505.954.329;Antirheumatic Agents;D018501
B03.510.400.800.872.225;Streptococcus equi;D018502
B03.510.550.737.872.225;Streptococcus equi;D018502
G05.360.340.375;Genome, Protozoan;D018503
G16.500.275.157.240;Ecological Systems, Closed;D018504
N06.230.124.240;Ecological Systems, Closed;D018504
N06.230.150.225;Ecological Systems, Closed;D018504
N06.850.780.200.800.800.900;Waste Management;D018505
N06.850.860.510.900;Waste Management;D018505
G05.355.315.375;Gene Expression Regulation, Plant;D018506
G05.355.315.310;Gene Expression Regulation, Developmental;D018507
N06.850.780.200.800.800.900.900;Water Purification;D018508
N06.850.860.510.900.900;Water Purification;D018508
D13.444.308.315;DNA, Helminth;D018509
D13.444.735.520;RNA, Helminth;D018510
H01.770.787;Systems Integration;D018511
L01.906.787;Systems Integration;D018511
C03.695;Parasitemia;D018512
C23.550.470.790.500.580;Parasitemia;D018512
A18;Plant Structures;D018514
A18.024.812;Plant Leaves;D018515
A18.024.812.700;Pulvinus;D018516
A18.400;Plant Roots;D018517
A18.400.500.600;Plant Root Cap;D018518
A18.024.875.875;Meristem;D018519
A18.024.937.500;Meristem;D018519
A18.400.500;Meristem;D018519
A18.024.875;Plant Shoots;D018520
G15;Plant Physiological Phenomena;D018521
G07.700.320.249.845.400;Gravitropism;D018522
G15.744.900.400;Gravitropism;D018522
G07.700.320.249.845;Tropism;D018523
G15.744.900;Tropism;D018523
G07.700.320.249.845.700;Phototropism;D018524
G15.744.900.700;Phototropism;D018524
G07.700.320.625.249;Germination;D018525
G15.744.300;Germination;D018525
G15.744.750;Plant Transpiration;D018526
J01.040.581;Hydroponics;D018527
D12.776.157.530.100;ATP-Binding Cassette Transporters;D018528
D12.776.395.550.020;ATP-Binding Cassette Transporters;D018528
D12.776.543.550.192;ATP-Binding Cassette Transporters;D018528
D12.776.543.585.100;ATP-Binding Cassette Transporters;D018528
E02.642.500;Nutritional Support;D018529
A03.556.875.875.578;Gastric Stump;D018530
J01.937.285.850.900;Spacecraft;D018531
B01.650.940.800.575.100.401.625;Peas;D018532
J02.500.850.500.500;Peas;D018532
G16.500.275.157.100;Biomass;D018533
N06.230.124.100;Biomass;D018533
G01.060.249.730.700.200;Earth (Planet);D018534
G01.060.249.730.700.625;Mars;D018535
G01.060.249.730.700.900;Venus;D018536
G01.060.249.730.700.762;Mercury (Planet);D018537
G01.060.249.730.700.412;Jupiter;D018538
G01.060.249.730.700.831;Saturn;D018539
G01.060.249.730.700.865;Uranus;D018540
G01.060.249.730.700.796;Neptune;D018541
G01.060.249.730.600.500;Pluto;D018542
G01.060.249.730.600;Minor Planets;D018543
E05.974;Weightlessness Countermeasures;D018544
B01.650.940.800.575.100.100.500;Lettuce;D018545
J02.500.850.525;Lettuce;D018545
A18.024.875.750;Hypocotyl;D018546
A18.024.937.249;Hypocotyl;D018546
A18.550.500;Hypocotyl;D018546
A18.024.937;Plant Stems;D018547
A18.024.500.750.333;Cotyledon;D018548
A18.024.875.500;Cotyledon;D018548
C08.127.446.135.140.200;Cryptogenic Organizing Pneumonia;D018549
C08.381.483.487.249;Cryptogenic Organizing Pneumonia;D018549
C08.381.495.146.135.140.200;Cryptogenic Organizing Pneumonia;D018549
G06.099.225.500.175;Cephalosporin Resistance;D018550
G06.225.347.500.175;Cephalosporin Resistance;D018550
G07.690.320.269.347.500.175;Cephalosporin Resistance;D018550
B01.650.940.800.575.100.905.322;Lycopersicon esculentum;D018551
J02.500.850.533;Lycopersicon esculentum;D018551
B01.650.940.800.575.100.075.288;Daucus carota;D018552
J02.500.850.311;Daucus carota;D018552
B01.650.940.800.575.100.300.188.666;Cucumis sativus;D018553
J02.500.850.250;Cucumis sativus;D018553
B01.650.940.800.575.100.822.060;Avena sativa;D018554
J02.500.200.066;Avena sativa;D018554
J02.500.300.100.088;Avena sativa;D018554
B01.650.510.344;Crops, Agricultural;D018556
J02.500.300;Crops, Agricultural;D018556
I01.409.137.500.984;United States National Aeronautics and Space Administration;D018557
N03.540.348.500.500.984;United States National Aeronautics and Space Administration;D018557
H01.158.273.295;Exobiology;D018559
N06.230.150.440;Space Simulation;D018561
N06.850.310;Disease Transmission, Infectious;D018562
E05.318.362;Disease Notification;D018563
N06.850.520.373;Disease Notification;D018563
N06.850.780.200.262;Disease Notification;D018563
G07.690.812.240.511;Food-Drug Interactions;D018565
G07.700.680.240.511;Food-Drug Interactions;D018565
G08.686.785.760.769.500;Pregnancy, High-Risk;D018566
C04.588.180.260;Breast Neoplasms, Male;D018567
C17.800.090.500.260;Breast Neoplasms, Male;D018567
E01.370.600.115.100.160.100.500;Crown-Rump Length;D018568
E05.041.124.160.500.500;Crown-Rump Length;D018568
G07.100.100.160.100.500;Crown-Rump Length;D018568
G07.100.100.250;Crown-Rump Length;D018568
N06.850.505.200.100.400;Crown-Rump Length;D018568
E05.318.740.600.800.715;Risk Assessment;D018570
N04.452.871.715;Risk Assessment;D018570
N05.715.360.750.625.700.690;Risk Assessment;D018570
N06.850.505.715;Risk Assessment;D018570
N06.850.520.830.600.800.715;Risk Assessment;D018570
E05.318.308.250.700.650;Sentinel Surveillance;D018571
E05.318.650;Sentinel Surveillance;D018571
N05.715.360.300.375.625.650;Sentinel Surveillance;D018571
N06.850.520.308.250.700.650;Sentinel Surveillance;D018571
N06.850.520.699;Sentinel Surveillance;D018571
N06.850.780.675.650;Sentinel Surveillance;D018571
E01.789.200;Disease-Free Survival;D018572
E05.318.740.998.300;Disease-Free Survival;D018572
N05.715.360.750.795.300;Disease-Free Survival;D018572
N06.850.520.830.998.300;Disease-Free Survival;D018572
N03.540.483;Home Care Agencies;D018574
N02.421.143.524.403;Home Care Services, Hospital-Based;D018575
M01.526.485.067.350;Home Health Aides;D018576
N02.360.067.350;Home Health Aides;D018576
M01.276;Homebound Persons;D018577
N02.278.354.458;Hospital-Physician Relations;D018578
N04.452.442.530;Hospital-Physician Relations;D018578
N04.452.758.275;Hospital-Physician Relations;D018578
N04.452.822.379;Hospital-Physician Relations;D018578
E05.581.500.653;Patient Selection;D018579
N04.590.731;Patient Selection;D018579
I01.880.604.622.500;Mandatory Testing;D018580
N03.706.657.500;Mandatory Testing;D018580
N06.850.780.200.550;Mandatory Testing;D018580
N06.850.780.500.412;Mandatory Testing;D018580
J01.897.900;Technology Transfer;D018581
L01.143.320.800;Technology Transfer;D018581
N01.824.417.700.662;Sick Leave;D018582
N04.452.677.800.662;Sick Leave;D018582
G01.374.705;Pliability;D018583
N02.278.354.550.380.500;Physician Self-Referral;D018584
N04.452.442.550.380.500;Physician Self-Referral;D018584
N04.452.758.849.500;Physician Self-Referral;D018584
N05.350.225.500;Physician Self-Referral;D018584
M01.975.155;Battered Women;D018585
N02.278.065.900.205;Bone Banks;D018586
E02.875.800.968;Oocyte Donation;D018587
E05.820.800.968;Oocyte Donation;D018587
N03.219.442.195;Fee-for-Service Plans;D018588
N03.219.521.710.305.090;Fee-for-Service Plans;D018588
N04.452.758.745.225;Fee-for-Service Plans;D018588
C06.405.748.543;Gastroparesis;D018589
C23.888.592.636.263;Gastroparesis;D018589
E01.370.378.860;Uterine Monitoring;D018590
E01.370.520.860;Uterine Monitoring;D018590
E05.318.780.150;Cross-Over Studies;D018592
N05.715.360.780.150;Cross-Over Studies;D018592
N06.850.520.445.150;Cross-Over Studies;D018592
I01.076.201.450.560;Human Body;D018594
K01.093.378;Human Body;D018594
I01.696.116;Colonialism;D018595
K01.844.231;Hinduism;D018596
K01.844.188.715;Saints;D018597
G02.111.570.080.708.800.550;Minisatellite Repeats;D018598
G05.360.080.708.800.550;Minisatellite Repeats;D018598
G05.360.340.024.850.550;Minisatellite Repeats;D018598
E02.190.901.968;Witchcraft;D018599
I01.076.201.450.897.439.925;Witchcraft;D018599
H01.158.100.529.500;Teratology;D018600
H01.158.273.200.350.500;Teratology;D018600
C01.252.410.040.552.846.719.500;King's Evil;D018601
C15.604.921.500;King's Evil;D018601
C25.723.756.600;Milk Sickness;D018602
E05.478.274;Epitope Mapping;D018604
E05.601.690.300;Epitope Mapping;D018604
G02.149.767.830;Spontaneous Combustion;D018605
G02.842.750.830;Spontaneous Combustion;D018605
N06.230.216.750;Spontaneous Combustion;D018605
E04.520.050.060.600;Pregnancy Reduction, Multifetal;D018607
E04.520.050.600;Pregnancy Reduction, Multifetal;D018607
E01.370.350.850.850;Ultrasonography, Doppler;D018608
Z01.252.474.164.900;Tibet;D018609
E04.035.410;Heart Bypass, Right;D018610
E04.100.376.410;Heart Bypass, Right;D018610
E04.100.814.868.875;Heart Bypass, Right;D018610
E04.928.220.370;Heart Bypass, Right;D018610
E04.292.465;Heart Bypass, Left;D018611
Z01.586.035.175;Byzantium;D018612
E01.370.350.515.395;Microscopy, Confocal;D018613
E05.595.395;Microscopy, Confocal;D018613
C23.888.119.344.672;Sweating Sickness;D018614
E01.370.350.850.850.850.850;Ultrasonography, Doppler, Color;D018615
E01.370.350.850.850.850;Ultrasonography, Doppler, Duplex;D018616
E01.370.350.850.850.860;Ultrasonography, Doppler, Pulsed;D018617
E01.370.350.130.750.220.220;Echocardiography, Doppler, Color;D018618
E01.370.350.850.220.220.220;Echocardiography, Doppler, Color;D018618
E01.370.350.850.850.220.220;Echocardiography, Doppler, Color;D018618
E01.370.350.850.850.850.850.220;Echocardiography, Doppler, Color;D018618
E01.370.370.380.220.220.220;Echocardiography, Doppler, Color;D018618
E01.370.350.130.750.220.225;Echocardiography, Doppler, Pulsed;D018619
E01.370.350.850.220.220.225;Echocardiography, Doppler, Pulsed;D018619
E01.370.350.850.850.220.225;Echocardiography, Doppler, Pulsed;D018619
E01.370.350.850.850.860.225;Echocardiography, Doppler, Pulsed;D018619
E01.370.370.380.220.220.225;Echocardiography, Doppler, Pulsed;D018619
D12.776.785.700;PrPSc Proteins;D018620
D12.776.785.680;PrPC Proteins;D018621
D12.776.785.700.700;PrP 27-30 Protein;D018622
E01.370.350.515.666.400;Microscopy, Atomic Force;D018625
E05.595.666.400;Microscopy, Atomic Force;D018625
D13.444.308.760;Retroelements;D018626
G02.111.570.080.708.330.800;Retroelements;D018626
G05.360.080.708.330.800;Retroelements;D018626
G05.360.340.024.425.800;Retroelements;D018626
G05.380.350;Gene Dosage;D018628
E05.196.566.760;Spectrometry, Mass, Secondary Ion;D018629
C11.768.890;Vitreoretinopathy, Proliferative;D018630
C11.975;Vitreoretinopathy, Proliferative;D018630
D08.811.277.040.330.300.400.500;ras Proteins;D018631
D12.644.360.525.500;ras Proteins;D018631
D12.776.157.325.515.500;ras Proteins;D018631
D12.776.476.525.500;ras Proteins;D018631
B01.050.050.157.520.600;Mice, Inbred SENCAR;D018632
B01.050.050.199.520.520.600;Mice, Inbred SENCAR;D018632
B01.050.150.900.649.865.635.505.500.400.600;Mice, Inbred SENCAR;D018632
C14.240.850.937;Pulmonary Atresia;D018633
C14.280.484.640;Pulmonary Atresia;D018633
C16.131.240.850.906;Pulmonary Atresia;D018633
M01.526.485.905;Veterinarians;D018634
N02.360.905;Veterinarians;D018634
N06.230.100.350;Rescue Work;D018635
C14.240.400.625;Hypoplastic Left Heart Syndrome;D018636
C14.280.400.625;Hypoplastic Left Heart Syndrome;D018636
C16.131.240.400.625;Hypoplastic Left Heart Syndrome;D018636
D26.776.210;Contact Lens Solutions;D018639
D27.505.954.122.425.150;Contact Lens Solutions;D018639
D27.720.274.150;Contact Lens Solutions;D018639
C07.650;Stomatognathic System Abnormalities;D018640
C16.131.850;Stomatognathic System Abnormalities;D018640
I01.076.201.450.226.200;Arab World;D018643
I01.076.201.450.226.800.500;Roman World;D018644
I01.076.201.450.226.800.250;Greek World;D018645
J02.200.100.100;Absinthe;D018646
D05.750.078.840.109;Amber;D018647
D20.215.721.500.109;Amber;D018647
D20.080;Ambergris;D018648
B01.650.940.800.575.100.575.647.500;Ocimum basilicum;D018649
B01.650.940.800.575.100.100.075;Arnica;D018650
B01.650.940.800.575.100.100.200;Chicory;D018651
J02.500.850.237;Chicory;D018651
B01.650.940.800.575.100.075.388;Hemlock;D018652
B01.650.940.800.575.400.122.188.500;Juniperus;D018653
E01.370.225.500.195.107.595.500;Lymphocyte Count;D018655
E01.370.225.625.107.595.500;Lymphocyte Count;D018655
E05.200.500.195.107.595.500;Lymphocyte Count;D018655
E05.200.625.107.595.500;Lymphocyte Count;D018655
E05.242.195.107.595.500;Lymphocyte Count;D018655
G04.170.107.595.500;Lymphocyte Count;D018655
G09.188.105.595.500;Lymphocyte Count;D018655
A10.690.552.500.500.600;Muscle Fibers, Fast-Twitch;D018656
A11.620.249.400;Muscle Fibers, Fast-Twitch;D018656
A10.690.552.500.500.700;Muscle Fibers, Slow-Twitch;D018657
A11.620.249.700;Muscle Fibers, Slow-Twitch;D018657
C14.280.470.475.900;Ventricular Septal Rupture;D018658
E01.370.370.140.100;Blood Pressure Monitoring, Ambulatory;D018660
E01.370.520.500.100;Blood Pressure Monitoring, Ambulatory;D018660
B03.440.860.580.553.553.645;Mycoplasma penetrans;D018661
E04.210.390;Fundoplication;D018662
D27.505.519.625.050;Adrenergic Agents;D018663
D27.505.696.577.050;Adrenergic Agents;D018663
D12.644.276.374.465.512;Interleukin-12;D018664
D12.776.467.374.465.512;Interleukin-12;D018664
D23.529.374.465.512;Interleukin-12;D018664
E01.370.388.250.920;Ureteroscopy;D018666
E01.370.390.800;Ureteroscopy;D018666
E04.800.250.920;Ureteroscopy;D018666
E04.950.774.840;Ureteroscopy;D018666
E01.370.370.750;Tilt-Table Test;D018667
B01.050.150.900.649.077.380.373.322;Muntjacs;D018668
E01.370.520.500;Monitoring, Ambulatory;D018670
N02.421.143.827.708;Needle-Exchange Programs;D018671
N02.421.726.708;Needle-Exchange Programs;D018671
N03.349.650.185;Community Health Planning;D018672
I01.655.500.608.400.650;Nutrition Policy;D018673
I01.880.604.825.608.400.650;Nutrition Policy;D018673
N03.623.500.608.428.650;Nutrition Policy;D018673
D27.505.519.625.050.200;Adrenergic Antagonists;D018674
D27.505.696.577.050.200;Adrenergic Antagonists;D018674
E05.940;Toxicity Tests;D018675
C07.793.850;Tooth Injuries;D018677
C26.900;Tooth Injuries;D018677
D27.505.519.625.120;Cholinergic Agents;D018678
D27.505.696.577.120;Cholinergic Agents;D018678
D27.505.519.625.120.140;Cholinergic Agonists;D018679
D27.505.696.577.120.140;Cholinergic Agonists;D018679
D27.505.519.625.120.200;Cholinergic Antagonists;D018680
D27.505.696.577.120.200;Cholinergic Antagonists;D018680
D27.505.696.277.100.035;Anesthetics, General;D018681
D27.505.954.427.210.100.035;Anesthetics, General;D018681
D27.505.519.625.240;GABA Agents;D018682
D27.505.696.577.240;GABA Agents;D018682
D27.505.519.625.190;Excitatory Amino Acid Agents;D018683
D27.505.696.577.190;Excitatory Amino Acid Agents;D018683
D27.505.519.625.300;Glycine Agents;D018684
D27.505.696.577.300;Glycine Agents;D018684
D27.505.696.277.100.035.060;Anesthetics, Inhalation;D018685
D27.505.954.427.210.100.035.060;Anesthetics, Inhalation;D018685
D27.505.696.277.100.035.075;Anesthetics, Intravenous;D018686
D27.505.954.427.210.100.035.075;Anesthetics, Intravenous;D018686
D27.505.954.427.700.122.050;Antidepressive Agents, Second-Generation;D018687
B01.043.075.189.250.750.550;Neospora;D018688
D27.505.696.663.850;Sensory System Agents;D018689
D27.505.519.625.190.200;Excitatory Amino Acid Agonists;D018690
D27.505.696.577.190.200;Excitatory Amino Acid Agonists;D018690
D27.505.519.625.190.300;Excitatory Amino Acid Antagonists;D018691
D27.505.696.577.190.300;Excitatory Amino Acid Antagonists;D018691
D27.505.696.277.950.025;Antimanic Agents;D018692
D27.505.954.427.210.950.025;Antimanic Agents;D018692
D27.505.954.427.700.872.025;Antimanic Agents;D018692
D27.505.696.706.548;Neuroprotective Agents;D018696
D27.505.954.427.575;Neuroprotective Agents;D018696
D27.505.954.427.637;Nootropic Agents;D018697
D12.125.067.750;Glutamic Acid;D018698
D12.125.119.450;Glutamic Acid;D018698
D12.125.427.300;Glutamic Acid;D018698
A11.284.430.214.190.875.190.880.180;Coated Vesicles;D018699
E02.319.694;Pleurodesis;D018700
C02.782.580;Mononegavirales Infections;D018701
C02.782.580.250;Filoviridae Infections;D018702
G05.285;Founder Effect;D018703
E06.658.453.637;Orthodontic Retainers;D018704
G01.311.340.900;Volcanic Eruptions;D018707
G01.595.340.900;Volcanic Eruptions;D018707
B04.820.562;Picobirnavirus;D018708
B04.909.777.610;Picobirnavirus;D018708
B04.970.610;Picobirnavirus;D018708
E05.318.740.995;Statistics, Nonparametric;D018709
N05.715.360.750.760;Statistics, Nonparametric;D018709
N06.850.520.830.995;Statistics, Nonparametric;D018709
N02.278.035.380.600;Pain Clinics;D018710
N02.278.035.516;Pain Clinics;D018710
N02.278.354.422.527.600;Pain Clinics;D018710
N04.452.442.422.527.600;Pain Clinics;D018710
D27.505.696.663.850.014.040;Analgesics, Non-Narcotic;D018712
D27.505.954.427.040.100;Analgesics, Non-Narcotic;D018712
B03.140.094.640.375;Prevotella intermedia;D018713
B03.440.425.410.194.640.375;Prevotella intermedia;D018713
E02.186.775;Radiotherapy, Adjuvant;D018714
E02.815.600;Radiotherapy, Adjuvant;D018714
E01.370.350.515.690;Microscopy, Video;D018715
E05.595.690;Microscopy, Video;D018715
J01.897.280.500.898.475;Microscopy, Video;D018715
L01.178.820.090.898.475;Microscopy, Video;D018715
L01.178.847.823.475;Microscopy, Video;D018715
G02.111.087.560;Molecular Mimicry;D018716
G02.149.115.560;Molecular Mimicry;D018716
G05.355.590;Molecular Mimicry;D018716
A11.284.149.648;Purple Membrane;D018717
A20.871;Purple Membrane;D018717
E02.319.444;Home Infusion Therapy;D018718
N02.421.143.524.436;Home Infusion Therapy;D018718
D08.811.913.696.620.682.725.400.150;Receptor, erbB-2;D018719
D12.776.543.750.060.374;Receptor, erbB-2;D018719
D12.776.543.750.750.400.350;Receptor, erbB-2;D018719
D12.776.624.664.700.642;Receptor, erbB-2;D018719
D23.101.840.642;Receptor, erbB-2;D018719
B03.140.094.640;Prevotella;D018720
B03.440.425.410.194.640;Prevotella;D018720
D27.505.519.625.120.140.500;Muscarinic Agonists;D018721
D27.505.696.577.120.140.500;Muscarinic Agonists;D018721
D27.505.519.625.120.140.700;Nicotinic Agonists;D018722
D27.505.696.577.120.140.700;Nicotinic Agonists;D018722
D02.092.877.883.088.100;Bethanechol;D018723
D02.675.276.148.100;Bethanechol;D018723
B01.650.940.800.575.100.200.800;Spinacia oleracea;D018724
J02.500.850.800;Spinacia oleracea;D018724
D20.749.850;Tar-Water;D018725
D27.505.954.427.090;Anti-Dyskinesia Agents;D018726
D27.505.519.625.120.200.500;Muscarinic Antagonists;D018727
D27.505.696.577.120.200.500;Muscarinic Antagonists;D018727
A08.186.211.464.710.225;Entorhinal Cortex;D018728
A08.186.211.730.885.287.500.863.648.225;Entorhinal Cortex;D018728
E04.035.410.295;Fontan Procedure;D018729
E04.100.376.410.295;Fontan Procedure;D018729
E04.100.376.724.500;Fontan Procedure;D018729
E04.100.814.868.875.295;Fontan Procedure;D018729
E04.928.220.370.295;Fontan Procedure;D018729
E04.928.220.560.500;Fontan Procedure;D018729
F01.145.179.500;Infant Behavior;D018730
I01.076.368.400;Forensic Anthropology;D018732
I01.198.780.750;Forensic Anthropology;D018732
D27.505.519.625.120.200.700;Nicotinic Antagonists;D018733
D27.505.696.577.120.200.700;Nicotinic Antagonists;D018733
G05.360.340.024.340.375.500.791.295.305;Genes, erbB-2;D018734
D13.444.308.135;DNA Adducts;D018736
G05.355.180.104;DNA Adducts;D018736
E01.370.600.425.500;Hand Strength;D018737
G11.427.560.500;Hand Strength;D018737
D02.092.877.250.592.400;Hexamethonium;D018738
D02.675.276.558.592.500;Hexamethonium;D018738
D12.776.624.664.520.750.883;Oncogene Proteins v-erbB;D018739
D12.776.964.700.750.883;Oncogene Proteins v-erbB;D018739
D12.776.964.775.750.883;Oncogene Proteins v-erbB;D018739
G05.365.331;Genetic Heterogeneity;D018740
G05.360.340.024.220.760;Replication Origin;D018741
G05.360.340.024.745.725;Replication Origin;D018741
D13.444.308.283.170;DNA, Chloroplast;D018742
D13.444.308.435.275;DNA, Chloroplast;D018742
E02.760.703;Perinatal Care;D018743
N02.421.088.120.180;Perinatal Care;D018743
N02.421.143.620.550;Perinatal Care;D018743
N02.421.585.703;Perinatal Care;D018743
D13.444.308.435;DNA, Plant;D018744
G05.360.340.365;Genome, Plant;D018745
C23.550.470.790;Systemic Inflammatory Response Syndrome;D018746
C23.550.835.900;Systemic Inflammatory Response Syndrome;D018746
D13.444.735.476;RNA, Chloroplast;D018747
D13.444.735.635.575;RNA, Chloroplast;D018747
D13.444.735.635;RNA, Plant;D018749
D03.438.857.160;6-Cyano-7-nitroquinoxaline-2,3-dione;D018750
E02.642.249.260;Diet, Fat-Restricted;D018752
G07.610.240.260;Diet, Fat-Restricted;D018752
E02.642.249.280;Diet, Protein-Restricted;D018753
G07.610.240.280;Diet, Protein-Restricted;D018753
C14.280.945;Ventricular Dysfunction;D018754
D27.505.519.625.240.200;GABA Agonists;D018755
D27.505.696.577.240.200;GABA Agonists;D018755
D27.505.519.625.240.300;GABA Antagonists;D018756
D27.505.696.577.240.300;GABA Antagonists;D018756
D27.505.519.625.240.500;GABA Modulators;D018757
D27.505.696.577.240.500;GABA Modulators;D018757
D27.505.954.888;Stimulants, Historical;D018758
D27.505.519.625.050.601;Adrenergic Uptake Inhibitors;D018759
D27.505.519.625.600.050;Adrenergic Uptake Inhibitors;D018759
D27.505.696.577.050.601;Adrenergic Uptake Inhibitors;D018759
D27.505.696.577.600.050;Adrenergic Uptake Inhibitors;D018759
C04.588.322.400.500;Multiple Endocrine Neoplasia Type 1;D018761
C04.651.600.500;Multiple Endocrine Neoplasia Type 1;D018761
C04.700.630.500;Multiple Endocrine Neoplasia Type 1;D018761
C16.320.700.630.500;Multiple Endocrine Neoplasia Type 1;D018761
C19.344.400.500;Multiple Endocrine Neoplasia Type 1;D018761
G11.427.550;Muscle Fatigue;D018763
D27.505.519.625.150.800;Dopamine Uptake Inhibitors;D018765
D27.505.519.625.600.220;Dopamine Uptake Inhibitors;D018765
D27.505.696.577.150.800;Dopamine Uptake Inhibitors;D018765
D27.505.696.577.600.220;Dopamine Uptake Inhibitors;D018765
C05.550.091;Arthralgia;D018771
C23.888.646.130;Arthralgia;D018771
F02.830.816.444.350;Arthralgia;D018771
G11.561.600.810.444.350;Arthralgia;D018771
E06.323.764;Dental Marginal Adaptation;D018772
E06.658.224;Dental Marginal Adaptation;D018772
E06.780.620;Dental Marginal Adaptation;D018772
G05.360.340.024.340.375.500.791.295.300;Genes, erbB-1;D018773
D12.776.624.664.520.750.882;Oncogene Proteins v-erbA;D018774
D12.776.964.700.750.882;Oncogene Proteins v-erbA;D018774
D12.776.964.775.750.882;Oncogene Proteins v-erbA;D018774
E05.118;Bone Demineralization Technique;D018775
G05.360.340.024.340.375.500.791.290;Genes, erbA;D018776
C20.543.312.500;Multiple Chemical Sensitivity;D018777
C21.223.500;Multiple Chemical Sensitivity;D018777
C02.782.147.420;Hantavirus Infections;D018778
E01.370.370.380.240.100;Body Surface Potential Mapping;D018780
E01.370.370.380.240.850.100;Body Surface Potential Mapping;D018780
E01.370.405.240.100;Body Surface Potential Mapping;D018780
E01.370.405.240.850.100;Body Surface Potential Mapping;D018780
C10.228.140.546.399.875;Tension-Type Headache;D018781
F02.463.425.507;Maze Learning;D018782
C12.294.644.486.500;Impotence, Vasculogenic;D018783
C01.539.830.025.020;Abdominal Abscess;D018784
C14.240.400.920;Tricuspid Atresia;D018785
C14.280.400.920;Tricuspid Atresia;D018785
C14.280.484.845;Tricuspid Atresia;D018785
C16.131.240.400.920;Tricuspid Atresia;D018785
D25.130.325;Bone Substitutes;D018786
J01.637.051.130.325;Bone Substitutes;D018786
H02.403.429.515.500;Radiation Oncology;D018787
H02.403.740.650;Radiation Oncology;D018787
N06.850.135.848;Radioactive Hazard Release;D018788
E01.370.225.500.195.107.595.500.150;CD4 Lymphocyte Count;D018791
E01.370.225.625.107.595.500.150;CD4 Lymphocyte Count;D018791
E05.200.500.195.107.595.500.150;CD4 Lymphocyte Count;D018791
E05.200.625.107.595.500.150;CD4 Lymphocyte Count;D018791
E05.242.195.107.595.500.150;CD4 Lymphocyte Count;D018791
G04.170.107.595.500.150;CD4 Lymphocyte Count;D018791
G09.188.105.595.500.150;CD4 Lymphocyte Count;D018791
C02.182.500.300;Encephalitis, Viral;D018792
C02.290;Encephalitis, Viral;D018792
C10.228.228.210.150.300;Encephalitis, Viral;D018792
C10.228.228.245.340;Encephalitis, Viral;D018792
D12.644.276.374.465.513;Interleukin-13;D018793
D12.776.467.374.465.513;Interleukin-13;D018793
D23.529.374.465.513;Interleukin-13;D018793
F02.463.425.720;Problem-Based Learning;D018794
I02.158.660;Problem-Based Learning;D018794
I02.903.565;Problem-Based Learning;D018794
E05.337.275;Device Approval;D018795
N06.850.210.275;Device Approval;D018795
D12.776.124.486.485.114.580;Immunoconjugates;D018796
D12.776.124.790.651.114.580;Immunoconjugates;D018796
D12.776.377.715.548.114.580;Immunoconjugates;D018796
D12.776.167;Cell Cycle Proteins;D018797
C15.378.071.196.300;Anemia, Iron-Deficiency;D018798
C18.452.565.100;Anemia, Iron-Deficiency;D018798
D12.776.395.550.200.450;Intercellular Adhesion Molecule-1;D018799
D12.776.543.550.200.450;Intercellular Adhesion Molecule-1;D018799
D23.050.301.264.035.400;Intercellular Adhesion Molecule-1;D018799
D23.050.301.350.450;Intercellular Adhesion Molecule-1;D018799
D23.101.100.110.400;Intercellular Adhesion Molecule-1;D018799
D12.776.395.550.050;Antigens, Thy-1;D018800
D12.776.543.550.189;Antigens, Thy-1;D018800
D23.050.301.264.035.270;Antigens, Thy-1;D018800
D23.050.301.264.930;Antigens, Thy-1;D018800
D23.101.100.110.270;Antigens, Thy-1;D018800
D23.101.100.930;Antigens, Thy-1;D018800
D23.050.301.264.035.102;Antigens, CD2;D018801
D23.050.301.264.894.090;Antigens, CD2;D018801
D23.101.100.110.102;Antigens, CD2;D018801
D23.101.100.894.090;Antigens, CD2;D018801
N04.590.233.675;Patient-Centered Care;D018802
N04.590.233.727.407;Patient-Centered Care;D018802
N04.590.720;Patient-Centered Care;D018802
E05.318.740.500.600;Models, Economic;D018803
E05.599.835.890;Models, Economic;D018803
N05.715.360.750.530.500;Models, Economic;D018803
N06.850.520.830.500.600;Models, Economic;D018803
C02.782.147.420.380;Hantavirus Pulmonary Syndrome;D018804
C08.618.846.450;Hantavirus Pulmonary Syndrome;D018804
C01.539.757;Sepsis;D018805
C23.550.470.790.500;Sepsis;D018805
E05.318.308.250.475.365;APACHE;D018806
G05.365.795.600;Polymorphism, Single-Stranded Conformational;D018807
D12.776.260.108.875;Transcription Factor AP-1;D018808
D12.776.930.127.875;Transcription Factor AP-1;D018808
D12.776.660.740;Proliferating Cell Nuclear Antigen;D018809
D23.050.290.750;Proliferating Cell Nuclear Antigen;D018809
D23.101.840.600;Proliferating Cell Nuclear Antigen;D018809
E01.370.350.500.500;Magnetic Resonance Angiography;D018810
E01.370.350.825.500.500;Magnetic Resonance Angiography;D018810
E01.370.370.050.500;Magnetic Resonance Angiography;D018810
N06.850.460.350.145;Maternal Exposure;D018811
N06.850.460.350.700;Paternal Exposure;D018812
C04.588.322.400.505;Multiple Endocrine Neoplasia Type 2a;D018813
C04.651.600.505;Multiple Endocrine Neoplasia Type 2a;D018813
C04.700.630.505;Multiple Endocrine Neoplasia Type 2a;D018813
C16.320.700.630.505;Multiple Endocrine Neoplasia Type 2a;D018813
C19.344.400.505;Multiple Endocrine Neoplasia Type 2a;D018813
C04.588.322.400.510;Multiple Endocrine Neoplasia Type 2b;D018814
C04.651.600.510;Multiple Endocrine Neoplasia Type 2b;D018814
C04.700.630.510;Multiple Endocrine Neoplasia Type 2b;D018814
C16.320.700.630.510;Multiple Endocrine Neoplasia Type 2b;D018814
C19.344.400.510;Multiple Endocrine Neoplasia Type 2b;D018814
G05.360.340.024.340.375.500.791.295;Genes, erbB;D018815
G05.360.340.024.340.220;Genes, cdc;D018816
D02.092.471.683.152.670;N-Methyl-3,4-methylenedioxyamphetamine;D018817
D03.438.079.300;Fenoldopam;D018818
D08.811.277.656.350.350.126;Dipeptidyl Peptidase 4;D018819
D08.811.277.656.959.250;Dipeptidyl Peptidase 4;D018819
D23.050.301.264.035.282;Dipeptidyl Peptidase 4;D018819
D23.050.301.264.894.160;Dipeptidyl Peptidase 4;D018819
D23.101.100.110.282;Dipeptidyl Peptidase 4;D018819
D23.101.100.894.160;Dipeptidyl Peptidase 4;D018819
D12.776.395.550.200.275.750;Antigens, CD18;D018821
D12.776.543.550.200.275.750;Antigens, CD18;D018821
D12.776.543.750.705.408.200.249;Antigens, CD18;D018821
D12.776.543.750.705.408.600.100.750;Antigens, CD18;D018821
D12.776.543.750.705.833.249.750;Antigens, CD18;D018821
D23.050.301.264.035.118;Antigens, CD18;D018821
D23.050.301.264.894.118;Antigens, CD18;D018821
D23.050.301.350.275.750;Antigens, CD18;D018821
D23.101.100.110.118;Antigens, CD18;D018821
D23.101.100.894.118;Antigens, CD18;D018821
D06.472.699.327.935.119;alpha-Endorphin;D018822
D06.472.699.631.525.600.119;alpha-Endorphin;D018822
D12.644.400.400.935.119;alpha-Endorphin;D018822
D12.644.400.575.241.039;alpha-Endorphin;D018822
D12.644.468.241.039;alpha-Endorphin;D018822
D12.644.548.365.935.119;alpha-Endorphin;D018822
D12.644.548.691.525.690.119;alpha-Endorphin;D018822
D12.776.641.650.405.935.119;alpha-Endorphin;D018822
D12.776.641.650.575.241.080.500.500;alpha-Endorphin;D018822
D06.472.699.327.935.505;gamma-Endorphin;D018823
D06.472.699.631.525.600.505;gamma-Endorphin;D018823
D12.644.400.400.935.505;gamma-Endorphin;D018823
D12.644.400.575.241.540;gamma-Endorphin;D018823
D12.644.468.241.540;gamma-Endorphin;D018823
D12.644.548.365.935.505;gamma-Endorphin;D018823
D12.644.548.691.525.690.505;gamma-Endorphin;D018823
D12.776.641.650.405.935.505;gamma-Endorphin;D018823
D12.776.641.650.575.241.080.500;gamma-Endorphin;D018823
D08.811.277.656.350.100.160;Antigens, CD13;D018826
D08.811.277.656.350.555.100;Antigens, CD13;D018826
D08.811.277.656.675.555.100;Antigens, CD13;D018826
D23.050.301.264.035.113;Antigens, CD13;D018826
D23.050.301.264.894.113;Antigens, CD13;D018826
D23.101.100.110.113;Antigens, CD13;D018826
D23.101.100.894.113;Antigens, CD13;D018826
C04.557.470.200.280;Carcinoma, Lewis Lung;D018827
C04.619.230;Carcinoma, Lewis Lung;D018827
D12.776.124.486.485.114.323.480;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.124.486.485.114.648;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.124.790.651.114.323.480;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.124.790.651.114.648;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.377.715.548.114.323.480;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.377.715.548.114.648;Immunoglobulins, Thyroid-Stimulating;D018828
D12.776.097.120.050;Adhesins, Bacterial;D018829
D12.776.543.100.050;Adhesins, Bacterial;D018829
D23.050.161.050;Adhesins, Bacterial;D018829
D12.776.097.120.050.040;Adhesins, Escherichia coli;D018830
D12.776.097.275.500;Adhesins, Escherichia coli;D018830
D12.776.543.100.050.040;Adhesins, Escherichia coli;D018830
D23.050.161.050.040;Adhesins, Escherichia coli;D018830
D12.776.580;Molecular Chaperones;D018832
D08.811.277.040.025.142;Chaperonins;D018833
D12.776.580.216.210;Chaperonins;D018833
D08.811.277.040.025.142.500.500;Chaperonin 60;D018834
D12.776.580.216.210.590.750;Chaperonin 60;D018834
D12.776.580.216.210.590.500;Chaperonin 10;D018835
D23.469;Inflammation Mediators;D018836
D12.776.580.216.375;HSP70 Heat-Shock Proteins;D018840
D12.776.580.216.380;HSP90 Heat-Shock Proteins;D018841
Z01.542.248.517;Macedonia (Republic);D018843
Z01.586.980.557;Macedonia (Republic);D018843
D08.811.913.696.620.682.700.200;Cyclin-Dependent Kinases;D018844
D08.811.913.696.620.682.700.646.500;Cyclin-Dependent Kinases;D018844
D12.644.360.250;Cyclin-Dependent Kinases;D018844
D12.776.167.200;Cyclin-Dependent Kinases;D018844
D12.776.476.250;Cyclin-Dependent Kinases;D018844
D23.050.301.264.035.111;Antigens, CD11;D018845
D23.101.100.110.111;Antigens, CD11;D018845
D12.125.427;Excitatory Amino Acids;D018846
D12.644.400.575;Opioid Peptides;D018847
D12.644.468;Opioid Peptides;D018847
D12.776.641.650.575;Opioid Peptides;D018847
V03.200.500;Controlled Clinical Trial;D018848
E05.318.760.535.365;Controlled Clinical Trials as Topic;D018849
E05.337.250.365;Controlled Clinical Trials as Topic;D018849
N05.715.360.775.235.387;Controlled Clinical Trials as Topic;D018849
N06.850.520.450.535.365;Controlled Clinical Trials as Topic;D018849
N03.219.521.576.343.820;Managed Competition;D018854
N03.219.521.576.343.962;Single-Payer System;D018855
N03.219.521.855;Single-Payer System;D018855
N03.349.550.805;Single-Payer System;D018855
C12.777.829.495.500;Cystitis, Interstitial;D018856
C13.351.968.829.495.500;Cystitis, Interstitial;D018856
J01.576.423.200.375;Food Packaging;D018857
J01.576.423.850.600;Food Packaging;D018857
J01.576.761.400;Food Packaging;D018857
A10.549.250;Germinal Center;D018858
A10.549.400.500;Germinal Center;D018858
A15.382.520.604.250;Germinal Center;D018858
A15.382.520.604.412.500;Germinal Center;D018858
A10.272.497.500;Hair Follicle;D018859
A17.360.710;Hair Follicle;D018859
A17.815.250.500;Hair Follicle;D018859
C10.228.140.300.750;Sneddon Syndrome;D018860
C14.907.253.774;Sneddon Syndrome;D018860
C17.800.862.775;Sneddon Syndrome;D018860
A08.663.650.915.750.425;Merkel Cells;D018862
A08.800.950.750.425;Merkel Cells;D018862
A11.436.660;Merkel Cells;D018862
A11.671.650.915.750.425;Merkel Cells;D018862
I01.076.201.450.350;Cultural Diversity;D018864
I01.880.143.450;Cultural Diversity;D018864
H01.770.644.145.124;Dental Research;D018865
H02.163.090;Dental Research;D018865
N03.219.521.576.300;Insurance, Disability;D018868
G07.700.830.500;Heat-Shock Response;D018869
A11.284.430.214.190.875.248.300;Endoplasmic Reticulum, Rough;D018870
A11.284.430.214.190.875.811.740.300;Endoplasmic Reticulum, Rough;D018870
A11.284.430.214.190.875.248.310;Endoplasmic Reticulum, Smooth;D018871
E05.318.308.985.775;Pregnancy Rate;D018873
G08.686.705;Pregnancy Rate;D018873
L01.280.975.775;Pregnancy Rate;D018873
N01.224.935.849;Pregnancy Rate;D018873
N06.850.505.400.975.775;Pregnancy Rate;D018873
N06.850.520.308.985.775;Pregnancy Rate;D018873
A11.251.800;Spheroids, Cellular;D018874
L01.453.245.945;Vocabulary, Controlled;D018875
C20.543.312;Environmental Illness;D018876
C21.223;Environmental Illness;D018876
C20.543.312.750;Sick Building Syndrome;D018877
C21.223.750;Sick Building Syndrome;D018877
A16.567;Limb Buds;D018878
C14.280.067.325.500;Ventricular Premature Complexes;D018879
C23.550.073.325.800;Ventricular Premature Complexes;D018879
C14.280.067.325.250;Atrial Premature Complexes;D018880
C23.550.073.325.050;Atrial Premature Complexes;D018880
N01.400.700;Suburban Health;D018881
C26.522;Heat Stress Disorders;D018882
C26.522.500;Heat Stroke;D018883
B01.050.500.131.166.132.832.400.425;Ixodes;D018884
C10.597.606.150.500.800.100.111;Aphasia, Conduction;D018886
C23.888.592.604.150.500.800.100.111;Aphasia, Conduction;D018886
C10.228.140.490.535;Landau-Kleffner Syndrome;D018887
C10.228.140.380.132;Aphasia, Primary Progressive;D018888
C10.597.606.150.500.800.100.155;Aphasia, Primary Progressive;D018888
C23.888.592.604.150.500.800.100.155;Aphasia, Primary Progressive;D018888
F03.087.400.125;Aphasia, Primary Progressive;D018888
E04.555.120.380;Ilizarov Technique;D018889
E04.555.300.380;Ilizarov Technique;D018889
E02.319.162;Chemoprevention;D018890
A08.186.211.464.405.200;Dentate Gyrus;D018891
A08.186.211.730.885.287.500.345.200;Dentate Gyrus;D018891
G02.149.767.710;Proton-Motive Force;D018892
G02.842.750.710;Proton-Motive Force;D018892
G03.495.335.770;Proton-Motive Force;D018892
E05.927.100;Bronchoalveolar Lavage;D018893
D27.505.519.389.675.850;Reverse Transcriptase Inhibitors;D018894
D27.505.954.122.388.077.750;Reverse Transcriptase Inhibitors;D018894
G02.111.570.080.708.800.500;Microsatellite Repeats;D018895
G05.360.080.708.800.500;Microsatellite Repeats;D018895
G05.360.340.024.850.500;Microsatellite Repeats;D018895
G02.111.570.080.380.160;CpG Islands;D018899
G05.360.080.380.160;CpG Islands;D018899
G05.360.340.024.159;CpG Islands;D018899
G02.111.570.080.708.800.500.150;Dinucleotide Repeats;D018900
G05.360.080.708.800.500.150;Dinucleotide Repeats;D018900
G05.360.340.024.850.500.150;Dinucleotide Repeats;D018900
C10.228.140.163.100.680;Peroxisomal Disorders;D018901
C16.320.565.189.680;Peroxisomal Disorders;D018901
C16.320.565.663;Peroxisomal Disorders;D018901
C18.452.132.100.680;Peroxisomal Disorders;D018901
C18.452.648.189.680;Peroxisomal Disorders;D018901
C18.452.648.663;Peroxisomal Disorders;D018901
C05.116.099.708.195.200;Chondrodysplasia Punctata, Rhizomelic;D018902
C16.320.565.663.200;Chondrodysplasia Punctata, Rhizomelic;D018902
C18.452.648.663.200;Chondrodysplasia Punctata, Rhizomelic;D018902
E02.594.480.875;Photorefractive Keratectomy;D018903
E04.014.520.480.875;Photorefractive Keratectomy;D018903
E04.540.825.437.500;Photorefractive Keratectomy;D018903
D27.505.519.124.035;Antineoplastic Agents, Alkylating;D018906
D27.505.954.248.150;Antineoplastic Agents, Alkylating;D018906
D27.888.569.035.035;Antineoplastic Agents, Alkylating;D018906
I01.880.604.473.352.500;Privacy;D018907
N03.706.437.352.500;Privacy;D018907
N03.706.615.862;Privacy;D018907
C05.651.515;Muscle Weakness;D018908
C10.597.613.593;Muscle Weakness;D018908
C23.550.695;Muscle Weakness;D018908
C23.888.592.608.593;Muscle Weakness;D018908
G02.111.570.790.709.610.640.750;src Homology Domains;D018909
I03.450.642.693.930;Video Games;D018910
L01.224.900.930;Video Games;D018910
G02.111.570.080.708.800.500.850;Trinucleotide Repeats;D018911
G05.360.080.708.800.500.850;Trinucleotide Repeats;D018911
G05.360.340.024.850.500.850;Trinucleotide Repeats;D018911
M01.686.754.167;Arabs;D018912
G07.265.500.350;Event-Related Potentials, P300;D018913
G11.561.270.350;Event-Related Potentials, P300;D018913
A11.270;Cells, Immobilized;D018914
E06.397.778.889;Root Canal Preparation;D018915
E06.931.625;Root Canal Preparation;D018915
A07.030;Blood-Aqueous Barrier;D018916
A09.371.894.030;Blood-Aqueous Barrier;D018916
C10.292.700.600;Optic Neuropathy, Ischemic;D018917
C11.640.643;Optic Neuropathy, Ischemic;D018917
C14.907.601;Optic Neuropathy, Ischemic;D018917
E04.540.825.249.704;Phacoemulsification;D018918
E04.943.875;Phacoemulsification;D018918
G09.330.190.751;Neovascularization, Physiologic;D018919
E05.240.374;Coculture Techniques;D018920
C15.378.553.560;Leukostasis;D018921
A11.251.210.190.465;HL-60 Cells;D018922
A11.251.860.180.465;HL-60 Cells;D018922
A11.627.340.360.500;HL-60 Cells;D018922
C24.653;Persian Gulf Syndrome;D018923
G09.330.380.906;Vascular Capacitance;D018924
D12.644.276.374.200;Chemokines;D018925
D12.776.467.374.200;Chemokines;D018925
D23.125.300;Chemokines;D018925
D23.469.200;Chemokines;D018925
D23.529.374.200;Chemokines;D018925
D27.505.954.016;Anti-Allergic Agents;D018926
D27.505.954.796.050;Anti-Asthmatic Agents;D018927
G12.450.573;Immunity, Mucosal;D018928
E01.370.225.500.223;Cell Culture Techniques;D018929
E05.200.500.223;Cell Culture Techniques;D018929
E05.240.249;Cell Culture Techniques;D018929
E05.242.223;Cell Culture Techniques;D018929
D27.505.954.248.169;Antineoplastic Agents, Hormonal;D018931
D12.644.276.374.200.110.990.600;Chemokine CCL2;D018932
D12.776.467.374.200.110.990.600;Chemokine CCL2;D018932
D23.125.300.110.990.600;Chemokine CCL2;D018932
D23.469.200.110.990.600;Chemokine CCL2;D018932
D23.529.374.200.110.990.500;Chemokine CCL2;D018932
A11.284.180.690;Pili, Sex;D018933
A20.867;Pili, Sex;D018933
C01.252.377;Fournier Gangrene;D018934
C12.294.229;Fournier Gangrene;D018934
D23.050.327.495.505;Hepatitis C Antigens;D018936
D12.776.124.486.485.114.254.450.510;Hepatitis C Antibodies;D018937
D12.776.124.790.651.114.254.450.510;Hepatitis C Antibodies;D018937
D12.776.377.715.548.114.254.450.510;Hepatitis C Antibodies;D018937
A11.251.210.190.160;Caco-2 Cells;D018938
A11.251.860.180.160;Caco-2 Cells;D018938
A11.436.140;Caco-2 Cells;D018938
H02.478.676.313;Holistic Nursing;D018939
K01.752.712.708;Holistic Nursing;D018939
N02.421.533.282;Holistic Nursing;D018939
B01.050.150.900.493.370;Elasmobranchii;D018940
D23.050.301.264.035.119;Antigens, CD19;D018941
D23.050.301.264.051.119;Antigens, CD19;D018941
D23.101.100.110.119;Antigens, CD19;D018941
D23.101.100.150.119;Antigens, CD19;D018941
D02.540.505;Macrolides;D018942
D02.540.576.500;Macrolides;D018942
D04.345.674.500;Macrolides;D018942
D02.455.426.559.847.562.050;Anthracyclines;D018943
D04.615.562.050;Anthracyclines;D018943
D09.408.051.059;Anthracyclines;D018943
D12.644.276.374.200.110.990;Monocyte Chemoattractant Proteins;D018945
D12.776.467.374.200.110.990;Monocyte Chemoattractant Proteins;D018945
D23.125.300.110.990;Monocyte Chemoattractant Proteins;D018945
D23.469.200.110.990;Monocyte Chemoattractant Proteins;D018945
D23.529.374.200.110.990;Monocyte Chemoattractant Proteins;D018945
D12.644.276.374.200.110.250;Chemokine CCL5;D018946
D12.776.467.374.200.110.250;Chemokine CCL5;D018946
D23.125.300.110.250;Chemokine CCL5;D018946
D23.469.200.110.250;Chemokine CCL5;D018946
D23.529.374.200.110.250;Chemokine CCL5;D018946
Z01.639.760.815.800;Samoa;D018947
Z01.639.760.815.800.100;American Samoa;D018948
D23.050.301.264.035.100;Antigens, CD1;D018949
D23.050.301.264.894.080;Antigens, CD1;D018949
D23.101.100.110.100;Antigens, CD1;D018949
D23.101.100.894.080;Antigens, CD1;D018949
D12.776.395.550.448.100;Antigens, CD14;D018950
D12.776.543.484.500.100;Antigens, CD14;D018950
D12.776.543.550.418.100;Antigens, CD14;D018950
D12.776.543.750.705.045;Antigens, CD14;D018950
D23.050.301.264.035.114;Antigens, CD14;D018950
D23.050.301.264.900.045;Antigens, CD14;D018950
D23.101.100.110.114;Antigens, CD14;D018950
D23.101.100.900.045;Antigens, CD14;D018950
D23.050.301.264.035.120;Antigens, CD20;D018951
D23.050.301.264.051.120;Antigens, CD20;D018951
D23.101.100.110.120;Antigens, CD20;D018951
D23.101.100.150.120;Antigens, CD20;D018951
D23.050.301.264.035.134;Antigens, CD34;D018952
D23.101.100.110.134;Antigens, CD34;D018952
E02.190.599.186;Kinesiology, Applied;D018953
E02.779.867.344;Kinesiology, Applied;D018953
D26.355;Drugs, Essential;D018954
D12.776.157.530.300.500;Antigens, CD36;D018955
D12.776.395.550.625.136;Antigens, CD36;D018955
D12.776.543.550.625.136;Antigens, CD36;D018955
D12.776.543.585.300.500;Antigens, CD36;D018955
D12.776.543.750.011;Antigens, CD36;D018955
D12.776.543.750.705.675.136;Antigens, CD36;D018955
D12.776.543.750.705.940.625.249;Antigens, CD36;D018955
D12.776.543.750.710.450.750.625.249;Antigens, CD36;D018955
D23.050.301.264.035.136;Antigens, CD36;D018955
D23.101.100.110.136;Antigens, CD36;D018955
D23.050.301.264.035.105;Antigens, CD5;D018956
D23.050.301.264.051.101;Antigens, CD5;D018956
D23.050.301.264.894.101;Antigens, CD5;D018956
D23.101.100.110.105;Antigens, CD5;D018956
D23.101.100.150.101;Antigens, CD5;D018956
D23.101.100.894.101;Antigens, CD5;D018956
D12.776.395.550.448.140;Antigens, CD59;D018957
D12.776.543.484.500.140;Antigens, CD59;D018957
D12.776.543.550.418.140;Antigens, CD59;D018957
D23.050.301.264.035.159;Antigens, CD59;D018957
D23.101.100.110.159;Antigens, CD59;D018957
D12.776.395.550.448.130;Antigens, CD55;D018958
D12.776.543.484.500.130;Antigens, CD55;D018958
D12.776.543.550.418.130;Antigens, CD55;D018958
D23.050.301.264.035.155;Antigens, CD55;D018958
D23.101.100.110.155;Antigens, CD55;D018958
D23.050.301.264.035.157;Antigens, CD57;D018959
D23.050.301.264.894.157;Antigens, CD57;D018959
D23.101.100.110.157;Antigens, CD57;D018959
D23.101.100.894.157;Antigens, CD57;D018959
D12.776.395.550.200.625.144;Antigens, CD44;D018960
D12.776.543.550.200.625.144;Antigens, CD44;D018960
D12.776.543.750.705.877.144;Antigens, CD44;D018960
D23.050.301.264.035.850.144;Antigens, CD44;D018960
D23.050.301.350.625.144;Antigens, CD44;D018960
D23.101.100.110.850.144;Antigens, CD44;D018960
J01.897.280;Educational Technology;D018961
E01.370.225.998.110.625;Phlebotomy;D018962
E02.800.558;Phlebotomy;D018962
E04.665.150.625;Phlebotomy;D018962
E05.200.998.110.625;Phlebotomy;D018962
D23.050.327.495;Hepatitis Antigens;D018963
G02.111.087.675.871.200;Frameshifting, Ribosomal;D018965
G02.149.115.675.871.200;Frameshifting, Ribosomal;D018965
G03.495.770.871.200;Frameshifting, Ribosomal;D018965
G05.355.315.215;Frameshifting, Ribosomal;D018965
L01.178.476;Library Materials;D018966
D03.383.742.698.685;Risperidone;D018967
D12.776.395.550.034;Antigens, CD58;D018968
D12.776.543.550.158;Antigens, CD58;D018968
D23.050.301.264.035.158;Antigens, CD58;D018968
D23.101.100.110.158;Antigens, CD58;D018968
D12.776.157.420;Insulin-Like Growth Factor Binding Proteins;D018969
D12.776.157.420.250;Insulin-Like Growth Factor Binding Protein 1;D018970
D12.776.157.420.260;Insulin-Like Growth Factor Binding Protein 2;D018971
D12.776.157.420.270;Insulin-Like Growth Factor Binding Protein 3;D018972
I01.880.604.583.458;Intellectual Property;D018973
N03.706.535.518;Intellectual Property;D018973
D12.776.157.420.280;Insulin-Like Growth Factor Binding Protein 4;D018974
D12.776.157.420.290;Insulin-Like Growth Factor Binding Protein 5;D018975
D12.776.157.420.300;Insulin-Like Growth Factor Binding Protein 6;D018976
D27.505.696.377.605;Micronutrients;D018977
J02.500.631;Micronutrients;D018977
G07.700.320.500.550.750;Molting;D018978
C05.651.594.600;Myositis, Inclusion Body;D018979
C10.668.491.562.500;Myositis, Inclusion Body;D018979
C10.597.606.643.970;Williams Syndrome;D018980
C14.280.484.150.535.960;Williams Syndrome;D018980
C16.131.260.970;Williams Syndrome;D018980
C16.320.180.970;Williams Syndrome;D018980
C16.320.565.202.125;Congenital Disorders of Glycosylation;D018981
C18.452.648.202.125;Congenital Disorders of Glycosylation;D018981
E05.393.300;DNA Footprinting;D018983
E05.393.600.300;DNA Footprinting;D018983
D23.050.550.402;Epitopes, T-Lymphocyte;D018984
D23.050.550.395;Epitopes, B-Lymphocyte;D018985
J01.937.500;Motor Vehicles;D018986
A03.556.500.760.640;Salivary Ducts;D018987
A10.336.779.640;Salivary Ducts;D018987
A14.549.760.640;Salivary Ducts;D018987
G06.099.112.105;Bacterial Translocation;D018988
G06.590.110.105;Bacterial Translocation;D018988
D10.570.780.500;Myelin Proteolipid Protein;D018991
D12.776.543.620.580;Myelin Proteolipid Protein;D018991
D12.776.641.580.580;Myelin Proteolipid Protein;D018991
D12.776.816.500;Myelin Proteolipid Protein;D018991
D12.776.395.550.570;Myelin-Associated Glycoprotein;D018992
D12.776.503.921.049;Myelin-Associated Glycoprotein;D018992
D12.776.543.550.555;Myelin-Associated Glycoprotein;D018992
D12.776.543.620.530;Myelin-Associated Glycoprotein;D018992
D12.776.641.580.500;Myelin-Associated Glycoprotein;D018992
D23.050.301.264.035.913.049;Myelin-Associated Glycoprotein;D018992
D23.101.100.110.929.049;Myelin-Associated Glycoprotein;D018992
D12.776.395.550.200.250.500;Myelin P0 Protein;D018993
D12.776.395.570;Myelin P0 Protein;D018993
D12.776.543.550.200.250.500;Myelin P0 Protein;D018993
D12.776.543.620.570;Myelin P0 Protein;D018993
D12.776.641.580.550;Myelin P0 Protein;D018993
D23.050.301.350.250.500;Myelin P0 Protein;D018993
D05.750.078.730.475.200;Myosin Light Chains;D018994
D12.776.157.125.475;Myosin Light Chains;D018994
D12.776.210.500.600.200;Myosin Light Chains;D018994
D12.776.220.525.475.200;Myosin Light Chains;D018994
D05.750.078.730.475.100;Myosin Heavy Chains;D018995
D12.776.210.500.600.100;Myosin Heavy Chains;D018995
D12.776.220.525.475.100;Myosin Heavy Chains;D018995
D12.776.157.170.500;Myelin P2 Protein;D018996
D12.776.543.620.575;Myelin P2 Protein;D018996
D12.776.641.580.560;Myelin P2 Protein;D018996
D06.472.699.322.326.125;Chorionic Gonadotropin, beta Subunit, Human;D018997
D06.472.699.649.367.125;Chorionic Gonadotropin, beta Subunit, Human;D018997
D12.644.548.726.367.125;Chorionic Gonadotropin, beta Subunit, Human;D018997
D12.776.780.400.125;Chorionic Gonadotropin, beta Subunit, Human;D018997
D23.101.175;Chorionic Gonadotropin, beta Subunit, Human;D018997
D23.101.840.325;Chorionic Gonadotropin, beta Subunit, Human;D018997
D08.811.682.732.512.900;Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate;D018998
D12.776.503.499.968.900;Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate;D018998
D12.776.765.678.968.900;Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate;D018998
D12.644.115;Charybdotoxin;D018999
D20.888.065.830.150;Charybdotoxin;D018999
D23.946.833.065.830.150;Charybdotoxin;D018999
D12.125.072.050.875.750;Phosphotyrosine;D019000
D12.125.740.740;Phosphotyrosine;D019000
D08.811.682.664.500.772;Nitric Oxide Synthase;D019001
D12.776.395.550.200.250.520.156;Antigens, CD56;D019002
D12.776.543.550.200.250.520.156;Antigens, CD56;D019002
D23.050.301.264.035.156;Antigens, CD56;D019002
D23.050.301.264.894.156;Antigens, CD56;D019002
D23.050.301.350.250.520.156;Antigens, CD56;D019002
D23.101.100.110.156;Antigens, CD56;D019002
D23.101.100.894.156;Antigens, CD56;D019002
D08.811.150.280.260.420;Deoxyribonuclease HpaII;D019003
D08.811.277.352.335.350.300.260.300;Deoxyribonuclease HpaII;D019003
D08.811.277.352.355.325.300.260.300;Deoxyribonuclease HpaII;D019003
D12.644.400.250;Galanin;D019004
D12.776.641.650.250;Galanin;D019004
D12.776.157.530.400.175.125;Cystic Fibrosis Transmembrane Conductance Regulator;D019005
D12.776.543.550.425.175.125;Cystic Fibrosis Transmembrane Conductance Regulator;D019005
D12.776.543.585.400.175.125;Cystic Fibrosis Transmembrane Conductance Regulator;D019005
D12.776.395.550.200.250.520;Neural Cell Adhesion Molecules;D019006
D12.776.543.550.200.250.520;Neural Cell Adhesion Molecules;D019006
D23.050.301.350.250.520;Neural Cell Adhesion Molecules;D019006
D12.776.395.550.200.700.775;P-Selectin;D019007
D12.776.395.550.625.905;P-Selectin;D019007
D12.776.503.843.775;P-Selectin;D019007
D12.776.543.550.200.700.775;P-Selectin;D019007
D12.776.543.550.625.905;P-Selectin;D019007
D23.050.301.264.035.912.775;P-Selectin;D019007
D23.050.301.350.700.775;P-Selectin;D019007
D23.101.100.110.918.775;P-Selectin;D019007
G07.690.320.395;Drug Resistance, Neoplasm;D019008
D08.811.913.696.620.682.725.400.050;Proto-Oncogene Proteins c-kit;D019009
D12.776.543.750.060.124;Proto-Oncogene Proteins c-kit;D019009
D12.776.543.750.705.852.150.100;Proto-Oncogene Proteins c-kit;D019009
D12.776.543.750.750.400.200.170;Proto-Oncogene Proteins c-kit;D019009
D12.776.624.664.700.183;Proto-Oncogene Proteins c-kit;D019009
D23.050.301.264.035.590;Proto-Oncogene Proteins c-kit;D019009
D23.101.100.110.590;Proto-Oncogene Proteins c-kit;D019009
D12.776.395.550.200.920;Vascular Cell Adhesion Molecule-1;D019010
D12.776.543.550.200.920;Vascular Cell Adhesion Molecule-1;D019010
D23.050.301.264.035.920;Vascular Cell Adhesion Molecule-1;D019010
D23.050.301.350.920;Vascular Cell Adhesion Molecule-1;D019010
D23.101.100.110.970;Vascular Cell Adhesion Molecule-1;D019010
D23.050.301.264.035.107;Antigens, CD7;D019011
D23.050.301.264.894.107;Antigens, CD7;D019011
D23.101.100.110.107;Antigens, CD7;D019011
D23.101.100.894.107;Antigens, CD7;D019011
D12.776.543.750.705.408.200.500;Antigens, CD29;D019012
D23.050.301.264.035.129;Antigens, CD29;D019012
D23.050.301.264.129;Antigens, CD29;D019012
D23.101.100.110.129;Antigens, CD29;D019012
D23.101.100.129;Antigens, CD29;D019012
D12.776.543.750.705.852.760.097;Antigens, CD40;D019013
D23.050.301.264.035.140;Antigens, CD40;D019013
D23.050.301.264.051.140;Antigens, CD40;D019013
D23.101.100.110.140;Antigens, CD40;D019013
D23.101.100.150.140;Antigens, CD40;D019013
D12.776.543.750.073.500;Antigens, CD95;D019014
D12.776.543.750.705.852.760.195;Antigens, CD95;D019014
D23.050.301.264.035.195;Antigens, CD95;D019014
D23.101.100.110.195;Antigens, CD95;D019014
G01.311.330;Geologic Sediments;D019015
G16.500.320;Geologic Sediments;D019015
D01.578.500;Mineral Fibers;D019016
Z01.058.290.120.292;Eritrea;D019017
E02.190.525.249;Imagery (Psychotherapy);D019018
F04.754.462;Imagery (Psychotherapy);D019018
E05.393.420.175;Directed Molecular Evolution;D019020
H01.158.273.602;Natural History;D019021
H01.770.552;Natural History;D019021
K01.400.703;Natural History;D019021
I01.880.787.190.500;Almshouses;D019022
E07.230.750;Stethoscopes;D019023
K01.400.552.053;Barber Surgeons;D019024
E07.546;Medicine Chests;D019026
E01.370.350.500.510;Magnetic Resonance Imaging, Cine;D019028
E01.370.350.825.500.510;Magnetic Resonance Imaging, Cine;D019028
Z01.639.760.680.717;Palau;D019029
D12.776.543.750.705.408.460.870;Receptors, Vitronectin;D019030
D12.776.543.750.705.408.925;Receptors, Vitronectin;D019030
E05.196.566.755;Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization;D019032
N04.590.374.142;Delivery of Health Care, Integrated;D019033
N05.300.262;Delivery of Health Care, Integrated;D019033
J01.897.280.500.668.800.250.100;CD-I;D019034
J01.897.280.500.898.800.250.100;CD-I;D019034
L01.178.590.875.800.250.100;CD-I;D019034
L01.178.820.090.668.800.250.100;CD-I;D019034
L01.178.820.090.898.800.250.100;CD-I;D019034
L01.224.230.260.115.475.600.325.500;CD-I;D019034
L01.240.960.800.250.100;CD-I;D019034
N02.421.816;Rural Health Services;D019035
N02.421.908;Suburban Health Services;D019036
N02.421.914;Urban Health Services;D019037
D12.776.395.550.625.460;Platelet Glycoprotein GPIb-IX Complex;D019038
D12.776.395.550.625.800.780;Platelet Glycoprotein GPIb-IX Complex;D019038
D12.776.543.550.625.460;Platelet Glycoprotein GPIb-IX Complex;D019038
D12.776.543.550.625.800.780;Platelet Glycoprotein GPIb-IX Complex;D019038
D12.776.543.750.705.675.568;Platelet Glycoprotein GPIb-IX Complex;D019038
D12.776.395.550.625.785;Platelet Glycoprotein GPIIb-IIIa Complex;D019039
D12.776.543.550.625.785;Platelet Glycoprotein GPIIb-IIIa Complex;D019039
D12.776.543.750.705.408.460.700;Platelet Glycoprotein GPIIb-IIIa Complex;D019039
D12.776.543.750.705.675.784;Platelet Glycoprotein GPIIb-IIIa Complex;D019039
D12.776.395.550.200.700.300;E-Selectin;D019040
D12.776.503.843.300;E-Selectin;D019040
D12.776.543.550.200.700.300;E-Selectin;D019040
D23.050.301.264.035.912.300;E-Selectin;D019040
D23.050.301.350.700.300;E-Selectin;D019040
D23.101.100.110.918.300;E-Selectin;D019040
D12.776.395.550.200.625.903;L-Selectin;D019041
D12.776.395.550.200.700.510;L-Selectin;D019041
D12.776.503.843.510;L-Selectin;D019041
D12.776.543.550.200.625.903;L-Selectin;D019041
D12.776.543.550.200.700.510;L-Selectin;D019041
D12.776.543.750.705.877.903;L-Selectin;D019041
D23.050.301.264.035.850.903;L-Selectin;D019041
D23.050.301.264.035.912.510;L-Selectin;D019041
D23.050.301.350.625.903;L-Selectin;D019041
D23.050.301.350.700.510;L-Selectin;D019041
D23.101.100.110.850.903;L-Selectin;D019041
D23.101.100.110.918.510;L-Selectin;D019041
C04.588.839.500;Muscle Neoplasms;D019042
C05.651.494;Muscle Neoplasms;D019042
C04.588.839.750;Vascular Neoplasms;D019043
C14.907.936;Vascular Neoplasms;D019043
E01.370.225.500.386.400;Image Cytometry;D019044
E05.196.712.516.600.240.400;Image Cytometry;D019044
E05.200.500.386.400;Image Cytometry;D019044
E05.242.386.400;Image Cytometry;D019044
C04.588.448.200;Bone Marrow Neoplasms;D019046
C15.378.190.250;Bone Marrow Neoplasms;D019046
C15.378.400.200;Bone Marrow Neoplasms;D019046
E07.671;Phantoms, Imaging;D019047
C04.557.470.200.240.500;Prostatic Intraepithelial Neoplasia;D019048
I01.615.500.250;Developed Countries;D019049
E02.190.599.092;Acupressure;D019050
E02.779.867.171;Acupressure;D019050
E04.525.210.700;Rhizotomy;D019051
C13.703.844.253;Depression, Postpartum;D019052
F03.600.300.350;Depression, Postpartum;D019052
C02.782.815.616.400.480;HIV Enteropathy;D019053
C02.800.801.400.480;HIV Enteropathy;D019053
C06.405.469.400;HIV Enteropathy;D019053
C20.673.480.480;HIV Enteropathy;D019053
G07.265.500.385;Evoked Potentials, Motor;D019054
G11.561.270.385;Evoked Potentials, Motor;D019054
E05.940.600;No-Observed-Adverse-Effect Level;D019055
G07.690.620;No-Observed-Adverse-Effect Level;D019055
D12.776.543.750.705.871.700;Receptors, Polymeric Immunoglobulin;D019056
E05.318.740.100.500.700;Quality-Adjusted Life Years;D019057
L01.280.975.475.700;Quality-Adjusted Life Years;D019057
N01.224.935.530.700;Quality-Adjusted Life Years;D019057
I01.880.656.300;Community Networks;D019058
L01.700.508.300.184;Community Networks;D019058
N02.421.143.202;Community Networks;D019058
E04.800;Surgical Procedures, Minimally Invasive;D019060
D08.811.913.696.620.682.725.800;src-Family Kinases;D019061
D12.776.395.550.200.250.150;Cell Adhesion Molecules, Neuron-Glia;D019062
D12.776.543.550.200.250.150;Cell Adhesion Molecules, Neuron-Glia;D019062
D23.050.301.350.250.150;Cell Adhesion Molecules, Neuron-Glia;D019062
D12.776.860.300.850;Tenascin;D019063
J01.576.761;Product Packaging;D019064
G06.590.875.780.950;Virus Assembly;D019065
G06.920.875.780.950;Virus Assembly;D019065
C23.550.291.812;Facies;D019066
E01.370.600.230;Facies;D019066
G06.590.875.040;Antibody-Dependent Enhancement;D019067
G06.920.875.040;Antibody-Dependent Enhancement;D019067
G12.425.040;Antibody-Dependent Enhancement;D019067
B01.650.940.800.575.137.500;Bryopsida;D019068
G03.495.278;Cell Respiration;D019069
G04.299.305;Cell Respiration;D019069
G04.172;Cell Lineage;D019070
G07.700.320.500.325.180.500;Cell Lineage;D019070
G08.686.155;Cell Lineage;D019070
G08.686.785.760.170.104.249;Cell Lineage;D019070
Z01.586.035.725;Persia;D019071
E02.319.162.150;Antibiotic Prophylaxis;D019072
E02.319.703.150;Antibiotic Prophylaxis;D019072
A11.251.210.190.475;HT29 Cells;D019073
A11.251.860.180.475;HT29 Cells;D019073
A11.436.365;HT29 Cells;D019073
A07.231.114.330;Epigastric Arteries;D019074
E05.196.401.190;Electrophoresis, Capillary;D019075
E05.301.300.190;Electrophoresis, Capillary;D019075
G05.360.340.024.340.825;Transgenes;D019076
G02.111.570.790.709.600.040.360.360;Helix-Turn-Helix Motifs;D019077
C17.800.621.250;Cafe-au-Lait Spots;D019080
C23.888.885.250;Cafe-au-Lait Spots;D019080
D09.698.718.450.600;O Antigens;D019081
D10.494.600;O Antigens;D019081
D23.050.161.616.525.600;O Antigens;D019081
D23.946.123.329.500.600;O Antigens;D019081
C16.131.077.860;Smith-Lemli-Opitz Syndrome;D019082
C16.320.565.398.850;Smith-Lemli-Opitz Syndrome;D019082
C16.320.565.925.875;Smith-Lemli-Opitz Syndrome;D019082
C18.452.584.500.937;Smith-Lemli-Opitz Syndrome;D019082
C18.452.648.398.850;Smith-Lemli-Opitz Syndrome;D019082
C18.452.648.925.875;Smith-Lemli-Opitz Syndrome;D019082
Z01.542.580;Mediterranean Region;D019083
E01.370.225.500.607.512.240.310;Fluorescent Antibody Technique, Indirect;D019084
E01.370.225.750.551.512.240.310;Fluorescent Antibody Technique, Indirect;D019084
E05.200.500.607.512.240.310;Fluorescent Antibody Technique, Indirect;D019084
E05.200.750.551.512.240.310;Fluorescent Antibody Technique, Indirect;D019084
E05.478.412.310;Fluorescent Antibody Technique, Indirect;D019084
E05.478.583.375.310;Fluorescent Antibody Technique, Indirect;D019084
E01.370.225.500.607.512.240.300;Fluorescent Antibody Technique, Direct;D019085
E01.370.225.750.551.512.240.300;Fluorescent Antibody Technique, Direct;D019085
E05.200.500.607.512.240.300;Fluorescent Antibody Technique, Direct;D019085
E05.200.750.551.512.240.300;Fluorescent Antibody Technique, Direct;D019085
E05.478.412.300;Fluorescent Antibody Technique, Direct;D019085
E05.478.583.375.300;Fluorescent Antibody Technique, Direct;D019085
D02.455.426.100.080.085;Bicyclo Compounds, Heterocyclic;D019086
D03.438.260;Bicyclo Compounds, Heterocyclic;D019086
D03.605.084;Bicyclo Compounds, Heterocyclic;D019086
D04.075.080.875;Bicyclo Compounds, Heterocyclic;D019086
D12.776.395.550.200.700;Selectins;D019087
D12.776.503.843;Selectins;D019087
D12.776.543.550.200.700;Selectins;D019087
D23.050.301.264.035.912;Selectins;D019087
D23.050.301.350.700;Selectins;D019087
D23.101.100.110.918;Selectins;D019087
D12.644.276.374.410.800;Stem Cell Factor;D019089
D12.776.467.374.410.800;Stem Cell Factor;D019089
D23.529.374.410.800;Stem Cell Factor;D019089
N04.590.233.624.250;Case Management;D019090
N04.590.233.624.625;Critical Pathways;D019091
N04.590.275;Critical Pathways;D019091
E01.370.225.500.384.100.160;Conization;D019092
E01.370.225.998.054.160;Conization;D019092
E01.370.388.100.160;Conization;D019092
E04.074.160;Conization;D019092
E05.200.500.384.100.160;Conization;D019092
E05.200.998.054.160;Conization;D019092
E05.242.384.100.160;Conization;D019092
E02.218.085.165;Circumcision, Female;D019093
E04.085.165;Circumcision, Female;D019093
E04.950.300.200;Circumcision, Female;D019093
I01.076.201.450.199;Circumcision, Female;D019093
E06.780.345.630;Dental Prosthesis, Implant-Supported;D019094
E07.695.190.185;Dental Prosthesis, Implant-Supported;D019094
N04.452.442.452.680;Point-of-Care Systems;D019095
N04.452.515.360.652;Point-of-Care Systems;D019095
N04.590.874;Point-of-Care Systems;D019095
D12.776.124.920;Vitronectin;D019096
D12.776.395.970;Vitronectin;D019096
D12.776.860.300.920;Vitronectin;D019096
E05.196.885;Spin Trapping;D019097
D08.811.913.696.445.308.300.750.750;Telomerase;D019098
D12.776.157.725.500.921;Telomerase;D019098
D12.776.664.962.500.921;Telomerase;D019098
M01.060.703.520.460.600;Infant, Very Low Birth Weight;D019102
E05.393.525.700;Random Amplified Polymorphic DNA Technique;D019105
E05.393.620.500.687;Random Amplified Polymorphic DNA Technique;D019105
E05.601.700;Random Amplified Polymorphic DNA Technique;D019105
C23.550.414.941;Postoperative Hemorrhage;D019106
C23.550.767.850;Postoperative Hemorrhage;D019106
A11.284.149.165.420.820;Tight Junctions;D019108
G01.060.249.500;Meteoroids;D019110
E07.190.250.260;Condoms, Female;D019111
E05.920.700;Teleradiology;D019112
H02.010.850.700;Teleradiology;D019112
H02.403.840.700;Teleradiology;D019112
L01.178.847.652.700;Teleradiology;D019112
N04.452.515.825.500;Teleradiology;D019112
N04.590.374.800.700;Teleradiology;D019112
H02.403.650.600;Telepathology;D019113
H02.403.840.600;Telepathology;D019113
L01.178.847.652.600;Telepathology;D019113
N04.590.374.800.600;Telepathology;D019113
L01.178.847.652.550;Remote Consultation;D019114
N04.452.758.849.550;Remote Consultation;D019114
N04.590.374.800.550;Remote Consultation;D019114
C01.252.825.340;Fasciitis, Necrotizing;D019115
C05.321.550;Fasciitis, Necrotizing;D019115
B03.440.400.425.251.100;Burkholderia;D019117
B03.660.075.077.100;Burkholderia;D019117
C01.252.400.170;Burkholderia Infections;D019121
E02.190.525.374;Meditation;D019122
E02.190.901.455;Meditation;D019122
F04.754.137.750.500;Meditation;D019122
J02.500.525.450;Health Food;D019123
E02.190.525.906;Therapeutic Touch;D019124
E02.190.901.830;Therapeutic Touch;D019124
I01.409.137.500.999;United States Social Security Administration;D019131
N03.540.348.500.500.999;United States Social Security Administration;D019131
D12.776.124.486.485.114.143;Antibodies, Blocking;D019138
D12.776.124.790.651.114.143;Antibodies, Blocking;D019138
D12.776.377.715.548.114.143;Antibodies, Blocking;D019138
G12.425.905;Tumor Escape;D019139
E06.170.152;Dental Care for Children;D019140
N02.421.240.190.215;Dental Care for Children;D019140
D27.505.954.796;Respiratory System Agents;D019141
C02.782.417.415;Hemorrhagic Fever, Ebola;D019142
C02.782.580.250.400;Hemorrhagic Fever, Ebola;D019142
C23.996.550;Hemorrhagic Fever, Ebola;D019142
G05.355.044.250;Evolution, Molecular;D019143
G16.100.178.250;Evolution, Molecular;D019143
H02.478.676.789;Rehabilitation Nursing;D019145
N02.421.533.889;Rehabilitation Nursing;D019145
L01.224.900.590;Hypermedia;D019146
A09.531.940;Vomeronasal Organ;D019147
E03.706;Neuromuscular Blockade;D019148
E05.635;Neuromuscular Blockade;D019148
E07.115;Bioreactors;D019149
J01.897.120.115;Bioreactors;D019149
C10.228.140.744;Neuroaxonal Dystrophies;D019150
D12.644.555;Peptide Library;D019151
G02.111.570.060.620;Peptide Library;D019151
G05.360.325.640;Peptide Library;D019151
E01.370.225.998.329;Paracentesis;D019152
E02.800.550;Paracentesis;D019152
E04.665.600;Paracentesis;D019152
E05.200.998.329;Paracentesis;D019152
G02.111.087.675.871.790.600.700;Protein Splicing;D019154
G02.111.087.693.600.700;Protein Splicing;D019154
G02.149.115.675.871.790.600.700;Protein Splicing;D019154
G02.149.115.693.600.700;Protein Splicing;D019154
G03.495.770.871.790.600.700;Protein Splicing;D019154
G05.355.315.670.600.700;Protein Splicing;D019154
D26.939;Veterinary Drugs;D019155
Z01.756.342;Indian Ocean;D019156
E02.592.325;Ischemic Preconditioning, Myocardial;D019157
E05.516.325;Ischemic Preconditioning, Myocardial;D019157
D02.241.081.844.562.668.050;N-Acetylneuraminic Acid;D019158
D02.241.511.902.562.668.050;N-Acetylneuraminic Acid;D019158
D09.067.687.668.030;N-Acetylneuraminic Acid;D019158
D09.811.589.668.030;N-Acetylneuraminic Acid;D019158
D12.776.157.427.374;Nonheme Iron Proteins;D019159
D12.776.556.579.374;Nonheme Iron Proteins;D019159
E01.370.350.850.280;Endosonography;D019160
D27.505.519.186.071.202.370;Hydroxymethylglutaryl-CoA Reductase Inhibitors;D019161
D27.505.519.389.370;Hydroxymethylglutaryl-CoA Reductase Inhibitors;D019161
D27.505.954.557.500.202.370;Hydroxymethylglutaryl-CoA Reductase Inhibitors;D019161
D27.505.696.277.100.017;Anesthetics, Combined;D019162
D27.505.954.427.210.100.017;Anesthetics, Combined;D019162
D27.720.470.410.690;Reducing Agents;D019163
E07.858.082.620;Liver, Artificial;D019164
D27.505.696.282.050;Appetite Stimulants;D019167
D27.505.954.427.220.050;Appetite Stimulants;D019167
E04.035.760.795;Portasystemic Shunt, Transjugular Intrahepatic;D019168
E04.100.814.868.937.830;Portasystemic Shunt, Transjugular Intrahepatic;D019168
A11.251.210.190.495;Jurkat Cells;D019169
A11.251.860.180.495;Jurkat Cells;D019169
A15.382.490.555.567.569.440;Jurkat Cells;D019169
A16.504.660.750;Somites;D019170
E02.095.465.425.450.800;Transplantation Conditioning;D019172
E05.478.610.800;Transplantation Conditioning;D019172
G02.111.087.029.538.161;DNA Methylation;D019175
G02.111.087.218;DNA Methylation;D019175
G02.149.115.029.538.161;DNA Methylation;D019175
G02.149.115.218;DNA Methylation;D019175
G03.495.130.538.161;DNA Methylation;D019175
G05.355.190;DNA Methylation;D019175
B04.715.635;Potyviridae;D019176
B04.820.590;Potyviridae;D019176
B04.715.081;Bromoviridae;D019177
B04.820.081;Bromoviridae;D019177
B04.715.081.050;Alfamovirus;D019178
B04.715.464.040;Alfamovirus;D019178
B04.820.081.050;Alfamovirus;D019178
B04.820.464.040;Alfamovirus;D019178
B04.715.081.400;Ilarvirus;D019179
B04.820.081.400;Ilarvirus;D019179
B04.715.150;Comoviridae;D019180
B04.820.150;Comoviridae;D019180
B04.715.150.250;Fabavirus;D019181
B04.820.150.250;Fabavirus;D019181
B04.715.810;Tombusviridae;D019183
B04.820.860;Tombusviridae;D019183
B04.715.810.150;Carmovirus;D019184
B04.820.860.150;Carmovirus;D019184
B01.050.150.900.090.608.700.500;Notophthalmus;D019185
E04.545.500;Mandibular Advancement;D019186
E06.645.500;Mandibular Advancement;D019186
E06.658.280;Mandibular Advancement;D019186
D01.142;Cadmium Compounds;D019187
D26.776.675;Organ Preservation Solutions;D019188
C18.452.565;Iron Metabolism Disorders;D019189
C18.452.565.500;Iron Overload;D019190
B04.715.750;Sequiviridae;D019191
B04.820.750;Sequiviridae;D019191
B04.715.750.750;Sequivirus;D019192
B04.820.750.750;Sequivirus;D019192
B04.715.750.900;Waikavirus;D019193
B04.820.750.900;Waikavirus;D019193
E02.592;Ischemic Preconditioning;D019194
E05.516;Ischemic Preconditioning;D019194
B04.280.092.074;Badnavirus;D019195
B04.715.068;Badnavirus;D019195
B04.715.102.074;Badnavirus;D019195
B04.820.880;Totiviridae;D019196
B04.820.880.800;Totivirus;D019197
B04.820.880.400;Giardiavirus;D019198
B04.820.880.500;Leishmaniavirus;D019199
B04.820.069;Astroviridae;D019200
B04.909.777.099;Astroviridae;D019200
B04.820.075.050;Aquabirnavirus;D019201
B04.909.777.123.050;Aquabirnavirus;D019201
B04.820.075.060;Avibirnavirus;D019202
B04.909.777.123.060;Avibirnavirus;D019202
B04.820.075.200;Entomobirnavirus;D019203
B04.909.777.123.200;Entomobirnavirus;D019203
D08.811.277.040.330.300;GTP-Binding Proteins;D019204
D12.776.157.325;GTP-Binding Proteins;D019204
D08.811.277.040.330.300.200.100.400;GTP-Binding Protein alpha Subunits, Gs;D019205
D12.644.360.375.100.400;GTP-Binding Protein alpha Subunits, Gs;D019205
D12.776.157.325.332.100.400;GTP-Binding Protein alpha Subunits, Gs;D019205
D12.776.476.375.100.400;GTP-Binding Protein alpha Subunits, Gs;D019205
D12.776.543.325.100.400;GTP-Binding Protein alpha Subunits, Gs;D019205
D08.811.277.040.330.300.200.100.200;GTP-Binding Protein alpha Subunits, Gi-Go;D019206
D12.644.360.375.100.200;GTP-Binding Protein alpha Subunits, Gi-Go;D019206
D12.776.157.325.332.100.200;GTP-Binding Protein alpha Subunits, Gi-Go;D019206
D12.776.476.375.100.200;GTP-Binding Protein alpha Subunits, Gi-Go;D019206
D12.776.543.325.100.200;GTP-Binding Protein alpha Subunits, Gi-Go;D019206
D02.455.326.271.665.202.123;beta Carotene;D019207
D02.455.426.392.368.367.379.249.050;beta Carotene;D019207
D02.455.849.131.123;beta Carotene;D019207
D23.767.261.050;beta Carotene;D019207
D12.644.276.860.100;Brain-Derived Neurotrophic Factor;D019208
D12.776.467.860.100;Brain-Derived Neurotrophic Factor;D019208
D12.776.641.600.100;Brain-Derived Neurotrophic Factor;D019208
D23.529.850.100;Brain-Derived Neurotrophic Factor;D019208
D05.750.078.730.825.900;Troponin C;D019209
D12.776.157.125.900;Troponin C;D019209
D12.776.210.500.910.900;Troponin C;D019209
D12.776.220.525.825.900;Troponin C;D019209
D05.750.078.730.825.925;Troponin I;D019210
D12.776.210.500.910.925;Troponin I;D019210
D12.776.220.525.825.925;Troponin I;D019210
B04.280.382.150.750;Roseolovirus;D019211
B04.909.204.382.150.750;Roseolovirus;D019211
J01.897.280.500.633;Multimedia;D019212
L01.178.820.090.633;Multimedia;D019212
B04.820.455.600.650.750;Rubulavirus;D019213
B04.909.777.455.600.650.750;Rubulavirus;D019213
C07.465.714.258.428;Gingival Overgrowth;D019214
V01.175;Biography;D019215
V02.170;Biography;D019215
V02.530.150;Biography;D019215
D01.268.556;Metals, Heavy;D019216
D01.552.544;Metals, Heavy;D019216
C07.793.818.249;Tooth Attrition;D019217
B04.280.580.650.200;Erythrovirus;D019218
B04.909.204.671.650.200;Erythrovirus;D019218
B04.280.580.650;Parvovirinae;D019219
B04.909.204.671.650;Parvovirinae;D019219
G01.750.770.776.283;High-Energy Shock Waves;D019220
I01.880.604.583.080.134.300;Mandatory Reporting;D019221
I01.880.604.583.527;Mandatory Reporting;D019221
I01.880.604.622.249;Mandatory Reporting;D019221
N03.706.535.615;Mandatory Reporting;D019221
N03.706.657.249;Mandatory Reporting;D019221
F02.463.509;Mind-Body Relations, Metaphysical;D019222
B04.280.580.150;Densovirinae;D019223
B04.525.150;Densovirinae;D019223
A02.835.583.861.900;Temporomandibular Joint Disc;D019224
A14.907.900;Temporomandibular Joint Disc;D019224
C07.465.672;Oral Ulcer;D019226
A14.549.167.900.750.700;Tooth Apex;D019227
A14.549.167.900.710;Tooth Crown;D019228
A14.549.167.237;Dentition, Permanent;D019229
N04.761.700.250.295;Dental Audit;D019230
N05.700.175.250;Dental Audit;D019230
E06.931.750;Tooth Preparation, Prosthodontic;D019231
E06.323.400;Dental Restoration Failure;D019232
E06.780.345.725;Dental Restoration Failure;D019232
E02.887;Retreatment;D019233
A12.383.250;Dentinal Fluid;D019234
B04.820.455.750.250;Ephemerovirus;D019235
B04.909.777.455.750.250;Ephemerovirus;D019235
A14.549.167.900.700;Tooth Cervix;D019237
N04.590.500;Dentist's Practice Patterns;D019239
N05.300.300;Dentist's Practice Patterns;D019239
B04.123.210;Corticoviridae;D019240
B04.100.224;Fuselloviridae;D019241
B04.280.224;Fuselloviridae;D019241
E06.640;Oral Medicine;D019242
H02.163.670;Oral Medicine;D019242
E06.420.500;Enamel Microabrasion;D019243
D13.444.735.721;RNA, Satellite;D019244
G01.374.180;Compressive Strength;D019245
E06.931;Tooth Preparation;D019246
C02.782.815.616.400.520;HIV Wasting Syndrome;D019247
C02.800.801.400.520;HIV Wasting Syndrome;D019247
C18.452.915.520;HIV Wasting Syndrome;D019247
C18.654.940.520;HIV Wasting Syndrome;D019247
C20.673.480.520;HIV Wasting Syndrome;D019247
E04.545.440;Jaw Fixation Techniques;D019248
E06.645.440;Jaw Fixation Techniques;D019248
E06.780.345.593.185;Dental Implants, Single-Tooth;D019250
E07.695.185.185;Dental Implants, Single-Tooth;D019250
A21.249.500;Nucleocapsid;D019251
B04.950.500;Nucleocapsid;D019251
E01.370.350.600.350.700.690;Radiography, Dental, Digital;D019252
E01.370.350.700.700.690;Radiography, Dental, Digital;D019252
E01.370.350.700.720.720;Radiography, Dental, Digital;D019252
E06.342.764.716;Radiography, Dental, Digital;D019252
D12.644.360.075.718;Proto-Oncogene Proteins c-bcl-2;D019253
D12.776.476.075.718;Proto-Oncogene Proteins c-bcl-2;D019253
D12.776.624.664.700.169;Proto-Oncogene Proteins c-bcl-2;D019253
G05.360.340.024.340.375.500.791.150;Genes, bcl-2;D019254
D08.811.682.608.575;NADPH Oxidase;D019255
D12.776.331.894;NADPH Oxidase;D019255
D01.142.175;Cadmium Chloride;D019256
D01.210.450.150.125;Cadmium Chloride;D019256
D03.438.810.842;Quinpirole;D019257
D03.494.802;Quinpirole;D019257
D03.438.531.770;Saquinavir;D019258
D03.438.810.900;Saquinavir;D019258
D03.383.742.680.245.500.950.500;Lamivudine;D019259
D13.570.230.329.950.500;Lamivudine;D019259
D13.570.230.500.925.500;Lamivudine;D019259
D13.570.685.245.500.950.500;Lamivudine;D019259
F01.470.342;Expressed Emotion;D019260
A08.186.211.464.200;Epithalamus;D019261
A08.186.211.730.317.200;Epithalamus;D019261
A08.186.211.464.200.360;Habenula;D019262
A08.186.211.730.317.200.360;Habenula;D019262
F03.600.300.400;Dysthymic Disorder;D019263
E02.095.465.425.400.330.050;Adoptive Transfer;D019264
E05.478.550.520.050;Adoptive Transfer;D019264
E01.370.350.750;Spectroscopy, Near-Infrared;D019265
E05.196.867.851;Spectroscopy, Near-Infrared;D019265
D01.490.600;Iron, Dietary;D019266
D02.691.550.600;Iron, Dietary;D019266
D12.776.964.970.880.345.500;Hemagglutinin Glycoproteins, Influenza Virus;D019267
D12.776.124.486.485.114.323.190;Antibodies, Antineutrophil Cytoplasmic;D019268
D12.776.124.790.651.114.323.190;Antibodies, Antineutrophil Cytoplasmic;D019268
D12.776.377.715.548.114.323.190;Antibodies, Antineutrophil Cytoplasmic;D019268
D23.101.050;Antibodies, Antineutrophil Cytoplasmic;D019268
D10.570.755.375.760.400.942.625.900;Phosphatidylinositol 4,5-Diphosphate;D019269
D09.067.342.300;Fructosamine;D019270
D03.438.759.758.399.475;Hypoxanthine;D019271
D08.811.277.656.300.760.560.500;Leukocyte Elastase;D019272
D08.811.277.656.959.350.560.500;Leukocyte Elastase;D019272
D08.811.277.656.300.480.153.100;Botulinum Toxins, Type A;D019274
D08.811.277.656.675.374.153.100;Botulinum Toxins, Type A;D019274
D12.776.097.156.100;Botulinum Toxins, Type A;D019274
D23.946.123.179.050;Botulinum Toxins, Type A;D019274
D27.720.470.410.650;Radiopharmaceuticals;D019275
A11.284.149.165.355;Glycocalyx;D019276
G01.906.345;Entropy;D019277
D08.811.277.656.300.480.525.700.200;Matrix Metalloproteinase 3;D019278
D08.811.277.656.675.374.525.700.200;Matrix Metalloproteinase 3;D019278
D05.750.716.822.730;Resin Cements;D019279
D25.339.291.750;Resin Cements;D019279
D25.720.716.822.730;Resin Cements;D019279
J01.637.051.339.291.750;Resin Cements;D019279
J01.637.051.720.716.822.730;Resin Cements;D019279
C16.131.077.208;Branchio-Oto-Renal Syndrome;D019280
C16.131.260.090;Branchio-Oto-Renal Syndrome;D019280
C16.320.180.090;Branchio-Oto-Renal Syndrome;D019280
G02.111.087.215;Dimerization;D019281
G02.149.115.215;Dimerization;D019281
G02.149.250;Dimerization;D019281
G03.495.320;Dimerization;D019281
C18.452.915;Wasting Syndrome;D019282
C18.654.940;Wasting Syndrome;D019282
C06.689.750.650;Pancreatitis, Acute Necrotizing;D019283
D02.455.426.392.368.284.500.888;Thapsigargin;D019284
D02.455.849.765.793.888;Thapsigargin;D019284
D08.811.277.656.300.760.247;Endopeptidase K;D019286
D08.811.277.656.959.350.247;Endopeptidase K;D019286
D01.875.800.800.850.950;Zinc Sulfate;D019287
D01.975.987;Zinc Sulfate;D019287
B04.280.382.400.700.330;Herpesvirus 8, Human;D019288
B04.909.204.210.400.700.330;Herpesvirus 8, Human;D019288
B04.909.204.382.400.700.330;Herpesvirus 8, Human;D019288
B04.909.574.204.500.700.330;Herpesvirus 8, Human;D019288
D02.241.755.812.800;Pyruvic Acid;D019289
D04.808.745.432.531.500;Megestrol Acetate;D019290
A01.456.830;Skull Base;D019291
A02.835.232.781.750;Skull Base;D019291
C04.588.149.721.828;Skull Base Neoplasms;D019292
C05.116.231.754.829;Skull Base Neoplasms;D019292
C16.320.565.398.925;Xanthomatosis, Cerebrotendinous;D019294
C18.452.584.750.975;Xanthomatosis, Cerebrotendinous;D019294
C18.452.648.398.925;Xanthomatosis, Cerebrotendinous;D019294
H01.158.273.180;Computational Biology;D019295
E01.370.386.700.150;Capnography;D019296
D02.455.426.559.389.657.566.304.500;2,4-Dinitrophenol;D019297
D02.640.743.304.250;2,4-Dinitrophenol;D019297
D09.894.417.448.500;Glucose-6-Phosphate;D019298
E04.188;Decompression, Surgical;D019299
N02.421.450;Medical Errors;D019300
D10.251.355.325.600.525;Oleic Acid;D019301
D12.776.964.775.325.164.374;HIV Envelope Protein gp160;D019302
D12.776.964.775.562.500.750;HIV Envelope Protein gp160;D019302
D12.776.964.970.880.325.164.374;HIV Envelope Protein gp160;D019302
L01.143.506.423.452;Multilingualism;D019303
D04.808.668.651.568.291.250;Ethinyl Estradiol-Norgestrel Combination;D019304
D04.808.668.651.693.762.225;Ethinyl Estradiol-Norgestrel Combination;D019304
D06.472.334.851.437.968.500.250;Ethinyl Estradiol-Norgestrel Combination;D019304
C10.228.140.490.360.280;Epilepsy, Rolandic;D019305
B01.650.940.800.575.100.100.100;Artemisia;D019306
D02.886.590.700.545;1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine;D019307
D03.383.606.527;1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine;D019307
D03.438.531.400;1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine;D019307
D10.251.694.750;Palmitic Acid;D019308
D23.050.290.249;Epstein-Barr Virus Nuclear Antigens;D019309
D23.050.327.300;Epstein-Barr Virus Nuclear Antigens;D019309
C15.604.613;Pseudolymphoma;D019310
D03.132.436.750;Staurosporine;D019311
D03.438.473.144.750;Staurosporine;D019311
D03.438.473.402.750;Staurosporine;D019311
D03.494.148.750;Staurosporine;D019311
D12.776.624.776.100;BRCA1 Protein;D019313
D12.776.660.100;BRCA1 Protein;D019313
D12.776.744.100;BRCA1 Protein;D019313
D12.776.930.137;BRCA1 Protein;D019313
D04.808.054.079.429.625.300;Dehydroepiandrosterone Sulfate;D019314
D04.808.578.502.400.300;Dehydroepiandrosterone Sulfate;D019314
D06.472.040.502.400.300;Dehydroepiandrosterone Sulfate;D019314
D06.472.334.851.968.952.300;Dehydroepiandrosterone Sulfate;D019314
C11.675.700;Retrobulbar Hemorrhage;D019315
C23.550.414.960;Retrobulbar Hemorrhage;D019315
B04.820.504.080.100.700;Porcine respiratory and reproductive syndrome virus;D019316
B04.909.777.500.080.500.800;Porcine respiratory and reproductive syndrome virus;D019316
H02.249.750;Evidence-Based Medicine;D019317
H02.403.200.400;Evidence-Based Medicine;D019317
C02.782.600.100.700;Porcine Reproductive and Respiratory Syndrome;D019318
C22.905.700;Porcine Reproductive and Respiratory Syndrome;D019318
D02.355.291.705;Okadaic Acid;D019319
C14.907.355.590.400;Embolism, Paradoxical;D019320
C14.907.355.830.850.400;Embolism, Paradoxical;D019320
D12.125.068.050.650;omega-N-Methylarginine;D019323
D12.125.095.104.650;omega-N-Methylarginine;D019323
D12.125.142.087.500;omega-N-Methylarginine;D019323
D03.438.150.266.450.175.100;beta-Naphthoflavone;D019324
D03.830.219.266.450.175.100;beta-Naphthoflavone;D019324
D09.408.348.500.500;3-O-Methylglucose;D019325
D09.408.514.622.500;3-O-Methylglucose;D019325
D04.808.745.745.654.829.395.400;17-alpha-Hydroxyprogesterone;D019326
D06.472.334.851.687.750.478.400;17-alpha-Hydroxyprogesterone;D019326
D01.875.800.800.850.150;Copper Sulfate;D019327
D02.886.030.676.620.125;Buthionine Sulfoximine;D019328
D12.125.166.676.620.125;Buthionine Sulfoximine;D019328
D03.383.129.308.428;Idazoxan;D019329
D03.383.231.388.425;Idazoxan;D019329
D12.125.068.050.525;NG-Nitroarginine Methyl Ester;D019331
D12.125.095.104.525;NG-Nitroarginine Methyl Ester;D019331
D12.644.276.400.225;Endothelin-1;D019332
D12.776.467.400.225;Endothelin-1;D019332
D23.529.400.225;Endothelin-1;D019332
D12.644.276.400.235;Endothelin-2;D019333
D12.776.467.400.235;Endothelin-2;D019333
D23.529.400.235;Endothelin-2;D019333
D12.644.276.400.245;Endothelin-3;D019334
D12.776.467.400.245;Endothelin-3;D019334
D23.529.400.245;Endothelin-3;D019334
D12.125.068.050.587;Nitroarginine;D019335
D12.125.095.104.587;Nitroarginine;D019335
F04.096.628.255;Cognitive Science;D019336
C04.588.448;Hematologic Neoplasms;D019337
C15.378.400;Hematologic Neoplasms;D019337
E02.319.698;Polypharmacy;D019338
C16.131.831.675;Port-Wine Stain;D019339
C17.800.804.675;Port-Wine Stain;D019339
E04.545.575;Osteotomy, Le Fort;D019340
E04.555.580.580;Osteotomy, Le Fort;D019340
E06.645.575;Osteotomy, Le Fort;D019340
E02.190.525.061;Aromatherapy;D019341
E02.190.755.100;Aromatherapy;D019341
E02.190.888.061;Aromatherapy;D019341
F04.754.035;Aromatherapy;D019341
D02.241.081.018.165;Acetic Acid;D019342
D10.251.400.045.500;Acetic Acid;D019342
D02.241.081.901.434.249;Citric Acid;D019343
D02.241.511.459.450;Lactic Acid;D019344
D02.241.081.018.165.750;Zinc Acetate;D019345
D02.241.081.018.165.500;Sodium Acetate;D019346
D01.745.312;Potassium Acetate;D019347
D02.241.081.018.165.249;Potassium Acetate;D019347
K01.752.667.400;Empiricism;D019348
C02.256.466.850;Roseolovirus Infections;D019349
C02.782.105;Astroviridae Infections;D019350
C02.782.580.600.680;Rubulavirus Infections;D019351
I01.240.205;Censuses;D019352
N01.224.175;Censuses;D019352
N06.850.505.400.225;Censuses;D019352
N06.850.392;Endemic Diseases;D019353
D02.241.511.459.800;Sodium Lactate;D019354
D01.146.307;Calcium Citrate;D019355
D02.241.081.901.434.249.500;Calcium Citrate;D019355
J02.500.512.400.125;Calcium Citrate;D019355
K01.400.552.169;Grave Robbing;D019356
D02.241.081.901.434.249.750;Potassium Citrate;D019357
D27.720.368.350;Fat Substitutes;D019358
J02.500.512.350;Fat Substitutes;D019358
K01.468;Knowledge;D019359
L01.535;Knowledge;D019359
D08.244.453.040.888;Cytochrome P-450 CYP2B1;D019362
D08.811.682.690.708.170.040.499;Cytochrome P-450 CYP2B1;D019362
D12.776.422.220.453.040.777;Cytochrome P-450 CYP2B1;D019362
D08.244.453.040.555;Cytochrome P-450 CYP1A1;D019363
D08.811.682.690.708.170.040.332;Cytochrome P-450 CYP1A1;D019363
D12.776.422.220.453.040.332;Cytochrome P-450 CYP1A1;D019363
K01.752.667.750;Humoralism;D019364
K01.400.899.500;Metaphor;D019365
K01.752.798.500;Metaphor;D019365
I01.076.201.450.226.800;Western World;D019366
E02.190.488.510.500;Medicine, Unani;D019367
I01.076.201.450.654.510.500;Medicine, Unani;D019367
I01.076.201.450.654.745;Medicine, Unani;D019367
K01.400.552.643.500;Medicine, Unani;D019367
K01.637;Nature;D019368
K01.752.400;Life;D019369
E05.581.249;Observation;D019370
H01.277.500.097.500;Topography, Medical;D019371
H02.403.352.500;Topography, Medical;D019371
N02.278.825.700;Orphanages;D019372
D10.251.355.096.450.425;12-Hydroxy-5,8,10,14-eicosatetraenoic Acid;D019377
D10.251.355.255.100.300.425;12-Hydroxy-5,8,10,14-eicosatetraenoic Acid;D019377
D06.472.699.590.850;Teriparatide;D019379
D12.644.548.587.850;Teriparatide;D019379
D27.505.954.122.388.077.088;Anti-HIV Agents;D019380
D06.472.699.631.525.425.875;Human Growth Hormone;D019382
D12.644.548.691.525.425.875;Human Growth Hormone;D019382
D27.505.519.389.675;Nucleic Acid Synthesis Inhibitors;D019384
D02.705.429.500.100;Alendronate;D019386
D08.244.453.040.777;Cytochrome P-450 CYP1A2;D019388
D08.811.682.690.708.170.040.443;Cytochrome P-450 CYP1A2;D019388
D12.776.422.220.453.040.555;Cytochrome P-450 CYP1A2;D019388
D08.244.453.040.944;Cytochrome P-450 CYP2D6;D019389
D08.811.682.690.708.170.040.555;Cytochrome P-450 CYP2D6;D019389
D12.776.422.220.453.040.888;Cytochrome P-450 CYP2D6;D019389
D12.776.306.090;Arrestins;D019390
D12.776.543.090;Arrestins;D019390
D08.244.453.040.972;Cytochrome P-450 CYP2E1;D019392
D08.811.682.662.582.338;Cytochrome P-450 CYP2E1;D019392
D08.811.682.690.708.170.040.777;Cytochrome P-450 CYP2E1;D019392
D12.776.422.220.453.040.944;Cytochrome P-450 CYP2E1;D019392
D12.776.306.090.050;Arrestin;D019393
D12.776.543.090.050;Arrestin;D019393
D23.050.301.280;Arrestin;D019393
D12.776.660.625.500;Ki-67 Antigen;D019394
D23.050.290.500;Ki-67 Antigen;D019394
D23.101.840.400;Ki-67 Antigen;D019394
D12.644.875;Tissue Polypeptide Antigen;D019396
D23.050.285.840;Tissue Polypeptide Antigen;D019396
D23.101.840.880;Tissue Polypeptide Antigen;D019396
E07.858.082.760;Pancreas, Artificial;D019397
G05.360.340.024.340.375.249.100;Genes, BRCA1;D019398
G05.360.340.024.340.415.400.100;Genes, BRCA1;D019398
B04.265.658.850;Tobacco mosaic satellite virus;D019400
D13.444.735.721.250;Cucumber Mosaic Virus Satellite;D019401
D12.644.276.374.200.600;Macrophage Inflammatory Proteins;D019402
D12.776.467.374.200.600;Macrophage Inflammatory Proteins;D019402
D23.125.300.600;Macrophage Inflammatory Proteins;D019402
D23.469.200.600;Macrophage Inflammatory Proteins;D019402
D23.529.374.200.600;Macrophage Inflammatory Proteins;D019402
D08.244.453.915.050;Aldosterone Synthase;D019405
D08.811.682.690.708.170.915.050;Aldosterone Synthase;D019405
D08.811.682.690.708.783.050;Aldosterone Synthase;D019405
D12.776.422.220.453.915.050;Aldosterone Synthase;D019405
D12.776.395.550.200.131;Antigens, CD31;D019408
D12.776.543.550.200.131;Antigens, CD31;D019408
D23.050.301.264.035.131;Antigens, CD31;D019408
D23.050.301.264.900.131;Antigens, CD31;D019408
D23.050.301.350.131;Antigens, CD31;D019408
D23.101.100.110.131;Antigens, CD31;D019408
D23.101.100.900.131;Antigens, CD31;D019408
D12.644.276.374.465.515;Interleukin-15;D019409
D12.776.467.374.465.515;Interleukin-15;D019409
D23.529.374.465.515;Interleukin-15;D019409
D12.644.276.374.465.516;Interleukin-16;D019410
D12.776.467.374.465.516;Interleukin-16;D019410
D23.529.374.465.516;Interleukin-16;D019410
E01.370.225;Clinical Laboratory Techniques;D019411
E05.200;Clinical Laboratory Techniques;D019411
H01.158.100.185;Anatomy, Cross-Sectional;D019412
I01.076.201.450.654.558.520.300;Qi;D019413
K01.752.730;Qi;D019413
B03.250;Chlorobi;D019414
G01.374.676.860.500;Torque;D019415
G01.595.540.860.500;Torque;D019415
G11.427.590.530.478;Head Movements;D019416
E05.472.760.370;Hindlimb Suspension;D019417
E05.977.400;Hindlimb Suspension;D019417
N06.230.150.440.950.400;Hindlimb Suspension;D019417
G01.060.374.270.500;Evolution, Chemical;D019418
G01.595.060.270.500;Evolution, Chemical;D019418
G02.111.087.468;Evolution, Chemical;D019418
G02.149.115.468;Evolution, Chemical;D019418
G02.149.260;Evolution, Chemical;D019418
G01.060.374.270;Evolution, Planetary;D019419
G01.311.340.449;Evolution, Planetary;D019419
G01.595.060.270;Evolution, Planetary;D019419
G01.595.340.449;Evolution, Planetary;D019419
D09.301.325;Dietary Sucrose;D019422
D09.698.629.305.770.200;Dietary Sucrose;D019422
J02.500.362.325;Dietary Sucrose;D019422
E02.190.488.830;Shamanism;D019423
E02.190.901.788;Shamanism;D019423
I01.076.201.450.654.830;Shamanism;D019423
Z01.107.084.900.262;Dominica;D019424
Z01.639.880.262;Dominica;D019424
Z01.107.084.900.362;Grenada;D019425
Z01.639.880.362;Grenada;D019425
D08.811.739.500;Integrases;D019426
D08.811.739.500.667.500;HIV Integrase;D019427
D08.811.913.696.445.825.500;HIV Integrase;D019427
D12.776.964.775.375.545.500;HIV Integrase;D019427
D12.776.964.775.562.875.500;HIV Integrase;D019427
D12.776.964.970.600.850.375.545.500;HIV Integrase;D019427
D27.505.519.389.375.400;HIV Integrase Inhibitors;D019428
D27.505.954.122.388.077.088.314;HIV Integrase Inhibitors;D019428
D27.505.519.389.375;Integrase Inhibitors;D019429
Z01.107.084.900.393;Guadeloupe;D019430
Z01.639.880.393;Guadeloupe;D019430
Z01.107.084.900.825;Saint Lucia;D019431
Z01.639.880.825;Saint Lucia;D019431
Z01.639.040.695;Falkland Islands;D019432
D20.215.894.899.290.130;Chickenpox Vaccine;D019433
Z01.542.363.161.500;Guernsey;D019435
Z01.639.280.161.500;Guernsey;D019435
Z01.107.084.900.862;Saint Vincent and the Grenadines;D019436
Z01.639.880.862;Saint Vincent and the Grenadines;D019436
Z01.107.084.900.787;Saint Kitts and Nevis;D019437
Z01.639.880.787;Saint Kitts and Nevis;D019437
D02.886.675.653;Ritonavir;D019438
D03.383.129.708.653;Ritonavir;D019438
A06.224.161;Chromaffin Cells;D019439
A11.299;Chromaffin Cells;D019439
D27.505.954.427.140;Anti-Obesity Agents;D019440
A18.024.750;Plant Epidermis;D019441
E07.700.600.700;Space Suits;D019442
J01.637.215.600.700;Space Suits;D019442
J01.637.708.600.700;Space Suits;D019442
D20.633.222.200;Cosmic Dust;D019443
G01.060.249.159.200;Cosmic Dust;D019443
G16.500.275.240.200;Cosmic Dust;D019443
D12.776.828.868.910;Vaccines, DNA;D019444
D20.215.894.865.910;Vaccines, DNA;D019444
D23.050.865.910;Vaccines, DNA;D019444
G01.060.374.800;Solar Activity;D019445
G01.595.060.800;Solar Activity;D019445
C01.539.757.100.275;Endotoxemia;D019446
C01.539.861.375;Endotoxemia;D019446
C23.550.470.790.500.100.275;Endotoxemia;D019446
H01.158.273.118.299;Ethnobotany;D019448
C06.405.205.462.624.500;Pouchitis;D019449
C06.405.469.326.875.500;Pouchitis;D019449
C06.405.469.420.520.500;Pouchitis;D019449
G05.360.340.024.340.361;Genes, MDR;D019450
G05.360.340.024.340.645.500;Genes, MDR;D019450
L01.399;Information Management;D019451
M01.873;Terminally Ill;D019452
B03.440.450.425.325.300.800.250.500;Escherichia coli O157;D019453
B03.660.250.150.180.100.800.250.500;Escherichia coli O157;D019453
E02.168;Chronotherapy;D019454
F02.739.794.837;Self Psychology;D019455
I01.240.600.400;Health Transition;D019456
N01.224.625.400;Health Transition;D019456
N06.850.505.400.700.400;Health Transition;D019456
N06.850.650;Health Transition;D019456
C23.550.210.170;Chromosome Breakage;D019457
G05.355.180.210.170;Chromosome Breakage;D019457
G05.365.590.175.175;Chromosome Breakage;D019457
N03.219.521.576.265;Insurance Coverage;D019458
A10.272.850;Urothelium;D019459
J01.576.919;Tobacco Industry;D019460
N01.824.417.510.300;Employee Retirement Income Security Act;D019461
N01.824.417.700.325.300;Employee Retirement Income Security Act;D019461
N03.219.521.576.343.290.300;Employee Retirement Income Security Act;D019461
N03.706.615.215;Employee Retirement Income Security Act;D019461
N04.452.677.800.325.300;Employee Retirement Income Security Act;D019461
C10.177.575.600.800;Syncope, Vasovagal;D019462
C10.597.606.358.800.600.500;Syncope, Vasovagal;D019462
C23.888.592.604.359.800.600.500;Syncope, Vasovagal;D019462
B01.050.050.157.520.555;Mice, Inbred MRL lpr;D019463
B01.050.050.199.520.520.555;Mice, Inbred MRL lpr;D019463
B01.050.150.900.649.865.635.505.500.400.555;Mice, Inbred MRL lpr;D019463
N03.219.900.940;Tax Exemption;D019464
C05.660.207;Craniofacial Abnormalities;D019465
C16.131.621.207;Craniofacial Abnormalities;D019465
G01.590.540.333;Glare;D019466
G14.400;Glare;D019466
E02.760.850;Subacute Care;D019467
N02.421.585.850;Subacute Care;D019467
N04.590.607;Disease Management;D019468
D03.383.725.385;Indinavir;D019469
E02.319.267.530.620.570.100;Biolistics;D019470
E05.393.350.100;Biolistics;D019470
G01.595.240;Elementary Particle Interactions;D019471
N03.219.521.576.265.500;Universal Coverage;D019472
D12.776.260.775.875;Transcription Factors, TFII;D019473
D12.776.930.930.875;Transcription Factors, TFII;D019473
D12.776.260.775.937;Transcription Factors, TFIII;D019474
D12.776.930.930.937;Transcription Factors, TFIII;D019474
D08.244.453.085;Camphor 5-Monooxygenase;D019475
D08.811.682.690.708.170.085;Camphor 5-Monooxygenase;D019475
D12.776.422.220.453.085;Camphor 5-Monooxygenase;D019475
D12.776.092.500;Insect Proteins;D019476
V02.700.600;Portraits;D019477
V02.050;Academic Dissertations;D019478
V02.060;Account Books;D019479
V01.100;Advertisements;D019480
V02.100;Advertisements;D019480
V02.355.249;Advertisements;D019480
V02.110;Almanacs;D019482
D12.644.138;Disintegrins;D019483
V02.070;Addresses;D019484
D12.644.276.954.200;Bone Morphogenetic Proteins;D019485
D12.776.467.942.200;Bone Morphogenetic Proteins;D019485
D23.529.942.200;Bone Morphogenetic Proteins;D019485
V01.110;Animation;D019486
V02.120;Animation;D019486
V02.130;Annual Reports;D019487
V01.140;Architectural Drawings;D019488
V02.140;Architectural Drawings;D019488
V01.185;Book Illustrations;D019489
V02.200;Broadsides;D019490
V01.195;Bookplates;D019491
V01.185.500;Caricatures;D019492
V02.225;Caricatures;D019492
V02.235;Cartoons;D019493
V02.540.200;Cartoons;D019493
V02.240;Catalogs;D019494
D20.215.894.200;Cancer Vaccines;D019496
V02.305;Diaries;D019497
V02.315;Documentaries and Factual Films;D019499
V02.350;Encyclopedias;D019500
V02.355;Ephemera;D019502
V02.375;Eulogies;D019504
V02.375.400;Funeral Sermons;D019505
V02.510;Guidebooks;D019508
V02.695.500;Herbals;D019509
C06.689.750.660;Pancreatitis, Alcoholic;D019512
C25.100.087.730;Pancreatitis, Alcoholic;D019512
K01.316.400.400;Feminism;D019513
K01.752.256.120.400;Feminism;D019513
V01.255.500.500;Instructional Films and Videos;D019514
V02.575;Instructional Films and Videos;D019514
E06.658.578.229;Orthodontic Space Closure;D019516
V02.940;Unedited Footage;D019517
G10.261.700;Postprandial Period;D019518
V02.355.500;Posters;D019519
M01.898.656;Living Donors;D019520
G07.700.320.500.100;Body Patterning;D019521
C13.351.500.894.700;Vaginal Discharge;D019522
V02.070.750;Sermons;D019523
V02.240.500;Price Lists;D019525
V02.355.775;Prospectuses;D019527
V02.607;Lecture Notes;D019528
F01.145.802.975;Sexuality;D019529
G08.686.867;Sexuality;D019529
V02.070.500;Lectures;D019531
V01.185.687;Maps;D019532
V02.700.450;Maps;D019532
B03.510.400.800.872.875.600;Streptococcus oralis;D019533
B03.510.550.737.872.875.600;Streptococcus oralis;D019533
C05.550.840;Shoulder Impingement Syndrome;D019534
B03.440.860.580.553.553.400;Mycoplasma hominis;D019535
E05.318.308.335;Health Care Surveys;D019538
N03.349.380.210;Health Care Surveys;D019538
N05.425.210;Health Care Surveys;D019538
N05.715.360.300.387;Health Care Surveys;D019538
N06.850.520.308.335;Health Care Surveys;D019538
V02.695;Pharmacopoeias;D019539
E05.318.740.200;Area Under Curve;D019540
G03.787.101;Area Under Curve;D019540
G07.690.725.064;Area Under Curve;D019540
N06.850.520.830.200;Area Under Curve;D019540
V02.355.750;Programs;D019542
E05.325.192;Equipment Failure Analysis;D019544
F02.463.188.675;Intuition;D019545
F04.754.864.581.136;Couples Therapy;D019546
C10.597.617.576;Neck Pain;D019547
C23.888.592.612.553;Neck Pain;D019547
C23.888.646.501;Neck Pain;D019547
M01.135;Crime Victims;D019548
H02.403.720.750.250;Environmental Medicine;D019550
N06.850.420;Environmental Medicine;D019550
D27.505.954.122.425.300;Dental Disinfectants;D019551
D27.720.274.300;Dental Disinfectants;D019551
E06.470;Infection Control, Dental;D019552
N06.850.780.200.450.500;Infection Control, Dental;D019552
C07.793.237.910;Tooth, Nonvital;D019553
E06.780.345.737.125;Dental Restoration Wear;D019554
F01.829.401.205.500;Physician-Nurse Relations;D019555
A11.251.210.172.500;COS Cells;D019556
A11.329.228.220;COS Cells;D019556
C17.800.174.550;Dermatitis, Perioral;D019557
C17.800.271.250;Dermatitis, Perioral;D019557
E06.658.578.200;Occlusal Adjustment;D019558
C14.907.218;Capillary Leak Syndrome;D019559
E01.370.350.130.750.230;Echocardiography, Three-Dimensional;D019560
E01.370.350.400.200;Echocardiography, Three-Dimensional;D019560
E01.370.350.850.220.230;Echocardiography, Three-Dimensional;D019560
E01.370.370.380.220.230;Echocardiography, Three-Dimensional;D019560
E01.370.350.130.750.230.230;Echocardiography, Four-Dimensional;D019561
E01.370.350.400.200.230;Echocardiography, Four-Dimensional;D019561
E01.370.350.850.220.230.230;Echocardiography, Four-Dimensional;D019561
E01.370.370.380.220.230.230;Echocardiography, Four-Dimensional;D019561
E01.370.225.875.950;Viral Load;D019562
E05.200.875.950;Viral Load;D019562
G06.920.850;Viral Load;D019562
H01.671.515;Mechanics;D019563
N02.421.380.900;Unnecessary Procedures;D019564
N05.300.150.395.900;Unnecessary Procedures;D019564
D01.268.557;Metals, Light;D019565
D01.552.547;Metals, Light;D019565
C26.117;Back Injuries;D019567
C08.381.748.500;Lung, Hyperlucent;D019568
C07.465.364;Hemifacial Spasm;D019569
C10.597.613.750.400;Hemifacial Spasm;D019569
C23.888.592.608.750.400;Hemifacial Spasm;D019569
N06.850.460.350.112;Inhalation Exposure;D019570
C14.240.400.145;Arrhythmogenic Right Ventricular Dysplasia;D019571
C14.280.238.028;Arrhythmogenic Right Ventricular Dysplasia;D019571
C14.280.400.145;Arrhythmogenic Right Ventricular Dysplasia;D019571
C16.131.240.400.145;Arrhythmogenic Right Ventricular Dysplasia;D019571
C04.588.364.818;Retinal Neoplasms;D019572
C11.319.475;Retinal Neoplasms;D019572
C11.768.717;Retinal Neoplasms;D019572
A09.371.060.217.325;Epithelium, Corneal;D019573
A10.272.510;Epithelium, Corneal;D019573
C04.588.614.300.600;Optic Nerve Neoplasms;D019574
C04.588.614.596.240.240;Optic Nerve Neoplasms;D019574
C10.292.225.800;Optic Nerve Neoplasms;D019574
C10.292.700.500;Optic Nerve Neoplasms;D019574
C10.551.360.500;Optic Nerve Neoplasms;D019574
C11.640.544;Optic Nerve Neoplasms;D019574
C10.597.751.941.162.250;Blindness, Cortical;D019575
C11.966.075.250;Blindness, Cortical;D019575
C23.888.592.763.941.162.250;Blindness, Cortical;D019575
B01.050.150.900.649.189.566;Porpoises;D019576
B01.050.150.900.649.865.600;Mole Rats;D019577
C10.177.575.550;Multiple System Atrophy;D019578
C10.228.140.079.612;Multiple System Atrophy;D019578
C10.228.662.550;Multiple System Atrophy;D019578
C10.574.625;Multiple System Atrophy;D019578
A08.186.211.730.885.287.500.420;Neocortex;D019579
A08.186.211.464.730;Perforant Pathway;D019580
A08.612.600;Perforant Pathway;D019580
A08.637.500;Neuropil;D019581
A08.663.703;Neuropil;D019581
A11.650.500;Neuropil;D019581
A11.671.685;Neuropil;D019581
E02.815.639.200;Dose Fractionation;D019583
C23.888.475;Hot Flashes;D019584
C10.228.140.638;Intracranial Hypotension;D019585
C10.228.140.631;Intracranial Hypertension;D019586
J02.500.456;Dietary Supplements;D019587
C23.888.069;Aging, Premature;D019588
A14.549.167.900;Tooth Components;D019589
D12.776.964.970.600;Nucleocapsid Proteins;D019590
C23.888.681;Pseudophakia;D019591
C02.081.270.200;Dengue Hemorrhagic Fever;D019595
C02.782.350.250.214.200;Dengue Hemorrhagic Fever;D019595
C02.782.417.214.200;Dengue Hemorrhagic Fever;D019595
C23.996.300.320;Dengue Hemorrhagic Fever;D019595
C23.996.337;Dengue Hemorrhagic Fever;D019595
B01.050.150.900.649.147.153.900;Wolves;D019596
B01.650.940.800.575.100.620.500;Flax;D019597
A08.186.211.464.405.200.500;Mossy Fibers, Hippocampal;D019599
A08.186.211.730.885.287.500.345.200.500;Mossy Fibers, Hippocampal;D019599
A08.663.542.145.750.500;Mossy Fibers, Hippocampal;D019599
A08.850.700.500;Mossy Fibers, Hippocampal;D019599
A11.671.137.560;Mossy Fibers, Hippocampal;D019599
A08.637.500.550;Neuropil Threads;D019600
A08.663.703.550;Neuropil Threads;D019600
A11.284.430.214.190.750.602.620;Neuropil Threads;D019600
A11.650.500.550;Neuropil Threads;D019600
A11.671.685.550;Neuropil Threads;D019600
Z01.107.567.875.580;Pacific States;D019601
J02;Food and Beverages;D019602
B02.200.850;Thermoplasmales;D019603
B02.200;Euryarchaeota;D019605
D12.125.740;Phosphoamino Acids;D019606
B01.650.940.800.575.100.157;Brassicaceae;D019607
B02.200.080;Archaeoglobales;D019608
B02.200.080.080;Archaeoglobus;D019609
G07.690.812.195;Cytoprotection;D019610
G07.700.680.195;Cytoprotection;D019610
B02.200.080.080.100;Archaeoglobus fulgidus;D019611
B01.650.940.800.575.100.825.333;Fagopyrum;D019612
J02.500.200.175;Fagopyrum;D019612
J02.500.300.100.175;Fagopyrum;D019612
B02.200.400.400.400;Haloarcula;D019613
B02.200.400.400.400.410;Haloarcula marismortui;D019614
B02.075;Crenarchaeota;D019615
E04.928;Thoracic Surgical Procedures;D019616
B02.200.400.400.410.450;Halobacterium salinarum;D019617
B02.075.800;Thermoproteales;D019619
B02.075.200.500;Desulfurococcaceae;D019620
B02.200.400.400.440;Haloferax;D019621
B02.200.400.400.440.900;Haloferax volcanii;D019622
B02.200.400.400.440.500;Haloferax mediterranei;D019623
B02.075.800.800;Thermoproteaceae;D019624
B02.200.400.400.420;Halococcus;D019625
B02.200.400.400.550;Natronobacterium;D019633
B02.200.400.400.560;Natronococcus;D019634
E04.525;Neurosurgical Procedures;D019635
C10.574;Neurodegenerative Diseases;D019636
E02.718;Orthopedic Procedures;D019637
E04.555;Orthopedic Procedures;D019637
B02.200.705.500;Methanomicrobiaceae;D019638
B02.200.705.750;Methanospirillum;D019639
B02.200.765;Methanosarcinales;D019640
D13.444.308.180;DNA, Archaeal;D019641
D13.444.735.300;RNA, Archaeal;D019642
E04.555.110.110;Arthroplasty, Replacement;D019643
E04.650.110;Arthroplasty, Replacement;D019643
E04.555.110.110.110;Arthroplasty, Replacement, Hip;D019644
E04.650.110.110;Arthroplasty, Replacement, Hip;D019644
E04.555.110.110.115;Arthroplasty, Replacement, Knee;D019645
E04.650.110.115;Arthroplasty, Replacement, Knee;D019645
G01.374.715.250.500;Decompression, Explosive;D019646
E04.545;Oral Surgical Procedures;D019647
E06.645;Oral Surgical Procedures;D019647
J02.500.525;Foods, Specialized;D019648
J01.576.423;Food Industry;D019649
E02.095.410;Hematopoietic Stem Cell Mobilization;D019650
E04.680;Reconstructive Surgical Procedures;D019651
J01.576.370;Extraction and Processing Industry;D019652
D27.505.696.477.656.750;Myeloablative Agonists;D019653
D27.505.954.248.589;Myeloablative Agonists;D019653
E04.540.825.600;Lens Implantation, Intraocular;D019654
G05.420.720;Quantitative Trait, Heritable;D019655
G05.365.590.029.530;Loss of Heterozygosity;D019656
B01.650.940.800.575.100.905;Solanaceae;D019657
B01.650.940.800.575.100.620;Linaceae;D019658
B01.650.940.800.575.100.100;Asteraceae;D019659
B01.650.940.800.575.100.700;Malvaceae;D019660
B01.650.940.800.575.100.075;Apiaceae;D019661
B01.650.940.800.575.100.300;Cucurbitaceae;D019662
B01.650.940.800.575.100.200;Chenopodiaceae;D019663
B01.650.940.800.575.100.825;Polygonaceae;D019664
B01.650.940.800.575.100.350;Euphorbiaceae;D019665
B01.650.940.800.575.100.850;Rubiaceae;D019666
B01.650.940.800.575.100.610;Liliaceae;D019668
B01.650.940.800.575;Embryophyta;D019669
G05.360.340.024.340.475;Genes, T-Cell Receptor;D019672
G05.360.340.024.340.475.050;Genes, T-Cell Receptor alpha;D019673
G05.360.340.024.340.475.080;Genes, T-Cell Receptor beta;D019674
G05.360.340.024.340.475.400;Genes, T-Cell Receptor gamma;D019675
G05.360.340.024.340.475.240;Genes, T-Cell Receptor delta;D019676
E05.393.220.250;Artificial Gene Fusion;D019677
D12.644.276.812.654.350;Kininogen, High-Molecular-Weight;D019679
D12.776.124.125.635.480;Kininogen, High-Molecular-Weight;D019679
D12.776.467.812.654.350;Kininogen, High-Molecular-Weight;D019679
D12.776.811.420.350;Kininogen, High-Molecular-Weight;D019679
D23.119.630.480;Kininogen, High-Molecular-Weight;D019679
D23.469.050.375.425.350;Kininogen, High-Molecular-Weight;D019679
D23.529.812.654.350;Kininogen, High-Molecular-Weight;D019679
G02.111.570.080.708.800.140.865;Trinucleotide Repeat Expansion;D019680
G02.111.570.080.708.800.500.850.200;Trinucleotide Repeat Expansion;D019680
G05.355.600.220.865;Trinucleotide Repeat Expansion;D019680
G05.360.080.708.800.074.865;Trinucleotide Repeat Expansion;D019680
G05.360.080.708.800.500.850.200;Trinucleotide Repeat Expansion;D019680
G05.360.340.024.189.220.865;Trinucleotide Repeat Expansion;D019680
G05.360.340.024.850.500.850.200;Trinucleotide Repeat Expansion;D019680
G05.365.590.220.865;Trinucleotide Repeat Expansion;D019680
B01.650.940.800.575.400;Gymnosperms;D019681
G05.420.655;Penetrance;D019683
G05.695.650;Penetrance;D019683
B01.650.940.800.575.100;Angiosperms;D019684
B01.650.940.800.575.100.842;Rosales;D019685
B01.650.940.800.575.100.575;Lamiaceae;D019686
C13.351.500.852.726;Uterine Inversion;D019687
C13.703.420.814;Uterine Inversion;D019687
B03.440.475;Gram-Negative Oxygenic Photosynthetic Bacteria;D019688
D02.092.570.665.810;Technetium Tc 99m Exametazime;D019690
D02.691.825.562;Technetium Tc 99m Exametazime;D019690
B03.440.475.100.655.620;Prochloron;D019691
B03.440.475.100.655.640;Prochlorothrix;D019692
C06.552.380.350.050;Hepatitis, Autoimmune;D019693
C20.111.567;Hepatitis, Autoimmune;D019693
C02.256.430.400.100;Hepatitis B, Chronic;D019694
C02.440.435.100;Hepatitis B, Chronic;D019694
C06.552.380.350.100;Hepatitis B, Chronic;D019694
C06.552.380.705.437.100;Hepatitis B, Chronic;D019694
D02.455.849.919.530.466;Glycyrrhizic Acid;D019695
D08.811.399.325.500;Peptidylprolyl Isomerase;D019696
B01.650.940.800.575.100.610.100.600;Onions;D019697
J02.500.850.100.500;Onions;D019697
C02.440.440.120;Hepatitis C, Chronic;D019698
C02.782.350.350.120;Hepatitis C, Chronic;D019698
C06.552.380.350.120;Hepatitis C, Chronic;D019698
C06.552.380.705.440.120;Hepatitis C, Chronic;D019698
D12.776.395.550.895;Thrombospondins;D019699
D12.776.543.550.895;Thrombospondins;D019699
D12.776.395.550.895.800;Thrombospondin 1;D019700
D12.776.543.550.895.800;Thrombospondin 1;D019700
C02.440.450.100;Hepatitis D, Chronic;D019701
C02.782.450.100;Hepatitis D, Chronic;D019701
C06.552.380.350.220;Hepatitis D, Chronic;D019701
C06.552.380.705.450.100;Hepatitis D, Chronic;D019701
D08.811.277.352.650.625.150;Calcineurin;D019703
D12.644.360.087;Calcineurin;D019703
D12.776.476.087;Calcineurin;D019703
D08.811.399.475.800.550;Protein Disulfide-Isomerases;D019704
G04.580.887.249;Excitatory Postsynaptic Potentials;D019706
G07.265.337.900.750.199;Excitatory Postsynaptic Potentials;D019706
G07.265.750.887.249;Excitatory Postsynaptic Potentials;D019706
G07.700.240.900.750.199;Excitatory Postsynaptic Potentials;D019706
G11.561.570.918.249;Excitatory Postsynaptic Potentials;D019706
G11.561.600.835.750.199;Excitatory Postsynaptic Potentials;D019706
D12.776.543.750.100.160;Receptors, Chemokine;D019707
D12.776.543.750.705.852.125;Receptors, Chemokine;D019707
D23.050.301.264.035.605;Receptors, Chemokine;D019707
D23.101.100.110.605;Receptors, Chemokine;D019707
B02.500;Korarchaeota;D019708
B02.200.825;Thermococcales;D019709
B02.200.825.800;Thermococcaceae;D019710
B02.200.825.800.650;Pyrococcus;D019711
B02.200.825.800.800;Thermococcus;D019712
D12.776.543.750.100.160.150.500;Receptors, CCR5;D019713
D12.776.543.750.705.852.125.150.500;Receptors, CCR5;D019713
D12.776.543.750.925.700.605;Receptors, CCR5;D019713
D23.050.301.264.035.605.150.500;Receptors, CCR5;D019713
D23.101.100.110.605.150.500;Receptors, CCR5;D019713
D12.776.645.875;Tissue Inhibitor of Metalloproteinases;D019714
D12.776.645.875.450;Tissue Inhibitor of Metalloproteinase-1;D019715
D12.776.645.875.500;Tissue Inhibitor of Metalloproteinase-2;D019716
D12.776.645.875.550;Tissue Inhibitor of Metalloproteinase-3;D019717
D12.776.543.750.100.160.500.400;Receptors, CXCR4;D019718
D12.776.543.750.705.852.125.500.400;Receptors, CXCR4;D019718
D12.776.543.750.925.700.650;Receptors, CXCR4;D019718
D23.050.301.264.035.605.500.400;Receptors, CXCR4;D019718
D23.101.100.110.605.500.400;Receptors, CXCR4;D019718
E07.230;Diagnostic Equipment;D019719
E07.230.550;Otoscopes;D019720
E07.230.540;Ophthalmoscopes;D019721
E07.230.740;Sphygmomanometers;D019722
E07.230.220;Endoscopes;D019723
E07.858.240;Endoscopes;D019723
I01.880.604.583.659;Presumed Consent;D019724
N03.706.535.664;Presumed Consent;D019724
N03.706.615.420.500;Patient Self-Determination Act;D019726
N03.706.615.808;Patient Self-Determination Act;D019726
M01.380.600;Proxy;D019727
D12.644.276.812.654.400;Kininogen, Low-Molecular-Weight;D019728
D12.776.124.125.635.490;Kininogen, Low-Molecular-Weight;D019728
D12.776.467.812.654.400;Kininogen, Low-Molecular-Weight;D019728
D12.776.811.420.400;Kininogen, Low-Molecular-Weight;D019728
D23.119.630.490;Kininogen, Low-Molecular-Weight;D019728
D23.469.050.375.425.400;Kininogen, Low-Molecular-Weight;D019728
D23.529.812.654.400;Kininogen, Low-Molecular-Weight;D019728
D08.811.464.263;Carbon-Oxygen Ligases;D019729
D08.811.464.267;Carbon-Sulfur Ligases;D019730
D08.811.464.259;Carbon-Nitrogen Ligases;D019731
D08.811.464.259.200;Amide Synthases;D019732
D08.811.464.259.400;Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor;D019733
D08.811.464.257;Carbon-Carbon Ligases;D019735
E07.695;Prostheses and Implants;D019736
E07.945;Transplants;D019737
A10.850;Surgically-Created Structures;D019738
E07.862;Surgically-Created Structures;D019738
A10.850.700;Skeletal Muscle Ventricle;D019739
E07.862.700;Skeletal Muscle Ventricle;D019739
B03.440.450.600.450.330.150;Haemophilus influenzae type b;D019741
B03.660.250.550.290.330.150;Haemophilus influenzae type b;D019741
D12.644.276.374.200.110;Chemokines, CC;D019742
D12.776.467.374.200.110;Chemokines, CC;D019742
D23.125.300.110;Chemokines, CC;D019742
D23.469.200.110;Chemokines, CC;D019742
D23.529.374.200.110;Chemokines, CC;D019742
D12.644.276.374.200.120;Chemokines, CXC;D019743
D12.776.467.374.200.120;Chemokines, CXC;D019743
D23.125.300.120;Chemokines, CXC;D019743
D23.469.200.120;Chemokines, CXC;D019743
D23.529.374.200.120;Chemokines, CXC;D019743
D12.644.276.374.200.100;Chemokines, C;D019744
D12.776.467.374.200.100;Chemokines, C;D019744
D23.125.300.100;Chemokines, C;D019744
D23.469.200.100;Chemokines, C;D019744
D23.529.374.200.100;Chemokines, C;D019744
D08.811.399.325;cis-trans-Isomerases;D019745
D08.811.399.475;Intramolecular Oxidoreductases;D019746
D08.811.399.475.200;Aldose-Ketose Isomerases;D019747
D08.811.399.475.400;Carbon-Carbon Double Bond Isomerases;D019748
D08.811.399.475.800;Sulfur-Sulfur Bond Isomerases;D019749
D08.811.399.520;Intramolecular Transferases;D019751
D08.811.399.430;Intramolecular Lyases;D019753
D08.811.520.224;Carbon-Carbon Lyases;D019755
D08.811.520.241;Carbon-Oxygen Lyases;D019757
D08.811.520.232;Carbon-Nitrogen Lyases;D019759
D08.811.520.232.300;Amidine-Lyases;D019760
D08.811.520.650;Phosphorus-Oxygen Lyases;D019761
D08.811.520.241.700.512;Heparin Lyase;D019763
D08.811.520.224.125.500;Phosphoenolpyruvate Carboxykinase (ATP);D019764
D08.811.520.241.700.350.500.500;Chondroitin ABC Lyase;D019765
G05.360.340.024.340.200;Genes, Archaeal;D019766
G05.360.340.050.500;Genes, Archaeal;D019766
C05.660.207.540;Maxillofacial Abnormalities;D019767
C07.650.500;Maxillofacial Abnormalities;D019767
C16.131.621.207.540;Maxillofacial Abnormalities;D019767
C16.131.850.500;Maxillofacial Abnormalities;D019767
B01.650.940.800.575.100.590;Lauraceae;D019770
E04.525.210.145;Axotomy;D019771
D03.132.151.850;Topotecan;D019772
C11.768.328;Epiretinal Membrane;D019773
D23.113;Blood Coagulation Factor Inhibitors;D019774
B03.440.450.425.800.200;Salmonella enterica;D019779
B03.660.250.150.710.160;Salmonella enterica;D019779
D02.241.081.583.900;Technetium Tc 99m Lidofenin;D019780
D02.491.485.900;Technetium Tc 99m Lidofenin;D019780
D02.691.825.710;Technetium Tc 99m Lidofenin;D019780
D12.125.072.401.900;Technetium Tc 99m Lidofenin;D019780
E01.370.380.150;Corneal Topography;D019781
D02.886.675.651;Riluzole;D019782
D03.383.129.708.089.611;Riluzole;D019782
D03.438.185.611;Riluzole;D019782
D02.241.081.337.759.500.725;Technetium Tc 99m Dimercaptosuccinic Acid;D019783
D02.691.825.468;Technetium Tc 99m Dimercaptosuccinic Acid;D019783
D02.886.489.750.725;Technetium Tc 99m Dimercaptosuccinic Acid;D019783
D02.241.081.583.400;Technetium Tc 99m Diethyl-iminodiacetic Acid;D019784
D02.491.485.400;Technetium Tc 99m Diethyl-iminodiacetic Acid;D019784
D02.691.825.445;Technetium Tc 99m Diethyl-iminodiacetic Acid;D019784
D12.125.072.401.830;Technetium Tc 99m Diethyl-iminodiacetic Acid;D019784
D02.241.081.583.450;Technetium Tc 99m Disofenin;D019785
D02.491.485.450;Technetium Tc 99m Disofenin;D019785
D02.691.825.475;Technetium Tc 99m Disofenin;D019785
D12.125.072.401.840;Technetium Tc 99m Disofenin;D019785
D02.092.782.590.401;Gadolinium DTPA;D019786
D02.241.081.018.639.400;Gadolinium DTPA;D019786
D02.691.400;Gadolinium DTPA;D019786
D10.251.355.310.515.500;Linoleic Acid;D019787
D10.251.355.343.500.500;Linoleic Acid;D019787
D09.254.229.500;Fluorodeoxyglucose F18;D019788
D02.092.877.787.500;Tetraethylammonium;D019789
D02.675.276.787.500;Tetraethylammonium;D019789
D02.078.370.472;Guanidine;D019791
D02.455.426.559.847.885.347.390;Fluorescein;D019793
D03.494.953.275.390;Fluorescein;D019793
D04.615.885.347.390;Fluorescein;D019793
D02.241.081.844.387.388.175;2,3-Diphosphoglycerate;D019794
D02.241.511.902.387.388.175;2,3-Diphosphoglycerate;D019794
D02.705.400.140.175;2,3-Diphosphoglycerate;D019794
D09.811.366.388.175;2,3-Diphosphoglycerate;D019794
D02.737.637.650.500.500;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;D019796
D10.251.355.255.100.637.025.650.500.500;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;D019796
D10.251.355.255.550.025.650.500.500;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;D019796
D23.469.050.175.725.720.720.500.500;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;D019796
D23.469.700.630.500;15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid;D019796
D02.078.370.510;3-Iodobenzylguanidine;D019797
D02.455.426.559.389.454.300;3-Iodobenzylguanidine;D019797
D02.455.526.581.496.300;3-Iodobenzylguanidine;D019797
D03.438.733.631.202.500;Neopterin;D019798
D08.211.090.500;Neopterin;D019798
D02.455.426.559.389.657.595;Phenol;D019800
D02.241.081.337.759.625;Succinic Acid;D019802
D12.644.456.448.500;Glutathione Disulfide;D019803
D02.241.223.100.050.300.500;Mesalamine;D019804
D02.241.223.100.300.595.100.540;Mesalamine;D019804
D02.241.511.390.595.100.540;Mesalamine;D019804
D02.455.426.559.389.127.020.452.750;Mesalamine;D019804
D02.455.426.559.389.127.281.595.100.540;Mesalamine;D019804
D02.455.426.559.389.657.410.595.100.540;Mesalamine;D019804
D12.125.072.050.875.485.050;alpha-Methyltyrosine;D019805
D03.383.129.578.150;Cromakalim;D019806
D03.438.150.455;Cromakalim;D019806
D03.830.219.455;Cromakalim;D019806
D02.241.081.018.487.500;Iodoacetic Acid;D019807
D02.455.526.581.247.500;Iodoacetic Acid;D019807
D02.455.426.559.389.185.475;Losartan;D019808
D03.383.129.308.507;Losartan;D019808
D03.383.129.617.467;Losartan;D019808
D12.776.097.835;Streptavidin;D019809
D01.625.100.750;Sodium Azide;D019810
D01.857.462;Sodium Azide;D019810
D01.625.075.525;Hydroxylamine;D019811
D09.698.373.425.500;Heparan Sulfate Proteoglycans;D019812
D09.698.735.400;Heparan Sulfate Proteoglycans;D019812
D12.776.395.650.350;Heparan Sulfate Proteoglycans;D019812
D02.442.600.400.200;1,2-Dimethylhydrazine;D019813
D10.251.640.630;Myristic Acid;D019814
D02.241.081.337.593.750;Oxalic Acid;D019815
D02.241.223.100.120;Benzoic Acid;D019817
D02.455.426.559.389.127.117;Benzoic Acid;D019817
D02.065.589.099.374.160;Clavulanic Acid;D019818
D04.075.080.875.099.221.374.160;Clavulanic Acid;D019818
D04.808.745.745.654.105;Budesonide;D019819
D03.132.960.938;Xanthine;D019820
D03.438.759.758.824.938;Xanthine;D019820
D02.455.426.559.847.638.400.900;Simvastatin;D019821
D04.615.638.400.900;Simvastatin;D019821
D06.472.699.327.935.492;beta-MSH;D019824
D06.472.699.327.935.531.750.075;beta-MSH;D019824
D06.472.699.631.525.600.492;beta-MSH;D019824
D06.472.699.631.525.600.531.750.075;beta-MSH;D019824
D12.644.400.400.935.492;beta-MSH;D019824
D12.644.400.400.935.531.750.075;beta-MSH;D019824
D12.644.400.460.075;beta-MSH;D019824
D12.644.548.365.935.492;beta-MSH;D019824
D12.644.548.365.935.531.750.075;beta-MSH;D019824
D12.644.548.691.525.690.492;beta-MSH;D019824
D12.644.548.691.525.690.531.750.075;beta-MSH;D019824
D12.776.641.650.405.935.492;beta-MSH;D019824
D12.776.641.650.405.935.531.750.075;beta-MSH;D019824
D12.776.641.650.460.075;beta-MSH;D019824
D06.472.699.327.935.524;gamma-MSH;D019825
D06.472.699.327.935.531.750.115;gamma-MSH;D019825
D06.472.699.631.525.600.524;gamma-MSH;D019825
D06.472.699.631.525.600.531.750.115;gamma-MSH;D019825
D12.644.400.400.935.524;gamma-MSH;D019825
D12.644.400.400.935.531.750.115;gamma-MSH;D019825
D12.644.400.460.115;gamma-MSH;D019825
D12.644.548.365.935.524;gamma-MSH;D019825
D12.644.548.365.935.531.750.115;gamma-MSH;D019825
D12.644.548.691.525.690.524;gamma-MSH;D019825
D12.644.548.691.525.690.531.750.115;gamma-MSH;D019825
D12.776.641.650.405.935.524;gamma-MSH;D019825
D12.776.641.650.405.935.531.750.115;gamma-MSH;D019825
D12.776.641.650.460.115;gamma-MSH;D019825
D04.808.105.225.130;Cholic Acid;D019826
D04.808.221.430.130;Cholic Acid;D019826
D03.383.725.506;Nevirapine;D019829
D03.438.759.590.138.025;Adenosine-5'-(N-ethylcarboxamide);D019830
D13.570.583.138.025;Adenosine-5'-(N-ethylcarboxamide);D019830
D13.570.800.096.250;Adenosine-5'-(N-ethylcarboxamide);D019830
D12.776.157.530.450.162.442;Sodium-Calcium Exchanger;D019831
D12.776.543.585.450.162.442;Sodium-Calcium Exchanger;D019831
D02.145.074.722.900.700.550;N-Methylscopolamine;D019832
D03.132.889.848.661.550;N-Methylscopolamine;D019832
D03.605.869.900.700.550;N-Methylscopolamine;D019832
D04.075.080.875.099.722.900.700.550;N-Methylscopolamine;D019832
D03.438.150.266.450.400.375;Genistein;D019833
D03.830.219.266.450.400.375;Genistein;D019833
D12.644.400.235;FMRFamide;D019835
D12.776.641.650.235;FMRFamide;D019835
E01.370.378.625;Preimplantation Diagnosis;D019836
D12.776.157.530.400.150.800;Ryanodine Receptor Calcium Release Channel;D019837
D12.776.210.500.800;Ryanodine Receptor Calcium Release Channel;D019837
D12.776.543.550.425.150.800;Ryanodine Receptor Calcium Release Channel;D019837
D12.776.543.585.400.150.800;Ryanodine Receptor Calcium Release Channel;D019837
C26.700;Neck Injuries;D019838
D02.033.755.615;2-Propanol;D019840
E01.370.350.700.715.250;Defecography;D019841
A07.231.114.248;Ciliary Arteries;D019842
D12.776.090;Archaeal Proteins;D019843
D12.776.124.486.485.114.089;Antibodies, Archaeal;D019844
D12.776.124.790.651.114.107;Antibodies, Archaeal;D019844
D12.776.377.715.548.114.107;Antibodies, Archaeal;D019844
D23.050.140;Antigens, Archaeal;D019845
C10.114.750.100.500;Miller Fisher Syndrome;D019846
C10.228.140.252.500;Miller Fisher Syndrome;D019846
C10.292.562.350;Miller Fisher Syndrome;D019846
C10.314.750.450.500;Miller Fisher Syndrome;D019846
C10.668.829.350.500;Miller Fisher Syndrome;D019846
C10.668.829.800.750.300.500;Miller Fisher Syndrome;D019846
C11.590.312;Miller Fisher Syndrome;D019846
C20.111.258.750.400.500;Miller Fisher Syndrome;D019846
A11.284.187.167;Chromosomes, Archaeal;D019847
G05.360.162.167;Chromosomes, Archaeal;D019847
G05.355.315.290;Gene Expression Regulation, Archaeal;D019848
G05.355.865;Sex Determination Processes;D019849
G07.700.320.500.325.377.812;Sex Determination Processes;D019849
G07.700.320.750.437;Sex Determination Processes;D019849
G08.686.785.880.437;Sex Determination Processes;D019849
D02.033.415.500;Heptanol;D019850
D10.289.500;Heptanol;D019850
C15.378.925;Thrombophilia;D019851
D08.811.913.696.620.200;Diacylglycerol Kinase;D019852
D08.811.913.555.500.800.650;O(6)-Methylguanine-DNA Methyltransferase;D019853
D02.033.455.250.268;Ethylene Glycol;D019855
D02.033.100.291.375;Ethanolamine;D019856
D02.033.375.291.375;Ethanolamine;D019856
D02.092.063.291.375;Ethanolamine;D019856
E04.555.120.690;Osteogenesis, Distraction;D019857
A06.390;Enteroendocrine Cells;D019858
A11.382.625;Enteroendocrine Cells;D019858
A11.436.294;Enteroendocrine Cells;D019858
D08.811.913.696.620.682.725.400.075;Proto-Oncogene Proteins c-met;D019859
D12.776.543.750.060.186;Proto-Oncogene Proteins c-met;D019859
D12.776.543.750.750.400.100;Proto-Oncogene Proteins c-met;D019859
D12.776.624.664.700.186;Proto-Oncogene Proteins c-met;D019859
D08.811.913.696.620.682.725.800.315;Lymphocyte Specific Protein Tyrosine Kinase p56(lck);D019860
D12.776.624.664.700.128;Lymphocyte Specific Protein Tyrosine Kinase p56(lck);D019860
A06.224.365;Enterochromaffin-like Cells;D019861
A06.390.043;Enterochromaffin-like Cells;D019861
A11.382.625.047;Enterochromaffin-like Cells;D019861
A11.436.294.047;Enterochromaffin-like Cells;D019861
B01.650.940.800.575.100.975;Zingiberales;D019862
A03.556.875.875.440.300;Gastrin-Secreting Cells;D019863
A06.390.065;Gastrin-Secreting Cells;D019863
A10.615.550.291.300;Gastrin-Secreting Cells;D019863
A11.382.625.055;Gastrin-Secreting Cells;D019863
A11.436.294.055;Gastrin-Secreting Cells;D019863
A03.556.875.875.440.854;Somatostatin-Secreting Cells;D019864
A03.734.414.793;Somatostatin-Secreting Cells;D019864
A06.390.825;Somatostatin-Secreting Cells;D019864
A06.407.414.793;Somatostatin-Secreting Cells;D019864
A10.615.550.291.825;Somatostatin-Secreting Cells;D019864
A11.382.625.950;Somatostatin-Secreting Cells;D019864
A11.436.294.950;Somatostatin-Secreting Cells;D019864
C08.381.483.156;Anti-Glomerular Basement Membrane Disease;D019867
C12.777.419.570.363.304;Anti-Glomerular Basement Membrane Disease;D019867
C13.351.968.419.570.363.304;Anti-Glomerular Basement Membrane Disease;D019867
C20.111.190;Anti-Glomerular Basement Membrane Disease;D019867
D08.811.913.696.620.475;Kanamycin Kinase;D019868
D08.811.913.696.620.500;Phosphatidylinositol 3-Kinases;D019869
D08.811.913.696.620.550;1-Phosphatidylinositol 4-Kinase;D019870
C16.131.831.150;Dyskeratosis Congenita;D019871
C16.320.322.108;Dyskeratosis Congenita;D019871
C16.320.850.235;Dyskeratosis Congenita;D019871
C17.800.804.150;Dyskeratosis Congenita;D019871
C17.800.827.235;Dyskeratosis Congenita;D019871
A03.556.875.875.440.150;Chief Cells, Gastric;D019872
A10.615.550.291.150;Chief Cells, Gastric;D019872
A11.436.150;Chief Cells, Gastric;D019872
C20.683.780.640.700;Schnitzler Syndrome;D019873
D08.811.913.555;One-Carbon Group Transferases;D019875
J01.637.825;Sports Equipment;D019876
D08.811.913.555.400;Hydroxymethyl and Formyl Transferases;D019877
D08.811.913.555.275;Carboxyl and Carbamoyl Transferases;D019878
A03.556.124.369.700;Paneth Cells;D019879
A10.615.550.444.700;Paneth Cells;D019879
A11.436.700;Paneth Cells;D019879
D08.811.913.200;Aldehyde-Ketone Transferases;D019880
D08.811.913.050.200;Aminoacyltransferases;D019881
E04.540.104;Blepharoplasty;D019882
E04.680.275.090;Blepharoplasty;D019882
D08.811.913.225;Alkyl and Aryl Transferases;D019883
D08.811.913.477;Nitrogenous Group Transferases;D019884
D08.811.913.817;Sulfur Group Transferases;D019885
D06.472.317.410;Gastrin-Releasing Peptide;D019886
D12.644.400.315;Gastrin-Releasing Peptide;D019886
D12.776.641.650.315;Gastrin-Releasing Peptide;D019886
D12.776.503.499.625;Peanut Agglutinin;D019887
D12.776.765.678.625;Peanut Agglutinin;D019887
D03.438.531.520;Nelfinavir;D019888
G04.299.151.825.597;Leukopoiesis;D019891
G09.188.124.544.597;Leukopoiesis;D019891
D08.811.913.696.620.682.700.300;eIF-2 Kinase;D019892
D12.644.360.275;eIF-2 Kinase;D019892
D12.776.476.275;eIF-2 Kinase;D019892
D08.811.913.696.620.682.700.862;Ribosomal Protein S6 Kinases;D019893
D12.644.360.600;Ribosomal Protein S6 Kinases;D019893
D12.776.476.600;Ribosomal Protein S6 Kinases;D019893
D06.472.317.662;Peptide YY;D019894
D06.472.699.595;Peptide YY;D019894
D12.644.548.595;Peptide YY;D019894
D08.811.739.500.667;Transposases;D019895
D08.811.913.696.445.825;Transposases;D019895
C06.552.074;alpha 1-Antitrypsin Deficiency;D019896
C08.381.112;alpha 1-Antitrypsin Deficiency;D019896
C16.320.060;alpha 1-Antitrypsin Deficiency;D019896
C23.550.325.500.500;alpha 1-Antitrypsin Deficiency;D019896
A11.284.295.680;Periplasm;D019897
G04.299.122.100;Autocrine Communication;D019898
G04.299.122.600;Paracrine Communication;D019899
D03.383.773.170;3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer;D019900
G02.111.570.080.689.450;Locus Control Region;D019901
G05.360.080.689.450;Locus Control Region;D019901
G05.360.340.024.380.249;Locus Control Region;D019901
A11.329.171;Chondrocytes;D019902
D02.241.081.069.800.550.500;Polymethyl Methacrylate;D019904
D05.750.716.822.111.650.605.500;Polymethyl Methacrylate;D019904
D25.720.716.822.111.650.605.500;Polymethyl Methacrylate;D019904
J01.637.051.720.716.822.111.650.605.500;Polymethyl Methacrylate;D019904
D02.033.160.100;Benzyl Alcohol;D019905
D02.455.426.559.389.140.200.100;Benzyl Alcohol;D019905
E05.196.867.519.550;Nuclear Magnetic Resonance, Biomolecular;D019906
B03.510.024.049.525.500.720.325;Mycobacterium fortuitum;D019907
B03.510.460.400.410.552.552.720.325;Mycobacterium fortuitum;D019907
D08.811.913.696.620.682.700.559.842.500;Proto-Oncogene Proteins c-raf;D019908
D12.644.360.400.842.500;Proto-Oncogene Proteins c-raf;D019908
D12.776.476.400.842.500;Proto-Oncogene Proteins c-raf;D019908
D12.776.624.664.700.204.500;Proto-Oncogene Proteins c-raf;D019908
B03.510.024.049.525.500.720.400;Mycobacterium kansasii;D019909
B03.510.460.400.410.552.552.720.400;Mycobacterium kansasii;D019909
B03.510.024.049.525.500.720.500;Mycobacterium marinum;D019910
B03.510.460.400.410.552.552.720.500;Mycobacterium marinum;D019910
B03.510.024.049.525.500.720.700;Mycobacterium ulcerans;D019911
B03.510.460.400.410.552.552.720.700;Mycobacterium ulcerans;D019911
B03.510.024.049.525.500.720.950;Mycobacterium xenopi;D019912
B03.510.460.400.410.552.552.720.950;Mycobacterium xenopi;D019912
D12.644.770.610;Nuclear Localization Signals;D019913
G02.111.570.060.670.610;Nuclear Localization Signals;D019913
D08.811.913.696.445.308.300.875;Taq Polymerase;D019914
D08.811.913.696.445.735.270.375;DNA Primase;D019915
D08.811.913.696.445.184;Choline-Phosphate Cytidylyltransferase;D019916
E04.100.814.868.500;Blood Vessel Prosthesis Implantation;D019917
E04.650.200;Blood Vessel Prosthesis Implantation;D019917
E04.100.376.485;Heart Valve Prosthesis Implantation;D019918
E04.650.410;Heart Valve Prosthesis Implantation;D019918
E04.928.220.410;Heart Valve Prosthesis Implantation;D019918
E04.650;Prosthesis Implantation;D019919
D27.720.470.410.080.600;Photoaffinity Labels;D019920
E05.393.525.085;Biotinylation;D019921
G02.111.087.157;Biotinylation;D019921
G02.149.115.157;Biotinylation;D019921
G03.495.233;Biotinylation;D019921
D12.776.395.550.400;GAP-43 Protein;D019922
D12.776.543.550.400;GAP-43 Protein;D019922
D12.776.641.400;GAP-43 Protein;D019922
E04.540.825.249.352;Capsulorhexis;D019923
E05.820.240;Embryo Disposition;D019924
D12.644.360.262.100;Cyclin A;D019925
D12.776.167.218.100;Cyclin A;D019925
D12.776.476.262.100;Cyclin A;D019925
D12.644.360.262.120;Cyclin B;D019926
D12.776.167.218.120;Cyclin B;D019926
D12.776.476.262.120;Cyclin B;D019926
D12.644.360.262.180;Cyclin E;D019927
D12.776.167.218.180;Cyclin E;D019927
D12.776.476.262.180;Cyclin E;D019927
E02.218.565.210;Breast Implantation;D019928
E04.650.210;Breast Implantation;D019928
E04.680.500.210;Breast Implantation;D019928
E04.580.450.220;Cochlear Implantation;D019929
E04.650.220;Cochlear Implantation;D019929
E04.545.510.500;Mandibular Prosthesis Implantation;D019930
E04.650.510.500;Mandibular Prosthesis Implantation;D019930
E06.645.510.500;Mandibular Prosthesis Implantation;D019930
E04.545.510;Maxillofacial Prosthesis Implantation;D019931
E04.650.510;Maxillofacial Prosthesis Implantation;D019931
E06.645.510;Maxillofacial Prosthesis Implantation;D019931
E04.580.450.600;Ossicular Replacement;D019933
E04.650.600;Ossicular Replacement;D019933
E01.370.225.625.115.320;International Normalized Ratio;D019934
E05.200.625.115.320;International Normalized Ratio;D019934
E04.650.620;Penile Implantation;D019935
E04.950.774.860.620;Penile Implantation;D019935
J02.500.456.500;Probiotics;D019936
E01.370;Diagnostic Techniques and Procedures;D019937
D12.644.360.262.150.100;Cyclin D1;D019938
D12.776.167.218.150.100;Cyclin D1;D019938
D12.776.476.262.150.100;Cyclin D1;D019938
D12.776.624.664.700.100;Cyclin D1;D019938
G05.360.340.024.340.375.500.791.148;Genes, bcl-1;D019940
D12.644.360.225.200;Cyclin-Dependent Kinase Inhibitor p16;D019941
D12.776.167.187.200;Cyclin-Dependent Kinase Inhibitor p16;D019941
D12.776.476.225.200;Cyclin-Dependent Kinase Inhibitor p16;D019941
D12.776.624.776.355.200;Cyclin-Dependent Kinase Inhibitor p16;D019941
G05.360.340.024.340.375.249.375;Genes, p16;D019942
G05.360.340.024.340.415.400.375;Genes, p16;D019942
E05.393.420.601.035;Amino Acid Substitution;D019943
G05.355.600.109;Amino Acid Substitution;D019943
D02.033.455.706.725;Propylene Glycol;D019946
D12.776.543.750.705.852.420.400;Receptors, Interleukin-6;D019947
D12.776.543.750.705.852.420.360;Receptors, Interleukin-4;D019948
D08.811.913.696.620.682.700.567.342.500;Mitogen-Activated Protein Kinase 1;D019950
D08.811.913.696.620.682.700.646.750.249.500;Mitogen-Activated Protein Kinase 1;D019950
D12.644.360.450.169.500;Mitogen-Activated Protein Kinase 1;D019950
D12.776.476.450.169.500;Mitogen-Activated Protein Kinase 1;D019950
D08.811.913.696.445.308.300.112;DNA Polymerase beta;D019951
F03.550;Mental Disorders Diagnosed in Childhood;D019952
C10.597.606;Neurobehavioral Manifestations;D019954
C23.888.592.604;Neurobehavioral Manifestations;D019954
F01.700;Neurobehavioral Manifestations;D019954
F03.550.150.300;Conduct Disorder;D019955
F03.550.787;Stereotypic Movement Disorder;D019956
F03.550.650;Motor Skills Disorders;D019957
F03.550.150;Attention Deficit and Disruptive Behavior Disorders;D019958
F03.550.400;Feeding and Eating Disorders of Childhood;D019959
F03.550.375;Elimination Disorders;D019960
F03.550.750;Reactive Attachment Disorder;D019962
E01.370.225.124;Clinical Chemistry Tests;D019963
E05.200.124;Clinical Chemistry Tests;D019963
F03.600;Mood Disorders;D019964
F03.087;Delirium, Dementia, Amnestic, Cognitive Disorders;D019965
C25;Substance-Related Disorders;D019966
F03.900;Substance-Related Disorders;D019966
F03.700;Schizophrenia and Disorders with Psychotic Features;D019967
F03.800;Sexual and Gender Disorders;D019968
C25.225;Amphetamine-Related Disorders;D019969
F03.900.225;Amphetamine-Related Disorders;D019969
C25.300;Cocaine-Related Disorders;D019970
F03.900.300;Cocaine-Related Disorders;D019970
C25.100;Alcohol-Related Disorders;D019973
F03.900.100;Alcohol-Related Disorders;D019973
B01.050.150.900.649.801.400.112.400.600;Pan paniscus;D019974
E05.393.240;Cloning, Organism;D019976
E05.820.180;Cloning, Organism;D019976
D02.065.589.099.374.160.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D02.065.589.099.750.750.050.050.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D02.886.108.750.750.050.050.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D03.438.260.825.750.050.050.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D03.605.084.737.750.050.050.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D04.075.080.875.099.221.374.160.060;Amoxicillin-Potassium Clavulanate Combination;D019980
D04.075.080.875.099.221.750.750.050.050.500;Amoxicillin-Potassium Clavulanate Combination;D019980
J01.576.489;Health Care Sector;D019981
N03.219.650;Health Care Sector;D019981
N03.349.380.710;Organizational Case Studies;D019982
N05.715.360.455;Organizational Case Studies;D019982
N04.761.337;Guideline Adherence;D019983
N05.715.360.395;Guideline Adherence;D019983
N04.761.789;Quality Indicators, Health Care;D019984
N04.452.500.150;Benchmarking;D019985
N04.761.685.150;Benchmarking;D019985
N04.761.700.150;Benchmarking;D019985
N05.700.150;Benchmarking;D019985
N05.715.360.650.150;Benchmarking;D019985
M01.150.400;Hearing Impaired Persons;D019986
M01.150.850;Visually Impaired Persons;D019987
M01.150.200;Disabled Children;D019988
M01.150.600;Mentally Disabled Persons;D019989
E02.760.731;Perioperative Care;D019990
E04.604;Perioperative Care;D019990
N02.421.585.722;Perioperative Care;D019990
V02.300;Database;D019991
L01.470.750;Databases as Topic;D019992
L01.700.508.300.188;Databases as Topic;D019992
D27.720.470;Laboratory Chemicals;D019995
D08.811.399.894;Racemases and Epimerases;D019998
D26.255.775;Pharmaceutical Solutions;D019999
D26.776.708;Pharmaceutical Solutions;D019999
D27.720.280.775;Pharmaceutical Solutions;D019999
L01.700.508.300.190;Decision Support Systems, Clinical;D020000
D02.033.415.110.175;1-Butanol;D020001
D10.289.110.175;1-Butanol;D020001
D02.033.415.110.855;tert-Butyl Alcohol;D020002
D10.289.110.855;tert-Butyl Alcohol;D020002
D02.033.415.600.600;1-Octanol;D020003
D10.289.600.610;1-Octanol;D020003
D02.033.755;Propanols;D020005
E07.695.340;Implants, Experimental;D020007
D03.383.606.350;Delavirdine;D020008
D03.438.473.250;Delavirdine;D020008
F01.145.802.975.400;Heterosexuality;D020010
G08.686.867.400;Heterosexuality;D020010
D27.505.696.706;Protective Agents;D020011
D27.720.799;Protective Agents;D020011
G02.111.087.800.800.100;Calcium Signaling;D020013
G02.149.115.800.800.100;Calcium Signaling;D020013
G03.495.166.500.100;Calcium Signaling;D020013
G04.299.880.800.100;Calcium Signaling;D020013
A11.251.210.190.510;K562 Cells;D020014
A11.251.860.180.510;K562 Cells;D020014
A11.443.240.497.480;K562 Cells;D020014
C15.378.100.100.037;Activated Protein C Resistance;D020016
C15.378.100.141.036;Activated Protein C Resistance;D020016
C15.378.925.050;Activated Protein C Resistance;D020016
C16.320.099.037;Activated Protein C Resistance;D020016
F03.800.800;Sexual Dysfunctions, Psychological;D020018
C03.105.250.550;Neurocysticercosis;D020019
C03.335.190.902.185.550;Neurocysticercosis;D020019
C10.228.228.205.250.550;Neurocysticercosis;D020019
C23.550.291.687.500;Genetic Predisposition to Disease;D020022
G05.380.355;Genetic Predisposition to Disease;D020022
D06.347.565;Leukotriene Antagonists;D020024
D27.505.696.399.450.565;Leukotriene Antagonists;D020024
D27.888.569.100.675;Peroxisome Proliferators;D020025
B02.200.825.800.650.300;Pyrococcus furiosus;D020027
G02.111.087.620.500;Base Pairing;D020029
G02.111.570.790.486.100;Base Pairing;D020029
G02.149.115.620.500;Base Pairing;D020029
G05.360.580.100;Base Pairing;D020029
D27.505.519.656;Nitric Oxide Donors;D020030
D27.505.954.411.590;Nitric Oxide Donors;D020030
C02.256.466.313;Epstein-Barr Virus Infections;D020031
C02.928.313;Epstein-Barr Virus Infections;D020031
C04.619.935.313;Epstein-Barr Virus Infections;D020031
C04.925.313;Epstein-Barr Virus Infections;D020031
D02.455.426.559.389.150.795;Tyrphostins;D020032
D02.626.886;Tyrphostins;D020032
D03.438.857.885;Tyrphostins;D020032
D12.776.800;Protein Isoforms;D020033
D02.715.650.700.755;Silicone Gels;D020034
D05.750.900.850.905;Silicone Gels;D020034
D25.720.900.850.905;Silicone Gels;D020034
J01.637.051.720.900.850.905;Silicone Gels;D020034
D08.811.255;Holoenzymes;D020035
B01.300.107.650;Onygenales;D020036
B01.300.107.800;Sordariales;D020037
D13.444.735.790.552.968;RNA, Spliced Leader;D020038
G02.111.087.750.700.750;Trans-Splicing;D020040
G02.149.115.750.700.750;Trans-Splicing;D020040
G03.495.839.700.750;Trans-Splicing;D020040
G05.355.315.700.700.750;Trans-Splicing;D020040
C15.604.315.300;Histiocytic Necrotizing Lymphadenitis;D020042
G05.360.340.024.340.270;Genes, Essential;D020043
B01.043.214.600;Pfiesteria piscicida;D020045
C06.405.469.860.810;Rectocele;D020047
B01.050.500.131.617.140.100;Blattellidae;D020048
B01.050.500.131.617.485;Isoptera;D020049
B01.050.500.131.617.590;Mantodea;D020050
D08.811.277.352.827.070.060;N-Acetylgalactosamine-4-Sulfatase;D020051
D08.811.277.352.827.180.175.060;N-Acetylgalactosamine-4-Sulfatase;D020051
D02.455.426.559.389.150.750.800;Styrene;D020058
D08.811.277.656.074.500.185;Cathepsin E;D020059
D08.811.277.656.224.250;Cathepsin E;D020059
D08.811.277.656.300.048.185;Cathepsin E;D020059
B01.050.500.131.617.690.060.730;Phthirus;D020061
B01.050.500.131.617.412.420;Heteroptera;D020062
B01.050.500.131.617.412.420.150;Cimicidae;D020063
B01.050.500.131.617.412.420.700;Reduviidae;D020064
C06.552.455;Hepatopulmonary Syndrome;D020065
C08.381.385;Hepatopulmonary Syndrome;D020065
D12.776.820.500;Merozoite Surface Protein 1;D020066
D23.050.293.500;Merozoite Surface Protein 1;D020066
B01.300.107.795.990;Zygosaccharomyces;D020068
C05.550.091.700;Shoulder Pain;D020069
C23.888.646.130.700;Shoulder Pain;D020069
C23.888.646.793;Shoulder Pain;D020069
G08.686.785.760.769.326.100;Cervical Ripening;D020070
G02.111.570.080.708.330;Interspersed Repetitive Sequences;D020071
G05.360.080.708.330;Interspersed Repetitive Sequences;D020071
G05.360.340.024.425;Interspersed Repetitive Sequences;D020071
B01.300.179.120;Polyporales;D020072
G08.686.340;Gravidity;D020073
G08.686.785.760.769.213;Gravidity;D020073
N06.850.490.812.250;Gravidity;D020073
B01.300.179.100.515;Lentinula;D020074
B01.300.179.120.760.649;Phanerochaete;D020075
B01.300.179.100.650;Pleurotus;D020076
B04.820.650.250;Endogenous Retroviruses;D020077
B04.909.574.807.250;Endogenous Retroviruses;D020077
B04.909.777.731.250;Endogenous Retroviruses;D020077
G02.111.570.080.708.330.800.175;Endogenous Retroviruses;D020077
G05.360.080.708.330.800.175;Endogenous Retroviruses;D020077
G05.360.340.024.425.800.175;Endogenous Retroviruses;D020077
C10.597.609;Neurogenic Inflammation;D020078
C23.550.470.448;Neurogenic Inflammation;D020078
G02.111.570.080.708.850;Terminal Repeat Sequences;D020079
G05.360.080.708.850;Terminal Repeat Sequences;D020079
G02.111.570.080.708.800;Tandem Repeat Sequences;D020080
G05.360.080.708.800;Tandem Repeat Sequences;D020080
G05.360.340.024.850;Tandem Repeat Sequences;D020080
B01.300.107.715;Phyllachorales;D020081
B01.300.107.575;Magnaporthe;D020082
C05.116.099.708.025;Acquired Hyperostosis Syndrome;D020083
G02.111.570.080.708.330.800.400;Long Interspersed Nucleotide Elements;D020084
G05.360.080.708.330.800.400;Long Interspersed Nucleotide Elements;D020084
G05.360.340.024.425.800.400;Long Interspersed Nucleotide Elements;D020084
B01.300.665.600;Neocallimastigales;D020085
G02.111.570.080.708.330.800.800;Short Interspersed Nucleotide Elements;D020086
G05.360.080.708.330.800.800;Short Interspersed Nucleotide Elements;D020086
G05.360.340.024.425.800.800;Short Interspersed Nucleotide Elements;D020086
G02.111.570.080.708.330.800.800.050;Alu Elements;D020087
G05.360.080.708.330.800.800.050;Alu Elements;D020087
G05.360.340.024.425.800.800.050;Alu Elements;D020087
B01.300.665.600.600;Neocallimastix;D020088
B01.300.665.600.675;Piromyces;D020089
G04.299.134.220.220.625;Chromosome Segregation;D020090
G05.355.105.220.625;Chromosome Segregation;D020090
B01.300.300.300;Entomophthorales;D020091
B01.300.300.300.150;Conidiobolus;D020092
B01.300.300.500.150;Cunninghamella;D020093
B01.300.300.500.480;Mortierella;D020094
B01.300.300.500.030;Absidia;D020095
C01.703.980;Zygomycosis;D020096
D06.472.699.584.625;Natriuretic Peptide, Brain;D020097
D12.644.548.585.625;Natriuretic Peptide, Brain;D020097
D12.776.641.590;Natriuretic Peptide, Brain;D020097
D06.472.699.584.750;Natriuretic Peptide, C-Type;D020098
D12.644.548.585.750;Natriuretic Peptide, C-Type;D020098
D25.130.420;Coated Materials, Biocompatible;D020099
J01.637.051.130.420;Coated Materials, Biocompatible;D020099
D20.280.320.375;Hydrogels;D020100
D26.255.165.320.375;Hydrogels;D020100
G08.686.785.760.277.800.100;Acrosome Reaction;D020101
B03.510.024.049.525.500.720.662;Mycobacterium smegmatis;D020102
B03.510.460.400.410.552.552.720.662;Mycobacterium smegmatis;D020102
B01.300.300.500.795;Rhizomucor;D020103
D08.811.399.325.500.400;Immunophilins;D020104
D12.776.543.750.705.400;Immunophilins;D020104
D12.776.827.275;Immunophilins;D020104
D02.092.080.085.543;Milrinone;D020105
D03.383.725.050.085.543;Milrinone;D020105
D02.065.122.015;Acrylamide;D020106
D02.241.081.069.094.015;Acrylamide;D020106
D05.750.078.730.825.962;Troponin T;D020107
D12.776.210.500.910.962;Troponin T;D020107
D12.776.220.525.825.962;Troponin T;D020107
D02.583.575;Nicorandil;D020108
D03.066.515.530.498;Nicorandil;D020108
D03.383.725.547.530.498;Nicorandil;D020108
D03.438.079.080.070.200;Devazepide;D020109
D02.078.370.729;Pinacidil;D020110
D02.455.526.439.773.292.077;Chlorodiphenyl (54% Chlorine);D020111
D02.455.526.439.785.292.077;Chlorodiphenyl (54% Chlorine);D020111
D03.494.953.600.500;Rhodamine 123;D020112
D02.455.426.559.389.657.625.555;Phenolphthalein;D020113
B03.440.647.650.650.125;Rickettsia conorii;D020114
B03.660.050.765.650.650.180;Rickettsia conorii;D020114
D08.622.509.725;Pepsinogen C;D020115
D08.622.509.700;Pepsinogen A;D020116
D02.065.277.135;Cisapride;D020117
D02.241.223.100.050.500.700;Cisapride;D020117
D02.241.223.100.100.135;Cisapride;D020117
D02.241.223.100.200.374;Cisapride;D020117
D02.455.426.559.389.127.020.937.700;Cisapride;D020117
D02.455.426.559.389.127.085.135;Cisapride;D020117
D02.455.426.559.389.127.250.374;Cisapride;D020117
D03.383.621.135;Cisapride;D020117
B03.440.400.425.251.200.200;Cupriavidus necator;D020118
B03.660.075.077.200.200;Cupriavidus necator;D020118
D02.033.100.624.698.699.420;Iodocyanopindolol;D020120
D02.033.100.624.748.420;Iodocyanopindolol;D020120
D02.033.755.624.698.699.420;Iodocyanopindolol;D020120
D02.033.755.624.748.420;Iodocyanopindolol;D020120
D02.092.063.624.698.699.420;Iodocyanopindolol;D020120
D13.444.735.544.875.885;5' Untranslated Regions;D020121
D13.444.735.790.878.885;5' Untranslated Regions;D020121
G05.360.340.024.220.880.885;5' Untranslated Regions;D020121
G05.360.340.024.340.137.910.885;5' Untranslated Regions;D020121
D02.389.338.825;tert-Butylhydroperoxide;D020122
D02.737.825;tert-Butylhydroperoxide;D020122
D02.540.505.760;Sirolimus;D020123
B03.440.425.410.750;Thermotoga maritima;D020124
G05.365.590.650;Mutation, Missense;D020125
D02.540.505.100;Brefeldin A;D020126
G16.757;Recovery of Function;D020127
E05.940.350;Inhibitory Concentration 50;D020128
G07.690.420;Inhibitory Concentration 50;D020128
A11.284.430.214.190.875.080;Bacterial Chromatophores;D020130
A20.374;Bacterial Chromatophores;D020130
G05.360.340.024.340.250;Genes, Duplicate;D020131
C23.550.291.687.500.500;Anticipation, Genetic;D020132
G05.420.040;Anticipation, Genetic;D020132
E05.393.620.500.725;Reverse Transcriptase Polymerase Chain Reaction;D020133
G02.111.570.120.704;Catalytic Domain;D020134
G02.111.570.790.709.610.189;Catalytic Domain;D020134
D13.695.578.424.550;Peptide Nucleic Acids;D020135
D02.033.455.250.700.485;Hydrogel;D020136
D05.750.741.485;Hydrogel;D020136
D25.720.741.485;Hydrogel;D020136
D26.255.165.320.375.375;Hydrogel;D020136
J01.637.051.720.741.485;Hydrogel;D020136
G05.365.590.060;Base Pair Mismatch;D020137
C16.320.565.100.480;Hyperhomocysteinemia;D020138
C18.452.603.378;Hyperhomocysteinemia;D020138
C18.452.648.100.480;Hyperhomocysteinemia;D020138
C18.654.521.500.133.699.418;Hyperhomocysteinemia;D020138
C05.660.417;Gastroschisis;D020139
C16.131.621.417;Gastroschisis;D020139
C23.300.707.374.500;Gastroschisis;D020139
C10.228.140.163.100.435;Lysosomal Storage Diseases, Nervous System;D020140
C16.320.565.189.435;Lysosomal Storage Diseases, Nervous System;D020140
C16.320.565.595.554;Lysosomal Storage Diseases, Nervous System;D020140
C18.452.132.100.435;Lysosomal Storage Diseases, Nervous System;D020140
C18.452.648.189.435;Lysosomal Storage Diseases, Nervous System;D020140
C18.452.648.595.554;Lysosomal Storage Diseases, Nervous System;D020140
C14.907.454;Hemostatic Disorders;D020141
C15.378.463.515;Hemostatic Disorders;D020141
C10.228.140.163.100.435.825.300.300;Gangliosidoses, GM2;D020143
C16.320.565.189.435.825.300.300;Gangliosidoses, GM2;D020143
C16.320.565.398.641.803.350.300;Gangliosidoses, GM2;D020143
C16.320.565.595.554.825.300.300;Gangliosidoses, GM2;D020143
C18.452.132.100.435.825.300.300;Gangliosidoses, GM2;D020143
C18.452.584.687.803.350.300;Gangliosidoses, GM2;D020143
C18.452.648.189.435.825.300.300;Gangliosidoses, GM2;D020143
C18.452.648.398.641.803.350.300;Gangliosidoses, GM2;D020143
C18.452.648.595.554.825.300.300;Gangliosidoses, GM2;D020143
C10.228.140.079.127;Basal Ganglia Cerebrovascular Disease;D020144
C10.228.140.300.100;Basal Ganglia Cerebrovascular Disease;D020144
C14.907.253.061;Basal Ganglia Cerebrovascular Disease;D020144
C10.228.140.079.127.500;Basal Ganglia Hemorrhage;D020145
C10.228.140.300.100.200;Basal Ganglia Hemorrhage;D020145
C10.228.140.300.535.200.150;Basal Ganglia Hemorrhage;D020145
C14.907.253.061.200;Basal Ganglia Hemorrhage;D020145
C14.907.253.573.200.150;Basal Ganglia Hemorrhage;D020145
C23.550.414.913.100.200;Basal Ganglia Hemorrhage;D020145
C10.228.140.079.127.500.500;Putaminal Hemorrhage;D020146
C10.228.140.300.100.200.500;Putaminal Hemorrhage;D020146
C10.228.140.300.535.200.150.500;Putaminal Hemorrhage;D020146
C14.907.253.061.200.500;Putaminal Hemorrhage;D020146
C14.907.253.573.200.150.500;Putaminal Hemorrhage;D020146
C23.550.414.913.100.200.500;Putaminal Hemorrhage;D020146
C15.378.100.141;Coagulation Protein Disorders;D020147
D02.241.081.114.750;Butyric Acid;D020148
D10.251.400.143.500;Butyric Acid;D020148
C10.720.475.500;Manganese Poisoning;D020149
C25.723.618;Manganese Poisoning;D020149
C10.228.140.079.294;Chorea Gravidarum;D020150
C10.228.662.262.249.500;Chorea Gravidarum;D020150
C13.703.141;Chorea Gravidarum;D020150
C15.378.100.100.690;Protein C Deficiency;D020151
C15.378.147.880;Protein C Deficiency;D020151
C15.378.925.795;Protein C Deficiency;D020151
C16.320.099.690;Protein C Deficiency;D020151
C15.378.100.100.075;Antithrombin III Deficiency;D020152
C15.378.147.150;Antithrombin III Deficiency;D020152
C15.378.925.075;Antithrombin III Deficiency;D020152
C16.320.099.075;Antithrombin III Deficiency;D020152
D02.241.081.114.937.349;3-Hydroxybutyric Acid;D020155
D02.241.511.400;3-Hydroxybutyric Acid;D020155
D02.522.585.087;3-Hydroxybutyric Acid;D020155
D10.251.400.143.781.500;3-Hydroxybutyric Acid;D020155
D02.241.223.100.300.595.608;Salicylic Acid;D020156
D02.241.511.390.595.608;Salicylic Acid;D020156
D02.455.426.559.389.127.281.595.608;Salicylic Acid;D020156
D02.455.426.559.389.657.410.595.608;Salicylic Acid;D020156
C16.320.565.151;Amino Acid Transport Disorders, Inborn;D020157
C18.452.648.151;Amino Acid Transport Disorders, Inborn;D020157
C10.228.140.163.100.375;Hyperglycinemia, Nonketotic;D020158
C16.320.565.100.477;Hyperglycinemia, Nonketotic;D020158
C16.320.565.189.375;Hyperglycinemia, Nonketotic;D020158
C18.452.132.100.375;Hyperglycinemia, Nonketotic;D020158
C18.452.648.100.477;Hyperglycinemia, Nonketotic;D020158
C18.452.648.189.375;Hyperglycinemia, Nonketotic;D020158
C10.228.140.163.100.937.374;Citrullinemia;D020159
C16.320.565.100.940.374;Citrullinemia;D020159
C16.320.565.189.937.374;Citrullinemia;D020159
C18.452.132.100.937.374;Citrullinemia;D020159
C18.452.648.100.940.374;Citrullinemia;D020159
C18.452.648.189.937.374;Citrullinemia;D020159
D02.241.223.100.120.500;Sodium Benzoate;D020160
D02.455.426.559.389.127.117.500;Sodium Benzoate;D020160
E05.393.183.620;Physical Chromosome Mapping;D020161
C10.228.140.163.100.937.500;Hyperargininemia;D020162
C16.320.565.100.940.500;Hyperargininemia;D020162
C16.320.565.189.937.500;Hyperargininemia;D020162
C18.452.132.100.937.437;Hyperargininemia;D020162
C18.452.648.100.940.437;Hyperargininemia;D020162
C18.452.648.189.937.437;Hyperargininemia;D020162
C10.228.140.163.100.937.750;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C16.320.322.828;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C16.320.565.100.940.750;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C16.320.565.189.937.750;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C18.452.132.100.937.500;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C18.452.648.100.940.500;Ornithine Carbamoyltransferase Deficiency Disease;D020163
C18.452.648.189.937.500;Ornithine Carbamoyltransferase Deficiency Disease;D020163
D27;Chemical Actions and Uses;D020164
C10.228.140.163.100.937.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C16.320.565.100.940.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C16.320.565.189.937.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C18.452.132.100.937.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C18.452.648.100.940.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C18.452.648.189.937.249;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C18.452.660.097;Carbamoyl-Phosphate Synthase I Deficiency Disease;D020165
C10.228.140.163.100.380;Hyperlysinemias;D020167
C16.320.565.100.544;Hyperlysinemias;D020167
C16.320.565.189.380;Hyperlysinemias;D020167
C18.452.132.100.380;Hyperlysinemias;D020167
C18.452.648.100.544;Hyperlysinemias;D020167
C18.452.648.189.380;Hyperlysinemias;D020167
D12.776.157.530.100.652.500;P-Glycoprotein;D020168
D12.776.157.530.450.074.500.500.750;P-Glycoprotein;D020168
D12.776.395.550.020.610.610;P-Glycoprotein;D020168
D12.776.543.550.192.610.610;P-Glycoprotein;D020168
D12.776.543.585.100.610.500;P-Glycoprotein;D020168
D12.776.543.585.450.074.500.500.750;P-Glycoprotein;D020168
D08.811.277.656.262.500.126;Caspases;D020169
D08.811.277.656.300.200.126;Caspases;D020169
D12.644.360.075.405;Caspases;D020169
D12.776.476.075.405;Caspases;D020169
D08.811.277.656.262.500.126.550.100;Caspase 1;D020170
D08.811.277.656.300.200.126.550.100;Caspase 1;D020170
D12.644.360.075.405.550.100;Caspase 1;D020170
D12.776.476.075.405.550.100;Caspase 1;D020170
B01.300.381.128;Botrytis;D020171
B01.300.381.950;Verticillium;D020172
C10.228.140.163.100.875;Tyrosinemias;D020176
C16.320.565.100.880;Tyrosinemias;D020176
C16.320.565.189.875;Tyrosinemias;D020176
C18.452.132.100.875;Tyrosinemias;D020176
C18.452.648.100.880;Tyrosinemias;D020176
C18.452.648.189.875;Tyrosinemias;D020176
C10.886.425.800.200.400;Hypersomnolence, Idiopathic;D020177
F03.870.400.800.200.400;Hypersomnolence, Idiopathic;D020177
C10.281.800;Sleep Disorders, Circadian Rhythm;D020178
C10.886.425.200;Sleep Disorders, Circadian Rhythm;D020178
C24.900;Sleep Disorders, Circadian Rhythm;D020178
F03.870.400.200;Sleep Disorders, Circadian Rhythm;D020178
C10.281.440;Jet Lag Syndrome;D020179
C10.886.425.200.500;Jet Lag Syndrome;D020179
F03.870.400.200.500;Jet Lag Syndrome;D020179
E05.393.661.250;Heteroduplex Analysis;D020180
C08.618.085.852.850;Sleep Apnea, Obstructive;D020181
C10.886.425.800.750.850;Sleep Apnea, Obstructive;D020181
C08.618.085.852.800;Sleep Apnea, Central;D020182
C10.886.425.800.750.800;Sleep Apnea, Central;D020182
C10.886.659.627;Nocturnal Paroxysmal Dystonia;D020183
F03.870.664.627;Nocturnal Paroxysmal Dystonia;D020183
C10.886.659.635.600;Night Terrors;D020184
F03.870.664.635.600;Night Terrors;D020184
C07.793.099.500;Sleep Bruxism;D020186
C10.886.659.637;Sleep Bruxism;D020186
F03.870.664.637;Sleep Bruxism;D020186
C10.886.659.633.700;REM Sleep Behavior Disorder;D020187
F03.870.664.633.700;REM Sleep Behavior Disorder;D020187
C10.886.659.633.800;Sleep Paralysis;D020188
F03.870.664.633.800;Sleep Paralysis;D020188
C10.886.425.800.600;Nocturnal Myoclonus Syndrome;D020189
C10.886.659.618;Nocturnal Myoclonus Syndrome;D020189
C10.228.140.490.250.670;Myoclonic Epilepsy, Juvenile;D020190
C10.228.140.490.250.650;Myoclonic Epilepsies, Progressive;D020191
C10.228.140.490.250.650.500;Lafora Disease;D020192
C10.574.500.529;Lafora Disease;D020192
C16.320.400.480;Lafora Disease;D020192
C10.228.140.490.250.650.900;Unverricht-Lundborg Syndrome;D020194
C10.574.500.875;Unverricht-Lundborg Syndrome;D020194
C16.320.400.940;Unverricht-Lundborg Syndrome;D020194
C10.228.140.490.450;Epilepsy, Reflex;D020195
C10.900;Trauma, Nervous System;D020196
C26.915;Trauma, Nervous System;D020196
C10.900.300.675;Head Injuries, Penetrating;D020197
C26.260.538;Head Injuries, Penetrating;D020197
C26.915.300.475;Head Injuries, Penetrating;D020197
C26.986.500;Head Injuries, Penetrating;D020197
C10.228.140.300.535.450;Intracranial Hemorrhage, Traumatic;D020198
C10.900.300.837;Intracranial Hemorrhage, Traumatic;D020198
C14.907.253.573.400;Intracranial Hemorrhage, Traumatic;D020198
C26.260.616;Intracranial Hemorrhage, Traumatic;D020198
C26.915.300.490;Intracranial Hemorrhage, Traumatic;D020198
C10.228.140.300.535.450.400.050;Hematoma, Subdural, Acute;D020199
C10.900.300.837.600.050;Hematoma, Subdural, Acute;D020199
C14.907.253.573.400.450.050;Hematoma, Subdural, Acute;D020199
C23.550.414.838.700.100;Hematoma, Subdural, Acute;D020199
C23.550.414.913.700.100;Hematoma, Subdural, Acute;D020199
C26.260.616.600.050;Hematoma, Subdural, Acute;D020199
C26.915.300.490.450.050;Hematoma, Subdural, Acute;D020199
C10.228.140.300.535.450.400.120;Hematoma, Subdural, Chronic;D020200
C10.900.300.837.600.120;Hematoma, Subdural, Chronic;D020200
C14.907.253.573.400.450.120;Hematoma, Subdural, Chronic;D020200
C23.550.414.838.700.200;Hematoma, Subdural, Chronic;D020200
C23.550.414.913.700.200;Hematoma, Subdural, Chronic;D020200
C26.260.616.600.120;Hematoma, Subdural, Chronic;D020200
C26.915.300.490.450.120;Hematoma, Subdural, Chronic;D020200
C10.228.140.199.275;Brain Hemorrhage, Traumatic;D020201
C10.228.140.300.535.450.200;Brain Hemorrhage, Traumatic;D020201
C10.900.300.087.187;Brain Hemorrhage, Traumatic;D020201
C10.900.300.837.150;Brain Hemorrhage, Traumatic;D020201
C14.907.253.573.400.150;Brain Hemorrhage, Traumatic;D020201
C26.260.118.175;Brain Hemorrhage, Traumatic;D020201
C26.915.300.200.175;Brain Hemorrhage, Traumatic;D020201
C26.915.300.490.150;Brain Hemorrhage, Traumatic;D020201
C10.228.140.199.275.300;Cerebral Hemorrhage, Traumatic;D020202
C10.228.140.300.535.200.200;Cerebral Hemorrhage, Traumatic;D020202
C10.228.140.300.535.450.200.750;Cerebral Hemorrhage, Traumatic;D020202
C10.900.300.087.187.300;Cerebral Hemorrhage, Traumatic;D020202
C10.900.300.837.150.650;Cerebral Hemorrhage, Traumatic;D020202
C14.907.253.573.200.200;Cerebral Hemorrhage, Traumatic;D020202
C14.907.253.573.400.150.300;Cerebral Hemorrhage, Traumatic;D020202
C26.260.118.175.300;Cerebral Hemorrhage, Traumatic;D020202
C26.915.300.200.175.300;Cerebral Hemorrhage, Traumatic;D020202
C26.915.300.490.150.300;Cerebral Hemorrhage, Traumatic;D020202
C10.228.140.199.275.200;Brain Stem Hemorrhage, Traumatic;D020203
C10.228.140.300.535.450.200.500;Brain Stem Hemorrhage, Traumatic;D020203
C10.900.300.087.187.200;Brain Stem Hemorrhage, Traumatic;D020203
C10.900.300.837.150.300;Brain Stem Hemorrhage, Traumatic;D020203
C14.907.253.573.400.150.200;Brain Stem Hemorrhage, Traumatic;D020203
C26.260.118.175.150;Brain Stem Hemorrhage, Traumatic;D020203
C26.915.300.200.175.200;Brain Stem Hemorrhage, Traumatic;D020203
C26.915.300.490.150.200;Brain Stem Hemorrhage, Traumatic;D020203
C10.900.300.918.300;Skull Fracture, Depressed;D020204
C26.260.836.300;Skull Fracture, Depressed;D020204
C26.404.750.890;Skull Fracture, Depressed;D020204
C26.915.300.745.350;Skull Fracture, Depressed;D020204
C10.900.300.918.150;Skull Fracture, Basilar;D020205
C26.260.836.150;Skull Fracture, Basilar;D020205
C26.404.750.821;Skull Fracture, Basilar;D020205
C26.915.300.745.300;Skull Fracture, Basilar;D020205
C10.228.140.300.535.450.650;Subarachnoid Hemorrhage, Traumatic;D020206
C10.228.140.300.535.800.700;Subarachnoid Hemorrhage, Traumatic;D020206
C10.900.300.837.800;Subarachnoid Hemorrhage, Traumatic;D020206
C14.907.253.535.600;Subarachnoid Hemorrhage, Traumatic;D020206
C14.907.253.573.400.700;Subarachnoid Hemorrhage, Traumatic;D020206
C14.907.253.573.800.700;Subarachnoid Hemorrhage, Traumatic;D020206
C26.260.616.800;Subarachnoid Hemorrhage, Traumatic;D020206
C26.915.300.490.700;Subarachnoid Hemorrhage, Traumatic;D020206
C10.597.606.358.800.200.200;Coma, Post-Head Injury;D020207
C10.900.300.175;Coma, Post-Head Injury;D020207
C26.260.222;Coma, Post-Head Injury;D020207
C26.915.300.350;Coma, Post-Head Injury;D020207
C10.228.140.140.127;Brain Injury, Chronic;D020208
C10.228.140.199.500;Brain Injury, Chronic;D020208
C10.900.300.087.250;Brain Injury, Chronic;D020208
C26.260.118.200;Brain Injury, Chronic;D020208
C26.915.300.200.200;Brain Injury, Chronic;D020208
C10.292.262;Cranial Nerve Injuries;D020209
C10.900.300.218;Cranial Nerve Injuries;D020209
C26.260.237;Cranial Nerve Injuries;D020209
C26.915.300.400;Cranial Nerve Injuries;D020209
C10.228.854.770.500;Central Cord Syndrome;D020210
C10.900.850.625;Central Cord Syndrome;D020210
C26.819.339;Central Cord Syndrome;D020210
C10.177.090;Autonomic Dysreflexia;D020211
C10.900.850.250;Autonomic Dysreflexia;D020211
C10.228.140.300.200.345;Carotid Artery Injuries;D020212
C10.228.140.300.350.500;Carotid Artery Injuries;D020212
C10.900.250.300;Carotid Artery Injuries;D020212
C14.907.253.123.345;Carotid Artery Injuries;D020212
C14.907.253.535.500;Carotid Artery Injuries;D020212
C26.915.200.200;Carotid Artery Injuries;D020212
C10.228.140.300.350;Cerebrovascular Trauma;D020214
C10.900.250;Cerebrovascular Trauma;D020214
C14.907.253.535;Cerebrovascular Trauma;D020214
C26.915.200;Cerebrovascular Trauma;D020214
C10.228.140.300.200.345.300;Carotid Artery, Internal, Dissection;D020215
C10.228.140.300.200.356;Carotid Artery, Internal, Dissection;D020215
C10.228.140.300.350.500.300;Carotid Artery, Internal, Dissection;D020215
C10.900.250.300.300;Carotid Artery, Internal, Dissection;D020215
C14.907.055.050.150;Carotid Artery, Internal, Dissection;D020215
C14.907.253.123.345.300;Carotid Artery, Internal, Dissection;D020215
C14.907.253.123.356;Carotid Artery, Internal, Dissection;D020215
C14.907.253.535.500.300;Carotid Artery, Internal, Dissection;D020215
C26.915.200.200.500;Carotid Artery, Internal, Dissection;D020215
C10.228.140.300.200.345.350;Carotid-Cavernous Sinus Fistula;D020216
C10.228.140.300.200.357;Carotid-Cavernous Sinus Fistula;D020216
C10.228.140.300.350.500.350;Carotid-Cavernous Sinus Fistula;D020216
C10.900.250.300.400;Carotid-Cavernous Sinus Fistula;D020216
C14.907.253.123.345.400;Carotid-Cavernous Sinus Fistula;D020216
C14.907.253.123.357;Carotid-Cavernous Sinus Fistula;D020216
C14.907.253.535.500.350;Carotid-Cavernous Sinus Fistula;D020216
C26.915.200.200.550;Carotid-Cavernous Sinus Fistula;D020216
C10.228.140.300.350.875;Vertebral Artery Dissection;D020217
C10.228.140.300.950;Vertebral Artery Dissection;D020217
C10.900.250.650;Vertebral Artery Dissection;D020217
C14.907.055.050.575;Vertebral Artery Dissection;D020217
C14.907.253.535.800;Vertebral Artery Dissection;D020217
C14.907.253.953;Vertebral Artery Dissection;D020217
C26.915.200.600;Vertebral Artery Dissection;D020217
G02.111.570.080.689.330.700;Response Elements;D020218
G02.111.570.080.689.675.700;Response Elements;D020218
G05.360.080.689.330.700;Response Elements;D020218
G05.360.080.689.675.700;Response Elements;D020218
G05.360.340.024.340.137.750.249.765;Response Elements;D020218
G05.360.340.024.340.137.750.680.765;Response Elements;D020218
G07.700.320.500.325.377.625.180;Chondrogenesis;D020219
G11.427.590.560.180;Chondrogenesis;D020219
C10.292.262.500;Facial Nerve Injuries;D020220
C10.292.300.500;Facial Nerve Injuries;D020220
C10.900.300.218.300;Facial Nerve Injuries;D020220
C26.260.237.325;Facial Nerve Injuries;D020220
C26.915.300.400.300;Facial Nerve Injuries;D020220
C10.292.262.750;Optic Nerve Injuries;D020221
C10.292.700.475;Optic Nerve Injuries;D020221
C10.900.300.218.550;Optic Nerve Injuries;D020221
C11.640.530;Optic Nerve Injuries;D020221
C26.260.237.650;Optic Nerve Injuries;D020221
C26.915.300.400.650;Optic Nerve Injuries;D020221
C10.292.150.100;Abducens Nerve Injury;D020222
C10.292.262.200;Abducens Nerve Injury;D020222
C10.900.300.218.150;Abducens Nerve Injury;D020222
C26.260.237.162;Abducens Nerve Injury;D020222
C26.915.300.400.100;Abducens Nerve Injury;D020222
E01.370.225.500.620.670.325.350.125;Chromosome Painting;D020223
E01.370.225.750.600.670.325.350.125;Chromosome Painting;D020223
E05.200.500.620.670.325.350.125;Chromosome Painting;D020223
E05.200.750.600.670.325.350.125;Chromosome Painting;D020223
E05.393.285.350.125;Chromosome Painting;D020223
E05.393.661.475.350.125;Chromosome Painting;D020223
G05.360.340.024.340.137.275;Expressed Sequence Tags;D020224
C10.228.140.300.525.425.500.750;Sagittal Sinus Thrombosis;D020225
C14.907.253.566.350.500.750;Sagittal Sinus Thrombosis;D020225
C14.907.355.590.213.350.500.750;Sagittal Sinus Thrombosis;D020225
C14.907.355.830.850.213.350.500.750;Sagittal Sinus Thrombosis;D020225
C10.228.140.300.525.425.500.375;Cavernous Sinus Thrombosis;D020226
C14.907.253.566.350.500.375;Cavernous Sinus Thrombosis;D020226
C14.907.355.590.213.350.500.375;Cavernous Sinus Thrombosis;D020226
C14.907.355.830.850.213.350.500.375;Cavernous Sinus Thrombosis;D020226
C10.228.140.300.525.425.500.562;Lateral Sinus Thrombosis;D020227
C14.907.253.566.350.500.562;Lateral Sinus Thrombosis;D020227
C14.907.355.590.213.350.500.562;Lateral Sinus Thrombosis;D020227
C14.907.355.830.850.213.350.500.562;Lateral Sinus Thrombosis;D020227
D27.505;Pharmacologic Actions;D020228
C25.723.276.720;Serotonin Syndrome;D020230
B01.300.381.235;Colletotrichum;D020231
C10.228.140.380.326;Kluver-Bucy Syndrome;D020232
C10.228.140.646;Kluver-Bucy Syndrome;D020232
F03.087.400.431;Kluver-Bucy Syndrome;D020232
C10.597.404;Gait Disorders, Neurologic;D020233
C23.888.592.413;Gait Disorders, Neurologic;D020233
C10.597.350.090.750;Gait Ataxia;D020234
C10.597.404.450;Gait Ataxia;D020234
C23.888.592.350.090.600;Gait Ataxia;D020234
C23.888.592.413.450;Gait Ataxia;D020234
C10.597.404.400;Gait Apraxia;D020235
C10.597.606.881.350.600;Gait Apraxia;D020235
C23.888.592.413.400;Gait Apraxia;D020235
C23.888.592.604.882.350.600;Gait Apraxia;D020235
F01.700.080.500;Gait Apraxia;D020235
C10.228.140.060;Amnesia, Transient Global;D020236
C10.597.606.525.100.800;Amnesia, Transient Global;D020236
C23.888.592.604.529.100.800;Amnesia, Transient Global;D020236
F01.700.625.100.800;Amnesia, Transient Global;D020236
F03.087.200.800;Amnesia, Transient Global;D020236
C10.597.606.150.500.300.200.100;Alexia, Pure;D020237
C23.888.592.604.150.500.300.200.100;Alexia, Pure;D020237
F03.087.700.500;Alexia, Pure;D020237
C10.597.606.762.100.650;Prosopagnosia;D020238
C23.888.592.604.764.100.650;Prosopagnosia;D020238
F01.700.750.100.650;Prosopagnosia;D020238
G04.299.785;Receptor Cross-Talk;D020239
C10.597.606.881.350.200;Apraxia, Ideomotor;D020240
C23.888.592.604.882.350.200;Apraxia, Ideomotor;D020240
F01.700.875.350.200;Apraxia, Ideomotor;D020240
C02.081.355.677;Encephalomyelitis, Western Equine;D020241
C02.182.500.300.450.300;Encephalomyelitis, Western Equine;D020241
C02.290.450.250;Encephalomyelitis, Western Equine;D020241
C02.782.930.100.370.662;Encephalomyelitis, Western Equine;D020241
C10.228.228.210.150.300.450.800;Encephalomyelitis, Western Equine;D020241
C10.228.228.245.340.450.250;Encephalomyelitis, Western Equine;D020241
C10.228.228.291.323.662;Encephalomyelitis, Western Equine;D020241
C10.228.440.406.250;Encephalomyelitis, Western Equine;D020241
C02.081.355.177;Encephalomyelitis, Eastern Equine;D020242
C02.182.500.300.450.200;Encephalomyelitis, Eastern Equine;D020242
C02.290.450.200;Encephalomyelitis, Eastern Equine;D020242
C02.782.930.100.370.162;Encephalomyelitis, Eastern Equine;D020242
C10.228.228.210.150.300.450.200;Encephalomyelitis, Eastern Equine;D020242
C10.228.228.245.340.450.200;Encephalomyelitis, Eastern Equine;D020242
C10.228.228.291.323.162;Encephalomyelitis, Eastern Equine;D020242
C10.228.440.406.200;Encephalomyelitis, Eastern Equine;D020242
C10.228.140.300.150.477.200.400;Infarction, Anterior Cerebral Artery;D020243
C10.228.140.300.510.200.325;Infarction, Anterior Cerebral Artery;D020243
C10.228.140.300.775.200.200.400;Infarction, Anterior Cerebral Artery;D020243
C14.907.253.092.477.200.400;Infarction, Anterior Cerebral Artery;D020243
C14.907.253.560.200.325;Infarction, Anterior Cerebral Artery;D020243
C14.907.253.855.200.200.400;Infarction, Anterior Cerebral Artery;D020243
C10.228.140.300.150.477.200.450;Infarction, Middle Cerebral Artery;D020244
C10.228.140.300.510.200.387;Infarction, Middle Cerebral Artery;D020244
C10.228.140.300.775.200.200.450;Infarction, Middle Cerebral Artery;D020244
C14.907.253.092.477.200.450;Infarction, Middle Cerebral Artery;D020244
C14.907.253.560.200.387;Infarction, Middle Cerebral Artery;D020244
C14.907.253.855.200.200.450;Infarction, Middle Cerebral Artery;D020244
D02.241.223.100.200.311.275;p-Chloromercuribenzoic Acid;D020245
D02.241.223.100.500.261.275;p-Chloromercuribenzoic Acid;D020245
D02.455.426.559.389.127.250.311.275;p-Chloromercuribenzoic Acid;D020245
D02.455.426.559.389.127.500.261.275;p-Chloromercuribenzoic Acid;D020245
D02.691.750.740.644.261.275;p-Chloromercuribenzoic Acid;D020245
C14.907.355.830.925;Venous Thrombosis;D020246
E02.779.933;Myofunctional Therapy;D020247
E02.831.464;Myofunctional Therapy;D020247
E02.831.727.442;Myofunctional Therapy;D020247
E06.603;Myofunctional Therapy;D020247
E02.319.452;Hormone Replacement Therapy;D020249
C23.550.767.859;Postoperative Nausea and Vomiting;D020250
C23.888.821.712.700;Postoperative Nausea and Vomiting;D020250
C23.888.821.937.059;Postoperative Nausea and Vomiting;D020250
C06.405.748.280;Gastric Antral Vascular Ectasia;D020252
C14.907.075.280;Gastric Antral Vascular Ectasia;D020252
C07.793.710;Tooth Ankylosis;D020254
C11.980;Vitreous Detachment;D020255
C11.941.160.244;Choroidal Neovascularization;D020256
C23.550.589.500.145;Choroidal Neovascularization;D020256
C23.300.985;Ventricular Remodeling;D020257
G09.330.190.962.975;Ventricular Remodeling;D020257
C10.720;Neurotoxicity Syndromes;D020258
C25.723.705;Neurotoxicity Syndromes;D020258
C10.720.475;Heavy Metal Poisoning, Nervous System;D020260
C10.720.475.150;Arsenic Poisoning;D020261
C25.723.097;Arsenic Poisoning;D020261
C10.720.475.600;Mercury Poisoning, Nervous System;D020262
C25.723.647.500;Mercury Poisoning, Nervous System;D020262
C10.720.475.400;Lead Poisoning, Nervous System;D020263
C25.723.589.500;Lead Poisoning, Nervous System;D020263
C10.720.475.400.700;Lead Poisoning, Nervous System, Childhood;D020264
C25.723.589.500.700;Lead Poisoning, Nervous System, Childhood;D020264
C10.720.475.400.350;Lead Poisoning, Nervous System, Adult;D020265
C25.723.589.500.400;Lead Poisoning, Nervous System, Adult;D020265
E02.815.635.700;Radiotherapy, Conformal;D020266
L01.700.508.100.710.600.550;Radiotherapy, Conformal;D020266
C10.228.140.079.862.800.300;MPTP Poisoning;D020267
C10.228.662.600.700.250;MPTP Poisoning;D020267
C10.720.606;MPTP Poisoning;D020267
C25.723.705.400;MPTP Poisoning;D020267
C10.720.112;Alcohol-Induced Disorders, Nervous System;D020268
C25.100.087.193;Alcohol-Induced Disorders, Nervous System;D020268
C25.723.705.150;Alcohol-Induced Disorders, Nervous System;D020268
C10.668.829.800.050;Alcoholic Neuropathy;D020269
C10.720.112.400;Alcoholic Neuropathy;D020269
C25.100.087.193.400;Alcoholic Neuropathy;D020269
C25.723.705.150.400;Alcoholic Neuropathy;D020269
C10.597.742.143;Alcohol Withdrawal Seizures;D020270
C10.720.112.300;Alcohol Withdrawal Seizures;D020270
C25.100.087.193.300;Alcohol Withdrawal Seizures;D020270
C25.723.705.150.300;Alcohol Withdrawal Seizures;D020270
C25.835.500;Alcohol Withdrawal Seizures;D020270
C10.574.500;Heredodegenerative Disorders, Nervous System;D020271
C16.320.400;Heredodegenerative Disorders, Nervous System;D020271
E07.695.540;Orbital Implants;D020273
C10.114;Autoimmune Diseases of the Nervous System;D020274
C20.111.258;Autoimmune Diseases of the Nervous System;D020274
C10.114.750.100;Guillain-Barre Syndrome;D020275
C10.314.750.450;Guillain-Barre Syndrome;D020275
C10.668.829.350;Guillain-Barre Syndrome;D020275
C10.668.829.800.750.300;Guillain-Barre Syndrome;D020275
C20.111.258.750.400;Guillain-Barre Syndrome;D020275
M01.643.836.400;HIV Long-Term Survivors;D020276
M01.860.400;HIV Long-Term Survivors;D020276
C10.114.750.175;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating;D020277
C10.314.750.700;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating;D020277
C10.668.829.800.750.600;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating;D020277
C20.111.258.750.800;Polyradiculoneuropathy, Chronic Inflammatory Demyelinating;D020277
C10.114.375;Demyelinating Autoimmune Diseases, CNS;D020278
C10.228.140.695.562;Demyelinating Autoimmune Diseases, CNS;D020278
C10.228.518.562;Demyelinating Autoimmune Diseases, CNS;D020278
C10.314.350;Demyelinating Autoimmune Diseases, CNS;D020278
C20.111.258.250;Demyelinating Autoimmune Diseases, CNS;D020278
C10.228.140.163.100.362;Hereditary Central Nervous System Demyelinating Diseases;D020279
C10.228.140.695.625;Hereditary Central Nervous System Demyelinating Diseases;D020279
C10.228.518.625;Hereditary Central Nervous System Demyelinating Diseases;D020279
C10.314.400;Hereditary Central Nervous System Demyelinating Diseases;D020279
C10.574.500.494;Hereditary Central Nervous System Demyelinating Diseases;D020279
C16.320.400.367;Hereditary Central Nervous System Demyelinating Diseases;D020279
C16.320.565.189.362;Hereditary Central Nervous System Demyelinating Diseases;D020279
C18.452.132.100.362;Hereditary Central Nervous System Demyelinating Diseases;D020279
C18.452.648.189.362;Hereditary Central Nervous System Demyelinating Diseases;D020279
D02.092.705.800;Sertraline;D020280
D02.455.426.559.847.638.845.800;Sertraline;D020280
D04.615.638.845.800;Sertraline;D020280
D12.776.752;Photoreceptors, Microbial;D020283
E01.370.350.515.402.150;Cryoelectron Microscopy;D020285
E05.595.402.150;Cryoelectron Microscopy;D020285
A07.231.330.600;Pericytes;D020286
A10.272.491.355.600;Pericytes;D020286
A11.710;Pericytes;D020286
A16.504.660.600;Pericytes;D020286
E05.393.475;In Situ Nick-End Labeling;D020287
C04.588.614.250.195.205.200.500;Papilloma, Choroid Plexus;D020288
C10.228.140.211.280.300.500;Papilloma, Choroid Plexus;D020288
C10.551.240.250.200.200.500;Papilloma, Choroid Plexus;D020288
C10.114.875;Vasculitis, Central Nervous System;D020293
C10.228.140.300.850;Vasculitis, Central Nervous System;D020293
C14.907.253.946;Vasculitis, Central Nervous System;D020293
C14.907.940.907;Vasculitis, Central Nervous System;D020293
C20.111.258.962;Vasculitis, Central Nervous System;D020293
C10.668.758.800;Myasthenic Syndromes, Congenital;D020294
C16.320.590;Myasthenic Syndromes, Congenital;D020294
C04.588.614.250.195.411.100;Brain Stem Neoplasms;D020295
C10.228.140.211.500.100;Brain Stem Neoplasms;D020295
C10.551.240.250.400.200;Brain Stem Neoplasms;D020295
B01.050.050.157.040;Animals, Congenic;D020296
B01.050.050.199.040;Animals, Congenic;D020296
B01.050.050.199.520.040;Animals, Congenic;D020296
B01.050.050.157.040.500;Mice, Congenic;D020297
B01.050.050.199.040.500;Mice, Congenic;D020297
B01.050.050.199.520.040.500;Mice, Congenic;D020297
B01.050.150.900.649.865.635.505.500.150;Mice, Congenic;D020297
A11.251.210.190.880;U937 Cells;D020298
A11.251.860.180.880;U937 Cells;D020298
A11.627.482.665.500;U937 Cells;D020298
A11.627.624.249.500;U937 Cells;D020298
A11.627.635.675.750.500;U937 Cells;D020298
C10.228.140.300.535.325;Intracranial Hemorrhage, Hypertensive;D020299
C14.907.253.573.350;Intracranial Hemorrhage, Hypertensive;D020299
C10.228.140.300.535;Intracranial Hemorrhages;D020300
C14.907.253.573;Intracranial Hemorrhages;D020300
C23.550.414.913;Intracranial Hemorrhages;D020300
C10.228.140.300.900;Vasospasm, Intracranial;D020301
C14.907.253.951;Vasospasm, Intracranial;D020301
A11.284.430.214.190.500.950;Weibel-Palade Bodies;D020302
A11.284.430.214.190.875.190.190.950;Weibel-Palade Bodies;D020302
B01.050.050.157.760.165;Rats, Inbred Dahl;D020303
B01.050.050.199.520.760.165;Rats, Inbred Dahl;D020303
B01.050.150.900.649.865.635.505.700.400.165;Rats, Inbred Dahl;D020303
B01.050.150.900.248.815;Raptors;D020304
B01.050.150.900.248.815.550;Strigiformes;D020305
B01.050.150.900.248.870;Strigiformes;D020305
C01.252.410.040.552.846.570;Tuberculosis, Central Nervous System;D020306
C10.228.228.180.850;Tuberculosis, Central Nervous System;D020306
B01.050.150.900.248.250.200;Eagles;D020307
B01.050.150.900.248.815.350.200;Eagles;D020307
B01.050.150.900.248.620.750;Songbirds;D020308
B01.050.150.900.248.600.800;Struthioniformes;D020310
B01.050.150.900.248.600.750;Rheiformes;D020311
B01.050.150.900.248.600.200;Dromaiidae;D020312
D27.720;Specialty Uses of Chemicals;D020313
C01.703.181;Central Nervous System Fungal Infections;D020314
C10.228.228.198;Central Nervous System Fungal Infections;D020314
C20.543.600;Latex Hypersensitivity;D020315
B01.050.150.900.493.817.750.705.790;Salmo salar;D020317
B01.050.150.900.649.865.635.505.700.500;Rats, Long-Evans;D020318
D13.150.200.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.150.480.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.444.308.150.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.444.600.150.200.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.444.600.150.640.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.695.578.424.480.640;Oligodeoxyribonucleotides, Antisense;D020319
D27.720.470.530.600.150.200.640;Oligodeoxyribonucleotides, Antisense;D020319
D27.720.470.530.600.150.640.640;Oligodeoxyribonucleotides, Antisense;D020319
D13.150.480.645;Oligoribonucleotides, Antisense;D020320
D13.150.650.640;Oligoribonucleotides, Antisense;D020320
D13.444.600.150.640.645;Oligoribonucleotides, Antisense;D020320
D13.444.600.150.760.640;Oligoribonucleotides, Antisense;D020320
D13.444.735.150.640;Oligoribonucleotides, Antisense;D020320
D13.695.578.424.480.645;Oligoribonucleotides, Antisense;D020320
D27.720.470.530.600.150.640.645;Oligoribonucleotides, Antisense;D020320
D27.720.470.530.600.150.760.645;Oligoribonucleotides, Antisense;D020320
C10.597.350.700;Tics;D020323
C23.888.592.350.700;Tics;D020323
C10.597.606.525.100.075;Amnesia, Anterograde;D020324
C23.888.592.604.529.100.075;Amnesia, Anterograde;D020324
F01.700.625.100.075;Amnesia, Anterograde;D020324
F03.087.200.137;Amnesia, Anterograde;D020324
C10.228.140.546.399.750.250;Migraine with Aura;D020325
C10.228.140.546.399.750.450;Migraine without Aura;D020326
E07.695.250;Glaucoma Drainage Implants;D020327
C10.228.662.350;Essential Tremor;D020329
C02.256.466.087;Bell Palsy;D020330
C07.465.094;Bell Palsy;D020330
C10.292.300.250;Bell Palsy;D020330
C10.292.300.825;Mobius Syndrome;D020331
C16.131.077.578;Mobius Syndrome;D020331
C16.614.595;Mobius Syndrome;D020331
B01.050.050.157.760.275;Rats, Inbred LEC;D020332
B01.050.050.199.520.760.275;Rats, Inbred LEC;D020332
B01.050.150.900.649.865.635.505.700.400.275;Rats, Inbred LEC;D020332
C10.292.562.900;Tolosa-Hunt Syndrome;D020333
C11.590.905;Tolosa-Hunt Syndrome;D020333
B01.050.050.157.760.290;Rats, Inbred OLETF;D020334
B01.050.050.199.520.760.290;Rats, Inbred OLETF;D020334
B01.050.150.900.649.865.635.505.700.400.290;Rats, Inbred OLETF;D020334
C10.597.636.500;Paraparesis;D020335
C23.888.592.643.500;Paraparesis;D020335
C10.597.636.500.500;Paraparesis, Spastic;D020336
C23.888.592.643.500.500;Paraparesis, Spastic;D020336
C09.218.807.800.837;Vestibular Neuronitis;D020338
C10.292.910.850;Vestibular Neuronitis;D020338
C04.557.465.625.600.380.080.667;Optic Nerve Glioma;D020339
C04.557.465.625.600.380.795;Optic Nerve Glioma;D020339
C04.557.470.670.380.080.667;Optic Nerve Glioma;D020339
C04.557.470.670.380.795;Optic Nerve Glioma;D020339
C04.557.580.625.600.380.080.667;Optic Nerve Glioma;D020339
C04.557.580.625.600.380.795;Optic Nerve Glioma;D020339
C04.588.614.300.600.600;Optic Nerve Glioma;D020339
C04.588.614.596.240.240.500;Optic Nerve Glioma;D020339
C10.292.225.800.500;Optic Nerve Glioma;D020339
C10.292.700.500.500;Optic Nerve Glioma;D020339
C10.551.360.500.500;Optic Nerve Glioma;D020339
C11.640.544.500;Optic Nerve Glioma;D020339
F01.145.940;Tobacco Use Cessation;D020340
E07.695.025;Absorbable Implants;D020341
E05.355;Finite Element Analysis;D020342
C10.228.140.631.500;Hypertensive Encephalopathy;D020343
C06.405.205.596.700;Enterocolitis, Necrotizing;D020345
C06.405.469.363.700;Enterocolitis, Necrotizing;D020345
D12.776.157.530.400.500.040;Aquaporins;D020346
D12.776.543.550.425.730.040;Aquaporins;D020346
D12.776.543.585.400.730.040;Aquaporins;D020346
C23.550.537;Lithiasis;D020347
E05.196.890;Surface Plasmon Resonance;D020349
E05.601.123.700;Surface Plasmon Resonance;D020349
G12.425.901.402.320;Graft vs Tumor Effect;D020350
D04.808.105.225.130.330;Cholates;D020355
D04.808.221.430.130.330;Cholates;D020355
B03.440.425.410.096.877;Selenomonas;D020357
B03.440.425.410.700;Selenomonas;D020357
D04.808.105.225.130.330.850;Sodium Cholate;D020358
D04.808.221.430.130.330.850;Sodium Cholate;D020358
E02.186.450;Neoadjuvant Therapy;D020360
C04.588.614.550;Paraneoplastic Syndromes, Nervous System;D020361
C04.730.856;Paraneoplastic Syndromes, Nervous System;D020361
C10.574.781;Paraneoplastic Syndromes, Nervous System;D020361
C04.588.614.550.650;Paraneoplastic Cerebellar Degeneration;D020362
C04.730.856.650;Paraneoplastic Cerebellar Degeneration;D020362
C10.228.140.252.620;Paraneoplastic Cerebellar Degeneration;D020362
C10.574.781.700;Paraneoplastic Cerebellar Degeneration;D020362
C04.588.614.550.450;Limbic Encephalitis;D020363
C04.730.856.437;Limbic Encephalitis;D020363
C10.228.140.430.525;Limbic Encephalitis;D020363
C10.228.228.245.700;Limbic Encephalitis;D020363
C10.574.781.550;Limbic Encephalitis;D020363
C04.588.614.550.700;Paraneoplastic Polyneuropathy;D020364
C04.730.856.700;Paraneoplastic Polyneuropathy;D020364
C10.574.781.850;Paraneoplastic Polyneuropathy;D020364
C10.668.829.800.662;Paraneoplastic Polyneuropathy;D020364
D08.811.913.696.445.735.720;RNA Helicases;D020365
D02.241.081.069.800.550.450;Methylmethacrylate;D020366
D05.750.716.822.111.650.605.450;Methylmethacrylate;D020366
D25.720.716.822.111.650.605.450;Methylmethacrylate;D020366
J01.637.051.720.716.822.111.650.605.450;Methylmethacrylate;D020366
D02.092.471.683.152.535;Iofetamine;D020367
B03.440.400.425.200.090;Bradyrhizobium;D020369
B03.440.400.425.205;Bradyrhizobium;D020369
B03.660.050.035.090;Bradyrhizobium;D020369
C05.550.114.606.500;Osteoarthritis, Knee;D020370
C05.799.613.500;Osteoarthritis, Knee;D020370
C10.228.140.163.100.362.775;Pelizaeus-Merzbacher Disease;D020371
C10.228.140.695.625.775;Pelizaeus-Merzbacher Disease;D020371
C10.228.518.625.775;Pelizaeus-Merzbacher Disease;D020371
C10.314.400.775;Pelizaeus-Merzbacher Disease;D020371
C16.320.322.906;Pelizaeus-Merzbacher Disease;D020371
C16.320.565.189.362.775;Pelizaeus-Merzbacher Disease;D020371
C18.452.132.100.362.775;Pelizaeus-Merzbacher Disease;D020371
C18.452.648.189.362.775;Pelizaeus-Merzbacher Disease;D020371
D02.092.471.683.338;Dexfenfluramine;D020372
E05.196.181.500;Chromatography, Micellar Electrokinetic Capillary;D020374
I02.195;Education, Distance;D020375
B03.440.425.410.400;Dichelobacter nodosus;D020376
B03.440.450.342.550;Dichelobacter nodosus;D020376
B03.660.250.080.550;Dichelobacter nodosus;D020376
F01.752.747.792.700;Self Efficacy;D020377
G16.500.275.074;Confined Spaces;D020378
N06.230.074;Confined Spaces;D020378
N04.452.871.715.800;Risk Adjustment;D020379
N04.761.789.800;Risk Adjustment;D020379
N05.715.360.750.625.700.690.800;Risk Adjustment;D020379
I02.594;Needs Assessment;D020380
N03.349.380.565;Needs Assessment;D020380
N05.300.537;Needs Assessment;D020380
D12.644.276.374.465.517;Interleukin-17;D020381
D12.776.467.374.465.517;Interleukin-17;D020381
D23.529.374.465.517;Interleukin-17;D020381
D12.644.276.374.465.518;Interleukin-18;D020382
D12.776.467.374.465.518;Interleukin-18;D020382
D23.529.374.465.518;Interleukin-18;D020382
D09.400.410.420.525;Neutral Glycosphingolipids;D020383
D10.390.470.675;Neutral Glycosphingolipids;D020383
D10.570.877.360.612;Neutral Glycosphingolipids;D020383
D09.400.410.420.025;Acidic Glycosphingolipids;D020384
D10.390.470.025;Acidic Glycosphingolipids;D020384
D10.570.877.360.025;Acidic Glycosphingolipids;D020384
C10.597.613.650;Myokymia;D020385
C23.888.592.608.650;Myokymia;D020385
C05.651.392;Isaacs Syndrome;D020386
C10.668.402;Isaacs Syndrome;D020386
C10.668.829.425;Isaacs Syndrome;D020386
G16.500.275.157.250;Food Chain;D020387
N06.230.124.250;Food Chain;D020387
C05.651.534.500.300;Muscular Dystrophy, Duchenne;D020388
C10.668.491.175.500.300;Muscular Dystrophy, Duchenne;D020388
C16.320.322.562;Muscular Dystrophy, Duchenne;D020388
C16.320.577.300;Muscular Dystrophy, Duchenne;D020388
C05.651.534.500.350;Muscular Dystrophy, Emery-Dreifuss;D020389
C10.668.491.175.500.350;Muscular Dystrophy, Emery-Dreifuss;D020389
C16.320.322.625;Muscular Dystrophy, Emery-Dreifuss;D020389
C16.320.577.350;Muscular Dystrophy, Emery-Dreifuss;D020389
A02.835.232.781.324.502.125.800;Tooth Socket;D020390
A14.521.125.800;Tooth Socket;D020390
A14.549.167.646.094.800;Tooth Socket;D020390
C05.651.534.500.400;Muscular Dystrophy, Facioscapulohumeral;D020391
C10.668.491.175.500.400;Muscular Dystrophy, Facioscapulohumeral;D020391
C16.320.577.400;Muscular Dystrophy, Facioscapulohumeral;D020391
A08.186.211.730.317.800.240;Entopeduncular Nucleus;D020392
E02.779.867.466;Manipulation, Spinal;D020393
A11.284.430.214.190.875.930;Vault Ribonucleoprotein Particles;D020394
D12.776.157.725.500.937;Vault Ribonucleoprotein Particles;D020394
D12.776.664.962.500.937;Vault Ribonucleoprotein Particles;D020394
D12.776.543.750.705.852.420.420;Receptors, Interleukin-7;D020395
D23.050.301.264.035.715;Receptors, Interleukin-7;D020395
D23.101.100.110.715;Receptors, Interleukin-7;D020395
A03.556.124.369.320;Goblet Cells;D020397
A04.329.597.320;Goblet Cells;D020397
A04.531.520.320;Goblet Cells;D020397
A04.760.259;Goblet Cells;D020397
A10.615.550.444.321;Goblet Cells;D020397
A10.615.550.760.520.320;Goblet Cells;D020397
A10.615.550.760.600.320;Goblet Cells;D020397
A11.436.298;Goblet Cells;D020397
N03.219.521.346.506.564.663.757;Medicare Part C;D020398
N03.219.521.576.343.840.877;Medicare Part C;D020398
N03.706.615.420.249;Medicare Part C;D020398
N04.452.758.708;Practice Management;D020399
N03.219.521.576.343.800.875;Provider-Sponsored Organizations;D020400
N04.590.374.142.600;Provider-Sponsored Organizations;D020400
N04.590.374.410.875;Provider-Sponsored Organizations;D020400
N05.300.262.600;Provider-Sponsored Organizations;D020400
E01.370.225.500.620.670.325.680;Primed In Situ Labeling;D020401
E01.370.225.750.600.670.325.680;Primed In Situ Labeling;D020401
E05.200.500.620.670.325.680;Primed In Situ Labeling;D020401
E05.200.750.600.670.325.680;Primed In Situ Labeling;D020401
E05.393.620.500.650;Primed In Situ Labeling;D020401
E05.393.661.475.680;Primed In Situ Labeling;D020401
N03.219.151.170.650;Medical Savings Accounts;D020402
N03.219.521.576.090.650;Medical Savings Accounts;D020402
N03.219.521.576.343.830;Medical Savings Accounts;D020402
N03.219.559.500;Medical Savings Accounts;D020402
N03.219.521.576.343.800.700;Patient Freedom of Choice Laws;D020403
N03.706.615.805;Patient Freedom of Choice Laws;D020403
N04.590.374.410.700;Patient Freedom of Choice Laws;D020403
D10.570.755.375.760.400;Glycerophospholipids;D020404
A17.815.180;Dermis;D020405
N03.219.521.710.305.200.500;Medicare Payment Advisory Commission;D020406
L01.224.230.110.500;Internet;D020407
N03.219.521.576.343.349;Health Insurance Portability and Accountability Act;D020408
N03.706.615.273;Health Insurance Portability and Accountability Act;D020408
D05.500.500;Molecular Motor Proteins;D020409
D08.811.277.040.025.193;Molecular Motor Proteins;D020409
D12.776.395.550.200.250.150.050;Activated-Leukocyte Cell Adhesion Molecule;D020410
D12.776.543.550.200.250.150.050;Activated-Leukocyte Cell Adhesion Molecule;D020410
D12.776.860.300.030;Activated-Leukocyte Cell Adhesion Molecule;D020410
D23.050.301.264.035.030;Activated-Leukocyte Cell Adhesion Molecule;D020410
D23.050.301.350.250.150.050;Activated-Leukocyte Cell Adhesion Molecule;D020410
D23.101.100.110.030;Activated-Leukocyte Cell Adhesion Molecule;D020410
E05.196.630.570.660;Oligonucleotide Array Sequence Analysis;D020411
E05.393.525.640;Oligonucleotide Array Sequence Analysis;D020411
E05.393.661.640;Oligonucleotide Array Sequence Analysis;D020411
E05.393.760.640;Oligonucleotide Array Sequence Analysis;D020411
E05.588.570.660;Oligonucleotide Array Sequence Analysis;D020411
E05.601.640;Oligonucleotide Array Sequence Analysis;D020411
G05.420.590;Multifactorial Inheritance;D020412
D13.444.735.544.875.880;3' Untranslated Regions;D020413
D13.444.735.790.878.880;3' Untranslated Regions;D020413
G05.360.340.024.220.880.880;3' Untranslated Regions;D020413
G05.360.340.024.340.137.910.880;3' Untranslated Regions;D020413
N03.219.463.800.800;Risk Sharing, Financial;D020414
N04.452.871.800;Risk Sharing, Financial;D020414
N01.824.245.600;Personnel Downsizing;D020415
N04.452.677.450;Personnel Downsizing;D020415
N03.219.463.100.600;Outsourced Services;D020416
C10.292.562.675.300;Nystagmus, Congenital;D020417
C11.590.400.300;Nystagmus, Congenital;D020417
C16.614.643;Nystagmus, Congenital;D020417
D12.776.037;Algal Proteins;D020418
A08.663.650.850.625.670;Photoreceptor Cells, Vertebrate;D020419
A08.663.650.915.937.670;Photoreceptor Cells, Vertebrate;D020419
A08.800.950.937.670;Photoreceptor Cells, Vertebrate;D020419
A09.371.729.831.625.670;Photoreceptor Cells, Vertebrate;D020419
A11.671.650.850.625.670;Photoreceptor Cells, Vertebrate;D020419
A11.671.650.915.937.670;Photoreceptor Cells, Vertebrate;D020419
A12.383.200;Cyst Fluid;D020420
C10.292.887;Vagus Nerve Diseases;D020421
C10.668.829.500;Mononeuropathies;D020422
C10.668.829.500.500;Median Neuropathy;D020423
C10.668.829.500.850;Ulnar Neuropathies;D020424
C10.668.829.500.650;Radial Neuropathy;D020425
C10.668.829.500.675;Sciatic Neuropathy;D020426
C10.668.829.500.600;Peroneal Neuropathies;D020427
C10.668.829.500.200;Femoral Neuropathy;D020428
C10.668.829.500.700;Tibial Neuropathy;D020429
C10.668.829.500.850.200;Cubital Tunnel Syndrome;D020430
C10.668.829.550.925.200;Cubital Tunnel Syndrome;D020430
C26.844.150.957.200;Cubital Tunnel Syndrome;D020430
C10.292.650;Olfactory Nerve Diseases;D020431
C10.292.850;Trochlear Nerve Diseases;D020432
C10.292.775;Trigeminal Nerve Diseases;D020433
C10.292.150;Abducens Nerve Diseases;D020434
C10.292.450;Glossopharyngeal Nerve Diseases;D020435
C10.292.175;Accessory Nerve Diseases;D020436
C10.292.525;Hypoglossal Nerve Diseases;D020437
A08.663.300;Growth Cones;D020439
A11.284.180.075.249;Growth Cones;D020439
A11.284.180.225.340;Growth Cones;D020439
A11.284.180.610.345;Growth Cones;D020439
A11.671.137.340;Growth Cones;D020439
A11.671.240.340;Growth Cones;D020439
A11.671.300;Growth Cones;D020439
G05.355.600.320;Gene Duplication;D020440
G05.365.590.320;Gene Duplication;D020440
B01.650.940.800.575.400.300;Ginkgo biloba;D020441
D02.033.455.250.700.682;Poloxamer;D020442
D05.750.741.667;Poloxamer;D020442
D25.720.741.667;Poloxamer;D020442
J01.637.051.720.741.667;Poloxamer;D020442
N04.452.758.708.600;Practice Valuation and Purchase;D020443
N03.219.521.710.305.290;Reimbursement, Disproportionate Share;D020444
M01.526.485.630.490.400;Hospitalists;D020445
M01.526.485.740.422.400;Hospitalists;D020445
M01.526.485.810.580;Hospitalists;D020445
N02.360.630.490.400;Hospitalists;D020445
N02.360.740.422.400;Hospitalists;D020445
N02.360.810.580;Hospitalists;D020445
N02.278.207;Fitness Centers;D020446
C10.886.659;Parasomnias;D020447
F03.870.664;Parasomnias;D020447
B01.650.940.800.575.100.928;Theales;D020448
G02.111.570.060.720;Repetitive Sequences, Amino Acid;D020449
G01.249.467;Heavy Ions;D020450
E05.393.183.620.160;Contig Mapping;D020451
E05.393.260;Contig Mapping;D020451
L01.737.498;Journalism;D020452
B01.050.150.900.649.879;Sirenia;D020453
B01.050.150.900.649.879.125;Dugong;D020454
B01.050.150.900.649.879.750;Trichechus;D020455
B01.050.150.900.649.879.750.350;Trichechus inunguis;D020456
B01.050.150.900.649.879.750.500;Trichechus manatus;D020457
I01.880.604.583.427.635;Third-Party Consent;D020458
N03.706.535.489.635;Third-Party Consent;D020458
G05.360.340.024.340.645.750;Genes, rRNA;D020459
A11.284.430.214.190.500.560;Melanosomes;D020460
A11.284.430.214.190.875.190.190.560;Melanosomes;D020460
A11.436.265.531.560;Melanosomes;D020460
A11.436.613.560;Melanosomes;D020460
B01.300.381.515;Madurella;D020461
B01.300.381.385;Gliocladium;D020462
V02.025;Abbreviations;D020463
V02.115;Anecdotes;D020465
V02.150;Atlases;D020466
V01.165.150;Biobibliography;D020467
V02.165.500;Biobibliography;D020467
V01.200;Charts;D020468
V02.245;Charts;D020468
V02.250;Chronology;D020469
V02.260;Collected Works;D020470
V02.265;Collections;D020471
V01.185.625;Drawings;D020472
V02.700.300;Drawings;D020472
V02.365;Essays;D020474
V02.395;Examination Questions;D020475
V02.415;Exhibitions;D020476
V02.460;Forms;D020478
V02.520;Handbooks;D020479
V02.540;Humor;D020480
V02.550;Indexes;D020481
V02.725.500;Juvenile Literature;D020482
V02.605;Laboratory Manuals;D020484
V02.620;Legislation;D020485
V02.630;Manuscripts;D020486
V02.668;Nurses' Instruction;D020488
V02.670;Outlines;D020489
V02.675;Patents;D020490
V02.690;Periodicals;D020492
V02.170.875.500;Autobiography;D020493
V02.310.500;Phrases;D020494
V02.700;Pictorial Works;D020495
V02.725;Popular Works;D020496
V02.734;Problems and Exercises;D020497
V02.735;Programmed Instruction;D020498
V02.925;Statistics;D020500
V02.930;Tables;D020501
V02.310.750;Terminology;D020502
V02.945;Union Lists;D020503
V01.070;Abstracts;D020504
V02.035;Abstracts;D020504
V02.260.260;Collected Correspondence;D020505
D13.444.735.544.875;Untranslated Regions;D020506
D13.444.735.790.878;Untranslated Regions;D020506
G05.360.340.024.220.880;Untranslated Regions;D020506
G05.360.340.024.340.137.910;Untranslated Regions;D020506
V02.750;Resource Guides;D020507
B01.300.300;Fungi, Unclassified;D020508
C10.668.758;Neuromuscular Junction Diseases;D020511
C05.651.575.300;Myopathy, Central Core;D020512
C10.668.491.550.300;Myopathy, Central Core;D020512
C05.651.701.600;Paralysis, Hyperkalemic Periodic;D020513
C10.668.491.650.600;Paralysis, Hyperkalemic Periodic;D020513
C16.320.565.618.711.600;Paralysis, Hyperkalemic Periodic;D020513
C18.452.648.618.711.600;Paralysis, Hyperkalemic Periodic;D020513
C05.651.701.450;Hypokalemic Periodic Paralysis;D020514
C10.668.491.650.450;Hypokalemic Periodic Paralysis;D020514
C16.320.565.618.711.550;Hypokalemic Periodic Paralysis;D020514
C18.452.648.618.711.550;Hypokalemic Periodic Paralysis;D020514
C10.668.829.100;Brachial Plexus Neuropathies;D020516
A07.541.358.100;Atrial Appendage;D020517
C06.552.270;Focal Nodular Hyperplasia;D020518
E01.370.225.998.329.620;Pericardiocentesis;D020519
E02.800.550.620;Pericardiocentesis;D020519
E04.100.376.745;Pericardiocentesis;D020519
E04.665.600.620;Pericardiocentesis;D020519
E04.928.220.620;Pericardiocentesis;D020519
E05.200.998.329.620;Pericardiocentesis;D020519
C10.228.140.300.150.477;Brain Infarction;D020520
C10.228.140.300.775.200;Brain Infarction;D020520
C14.907.253.092.477;Brain Infarction;D020520
C14.907.253.855.200;Brain Infarction;D020520
C10.228.140.300.775;Stroke;D020521
C14.907.253.855;Stroke;D020521
C04.557.386.480.525;Lymphoma, Mantle-Cell;D020522
C15.604.515.569.480.525;Lymphoma, Mantle-Cell;D020522
C20.683.515.761.480.525;Lymphoma, Mantle-Cell;D020522
D12.644.276.374.200.130;Chemokines, CX3C;D020523
D12.776.467.374.200.130;Chemokines, CX3C;D020523
D23.125.300.130;Chemokines, CX3C;D020523
D23.469.200.130;Chemokines, CX3C;D020523
D23.529.374.200.130;Chemokines, CX3C;D020523
A11.284.430.214.190.875.700.140.800;Thylakoids;D020524
E01.370.225.875.985;Xenodiagnosis;D020525
E01.370.985;Xenodiagnosis;D020525
E05.200.875.985;Xenodiagnosis;D020525
C10.228.140.300.150.477.100;Brain Stem Infarctions;D020526
C10.228.140.300.775.200.100;Brain Stem Infarctions;D020526
C14.907.253.092.477.100;Brain Stem Infarctions;D020526
C14.907.253.855.200.100;Brain Stem Infarctions;D020526
E01.370.350.515.666;Microscopy, Scanning Probe;D020527
E05.595.666;Microscopy, Scanning Probe;D020527
C10.114.375.500.200;Multiple Sclerosis, Chronic Progressive;D020528
C10.314.350.500.200;Multiple Sclerosis, Chronic Progressive;D020528
C20.111.258.250.500.200;Multiple Sclerosis, Chronic Progressive;D020528
C10.114.375.500.600;Multiple Sclerosis, Relapsing-Remitting;D020529
C10.314.350.500.600;Multiple Sclerosis, Relapsing-Remitting;D020529
C20.111.258.250.500.600;Multiple Sclerosis, Relapsing-Remitting;D020529
A08.186.211.730.317.800;Subthalamus;D020530
A08.186.211.730.317.800.800;Subthalamic Nucleus;D020531
A08.186.211.730.885.287.249.880.100;Basal Nucleus of Meynert;D020532
D27.505.696.377.077.099;Angiogenesis Inhibitors;D020533
D27.505.696.377.450.100;Angiogenesis Inhibitors;D020533
D27.505.954.248.025;Angiogenesis Inhibitors;D020533
A08.186.211.464.710;Parahippocampal Gyrus;D020534
A08.186.211.730.885.287.500.863.648;Parahippocampal Gyrus;D020534
E01.370.388.250.950;Video-Assisted Surgery;D020535
E04.800.250.950;Video-Assisted Surgery;D020535
D27.505.519.374;Enzyme Activators;D020536
D13.444.735.628.818.800;RNA, Small Nucleolar;D020537
D13.444.735.790.552.937.800;RNA, Small Nucleolar;D020537
E05.393.760.705;Sequence Analysis, Protein;D020539
A08.186.211.132.810.428;Metencephalon;D020540
A08.186.211.865.428;Metencephalon;D020540
A11.284.430.106.279.345.195;Coiled Bodies;D020541
A08.186.211.276.840;Third Ventricle;D020542
D12.776.817;Proteome;D020543
G12.425.901.402.320.320;Graft vs Leukemia Effect;D020544
A04.760;Respiratory Mucosa;D020545
A10.615.550.760;Respiratory Mucosa;D020545
A08.186.211.276.500;Fourth Ventricle;D020546
A08.186.211.276.650;Lateral Ventricles;D020547
D27.505.519.374.200;GTP Phosphohydrolase Activators;D020549
E02.319.283.600;Pulse Therapy, Drug;D020551
E05.196.401.153.150;Comet Assay;D020552
E05.301.300.100.150;Comet Assay;D020552
E05.393.560.150;Comet Assay;D020552
E05.940.560.150;Comet Assay;D020552
E02.875.800.750.700;Sperm Injections, Intracytoplasmic;D020554
E05.820.800.750.700;Sperm Injections, Intracytoplasmic;D020554
D12.644.360.325;GTP-Binding Protein Regulators;D020555
D12.776.402;GTP-Binding Protein Regulators;D020555
D12.776.476.325;GTP-Binding Protein Regulators;D020555
G12.425.898;Neutrophil Infiltration;D020556
E05.599.395.642.550;Neurolinguistic Programming;D020557
E05.599.695.550;Neurolinguistic Programming;D020557
F02.463.425.575;Neurolinguistic Programming;D020557
F02.694.550;Neurolinguistic Programming;D020557
F02.784.629.529.550;Neurolinguistic Programming;D020557
F04.096.586.550;Neurolinguistic Programming;D020557
L01.143.506.598.628.550;Neurolinguistic Programming;D020557
D08.811.277.040.330;GTP Phosphohydrolases;D020558
D08.811.277.040.330.300.400;Monomeric GTP-Binding Proteins;D020559
D12.644.360.525;Monomeric GTP-Binding Proteins;D020559
D12.776.157.325.515;Monomeric GTP-Binding Proteins;D020559
D12.776.476.525;Monomeric GTP-Binding Proteins;D020559
B03.660;Proteobacteria;D020560
B03.660.050;Alphaproteobacteria;D020561
B03.660.075;Betaproteobacteria;D020562
B03.660.250;Gammaproteobacteria;D020563
B03.660.125;Deltaproteobacteria;D020564
B03.660.150;Epsilonproteobacteria;D020565
A10.549.250.200;Dendritic Cells, Follicular;D020566
A10.549.400.500.200;Dendritic Cells, Follicular;D020566
A11.066.275;Dendritic Cells, Follicular;D020566
A15.382.066.275;Dendritic Cells, Follicular;D020566
A15.382.520.604.250.200;Dendritic Cells, Follicular;D020566
A15.382.520.604.412.500.200;Dendritic Cells, Follicular;D020566
C23.888.144.300;Fetal Weight;D020567
E01.370.600.115.100.160.120.300;Fetal Weight;D020567
E05.041.124.160.750.300;Fetal Weight;D020567
G07.100.100.160.120.300;Fetal Weight;D020567
G07.700.320.249.314.120.300;Fetal Weight;D020567
G07.700.320.500.325.235.937;Fetal Weight;D020567
G08.686.280;Fetal Weight;D020567
D12.776.260.682;Proto-Oncogene Proteins c-rel;D020569
D12.776.624.664.700.192;Proto-Oncogene Proteins c-rel;D020569
D12.776.660.767;Proto-Oncogene Proteins c-rel;D020569
D12.776.930.656;Proto-Oncogene Proteins c-rel;D020569
G05.360.340.024.340.375.500.791.418;Genes, myb;D020570
G05.360.340.024.340.375.500.791.560;Genes, sis;D020571
D12.776.624.664.520.750.925;Oncogene Proteins v-rel;D020572
D12.776.964.700.750.925;Oncogene Proteins v-rel;D020572
D12.776.964.775.750.925;Oncogene Proteins v-rel;D020572
G05.360.340.024.340.375.500.791.552;Genes, rel;D020573
D12.644.276.910.650;Proto-Oncogene Proteins c-sis;D020574
D12.776.124.625.650;Proto-Oncogene Proteins c-sis;D020574
D12.776.260.690;Proto-Oncogene Proteins c-sis;D020574
D12.776.467.910.650;Proto-Oncogene Proteins c-sis;D020574
D12.776.624.664.700.195;Proto-Oncogene Proteins c-sis;D020574
D23.529.910.650;Proto-Oncogene Proteins c-sis;D020574
D12.776.624.664.520.750.935;Oncogene Proteins v-sis;D020575
D12.776.964.700.750.935;Oncogene Proteins v-sis;D020575
D12.776.964.775.750.935;Oncogene Proteins v-sis;D020575
B03.440.400.425.100.550;Gluconobacter;D020576
B03.660.050.663.050.415;Gluconobacter;D020576
B03.440.647.825;Wolbachia;D020577
B03.660.050.765.825;Wolbachia;D020577
B03.440.400.425.750;Sphingomonas;D020578
B03.660.050.800.750;Sphingomonas;D020578
B03.440.400.425.700.887;Sinorhizobium;D020579
B03.660.050.730.835;Sinorhizobium;D020579
B03.440.400.425.487.500;Methylobacterium;D020580
B03.660.050.500.500;Methylobacterium;D020580
B03.440.540;Methylosinus;D020581
B03.660.050.512.500;Methylosinus;D020581
B03.660.050.350.400;Hyphomicrobium;D020582
B03.440.400.425.127;Azorhizobium;D020583
B03.660.050.350.080;Azorhizobium;D020583
B03.440.400.425.935;Xanthobacter;D020584
B03.660.050.350.950;Xanthobacter;D020584
B03.440.400.425.292.150;Comamonas;D020585
B03.660.075.102.150;Comamonas;D020585
B03.440.425.400.750;Thiocapsa;D020586
B03.660.250.110.750;Thiocapsa;D020586
B03.440.425.410.405.500;Ectothiorhodospira;D020587
B03.660.250.145.500;Ectothiorhodospira;D020587
B03.440.400.425.967.750;Stenotrophomonas;D020588
B03.660.250.915.750;Stenotrophomonas;D020588
B03.440.400.840;Vitreoscilla;D020589
B03.660.075.525.900;Vitreoscilla;D020589
B03.440.400.425.126;Alteromonas;D020591
B03.660.250.021.020;Alteromonas;D020591
B03.440.450.690;Shewanella;D020592
B03.660.250.021.755;Shewanella;D020592
B03.440.450.425.890;Xenorhabdus;D020593
B03.660.250.150.910;Xenorhabdus;D020593
B03.440.450.425.260;Edwardsiella;D020594
B03.660.250.150.160;Edwardsiella;D020594
B03.440.450.425.375;Hafnia;D020595
B03.660.250.150.280;Hafnia;D020595
B03.440.450.425.500;Morganella;D020596
B03.660.250.150.500;Morganella;D020596
B03.660.125.500.710;Stigmatella;D020597
D12.776.260.675;Proto-Oncogene Proteins c-myb;D020598
D12.776.624.664.700.188;Proto-Oncogene Proteins c-myb;D020598
D12.776.930.653;Proto-Oncogene Proteins c-myb;D020598
B03.440.400.425.127.100;Azorhizobium caulinodans;D020599
B03.660.050.350.080.100;Azorhizobium caulinodans;D020599
B03.440.400.425.100.550.550;Gluconobacter oxydans;D020600
B03.660.050.663.050.415.550;Gluconobacter oxydans;D020600
B03.440.400.425.487.500.150;Methylobacterium extorquens;D020601
B03.660.050.500.500.150;Methylobacterium extorquens;D020601
B03.440.540.500;Methylosinus trichosporium;D020602
B03.660.050.512.500.750;Methylosinus trichosporium;D020602
B03.440.400.425.292.150.750;Comamonas testosteroni;D020604
B03.660.075.102.150.750;Comamonas testosteroni;D020604
B03.440.400.425.292.170.030;Delftia acidovorans;D020605
B03.660.075.102.170.030;Delftia acidovorans;D020605
B03.660.125.500.710.050;Stigmatella aurantiaca;D020606
B03.440.425.410.405.750;Halorhodospira halophila;D020607
B03.660.250.145.750;Halorhodospira halophila;D020607
B03.440.425.410.405.500.720;Ectothiorhodospira shaposhnikovii;D020608
B03.660.250.145.500.720;Ectothiorhodospira shaposhnikovii;D020608
B03.440.450.425.260.750;Edwardsiella tarda;D020609
B03.660.250.150.160.750;Edwardsiella tarda;D020609
B03.440.450.425.260.340;Edwardsiella ictaluri;D020610
B03.660.250.150.160.340;Edwardsiella ictaluri;D020610
B03.440.450.425.375.050;Hafnia alvei;D020611
B03.660.250.150.280.050;Hafnia alvei;D020611
B03.440.450.425.500.500;Morganella morganii;D020613
B03.660.250.150.500.500;Morganella morganii;D020613
B03.440.450.690.590;Shewanella putrefaciens;D020614
B03.660.250.021.755.750;Shewanella putrefaciens;D020614
B03.440.400.425.967.750.500;Stenotrophomonas maltophilia;D020615
B03.660.250.915.750.500;Stenotrophomonas maltophilia;D020615
B03.440.425.400.750.660;Thiocapsa roseopersicina;D020616
B03.660.250.110.750.660;Thiocapsa roseopersicina;D020616
B03.440.400.425.500.500;Methylococcus;D020618
B03.660.250.500.500;Methylococcus;D020618
B03.440.400.425.500.500.100;Methylococcus capsulatus;D020619
B03.660.250.500.500.100;Methylococcus capsulatus;D020619
B03.440.400.425.500.505;Methylomonas;D020620
B03.660.250.500.505;Methylomonas;D020620
B03.440.400.425.575.650;Ochrobactrum anthropi;D020621
B03.660.050.070.700.650;Ochrobactrum anthropi;D020621
B03.440.400.425.110;Afipia;D020622
B03.440.400.425.200.040;Afipia;D020622
B03.660.050.035.040;Afipia;D020622
B03.440.645;Rhodomicrobium;D020623
B03.660.050.350.675;Rhodomicrobium;D020623
B03.440.425.410.580;Oxalobacter formigenes;D020624
B03.660.075.600.600;Oxalobacter formigenes;D020624
B03.440.400.425.117.800.200;Taylorella equigenitalis;D020625
B03.660.075.027.800.200;Taylorella equigenitalis;D020625
D12.776.624.664.520.750.903;Oncogene Proteins v-myb;D020626
D12.776.964.700.750.903;Oncogene Proteins v-myb;D020626
D12.776.964.775.750.903;Oncogene Proteins v-myb;D020626
B03.440.450.040;Azoarcus;D020627
B03.660.075.655.070;Azoarcus;D020627
B03.440.425.410.745;Thauera;D020628
B03.660.075.655.800;Thauera;D020628
B03.440.400.425.525.520;Methylophilus;D020629
B03.660.075.495.520;Methylophilus;D020629
B03.440.400.425.525.520.500;Methylophilus methylotrophus;D020630
B03.660.075.495.520.500;Methylophilus methylotrophus;D020630
B03.440.400.425.525.500;Methylobacillus;D020631
B03.660.075.495.500;Methylobacillus;D020631
B03.440.400.425.377.500;Halomonas;D020632
B03.660.250.350.500;Halomonas;D020632
B03.440.400.425.625.150;Cellvibrio;D020633
B03.660.250.580.100;Cellvibrio;D020633
B03.440.100;Buchnera;D020635
B03.660.250.150.047;Buchnera;D020635
B03.440.450.425.580;Pantoea;D020636
B03.660.250.150.540;Pantoea;D020636
B03.440.450.425.590;Photorhabdus;D020637
B03.660.250.150.545;Photorhabdus;D020637
B03.440.450.650;Rahnella;D020638
B03.660.250.150.655;Rahnella;D020638
B03.440.520;Lawsonia Bacteria;D020639
B03.660.125.460;Lawsonia Bacteria;D020639
B03.440.050;Arcobacter;D020640
B03.660.150.050;Arcobacter;D020640
G05.365.795.598;Polymorphism, Single Nucleotide;D020641
C16.320.565.663.025;Acatalasia;D020642
C18.452.648.663.025;Acatalasia;D020642
A08.186.211.730.317.826.701.080;Anterior Thalamic Nuclei;D020643
A08.186.211.730.317.826.701.500;Midline Thalamic Nuclei;D020644
A08.186.211.730.317.826.701.490;Mediodorsal Thalamic Nucleus;D020645
A08.186.211.730.317.826.701.460;Intralaminar Thalamic Nuclei;D020646
A08.186.211.730.317.826.701.485;Lateral Thalamic Nuclei;D020647
D08.811.277.040.330.300.100.101;Peptide Elongation Factor 1;D020648
D12.776.157.325.150.101;Peptide Elongation Factor 1;D020648
D12.776.835.700.350.101;Peptide Elongation Factor 1;D020648
A08.186.211.730.317.826.701.485.600;Pulvinar;D020649
E05.916.039.312;Combinatorial Chemistry Techniques;D020650
G02.607.750.155.249;Combinatorial Chemistry Techniques;D020650
J01.897.836.249.249;Combinatorial Chemistry Techniques;D020650
A08.186.211.730.317.826.701.900;Ventral Thalamic Nuclei;D020651
D08.811.277.040.330.300.100.102;Peptide Elongation Factor 2;D020652
D12.776.157.325.150.102;Peptide Elongation Factor 2;D020652
D12.776.835.700.350.102;Peptide Elongation Factor 2;D020652
D08.811.277.040.330.300.100.200;Peptide Elongation Factor G;D020653
D12.776.157.325.150.200;Peptide Elongation Factor G;D020653
D12.776.835.700.350.200;Peptide Elongation Factor G;D020653
A08.186.211.730.317.826.701.700;Posterior Thalamic Nuclei;D020656
D12.644.360.325.300;Guanine Nucleotide Exchange Factors;D020662
D12.776.402.300;Guanine Nucleotide Exchange Factors;D020662
D12.776.476.325.300;Guanine Nucleotide Exchange Factors;D020662
D12.644.360.325.300.700;ras Guanine Nucleotide Exchange Factors;D020663
D12.776.402.300.700;ras Guanine Nucleotide Exchange Factors;D020663
D12.776.476.325.300.700;ras Guanine Nucleotide Exchange Factors;D020663
D12.644.360.325.300.700.700;Son of Sevenless Proteins;D020664
D12.776.402.300.700.700;Son of Sevenless Proteins;D020664
D12.776.476.325.300.700.700;Son of Sevenless Proteins;D020664
A08.186.211.464.750;Septum of Brain;D020665
A08.186.211.730.885.750;Septum of Brain;D020665
D12.644.360.325.300.700.500;ras-GRF1;D020666
D12.776.402.300.700.500;ras-GRF1;D020666
D12.776.476.325.300.700.500;ras-GRF1;D020666
A08.186.211.730.885.380;Diagonal Band of Broca;D020667
D08.811.277.040.330.300.400.475;rap GTP-Binding Proteins;D020668
D12.644.360.525.475;rap GTP-Binding Proteins;D020668
D12.776.157.325.515.475;rap GTP-Binding Proteins;D020668
D12.776.476.525.475;rap GTP-Binding Proteins;D020668
E07.230.220.280;Fetoscopes;D020669
E07.858.240.280;Fetoscopes;D020669
A08.186.211.464.699.400;Islands of Calleja;D020670
A08.186.211.730.885.600.400;Islands of Calleja;D020670
A08.186.854.610;Posterior Horn Cells;D020671
A08.663.650.675;Posterior Horn Cells;D020671
A11.671.650.675;Posterior Horn Cells;D020671
D12.644.360.378;I-kappa B Proteins;D020672
D12.776.260.420;I-kappa B Proteins;D020672
D12.776.476.381;I-kappa B Proteins;D020672
D12.776.930.326;I-kappa B Proteins;D020672
G02.111.087.690.501.500;Protein Renaturation;D020673
G02.149.115.690.501.500;Protein Renaturation;D020673
A11.284.430.214.190.500.585.600;Peroxisomes;D020675
A11.284.430.214.190.875.190.190.755.600;Peroxisomes;D020675
A11.284.430.214.190.500.585.250;Glyoxysomes;D020676
A11.284.430.214.190.875.190.190.755.250;Glyoxysomes;D020676
E07.230.220.040;Angioscopes;D020677
E07.858.240.040;Angioscopes;D020677
E01.370.370.560;Microscopic Angioscopy;D020678
E07.230.220.060;Arthroscopes;D020679
E07.858.240.060;Arthroscopes;D020679
E07.230.220.090;Bronchoscopes;D020680
E07.858.240.090;Bronchoscopes;D020680
E07.230.220.170;Colposcopes;D020681
E07.858.240.170;Colposcopes;D020681
D02.065.589.099.249.190.190.115;Cefixime;D020682
D02.886.665.074.190.190.115;Cefixime;D020682
D04.075.080.875.099.221.249.190.190.115;Cefixime;D020682
E07.230.220.180;Culdoscopes;D020683
E07.858.240.180;Culdoscopes;D020683
E07.230.220.190;Cystoscopes;D020684
E07.858.240.190;Cystoscopes;D020684
E07.230.220.260.160;Colonoscopes;D020685
E07.858.240.260.160;Colonoscopes;D020685
D08.811.277.352.650.625.225.100;cdc25 Phosphatases;D020687
D08.811.277.352.650.775.250.100;cdc25 Phosphatases;D020687
D12.644.360.268.100;cdc25 Phosphatases;D020687
D12.776.167.100;cdc25 Phosphatases;D020687
D12.776.476.268.100;cdc25 Phosphatases;D020687
D08.811.277.656.350;Exopeptidases;D020689
D12.644.360.325.150;GTPase-Activating Proteins;D020690
D12.776.402.150;GTPase-Activating Proteins;D020690
D12.776.476.325.150;GTPase-Activating Proteins;D020690
D08.811.277.040.330.300.400.400;rab GTP-Binding Proteins;D020691
D12.644.360.525.400;rab GTP-Binding Proteins;D020691
D12.776.157.325.515.400;rab GTP-Binding Proteins;D020691
D12.776.476.525.400;rab GTP-Binding Proteins;D020691
D08.811.277.040.330.300.400.400.100;rab3 GTP-Binding Proteins;D020692
D12.644.360.525.400.100;rab3 GTP-Binding Proteins;D020692
D12.776.157.325.515.400.100;rab3 GTP-Binding Proteins;D020692
D12.776.476.525.400.100;rab3 GTP-Binding Proteins;D020692
D08.811.277.040.330.300.400.400.050;rab2 GTP-Binding Protein;D020693
D12.644.360.525.400.050;rab2 GTP-Binding Protein;D020693
D12.776.157.325.515.400.050;rab2 GTP-Binding Protein;D020693
D12.776.476.525.400.050;rab2 GTP-Binding Protein;D020693
E07.230.220.260.160.800;Sigmoidoscopes;D020694
E07.858.240.260.160.800;Sigmoidoscopes;D020694
D08.811.277.040.330.300.400.400.150;rab4 GTP-Binding Proteins;D020695
D12.644.360.525.400.150;rab4 GTP-Binding Proteins;D020695
D12.776.157.325.515.400.150;rab4 GTP-Binding Proteins;D020695
D12.776.476.525.400.150;rab4 GTP-Binding Proteins;D020695
D08.811.277.040.330.300.400.400.200;rab5 GTP-Binding Proteins;D020696
D12.644.360.525.400.200;rab5 GTP-Binding Proteins;D020696
D12.776.157.325.515.400.200;rab5 GTP-Binding Proteins;D020696
D12.776.476.525.400.200;rab5 GTP-Binding Proteins;D020696
E07.230.220.260.200;Duodenoscopes;D020698
E07.858.240.260.200;Duodenoscopes;D020698
E07.230.220.260.320;Gastroscopes;D020699
E07.858.240.260.320;Gastroscopes;D020699
E07.230.220.260.680;Proctoscopes;D020700
E07.858.240.260.680;Proctoscopes;D020700
E07.230.220.260.260;Esophagoscopes;D020701
E07.858.240.260.260;Esophagoscopes;D020701
E07.230.220.390;Hysteroscopes;D020702
E07.858.240.390;Hysteroscopes;D020702
D12.644.360.325.150.500;ras GTPase-Activating Proteins;D020703
D12.776.402.150.500;ras GTPase-Activating Proteins;D020703
D12.776.476.325.150.500;ras GTPase-Activating Proteins;D020703
E07.230.220.525;Laryngoscopes;D020704
E07.858.240.525;Laryngoscopes;D020704
E07.230.220.520;Laparoscopes;D020706
E07.858.240.520;Laparoscopes;D020706
E07.230.220.565;Mediastinoscopes;D020707
E07.858.240.565;Mediastinoscopes;D020707
E07.230.220.850;Thoracoscopes;D020708
E07.858.240.850;Thoracoscopes;D020708
E07.230.220.895;Ureteroscopes;D020709
E07.858.240.895;Ureteroscopes;D020709
D12.644.360.325.150.750;RGS Proteins;D020710
D12.776.402.150.750;RGS Proteins;D020710
D12.776.476.325.150.750;RGS Proteins;D020710
N03.706.615.917;Threshold Limit Values;D020711
N06.850.460.350.600.807;Threshold Limit Values;D020711
A08.186.211.464.265;Fornix, Brain;D020712
A08.186.211.730.885.400;Fornix, Brain;D020712
G06.099.225.984;Vancomycin Resistance;D020713
G06.225.347.984;Vancomycin Resistance;D020713
G07.690.320.269.347.984;Vancomycin Resistance;D020713
E05.940.481;Maximum Tolerated Dose;D020714
G07.690.570;Maximum Tolerated Dose;D020714
D12.644.360.325.300.200;Eukaryotic Initiation Factor-2B;D020717
D12.776.402.300.200;Eukaryotic Initiation Factor-2B;D020717
D12.776.476.325.300.200;Eukaryotic Initiation Factor-2B;D020717
D12.776.835.725.868.374;Eukaryotic Initiation Factor-2B;D020717
D12.776.157.725.500.875.590;Ribonucleoproteins, Small Nucleolar;D020718
D12.776.664.962.500.875.590;Ribonucleoproteins, Small Nucleolar;D020718
D02.241.081.844.915.162.500;Glucuronides;D020719
D02.241.152.811.162.750;Glucuronides;D020719
D02.241.511.902.915.162.750;Glucuronides;D020719
D09.811.922.162.750;Glucuronides;D020719
C10.114.656.300;Myasthenia Gravis, Autoimmune, Experimental;D020720
C10.114.703.350;Myasthenia Gravis, Autoimmune, Experimental;D020720
C10.668.758.725.300;Myasthenia Gravis, Autoimmune, Experimental;D020720
C20.111.258.500.300;Myasthenia Gravis, Autoimmune, Experimental;D020720
C20.111.258.625.350;Myasthenia Gravis, Autoimmune, Experimental;D020720
E05.598.500.500.750;Myasthenia Gravis, Autoimmune, Experimental;D020720
C10.114.703;Nervous System Autoimmune Disease, Experimental;D020721
C20.111.258.625;Nervous System Autoimmune Disease, Experimental;D020721
E05.598.500.500;Nervous System Autoimmune Disease, Experimental;D020721
D02.241.081.844.915.162.249;Glucuronic Acid;D020723
D02.241.152.811.162.500;Glucuronic Acid;D020723
D02.241.511.902.915.162.500;Glucuronic Acid;D020723
D09.811.922.162.500;Glucuronic Acid;D020723
D25.720.327;Elastomers;D020724
J01.637.051.720.327;Elastomers;D020724
J01.637.412;Elastomers;D020724
D08.811.277.040.330.300.400.450;ral GTP-Binding Proteins;D020725
D12.644.360.525.450;ral GTP-Binding Proteins;D020725
D12.776.157.325.515.450;ral GTP-Binding Proteins;D020725
D12.776.476.525.450;ral GTP-Binding Proteins;D020725
D12.644.360.325.300.600;ral Guanine Nucleotide Exchange Factor;D020726
D12.776.402.300.600;ral Guanine Nucleotide Exchange Factor;D020726
D12.776.476.325.300.600;ral Guanine Nucleotide Exchange Factor;D020726
D08.811.277.040.330.300.400.100;ADP-Ribosylation Factors;D020727
D12.644.360.525.100;ADP-Ribosylation Factors;D020727
D12.776.157.325.515.100;ADP-Ribosylation Factors;D020727
D12.776.476.525.100;ADP-Ribosylation Factors;D020727
E04.950.774.860.625.750;Transurethral Resection of Prostate;D020728
D12.644.360.325.150.500.500;p120 GTPase Activating Protein;D020729
D12.776.402.150.500.500;p120 GTPase Activating Protein;D020729
D12.776.476.325.150.500.500;p120 GTPase Activating Protein;D020729
D12.644.360.325.225;Guanine Nucleotide Dissociation Inhibitors;D020730
D12.776.402.225;Guanine Nucleotide Dissociation Inhibitors;D020730
D12.776.476.325.225;Guanine Nucleotide Dissociation Inhibitors;D020730
E02.594.480.750;Keratomileusis, Laser In Situ;D020731
E04.014.520.480.750;Keratomileusis, Laser In Situ;D020731
E04.540.825.437.374;Keratomileusis, Laser In Situ;D020731
E01.370.225.500.385;Cytogenetic Analysis;D020732
E05.200.500.385;Cytogenetic Analysis;D020732
E05.242.385;Cytogenetic Analysis;D020732
E05.393.285;Cytogenetic Analysis;D020732
D13.444.735.790.552.750;RNA, Small Cytoplasmic;D020733
C10.228.140.079.862;Parkinsonian Disorders;D020734
C10.228.662.600;Parkinsonian Disorders;D020734
D12.644.360.325.300.300;Guanine Nucleotide-Releasing Factor 2;D020735
D12.776.402.300.300;Guanine Nucleotide-Releasing Factor 2;D020735
D12.776.476.325.300.300;Guanine Nucleotide-Releasing Factor 2;D020735
D12.776.157.725.500.750;Ribonucleoproteins, Small Cytoplasmic;D020736
D12.776.664.962.500.750;Ribonucleoproteins, Small Cytoplasmic;D020736
D06.472.699.042.500;Leptin;D020738
D12.644.276.024.500;Leptin;D020738
D12.644.548.011.500;Leptin;D020738
D12.776.467.024.500;Leptin;D020738
D23.529.024.500;Leptin;D020738
C10.228.140.163.100;Brain Diseases, Metabolic, Inborn;D020739
C16.320.565.189;Brain Diseases, Metabolic, Inborn;D020739
C18.452.132.100;Brain Diseases, Metabolic, Inborn;D020739
C18.452.648.189;Brain Diseases, Metabolic, Inborn;D020739
D12.644.360.325.150.100;Chimerin Proteins;D020740
D12.776.402.150.100;Chimerin Proteins;D020740
D12.776.476.325.150.100;Chimerin Proteins;D020740
D12.776.641.124;Chimerin Proteins;D020740
D08.811.277.040.330.300.400.700;rho GTP-Binding Proteins;D020741
D12.644.360.525.700;rho GTP-Binding Proteins;D020741
D12.776.157.325.515.700;rho GTP-Binding Proteins;D020741
D12.776.476.525.700;rho GTP-Binding Proteins;D020741
D08.811.277.040.330.300.400.700.200;rhoA GTP-Binding Protein;D020742
D12.644.360.525.700.200;rhoA GTP-Binding Protein;D020742
D12.776.157.325.515.700.200;rhoA GTP-Binding Protein;D020742
D12.776.476.525.700.200;rhoA GTP-Binding Protein;D020742
D08.811.277.040.330.300.400.700.300;rhoB GTP-Binding Protein;D020743
D12.644.360.525.700.300;rhoB GTP-Binding Protein;D020743
D12.776.157.325.515.700.300;rhoB GTP-Binding Protein;D020743
D12.776.476.525.700.300;rhoB GTP-Binding Protein;D020743
D08.811.277.040.330.300.400.700.100;rac GTP-Binding Proteins;D020744
D12.644.360.525.700.100;rac GTP-Binding Proteins;D020744
D12.776.157.325.515.700.100;rac GTP-Binding Proteins;D020744
D12.776.476.525.700.100;rac GTP-Binding Proteins;D020744
G05.360.340.050;Genome, Archaeal;D020745
D12.776.157.530.400.150.400;Calcium Channels, L-Type;D020746
D12.776.543.550.425.150.400;Calcium Channels, L-Type;D020746
D12.776.543.585.400.150.400;Calcium Channels, L-Type;D020746
D12.776.157.530.400.150.720;Calcium Channels, T-Type;D020747
D12.776.543.550.425.150.720;Calcium Channels, T-Type;D020747
D12.776.543.585.400.150.720;Calcium Channels, T-Type;D020747
D02.455.426.559.847.638.960.585;Mibefradil;D020748
D03.438.103.618;Mibefradil;D020748
D04.615.638.960.585;Mibefradil;D020748
C25.100.087;Alcohol-Induced Disorders;D020751
C10.562;Neurocutaneous Syndromes;D020752
C16.131.077.350.712;Neurocutaneous Syndromes;D020752
C16.131.831.350.712;Neurocutaneous Syndromes;D020752
C16.320.850.250.712;Neurocutaneous Syndromes;D020752
C17.800.804.350.712;Neurocutaneous Syndromes;D020752
C17.800.827.250.712;Neurocutaneous Syndromes;D020752
C10.228.140.252.190.530;Spinocerebellar Ataxias;D020754
C10.228.140.252.700.700;Spinocerebellar Ataxias;D020754
C10.228.854.787.875;Spinocerebellar Ataxias;D020754
C10.574.500.825.700;Spinocerebellar Ataxias;D020754
C10.597.350.090.500.530;Spinocerebellar Ataxias;D020754
C16.320.400.780.875;Spinocerebellar Ataxias;D020754
D12.776.543.990.300;Coat Protein Complex I;D020755
D12.776.543.990.300.300;Coatomer Protein;D020756
C10.597.751.941.162.125;Amaurosis Fugax;D020757
C11.966.075.125;Amaurosis Fugax;D020757
C23.888.592.763.941.162.125;Amaurosis Fugax;D020757
C10.228.854.785;Spinal Cord Vascular Diseases;D020758
C14.907.790;Spinal Cord Vascular Diseases;D020758
C10.228.854.785.100;Anterior Spinal Artery Syndrome;D020759
C10.228.854.785.650.100;Anterior Spinal Artery Syndrome;D020759
C14.907.790.100;Anterior Spinal Artery Syndrome;D020759
C14.907.790.550.100;Anterior Spinal Artery Syndrome;D020759
C10.228.854.785.650;Spinal Cord Ischemia;D020760
C14.907.790.550;Spinal Cord Ischemia;D020760
D08.811.277.040.330.300.400.400.025;rab1 GTP-Binding Proteins;D020761
D12.644.360.525.400.025;rab1 GTP-Binding Proteins;D020761
D12.776.157.325.515.400.025;rab1 GTP-Binding Proteins;D020761
D12.776.476.525.400.025;rab1 GTP-Binding Proteins;D020761
C10.228.140.300.150.477.200.475;Infarction, Posterior Cerebral Artery;D020762
C10.228.140.300.510.200.418;Infarction, Posterior Cerebral Artery;D020762
C10.228.140.300.775.200.200.475;Infarction, Posterior Cerebral Artery;D020762
C14.907.253.092.477.200.475;Infarction, Posterior Cerebral Artery;D020762
C14.907.253.560.200.418;Infarction, Posterior Cerebral Artery;D020762
C14.907.253.855.200.200.475;Infarction, Posterior Cerebral Artery;D020762
C23.300;Pathological Conditions, Anatomical;D020763
D08.811.277.040.330.300.400.700.050;cdc42 GTP-Binding Protein;D020764
D12.644.360.525.700.050;cdc42 GTP-Binding Protein;D020764
D12.776.157.325.515.700.050;cdc42 GTP-Binding Protein;D020764
D12.776.476.525.700.050;cdc42 GTP-Binding Protein;D020764
C10.228.140.300.510;Intracranial Arterial Diseases;D020765
C14.907.253.560;Intracranial Arterial Diseases;D020765
C10.228.140.300.525.400;Intracranial Embolism;D020766
C14.907.253.566.300;Intracranial Embolism;D020766
C14.907.355.590.213.300;Intracranial Embolism;D020766
C14.907.355.830.850.213.300;Intracranial Embolism;D020766
C10.228.140.300.525.425;Intracranial Thrombosis;D020767
C14.907.253.566.350;Intracranial Thrombosis;D020767
C14.907.355.590.213.350;Intracranial Thrombosis;D020767
C14.907.355.830.850.213.350;Intracranial Thrombosis;D020767
A07.231.114.228.550;Middle Cerebral Artery;D020768
A07.231.114.228.700;Posterior Cerebral Artery;D020769
D05.750.716.822.308.300;Compomers;D020770
D25.339.291.150;Compomers;D020770
D25.339.816.500.300;Compomers;D020770
D25.720.716.822.308.300;Compomers;D020770
J01.637.051.339.291.150;Compomers;D020770
J01.637.051.339.816.500.300;Compomers;D020770
J01.637.051.720.716.822.308.300;Compomers;D020770
A07.231.114.228.100;Anterior Cerebral Artery;D020771
A08.186.211.730.885.435;Internal Capsule;D020772
A08.612.435;Internal Capsule;D020772
C10.228.140.546;Headache Disorders;D020773
C10.228.140.380.615;Pick Disease of the Brain;D020774
F03.087.400.675;Pick Disease of the Brain;D020774
E01.370.388.250.840.830;Thoracic Surgery, Video-Assisted;D020775
E01.370.388.250.950.830;Thoracic Surgery, Video-Assisted;D020775
E04.800.250.840.830;Thoracic Surgery, Video-Assisted;D020775
E04.800.250.950.830;Thoracic Surgery, Video-Assisted;D020775
E04.928.752.830;Thoracic Surgery, Video-Assisted;D020775
E07.230.220.260;Endoscopes, Gastrointestinal;D020776
E07.858.240.260;Endoscopes, Gastrointestinal;D020776
D08.811.277.656.300.480.205.352;Matrix Metalloproteinase 2;D020778
D08.811.277.656.300.480.252.420;Matrix Metalloproteinase 2;D020778
D08.811.277.656.300.480.525.700.150;Matrix Metalloproteinase 2;D020778
D08.811.277.656.675.374.205.352;Matrix Metalloproteinase 2;D020778
D08.811.277.656.675.374.252.420;Matrix Metalloproteinase 2;D020778
D08.811.277.656.675.374.525.700.150;Matrix Metalloproteinase 2;D020778
C10.500.190.800;Sinus Pericranii;D020779
C14.240.850.875.750;Sinus Pericranii;D020779
C16.131.666.190.800;Sinus Pericranii;D020779
D08.811.277.656.300.480.205.360;Matrix Metalloproteinase 9;D020780
D08.811.277.656.300.480.252.445;Matrix Metalloproteinase 9;D020780
D08.811.277.656.300.480.525.700.350;Matrix Metalloproteinase 9;D020780
D08.811.277.656.675.374.205.360;Matrix Metalloproteinase 9;D020780
D08.811.277.656.675.374.252.445;Matrix Metalloproteinase 9;D020780
D08.811.277.656.675.374.525.700.350;Matrix Metalloproteinase 9;D020780
D08.811.277.656.300.480.205.351;Matrix Metalloproteinase 1;D020781
D08.811.277.656.300.480.525.700.100;Matrix Metalloproteinase 1;D020781
D08.811.277.656.675.374.205.351;Matrix Metalloproteinase 1;D020781
D08.811.277.656.675.374.525.700.100;Matrix Metalloproteinase 1;D020781
D08.811.277.656.300.480.525;Matrix Metalloproteinases;D020782
D08.811.277.656.675.374.525;Matrix Metalloproteinases;D020782
D08.811.277.656.300.480.525.700.250;Matrix Metalloproteinase 7;D020783
D08.811.277.656.675.374.525.700.250;Matrix Metalloproteinase 7;D020783
D08.811.277.656.300.480.205.358;Matrix Metalloproteinase 8;D020784
D08.811.277.656.300.480.525.700.300;Matrix Metalloproteinase 8;D020784
D08.811.277.656.675.374.205.358;Matrix Metalloproteinase 8;D020784
D08.811.277.656.675.374.525.700.300;Matrix Metalloproteinase 8;D020784
C10.500.190;Central Nervous System Vascular Malformations;D020785
C14.240.850.875;Central Nervous System Vascular Malformations;D020785
C16.131.240.850.875;Central Nervous System Vascular Malformations;D020785
C16.131.666.190;Central Nervous System Vascular Malformations;D020785
C04.557.645.375.385.500;Hemangioma, Cavernous, Central Nervous System;D020786
C10.500.190.200;Hemangioma, Cavernous, Central Nervous System;D020786
C14.240.850.875.249;Hemangioma, Cavernous, Central Nervous System;D020786
C14.907.454.385.500;Hemangioma, Cavernous, Central Nervous System;D020786
C15.378.463.515.385.500;Hemangioma, Cavernous, Central Nervous System;D020786
C16.131.666.190.200;Hemangioma, Cavernous, Central Nervous System;D020786
C04.557.645.375.185;Central Nervous System Venous Angioma;D020787
C10.500.190.100;Central Nervous System Venous Angioma;D020787
C14.240.850.875.124;Central Nervous System Venous Angioma;D020787
C16.131.666.190.100;Central Nervous System Venous Angioma;D020787
C10.228.140.617.200;Bardet-Biedl Syndrome;D020788
C16.131.077.112;Bardet-Biedl Syndrome;D020788
D08.811.277.656.224.130;Cathepsin C;D020789
D08.811.277.656.262.186;Cathepsin C;D020789
D08.811.277.656.350.350.100;Cathepsin C;D020789
C12.777.419.135.750;Diabetes Insipidus, Neurogenic;D020790
C13.351.968.419.135.750;Diabetes Insipidus, Neurogenic;D020790
C19.700.159.750;Diabetes Insipidus, Neurogenic;D020790
D08.811.277.656.300.760.955;Venombin A;D020791
D08.811.277.656.959.350.955;Venombin A;D020791
C07.465.815.497;Salivary Calculi;D020792
C23.300.175.700;Salivary Calculi;D020792
N04.452.758.849.350;Gatekeeping;D020793
D08.811.913.696.620.682.725.400;Receptor Protein-Tyrosine Kinases;D020794
D12.776.543.750.060;Receptor Protein-Tyrosine Kinases;D020794
C10.597.751.941.661;Photophobia;D020795
C11.966.741;Photophobia;D020795
C23.888.592.763.941.661;Photophobia;D020795
D08.811.913.696.620.682.725.400.900.500;Receptor, Platelet-Derived Growth Factor alpha;D020796
D12.776.543.750.060.625.300;Receptor, Platelet-Derived Growth Factor alpha;D020796
D12.776.543.750.750.400.630.300;Receptor, Platelet-Derived Growth Factor alpha;D020796
D08.811.913.696.620.682.725.400.900.750;Receptor, Platelet-Derived Growth Factor beta;D020797
D12.776.543.750.060.625.400;Receptor, Platelet-Derived Growth Factor beta;D020797
D12.776.543.750.750.400.630.400;Receptor, Platelet-Derived Growth Factor beta;D020797
E05.393.220.870;Two-Hybrid System Techniques;D020798
E05.393.525.870;Two-Hybrid System Techniques;D020798
E05.601.690.650;Two-Hybrid System Techniques;D020798
D08.811.277.352.100.400.745;Pancrelipase;D020799
D20.777.500.745;Pancrelipase;D020799
D12.776.543.750.750.400.550.500;Receptor, Nerve Growth Factor;D020800
D12.776.543.750.750.400.550.250;Receptor, Ciliary Neurotrophic Factor;D020801
C01.252.200.250;Epidural Abscess;D020802
C01.539.830.025.325;Epidural Abscess;D020802
C10.228.228.180.375;Epidural Abscess;D020802
C10.228.228.300;Epidural Abscess;D020802
C10.228.228.709.350;Epidural Abscess;D020802
C10.228.854.303;Epidural Abscess;D020802
C02.182.500.300.350;Encephalitis, Herpes Simplex;D020803
C02.256.466.262;Encephalitis, Herpes Simplex;D020803
C02.290.325;Encephalitis, Herpes Simplex;D020803
C10.228.228.210.150.300.350;Encephalitis, Herpes Simplex;D020803
C10.228.228.245.340.332;Encephalitis, Herpes Simplex;D020803
C02.182.500.300.400;Encephalitis, Varicella Zoster;D020804
C02.256.466.279;Encephalitis, Varicella Zoster;D020804
C02.290.355;Encephalitis, Varicella Zoster;D020804
C10.228.228.210.150.300.400;Encephalitis, Varicella Zoster;D020804
C10.228.228.245.340.355;Encephalitis, Varicella Zoster;D020804
C02.182;Central Nervous System Viral Diseases;D020805
C10.228.228.210;Central Nervous System Viral Diseases;D020805
C01.252.200;Central Nervous System Bacterial Infections;D020806
C01.395.500;Central Nervous System Bacterial Infections;D020806
C10.228.228.180;Central Nervous System Bacterial Infections;D020806
C03.105;Central Nervous System Parasitic Infections;D020807
C10.228.228.205;Central Nervous System Parasitic Infections;D020807
C03.105.300;Central Nervous System Protozoal Infections;D020808
C03.752.100;Central Nervous System Protozoal Infections;D020808
C10.228.228.205.300;Central Nervous System Protozoal Infections;D020808
C03.105.250;Central Nervous System Helminthiasis;D020809
C10.228.228.205.250;Central Nervous System Helminthiasis;D020809
J01.897.115;Biomedical Technology;D020811
D08.811.913.696.620.682.725.400.800;Receptor, trkC;D020812
D12.776.543.750.060.499;Receptor, trkC;D020812
D12.776.543.750.750.400.550.700;Receptor, trkC;D020812
D08.811.913.696.620.682.725.400.700;Receptor, trkB;D020813
D12.776.543.750.060.498;Receptor, trkB;D020813
D12.776.543.750.750.400.550.600;Receptor, trkB;D020813
C01.252.200.500.400;Meningitis, Escherichia coli;D020814
C01.252.400.310.330.500;Meningitis, Escherichia coli;D020814
C10.228.228.180.500.350;Meningitis, Escherichia coli;D020814
C10.228.228.507.280.350;Meningitis, Escherichia coli;D020814
D12.776.775;Polyproteins;D020815
G02.111.570.060.040;Amino Acid Motifs;D020816
G02.111.570.790.709.600.040;Amino Acid Motifs;D020816
F03.550.325.100;Asperger Syndrome;D020817
C03.105.250.600;Neuroschistosomiasis;D020818
C03.335.865.859.213;Neuroschistosomiasis;D020818
C10.228.228.205.250.600;Neuroschistosomiasis;D020818
C10.228.228.709;Perimeningeal Infections;D020819
C10.228.662.262;Dyskinesias;D020820
C10.597.350;Dyskinesias;D020820
C23.888.592.350;Dyskinesias;D020820
C10.228.662.300;Dystonic Disorders;D020821
D08.811.277.040.330.300.400.100.100;ADP-Ribosylation Factor 1;D020823
D12.644.360.525.100.100;ADP-Ribosylation Factor 1;D020823
D12.776.157.325.515.100.100;ADP-Ribosylation Factor 1;D020823
D12.776.476.525.100.100;ADP-Ribosylation Factor 1;D020823
D12.776.543.990.300.150;ADP-Ribosylation Factor 1;D020823
A08.612.220.725;Spinocerebellar Tracts;D020824
D12.776.260.725;T-Box Domain Proteins;D020825
D12.776.930.850;T-Box Domain Proteins;D020825
D08.811.277.040.330.300.400.400.100.500;rab3A GTP-Binding Protein;D020826
D12.644.360.525.400.100.100;rab3A GTP-Binding Protein;D020826
D12.776.157.325.515.400.100.100;rab3A GTP-Binding Protein;D020826
D12.776.476.525.400.100.100;rab3A GTP-Binding Protein;D020826
D08.811.277.040.330.300.400.475.100;rap1 GTP-Binding Proteins;D020827
D12.644.360.525.475.100;rap1 GTP-Binding Proteins;D020827
D12.776.157.325.515.475.100;rap1 GTP-Binding Proteins;D020827
D12.776.476.525.475.100;rap1 GTP-Binding Proteins;D020827
C10.597.622.714;Pseudobulbar Palsy;D020828
C23.888.592.636.711;Pseudobulbar Palsy;D020828
B01.650.940.800.575.175;Equisetum;D020829
D08.811.277.040.330.300.400.700.100.500;rac1 GTP-Binding Protein;D020830
D12.644.360.525.700.100.100;rac1 GTP-Binding Protein;D020830
D12.776.157.325.515.700.100.100;rac1 GTP-Binding Protein;D020830
D12.776.476.525.700.100.100;rac1 GTP-Binding Protein;D020830
E02.190.044.133;Acupuncture, Ear;D020831
E02.190.204.500;Acupuncture, Ear;D020831
G02.111.570.790.709.600.040.360.240;EF Hand Motifs;D020832
C10.228.140.199.600;Diffuse Axonal Injury;D020833
C10.900.300.087.500;Diffuse Axonal Injury;D020833
C26.260.118.300;Diffuse Axonal Injury;D020833
C26.915.300.200.300;Diffuse Axonal Injury;D020833
H01.158.703.015;Ethnopharmacology;D020834
H02.628.100;Ethnopharmacology;D020834
I01.076.201.450.654.252;Ethnopharmacology;D020834
E02.190.488.585.600;Medicine, Kampo;D020835
I01.076.201.450.654.558.600;Medicine, Kampo;D020835
G02.111.570.790.709.550;Protein Structure, Quaternary;D020836
D12.644.360.325.300.700.700.630;SOS1 Protein;D020837
D12.776.402.300.700.700.650;SOS1 Protein;D020837
D12.776.476.325.300.700.700.630;SOS1 Protein;D020837
B01.650.940.800.575.100.100.141;Calendula;D020838
D12.644.360.325.300.700.700.600;Son of Sevenless Protein, Drosophila;D020839
D12.776.402.300.700.700.600;Son of Sevenless Protein, Drosophila;D020839
D12.776.476.325.300.700.700.600;Son of Sevenless Protein, Drosophila;D020839
D08.811.277.656.300.760.442.875;Tissue Kallikreins;D020840
D08.811.277.656.959.350.442.875;Tissue Kallikreins;D020840
D23.101.840.870;Tissue Kallikreins;D020840
D08.811.277.656.300.760.442.700;Plasma Kallikrein;D020842
D08.811.277.656.959.350.442.700;Plasma Kallikrein;D020842
B01.650.940.800.575.100.100.195;Chamomile;D020843
B01.650.940.800.575.100.150.210;Comfrey;D020844
D06.347.360.827;Selective Estrogen Receptor Modulators;D020845
D27.505.696.399.450.360.827;Selective Estrogen Receptor Modulators;D020845
D08.811.277.040.330.300.400.700.060;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;D020846
D12.644.360.525.700.050.500;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;D020846
D12.776.157.325.515.700.050.500;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;D020846
D12.776.354.750.249;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;D020846
D12.776.476.525.700.050.500;cdc42 GTP-Binding Protein, Saccharomyces cerevisiae;D020846
D06.347.360;Estrogen Receptor Modulators;D020847
D27.505.696.399.450.360;Estrogen Receptor Modulators;D020847
D12.644.360.325.150.100.200;Chimerin 1;D020848
D12.776.402.150.100.200;Chimerin 1;D020848
D12.776.476.325.150.100.200;Chimerin 1;D020848
D12.776.641.124.200;Chimerin 1;D020848
D02.455.426.559.389.150.700.900.775;Raloxifene;D020849
C01.252.200.450;Lyme Neuroborreliosis;D020852
C01.252.400.155.569.600;Lyme Neuroborreliosis;D020852
C01.252.400.825.480.700;Lyme Neuroborreliosis;D020852
C01.252.847.193.569.600;Lyme Neuroborreliosis;D020852
C10.228.228.180.437;Lyme Neuroborreliosis;D020852
G02.111.570.080.040;AT Rich Sequence;D020856
G05.360.080.040;AT Rich Sequence;D020856
C05.330.488.300;Hallux Limitus;D020857
C05.550.445;Hallux Limitus;D020857
E04.936.537;Tissue and Organ Harvesting;D020858
C05.330.488.310;Hallux Rigidus;D020859
C05.550.450;Hallux Rigidus;D020859
D08.811.277.656.300.760.787.805;Subtilisin;D020860
D08.811.277.656.959.350.787.805;Subtilisin;D020860
G02.111.570.080.380;GC Rich Sequence;D020862
G05.360.080.380;GC Rich Sequence;D020862
C04.588.614.250.387;Central Nervous System Cysts;D020863
C10.500.142;Central Nervous System Cysts;D020863
C10.551.240.375;Central Nervous System Cysts;D020863
C16.131.666.142;Central Nervous System Cysts;D020863
D12.776.157.530.400.150.585;Calcium Channels, N-Type;D020864
D12.776.543.550.425.150.585;Calcium Channels, N-Type;D020864
D12.776.543.585.400.150.585;Calcium Channels, N-Type;D020864
D12.776.157.530.400.150.585.792;Calcium Channels, P-Type;D020865
D12.776.543.550.425.150.585.792;Calcium Channels, P-Type;D020865
D12.776.543.585.400.150.585.792;Calcium Channels, P-Type;D020865
D20.888.590.162.720.700;omega-Conotoxin GVIA;D020866
D23.946.580.590.162.720.700;omega-Conotoxin GVIA;D020866
D23.946.833.590.162.720.700;omega-Conotoxin GVIA;D020866
D12.644.400.562;omega-Agatoxin IVA;D020867
D12.776.092.249.500;omega-Agatoxin IVA;D020867
D20.888.065.870.324.500;omega-Agatoxin IVA;D020867
D23.946.833.065.870.324.500;omega-Agatoxin IVA;D020867
G05.355.315.203.374;Gene Silencing;D020868
E05.393.332;Gene Expression Profiling;D020869
G02.111.780;RNA Stability;D020871
D12.644.400.575.281.075;Enkephalin, Ala(2)-MePhe(4)-Gly(5)-;D020875
D12.644.468.281.075;Enkephalin, Ala(2)-MePhe(4)-Gly(5)-;D020875
D12.776.641.650.575.281.075;Enkephalin, Ala(2)-MePhe(4)-Gly(5)-;D020875
E04.199;Device Removal;D020878
C10.597.613;Neuromuscular Manifestations;D020879
C23.888.592.608;Neuromuscular Manifestations;D020879
D12.644.276.860.550;Neuregulins;D020880
D12.776.467.860.550;Neuregulins;D020880
D12.776.641.600.550;Neuregulins;D020880
D23.529.850.550;Neuregulins;D020880
D12.644.400.575.281.600;Enkephalin, D-Penicillamine (2,5)-;D020881
D12.644.468.281.600;Enkephalin, D-Penicillamine (2,5)-;D020881
D12.776.641.650.575.281.600;Enkephalin, D-Penicillamine (2,5)-;D020881
E04.520.365;Hysterotomy;D020883
E04.520.155;Colpotomy;D020884
E04.950.300.220;Colpotomy;D020884
D12.776.157.725.500.875.625;Ribonucleoprotein, U7 Small Nuclear;D020885
D12.776.664.962.500.875.625;Ribonucleoprotein, U7 Small Nuclear;D020885
C10.597.751.791;Somatosensory Disorders;D020886
C23.888.592.763.770;Somatosensory Disorders;D020886
D01.810.900;Selenious Acid;D020887
D02.241.081.114.500.350.900;Vigabatrin;D020888
D12.125.190.350.900;Vigabatrin;D020888
D03.383.773.812.785;Rolipram;D020889
D12.644.276.860.550.750;Neuregulin-1;D020890
D12.776.467.860.550.750;Neuregulin-1;D020890
D12.776.641.600.550.750;Neuregulin-1;D020890
D23.529.850.550.750;Neuregulin-1;D020890
D02.065.277.761;Raclopride;D020891
D02.241.223.100.100.761;Raclopride;D020891
D02.241.223.100.200.937;Raclopride;D020891
D02.455.426.559.389.127.085.761;Raclopride;D020891
D02.455.426.559.389.127.250.937;Raclopride;D020891
D08.811.913.696.620.682.725.400.175;Receptor, erbB-3;D020893
D12.776.543.750.060.437;Receptor, erbB-3;D020893
D12.776.543.750.750.400.360;Receptor, erbB-3;D020893
D12.776.624.664.700.790;Receptor, erbB-3;D020893
D23.101.840.721;Receptor, erbB-3;D020893
A11.284.295.310.560;Microfibrils;D020894
A03.556.124.369.290;Enterocytes;D020895
A10.615.550.444.290;Enterocytes;D020895
A11.436.290;Enterocytes;D020895
C23.550.455;Hypovolemia;D020896
A16.675;Organizers, Embryonic;D020897
B01.650.940.800.575.100.100.310;Echinacea;D020900
B01.650.940.800.575.100.812.666.249;Kava;D020901
B01.650.940.800.575.100.928.249.500;Hypericum;D020902
B01.650.940.800.575.100.100.874.500;Tanacetum parthenium;D020903
D12.644.276.860.325;Glia Maturation Factor;D020904
D12.776.467.860.325;Glia Maturation Factor;D020904
D12.776.641.600.325;Glia Maturation Factor;D020904
D23.529.850.325;Glia Maturation Factor;D020904
E06.020;Air Abrasion, Dental;D020906
D12.776.157.530.400.150.585.826;Calcium Channels, Q-Type;D020907
D12.776.543.550.425.150.585.826;Calcium Channels, Q-Type;D020907
D12.776.543.585.400.150.585.826;Calcium Channels, Q-Type;D020907
D12.776.157.530.400.150.585.867;Calcium Channels, R-Type;D020908
D12.776.543.550.425.150.585.867;Calcium Channels, R-Type;D020908
D12.776.543.585.400.150.585.867;Calcium Channels, R-Type;D020908
D09.698.629.802.100;Acarbose;D020909
D03.438.473.420.485;Ketorolac;D020910
D03.438.473.420.742;Ketorolac Tromethamine;D020911
D02.065.277.600;Moclobemide;D020912
D02.241.223.100.100.600;Moclobemide;D020912
D02.241.223.100.200.875;Moclobemide;D020912
D02.455.426.559.389.127.085.600;Moclobemide;D020912
D02.455.426.559.389.127.250.875;Moclobemide;D020912
D03.438.473.766;Perindopril;D020913
C05.651.575;Myopathies, Structural, Congenital;D020914
C10.668.491.550;Myopathies, Structural, Congenital;D020914
C10.597.606.525.400;Korsakoff Syndrome;D020915
C10.720.112.100.500;Korsakoff Syndrome;D020915
C23.888.592.604.529.400;Korsakoff Syndrome;D020915
C25.100.087.193.100.500;Korsakoff Syndrome;D020915
C25.723.705.150.100.500;Korsakoff Syndrome;D020915
F01.700.625.400;Korsakoff Syndrome;D020915
F03.087.200.125.500;Korsakoff Syndrome;D020915
F03.900.100.050.500;Korsakoff Syndrome;D020915
D20.888.590.162;Conotoxins;D020916
D23.946.580.590.162;Conotoxins;D020916
D23.946.833.590.162;Conotoxins;D020916
D08.811.913.696.620.682.725.400.660;Receptor, trkA;D020917
D12.776.543.750.060.496;Receptor, trkA;D020917
D12.776.543.750.750.400.550.550;Receptor, trkA;D020917
C10.177.195;Complex Regional Pain Syndromes;D020918
C10.668.829.250;Complex Regional Pain Syndromes;D020918
C10.886.425.800;Sleep Disorders, Intrinsic;D020919
F03.870.400.800;Sleep Disorders, Intrinsic;D020919
C10.886.425;Dyssomnias;D020920
F03.870.400;Dyssomnias;D020920
C10.886.659.635;Sleep Arousal Disorders;D020921
F03.870.664.635;Sleep Arousal Disorders;D020921
C10.886.659.700;Sleep-Wake Transition Disorders;D020922
F03.870.664.700;Sleep-Wake Transition Disorders;D020922
C10.886.659.633;REM Sleep Parasomnias;D020923
F03.870.664.633;REM Sleep Parasomnias;D020923
C23.888.942;Urological Manifestations;D020924
C10.228.140.300.150.716;Hypoxia-Ischemia, Brain;D020925
C10.228.140.624.500;Hypoxia-Ischemia, Brain;D020925
C14.907.253.092.716;Hypoxia-Ischemia, Brain;D020925
D03.383.129.308.521;Medetomidine;D020926
D03.383.129.308.245;Dexmedetomidine;D020927
D08.811.913.696.620.682.700.567;Mitogen-Activated Protein Kinases;D020928
D08.811.913.696.620.682.700.646.750;Mitogen-Activated Protein Kinases;D020928
D12.644.360.450;Mitogen-Activated Protein Kinases;D020928
D12.776.476.450;Mitogen-Activated Protein Kinases;D020928
D08.811.913.696.620.682.700.565;Mitogen-Activated Protein Kinase Kinases;D020929
D08.811.913.696.620.682.725.200;Mitogen-Activated Protein Kinase Kinases;D020929
D12.644.360.440;Mitogen-Activated Protein Kinase Kinases;D020929
D12.776.476.440;Mitogen-Activated Protein Kinase Kinases;D020929
D08.811.913.696.620.682.700.559;MAP Kinase Kinase Kinases;D020930
D12.644.360.400;MAP Kinase Kinase Kinases;D020930
D12.776.476.400;MAP Kinase Kinase Kinases;D020930
D08.811.277.040.330.300.400.462;ran GTP-Binding Protein;D020931
D12.644.360.525.462;ran GTP-Binding Protein;D020931
D12.776.157.325.515.462;ran GTP-Binding Protein;D020931
D12.776.157.530.750.750;ran GTP-Binding Protein;D020931
D12.776.476.525.462;ran GTP-Binding Protein;D020931
D12.776.543.585.750.750;ran GTP-Binding Protein;D020931
D12.776.660.768;ran GTP-Binding Protein;D020931
D12.644.276.860.437;Nerve Growth Factor;D020932
D12.776.467.860.437;Nerve Growth Factor;D020932
D12.776.641.600.437;Nerve Growth Factor;D020932
D23.529.850.437;Nerve Growth Factor;D020932
D12.644.276.860.775;Neurotrophin 3;D020933
D12.776.467.860.775;Neurotrophin 3;D020933
D12.776.641.600.775;Neurotrophin 3;D020933
D23.529.850.775;Neurotrophin 3;D020933
D12.644.276.860.212;Ciliary Neurotrophic Factor;D020934
D12.776.467.860.212;Ciliary Neurotrophic Factor;D020934
D12.776.641.600.212;Ciliary Neurotrophic Factor;D020934
D23.529.850.212;Ciliary Neurotrophic Factor;D020934
G02.111.087.800.560;MAP Kinase Signaling System;D020935
G02.149.115.800.560;MAP Kinase Signaling System;D020935
G03.495.553.560;MAP Kinase Signaling System;D020935
G04.299.880.560;MAP Kinase Signaling System;D020935
C10.228.140.490.370;Epilepsy, Benign Neonatal;D020936
C16.614.258;Epilepsy, Benign Neonatal;D020936
C10.228.140.490.360.275;Epilepsy, Partial, Sensory;D020937
C10.228.140.490.360.272;Epilepsy, Partial, Motor;D020938
B01.650.940.800.575.100.975.900.444;Ginger;D020939
B01.300.179.120.379.700;Reishi;D020940
C10.114.656.650;Myasthenia Gravis, Neonatal;D020941
C10.668.758.725.650;Myasthenia Gravis, Neonatal;D020941
C20.111.258.500.650;Myasthenia Gravis, Neonatal;D020941
B01.300.179.100.515.810;Shiitake Mushrooms;D020942
C02.782.815.616.400.048;AIDS Arteritis, Central Nervous System;D020943
C02.800.801.400.048;AIDS Arteritis, Central Nervous System;D020943
C10.114.875.175;AIDS Arteritis, Central Nervous System;D020943
C10.228.140.300.850.125;AIDS Arteritis, Central Nervous System;D020943
C14.907.184.140;AIDS Arteritis, Central Nervous System;D020943
C14.907.253.946.175;AIDS Arteritis, Central Nervous System;D020943
C14.907.940.090.170;AIDS Arteritis, Central Nervous System;D020943
C14.907.940.907.175;AIDS Arteritis, Central Nervous System;D020943
C20.673.480.048;AIDS Arteritis, Central Nervous System;D020943
B01.650.940.800.575.100.100.525;Milk Thistle;D020944
C10.114.875.850;Lupus Vasculitis, Central Nervous System;D020945
C10.228.140.300.850.750;Lupus Vasculitis, Central Nervous System;D020945
C10.228.140.430.550.500;Lupus Vasculitis, Central Nervous System;D020945
C10.228.228.245.550.500;Lupus Vasculitis, Central Nervous System;D020945
C10.228.228.507.850.500;Lupus Vasculitis, Central Nervous System;D020945
C10.228.228.553.450;Lupus Vasculitis, Central Nervous System;D020945
C10.228.566.500.500;Lupus Vasculitis, Central Nervous System;D020945
C14.907.253.946.850;Lupus Vasculitis, Central Nervous System;D020945
C14.907.940.907.850;Lupus Vasculitis, Central Nervous System;D020945
C17.300.480.750;Lupus Vasculitis, Central Nervous System;D020945
C20.111.258.962.900;Lupus Vasculitis, Central Nervous System;D020945
C20.111.590.750;Lupus Vasculitis, Central Nervous System;D020945
B01.650.940.800.575.400.122.833.500;Taxus;D020946
D10.627.675.775;Tea Tree Oil;D020947
D10.627.700.940;Tea Tree Oil;D020947
D20.215.784.750.940;Tea Tree Oil;D020947
B01.650.940.800.575.100.850.909.500;Cat's Claw;D020948
B01.300.340.915;Usnea;D020949
B05.350.915;Usnea;D020949
B01.650.940.800.575.100.960.888;Vitex;D020950
C01.703.513.249.537;Neuroaspergillosis;D020953
C10.228.228.198.750;Neuroaspergillosis;D020953
F01.829.263.750;Single-Parent Family;D020954
I01.880.225.750;Single-Parent Family;D020954
C10.228.140.079.612.800;Striatonigral Degeneration;D020955
C10.228.662.550.800;Striatonigral Degeneration;D020955
C10.574.625.800;Striatonigral Degeneration;D020955
Z01.107.567.176.614;Nunavut;D020957
Z01.338.240;Australian Capital Territory;D020958
D02.455.326.271.665.550.500;Polyethylene;D020959
D05.750.716.507.500;Polyethylene;D020959
D25.720.716.507.500;Polyethylene;D020959
J01.637.051.720.716.507.500;Polyethylene;D020959
D20.888.590.162.720;omega-Conotoxins;D020960
D23.946.580.590.162.720;omega-Conotoxins;D020960
D23.946.833.590.162.720;omega-Conotoxins;D020960
C10.228.140.079.862.400;Lewy Body Disease;D020961
C10.228.140.380.422;Lewy Body Disease;D020961
C10.228.662.600.200;Lewy Body Disease;D020961
C10.574.531;Lewy Body Disease;D020961
F03.087.400.512;Lewy Body Disease;D020961
D08.811.277.040.330.300.200;Heterotrimeric GTP-Binding Proteins;D020962
D12.644.360.375;Heterotrimeric GTP-Binding Proteins;D020962
D12.776.157.325.332;Heterotrimeric GTP-Binding Proteins;D020962
D12.776.476.375;Heterotrimeric GTP-Binding Proteins;D020962
D12.776.543.325;Heterotrimeric GTP-Binding Proteins;D020962
D08.811.277.040.330.300.100;GTP Phosphohydrolase-Linked Elongation Factors;D020963
D12.776.157.325.150;GTP Phosphohydrolase-Linked Elongation Factors;D020963
D12.776.835.700.350;GTP Phosphohydrolase-Linked Elongation Factors;D020963
C13.703.039.711;Embryo Loss;D020964
C23.550.260.440;Embryo Loss;D020964
C05.651.534;Muscular Disorders, Atrophic;D020966
C10.668.491.175;Muscular Disorders, Atrophic;D020966
C10.668.550;Muscular Disorders, Atrophic;D020966
C05.651.662;Myotonic Disorders;D020967
C10.668.491.606;Myotonic Disorders;D020967
C10.668.829.100.500;Brachial Plexus Neuritis;D020968
C10.668.829.650.250;Brachial Plexus Neuritis;D020968
C23.550.291;Disease Attributes;D020969
G09.330.190.163.749;Placental Circulation;D021041
E02.041.625.525;Liquid Ventilation;D021061
E02.880.820.525;Liquid Ventilation;D021061
C10.281;Chronobiology Disorders;D021081
E05.393.183.620.405;Radiation Hybrid Mapping;D021101
E05.393.525.300;Branched DNA Signal Amplification Assay;D021121
E05.393.661.124;Branched DNA Signal Amplification Assay;D021121
E05.601.300;Branched DNA Signal Amplification Assay;D021121
D12.776.813;Protein Subunits;D021122
E05.393.620;Nucleic Acid Amplification Techniques;D021141
E05.393.620.700;Self-Sustained Sequence Replication;D021161
C20.543.480.370.150;Egg Hypersensitivity;D021181
C20.543.480.370.850;Wheat Hypersensitivity;D021182
C20.543.480.370.675;Peanut Hypersensitivity;D021183
C20.543.480.370.550;Nut Hypersensitivity;D021184
E05.196.566.600;Spectrometry, Mass, Electrospray Ionization;D021241
E01.370.225.940;Parasitic Sensitivity Tests;D021261
E05.200.940;Parasitic Sensitivity Tests;D021261
E05.337.550.700;Parasitic Sensitivity Tests;D021261
G02.111.830.500;Quantitative Structure-Activity Relationship;D021281
G07.690.830.500;Quantitative Structure-Activity Relationship;D021281
D12.776.053;Antifreeze Proteins;D021301
D12.776.053.500;Antifreeze Proteins, Type IV;D021302
D12.776.053.100;Antifreeze Proteins, Type I;D021322
D12.776.053.200;Antifreeze Proteins, Type II;D021341
D12.776.053.350;Antifreeze Proteins, Type III;D021343
A02.835.232.087.319.150.750;Scaphoid Bone;D021361
A02.835.232.781.324.502.660;Palate, Hard;D021362
A14.521.658.660;Palate, Hard;D021362
A14.549.617.660;Palate, Hard;D021362
G03.495.166.700;Protein Transport;D021381
D12.644.770;Protein Sorting Signals;D021382
G02.111.570.060.670;Protein Sorting Signals;D021382
C04.557.470.200.025.232.750;Carcinoma, Pancreatic Ductal;D021441
C04.557.470.615.132.750;Carcinoma, Pancreatic Ductal;D021441
C04.588.274.761.750;Carcinoma, Pancreatic Ductal;D021441
C04.588.322.475.750;Carcinoma, Pancreatic Ductal;D021441
C06.301.761.750;Carcinoma, Pancreatic Ductal;D021441
C06.689.667.625;Carcinoma, Pancreatic Ductal;D021441
C19.344.421.750;Carcinoma, Pancreatic Ductal;D021441
B01.050.050.284;Animals, Outbred Strains;D021461
C23.888.646.451;Flank Pain;D021501
E01.370.225.875.150.125.765;Ribotyping;D021521
E05.200.875.150.125.765;Ribotyping;D021521
E05.393.290.765;Ribotyping;D021521
E07.858.082.212;Bioartificial Organs;D021522
B01.050.150.900.493.602.750;Sea Bream;D021541
D12.125.154;Amino Acids, Neutral;D021542
G03.495.166.310.100;Active Transport, Cell Nucleus;D021581
G03.495.166.700.100;Active Transport, Cell Nucleus;D021581
A11.284.430.214.190.875.336.850;trans-Golgi Network;D021601
E01.370.350.400;Imaging, Three-Dimensional;D021621
L01.224.308.410;Imaging, Three-Dimensional;D021621
F02.463.425.540.706;Recognition (Psychology);D021641
N04.452.758.372;Management Service Organizations;D021661
B01.300.381.785;Scedosporium;D021681
E01.370.225.500.384.100.580;Sentinel Lymph Node Biopsy;D021701
E01.370.225.998.054.580;Sentinel Lymph Node Biopsy;D021701
E01.370.388.100.580;Sentinel Lymph Node Biopsy;D021701
E04.074.580;Sentinel Lymph Node Biopsy;D021701
E04.446.819;Sentinel Lymph Node Biopsy;D021701
E05.200.500.384.100.580;Sentinel Lymph Node Biopsy;D021701
E05.200.998.054.580;Sentinel Lymph Node Biopsy;D021701
E05.242.384.100.580;Sentinel Lymph Node Biopsy;D021701
E02.148.106;Balloon Occlusion;D021721
E02.520.179;Balloon Occlusion;D021721
E02.926.500.074;Balloon Occlusion;D021721
B01.043.075.189.250;Eimeriida;D021741
B01.043.075.189.250.150;Cryptosporidiidae;D021742
B01.043.075.189.250.250;Eimeriidae;D021743
B01.043.075.189.250.250.200;Cyclospora;D021744
B01.043.075.189.250.750;Sarcocystidae;D021745
C12.706.629;Multicystic Dysplastic Kidney;D021782
C12.777.419.403.750;Multicystic Dysplastic Kidney;D021782
C13.351.875.558;Multicystic Dysplastic Kidney;D021782
C13.351.968.419.403.750;Multicystic Dysplastic Kidney;D021782
C16.131.939.629;Multicystic Dysplastic Kidney;D021782
A02.835.583.979;Zygapophyseal Joint;D021801
C01.539.221.500;Communicable Diseases, Emerging;D021821
F01.145.802.845;Safe Sex;D021841
B01.300.360.520;Microsporidia, Unclassified;D021861
B01.300.360.500.500.100.200;Enterocytozoon;D021862
B01.300.360.500.500.100.900;Vittaforma;D021863
B01.300.360.500.500.600.650;Pleistophora;D021864
C03.752.250.410;Isosporiasis;D021865
C03.752.250.280;Cyclosporiasis;D021866
D08.811.165;DNA, Catalytic;D021881
D08.811.913.696.445.735.265;DNA, Catalytic;D021881
D13.444.308.243;DNA, Catalytic;D021881
D13.444.308.324;DNA, Intergenic;D021901
G05.360.340.024.220;DNA, Intergenic;D021901
B03.440.450.425.275.099;Enterobacter aerogenes;D021902
B03.660.250.150.170.049;Enterobacter aerogenes;D021902
D13.444.308.324.230;DNA, Ribosomal Spacer;D021903
D13.444.308.475.230;DNA, Ribosomal Spacer;D021903
C14.280.484.150.535;Aortic Stenosis, Supravalvular;D021921
C14.280.955.249.535;Aortic Stenosis, Supravalvular;D021921
C14.280.484.150.070.210;Discrete Subaortic Stenosis;D021922
C14.280.955.249.070.210;Discrete Subaortic Stenosis;D021922
A11.284.149.165.175.160;Caveolae;D021941
A11.284.149.165.570.160;Caveolae;D021941
A11.284.430.214.190.875.190.880.180.160;Caveolae;D021941
A11.284.149.165;Cell Membrane Structures;D021961
A11.284.149.165.570;Membrane Microdomains;D021962
A11.284.149.165.165;Cell-Matrix Junctions;D021982
D08.811.399.325.500.400.300;Cyclophilins;D021983
D12.776.543.750.705.400.300;Cyclophilins;D021983
D12.776.827.275.300;Cyclophilins;D021983
D08.811.399.325.500.400.300.500;Cyclophilin A;D021984
A11.284.149.165.165.285;Focal Adhesions;D022001
A11.284.149.165.165.360;Hemidesmosomes;D022002
A11.284.430.106.279;Cell Nucleus Structures;D022003
A11.284.430.106.279.345.190.160;Chromosome Structures;D022004
G05.360.160;Chromosome Structures;D022004
A11.284.149.165.420.020;Adherens Junctions;D022005
D08.811.399.325.500.400.700;Tacrolimus Binding Proteins;D022021
D12.776.543.750.705.400.700;Tacrolimus Binding Proteins;D022021
D12.776.827.275.700;Tacrolimus Binding Proteins;D022021
A11.284.430.106.279.692.630;Nuclear Pore;D022022
A11.284.430.106.279.345.190.160.180.270;Euchromatin;D022041
D12.776.664.224.270;Euchromatin;D022041
G05.360.160.180.270;Euchromatin;D022041
D08.811.399.325.500.400.700.500;Tacrolimus Binding Protein 1A;D022061
D12.776.543.750.705.400.700.500;Tacrolimus Binding Protein 1A;D022061
D12.776.827.275.700.500;Tacrolimus Binding Protein 1A;D022061
E01.370.370.380.245;Electrophysiologic Techniques, Cardiac;D022062
E01.370.405.267;Electrophysiologic Techniques, Cardiac;D022062
A11.284.180;Cell Surface Extensions;D022081
A11.284;Cellular Structures;D022082
A11.284.430.214.190;Cytoplasmic Structures;D022083
A11.284.430.214.190.750.585;Microtubule-Organizing Center;D022101
D20.215.894.135.225;Cholera Vaccines;D022121
D20.215.894.135.063;Anthrax Vaccines;D022122
D20.215.894.135.492;Lyme Disease Vaccines;D022123
C23.550.421;Hyperammonemia;D022124
C26.540;Lacerations;D022125
I01.880.604.473.352.500.030;Access to Information;D022126
L01.143.024;Access to Information;D022126
L01.737.030;Access to Information;D022126
B04.820.650.124.400;Jaagsiekte sheep retrovirus;D022141
B04.909.574.807.124.400;Jaagsiekte sheep retrovirus;D022141
B04.909.777.731.124.400;Jaagsiekte sheep retrovirus;D022141
A11.284.430.214.190.875.190.880.810;Secretory Vesicles;D022142
H02.478.676.218;Family Nursing;D022143
A11.284.430.214.190.875.190.880;Transport Vesicles;D022161
A11.284.430.214.190.875.190;Cytoplasmic Vesicles;D022162
A11.284.430.214.190.875.190.880.180.170;Clathrin-Coated Vesicles;D022163
A11.284.430.214.190.875.190.880.180.180;COP-Coated Vesicles;D022181
A11.284.187.178;Chromosomes, Artificial;D022201
G05.360.162.178;Chromosomes, Artificial;D022201
G05.360.337.249;Chromosomes, Artificial;D022201
A11.284.187.178.170;Chromosomes, Artificial, Bacterial;D022202
A11.284.187.190.170;Chromosomes, Artificial, Bacterial;D022202
A20.812.170;Chromosomes, Artificial, Bacterial;D022202
G05.360.162.178.170;Chromosomes, Artificial, Bacterial;D022202
G05.360.162.190.170;Chromosomes, Artificial, Bacterial;D022202
G05.360.337.249.170;Chromosomes, Artificial, Bacterial;D022202
A11.284.187.178.190;Chromosomes, Artificial, Mammalian;D022221
A11.284.187.520.190;Chromosomes, Artificial, Mammalian;D022221
G05.360.162.178.190;Chromosomes, Artificial, Mammalian;D022221
G05.360.162.520.190;Chromosomes, Artificial, Mammalian;D022221
G05.360.337.249.190;Chromosomes, Artificial, Mammalian;D022221
A11.284.187.178.190.117;Chromosomes, Artificial, Human;D022222
A11.284.187.520.190.117;Chromosomes, Artificial, Human;D022222
A11.284.187.520.300.117;Chromosomes, Artificial, Human;D022222
G05.360.162.178.190.117;Chromosomes, Artificial, Human;D022222
G05.360.162.520.190.117;Chromosomes, Artificial, Human;D022222
G05.360.162.520.300.117;Chromosomes, Artificial, Human;D022222
G05.360.337.249.190.117;Chromosomes, Artificial, Human;D022222
D20.215.894.860;Vaccines, Subunit;D022223
D20.215.894.899.500;Parainfluenza Vaccines;D022241
D20.215.894.135.750.600;Pneumococcal Vaccines;D022242
D20.215.894.899.760;Rotavirus Vaccines;D022243
D20.215.894.899.730;Respiratory Syncytial Virus Vaccines;D022261
D20.215.894.135.720;Shigella Vaccines;D022281
D20.215.894.860.900;Vaccines, Acellular;D022282
D20.215.894.899.290;Herpesvirus Vaccines;D022283
D20.215.894.899.290.400;Herpes Simplex Virus Vaccines;D022301
D20.215.894.899.320;Japanese Encephalitis Vaccines;D022321
D20.215.894.899.970;Yellow Fever Vaccine;D022341
D20.215.894.135.390;Escherichia coli Vaccines;D022361
D20.215.894.899.955.395;Hepatitis A Vaccines;D022362
D20.215.894.135.500;Meningococcal Vaccines;D022401
D20.215.894.899.632;Pseudorabies Vaccines;D022421
D20.215.894.135.310;Diphtheria-Tetanus Vaccine;D022422
D20.215.894.691.263.310;Diphtheria-Tetanus Vaccine;D022422
D20.215.894.691.824.310;Diphtheria-Tetanus Vaccine;D022422
D20.215.894.815.320;Diphtheria-Tetanus Vaccine;D022422
A11.627;Myeloid Cells;D022423
D12.776.543.990.100;Caveolins;D022461
D12.776.828.868.915;Vaccines, Edible;D022462
D20.215.894.860.915;Vaccines, Edible;D022462
D20.215.894.865.915;Vaccines, Edible;D022462
D23.050.865.915;Vaccines, Edible;D022462
D20.215.894.899.120;Cytomegalovirus Vaccines;D022482
D20.215.894.899.290.500;Marek Disease Vaccines;D022501
A11.284.430.214.190.750.050.830;Stress Fibers;D022502
E05.393.620.311;Ligase Chain Reaction;D022521
D20.215.894.135.750;Streptococcal Vaccines;D022541
D20.215.894.815.500;Measles-Mumps-Rubella Vaccine;D022542
D20.215.894.899.390;Measles-Mumps-Rubella Vaccine;D022542
D20.215.894.899.404.500;Measles-Mumps-Rubella Vaccine;D022542
D20.215.894.899.488.500;Measles-Mumps-Rubella Vaccine;D022542
D20.215.894.899.779.500;Measles-Mumps-Rubella Vaccine;D022542
E02.365.647.110.500;Advanced Cardiac Life Support;D022561
E02.760.440.028;Advanced Cardiac Life Support;D022561
N02.421.585.440.028;Advanced Cardiac Life Support;D022561
D20.215.894.135.685;Salmonella Vaccines;D022562
D20.215.894.845;Vaccines, Marker;D022581
D08.811.277.450.430.700.750.750;Shiga Toxins;D022603
D23.946.123.794;Shiga Toxins;D022603
D23.946.330.575;Shiga Toxins;D022603
D08.811.277.450.430.700.750.750.500;Shiga Toxin;D022621
D23.946.123.794.500;Shiga Toxin;D022621
D23.946.330.575.500;Shiga Toxin;D022621
D08.811.277.450.430.700.750.750.120;Shiga Toxin 1;D022622
D12.776.097.275.877;Shiga Toxin 1;D022622
D23.946.123.794.100;Shiga Toxin 1;D022622
D23.946.330.575.120;Shiga Toxin 1;D022622
D08.811.277.450.430.700.750.750.124;Shiga Toxin 2;D022641
D12.776.097.275.879;Shiga Toxin 2;D022641
D23.946.123.794.124;Shiga Toxin 2;D022641
D23.946.330.575.124;Shiga Toxin 2;D022641
D20.215.894.818;Vaccines, Contraceptive;D022642
D13.444.735.790;RNA, Untranslated;D022661
D20.215.894.135.290;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D20.215.894.135.535.295;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D20.215.894.691.263.290;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D20.215.894.691.824.290;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D20.215.894.815.149;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D20.215.894.860.900.267;Diphtheria-Tetanus-acellular Pertussis Vaccines;D022681
D25.479.900;Virosomes;D022701
D26.255.260.900;Virosomes;D022701
D27.720.280.260.900;Virosomes;D022701
J01.637.051.479.900;Virosomes;D022701
J01.637.087.500.900;Virosomes;D022701
D12.776.543.750.070.300.300.340.900;Receptors, Adrenergic, beta-3;D022702
D12.776.543.750.100.150.300.340.900;Receptors, Adrenergic, beta-3;D022702
D12.776.543.750.720.300.300.300.340.300;Receptors, Adrenergic, beta-3;D022702
D12.776.828.868.940;Vaccines, Virosome;D022721
D20.215.894.865.940;Vaccines, Virosome;D022721
D23.050.865.940;Vaccines, Virosome;D022721
G07.110.232.778;Thermogenesis;D022722
G07.700.100.778;Thermogenesis;D022722
G07.700.360.265.500;Thermogenesis;D022722
G05.355.760.390;Gene Transfer, Horizontal;D022761
D12.776.260.108.124;CCAAT-Enhancer-Binding Proteins;D022762
D12.776.660.167;CCAAT-Enhancer-Binding Proteins;D022762
D12.776.930.127.124;CCAAT-Enhancer-Binding Proteins;D022762
D12.776.260.108.124.500;CCAAT-Enhancer-Binding Protein-alpha;D022763
D12.776.660.167.500;CCAAT-Enhancer-Binding Protein-alpha;D022763
D12.776.930.127.124.500;CCAAT-Enhancer-Binding Protein-alpha;D022763
A11.436.348;Hepatocytes;D022781
D12.776.260.108.124.750;CCAAT-Enhancer-Binding Protein-beta;D022782
D12.776.660.167.750;CCAAT-Enhancer-Binding Protein-beta;D022782
D12.776.930.127.124.750;CCAAT-Enhancer-Binding Protein-beta;D022782
B04.280.037.800;Torque teno virus;D022783
B04.909.204.099.800;Torque teno virus;D022783
B04.970.060.800;Torque teno virus;D022783
D12.644.541.500.650.500.180;Complementarity Determining Regions;D022801
D12.776.124.486.485.680.650.500.180;Complementarity Determining Regions;D022801
D12.776.124.486.485.797.180;Complementarity Determining Regions;D022801
D12.776.124.790.651.680.650.500.180;Complementarity Determining Regions;D022801
D12.776.124.790.651.797.180;Complementarity Determining Regions;D022801
D12.776.377.715.548.680.650.500.180;Complementarity Determining Regions;D022801
D12.776.377.715.548.797.180;Complementarity Determining Regions;D022801
D12.776.543.750.705.816.824.300;Complementarity Determining Regions;D022801
G02.111.570.060.425.160;Complementarity Determining Regions;D022801
D13.444.735.544.550;RNA Splice Sites;D022821
G02.111.570.080.689.687.490;RNA Splice Sites;D022821
G05.360.080.689.687.490;RNA Splice Sites;D022821
G05.360.340.024.340.137.800;RNA Splice Sites;D022821
C11.270.040.545.400;Hermanski-Pudlak Syndrome;D022861
C15.378.100.100.515;Hermanski-Pudlak Syndrome;D022861
C15.378.100.685.400;Hermanski-Pudlak Syndrome;D022861
C15.378.140.735.400;Hermanski-Pudlak Syndrome;D022861
C15.378.463.735.400;Hermanski-Pudlak Syndrome;D022861
C16.320.099.515;Hermanski-Pudlak Syndrome;D022861
C16.320.290.040.100.400;Hermanski-Pudlak Syndrome;D022861
C16.320.565.100.102.100.400;Hermanski-Pudlak Syndrome;D022861
C16.320.850.080.100.400;Hermanski-Pudlak Syndrome;D022861
C17.800.621.440.102.100.400;Hermanski-Pudlak Syndrome;D022861
C17.800.827.080.100.400;Hermanski-Pudlak Syndrome;D022861
C18.452.648.100.102.100.400;Hermanski-Pudlak Syndrome;D022861
D02.455.526.913;Trihalomethanes;D022882
V02.950;Unpublished Works;D022902
V02.500;Government Publications;D022903
V02.180;Book Reviews;D022921
V02.450;Fictional Works;D022922
V02.660.500;Textbooks;D022923
G05.365.590.029;Allelic Imbalance;D022981
G12.425.746.425.955;Transplantation Tolerance;D023001
E05.337.550.200.900;Xenograft Model Antitumor Assays;D023041
E05.624.850;Xenograft Model Antitumor Assays;D023041
G05.340;Gene Order;D023061
D12.776.543.750.100.160.500.750.500;Receptors, Interleukin-8A;D023062
D12.776.543.750.705.852.125.500.750.500;Receptors, Interleukin-8A;D023062
D12.776.543.750.705.852.420.421.500;Receptors, Interleukin-8A;D023062
D23.050.301.264.035.605.500.750.500;Receptors, Interleukin-8A;D023062
D23.050.301.264.035.782;Receptors, Interleukin-8A;D023062
D23.101.100.110.605.500.750.500;Receptors, Interleukin-8A;D023062
D23.101.100.110.782;Receptors, Interleukin-8A;D023062
D12.776.543.750.100.160.500.750.750;Receptors, Interleukin-8B;D023063
D12.776.543.750.705.852.125.500.750.750;Receptors, Interleukin-8B;D023063
D12.776.543.750.705.852.420.421.750;Receptors, Interleukin-8B;D023063
D23.050.301.264.035.605.500.750.750;Receptors, Interleukin-8B;D023063
D23.101.100.110.605.500.750.750;Receptors, Interleukin-8B;D023063
D12.776.260.108.124.249;CCAAT-Binding Factor;D023081
D12.776.660.167.249;CCAAT-Binding Factor;D023081
D12.776.930.127.124.249;CCAAT-Binding Factor;D023081
D12.644.050.200;Defensins;D023082
D12.776.543.695.054.200;Defensins;D023082
D12.644.050.200.075;beta-Defensins;D023083
D12.776.543.695.054.200.075;beta-Defensins;D023083
D12.644.050.200.050;alpha-Defensins;D023084
D12.776.543.695.054.200.050;alpha-Defensins;D023084
G04.299.139.160.060;Anoikis;D023102
D13.444.735.544.527;RNA, Messenger, Stored;D023121
B04.280.382.100.900.440;Herpesvirus 4, Equid;D023141
B04.909.204.382.100.900.440;Herpesvirus 4, Equid;D023141
D12.644.050;Antimicrobial Cationic Peptides;D023181
D12.776.543.695.054;Antimicrobial Cationic Peptides;D023181
D12.644.276.374.750.124;CD40 Ligand;D023201
D12.644.276.972.124;CD40 Ligand;D023201
D12.776.395.550.185;CD40 Ligand;D023201
D12.776.467.374.750.124;CD40 Ligand;D023201
D12.776.467.972.124;CD40 Ligand;D023201
D12.776.543.550.198;CD40 Ligand;D023201
D23.050.301.264.035.278;CD40 Ligand;D023201
D23.101.100.110.278;CD40 Ligand;D023201
D23.529.374.750.124;CD40 Ligand;D023201
D23.529.972.124;CD40 Ligand;D023201
E02.319.310.075;Antiretroviral Therapy, Highly Active;D023241
E05.318.308.940.968.875.260;Glasgow Outcome Scale;D023261
E05.944.510;Glasgow Outcome Scale;D023261
L01.280.900.968.875.260;Glasgow Outcome Scale;D023261
N04.452.859.564.800.260;Glasgow Outcome Scale;D023261
N05.715.360.300.715.500.800.335;Glasgow Outcome Scale;D023261
H01.158.273.180.350;Genomics;D023281
H01.158.273.343.350;Genomics;D023281
E05.393.600;Nuclease Protection Assays;D023282
E05.196.700.690;Protein Footprinting;D023302
E05.393.760.705.685.690;Protein Footprinting;D023302
D03.383.129.462.600;Oxazolidinones;D023303
D20.215.894.899.623;Poliovirus Vaccines;D023321
C23.888.208;Chills;D023341
V03.950;Validation Studies;D023361
V03.400;Evaluation Studies;D023362
E05.315;Endpoint Determination;D023381
E05.940.790;Toxicity Tests, Acute;D023382
E05.017.080;Animal Use Alternatives;D023401
E05.598;Models, Animal;D023421
E05.940.790.500;Skin Irritancy Tests;D023422
E01.370.225.812.871.450;Local Lymph Node Assay;D023441
E05.200.812.871.450;Local Lymph Node Assay;D023441
E05.478.594.890.450;Local Lymph Node Assay;D023441
A11.148.378.590;Myeloid Progenitor Cells;D023461
A11.627.635;Myeloid Progenitor Cells;D023461
A11.872.378.590;Myeloid Progenitor Cells;D023461
A15.378.316.378.590;Myeloid Progenitor Cells;D023461
I01.198.240.856.800;Terrorism;D023481
I01.880.735.900.800;Terrorism;D023481
I01.198.240.856.800.100;Bioterrorism;D023482
I01.880.735.900.800.100;Bioterrorism;D023482
I01.880.735.944.226.100;Bioterrorism;D023482
B03.440.190.190.230;Chlamydophila;D023501
B03.440.190.190.190.500;Chlamydia muridarum;D023502
C01.252.400.210.250;Chlamydophila Infections;D023521
D27.505.519.468;HIV Fusion Inhibitors;D023581
D27.505.954.122.388.077.088.209;HIV Fusion Inhibitors;D023581
D20.215.894.067;Alzheimer Vaccines;D023582
B04.100;Archaeal Viruses;D023641
B04.100.700;Rudiviridae;D023642
B04.280.775;Rudiviridae;D023642
B04.100.450;Lipothrixviridae;D023643
B04.280.450;Lipothrixviridae;D023643
B04.100.250;Guttaviridae;D023644
B04.280.362;Guttaviridae;D023644
B01.050.150.900.493.385;Esociformes;D023661
B01.050.150.900.493.602.200;Cichlids;D023681
B01.050.150.900.493.850;Smegmamorpha;D023701
B01.050.150.900.493.378.430;Gymnotiformes;D023702
B01.050.150.900.493.875;Tetraodontiformes;D023721
B01.050.150.900.493.875.800;Takifugu;D023741
B01.050.150.900.493.850.139;Beloniformes;D023761
B01.050.150.900.493.850.280.214;Fundulidae;D023781
E02.299;Directly Observed Therapy;D023801
E04.520.100;Cerclage, Cervical;D023802
E04.100.814.603;Limb Salvage;D023821
E04.555.400;Limb Salvage;D023821
E04.680.350;Limb Salvage;D023821
E05.240.311.500;Tissue Engineering;D023822
J01.293.069.249.500;Tissue Engineering;D023822
E01.370.386.870;Rhinometry, Acoustic;D023842
E01.370.350.600.631;Photography, Dental;D023861
E05.712.315;Photography, Dental;D023861
E06.342.488;Photography, Dental;D023861
E01.370.350.350.810.180;Colonography, Computed Tomographic;D023881
E01.370.350.600.350.700.810.180;Colonography, Computed Tomographic;D023881
E01.370.350.700.700.810.180;Colonography, Computed Tomographic;D023881
E01.370.350.700.810.810.180;Colonography, Computed Tomographic;D023881
E01.370.372.230;Colonography, Computed Tomographic;D023881
G11.561.225.425.500;Dominance, Ocular;D023882
G14.264;Dominance, Ocular;D023882
G04.299.134.220.220.687.444.299;Chromosome Pairing;D023902
G04.299.134.220.220.875.500.299;Chromosome Pairing;D023902
G05.355.105.220.687.500.299;Chromosome Pairing;D023902
G05.355.105.220.875.500.299;Chromosome Pairing;D023902
C14.280.647.250.285.200;Coronary Restenosis;D023903
C14.907.585.250.285.200;Coronary Restenosis;D023903
C14.280.647.250.285;Coronary Stenosis;D023921
C14.907.585.250.285;Coronary Stenosis;D023921
C12.706.316.064.249;Gonadal Dysgenesis, 46,XX;D023961
C12.706.316.309.193;Gonadal Dysgenesis, 46,XX;D023961
C13.351.875.253.064.249;Gonadal Dysgenesis, 46,XX;D023961
C13.351.875.253.309.193;Gonadal Dysgenesis, 46,XX;D023961
C16.131.939.316.064.249;Gonadal Dysgenesis, 46,XX;D023961
C16.131.939.316.309.193;Gonadal Dysgenesis, 46,XX;D023961
C19.391.119.064.249;Gonadal Dysgenesis, 46,XX;D023961
C19.391.119.309.193;Gonadal Dysgenesis, 46,XX;D023961
C04.557.337.539.775;Sarcoma, Myeloid;D023981
C04.557.450.795.853;Sarcoma, Myeloid;D023981
D12.776.660.235.400.400;HMGN Proteins;D024001
D12.776.664.235.400.400;HMGN Proteins;D024001
D12.776.260.356;HMGB Proteins;D024002
D12.776.660.235.400.600;HMGB Proteins;D024002
D12.776.664.235.400.600;HMGB Proteins;D024002
D12.776.260.312;HMGA Proteins;D024003
D12.776.660.235.400.500;HMGA Proteins;D024003
D12.776.664.235.400.500;HMGA Proteins;D024003
D12.776.860.300.250.400.550;Fibril-Associated Collagens;D024021
D05.750.078.280.300;Fibrillar Collagens;D024022
D12.776.860.300.250.300;Fibrillar Collagens;D024022
D12.776.860.300.250.400;Non-Fibrillar Collagens;D024041
D05.750.078.280.300.100;Collagen Type I;D024042
D12.776.860.300.250.300.100;Collagen Type I;D024042
D05.750.078.280.300.200;Collagen Type II;D024043
D12.776.860.300.250.300.200;Collagen Type II;D024043
D05.750.078.280.300.300;Collagen Type III;D024061
D12.776.860.300.250.300.300;Collagen Type III;D024061
D05.750.078.280.300.400;Collagen Type V;D024062
D12.776.860.300.250.300.400;Collagen Type V;D024062
D12.776.860.300.250.400.550.200;Collagen Type IX;D024081
D12.776.860.300.250.400.550.300;Collagen Type XII;D024082
D12.776.575;Mitochondrial Proteins;D024101
D12.776.860.300.250.400.400;Collagen Type VIII;D024102
D12.776.860.300.250.400.500;Collagen Type X;D024121
D12.776.860.300.250.400.100;Collagen Type IV;D024141
D12.776.860.300.250.400.200;Collagen Type VI;D024142
D12.776.860.300.250.400.300;Collagen Type VII;D024143
D05.750.078.280.300.500;Collagen Type XI;D024161
D12.776.860.300.250.300.500;Collagen Type XI;D024161
E04.708;Second-Look Surgery;D024162
D12.776.860.300.250.400.525;Collagen Type XIII;D024181
C23.550.210.645.890;Uniparental Disomy;D024182
G05.365.590.175.935;Uniparental Disomy;D024182
G04.299.122.155;Bystander Effect;D024201
E05.196.401.500;Electrophoretic Mobility Shift Assay;D024202
E02.183.750;Antineoplastic Protocols;D024221
E02.319.077;Antineoplastic Protocols;D024221
N05.715.360.775.225.500;Antineoplastic Protocols;D024221
D12.776.660.235.400.400.200;HMGN1 Protein;D024241
D12.776.664.235.400.400.200;HMGN1 Protein;D024241
D12.776.660.235.400.400.300;HMGN2 Protein;D024242
D12.776.664.235.400.400.300;HMGN2 Protein;D024242
D12.776.260.356.300;HMGB1 Protein;D024243
D12.776.660.235.400.600.300;HMGB1 Protein;D024243
D12.776.664.235.400.600.300;HMGB1 Protein;D024243
D12.776.260.356.600;HMGB2 Protein;D024261
D12.776.660.235.400.600.600;HMGB2 Protein;D024261
D12.776.664.235.400.600.600;HMGB2 Protein;D024261
G05.360.340.024.340.450;Genes, sry;D024282
A18.024.750.200;Plant Bark;D024301
D02.455.326.271.665.202.912;zeta Carotene;D024321
D02.455.426.392.368.367.379.249.925;zeta Carotene;D024321
D02.455.849.131.912;zeta Carotene;D024321
D23.767.261.925;zeta Carotene;D024321
D12.125.072.050;Amino Acids, Aromatic;D024322
D02.455.326.271.665.202.868;Xanthophylls;D024341
D02.455.426.392.368.367.379.249.887;Xanthophylls;D024341
D02.455.849.131.868;Xanthophylls;D024341
D23.767.261.887;Xanthophylls;D024341
D12.125.067;Amino Acids, Acidic;D024342
C07.793.494.825;Open Bite;D024343
D12.125.068;Amino Acids, Basic;D024361
N04.761.040;Advance Directive Adherence;D024362
N05.715.360.317;Advance Directive Adherence;D024362
G05.360.340.024.340.137.750.840;Transcription Initiation Site;D024363
F01.829.316.616.625;Professional Role;D024382
D08.811.520.241.300.150.100;Carbonic Anhydrase I;D024401
D08.811.520.241.300.150.200;Carbonic Anhydrase II;D024402
D08.811.520.241.300.150.300;Carbonic Anhydrase III;D024403
D08.811.520.241.300.150.500;Carbonic Anhydrase V;D024404
A07.231.114.379;Gastroepiploic Artery;D024405
D27.888.569.468.060;Aneugens;D024422
D08.811.913.477.700.225.500;Aspartate Aminotransferase, Mitochondrial;D024442
D08.811.913.477.700.225.249;Aspartate Aminotransferase, Cytoplasmic;D024443
D05.750.078.730.475.470;Myosin Type I;D024461
D08.811.277.040.025.193.750.500;Myosin Type I;D024461
D12.776.210.500.600.465;Myosin Type I;D024461
D12.776.220.525.475.470;Myosin Type I;D024461
D05.750.078.730.475.475;Myosin Type II;D024462
D08.811.277.040.025.193.750.750;Myosin Type II;D024462
D12.776.210.500.600.470;Myosin Type II;D024462
D12.776.220.525.475.475;Myosin Type II;D024462
D02.455.426.559.847.638.721.374.844;Vitamin K 2;D024482
D02.455.849.291.523.500.844;Vitamin K 2;D024482
D02.806.550.750;Vitamin K 2;D024482
D04.615.638.721.374.844;Vitamin K 2;D024482
D02.455.426.559.847.638.721.374.922;Vitamin K 3;D024483
D02.455.849.291.523.500.922;Vitamin K 3;D024483
D02.806.550.875;Vitamin K 3;D024483
D04.615.638.721.374.922;Vitamin K 3;D024483
D05.750.078.730.475.475.500;Nonmuscle Myosin Type IIB;D024501
D08.811.277.040.025.193.750.750.500;Nonmuscle Myosin Type IIB;D024501
D12.776.210.500.600.470.500;Nonmuscle Myosin Type IIB;D024501
D12.776.220.525.475.475.500;Nonmuscle Myosin Type IIB;D024501
D03.438.150.909.750.249;alpha-Tocopherol;D024502
D03.830.219.909.750.249;alpha-Tocopherol;D024502
D03.438.150.909.750.374;beta-Tocopherol;D024503
D03.830.219.909.750.374;beta-Tocopherol;D024503
D03.438.150.909.750.500;gamma-Tocopherol;D024504
D03.830.219.909.750.500;gamma-Tocopherol;D024504
D03.438.150.909.750;Tocopherols;D024505
D03.830.219.909.750;Tocopherols;D024505
G05.360.340.024.220.282;5' Flanking Region;D024506
G05.360.340.024.340.137.295;5' Flanking Region;D024506
D05.750.078.730.475.475.249;Nonmuscle Myosin Type IIA;D024507
D08.811.277.040.025.193.750.750.374;Nonmuscle Myosin Type IIA;D024507
D12.776.210.500.600.470.374;Nonmuscle Myosin Type IIA;D024507
D12.776.220.525.475.475.249;Nonmuscle Myosin Type IIA;D024507
D03.438.150.909.875;Tocotrienols;D024508
D03.830.219.909.875;Tocotrienols;D024508
G05.360.340.024.220.280;3' Flanking Region;D024509
G05.360.340.024.340.137.290;3' Flanking Region;D024509
G07.700.320.500.325.377.625.590;Muscle Development;D024510
G11.427.590.560.590;Muscle Development;D024510
A13.641;Mushroom Bodies;D024521
G05.360.340.024.340.375.249.105;Genes, BRCA2;D024522
G05.360.340.024.340.415.400.105;Genes, BRCA2;D024522
B01.050.150.900.493.039;Batrachoidiformes;D024541
B01.050.150.200.400;Hyperotreti;D024561
B01.050.500.272.400;Hyperotreti;D024561
D08.811.682.657.163.750.350;Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating);D024581
D08.811.682.657.163.750.250;Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+);D024601
D08.811.682.657.163.750.300;Glyceraldehyde-3-Phosphate Dehydrogenase (NADP+)(Phosphorylating);D024602
D12.776.157.530.400.600.900;Potassium Channels, Voltage-Gated;D024642
D12.776.543.550.425.750.900;Potassium Channels, Voltage-Gated;D024642
D12.776.543.585.400.750.900;Potassium Channels, Voltage-Gated;D024642
D12.776.157.530.400.600.450;Potassium Channels, Inwardly Rectifying;D024661
D12.776.543.550.425.750.450;Potassium Channels, Inwardly Rectifying;D024661
D12.776.543.585.400.750.450;Potassium Channels, Inwardly Rectifying;D024661
D12.776.157.530.400.600.150;Potassium Channels, Calcium-Activated;D024681
D12.776.543.550.425.750.150;Potassium Channels, Calcium-Activated;D024681
D12.776.543.585.400.750.150;Potassium Channels, Calcium-Activated;D024681
D12.776.313.249;BRCA2 Protein;D024682
D12.776.624.776.101;BRCA2 Protein;D024682
D12.776.660.105;BRCA2 Protein;D024682
D12.776.157.530.400.600.850;Potassium Channels, Tandem Pore Domain;D024683
D12.776.543.550.425.750.850;Potassium Channels, Tandem Pore Domain;D024683
D12.776.543.585.400.750.850;Potassium Channels, Tandem Pore Domain;D024683
D05.750.078.730.475.750;Myosin Type V;D024701
D08.811.277.040.025.193.750.875;Myosin Type V;D024701
D12.776.220.525.475.750;Myosin Type V;D024701
G02.111.570.080.689.330.240;E-Box Elements;D024721
G05.360.080.689.330.240;E-Box Elements;D024721
G05.360.340.024.340.137.750.249.240;E-Box Elements;D024721
D05.750.078.730.475.475.124;Cardiac Myosins;D024722
D08.811.277.040.025.193.750.750.124;Cardiac Myosins;D024722
D12.776.210.500.600.470.249;Cardiac Myosins;D024722
D12.776.220.525.475.475.124;Cardiac Myosins;D024722
D05.750.078.730.475.475.124.500;Ventricular Myosins;D024723
D08.811.277.040.025.193.750.750.124.500;Ventricular Myosins;D024723
D12.776.210.500.600.470.249.500;Ventricular Myosins;D024723
D12.776.220.525.475.475.124.500;Ventricular Myosins;D024723
C14.280.238.100.500;Cardiomyopathy, Hypertrophic, Familial;D024741
C16.320.160;Cardiomyopathy, Hypertrophic, Familial;D024741
G02.111.570.790.709.610.380;HMG-Box Domains;D024742
D05.750.078.730.475.475.124.249;Atrial Myosins;D024743
D08.811.277.040.025.193.750.750.124.249;Atrial Myosins;D024743
D12.776.210.500.600.470.249.249;Atrial Myosins;D024743
D12.776.220.525.475.475.124.249;Atrial Myosins;D024743
D05.750.078.730.475.475.750;Skeletal Muscle Myosins;D024744
D08.811.277.040.025.193.750.750.750;Skeletal Muscle Myosins;D024744
D12.776.210.500.600.470.750;Skeletal Muscle Myosins;D024744
D12.776.220.525.475.475.750;Skeletal Muscle Myosins;D024744
D05.750.078.730.475.475.875;Smooth Muscle Myosins;D024745
D08.811.277.040.025.193.750.750.875;Smooth Muscle Myosins;D024745
D12.776.210.500.600.470.875;Smooth Muscle Myosins;D024745
D12.776.220.525.475.475.875;Smooth Muscle Myosins;D024745
G02.111.570.790.709.600.040.050;AT-Hook Motifs;D024761
E02.596;Leeching;D024763
E02.319.913.500;Hirudin Therapy;D024764
C10.574.945;Tauopathies;D024801
F01.829.316.616.625.450;Nurse's Role;D024802
N05.300.100.337;Nurse's Role;D024802
E05.104;Biomedical Enhancement;D024803
J01.897.115.250;Biomedical Enhancement;D024803
C18.452.394.968.500.570;Metabolic Syndrome X;D024821
C18.452.625;Metabolic Syndrome X;D024821
D03.438.810.835.322;Fluoroquinolones;D024841
E05.104.500;Genetic Enhancement;D024861
E05.393.420.451;Genetic Enhancement;D024861
J01.897.115.250.500;Genetic Enhancement;D024861
A11.690;Oxyphil Cells;D024862
G06.099.225;Drug Resistance, Bacterial;D024881
G06.225.347;Drug Resistance, Bacterial;D024881
G07.690.320.269.347;Drug Resistance, Bacterial;D024881
G06.225.420;Drug Resistance, Viral;D024882
G06.920.225;Drug Resistance, Viral;D024882
G07.690.320.269.420;Drug Resistance, Viral;D024882
G06.099.225.812;Drug Resistance, Multiple, Bacterial;D024901
G06.225.347.812;Drug Resistance, Multiple, Bacterial;D024901
G07.690.320.269.347.812;Drug Resistance, Multiple, Bacterial;D024901
G07.690.320.300.500;Drug Resistance, Multiple, Bacterial;D024901
G06.225.420.500;Drug Resistance, Multiple, Viral;D024921
G06.920.225.500;Drug Resistance, Multiple, Viral;D024921
G07.690.320.269.420.500;Drug Resistance, Multiple, Viral;D024921
G07.690.320.300.750;Drug Resistance, Multiple, Viral;D024921
D08.811.913.400.450.460.400.374;Starch Phosphorylase;D024941
D08.811.913.400.450.460.400.186;Glycogen Phosphorylase;D024981
D08.811.913.400.450.460.400.186.312;Glycogen Phosphorylase, Muscle Form;D024982
D08.811.913.400.450.460.400.186.124;Glycogen Phosphorylase, Liver Form;D025001
D08.811.913.400.450.460.400.186.061;Glycogen Phosphorylase, Brain Form;D025002
G07.700.320.500.325.377.750.325;Cementogenesis;D025021
F01.145.113.069.500;Animal Migration;D025041
A08.663.358.050;Amacrine Cells;D025042
A08.663.650.850.500;Amacrine Cells;D025042
A09.371.729.831.500;Amacrine Cells;D025042
A11.671.358.050;Amacrine Cells;D025042
A11.671.650.850.500;Amacrine Cells;D025042
B01.050.150.900.833.150;Dinosaurs;D025061
B01.300.107.795.980;Yarrowia;D025062
B01.300.930.980;Yarrowia;D025062
C16.131.260;Chromosome Disorders;D025063
C16.320.180;Chromosome Disorders;D025063
C16.131.260.830;Sex Chromosome Disorders;D025064
C16.320.180.830;Sex Chromosome Disorders;D025064
B03.440.425.410.711.193.150.125;Borrelia burgdorferi;D025065
B03.851.595.193.150.125;Borrelia burgdorferi;D025065
D03.383.725.676.925;Vitamin B 6;D025101
D05.750.078.730.475.612;Myosin Type III;D025102
D08.811.277.040.025.193.750.812;Myosin Type III;D025102
D08.811.913.696.310;Myosin Type III;D025102
D12.776.220.525.475.612;Myosin Type III;D025102
D05.750.078.730.475.681;Myosin Type IV;D025121
D08.811.277.040.025.193.750.843;Myosin Type IV;D025121
D12.776.220.525.475.681;Myosin Type IV;D025121
G06.225.383;Drug Resistance, Fungal;D025141
G07.690.320.269.383;Drug Resistance, Fungal;D025141
D08.811.913.696.650.150;ATP Synthetase Complexes;D025181
E01.370.225.880;Molecular Diagnostic Techniques;D025202
E05.200.880;Molecular Diagnostic Techniques;D025202
E05.393.520;Molecular Diagnostic Techniques;D025202
D08.811.913.696.620.225.850.500.500;Phosphofructokinase-1, Muscle Type;D025203
D08.811.913.696.620.225.850;Phosphofructokinases;D025221
D08.811.277.040.025.325.500;Chloroplast Proton-Translocating ATPases;D025222
D08.811.913.696.650.150.500.500;Chloroplast Proton-Translocating ATPases;D025222
D12.776.157.530.450.250.875.500.500;Chloroplast Proton-Translocating ATPases;D025222
D12.776.183.750.500;Chloroplast Proton-Translocating ATPases;D025222
D12.776.543.585.450.250.875.500.500;Chloroplast Proton-Translocating ATPases;D025222
D12.776.543.983.249;Chloroplast Proton-Translocating ATPases;D025222
D12.776.765.199.750.374;Chloroplast Proton-Translocating ATPases;D025222
C05.116.900.853.625;Spondylarthritis;D025241
C05.550.114.865;Spondylarthritis;D025241
C05.116.900.853.625.800;Spondylarthropathies;D025242
C05.550.114.865.800;Spondylarthropathies;D025242
D08.811.277.040.025.325.249;Bacterial Proton-Translocating ATPases;D025243
D08.811.913.696.650.150.500.249;Bacterial Proton-Translocating ATPases;D025243
D12.776.097.130;Bacterial Proton-Translocating ATPases;D025243
D12.776.157.530.450.250.875.500.249;Bacterial Proton-Translocating ATPases;D025243
D12.776.543.585.450.250.875.500.249;Bacterial Proton-Translocating ATPases;D025243
D08.811.277.040.025.325.750;Mitochondrial Proton-Translocating ATPases;D025261
D08.811.913.696.650.150.500.750;Mitochondrial Proton-Translocating ATPases;D025261
D12.776.157.530.450.250.875.500.750;Mitochondrial Proton-Translocating ATPases;D025261
D12.776.543.585.450.250.875.500.750;Mitochondrial Proton-Translocating ATPases;D025261
D12.776.543.585.475.625;Mitochondrial Proton-Translocating ATPases;D025261
D12.776.575.750.625;Mitochondrial Proton-Translocating ATPases;D025261
D08.811.277.040.025.325.875;Vacuolar Proton-Translocating ATPases;D025262
D08.811.913.696.650.150.500.875;Vacuolar Proton-Translocating ATPases;D025262
D12.776.157.530.450.250.875.500.875;Vacuolar Proton-Translocating ATPases;D025262
D12.776.543.585.450.250.875.500.875;Vacuolar Proton-Translocating ATPases;D025262
A19.687;Mycelium;D025282
A19.687.400;Hyphae;D025301
E02.950.875;Surgery, Computer-Assisted;D025321
E04.749;Surgery, Computer-Assisted;D025321
L01.700.508.100.710.800;Surgery, Computer-Assisted;D025321
E05.318.740.562;Principal Component Analysis;D025341
D04.345.566.802;Streptogramins;D025361
D12.644.641.802;Streptogramins;D025361
D04.345.566.802.500;Streptogramin Group A;D025362
D12.644.641.802.500;Streptogramin Group A;D025362
E01.370.386.740;Rhinomanometry;D025363
E05.559.740;Rhinomanometry;D025363
D04.345.566.802.500.500;Streptogramin A;D025364
D04.345.566.802.875.500;Streptogramin A;D025364
D12.644.641.802.500.500;Streptogramin A;D025364
D12.644.641.802.875.500;Streptogramin A;D025364
D04.345.566.802.750.500;Streptogramin B;D025381
D12.644.641.802.750.500;Streptogramin B;D025381
D04.345.566.802.750;Streptogramin Group B;D025382
D12.644.641.802.750;Streptogramin Group B;D025382
E01.370.350.130.750.228;Echocardiography, Stress;D025401
E01.370.350.850.220.228;Echocardiography, Stress;D025401
E01.370.370.380.220.228;Echocardiography, Stress;D025401
D03.132.327.412.150;Dihydroergocornine;D025441
D03.549.562.150;Dihydroergocornine;D025441
D03.132.327.412.175;Dihydroergocristine;D025442
D03.549.562.200;Dihydroergocristine;D025442
D03.132.327.412.200;Dihydroergocryptine;D025443
D03.549.562.250;Dihydroergocryptine;D025443
G07.700.360.732;Feedback, Physiological;D025461
L01.143.283.425.311;Feedback, Physiological;D025461
D08.811.277.352.650.622;Phosphofructokinase-2;D025481
D08.811.913.696.620.225.850.750;Phosphofructokinase-2;D025481
D08.811.913.696.620.225.850.500.249;Phosphofructokinase-1, Liver Type;D025501
D08.811.913.696.620.225.850.500.750;Phosphofructokinase-1, Type C;D025502
D12.776.624.776;Tumor Suppressor Proteins;D025521
B04.123.150.700.065;Bacteriophage N4;D025522
B04.123.205.280;Bacteriophage N4;D025522
B04.280.090.700.065;Bacteriophage N4;D025522
B04.123.150.800.200;Bacteriophage HK022;D025523
B04.123.205.200;Bacteriophage HK022;D025523
B04.280.090.800.200;Bacteriophage HK022;D025523
D12.776.752.249.500;Bacteriochlorophyll A;D025541
D12.644.360.325.150.500.460;Neurofibromin 1;D025542
D12.776.402.150.500.460;Neurofibromin 1;D025542
D12.776.476.325.150.500.460;Neurofibromin 1;D025542
D12.776.624.776.610;Neurofibromin 1;D025542
B04.123.370.400.240;Bacteriophage IKe;D025543
B04.280.400.400.240;Bacteriophage IKe;D025543
B04.123.370.400.300;Bacteriophage Pf1;D025561
B04.123.660.535;Bacteriophage Pf1;D025561
B04.280.400.400.300;Bacteriophage Pf1;D025561
D12.776.543.685;Neurofibromin 2;D025581
D12.776.624.776.612;Neurofibromin 2;D025581
D05.500.117.249;Adenomatous Polyposis Coli Protein;D025601
D12.776.220.040;Adenomatous Polyposis Coli Protein;D025601
D12.776.476.081.249;Adenomatous Polyposis Coli Protein;D025601
D12.776.624.776.049;Adenomatous Polyposis Coli Protein;D025601
D12.776.090.300;Halorhodopsins;D025602
D12.776.157.530.450.074.249;Halorhodopsins;D025602
D12.776.543.585.450.074.249;Halorhodopsins;D025602
D12.776.752.812.500;Halorhodopsins;D025602
D12.776.752.812.750;Sensory Rhodopsins;D025603
D12.776.752.812;Rhodopsins, Microbial;D025604
B04.123.205.350;Bacteriophage PRD1;D025622
B04.123.900.150;Bacteriophage PRD1;D025622
B04.265.658.860;Tobacco necrosis satellite virus;D025641
B04.280.030.500.675;Adenoviruses, Porcine;D025662
B04.909.204.097.500.675;Adenoviruses, Porcine;D025662
B04.280.030.100.250;Fowl adenovirus A;D025681
B04.909.204.097.100.250;Fowl adenovirus A;D025681
B04.280.498.500;Nanovirus;D025682
B04.715.499.500;Nanovirus;D025682
B04.970.540;Nanovirus;D025682
B04.280.049;Asfarviridae;D025701
B04.909.204.102;Asfarviridae;D025701
D12.776.624.776.960;WT1 Proteins;D025721
B04.280.065.249;Granulovirus;D025722
B04.525.100.249;Granulovirus;D025722
D12.776.260.312.500;HMGA1a Protein;D025741
D12.776.660.235.400.500.100;HMGA1a Protein;D025741
D12.776.664.235.400.500.100;HMGA1a Protein;D025741
D12.776.260.312.750;HMGA1b Protein;D025742
D12.776.660.235.400.500.200;HMGA1b Protein;D025742
D12.776.664.235.400.500.200;HMGA1b Protein;D025742
D12.776.260.312.937;HMGA2 Protein;D025743
D12.776.660.235.400.500.600;HMGA2 Protein;D025743
D12.776.664.235.400.500.600;HMGA2 Protein;D025743
D04.345.566.802.249;Mikamycin;D025761
D12.644.641.802.249;Mikamycin;D025761
D04.345.566.802.374;Pristinamycin;D025762
D12.644.641.802.374;Pristinamycin;D025762
D04.345.566.802.812;Vernamycin B;D025763
D12.644.641.802.812;Vernamycin B;D025763
D12.776.260.312.875;HMGA1c Protein;D025764
D12.776.660.235.400.500.400;HMGA1c Protein;D025764
D12.776.664.235.400.500.300;HMGA1c Protein;D025764
D12.776.260.356.800;HMGB3 Protein;D025765
D12.776.660.235.400.600.800;HMGB3 Protein;D025765
D12.776.664.235.400.600.800;HMGB3 Protein;D025765
D08.811.682.047.385.415.250;Hydroxymethylglutaryl-CoA Reductases, NAD-Dependent;D025781
D08.811.682.047.385.415.750;Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent;D025782
D12.776.947.500;Ubiquitin;D025801
G01.358.500.249.270;Electric Capacitance;D025802
D12.776.167.600;Tumor Suppressor Protein p14ARF;D025803
D12.776.624.776.772;Tumor Suppressor Protein p14ARF;D025803
D12.776.947.500.500;Polyubiquitin;D025821
D12.776.947.500.750;Ubiquitin C;D025822
D12.776.947.249;Small Ubiquitin-Related Modifier Proteins;D025841
D12.776.947.249.500;SUMO-1 Protein;D025842
C15.378.100.100;Blood Coagulation Disorders, Inherited;D025861
C16.320.099;Blood Coagulation Disorders, Inherited;D025861
B04.280.382.100.900.410;Herpesvirus 5, Bovine;D025881
B04.909.204.382.100.900.410;Herpesvirus 5, Bovine;D025881
D08.811.277.656.350.245.224;Carboxypeptidase U;D025901
D08.811.277.656.350.555.300;Carboxypeptidase U;D025901
D08.811.277.656.675.555.300;Carboxypeptidase U;D025901
D08.811.277.656.837.186;Carboxypeptidase U;D025901
B04.280.382.100.374;Iltovirus;D025921
B04.909.204.382.100.374;Iltovirus;D025921
B04.280.382.100.562;Mardivirus;D025922
B04.909.204.382.100.562;Mardivirus;D025922
E05.196.181.750;Chromatography, Supercritical Fluid;D025924
E05.601.690;Protein Interaction Mapping;D025941
D09.698.629.553;Oligosaccharides, Branched-Chain;D025942
B04.280.382.100.562.405;Herpesvirus 3, Gallid;D025961
B04.909.204.382.100.562.405;Herpesvirus 3, Gallid;D025961
C10.500.840;Septo-Optic Dysplasia;D025962
C16.131.666.845;Septo-Optic Dysplasia;D025962
C26.531;Hip Injuries;D025981
B04.280.382.100.562.550;Herpesvirus 1, Meleagrid;D026002
B04.909.204.382.100.562.550;Herpesvirus 1, Meleagrid;D026002
B04.280.382.400.700.300;Herpesvirus 4, Bovine;D026021
B04.909.204.210.400.700.300;Herpesvirus 4, Bovine;D026021
B04.909.204.382.400.700.300;Herpesvirus 4, Bovine;D026021
B04.909.574.204.500.700.300;Herpesvirus 4, Bovine;D026021
D02.455.849.575.812.636;Permethrin;D026023
D01.339.431.500;Singlet Oxygen;D026082
D03.132.436;Indole Alkaloids;D026121
D03.438.473.402;Indole Alkaloids;D026121
D08.811.913.050.200.800.300;Factor XIIIa;D026122
D12.776.124.125.475.500;Factor XIIIa;D026122
D23.119.475.500;Factor XIIIa;D026122
G06.225.383.500;Drug Resistance, Multiple, Fungal;D026141
G07.690.320.269.383.500;Drug Resistance, Multiple, Fungal;D026141
G07.690.320.300.625;Drug Resistance, Multiple, Fungal;D026141
D12.776.260.400.249;MADS Domain Proteins;D026161
D12.776.930.397;MADS Domain Proteins;D026161
E02.190.599;Musculoskeletal Manipulations;D026201
E02.779.867;Musculoskeletal Manipulations;D026201
E02.779.474;Exercise Movement Techniques;D026241
D12.644.136;Diazepam Binding Inhibitor;D026261
D12.776.260.400.249.374;DEFICIENS Protein;D026281
D12.776.765.249;DEFICIENS Protein;D026281
D12.776.930.397.374;DEFICIENS Protein;D026281
E02.190.599.280;Manipulation, Osteopathic;D026301
E02.779.867.444;Manipulation, Osteopathic;D026301
E02.190.525.890;Tai Ji;D026302
E02.779.474.913;Tai Ji;D026302
I03.450.642.845.560.500;Tai Ji;D026302
B01.650.940.800.575.100.812;Piperaceae;D026321
J02.500.250.725.500;Black Pepper;D026322
B01.650.940.800.575.100.765.500;Myristica fragrans;D026323
B01.650.940.800.575.100.765;Myristicaceae;D026324
D12.776.354.750.500;MCM1 Protein;D026341
D12.776.930.397.750;MCM1 Protein;D026341
D12.776.260.400.249.249;AGAMOUS Protein, Arabidopsis;D026342
D12.776.765.149.500;AGAMOUS Protein, Arabidopsis;D026342
D12.776.930.397.249;AGAMOUS Protein, Arabidopsis;D026342
D01.625.700;Reactive Nitrogen Species;D026361
D02.654.846;Reactive Nitrogen Species;D026361
D12.776.260.400.249.875;Serum Response Factor;D026362
D12.776.930.397.875;Serum Response Factor;D026362
D02.654.846.500;S-Nitrosothiols;D026403
D02.886.489.650;S-Nitrosothiols;D026403
E02.190.888;Sensory Art Therapies;D026421
D02.654.846.500.249;S-Nitrosoglutathione;D026422
D02.886.489.650.750;S-Nitrosoglutathione;D026422
D12.644.456.448.750;S-Nitrosoglutathione;D026422
D02.654.846.500.124;S-Nitroso-N-Acetylpenicillamine;D026423
D02.886.030.786.500;S-Nitroso-N-Acetylpenicillamine;D026423
D02.886.489.650.500;S-Nitroso-N-Acetylpenicillamine;D026423
D12.125.166.786.500;S-Nitroso-N-Acetylpenicillamine;D026423
E02.190.525;Mind-Body Therapies;D026441
E02.190.901;Spiritual Therapies;D026443
D04.808.247.222.265.165;Ecdysteroids;D026461
D04.808.247.808.756.143;Ecdysteroids;D026461
D06.472.445.573.271;Ecdysteroids;D026461
E05.196.401.143.500;Blotting, Far-Western;D026481
E05.301.300.096.500;Blotting, Far-Western;D026481
E05.393.525.262.500;Blotting, Far-Western;D026481
E05.478.566.320.200.200;Blotting, Far-Western;D026481
E05.601.495.320.200.500;Blotting, Far-Western;D026481
E05.601.690.149;Blotting, Far-Western;D026481
E05.196.401.133;Blotting, Southwestern;D026501
E05.301.300.093;Blotting, Southwestern;D026501
E05.393.525.225;Blotting, Southwestern;D026501
E05.601.152;Blotting, Southwestern;D026501
D12.776.526;LDL-Receptor Related Proteins;D026502
D12.776.543.750.710.450.500;LDL-Receptor Related Proteins;D026502
D12.776.526.100;Low Density Lipoprotein Receptor-Related Protein-1;D026503
D12.776.543.750.710.450.500.100;Low Density Lipoprotein Receptor-Related Protein-1;D026503
D23.050.301.264.035.502;Low Density Lipoprotein Receptor-Related Protein-1;D026503
D23.101.100.110.498;Low Density Lipoprotein Receptor-Related Protein-1;D026503
D23.050.422.500;Heymann Nephritis Antigenic Complex;D026541
D12.776.526.200;Low Density Lipoprotein Receptor-Related Protein-2;D026561
D12.776.543.750.710.450.500.200;Low Density Lipoprotein Receptor-Related Protein-2;D026561
D23.050.422.500.500;Low Density Lipoprotein Receptor-Related Protein-2;D026561
D12.776.543.475;LDL-Receptor Related Protein-Associated Protein;D026563
D23.050.422.500.750;LDL-Receptor Related Protein-Associated Protein;D026563
D12.125.067.500.275;Isoaspartic Acid;D026581
D12.125.119.170.275;Isoaspartic Acid;D026581
D08.811.913.555.500.800.800.700;Protein D-Aspartate-L-Isoaspartate Methyltransferase;D026601
A08.663.748;Nitrergic Neurons;D026602
A11.671.738;Nitrergic Neurons;D026602
D12.125.067.500.150;D-Aspartic Acid;D026603
D12.125.119.170.150;D-Aspartic Acid;D026603
N05.700.685.149;Clinical Trials Data Monitoring Committees;D026661
C18.654.521.500.133.699.901;Vitamin B 6 Deficiency;D026681
N03.706.742.500;Advisory Committees;D026683
F02.600;Personal Autonomy;D026684
I01.880.604.473.380.500;Personal Autonomy;D026684
K01.316.756.650;Personal Autonomy;D026684
K01.752.256.830.650;Personal Autonomy;D026684
N03.706.437.380.500;Personal Autonomy;D026684
K01.316.756.500;Beneficence;D026686
K01.752.256.830.500;Beneficence;D026686
K01.316.034;Bioethical Issues;D026688
K01.316.163;Ethical Analysis;D026689
K01.752.256.113;Ethical Analysis;D026689
K01.316.070.500;Ethics, Clinical;D026690
K01.316.333.132;Ethics, Clinical;D026690
N05.350.200.500;Ethics, Clinical;D026690
N05.350.340.162;Ethics, Clinical;D026690
F01.829.547;Paternalism;D026706
K01.752.400.900;Value of Life;D026712
G02.111.087.750.225;RNA 3' End Processing;D026721
G02.149.115.750.225;RNA 3' End Processing;D026721
G03.495.839.225;RNA 3' End Processing;D026721
G05.355.315.700.225;RNA 3' End Processing;D026721
G02.111.087.750.225.710;Polyadenylation;D026723
G02.149.115.750.225.710;Polyadenylation;D026723
G03.495.839.225.710;Polyadenylation;D026723
G05.355.315.700.225.710;Polyadenylation;D026723
K01.316.167;Ethical Review;D026724
N05.350.250;Ethical Review;D026724
E02.779;Physical Therapy Modalities;D026741
H02.010.625;Physical Therapy Specialty;D026761
B04.280.350.500;Maize streak virus;D026762
B04.715.270.500;Maize streak virus;D026762
B01.650.940.800.575.100.905.347;Mandragora;D026781
G02.111.810.550.830;Synteny;D026801
G05.810.550.830;Synteny;D026801
K01.316.171;Ethicists;D026822
M01.526.276;Ethicists;D026822
N05.350.262;Ethicists;D026822
B01.050.500.131.166.132.832.100.700;Ornithodoros;D026861
B01.050.500.131.166.132.832.100;Argasidae;D026862
B01.050.500.131.166.132.832.400;Ixodidae;D026863
B01.050.500.131.166.132.832.100.100;Argas;D026864
H02.004;Acupuncture;D026881
E02.190.599.233;Manipulation, Chiropractic;D026882
D12.776.157.530;Membrane Transport Proteins;D026901
D12.776.543.585;Membrane Transport Proteins;D026901
D27.505.519.562.500;Potassium Channel Blockers;D026902
D27.505.954.411.645;Potassium Channel Blockers;D026902
D12.776.157.530.200;Amino Acid Transport Systems;D026905
D12.776.543.585.200;Amino Acid Transport Systems;D026905
D12.776.157.530.200.500;Amino Acid Transport Systems, Neutral;D026921
D12.776.543.585.200.500;Amino Acid Transport Systems, Neutral;D026921
D12.776.157.530.200.249;Amino Acid Transport Systems, Acidic;D026922
D12.776.543.585.200.249;Amino Acid Transport Systems, Acidic;D026922
D12.776.157.530.200.374;Amino Acid Transport Systems, Basic;D026923
D12.776.543.585.200.374;Amino Acid Transport Systems, Basic;D026923
D12.776.157.530.200.500.100;Amino Acid Transport System A;D026924
D12.776.543.585.200.500.100;Amino Acid Transport System A;D026924
D27.505.519.562.750;Sodium Channel Blockers;D026941
D27.505.954.411.720;Sodium Channel Blockers;D026941
D08.811.399.403;DNA Topoisomerases;D026942
D12.776.157.530.200.500.200;Amino Acid Transport System ASC;D026962
D12.776.543.585.200.500.200;Amino Acid Transport System ASC;D026962
B01.650.940.800.575.100.950.888;Urtica dioica;D026982
B01.650.940.800.575.100.950;Urticaceae;D027003
G05.355.600.810;Somatic Hypermutation, Immunoglobulin;D027041
G12.425.742.765;Somatic Hypermutation, Immunoglobulin;D027041
G12.500.349.765;Somatic Hypermutation, Immunoglobulin;D027041
A11.284.187.178.195;Chromosomes, Artificial, P1 Bacteriophage;D027042
G05.360.162.178.195;Chromosomes, Artificial, P1 Bacteriophage;D027042
G05.360.337.249.195;Chromosomes, Artificial, P1 Bacteriophage;D027042
D12.776.157.530.200.500.500;Amino Acid Transport System L;D027062
D12.776.543.585.200.500.500;Amino Acid Transport System L;D027062
D08.811.399.403.741.149;DNA Gyrase;D027081
D12.776.097.237;DNA Gyrase;D027081
D08.811.399.403.741.224;DNA Topoisomerase IV;D027101
D12.776.097.256;DNA Topoisomerase IV;D027101
A08.340.685;Satellite Cells, Perineuronal;D027161
A08.637.685;Satellite Cells, Perineuronal;D027161
A11.650.775;Satellite Cells, Perineuronal;D027161
D12.776.157.530.200.374.600;Amino Acid Transport System y+;D027182
D12.776.543.585.200.374.600;Amino Acid Transport System y+;D027182
D12.776.157.530.200.374.600.200;Cationic Amino Acid Transporter 1;D027201
D12.776.543.585.200.374.600.200;Cationic Amino Acid Transporter 1;D027201
D12.776.157.530.200.374.600.300;Cationic Amino Acid Transporter 2;D027202
D12.776.543.585.200.374.600.300;Cationic Amino Acid Transporter 2;D027202
D12.776.157.530.200.374.750;Amino Acid Transport System y+L;D027241
D12.776.543.585.200.374.750;Amino Acid Transport System y+L;D027241
D12.776.157.530.200.374.750.500;Antigens, CD98;D027261
D12.776.157.530.200.500.500.500;Antigens, CD98;D027261
D12.776.543.585.200.374.750.500;Antigens, CD98;D027261
D12.776.543.585.200.500.500.500;Antigens, CD98;D027261
D23.050.301.264.035.198;Antigens, CD98;D027261
D23.101.100.110.198;Antigens, CD98;D027261
D12.776.157.530.200.374.750.500.250;Antigens, CD98 Heavy Chain;D027282
D12.776.157.530.200.500.500.500.250;Antigens, CD98 Heavy Chain;D027282
D12.776.543.585.200.374.750.500.250;Antigens, CD98 Heavy Chain;D027282
D12.776.543.585.200.500.500.500.250;Antigens, CD98 Heavy Chain;D027282
D23.050.301.264.035.198.500;Antigens, CD98 Heavy Chain;D027282
D23.101.100.110.198.500;Antigens, CD98 Heavy Chain;D027282
D12.776.157.530.200.500.500.500.300.500;Large Neutral Amino Acid-Transporter 1;D027283
D12.776.543.585.200.500.500.500.500.500;Large Neutral Amino Acid-Transporter 1;D027283
D23.050.301.264.035.198.625.500;Large Neutral Amino Acid-Transporter 1;D027283
D23.101.100.110.198.625.500;Large Neutral Amino Acid-Transporter 1;D027283
D12.776.157.530.200.374.750.500.625;Antigens, CD98 Light Chains;D027301
D12.776.157.530.200.500.500.500.300;Antigens, CD98 Light Chains;D027301
D12.776.543.585.200.374.750.500.500;Antigens, CD98 Light Chains;D027301
D12.776.543.585.200.500.500.500.500;Antigens, CD98 Light Chains;D027301
D23.050.301.264.035.198.625;Antigens, CD98 Light Chains;D027301
D23.101.100.110.198.625;Antigens, CD98 Light Chains;D027301
D12.776.157.530.450.074;Anion Transport Proteins;D027321
D12.776.543.585.450.074;Anion Transport Proteins;D027321
D12.776.157.530.200.249.500;Amino Acid Transport System X-AG;D027322
D12.776.543.585.200.249.500;Amino Acid Transport System X-AG;D027322
D12.776.157.530.200.249.500.500.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.157.530.450.625.147.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.157.530.562.374.781.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.543.585.200.249.500.500.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.543.585.450.625.147.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.543.585.562.374.781.500;Excitatory Amino Acid Transporter 1;D027341
D12.776.157.530.200.249.500.500.750;Excitatory Amino Acid Transporter 2;D027342
D12.776.157.530.450.625.147.750;Excitatory Amino Acid Transporter 2;D027342
D12.776.157.530.562.374.781.750;Excitatory Amino Acid Transporter 2;D027342
D12.776.543.585.200.249.500.500.750;Excitatory Amino Acid Transporter 2;D027342
D12.776.543.585.450.625.147.750;Excitatory Amino Acid Transporter 2;D027342
D12.776.543.585.562.374.781.750;Excitatory Amino Acid Transporter 2;D027342
A18.024.937.750;Rhizome;D027343
A18.400.750;Rhizome;D027343
D12.776.157.530.450.074.500;Organic Anion Transporters;D027361
D12.776.543.585.450.074.500;Organic Anion Transporters;D027361
D12.776.157.530.450.074.500.781.750;Organic Anion Transport Protein 1;D027362
D12.776.543.585.450.074.500.875.750;Organic Anion Transport Protein 1;D027362
D12.776.543.585.450.162.234;Organic Anion Transport Protein 1;D027362
D12.776.157.530.450.074.500.781.500;Organic Anion Transport Polypeptide C;D027381
D12.776.543.585.450.074.500.875.500;Organic Anion Transport Polypeptide C;D027381
B04.280.640;Polyomaviridae;D027382
B04.909.204.210.620;Polyomaviridae;D027382
B04.909.574.204.670;Polyomaviridae;D027382
B04.909.675;Polyomaviridae;D027382
B04.280.535;Papillomaviridae;D027383
B04.909.204.210.655;Papillomaviridae;D027383
B04.909.574.204.655;Papillomaviridae;D027383
B04.909.624;Papillomaviridae;D027383
D08.811.913.696.620.682.700.559.842.249;Oncogene Proteins v-raf;D027384
D12.644.360.400.842.249;Oncogene Proteins v-raf;D027384
D12.776.476.400.842.249;Oncogene Proteins v-raf;D027384
D12.776.624.664.520.750.920;Oncogene Proteins v-raf;D027384
D12.776.964.700.750.920;Oncogene Proteins v-raf;D027384
D12.776.964.775.750.920;Oncogene Proteins v-raf;D027384
B01.650.940.800.575.100.590.650;Persea;D027421
B01.650.940.800.575.100.590.825;Umbellularia;D027422
B01.650.940.800.575.100.590.149.249;Cinnamomum camphora;D027423
B01.650.940.800.575.100.590.149;Cinnamomum;D027424
D12.776.157.530.100.304;Multidrug Resistance-Associated Proteins;D027425
D12.776.157.530.450.074.500.500.500;Multidrug Resistance-Associated Proteins;D027425
D12.776.543.585.100.304;Multidrug Resistance-Associated Proteins;D027425
D12.776.543.585.450.074.500.500.500;Multidrug Resistance-Associated Proteins;D027425
B01.650.940.800.575.100.590.737;Sassafras;D027441
B01.650.940.800.575.100.590.399;Laurus;D027442
B01.650.940.800.575.100.590.524;Lindera;D027443
B01.650.940.800.575.100.590.587;Ocotea;D027444
B01.650.940.800.575.100.200.399;Beta vulgaris;D027461
B01.650.940.800.575.100.200.599;Chenopodium;D027462
B01.650.940.800.575.100.200.599.500;Chenopodium album;D027463
B01.650.940.800.575.100.200.599.750;Chenopodium ambrosioides;D027464
B01.650.940.800.575.100.200.599.875;Chenopodium quinoa;D027465
B01.650.940.800.575.100.200.199;Atriplex;D027466
B01.650.940.800.575.100.200.299;Bassia scoparia;D027467
B01.650.940.800.575.100.100.255;Crepis;D027468
B01.650.940.800.575.100.087;Araliaceae;D027481
D12.776.157.530.450.074.500.400;Monocarboxylic Acid Transporters;D027501
D12.776.543.585.450.074.500.300;Monocarboxylic Acid Transporters;D027501
B01.650.940.800.575.100.575.538;Nepeta;D027521
B01.650.940.800.575.100.575.465;Marrubium;D027522
B01.650.940.800.575.100.575.428;Lavandula;D027523
B01.650.940.800.575.100.575.483;Mentha;D027541
B01.650.940.800.575.100.575.757;Rosmarinus;D027542
B01.650.940.800.575.100.575.922.770;Salvia officinalis;D027543
B01.650.940.800.575.100.575.922;Salvia;D027544
B01.650.940.800.575.100.575.922.750;Salvia miltiorrhiza;D027561
B01.650.940.800.575.100.175;Cannabaceae;D027581
B01.650.940.800.575.100.175.750;Humulus;D027582
C02.256.721;Polyomavirus Infections;D027601
G02.111.570.080.689.330.700.800;Serum Response Element;D027602
G02.111.570.080.689.675.700.800;Serum Response Element;D027602
G05.360.080.689.330.700.800;Serum Response Element;D027602
G05.360.080.689.675.700.800;Serum Response Element;D027602
G05.360.340.024.340.137.750.249.765.800;Serum Response Element;D027602
G05.360.340.024.340.137.750.680.765.800;Serum Response Element;D027602
B01.650.940.800.575.100.549;Iridaceae;D027621
B01.650.940.800.575.100.549.500;Crocus;D027622
B01.650.940.800.575.100.018.500;Yucca;D027623
E02.190.525.311;Laughter Therapy;D027641
E02.190.755.624;Eclecticism, Historical;D027681
D12.776.157.530.450.250;Cation Transport Proteins;D027682
D12.776.543.585.450.250;Cation Transport Proteins;D027682
D12.776.157.530.450.250.812;Organic Cation Transport Proteins;D027701
D12.776.543.585.450.250.812;Organic Cation Transport Proteins;D027701
D12.776.157.530.450.250.812.500;Organic Cation Transporter 1;D027702
D12.776.543.585.450.250.812.500;Organic Cation Transporter 1;D027702
B01.650.940.800.575.100.037;Amaranthaceae;D027703
B01.650.940.800.575.100.037.130;Amaranthus;D027721
B01.650.940.800.575.100.238;Convolvulaceae;D027722
B01.650.940.800.575.100.238.500.500;Ipomoea batatas;D027723
E02.875.800;Reproductive Techniques, Assisted;D027724
E05.820.800;Reproductive Techniques, Assisted;D027724
B01.650.940.800.575.100.238.500;Ipomoea;D027741
B01.650.940.800.575.100.325.500;Dioscorea;D027742
B01.650.940.800.575.100.325;Dioscoreaceae;D027743
B01.650.940.800.575.100.325.750;Tamus;D027744
B01.650.940.800.575.100.610.162;Asparagus Plant;D027761
B01.650.940.800.575.100.610.500;Lilium;D027762
B01.650.940.800.575.100.610.100.800;Shallots;D027781
J02.500.850.750;Shallots;D027781
B01.650.940.800.575.100.610.100.149;Chive;D027782
J02.500.850.243;Chive;D027782
B01.650.940.800.575.100.610.350;Galanthus;D027801
B01.650.940.800.575.100.610.425;Hypoxis;D027802
B01.650.940.800.575.100.401.649;Phaseolus;D027805
B01.650.940.800.575.100.401.450;Lens Plant;D027806
B01.650.940.800.575.100.401.375;Lathyrus;D027807
B01.650.940.800.575.100.875;Rutaceae;D027821
B01.650.940.800.575.100.773;Myrtaceae;D027822
B01.650.940.800.575.100.840;Rhamnaceae;D027823
B01.650.940.800.575.100.842.500;Rosaceae;D027824
B01.650.940.800.575.100.842.500.177;Crataegus;D027825
B01.650.940.800.575.100.842.500.750;Rosa;D027826
B01.650.940.800.575.100.773.777;Pimenta;D027841
B01.650.940.800.575.100.773.374;Eugenia;D027842
B01.650.940.800.575.100.965.500;Vitis;D027843
B01.650.940.800.575.100.965;Vitaceae;D027844
B01.650.940.800.575.100.842.500.444;Malus;D027845
B01.650.940.800.575.100.842.500.625;Prunus;D027861
B01.650.940.800.575.100.018;Agavaceae;D027881
B01.650.940.800.575.100.018.249;Agave;D027882
B01.650.940.800.575.100.401.087;Astragalus Plant;D027883
B01.650.940.800.575.100.401.087.500;Astragalus gummifer;D027884
B01.650.940.800.575.100.401.087.750;Astragalus membranaceus;D027885
B01.650.940.800.575.100.008;Acanthaceae;D027901
B01.650.940.800.575.100.008.022;Adhatoda;D027902
B01.650.940.800.575.100.180;Caprifoliaceae;D027922
B01.650.940.800.575.100.180.500;Sambucus;D027923
B01.650.940.800.575.100.180.500.500;Sambucus nigra;D027924
B01.650.940.800.575.100.180.750;Viburnum;D027925
B01.650.940.800.575.100.044;Anacardiaceae;D027926
B01.650.940.800.575.100.044.555;Pistacia;D027927
D12.776.157.530.450.162.276;Potassium-Hydrogen Antiporters;D027961
D12.776.543.550.190.442;Potassium-Hydrogen Antiporters;D027961
D12.776.543.585.450.162.276;Potassium-Hydrogen Antiporters;D027961
D12.776.157.530.450.162.193;Chloride-Bicarbonate Antiporters;D027963
D12.776.543.550.190.276;Chloride-Bicarbonate Antiporters;D027963
D12.776.543.585.450.162.193;Chloride-Bicarbonate Antiporters;D027963
D12.776.157.530.450.625;Symporters;D027981
D12.776.543.585.450.625;Symporters;D027981
D12.776.157.530.450.625.500;Sodium-Bicarbonate Symporters;D027982
D12.776.543.585.450.625.500;Sodium-Bicarbonate Symporters;D027982
B01.650.940.800.575.100.087.249;Aralia;D027983
B01.650.940.800.575.100.087.374;Eleutherococcus;D028001
B01.650.940.800.575.100.087.450;Oplopanax;D028002
D12.776.157.530.450.625.750;Sodium-Potassium-Chloride Symporters;D028021
D12.776.543.585.450.625.750;Sodium-Potassium-Chloride Symporters;D028021
E02.594.540;Laser Therapy, Low-Level;D028022
E02.774.500;Laser Therapy, Low-Level;D028022
B01.650.940.800.575.100.093;Arecaceae;D028023
B01.650.940.800.575.100.093.750;Serenoa;D028024
B01.650.940.800.575.100.075.180;Centella;D028041
B01.650.940.800.575.100.075.798;Pimpinella;D028042
D12.776.157.648;Phosphate-Binding Proteins;D028044
D12.776.157.530.450.074.750;Phosphate Transport Proteins;D028061
D12.776.157.648.500;Phosphate Transport Proteins;D028061
D12.776.543.585.450.074.750;Phosphate Transport Proteins;D028061
D12.776.157.530.450.074.750.500;Proton-Phosphate Symporters;D028081
D12.776.157.530.450.625.249;Proton-Phosphate Symporters;D028081
D12.776.157.648.500.500;Proton-Phosphate Symporters;D028081
D12.776.543.585.450.074.750.500;Proton-Phosphate Symporters;D028081
D12.776.543.585.450.625.249;Proton-Phosphate Symporters;D028081
B01.650.940.800.575.100.150;Boraginaceae;D028082
B01.650.940.800.575.100.892;Scrophulariaceae;D028083
B01.650.940.800.575.100.928.249;Clusiaceae;D028084
B01.650.940.800.575.100.795;Papaveraceae;D028101
B04.280.650.160.100.149;Canarypox virus;D028121
B04.909.204.783.160.100.149;Canarypox virus;D028121
B01.650.940.800.575.100.125;Berberidaceae;D028141
B01.650.940.800.575.100.125.249;Berberis;D028142
B01.650.940.800.575.100.125.374;Mahonia;D028143
B01.650.940.800.575.100.125.500.500;Podophyllum peltatum;D028144
B01.650.940.800.575.100.125.311;Caulophyllum;D028145
B01.650.940.800.575.100.955;Valerianaceae;D028161
B01.650.940.800.575.100.150.444;Heliotropium;D028162
B01.650.940.800.575.100.735.888;Viscaceae;D028163
B01.650.940.800.575.100.735.888.750;Viscum;D028181
B01.650.940.800.575.100.735.888.750.500;Viscum album;D028182
B01.650.940.800.575.100.735.249;Loranthaceae;D028183
B01.650.940.800.575.100.735.888.699;Phoradendron;D028184
B01.650.940.800.575.400.122.666;Pinaceae;D028201
B01.650.940.800.575.400.122.666.033;Abies;D028202
B01.650.940.800.575.400.122.666.222;Cedrus;D028203
B01.650.940.800.575.400.122.666.444;Larix;D028221
B01.650.940.800.575.400.122.666.755;Picea;D028222
B01.650.940.800.575.400.122.666.777;Pinus;D028223
B01.650.940.800.575.400.122.666.984;Pseudotsuga;D028224
B01.650.940.800.575.400.122.666.992;Tsuga;D028225
C16.320.565.176;Amyloidosis, Familial;D028226
C18.452.648.176;Amyloidosis, Familial;D028226
C18.452.845.500.075;Amyloidosis, Familial;D028226
C10.574.500.050;Amyloid Neuropathies, Familial;D028227
C10.668.829.050.050;Amyloid Neuropathies, Familial;D028227
C16.320.400.050;Amyloid Neuropathies, Familial;D028227
C16.320.565.176.050;Amyloid Neuropathies, Familial;D028227
C18.452.648.176.050;Amyloid Neuropathies, Familial;D028227
C18.452.845.500.050.050;Amyloid Neuropathies, Familial;D028227
C18.452.845.500.075.050;Amyloid Neuropathies, Familial;D028227
B01.650.940.800.575.100.928.500.500.500;Camellia sinensis;D028241
B01.650.940.800.575.100.928.500;Theaceae;D028242
C10.228.140.163.100.168;Cerebral Amyloid Angiopathy, Familial;D028243
C10.228.140.300.275.311;Cerebral Amyloid Angiopathy, Familial;D028243
C10.228.140.300.510.200.200.160;Cerebral Amyloid Angiopathy, Familial;D028243
C14.907.253.329.311;Cerebral Amyloid Angiopathy, Familial;D028243
C14.907.253.560.200.200.160;Cerebral Amyloid Angiopathy, Familial;D028243
C16.320.565.176.160;Cerebral Amyloid Angiopathy, Familial;D028243
C16.320.565.189.168;Cerebral Amyloid Angiopathy, Familial;D028243
C18.452.132.100.168;Cerebral Amyloid Angiopathy, Familial;D028243
C18.452.648.176.160;Cerebral Amyloid Angiopathy, Familial;D028243
C18.452.648.189.168;Cerebral Amyloid Angiopathy, Familial;D028243
C18.452.845.500.075.160;Cerebral Amyloid Angiopathy, Familial;D028243
C18.452.845.500.100.160;Cerebral Amyloid Angiopathy, Familial;D028243
B01.650.940.800.575.100.928.500.500;Camellia;D028244
B01.650.940.800.575.100.795.249;Chelidonium;D028281
B04.280.580.650.600.325;Feline panleukopenia virus;D028301
B04.909.204.671.650.600.325;Feline panleukopenia virus;D028301
D20.215.784;Plant Preparations;D028321
D06.472.334.500.500;Inhibin-beta Subunits;D028322
D06.472.334.968.500;Inhibin-beta Subunits;D028322
D06.472.699.009.500;Inhibin-beta Subunits;D028322
D06.472.699.337.500;Inhibin-beta Subunits;D028322
D12.644.548.009.500;Inhibin-beta Subunits;D028322
D12.644.548.387.500;Inhibin-beta Subunits;D028322
D12.776.395.022.500;Inhibin-beta Subunits;D028322
D12.776.395.439.500;Inhibin-beta Subunits;D028322
B04.280.580.650.600.690;Parvovirus, Porcine;D028323
B04.909.204.671.650.600.690;Parvovirus, Porcine;D028323
D06.472.334.500;Activins;D028341
D06.472.699.009;Activins;D028341
D12.644.548.009;Activins;D028341
D12.776.395.022;Activins;D028341
C18.452.660;Mitochondrial Diseases;D028361
B04.820.504;Nidovirales;D028381
B04.909.777.500;Nidovirales;D028381
B04.820.504.080;Arteriviridae;D028382
B04.909.777.500.080;Arteriviridae;D028382
D10.251.355.255.100.375;Isoprostanes;D028421
D10.251.355.411;Isoprostanes;D028421
D10.251.355.255.100.375.500;F2-Isoprostanes;D028441
D10.251.355.411.500;F2-Isoprostanes;D028441
B01.650.940.800.575.100.987;Zygophyllaceae;D028461
B01.650.940.800.575.100.300.188;Cucumis;D028462
B01.650.940.800.575.100.300.188.444;Cucumis melo;D028463
B01.650.940.800.575.100.300.222;Cucurbita;D028464
B01.650.940.800.575.100.350.333;Euphorbia;D028481
B01.650.940.800.575.100.350.399;Hevea;D028482
B01.650.940.800.575.100.700.100;Abelmoschus;D028483
B01.650.940.800.575.100.700.555;Malva;D028501
B01.650.940.800.575.100.825.437;Polygonum;D028502
B01.650.940.800.575.100.850.200;Cephaelis;D028503
B01.650.940.800.575.100.975.555.500;Musa;D028521
B01.650.940.800.575.100.975.555;Musaceae;D028522
B01.650.940.800.575.100.975.900.333;Elettaria;D028523
B01.650.940.800.575.100.075.077;Anethum graveolens;D028524
B01.650.940.800.575.100.075.099;Apium graveolens;D028525
B01.650.940.800.575.100.075.211;Coriandrum;D028526
B01.650.940.800.575.100.075.233;Cuminum;D028527
B01.650.940.800.575.100.075.750;Petroselinum;D028528
B01.650.940.800.575.100.075.625;Pastinaca;D028529
D01.268.956;Transition Elements;D028561
D01.268.477;Lanthanoid Series Elements;D028581
D01.268.558.362;Lanthanoid Series Elements;D028581
D01.552.550.399;Lanthanoid Series Elements;D028581
E02.760.905.199.249;Euthanasia, Active;D028601
I01.880.735.344.500.249;Euthanasia, Active;D028601
N02.421.585.905.199.500;Euthanasia, Active;D028601
M01.150.725;Mentally Ill Persons;D028642
K01.316.090;Complicity;D028661
K01.752.256.090;Complicity;D028661
K01.316.756;Principle-Based Ethics;D028662
K01.752.256.830;Principle-Based Ethics;D028662
K01.316.169;Ethical Theory;D028663
K01.752.256.118;Ethical Theory;D028663
K01.316.630.595.500;Moral Obligations;D028681
K01.752.256.547.599.500;Moral Obligations;D028681
I01.696.586;National Socialism;D028683
I01.880.604.473.650;Patient Rights;D028701
N03.706.437.650;Patient Rights;D028701
F01.829.500.840;Virtues;D028722
K01.316.630.840;Virtues;D028722
K01.752.256.547.840;Virtues;D028722
K01.316.722;Personhood;D028723
K01.752.256.660;Personhood;D028723
K01.844.949;Theology;D028725
K01.316.173.500;Ethics Committees, Clinical;D028741
N04.452.758.788.300.500;Ethics Committees, Clinical;D028741
N05.350.268.500;Ethics Committees, Clinical;D028741
N05.700.685.300.500;Ethics Committees, Clinical;D028741
F01.145.813.555;Professional Misconduct;D028743
K01.316.768;Professional Misconduct;D028743
K01.316.173.750;Ethics Committees, Research;D028744
N04.452.758.788.300.750;Ethics Committees, Research;D028744
N05.350.268.750;Ethics Committees, Research;D028744
N05.700.685.300.750;Ethics Committees, Research;D028744
E02.760.952;Withholding Treatment;D028761
N02.421.585.952;Withholding Treatment;D028761
K01.316.165;Ethical Relativism;D028781
K01.752.256.116;Ethical Relativism;D028781
D12.776.157.530.750.625;Nuclear Pore Complex Proteins;D028861
D12.776.543.585.750.625;Nuclear Pore Complex Proteins;D028861
D12.776.157.530.750.500;Karyopherins;D028884
D12.776.543.585.750.500;Karyopherins;D028884
D12.776.660.502;Karyopherins;D028884
D12.776.157.530.750.500.100;alpha Karyopherins;D028901
D12.776.543.585.750.500.100;alpha Karyopherins;D028901
D12.776.660.502.100;alpha Karyopherins;D028901
C16.320.565.100.620.100;Biotinidase Deficiency;D028921
C16.320.565.202.720.100;Biotinidase Deficiency;D028921
C18.452.648.100.620.100;Biotinidase Deficiency;D028921
C18.452.648.202.720.100;Biotinidase Deficiency;D028921
C16.320.565.100.620.380;Holocarboxylase Synthetase Deficiency;D028922
C16.320.565.202.720.380;Holocarboxylase Synthetase Deficiency;D028922
C18.452.648.100.620.380;Holocarboxylase Synthetase Deficiency;D028922
C18.452.648.202.720.380;Holocarboxylase Synthetase Deficiency;D028922
B04.820.504.540.150.210;Coronavirus 229E, Human;D028941
B04.909.777.500.540.150.210;Coronavirus 229E, Human;D028941
D12.776.157.530.750.500.249;beta Karyopherins;D028961
D12.776.543.585.750.500.249;beta Karyopherins;D028961
D12.776.660.502.500;beta Karyopherins;D028961
B04.820.504.540.150.220;Coronavirus OC43, Human;D028962
B04.909.777.500.540.150.220;Coronavirus OC43, Human;D028962
B04.820.455.149;Bornaviridae;D028981
B04.909.777.455.149;Bornaviridae;D028981
H01.158.273.118.598.500;Herbal Medicine;D029001
H01.158.703.060.500;Herbal Medicine;D029001
H02.628.190;Herbal Medicine;D029001
E02.056.902;Steam Bath;D029002
E02.565.640;Steam Bath;D029002
E02.779.249.902;Steam Bath;D029002
E02.779.496.640;Steam Bath;D029002
C02.782.580.600.500.600;Peste-des-Petits-Ruminants;D029021
C22.706;Peste-des-Petits-Ruminants;D029021
B01.650.940.800.575.100.010;Acoraceae;D029022
B01.650.940.800.575.100.010.500;Acorus;D029023
B04.820.455.300.650;Marburgvirus;D029024
B04.909.777.455.300.650;Marburgvirus;D029024
B01.650.940.800.575.100.928.124;Actinidiaceae;D029041
B01.650.940.800.575.100.928.124.500;Actinidia;D029042
B04.820.455.300.200;Ebolavirus;D029043
B04.909.777.455.300.200;Ebolavirus;D029043
B01.650.940.800.575.100.037.100;Achyranthes;D029044
B01.650.940.800.575.100.044.666;Rhus;D029045
B01.650.940.800.575.100.065;Annonaceae;D029061
B01.650.940.800.575.100.081;Apocynaceae;D029062
B01.650.940.800.575.100.084;Aquifoliaceae;D029063
B01.650.940.800.575.100.085;Araceae;D029064
B01.650.940.800.575.100.096;Aristolochiaceae;D029065
B01.650.940.800.575.100.099;Asclepiadaceae;D029067
B01.650.940.800.575.100.112;Balsaminaceae;D029068
B01.650.940.800.575.100.112.500;Impatiens;D029069
B04.820.455.600.650.700.800;Sendai virus;D029082
B04.909.777.455.600.650.700.800;Sendai virus;D029082
B04.820.455.600.650.700.700;Parainfluenza Virus 3, Bovine;D029101
B04.909.777.455.600.650.700.700;Parainfluenza Virus 3, Bovine;D029101
B04.820.455.600.670.500;Metapneumovirus;D029121
B04.820.455.600.670.600.550;Murine pneumonia virus;D029122
B04.820.455.750.600;Novirhabdovirus;D029141
B04.909.777.455.750.600;Novirhabdovirus;D029141
B04.820.455.750.600.400;Infectious hematopoietic necrosis virus;D029142
B04.909.777.455.750.600.400;Infectious hematopoietic necrosis virus;D029142
B04.715.081.700;Oleavirus;D029161
B04.820.081.700;Oleavirus;D029161
F02.880.705;Spirituality;D029181
K01.844.664.500;Spirituality;D029181
B01.650.940.800.575.100.475;Hamamelidaceae;D029201
E02.190.901.155;Faith Healing;D029221
B01.650.940.800.575.100.812.666.500;Piper nigrum;D029222
B04.280.045;Ascoviridae;D029223
B04.525.045;Ascoviridae;D029223
C10.292.700.225.500.100;Optic Atrophy, Autosomal Dominant;D029241
C10.574.500.662.100;Optic Atrophy, Autosomal Dominant;D029241
C11.270.564.100;Optic Atrophy, Autosomal Dominant;D029241
C11.640.451.451.100;Optic Atrophy, Autosomal Dominant;D029241
C16.320.290.564.100;Optic Atrophy, Autosomal Dominant;D029241
C16.320.400.630.100;Optic Atrophy, Autosomal Dominant;D029241
C18.452.660.665;Optic Atrophy, Autosomal Dominant;D029241
C10.292.700.225.500.400;Optic Atrophy, Hereditary, Leber;D029242
C10.574.500.662.400;Optic Atrophy, Hereditary, Leber;D029242
C11.270.564.400;Optic Atrophy, Hereditary, Leber;D029242
C11.640.451.451.400;Optic Atrophy, Hereditary, Leber;D029242
C16.320.290.564.400;Optic Atrophy, Hereditary, Leber;D029242
C16.320.400.630.400;Optic Atrophy, Hereditary, Leber;D029242
C18.452.660.670;Optic Atrophy, Hereditary, Leber;D029242
B04.820.087.440.700;Sin Nombre virus;D029261
B04.909.777.147.440.700;Sin Nombre virus;D029261
B04.820.087.440.600;Puumala virus;D029262
B04.909.777.147.440.600;Puumala virus;D029262
B04.820.087.440.690;Seoul virus;D029263
B04.909.777.147.440.690;Seoul virus;D029263
B04.820.087.565.600;Nairobi sheep disease virus;D029281
B04.909.777.147.565.600;Nairobi sheep disease virus;D029281
V01.665;Patient Education Handout;D029282
V02.725.750;Patient Education Handout;D029282
B04.820.087.710.750;Sandfly fever Naples virus;D029301
B04.909.777.147.710.750;Sandfly fever Naples virus;D029301
B04.820.095.500;Lagovirus;D029321
B04.909.777.162.500;Lagovirus;D029321
B04.820.095.550;Norovirus;D029322
B04.909.777.162.550;Norovirus;D029322
B04.820.095.775;Sapovirus;D029341
B04.909.777.162.775;Sapovirus;D029341
B04.820.095.887;Vesivirus;D029342
B04.909.777.162.887;Vesivirus;D029342
D12.776.157.530.450.074.500.781;Organic Anion Transporters, Sodium-Independent;D029362
D12.776.543.585.450.074.500.875;Organic Anion Transporters, Sodium-Independent;D029362
D12.776.157.530.450.074.500.687;Organic Anion Transporters, Sodium-Dependent;D029363
D12.776.543.585.450.074.500.812;Organic Anion Transporters, Sodium-Dependent;D029363
B04.715.780;Tenuivirus;D029364
B04.820.800;Tenuivirus;D029364
B04.909.777.827;Tenuivirus;D029364
D12.776.157.530.450.074.500.500;Organic Anion Transporters, ATP-Dependent;D029365
D12.776.543.585.450.074.500.500;Organic Anion Transporters, ATP-Dependent;D029365
B04.715.110;Closteroviridae;D029381
B04.820.110;Closteroviridae;D029381
D12.776.157.530.450.074.500.199;Dicarboxylic Acid Transporters;D029382
D12.776.543.585.450.074.500.149;Dicarboxylic Acid Transporters;D029382
B04.715.110.175;Crinivirus;D029383
B04.820.110.175;Crinivirus;D029383
B01.650.940.800.575.100.137;Betulaceae;D029401
B01.650.940.800.575.100.143;Bignoniaceae;D029402
B01.650.940.800.575.100.162;Burseraceae;D029403
D08.811.913.696.620.682.700.062;Activin Receptors;D029404
D12.776.543.750.750.400.820.500;Activin Receptors;D029404
B04.820.250.400;GB virus A;D029405
B04.909.777.310.400;GB virus A;D029405
B04.450.355;GB virus B;D029406
B04.820.250.475.405;GB virus B;D029406
B04.909.777.310.475.405;GB virus B;D029406
B04.450.360;GB virus C;D029407
B04.820.250.410;GB virus C;D029407
B04.909.777.310.410;GB virus C;D029407
B01.650.940.800.575.100.168;Cactaceae;D029421
B01.650.940.800.575.100.171;Campanulaceae;D029422
C08.381.495.389;Pulmonary Disease, Chronic Obstructive;D029424
B01.650.940.800.575.100.192.500;Carica;D029441
C10.228.140.163.100.435.810;Sialic Acid Storage Disease;D029461
C16.320.565.189.435.810;Sialic Acid Storage Disease;D029461
C16.320.565.595.554.810;Sialic Acid Storage Disease;D029461
C18.452.132.100.435.810;Sialic Acid Storage Disease;D029461
C18.452.648.189.435.810;Sialic Acid Storage Disease;D029461
C18.452.648.595.554.810;Sialic Acid Storage Disease;D029461
C08.127.446.567;Bronchitis, Chronic;D029481
C08.381.495.146.567;Bronchitis, Chronic;D029481
C08.381.495.389.500;Bronchitis, Chronic;D029481
C08.730.099.567;Bronchitis, Chronic;D029481
B04.820.455.600.650.750.717;Parainfluenza Virus 4, Human;D029482
B04.909.777.455.600.650.750.717;Parainfluenza Virus 4, Human;D029482
B01.650.940.800.575.100.475.500;Hamamelis;D029501
C15.378.071.085.080;Anemia, Hypoplastic, Congenital;D029502
C15.378.190.196.080;Anemia, Hypoplastic, Congenital;D029502
C16.320.077;Anemia, Hypoplastic, Congenital;D029502
C15.378.071.085.080.090;Anemia, Diamond-Blackfan;D029503
C15.378.071.750.500;Anemia, Diamond-Blackfan;D029503
C15.378.190.196.080.090;Anemia, Diamond-Blackfan;D029503
C16.320.077.090;Anemia, Diamond-Blackfan;D029503
B04.820.545.405;Influenzavirus A;D029521
B04.909.777.545.405;Influenzavirus A;D029521
B01.650.940.800.575.100.531;Hydrophyllaceae;D029522
B01.650.940.800.575.100.539;Illicium;D029523
B04.820.545.407;Influenzavirus B;D029524
B04.909.777.545.407;Influenzavirus B;D029524
B01.650.940.800.575.100.569;Juglandaceae;D029525
B01.650.940.800.575.100.638;Loganiaceae;D029541
B01.650.940.800.575.525;Lycopodiaceae;D029542
D12.776.157.530.750;Nucleocytoplasmic Transport Proteins;D029543
D12.776.543.585.750;Nucleocytoplasmic Transport Proteins;D029543
B04.820.565.070.250;Foot-and-Mouth Disease Virus;D029544
B04.909.777.618.070.250;Foot-and-Mouth Disease Virus;D029544
B01.650.940.800.575.100.665;Lythraceae;D029561
B01.650.940.800.575.100.680;Magnoliaceae;D029562
D12.776.157.530.750.200;Cellular Apoptosis Susceptibility Protein;D029563
D12.776.167.150;Cellular Apoptosis Susceptibility Protein;D029563
D12.776.543.585.750.200;Cellular Apoptosis Susceptibility Protein;D029563
B01.650.940.800.575.100.690;Malpighiaceae;D029581
B01.650.940.800.575.100.715;Meliaceae;D029582
B01.650.940.800.575.100.725;Menispermaceae;D029583
D12.776.866.249;Prostatic Secretory Proteins;D029584
B01.650.940.800.575.100.745;Monimiaceae;D029585
B01.650.940.800.575.100.750;Moraceae;D029586
B01.650.940.800.575.100.752;Moringa;D029587
B01.650.940.800.575.100.752.500;Moringa oleifera;D029588
D12.776.866;Seminal Plasma Proteins;D029589
B01.650.940.800.575.100.760;Myricaceae;D029590
B01.650.940.800.575.100.770;Myrsinaceae;D029591
B01.650.940.800.575.100.782;Oleaceae;D029592
C14.280.067.565.440;Jervell-Lange Nielsen Syndrome;D029593
C16.131.240.400.715.440;Jervell-Lange Nielsen Syndrome;D029593
B01.650.940.800.575.100.786;Onagraceae;D029594
B01.650.940.800.575.100.787;Orchidaceae;D029595
B01.650.940.800.575.100.789;Paeonia;D029596
C14.280.067.565.720;Romano-Ward Syndrome;D029597
C16.131.240.400.715.720;Romano-Ward Syndrome;D029597
C23.550.073.547.720;Romano-Ward Syndrome;D029597
B01.650.940.800.575.100.803.500;Passiflora;D029598
B01.650.940.800.575.100.806;Pedaliaceae;D029601
B01.650.940.800.575.100.809;Phytolaccaceae;D029602
B01.650.940.800.575.100.809.500;Phytolacca;D029603
B01.650.940.800.575.100.809.500.500;Phytolacca americana;D029604
B01.650.940.800.575.100.809.500.750;Phytolacca dodecandra;D029605
B01.650.940.800.575.100.821;Plumbaginaceae;D029606
D12.776.866.500;Seminal Vesicle Secretory Proteins;D029607
B01.650.940.800.575.100.823;Polygalaceae;D029608
B01.650.940.800.575.250.700;Polypodiaceae;D029621
B01.650.940.800.575.100.827;Portulacaceae;D029622
B01.650.940.800.575.100.829;Primulaceae;D029623
B01.650.940.800.575.250;Ferns;D029624
B01.650.940.800.575.250.750;Pteridaceae;D029625
B01.650.940.800.575.100.838;Ranunculaceae;D029626
B01.650.940.800.575.100.842.249;Crassulaceae;D029627
B01.650.940.800.575.100.842.374;Hydrangeaceae;D029628
B01.650.940.800.575.100.881;Salicaceae;D029629
B01.650.940.800.575.100.884;Santalaceae;D029630
B01.650.940.800.575.100.885;Sapindaceae;D029631
B01.650.940.800.575.100.886;Sapotaceae;D029632
B01.650.940.800.575.100.889;Schisandraceae;D029633
B01.650.940.800.575.100.898;Simaroubaceae;D029641
B01.650.940.800.575.100.901;Smilacaceae;D029642
B01.650.940.800.575.100.915;Sterculiaceae;D029643
B01.650.940.800.575.100.920;Styracaceae;D029644
B01.650.940.800.575.100.932;Thymelaeaceae;D029645
B01.650.940.800.575.100.938;Tiliaceae;D029646
B01.650.940.800.575.100.947;Turnera;D029647
B01.650.940.800.575.100.960;Verbenaceae;D029648
B01.650.940.800.575.100.962;Violaceae;D029649
B04.820.565.284.200;Enterovirus, Bovine;D029650
B04.909.777.618.284.200;Enterovirus, Bovine;D029650
B01.650.940.800.575.100.137.500;Alnus;D029661
B01.650.940.800.575.100.137.750;Betula;D029662
B01.650.940.800.575.100.143.500;Tabebuia;D029663
D12.776.765.149;Arabidopsis Proteins;D029681
B01.650.940.800.575.100.150.122;Amsinckia;D029682
B01.650.940.800.575.100.150.188;Borago;D029683
B01.650.940.800.575.100.150.501;Lithospermum;D029684
B01.650.940.800.575.100.150.750;Pulmonaria;D029685
B01.650.940.800.575.100.157.600;Lepidium;D029686
B01.650.940.800.575.100.157.244;Capsella;D029687
B01.650.940.800.575.100.157.200.249;Brassica napus;D029688
D12.776.354.750;Saccharomyces cerevisiae Proteins;D029701
D12.776.354.875;Schizosaccharomyces pombe Proteins;D029702
D12.776.092.500.462;Drosophila Proteins;D029721
B01.650.940.800.575.100.157.200.277;Brassica rapa;D029741
D12.776.419.500;Caenorhabditis elegans Proteins;D029742
B01.650.940.800.575.100.162.111;Boswellia;D029743
B01.650.940.800.575.100.162.166;Commiphora;D029744
B01.650.940.800.575.100.171.200;Codonopsis;D029745
B01.650.940.800.575.100.171.600;Lobelia;D029746
B01.650.940.800.575.100.168.500;Opuntia;D029747
B01.650.940.800.575.100.195;Caryophyllaceae;D029748
B01.650.940.800.575.100.195.222;Dianthus;D029749
B01.650.940.800.575.100.195.611;Saponaria;D029750
B01.650.940.800.575.100.195.655;Silene;D029751
B01.650.940.800.575.100.195.827;Stellaria;D029752
B01.650.940.800.575.100.197;Celastraceae;D029753
B01.650.940.800.575.100.197.155;Catha;D029754
B01.650.940.800.575.100.197.577;Maytenus;D029755
B01.650.940.800.575.100.197.366;Euonymus;D029756
B01.650.940.800.575.100.197.788;Tripterygium;D029757
B01.650.940.800.575.100.204.177;Cistus;D029758
B01.650.940.800.575.100.928.249.166;Calophyllum;D029759
B01.650.940.800.575.100.928.249.333;Garcinia;D029760
B01.650.940.800.575.100.928.249.333.200;Garcinia cambogia;D029761
B01.650.940.800.575.100.928.249.333.600;Garcinia mangostana;D029762
B01.650.940.800.575.100.928.249.333.400;Garcinia kola;D029763
B01.650.940.800.575.100.228;Combretaceae;D029764
B01.650.940.800.575.100.228.166;Combretum;D029765
B01.650.940.800.575.100.228.583;Terminalia;D029766
B01.650.940.800.575.100.241;Cornaceae;D029767
B01.650.940.800.575.100.241.299;Cornus;D029768
B01.650.940.800.575.100.778.188;Camptotheca;D029769
B01.650.940.800.575.100.975.124;Costus;D029770
B01.650.940.800.575.100.842.249.500;Rhodiola;D029771
B01.650.940.800.575.100.300.093;Bryonia;D029772
B01.650.940.800.575.100.300.140;Citrullus;D029773
B01.650.940.800.575.100.300.444;Gynostemma;D029774
B01.650.940.800.575.100.300.655;Momordica;D029775
B01.650.940.800.575.100.300.522;Luffa;D029776
B01.650.940.800.575.100.300.655.249;Momordica charantia;D029777
B01.650.940.800.575.100.300.827;Trichosanthes;D029778
B01.650.940.800.575.400.122.188;Cupressaceae;D029779
B01.650.940.800.575.400.122.188.199;Chamaecyparis;D029780
B01.650.940.800.575.400.122.188.266;Cupressus;D029781
B01.650.940.800.575.400.122.188.599;Libocedrus;D029782
B01.650.940.800.575.400.122.188.799;Thuja;D029783
B01.650.940.800.575.400.186.199;Cycas;D029784
B01.650.940.800.575.100.312;Cyperaceae;D029785
B01.650.940.800.575.100.312.199;Cyperus;D029786
B01.650.940.800.575.100.329.500;Drosera;D029787
B01.650.940.800.575.100.333.500;Diospyros;D029788
B01.650.940.800.575.400.344.222;Ephedra;D029789
B01.650.940.800.575.400.344.222.500;Ephedra sinica;D029790
B01.650.940.800.575.100.343;Ericaceae;D029791
B01.650.940.800.575.100.343.099;Arctostaphylos;D029792
B01.650.940.800.575.100.343.549;Rhododendron;D029793
B01.650.940.800.575.100.343.324;Ledum;D029794
B01.650.940.800.575.100.343.211;Calluna;D029795
B01.650.940.800.575.100.343.774;Vaccinium;D029796
B01.650.940.800.575.100.343.774.500;Huckleberry Plant;D029797
B01.650.940.800.575.100.343.774.249;Blueberry Plant;D029798
B01.650.940.800.575.100.343.774.750;Vaccinium macrocarpon;D029799
B01.650.940.800.575.100.343.774.875;Vaccinium myrtillus;D029800
B01.650.940.800.575.100.343.774.937;Vaccinium vitis-idaea;D029801
B01.650.940.800.575.100.350.199;Croton;D029802
B01.650.940.800.575.100.350.622;Phyllanthus;D029803
B04.820.565.284.180;Enterovirus A, Human;D029821
B04.909.777.618.284.180;Enterovirus A, Human;D029821
B04.820.565.284.182;Enterovirus B, Human;D029822
B04.909.777.618.284.182;Enterovirus B, Human;D029822
B01.650.940.800.575.100.350.622.500;Phyllanthus emblica;D029842
B01.650.940.800.575.100.350.825;Suregada;D029843
D12.776.045;Amphibian Proteins;D029845
B01.650.940.800.575.100.401.718;Senna Plant;D029846
B01.650.940.800.575.100.401.875;Tamarindus;D029861
B01.650.940.800.575.100.401.702;Prosopis;D029862
B01.650.940.800.575.100.401.150;Cicer;D029863
B01.650.940.800.575.100.401.175;Crotalaria;D029864
B01.650.940.800.575.100.401.187;Cytisus;D029865
B01.650.940.800.575.100.401.191;Derris;D029866
D12.776.045.500;Xenopus Proteins;D029867
B01.650.940.800.575.100.401.250;Galega;D029881
B01.650.940.800.575.100.401.300.500;Glycyrrhiza uralensis;D029882
B01.650.940.800.575.100.401.337;Indigofera;D029883
B01.650.940.800.575.100.401.525;Lespedeza;D029884
B01.650.940.800.575.100.401.562;Lotus;D029885
B01.650.940.800.575.100.401.581;Maackia;D029901
B01.650.940.800.575.100.401.590;Medicago;D029902
B01.650.940.800.575.100.401.592;Melilotus;D029903
B01.650.940.800.575.100.401.601;Myroxylon;D029904
B01.650.940.800.575.100.401.611;Pachyrhizus;D029905
B01.650.940.800.575.100.401.694;Physostigma;D029906
B01.650.940.800.575.100.401.710;Psoralea;D029907
B01.650.940.800.575.100.401.714;Pueraria;D029908
B01.650.940.800.575.100.401.734;Sophora;D029909
B01.650.940.800.575.100.401.937;Trigonella;D029910
B01.650.940.800.575.100.401.093;Caesalpinia;D029911
B01.650.940.800.575.100.401.012;Abrus;D029912
B01.650.940.800.575.100.401.906;Trifolium;D029921
D12.776.325;Fish Proteins;D029941
D12.776.325.500;Zebrafish Proteins;D029961
B01.650.940.800.575.100.425;Fagaceae;D029962
B01.650.940.800.575.100.425.500;Quercus;D029963
B01.650.940.800.575.100.425.249;Fagus;D029964
B01.650.940.800.575.100.450;Gentianaceae;D029965
B01.650.940.800.575.100.450.188;Centaurium;D029966
B01.650.940.800.575.100.450.594;Swertia;D029967
D12.776.097.275;Escherichia coli Proteins;D029968
B01.650.940.800.575.100.075.088;Angelica;D029969
B01.650.940.800.575.100.075.088.077;Angelica archangelica;D029970
B01.650.940.800.575.100.075.088.538;Angelica sinensis;D029971
B01.650.940.800.575.100.075.144;Bupleurum;D029972
B01.650.940.800.575.100.075.166;Carum;D029974
B01.650.940.800.575.100.075.388.155;Cicuta;D029981
B01.650.940.800.575.100.075.388.188;Conium;D029982
B01.650.940.800.575.100.075.333;Foeniculum;D030001
B01.650.940.800.575.100.075.411;Heracleum;D030002
B01.650.940.800.575.100.075.488;Levisticum;D030003
B01.650.940.800.575.100.075.511;Ligusticum;D030004
B01.650.940.800.575.100.075.875;Sanicula;D030005
B01.650.940.800.575.100.081.088;Amsonia;D030006
B01.650.940.800.575.100.081.432;Nerium;D030007
B01.650.940.800.575.100.081.260;Catharanthus;D030008
B01.650.940.800.575.100.081.174;Aspidosperma;D030009
B01.650.940.800.575.100.081.131;Apocynum;D030010
B01.650.940.800.575.100.081.604;Ochrosia;D030011
B01.650.940.800.575.100.450.391;Gentiana;D030012
B01.650.940.800.575.100.081.833;Strophanthus;D030013
B01.650.940.800.575.100.081.888;Tabernaemontana;D030014
B04.820.565.284.184;Enterovirus C, Human;D030015
B04.909.777.618.284.184;Enterovirus C, Human;D030015
B04.820.565.284.188;Enterovirus D, Human;D030016
B04.909.777.618.284.188;Enterovirus D, Human;D030016
B01.650.940.800.575.100.084.500;Ilex;D030017
B01.650.940.800.575.100.084.500.500;Ilex guayusa;D030018
B01.650.940.800.575.100.084.500.750;Ilex paraguariensis;D030019
B01.650.940.800.575.100.084.500.875;Ilex vomitoria;D030020
B01.650.940.800.575.100.085.500;Pinellia;D030021
B01.650.940.800.575.100.096.211;Aristolochia;D030022
B01.650.940.800.575.100.096.233;Asarum;D030023
B01.650.940.800.575.100.975.900.166;Curcuma;D030024
B04.450.420.410;Hepatitis A virus;D030041
B04.820.565.400.410;Hepatitis A virus;D030041
B04.909.777.618.400.410;Hepatitis A virus;D030041
B04.820.565.700;Parechovirus;D030061
B04.909.777.618.700;Parechovirus;D030061
B04.820.630.550.750;Palyam Virus;D030081
B04.909.777.714.550.750;Palyam Virus;D030081
B04.820.630.590.500;Orthoreovirus, Avian;D030101
B04.909.777.714.590.500;Orthoreovirus, Avian;D030101
B04.820.630.590.550;Orthoreovirus, Mammalian;D030102
B04.909.777.714.590.550;Orthoreovirus, Mammalian;D030102
B04.820.650.124;Betaretrovirus;D030121
B04.909.574.807.124;Betaretrovirus;D030121
B04.909.777.731.124;Betaretrovirus;D030121
F01.058.288;Feedback, Psychological;D030141
F04.754.308;Feedback, Psychological;D030141
L01.143.283.425.624;Feedback, Psychological;D030141
D12.776.093;Avian Proteins;D030161
D12.776.831;Reptilian Proteins;D030162
G02.111.570.080.689.330.700.920;Vitamin D Response Element;D030181
G02.111.570.080.689.675.700.920;Vitamin D Response Element;D030181
G05.360.080.689.330.700.920;Vitamin D Response Element;D030181
G05.360.080.689.675.700.920;Vitamin D Response Element;D030181
G05.360.340.024.340.137.750.249.765.920;Vitamin D Response Element;D030181
G05.360.340.024.340.137.750.680.765.920;Vitamin D Response Element;D030181
D08.811.913.696.620.682.700.062.500;Activin Receptors, Type I;D030201
D12.776.543.750.750.400.820.500.500;Activin Receptors, Type I;D030201
B01.650.940.800.575.100.915.166;Cola;D030221
B04.820.250.700.150.100;Diarrhea Virus 1, Bovine Viral;D030241
B04.909.777.310.700.150.100;Diarrhea Virus 1, Bovine Viral;D030241
B04.820.250.700.150.120;Diarrhea Virus 2, Bovine Viral;D030242
B04.909.777.310.700.150.120;Diarrhea Virus 2, Bovine Viral;D030242
C02.782.350.675.400;Hemorrhagic Syndrome, Bovine;D030243
C22.196.400;Hemorrhagic Syndrome, Bovine;D030243
B04.820.650.200.725;Primate T-lymphotropic virus 1;D030261
B04.909.574.807.200.725;Primate T-lymphotropic virus 1;D030261
B04.909.777.731.200.725;Primate T-lymphotropic virus 1;D030261
D12.776.765.741;Soybean Proteins;D030262
J02.500.850.500.700.500.750;Soybean Proteins;D030262
B04.820.650.200.730;Primate T-lymphotropic virus 2;D030263
B04.909.574.807.200.730;Primate T-lymphotropic virus 2;D030263
B04.909.777.731.200.730;Primate T-lymphotropic virus 2;D030263
B04.820.650.200.730.810;Simian T-lymphotropic virus 2;D030281
B04.820.650.805.855;Simian T-lymphotropic virus 2;D030281
B04.909.574.807.200.730.810;Simian T-lymphotropic virus 2;D030281
B04.909.574.807.805.855;Simian T-lymphotropic virus 2;D030281
B04.909.777.731.200.730.810;Simian T-lymphotropic virus 2;D030281
B04.909.777.731.805.855;Simian T-lymphotropic virus 2;D030281
B04.820.650.200.735;Primate T-lymphotropic virus 3;D030282
B04.909.574.807.200.735;Primate T-lymphotropic virus 3;D030282
B04.909.777.731.200.735;Primate T-lymphotropic virus 3;D030282
B04.820.650.260;Epsilonretrovirus;D030283
B04.909.574.807.260;Epsilonretrovirus;D030283
B04.909.777.731.260;Epsilonretrovirus;D030283
D08.811.913.696.620.682.700.062.750;Activin Receptors, Type II;D030301
D12.776.543.750.750.400.820.500.750;Activin Receptors, Type II;D030301
C04.557.435.595.220;Denys-Drash Syndrome;D030321
C04.588.945.947.535.585.220;Denys-Drash Syndrome;D030321
C04.700.635.220;Denys-Drash Syndrome;D030321
C12.706.316.096.562;Denys-Drash Syndrome;D030321
C12.758.820.750.585.220;Denys-Drash Syndrome;D030321
C12.777.419.473.585.220;Denys-Drash Syndrome;D030321
C13.351.875.253.096.562;Denys-Drash Syndrome;D030321
C13.351.937.820.535.585.220;Denys-Drash Syndrome;D030321
C13.351.968.419.473.585.220;Denys-Drash Syndrome;D030321
C16.131.939.316.096.562;Denys-Drash Syndrome;D030321
C16.320.700.642.220;Denys-Drash Syndrome;D030321
C19.391.119.096.562;Denys-Drash Syndrome;D030321
C02.782.600;Nidovirales Infections;D030341
C16.320;Genetic Diseases, Inborn;D030342
C02.256.650;Papillomavirus Infections;D030361
C02.928.725;Papillomavirus Infections;D030361
B04.525.515;Nodaviridae;D030381
B04.820.515;Nodaviridae;D030381
C16.320.565.240;Cytochrome-c Oxidase Deficiency;D030401
C18.452.660.195;Cytochrome-c Oxidase Deficiency;D030401
D01.625.600.800;Peroxynitrous Acid;D030421
D01.625.700.750;Peroxynitrous Acid;D030421
B01.650.940.800.575.100.100.700;Saussurea;D030441
D05.500.562.625.875;Pyruvate Dehydrogenase (Lipoamide);D030481
D08.811.600.741.725;Pyruvate Dehydrogenase (Lipoamide);D030481
D08.811.682.657.350.875;Pyruvate Dehydrogenase (Lipoamide);D030481
D12.776.298;Epididymal Secretory Proteins;D030501
B01.650.940.800.575.100.975.900;Zingiberaceae;D030521
L01.470.750.750.325;Databases, Genetic;D030541
L01.700.508.300.188.400.325;Databases, Genetic;D030541
L01.470.750.750.300.500;Databases, Nucleic Acid;D030561
L01.470.750.750.325.630;Databases, Nucleic Acid;D030561
L01.700.508.300.188.400.300.500;Databases, Nucleic Acid;D030561
L01.700.508.300.188.400.325.630;Databases, Nucleic Acid;D030561
L01.470.750.750.300.750;Databases, Protein;D030562
L01.470.750.750.325.710;Databases, Protein;D030562
L01.700.508.300.188.400.300.750;Databases, Protein;D030562
L01.700.508.300.188.400.325.710;Databases, Protein;D030562
B01.650.940.800.575.100.204;Cistaceae;D030601
I01.880.604.473.352.500.320;Genetic Privacy;D030661
I01.880.604.473.650.500.320;Genetic Privacy;D030661
I01.880.604.583.080.320;Genetic Privacy;D030661
N03.706.437.352.500.320;Genetic Privacy;D030661
N03.706.437.650.124.320;Genetic Privacy;D030661
N03.706.535.230.320;Genetic Privacy;D030661
B01.650.940.800.575.100.750.500;Ficus;D030681
B01.650.940.800.575.100.778;Nyssaceae;D030701
B01.650.940.800.575.100.776;Nymphaeaceae;D030702
B01.650.940.800.575.100.776.500;Nymphaea;D030721
D08.811.520.241.300.150.400;Carbonic Anhydrase IV;D030741
D12.776.395.550.448.160;Carbonic Anhydrase IV;D030741
D12.776.543.484.500.160;Carbonic Anhydrase IV;D030741
D12.776.543.550.418.160;Carbonic Anhydrase IV;D030741
G08.686.195;Estrous Cycle;D030762
B05.620;Organisms, Genetically Modified;D030781
B01.050.050.136;Animals, Genetically Modified;D030801
B05.620.136;Animals, Genetically Modified;D030801
B01.650.520;Plants, Genetically Modified;D030821
B05.620.600;Plants, Genetically Modified;D030821
J02.500.518;Food, Genetically Modified;D030841
I01.261.100;Capitalism;D030861
I01.696.100;Capitalism;D030861
F01.829.401.046;Disclosure;D030881
I01.880.604.583.080.134;Disclosure;D030881
L01.143.335;Disclosure;D030881
B01.650.940.800.575.100.346;Erythroxylaceae;D030921
C05.116.099.052;Acro-Osteolysis;D030981
C05.116.264.579.052;Acro-Osteolysis;D030981
B01.650.940.800.575.100.009;Aceraceae;D031001
B01.650.940.800.575.100.009.500;Acer;D031002
B01.650.940.800.575.100.014;Adoxaceae;D031003
B01.650.940.800.575.100.044.277;Anacardium;D031021
B01.650.940.800.575.100.044.416;Mangifera;D031022
B01.650.940.800.575.100.044.705;Semecarpus;D031023
B01.650.940.800.575.100.065.500;Annona;D031041
B01.650.940.800.575.100.065.750;Asimina;D031042
B01.650.940.800.575.100.065.875;Guatteria;D031043
B01.650.940.800.575.100.065.937;Polyalthia;D031044
B01.650.940.800.575.100.065.968;Rollinia;D031045
B01.650.940.800.575.100.065.984;Uvaria;D031046
B01.650.940.800.575.100.075.199;Cnidium;D031048
B01.650.940.800.575.100.075.294;Eryngium;D031049
B01.650.940.800.575.100.075.568;Oenanthe;D031050
B01.650.940.800.575.100.081.043;Alstonia;D031051
B01.650.940.800.575.100.081.944;Thevetia;D031052
B01.650.940.800.575.100.081.972;Vinca;D031053
B01.650.940.800.575.100.085.066;Alocasia;D031055
B01.650.940.800.575.100.085.077;Amorphophallus;D031056
B01.650.940.800.575.100.085.088;Arisaema;D031057
B01.650.940.800.575.100.085.109;Arum;D031058
B01.650.940.800.575.100.085.177;Calla Plant;D031059
B01.650.940.800.575.100.085.199;Colocasia;D031060
B01.650.940.800.575.100.085.211;Cyrtosperma;D031061
B01.650.940.800.575.100.085.488;Philodendron;D031062
B01.650.940.800.575.100.085.944;Xanthosoma;D031063
B01.650.940.800.575.100.085.972;Zantedeschia;D031064
B01.650.940.800.575.100.087.033;Acanthopanax;D031065
B01.650.940.800.575.100.093.188;Calamus;D031081
B01.650.940.800.575.100.099.500;Marsdenia;D031101
B01.650.940.800.575.100.099.249;Hemidesmus;D031102
B01.650.940.800.575.100.099.222;Gymnema;D031103
B01.650.940.800.575.100.099.222.500;Gymnema sylvestre;D031104
B01.650.940.800.575.100.099.110;Cynanchum;D031105
B01.650.940.800.575.100.099.099;Cryptolepis;D031106
B01.650.940.800.575.100.099.077;Calotropis;D031107
B01.650.940.800.575.100.099.038;Asclepias;D031108
B01.650.940.800.575.100.099.750;Periploca;D031109
B01.650.940.800.575.100.099.875;Tylophora;D031110
B01.650.940.800.575.100.106;Balanophoraceae;D031111
B01.650.940.800.575.100.118;Begoniaceae;D031112
B03.440.450.600.500;Mannheimia;D031121
B03.660.250.550.500;Mannheimia;D031121
B03.440.400.425.622;Pseudoalteromonas;D031161
B03.660.250.021.600;Pseudoalteromonas;D031161
B01.650.940.800.575.100.100.037;Achillea;D031162
B01.650.940.800.575.100.100.056;Ageratum;D031163
B01.650.940.800.575.100.100.065;Ambrosia;D031164
B01.650.940.800.575.100.100.070;Ammi;D031165
B01.650.940.800.575.100.100.195.099;Anthemis;D031166
B01.650.940.800.575.100.100.195.288;Chamaemelum;D031167
B01.650.940.800.575.100.100.195.488;Matricaria;D031168
B01.650.940.800.575.100.100.195.744;Tripleurospermum;D031169
B01.650.940.800.575.100.100.072;Arctium;D031170
B01.650.940.800.575.100.100.100.099;Artemisia absinthium;D031171
B01.650.940.800.575.100.100.100.144;Artemisia annua;D031172
B01.650.940.800.575.100.100.111;Aster Plant;D031173
B01.650.940.800.575.100.100.126;Atractylodes;D031174
B01.650.940.800.575.100.100.133;Baccharis;D031175
B01.650.940.800.575.100.100.137;Bidens;D031176
B01.650.940.800.575.100.100.168;Carduus;D031177
B01.650.940.800.575.100.100.181;Carthamus;D031178
B01.650.940.800.575.100.100.188;Centaurea;D031179
B01.650.940.800.575.100.100.227;Cirsium;D031180
B01.650.940.800.575.100.100.241;Cnicus;D031181
B01.650.940.800.575.100.100.317;Echinops Plant;D031182
B01.650.940.800.575.100.100.562;Onopordum;D031183
B01.650.940.800.575.100.100.833;Sonchus;D031184
B01.650.940.800.575.100.100.750;Scolymus;D031185
B01.650.940.800.575.100.100.775;Scorzonera;D031186
B01.650.940.800.575.100.100.181.500;Carthamus tinctorius;D031187
B01.650.940.800.575.100.100.916;Tragopogon;D031188
B01.650.940.800.575.100.100.206;Chrysanthemum;D031202
B01.650.940.800.575.100.100.874;Tanacetum;D031203
E02.642.249.200;Caloric Restriction;D031204
G07.610.240.340.150;Caloric Restriction;D031204
B01.650.940.800.575.100.100.895;Taraxacum;D031205
B01.650.940.800.575.100.100.358;Haplopappus;D031206
B01.650.940.800.575.100.100.958;Tussilago;D031207
B01.650.940.800.575.100.100.979;Verbesina;D031208
B01.650.940.800.575.100.100.989;Wedelia;D031209
B01.650.940.800.575.100.100.994;Xanthium;D031210
B01.650.940.800.575.100.137.875;Corylus;D031211
B01.650.940.800.575.100.146;Bixaceae;D031212
B01.650.940.800.575.100.150.327;Cordia;D031213
B01.650.940.800.575.100.157.150;Arabis;D031214
B01.650.940.800.575.100.157.175;Armoracia;D031215
B01.650.940.800.575.100.157.187;Barbarea;D031216
B01.650.940.800.575.100.157.255;Cardamine;D031217
B01.650.940.800.575.100.157.277;Crambe Plant;D031218
B01.650.940.800.575.100.157.438;Isatis;D031219
B01.650.940.800.575.100.157.600.500;Lepidium sativum;D031220
C26.289.500;Knee Dislocation;D031221
C26.558.554.500;Knee Dislocation;D031221
C26.289.625;Patellar Dislocation;D031222
C26.558.554.750;Patellar Dislocation;D031222
B01.650.940.800.575.100.157.644;Nasturtium;D031223
B01.650.940.800.575.100.157.711;Raphanus;D031224
B01.650.940.800.575.100.157.744;Rorippa;D031225
B01.650.940.800.575.100.157.811;Sinapis;D031226
B01.650.940.800.575.100.157.905;Thlaspi;D031227
B01.650.940.800.575.100.157.952;Wasabia;D031228
B01.650.940.800.575.100.159;Bromeliaceae;D031229
B01.650.940.800.575.100.159.099;Ananas;D031230
B01.650.940.800.575.100.159.244;Bromelia;D031231
B01.650.940.800.575.100.159.622;Tillandsia;D031232
B01.650.940.800.575.100.162.138;Bursera;D031233
B01.650.940.800.575.100.165;Buxaceae;D031234
B01.650.940.800.575.100.165.500;Buxus;D031235
B01.650.940.800.575.100.165.750;Pachysandra;D031236
B01.650.940.800.575.100.169;Calycanthaceae;D031237
B01.650.940.800.575.100.171.800;Platycodon;D031238
B01.650.940.800.575.100.180.388;Lonicera;D031239
B01.650.940.800.575.100.180.625;Symphoricarpos;D031240
B01.650.940.800.575.100.192;Caricaceae;D031241
B01.650.940.800.575.100.195.055;Agrostemma;D031242
B01.650.940.800.575.100.195.077;Arenaria Plant;D031243
B01.650.940.800.575.100.195.416;Lychnis;D031244
B01.650.940.800.575.100.195.913;Vaccaria;D031245
B01.650.940.800.575.100.196;Cecropiaceae;D031246
B01.650.940.800.575.100.197.199;Celastrus;D031247
B01.650.940.800.575.100.200.699;Salsola;D031248
C15.604.250.410.224;Erdheim-Chester Disease;D031249
B01.650.940.800.575.100.216;Clethraceae;D031250
B01.650.940.800.575.100.928.249.249;Clusia;D031251
B01.650.940.800.575.100.928.249.750;Mammea;D031252
B01.650.940.800.575.100.238.249;Calystegia;D031253
B01.650.940.800.575.100.238.374;Convolvulus;D031254
B01.650.940.800.575.100.312.099;Carex Plant;D031255
B01.650.940.800.575.100.312.299;Eleocharis;D031256
B01.650.940.800.575.100.329;Droseraceae;D031257
C22.131.728.650;Poult Enteritis Mortality Syndrome;D031261
B01.650.940.800.575.100.333;Ebenaceae;D031262
B01.650.940.800.575.100.336;Elaeagnaceae;D031263
B01.650.940.800.575.100.336.500;Hippophae;D031281
B01.650.940.800.575.100.343.267;Gaultheria;D031282
B01.650.940.800.575.100.348;Eucommiaceae;D031283
B01.650.940.800.575.100.350.077;Aleurites;D031284
B01.650.940.800.575.100.350.461;Hippomane;D031285
B01.650.940.800.575.100.350.488;Jatropha;D031286
B01.650.940.800.575.100.350.737;Sapium;D031287
B01.650.940.800.575.100.401.125;Chamaecrista;D031288
B01.650.940.800.575.100.401.051;Albizzia;D031289
B01.650.940.800.575.100.401.090;Butea;D031290
B01.650.940.800.575.100.401.112;Castanospermum;D031291
B01.650.940.800.575.100.401.162;Clitoria;D031292
B01.650.940.800.575.100.401.181;Cyamopsis;D031293
B01.650.940.800.575.100.401.196;Dolichos;D031294
B01.650.940.800.575.100.401.318;Griffonia;D031295
B01.650.940.800.575.100.401.356;Laburnum;D031296
B01.650.940.800.575.100.401.571;Lupinus;D031297
B01.650.940.800.575.100.401.596;Mimosa;D031298
B01.650.940.800.575.100.401.598;Mucuna;D031299
C11.768.757;Retinal Vasculitis;D031300
C14.907.940.815;Retinal Vasculitis;D031300
B01.650.940.800.575.100.401.716;Robinia;D031301
B01.650.940.800.575.100.401.812;Spartium;D031302
B01.650.940.800.575.100.401.843;Sphenostylis;D031303
B01.650.940.800.575.100.401.890;Tephrosia;D031304
B01.650.940.800.575.100.401.898;Tetrapleura;D031305
B01.650.940.800.575.100.401.968;Vicia;D031306
B01.650.940.800.575.100.401.968.500;Vicia faba;D031307
B01.650.940.800.575.100.437;Flacourtiaceae;D031308
B01.650.940.800.575.100.437.500;Ryania;D031309
B01.650.940.800.575.100.443;Fumariaceae;D031310
B01.650.940.800.575.100.443.500;Corydalis;D031311
B01.650.940.800.575.100.443.750;Fumaria;D031312
B01.650.940.800.575.100.450.492;Gentianella;D031313
B01.650.940.800.575.100.462;Geraniaceae;D031314
B01.650.940.800.575.100.462.500;Geranium;D031315
B01.650.940.800.575.100.462.750;Pelargonium;D031316
B01.650.940.800.575.100.475.750;Liquidambar;D031317
B01.650.940.800.575.100.503;Hippocastanaceae;D031318
B01.650.940.800.575.100.503.500;Aesculus;D031319
B01.650.940.800.575.100.517;Hippocrateaceae;D031320
B01.650.940.800.575.100.025.399;Hydrocharitaceae;D031321
B01.650.940.800.575.100.531.500;Eriodictyon;D031322
B01.650.940.800.575.100.549.750;Iris Plant;D031323
B01.650.940.800.575.100.569.500;Juglans;D031324
B01.650.940.800.575.100.569.249;Carya;D031325
B01.650.940.800.575.100.572;Krameriaceae;D031326
B01.650.940.800.575.100.575.049;Agastache;D031327
B01.650.940.800.575.100.575.051;Ajuga;D031328
B01.650.940.800.575.100.575.075;Ballota;D031329
B01.650.940.800.575.100.575.166;Coleus;D031330
B01.650.940.800.575.100.575.297;Hyptis;D031331
B01.650.940.800.575.100.575.446;Leonurus;D031332
B01.650.940.800.575.100.575.455;Lycopus;D031333
B01.650.940.800.575.100.575.474;Melissa;D031334
B01.650.940.800.575.100.575.483.500;Mentha pulegium;D031335
B01.650.940.800.575.100.575.231;Hedeoma;D031336
B01.650.940.800.575.100.575.483.750;Mentha spicata;D031337
B01.650.940.800.575.100.575.510;Monarda;D031338
B01.650.940.800.575.100.575.647;Ocimum;D031339
B01.650.940.800.575.100.575.702;Origanum;D031341
B01.650.940.800.575.100.575.729;Orthosiphon;D031342
B01.650.940.800.575.100.575.743;Perilla;D031343
B01.650.940.800.575.100.575.743.500;Perilla frutescens;D031344
B01.650.940.800.575.100.575.750;Phlomis;D031345
B01.650.940.800.575.100.575.753;Plectranthus;D031346
B01.650.940.800.575.100.575.755;Prunella;D031347
B01.650.940.800.575.100.575.756;Rabdosia;D031361
B01.650.940.800.575.100.575.935;Satureja;D031362
B01.650.940.800.575.100.575.942;Scutellaria;D031363
B01.650.940.800.575.100.575.942.500;Scutellaria baicalensis;D031364
B01.650.940.800.575.100.575.945;Sideritis;D031365
B01.650.940.800.575.100.575.947;Stachys;D031366
B01.650.940.800.575.100.575.948;Teucrium;D031367
C02.256.466.423.970;Zoster Sine Herpete;D031368
B01.650.940.800.575.100.590.177;Cryptocarya;D031369
B01.650.940.800.575.100.600;Lecythidaceae;D031381
B01.650.940.800.575.100.600.099;Barringtonia;D031382
B01.650.940.800.575.100.600.133;Bertholletia;D031383
B01.650.940.800.575.100.610.688;Polygonatum;D031384
B01.650.940.800.575.100.610.744;Smilacina;D031401
B01.650.940.800.575.100.610.111;Alstroemeria;D031402
B01.650.940.800.575.100.610.117;Anemarrhena;D031403
B01.650.940.800.575.100.610.181;Camassia;D031404
B01.650.940.800.575.100.610.211;Convallaria;D031405
B01.650.940.800.575.100.610.222;Cordyline;D031406
B01.650.940.800.575.100.610.233;Crinum;D031407
B01.650.940.800.575.100.610.255;Curculigo;D031408
B01.650.940.800.575.100.610.277;Dracaena;D031409
B01.650.940.800.575.100.610.313;Fritillaria;D031410
B01.650.940.800.575.100.610.387;Hemerocallis;D031421
B01.650.940.800.575.100.610.406;Hosta;D031422
B01.650.940.800.575.100.610.415;Hyacinthus;D031423
B01.650.940.800.575.100.610.509;Liriope Plant;D031424
A11.284.149.165.420.625;Plasmodesmata;D031425
B01.650.940.800.575.100.610.533;Lycoris;D031426
B01.650.940.800.575.100.610.555;Narcissus;D031427
B01.650.940.800.575.100.610.588;Ophiopogon;D031441
B01.650.940.800.575.100.610.593;Ornithogalum;D031442
B01.650.940.800.575.100.610.716;Ruscus;D031443
B01.650.940.800.575.100.610.730;Sansevieria;D031444
B01.650.940.800.575.100.610.737;Scilla;D031445
B01.650.940.800.575.100.610.772;Trillium;D031446
B01.650.940.800.575.100.610.786;Tulipa;D031447
B01.650.940.800.575.100.610.793;Urginea;D031448
B01.650.940.800.575.100.610.900;Zigadenus;D031449
B01.650.940.800.575.100.638.500;Gelsemium;D031450
B01.650.940.800.575.100.638.750;Strychnos;D031451
B01.650.940.800.575.100.638.750.500;Strychnos nux-vomica;D031461
B01.650.940.800.575.100.106.500;Cynomorium;D031482
B01.650.940.800.575.100.177;Capparaceae;D031483
B01.650.940.800.575.100.177.500;Capparis;D031484
B01.650.940.800.575.100.177.750;Cleome;D031485
B01.650.940.800.575.100.401.275;Gleditsia;D031501
E05.196.155.500;Fractionation, Field Flow;D031521
E05.196.712.516.600.676.500;Fluorescence Resonance Energy Transfer;D031541
G01.154.100.240.280;Fluorescence Resonance Energy Transfer;D031541
G01.595.100.240.280;Fluorescence Resonance Energy Transfer;D031541
G02.111.087.242.280;Fluorescence Resonance Energy Transfer;D031541
G02.149.115.242.280;Fluorescence Resonance Energy Transfer;D031541
B01.650.940.800.575.100.665.500;Lythrum;D031561
B01.650.940.800.575.100.665.249;Cuphea;D031562
B01.650.940.800.575.100.665.374;Lagerstroemia;D031563
B01.650.940.800.575.100.665.437;Lawsonia Plant;D031564
B01.650.940.800.575.100.665.750;Woodfordia;D031565
B01.650.940.800.575.100.680.500;Magnolia;D031566
B01.650.940.800.575.100.680.249;Liriodendron;D031567
B01.650.940.800.575.100.690.099;Banisteriopsis;D031581
B01.650.940.800.575.100.690.355;Galphimia;D031582
B01.650.940.800.575.100.700.115;Althaea;D031583
B01.650.940.800.575.100.700.288;Hibiscus;D031584
B01.650.940.800.575.100.715.500;Melia;D031585
B01.650.940.800.575.100.715.500.500;Melia azedarach;D031586
B01.650.940.800.575.100.715.249;Cedrela;D031587
B01.650.940.800.575.100.715.124;Azadirachta;D031601
B01.650.940.800.575.100.715.061;Aglaia;D031602
B01.650.940.800.575.100.725.500;Menispermum;D031603
B01.650.940.800.575.100.725.249;Cyclea;D031604
B01.650.940.800.575.100.725.124;Cocculus;D031605
B01.650.940.800.575.100.725.111;Cissampelos;D031606
B01.650.940.800.575.100.725.750;Stephania;D031607
A08.186.211.132.810.406.286;Area Postrema;D031608
A08.186.211.865.467.500.286;Area Postrema;D031608
B01.650.940.800.575.100.725.750.500;Stephania tetrandra;D031609
B01.650.940.800.575.100.725.875;Tinospora;D031610
B01.650.940.800.575.100.745.500;Peumus;D031611
B01.650.940.800.575.100.750.055;Antiaris;D031621
B01.650.940.800.575.100.750.088;Artocarpus;D031622
B01.650.940.800.575.100.750.144;Broussonetia;D031623
B01.650.940.800.575.100.750.599;Maclura;D031624
B01.650.940.800.575.100.750.633;Morus;D031625
B01.650.940.800.575.100.760.500;Myrica;D031641
B01.650.940.800.575.100.756;Myoporaceae;D031642
B01.650.940.800.575.100.756.500;Myoporum;D031643
B01.650.940.800.575.100.770.066;Ardisia;D031644
B01.650.940.800.575.100.770.533;Embelia;D031645
B01.650.940.800.575.100.773.522;Feijoa;D031646
B01.650.940.800.575.100.773.888;Psidium;D031647
B01.650.940.800.575.100.773.649;Kunzea;D031648
B01.650.940.800.575.100.773.713;Leptospermum;D031649
B01.650.940.800.575.100.773.745;Melaleuca;D031650
B01.650.940.800.575.100.773.761;Myrtus;D031651
B01.650.940.800.575.100.774;Nelumbonaceae;D031652
B01.650.940.800.575.100.774.500;Nelumbo;D031653
B01.650.940.800.575.100.776.488;Nuphar;D031654
B01.650.940.800.575.100.778.594;Nyssa;D031655
B01.650.940.800.575.100.780;Olacaceae;D031656
B01.650.940.800.575.100.782.333;Forsythia;D031657
B01.650.940.800.575.100.782.666;Olea;D031658
B01.650.940.800.575.100.782.499;Ligustrum;D031659
B01.650.940.800.575.100.782.416;Jasminum;D031660
B01.650.940.800.575.100.782.374;Fraxinus;D031661
B01.650.940.800.575.100.782.833;Syringa;D031662
B01.650.940.800.575.100.786.222;Clarkia;D031663
B01.650.940.800.575.100.786.611;Oenothera;D031664
B01.650.940.800.575.100.786.611.500;Oenothera biennis;D031665
B01.650.940.800.575.100.786.416;Epilobium;D031666
B01.650.940.800.575.100.787.222;Dendrobium;D031667
B01.650.940.800.575.100.787.500;Gastrodia;D031668
B01.650.940.800.575.100.787.888;Vanilla;D031669
B01.650.940.800.575.100.788;Orobanchaceae;D031670
B01.650.940.800.575.100.788.500;Cistanche;D031671
B01.650.940.800.575.100.788.750;Orobanche;D031672
B01.650.940.800.575.100.792;Pandanaceae;D031673
B01.650.940.800.575.100.795.124;Argemone;D031674
B01.650.940.800.575.100.795.374;Eschscholzia;D031675
B01.650.940.800.575.100.795.750;Sanguinaria;D031681
B01.650.940.800.575.100.803;Passifloraceae;D031683
B01.650.940.800.575.100.806.500;Harpagophytum;D031684
B01.650.940.800.575.100.806.750;Sesamum;D031685
B01.650.940.800.575.100.100.853;Tagetes;D031686
B01.650.940.800.575.100.812.666;Piper;D031701
B01.650.940.800.575.100.822.033;Agropyron;D031702
B01.650.940.800.575.100.822.044;Agrostis;D031703
B01.650.940.800.575.100.812.666.374;Piper betle;D031721
B01.650.940.800.575.100.822.055;Andropogon;D031722
B01.650.940.800.575.100.822.066;Bambusa;D031723
B01.650.940.800.575.100.822.077;Bromus;D031724
B01.650.940.800.575.100.822.151;Cenchrus;D031741
B01.650.940.800.575.100.822.227;Coix;D031742
B01.650.940.800.575.100.822.266;Cymbopogon;D031743
B01.650.940.800.575.100.822.288;Cynodon;D031744
B01.650.940.800.575.100.822.299;Dactylis;D031745
B01.650.940.800.575.100.822.311;Digitaria;D031746
B01.650.940.800.575.100.822.322;Echinochloa;D031747
B01.650.940.800.575.100.822.333;Eleusine;D031748
B01.650.940.800.575.100.822.344;Elymus;D031749
B01.650.940.800.575.100.822.355;Eragrostis;D031750
B01.650.940.800.575.100.822.427;Festuca;D031751
B01.650.940.800.575.100.822.463;Holcus;D031752
B01.650.940.800.575.100.822.744;Paspalum;D031781
B01.650.940.800.575.100.822.755;Pennisetum;D031782
B01.650.940.800.575.100.822.777;Phalaris;D031783
B01.650.940.800.575.100.822.788;Phleum;D031784
B01.650.940.800.575.100.822.793;Poa;D031785
B01.650.940.800.575.100.822.835;Saccharum;D031786
B01.650.940.800.575.100.822.844;Sasa;D031787
B01.650.940.800.575.100.823.500;Polygala;D031801
B01.650.940.800.575.100.823.750;Securidaca;D031802
B01.650.940.800.575.100.825.306;Eriogonum;D031803
B01.650.940.800.575.100.825.850;Rumex;D031804
B01.650.940.800.575.100.826;Pontederiaceae;D031805
B01.650.940.800.575.100.826.500;Eichhornia;D031806
B01.650.940.800.575.100.025.699;Potamogetonaceae;D031821
B01.650.940.800.575.100.827.500;Portulaca;D031822
B01.650.940.800.575.100.829.099;Anagallis;D031823
B01.650.940.800.575.100.829.549;Cyclamen;D031824
B01.650.940.800.575.100.829.774;Primula;D031825
B01.650.940.800.575.100.833;Punicaceae;D031826
B01.650.940.800.575.100.835;Pyrolaceae;D031827
B01.650.940.800.575.100.835.500;Pyrola;D031828
B01.650.940.800.575.100.838.022;Aconitum;D031841
B01.650.940.800.575.100.838.033;Actaea;D031842
B01.650.940.800.575.100.838.036;Adonis;D031843
B01.650.940.800.575.100.838.518;Nigella;D031844
C05.116.099.052.400;Hajdu-Cheney Syndrome;D031845
C05.116.264.579.052.400;Hajdu-Cheney Syndrome;D031845
C16.131.621.445;Hajdu-Cheney Syndrome;D031845
C16.320.355;Hajdu-Cheney Syndrome;D031845
B01.650.940.800.575.100.838.518.500;Nigella damascena;D031861
B01.650.940.800.575.100.838.518.750;Nigella sativa;D031881
B01.650.940.800.575.100.838.277;Delphinium;D031882
B01.650.940.800.575.100.838.077;Anemone;D031883
B01.650.940.800.575.100.838.088;Aquilegia;D031884
B01.650.940.800.575.100.838.182;Cimicifuga;D031885
C04.557.465.955.416;Gestational Trophoblastic Disease;D031901
C04.850.908.416;Gestational Trophoblastic Disease;D031901
C13.703.720.949.416;Gestational Trophoblastic Disease;D031901
C02.782.580.830.450;Hemorrhagic Septicemia, Viral;D031941
C22.362.450;Hemorrhagic Septicemia, Viral;D031941
C23.550.470.790.500.900.400;Hemorrhagic Septicemia, Viral;D031941
B01.650.940.800.575.100.100.269;Cynara;D031942
B01.650.940.800.575.100.100.269.500;Cynara scolymus;D031943
B01.650.940.800.575.100.100.289;Dahlia;D031944
B01.650.940.800.575.100.100.248;Coreopsis;D031945
B01.650.940.800.575.100.838.666;Pulsatilla;D031946
B01.650.940.800.575.100.838.733;Ranunculus;D031947
B01.650.940.800.575.100.838.766;Semiaquilegia;D031948
B01.650.940.800.575.100.838.883;Thalictrum;D031949
B01.650.940.800.575.100.838.941;Xanthorhiza;D031950
B01.650.940.800.575.100.839;Resedaceae;D031951
B01.650.940.800.575.100.840.111;Ceanothus;D031952
B01.650.940.800.575.100.840.133;Colubrina;D031953
C04.557.465.955.207.750;Choriocarcinoma, Non-gestational;D031954
C04.557.470.200.025.455.750;Choriocarcinoma, Non-gestational;D031954
B01.650.940.800.575.100.840.316;Frangula;D031955
B01.650.940.800.575.100.840.408;Karwinskia;D031956
B01.650.940.800.575.100.840.833;Ziziphus;D031957
B01.650.940.800.575.100.842.222;Connaraceae;D031961
B01.650.940.800.575.100.842.249.249;Kalanchoe;D031962
B01.650.940.800.575.100.842.249.750;Sedum;D031963
B01.650.940.800.575.100.842.311;Grossulariaceae;D031964
B01.650.940.800.575.100.842.311.500;Ribes;D031965
B01.650.940.800.575.100.842.374.500;Hydrangea;D031966
B01.650.940.800.575.100.842.500.033;Agrimonia;D031981
B01.650.940.800.575.100.842.500.055;Alchemilla;D031982
B01.650.940.800.575.100.842.500.222;Eriobotrya;D031983
B01.650.940.800.575.100.842.500.244;Filipendula;D031984
B01.650.940.800.575.100.842.500.266;Fragaria;D031985
B01.650.940.800.575.100.842.500.288;Geum;D031986
B01.650.940.800.575.100.842.500.601;Potentilla;D031987
B01.650.940.800.575.100.842.500.687;Pygeum;D031988
B01.650.940.800.575.100.842.500.699;Pyrus;D031989
B01.650.940.800.575.100.842.500.724;Quillaja;D031990
B01.650.940.800.575.100.842.500.693;Pyracantha;D031991
B01.650.940.800.575.100.842.500.808;Spiraea;D031992
B01.650.940.800.575.100.842.500.779;Sanguisorba;D031993
B01.650.940.800.575.100.842.500.793;Sorbus;D031994
B01.650.940.800.575.100.842.750;Saxifragaceae;D031995
B01.650.940.800.575.100.842.750.500;Heuchera;D031996
N04.590.374.070;Delegation, Professional;D032022
G02.111.570.080.708.330.200.500;Integrons;D032023
N04.452.677.445;Personnel Delegation;D032024
G05.360.340.024.340.385.600;Nested Genes;D032041
B01.650.940.800.575.100.850.377;Galium;D032061
B01.650.940.800.575.100.850.388;Gardenia;D032062
B01.650.940.800.575.100.850.404;Hamelia;D032063
B01.650.940.800.575.100.850.422;Hedyotis;D032064
B01.650.940.800.575.100.850.555;Mitragyna;D032065
B01.650.940.800.575.100.850.566;Morinda;D032066
B01.650.940.800.575.100.850.611;Oldenlandia;D032067
B01.650.940.800.575.100.850.805;Pausinystalia;D032068
B01.650.940.800.575.100.850.844;Psychotria;D032069
B01.650.940.800.575.100.850.909;Uncaria;D032070
B01.650.940.800.575.100.875.155;Casimiroa;D032081
B01.650.940.800.575.100.875.177.077;Citrus aurantiifolia;D032082
B01.650.940.800.575.100.875.177.538;Citrus paradisi;D032083
B01.650.940.800.575.100.875.177.769;Citrus sinensis;D032084
D13.444.308.580;Isochores;D032085
G05.360.340.024.430;Isochores;D032085
B01.650.940.800.575.100.875.333;Evodia;D032086
B01.650.940.800.575.100.875.666;Murraya;D032101
B01.650.940.800.575.100.875.717;Phellodendron;D032102
B01.650.940.800.575.100.875.733;Pilocarpus;D032103
B01.650.940.800.575.100.875.755;Poncirus;D032104
B01.650.940.800.575.100.875.788;Ruta;D032105
B01.650.940.800.575.100.875.922;Zanthoxylum;D032106
B01.650.940.800.575.100.881.666;Populus;D032107
B01.650.940.800.575.100.881.833;Salix;D032108
B01.650.940.800.575.100.882;Salvadoraceae;D032121
B01.650.940.800.575.100.884.666;Pyrularia;D032122
B01.650.940.800.575.100.884.833;Santalum;D032123
B01.650.940.800.575.100.885.111;Blighia;D032124
B01.650.940.800.575.100.885.444;Litchi;D032125
B01.650.940.800.575.100.885.722;Paullinia;D032126
B01.650.940.800.575.100.885.861;Sapindus;D032127
B01.650.940.800.575.100.886.500;Madhuca;D032128
B01.650.940.800.575.100.886.555;Manilkara;D032129
B01.650.940.800.575.100.886.577;Mimusops;D032130
B01.650.940.800.575.100.886.666;Palaquium;D032131
B01.650.940.800.575.100.886.699;Pouteria;D032132
B01.650.940.800.575.100.886.849;Synsepalum;D032133
B01.650.940.800.575.100.888;Saururaceae;D032134
B01.650.940.800.575.100.889.500;Kadsura;D032135
B01.650.940.800.575.100.889.750;Schisandra;D032141
B01.650.940.800.575.100.892.055;Antirrhinum;D032161
B01.650.940.800.575.100.892.194;Craterostigma;D032181
B01.650.940.800.575.100.892.366;Euphrasia;D032201
B01.650.940.800.575.100.892.555;Linaria;D032221
B01.650.940.800.575.100.892.599;Mimulus;D032241
B01.650.940.800.575.100.892.811;Picrorhiza;D032261
B01.650.940.800.575.100.892.705;Pedicularis;D032262
B01.650.940.800.575.100.892.758;Penstemon;D032263
B01.650.940.800.575.100.892.905;Veronica;D032264
B01.650.940.800.575.100.892.899;Verbascum;D032265
B01.650.940.800.575.100.892.855;Scrophularia;D032266
B01.650.940.800.575.100.892.833;Rehmannia;D032267
B01.650.940.800.575.100.898.044;Ailanthus;D032268
B01.650.940.800.575.100.898.111;Brucea;D032269
B01.650.940.800.575.100.898.555;Picrasma;D032270
B01.650.940.800.575.100.898.599;Quassia;D032271
B01.650.940.800.575.100.898.799;Simarouba;D032272
B01.650.940.800.575.100.901.500;Smilax;D032281
B01.650.940.800.575.100.905.049;Atropa;D032282
B01.650.940.800.575.100.905.166;Cestrum;D032301
B01.650.940.800.575.100.905.188;Datura;D032302
B01.650.940.800.575.100.905.202;Duboisia;D032303
B01.650.940.800.575.100.905.274;Hyoscyamus;D032304
B01.650.940.800.575.100.905.310;Lycium;D032305
B01.650.940.800.575.100.905.448;Petunia;D032306
B01.650.940.800.575.100.905.499;Physalis;D032321
B01.650.940.800.575.100.905.725;Solanum;D032322
B01.650.940.800.575.100.905.725.666;Solanum melongena;D032323
B01.650.940.800.575.100.905.725.699;Solanum nigrum;D032324
B01.650.940.800.575.100.905.950;Withania;D032341
A11.620;Muscle Cells;D032342
B01.650.940.800.575.100.915.583;Sterculia;D032361
B01.650.940.800.575.100.920.777;Styrax;D032362
B01.650.940.800.575.100.924;Tamaricaceae;D032363
B01.650.940.800.575.100.932.500;Daphne;D032364
B01.650.940.800.575.100.932.909;Wikstroemia;D032365
B01.650.940.800.575.100.938.144;Corchorus;D032381
B01.650.940.800.575.100.938.333;Grewia;D032382
A07.541.704.570;Myocytes, Cardiac;D032383
A10.690.552.750.570;Myocytes, Cardiac;D032383
A11.620.500;Myocytes, Cardiac;D032383
B01.650.940.800.575.100.938.777;Tilia;D032384
B01.650.940.800.575.100.938.888;Triumfetta;D032385
A07.541.704.500;Myoblasts, Cardiac;D032386
A10.690.552.750.500;Myoblasts, Cardiac;D032386
A11.635.470;Myoblasts, Cardiac;D032386
A11.872.645.470;Myoblasts, Cardiac;D032386
B01.650.940.800.575.100.942;Tropaeolaceae;D032387
B01.650.940.800.575.100.942.500;Tropaeolum;D032388
A11.620.520;Myocytes, Smooth Muscle;D032389
A11.635.510;Myoblasts, Smooth Muscle;D032390
A11.872.645.510;Myoblasts, Smooth Muscle;D032390
B01.650.940.800.575.100.948;Typhaceae;D032401
B01.650.940.800.575.100.950.077;Boehmeria;D032402
B01.650.940.800.575.100.950.777;Parietaria;D032403
B01.650.940.800.575.100.955.443;Nardostachys;D032404
B01.650.940.800.575.100.955.665;Patrinia;D032405
B01.650.940.800.575.100.955.944;Valerianella;D032406
B01.650.940.800.575.100.960.066;Avicennia;D032407
B01.650.940.800.575.100.960.144;Callicarpa;D032408
B01.650.940.800.575.100.960.155;Clerodendrum;D032409
B01.650.940.800.575.100.960.411;Lantana;D032410
B01.650.940.800.575.100.960.433;Lippia;D032411
B01.650.940.800.575.100.960.855;Verbena;D032412
B01.650.940.800.575.100.962.888;Viola;D032413
B01.650.940.800.575.100.965.044;Ampelopsis;D032421
B01.650.940.800.575.100.965.272;Cissus;D032422
B01.650.940.800.575.100.970;Winteraceae;D032423
B01.650.940.800.575.100.970.199;Drimys;D032424
B01.650.940.800.575.100.970.599;Pseudowintera;D032425
B01.650.940.800.575.100.975.522;Marantaceae;D032426
B01.650.940.800.575.100.975.323;Heliconiaceae;D032427
B01.650.940.800.575.100.975.727;Strelitziaceae;D032428
B01.650.940.800.575.100.975.900.033;Alpinia;D032429
B01.650.940.800.575.100.987.088;Balanites;D032430
B01.650.940.800.575.100.987.277;Guaiacum;D032441
B01.650.940.800.575.100.987.399;Larrea;D032442
B01.650.940.800.575.100.987.699;Peganum;D032443
B01.650.940.800.575.100.987.849;Tribulus;D032444
B01.650.940.800.575.100.987.924;Zygophyllum;D032445
A11.635;Myoblasts;D032446
A11.872.645;Myoblasts;D032446
B01.650.940.800.575.100.401.984;Wisteria;D032447
A11.635.500;Myoblasts, Skeletal;D032448
A11.872.645.500;Myoblasts, Skeletal;D032448
B01.650.940.800.575.100.401.096;Canavalia;D032449
A11.284.187.560;Chromosomes, Plant;D032461
A18.005;Chromosomes, Plant;D032461
G05.360.162.560;Chromosomes, Plant;D032461
B01.650.940.800.575.400.186;Cycadophyta;D032462
B01.650.940.800.575.400.186.955;Zamiaceae;D032481
B01.650.940.800.575.400.122;Coniferophyta;D032482
B01.650.940.800.575.400.122.166;Cephalotaxus;D032483
B01.650.940.800.575.400.122.855;Taxodiaceae;D032484
B01.650.940.800.575.400.122.855.166;Cryptomeria;D032485
B01.650.940.800.575.400.122.855.177;Cunninghamia;D032486
B01.650.940.800.575.400.122.855.777;Sequoia;D032487
B01.650.940.800.575.400.122.855.788;Sequoiadendron;D032488
B01.650.940.800.575.400.122.855.833;Taxodium;D032489
B01.650.940.800.575.400.122.833;Taxaceae;D032490
B01.650.940.800.575.250.222;Dryopteridaceae;D032491
B01.650.940.800.575.250.222.222;Dryopteris;D032492
B01.650.940.800.575.250.222.611;Polystichum;D032493
B01.650.940.800.575.250.700.666;Polypodium;D032494
B01.650.940.800.575.250.750.666;Pteris;D032495
A11.635.500.700;Satellite Cells, Skeletal Muscle;D032496
A11.872.645.500.700;Satellite Cells, Skeletal Muscle;D032496
B01.650.940.800.575.250.199;Dennstaedtiaceae;D032497
B01.650.940.800.575.250.199.666;Pteridium;D032498
B01.650.940.800.575.525.333;Huperzia;D032501
B01.650.940.800.575.525.666;Lycopodium;D032502
B01.650.940.800.575.825;Selaginellaceae;D032503
G12.450.562;Immunity, Herd;D032521
E02.095.465.425.400.530.890.500;Mass Vaccination;D032541
E05.478.550.600.890.500;Mass Vaccination;D032541
N02.421.143.827.608.500;Mass Vaccination;D032541
N02.421.726.608.500;Mass Vaccination;D032541
N02.421.726.758.310.890.500;Mass Vaccination;D032541
N06.850.780.200.425.900.500;Mass Vaccination;D032541
N06.850.780.680.310.890.500;Mass Vaccination;D032541
J01.576.885.800.299;Cotton Fiber;D032561
D20.215.894.135.825;Tuberculosis Vaccines;D032581
B01.650.940.800.575.100.157.357;Erysimum;D032601
B01.650.940.800.575.100.401.098;Caragana;D032602
B01.650.940.800.575.100.905.612;Scopolia;D032603
B01.650.940.800.575.100.022;Alangiaceae;D032604
E05.393.420.238;DNA Shuffling;D032621
B01.300.107.320;Eurotiales;D032641
B01.300.107.501.220;Cordyceps;D032661
E01.370.225.500.385.315.800;Spectral Karyotyping;D032681
E05.200.500.385.315.800;Spectral Karyotyping;D032681
E05.242.385.315.800;Spectral Karyotyping;D032681
E05.393.285.350.125.800;Spectral Karyotyping;D032681
E05.393.285.475.800;Spectral Karyotyping;D032681
E05.393.661.475.350.125.800;Spectral Karyotyping;D032681
H01.158.550.100;Biomimetics;D032701
J01.897.120.100;Biomimetics;D032701
F01.829.263.065;Adult Children;D032721
I01.880.225.281;Adult Children;D032721
M01.055;Adult Children;D032721
N04.590.233.624.124;Advance Care Planning;D032722
B01.300.107.320.500;Monascus;D032741
E05.017;Animal Experimentation;D032761
H01.770.644.053;Animal Experimentation;D032761
E05.445.100;Autoexperimentation;D032762
H01.770.644.145.365.100;Autoexperimentation;D032762
H01.770.644.302.100;Autoexperimentation;D032762
E02.085;Behavior Control;D032763
F04.047;Behavior Control;D032763
I01.880.630.099;Behavior Control;D032763
K01.316.163.150;Casuistry;D032764
K01.752.256.113.150;Casuistry;D032764
K01.316.080;Codes of Ethics;D032781
N04.761.700.350.324;Codes of Ethics;D032781
N05.350.340.080;Codes of Ethics;D032781
N05.700.350.324;Codes of Ethics;D032781
E04.540.480;Iridectomy;D032801
N04.452.122;Committee Membership;D032802
F01.145.813.191.250;Commodification;D032821
J01.219.187;Commodification;D032821
B01.650.940.800.575.100.725.625;Sinomenium;D032841
B01.300.107.320.200;Emericella;D032842
B01.650.940.800.575.100.892.124;Buddleja;D032861
B01.650.940.800.575.100.590.555;Litsea;D032862
F02.463.188.357;Comprehension;D032882
B01.300.107.320.800;Talaromyces;D032901
B01.300.179.120.379;Ganoderma;D032902
K01.844.799.214;Confucianism;D032903
B01.650.940.800.575.100.590.149.124;Cinnamomum aromaticum;D032904
F01.829.316.068;Consensus;D032921
F02.463.785.373.433;Consensus;D032921
A05.360.490.890.830;Sperm Midpiece;D032961
A11.497.760.450;Sperm Midpiece;D032961
I01.880.604.583.427.134;Consent Forms;D032962
N03.706.535.489.134;Consent Forms;D032962
N04.452.859.198;Consent Forms;D032962
N05.715.360.300.715.245;Consent Forms;D032962
F01.145.813.191;Dehumanization;D032981
I01.880.604.583.090;Contracts;D032982
N03.706.535.241;Contracts;D032982
B01.650.940.800.575.100.822.871;Setaria Plant;D032983
K01.316.366;Ethics, Research;D032984
N05.350.670;Ethics, Research;D032984
N02.421.911.200;Directed Tissue Donation;D033001
F01.829.401.650.505;Duty to Recontact;D033002
I01.880.604.583.166;Duty to Recontact;D033002
N03.706.535.247;Duty to Recontact;D033002
K01.844.188.502;Eastern Orthodoxy;D033003
B01.650.940.800.575.100.401.606;Oxytropis;D033021
B01.650.940.800.575.100.401.968.750;Vicia sativa;D033022
A02.835.583.378;Foot Joints;D033023
E05.313;Embryo Research;D033041
H01.770.644.145.250;Embryo Research;D033041
E05.349;Fetal Research;D033042
H01.770.644.145.300;Fetal Research;D033042
K01.316.167.200;Ethics Consultation;D033061
N04.452.758.849.174;Ethics Consultation;D033061
N05.350.250.200;Ethics Consultation;D033061
M01.252;Friends;D033062
G01.374.820;Shear Strength;D033081
E02.760.905.199.249.200;Euthanasia, Active, Voluntary;D033101
I01.880.735.344.500.249.200;Euthanasia, Active, Voluntary;D033101
N02.421.585.905.199.500.200;Euthanasia, Active, Voluntary;D033101
F04.096.276.400;Genetic Determinism;D033141
N02.421.308;Genetic Services;D033142
I01.880.604.394;Government Regulation;D033161
N03.706.358;Government Regulation;D033161
E01.410;Incidental Findings;D033162
L01.143.443;Information Dissemination;D033181
F01.658.650;Intention;D033182
F02.463.306;Intention;D033182
F01.829.401.205.249;Interdisciplinary Communication;D033183
L01.143.474;Interdisciplinary Communication;D033183
B01.050.500.131.365.250;Euphausiacea;D033201
B01.050.500.131.365.060;Anostraca;D033202
K01.844.188.573;Jehovah's Witnesses;D033221
M01.352;Jehovah's Witnesses;D033221
I01.880.604.583.474;Judicial Role;D033222
M01.526.520;Lawyers;D033241
M01.416;Minors;D033242
F01.829.263.370.215.500;Maternal-Fetal Relations;D033261
E05.318.308.502;Narration;D033262
F01.145.209.459;Narration;D033262
L01.280.660;Narration;D033262
N05.715.360.300.480;Narration;D033262
N06.850.520.308.502;Narration;D033262
E05.445.750;Nontherapeutic Human Experimentation;D033281
H01.770.644.145.365.750;Nontherapeutic Human Experimentation;D033281
H01.770.644.302.750;Nontherapeutic Human Experimentation;D033281
I01.880.604.583.427.635.500;Parental Consent;D033282
N03.706.535.489.635.500;Parental Consent;D033282
I01.880.604.473.352.500.030.500;Patient Access to Records;D033283
I01.880.604.473.650.827;Patient Access to Records;D033283
N03.706.437.650.406;Patient Access to Records;D033283
A05.360.319.679.490.373.500;Deciduoma;D033301
A16.710.289.500;Deciduoma;D033301
K01.752.720;Postmodernism;D033302
K01.844.188.644;Protestantism;D033303
B01.050.500.131.365.055;Amphipoda;D033304
B01.050.500.131.365.400;Isopoda;D033321
B01.050.500.131.365.070;Arguloida;D033341
B01.050.500.131.365.160;Copepoda;D033342
B01.050.500.131.365.150;Cladocera;D033361
E05.196.309.711;Powder Diffraction;D033362
E05.196.309.555;Neutron Diffraction;D033363
E05.196.822.650;Neutron Diffraction;D033363
G01.595.861.650;Neutron Diffraction;D033363
G02.149.767.642;Neutron Diffraction;D033363
G02.842.750.642;Neutron Diffraction;D033363
B01.050.500.131.365.190;Decapoda (Crustacea);D033364
B01.050.500.131.365.190.050;Anomura;D033381
E01.370.350.515.370;Microscopy, Acoustic;D033401
E01.370.350.850.565;Microscopy, Acoustic;D033401
E05.595.370;Microscopy, Acoustic;D033401
K01.752.400.100;Beginning of Human Life;D033421
H02.403.059;Andrology;D033441
C23.550.449;Hyperuricemia;D033461
A11.284.187.520;Chromosomes, Mammalian;D033481
G05.360.162.520;Chromosomes, Mammalian;D033481
B01.050.500.131.365.190.150;Crangonidae;D033501
B01.050.500.131.365.190.625;Palinuridae;D033521
B01.050.500.131.365.190.615;Palaemonidae;D033541
B01.050.500.131.365.190.635;Pandalidae;D033542
B01.050.500.131.365.190.660;Penaeidae;D033561
E04.936.225.687;Stem Cell Transplantation;D033581
B03.510.024.049.300;Gordonia Bacterium;D033601
B01.050.500.131.617.289.850;Tephritidae;D033621
B01.050.500.131.617.289.850.150;Ceratitis capitata;D033622
B01.650.940.800.575.100.401.594;Millettia;D033641
A11.870.740.600;Oocysts;D033661
B05.500.675;Oocysts;D033661
B05.775.740.600;Oocysts;D033661
G07.700.320.500.550.500.675;Oocysts;D033661
D12.776.543.585.475;Mitochondrial Membrane Transport Proteins;D033681
D12.776.575.750;Mitochondrial Membrane Transport Proteins;D033681
D12.776.157.530.625;Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins;D033701
D12.776.543.585.625;Nucleobase, Nucleoside, Nucleotide, and Nucleic Acid Transport Proteins;D033701
D12.776.157.530.625.500;Nucleobase Transport Proteins;D033702
D12.776.543.585.625.500;Nucleobase Transport Proteins;D033702
D12.776.157.530.625.750;Nucleoside Transport Proteins;D033703
D12.776.543.585.625.750;Nucleoside Transport Proteins;D033703
D12.776.157.530.625.875;Nucleotide Transport Proteins;D033704
D12.776.543.585.625.875;Nucleotide Transport Proteins;D033704
D12.776.157.530.625.750.500;Equilibrative Nucleoside Transport Proteins;D033705
D12.776.543.585.625.750.500;Equilibrative Nucleoside Transport Proteins;D033705
D12.776.157.530.625.750.500.500;Equilibrative Nucleoside Transporter 1;D033721
D12.776.543.585.625.750.500.500;Equilibrative Nucleoside Transporter 1;D033721
D12.776.157.530.625.750.500.750;Equilibrative-Nucleoside Transporter 2;D033722
D12.776.543.585.625.750.500.750;Equilibrative-Nucleoside Transporter 2;D033722
D12.776.157.530.625.875.500.100;Adenine Nucleotide Translocator 1;D033741
D12.776.543.585.450.162.225.100;Adenine Nucleotide Translocator 1;D033741
D12.776.543.585.475.500.100;Adenine Nucleotide Translocator 1;D033741
D12.776.543.585.625.875.500.100;Adenine Nucleotide Translocator 1;D033741
D12.776.575.750.500.100;Adenine Nucleotide Translocator 1;D033741
D12.776.157.530.625.875.500.200;Adenine Nucleotide Translocator 2;D033742
D12.776.543.585.450.162.225.200;Adenine Nucleotide Translocator 2;D033742
D12.776.543.585.475.500.200;Adenine Nucleotide Translocator 2;D033742
D12.776.543.585.625.875.500.200;Adenine Nucleotide Translocator 2;D033742
D12.776.575.750.500.200;Adenine Nucleotide Translocator 2;D033742
A11.870.740;Spores, Protozoan;D033761
B05.775.740;Spores, Protozoan;D033761
D12.776.157.530.625.875.500.300;Adenine Nucleotide Translocator 3;D033781
D12.776.543.585.450.162.225.300;Adenine Nucleotide Translocator 3;D033781
D12.776.543.585.475.500.300;Adenine Nucleotide Translocator 3;D033781
D12.776.543.585.625.875.500.300;Adenine Nucleotide Translocator 3;D033781
D12.776.575.750.500.300;Adenine Nucleotide Translocator 3;D033781
D12.776.157.427;Iron-Binding Proteins;D033862
D12.776.556.579;Iron-Binding Proteins;D033862
D12.776.157.905;Transferrin-Binding Proteins;D033863
D12.776.097.120.300.500;Transferrin-Binding Protein A;D033881
D12.776.157.905.500.249.500;Transferrin-Binding Protein A;D033881
D12.776.543.750.850.249.500;Transferrin-Binding Protein A;D033881
D12.776.097.120.300.750;Transferrin-Binding Protein B;D033882
D12.776.157.905.500.249.750;Transferrin-Binding Protein B;D033882
D12.776.543.750.850.249.750;Transferrin-Binding Protein B;D033882
D12.776.097.120.300;Bacterial Transferrin Receptor Complex;D033901
D12.776.097.141;Bacterial Transferrin Receptor Complex;D033901
D12.776.157.905.500.249;Bacterial Transferrin Receptor Complex;D033901
D12.776.543.750.850.249;Bacterial Transferrin Receptor Complex;D033901
D12.776.097.577.500;Periplasmic Binding Proteins;D033902
D12.776.157.622;Periplasmic Binding Proteins;D033902
D12.776.090.650;Periplasmic Proteins;D033903
D12.776.097.577;Periplasmic Proteins;D033903
D12.776.765.537;Periplasmic Proteins;D033903
D12.776.543.990;Vesicular Transport Proteins;D033921
D12.776.543.990.200.500;Clathrin Heavy Chains;D033922
D12.776.543.990.200.750;Clathrin Light Chains;D033941
D12.776.543.990.150;Adaptor Proteins, Vesicular Transport;D033942
D12.776.543.990.150.100;Adaptor Protein Complex 1;D033961
D12.776.543.990.150.200;Adaptor Protein Complex 2;D033962
D12.776.543.990.150.300;Adaptor Protein Complex 3;D033963
D12.776.543.990.150.400;Adaptor Protein Complex 4;D033964
D12.776.543.990.150.500.100;Adaptor Protein Complex alpha Subunits;D033965
D12.776.543.990.150.500.200;Adaptor Protein Complex beta Subunits;D033966
D12.776.543.990.150.500.300;Adaptor Protein Complex delta Subunits;D033981
D12.776.543.990.150.500.400;Adaptor Protein Complex gamma Subunits;D033982
D12.776.543.990.150.500.500;Adaptor Protein Complex mu Subunits;D033983
D12.776.543.990.150.500;Adaptor Protein Complex Subunits;D034001
D12.776.543.990.150.500.750;Adaptor Protein Complex sigma Subunits;D034002
D12.776.543.990.049;Auxilins;D034021
D12.776.543.990.150.750;Monomeric Clathrin Assembly Proteins;D034041
G04.299.151.825.798;Thrombopoiesis;D034061
G09.188.124.544.798;Thrombopoiesis;D034061
C10.228.228.800.392;Insomnia, Fatal Familial;D034062
C10.574.843.512;Insomnia, Fatal Familial;D034062
C10.886.425.800.800.400;Insomnia, Fatal Familial;D034062
C10.228.228.800.858;Wasting Disease, Chronic;D034081
C10.574.843.925;Wasting Disease, Chronic;D034081
C22.955;Wasting Disease, Chronic;D034081
A11.870.740.600.800;Sporozoites;D034101
B05.500.675.800;Sporozoites;D034101
B05.775.740.600.800;Sporozoites;D034101
G07.700.320.500.550.500.675.800;Sporozoites;D034101
N02.421.800;Reproductive Health Services;D034121
C15.378.147.607.500;Hypoalbuminemia;D034141
C01.539.635;Pelvic Infection;D034161
B01.650.940.800.575.100.125.342;Epimedium;D034181
B01.650.940.800.575.100.306;Cuscuta;D034182
L01.224.230.260.550.500;Computers, Handheld;D034201
B03.440.450.510;Moritella;D034221
B03.660.250.021.500;Moritella;D034221
B03.660.250.021;Alteromonadaceae;D034241
D02.455.426.392.368.408;Cyclooctanes;D034242
D02.540.505.187;Epothilones;D034261
D08.811.277.040.330.200;Dynamins;D034281
D12.776.220.600.450.200;Dynamins;D034281
D12.776.543.990.400;Dynamins;D034281
D08.811.277.040.330.200.100;Dynamin I;D034284
D12.776.220.600.450.200.100;Dynamin I;D034284
D12.776.543.990.400.100;Dynamin I;D034284
D08.811.277.040.330.200.200;Dynamin II;D034285
D12.776.220.600.450.200.200;Dynamin II;D034285
D12.776.543.990.400.200;Dynamin II;D034285
D08.811.277.040.330.200.300;Dynamin III;D034286
D12.776.220.600.450.200.300;Dynamin III;D034286
D12.776.543.990.400.300;Dynamin III;D034286
B03.510.400.200;Deinococcus;D034301
C23.550.425;Hyperamylasemia;D034321
D02.455.426.559.847.723.089;Aristolochic Acids;D034341
D02.640.139;Aristolochic Acids;D034341
D04.615.723.089;Aristolochic Acids;D034341
B03.510.400.800.872.875.500;Streptococcus mitis;D034361
B03.510.550.737.872.875.500;Streptococcus mitis;D034361
B01.650.940.800.575.100.892.877;Striga;D034362
B03.510.400.800.872.875;Viridans Streptococci;D034363
B03.510.550.737.872.875;Viridans Streptococci;D034363
B03.510.400.800.872.875.475;Streptococcus milleri Group;D034364
B03.510.550.737.872.875.475;Streptococcus milleri Group;D034364
B03.510.400.800.872.875.475.150;Streptococcus constellatus;D034365
B03.510.550.737.872.875.475.150;Streptococcus constellatus;D034365
B03.510.400.800.872.875.475.080;Streptococcus anginosus;D034366
B03.510.550.737.872.875.475.080;Streptococcus anginosus;D034366
B03.510.400.800.872.875.475.400;Streptococcus intermedius;D034367
B03.510.550.737.872.875.475.400;Streptococcus intermedius;D034367
C09.218.458.341;Hearing Loss;D034381
C10.597.751.418.341;Hearing Loss;D034381
C23.888.592.763.393.341;Hearing Loss;D034381
B01.650.940.800.575.100.949;Ulmaceae;D034401
B01.650.940.800.575.100.949.777;Trema;D034402
B01.650.940.800.575.100.949.888;Ulmus;D034403
B01.050.150.900.649.077.880.399;Sus scrofa;D034421
D12.776.157.725.500.500;Heterogeneous-Nuclear Ribonucleoproteins;D034441
D12.776.664.962.500.500;Heterogeneous-Nuclear Ribonucleoproteins;D034441
D12.125.481.700;N-substituted Glycines;D034442
D12.644.679.500;N-substituted Glycines;D034442
G03.495.166.850;RNA Transport;D034443
D12.644.679;Peptoids;D034444
E02.875.194.670;Ovulation Inhibition;D034445
G08.686.785.760.690.493;Ovulation Inhibition;D034445
G08.686.785.760.690.355;Luteinization;D034461
F01.829.401.094;Dissent and Disputes;D034462
F02.463.785.373.476;Dissent and Disputes;D034462
D12.776.157.725.500.500.100;Heterogeneous-Nuclear Ribonucleoprotein Group A-B;D034481
D12.776.260.735.500;Heterogeneous-Nuclear Ribonucleoprotein Group A-B;D034481
D12.776.660.235.700.500;Heterogeneous-Nuclear Ribonucleoprotein Group A-B;D034481
D12.776.664.962.500.500.100;Heterogeneous-Nuclear Ribonucleoprotein Group A-B;D034481
D12.776.157.725.500.500.200;Heterogeneous-Nuclear Ribonucleoprotein Group C;D034482
D12.776.664.962.500.500.200;Heterogeneous-Nuclear Ribonucleoprotein Group C;D034482
D12.776.260.735;Telomere-Binding Proteins;D034501
D12.776.660.235.700;Telomere-Binding Proteins;D034501
D12.776.157.725.500.500.300;Heterogeneous-Nuclear Ribonucleoprotein D;D034502
D12.776.664.962.500.500.300;Heterogeneous-Nuclear Ribonucleoprotein D;D034502
D12.776.660.650;Nuclear Matrix-Associated Proteins;D034521
D12.776.157.725.500.500.400;Heterogeneous-Nuclear Ribonucleoprotein Group F-H;D034541
D12.776.664.962.500.500.400;Heterogeneous-Nuclear Ribonucleoprotein Group F-H;D034541
B01.050.150.900.649.077.380.791.150;Sheep, Domestic;D034561
B01.050.150.900.649.077.380.791.100;Sheep, Bighorn;D034581
A17;Integumentary System;D034582
B01.050.150.900.649.521.400;Hares;D034621
G05.355.315.203.374.790;RNA Interference;D034622
D12.776.157.725.500.500.500;Heterogeneous-Nuclear Ribonucleoprotein K;D034641
D12.776.260.268;Heterogeneous-Nuclear Ribonucleoprotein K;D034641
D12.776.664.962.500.500.500;Heterogeneous-Nuclear Ribonucleoprotein K;D034641
D12.776.157.725.500.500.600;Heterogeneous-Nuclear Ribonucleoprotein L;D034664
D12.776.664.962.500.500.600;Heterogeneous-Nuclear Ribonucleoprotein L;D034664
B01.650.940.800.575.100.892.089;Bacopa;D034681
K01.844.188.466;Church of Jesus Christ of Latter-day Saints;D034682
C04.557.450.565.465.500;Mastocytosis, Cutaneous;D034701
C17.800.508.473;Mastocytosis, Cutaneous;D034701
D12.776.157.725.500.500.905;RNA-Binding Protein FUS;D034702
D12.776.624.664.700.915;RNA-Binding Protein FUS;D034702
D12.776.664.962.500.500.902;RNA-Binding Protein FUS;D034702
C04.557.450.565.465.750;Mastocytosis, Systemic;D034721
D12.776.157.725.500.500.800;Heterogeneous-Nuclear Ribonucleoprotein U;D034722
D12.776.660.650.500;Heterogeneous-Nuclear Ribonucleoprotein U;D034722
D12.776.664.962.500.500.800;Heterogeneous-Nuclear Ribonucleoprotein U;D034722
K01.752.256.101;Double Effect Principle;D034723
D13.150.650.700;RNA, Small Interfering;D034741
D13.444.735.150.700;RNA, Small Interfering;D034741
D13.444.735.790.552.875;RNA, Small Interfering;D034741
L01.143.506.423.906.377.333;Electronic Mail;D034742
L01.178.847.249;Electronic Mail;D034742
D08.811.277.352.355.350.810;RNA-Induced Silencing Complex;D034743
D08.811.277.352.700.350.810;RNA-Induced Silencing Complex;D034743
D12.776.157.725.500.906;RNA-Induced Silencing Complex;D034743
D12.776.664.962.500.906;RNA-Induced Silencing Complex;D034743
D12.776.157.725.500.500.700;Heterogeneous-Nuclear Ribonucleoprotein Group M;D034761
D12.776.664.962.500.500.700;Heterogeneous-Nuclear Ribonucleoprotein Group M;D034761
B01.650.940.800.575.100.037.333;Celosia;D034762
D12.776.503.687;Receptors, N-Acetylglucosamine;D034781
D12.776.543.750.715;Receptors, N-Acetylglucosamine;D034781
C04.557.450.565.465.249;Mastocytoma;D034801
C17.800.508.236;Mastocytoma;D034801
D12.776.157.725.500.500.900;RNA-Binding Protein EWS;D034802
D12.776.624.664.700.913;RNA-Binding Protein EWS;D034802
D12.776.664.962.500.500.900;RNA-Binding Protein EWS;D034802
B01.650.940.800.575.100.233;Commelinaceae;D034821
B01.650.940.800.575.100.233.222;Commelina;D034822
B01.650.940.800.575.100.233.611;Tradescantia;D034823
A01.923.047.025;Abdominal Cavity;D034841
A01.923.047.050;Abdominal Wall;D034861
A11.284.149.165.630.500;Nuclear Lamina;D034881
A11.284.430.106.279.345.700.700;Nuclear Lamina;D034881
A11.284.430.106.279.692.314;Nuclear Lamina;D034881
A11.284.835.514.700.500;Nuclear Lamina;D034881
D12.776.660.650.875;Lamins;D034882
B01.650.940.800.575.100.025.033;Alismataceae;D034901
B01.650.940.800.575.100.025.033.044;Alisma;D034902
B01.650.940.800.575.100.025.033.777;Sagittaria;D034903
D12.776.660.650.875.500;Lamin Type A;D034904
D12.776.660.650.875.750;Lamin Type B;D034921
A01.378.800;Upper Extremity;D034941
D12.776.660.625;Antigens, Nuclear;D034961
D23.050.290;Antigens, Nuclear;D034961
D12.776.097.513;Integration Host Factors;D034982
D12.776.260.495;Integration Host Factors;D034982
D23.297.500;Integration Host Factors;D034982
D12.776.097.513.500;Host Factor 1 Protein;D035001
D12.776.157.725.249;Host Factor 1 Protein;D035001
D12.776.664.962.249;Host Factor 1 Protein;D035001
A01.378.610;Lower Extremity;D035002
D12.776.097.312;Factor For Inversion Stimulation Protein;D035021
D12.776.260.246;Factor For Inversion Stimulation Protein;D035021
E01.370.500.174;Anonymous Testing;D035041
E05.318.308.250.580.174;Anonymous Testing;D035041
N02.421.143.827.233.443.062;Anonymous Testing;D035041
N02.421.726.233.443.221;Anonymous Testing;D035041
N05.715.360.300.375.500.174;Anonymous Testing;D035041
N06.850.520.308.250.580.174;Anonymous Testing;D035041
N06.850.780.500.162;Anonymous Testing;D035041
E05.318.780.074;Control Groups;D035061
E05.581.500.149;Control Groups;D035061
L01.737.484;Editorial Policies;D035081
I01.409.137;Federal Government;D035082
N03.540.348.500;Federal Government;D035082
N04.452.977;Voluntary Programs;D035141
B01.650.940.800.575.100.148;Bombacaceae;D035161
B01.650.940.800.575.100.148.500;Adansonia;D035162
B01.650.940.800.575.100.148.750;Bombax;D035163
B01.650.940.800.575.100.148.875;Ceiba;D035164
D12.776.260.775;Transcription Factors, General;D035165
D12.776.930.930;Transcription Factors, General;D035165
D12.776.260.775.374;TATA-Box Binding Protein;D035181
D12.776.260.775.875.750.500;TATA-Box Binding Protein;D035181
D12.776.930.930.374;TATA-Box Binding Protein;D035181
D12.776.930.930.875.750.500;TATA-Box Binding Protein;D035181
D12.776.260.775.812;TATA Box Binding Protein-Like Proteins;D035182
D12.776.930.930.812;TATA Box Binding Protein-Like Proteins;D035182
B01.650.940.800.575.100.822.071;Brachiaria;D035201
A18.024;Plant Components, Aerial;D035261
A01.456.830.150;Cranial Fossa, Anterior;D035262
A02.835.232.781.750.150;Cranial Fossa, Anterior;D035262
A18.024.249;Flowering Tops;D035263
A18.024.249.500;Flowers;D035264
A18.400.625;Plant Tubers;D035281
A01.456.830.165;Cranial Fossa, Middle;D035301
A02.835.232.781.750.165;Cranial Fossa, Middle;D035301
D12.776.260.735.750;Telomeric Repeat Binding Protein 1;D035321
D12.776.660.235.700.750;Telomeric Repeat Binding Protein 1;D035321
B01.650.940.800.575.100.707;Melastomataceae;D035322
D12.776.260.735.875;Telomeric Repeat Binding Protein 2;D035341
D12.776.660.235.700.875;Telomeric Repeat Binding Protein 2;D035341
D12.776.260.775.937.500;Transcription Factor TFIIIB;D035361
D12.776.930.930.937.500;Transcription Factor TFIIIB;D035361
D12.776.260.775.875.750;Transcription Factor TFIID;D035362
D12.776.930.930.875.750;Transcription Factor TFIID;D035362
D12.776.260.775.186;TATA-Binding Protein Associated Factors;D035381
D12.776.930.930.186;TATA-Binding Protein Associated Factors;D035381
B01.650.940.800.575.100.100.244;Conyza;D035401
A01.456.505.750;Parotid Region;D035421
A01.923.761.800.650;Pleural Cavity;D035422
A01.923.761.800;Thoracic Cavity;D035423
A01.923.761.850;Thoracic Wall;D035441
B01.650.940.800.575.100.081.346;Holarrhena;D035462
D12.776.260.775.092;Pol1 Transcription Initiation Complex Proteins;D035463
D12.776.930.930.092;Pol1 Transcription Initiation Complex Proteins;D035463
K01.316.163.750;Retrospective Moral Judgment;D035481
K01.752.256.113.750;Retrospective Moral Judgment;D035481
E05.318.740.600.900;Uncertainty;D035501
F02.463.785.373.820;Uncertainty;D035501
G17.680.875;Uncertainty;D035501
N05.715.360.750.625.850;Uncertainty;D035501
N06.850.520.830.600.900;Uncertainty;D035501
F01.829.401.825;Trust;D035502
F04.096.939;Sociobiology;D035503
H01.158.273.866;Sociobiology;D035503
I01.880.604.583.858;Supreme Court Decisions;D035521
D12.776.260.775.875.374;Transcription Factor TFIIA;D035561
D12.776.930.930.875.374;Transcription Factor TFIIA;D035561
D12.776.260.775.875.562;Transcription Factor TFIIB;D035581
D12.776.930.930.875.562;Transcription Factor TFIIB;D035581
D12.776.260.775.937.249;Transcription Factor TFIIIA;D035582
D12.776.930.930.937.249;Transcription Factor TFIIIA;D035582
C23.550.291.906;Rare Diseases;D035583
D12.776.930.955;Transcriptional Elongation Factors;D035602
I01.880.448;Secularism;D035621
K01.922;Secularism;D035621
I01.880.604.583.080.134.399;Parental Notification;D035622
E02.880.130;Chest Wall Oscillation;D035641
F01.145.813.963;Whistleblowing;D035642
I01.880.604.583.080.134.900;Whistleblowing;D035642
I01.880.604.100.049;Animal Care Committees;D035661
B01.650.940.800.575.250.750.044;Adiantum;D035681
B01.650.940.800.575.400.344;Gnetophyta;D035682
D13.150.650.319;MicroRNAs;D035683
D13.444.735.150.319;MicroRNAs;D035683
D13.444.735.790.552.500;MicroRNAs;D035683
B01.650.940.800.575.400.344.333;Gnetum;D035684
B01.650.940.800.575.100.008.044;Andrographis;D035685
B01.650.940.800.575.100.898.333;Eurycoma;D035701
B01.650.940.800.575.100.196.188;Cecropia Plant;D035702
E02.931;Therapies, Investigational;D035703
B01.650.940.800.575.100.740;Molluginaceae;D035704
B01.650.940.800.575.100.401.712;Pterocarpus;D035721
B01.650.940.800.575.100.020;Aizoaceae;D035722
B01.650.940.800.575.100.020.500;Mesembryanthemum;D035723
B01.650.940.800.575.100.100.984;Vernonia;D035741
B01.650.940.800.575.100.100.512;Mikania;D035742
K01.316.163.875;Wedge Argument;D035761
K01.752.256.113.875;Wedge Argument;D035761
F01.829.263.500.490;Siblings;D035781
I01.880.225.500.505;Siblings;D035781
M01.781;Siblings;D035781
B01.650.940.800.575.100.401.190;Dalbergia;D035782
B01.650.940.800.575.100.975.900.099;Amomum;D035801
F04.096.144;Behavioral Research;D035841
H01.770.644.108;Behavioral Research;D035841
M01.774;Research Subjects;D035842
H01.770.644.145;Biomedical Research;D035843
F01.829.401.650.837;Researcher-Subject Relations;D035844
E05.313.750;Research Embryo Creation;D035845
I01.880.604.594;Law Enforcement;D035846
M01.965;Vulnerable Populations;D035862
F01.752.747.616;Moral Development;D035863
F01.829.500.679;Moral Development;D035863
K01.316.630.472;Moral Development;D035863
I01.880.604.583.050;Compensation and Redress;D035881
N03.219.075;Compensation and Redress;D035881
N03.706.535.125;Compensation and Redress;D035881
B01.300.107.501.430;Hypocrea;D035901
D23.050.327.495.249;Hepatitis A Antigens;D035921
D12.776.124.486.485.114.254.450.251;Hepatitis A Antibodies;D035922
D12.776.124.790.651.114.254.450.251;Hepatitis A Antibodies;D035922
D12.776.377.715.548.114.254.450.251;Hepatitis A Antibodies;D035922
D23.050.327.495.752;Hepatitis delta Antigens;D035923
B01.650.940.800.575.100.100.543;Montanoa;D035924
D12.776.494;Iron-Regulatory Proteins;D035925
B01.650.940.800.575.462;Hepatophyta;D035926
D08.811.520.241.300.050.500;Iron Regulatory Protein 1;D035941
D12.776.157.427.374.375.960;Iron Regulatory Protein 1;D035941
D12.776.157.725.374;Iron Regulatory Protein 1;D035941
D12.776.494.500;Iron Regulatory Protein 1;D035941
D12.776.556.579.374.375.960;Iron Regulatory Protein 1;D035941
D12.776.664.962.374;Iron Regulatory Protein 1;D035941
D08.811.520.241.300.050.750;Iron Regulatory Protein 2;D035942
D12.776.157.427.374.375.961;Iron Regulatory Protein 2;D035942
D12.776.157.725.437;Iron Regulatory Protein 2;D035942
D12.776.494.750;Iron Regulatory Protein 2;D035942
D12.776.556.579.374.375.962;Iron Regulatory Protein 2;D035942
D12.776.664.962.437;Iron Regulatory Protein 2;D035942
B01.650.940.800.575.100.025;Alismatidae;D035961
B01.650.940.800.575.100.025.977;Zosteraceae;D035962
D02.355.291.866;Oxocins;D035964
D03.383.585;Oxocins;D035964
B01.650.940.800.575.100.087.412;Hedera;D035981
D08.811.913.400.725.115;ADP Ribose Transferases;D036002
D12.776.964.970.600.550;Capsid Proteins;D036022
B01.650.940.800.575.100.905.725.610;Solanum glaucophyllum;D036061
D08.811.913.696.620.682.725.400.850;Receptors, Eph Family;D036081
D12.776.543.750.060.500;Receptors, Eph Family;D036081
D08.811.913.696.620.682.725.400.850.050;Receptor, EphA1;D036082
D12.776.543.750.060.500.050;Receptor, EphA1;D036082
B01.650.940.800.575.100.100.118;Atractylis;D036083
B01.650.940.800.575.100.100.154;Callilepis;D036084
E04.936.225.687.312;Cord Blood Stem Cell Transplantation;D036101
E04.936.225.687.750;Peripheral Blood Stem Cell Transplantation;D036102
H01.603;Nanotechnology;D036103
J01.897.520.600;Nanotechnology;D036103
D08.811.913.696.620.682.725.400.850.100;Receptor, EphA2;D036104
D12.776.543.750.060.500.100;Receptor, EphA2;D036104
D08.811.913.696.620.682.725.400.850.150;Receptor, EphA3;D036121
D12.776.543.750.060.500.150;Receptor, EphA3;D036121
D08.811.913.696.620.682.725.400.850.200;Receptor, EphA4;D036122
D12.776.543.750.060.500.200;Receptor, EphA4;D036122
D08.811.913.696.620.682.725.400.850.250;Receptor, EphA5;D036123
D12.776.543.750.060.500.250;Receptor, EphA5;D036123
D08.811.913.696.620.682.725.400.850.300;Receptor, EphA6;D036124
D12.776.543.750.060.500.300;Receptor, EphA6;D036124
D08.811.913.696.620.682.725.400.850.400;Receptor, EphA7;D036141
D12.776.543.750.060.500.350;Receptor, EphA7;D036141
B01.650.940.800.575.100.575.483.444;Mentha piperita;D036142
D08.811.913.696.620.682.725.400.850.500;Receptor, EphA8;D036143
D12.776.543.750.060.500.400;Receptor, EphA8;D036143
D02.455.849.919.277;Ginsenosides;D036145
D09.408.782.300;Ginsenosides;D036145
D08.811.913.696.620.682.725.400.850.650;Receptor, EphB2;D036183
D12.776.543.750.060.500.500;Receptor, EphB2;D036183
D08.811.913.696.620.682.725.400.850.800;Receptor, EphB5;D036201
D12.776.543.750.060.500.875;Receptor, EphB5;D036201
D08.811.913.696.620.682.725.400.850.700;Receptor, EphB3;D036223
D12.776.543.750.060.500.687;Receptor, EphB3;D036223
D08.811.913.696.620.682.725.400.850.750;Receptor, EphB4;D036224
D12.776.543.750.060.500.781;Receptor, EphB4;D036224
D08.811.913.696.620.682.725.400.850.600;Receptor, EphB1;D036225
D12.776.543.750.060.500.450;Receptor, EphB1;D036225
A18.550;Seedling;D036226
D12.776.543.750.060.500.937;Receptor, EphB6;D036261
H01.770.644.241;Empirical Research;D036262
H01.158.273.343.249;Genetic Research;D036281
H01.770.644.145.350;Genetic Research;D036281
H01.770.644.241.850;Qualitative Research;D036301
E05.445.875;Therapeutic Human Experimentation;D036302
H01.770.644.145.365.875;Therapeutic Human Experimentation;D036302
H01.770.644.302.875;Therapeutic Human Experimentation;D036302
D12.644.276;Intercellular Signaling Peptides and Proteins;D036341
D12.776.467;Intercellular Signaling Peptides and Proteins;D036341
D23.529;Intercellular Signaling Peptides and Proteins;D036341
D12.644.276.500;Ephrins;D036342
D12.776.467.500;Ephrins;D036342
D12.776.543.287;Ephrins;D036342
D23.529.500;Ephrins;D036342
D03.438.127.637;Pterocarpans;D036343
D03.438.150.266.450.400.687;Pterocarpans;D036343
D03.549.748;Pterocarpans;D036343
D03.830.219.266.450.400.687;Pterocarpans;D036343
D06.472.699;Peptide Hormones;D036361
D12.644.548;Peptide Hormones;D036361
D02.455.326.146.485.222;Diarylheptanoids;D036381
D02.455.426.559.694;Diarylheptanoids;D036381
D12.644.276.500.100;Ephrin-A1;D036382
D12.776.395.550.448.300;Ephrin-A1;D036382
D12.776.467.500.100;Ephrin-A1;D036382
D12.776.543.287.100;Ephrin-A1;D036382
D12.776.543.484.500.300;Ephrin-A1;D036382
D12.776.543.550.418.300;Ephrin-A1;D036382
D23.529.500.100;Ephrin-A1;D036382
D12.644.276.500.200;Ephrin-A2;D036383
D12.776.395.550.448.310;Ephrin-A2;D036383
D12.776.467.500.200;Ephrin-A2;D036383
D12.776.543.287.200;Ephrin-A2;D036383
D12.776.543.484.500.310;Ephrin-A2;D036383
D12.776.543.550.418.310;Ephrin-A2;D036383
D23.529.500.200;Ephrin-A2;D036383
D12.644.276.500.300;Ephrin-A3;D036384
D12.776.395.550.448.320;Ephrin-A3;D036384
D12.776.467.500.300;Ephrin-A3;D036384
D12.776.543.287.300;Ephrin-A3;D036384
D12.776.543.484.500.320;Ephrin-A3;D036384
D12.776.543.550.418.320;Ephrin-A3;D036384
D23.529.500.300;Ephrin-A3;D036384
D12.644.276.500.400;Ephrin-A4;D036385
D12.776.395.550.448.330;Ephrin-A4;D036385
D12.776.467.500.400;Ephrin-A4;D036385
D12.776.543.287.400;Ephrin-A4;D036385
D12.776.543.484.500.330;Ephrin-A4;D036385
D12.776.543.550.418.330;Ephrin-A4;D036385
D23.529.500.400;Ephrin-A4;D036385
D12.644.276.500.500;Ephrin-A5;D036386
D12.776.395.550.448.340;Ephrin-A5;D036386
D12.776.467.500.500;Ephrin-A5;D036386
D12.776.543.287.500;Ephrin-A5;D036386
D12.776.543.484.500.340;Ephrin-A5;D036386
D12.776.543.550.418.340;Ephrin-A5;D036386
D23.529.500.500;Ephrin-A5;D036386
D12.644.276.500.600;Ephrin-B1;D036387
D12.776.467.500.600;Ephrin-B1;D036387
D12.776.543.287.600;Ephrin-B1;D036387
D23.529.500.600;Ephrin-B1;D036387
D12.644.276.500.700;Ephrin-B2;D036388
D12.776.467.500.700;Ephrin-B2;D036388
D12.776.543.287.700;Ephrin-B2;D036388
D23.529.500.700;Ephrin-B2;D036388
D12.644.276.500.800;Ephrin-B3;D036389
D12.776.467.500.800;Ephrin-B3;D036389
D12.776.543.287.800;Ephrin-B3;D036389
D23.529.500.800;Ephrin-B3;D036389
E05.940.800;Toxicity Tests, Chronic;D036401
A08.663.542.756;Nerve Fibers, Unmyelinated;D036421
B01.050.150.900.493.595;Osmeriformes;D036441
B01.650.940.800.575.100.350.505;Mallotus Plant;D036461
B01.650.940.800.575.100.401.088;Bauhinia;D036481
E07.605.500;Metered Dose Inhalers;D036501
E02.319.267.510.555;Infusions, Intralesional;D036502
E07.605.500.500;Inhalation Spacers;D036503
D08.811.277.450.430.400.060;ADP-ribosyl Cyclase;D036541
D08.811.913.400.725.115.660.060;ADP-ribosyl Cyclase;D036541
E01.370.350.350.810.800;Tomography, Spiral Computed;D036542
E01.370.350.600.350.700.810.800;Tomography, Spiral Computed;D036542
E01.370.350.700.700.810.800;Tomography, Spiral Computed;D036542
E01.370.350.700.810.810.800;Tomography, Spiral Computed;D036542
E01.370.350.825.810.810.800;Tomography, Spiral Computed;D036542
B01.650.940.800.575.100.401.094;Cajanus;D036561
B01.650.940.800.575.100.100.425;Helichrysum;D036562
D03.438.759.646.138.124.070.125.195;Cyclic ADP-Ribose;D036563
D09.408.620.569.070.125.195;Cyclic ADP-Ribose;D036563
D13.695.667.138.124.070.125.195;Cyclic ADP-Ribose;D036563
D13.695.827.068.124.070.125.195;Cyclic ADP-Ribose;D036563
D13.695.827.708.070.125.195;Cyclic ADP-Ribose;D036563
B01.650.940.800.575.100.100.631;Ratibida;D036581
B01.650.940.800.575.100.100.665;Rudbeckia;D036582
B01.650.940.800.575.100.100.337;Eclipta;D036601
B01.650.940.800.575.100.100.347;Eupatorium;D036602
B01.650.940.800.575.100.100.046;Ageratina;D036603
B01.650.940.800.575.100.100.203;Chromolaena;D036604
B01.650.940.800.575.100.100.352;Geigeria;D036621
B01.650.940.800.575.100.100.355;Gnaphalium;D036622
B01.650.940.800.575.100.100.356;Grindelia;D036623
B01.650.940.800.575.100.100.816;Solidago;D036624
B01.650.940.800.575.100.100.843;Stevia;D036625
E01.370.350.515.458.500;Microscopy, Fluorescence, Multiphoton;D036641
E05.595.458.500;Microscopy, Fluorescence, Multiphoton;D036641
B01.650.940.800.575.100.150.385;Echium;D036661
E05.196.712.516.600.393;Fluorescence Recovery After Photobleaching;D036681
D02.455.849.919.490;Limonins;D036701
D02.455.849.919.570;Quassins;D036702
A16.331.099;Blastula;D036703
B01.650.940.800.575.100.892.844;Scoparia;D036721
G05.360.600.550;Plant Tumor-Inducing Plasmids;D036741
E02.565.280.945.399.500;Ultrasound, High-Intensity Focused, Transrectal;D036761
E04.014.380.500;Ultrasound, High-Intensity Focused, Transrectal;D036761
E04.950.774.860.625.875;Ultrasound, High-Intensity Focused, Transrectal;D036761
D12.776.097.120.425;Fimbriae Proteins;D036781
D12.776.543.100.300;Fimbriae Proteins;D036781
G08.686.785.760.769.490;Parturition;D036801
C04.557.450.565.325;Endometrial Stromal Tumors;D036821
C04.557.450.795.332;Endometrial Stromal Tumors;D036821
C13.351.500.852.762.200.500;Endometrial Stromal Tumors;D036821
C13.351.937.418.875.200.374;Endometrial Stromal Tumors;D036821
C25.723.415.246;Ciguatera Poisoning;D036841
E04.520.252;Delivery, Obstetric;D036861
G11.561.600.635.355;Long-Term Synaptic Depression;D036881
B01.650.940.800.575.100.087.431;Kalopanax;D036882
B01.650.940.800.575.100.100.596;Petasites;D036901
B01.650.940.800.575.100.081.986;Voacanga;D036902
B01.650.940.800.575.100.401.082;Aspalathus;D036903
G04.299.283.424.233.500;Leukocyte Rolling;D036904
B01.650.940.800.575.100.875.255;Dictamnus;D036905
B01.650.940.800.575.100.100.041;Achyrocline;D036921
B01.650.940.800.575.100.812.332;Peperomia;D036941
D12.776.260.532;Matrix Attachment Region Binding Proteins;D036961
C05.321.600;Fasciitis, Plantar;D036981
C05.360.350;Fasciitis, Plantar;D036981
C05.116.540.310.600;Heel Spur;D036982
C05.360.400;Heel Spur;D036982
F02.784.176.279;Directive Counseling;D037001
F04.408.413.349;Directive Counseling;D037001
N02.421.461.363.349;Directive Counseling;D037001
D12.776.260.698.850.500;Thyroid Hormone Receptors alpha;D037021
D12.776.624.664.700.830.500;Thyroid Hormone Receptors alpha;D037021
D12.776.826.850.500;Thyroid Hormone Receptors alpha;D037021
D12.776.930.669.850.500;Thyroid Hormone Receptors alpha;D037021
E02.875.800.986;Posthumous Conception;D037022
E05.820.800.986;Posthumous Conception;D037022
I01.409.137.500;United States Government Agencies;D037041
N03.540.348.500.500;United States Government Agencies;D037041
D12.776.260.698.850.750;Thyroid Hormone Receptors beta;D037042
D12.776.624.664.700.830.750;Thyroid Hormone Receptors beta;D037042
D12.776.826.850.750;Thyroid Hormone Receptors beta;D037042
D12.776.930.669.850.750;Thyroid Hormone Receptors beta;D037042
C05.360.500;Metatarsalgia;D037061
C05.550.610;Metatarsalgia;D037061
C10.597.617.560;Metatarsalgia;D037061
C23.888.592.612.540;Metatarsalgia;D037061
C23.888.646.498;Metatarsalgia;D037061
C05.360.750;Posterior Tibial Tendon Dysfunction;D037081
D06.472.699.322.576.463.500;Luteinizing Hormone, beta Subunit;D037101
D06.472.699.631.525.343.463.500;Luteinizing Hormone, beta Subunit;D037101
D12.644.548.691.525.343.463.500;Luteinizing Hormone, beta Subunit;D037101
D12.776.503;Lectins;D037102
D12.776.503.499;Plant Lectins;D037121
D12.776.765.678;Plant Lectins;D037121
I01.880.604.622;Mandatory Programs;D037141
N03.706.657;Mandatory Programs;D037141
N04.452.521;Mandatory Programs;D037141
B01.650.940.800.575.100.100.349;Flaveria;D037142
D12.776.503.307;Galectins;D037161
D12.776.503.280;Lectins, C-Type;D037181
G12.450.900;T-Cell Antigen Receptor Specificity;D037182
D06.472.699.322.576.288.500;Follicle Stimulating Hormone, beta Subunit;D037201
D06.472.699.631.525.343.288.500;Follicle Stimulating Hormone, beta Subunit;D037201
D12.644.548.691.525.343.288.500;Follicle Stimulating Hormone, beta Subunit;D037201
D12.776.503.280.249;Collectins;D037222
D12.776.503.311;Mannose-Binding Lectins;D037241
D12.776.503.280.124;Asialoglycoprotein Receptor;D037263
D12.776.543.750.024;Asialoglycoprotein Receptor;D037263
D12.644.360.381.311;Calnexin;D037281
D12.776.157.125.412.311;Calnexin;D037281
D12.776.476.387.311;Calnexin;D037281
D12.776.503.295;Calnexin;D037281
D12.776.543.162;Calnexin;D037281
D12.644.360.381.374;Calreticulin;D037282
D12.776.157.125.412.374;Calreticulin;D037282
D12.776.476.387.374;Calreticulin;D037282
D12.776.503.303;Calreticulin;D037282
B01.050.500.325;Ctenophora;D037302
D06.472.699.631.525.883.500;Thyrotropin, beta Subunit;D037322
D12.644.548.691.525.883.500;Thyrotropin, beta Subunit;D037322
D02.455.326.146.432;Fumonisins;D037341
D23.946.587.385;Fumonisins;D037341
D08.811.913.400.725.115.680;Pertussis Toxin;D037342
D23.946.123.946.690;Pertussis Toxin;D037342
D23.946.896.980.690;Pertussis Toxin;D037342
D08.811.520.650.200.040;Adenylate Cyclase Toxin;D037361
D23.946.123.946.040;Adenylate Cyclase Toxin;D037361
D23.946.896.980.040;Adenylate Cyclase Toxin;D037361
B01.050.500.308.690;Scyphozoa;D037401
B01.050.500.308.485;Hydrozoa;D037402
B01.050.500.308.237;Anthozoa;D037421
B01.050.500.308.690.750;Sea Nettle, East Coast;D037441
B01.050.500.308.361;Cubozoa;D037462
D12.776.503.307.100;Galectin 1;D037483
D12.776.503.307.200;Galectin 2;D037501
D12.776.503.307.300;Galectin 3;D037502
D23.946.896;Virulence Factors;D037521
D12.776.503.307.400;Galectin 4;D037541
D12.776.124.486.485.114.323.390;Immunoconglutinins;D037561
D12.776.124.790.651.114.323.390;Immunoconglutinins;D037561
D12.776.377.715.548.114.323.390;Immunoconglutinins;D037561
G12.425.255.849;Complement Pathway, Mannose-Binding Lectin;D037582
D12.776.503.280.249.500;Mannose-Binding Lectin;D037601
D12.776.503.311.500;Mannose-Binding Lectin;D037601
B01.650.940.800.575.100.575.362;Isodon;D037602
D02.389.338.055;Artemisinins;D037621
D02.455.849.765.211;Artemisinins;D037621
D02.737.055;Artemisinins;D037621
D12.776.823;Pulmonary Surfactant-Associated Proteins;D037661
D12.776.503.280.249.600;Pulmonary Surfactant-Associated Protein A;D037662
D12.776.823.100;Pulmonary Surfactant-Associated Protein A;D037662
D12.776.503.280.249.625;Pulmonary Surfactant-Associated Protein D;D037663
D12.776.823.249;Pulmonary Surfactant-Associated Protein D;D037663
D12.776.543.701;Pulmonary Surfactant-Associated Protein B;D037701
D12.776.823.124;Pulmonary Surfactant-Associated Protein B;D037701
D12.776.543.717;Pulmonary Surfactant-Associated Protein C;D037721
D12.776.816.750;Pulmonary Surfactant-Associated Protein C;D037721
D12.776.823.186;Pulmonary Surfactant-Associated Protein C;D037721
D01.268.150.250;Fullerenes;D037741
J01.637.512.600.612.350;Fullerenes;D037741
D01.268.150.250.500;Nanotubes, Carbon;D037742
J01.637.512.850.500;Nanotubes, Carbon;D037742
D08.811.277.087.520.200.650;Sirtuins;D037761
D08.811.913.400.725.115.961;Sirtuins;D037761
D12.776.476.900;Sirtuins;D037761
C05.330.615;Hammer Toe Syndrome;D037801
B01.650.940.800.575.100.437.249;Casearia;D037821
M01.975.807;Pregnant Women;D037841
A16.378.099;Aborted Fetus;D037881
E02.760.905.199.249.750;Euthanasia, Animal;D037901
E05.335;Euthanasia, Animal;D037901
N02.421.585.905.199.500.750;Euthanasia, Animal;D037901
F01.145.813.208;Gift Giving;D037921
G02.111.570.080.689.755;Silencer Elements, Transcriptional;D037941
G05.360.080.689.755;Silencer Elements, Transcriptional;D037941
G05.360.340.024.815;Silencer Elements, Transcriptional;D037941
B01.650.940.800.575.462.500;Frullania;D037961
E04.446.318;Neck Dissection;D037981
E04.580.411;Neck Dissection;D037981
G04.299.151.825.597.500;Lymphopoiesis;D038041
G09.188.124.544.597.500;Lymphopoiesis;D038041
G04.299.151.825.597.750;Myelopoiesis;D038042
G09.188.124.544.597.750;Myelopoiesis;D038042
C05.660.585.512;Lower Extremity Deformities, Congenital;D038061
C16.131.621.585.512;Lower Extremity Deformities, Congenital;D038061
C05.660.585.988;Upper Extremity Deformities, Congenital;D038062
C16.131.621.585.988;Upper Extremity Deformities, Congenital;D038062
G07.700.320.500.325.377;Organogenesis;D038081
G08.686.785.760.170.450;Organogenesis;D038081
G02.111.570.080.689.390;Insulator Elements;D038101
G05.360.080.689.390;Insulator Elements;D038101
G05.360.340.024.420;Insulator Elements;D038101
B01.650.940.800.575.100.100.471;Inula;D038143
I03.450.642.845.787;Snow Sports;D038161
D08.811.682.662.171;FMN Reductase;D038181
D12.776.306.366.100;alpha-Crystallins;D038201
D12.776.580.157;alpha-Crystallins;D038201
D12.776.306.366.100.149;alpha-Crystallin A Chain;D038202
D12.776.580.157.149;alpha-Crystallin A Chain;D038202
D12.776.306.366.100.300;alpha-Crystallin B Chain;D038203
D12.776.580.157.300;alpha-Crystallin B Chain;D038203
D12.776.306.366.300;beta-Crystallins;D038204
D12.776.306.366.300.100;beta-Crystallin A Chain;D038205
D12.776.306.366.300.200;beta-Crystallin B Chain;D038206
D08.811.520.232.300.400.500;delta-Crystallins;D038207
D12.776.306.366.310;delta-Crystallins;D038207
D08.811.682.047.551.249;epsilon-Crystallins;D038221
D12.776.306.366.350;epsilon-Crystallins;D038221
D12.776.306.366.850;gamma-Crystallins;D038222
C10.228.140.199.250.500;Post-Concussion Syndrome;D038223
C10.900.300.087.125.500;Post-Concussion Syndrome;D038223
C10.900.300.350.300.500;Post-Concussion Syndrome;D038223
C26.260.118.150.500;Post-Concussion Syndrome;D038223
C26.915.300.200.150.500;Post-Concussion Syndrome;D038223
C26.974.150.500;Post-Concussion Syndrome;D038223
C26.974.382.200.500;Post-Concussion Syndrome;D038223
D08.811.682.657.163.249.750;omega-Crystallins;D038224
D12.776.306.366.925;omega-Crystallins;D038224
D08.811.520.241.300.500.500;tau-Crystallins;D038225
D12.776.306.366.962;tau-Crystallins;D038225
D08.811.682.608.800.500.500;zeta-Crystallins;D038226
D12.776.306.366.981;zeta-Crystallins;D038226
C10.228.140.163.100.362.312;Alexander Disease;D038261
C10.228.140.695.625.312;Alexander Disease;D038261
C10.228.518.625.312;Alexander Disease;D038261
C10.314.400.312;Alexander Disease;D038261
C10.574.500.024;Alexander Disease;D038261
C16.320.400.024;Alexander Disease;D038261
C16.320.565.189.362.312;Alexander Disease;D038261
C18.452.132.100.362.312;Alexander Disease;D038261
C18.452.648.189.362.312;Alexander Disease;D038261
E07.305.250.319.381.500.249;Auditory Brain Stem Implants;D038262
E07.695.075;Auditory Brain Stem Implants;D038262
E07.695.202.381.500.249;Auditory Brain Stem Implants;D038262
E07.814.458.074;Auditory Brain Stem Implants;D038262
E04.580.450.109;Auditory Brain Stem Implantation;D038263
E04.650.155;Auditory Brain Stem Implantation;D038263
D12.776.354.750.750;Silent Information Regulator Proteins, Saccharomyces cerevisiae;D038281
D12.776.660.820;Silent Information Regulator Proteins, Saccharomyces cerevisiae;D038281
E01.370.225.875.977;Virus Inactivation;D038301
E05.200.875.977;Virus Inactivation;D038301
G06.590.875.730;Virus Inactivation;D038301
G06.920.875.730;Virus Inactivation;D038301
G03.345;Glycemic Index;D038321
G07.610.660.500;Glycemic Index;D038321
J01.576.423.850.730.750.500;Glycemic Index;D038321
N06.850.601.750.500;Glycemic Index;D038321
D08.811.913.696.620.682.700.429;Glycogen Synthase Kinases;D038341
D12.644.360.300;Glycogen Synthase Kinases;D038341
D12.776.476.300;Glycogen Synthase Kinases;D038341
E01.158.600.339;Neuronavigation;D038361
E01.370.350.350.349;Neuronavigation;D038361
E04.525.800.324;Neuronavigation;D038361
E05.873.249;Neuronavigation;D038361
D05.500.117.875;Glycogen Synthase Kinase 3;D038362
D08.811.913.696.620.682.700.429.500;Glycogen Synthase Kinase 3;D038362
D08.811.913.696.620.682.700.646.625;Glycogen Synthase Kinase 3;D038362
D12.644.360.300.500;Glycogen Synthase Kinase 3;D038362
D12.776.476.081.875;Glycogen Synthase Kinase 3;D038362
D12.776.476.300.500;Glycogen Synthase Kinase 3;D038362
B03.440.400.425.550.550.641.700;Neisseria meningitidis, Serogroup A;D038381
B03.660.075.525.520.500.700;Neisseria meningitidis, Serogroup A;D038381
E04.525.160.500;Hemispherectomy;D038421
E02.642.249.270;Diet, Mediterranean;D038441
G07.610.240.270;Diet, Mediterranean;D038441
D08.811.913.696.620.682.700.646;Proline-Directed Protein Kinases;D038461
E04.525.044;Anterior Temporal Lobectomy;D038481
D08.811.913.400.725.115.690.840;Tankyrases;D038501
G08.686.785.760.170.104.875;Twinning, Monozygotic;D038522
E01.370.350.500.150;Diffusion Magnetic Resonance Imaging;D038524
E01.370.350.825.500.150;Diffusion Magnetic Resonance Imaging;D038524
B03.440.400.425.550.550.641.710;Neisseria meningitidis, Serogroup B;D038541
B03.660.075.525.520.500.710;Neisseria meningitidis, Serogroup B;D038541
B03.440.400.425.550.550.641.720;Neisseria meningitidis, Serogroup C;D038542
B03.660.075.525.520.500.720;Neisseria meningitidis, Serogroup C;D038542
B03.440.400.425.550.550.641.820;Neisseria meningitidis, Serogroup Y;D038581
B03.660.075.525.520.500.820;Neisseria meningitidis, Serogroup Y;D038581
B03.440.400.425.550.550.641.800;Neisseria meningitidis, Serogroup W-135;D038582
B03.660.075.525.520.500.800;Neisseria meningitidis, Serogroup W-135;D038582
D12.776.835.931;Ribosomal Protein S6;D038601
B01.050.150.900.649.865.635.505.500.550.100;Mice, Biozzi;D038602
D13.444.735.790.878.942;Regulatory Sequences, Ribonucleic Acid;D038621
G02.111.570.080.689.687;Regulatory Sequences, Ribonucleic Acid;D038621
G05.360.080.689.687;Regulatory Sequences, Ribonucleic Acid;D038621
I01.615;Internationality;D038622
G02.111.570.080.689.687.275;RNA 5' Terminal Oligopyrimidine Sequence;D038641
G05.360.080.689.687.275;RNA 5' Terminal Oligopyrimidine Sequence;D038641
G05.360.340.024.340.137.785;RNA 5' Terminal Oligopyrimidine Sequence;D038641
C10.900.300.087.850;Shaken Baby Syndrome;D038642
C26.260.118.825;Shaken Baby Syndrome;D038642
C26.915.300.200.825;Shaken Baby Syndrome;D038642
D12.776.157.247;Follistatin;D038681
D12.776.157.286;Follistatin-Related Proteins;D038702
D08.811.913.696.620.682.700.862.500;Ribosomal Protein S6 Kinases, 90-kDa;D038744
D12.644.360.600.500;Ribosomal Protein S6 Kinases, 90-kDa;D038744
D12.776.476.600.500;Ribosomal Protein S6 Kinases, 90-kDa;D038744
G02.149.767.690.680;Photobleaching;D038761
G02.842.750.690.680;Photobleaching;D038761
D08.811.913.696.620.682.700.862.249;Ribosomal Protein S6 Kinases, 70-kDa;D038762
D12.644.360.600.249;Ribosomal Protein S6 Kinases, 70-kDa;D038762
D12.776.476.600.249;Ribosomal Protein S6 Kinases, 70-kDa;D038762
E01.370.382.637;Otoscopy;D038781
L01.453.245.945.400;International Classification of Diseases;D038801
A18.400.525;Mycorrhizae;D038821
A19.690;Mycorrhizae;D038821
B01.300.655;Mycorrhizae;D038821
B05.550;Mycorrhizae;D038821
I01.076.201.450.654.558.800;Medicine, Tibetan Traditional;D038861
C10.597.606.643.455;Mental Retardation, X-Linked;D038901
C16.320.322.500;Mental Retardation, X-Linked;D038901
C16.320.400.525;Mental Retardation, X-Linked;D038901
C10.597.606.643.455.249;Coffin-Lowry Syndrome;D038921
C16.320.322.500.249;Coffin-Lowry Syndrome;D038921
C16.320.400.525.249;Coffin-Lowry Syndrome;D038921
D12.776.157.725.468;Polypyrimidine Tract-Binding Protein;D038941
D12.776.664.962.468;Polypyrimidine Tract-Binding Protein;D038941
D03.438.759.646.138.124.070.125.040;O-Acetyl-ADP-Ribose;D038961
D09.408.620.569.070.125.040;O-Acetyl-ADP-Ribose;D038961
D13.695.667.138.124.070.125.040;O-Acetyl-ADP-Ribose;D038961
D13.695.827.068.124.070.125.040;O-Acetyl-ADP-Ribose;D038961
D13.695.827.708.070.125.040;O-Acetyl-ADP-Ribose;D038961
D12.776.543.750.072;Receptors, Collagen;D038981
D12.776.395.550.625.298;Integrin alpha2beta1;D038982
D12.776.543.550.625.298;Integrin alpha2beta1;D038982
D12.776.543.750.072.200;Integrin alpha2beta1;D038982
D12.776.543.750.705.408.530.249;Integrin alpha2beta1;D038982
D12.776.543.750.705.408.850.199;Integrin alpha2beta1;D038982
D12.776.543.750.705.675.352;Integrin alpha2beta1;D038982
D12.776.543.750.705.876.280;Integrin alpha2beta1;D038982
D09.400.410.209;Galactolipids;D038983
D10.390.355;Galactolipids;D038983
D12.776.543.750.705.408.100;Integrin alpha Chains;D039001
B04.123.655;Prophages;D039002
A10.850.200;Colonic Pouches;D039021
E07.862.200;Colonic Pouches;D039021
D12.776.395.550.200.625.347;Integrin alpha4beta1;D039041
D12.776.543.550.200.625.347;Integrin alpha4beta1;D039041
D12.776.543.750.705.408.530.500;Integrin alpha4beta1;D039041
D12.776.543.750.705.408.850.299;Integrin alpha4beta1;D039041
D12.776.543.750.705.877.347;Integrin alpha4beta1;D039041
D23.050.301.264.035.850.347;Integrin alpha4beta1;D039041
D23.050.301.350.625.347;Integrin alpha4beta1;D039041
D23.101.100.110.850.347;Integrin alpha4beta1;D039041
L01.453.245.945.720;Systematized Nomenclature of Medicine;D039061
D12.776.395.550.625.379;Integrin alpha5beta1;D039081
D12.776.543.550.625.379;Integrin alpha5beta1;D039081
D12.776.543.750.705.408.530.750;Integrin alpha5beta1;D039081
D12.776.543.750.705.408.850.349;Integrin alpha5beta1;D039081
D12.776.543.750.705.675.460;Integrin alpha5beta1;D039081
D12.776.543.750.705.876.374;Integrin alpha5beta1;D039081
D12.776.157.725.452;Poly(A)-Binding Proteins;D039102
D12.776.664.962.452;Poly(A)-Binding Proteins;D039102
D12.776.157.725.452.500;Poly(A)-Binding Protein II;D039103
D12.776.664.962.452.500;Poly(A)-Binding Protein II;D039103
G02.111.570.080.689.687.249;RNA 3' Polyadenylation Signals;D039104
G05.360.080.689.687.249;RNA 3' Polyadenylation Signals;D039104
G05.360.340.024.340.137.775;RNA 3' Polyadenylation Signals;D039104
B01.650.940.800.575.100.831;Proteaceae;D039105
B01.650.940.800.575.100.831.500;Macadamia;D039106
D12.776.395.550.625.419;Integrin alpha6beta1;D039121
D12.776.543.550.625.419;Integrin alpha6beta1;D039121
D12.776.543.750.705.408.850.674;Integrin alpha6beta1;D039121
D12.776.543.750.705.675.514;Integrin alpha6beta1;D039121
D12.776.543.750.705.876.500;Integrin alpha6beta1;D039121
D12.776.157.725.452.249;Poly(A)-Binding Protein I;D039122
D12.776.664.962.452.249;Poly(A)-Binding Protein I;D039122
C05.651.534.500.450;Muscular Dystrophy, Oculopharyngeal;D039141
C10.668.491.175.500.450;Muscular Dystrophy, Oculopharyngeal;D039141
C16.320.577.450;Muscular Dystrophy, Oculopharyngeal;D039141
D12.776.543.750.705.408.460.170;Integrin alpha6beta4;D039161
D12.776.543.750.705.876.750;Integrin alpha6beta4;D039161
D08.244.453.915.737;Steroid 16-alpha-Hydroxylase;D039181
D08.811.682.690.708.170.915.737;Steroid 16-alpha-Hydroxylase;D039181
D08.811.682.690.708.783.737;Steroid 16-alpha-Hydroxylase;D039181
D12.776.422.220.453.915.737;Steroid 16-alpha-Hydroxylase;D039181
D12.776.543.750.072.300;Integrin alpha3beta1;D039201
D12.776.543.750.705.408.850.249;Integrin alpha3beta1;D039201
D12.776.543.750.705.876.311;Integrin alpha3beta1;D039201
D12.776.157.725.124;mRNA Cleavage and Polyadenylation Factors;D039221
D12.776.664.962.444;mRNA Cleavage and Polyadenylation Factors;D039221
D12.776.543.750.072.100;Integrin alpha1beta1;D039222
D12.776.543.750.705.408.850.099;Integrin alpha1beta1;D039222
D12.776.543.750.705.876.249;Integrin alpha1beta1;D039222
D12.776.157.725.124.240;Cleavage And Polyadenylation Specificity Factor;D039223
D12.776.664.962.444.240;Cleavage And Polyadenylation Specificity Factor;D039223
D12.776.157.725.124.249;Cleavage Stimulation Factor;D039241
D12.776.664.962.444.249;Cleavage Stimulation Factor;D039241
B01.650.940.800.575.100.344;Eriocaulaceae;D039262
B01.650.940.800.575.100.775;Nyctaginaceae;D039281
B01.650.940.800.575.100.775.500;Mirabilis;D039282
L01.224.230.260.315;Computers, Molecular;D039301
L01.224.300;Computers, Molecular;D039301
D12.776.395.550.625.439;Integrin alphaVbeta3;D039302
D12.776.543.550.625.439;Integrin alphaVbeta3;D039302
D12.776.543.750.705.408.460.870.500;Integrin alphaVbeta3;D039302
D12.776.543.750.705.675.541;Integrin alphaVbeta3;D039302
B01.650.940.800.575.100.838.397;Hydrastis;D039321
B01.650.940.800.575.100.838.337;Helleborus;D039322
B01.650.940.800.575.100.838.229;Coptis;D039323
B01.650.940.800.575.100.838.205;Clematis;D039324
D12.776.543.750.705.408.495;Receptors, Fibrinogen;D039341
G05.355;Genetic Processes;D039361
D12.776.157.725.750;RNA Cap-Binding Proteins;D039381
D12.776.664.962.750;RNA Cap-Binding Proteins;D039381
G07.610.566;Maternal Nutritional Physiological Phenomena;D039382
G07.610.566.624;Prenatal Nutritional Physiological Phenomena;D039401
G08.686.785.760.769.600;Prenatal Nutritional Physiological Phenomena;D039401
D12.776.543.750.705.408.100.350;Integrin alpha2;D039421
D23.050.301.264.035.287;Integrin alpha2;D039421
D23.101.100.110.288;Integrin alpha2;D039421
D12.776.543.750.705.408.100.400;Integrin alpha3;D039422
D23.050.301.264.035.289;Integrin alpha3;D039422
D23.101.100.110.290;Integrin alpha3;D039422
D12.776.543.750.705.408.100.300;Integrin alpha1;D039423
D23.050.301.264.035.286;Integrin alpha1;D039423
D23.101.100.110.286;Integrin alpha1;D039423
D12.776.543.750.705.408.100.450;Integrin alpha4;D039441
D23.050.301.264.035.291;Integrin alpha4;D039441
D23.101.100.110.292;Integrin alpha4;D039441
D12.776.543.750.705.408.100.150;Antigens, CD11b;D039481
D23.050.301.264.035.111.049;Antigens, CD11b;D039481
D23.101.100.110.111.049;Antigens, CD11b;D039481
D12.776.543.750.705.408.100.500;Integrin alpha5;D039482
D23.050.301.264.035.293;Integrin alpha5;D039482
D23.101.100.110.294;Integrin alpha5;D039482
D12.776.157.725.750.750;Nuclear Cap-Binding Protein Complex;D039502
D12.776.664.962.750.750;Nuclear Cap-Binding Protein Complex;D039502
D12.776.543.750.705.408.100.550;Integrin alpha6;D039503
D23.050.301.264.035.296;Integrin alpha6;D039503
D23.101.100.110.297;Integrin alpha6;D039503
D12.776.395.550.200.275.500;Antigens, CD11c;D039521
D12.776.543.550.200.275.500;Antigens, CD11c;D039521
D12.776.543.750.705.408.100.200;Antigens, CD11c;D039521
D12.776.543.750.705.408.600.100.500;Antigens, CD11c;D039521
D12.776.543.750.705.833.249.500;Antigens, CD11c;D039521
D23.050.301.264.035.111.074;Antigens, CD11c;D039521
D23.050.301.350.275.500;Antigens, CD11c;D039521
D23.101.100.110.111.074;Antigens, CD11c;D039521
D12.776.157.725.750.374;Eukaryotic Initiation Factor-4E;D039561
D12.776.835.725.868.500.750;Eukaryotic Initiation Factor-4E;D039561
D12.776.664.962.750.374;Eukaryotic Initiation Factor-4F;D039562
D12.776.835.725.868.500;Eukaryotic Initiation Factor-4F;D039562
D27.505.519.625.375.425.400.500;Histamine H1 Antagonists, Non-Sedating;D039563
D27.505.696.577.375.425.400.500;Histamine H1 Antagonists, Non-Sedating;D039563
D12.776.543.750.705.408.100.900;Integrin alphaV;D039564
D23.050.301.264.035.298;Integrin alphaV;D039564
D23.101.100.110.298;Integrin alphaV;D039564
D08.811.913.696.445.735.720.500;Eukaryotic Initiation Factor-4A;D039601
D12.776.835.725.868.500.500;Eukaryotic Initiation Factor-4A;D039601
N04.590.374.034;After-Hours Care;D039602
N05.300.049;After-Hours Care;D039602
D12.776.835.725.868.500.875;Eukaryotic Initiation Factor-4G;D039603
L01.143.140;Answering Services;D039604
L01.178.847.698.249;Answering Services;D039604
N04.590.374.034.500;Answering Services;D039604
N05.300.049.500;Answering Services;D039604
D12.776.835.725.868.437;Eukaryotic Initiation Factor-3;D039621
D12.776.543.750.705.408.200;Integrin beta Chains;D039641
D12.776.835.725.868;Eukaryotic Initiation Factors;D039642
D12.776.543.750.705.408.200.750;Integrin beta3;D039661
D23.050.301.264.035.302;Integrin beta3;D039661
D23.101.100.110.299;Integrin beta3;D039661
D12.776.835.725.934;Prokaryotic Initiation Factors;D039662
D12.776.543.750.705.408.200.800;Integrin beta4;D039663
D23.050.301.264.035.303;Integrin beta4;D039663
D23.101.100.110.302;Integrin beta4;D039663
D12.776.835.725.934.750;Prokaryotic Initiation Factor-3;D039665
D03.438.150.446.853;Pyranocoumarins;D039681
D03.830.219.446.853;Pyranocoumarins;D039681
D03.830.711;Pyranocoumarins;D039681
C02.782.815.616.400.400;HIV-Associated Lipodystrophy Syndrome;D039682
C02.800.801.400.400;HIV-Associated Lipodystrophy Syndrome;D039682
C17.800.849.391.400;HIV-Associated Lipodystrophy Syndrome;D039682
C18.452.584.625.400;HIV-Associated Lipodystrophy Syndrome;D039682
C18.452.880.391.400;HIV-Associated Lipodystrophy Syndrome;D039682
C20.673.480.400;HIV-Associated Lipodystrophy Syndrome;D039682
L01.453.245.945.160;Current Procedural Terminology;D039702
L01.453.245.945.500;Logical Observation Identifiers Names and Codes;D039703
L01.453.245.945.200;Diagnostic and Statistical Manual of Mental Disorders;D039721
D23.050.181;Antigens, Dermatophagoides;D039741
B01.650.940.800.575.100.401.262;Genista;D039761
B01.650.940.800.575.100.401.952;Ulex;D039762
L01.470.750.500.650;PubMed;D039781
L01.700.508.280.750;PubMed;D039781
L01.700.508.300.188.300.650;PubMed;D039781
L01.700.508.300.742.650;PubMed;D039781
D02.455.849.575;Monoterpenes;D039821
D02.455.849.575.500;Iridoids;D039823
D03.383.663.491;Iridoids;D039823
D03.830.491;Iridoids;D039823
D12.776.157.125.750.500;Leukocyte L1 Antigen Complex;D039841
D12.776.641.655.500;Leukocyte L1 Antigen Complex;D039841
D23.050.301.562;Leukocyte L1 Antigen Complex;D039841
D12.776.395.550.200.250.520.578;Neural Cell Adhesion Molecule L1;D039842
D12.776.543.550.200.250.520.578;Neural Cell Adhesion Molecule L1;D039842
D23.050.301.350.250.520.578;Neural Cell Adhesion Molecule L1;D039842
D12.776.835.725.934.374;Prokaryotic Initiation Factor-1;D039861
D12.776.835.725.934.562;Prokaryotic Initiation Factor-2;D039881
A11.872.870;Totipotent Stem Cells;D039901
A11.872.590;Multipotent Stem Cells;D039902
B03.510.024;Actinobacteria;D039903
B03.510.460.400.400.049;Actinobacteria;D039903
A11.872.700;Pluripotent Stem Cells;D039904
D12.776.543.750.055;Neuropilins;D039921
C01.252.410.110;Bifidobacteriales Infections;D039941
D12.776.543.750.055.500;Neuropilin-1;D039942
D12.776.543.750.055.750;Neuropilin-2;D039943
D12.644.276.923;Semaphorins;D039961
D12.776.467.923;Semaphorins;D039961
D23.529.923;Semaphorins;D039961
B01.050.500.131.166.132.419.600;Pyroglyphidae;D039981
B01.050.500.131.166.132.419.600.200;Dermatophagoides farinae;D040001
B01.050.500.131.166.132.419.600.215;Dermatophagoides pteronyssinus;D040002
B01.050.500.131.166.132.419.750;Sarcoptidae;D040021
B01.050.500.131.166.132.419.050;Acaridae;D040041
B01.050.500.131.166.132.419.575;Psoroptidae;D040042
D12.644.360.325.150.300;Eukaryotic Initiation Factor-5;D040061
D12.776.402.150.300;Eukaryotic Initiation Factor-5;D040061
D12.776.476.325.150.300;Eukaryotic Initiation Factor-5;D040061
D12.776.835.725.868.750;Eukaryotic Initiation Factor-5;D040061
E05.196.630.570.700;Protein Array Analysis;D040081
E05.393.525.680;Protein Array Analysis;D040081
E05.588.570.700;Protein Array Analysis;D040081
E05.601.680;Protein Array Analysis;D040081
B01.050.500.131.166.132.419.850;Tetranychidae;D040102
D12.644.276.923.374;Semaphorin-3A;D040121
D12.776.467.923.374;Semaphorin-3A;D040121
D23.529.923.374;Semaphorin-3A;D040121
B03.300.390.400.800;Staphylococcaceae;D040141
B03.510.100.750;Staphylococcaceae;D040141
B03.510.400.790;Staphylococcaceae;D040141
B03.510.024.049.180.100;Brevibacterium flavum;D040142
B03.510.024.049.150;Cellulomonas;D040143
B03.510.024.049.250;Frankia;D040161
C16.320.322;Genetic Diseases, X-Linked;D040181
D12.776.543.750.705.408.100.950;Platelet Membrane Glycoprotein IIb;D040201
D23.050.301.264.035.587;Platelet Membrane Glycoprotein IIb;D040201
D23.101.100.110.587;Platelet Membrane Glycoprotein IIb;D040201
J01.219.687.750;Social Marketing;D040241
N05.300.430.500.500;Social Marketing;D040241
F01.145.699;Risk Reduction Behavior;D040242
F01.145.477;Harm Reduction;D040261
D08.811.913.696.620.682.725.400.950;Receptors, Vascular Endothelial Growth Factor;D040262
D12.776.543.750.060.750;Receptors, Vascular Endothelial Growth Factor;D040262
D12.776.543.750.750.400.910;Receptors, Vascular Endothelial Growth Factor;D040262
D08.811.913.696.620.682.725.400.950.100;Vascular Endothelial Growth Factor Receptor-1;D040281
D12.776.543.750.060.750.100;Vascular Endothelial Growth Factor Receptor-1;D040281
D12.776.543.750.750.400.910.100;Vascular Endothelial Growth Factor Receptor-1;D040281
D08.811.913.696.620.682.725.400.950.200;Vascular Endothelial Growth Factor Receptor-2;D040301
D12.776.543.750.060.750.200;Vascular Endothelial Growth Factor Receptor-2;D040301
D12.776.543.750.750.400.910.200;Vascular Endothelial Growth Factor Receptor-2;D040301
D08.811.913.696.620.682.725.400.950.300;Vascular Endothelial Growth Factor Receptor-3;D040321
D12.776.543.750.060.750.300;Vascular Endothelial Growth Factor Receptor-3;D040321
D12.776.543.750.750.400.910.300;Vascular Endothelial Growth Factor Receptor-3;D040321
G05.360;Genetic Structures;D040342
E05.318.308.250.149;Behavioral Risk Factor Surveillance System;D040343
N05.715.360.300.375.149;Behavioral Risk Factor Surveillance System;D040343
N06.850.520.308.250.149;Behavioral Risk Factor Surveillance System;D040343
N02.370.300;Healthy People Programs;D040361
N02.421.726.507.300;Healthy People Programs;D040361
L01.470.750.750.462;Geographic Information Systems;D040362
L01.700.508.300.314;Geographic Information Systems;D040362
N03.540.828.052;American Public Health Association;D040363
I02.358.556;Education, Public Health Professional;D040381
L01.178.847.698.300;Cellular Phone;D040421
M01.526.485.410;Health Educators;D040441
L01.313.750;Public Health Informatics;D040442
M01.848.769.925;Students, Public Health;D040443
G05.360.340.024.340.137;Gene Components;D040461
G05.360.340.024;Genome Components;D040481
D12.776.157.125.750.500.100;Calgranulin A;D040501
D12.776.641.655.500.100;Calgranulin A;D040501
D23.050.301.562.100;Calgranulin A;D040501
D12.776.157.125.750.500.200;Calgranulin B;D040502
D12.776.641.655.500.200;Calgranulin B;D040502
D23.050.301.562.200;Calgranulin B;D040502
B01.650.940.800.575.100.850.275;Coffea;D040503
A10.165.887;Subcutaneous Tissue;D040521
J01.219.687;Marketing;D040541
G01.154.100.440;Mechanotransduction, Cellular;D040542
G01.595.100.440;Mechanotransduction, Cellular;D040542
G02.111.087.800.580;Mechanotransduction, Cellular;D040542
G02.149.115.800.580;Mechanotransduction, Cellular;D040542
G04.299.880.580;Mechanotransduction, Cellular;D040542
N02.278.825.187;Assisted Living Facilities;D040561
G05.420;Inheritance Patterns;D040582
G05.360.340.024.380.937;Quantitative Trait Loci;D040641
G02.111.570.790.709.805;Structural Homology, Protein;D040681
G02.111.810.200.820;Structural Homology, Protein;D040681
G05.820;Structural Homology, Protein;D040681
F03.080.931.550;Stress Disorders, Traumatic, Acute;D040701
G05.350;Genetic Load;D040741
J01.637.087;Biomimetic Materials;D040761
F01.510;Human Characteristics;D040821
I01.261.750;Resource Allocation;D040841
K01.316.181;Ethics, Business;D040861
D12.776.543.750.705.408.100.100;Antigens, CD11a;D040881
D23.050.301.264.035.111.024;Antigens, CD11a;D040881
D23.101.100.110.111.024;Antigens, CD11a;D040881
H01.158.201.843;Proteomics;D040901
H01.158.273.180.350.700;Proteomics;D040901
H01.158.273.343.350.700;Proteomics;D040901
H01.181.122.738;Proteomics;D040901
F03.080.931;Stress Disorders, Traumatic;D040921
G05.355.380;Heredity;D040941
G05.330.320;Genetic Drift;D040961
G05.355.044.300;Genetic Drift;D040961
B03.440.400.425.537.050.099;Acinetobacter baumannii;D040981
B03.660.250.530.050.099;Acinetobacter baumannii;D040981
B01.043.075.600.580.070.550;Babesia microti;D041001
B03.440.400.425.215.500.150;Brucella canis;D041002
B03.660.050.070.100.150;Brucella canis;D041002
B03.440.400.425.215.500.750;Brucella suis;D041021
B03.660.050.070.100.750;Brucella suis;D041021
B01.300.381.147.800;Candida tropicalis;D041022
B01.300.930.176.800;Candida tropicalis;D041022
B03.440.450.425.200.475;Citrobacter koseri;D041041
B03.660.250.150.100.475;Citrobacter koseri;D041041
B03.440.040.287.090;Ehrlichia canis;D041061
B03.660.050.020.287.090;Ehrlichia canis;D041061
B03.440.040.050.600;Anaplasma phagocytophilum;D041081
B03.660.050.020.050.600;Anaplasma phagocytophilum;D041081
B03.440.040.525.720;Neorickettsia sennetsu;D041101
B03.660.050.020.525.720;Neorickettsia sennetsu;D041101
B03.440.040.525;Neorickettsia;D041102
B03.660.050.020.525;Neorickettsia;D041102
B03.440.040.525.700;Neorickettsia risticii;D041103
B03.660.050.020.525.700;Neorickettsia risticii;D041103
B03.440.450.425.425.580;Klebsiella oxytoca;D041121
B03.660.250.150.400.580;Klebsiella oxytoca;D041121
B01.043.075.380.611.700;Plasmodium ovale;D041122
B03.440.647.650.650.040;Rickettsia akari;D041141
B03.660.050.765.650.650.040;Rickettsia akari;D041141
B03.440.647.650.650.362;Rickettsia felis;D041161
B03.660.050.765.650.650.320;Rickettsia felis;D041161
B03.300.390.400.800.750.400;Staphylococcus haemolyticus;D041162
B03.510.100.750.750.400;Staphylococcus haemolyticus;D041162
B03.510.400.790.750.400;Staphylococcus haemolyticus;D041162
B03.300.390.400.800.750.425;Staphylococcus hominis;D041181
B03.510.100.750.750.425;Staphylococcus hominis;D041181
B03.510.400.790.750.425;Staphylococcus hominis;D041181
B01.050.500.500.736.215.895.775;Taenia solium;D041201
B01.050.500.500.736.215.895.643;Taenia saginata;D041202
B01.300.381.147.400;Candida glabrata;D041221
B01.300.930.176.400;Candida glabrata;D041221
B03.440.450.900.859.225.151;Vibrio cholerae O1;D041241
B03.660.250.830.830.100.151;Vibrio cholerae O1;D041241
B03.440.450.900.859.225.200;Vibrio cholerae O139;D041242
B03.660.250.830.830.100.200;Vibrio cholerae O139;D041242
B03.440.450.900.859.900;Vibrio vulnificus;D041261
B03.660.250.830.830.900;Vibrio vulnificus;D041261
B03.440.400.425.475.475.400.050;Leptospira interrogans serovar australis;D041281
B03.851.475.475.400.050;Leptospira interrogans serovar australis;D041281
B03.440.400.425.475.475.400.055;Leptospira interrogans serovar autumnalis;D041301
B03.851.475.475.400.055;Leptospira interrogans serovar autumnalis;D041301
A11.284.187.520.300.325.680;Chromosomes, Human, X;D041321
A11.284.187.865.982.500;Chromosomes, Human, X;D041321
G05.360.162.520.300.325.680;Chromosomes, Human, X;D041321
G05.360.162.865.982.500;Chromosomes, Human, X;D041321
A11.284.187.520.300.505.757;Chromosomes, Human, Y;D041322
A11.284.187.865.983.500;Chromosomes, Human, Y;D041322
G05.360.162.520.300.505.757;Chromosomes, Human, Y;D041322
G05.360.162.865.983.500;Chromosomes, Human, Y;D041322
B03.440.400.425.475.475.400.150;Leptospira interrogans serovar canicola;D041341
B03.851.475.475.400.150;Leptospira interrogans serovar canicola;D041341
E07.325.068;Absorbent Pads;D041342
B03.440.400.425.475.475.400.400;Leptospira interrogans serovar hebdomadis;D041343
B03.851.475.475.400.400;Leptospira interrogans serovar hebdomadis;D041343
E07.490.500;Pacifiers;D041361
E07.325.068.249;Diapers, Infant;D041381
E07.325.068.124;Diapers, Adult;D041382
B03.440.400.425.475.475.400.420;Leptospira interrogans serovar icterohaemorrhagiae;D041383
B03.851.475.475.400.420;Leptospira interrogans serovar icterohaemorrhagiae;D041383
B03.440.400.425.475.475.400.650;Leptospira interrogans serovar pomona;D041401
B03.851.475.475.400.650;Leptospira interrogans serovar pomona;D041401
C11.768.585.865;Retinoschisis;D041441
B02.075.200;Desulfurococcales;D041521
B02.075.200.500.050;Aeropyrum;D041522
B02.075.200.650;Pyrodictiaceae;D041523
B02.075.725.725.030;Acidianus;D041541
B02.075.800.800.800;Thermoproteus;D041542
B02.075.800.800.650;Pyrobaculum;D041543
B02.075.800.780;Thermofilaceae;D041561
B02.200.492.500.515;Methanobrevibacter;D041581
B01.650.940.800.575.100.238.124;Bonamia Plant;D041601
B01.680.400;Haplosporida;D041602
B01.650.940.800.575.400.122.666.777.888;Pinus taeda;D041603
B01.650.940.800.575.400.122.666.777.600;Pinus ponderosa;D041604
B01.650.940.800.575.400.122.666.777.744;Pinus sylvestris;D041605
B01.650.940.800.575.100.756.249;Eremophila Plant;D041621
E01.370.350.589.249;Tomography, Optical;D041622
E01.370.350.825.805;Tomography, Optical;D041622
E05.642.249;Tomography, Optical;D041622
E01.370.350.589.249.500;Tomography, Optical Coherence;D041623
E01.370.350.825.805.500;Tomography, Optical Coherence;D041623
E05.642.249.500;Tomography, Optical Coherence;D041623
G07.700.320.500.325.377.625;Musculoskeletal Development;D041641
G11.427.590.560;Musculoskeletal Development;D041641
A11.251.210.700.550;NIH 3T3 Cells;D041681
A11.329.228.900.550;NIH 3T3 Cells;D041681
A11.251.210.700.775;Swiss 3T3 Cells;D041701
A11.329.228.900.775;Swiss 3T3 Cells;D041701
A11.251.210.700.080;BALB 3T3 Cells;D041702
A11.329.228.900.080;BALB 3T3 Cells;D041702
A11.251.210.700.775.800;3T3-L1 Cells;D041721
A11.329.228.900.775.800;3T3-L1 Cells;D041721
G05.360.340.024.340.825.500;Genes, Transgenic, Suicide;D041722
A03.556.249;Lower Gastrointestinal Tract;D041741
A03.556.875;Upper Gastrointestinal Tract;D041742
G07.690.812.240.755;Herb-Drug Interactions;D041743
G07.700.680.240.755;Herb-Drug Interactions;D041743
C06.130.409.178;Cholecystolithiasis;D041761
C06.130.564.332;Cholecystolithiasis;D041761
C23.550.429.500.755;Jaundice, Obstructive;D041781
C23.888.885.375.500;Jaundice, Obstructive;D041781
B03.440.400.425.100.110;Acidiphilium;D041801
B03.660.050.663.050.020;Acidiphilium;D041801
B03.440.400.425.365;Gluconacetobacter;D041821
B03.660.050.663.050.400;Gluconacetobacter;D041821
B03.440.400.425.365.500;Gluconacetobacter xylinus;D041822
B03.660.050.663.050.400.500;Gluconacetobacter xylinus;D041822
B03.440.400.425.200;Bradyrhizobiaceae;D041841
B03.660.050.035;Bradyrhizobiaceae;D041841
B03.275.150;Chloroflexus;D041861
B03.440.210;Chloroflexus;D041861
B03.275;Chloroflexi;D041862
C06.130.564.263.500;Cholecystitis, Acute;D041881
C06.130.564.263.500.500;Emphysematous Cholecystitis;D041882
B03.250.140;Chlorobium;D041883
B03.440.425.410.275;Chlorobium;D041883
B01.650.940.800.575.100.910;Stemonaceae;D041901
B03.660.050.750;Rhodobacteraceae;D041902
B03.440.646;Rhodovulum;D041903
B03.660.050.750.725;Rhodovulum;D041903
B03.440.680;Roseobacter;D041904
B03.660.050.750.750;Roseobacter;D041904
A11.443;Erythroid Cells;D041905
B03.660.050.350;Hyphomicrobiaceae;D041921
F01.525.049;Adolescent Development;D041923
G07.700.320.374.500;Adolescent Development;D041923
J02.200.712;Milk Substitutes;D041941
J02.200.712.500;Soy Milk;D041942
J02.500.850.500.700.500.500;Soy Milk;D041942
J02.200.700.249;Infant Formula;D041943
J02.200.712.249;Infant Formula;D041943
J02.500.350.525.332;Infant Formula;D041943
J02.500.525.350.500;Infant Formula;D041943
J02.500.525.500.500;Infant Formula;D041943
E05.196.344;Deuterium Exchange Measurement;D041961
B03.440.400.645;Thiotrichaceae;D041962
B03.660.250.770;Thiotrichaceae;D041962
B03.140;Bacteroidetes;D041963
B03.140.130;Cytophagaceae;D041964
B03.440.400.425.300;Cytophagaceae;D041964
B03.140.190;Flavobacteriaceae;D041965
B03.440.400.425.310;Flavobacteriaceae;D041965
A03.556;Gastrointestinal Tract;D041981
B03.440.425.410.405;Ectothiorhodospiraceae;D042001
B03.660.250.145;Ectothiorhodospiraceae;D042001
G04.299.452.095;Chromatin Assembly and Disassembly;D042002
G05.355.192.095;Chromatin Assembly and Disassembly;D042002
G05.355.315.095;Chromatin Assembly and Disassembly;D042002
G04.299.452;DNA Packaging;D042003
G05.355.192;DNA Packaging;D042003
B03.440.400.425.215;Brucellaceae;D042021
B03.660.050.070;Brucellaceae;D042021
B03.440.400.425.575;Ochrobactrum;D042041
B03.660.050.070.700;Ochrobactrum;D042041
B03.440.400.425.215.500.625;Brucella ovis;D042061
B03.660.050.070.100.625;Brucella ovis;D042061
B03.660.050.032;Beijerinckiaceae;D042062
B03.440.400.425.288;Caulobacteraceae;D042063
B03.660.050.090;Caulobacteraceae;D042063
B03.440.400.425.708.100.510;Azospirillum lipoferum;D042081
B03.660.050.663.750.100.510;Azospirillum lipoferum;D042081
B03.440.400.425.487;Methylobacteriaceae;D042082
B03.660.050.500;Methylobacteriaceae;D042082
B03.660.050.512;Methylocystaceae;D042083
B03.440.400.425.600.690;Paracoccus pantotrophus;D042084
B03.660.050.750.600.600;Paracoccus pantotrophus;D042084
C06.130.564.263.249;Acalculous Cholecystitis;D042101
E02.875.194.285;Contraception, Barrier;D042121
B03.440.400.425.700.800.600;Rhizobium phaseoli;D042161
B03.660.050.730.670.600;Rhizobium phaseoli;D042161
B03.440.400.425.700.800.800;Rhizobium tropici;D042162
B03.660.050.730.670.800;Rhizobium tropici;D042162
B03.440.400.425.700.800.337;Rhizobium etli;D042163
B03.660.050.730.670.337;Rhizobium etli;D042163
B03.440.400.425.700.887.249;Sinorhizobium fredii;D042181
B03.660.050.730.835.399;Sinorhizobium fredii;D042181
B03.440.400.425.708.733.150;Rhodospirillum centenum;D042182
B03.660.050.663.750.733.150;Rhodospirillum centenum;D042182
B03.440.400.425.708.500;Magnetospirillum;D042201
B03.660.050.663.750.500;Magnetospirillum;D042201
E01.390;Early Diagnosis;D042241
E07.230.540.500;Retinoscopes;D042261
E01.370.380.560.500;Retinoscopy;D042262
B03.660.050.340;Holosporaceae;D042281
E01.370.225.500.620.520;Microdissection;D042282
E01.370.225.750.600.520;Microdissection;D042282
E01.370.225.998.221.580;Microdissection;D042282
E04.221.580;Microdissection;D042282
E05.200.750.600.520;Microdissection;D042282
E05.200.998.221.580;Microdissection;D042282
E05.591.560;Microdissection;D042282
B03.660.050.800;Sphingomonadaceae;D042301
B03.440.040.050.100;Anaplasma centrale;D042321
B03.660.050.020.050.100;Anaplasma centrale;D042321
B03.440.040.050.500;Anaplasma marginale;D042322
B03.660.050.020.050.500;Anaplasma marginale;D042322
B03.440.040.050.575;Anaplasma ovis;D042323
B03.660.050.020.050.575;Anaplasma ovis;D042323
D06.472.334;Gonadal Hormones;D042341
A01.236.249;Mammary Glands, Human;D042361
A10.336.532;Mammary Glands, Human;D042361
A11.148.350.350;Granulocyte Precursor Cells;D042381
A11.148.378.590.675.500;Granulocyte Precursor Cells;D042381
A11.627.340.360;Granulocyte Precursor Cells;D042381
A11.627.635.675.500;Granulocyte Precursor Cells;D042381
A11.872.378.590.635.500;Granulocyte Precursor Cells;D042381
A15.378.316.340.350;Granulocyte Precursor Cells;D042381
A15.378.316.378.590.675.500;Granulocyte Precursor Cells;D042381
B03.440.400.425.117;Alcaligenaceae;D042401
B03.660.075.027;Alcaligenaceae;D042401
B03.440.400.425.117.024;Achromobacter;D042402
B03.660.075.027.030;Achromobacter;D042402
G02.111.570.060.360;Histone Code;D042421
G05.360.360;Histone Code;D042421
B03.440.400.425.117.024.100;Achromobacter cycloclastes;D042422
B03.660.075.027.030.100;Achromobacter cycloclastes;D042422
B03.440.400.425.117.024.120;Achromobacter denitrificans;D042441
B03.660.075.027.030.120;Achromobacter denitrificans;D042441
D12.644.276.100.800;Vascular Endothelial Growth Factors;D042442
D12.776.467.100.800;Vascular Endothelial Growth Factors;D042442
D23.529.100.800;Vascular Endothelial Growth Factors;D042442
D12.644.276.100.800.200;Vascular Endothelial Growth Factor A;D042461
D12.776.467.100.800.200;Vascular Endothelial Growth Factor A;D042461
D23.529.100.800.200;Vascular Endothelial Growth Factor A;D042461
D03.438.810.835.055;4-Quinolones;D042462
B03.440.400.425.117.050.200;Alcaligenes faecalis;D042481
B03.660.075.027.050.200;Alcaligenes faecalis;D042481
B03.440.400.425.117.075.099;Bordetella avium;D042482
B03.660.075.027.075.024;Bordetella avium;D042482
B03.440.400.425.117.075.540;Bordetella parapertussis;D042483
B03.660.075.027.075.590;Bordetella parapertussis;D042483
D12.644.276.100;Angiogenic Proteins;D042501
D12.776.467.100;Angiogenic Proteins;D042501
D23.529.100;Angiogenic Proteins;D042501
B03.440.400.425.117.800;Taylorella;D042502
B03.660.075.027.800;Taylorella;D042502
B03.440.400.425.251;Burkholderiaceae;D042521
B03.660.075.077;Burkholderiaceae;D042521
G02.111.087.222.760;DNA Replication Timing;D042522
G02.149.115.222.760;DNA Replication Timing;D042522
G05.355.200.760;DNA Replication Timing;D042522
A10.082.750;Intracellular Space;D042541
A11.284.430;Intracellular Space;D042541
D12.644.276.100.800.300;Vascular Endothelial Growth Factor B;D042561
D12.776.467.100.800.300;Vascular Endothelial Growth Factor B;D042561
D23.529.100.800.300;Vascular Endothelial Growth Factor B;D042561
A11.284.430.106.279.345;Intranuclear Space;D042581
D12.644.276.100.800.400;Vascular Endothelial Growth Factor C;D042582
D12.776.467.100.800.400;Vascular Endothelial Growth Factor C;D042582
D23.529.100.800.400;Vascular Endothelial Growth Factor C;D042582
G07.700.320.500.325.377.500;Lymphangiogenesis;D042583
A15.382.520.301;Lymphatic Vessels;D042601
B03.440.400.425.251.100.110;Burkholderia cepacia complex;D042602
B03.660.075.077.100.110;Burkholderia cepacia complex;D042602
B03.440.400.425.292;Comamonadaceae;D042621
B03.660.075.102;Comamonadaceae;D042621
G02.111.570.080.708.800.140;DNA Repeat Expansion;D042622
G05.355.600.220;DNA Repeat Expansion;D042622
G05.360.080.708.800.074;DNA Repeat Expansion;D042622
G05.360.340.024.189.220;DNA Repeat Expansion;D042622
G05.360.340.024.850.140;DNA Repeat Expansion;D042622
G05.365.590.220;DNA Repeat Expansion;D042622
D12.644.276.100.800.500;Vascular Endothelial Growth Factor D;D042643
D12.776.467.100.800.500;Vascular Endothelial Growth Factor D;D042643
D23.529.100.800.500;Vascular Endothelial Growth Factor D;D042643
D12.644.276.100.800.600;Vascular Endothelial Growth Factor, Endocrine-Gland-Derived;D042662
D12.776.467.100.800.600;Vascular Endothelial Growth Factor, Endocrine-Gland-Derived;D042662
D23.529.100.800.600;Vascular Endothelial Growth Factor, Endocrine-Gland-Derived;D042662
D12.644.276.100.100;Angiopoietins;D042682
D12.776.467.100.100;Angiopoietins;D042682
D23.529.100.100;Angiopoietins;D042682
D12.644.276.100.100.100;Angiopoietin-1;D042683
D12.776.467.100.100.100;Angiopoietin-1;D042683
D23.529.100.100.100;Angiopoietin-1;D042683
D12.644.276.100.100.200;Angiopoietin-2;D042702
D12.776.467.100.100.200;Angiopoietin-2;D042702
D23.529.100.100.200;Angiopoietin-2;D042702
D06.472.334.851.437.994;Estrogens, Esterified (USP);D042724
B03.440.400.425.251.100.355;Burkholderia gladioli;D042725
B03.660.075.077.100.355;Burkholderia gladioli;D042725
B03.440.400.425.251.100.477;Burkholderia mallei;D042726
B03.660.075.077.100.477;Burkholderia mallei;D042726
B03.440.400.425.292.170;Delftia;D042742
B03.660.075.102.170;Delftia;D042742
B03.440.400.425.292.500;Leptothrix;D042743
B03.660.075.102.500;Leptothrix;D042743
B03.440.400.425.292.750;Sphaerotilus;D042744
B03.660.075.102.750;Sphaerotilus;D042744
B03.440.400.425.525;Methylophilaceae;D042762
B03.660.075.495;Methylophilaceae;D042762
B03.440.400.425.103;Acidithiobacillus;D042763
B03.660.250.015;Acidithiobacillus;D042763
D08.811.913.696.620.682.725.400.925;Receptors, TIE;D042764
D12.776.543.750.060.687;Receptors, TIE;D042764
D06.472.334.851.437.968;Estrogenic Steroids, Alkylated;D042782
A11.436.275;Endothelial Cells;D042783
D08.811.913.696.620.682.725.400.925.500;Receptor, TIE-2;D042787
D12.776.543.750.060.687.500;Receptor, TIE-2;D042787
B03.440.400.425.587;Oxalobacteraceae;D042802
B03.660.075.600;Oxalobacteraceae;D042802
B03.440.400.425.587.400;Herbaspirillum;D042803
B03.660.075.600.400;Herbaspirillum;D042803
B03.440.400.425.550.550.125;Neisseria cinerea;D042804
B03.660.075.525.520.124;Neisseria cinerea;D042804
B03.440.400.425.550.550.299;Neisseria elongata;D042805
B03.660.075.525.520.262;Neisseria elongata;D042805
B03.440.400.425.550.550.600;Neisseria lactamica;D042806
B03.660.075.525.520.475;Neisseria lactamica;D042806
B03.440.400.425.550.550.660;Neisseria mucosa;D042807
B03.660.075.525.520.520;Neisseria mucosa;D042807
B03.440.400.425.550.550.800;Neisseria sicca;D042808
B03.660.075.525.520.760;Neisseria sicca;D042808
D08.811.913.696.620.682.725.400.925.249;Receptor, TIE-1;D042810
D12.776.543.750.060.687.249;Receptor, TIE-1;D042810
C23.550.362;Genomic Instability;D042822
G05.365.590.335;Genomic Instability;D042822
G05.370;Genomic Instability;D042822
D08.811.682.047.436.174;11-beta-Hydroxysteroid Dehydrogenases;D042842
D08.811.682.047.150.270.500;Glucose 1-Dehydrogenase;D042843
D08.811.682.047.551.500;L-Lactate Dehydrogenase (Cytochrome);D042844
D08.811.682.494;Laccase;D042845
D08.811.913.696.620.682.700.200.067;CDC2-CDC28 Kinases;D042846
D08.811.913.696.620.682.700.646.500.500;CDC2-CDC28 Kinases;D042846
D12.644.360.250.067;CDC2-CDC28 Kinases;D042846
D12.776.167.200.067;CDC2-CDC28 Kinases;D042846
D12.776.476.250.067;CDC2-CDC28 Kinases;D042846
D08.811.913.696.620.682.700.200.067.900;Cyclin-Dependent Kinase 9;D042863
D12.644.360.250.067.900;Cyclin-Dependent Kinase 9;D042863
D12.776.167.200.067.900;Cyclin-Dependent Kinase 9;D042863
D12.776.476.250.067.900;Cyclin-Dependent Kinase 9;D042863
D12.776.930.955.500.500;Cyclin-Dependent Kinase 9;D042863
C06.130.409.633;Gallstones;D042882
C06.130.564.332.500;Gallstones;D042882
C23.300.175.525;Gallstones;D042882
C06.130.120.250.174;Choledocholithiasis;D042883
C06.130.409.267;Choledocholithiasis;D042883
D08.811.913.696.620.682.700.626;Positive Transcriptional Elongation Factor B;D042925
D12.776.930.955.500;Positive Transcriptional Elongation Factor B;D042925
D08.811.682.690.708.170.035;Alkane 1-Monooxygenase;D042926
D08.811.682.657.163.311;Aldehyde Oxidase;D042931
D08.811.682.657.350.760;3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide);D042942
D08.811.682.660.350;Dihydrouracil Dehydrogenase (NADP);D042943
D08.811.682.660.200;Cholestenone 5 alpha-Reductase;D042944
D08.811.682.660.150.200;Acyl-CoA Oxidase;D042962
D12.776.331.149;Acyl-CoA Oxidase;D042962
D05.500.562.750.249;Electron Transport Complex II;D042963
D08.811.600.250.500.750;Electron Transport Complex II;D042963
D08.811.600.250.875.249;Electron Transport Complex II;D042963
D08.811.682.660.385;Electron Transport Complex II;D042963
D08.811.682.830.249;Electron Transport Complex II;D042963
D12.776.157.427.374.375.909;Electron Transport Complex II;D042963
D12.776.331.199.750;Electron Transport Complex II;D042963
D12.776.543.277.500.750;Electron Transport Complex II;D042963
D12.776.543.277.875.249;Electron Transport Complex II;D042963
D12.776.556.579.374.375.141;Electron Transport Complex II;D042963
D08.811.682.660.150.100;Acyl-CoA Dehydrogenase;D042964
D12.776.331.099;Acyl-CoA Dehydrogenase;D042964
D08.811.682.662.290;Methylenetetrahydrofolate Reductase (NADPH2);D042965
D12.776.331.775;Methylenetetrahydrofolate Reductase (NADPH2);D042965
D08.811.682.608.191.237;Cytochrome-B(5) Reductase;D042966
D12.776.331.186;Cytochrome-B(5) Reductase;D042966
D05.500.562.249;Electron Transport Complex I;D042967
D08.811.600.250.500.500;Electron Transport Complex I;D042967
D08.811.682.608.504;Electron Transport Complex I;D042967
D12.776.157.427.374.375.863;Electron Transport Complex I;D042967
D12.776.157.530.450.250.875.300;Electron Transport Complex I;D042967
D12.776.331.199.500;Electron Transport Complex I;D042967
D12.776.543.277.500.500;Electron Transport Complex I;D042967
D12.776.543.585.450.250.875.437;Electron Transport Complex I;D042967
D12.776.556.579.374.375.140;Electron Transport Complex I;D042967
D12.776.124.486.485.114.715;Oligoclonal Bands;D043025
D12.776.124.790.651.114.715;Oligoclonal Bands;D043025
D12.776.377.715.548.114.715;Oligoclonal Bands;D043025
D23.101.613;Oligoclonal Bands;D043025
A13.463;Hepatopancreas;D043143
D12.644.276.100.450;Angiostatic Proteins;D043165
D12.776.467.100.450;Angiostatic Proteins;D043165
D23.529.100.450;Angiostatic Proteins;D043165
B03.440.840;Spirillaceae;D043167
B03.660.075.710;Spirillaceae;D043167
D08.622.610.500;Angiostatins;D043168
D12.644.276.100.450.500;Angiostatins;D043168
D12.776.124.790.223.580.500;Angiostatins;D043168
D12.776.377.715.182.580.500;Angiostatins;D043168
D12.776.467.100.450.500;Angiostatins;D043168
D23.529.100.450.500;Angiostatins;D043168
D12.644.276.100.450.750;Endostatins;D043169
D12.776.467.100.450.750;Endostatins;D043169
D12.776.860.300.250.400.537.500;Endostatins;D043169
D23.529.100.450.750;Endostatins;D043169
D12.776.860.300.250.400.537;Collagen Type XVIII;D043170
C23.550.210.110;Chromosomal Instability;D043171
C23.550.362.180;Chromosomal Instability;D043171
G05.365.590.175.165;Chromosomal Instability;D043171
G05.370.180;Chromosomal Instability;D043171
D08.811.277.352.100.100;Carboxylesterase;D043182
C06.405.469.158.272.608;Irritable Bowel Syndrome;D043183
C16.320.565.925;Steroid Metabolism, Inborn Errors;D043202
C18.452.648.925;Steroid Metabolism, Inborn Errors;D043202
D08.811.277.352.100.680.750.937.249;1-Alkyl-2-acetylglycerophosphocholine Esterase;D043203
C16.320.565.925.500;Mineralocorticoid Excess Syndrome, Apparent;D043204
C18.452.648.925.500;Mineralocorticoid Excess Syndrome, Apparent;D043204
D08.811.682.047.436.174.300;11-beta-Hydroxysteroid Dehydrogenase Type 1;D043205
D08.811.682.047.436.174.600;11-beta-Hydroxysteroid Dehydrogenase Type 2;D043209
D08.811.277.352.335.375.750;Exodeoxyribonuclease V;D043211
D08.811.277.352.897.850;Ubiquitin Thiolesterase;D043222
D08.811.277.352.335.350.275;Deoxyribonuclease IV (Phage T4-Induced);D043223
D08.811.277.352.335.350.137;Deoxyribonuclease (Pyrimidine Dimer);D043224
G05.360.340.024.189;DNA Sequence, Unstable;D043243
D08.811.277.352.700.350.707;Ribonuclease III;D043244
D08.811.277.352.700.350.711;Ribonuclease P;D043262
D08.811.797.500;Ribonuclease P;D043262
D12.776.157.725.500.625;Ribonuclease P;D043262
D12.776.664.962.500.625;Ribonuclease P;D043262
D08.811.277.352.650.625.475;Myosin-Light-Chain Phosphatase;D043263
D08.811.277.352.640.430;Phosphodiesterase I;D043264
D08.811.277.352.640.700.700.500;Phosphatidylinositol Diacylglycerol-Lyase;D043265
D08.811.520.650.800;Phosphatidylinositol Diacylglycerol-Lyase;D043265
D08.811.277.352.827.070.625;Steryl-Sulfatase;D043266
G05.360.340.024.189.610;Chromosome Fragile Sites;D043283
J02.200.700.124;Cultured Milk Products;D043302
J02.500.350.525.221;Cultured Milk Products;D043302
D08.811.277.352.660.500;Aryldialkylphosphatase;D043303
D08.811.277.450.410.100.500;Lactase;D043322
D08.811.277.450.625.500;alpha-Mannosidase;D043323
D08.811.277.450.114;beta-Fructofuranosidase;D043324
D08.811.277.450.950.500;Xylan Endo-1,3-beta-Xylosidase;D043325
D08.811.277.450.420.200.500;Glucan 1,3-beta-Glucosidase;D043326
D04.808.054.079.429.824.832;Testosterone Propionate;D043343
D06.472.334.851.968.984.750;Testosterone Propionate;D043343
B01.050.150;Chordata;D043344
B03.660.075.655;Rhodocyclaceae;D043362
B03.660.075.400;Hydrogenophilaceae;D043363
D08.811.277.450.950.249;Endo-1,4-beta Xylanases;D043364
D08.811.277.450.420.200.400;Cellulose 1,4-beta-Cellobiosidase;D043366
B03.440.400.425.251.650;Ralstonia;D043367
B03.660.075.077.650;Ralstonia;D043367
B03.440.400.425.251.650.750;Ralstonia solanacearum;D043368
B03.660.075.077.650.750;Ralstonia solanacearum;D043368
B03.440.400.425.562;Nitrosomonadaceae;D043369
B03.660.075.550;Nitrosomonadaceae;D043369
B03.440.400.425.562.500.200;Nitrosomonas europaea;D043370
B03.660.075.550.500.200;Nitrosomonas europaea;D043370
D10.251.355.343;Fatty Acids, Omega-6;D043371
B03.440.400.400;Gallionellaceae;D043372
B03.660.075.375;Gallionellaceae;D043372
D06.472.699.631.525.343.288.625;Follicle Stimulating Hormone, Human;D043373
D08.811.074.249.500;DNA-Formamidopyrimidine Glycosylase;D043382
D08.811.277.450.430.099.500;DNA-Formamidopyrimidine Glycosylase;D043382
D08.811.277.063;Adenosylhomocysteinase;D043383
D08.811.277.656.350.100.373;Glutamyl Aminopeptidase;D043384
D08.811.277.656.350.555.600;Glutamyl Aminopeptidase;D043384
D08.811.277.656.675.555.600;Glutamyl Aminopeptidase;D043384
D08.811.277.656.224.062;Cathepsin A;D043402
D08.811.277.656.350.245.260;Cathepsin A;D043402
D08.811.277.656.959.200;Cathepsin A;D043402
D08.811.277.656.350.245.250;Carboxypeptidases A;D043422
D08.811.277.656.350.555.350;Carboxypeptidases A;D043422
D08.811.277.656.675.555.350;Carboxypeptidases A;D043422
D08.811.277.656.350.245.167;Carboxypeptidase H;D043423
D08.811.277.656.350.555.250;Carboxypeptidase H;D043423
D08.811.277.656.675.555.250;Carboxypeptidase H;D043423
D08.811.277.656.837.124;Carboxypeptidase H;D043423
D08.811.277.656.350.245.083;Carboxypeptidase B;D043424
D08.811.277.656.350.555.200;Carboxypeptidase B;D043424
D08.811.277.656.675.555.200;Carboxypeptidase B;D043424
D08.811.277.656.350.245.400;Glutamate Carboxypeptidase II;D043425
D08.811.277.656.350.555.500;Glutamate Carboxypeptidase II;D043425
D08.811.277.656.675.555.500;Glutamate Carboxypeptidase II;D043425
D08.811.277.656.837;Proprotein Convertases;D043484
A08.663.650.915.500.600.360;Glomus Tympanicum;D043485
A08.800.950.500.600.360;Glomus Tympanicum;D043485
A09.246.397.400;Glomus Tympanicum;D043485
A11.671.650.915.500.600.360;Glomus Tympanicum;D043485
D08.811.277.087.200;Biotinidase;D043523
D08.811.277.087.725;Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase;D043524
D08.811.277.151.486.625;Cytosine Deaminase;D043525
D13.444.308.574;DNA, Z-Form;D043542
G02.111.570.790.486.493;DNA, Z-Form;D043542
G05.360.580.493;DNA, Z-Form;D043542
D12.776.543.750.100;Receptors, G-Protein-Coupled;D043562
D12.776.543.750.100.660;Receptors, Pheromone;D043563
D12.776.543.750.775;Receptors, Pheromone;D043563
D08.811.277.040.600.399;Inorganic Pyrophosphatase;D043564
D12.776.157.530.450.250.875.487;Inorganic Pyrophosphatase;D043564
D12.776.543.585.450.250.875.487;Inorganic Pyrophosphatase;D043564
D04.808.745.558.075;5-alpha-Dihydroprogesterone;D043582
D06.472.334.851.687.750.070;5-alpha-Dihydroprogesterone;D043582
D08.811.277.040.465;Nucleoside-Triphosphatase;D043583
D12.776.543.750.100.475.200;Receptor, Muscarinic M2;D043585
D12.776.543.750.720.360.500.200;Receptor, Muscarinic M2;D043585
D08.811.520.224.125.387;Methylmalonyl-CoA Decarboxylase;D043586
D12.776.543.750.100.475.300;Receptor, Muscarinic M3;D043587
D12.776.543.750.720.360.500.300;Receptor, Muscarinic M3;D043587
D12.776.543.750.100.475.400;Receptor, Muscarinic M4;D043588
D12.776.543.750.720.360.500.400;Receptor, Muscarinic M4;D043588
D08.811.074.750;DNA-(Apurinic or Apyrimidinic Site) Lyase;D043603
D08.811.520.241.225;DNA-(Apurinic or Apyrimidinic Site) Lyase;D043603
C04.557.465.625.650.700.705.360;Glomus Tympanicum Tumor;D043604
C04.557.580.625.650.700.705.360;Glomus Tympanicum Tumor;D043604
D08.811.682.047.436.400.074;20-alpha-Hydroxysteroid Dehydrogenase;D043607
D12.776.543.750.100.475.500;Receptor, Muscarinic M5;D043642
D12.776.543.750.720.360.500.500;Receptor, Muscarinic M5;D043642
D12.776.543.750.100.475.100;Receptor, Muscarinic M1;D043643
D12.776.543.750.720.360.500.099;Receptor, Muscarinic M1;D043643
D12.776.543.750.100.700.700.100;Receptor, Adenosine A1;D043682
D12.776.543.750.720.700.700.100;Receptor, Adenosine A1;D043682
D12.776.543.750.810.700.100;Receptor, Adenosine A1;D043682
D12.776.543.750.100.700.700.200;Receptors, Adenosine A2;D043683
D12.776.543.750.720.700.700.200;Receptors, Adenosine A2;D043683
D12.776.543.750.810.700.200;Receptors, Adenosine A2;D043683
D12.776.543.750.100.700.700.300;Receptor, Adenosine A3;D043684
D12.776.543.750.720.700.700.300;Receptor, Adenosine A3;D043684
D12.776.543.750.810.700.300;Receptor, Adenosine A3;D043684
G11.427.590;Musculoskeletal Physiological Processes;D043702
D12.776.543.750.100.700.700.200.200;Receptor, Adenosine A2B;D043704
D12.776.543.750.720.700.700.200.200;Receptor, Adenosine A2B;D043704
D12.776.543.750.810.700.200.200;Receptor, Adenosine A2B;D043704
D12.776.543.750.100.700.700.200.100;Receptor, Adenosine A2A;D043705
D12.776.543.750.720.700.700.200.100;Receptor, Adenosine A2A;D043705
D12.776.543.750.810.700.200.100;Receptor, Adenosine A2A;D043705
G14.640;Ocular Physiological Processes;D043723
D08.811.464.938;Ubiquitin-Protein Ligase Complexes;D043743
F01.145.688;Reproductive Behavior;D043762
G08.686.785.760.891;Reproductive Behavior;D043762
D12.776.543.750.100.080.500;Receptor, Bradykinin B2;D043782
D12.776.543.750.720.600.220.500;Receptor, Bradykinin B2;D043782
D12.776.543.750.750.555.220.500;Receptor, Bradykinin B2;D043782
D12.776.543.750.100.080.249;Receptor, Bradykinin B1;D043783
D12.776.543.750.720.600.220.249;Receptor, Bradykinin B1;D043783
D12.776.543.750.750.555.220.249;Receptor, Bradykinin B1;D043783
D08.811.277.040.330.300.200.100.300;GTP-Binding Protein alpha Subunits, Gq-G11;D043802
D12.644.360.375.100.300;GTP-Binding Protein alpha Subunits, Gq-G11;D043802
D12.776.157.325.332.100.300;GTP-Binding Protein alpha Subunits, Gq-G11;D043802
D12.776.476.375.100.300;GTP-Binding Protein alpha Subunits, Gq-G11;D043802
D12.776.543.325.100.300;GTP-Binding Protein alpha Subunits, Gq-G11;D043802
D02.455.426.559.847.680;Phenalenes;D043803
D04.615.680;Phenalenes;D043803
D02.455.426.392.368.242;Cyclodecanes;D043822
D02.455.426.392.368.242.888;Taxoids;D043823
D02.455.849.291.850;Taxoids;D043823
B01.650.940.800.575.100.779;Ochnaceae;D043842
B01.650.940.800.575.100.100.506;Leuzea;D043843
D02.355.291.308;Crown Ethers;D043844
D04.345.051.500;Crown Ethers;D043844
D04.345.241.308;Crown Ethers;D043844
D02.825;Rotaxanes;D043862
D02.251;Catenanes;D043863
D02.251.500;DNA, Catenated;D043864
D13.444.308.283.084;DNA, Catenated;D043864
G02.111.570.790.486.212.084;DNA, Catenated;D043864
G05.360.580.156.084;DNA, Catenated;D043864
D12.776.543.750.100.125;Receptors, Cannabinoid;D043882
D12.776.543.750.100.125.100;Receptor, Cannabinoid, CB1;D043884
D12.776.543.750.100.125.200;Receptor, Cannabinoid, CB2;D043885
D12.776.543.750.100.170.100;Receptor, Cholecystokinin A;D043886
D12.776.543.750.720.600.270.100;Receptor, Cholecystokinin A;D043886
D12.776.543.750.750.360.200.100;Receptor, Cholecystokinin A;D043886
D12.776.543.750.750.555.270.100;Receptor, Cholecystokinin A;D043886
D12.776.543.750.100.170.200;Receptor, Cholecystokinin B;D043887
D12.776.543.750.720.600.270.200;Receptor, Cholecystokinin B;D043887
D12.776.543.750.750.360.200.200;Receptor, Cholecystokinin B;D043887
D12.776.543.750.750.555.270.200;Receptor, Cholecystokinin B;D043887
B02.200.825.800.650.400;Pyrococcus horikoshii;D043902
B02.200.825.800.650.020;Pyrococcus abyssi;D043903
H01.158.273.343.750.850;Toxicogenetics;D043922
H01.158.703.052.850;Toxicogenetics;D043922
H01.158.703.795.850;Toxicogenetics;D043922
H02.628.479.850;Toxicogenetics;D043922
H02.628.795.850;Toxicogenetics;D043922
D27.505.696.377.077;Angiogenesis Modulating Agents;D043924
D27.505.696.377.077.077;Angiogenesis Inducing Agents;D043925
J01.637.512.850;Nanotubes;D043942
C06.405.469.158.587;Diverticulosis, Colonic;D043963
B01.650.940.800.575.250.461;Marsileaceae;D043964
B01.650.940.800.575.100.841;Rhizophoraceae;D043982
B01.650.940.800.575.137;Bryophyta;D044002
B01.650.940.800.575.137.750;Sphagnopsida;D044003
D03.494.953.852;Xanthones;D044004
D03.438.531.820;Tetrahydroisoquinolines;D044005
D12.776.543.750.075.700.299;Receptors, Epoprostenol;D044006
D12.776.543.750.100.200.700.299;Receptors, Epoprostenol;D044006
B03.440.400.425.537;Moraxellaceae;D044007
B03.660.250.530;Moraxellaceae;D044007
D12.776.543.750.100.220.100;Receptor, Endothelin A;D044022
D12.776.543.750.750.320.100;Receptor, Endothelin A;D044022
D12.776.543.750.100.220.200;Receptor, Endothelin B;D044023
D12.776.543.750.750.320.200;Receptor, Endothelin B;D044023
D02.455.426.559.847.638.960.837;Tetralones;D044024
D04.615.638.960.837;Tetralones;D044024
D12.776.543.750.100.235;Receptors, Formyl Peptide;D044042
D12.776.543.750.705.873;Receptors, Formyl Peptide;D044042
D12.776.543.750.750.340;Receptors, Formyl Peptide;D044042
B03.440.450.425.585;Pectobacterium;D044043
B03.660.250.150.542;Pectobacterium;D044043
B03.440.450.019;Aeromonadaceae;D044044
B03.660.250.017;Aeromonadaceae;D044044
D10.251.355.255.375;Lipoxins;D044045
D10.251.355.255.100.637.550;Prostaglandins I;D044062
D10.251.355.255.550.550;Prostaglandins I;D044062
D23.469.050.175.725.895;Prostaglandins I;D044062
B03.440.425.410.722;Succinivibrionaceae;D044063
B03.660.250.740;Succinivibrionaceae;D044063
B03.440.425.410.145;Anaerobiospirillum;D044064
B03.660.250.740.050;Anaerobiospirillum;D044064
B03.440.450.342;Cardiobacteriaceae;D044065
B03.660.250.080;Cardiobacteriaceae;D044065
B03.440.450.342.100;Cardiobacterium;D044066
B03.660.250.080.100;Cardiobacterium;D044066
D12.776.543.750.075.575;Receptors, Lipoxin;D044067
B03.440.450.425.200.737;Citrobacter rodentium;D044082
B03.660.250.150.100.737;Citrobacter rodentium;D044082
B03.440.450.425.198.150;Cronobacter sakazakii;D044083
B03.660.250.150.098.150;Cronobacter sakazakii;D044083
B03.440.450.425.300.050;Erwinia amylovora;D044084
B03.660.250.150.175.050;Erwinia amylovora;D044084
E05.830.666;Microfluidics;D044085
H01.671.808.500;Microfluidics;D044085
J01.897.520.500.500;Microfluidics;D044085
B03.440.450.425.435;Kluyvera;D044086
B03.660.250.150.410;Kluyvera;D044086
D12.776.543.750.100.024;Receptor, Anaphylatoxin C5a;D044087
D12.776.543.750.705.833.550;Receptor, Anaphylatoxin C5a;D044087
D23.050.301.264.035.595;Receptor, Anaphylatoxin C5a;D044087
D23.101.100.110.595;Receptor, Anaphylatoxin C5a;D044087
D12.776.543.750.100.315;Receptors, Galanin;D044088
D12.776.543.750.720.600.410;Receptors, Galanin;D044088
D12.776.543.750.750.555.410;Receptors, Galanin;D044088
D12.644.400.275;Galanin-Like Peptide;D044089
B03.440.450.425.814.620;Serratia liquefaciens;D044090
B03.660.250.150.720.480;Serratia liquefaciens;D044090
D12.776.543.750.100.315.100;Receptor, Galanin, Type 1;D044091
D12.776.543.750.100.315.200;Receptor, Galanin, Type 2;D044092
D12.776.543.750.100.315.300;Receptor, Galanin, Type 3;D044093
D12.776.260.698.590;Receptors, Melatonin;D044094
D12.776.543.750.100.440;Receptors, Melatonin;D044094
B03.440.450.425.600.650;Proteus penneri;D044095
B03.660.250.150.590.670;Proteus penneri;D044095
B03.440.400.425.537.650;Psychrobacter;D044096
B03.660.250.530.650;Psychrobacter;D044096
D12.776.543.750.100.430;Receptors, Melanocortin;D044101
D12.776.543.750.720.600.285.500;Receptors, Melanocortin;D044101
D12.776.543.750.750.555.285.500;Receptors, Melanocortin;D044101
D12.776.543.750.750.660.285.500;Receptors, Melanocortin;D044101
D12.776.543.750.100.430.500;Receptor, Melanocortin, Type 1;D044102
D12.776.543.750.720.600.285.500.500;Receptor, Melanocortin, Type 1;D044102
D12.776.543.750.750.555.285.500.500;Receptor, Melanocortin, Type 1;D044102
D12.776.543.750.750.660.285.500.500;Receptor, Melanocortin, Type 1;D044102
D12.776.543.750.100.430.750;Receptor, Melanocortin, Type 2;D044103
D12.776.543.750.720.600.285.500.750;Receptor, Melanocortin, Type 2;D044103
D12.776.543.750.750.555.285.500.750;Receptor, Melanocortin, Type 2;D044103
D12.776.543.750.750.660.285.500.750;Receptor, Melanocortin, Type 2;D044103
D12.776.543.750.100.430.875;Receptor, Melanocortin, Type 3;D044104
D12.776.543.750.720.600.285.500.875;Receptor, Melanocortin, Type 3;D044104
D12.776.543.750.750.555.285.500.875;Receptor, Melanocortin, Type 3;D044104
D12.776.543.750.750.660.285.500.875;Receptor, Melanocortin, Type 3;D044104
D12.776.543.750.100.430.937;Receptor, Melanocortin, Type 4;D044105
D12.776.543.750.720.600.285.500.937;Receptor, Melanocortin, Type 4;D044105
D12.776.543.750.750.555.285.500.937;Receptor, Melanocortin, Type 4;D044105
D12.776.543.750.750.660.285.500.937;Receptor, Melanocortin, Type 4;D044105
B03.440.450.425.887;Wigglesworthia;D044106
B03.660.250.150.880;Wigglesworthia;D044106
D12.776.543.750.100.440.500;Receptor, Melatonin, MT1;D044122
D12.776.543.750.100.440.750;Receptor, Melatonin, MT2;D044123
B03.440.450.425.900.650;Yersinia ruckeri;D044124
B03.660.250.150.950.650;Yersinia ruckeri;D044124
B03.440.400.425.297;Coxiellaceae;D044125
B03.660.250.132;Coxiellaceae;D044125
G05.355.315.203;Epigenesis, Genetic;D044127
B03.440.400.425.450.450.400;Legionella longbeachae;D044128
B03.660.250.460.460.480;Legionella longbeachae;D044128
B03.440.400.425.377;Halomonadaceae;D044129
B03.660.250.350;Halomonadaceae;D044129
B03.440.595;Oceanospirillaceae;D044130
B03.660.250.540;Oceanospirillaceae;D044130
B03.440.450.009.200;Actinobacillus equuli;D044131
B03.660.250.550.050.200;Actinobacillus equuli;D044131
B03.440.450.009.700;Actinobacillus suis;D044132
B03.660.250.550.050.700;Actinobacillus suis;D044132
B03.440.450.009.675;Actinobacillus seminis;D044133
B03.660.250.550.050.675;Actinobacillus seminis;D044133
B03.440.450.600.450.665;Haemophilus paragallinarum;D044134
B03.660.250.550.290.665;Haemophilus paragallinarum;D044134
B03.440.450.600.450.675;Haemophilus parainfluenzae;D044135
B03.660.250.550.290.675;Haemophilus parainfluenzae;D044135
B03.440.450.600.450.690;Haemophilus paraphrophilus;D044136
B03.660.250.550.290.690;Haemophilus paraphrophilus;D044136
B03.440.450.600.450.700;Haemophilus parasuis;D044137
B03.660.250.550.290.700;Haemophilus parasuis;D044137
B03.440.450.600.450.750;Haemophilus somnus;D044138
B03.660.250.550.290.750;Haemophilus somnus;D044138
D12.776.543.750.100.047.687;Receptor, Angiotensin, Type 2;D044139
D12.776.543.750.720.600.150.687;Receptor, Angiotensin, Type 2;D044139
D12.776.543.750.750.130.875;Receptor, Angiotensin, Type 2;D044139
D12.776.543.750.750.555.150.875;Receptor, Angiotensin, Type 2;D044139
D12.776.543.750.100.047.625;Receptor, Angiotensin, Type 1;D044140
D12.776.543.750.720.600.150.625;Receptor, Angiotensin, Type 1;D044140
D12.776.543.750.750.130.750;Receptor, Angiotensin, Type 1;D044140
D12.776.543.750.750.555.150.750;Receptor, Angiotensin, Type 1;D044140
B03.440.450.600.600.650;Pasteurella pneumotropica;D044142
B03.660.250.550.590.650;Pasteurella pneumotropica;D044142
B03.440.612;Piscirickettsiaceae;D044147
B03.660.250.565;Piscirickettsiaceae;D044147
C15.604.451;Lymphatic Abnormalities;D044148
C16.131.482;Lymphatic Abnormalities;D044148
B03.440.450.900.859.030;Vibrio alginolyticus;D044149
B03.660.250.830.830.030;Vibrio alginolyticus;D044149
D06.472.699.591;Parathyroid Hormone-Related Protein;D044162
D12.644.276.908;Parathyroid Hormone-Related Protein;D044162
D12.644.548.588;Parathyroid Hormone-Related Protein;D044162
D12.776.467.890;Parathyroid Hormone-Related Protein;D044162
D23.529.890;Parathyroid Hormone-Related Protein;D044162
B03.440.450.900.859.225.075;Vibrio cholerae non-O1;D044163
B03.660.250.830.830.100.075;Vibrio cholerae non-O1;D044163
B03.440.450.900.859.500;Vibrio mimicus;D044164
B03.660.250.830.830.500;Vibrio mimicus;D044164
B03.440.450.900.050.930;Aliivibrio salmonicida;D044165
B03.660.250.830.050.930;Aliivibrio salmonicida;D044165
B03.440.400.425.967;Xanthomonadaceae;D044166
B03.660.250.915;Xanthomonadaceae;D044166
B03.440.400.425.967.950;Xylella;D044167
B03.660.250.915.950;Xylella;D044167
D12.776.543.750.100.650.100;Receptor, Parathyroid Hormone, Type 1;D044168
D12.776.543.750.750.600.100;Receptor, Parathyroid Hormone, Type 1;D044168
D12.776.543.750.100.115;Receptors, Calcium-Sensing;D044169
D03.132.098;Benzylisoquinolines;D044182
D03.438.531.085;Benzylisoquinolines;D044182
D12.776.543.750.100.650.200;Receptor, Parathyroid Hormone, Type 2;D044183
D12.776.543.750.750.600.200;Receptor, Parathyroid Hormone, Type 2;D044183
B03.440.400.425.967.930.850;Xanthomonas vesicatoria;D044184
B03.660.250.915.930.850;Xanthomonas vesicatoria;D044184
B03.440.400.425.625.625.120;Pseudomonas alcaligenes;D044202
B03.660.250.580.590.070;Pseudomonas alcaligenes;D044202
B03.440.400.425.625.625.500;Pseudomonas mendocina;D044203
B03.660.250.580.590.500;Pseudomonas mendocina;D044203
B03.440.400.425.625.625.650;Pseudomonas oleovorans;D044204
B03.660.250.580.590.570;Pseudomonas oleovorans;D044204
B03.440.400.425.625.625.662;Pseudomonas pseudoalcaligenes;D044205
B03.660.250.580.590.575;Pseudomonas pseudoalcaligenes;D044205
B03.440.400.425.625.625.350;Pseudomonas fragi;D044206
B03.660.250.580.590.230;Pseudomonas fragi;D044206
B03.440.400.425.395;Halothiobacillus;D044222
B03.660.250.110.400;Halothiobacillus;D044222
B03.440.400.425.625.625.750;Pseudomonas stutzeri;D044223
B03.660.250.580.590.750;Pseudomonas stutzeri;D044223
B03.440.400.425.625.625.770;Pseudomonas syringae;D044224
B03.660.250.580.590.770;Pseudomonas syringae;D044224
C01.252.400.719;Piscirickettsiaceae Infections;D044225
D10.251.355.920;Trans Fatty Acids;D044242
D10.251.355.343.500.750;Linoleic Acids, Conjugated;D044243
D12.776.543.750.075.700.800;Receptors, Thromboxane A2, Prostaglandin H2;D044244
D12.776.543.750.075.800.500;Receptors, Thromboxane A2, Prostaglandin H2;D044244
D12.776.543.750.100.200.700.800;Receptors, Thromboxane A2, Prostaglandin H2;D044244
D12.776.543.750.100.200.800.500;Receptors, Thromboxane A2, Prostaglandin H2;D044244
D02.737.637.650.500;Prostaglandin H2;D044262
D10.251.355.255.100.637.025.650.500;Prostaglandin H2;D044262
D10.251.355.255.550.025.650.500;Prostaglandin H2;D044262
D23.469.050.175.725.720.720.500;Prostaglandin H2;D044262
D12.776.543.750.070.800.100;Receptors, Serotonin, 5-HT1;D044263
D12.776.543.750.100.800.100;Receptors, Serotonin, 5-HT1;D044263
D12.776.543.750.720.300.800.100;Receptors, Serotonin, 5-HT1;D044263
D12.776.543.750.070.800.100.100;Receptor, Serotonin, 5-HT1A;D044282
D12.776.543.750.100.800.100.100;Receptor, Serotonin, 5-HT1A;D044282
D12.776.543.750.720.300.800.100.100;Receptor, Serotonin, 5-HT1A;D044282
D12.776.543.750.070.800.100.150;Receptor, Serotonin, 5-HT1B;D044302
D12.776.543.750.100.800.100.150;Receptor, Serotonin, 5-HT1B;D044302
D12.776.543.750.720.300.800.100.150;Receptor, Serotonin, 5-HT1B;D044302
D12.776.543.750.720.670.100.500;Receptor, Serotonin, 5-HT1B;D044302
C18.654.521;Malnutrition;D044342
C18.654.726;Overnutrition;D044343
D08.811.277.352.660;Phosphoric Triester Hydrolases;D044345
D12.776.543.750.070.800.100.200;Receptor, Serotonin, 5-HT1D;D044346
D12.776.543.750.100.800.100.200;Receptor, Serotonin, 5-HT1D;D044346
D12.776.543.750.720.300.800.100.200;Receptor, Serotonin, 5-HT1D;D044346
D12.776.543.750.720.670.100.750;Receptor, Serotonin, 5-HT1D;D044346
F04.096.837;Sexology;D044347
D12.776.543.750.070.800.200;Receptors, Serotonin, 5-HT2;D044348
D12.776.543.750.100.800.200;Receptors, Serotonin, 5-HT2;D044348
D12.776.543.750.720.300.800.200;Receptors, Serotonin, 5-HT2;D044348
Z01.678;Oceania;D044349
Z01.678.100;Australasia;D044362
E02.875.194.540;Contraception, Postcoital;D044363
E05.927.852;Vaginal Douching;D044364
D08.811.277.040.330.300.200.100.100;GTP-Binding Protein alpha Subunits, G12-G13;D044365
D12.644.360.375.100.100;GTP-Binding Protein alpha Subunits, G12-G13;D044365
D12.776.157.325.332.100.100;GTP-Binding Protein alpha Subunits, G12-G13;D044365
D12.776.476.375.100.100;GTP-Binding Protein alpha Subunits, G12-G13;D044365
D12.776.543.325.100.100;GTP-Binding Protein alpha Subunits, G12-G13;D044365
G01.906.595.850;Transition Temperature;D044366
G01.595.680;Phase Transition;D044367
G02.149.767.680;Phase Transition;D044367
G02.842.750.680;Phase Transition;D044367
M01.686;Population Groups;D044382
N01.224.708;Population Groups;D044382
M01.686.508.100;African Continental Ancestry Group;D044383
E01.370.378.530.775;Ovulation Prediction;D044384
E02.875.745;Ovulation Prediction;D044384
E05.820.745;Ovulation Prediction;D044384
D08.811.277.040.330.300.200.100;GTP-Binding Protein alpha Subunits;D044385
D12.644.360.375.100;GTP-Binding Protein alpha Subunits;D044385
D12.776.157.325.332.100;GTP-Binding Protein alpha Subunits;D044385
D12.776.476.375.100;GTP-Binding Protein alpha Subunits;D044385
D12.776.543.325.100;GTP-Binding Protein alpha Subunits;D044385
D12.644.360.375.520;GTP-Binding Protein beta Subunits;D044387
D12.776.157.325.332.520;GTP-Binding Protein beta Subunits;D044387
D12.776.476.375.520;GTP-Binding Protein beta Subunits;D044387
D12.776.543.325.450;GTP-Binding Protein beta Subunits;D044387
D12.644.360.375.730;GTP-Binding Protein gamma Subunits;D044388
D12.776.157.325.332.730;GTP-Binding Protein gamma Subunits;D044388
D12.776.476.375.730;GTP-Binding Protein gamma Subunits;D044388
D12.776.543.325.625;GTP-Binding Protein gamma Subunits;D044388
D12.776.543.750.070.800.200.100;Receptor, Serotonin, 5-HT2A;D044402
D12.776.543.750.100.800.200.100;Receptor, Serotonin, 5-HT2A;D044402
D12.776.543.750.720.300.800.200.100;Receptor, Serotonin, 5-HT2A;D044402
D12.776.543.750.070.800.200.150;Receptor, Serotonin, 5-HT2B;D044403
D12.776.543.750.100.800.200.150;Receptor, Serotonin, 5-HT2B;D044403
D12.776.543.750.720.300.800.200.150;Receptor, Serotonin, 5-HT2B;D044403
G02.111.570.080.708.330.330;Genomic Islands;D044404
G05.360.080.708.330.330;Genomic Islands;D044404
G05.360.340.024.425.500;Genomic Islands;D044404
D12.776.543.750.070.800.200.575;Receptor, Serotonin, 5-HT2C;D044405
D12.776.543.750.100.800.200.200;Receptor, Serotonin, 5-HT2C;D044405
D12.776.543.750.720.300.800.200.200;Receptor, Serotonin, 5-HT2C;D044405
D12.776.157.530.400.400.100.700;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.550.425.500.100.700;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.585.400.500.100.700;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.750.051.750;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.750.070.800.300;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.750.720.300.800.300;Receptors, Serotonin, 5-HT3;D044406
D12.776.543.750.070.800.400;Receptors, Serotonin, 5-HT4;D044422
D12.776.543.750.100.800.400;Receptors, Serotonin, 5-HT4;D044422
D12.776.543.750.720.300.800.400;Receptors, Serotonin, 5-HT4;D044422
B01.750.600.425;Kelp;D044423
B05.080.750.450;Kelp;D044423
B01.650.232.200;Cyanophora;D044424
B01.650.940.800.150.150.575;Nitella;D044443
B01.650.940.150.800;Scenedesmus;D044444
B01.650.940.150.900;Ulva;D044445
B01.650.940.150.950;Volvox;D044446
D12.776.543.750.792;Receptors, Proteinase-Activated;D044462
D12.776.395.550.625.800.790;Receptor, PAR-1;D044463
D12.776.543.550.625.800.790;Receptor, PAR-1;D044463
D12.776.543.750.100.875.500;Receptor, PAR-1;D044463
D12.776.543.750.750.850.399;Receptor, PAR-1;D044463
D12.776.543.750.792.500.500;Receptor, PAR-1;D044463
D12.776.543.750.100.035;Receptor, PAR-2;D044464
D12.776.543.750.792.249;Receptor, PAR-2;D044464
M01.686.508.400;European Continental Ancestry Group;D044465
M01.686.508.200;Asian Continental Ancestry Group;D044466
M01.686.508.150;American Native Continental Ancestry Group;D044467
M01.686.508.600;Oceanic Ancestry Group;D044468
M01.686.508;Continental Population Groups;D044469
D02.065.064.294;Benzeneacetamides;D044482
D02.455.426.559.389.048;Benzeneacetamides;D044482
C06.405.469.578;Intestinal Polyposis;D044483
D08.811.074.249.750;Thymine DNA Glycosylase;D044502
D08.811.277.450.430.099.750;Thymine DNA Glycosylase;D044502
D03.383.742.698.421.500;5-Methylcytosine;D044503
C06.405.205.596.750;Enterocolitis, Neutropenic;D044504
C06.405.469.363.750;Enterocolitis, Neutropenic;D044504
B01.650.940.800.150.150;Characeae;D044522
B01.750.150;Chrysophyta;D044523
C05.660.207.525;LEOPARD Syndrome;D044542
C14.240.400.695;LEOPARD Syndrome;D044542
C14.280.400.695;LEOPARD Syndrome;D044542
C14.280.484.716.525;LEOPARD Syndrome;D044542
C16.131.077.525;LEOPARD Syndrome;D044542
C16.131.240.400.685;LEOPARD Syndrome;D044542
C16.131.621.207.525;LEOPARD Syndrome;D044542
C17.800.621.430.530.550.525;LEOPARD Syndrome;D044542
D08.811.797.750;RNA, Ribosomal, Self-Splicing;D044563
D08.811.913.696.445.735.917;RNA, Ribosomal, Self-Splicing;D044563
D13.444.735.686.845;RNA, Ribosomal, Self-Splicing;D044563
E07.230.220.707;Neuroendoscopes;D044582
E07.858.240.707;Neuroendoscopes;D044582
E01.370.376.525;Neuroendoscopy;D044583
E01.370.388.250.700;Neuroendoscopy;D044583
E04.525.562;Neuroendoscopy;D044583
E04.800.250.700;Neuroendoscopy;D044583
C04.557.470.200.025.232;Carcinoma, Ductal;D044584
C04.557.470.615.132;Carcinoma, Ductal;D044584
D08.811.277.450.420.200;Cellulases;D044602
A11.284.180.120;Cellulosomes;D044603
A14.549.167.900.255.500;Dental Pellicle;D044622
E02.642;Nutrition Therapy;D044623
D08.811.277.450.420.200.550;Glucan 1,4-beta-Glucosidase;D044643
D08.811.277.450.420.200.450;Endo-1,3(4)-beta-Glucanase;D044644
B01.750.600.212;Fucus;D044645
B01.750.600.040;Ascophyllum;D044646
B01.750.600.725;Sargassum;D044647
B01.750.600.800;Undaria;D044648
B01.750.600.480;Macrocystis;D044662
B01.750.150.600;Ochromonas;D044663
B01.650.700.600;Porphyra;D044664
B01.650.700.610;Porphyridium;D044665
A03.556.124.526.356.333;Colon, Ascending;D044682
A03.556.249.249.356.333;Colon, Ascending;D044682
A03.556.124.526.356.500;Colon, Descending;D044683
A03.556.249.249.356.500;Colon, Descending;D044683
A03.556.124.526.356.834;Colon, Transverse;D044684
A03.556.249.249.356.834;Colon, Transverse;D044684
G09.772.770;Respiratory Physiological Processes;D044703
D13.444.308.130;DNA, A-Form;D044704
G02.111.570.790.486.128;DNA, A-Form;D044704
G05.360.580.114;DNA, A-Form;D044704
D13.444.308.227;DNA, C-Form;D044705
G02.111.570.790.486.156;DNA, C-Form;D044705
G05.360.580.128;DNA, C-Form;D044705
I01.198.780;Forensic Sciences;D044707
D13.444.308.291;DNA, Concatenated;D044708
G02.111.570.790.486.268;DNA, Concatenated;D044708
G05.360.580.212;DNA, Concatenated;D044708
I01.198.780.760;Forensic Ballistics;D044709
B01.650.700.500;Laurencia;D044722
B01.650.700.150;Chondrus;D044723
B01.650.700.325;Gracilaria;D044724
B01.650.700.585;Plocamium;D044725
B01.750.937.500;Lagenidium;D044726
B01.750.937.710;Peronospora;D044742
B01.750.937.050;Achlya;D044743
B01.750.937.075;Aphanomyces;D044744
B01.750.937.825;Saprolegnia;D044762
D08.811.464.938.500;Ubiquitin-Conjugating Enzymes;D044763
D08.811.464.938.249;Ubiquitin-Activating Enzymes;D044764
D08.811.464.938.750;Ubiquitin-Protein Ligases;D044767
G02.111.570.060.040.500;F-Box Motifs;D044782
G02.111.570.790.709.600.040.205;F-Box Motifs;D044782
D12.776.157.169;F-Box Proteins;D044783
B01.650.940.800.150.150.150;Chara;D044784
B01.206;Cryptophyta;D044785
D12.776.157.743;S-Phase Kinase-Associated Proteins;D044786
B01.268.250.320.500;Euglena longa;D044802
G16.500.275.157.049;Biodiversity;D044822
N06.230.124.049;Biodiversity;D044822
D08.811.464.938.750.750.500;Cullin Proteins;D044842
D12.776.167.175;Cullin Proteins;D044842
D08.811.464.938.750.750;SKP Cullin F-Box Protein Ligases;D044843
D12.776.157.169.500;beta-Transducin Repeat-Containing Proteins;D044844
B03.440.180.375;Campylobacter hyointestinalis;D044862
B03.660.150.100.297;Campylobacter hyointestinalis;D044862
B03.440.180.500;Campylobacter lari;D044863
B03.660.150.100.450;Campylobacter lari;D044863
C18.452.394;Glucose Metabolism Disorders;D044882
B03.440.180.650;Campylobacter rectus;D044883
B03.660.150.100.700;Campylobacter rectus;D044883
B03.440.180.700;Campylobacter sputorum;D044884
B03.660.150.100.740;Campylobacter sputorum;D044884
B03.440.180.800;Campylobacter upsaliensis;D044885
B03.660.150.100.850;Campylobacter upsaliensis;D044885
D08.811.277.450.625.750;beta-Mannosidase;D044902
C06.689.150;Congenital Hyperinsulinism;D044903
C16.614.200;Congenital Hyperinsulinism;D044903
C18.452.394.968.250;Congenital Hyperinsulinism;D044903
C18.452.394.984.200;Congenital Hyperinsulinism;D044903
C16.320.565.202.607;Mannosidase Deficiency Diseases;D044904
C16.320.565.595.577;Mannosidase Deficiency Diseases;D044904
C18.452.648.202.607;Mannosidase Deficiency Diseases;D044904
C18.452.648.595.577;Mannosidase Deficiency Diseases;D044904
C16.320.565.202.607.750;beta-Mannosidosis;D044905
C16.320.565.595.577.750;beta-Mannosidosis;D044905
C18.452.648.202.607.750;beta-Mannosidosis;D044905
C18.452.648.595.577.750;beta-Mannosidosis;D044905
B03.440.500.250;Helicobacter felis;D044922
B03.660.150.280.350;Helicobacter felis;D044922
B03.440.500.362;Helicobacter hepaticus;D044923
B03.660.150.280.410;Helicobacter hepaticus;D044923
D08.811.682.660;Oxidoreductases Acting on CH-CH Group Donors;D044925
D08.811.682.660.150.300;Butyryl-CoA Dehydrogenase;D044926
D12.776.331.174;Butyryl-CoA Dehydrogenase;D044926
D08.811.600.250.500;Electron-Transferring Flavoproteins;D044927
D12.776.331.199;Electron-Transferring Flavoproteins;D044927
D12.776.543.277.500;Electron-Transferring Flavoproteins;D044927
D08.811.682.660.150.150;Acyl-CoA Dehydrogenase, Long-Chain;D044942
D12.776.331.102;Acyl-CoA Dehydrogenase, Long-Chain;D044942
D08.811.682.690.708.392;Fatty Acid Desaturases;D044943
D08.811.682.660.150;Acyl-CoA Dehydrogenases;D044944
D03.438.150.266.450.700;Proanthocyanidins;D044945
D03.830.219.266.450.700;Proanthocyanidins;D044945
D05.750.078.937.429;Proanthocyanidins;D044945
D03.438.150.266.450.190;Biflavonoids;D044946
D03.830.219.266.450.190;Biflavonoids;D044946
D02.455.426.559.389.140.450.388;Flavonolignans;D044947
D03.438.150.266.450.268;Flavonolignans;D044947
D03.830.219.266.450.268;Flavonolignans;D044947
D03.438.150.266.450.284;Flavonols;D044948
D03.830.219.266.450.284;Flavonols;D044948
D03.438.150.266.450.284.388;Kaempferols;D044949
D03.830.219.266.450.284.388;Kaempferols;D044949
D03.438.150.266.450.252;Flavanones;D044950
D03.830.219.266.450.252;Flavanones;D044950
L01.224.308.189;Data Compression;D044962
L01.224.800.500;Data Compression;D044962
L01.470.500;Data Compression;D044962
E01.370.225.500.384.100.119.500;Biopsy, Fine-Needle;D044963
E01.370.225.998.054.119.500;Biopsy, Fine-Needle;D044963
E01.370.388.100.100.500;Biopsy, Fine-Needle;D044963
E04.074.119.500;Biopsy, Fine-Needle;D044963
E04.665.100.500;Biopsy, Fine-Needle;D044963
E05.200.500.384.100.119.500;Biopsy, Fine-Needle;D044963
E05.200.998.054.119.500;Biopsy, Fine-Needle;D044963
E05.242.384.100.119.500;Biopsy, Fine-Needle;D044963
E04.680.152;Cervicoplasty;D044964
D27.505.954.122.388.077;Anti-Retroviral Agents;D044966
A12.207.152.846;Serum;D044967
A15.145.846;Serum;D044967
H02.403.750;Regenerative Medicine;D044968
B01.050.500.131.617.289.275.612;Ochlerotatus;D044969
D08.811.682.047.436.350.100;3-alpha-Hydroxysteroid Dehydrogenase (B-Specific);D045002
D08.811.682.047.551;Lactate Dehydrogenases;D045022
A08.186.211.132.659.822.575;Pedunculopontine Tegmental Nucleus;D045042
A08.186.211.653.822.575;Pedunculopontine Tegmental Nucleus;D045042
D08.811.277.151.418;Methenyltetrahydrofolate Cyclohydrolase;D045064
D08.811.682.662.217;Methylenetetrahydrofolate Dehydrogenase (NAD+);D045102
D08.811.682.550;5,10-Methylenetetrahydrofolate Reductase (FADH2);D045103
G09.188.124;Blood Physiological Processes;D045123
G09.330.190;Cardiovascular Physiological Processes;D045125
G12.425.260;Cross-Priming;D045142
G12.425.747.150;Cross-Priming;D045142
G12.450.050.400.545.150;Cross-Priming;D045142
D02.886.675.933;Thiazolidinediones;D045162
D03.383.129.708.933;Thiazolidinediones;D045162
D12.776.124.486.485.114.248;Antibodies, Phospho-Specific;D045163
D12.776.124.790.651.114.248;Antibodies, Phospho-Specific;D045163
D12.776.377.715.548.114.248;Antibodies, Phospho-Specific;D045163
E04.936.225.687.625;Mesenchymal Stem Cell Transplantation;D045164
D06.472.334.851.968;Testosterone Congeners;D045165
D06.472.334.851.437;Estradiol Congeners;D045166
D06.472.334.851.687;Progesterone Congeners;D045167
C02.782.600.550.200.750;Severe Acute Respiratory Syndrome;D045169
C08.730.730;Severe Acute Respiratory Syndrome;D045169
G02.111.570.080.534;Matrix Attachment Regions;D045170
G05.360.080.534;Matrix Attachment Regions;D045170
B03.370;Fusobacteria;D045182
B03.370.437;Leptotrichia;D045183
B03.440.425.410.535;Leptotrichia;D045183
B03.370.600;Propionigenium;D045184
B03.440.425.410.600;Propionigenium;D045184
B03.140.094.625.350;Porphyromonas endodontalis;D045202
B03.440.425.410.194.625.350;Porphyromonas endodontalis;D045202
D08.811.600.250;Electron Transport Chain Complex Proteins;D045222
D12.776.543.277;Electron Transport Chain Complex Proteins;D045222
B03.140.094.640.550;Prevotella nigrescens;D045242
B03.440.425.410.194.640.550;Prevotella nigrescens;D045242
B03.140.094.640.700;Prevotella ruminicola;D045243
B03.440.425.410.194.640.700;Prevotella ruminicola;D045243
B03.140.750;Rhodothermus;D045245
B03.440.400.425.710;Rhodothermus;D045245
B03.140.190.600;Ornithobacterium;D045246
B03.440.400.425.310.600;Ornithobacterium;D045246
B03.440.602;Ornithobacterium;D045246
B03.140.190.120;Chryseobacterium;D045247
B03.440.400.425.310.120;Chryseobacterium;D045247
B03.140.130.200;Flexibacter;D045248
B03.440.400.425.300.200;Flexibacter;D045248
B03.140.800;Sphingobacterium;D045249
B03.440.400.425.745;Sphingobacterium;D045249
C23.888.760;Reticulocytosis;D045262
G09.188.760;Reticulocytosis;D045262
D08.244.175.500;Cytochromes a1;D045263
D12.776.422.220.175.500;Cytochromes a1;D045263
D08.244.175.249;Cytochromes a;D045264
D12.776.422.220.175.249;Cytochromes a;D045264
D06.472.699.584;Natriuretic Peptides;D045265
D12.644.548.585;Natriuretic Peptides;D045265
D08.244.175.600;Cytochromes a3;D045266
D12.776.422.220.175.600;Cytochromes a3;D045266
E07.230.380;Flowmeters;D045268
B03.440.425.410.200;Bilophila;D045282
B03.660.125.087;Bilophila;D045282
D27.505.696.560;Natriuretic Agents;D045283
D27.505.954.411.455;Natriuretic Agents;D045283
B03.440.425.410.350.040;Desulfovibrio africanus;D045284
B03.660.125.125.040;Desulfovibrio africanus;D045284
B03.900.350.040;Desulfovibrio africanus;D045284
B03.440.425.410.350.150;Desulfovibrio desulfuricans;D045285
B03.660.125.125.150;Desulfovibrio desulfuricans;D045285
B03.900.350.150;Desulfovibrio desulfuricans;D045285
B03.440.425.410.350.350;Desulfovibrio gigas;D045286
B03.660.125.125.350;Desulfovibrio gigas;D045286
B03.900.350.350;Desulfovibrio gigas;D045286
B03.440.425.410.360;Desulfuromonas;D045287
B03.660.125.150;Desulfuromonas;D045287
B03.900.370;Desulfuromonas;D045287
B03.440.425.410.430;Geobacter;D045302
B03.660.125.305;Geobacter;D045302
D08.244.187.249;Cytochromes b;D045303
D12.776.422.220.187.249;Cytochromes b;D045303
D08.244.286.100;Cytochromes c;D045304
D12.776.422.220.286.100;Cytochromes c;D045304
D08.244.286.150;Cytochromes c';D045305
D12.776.422.220.286.150;Cytochromes c';D045305
D05.500.562.488;Photosynthetic Reaction Center Complex Proteins;D045322
D08.811.600.710;Photosynthetic Reaction Center Complex Proteins;D045322
D12.776.183.750.750;Photosynthetic Reaction Center Complex Proteins;D045322
D12.776.543.983.500;Photosynthetic Reaction Center Complex Proteins;D045322
D12.776.765.199.750.750;Photosynthetic Reaction Center Complex Proteins;D045322
A11.251.210.190.380;HCT116 Cells;D045325
A11.251.860.180.380;HCT116 Cells;D045325
D05.500.562.488.500;Photosystem I Protein Complex;D045331
D08.811.600.710.500;Photosystem I Protein Complex;D045331
D12.776.157.530.450.250.875.492;Photosystem I Protein Complex;D045331
D12.776.183.750.750.500;Photosystem I Protein Complex;D045331
D12.776.543.585.450.250.875.492;Photosystem I Protein Complex;D045331
D12.776.543.983.500.500;Photosystem I Protein Complex;D045331
D12.776.765.199.750.750.500;Photosystem I Protein Complex;D045331
D05.500.562.488.750;Photosystem II Protein Complex;D045332
D08.811.600.710.750;Photosystem II Protein Complex;D045332
D12.776.183.750.750.750;Photosystem II Protein Complex;D045332
D12.776.543.983.500.750;Photosystem II Protein Complex;D045332
D12.776.765.199.750.750.750;Photosystem II Protein Complex;D045332
D12.644.641.548;Nanotubes, Peptide;D045333
J01.637.512.850.750;Nanotubes, Peptide;D045333
D05.500.562.488.490;Light-Harvesting Protein Complexes;D045342
D08.811.600.710.490;Light-Harvesting Protein Complexes;D045342
D12.776.183.750.750.490;Light-Harvesting Protein Complexes;D045342
D12.776.543.983.500.490;Light-Harvesting Protein Complexes;D045342
D12.776.765.199.750.750.490;Light-Harvesting Protein Complexes;D045342
D05.500.562.488.374;Cytochrome b6f Complex;D045346
D08.811.600.710.374;Cytochrome b6f Complex;D045346
D12.776.183.750.750.374;Cytochrome b6f Complex;D045346
D12.776.543.585.450.250.875.311;Cytochrome b6f Complex;D045346
D12.776.543.983.500.374;Cytochrome b6f Complex;D045346
D12.776.765.199.750.750.374;Cytochrome b6f Complex;D045346
D05.500.562.488.374.500;Cytochromes b6;D045347
D08.244.187.600;Cytochromes b6;D045347
D08.811.600.710.374.500;Cytochromes b6;D045347
D12.776.183.750.750.374.500;Cytochromes b6;D045347
D12.776.422.220.187.501;Cytochromes b6;D045347
D12.776.543.585.450.250.875.311.500;Cytochromes b6;D045347
D12.776.543.983.500.374.500;Cytochromes b6;D045347
D12.776.765.199.750.750.374.500;Cytochromes b6;D045347
D05.500.562.488.374.750;Cytochromes f;D045348
D08.244.726;Cytochromes f;D045348
D08.811.600.710.374.750;Cytochromes f;D045348
D12.776.183.750.750.374.750;Cytochromes f;D045348
D12.776.422.220.726;Cytochromes f;D045348
D12.776.543.585.450.250.875.311.750;Cytochromes f;D045348
D12.776.543.983.500.374.750;Cytochromes f;D045348
D12.776.765.199.750.750.374.750;Cytochromes f;D045348
D08.244.286.300;Cytochromes c2;D045362
D12.776.422.220.286.300;Cytochromes c2;D045362
B01.300.107.730.650;Pneumocystis carinii;D045363
D08.244.286.600;Cytochromes c6;D045365
D12.776.422.220.286.600;Cytochromes c6;D045365
B01.300.107.730.700;Pneumocystis jirovecii;D045382
D12.776.124.790.720.100.500;Pregnancy-Associated alpha 2-Macroglobulins;D045384
D12.776.780.675;Pregnancy-Associated alpha 2-Macroglobulins;D045384
B04.820.455.600.650.750.800;Simian virus 5;D045402
B04.909.777.455.600.650.750.800;Simian virus 5;D045402
B04.820.455.600.650.400;Henipavirus;D045403
B04.909.777.455.600.650.400;Henipavirus;D045403
B04.820.455.600.650.400.400;Hendra Virus;D045404
B04.909.777.455.600.650.400.400;Hendra Virus;D045404
B04.820.455.600.650.400.550;Nipah Virus;D045405
B04.909.777.455.600.650.400.550;Nipah Virus;D045405
E02.041.625.790.259;Continuous Positive Airway Pressure;D045422
E02.880.820.790.259;Continuous Positive Airway Pressure;D045422
E07.553;Microbubbles;D045423
D20;Complex Mixtures;D045424
E05.017.449;Rotarod Performance Test;D045442
D27.505.954.411.918.500;Endothelium-Dependent Relaxing Factors;D045462
C02.782.580.600.080;Avulavirus Infections;D045463
C02.782.580.600.400;Henipavirus Infections;D045464
B01.650.940.800.575.100.270;Corsiaceae;D045465
B01.650.940.800.575.100.318;Dilleniaceae;D045466
B01.650.940.800.575.100.339;Elaeocarpaceae;D045467
B01.650.940.800.575.100.825.437.500;Polygonum cuspidatum;D045468
B01.650.940.800.575.100.842.110;Chrysobalanaceae;D045469
B01.650.940.800.575.100.850.876;Rubia;D045470
B01.650.940.800.575.100.875.077;Aegle;D045471
B04.820.504.540.150.750;SARS Virus;D045473
B04.909.777.500.540.150.750;SARS Virus;D045473
G01.311.355.750.500;Hot Springs;D045482
G01.311.750;Rivers;D045483
G16.500.275.280.650;Rivers;D045483
N06.230.232.650;Rivers;D045483
B03.440.500.450;Helicobacter mustelae;D045502
B03.660.150.280.480;Helicobacter mustelae;D045502
B03.440.090.100.080;Bartonella bacilliformis;D045503
B03.660.050.030.040.080;Bartonella bacilliformis;D045503
D27.505.519;Molecular Mechanisms of Pharmacological Action;D045504
D27.505.696;Physiological Effects of Drugs;D045505
D27.505.954;Therapeutic Uses;D045506
D08.811.739;Recombinases;D045522
A11.284.149.165.695;Phycobilisomes;D045524
D05.500.562.488.490.500;Phycobilisomes;D045524
D08.811.600.710.490.500;Phycobilisomes;D045524
D03.438.810.835.661;PQQ Cofactor;D045542
D08.211.682;PQQ Cofactor;D045542
D02.806.400;Indolequinones;D045563
D03.438.473.412;Indolequinones;D045563
D08.811.739.800;Transposon Resolvases;D045564
D08.811.913.696.445.837;Transposon Resolvases;D045564
D08.811.277.352.335.350.400;Holliday Junction Resolvases;D045565
D08.811.277.352.355.325.400;Holliday Junction Resolvases;D045565
D08.811.739.250;Holliday Junction Resolvases;D045565
D13.444.308.295;DNA, Cruciform;D045566
G02.111.570.790.486.325;DNA, Cruciform;D045566
G05.360.580.325;DNA, Cruciform;D045566
D08.811.739.900;VDJ Recombinases;D045567
D08.811.913.696.445.950;VDJ Recombinases;D045567
D02.389.338.912;Tetraoxanes;D045568
D02.737.912;Tetraoxanes;D045568
B03.440.860.074.575;Phytoplasma;D045582
G04.299.125.180;Chromosome Positioning;D045584
D08.811.277.352.355.325.350;Flap Endonucleases;D045585
A11.284.420.400;Intranuclear Inclusion Bodies;D045586
C06.405.469.637.887;Steatorrhea;D045602
C18.452.603.887;Steatorrhea;D045602
B01.650.940.800.575.100.321;Dioncophyllaceae;D045603
A11.284.295.260;Extracellular Fluid;D045604
A12.207.270;Extracellular Fluid;D045604
B03.440.860.300.250;Entomoplasmataceae;D045622
B03.440.860.580.553.553.210;Mycoplasma capricolum;D045623
B03.440.860.300.750.625.500;Spiroplasma citri;D045642
D08.811.074;DNA Repair Enzymes;D045643
B03.440.860.580.553.553.050;Mycoplasma agalactiae;D045644
B03.440.860.580.553.553.075;Mycoplasma arthritidis;D045645
B03.440.860.580.553.553.195;Mycoplasma bovigenitalium;D045646
D08.811.074.249;DNA Glycosylases;D045647
D08.811.277.450.430.099;DNA Glycosylases;D045647
E06.931.475;Dental Etching;D045662
E07.595.650;Quantum Dots;D045663
J01.637.512.600.650;Quantum Dots;D045663
D08.811.277.656.300.760.640;Proprotein Convertase 1;D045664
D08.811.277.656.837.500;Proprotein Convertase 1;D045664
D08.811.277.656.959.350.640;Proprotein Convertase 1;D045664
B03.440.860.580.553.553.200;Mycoplasma bovis;D045682
D08.811.277.656.300.760.353;Furin;D045683
D08.811.277.656.837.249;Furin;D045683
D08.811.277.656.959.350.353;Furin;D045683
B03.440.860.580.553.553.220;Mycoplasma conjunctivae;D045684
B03.440.860.580.553.553.267;Mycoplasma dispar;D045685
B03.440.860.580.553.553.345;Mycoplasma gallisepticum;D045686
D08.811.277.656.300.760.648;Proprotein Convertase 5;D045702
D08.811.277.656.837.625;Proprotein Convertase 5;D045702
D08.811.277.656.959.350.648;Proprotein Convertase 5;D045702
D27.720.877.383;Emulsifying Agents;D045703
B03.440.860.580.553.553.355;Mycoplasma genitalium;D045704
B03.440.860.580.553.553.420;Mycoplasma hyopneumoniae;D045705
D08.811.277.656.300.760.646;Proprotein Convertase 2;D045706
D08.811.277.656.837.562;Proprotein Convertase 2;D045706
D08.811.277.656.959.350.646;Proprotein Convertase 2;D045706
B04.820.504.540.150.800.600;Porcine Respiratory Coronavirus;D045722
B04.909.777.500.540.150.800.600;Porcine Respiratory Coronavirus;D045722
C06.405.117.136;Diverticulosis, Esophageal;D045723
C06.405.748.142;Diverticulosis, Stomach;D045724
D03.383.129.578.840;Tetrapyrroles;D045725
D03.549.909;Tetrapyrroles;D045725
D04.345.783;Tetrapyrroles;D045725
D08.811.277.656.675;Metalloproteases;D045726
D08.811.277.656.350.555;Metalloexopeptidases;D045727
D08.811.277.656.675.555;Metalloexopeptidases;D045727
D03.383.129.578.840.437;Corrinoids;D045728
D03.549.909.437;Corrinoids;D045728
D04.345.783.437;Corrinoids;D045728
C01.252.620.540;Pneumonia of Swine, Mycoplasmal;D045729
C08.381.677.540.540;Pneumonia of Swine, Mycoplasmal;D045729
C08.730.610.540.540;Pneumonia of Swine, Mycoplasmal;D045729
C22.905.626;Pneumonia of Swine, Mycoplasmal;D045729
J02.500.850.500.700.500;Soy Foods;D045730
C17.300.799.602;Scleroderma, Diffuse;D045743
C17.800.784.602;Scleroderma, Diffuse;D045743
A11.251.210.190;Cell Line, Tumor;D045744
A11.251.860.180;Cell Line, Tumor;D045744
C17.300.799.801;Scleroderma, Limited;D045745
C17.800.784.801;Scleroderma, Limited;D045745
D08;Enzymes and Coenzymes;D045762
D02.455.849.486;Hemiterpenes;D045782
D20.215.784.750.186;Clove Oil;D045783
D02.455.426.559.847.723.590;Diterpenes, Abietane;D045784
D02.455.849.291.206;Diterpenes, Abietane;D045784
D04.615.723.590;Diterpenes, Abietane;D045784
D02.455.849.291.228;Diterpenes, Clerodane;D045785
D02.455.849.291.239;Diterpenes, Kaurane;D045786
D02.455.849.765.775;Sesquiterpenes, Eudesmane;D045787
D02.455.849.765.787;Sesquiterpenes, Germacrane;D045788
D02.455.426.392.368.284.500;Sesquiterpenes, Guaiane;D045789
D02.455.849.765.793;Sesquiterpenes, Guaiane;D045789
B03.440.860.580.553.553.425;Mycoplasma hyorhinis;D045790
B03.440.860.580.553.553.430;Mycoplasma hyosynoviae;D045791
D02.455.326.271.665.202.309;Norisoprenoids;D045792
D02.455.426.392.368.367.379.249.375;Norisoprenoids;D045792
D02.455.849.131.309;Norisoprenoids;D045792
B03.440.860.580.553.553.450;Mycoplasma iowae;D045793
B03.440.860.580.553.553.570;Mycoplasma meleagridis;D045794
B03.440.860.580.553.553.630;Mycoplasma orale;D045795
B03.440.860.580.553.553.635;Mycoplasma ovipneumoniae;D045802
B03.440.860.580.553.553.670;Mycoplasma pulmonis;D045803
B03.440.860.580.553.553.720;Mycoplasma salivarium;D045804
B03.440.860.580.553.553.770;Mycoplasma synoviae;D045805
F02.463.785.373.476.850;Refusal to Participate;D045808
I01.880.735.384;Human Rights Abuses;D045809
C06.405.469.531.568;Intestinal Volvulus;D045822
C23.300.970.500;Intestinal Volvulus;D045822
C06.405.469.531.492;Ileus;D045823
C01.252.400.260;Desulfovibrionaceae Infections;D045824
C01.252.400.388;Fusobacteriaceae Infections;D045825
C01.252.400.349;Flavobacteriaceae Infections;D045826
C01.252.400.245;Cytophagaceae Infections;D045827
C01.252.400.560;Moraxellaceae Infections;D045828
B03.335.300;Fibrobacter;D045848
B03.440.425.410.047.300;Fibrobacter;D045848
B03.440.425.410.096.020;Acidaminococcus;D045850
B03.440.425.400.500;Megasphaera;D045851
B03.440.425.410.096.755;Pectinatus;D045852
G09.772.770.755.700.275;Exhalation;D045853
B03.440.425.410.096;Veillonellaceae;D045854
B03.510.460.400.400.024;Acetobacterium;D045855
B03.440.425.410.237;Butyrivibrio;D045856
B03.510.460.400.400.124;Butyrivibrio;D045856
B03.510.400.687;Ruminococcus;D045857
B03.900.174;Desulfitobacterium;D045858
B03.510.415.400.230;Desulfotomaculum;D045859
B03.900.300;Desulfotomaculum;D045859
B01.650.940.800.575.100.822.894;Sorghum;D045868
C04.182.347;Ganglion Cysts;D045888
C17.300.550.274;Ganglion Cysts;D045888
C02.256.743.615;Monkeypox;D045908
C22.735.750;Monkeypox;D045908
C22.795.600;Monkeypox;D045908
D27.505.696.399.472.080;Anabolic Agents;D045930
B01.050.150.900.649.147.900;Viverridae;D045949
B01.050.150.900.649.147.410;Hyaenidae;D045968
B01.050.150.900.649.147.550;Mustelidae;D045969
B01.050.150.900.649.147.650;Procyonidae;D045988
B01.050.150.900.649.147.354;Felidae;D045989
B01.050.150.900.649.147.354.250;Felis;D045991
B01.050.150.900.649.147.354.500;Lynx;D046008
B01.050.150.900.649.147.354.600;Panthera;D046009
B01.050.150.900.649.147.354.600.800;Tigers;D046010
B01.050.150.900.649.147.354.630;Puma;D046011
B01.050.150.900.649.147.153;Canidae;D046028
B01.050.150.900.649.147.153.150;Coyotes;D046029
B01.050.150.900.649.147.153.400;Jackals;D046030
B01.050.150.900.649.147.153.700;Raccoon Dogs;D046031
E01.370.350.515.402.580.500;Microscopy, Energy-Filtering Transmission Electron;D046032
E05.196.867.838.500;Microscopy, Energy-Filtering Transmission Electron;D046032
E05.595.402.580.500;Microscopy, Energy-Filtering Transmission Electron;D046032
B01.050.150.900.649.147.600.700;Seals, Earless;D046048
B01.050.150.900.649.147.600.700.600;Phoca;D046049
B01.650.940.150.300;Caulerpa;D046068
B01.050.150.900.649.147.600.288;Fur Seals;D046069
B01.050.150.900.649.147.600.670;Sea Lions;D046070
C09.218.458.341.950;Hearing Loss, Unilateral;D046088
C10.597.751.418.341.950;Hearing Loss, Unilateral;D046088
C23.888.592.763.393.341.950;Hearing Loss, Unilateral;D046088
C09.218.458.341.849;Hearing Loss, Mixed Conductive-Sensorineural;D046089
C10.597.751.418.341.849;Hearing Loss, Mixed Conductive-Sensorineural;D046089
C23.888.592.763.393.341.849;Hearing Loss, Mixed Conductive-Sensorineural;D046089
B01.050.150.900.248.050;Anseriformes;D046090
B01.050.150.900.248.150;Charadriiformes;D046091
B01.050.150.900.248.165;Columbiformes;D046092
B01.050.150.900.248.250;Falconiformes;D046093
B01.050.150.900.248.815.350;Falconiformes;D046093
B01.050.150.900.248.350;Galliformes;D046094
B01.050.150.900.248.600;Palaeognathae;D046108
B01.050.150.900.248.620;Passeriformes;D046109
C13.703.395;Hypertension, Pregnancy-Induced;D046110
C14.907.489.480;Hypertension, Pregnancy-Induced;D046110
E02.467;Fetal Therapies;D046128
D20.215.894.899.205;Ebola Vaccines;D046129
E04.936.537.500;Donor Selection;D046148
N02.421.911.600;Donor Selection;D046148
E05.240.468;Embryo Culture Techniques;D046149
C05.116.099.343.679;Laron Syndrome;D046150
C16.320.240.750;Laron Syndrome;D046150
C19.297.656;Laron Syndrome;D046150
C16.131.894.500;Lingual Thyroid;D046151
C19.874.689.500;Lingual Thyroid;D046151
C04.557.450.565.370;Gastrointestinal Stromal Tumors;D046152
C06.301.371.308;Gastrointestinal Stromal Tumors;D046152
C06.405.249.308;Gastrointestinal Stromal Tumors;D046152
E01.370.350.515.184;Dermoscopy;D046169
G02.111.087.675.871.790;Protein Modification, Translational;D046188
G02.111.087.693;Protein Modification, Translational;D046188
G02.149.115.675.871.790;Protein Modification, Translational;D046188
G02.149.115.693;Protein Modification, Translational;D046188
G03.495.770.871.790;Protein Modification, Translational;D046188
G05.355.315.670;Protein Modification, Translational;D046188
E05.196.630;Microchip Analytical Procedures;D046208
E05.588;Microchip Analytical Procedures;D046208
E05.196.401.190.500;Electrophoresis, Microchip;D046209
E05.196.630.465.340;Electrophoresis, Microchip;D046209
E05.588.465.340;Electrophoresis, Microchip;D046209
E05.196.630.465;Microfluidic Analytical Techniques;D046210
E05.588.465;Microfluidic Analytical Techniques;D046210
E05.196.630.570;Microarray Analysis;D046228
E05.588.570;Microarray Analysis;D046228
C06.405.748.340.690.500;Pyloric Stenosis, Hypertrophic;D046248
G02.111.087.019.055.860;Transfer RNA Aminoacylation;D046249
G02.111.087.675.050.860;Transfer RNA Aminoacylation;D046249
G02.111.087.675.871.850;Transfer RNA Aminoacylation;D046249
G02.149.115.019.055.860;Transfer RNA Aminoacylation;D046249
G02.149.115.675.050.860;Transfer RNA Aminoacylation;D046249
G02.149.115.675.871.850;Transfer RNA Aminoacylation;D046249
G03.495.095.055.860;Transfer RNA Aminoacylation;D046249
G03.495.770.050.860;Transfer RNA Aminoacylation;D046249
G03.495.770.871.850;Transfer RNA Aminoacylation;D046249
I01.880.604.473.675;Reproductive Rights;D046269
N03.706.437.675;Reproductive Rights;D046269
E02.218.085.090;Body Piercing;D046288
E02.800.090;Body Piercing;D046288
E04.085.090;Body Piercing;D046288
E02.218.085;Body Modification, Non-Therapeutic;D046289
E04.085;Body Modification, Non-Therapeutic;D046289
C01.539.830.025.020.455.730;Liver Abscess, Pyogenic;D046290
C06.552.597.758;Liver Abscess, Pyogenic;D046290
B01.050.150.900.649.865.600.700;Spalax;D046308
B01.050.150.900.649.865.635.700;Spalax;D046308
B01.050.150.900.649.865.692;Porcupines;D046328
B01.050.150.900.649.865.663;Octodon;D046329
B01.050.150.900.649.865.640;Myoxidae;D046330
B01.050.150.900.649.865.545;Gophers;D046348
C06.552.830.074;Coproporphyria, Hereditary;D046349
C16.320.565.708.400.074;Coproporphyria, Hereditary;D046349
C16.320.850.742.074;Coproporphyria, Hereditary;D046349
C17.800.827.742.074;Coproporphyria, Hereditary;D046349
C17.800.849.617.400.074;Coproporphyria, Hereditary;D046349
C18.452.648.708.400.074;Coproporphyria, Hereditary;D046349
C18.452.811.400.074;Coproporphyria, Hereditary;D046349
C18.452.880.617.400.074;Coproporphyria, Hereditary;D046349
C06.552.830.625;Porphyria, Variegate;D046350
C16.320.565.708.400.625;Porphyria, Variegate;D046350
C16.320.850.742.625;Porphyria, Variegate;D046350
C17.800.827.742.625;Porphyria, Variegate;D046350
C17.800.849.617.400.625;Porphyria, Variegate;D046350
C18.452.648.708.400.625;Porphyria, Variegate;D046350
C18.452.811.400.625;Porphyria, Variegate;D046350
C18.452.880.617.400.625;Porphyria, Variegate;D046350
C06.552.830.812;Protoporphyria, Erythropoietic;D046351
C16.320.565.708.400.812;Protoporphyria, Erythropoietic;D046351
C16.320.850.742.812;Protoporphyria, Erythropoietic;D046351
C17.800.827.742.812;Protoporphyria, Erythropoietic;D046351
C17.800.849.617.400.812;Protoporphyria, Erythropoietic;D046351
C18.452.648.708.400.812;Protoporphyria, Erythropoietic;D046351
C18.452.811.400.812;Protoporphyria, Erythropoietic;D046351
C18.452.880.617.400.812;Protoporphyria, Erythropoietic;D046351
F01.145.113.555;Freezing Reaction, Cataleptic;D046352
F01.145.632.555;Freezing Reaction, Cataleptic;D046352
G11.427.590.530.698.555;Freezing Reaction, Cataleptic;D046352
F01.145.113.680;Immobility Response, Tonic;D046353
F01.145.632.680;Immobility Response, Tonic;D046353
G11.427.590.530.698.680;Immobility Response, Tonic;D046353
B01.050.150.900.248.620.750.150;Crows;D046368
B01.050.150.900.248.620.750.250;Finches;D046369
B01.050.150.900.248.620.750.700;Sparrows;D046370
B01.050.150.900.248.620.750.725;Swallows;D046388
B01.050.150.900.248.710.672.650.500;Melopsittacus;D046408
B01.050.150.900.248.710.672.650.650;Psittacula;D046409
B01.050.150.900.248.710.251;Cockatoos;D046410
B01.050.150.900.248.250.400;Hawks;D046428
B01.050.150.900.248.815.350.400;Hawks;D046428
B01.050.150.900.248.860;Spheniscidae;D046429
G01.311.400;Ice Cover;D046448
G16.500.275.410.500;Ice Cover;D046448
N06.230.291.500;Ice Cover;D046448
C23.300.707.374;Hernia, Abdominal;D046449
G07.700.320.750;Sexual Development;D046468
G08.686.785.880;Sexual Development;D046468
E05.240;Culture Techniques;D046508
E05.240.617;Tissue Culture Techniques;D046509
G05.365.590.175.125;Chimerism;D046528
E01.370.350.515.402.580;Microscopy, Electron, Transmission;D046529
E05.595.402.580;Microscopy, Electron, Transmission;D046529
C13.703.844.728;Pubic Symphysis Diastasis;D046548
C26.289.650;Pubic Symphysis Diastasis;D046548
D12.776.124.486.485.114.820;Plantibodies;D046549
D12.776.124.790.651.114.820;Plantibodies;D046549
D12.776.377.715.548.114.820;Plantibodies;D046549
A08.663.650.915.500.530.550;Neuroepithelial Bodies;D046568
A08.800.950.500.530.550;Neuroepithelial Bodies;D046568
A11.436.690.550;Neuroepithelial Bodies;D046568
A11.671.650.915.500.530.550;Neuroepithelial Bodies;D046568
A08.663.650.915.500.530;Neuroepithelial Cells;D046569
A08.663.650.915.750.600;Neuroepithelial Cells;D046569
A08.800.950.500.530;Neuroepithelial Cells;D046569
A08.800.950.750.600;Neuroepithelial Cells;D046569
A11.436.690;Neuroepithelial Cells;D046569
A11.671.650.915.500.530;Neuroepithelial Cells;D046569
A11.671.650.915.750.600;Neuroepithelial Cells;D046569
B02.600;Nanoarchaeota;D046588
C10.228.140.300.275.249;CADASIL;D046589
C10.228.140.300.400.203;CADASIL;D046589
C10.228.140.300.510.200.175;CADASIL;D046589
C10.228.140.380.230.124;CADASIL;D046589
C14.907.253.329.249;CADASIL;D046589
C14.907.253.560.200.175;CADASIL;D046589
C16.320.129;CADASIL;D046589
E05.196.867.838;Spectroscopy, Electron Energy-Loss;D046590
C10.597.350.675;Synkinesis;D046608
C23.888.592.350.675;Synkinesis;D046608
L01.346.596.413;Libraries, Digital;D046609
L01.700.508.300.742.470;Libraries, Digital;D046609
C06.130.120.250.098.800;Sphincter of Oddi Dysfunction;D046628
C10.228.140.300.535.450.400.400;Hematoma, Subdural, Intracranial;D046648
C10.900.300.837.600.400;Hematoma, Subdural, Intracranial;D046648
C14.907.253.573.400.450.400;Hematoma, Subdural, Intracranial;D046648
C23.550.414.838.700.400;Hematoma, Subdural, Intracranial;D046648
C23.550.414.913.700.400;Hematoma, Subdural, Intracranial;D046648
C26.260.616.600.400;Hematoma, Subdural, Intracranial;D046648
C26.915.300.490.450.400;Hematoma, Subdural, Intracranial;D046648
C23.550.414.838.700.700;Hematoma, Subdural, Spinal;D046649
L01.453.245.945.700.500;Medical Subject Headings;D046650
E05.318.308.985.550.287;Child Mortality;D046688
L01.280.975.550.287;Child Mortality;D046688
N01.224.935.698.150;Child Mortality;D046688
N06.850.505.400.975.550.287;Child Mortality;D046688
N06.850.520.308.985.550.287;Child Mortality;D046688
E05.318.308.985.550.362;Fetal Mortality;D046689
L01.280.975.550.362;Fetal Mortality;D046689
N01.224.935.698.300;Fetal Mortality;D046689
N06.850.505.400.975.550.362;Fetal Mortality;D046689
N06.850.520.308.985.550.362;Fetal Mortality;D046689
E02.342.250;Deep Brain Stimulation;D046690
E04.190;Deep Brain Stimulation;D046690
B01.050.150.900.248.710.672.050;Amazona;D046708
F02.463.593.524;Pattern Recognition, Physiological;D046709
B01.050.150.900.248.710.672.040;Agapornis;D046710
C06.405.205.265.173;Colitis, Microscopic;D046728
C06.405.469.158.188.173;Colitis, Microscopic;D046728
C06.405.205.265.173.500;Colitis, Collagenous;D046729
C06.405.469.158.188.173.500;Colitis, Collagenous;D046729
C06.405.205.265.173.750;Colitis, Lymphocytic;D046730
C06.405.469.158.188.173.750;Colitis, Lymphocytic;D046730
C23.550.414.838.355;Hematoma, Epidural, Spinal;D046748
B01.050.150.900.248.620.750.712;Starlings;D046749
C06.689.150.500;Nesidioblastosis;D046768
C16.614.200.500;Nesidioblastosis;D046768
C18.452.394.968.250.500;Nesidioblastosis;D046768
C18.452.394.984.200.500;Nesidioblastosis;D046768
C05.550.700;Patellofemoral Pain Syndrome;D046788
C05.182.100;Chondromalacia Patellae;D046789
C17.300.182.100;Chondromalacia Patellae;D046789
A03.734.540;Pancreas, Exocrine;D046790
A10.336.645;Pancreas, Exocrine;D046790
B04.280.030.080;Atadenovirus;D046808
B04.909.204.097.080;Atadenovirus;D046808
B04.280.030.750;Siadenovirus;D046809
B04.909.204.097.750;Siadenovirus;D046809
B04.280.120.400;Gyrovirus;D046810
B04.909.204.120.400;Gyrovirus;D046810
B04.820.504.770;Roniviridae;D046828
B04.820.545.450;Isavirus;D046829
B04.715.850;Tymoviridae;D046830
B04.820.900;Tymoviridae;D046830
B04.280.505.900;White spot syndrome virus 1;D046848
B04.280.505;Nimaviridae;D046849
B03.280.100.150;Anabaena cylindrica;D046868
B03.440.475.100.100.150;Anabaena cylindrica;D046868
B03.280.100.300;Anabaena flos-aquae;D046869
B03.440.475.100.100.300;Anabaena flos-aquae;D046869
B03.280.100.900;Anabaena variabilis;D046870
B03.440.475.100.100.900;Anabaena variabilis;D046870
E05.196.630.570.850;Tissue Array Analysis;D046888
E05.588.570.850;Tissue Array Analysis;D046888
B03.280.200;Cyanothece;D046889
B03.440.475.100.200;Cyanothece;D046889
B03.280.110;Aphanizomenon;D046890
B03.440.475.100.110;Aphanizomenon;D046890
B03.280.210;Cylindrospermopsis;D046891
B03.440.475.100.210;Cylindrospermopsis;D046891
G02.111.087.675.333;Peptide Biosynthesis, Nucleic Acid-Independent;D046908
G02.149.115.675.333;Peptide Biosynthesis, Nucleic Acid-Independent;D046908
G03.495.770.333;Peptide Biosynthesis, Nucleic Acid-Independent;D046908
G08.686.605.154;Fertile Period;D046910
D05;Macromolecular Substances;D046911
D05.500;Multiprotein Complexes;D046912
B01.650.940.800.575.100.401.590.750;Medicago truncatula;D046913
B01.650.940.800.575.100.401.194;Dipteryx;D046914
D08.811.710;Penicillin-Binding Proteins;D046915
D12.776.097.545;Penicillin-Binding Proteins;D046915
D08.811.913.400.450.780;Peptidoglycan Glycosyltransferase;D046928
D08.811.277.656.350.245.800;Serine-Type D-Ala-D-Ala Carboxypeptidase;D046929
D08.811.277.656.959.560;Serine-Type D-Ala-D-Ala Carboxypeptidase;D046929
B01.650.940.800.575.100.575.974;Thymus Plant;D046930
B03.280.500;Microcystis;D046931
B03.440.475.100.500;Microcystis;D046931
B03.280.550;Nodularia;D046932
B03.440.475.100.550;Nodularia;D046932
D02.455.849.291.400;Ginkgolides;D046934
D02.455.849.291.400.500;Bilobalides;D046935
B01.650.940.800.575.100.842.500.522;Photinia;D046936
B03.280.575;Nostoc;D046937
B03.440.475.100.575;Nostoc;D046937
B03.280.650;Plectonema;D046938
B03.440.475.100.650;Plectonema;D046938
B03.280.750;Synechocystis;D046939
B03.440.475.100.750;Synechocystis;D046939
B03.280.745;Synechococcus;D046940
B03.440.475.100.745;Synechococcus;D046940
D03.132.436.681;Secologanin Tryptamine Alkaloids;D046948
D03.438.473.402.681;Secologanin Tryptamine Alkaloids;D046948
B03.440.425.410.760;Thermotoga neapolitana;D046949
B03.510.460.400.400.800;Thermoanaerobacterium;D046950
B03.510.460.400.400.790;Thermoanaerobacter;D046968
B03.300.390.400.200.025;Clostridium acetobutylicum;D046969
B03.510.415.400.200.025;Clostridium acetobutylicum;D046969
B03.300.390.400.200.100;Clostridium beijerinckii;D046970
B03.510.415.400.200.100;Clostridium beijerinckii;D046970
B03.300.390.400.200.130;Clostridium bifermentans;D046971
B03.510.415.400.200.130;Clostridium bifermentans;D046971
B03.300.390.400.200.180;Clostridium butyricum;D046972
B03.510.415.400.200.180;Clostridium butyricum;D046972
B03.300.390.400.200.200;Clostridium cellulolyticum;D046973
B03.510.415.400.200.200;Clostridium cellulolyticum;D046973
B03.300.390.400.200.205;Clostridium cellulovorans;D046974
B03.510.415.400.200.205;Clostridium cellulovorans;D046974
B03.300.390.400.200.215;Clostridium chauvoei;D046975
B03.510.415.400.200.215;Clostridium chauvoei;D046975
D05.500.562.500;Proteasome Endopeptidase Complex;D046988
D08.811.277.656.918;Proteasome Endopeptidase Complex;D046988
D08.811.600.730;Proteasome Endopeptidase Complex;D046988
B01.650.940.800.575.462.750;Marchantia;D047008
B03.300.390.400.200.412;Clostridium histolyticum;D047009
B03.510.415.400.200.412;Clostridium histolyticum;D047009
B03.300.390.400.200.493;Clostridium kluyveri;D047010
B03.510.415.400.200.493;Clostridium kluyveri;D047010
D05.750.078.875;Silk;D047011
D12.776.092.500.809;Silk;D047011
D12.776.092.750;Silk;D047011
B03.300.390.400.200.160.050;Clostridium botulinum type A;D047013
B03.510.415.400.200.160.050;Clostridium botulinum type A;D047013
B03.300.390.400.200.160.100;Clostridium botulinum type B;D047014
B03.510.415.400.200.160.100;Clostridium botulinum type B;D047014
D04.345;Macrocyclic Compounds;D047028
D02.065.589.327;Lactams, Macrocyclic;D047029
D04.345.295;Lactams, Macrocyclic;D047029
D12.776.092.500.809.750;Sericins;D047030
D12.776.290.812;Vitellins;D047048
D08.811.913.050.134.127;Arylalkylamine N-Acetyltransferase;D047068
D03.383.129.539.850;Pyrazolones;D047069
E07.101.074;Bandages, Hydrocolloid;D047070
D09.698.365.089;beta-Glucans;D047071
D27.505.519.389.099;Aromatase Inhibitors;D047072
B01.050.500.802.200;Dysidea;D047088
B01.050.500.802.080;Axinella;D047089
D02.065.589.099;beta-Lactams;D047090
D02.886.108;beta-Lactams;D047090
D04.075.080.875.099.221;beta-Lactams;D047090
D12.776.124.486.379;Eosinophil Granule Proteins;D047091
D12.776.124.486.379.500;Eosinophil Major Basic Protein;D047093
G07.700.320.500.325.180;Embryonic Development;D047108
G08.686.785.760.170.104;Embryonic Development;D047108
G07.700.320.500.325.235;Fetal Development;D047109
G08.686.785.760.170.157;Fetal Development;D047109
B01.050.500.802.160;Callyspongia;D047128
B01.050.500.802.380;Haliclona;D047129
B01.050.500.802.650;Petrosia;D047130
B01.050.500.802.900;Xestospongia;D047131
B01.050.500.802.175;Crambe Sponge;D047132
D08.811.277.352.700.350.262;Eosinophil Cationic Protein;D047150
D12.776.124.486.379.249;Eosinophil Cationic Protein;D047150
D03.132.052;Amaryllidaceae Alkaloids;D047151
G02.111.570.790.709.600.040.127;Cystine Knot Motifs;D047168
D12.644.641.243;Cyclotides;D047169
D02.522.818.222;Chalcones;D047188
D03.438.150.266.450.221;Chalcones;D047188
D03.830.219.266.450.221;Chalcones;D047188
D08.811.277.352.700.350.381;Eosinophil-Derived Neurotoxin;D047208
D12.776.124.486.379.275;Eosinophil-Derived Neurotoxin;D047208
D08.811.682.732.440;Eosinophil Peroxidase;D047209
D12.776.124.486.379.600;Eosinophil Peroxidase;D047209
D27.505.519.162.500;Angiotensin II Type 1 Receptor Blockers;D047228
B01.050.500.802.670;Plakortis;D047229
B01.050.500.802.039;Agelas;D047230
B01.050.500.802.360;Geodia;D047231
B01.050.500.802.785;Theonella;D047232
B01.050.500.802.775;Suberites;D047233
D04.345.051;Crown Compounds;D047248
D04.345.025;Calixarenes;D047250
C16.131.894.500.500;Lingual Goiter;D047268
C19.874.283.802;Lingual Goiter;D047268
C19.874.689.500.500;Lingual Goiter;D047268
B01.050.500.408.578.800;Strongylocentrotus;D047269
B01.050.500.408.578.800.600;Strongylocentrotus purpuratus;D047270
B01.050.500.408.765.070;Asterias;D047271
B01.050.500.408.765.075;Asterina;D047288
B01.050.500.408.578.070;Arbacia;D047308
D03.438.150.266.450.260;Flavones;D047309
D03.830.219.266.450.260;Flavones;D047309
D03.438.150.266.450.260.110;Apigenin;D047310
D03.830.219.266.450.260.110;Apigenin;D047310
D03.438.150.266.450.260.555;Luteolin;D047311
D03.830.219.266.450.260.555;Luteolin;D047311
B01.050.500.408.578.600;Paracentrotus;D047328
B01.050.500.408.578.050;Anthocidaris;D047329
B01.050.500.408.578.400;Hemicentrotus;D047330
B01.050.500.408.578.500;Lytechinus;D047331
B01.050.500.408.560.400;Holothuria;D047332
D02.241.223.100.300.200.299;Hydrolyzable Tannins;D047348
D02.241.511.390.200.299;Hydrolyzable Tannins;D047348
D02.455.426.559.389.127.281.200.299;Hydrolyzable Tannins;D047348
D02.455.426.559.389.657.410.200.299;Hydrolyzable Tannins;D047348
D05.750.078.937.214;Hydrolyzable Tannins;D047348
E05.041.124.892;Tumor Burden;D047368
E05.393.170;Chromatin Immunoprecipitation;D047369
E05.478.605.160;Chromatin Immunoprecipitation;D047369
D08.811.913.696.620.682.700.140;Casein Kinases;D047388
D12.776.476.150;Casein Kinases;D047388
D05.500.117.750;Casein Kinase I;D047389
D08.811.913.696.620.682.700.140.300;Casein Kinase I;D047389
D12.776.476.081.750;Casein Kinase I;D047389
D12.776.476.150.299;Casein Kinase I;D047389
D08.811.913.696.620.682.700.140.600;Casein Kinase II;D047390
D12.776.476.150.600;Casein Kinase II;D047390
D04.345.103.222;alpha-Cyclodextrins;D047391
D09.698.365.855.400.375.222;alpha-Cyclodextrins;D047391
D04.345.103.333;beta-Cyclodextrins;D047392
D09.698.365.855.400.375.333;beta-Cyclodextrins;D047392
D04.345.103.444;gamma-Cyclodextrins;D047408
D09.698.365.855.400.375.444;gamma-Cyclodextrins;D047408
D27.505.519.389.755;Protein Kinase Inhibitors;D047428
E05.196.150.639;Immunoprecipitation;D047468
E05.478.605;Immunoprecipitation;D047468
D12.776.260.698.701.500;Retinoid X Receptors;D047488
D12.776.826.701.500;Retinoid X Receptors;D047488
D12.776.930.669.701.500;Retinoid X Receptors;D047488
C21.676;Preconception Injuries;D047489
D12.776.260.698.701.500.500;Retinoid X Receptor alpha;D047490
D12.776.826.701.500.500;Retinoid X Receptor alpha;D047490
D12.776.930.669.701.500.500;Retinoid X Receptor alpha;D047490
D12.776.260.698.701.500.750;Retinoid X Receptor gamma;D047491
D12.776.826.701.500.750;Retinoid X Receptor gamma;D047491
D12.776.930.669.701.500.750;Retinoid X Receptor gamma;D047491
D12.776.260.698.239;Peroxisome Proliferator-Activated Receptors;D047492
D12.776.826.239;Peroxisome Proliferator-Activated Receptors;D047492
D12.776.930.669.239;Peroxisome Proliferator-Activated Receptors;D047492
D12.776.260.698.239.500;PPAR alpha;D047493
D12.776.826.239.500;PPAR alpha;D047493
D12.776.930.669.239.500;PPAR alpha;D047493
D12.776.260.698.239.555;PPAR delta;D047494
D12.776.826.239.555;PPAR delta;D047494
D12.776.930.669.239.555;PPAR delta;D047494
D12.776.260.698.239.588;PPAR gamma;D047495
D12.776.826.239.588;PPAR gamma;D047495
D12.776.930.669.239.588;PPAR gamma;D047495
C06.552.308.500.750.500;Massive Hepatic Necrosis;D047508
B01.050.500.408.560.700;Stichopus;D047528
E07.305.250.159;Defibrillators;D047548
E04.100.376.719.332.199;Coronary Artery Bypass, Off-Pump;D047549
E04.100.814.868.750.199;Coronary Artery Bypass, Off-Pump;D047549
E04.928.220.520.220.189;Coronary Artery Bypass, Off-Pump;D047549
F01.145.802.987;Unsafe Sex;D047568
E01.370.225.500.386.400.500;Laser Scanning Cytometry;D047569
E01.370.350.515.395.500;Laser Scanning Cytometry;D047569
E05.196.712.516.600.240.400.500;Laser Scanning Cytometry;D047569
E05.200.500.386.400.500;Laser Scanning Cytometry;D047569
E05.242.386.400.500;Laser Scanning Cytometry;D047569
E05.595.395.500;Laser Scanning Cytometry;D047569
E02.120.527;Leukocyte Reduction Procedures;D047589
E05.242.363.540;Leukocyte Reduction Procedures;D047589
D02.806.400.500;Pyrroloiminoquinones;D047608
D03.438.473.412.500;Pyrroloiminoquinones;D047608
D03.438.810.553;Pyrroloiminoquinones;D047608
D12.776.260.698.750.350.174;Estrogen Receptor alpha;D047628
D12.776.826.750.350.174;Estrogen Receptor alpha;D047628
D12.776.930.669.750.350.174;Estrogen Receptor alpha;D047628
D12.776.260.698.750.350.262;Estrogen Receptor beta;D047629
D12.776.826.750.350.262;Estrogen Receptor beta;D047629
D12.776.930.669.750.350.262;Estrogen Receptor beta;D047629
D04.345.566.297;Depsipeptides;D047630
D12.644.641.297;Depsipeptides;D047630
G08.686.157.500.562;Perimenopause;D047648
G08.686.785.880.249.500.562;Perimenopause;D047648
G08.686.157.249;Andropause;D047649
G08.686.785.880.249.249;Andropause;D047649
G02.111.570.060.440;Inteins;D047668
G02.111.570.060.270;Exteins;D047669
C04.182.156;Breast Cyst;D047688
C17.800.090.249;Breast Cyst;D047688
C04.557.450.565.540;Myofibroma;D047708
C17.300.680.540;Myofibroma;D047708
B01.050.500.091.426.400;Hirudo medicinalis;D047709
C11.744.636.500;Myopia, Degenerative;D047728
C10.228.140.617.738.250.725;Pituitary ACTH Hypersecretion;D047748
C19.700.355.800;Pituitary ACTH Hypersecretion;D047748
D08.811.277.352.640.295;Glycerophosphoinositol Inositolphosphodiesterase;D047768
K01.400.504.875.100;American Revolution;D047788
K01.400.504.968.901;World War II;D047789
C12.706.316.129;Adrenogenital Syndrome;D047808
C13.351.875.253.129;Adrenogenital Syndrome;D047808
C16.131.939.316.129;Adrenogenital Syndrome;D047808
C19.391.119.129;Adrenogenital Syndrome;D047808
K01.400.504.968.900;World War I;D047828
K01.400.504.968.850;Vietnam Conflict;D047829
K01.400.504.968.400;Gulf War;D047830
K01.400.504.937.100;American Civil War;D047831
K01.400.504.937.750;Spanish-American War, 1898;D047832
K01.400.504.968.650;Russian-Japanese War;D047848
K01.400.504.937.500;Crimean War;D047849
K01.400.504.875.374;French Revolution;D047850
I01.198.240.856.800.750;September 11 Terrorist Attacks;D047851
K01.400.504.984.500;September 11 Terrorist Attacks;D047851
K01.400.504.968.150;Chernobyl Nuclear Accident;D047852
N06.850.135.848.500;Chernobyl Nuclear Accident;D047852
C04.588.894.797.520.933;Pulmonary Sclerosing Hemangioma;D047868
C08.381.540.867;Pulmonary Sclerosing Hemangioma;D047868
C08.785.520.867;Pulmonary Sclerosing Hemangioma;D047868
K01.400.504.968.500;Korean War;D047869
D12.776.543.750.073.750;Receptors, Tumor Necrosis Factor, Type I;D047888
D12.776.543.750.705.852.760.597;Receptors, Tumor Necrosis Factor, Type I;D047888
D23.050.301.264.035.908;Receptors, Tumor Necrosis Factor, Type I;D047888
D23.101.100.110.912;Receptors, Tumor Necrosis Factor, Type I;D047888
D12.776.543.750.705.852.760.798;Receptors, Tumor Necrosis Factor, Type II;D047889
D23.050.301.264.035.910;Receptors, Tumor Necrosis Factor, Type II;D047889
D23.101.100.110.916;Receptors, Tumor Necrosis Factor, Type II;D047889
D12.644.360;Intracellular Signaling Peptides and Proteins;D047908
D12.776.476;Intracellular Signaling Peptides and Proteins;D047908
C13.703.420.491.500;Premature Birth;D047928
G08.686.785.760.769.490.500;Term Birth;D047929
B03.300.390.400.200.160.150;Clostridium botulinum type C;D047968
B03.510.415.400.200.160.150;Clostridium botulinum type C;D047968
B03.300.390.400.200.160.200;Clostridium botulinum type D;D047969
B03.510.415.400.200.160.200;Clostridium botulinum type D;D047969
B03.300.390.400.200.160.250;Clostridium botulinum type E;D047970
B03.510.415.400.200.160.250;Clostridium botulinum type E;D047970
B03.300.390.400.200.160.300;Clostridium botulinum type F;D047971
B03.510.415.400.200.160.300;Clostridium botulinum type F;D047971
D12.644.360.024.500;Tumor Necrosis Factor Receptor-Associated Peptides and Proteins;D047988
D12.776.157.057.500;Tumor Necrosis Factor Receptor-Associated Peptides and Proteins;D047988
D12.776.476.024.500;Tumor Necrosis Factor Receptor-Associated Peptides and Proteins;D047988
B03.300.390.400.200.700;Clostridium sordellii;D047989
B03.510.415.400.200.700;Clostridium sordellii;D047989
D12.644.360.024.500.500;TNF Receptor-Associated Factor 1;D047990
D12.776.157.057.500.500;TNF Receptor-Associated Factor 1;D047990
D12.776.476.024.500.500;TNF Receptor-Associated Factor 1;D047990
B03.300.390.400.200.710;Clostridium sticklandii;D047991
B03.510.415.400.200.710;Clostridium sticklandii;D047991
D12.644.360.024.500.750;TNF Receptor-Associated Factor 2;D047992
D12.776.157.057.500.750;TNF Receptor-Associated Factor 2;D047992
D12.776.476.024.500.750;TNF Receptor-Associated Factor 2;D047992
D12.644.360.024.500.875;TNF Receptor-Associated Factor 3;D048008
D12.776.157.057.500.875;TNF Receptor-Associated Factor 3;D048008
D12.776.476.024.500.875;TNF Receptor-Associated Factor 3;D048008
B03.300.390.400.200.713;Clostridium symbiosum;D048009
B03.510.415.400.200.713;Clostridium symbiosum;D048009
B03.300.390.400.200.722;Clostridium tertium;D048010
B03.510.415.400.200.722;Clostridium tertium;D048010
B03.300.390.400.200.740;Clostridium tetanomorphum;D048012
B03.510.415.400.200.740;Clostridium tetanomorphum;D048012
B03.300.390.400.200.770;Clostridium thermocellum;D048013
B03.510.415.400.200.770;Clostridium thermocellum;D048013
B03.300.390.400.200.800;Clostridium tyrobutyricum;D048014
B03.510.415.400.200.800;Clostridium tyrobutyricum;D048014
D12.644.360.024.500.937;TNF Receptor-Associated Factor 5;D048015
D12.776.157.057.500.937;TNF Receptor-Associated Factor 5;D048015
D12.776.476.024.500.937;TNF Receptor-Associated Factor 5;D048015
B01.050.500.408.560.150;Cucumaria;D048016
D13.444.308.148;DNA, Algal;D048028
D12.644.360.024.500.968;TNF Receptor-Associated Factor 6;D048029
D12.776.157.057.500.968;TNF Receptor-Associated Factor 6;D048029
D12.776.476.024.500.968;TNF Receptor-Associated Factor 6;D048029
D13.444.735.130;RNA, Algal;D048030
D08.811.913.696.620.682.700.567.513;JNK Mitogen-Activated Protein Kinases;D048031
D08.811.913.696.620.682.700.646.750.374;JNK Mitogen-Activated Protein Kinases;D048031
D12.644.360.450.340;JNK Mitogen-Activated Protein Kinases;D048031
D12.776.476.450.340;JNK Mitogen-Activated Protein Kinases;D048031
L01.313.249;Dental Informatics;D048048
D08.811.913.696.620.682.700.567.342;Extracellular Signal-Regulated MAP Kinases;D048049
D08.811.913.696.620.682.700.646.750.249;Extracellular Signal-Regulated MAP Kinases;D048049
D12.644.360.450.169;Extracellular Signal-Regulated MAP Kinases;D048049
D12.776.476.450.169;Extracellular Signal-Regulated MAP Kinases;D048049
D08.811.913.696.620.682.700.567.878;p38 Mitogen-Activated Protein Kinases;D048051
D08.811.913.696.620.682.700.646.750.843;p38 Mitogen-Activated Protein Kinases;D048051
D12.644.360.450.835;p38 Mitogen-Activated Protein Kinases;D048051
D12.776.476.450.835;p38 Mitogen-Activated Protein Kinases;D048051
D08.811.913.696.620.682.700.567.342.750;Mitogen-Activated Protein Kinase 3;D048052
D08.811.913.696.620.682.700.646.750.249.750;Mitogen-Activated Protein Kinase 3;D048052
D12.644.360.450.169.750;Mitogen-Activated Protein Kinase 3;D048052
D12.776.476.450.169.750;Mitogen-Activated Protein Kinase 3;D048052
D08.811.913.696.620.682.700.567.342.875;Mitogen-Activated Protein Kinase 6;D048053
D08.811.913.696.620.682.700.646.750.249.875;Mitogen-Activated Protein Kinase 6;D048053
D12.644.360.450.169.875;Mitogen-Activated Protein Kinase 6;D048053
D12.776.476.450.169.875;Mitogen-Activated Protein Kinase 6;D048053
D08.811.913.696.620.682.700.567.342.937;Mitogen-Activated Protein Kinase 7;D048054
D08.811.913.696.620.682.700.646.750.249.937;Mitogen-Activated Protein Kinase 7;D048054
D12.644.360.450.169.937;Mitogen-Activated Protein Kinase 7;D048054
D12.776.476.450.169.937;Mitogen-Activated Protein Kinase 7;D048054
D08.811.913.696.620.682.700.567.513.500;Mitogen-Activated Protein Kinase 8;D048055
D08.811.913.696.620.682.700.646.750.374.500;Mitogen-Activated Protein Kinase 8;D048055
D12.644.360.450.340.500;Mitogen-Activated Protein Kinase 8;D048055
D12.776.476.450.340.500;Mitogen-Activated Protein Kinase 8;D048055
D08.811.913.696.620.682.700.567.513.750;Mitogen-Activated Protein Kinase 9;D048056
D08.811.913.696.620.682.700.646.750.374.750;Mitogen-Activated Protein Kinase 9;D048056
D12.644.360.450.340.750;Mitogen-Activated Protein Kinase 9;D048056
D12.776.476.450.340.750;Mitogen-Activated Protein Kinase 9;D048056
D08.811.913.696.620.682.700.567.513.800;Mitogen-Activated Protein Kinase 10;D048057
D08.811.913.696.620.682.700.646.750.374.800;Mitogen-Activated Protein Kinase 10;D048057
D12.644.360.450.340.800;Mitogen-Activated Protein Kinase 10;D048057
D12.776.476.450.340.800;Mitogen-Activated Protein Kinase 10;D048057
D12.776.260.698.239.530;PPAR-beta;D048068
D12.776.826.239.530;PPAR-beta;D048068
D12.776.930.669.239.530;PPAR-beta;D048068
D12.644.276.374.750;Tumor Necrosis Factors;D048069
D12.644.276.972;Tumor Necrosis Factors;D048069
D12.776.467.374.750;Tumor Necrosis Factors;D048069
D12.776.467.972;Tumor Necrosis Factors;D048069
D23.529.374.750;Tumor Necrosis Factors;D048069
D23.529.972;Tumor Necrosis Factors;D048069
C13.703.277.677;Fetal Nutrition Disorders;D048070
C18.654.521.625;Fetal Nutrition Disorders;D048070
L01.313;Informatics;D048088
C01.252.620.530;Pneumonia of Calves, Enzootic;D048089
C08.381.677.540.530;Pneumonia of Calves, Enzootic;D048089
C08.730.085.675;Pneumonia of Calves, Enzootic;D048089
C08.730.610.540.530;Pneumonia of Calves, Enzootic;D048089
C22.196.090.675;Pneumonia of Calves, Enzootic;D048089
C08.730.085;Bovine Respiratory Disease Complex;D048090
C22.196.090;Bovine Respiratory Disease Complex;D048090
E04.680.300;Guided Tissue Regeneration;D048091
L01.313.650;Nursing Informatics;D048108
D05.500.117.750.100;Casein Kinase Ialpha;D048128
D08.811.913.696.620.682.700.140.300.100;Casein Kinase Ialpha;D048128
D12.776.476.081.750.100;Casein Kinase Ialpha;D048128
D12.776.476.150.299.100;Casein Kinase Ialpha;D048128
D05.500.117.750.200;Casein Kinase Idelta;D048148
D08.811.913.696.620.682.700.140.300.200;Casein Kinase Idelta;D048148
D12.776.476.081.750.200;Casein Kinase Idelta;D048148
D12.776.476.150.299.200;Casein Kinase Idelta;D048148
D05.500.117.750.300;Casein Kinase Iepsilon;D048149
D08.811.913.696.620.682.700.140.300.300;Casein Kinase Iepsilon;D048149
D12.776.476.081.750.300;Casein Kinase Iepsilon;D048149
D12.776.476.150.299.300;Casein Kinase Iepsilon;D048149
B03.440.450.425.325.300.360;Escherichia coli K12;D048168
B03.660.250.150.180.100.360;Escherichia coli K12;D048168
B01.050.500.131.617.289.275.120.400;Anopheles gambiae;D048169
B03.300.390.400.810.768.500;Streptomyces lividans;D048170
B03.510.024.049.775.775.500;Streptomyces lividans;D048170
B03.510.415.400.810.768.500;Streptomyces lividans;D048170
B03.510.460.410.810.768.500;Streptomyces lividans;D048170
B01.050.500.131.617.678.369.500;Locusta migratoria;D048188
B01.050.500.500.736.215.454.410;Hymenolepis nana;D048189
B01.050.500.500.736.215.454.400;Hymenolepis diminuta;D048190
B03.510.460.400.410.475.475.612;Lactobacillus plantarum;D048191
B03.510.550.450.475.612;Lactobacillus plantarum;D048191
E01.370.350.850.865.500;Nuchal Translucency Measurement;D048208
E01.370.378.630.865.500;Nuchal Translucency Measurement;D048208
B01.050.500.500.736.215.327.400;Echinococcus granulosus;D048209
B01.050.500.500.736.215.327.500;Echinococcus multilocularis;D048210
E07.515;Intermittent Pneumatic Compression Devices;D048228
B02.075.725.725.725.800;Sulfolobus solfataricus;D048229
B03.510.024.049.180.300;Corynebacterium glutamicum;D048230
B03.510.460.400.400.200.300;Corynebacterium glutamicum;D048230
B01.046.500.100.075.080.150;Acanthamoeba castellanii;D048248
B03.510.400.800.872.800;Streptococcus thermophilus;D048249
B03.510.550.737.872.800;Streptococcus thermophilus;D048249
B01.050.150.900.493.370.853.392.800;Squalus;D048250
B01.050.150.900.493.370.853.392.800.500;Squalus acanthias;D048251
D05.750.078.139.500;Chitosan;D048271
D09.698.211.500;Chitosan;D048271
D03.383.129.308.436;Imidazolines;D048288
D03.383.129.308.432;Imidazolidines;D048289
D12.644.360.450.835.200;Mitogen-Activated Protein Kinase 11;D048290
D12.644.360.450.835.400;Mitogen-Activated Protein Kinase 12;D048291
D12.644.360.450.835.600;Mitogen-Activated Protein Kinase 13;D048292
B01.050.150.900.649.573.575.150;Didelphis;D048293
D12.644.360.450.835.800;Mitogen-Activated Protein Kinase 14;D048308
B01.050.150.900.649.573.575.500;Monodelphis;D048309
B01.050.150.900.649.573.600;Potoroidae;D048328
B01.050.150.900.649.573.587;Phalangeridae;D048329
B01.050.150.900.649.573.587.800;Trichosurus;D048330
G02.111.087.847.500;Reverse Transcription;D048348
G02.149.115.847.500;Reverse Transcription;D048348
G05.355.310.700.500;Reverse Transcription;D048348
B01.050.150.900.649.573.590;Phascolarctidae;D048368
D08.811.913.696.620.682.700.565.100;MAP Kinase Kinase 1;D048369
D08.811.913.696.620.682.725.200.100;MAP Kinase Kinase 1;D048369
D12.644.360.440.100;MAP Kinase Kinase 1;D048369
D12.776.476.440.100;MAP Kinase Kinase 1;D048369
D08.811.913.696.620.682.700.565.200;MAP Kinase Kinase 2;D048370
D08.811.913.696.620.682.725.200.200;MAP Kinase Kinase 2;D048370
D12.644.360.440.200;MAP Kinase Kinase 2;D048370
D12.776.476.440.200;MAP Kinase Kinase 2;D048370
D08.811.913.696.620.682.700.565.300;MAP Kinase Kinase 3;D048371
D08.811.913.696.620.682.725.200.300;MAP Kinase Kinase 3;D048371
D12.644.360.440.300;MAP Kinase Kinase 3;D048371
D12.776.476.440.300;MAP Kinase Kinase 3;D048371
B03.300.390.400.810.768.200;Streptomyces coelicolor;D048372
B03.510.024.049.775.775.200;Streptomyces coelicolor;D048372
B03.510.415.400.810.768.200;Streptomyces coelicolor;D048372
B03.510.460.410.810.768.200;Streptomyces coelicolor;D048372
B03.440.425.410.711.795.700;Treponema denticola;D048373
B03.851.595.795.200;Treponema denticola;D048373
B01.050.150.900.493.467;Gadiformes;D048388
B01.050.150.900.493.467.400;Gadus morhua;D048389
B01.650.940.150.469.400;Chlorella vulgaris;D048408
B03.440.450.019.025.690;Aeromonas salmonicida;D048409
B03.660.250.017.025.690;Aeromonas salmonicida;D048409
B01.050.150.900.493.559.600;Petromyzon;D048428
G04.325;Cell Size;D048429
G04.320;Cell Shape;D048430
D02.241.081.251.583;Phenylcarbamates;D048448
B01.300.107.800.700;Podospora;D048468
B01.043.185.650.375.550.637.150;Paramecium caudatum;D048488
B01.043.185.650.375.550.637.074;Paramecium aurelia;D048489
D08.811.913.696.620.682.700.559.842;raf Kinases;D048490
D12.644.360.400.842;raf Kinases;D048490
D12.776.476.400.842;raf Kinases;D048490
D12.776.624.664.700.204;raf Kinases;D048490
D12.776.476.400.842.374;Proto-Oncogene Proteins A-raf;D048491
B01.050.500.500.736.715.800.610.900;Paragonimus westermani;D048492
D08.811.913.696.620.682.700.559.842.374;Proto-Oncogene Proteins B-raf;D048493
D12.644.360.400.842.374;Proto-Oncogene Proteins B-raf;D048493
D12.776.476.400.842.437;Proto-Oncogene Proteins B-raf;D048493
D12.776.624.664.700.204.200;Proto-Oncogene Proteins B-raf;D048493
B01.050.500.131.166.132.832.400.712;Rhipicephalus;D048494
B01.050.500.131.166.132.832.400.712.700;Rhipicephalus sanguineus;D048508
B01.050.150.900.649.801.400.112.199.120.530;Mandrillus;D048528
B01.050.150.900.649.801.400.112.199.120.610.400;Papio hamadryas;D048529
B01.050.150.900.649.801.400.112.199.120.610.050;Papio anubis;D048530
B01.050.150.900.649.801.400.112.199.120.610.600;Papio papio;D048531
B01.050.150.900.649.801.400.112.199.120.610.150;Papio cynocephalus;D048548
B01.050.150.900.649.801.400.112.199.120.610.800;Papio ursinus;D048549
C06.552.308;Hepatic Insufficiency;D048550
B03.300.390.400.200.160.350;Clostridium botulinum type G;D048568
B03.510.415.400.200.160.350;Clostridium botulinum type G;D048568
D03.383.533.249;Benzoxazines;D048588
D03.438.209;Benzoxazines;D048588
B01.050.150.900.649.077.380.513.500;Rupicapra;D048608
D02.540.505.250.445;Ketolides;D048628
A11.284.430.106.570;Micronuclei, Chromosome-Defective;D048629
A11.284.430.214.190.875.117.570;Micronuclei, Chromosome-Defective;D048629
C23.550.210.570;Micronuclei, Chromosome-Defective;D048629
G05.365.590.175.570;Micronuclei, Chromosome-Defective;D048629
D08.811.464.257.275;Polyketide Synthases;D048630
D08.811.600.715;Polyketide Synthases;D048630
A11.284.430.106.575;Micronucleus, Germline;D048631
A11.284.430.214.190.875.117.575;Micronucleus, Germline;D048631
A11.284.430.106.550;Macronucleus;D048648
A11.284.430.214.190.875.117.550;Macronucleus;D048648
B03.510.460.400.410.475.475.250;Lactobacillus delbrueckii;D048668
B03.510.550.450.475.250;Lactobacillus delbrueckii;D048668
D08.811.913.696.620.682.700.565.600;MAP Kinase Kinase 6;D048669
D08.811.913.696.620.682.725.200.600;MAP Kinase Kinase 6;D048669
D12.644.360.440.600;MAP Kinase Kinase 6;D048669
D12.776.476.440.600;MAP Kinase Kinase 6;D048669
D08.811.913.696.620.682.700.565.400;MAP Kinase Kinase 4;D048670
D08.811.913.696.620.682.725.200.400;MAP Kinase Kinase 4;D048670
D12.644.360.440.400;MAP Kinase Kinase 4;D048670
D12.776.476.440.400;MAP Kinase Kinase 4;D048670
D08.811.913.696.620.682.700.565.500;MAP Kinase Kinase 5;D048671
D08.811.913.696.620.682.725.200.500;MAP Kinase Kinase 5;D048671
D12.644.360.440.500;MAP Kinase Kinase 5;D048671
D12.776.476.440.500;MAP Kinase Kinase 5;D048671
D08.811.913.696.620.682.700.565.700;MAP Kinase Kinase 7;D048688
D08.811.913.696.620.682.725.200.700;MAP Kinase Kinase 7;D048688
D12.644.360.440.700;MAP Kinase Kinase 7;D048688
D12.776.476.440.700;MAP Kinase Kinase 7;D048688
A19.374;Fruiting Bodies, Fungal;D048690
B01.300.179.100.350;Grifola;D048691
G04.299.233;Cell Growth Processes;D048708
G07.700.320.249.410;Cell Growth Processes;D048708
D08.811.913.696.620.682.700.559.100;MAP Kinase Kinase Kinase 1;D048728
D12.644.360.400.100;MAP Kinase Kinase Kinase 1;D048728
D12.776.476.400.100;MAP Kinase Kinase Kinase 1;D048728
D02.455.426.559.389.657.410.595.151;Anacardic Acids;D048729
D08.811.913.696.620.682.700.559.200;MAP Kinase Kinase Kinase 2;D048730
D12.644.360.400.200;MAP Kinase Kinase Kinase 2;D048730
D12.776.476.400.200;MAP Kinase Kinase Kinase 2;D048730
D08.811.913.696.620.682.700.559.300;MAP Kinase Kinase Kinase 3;D048748
D12.644.360.400.300;MAP Kinase Kinase Kinase 3;D048748
D12.776.476.400.300;MAP Kinase Kinase Kinase 3;D048748
G04.299.134.220.250;Cytokinesis;D048749
G04.299.134.220.220;Cell Nucleus Division;D048750
G05.355.105.220;Cell Nucleus Division;D048750
D08.811.913.696.620.682.700.559.400;MAP Kinase Kinase Kinase 4;D048768
D12.644.360.400.400;MAP Kinase Kinase Kinase 4;D048768
D12.776.476.400.400;MAP Kinase Kinase Kinase 4;D048768
G07.700.320;Growth and Development;D048788
D27.505.696.399.472.277.540.500;Phytoestrogens;D048789
B01.050.500.308.237.700;Renilla;D048790
D08.811.277.450.483.044;alpha-N-Acetylgalactosaminidase;D048809
D08.811.277.450.483.112;beta-N-Acetyl-Galactosaminidase;D048828
D08.811.913.696.620.682.700.559.500;MAP Kinase Kinase Kinase 5;D048848
D12.644.360.400.500;MAP Kinase Kinase Kinase 5;D048848
D12.776.476.400.500;MAP Kinase Kinase Kinase 5;D048848
D12.644.360.024;Adaptor Proteins, Signal Transducing;D048868
D12.776.157.057;Adaptor Proteins, Signal Transducing;D048868
D12.776.476.024;Adaptor Proteins, Signal Transducing;D048868
B01.050.500.131.617.069.307;Fireflies;D048888
B01.050.500.131.617.069.900;Weevils;D048889
B03.440.450.900.050.860;Aliivibrio fischeri;D048908
B03.660.250.830.050.860;Aliivibrio fischeri;D048908
C19.246.099;Diabetes Complications;D048909
B03.440.475.100.655;Prochlorophytes;D048928
B03.440.475.100.655.600;Prochlorococcus;D048929
D12.644.360.024.313;14-3-3 Proteins;D048948
D12.776.157.057.126;14-3-3 Proteins;D048948
D12.776.476.024.406;14-3-3 Proteins;D048948
C10.597.617.515;Labor Pain;D048949
C23.888.592.612.490;Labor Pain;D048949
C23.888.646.492;Labor Pain;D048949
C13.703.407;Morning Sickness;D048968
C23.888.821.937.049;Morning Sickness;D048968
E02.594.480;Corneal Surgery, Laser;D048988
E04.014.520.480;Corneal Surgery, Laser;D048988
E04.540.825.437;Corneal Surgery, Laser;D048988
E02.594.480.500;Keratectomy, Subepithelial, Laser-Assisted;D049008
E04.014.520.480.500;Keratectomy, Subepithelial, Laser-Assisted;D049008
E04.540.825.437.249;Keratectomy, Subepithelial, Laser-Assisted;D049008
D05.500.149;Dystrophin-Associated Protein Complex;D049028
D12.776.210.500.410;Dystrophin-Associated Proteins;D049029
D12.776.220.362;Dystrophin-Associated Proteins;D049029
D12.776.543.268;Dystrophin-Associated Proteins;D049029
D12.776.210.500.410.500;Dystroglycans;D049030
D12.776.220.362.249;Dystroglycans;D049030
D12.776.543.268.500;Dystroglycans;D049030
D12.776.210.500.410.750;Sarcoglycans;D049031
D12.776.543.268.750;Sarcoglycans;D049031
D12.776.543.550.712;Sarcoglycans;D049031
A10.615.284.375;Chorioallantoic Membrane;D049033
A13.350.575;Chorioallantoic Membrane;D049033
A16.331.400;Chorioallantoic Membrane;D049033
D23.641.399;Pheromones, Human;D049049
C05.660.207.707.624;Plagiocephaly, Nonsynostotic;D049068
C16.131.621.207.707.624;Plagiocephaly, Nonsynostotic;D049068
D08.811.277.656.149;ATP-Dependent Proteases;D049069
D08.811.277.656.149.099.750;Protease La;D049070
D08.811.277.656.300.065.750;Protease La;D049070
D08.811.277.656.149.099.500;Endopeptidase Clp;D049071
D08.811.277.656.300.065.500;Endopeptidase Clp;D049071
D12.776.183.249;Endopeptidase Clp;D049071
D12.776.575.374;Endopeptidase Clp;D049071
D12.776.765.199.249;Endopeptidase Clp;D049071
E02.065;Bariatrics;D049088
G04.299.233.500;Cell Enlargement;D049108
G07.700.320.249.410.500;Cell Enlargement;D049108
G04.299.233.750;Cell Proliferation;D049109
G07.700.320.249.410.750;Cell Proliferation;D049109
D08.211.790;Sphingolipid Activator Proteins;D049128
G02.111.087.019.055;Aminoacylation;D049148
G02.111.087.675.050;Aminoacylation;D049148
G02.149.115.019.055;Aminoacylation;D049148
G02.149.115.675.050;Aminoacylation;D049148
G02.149.465.030.526;Aminoacylation;D049148
G02.607.750.030.526;Aminoacylation;D049148
G03.495.095.055;Aminoacylation;D049148
G03.495.770.050;Aminoacylation;D049148
G08.686.785.760.769.570;Pregnancy, Unplanned;D049168
C13.703.824;Prenatal Injuries;D049188
L01.453.245.945.380;Healthcare Common Procedure Coding System;D049228
L01.700.508.300.680.350;Healthcare Common Procedure Coding System;D049228
N04.452.515.350;Healthcare Common Procedure Coding System;D049228
A08.663.256.200;Dendritic Spines;D049229
A11.284.180.225.169;Dendritic Spines;D049229
A11.671.240.169;Dendritic Spines;D049229
D12.776.260.698.701.500.625;Retinoid X Receptor beta;D049230
D12.776.826.701.500.625;Retinoid X Receptor beta;D049230
D12.776.930.669.701.500.625;Retinoid X Receptor beta;D049230
D08.211.790.500;Saposins;D049231
C26.986.224;Decapitation;D049248
I01.198.780.937.422;Exhumation;D049249
L01.224.900.889;Speech Recognition Software;D049250
E01.370.350.350.800.700;Positron-Emission Tomography;D049268
E01.370.350.600.350.800.399;Positron-Emission Tomography;D049268
E01.370.350.710.800.399;Positron-Emission Tomography;D049268
E01.370.350.825.800.399;Positron-Emission Tomography;D049268
E01.370.384.730.800.399;Positron-Emission Tomography;D049268
L01.178.847.900;Videoconferencing;D049269
C05.651.534.500.280;Muscular Dystrophies, Limb-Girdle;D049288
C10.668.491.175.500.149;Muscular Dystrophies, Limb-Girdle;D049288
C16.320.577.280;Muscular Dystrophies, Limb-Girdle;D049288
D08.211.790.249;G(M2) Activator Protein;D049289
C10.228.140.163.100.435.825.300.300.750;Tay-Sachs Disease, AB Variant;D049290
C16.320.565.189.435.825.300.300.750;Tay-Sachs Disease, AB Variant;D049290
C16.320.565.398.641.803.350.300.925;Tay-Sachs Disease, AB Variant;D049290
C16.320.565.595.554.825.300.300.920;Tay-Sachs Disease, AB Variant;D049290
C18.452.132.100.435.825.300.300.750;Tay-Sachs Disease, AB Variant;D049290
C18.452.584.687.803.350.300.925;Tay-Sachs Disease, AB Variant;D049290
C18.452.648.189.435.825.300.300.750;Tay-Sachs Disease, AB Variant;D049290
C18.452.648.398.641.803.350.300.925;Tay-Sachs Disease, AB Variant;D049290
C18.452.648.595.554.825.300.300.920;Tay-Sachs Disease, AB Variant;D049290
C23.550.470.640;Seroma;D049291
C23.550.522;Leukoaraiosis;D049292
L01.700.508.280.730;MedlinePlus;D049293
D12.776.157.674;Phospholipid Transfer Proteins;D049294
D12.776.543.693;Phospholipid Transfer Proteins;D049294
D08.811.682.690.416;Dioxygenases;D049308
C04.557.470.700.040;Acanthoma;D049309
C04.588.805.040;Acanthoma;D049309
C05.651.534.500.074;Distal Myopathies;D049310
C10.668.491.175.500.074;Distal Myopathies;D049310
C16.320.577.074;Distal Myopathies;D049310
D12.776.543.750.100.420;Receptors, Lysophospholipid;D049312
C04.557.665.560.615.530;Mongolian Spot;D049328
J01.637.512;Nanostructures;D049329
D12.776.543.750.100.420.500;Receptors, Lysosphingolipid;D049349
D12.776.543.750.100.420.249;Receptors, Lysophosphatidic Acid;D049368
D02.113.650;Polyanhydrides;D049388
D05.750.725;Polyanhydrides;D049388
D27.720.470.410.505;Luminescent Agents;D049408
D08.811.682.517.750;Luciferases, Firefly;D049409
D12.776.092.500.577;Luciferases, Firefly;D049409
D12.776.532.510.500;Luciferases, Firefly;D049409
D08.811.682.517.875;Luciferases, Renilla;D049410
D12.776.532.510.750;Luciferases, Renilla;D049410
D12.776.220.987;Utrophin;D049411
D12.776.543.985;Utrophin;D049411
A07.037;Blood-Nerve Barrier;D049428
A08.800.800.090;Blood-Nerve Barrier;D049428
H02.403.330.300;Forensic Pathology;D049429
H02.403.650.249;Forensic Pathology;D049429
I01.198.780.937.460;Forensic Pathology;D049429
E01.370.350.500.100;Cholangiopancreatography, Magnetic Resonance;D049448
E01.370.350.825.500.100;Cholangiopancreatography, Magnetic Resonance;D049448
E01.370.372.207;Cholangiopancreatography, Magnetic Resonance;D049448
G01.358.500.505.650.665;Luminescence;D049449
G01.590.540.665;Luminescence;D049449
G01.750.250.650.665;Luminescence;D049449
G01.750.770.578.665;Luminescence;D049449
G01.358.500.505.650.440;Incandescence;D049450
G01.590.540.440;Incandescence;D049450
G01.750.250.650.440;Incandescence;D049450
G01.750.770.578.440;Incandescence;D049450
E01.789.650;Nomograms;D049451
E05.318.740.500.625;Nomograms;D049451
E05.599.835.895;Nomograms;D049451
G17.582;Nomograms;D049451
N05.715.360.750.530.530;Nomograms;D049451
N06.850.520.830.500.625;Nomograms;D049451
D12.776.532.265;Green Fluorescent Proteins;D049452
D08.811.682.517.500;Luciferases, Bacterial;D049453
D12.776.097.529;Luciferases, Bacterial;D049453
D12.776.532.510.249;Luciferases, Bacterial;D049453
D02.886.675.298;Firefly Luciferin;D049454
D03.383.129.708.298;Firefly Luciferin;D049454
G04.299.134.220.220.781.812;Prometaphase;D049468
G04.299.134.220.220.812;Prometaphase;D049468
G05.355.105.220.781.812;Prometaphase;D049468
G05.355.105.220.812;Prometaphase;D049468
G04.299.134.220.220.687.444;Meiotic Prophase I;D049469
G04.299.134.220.220.875.500;Meiotic Prophase I;D049469
G05.355.105.220.687.500;Meiotic Prophase I;D049469
G05.355.105.220.875.500;Meiotic Prophase I;D049469
G04.299.134.220.220.687.444.600;Pachytene Stage;D049471
G04.299.134.220.220.875.500.600;Pachytene Stage;D049471
G05.355.105.220.687.500.600;Pachytene Stage;D049471
G05.355.105.220.875.500.600;Pachytene Stage;D049471
D12.644.360.562;Phosphatidylethanolamine Binding Protein;D049488
D12.776.157.661;Phosphatidylethanolamine Binding Protein;D049488
D12.776.476.555;Phosphatidylethanolamine Binding Protein;D049488
E01.370.350.755;Stroboscopy;D049489
H01.158.273.180.800;Systems Biology;D049490
D06.472.699.587.200.300;Insulin, Long-Acting;D049528
D12.644.548.586.200.300;Insulin, Long-Acting;D049528
G08.686.702;Postpartum Period;D049590
E01.370.600.115.100.160;Body Size;D049628
E05.041.124.160;Body Size;D049628
G07.100.100.160;Body Size;D049628
G07.700.320.249.314;Body Size;D049628
E01.370.600.115.100.960;Waist-Hip Ratio;D049629
E05.041.124.946;Waist-Hip Ratio;D049629
G07.100.100.960;Waist-Hip Ratio;D049629
A02.633.570.210;Esophageal Sphincter, Lower;D049630
A03.556.875.500.414.350;Esophageal Sphincter, Lower;D049630
A03.556.875.875.330.350;Esophageal Sphincter, Lower;D049630
A02.633.567.800.360;Esophageal Sphincter, Upper;D049631
A03.556.875.500.360;Esophageal Sphincter, Upper;D049631
A04.623.617.360;Esophageal Sphincter, Upper;D049631
A14.724.617.360;Esophageal Sphincter, Upper;D049631
Z01.252.145.281;East Timor;D049648
K01.400.475.500;History, 15th Century;D049668
K01.400.475.750;History, 16th Century;D049669
K01.400.504.750;History, 17th Century;D049670
K01.400.504.875;History, 18th Century;D049671
K01.400.504.937;History, 19th Century;D049672
K01.400.504.968;History, 20th Century;D049673
K01.400.504.984;History, 21st Century;D049674
K01.400.470;History, Ancient;D049690
K01.400.500;History, Medieval;D049691
K01.400.475;History, Early Modern 1451-1600;D049692
K01.400.504;History, Modern 1601-;D049711
G05.360.340.357;Genome, Insect;D049750
G05.360.340.337;Genome, Helminth;D049751
G05.360.340.024.340.290.089;Genes, Mating Type, Fungal;D049770
G05.360.340.325.500.089;Genes, Mating Type, Fungal;D049770
D12.644.770.600;Nuclear Export Signals;D049790
G02.111.570.060.670.600;Nuclear Export Signals;D049790
G05.355.044.350;Genetic Speciation;D049810
G16.100.178.350;Genetic Speciation;D049810
B04.280.037;Anellovirus;D049811
B04.909.204.099;Anellovirus;D049811
B04.970.060;Anellovirus;D049811
B01.050.500.644.116;Cephalopoda;D049830
B01.050.500.644.116.600;Octopodiformes;D049831
B01.050.500.644.116.150;Decapodiformes;D049832
B01.050.500.644.116.150.700;Sepia;D049833
B01.050.500.644.116.150.500;Loligo;D049834
B01.050.500.644.116.550;Nautilus;D049850
B01.050.500.644.400;Gastropoda;D049851
B01.050.500.644.400.150;Clione;D049852
B01.050.500.644.400.600;Pleurobranchaea;D049853
B01.050.500.644.400.400;Hermissenda;D049870
B01.050.500.644.400.800;Tritonia Sea Slug;D049871
B01.050.500.644.080;Bivalvia;D049872
B01.050.500.644.080.150;Cardiidae;D049873
B01.050.500.644.080.175;Corbicula;D049874
B01.050.500.644.080.225;Dreissena;D049875
B01.050.500.644.080.850;Unionidae;D049876
B01.050.500.644.080.850.050;Anodonta;D049877
B01.050.500.644.080.537.500;Mytilus;D049878
B01.050.500.644.080.537;Mytilidae;D049879
B01.050.500.644.080.537.500.500;Mytilus edulis;D049880
B01.050.500.644.080.850.850;Unio;D049881
B01.050.500.644.080.537.600;Perna;D049883
B01.050.500.644.080.750;Spisula;D049890
B01.050.500.644.080.500;Mercenaria;D049891
B01.050.500.644.080.535;Mya;D049892
B01.050.500.644.080.050;Arcidae;D049893
B01.050.500.644.080.050.700;Scapharca;D049894
B01.050.500.644.080.643.600;Ostrea;D049895
B01.050.500.644.080.643.150;Crassostrea;D049896
B01.050.500.644.080.660;Pectinidae;D049897
B01.050.500.644.080.660.600;Pecten;D049910
B01.050.500.644.080.670;Pinctada;D049911
C04.557.470.035.415;Growth Hormone-Secreting Pituitary Adenoma;D049912
C04.588.322.609.292;Growth Hormone-Secreting Pituitary Adenoma;D049912
C10.228.140.617.738.675.299;Growth Hormone-Secreting Pituitary Adenoma;D049912
C19.344.609.292;Growth Hormone-Secreting Pituitary Adenoma;D049912
C19.700.734.292;Growth Hormone-Secreting Pituitary Adenoma;D049912
C04.557.470.035.012;ACTH-Secreting Pituitary Adenoma;D049913
C04.588.322.609.145;ACTH-Secreting Pituitary Adenoma;D049913
C10.228.140.617.738.675.149;ACTH-Secreting Pituitary Adenoma;D049913
C19.344.609.145;ACTH-Secreting Pituitary Adenoma;D049913
C19.700.734.145;ACTH-Secreting Pituitary Adenoma;D049913
C18.452.284;DNA Repair-Deficiency Disorders;D049914
B01.650.940.800.575.100.238.500.750;Ipomoea nil;D049915
B01.050.500.644.600;Polyplacophora;D049916
B01.650.940.800.575.100.327;Dipsacaceae;D049917
B01.650.940.800.575.100.197.682;Salacia;D049918
B01.650.940.800.575.100.100.342;Erigeron;D049919
B03.440.400.425.251.650.600;Ralstonia pickettii;D049920
B03.660.075.077.650.600;Ralstonia pickettii;D049920
B03.440.400.425.251.200;Cupriavidus;D049921
B03.660.075.077.200;Cupriavidus;D049921
B01.650.940.800.575.100.822.942;Vetiveria;D049930
B01.650.940.800.575.100.401.726;Sesbania;D049931
C18.452.284.600;Nijmegen Breakage Syndrome;D049932
D03.438.150.446.139;Aminocoumarins;D049933
D03.830.219.446.139;Aminocoumarins;D049933
D03.438.150.446.598;Isocoumarins;D049934
D03.830.219.446.598;Isocoumarins;D049934
B01.650.940.800.575.100.489;Hernandiaceae;D049935
B01.650.940.800.575.118;Anthocerotophyta;D049936
C19.642.355.239;Hyperparathyroidism, Primary;D049950
G05.355.315.203.249.970;X Chromosome Inactivation;D049951
C11.270.842;Graves Ophthalmopathy;D049970
C11.675.349.500.500;Graves Ophthalmopathy;D049970
C19.874.283.605.500;Graves Ophthalmopathy;D049970
C19.874.397.370.500;Graves Ophthalmopathy;D049970
C20.111.555.500;Graves Ophthalmopathy;D049970
D02.886.655;Thiazides;D049971
D27.505.519.562;Membrane Transport Modulators;D049990
D12.776.157.530.450.625.374;Sodium Chloride Symporters;D049992
D27.505.519.562.812;Sodium Chloride Symporter Inhibitors;D049993
D27.505.696.560.500.863;Sodium Chloride Symporter Inhibitors;D049993
D27.505.519.562.906;Sodium Potassium Chloride Symporter Inhibitors;D049994
D27.505.696.560.500.931;Sodium Potassium Chloride Symporter Inhibitors;D049994
C16.320.427;Hyperthyroxinemia, Familial Dysalbuminemic;D050010
C19.874.410.249;Hyperthyroxinemia, Familial Dysalbuminemic;D050010
C14.280.067.565.070;Andersen Syndrome;D050030
C16.131.240.400.715.070;Andersen Syndrome;D050030
C23.550.073.547.070;Andersen Syndrome;D050030
C19.874.871.102.500;Hashimoto Disease;D050031
C13.703.844.714;Postpartum Thyroiditis;D050032
C19.874.871.102.750;Postpartum Thyroiditis;D050032
C16.131.894;Thyroid Dysgenesis;D050033
C19.874.689;Thyroid Dysgenesis;D050033
D27.505.696.560.249;Antidiuretic Agents;D050034
C12.706.316.309.631;Sexual Infantilism;D050035
C13.351.875.253.309.631;Sexual Infantilism;D050035
C16.131.939.316.309.631;Sexual Infantilism;D050035
C19.391.119.309.631;Sexual Infantilism;D050035
C19.391.482.814;Sexual Infantilism;D050035
G02.111.087.682;Protein Carbonylation;D050050
G02.149.115.682;Protein Carbonylation;D050050
G03.495.710.690;Protein Carbonylation;D050050
D12.776.157.530.400.901;Transient Receptor Potential Channels;D050051
D12.776.543.585.400.901;Transient Receptor Potential Channels;D050051
D12.776.157.530.400.901.500;TRPC Cation Channels;D050052
D12.776.543.585.400.901.500;TRPC Cation Channels;D050052
D12.776.157.530.400.901.555;TRPM Cation Channels;D050053
D12.776.543.585.400.901.555;TRPM Cation Channels;D050053
D27.505.696.242;Bone Density Conservation Agents;D050071
C22.196.963;White Heifer Disease;D050072
C12.706.316.343;Ovotesticular Disorders of Sex Development;D050090
C13.351.875.253.343;Ovotesticular Disorders of Sex Development;D050090
C16.131.939.316.343;Ovotesticular Disorders of Sex Development;D050090
C19.391.119.343;Ovotesticular Disorders of Sex Development;D050090
D05.750.327;Dendrimers;D050091
E02.319.300.380.200;Dendrimers;D050091
J01.637.512.600.200;Dendrimers;D050091
E02.065.062;Bariatric Surgery;D050110
E04.062;Bariatric Surgery;D050110
D02.491.567;Imino Sugars;D050111
D09.546.412;Imino Sugars;D050111
D02.491.567.500;Imino Pyranoses;D050112
D03.383.621.300;Imino Pyranoses;D050112
D09.546.412.500;Imino Pyranoses;D050112
D02.491.567.249;Imino Furanoses;D050113
D03.383.773.371;Imino Furanoses;D050113
D09.546.412.249;Imino Furanoses;D050113
E02.095.601;Oncolytic Virotherapy;D050130
D12.644.456.270;Chalones;D050150
A10.165.114.830.750;Subcutaneous Fat;D050151
A10.165.114.830.500.500;Intra-Abdominal Fat;D050152
A10.165.114.830.500;Abdominal Fat;D050153
E01.370.600.115.100.062.500;Adiposity;D050154
G02.111.097.134.500;Adiposity;D050154
G03.180.134.500;Adiposity;D050154
G07.100.049.134.500;Adiposity;D050154
G02.111.087.525;Lipogenesis;D050155
G02.149.115.525;Lipogenesis;D050155
G03.495.520.249;Lipogenesis;D050155
G04.299.151.149;Adipogenesis;D050156
C18.452.584.500;Dyslipidemias;D050171
G05.360.340.024.340.500;Genes, X-Linked;D050172
G05.420.457;Genes, X-Linked;D050172
G05.360.340.024.340.515;Genes, Y-Linked;D050173
G05.420.523;Genes, Y-Linked;D050173
C16.320.338;Genetic Diseases, Y-Linked;D050174
B01.300.360.500.500.600;Pansporablastina;D050175
C23.888.144.699;Overweight;D050177
E01.370.600.115.100.160.120.699;Overweight;D050177
G07.100.100.160.120.699;Overweight;D050177
D10.351.676;Monoglycerides;D050178
C14.907.137.126.307;Atherosclerosis;D050197
D02.033.100.624.698;Phenoxypropanolamines;D050198
D02.033.755.624.698;Phenoxypropanolamines;D050198
D02.092.063.624.698;Phenoxypropanolamines;D050198
A05.810.453.324.359.372.650;Podocytes;D050199
A05.810.453.736.520.720;Podocytes;D050199
A11.436.720;Podocytes;D050199
G03.495.244.820.500;Metabolic Detoxication, Phase I;D050216
G07.690.812.097.600.500;Metabolic Detoxication, Phase I;D050216
G07.700.680.097.600.500;Metabolic Detoxication, Phase I;D050216
G03.495.244.820.750;Metabolic Detoxication, Phase II;D050217
G07.690.812.097.600.750;Metabolic Detoxication, Phase II;D050217
G07.700.680.097.600.750;Metabolic Detoxication, Phase II;D050217
E01.370.600.115.100.062;Body Fat Distribution;D050218
G02.111.097.134;Body Fat Distribution;D050218
G03.180.134;Body Fat Distribution;D050218
G07.100.049.134;Body Fat Distribution;D050218
B01.300.360.500.500.600.050;Amblyospora;D050219
B01.300.360.500.500.600.400;Glugea;D050220
D27.505.519.593.249;Antimitotic Agents;D050256
D27.505.954.248.147;Antimitotic Agents;D050256
D27.505.519.593.249.500;Tubulin Modulators;D050257
D27.505.519.593;Mitosis Modulators;D050258
G05.360.340.024.340.365;Genes, Mitochondrial;D050259
G05.420.275.500;Genes, Mitochondrial;D050259
G02.111.087.160;Carbohydrate Metabolism;D050260
G02.149.115.160;Carbohydrate Metabolism;D050260
G03.495.256;Carbohydrate Metabolism;D050260
G02.111.087.160.625;Glycogenolysis;D050261
G02.149.115.160.625;Glycogenolysis;D050261
G03.495.256.625;Glycogenolysis;D050261
B01.300.360.500.500.600.500;Loma;D050262
B01.300.360.500.500.600.800;Thelohania;D050263
A02.835.232.087.319;Hand Bones;D050276
A02.835.232.043.300.800;Toe Phalanges;D050277
A02.835.232.087.319.350;Finger Phalanges;D050278
A02.835.232.087.319.550;Metacarpal Bones;D050279
A02.835.232.087.090;Arm Bones;D050280
A02.835.232.043;Bones of Lower Extremity;D050281
G06.580;Microbial Viability;D050296
B01.500;Mesomycetozoea;D050298
D27.505.519.421;Fibrin Modulating Agents;D050299
L01.700.508.300.408.600;Medical Order Entry Systems;D050316
L01.700.508.300.680.360.450;Medical Order Entry Systems;D050316
L01.700.508.300.695.600;Medical Order Entry Systems;D050316
N04.452.442.452.500;Medical Order Entry Systems;D050316
N04.452.515.360.500;Medical Order Entry Systems;D050316
N04.452.859.564.650.500;Medical Order Entry Systems;D050316
C05.116.099.343.796;Mulibrey Nanism;D050336
C16.320.240.875;Mulibrey Nanism;D050336
D02.092.877.883;Trimethyl Ammonium Compounds;D050337
D02.092.877.674;Phenylammonium Compounds;D050338
D02.092.877.096;Benzylammonium Compounds;D050339
G03.495.520;Lipid Metabolism;D050356
E04.555.130.100;Bone-Patellar Tendon-Bone Graft;D050376
E04.936.450.050.100;Bone-Patellar Tendon-Bone Graft;D050376
E04.936.337;Cold Ischemia;D050377
E05.760.833.445;Cold Ischemia;D050377
A11.118.637.555.567.550.500.700;T-Lymphocytes, Regulatory;D050378
A11.118.637.555.567.569.200.700;T-Lymphocytes, Regulatory;D050378
A11.118.637.555.567.569.500.700;T-Lymphocytes, Regulatory;D050378
A15.145.229.637.555.567.550.500.700;T-Lymphocytes, Regulatory;D050378
A15.145.229.637.555.567.569.200.700;T-Lymphocytes, Regulatory;D050378
A15.145.229.637.555.567.569.500.700;T-Lymphocytes, Regulatory;D050378
A15.382.490.555.567.550.500.700;T-Lymphocytes, Regulatory;D050378
A15.382.490.555.567.569.200.700;T-Lymphocytes, Regulatory;D050378
A15.382.490.555.567.569.500.700;T-Lymphocytes, Regulatory;D050378
C14.907.137.126.056;Arteriolosclerosis;D050379
C18.452.174.130.780.500;Monckeberg Medial Calcific Sclerosis;D050380
D12.776.157.530.400.150.900;TRPP Cation Channels;D050396
D12.776.157.530.400.901.777;TRPP Cation Channels;D050396
D12.776.543.585.400.150.900;TRPP Cation Channels;D050396
D12.776.543.585.400.901.777;TRPP Cation Channels;D050396
E02.815.635.700.700;Radiotherapy, Intensity-Modulated;D050397
L01.700.508.100.710.600.550.700;Radiotherapy, Intensity-Modulated;D050397
C04.588.149.030;Adamantinoma;D050398
C05.116.231.030;Adamantinoma;D050398
A03.734.414.065;Glucagon-Secreting Cells;D050416
A06.390.087;Glucagon-Secreting Cells;D050416
A06.407.414.043;Glucagon-Secreting Cells;D050416
A11.382.625.064;Glucagon-Secreting Cells;D050416
A11.436.294.064;Glucagon-Secreting Cells;D050416
A03.734.414.131;Insulin-Secreting Cells;D050417
A06.390.131;Insulin-Secreting Cells;D050417
A06.407.414.087;Insulin-Secreting Cells;D050417
A11.382.625.092;Insulin-Secreting Cells;D050417
A11.436.294.092;Insulin-Secreting Cells;D050417
A03.734.414.587;Pancreatic Polypeptide-Secreting Cells;D050418
A06.390.650;Pancreatic Polypeptide-Secreting Cells;D050418
A06.407.414.587;Pancreatic Polypeptide-Secreting Cells;D050418
A11.382.625.900;Pancreatic Polypeptide-Secreting Cells;D050418
A11.436.294.900;Pancreatic Polypeptide-Secreting Cells;D050418
G05.360.340.024.340.137.750;Regulatory Elements, Transcriptional;D050436
G05.360.340.024.340.230;Genes, Developmental;D050437
G05.360.340.024.340.335.300;Genes, Immunoglobulin Heavy Chain;D050438
G05.360.340.024.340.335.310;Genes, Immunoglobulin Light Chain;D050439
D12.776.124.486.485.705;Immunoglobulin Subunits;D050440
D12.776.124.790.651.705;Immunoglobulin Subunits;D050440
D12.776.377.715.548.705;Immunoglobulin Subunits;D050440
G05.360.340.024.340.137.232.920;VDJ Exons;D050441
G05.360.340.024.340.335.655;VDJ Exons;D050441
N06.850.295.300;Fomites;D050456
A05.810.453.736.560.254;Bowman Capsule;D050476
D06.472.699.322.576.583.500;Urofollitropin;D050477
D06.472.699.631.525.343.583.500;Urofollitropin;D050477
D12.644.548.691.525.343.583.500;Urofollitropin;D050477
D12.776.157.530.562;Neurotransmitter Transport Proteins;D050479
D12.776.543.585.562;Neurotransmitter Transport Proteins;D050479
D12.776.157.530.562.374;Plasma Membrane Neurotransmitter Transport Proteins;D050480
D12.776.543.585.562.374;Plasma Membrane Neurotransmitter Transport Proteins;D050480
D12.776.157.530.450.162.887;Vesicular Neurotransmitter Transport Proteins;D050481
D12.776.157.530.562.750;Vesicular Neurotransmitter Transport Proteins;D050481
D12.776.543.585.450.162.887;Vesicular Neurotransmitter Transport Proteins;D050481
D12.776.543.585.562.750;Vesicular Neurotransmitter Transport Proteins;D050481
D12.776.157.530.562.374.500;Catecholamine Plasma Membrane Transport Proteins;D050482
D12.776.543.585.562.374.500;Catecholamine Plasma Membrane Transport Proteins;D050482
D12.776.157.530.450.625.124;Dopamine Plasma Membrane Transport Proteins;D050483
D12.776.157.530.562.374.500.500;Dopamine Plasma Membrane Transport Proteins;D050483
D12.776.543.585.450.625.124;Dopamine Plasma Membrane Transport Proteins;D050483
D12.776.543.585.562.374.500.500;Dopamine Plasma Membrane Transport Proteins;D050483
D12.776.157.530.450.625.186;Norepinephrine Plasma Membrane Transport Proteins;D050484
D12.776.157.530.562.374.500.750;Norepinephrine Plasma Membrane Transport Proteins;D050484
D12.776.543.585.450.625.186;Norepinephrine Plasma Membrane Transport Proteins;D050484
D12.776.543.585.562.374.500.750;Norepinephrine Plasma Membrane Transport Proteins;D050484
D12.776.157.530.450.625.139;GABA Plasma Membrane Transport Proteins;D050485
D12.776.157.530.562.374.750;GABA Plasma Membrane Transport Proteins;D050485
D12.776.543.585.450.625.139;GABA Plasma Membrane Transport Proteins;D050485
D12.776.543.585.562.374.750;GABA Plasma Membrane Transport Proteins;D050485
D12.776.157.530.450.625.311;Serotonin Plasma Membrane Transport Proteins;D050486
D12.776.157.530.562.374.875;Serotonin Plasma Membrane Transport Proteins;D050486
D12.776.543.585.450.625.374;Serotonin Plasma Membrane Transport Proteins;D050486
D12.776.543.585.562.374.875;Serotonin Plasma Membrane Transport Proteins;D050486
D12.776.157.530.450.625.155;Glycine Plasma Membrane Transport Proteins;D050487
D12.776.157.530.562.374.812;Glycine Plasma Membrane Transport Proteins;D050487
D12.776.543.585.200.500.875;Glycine Plasma Membrane Transport Proteins;D050487
D12.776.543.585.450.625.155;Glycine Plasma Membrane Transport Proteins;D050487
D12.776.543.585.562.374.812;Glycine Plasma Membrane Transport Proteins;D050487
C05.330.612;Hallux Varus;D050488
C05.330.488.099;Bunion, Tailor's;D050489
D12.776.602.500.500.660;Oncogene Protein tpr-met;D050490
D12.776.624.664.500.660;Oncogene Protein tpr-met;D050490
D12.776.157.530.200.249.500.500;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.157.530.450.625.147;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.157.530.562.374.781;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.543.585.200.249.500.500;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.543.585.450.625.147;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.543.585.562.374.781;Glutamate Plasma Membrane Transport Proteins;D050491
D12.776.157.530.450.162.887.500;Vesicular Biogenic Amine Transport Proteins;D050492
D12.776.157.530.562.750.500;Vesicular Biogenic Amine Transport Proteins;D050492
D12.776.543.585.450.162.887.500;Vesicular Biogenic Amine Transport Proteins;D050492
D12.776.543.585.562.750.500;Vesicular Biogenic Amine Transport Proteins;D050492
D12.776.157.530.450.162.887.500.500;Vesicular Monoamine Transport Proteins;D050493
D12.776.157.530.562.750.500.500;Vesicular Monoamine Transport Proteins;D050493
D12.776.543.585.450.162.887.500.500;Vesicular Monoamine Transport Proteins;D050493
D12.776.543.585.562.750.500.500;Vesicular Monoamine Transport Proteins;D050493
D12.776.157.530.450.162.887.500.249;Vesicular Acetylcholine Transport Proteins;D050494
D12.776.157.530.562.750.500.249;Vesicular Acetylcholine Transport Proteins;D050494
D12.776.543.585.450.162.887.500.249;Vesicular Acetylcholine Transport Proteins;D050494
D12.776.543.585.562.750.500.249;Vesicular Acetylcholine Transport Proteins;D050494
D12.776.157.530.450.162.887.750;Vesicular Inhibitory Amino Acid Transport Proteins;D050495
D12.776.157.530.562.750.750;Vesicular Inhibitory Amino Acid Transport Proteins;D050495
D12.776.543.585.450.162.887.750;Vesicular Inhibitory Amino Acid Transport Proteins;D050495
D12.776.543.585.562.750.750;Vesicular Inhibitory Amino Acid Transport Proteins;D050495
D12.776.157.530.450.162.887.625;Vesicular Glutamate Transport Proteins;D050496
D12.776.157.530.562.750.625;Vesicular Glutamate Transport Proteins;D050496
D12.776.543.585.450.162.887.625;Vesicular Glutamate Transport Proteins;D050496
D12.776.543.585.562.750.625;Vesicular Glutamate Transport Proteins;D050496
G08.686.785.760.769.530.500;Stillbirth;D050497
G08.686.785.760.769.530.249;Live Birth;D050498
G08.686.760.204;Adrenarche;D050499
G08.686.785.880.374.204;Adrenarche;D050499
C06.689.750.830;Pancreatitis, Chronic;D050500
B03.280.575.150;Nostoc commune;D050501
B03.440.475.100.575.150;Nostoc commune;D050501
B03.280.575.500;Nostoc muscorum;D050502
B03.440.475.100.575.500;Nostoc muscorum;D050502
D08.811.682.690.416.333;Indoleamine-Pyrrole 2,3,-Dioxygenase;D050503
B04.700;Oncolytic Viruses;D050504
D12.776.602;Mutant Proteins;D050505
D12.776.602.500;Mutant Chimeric Proteins;D050506
A10.165.114.830.500.750;Subcutaneous Fat, Abdominal;D050507
A10.165.114.830.750.500;Subcutaneous Fat, Abdominal;D050507
A05.810.453.324.359.620;Mesangial Cells;D050527
A05.810.453.736.520.620;Mesangial Cells;D050527
A11.329.228.950;Mesangial Cells;D050527
E02.642.249.245;Diet, Carbohydrate-Restricted;D050528
G07.610.240.245;Diet, Carbohydrate-Restricted;D050528
A05.810.453.324.359.372.400;Glomerular Basement Membrane;D050533
A05.810.453.736.520.224;Glomerular Basement Membrane;D050533
A10.615.179.625;Glomerular Basement Membrane;D050533
A11.284.295.310.279;Glomerular Basement Membrane;D050533
D08.811.682.047.150.700.400.500;Glycerol-3-Phosphate Dehydrogenase (NAD+);D050536
D08.811.682.047.432;Hydroxypyruvate Reductase;D050537
D08.811.682.047.748;Malate Dehydrogenase (NADP+);D050538
D08.811.682.047.500;3-Isopropylmalate Dehydrogenase;D050539
D08.811.682.047.524;Ketol-Acid Reductoisomerase;D050540
A09.371.060.217.113;Bowman Membrane;D050541
D08.811.682.047.150.700.237;D-Xylulose Reductase;D050542
D08.811.682.047.150.650;Phosphoglycerate Dehydrogenase;D050543
D08.811.682.047.150.700.437;L-Gulonolactone Oxidase;D050544
D08.811.682.047.180;Choline Dehydrogenase;D050545
D05.500.562.488.374.875;Plastoquinol-Plastocyanin Reductase;D050547
D08.811.600.710.374.875;Plastoquinol-Plastocyanin Reductase;D050547
D08.811.682.771;Plastoquinol-Plastocyanin Reductase;D050547
D12.776.183.750.750.374.875;Plastoquinol-Plastocyanin Reductase;D050547
D12.776.543.585.450.250.875.311.875;Plastoquinol-Plastocyanin Reductase;D050547
D12.776.543.983.500.374.875;Plastoquinol-Plastocyanin Reductase;D050547
D12.776.765.199.750.750.374.875;Plastoquinol-Plastocyanin Reductase;D050547
D08.811.682.690.416.277;Catechol 1,2-Dioxygenase;D050548
D12.776.157.170;Fatty Acid-Binding Proteins;D050556
D08.811.682.690.416.305;Catechol 2,3-Dioxygenase;D050557
D08.811.682.690.416.319;Cysteine Dioxygenase;D050558
D08.811.682.690.708.392.312;beta-Carotene 15,15'-Monooxygenase;D050559
D08.811.682.690.416.326;Homogentisate 1,2-Dioxygenase;D050560
D08.811.682.690.416.328;3-Hydroxyanthranilate 3,4-Dioxygenase;D050561
D08.811.682.690.562;Inositol Oxygenase;D050562
D12.776.556.579.374.281;Inositol Oxygenase;D050562
D08.811.682.690.708.401;gamma-Butyrobetaine Dioxygenase;D050563
D08.244.453.957;Trans-Cinnamate 4-Monooxygenase;D050564
D08.811.682.690.708.826;Trans-Cinnamate 4-Monooxygenase;D050564
D08.811.682.690.708.062;Benzoate 4-Monooxygenase;D050565
D12.776.543.512;Membrane Fusion Proteins;D050576
D12.776.124.486.274.045.387;Complement C3-C5 Convertases;D050577
D12.776.124.486.274.045.387.500;Complement C3-C5 Convertases, Alternative Pathway;D050578
D12.776.124.486.274.045.387.750;Complement C3-C5 Convertases, Classical Pathway;D050579
D12.776.157.530.200.249.500.500.875;Excitatory Amino Acid Transporter 3;D050580
D12.776.157.530.450.625.147.875;Excitatory Amino Acid Transporter 3;D050580
D12.776.157.530.562.374.781.781;Excitatory Amino Acid Transporter 3;D050580
D12.776.543.585.200.249.500.500.875;Excitatory Amino Acid Transporter 3;D050580
D12.776.543.585.450.625.147.875;Excitatory Amino Acid Transporter 3;D050580
D12.776.543.585.562.374.781.781;Excitatory Amino Acid Transporter 3;D050580
D12.776.157.530.200.249.500.500.937;Excitatory Amino Acid Transporter 4;D050581
D12.776.157.530.450.625.147.937;Excitatory Amino Acid Transporter 4;D050581
D12.776.157.530.562.374.781.812;Excitatory Amino Acid Transporter 4;D050581
D12.776.543.585.200.249.500.500.937;Excitatory Amino Acid Transporter 4;D050581
D12.776.543.585.450.625.147.937;Excitatory Amino Acid Transporter 4;D050581
D12.776.543.585.562.374.781.812;Excitatory Amino Acid Transporter 4;D050581
D12.776.157.530.200.249.500.500.968;Excitatory Amino Acid Transporter 5;D050582
D12.776.157.530.450.625.147.968;Excitatory Amino Acid Transporter 5;D050582
D12.776.157.530.562.374.781.875;Excitatory Amino Acid Transporter 5;D050582
D12.776.543.585.200.249.500.500.968;Excitatory Amino Acid Transporter 5;D050582
D12.776.543.585.450.625.147.968;Excitatory Amino Acid Transporter 5;D050582
D12.776.543.585.562.374.781.875;Excitatory Amino Acid Transporter 5;D050582
G05.355.760.385.500;Oncogene Fusion;D050596
D12.776.157.530.450.162.887.625.500;Vesicular Glutamate Transport Protein 1;D050598
D12.776.157.530.562.750.625.500;Vesicular Glutamate Transport Protein 1;D050598
D12.776.543.585.450.162.887.625.500;Vesicular Glutamate Transport Protein 1;D050598
D12.776.543.585.562.750.625.500;Vesicular Glutamate Transport Protein 1;D050598
D12.776.157.530.450.162.887.625.750;Vesicular Glutamate Transport Protein 2;D050599
D12.776.157.530.562.750.625.750;Vesicular Glutamate Transport Protein 2;D050599
D12.776.543.585.450.162.887.625.750;Vesicular Glutamate Transport Protein 2;D050599
D12.776.543.585.562.750.625.750;Vesicular Glutamate Transport Protein 2;D050599
D12.776.543.512.249;SNARE Proteins;D050600
D12.776.543.990.775;SNARE Proteins;D050600
D08.811.682.690.708.557;Kynurenine 3-Monooxygenase;D050601
D08.811.682.690.708.392.468;Linoleoyl-CoA Desaturase;D050602
D08.811.682.690.708.749;Squalene Monooxygenase;D050603
D08.811.682.657.163.875;Succinate-Semialdehyde Dehydrogenase (NADP+);D050604
D08.811.682.657.163.812;Malonate-Semialdehyde Dehydrogenase (Acetylating);D050605
D08.811.277.656.300.760.501;Mannose-Binding Protein-Associated Serine Proteases;D050606
D08.811.277.656.959.350.501;Mannose-Binding Protein-Associated Serine Proteases;D050606
D12.776.124.486.274.045.387.875;Mannose-Binding Protein-Associated Serine Proteases;D050606
D02.691.675;Organogold Compounds;D050607
D12.776.157.530.450.074.750.750;Sodium-Phosphate Cotransporter Proteins;D050608
D12.776.157.530.450.625.625;Sodium-Phosphate Cotransporter Proteins;D050608
D12.776.157.648.500.750;Sodium-Phosphate Cotransporter Proteins;D050608
D12.776.543.585.450.074.750.750;Sodium-Phosphate Cotransporter Proteins;D050608
D12.776.543.585.450.625.625;Sodium-Phosphate Cotransporter Proteins;D050608
D12.776.157.530.450.074.750.750.500;Sodium-Phosphate Cotransporter Proteins, Type I;D050609
D12.776.157.530.450.625.625.500;Sodium-Phosphate Cotransporter Proteins, Type I;D050609
D12.776.157.648.500.750.500;Sodium-Phosphate Cotransporter Proteins, Type I;D050609
D12.776.543.585.450.074.750.750.500;Sodium-Phosphate Cotransporter Proteins, Type I;D050609
D12.776.543.585.450.625.625.500;Sodium-Phosphate Cotransporter Proteins, Type I;D050609
D12.776.157.530.450.074.750.750.750;Sodium-Phosphate Cotransporter Proteins, Type II;D050610
D12.776.157.530.450.625.625.750;Sodium-Phosphate Cotransporter Proteins, Type II;D050610
D12.776.157.648.500.750.750;Sodium-Phosphate Cotransporter Proteins, Type II;D050610
D12.776.543.585.450.074.750.750.750;Sodium-Phosphate Cotransporter Proteins, Type II;D050610
D12.776.543.585.450.625.625.750;Sodium-Phosphate Cotransporter Proteins, Type II;D050610
D12.776.157.530.450.074.750.750.875;Sodium-Phosphate Cotransporter Proteins, Type III;D050611
D12.776.157.530.450.625.625.875;Sodium-Phosphate Cotransporter Proteins, Type III;D050611
D12.776.157.648.500.750.875;Sodium-Phosphate Cotransporter Proteins, Type III;D050611
D12.776.543.585.450.074.750.750.875;Sodium-Phosphate Cotransporter Proteins, Type III;D050611
D12.776.543.585.450.625.625.875;Sodium-Phosphate Cotransporter Proteins, Type III;D050611
D12.776.157.530.300;Fatty Acid Transport Proteins;D050612
D12.776.543.585.300;Fatty Acid Transport Proteins;D050612
D12.776.157.530.450.074.750.750.750.124;Sodium-Phosphate Cotransporter Proteins, Type IIa;D050613
D12.776.157.530.450.625.625.750.124;Sodium-Phosphate Cotransporter Proteins, Type IIa;D050613
D12.776.157.648.500.750.750.124;Sodium-Phosphate Cotransporter Proteins, Type IIa;D050613
D12.776.543.585.450.074.750.750.750.124;Sodium-Phosphate Cotransporter Proteins, Type IIa;D050613
D12.776.543.585.450.625.625.750.124;Sodium-Phosphate Cotransporter Proteins, Type IIa;D050613
D12.776.157.530.450.074.750.750.750.249;Sodium-Phosphate Cotransporter Proteins, Type IIb;D050614
D12.776.157.530.450.625.625.750.249;Sodium-Phosphate Cotransporter Proteins, Type IIb;D050614
D12.776.157.648.500.750.750.249;Sodium-Phosphate Cotransporter Proteins, Type IIb;D050614
D12.776.543.585.450.074.750.750.750.249;Sodium-Phosphate Cotransporter Proteins, Type IIb;D050614
D12.776.543.585.450.625.625.750.249;Sodium-Phosphate Cotransporter Proteins, Type IIb;D050614
D12.776.157.530.450.074.750.750.750.500;Sodium-Phosphate Cotransporter Proteins, Type IIc;D050615
D12.776.157.530.450.625.625.750.500;Sodium-Phosphate Cotransporter Proteins, Type IIc;D050615
D12.776.157.648.500.750.750.500;Sodium-Phosphate Cotransporter Proteins, Type IIc;D050615
D12.776.543.585.450.074.750.750.750.500;Sodium-Phosphate Cotransporter Proteins, Type IIc;D050615
D12.776.543.585.450.625.625.750.500;Sodium-Phosphate Cotransporter Proteins, Type IIc;D050615
B01.050.150.900.649.189.865.100;Balaenoptera;D050616
B01.050.150.900.649.189.865.100.350;Fin Whale;D050617
D08.811.682.657.163.781;Glycolaldehyde Dehydrogenase;D050618
B01.050.150.900.649.189.865.100.500;Minke Whale;D050636
D12.776.543.750.070.300.400.500.249;Receptors, Dopamine D3;D050637
D12.776.543.750.100.150.400.500.500;Receptors, Dopamine D3;D050637
D12.776.543.750.720.300.300.400.500.249;Receptors, Dopamine D3;D050637
D12.776.543.750.070.300.400.500.500;Receptors, Dopamine D4;D050638
D12.776.543.750.100.150.400.500.750;Receptors, Dopamine D4;D050638
D12.776.543.750.720.300.300.400.500.500;Receptors, Dopamine D4;D050638
B01.050.150.900.649.189.865.400;Humpback Whale;D050640
D12.776.543.750.070.300.400.400.500;Receptors, Dopamine D5;D050641
D12.776.543.750.100.150.400.400.500;Receptors, Dopamine D5;D050641
D12.776.543.750.720.300.300.400.400.500;Receptors, Dopamine D5;D050641
B01.050.150.900.649.189.865.130;Bowhead Whale;D050642
B01.050.150.900.649.189.865.110;Beluga Whale;D050643
D08.811.682.657.163.843;Succinate-Semialdehyde Dehydrogenase;D050644
D08.811.682.657.350.825;2-Oxoisovalerate Dehydrogenase (Acylating);D050645
D08.811.682.657.163.827;Methylmalonate-Semialdehyde Dehydrogenase (Acylating);D050646
D08.811.682.657.163.796;L-Aminoadipate-Semialdehyde Dehydrogenase;D050647
D08.811.682.657.163.342;Aminomuconate-Semialdehyde Dehydrogenase;D050648
D12.776.260.760;Transcription Factor AP-2;D050656
D12.776.930.907;Transcription Factor AP-2;D050656
D12.776.930.155.200;Core Binding Factor alpha Subunits;D050657
D12.776.930.155.400;Core Binding Factor beta Subunit;D050658
D12.776.930.155.200.100;Core Binding Factor Alpha 1 Subunit;D050659
D12.776.930.155;Core Binding Factors;D050660
B01.050.150.900.649.189.865.750;Sperm Whale;D050661
D12.776.930.155.200.200;Core Binding Factor Alpha 2 Subunit;D050676
D12.776.930.155.200.300;Core Binding Factor Alpha 3 Subunit;D050677
D12.776.124.486.274.150.500;Complement C2a;D050678
D12.776.124.486.274.150.750;Complement C2b;D050679
D12.776.930.908;Transcription Factor DP1;D050680
B01.050.150.900.649.189.267.100;Bottle-Nosed Dolphin;D050681
D12.776.543.512.249.500;Q-SNARE Proteins;D050682
D12.776.543.990.775.500;Q-SNARE Proteins;D050682
D12.776.543.512.249.750;R-SNARE Proteins;D050683
D12.776.543.990.775.750;R-SNARE Proteins;D050683
D12.776.930.311;E2F Transcription Factors;D050684
B01.050.150.900.649.189.267.900;Whale, Killer;D050685
B01.050.150.900.649.189.267.920;Whales, Pilot;D050686
D12.644.360.024.328.049;E2F1 Transcription Factor;D050687
D12.776.157.057.158.049;E2F1 Transcription Factor;D050687
D12.776.476.024.414.049;E2F1 Transcription Factor;D050687
D12.776.660.769.049;E2F1 Transcription Factor;D050687
D12.776.930.311.500;E2F1 Transcription Factor;D050687
B01.050.150.900.649.189.267.150;Common Dolphins;D050696
D08.811.682.657.163.835;Retinal Dehydrogenase;D050697
D12.776.331.915;Retinal Dehydrogenase;D050697
D12.776.556.579.374.687;Retinal Dehydrogenase;D050697
D08.811.682.657.163.562;Glutamate-5-Semialdehyde Dehydrogenase;D050698
D12.776.930.311.750;E2F3 Transcription Factor;D050699
D12.776.930.311.875;E2F5 Transcription Factor;D050700
D12.776.930.311.937;E2F6 Transcription Factor;D050701
D12.776.930.311.968;E2F7 Transcription Factor;D050702
D12.776.930.311.625;E2F2 Transcription Factor;D050703
D12.776.930.311.812;E2F4 Transcription Factor;D050704
D08.811.520.650.600.500;Receptors, Guanylate Cyclase-Coupled;D050705
D12.776.543.750.120;Receptors, Guanylate Cyclase-Coupled;D050705
B01.050.150.900.649.189.267.750;Stenella;D050706
D12.776.124.486.274.920.662;Complement C4b-Binding Protein;D050716
D12.776.624.776.735;Retinoblastoma-Like Protein p130;D050717
D12.776.660.794;Retinoblastoma-Like Protein p130;D050717
D12.776.744.755;Retinoblastoma-Like Protein p130;D050717
D12.644.822.750.140.500;Complement C1 Inhibitor Protein;D050718
D12.644.861.140.500;Complement C1 Inhibitor Protein;D050718
D12.776.124.486.274.920.250.500;Complement C1 Inhibitor Protein;D050718
D12.776.395.320;Complement C1 Inhibitor Protein;D050718
D12.776.645.750.140.500;Complement C1 Inhibitor Protein;D050718
D12.776.872.140.500;Complement C1 Inhibitor Protein;D050718
D12.644.360.024.295;Crk-Associated Substrate Protein;D050719
D12.776.157.057.022;Crk-Associated Substrate Protein;D050719
D12.776.476.024.374;Crk-Associated Substrate Protein;D050719
D12.776.744.425;Crk-Associated Substrate Protein;D050719
D12.776.624.776.717;Retinoblastoma-Like Protein p107;D050720
D12.776.660.770;Retinoblastoma-Like Protein p107;D050720
D12.776.744.747;Retinoblastoma-Like Protein p107;D050720
D08.811.464.938.750.374;Proto-Oncogene Proteins c-cbl;D050721
D12.776.624.664.700.172;Proto-Oncogene Proteins c-cbl;D050721
D12.776.624.664.520.750.817;Oncogene Protein v-cbl;D050722
C26.404;Fractures, Bone;D050723
C26.411;Fractures, Cartilage;D050724
D12.776.624.664.520.420;Papillomavirus E7 Proteins;D050725
D08.811.682.657.163.468;Benzaldehyde Dehydrogenase (NADP+);D050727
D08.811.682.657.163.515;Betaine-Aldehyde Dehydrogenase;D050728
D12.776.624.664.520.750.846;Oncogene Protein v-crk;D050736
D12.644.360.024.318;Proto-Oncogene Proteins c-crk;D050737
D12.776.157.057.139;Proto-Oncogene Proteins c-crk;D050737
D12.776.476.024.409;Proto-Oncogene Proteins c-crk;D050737
D12.776.624.664.700.174;Proto-Oncogene Proteins c-crk;D050737
C03.600;Mesomycetozoea Infections;D050738
B01.050.150.900.649.189.566.600;Phocoena;D050741
D08.811.682.657.350.968;Pyruvate Synthase;D050743
D08.811.682.660.325;Dihydrouracil Dehydrogenase (NAD+);D050744
D08.811.682.660.390;Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific);D050745
D08.811.682.660.275;Dihydrodipicolinate Reductase;D050746
D08.811.682.660.387;Enoyl-(Acyl-Carrier-Protein) Reductase (NADH);D050753
D12.644.360.225;Cyclin-Dependent Kinase Inhibitor Proteins;D050756
D12.776.167.187;Cyclin-Dependent Kinase Inhibitor Proteins;D050756
D12.776.476.225;Cyclin-Dependent Kinase Inhibitor Proteins;D050756
D12.776.624.776.355;Cyclin-Dependent Kinase Inhibitor Proteins;D050756
D12.644.360.225.500;Cyclin-Dependent Kinase Inhibitor p21;D050759
D12.776.167.187.500;Cyclin-Dependent Kinase Inhibitor p21;D050759
D12.776.476.225.500;Cyclin-Dependent Kinase Inhibitor p21;D050759
D12.776.624.776.355.500;Cyclin-Dependent Kinase Inhibitor p21;D050759
D12.644.360.225.600;Cyclin-Dependent Kinase Inhibitor p27;D050760
D12.776.167.187.600;Cyclin-Dependent Kinase Inhibitor p27;D050760
D12.776.476.225.600;Cyclin-Dependent Kinase Inhibitor p27;D050760
D12.776.624.776.355.600;Cyclin-Dependent Kinase Inhibitor p27;D050760
D12.644.360.225.700;Cyclin-Dependent Kinase Inhibitor p57;D050761
D12.776.167.187.700;Cyclin-Dependent Kinase Inhibitor p57;D050761
D12.776.476.225.700;Cyclin-Dependent Kinase Inhibitor p57;D050761
D12.776.624.776.355.700;Cyclin-Dependent Kinase Inhibitor p57;D050761
D12.644.360.225.100;Cyclin-Dependent Kinase Inhibitor p15;D050762
D12.776.167.187.100;Cyclin-Dependent Kinase Inhibitor p15;D050762
D12.776.476.225.100;Cyclin-Dependent Kinase Inhibitor p15;D050762
D12.776.624.776.355.100;Cyclin-Dependent Kinase Inhibitor p15;D050762
D12.644.360.225.300;Cyclin-Dependent Kinase Inhibitor p18;D050763
D12.776.167.187.300;Cyclin-Dependent Kinase Inhibitor p18;D050763
D12.776.476.225.300;Cyclin-Dependent Kinase Inhibitor p18;D050763
D12.776.624.776.355.300;Cyclin-Dependent Kinase Inhibitor p18;D050763
D12.644.360.225.400;Cyclin-Dependent Kinase Inhibitor p19;D050764
D12.776.167.187.400;Cyclin-Dependent Kinase Inhibitor p19;D050764
D12.776.476.225.400;Cyclin-Dependent Kinase Inhibitor p19;D050764
D12.776.624.776.355.400;Cyclin-Dependent Kinase Inhibitor p19;D050764
D12.776.543.512.249.500.500;Qa-SNARE Proteins;D050765
D12.776.543.990.775.500.500;Qa-SNARE Proteins;D050765
D12.776.543.512.249.500.750;Qb-SNARE Proteins;D050766
D12.776.543.990.775.500.750;Qb-SNARE Proteins;D050766
D12.776.543.512.249.500.875;Qc-SNARE Proteins;D050767
D12.776.543.990.775.500.875;Qc-SNARE Proteins;D050767
D08.811.682.660.600;Protoporphyrinogen Oxidase;D050768
D12.776.543.697;Protoporphyrinogen Oxidase;D050768
D08.811.682.660.462;Isovaleryl-CoA Dehydrogenase;D050769
D08.811.682.660.425;Glutaryl-CoA Dehydrogenase;D050770
D12.776.124.486.274.450.625;Complement C5b;D050776
D12.776.220.600.450.480;Stathmin;D050777
D12.776.624.664.700.957;Stathmin;D050777
D12.776.744.772;Stathmin;D050777
D12.776.930.608;NFATC Transcription Factors;D050778
D12.776.157.725.444;Nuclear Factor 90 Proteins;D050779
D12.776.930.616;Nuclear Factor 90 Proteins;D050779
E01.370.376.850;Transcranial Magnetic Stimulation;D050781
E02.621.820;Transcranial Magnetic Stimulation;D050781
E01.370.225.124.210;Esophageal pH Monitoring;D050782
E01.370.372.255;Esophageal pH Monitoring;D050782
E01.370.520.215;Esophageal pH Monitoring;D050782
E01.370.520.500.240;Esophageal pH Monitoring;D050782
E05.200.124.210;Esophageal pH Monitoring;D050782
D12.776.260.665;Proto-Oncogene Proteins c-ets;D050783
D12.776.624.664.700.175;Proto-Oncogene Proteins c-ets;D050783
D12.776.930.635;Proto-Oncogene Proteins c-ets;D050783
D12.776.260.665.100;Proto-Oncogene Protein c-ets-1;D050784
D12.776.624.664.700.175.100;Proto-Oncogene Protein c-ets-1;D050784
D12.776.930.635.100;Proto-Oncogene Protein c-ets-1;D050784
E03.155.441;Cryoanesthesia;D050785
E02.258.750.500;Gastric Hypothermia;D050786
D12.776.260.665.200;Proto-Oncogene Protein c-ets-2;D050787
D12.776.624.664.700.175.200;Proto-Oncogene Protein c-ets-2;D050787
D12.776.930.635.200;Proto-Oncogene Protein c-ets-2;D050787
D08.811.682.664.500.062;Alanine Dehydrogenase;D050788
D08.811.682.664.500.526;Glycine Dehydrogenase;D050789
D08.811.682.664.500.484;Glutamate Synthase (NADH);D050790
D12.776.331.737;Glutamate Synthase (NADH);D050790
D12.644.360.024.342;STAT Transcription Factors;D050791
D12.776.157.057.186;STAT Transcription Factors;D050791
D12.776.476.024.421;STAT Transcription Factors;D050791
D12.776.930.840;STAT Transcription Factors;D050791
E04.100.376.374.500;Circulatory Arrest, Deep Hypothermia Induced;D050792
E04.928.220.360.500;Circulatory Arrest, Deep Hypothermia Induced;D050792
E06.658.578.225;Orthodontic Extrusion;D050793
D12.644.360.024.303.500.500;STAT1 Transcription Factor;D050794
D12.644.360.024.342.100;STAT1 Transcription Factor;D050794
D12.776.157.057.061.500.500;STAT1 Transcription Factor;D050794
D12.776.157.057.186.100;STAT1 Transcription Factor;D050794
D12.776.260.513.249.500;STAT1 Transcription Factor;D050794
D12.776.476.024.386.500.500;STAT1 Transcription Factor;D050794
D12.776.476.024.421.100;STAT1 Transcription Factor;D050794
D12.776.930.354.249.500;STAT1 Transcription Factor;D050794
D12.776.930.840.100;STAT1 Transcription Factor;D050794
D12.644.360.024.303.500.750;STAT2 Transcription Factor;D050795
D12.644.360.024.342.200;STAT2 Transcription Factor;D050795
D12.776.157.057.061.500.750;STAT2 Transcription Factor;D050795
D12.776.157.057.186.200;STAT2 Transcription Factor;D050795
D12.776.260.513.249.750;STAT2 Transcription Factor;D050795
D12.776.476.024.386.500.750;STAT2 Transcription Factor;D050795
D12.776.476.024.421.200;STAT2 Transcription Factor;D050795
D12.776.930.354.249.750;STAT2 Transcription Factor;D050795
D12.776.930.840.200;STAT2 Transcription Factor;D050795
D12.644.360.024.342.300;STAT3 Transcription Factor;D050796
D12.776.157.057.186.300;STAT3 Transcription Factor;D050796
D12.776.476.024.421.300;STAT3 Transcription Factor;D050796
D12.776.930.840.300;STAT3 Transcription Factor;D050796
D12.644.360.024.342.400;STAT4 Transcription Factor;D050797
D12.776.157.057.186.400;STAT4 Transcription Factor;D050797
D12.776.476.024.421.400;STAT4 Transcription Factor;D050797
D12.776.930.840.400;STAT4 Transcription Factor;D050797
C10.228.140.546.399.937.875;SUNCT Syndrome;D050798
D12.644.360.024.342.500;STAT5 Transcription Factor;D050799
D12.776.157.057.186.500;STAT5 Transcription Factor;D050799
D12.776.476.024.421.500;STAT5 Transcription Factor;D050799
D12.776.930.840.500;STAT5 Transcription Factor;D050799
D12.644.360.024.342.600;STAT6 Transcription Factor;D050800
D12.776.157.057.186.600;STAT6 Transcription Factor;D050800
D12.776.476.024.421.600;STAT6 Transcription Factor;D050800
D12.776.930.840.600;STAT6 Transcription Factor;D050800
D12.776.260.665.600;Ternary Complex Factors;D050801
D12.776.624.664.700.175.600;Ternary Complex Factors;D050801
D12.776.930.635.600;Ternary Complex Factors;D050801
D08.811.682.664.500.924;Valine Dehydrogenase (NADP+);D050802
D08.811.682.664.500.724;Leucine Dehydrogenase;D050803
D08.811.682.664.500.261;D-Aspartate Oxidase;D050804
C15.604.744.954;Wandering Spleen;D050805
E04.555.110.110.054;Arthroplasty, Replacement, Finger;D050806
E04.650.110.054;Arthroplasty, Replacement, Finger;D050806
D12.776.260.665.600.100;ets-Domain Protein Elk-1;D050807
D12.776.624.664.700.175.600.100;ets-Domain Protein Elk-1;D050807
D12.776.930.635.600.100;ets-Domain Protein Elk-1;D050807
D12.776.260.665.600.300;ets-Domain Protein Elk-4;D050808
D12.776.624.664.700.175.600.300;ets-Domain Protein Elk-4;D050808
D12.776.930.635.600.300;ets-Domain Protein Elk-4;D050808
D12.776.260.655;POU Domain Factors;D050809
D12.776.930.632;POU Domain Factors;D050809
D12.776.260.655.500;Octamer Transcription Factors;D050810
D12.776.930.632.500;Octamer Transcription Factors;D050810
D12.776.260.655.500.100;Octamer Transcription Factor-1;D050811
D12.776.930.632.500.100;Octamer Transcription Factor-1;D050811
E04.525.770;Split-Brain Procedure;D050812
D12.776.260.655.500.200;Octamer Transcription Factor-2;D050813
D12.776.930.632.500.200;Octamer Transcription Factor-2;D050813
D12.776.260.655.500.300;Octamer Transcription Factor-3;D050814
D12.776.930.632.500.300;Octamer Transcription Factor-3;D050814
C26.404.195;Fractures, Compression;D050815
D12.776.260.655.500.600;Octamer Transcription Factor-6;D050816
D12.776.930.632.500.600;Octamer Transcription Factor-6;D050816
D12.776.260.655.750;Transcription Factor Pit-1;D050817
D12.776.930.632.750;Transcription Factor Pit-1;D050817
D12.776.260.655.625;Transcription Factor Brn-3;D050818
D12.776.930.632.625;Transcription Factor Brn-3;D050818
D12.776.260.655.625.124;Transcription Factor Brn-3A;D050819
D12.776.930.632.625.500;Transcription Factor Brn-3A;D050819
D12.776.260.655.625.249;Transcription Factor Brn-3B;D050820
D12.776.930.632.625.750;Transcription Factor Brn-3B;D050820
D12.776.260.655.625.500;Transcription Factor Brn-3C;D050821
D12.776.930.632.625.875;Transcription Factor Brn-3C;D050821
D12.776.543.750.705.852.420.400.500;Cytokine Receptor gp130;D050822
D12.776.543.750.705.852.420.560.249;Cytokine Receptor gp130;D050822
D12.776.543.750.705.852.500.500;Cytokine Receptor gp130;D050822
D12.776.543.750.705.852.555.600.500;Cytokine Receptor gp130;D050822
D12.776.543.750.705.852.555.800.500;Cytokine Receptor gp130;D050822
D12.776.543.750.750.400.550.250.500;Cytokine Receptor gp130;D050822
D23.050.301.264.035.280;Cytokine Receptor gp130;D050822
D23.101.100.110.280;Cytokine Receptor gp130;D050822
A02.835.583.405;Hand Joints;D050823
A02.835.583.405.174;Carpal Joints;D050824
D12.776.543.512.249.500.750.500;Synaptosomal-Associated Protein 25;D050825
D12.776.543.512.249.500.875.500;Synaptosomal-Associated Protein 25;D050825
D12.776.543.990.775.500.750.500;Synaptosomal-Associated Protein 25;D050825
D12.776.543.990.775.500.875.500;Synaptosomal-Associated Protein 25;D050825
D12.644.360.024.374;Suppressor of Cytokine Signaling Proteins;D050826
D12.776.157.057.249;Suppressor of Cytokine Signaling Proteins;D050826
D12.776.476.024.437;Suppressor of Cytokine Signaling Proteins;D050826
D12.776.543.512.249.500.500.700;Syntaxin 1;D050827
D12.776.543.990.775.500.500.700;Syntaxin 1;D050827
D12.644.360.024.311;Protein Inhibitors of Activated STAT;D050828
D12.776.157.057.124;Protein Inhibitors of Activated STAT;D050828
D12.776.476.024.405;Protein Inhibitors of Activated STAT;D050828
D08.811.682.664.500.677;L-Amino Acid Oxidase;D050830
D12.644.360.024.303;Interferon-Stimulated Gene Factor 3;D050832
D12.776.157.057.061;Interferon-Stimulated Gene Factor 3;D050832
D12.776.260.513;Interferon-Stimulated Gene Factor 3;D050832
D12.776.476.024.386;Interferon-Stimulated Gene Factor 3;D050832
D12.776.930.354;Interferon-Stimulated Gene Factor 3;D050832
D12.644.360.024.303.500;Interferon-Stimulated Gene Factor 3, alpha Subunit;D050833
D12.776.157.057.061.500;Interferon-Stimulated Gene Factor 3, alpha Subunit;D050833
D12.776.260.513.249;Interferon-Stimulated Gene Factor 3, alpha Subunit;D050833
D12.776.476.024.386.500;Interferon-Stimulated Gene Factor 3, alpha Subunit;D050833
D12.776.930.354.249;Interferon-Stimulated Gene Factor 3, alpha Subunit;D050833
D12.644.360.024.302.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.644.360.024.303.750;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.157.057.050.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.157.057.061.750;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.260.504.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.260.513.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.476.024.385.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.476.024.386.750;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.930.332.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.776.930.354.500;Interferon-Stimulated Gene Factor 3, gamma Subunit;D050834
D12.644.360.024.302;Interferon Regulatory Factors;D050835
D12.776.157.057.050;Interferon Regulatory Factors;D050835
D12.776.260.504;Interferon Regulatory Factors;D050835
D12.776.476.024.385;Interferon Regulatory Factors;D050835
D12.776.930.332;Interferon Regulatory Factors;D050835
D12.644.360.024.302.249;Interferon Regulatory Factor-2;D050836
D12.776.157.057.050.249;Interferon Regulatory Factor-2;D050836
D12.776.260.504.249;Interferon Regulatory Factor-2;D050836
D12.776.476.024.385.249;Interferon Regulatory Factor-2;D050836
D12.776.930.332.249;Interferon Regulatory Factor-2;D050836
D08.811.682.657;Oxidoreductases Acting on Aldehyde or Oxo Group Donors;D050837
D12.644.360.024.302.374;Interferon Regulatory Factor-3;D050838
D12.776.157.057.050.374;Interferon Regulatory Factor-3;D050838
D12.776.260.504.374;Interferon Regulatory Factor-3;D050838
D12.776.476.024.385.374;Interferon Regulatory Factor-3;D050838
D12.776.744.562;Interferon Regulatory Factor-3;D050838
D12.776.930.332.374;Interferon Regulatory Factor-3;D050838
D12.644.360.024.302.437;Interferon Regulatory Factor-7;D050839
D12.776.157.057.050.437;Interferon Regulatory Factor-7;D050839
D12.776.260.504.437;Interferon Regulatory Factor-7;D050839
D12.776.476.024.385.437;Interferon Regulatory Factor-7;D050839
D12.776.744.631;Interferon Regulatory Factor-7;D050839
D12.776.930.332.437;Interferon Regulatory Factor-7;D050839
D05.500.562.452.200;Glycine Dehydrogenase (Decarboxylating);D050841
D08.811.600.391.200;Glycine Dehydrogenase (Decarboxylating);D050841
D08.811.682.664.500.498.500;Glycine Dehydrogenase (Decarboxylating);D050841
D08.811.682.662.693;1-Pyrroline-5-Carboxylate Dehydrogenase;D050842
D12.644.360.024.302.124;Interferon Regulatory Factor-1;D050856
D12.776.157.057.050.124;Interferon Regulatory Factor-1;D050856
D12.776.260.108.374;Interferon Regulatory Factor-1;D050856
D12.776.260.504.124;Interferon Regulatory Factor-1;D050856
D12.776.476.024.385.124;Interferon Regulatory Factor-1;D050856
D12.776.930.127.374;Interferon Regulatory Factor-1;D050856
D12.776.930.332.124;Interferon Regulatory Factor-1;D050856
D12.776.157.125.825;Synaptotagmins;D050857
D12.776.543.990.850;Synaptotagmins;D050857
D02.092.877.233;Betalains;D050858
D02.675.276.136;Betalains;D050858
D03.132.124;Betalains;D050858
D03.383.621.080;Betalains;D050858
D12.125.072.050.875.064;Betalains;D050858
D02.092.877.233.500;Betacyanins;D050859
D02.675.276.136.500;Betacyanins;D050859
D03.132.124.500;Betacyanins;D050859
D03.383.621.080.500;Betacyanins;D050859
D12.125.072.050.875.064.500;Betacyanins;D050859
D02.092.877.233.555;Betaxanthins;D050860
D02.675.276.136.555;Betaxanthins;D050860
D03.132.124.750;Betaxanthins;D050860
D03.383.621.080.750;Betaxanthins;D050860
D12.776.157.125.825.500;Synaptotagmin II;D050861
D12.776.543.990.850.500;Synaptotagmin II;D050861
D08.811.682.667;Oxidoreductases Acting on Sulfur Group Donors;D050862
D12.776.157.125.825.249;Synaptotagmin I;D050863
D12.776.543.990.850.249;Synaptotagmin I;D050863
D08.811.682.667.500;Sulfite Reductase (NADPH);D050864
J01.637.506;Liquid Crystals;D050866
D08.811.682.667.249;Sulfite Oxidase;D050876
D08.811.682.662.582.700;Sarcosine Oxidase;D050879
D12.776.331.943;Sarcosine Oxidase;D050879
D08.811.913.050.134.440;p300-CBP Transcription Factors;D050880
D12.776.930.622;p300-CBP Transcription Factors;D050880
D08.811.913.050.134.440.600;E1A-Associated p300 Protein;D050881
D12.776.930.622.600;E1A-Associated p300 Protein;D050881
D08.811.913.050.134.440.249;CREB-Binding Protein;D050882
D12.776.580.216.375.200;HSC70 Heat-Shock Proteins;D050883
D12.776.580.216.375.202;HSP72 Heat-Shock Proteins;D050884
D08.811.682.667.124;Hydrogensulfite Reductase;D050885
D12.776.580.216.270.500;HSP20 Heat-Shock Proteins;D050886
D12.776.580.216.270;Heat-Shock Proteins, Small;D050888
D08.811.682.667.374;Sulfite Reductase (Ferredoxin);D050889
D12.776.580.216.270.750;HSP30 Heat-Shock Proteins;D050890
D08.811.682.664;Oxidoreductases Acting on CH-NH2 Group Donors;D050891
D08.811.682.662.582.550;Sarcosine Dehydrogenase;D050892
D08.811.682.662.582.369;Dimethylglycine Dehydrogenase;D050893
D08.811.682.655.500.200;Nitrate Reductase (NADH);D050895
D12.776.331.899;Nitrate Reductase (NADH);D050895
D08.811.682.655.500.249;Nitrate Reductase (NAD(P)H);D050896
D12.776.157.427.374.375.977;Nitrate Reductase (NAD(P)H);D050896
D12.776.331.901;Nitrate Reductase (NAD(P)H);D050896
D12.776.556.579.374.375.977;Nitrate Reductase (NAD(P)H);D050896
D08.811.682.655.500.374;Nitrate Reductase (NADPH);D050897
D12.776.157.427.374.375.988;Nitrate Reductase (NADPH);D050897
D12.776.331.911;Nitrate Reductase (NADPH);D050897
D12.776.556.579.374.375.988;Nitrate Reductase (NADPH);D050897
D08.811.682.655.750.500;Nitrite Reductase (NAD(P)H);D050898
D08.811.682.655.249;GMP Reductase;D050899
D08.811.682.655.750.249;Ferredoxin-Nitrite Reductase;D050900
D12.776.157.427.374.375.150;Ferredoxin-Nitrite Reductase;D050900
D12.776.556.579.374.375.150;Ferredoxin-Nitrite Reductase;D050900
D08.811.682.655.500.124;Nitrate Reductase;D050901
D08.811.682.667.217;Sulfite Dehydrogenase;D050902
D08.811.913.555.500.650;Nicotinamide N-Methyltransferase;D050903
D08.811.913.555.500.625;Homocysteine S-Methyltransferase;D050904
D12.776.157.530.400.901.888;TRPV Cation Channels;D050916
D08.811.913.555.500.712;Phosphatidylethanolamine N-Methyltransferase;D050918
E05.318.308.985.525.080;Basic Reproduction Number;D050936
L01.280.975.525.080;Basic Reproduction Number;D050936
N01.224.935.597.080;Basic Reproduction Number;D050936
N06.850.310.149;Basic Reproduction Number;D050936
N06.850.505.400.975.525.080;Basic Reproduction Number;D050936
N06.850.520.308.985.525.080;Basic Reproduction Number;D050936
D08.811.913.555.500.425;Guanidinoacetate N-Methyltransferase;D050937
D08.811.913.555.500.387;Glycine N-Methyltransferase;D050938
G05.355.760.385;Gene Fusion;D050939
D08.811.913.555.500.175;Betaine-Homocysteine S-Methyltransferase;D050940
D08.811.913.555.500.710;Phosphatidyl-N-Methylethanolamine N-Methyltransferase;D050941
D12.776.580.216.292;HSP40 Heat-Shock Proteins;D050956
D12.776.580.216.375.800;HSP110 Heat-Shock Proteins;D050957
D12.644.861.350;HSP47 Heat-Shock Proteins;D050958
D12.776.395.420;HSP47 Heat-Shock Proteins;D050958
D12.776.580.216.295;HSP47 Heat-Shock Proteins;D050958
D12.776.872.350;HSP47 Heat-Shock Proteins;D050958
D05.500.562.452;Glycine Decarboxylase Complex;D050959
D08.811.600.391;Glycine Decarboxylase Complex;D050959
D08.811.682.664.500.498;Glycine Decarboxylase Complex;D050959
D05.500.562.452.100;Aminomethyltransferase;D050960
D08.811.600.391.100;Aminomethyltransferase;D050960
D08.811.913.555.400.100;Aminomethyltransferase;D050960
D05.500.562.452.175;Glycine Decarboxylase Complex H-Protein;D050961
D08.811.600.391.175;Glycine Decarboxylase Complex H-Protein;D050961
D12.776.260.108;Basic-Leucine Zipper Transcription Factors;D050976
D12.776.930.127;Basic-Leucine Zipper Transcription Factors;D050976
D12.776.260.108.500;Maf Transcription Factors;D050977
D12.776.930.127.500;Maf Transcription Factors;D050977
D12.776.260.108.500.500;Maf Transcription Factors, Small;D050978
D12.776.260.108.656.750;Maf Transcription Factors, Small;D050978
D12.776.260.235.750.750;Maf Transcription Factors, Small;D050978
D12.776.930.127.500.500;Maf Transcription Factors, Small;D050978
D12.776.930.127.656.750;Maf Transcription Factors, Small;D050978
D12.776.930.316.750.750;Maf Transcription Factors, Small;D050978
D12.776.260.257;GATA Transcription Factors;D050980
D12.776.930.321;GATA Transcription Factors;D050980
D12.776.260.235;Erythroid-Specific DNA-Binding Factors;D050981
D12.776.930.316;Erythroid-Specific DNA-Binding Factors;D050981
D12.776.260.235.500;GATA1 Transcription Factor;D050982
D12.776.260.257.100;GATA1 Transcription Factor;D050982
D12.776.930.316.500;GATA1 Transcription Factor;D050982
D12.776.930.321.100;GATA1 Transcription Factor;D050982
D12.776.260.108.656;NF-E2 Transcription Factor;D050983
D12.776.260.235.750;NF-E2 Transcription Factor;D050983
D12.776.930.127.656;NF-E2 Transcription Factor;D050983
D12.776.930.316.750;NF-E2 Transcription Factor;D050983
D12.776.260.108.656.770;NF-E2 Transcription Factor, p45 Subunit;D050984
D12.776.260.235.750.770;NF-E2 Transcription Factor, p45 Subunit;D050984
D12.776.930.127.656.770;NF-E2 Transcription Factor, p45 Subunit;D050984
D12.776.930.316.750.770;NF-E2 Transcription Factor, p45 Subunit;D050984
D12.776.260.108.500.500.750;MafK Transcription Factor;D050985
D12.776.260.108.656.750.750;MafK Transcription Factor;D050985
D12.776.260.235.750.750.750;MafK Transcription Factor;D050985
D12.776.930.127.500.500.750;MafK Transcription Factor;D050985
D12.776.930.127.656.750.750;MafK Transcription Factor;D050985
D12.776.930.316.750.750.750;MafK Transcription Factor;D050985
D12.776.260.235.875;YY1 Transcription Factor;D050986
D12.776.930.316.875;YY1 Transcription Factor;D050986
D12.776.543.512.249.750.500;Vesicle-Associated Membrane Protein 1;D050987
D12.776.543.990.775.750.500;Vesicle-Associated Membrane Protein 1;D050987
D12.776.543.512.249.750.750;Vesicle-Associated Membrane Protein 2;D050988
D12.776.543.990.775.750.750;Vesicle-Associated Membrane Protein 2;D050988
D12.776.260.235.625;GATA2 Transcription Factor;D050989
D12.776.260.257.200;GATA2 Transcription Factor;D050989
D12.776.930.316.625;GATA2 Transcription Factor;D050989
D12.776.930.321.200;GATA2 Transcription Factor;D050989
D12.776.260.235.687;GATA3 Transcription Factor;D050990
D12.776.260.257.300;GATA3 Transcription Factor;D050990
D12.776.930.316.687;GATA3 Transcription Factor;D050990
D12.776.930.321.300;GATA3 Transcription Factor;D050990
D12.776.260.257.400;GATA4 Transcription Factor;D050991
D12.776.930.321.400;GATA4 Transcription Factor;D050991
D12.776.260.257.500;GATA5 Transcription Factor;D050992
D12.776.930.321.500;GATA5 Transcription Factor;D050992
D12.776.260.257.600;GATA6 Transcription Factor;D050993
D12.776.930.321.600;GATA6 Transcription Factor;D050993
D12.776.157.530.400.500.520;Voltage-Dependent Anion Channels;D050994
D12.776.543.550.425.730.520;Voltage-Dependent Anion Channels;D050994
D12.776.543.585.400.730.520;Voltage-Dependent Anion Channels;D050994
D12.776.157.530.400.500.520.500;Voltage-Dependent Anion Channel 1;D050995
D12.776.543.550.425.730.520.500;Voltage-Dependent Anion Channel 1;D050995
D12.776.543.585.400.730.520.500;Voltage-Dependent Anion Channel 1;D050995
D12.776.543.585.475.750;Voltage-Dependent Anion Channel 1;D050995
D12.776.575.750.750;Voltage-Dependent Anion Channel 1;D050995
D12.776.157.530.400.500.520.750;Voltage-Dependent Anion Channel 2;D050996
D12.776.543.550.425.730.520.750;Voltage-Dependent Anion Channel 2;D050996
D12.776.543.585.400.730.520.750;Voltage-Dependent Anion Channel 2;D050996
D12.776.543.585.475.875;Voltage-Dependent Anion Channel 2;D050996
D12.776.575.750.875;Voltage-Dependent Anion Channel 2;D050996
H01.603.600;Nanomedicine;D050997
J01.897.115.625;Nanomedicine;D050997
J01.897.520.600.600;Nanomedicine;D050997
D12.644.360.075.718.750;bcl-2 Homologous Antagonist-Killer Protein;D050998
D12.776.476.075.718.425;bcl-2 Homologous Antagonist-Killer Protein;D050998
D12.644.360.075;Apoptosis Regulatory Proteins;D051017
D12.776.476.075;Apoptosis Regulatory Proteins;D051017
D12.644.360.075.718.937;bcl-X Protein;D051020
D12.776.476.075.718.875;bcl-X Protein;D051020
D12.644.360.075.718.968;BH3 Interacting Domain Death Agonist Protein;D051023
D12.776.476.075.718.937;BH3 Interacting Domain Death Agonist Protein;D051023
D12.644.360.075.718.100;bcl-Associated Death Protein;D051025
D12.776.476.075.718.100;bcl-Associated Death Protein;D051025
D12.776.744.049;bcl-Associated Death Protein;D051025
D08.811.913.555.400.750;Phosphoribosylglycinamide Formyltransferase;D051026
D08.811.913.555.400.625;Phosphoribosylaminoimidazolecarboxamide Formyltransferase;D051027
D12.644.360.075.718.400;bcl-2-Associated X Protein;D051028
D12.776.476.075.718.400;bcl-2-Associated X Protein;D051028
D08.811.682.608.047;Apoptosis Inducing Factor;D051033
D12.644.360.075.311;Apoptosis Inducing Factor;D051033
D12.776.331.161;Apoptosis Inducing Factor;D051033
D12.776.476.075.311;Apoptosis Inducing Factor;D051033
D12.644.360.075.437;Inhibitor of Apoptosis Proteins;D051034
D12.776.476.075.437;Inhibitor of Apoptosis Proteins;D051034
D12.776.157.530.400.600.150.500;Large-Conductance Calcium-Activated Potassium Channels;D051036
D12.776.543.550.425.750.150.500;Large-Conductance Calcium-Activated Potassium Channels;D051036
D12.776.543.585.400.750.150.500;Large-Conductance Calcium-Activated Potassium Channels;D051036
D12.776.157.530.400.600.150.500.500;Large-Conductance Calcium-Activated Potassium Channel alpha Subunits;D051037
D12.776.543.550.425.750.150.500.500;Large-Conductance Calcium-Activated Potassium Channel alpha Subunits;D051037
D12.776.543.585.400.750.150.500.249;Large-Conductance Calcium-Activated Potassium Channel alpha Subunits;D051037
D12.776.157.530.400.600.150.500.750;Large-Conductance Calcium-Activated Potassium Channel beta Subunits;D051038
D12.776.543.550.425.750.150.500.750;Large-Conductance Calcium-Activated Potassium Channel beta Subunits;D051038
D12.776.543.585.400.750.150.500.500;Large-Conductance Calcium-Activated Potassium Channel beta Subunits;D051038
B01.050.150.900.649.801.400.600.150.150.450;Leontopithecus;D051039
D12.776.543.512.249.750.875;Vesicle-Associated Membrane Protein 3;D051040
D12.776.543.990.775.750.875;Vesicle-Associated Membrane Protein 3;D051040
D08.811.913.555.400.300;Glutamate Formimidoyltransferase;D051042
D08.811.913.050.134.105;Amino-Acid N-Acetyltransferase;D051046
D05.500.562.625.750;Dihydrolipoyllysine-Residue Acetyltransferase;D051047
D08.811.600.741.625;Dihydrolipoyllysine-Residue Acetyltransferase;D051047
D08.811.913.050.134.310;Dihydrolipoyllysine-Residue Acetyltransferase;D051047
D08.811.913.050.387;Diacylglycerol O-Acyltransferase;D051048
D08.811.913.050.712;Sphingosine N-Acyltransferase;D051049
D08.811.913.050.134.850;Serine O-Acetyltransferase;D051050
D08.811.913.050.134.029;Acyl-Carrier Protein S-Acetyltransferase;D051051
D27.505.696.477.656.500;Complement Inactivating Agents;D051056
D08.811.913.696.620.682.700.755;Proto-Oncogene Proteins c-akt;D051057
D12.776.476.565;Proto-Oncogene Proteins c-akt;D051057
D12.776.624.664.700.168;Proto-Oncogene Proteins c-akt;D051057
D08.811.913.696.620.682.700.586;Oncogene Protein v-akt;D051058
D12.776.624.664.520.750.788;Oncogene Protein v-akt;D051058
D08.811.277.352.650.850;PTEN Phosphohydrolase;D051059
D12.776.476.590;PTEN Phosphohydrolase;D051059
D12.776.624.776.695;PTEN Phosphohydrolase;D051059
D08.811.913.696.620.682.725.800.551;Proto-Oncogene Proteins c-fyn;D051076
D12.776.476.571;Proto-Oncogene Proteins c-fyn;D051076
D12.776.624.664.700.180;Proto-Oncogene Proteins c-fyn;D051076
B01.050.150.900.649.801.400.600.075;Atelidae;D051077
B01.050.150.900.649.801.400.600;Platyrrhini;D051078
B01.050.150.900.649.801.400.112;Catarrhini;D051079
D08.811.913.050.170;Acyl-Carrier Protein S-Malonyltransferase;D051080
D08.811.913.050.134.375;Glucosamine 6-Phosphate N-Acetyltransferase;D051081
D08.811.913.050.600;Homoserine O-Succinyltransferase;D051082
D08.811.913.696.620.682.725.400.087;Proto-Oncogene Proteins c-ret;D051096
D12.776.543.750.060.217;Proto-Oncogene Proteins c-ret;D051096
D12.776.624.664.700.194;Proto-Oncogene Proteins c-ret;D051096
D12.776.395.550.448.400;Glial Cell Line-Derived Neurotrophic Factor Receptors;D051097
D12.776.543.484.500.400;Glial Cell Line-Derived Neurotrophic Factor Receptors;D051097
D12.776.543.550.418.400;Glial Cell Line-Derived Neurotrophic Factor Receptors;D051097
D12.776.543.750.750.400.550.124;Glial Cell Line-Derived Neurotrophic Factor Receptors;D051097
D12.644.276.860.381;Glial Cell Line-Derived Neurotrophic Factors;D051098
D12.776.467.860.381;Glial Cell Line-Derived Neurotrophic Factors;D051098
D12.776.641.600.381;Glial Cell Line-Derived Neurotrophic Factors;D051098
D23.529.850.381;Glial Cell Line-Derived Neurotrophic Factors;D051098
B01.050.150.900.649.801.400.800;Tarsii;D051099
D12.644.276.860.381.500;Glial Cell Line-Derived Neurotrophic Factor;D051100
D12.776.467.860.381.500;Glial Cell Line-Derived Neurotrophic Factor;D051100
D12.776.641.600.381.500;Glial Cell Line-Derived Neurotrophic Factor;D051100
D23.529.850.381.500;Glial Cell Line-Derived Neurotrophic Factor;D051100
D12.644.276.860.381.750;Neurturin;D051101
D12.776.467.860.381.750;Neurturin;D051101
D12.776.641.600.381.750;Neurturin;D051101
D23.529.850.381.750;Neurturin;D051101
D08.811.913.050.668;Serine C-Palmitoyltransferase;D051102
D08.811.913.050.173;1-Acylglycerol-3-Phosphate O-Acyltransferase;D051103
D12.776.543.750.705.940;Receptors, Scavenger;D051116
D12.776.543.750.710.450.750;Receptors, Scavenger;D051116
D12.776.543.750.705.940.500;Scavenger Receptors, Class A;D051117
D12.776.543.750.710.450.750.500;Scavenger Receptors, Class A;D051117
D12.776.543.750.705.940.625;Scavenger Receptors, Class B;D051122
D12.776.543.750.710.450.750.625;Scavenger Receptors, Class B;D051122
D12.776.543.750.705.940.687;Scavenger Receptors, Class C;D051124
D12.776.543.750.710.450.750.687;Scavenger Receptors, Class C;D051124
D12.776.543.750.705.940.718;Scavenger Receptors, Class D;D051126
D12.776.543.750.710.450.750.718;Scavenger Receptors, Class D;D051126
D12.776.543.750.705.940.734;Scavenger Receptors, Class E;D051127
D12.776.543.750.710.450.625.500;Scavenger Receptors, Class E;D051127
D12.776.543.750.710.450.750.734;Scavenger Receptors, Class E;D051127
D12.776.543.750.705.940.742;Scavenger Receptors, Class F;D051128
D12.776.543.750.710.450.750.742;Scavenger Receptors, Class F;D051128
D12.776.543.750.710.450.625;Receptors, Oxidized LDL;D051131
D08.811.739.650.500;Rad51 Recombinase;D051135
D12.776.260.695;Rad51 Recombinase;D051135
D12.776.863;Selenium-Binding Proteins;D051137
D12.776.864;Selenoproteins;D051140
D08.811.913.050.646;Retinol O-Fatty-Acyltransferase;D051142
D08.811.913.400.450.400.460;N-Acylsphingosine Galactosyltransferase;D051146
D08.811.913.400.450.400.475;Ganglioside Galactosyltransferase;D051147
D12.776.864.124;Selenoprotein P;D051149
D08.811.682.730;Methionine Sulfoxide Reductases;D051150
D12.776.864.100;Methionine Sulfoxide Reductases;D051150
D12.776.864.500;Selenoprotein W;D051151
D12.776.395.207;Clusterin;D051152
D12.776.580.215;Clusterin;D051152
D12.776.467.984;Wnt Proteins;D051153
D23.529.984;Wnt Proteins;D051153
D12.776.467.984.200;Wnt2 Protein;D051154
D12.776.624.664.700.978;Wnt2 Protein;D051154
D23.529.984.200;Wnt2 Protein;D051154
D12.776.467.984.100;Wnt1 Protein;D051155
D12.776.624.664.700.967;Wnt1 Protein;D051155
D23.529.984.100;Wnt1 Protein;D051155
D12.776.543.750.100.017;Frizzled Receptors;D051157
D12.776.543.750.962.500;Frizzled Receptors;D051157
D12.776.091.249;beta Catenin;D051176
D12.776.220.145.500;beta Catenin;D051176
D12.776.930.130;beta Catenin;D051176
D12.776.220.145;Catenins;D051177
D12.776.220.145.249;alpha Catenin;D051178
D12.776.220.790;Plakins;D051179
D12.776.220.790.500;Desmoplakins;D051180
D12.776.395.550.200.200.500;Desmosomal Cadherins;D051181
D12.776.543.550.200.200.500;Desmosomal Cadherins;D051181
D23.050.301.350.200.500;Desmosomal Cadherins;D051181
D12.776.395.550.200.200.500.500;Desmogleins;D051182
D12.776.543.550.200.200.500.500;Desmogleins;D051182
D23.050.301.350.200.500.500;Desmogleins;D051182
D12.776.395.550.200.200.500.500.500;Desmoglein 1;D051183
D12.776.543.550.200.200.500.500.500;Desmoglein 1;D051183
D23.050.301.350.200.500.500.500;Desmoglein 1;D051183
D23.050.422.124;Desmoglein 1;D051183
D12.776.395.550.200.200.500.500.750;Desmoglein 3;D051184
D12.776.543.550.200.200.500.500.750;Desmoglein 3;D051184
D23.050.301.350.200.500.500.750;Desmoglein 3;D051184
D23.050.422.249;Desmoglein 3;D051184
D12.776.091.500;gamma Catenin;D051185
D12.776.220.145.750;gamma Catenin;D051185
D12.776.091;Armadillo Domain Proteins;D051186
D12.776.395.550.200.200.500.249;Desmocollins;D051187
D12.776.543.550.200.200.500.249;Desmocollins;D051187
D23.050.301.350.200.500.249;Desmocollins;D051187
L01.224.065.480;Knowledge Bases;D051188
L01.700.508.300.550;Knowledge Bases;D051188
B01.050.150.900.649.865.635.505;Murinae;D051189
D12.776.220.790.750;Plectin;D051190
D12.776.744.736;Plectin;D051190
D12.776.091.750;Plakophilins;D051191
D12.776.220.885;Plakophilins;D051191
D12.776.543.750.705.910;Receptors, Pattern Recognition;D051192
D12.776.543.750.705.910.500;Toll-Like Receptors;D051193
D12.776.543.750.705.910.500.100;Toll-Like Receptor 1;D051194
D12.776.543.750.705.910.500.200;Toll-Like Receptor 2;D051195
D12.776.543.750.705.910.500.300;Toll-Like Receptor 3;D051196
D12.776.543.750.705.910.500.400;Toll-Like Receptor 4;D051197
D12.776.543.750.705.910.500.500;Toll-Like Receptor 5;D051198
D12.776.543.750.705.910.500.700;Toll-Like Receptor 7;D051199
D12.776.543.750.705.910.500.800;Toll-Like Receptor 8;D051200
D12.776.543.750.705.910.500.910;Toll-Like Receptor 10;D051201
D12.776.543.750.705.910.500.600;Toll-Like Receptor 6;D051216
D12.776.260.750;Toll-Like Receptor 9;D051217
D12.776.543.750.705.910.500.900;Toll-Like Receptor 9;D051217
D12.776.157.478;Lymphocyte Antigen 96;D051218
D23.050.301.593;Lymphocyte Antigen 96;D051218
D12.644.276.860.887;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
D12.644.400.625;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
D12.776.467.860.887;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
D12.776.641.600.887;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
D12.776.641.650.625;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
D23.529.850.887;Pituitary Adenylate Cyclase-Activating Polypeptide;D051219
A02.835.232.087.319.150.600;Pisiform Bone;D051220
A02.835.232.087.319.150.831;Triquetrum Bone;D051221
A02.835.232.087.319.150.800;Trapezium Bone;D051222
A02.835.232.087.319.150.805;Trapezoid Bone;D051223
A02.835.232.087.319.150.150;Capitate Bone;D051224
A02.835.232.087.319.150.400;Hamate Bone;D051225
D08.811.913.225.450;Geranyltranstransferase;D051228
D08.811.913.225.735;3-Phosphoshikimate 1-Carboxyvinyltransferase;D051229
D08.811.913.225.437;Farnesyltranstransferase;D051231
D08.811.913.225.443;Geranylgeranyl-Diphosphate Geranylgeranyltransferase;D051232
D12.776.543.750.100.665;Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide;D051236
D12.776.543.750.100.665.500;Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I;D051237
D12.776.543.750.100.665.760;Receptors, Vasoactive Intestinal Polypeptide, Type I;D051238
D12.776.543.750.100.900.520;Receptors, Vasoactive Intestinal Polypeptide, Type I;D051238
D12.776.543.750.100.665.750;Receptors, Vasoactive Intestinal Peptide, Type II;D051239
D12.776.543.750.100.900.500;Receptors, Vasoactive Intestinal Peptide, Type II;D051239
D12.644.360.024.264;Caveolin 1;D051242
D12.776.157.057.010;Caveolin 1;D051242
D12.776.476.024.280;Caveolin 1;D051242
D12.776.543.990.100.500;Caveolin 1;D051242
D12.776.744.287;Caveolin 1;D051242
D12.644.360.024.272;Caveolin 2;D051243
D12.776.157.057.012;Caveolin 2;D051243
D12.776.476.024.295;Caveolin 2;D051243
D12.776.543.990.100.750;Caveolin 2;D051243
D12.776.744.356;Caveolin 2;D051243
D12.776.210.500.235;Caveolin 3;D051244
D12.776.543.990.100.875;Caveolin 3;D051244
A08.663.358.700;Retinal Bipolar Cells;D051245
A08.663.650.850.750;Retinal Bipolar Cells;D051245
A09.371.729.831.750;Retinal Bipolar Cells;D051245
A11.671.358.700;Retinal Bipolar Cells;D051245
A11.671.650.850.750;Retinal Bipolar Cells;D051245
D12.776.157.530.500.500;Glucose Transport Proteins, Facilitative;D051246
D12.776.543.585.500.500;Glucose Transport Proteins, Facilitative;D051246
D12.776.157.530.450.625.437;Sodium-Glucose Transport Proteins;D051247
D12.776.157.530.500.750;Sodium-Glucose Transport Proteins;D051247
D12.776.543.585.450.625.562;Sodium-Glucose Transport Proteins;D051247
D12.776.543.585.500.750;Sodium-Glucose Transport Proteins;D051247
A08.663.650.850.937;Retinal Horizontal Cells;D051248
A09.371.729.831.937;Retinal Horizontal Cells;D051248
A11.671.650.850.937;Retinal Horizontal Cells;D051248
D12.776.260.108.500.061.625;Oncogene Protein v-maf;D051256
D12.776.624.664.520.750.860;Oncogene Protein v-maf;D051256
D12.776.930.127.500.061.625;Oncogene Protein v-maf;D051256
D12.776.964.700.750.817;Oncogene Protein v-maf;D051256
D12.776.964.775.750.817;Oncogene Protein v-maf;D051256
D12.776.260.108.500.061.750;Proto-Oncogene Proteins c-maf;D051257
D12.776.624.664.700.184;Proto-Oncogene Proteins c-maf;D051257
D12.776.930.127.500.061.750;Proto-Oncogene Proteins c-maf;D051257
D12.776.260.108.500.061.500;MafB Transcription Factor;D051258
D12.776.930.127.500.061.500;MafB Transcription Factor;D051258
D12.776.260.108.500.500.500;MafG Transcription Factor;D051259
D12.776.260.108.656.750.500;MafG Transcription Factor;D051259
D12.776.260.235.750.750.500;MafG Transcription Factor;D051259
D12.776.930.127.500.500.500;MafG Transcription Factor;D051259
D12.776.930.127.656.750.500;MafG Transcription Factor;D051259
D12.776.930.316.750.750.500;MafG Transcription Factor;D051259
D12.776.260.108.500.500.249;MafF Transcription Factor;D051260
D12.776.260.108.656.750.249;MafF Transcription Factor;D051260
D12.776.260.235.750.750.249;MafF Transcription Factor;D051260
D12.776.930.127.500.500.249;MafF Transcription Factor;D051260
D12.776.930.127.656.750.249;MafF Transcription Factor;D051260
D12.776.930.316.750.750.249;MafF Transcription Factor;D051260
C07.465.353;Granulomatosis, Orofacial;D051261
C23.550.384;Granulomatosis, Orofacial;D051261
D08.811.913.477.700.347;D-Alanine Transaminase;D051263
D12.776.260.615;Nuclear Respiratory Factors;D051264
D12.776.930.618;Nuclear Respiratory Factors;D051264
D12.776.260.108.710;NF-E2-Related Factor 1;D051265
D12.776.930.127.710;NF-E2-Related Factor 1;D051265
D12.776.260.615.500;Nuclear Respiratory Factor 1;D051266
D12.776.930.618.500;Nuclear Respiratory Factor 1;D051266
D12.776.260.108.737;NF-E2-Related Factor 2;D051267
D12.776.930.127.737;NF-E2-Related Factor 2;D051267
D12.776.260.615.249;GA-Binding Protein Transcription Factor;D051268
D12.776.930.618.249;GA-Binding Protein Transcription Factor;D051268
D12.776.157.530.450.625.437.500;Sodium-Glucose Transporter 1;D051269
D12.776.157.530.500.750.500;Sodium-Glucose Transporter 1;D051269
D12.776.543.585.450.625.562.500;Sodium-Glucose Transporter 1;D051269
D12.776.543.585.500.750.500;Sodium-Glucose Transporter 1;D051269
C10.228.140.546.399;Headache Disorders, Primary;D051270
C10.228.140.546.699;Headache Disorders, Secondary;D051271
D12.776.157.530.500.500.500;Glucose Transporter Type 1;D051272
D12.776.543.585.500.500.500;Glucose Transporter Type 1;D051272
D12.776.157.530.500.500.750;Glucose Transporter Type 2;D051273
D12.776.543.585.500.500.750;Glucose Transporter Type 2;D051273
D12.776.157.530.500.500.875;Glucose Transporter Type 3;D051274
D12.776.543.585.500.500.875;Glucose Transporter Type 3;D051274
D12.776.641.480;Glucose Transporter Type 3;D051274
D12.776.157.530.500.500.937;Glucose Transporter Type 4;D051275
D12.776.543.585.500.500.937;Glucose Transporter Type 4;D051275
D08.811.913.477.700.535;Leucine Transaminase;D051276
D08.811.913.477.700.800;Succinyldiaminopimelate Transaminase;D051277
D08.811.913.477.700.286;beta-Alanine-Pyruvate Transaminase;D051278
D08.811.913.477.700.850;Tryptophan Transaminase;D051279
D12.776.157.530.500.500.968;Glucose Transporter Type 5;D051296
D12.776.543.585.500.500.968;Glucose Transporter Type 5;D051296
D12.776.157.530.450.625.437.750;Sodium-Glucose Transporter 2;D051297
D12.776.157.530.500.750.750;Sodium-Glucose Transporter 2;D051297
D12.776.543.585.450.625.562.750;Sodium-Glucose Transporter 2;D051297
D12.776.543.585.500.750.750;Sodium-Glucose Transporter 2;D051297
C10.228.140.546.699.249;Post-Traumatic Headache;D051298
C10.228.140.546.699.124;Post-Dural Puncture Headache;D051299
D05.750.078.730.912;Wiskott-Aldrich Syndrome Protein Family;D051300
D12.776.220.525.912;Wiskott-Aldrich Syndrome Protein Family;D051300
D12.776.395.550.200.200.500.500.625;Desmoglein 2;D051301
D12.776.543.550.200.200.500.500.625;Desmoglein 2;D051301
D23.050.301.350.200.500.500.625;Desmoglein 2;D051301
C10.228.140.546.399.937.750;Paroxysmal Hemicrania;D051302
C10.228.140.546.399.937;Trigeminal Autonomic Cephalalgias;D051303
D05.750.078.730.637;Profilins;D051304
D12.776.210.500.775;Profilins;D051304
D12.776.220.525.637;Profilins;D051304
D08.811.913.477.700.550;L-Lysine 6-Transaminase;D051306
D08.811.913.477.700.120;2-Aminoadipate Transaminase;D051307
D08.811.913.477.700.525;Glycine Transaminase;D051308
D05.750.078.730.912.500;Wiskott-Aldrich Syndrome Protein;D051316
D12.776.220.525.912.500;Wiskott-Aldrich Syndrome Protein;D051316
D05.750.078.730.912.550;Wiskott-Aldrich Syndrome Protein, Neuronal;D051317
D12.776.220.525.912.550;Wiskott-Aldrich Syndrome Protein, Neuronal;D051317
A11.284.149.450.349;Mitochondrial Membranes;D051336
A11.284.835.514.349;Mitochondrial Membranes;D051336
I01.198.240.856.800.325;Chemical Terrorism;D051337
I01.880.735.900.800.150;Chemical Terrorism;D051337
I01.880.735.944.340.150;Chemical Terrorism;D051337
D05.750.078.730.212.500;Cofilin 1;D051338
D12.776.220.525.212.500;Cofilin 1;D051338
D05.750.078.730.212;Actin Depolymerizing Factors;D051339
D12.776.220.525.212;Actin Depolymerizing Factors;D051339
D05.750.078.730.212.750;Cofilin 2;D051340
D12.776.210.500.242;Cofilin 2;D051340
D12.776.220.525.212.750;Cofilin 2;D051340
G11.427.590.530.568.900.500;Dependent Ambulation;D051341
D05.750.078.730.032;Actin Capping Proteins;D051344
D12.776.220.525.032;Actin Capping Proteins;D051344
D05.750.078.730.212.875;Destrin;D051345
D12.776.220.525.212.875;Destrin;D051345
C23.888.550;Mobility Limitation;D051346
D05.750.078.730.032.500;CapZ Actin Capping Protein;D051347
D12.776.210.500.227;CapZ Actin Capping Protein;D051347
D12.776.220.525.032.500;CapZ Actin Capping Protein;D051347
D05.750.078.730.032.750;Tropomodulin;D051348
D12.776.210.500.847;Tropomodulin;D051348
D12.776.220.525.032.750;Tropomodulin;D051348
D05.750.078.730.281;Cortactin;D051356
D12.644.360.024.280;Cortactin;D051356
D12.776.157.057.014;Cortactin;D051356
D12.776.220.525.281;Cortactin;D051356
D12.776.476.024.311;Cortactin;D051356
D12.776.744.390;Cortactin;D051356
D08.811.913.696.620.682.700.200.323;Cyclin-Dependent Kinase 2;D051357
D08.811.913.696.620.682.700.646.500.750;Cyclin-Dependent Kinase 2;D051357
D12.644.360.250.323;Cyclin-Dependent Kinase 2;D051357
D12.776.167.200.323;Cyclin-Dependent Kinase 2;D051357
D12.776.476.250.323;Cyclin-Dependent Kinase 2;D051357
D08.811.913.696.620.682.700.200.451;Cyclin-Dependent Kinase 4;D051358
D08.811.913.696.620.682.700.646.500.875;Cyclin-Dependent Kinase 4;D051358
D12.644.360.250.451;Cyclin-Dependent Kinase 4;D051358
D12.776.167.200.451;Cyclin-Dependent Kinase 4;D051358
D12.776.476.250.451;Cyclin-Dependent Kinase 4;D051358
C15.604.250.410.575;Lymphohistiocytosis, Hemophagocytic;D051359
D08.811.913.696.620.682.700.200.067.875;Cyclin-Dependent Kinase 5;D051360
D08.811.913.696.620.682.700.646.500.500.500;Cyclin-Dependent Kinase 5;D051360
D12.644.360.250.067.875;Cyclin-Dependent Kinase 5;D051360
D12.776.167.200.067.875;Cyclin-Dependent Kinase 5;D051360
D12.776.476.250.067.875;Cyclin-Dependent Kinase 5;D051360
D08.811.913.696.620.682.700.200.515;Cyclin-Dependent Kinase 6;D051361
D08.811.913.696.620.682.700.646.500.937;Cyclin-Dependent Kinase 6;D051361
D12.644.360.250.515;Cyclin-Dependent Kinase 6;D051361
D12.776.167.200.515;Cyclin-Dependent Kinase 6;D051361
D12.776.476.250.515;Cyclin-Dependent Kinase 6;D051361
D05.750.078.730.246;Actin-Related Protein 2-3 Complex;D051376
D12.776.220.525.246;Actin-Related Protein 2-3 Complex;D051376
D05.750.078.730.246.500;Actin-Related Protein 2;D051377
D12.776.220.525.246.500;Actin-Related Protein 2;D051377
D05.750.078.730.246.750;Actin-Related Protein 3;D051378
D12.776.220.525.246.750;Actin-Related Protein 3;D051378
B01.050.150.900.649.865.635.505.500;Mice;D051379
D12.644.360.024.297;GRB2 Adaptor Protein;D051380
D12.776.157.057.026;GRB2 Adaptor Protein;D051380
D12.776.476.024.377;GRB2 Adaptor Protein;D051380
B01.050.150.900.649.865.635.505.700;Rats;D051381
D12.644.360.024.298;GRB7 Adaptor Protein;D051382
D12.776.157.057.028;GRB7 Adaptor Protein;D051382
D12.776.476.024.379;GRB7 Adaptor Protein;D051382
D12.644.360.024.300;GRB10 Adaptor Protein;D051383
D12.776.157.057.029;GRB10 Adaptor Protein;D051383
D12.776.476.024.380;GRB10 Adaptor Protein;D051383
D12.776.157.530.400.500.040.249;Aquaglyceroporins;D051397
D12.776.543.550.425.730.040.249;Aquaglyceroporins;D051397
D12.776.543.585.400.730.040.249;Aquaglyceroporins;D051397
D12.776.157.530.400.500.040.374;Aquaporin 1;D051398
D12.776.543.550.425.730.040.374;Aquaporin 1;D051398
D12.776.543.585.400.730.040.436;Aquaporin 1;D051398
D12.776.157.530.400.500.040.437;Aquaporin 2;D051399
D12.776.543.550.425.730.040.437;Aquaporin 2;D051399
D12.776.543.585.400.730.040.530;Aquaporin 2;D051399
D12.776.157.530.400.500.040.249.500;Aquaporin 3;D051400
D12.776.543.550.425.730.040.249.500;Aquaporin 3;D051400
D12.776.543.585.400.730.040.249.500;Aquaporin 3;D051400
D12.776.157.530.400.500.040.468;Aquaporin 4;D051401
D12.776.543.550.425.730.040.468;Aquaporin 4;D051401
D12.776.543.585.400.730.040.577;Aquaporin 4;D051401
D12.776.157.530.400.500.040.484;Aquaporin 5;D051402
D12.776.543.550.425.730.040.484;Aquaporin 5;D051402
D12.776.543.585.400.730.040.600;Aquaporin 5;D051402
D12.776.157.530.400.500.040.249.750;Aquaporin 6;D051403
D12.776.543.550.425.730.040.249.750;Aquaporin 6;D051403
D12.776.543.585.400.730.040.249.750;Aquaporin 6;D051403
D08.811.913.696.620.682.725.049;Focal Adhesion Protein-Tyrosine Kinases;D051416
D12.644.360.287;Focal Adhesion Protein-Tyrosine Kinases;D051416
D12.776.476.287;Focal Adhesion Protein-Tyrosine Kinases;D051416
D08.811.913.696.620.682.725.049.500;Focal Adhesion Kinase 1;D051417
D12.776.744.493;Focal Adhesion Kinase 1;D051417
D08.811.913.696.620.682.725.049.750;Focal Adhesion Kinase 2;D051418
D12.644.360.024.309;Paxillin;D051419
D12.776.157.057.092;Paxillin;D051419
D12.776.476.024.397;Paxillin;D051419
D12.776.512.374;Paxillin;D051419
D12.776.744.665;Paxillin;D051419
C12.777.419.780.750;Renal Insufficiency, Chronic;D051436
C13.351.968.419.780.750;Renal Insufficiency, Chronic;D051436
C12.777.419.780;Renal Insufficiency;D051437
C13.351.968.419.780;Renal Insufficiency;D051437
D12.776.543.512.249.500.500.750;Syntaxin 16;D051438
D12.776.543.990.775.500.500.750;Syntaxin 16;D051438
A02.165.308;Fibrocartilage;D051445
A10.165.382.350;Fibrocartilage;D051445
G05.330.159;Gene Flow;D051456
A02.165.407;Hyaline Cartilage;D051457
A10.165.382.400;Hyaline Cartilage;D051457
A02.165.257;Elastic Cartilage;D051472
A10.165.382.300;Elastic Cartilage;D051472
D12.776.260.108.500.061;Maf Transcription Factors, Large;D051473
D12.776.930.127.500.061;Maf Transcription Factors, Large;D051473
C10.597.617.682.550;Neuralgia, Postherpetic;D051474
C10.668.829.600.550;Neuralgia, Postherpetic;D051474
C23.888.592.612.664.550;Neuralgia, Postherpetic;D051474
C23.888.646.508.550;Neuralgia, Postherpetic;D051474
A02.165.308.800;Triangular Fibrocartilage;D051478
A02.835.583.405.930.800;Triangular Fibrocartilage;D051478
A10.165.382.350.800;Triangular Fibrocartilage;D051478
G15.649;Plant Infertility;D051479
D08.811.913.696.620.682.725.400.177;Receptor, Fibroblast Growth Factor, Type 1;D051496
D12.776.543.750.060.440;Receptor, Fibroblast Growth Factor, Type 1;D051496
D12.776.543.750.750.400.370.500;Receptor, Fibroblast Growth Factor, Type 1;D051496
D08.811.913.696.620.682.725.400.178;Receptor, Fibroblast Growth Factor, Type 2;D051497
D12.776.543.750.060.441;Receptor, Fibroblast Growth Factor, Type 2;D051497
D12.776.543.750.750.400.370.750;Receptor, Fibroblast Growth Factor, Type 2;D051497
D08.811.913.696.620.682.725.400.179;Receptor, Fibroblast Growth Factor, Type 3;D051498
D12.776.543.750.060.442;Receptor, Fibroblast Growth Factor, Type 3;D051498
D12.776.543.750.750.400.370.875;Receptor, Fibroblast Growth Factor, Type 3;D051498
D12.776.624.664.700.792;Receptor, Fibroblast Growth Factor, Type 3;D051498
D08.811.913.696.620.682.725.400.180;Receptor, Fibroblast Growth Factor, Type 4;D051499
D12.776.543.750.060.443;Receptor, Fibroblast Growth Factor, Type 4;D051499
D12.776.543.750.750.400.370.937;Receptor, Fibroblast Growth Factor, Type 4;D051499
D12.776.543.750.750.400.370.968;Receptor, Fibroblast Growth Factor, Type 5;D051500
C12.294.293;Hemospermia;D051516
E01.370.600.600.500;Digital Rectal Examination;D051517
D12.644.276.624.130;Fibroblast Growth Factor 3;D051518
D12.776.467.624.130;Fibroblast Growth Factor 3;D051518
D23.529.624.130;Fibroblast Growth Factor 3;D051518
D12.644.276.624.140;Fibroblast Growth Factor 4;D051519
D12.776.467.624.140;Fibroblast Growth Factor 4;D051519
D12.776.624.664.700.110;Fibroblast Growth Factor 4;D051519
D23.529.624.140;Fibroblast Growth Factor 4;D051519
D27.720.269.189;Antiperspirants;D051520
D12.644.276.624.150;Fibroblast Growth Factor 5;D051521
D12.776.467.624.150;Fibroblast Growth Factor 5;D051521
D23.529.624.150;Fibroblast Growth Factor 5;D051521
D12.644.276.624.160;Fibroblast Growth Factor 6;D051522
D12.776.467.624.160;Fibroblast Growth Factor 6;D051522
D12.776.624.664.700.112;Fibroblast Growth Factor 6;D051522
D23.529.624.160;Fibroblast Growth Factor 6;D051522
D12.644.276.624.170;Fibroblast Growth Factor 7;D051523
D12.776.467.624.170;Fibroblast Growth Factor 7;D051523
D23.529.624.170;Fibroblast Growth Factor 7;D051523
D12.644.276.624.180;Fibroblast Growth Factor 8;D051524
D12.776.467.624.180;Fibroblast Growth Factor 8;D051524
D23.529.624.180;Fibroblast Growth Factor 8;D051524
D12.644.276.624.190;Fibroblast Growth Factor 9;D051525
D12.776.467.624.190;Fibroblast Growth Factor 9;D051525
D23.529.624.190;Fibroblast Growth Factor 9;D051525
D12.644.276.624.200;Fibroblast Growth Factor 10;D051526
D12.776.467.624.200;Fibroblast Growth Factor 10;D051526
D23.529.624.200;Fibroblast Growth Factor 10;D051526
C04.557.695.607;Odontogenic Tumor, Squamous;D051527
D08.811.913.696.650.450;Guanylate Kinase;D051528
D12.776.260.262;Hepatocyte Nuclear Factors;D051536
D12.776.660.352;Hepatocyte Nuclear Factors;D051536
D12.776.930.323;Hepatocyte Nuclear Factors;D051536
D12.776.260.262.500;Hepatocyte Nuclear Factor 1;D051537
D12.776.660.352.500;Hepatocyte Nuclear Factor 1;D051537
D12.776.930.323.500;Hepatocyte Nuclear Factor 1;D051537
D12.776.260.262.500.500;Hepatocyte Nuclear Factor 1-alpha;D051538
D12.776.660.352.500.500;Hepatocyte Nuclear Factor 1-alpha;D051538
D12.776.930.323.500.500;Hepatocyte Nuclear Factor 1-alpha;D051538
D12.776.260.262.500.750;Hepatocyte Nuclear Factor 1-beta;D051539
D12.776.660.352.500.750;Hepatocyte Nuclear Factor 1-beta;D051539
D12.776.930.323.500.750;Hepatocyte Nuclear Factor 1-beta;D051539
D12.776.260.950;Winged-Helix Transcription Factors;D051540
D12.776.930.977;Winged-Helix Transcription Factors;D051540
D12.776.260.262.750;Hepatocyte Nuclear Factor 3-alpha;D051541
D12.776.260.950.249.500;Hepatocyte Nuclear Factor 3-alpha;D051541
D12.776.660.352.750;Hepatocyte Nuclear Factor 3-alpha;D051541
D12.776.930.323.750;Hepatocyte Nuclear Factor 3-alpha;D051541
D12.776.930.977.249.500;Hepatocyte Nuclear Factor 3-alpha;D051541
D12.776.260.262.875;Hepatocyte Nuclear Factor 3-beta;D051542
D12.776.260.950.249.750;Hepatocyte Nuclear Factor 3-beta;D051542
D12.776.660.352.875;Hepatocyte Nuclear Factor 3-beta;D051542
D12.776.930.323.875;Hepatocyte Nuclear Factor 3-beta;D051542
D12.776.930.977.249.750;Hepatocyte Nuclear Factor 3-beta;D051542
D12.776.260.262.937;Hepatocyte Nuclear Factor 3-gamma;D051543
D12.776.260.950.249.875;Hepatocyte Nuclear Factor 3-gamma;D051543
D12.776.660.352.937;Hepatocyte Nuclear Factor 3-gamma;D051543
D12.776.930.323.937;Hepatocyte Nuclear Factor 3-gamma;D051543
D12.776.930.977.249.875;Hepatocyte Nuclear Factor 3-gamma;D051543
D08.244.453.040.986;Cytochrome P-450 CYP3A;D051544
D08.811.682.662.582.353;Cytochrome P-450 CYP3A;D051544
D08.811.682.690.708.170.040.888;Cytochrome P-450 CYP3A;D051544
D12.776.422.220.453.040.972;Cytochrome P-450 CYP3A;D051544
D08.811.600.720.500;Cyclooxygenase 1;D051545
D08.811.600.720.750;Cyclooxygenase 2;D051546
D08.811.682.690.708.410.500;Heme Oxygenase-1;D051547
D08.811.913.050.134.407;Histone Acetyltransferases;D051548
D08.811.913.225.500.500;Glutathione S-Transferase pi;D051549
D08.811.913.696.620.682.700.494;I-kappa B Kinase;D051550
D12.644.360.376;I-kappa B Kinase;D051550
D12.776.476.378;I-kappa B Kinase;D051550
D08.811.913.696.620.682.700.364.049;beta-Adrenergic Receptor Kinases;D051552
D12.644.360.293.249;beta-Adrenergic Receptor Kinases;D051552
D12.776.476.293.249;beta-Adrenergic Receptor Kinases;D051552
C16.614.451;Hyperbilirubinemia, Neonatal;D051556
C23.550.429.249;Hyperbilirubinemia, Neonatal;D051556
D12.776.260.262.968;Hepatocyte Nuclear Factor 4;D051557
D12.776.260.698.119;Hepatocyte Nuclear Factor 4;D051557
D12.776.660.352.968;Hepatocyte Nuclear Factor 4;D051557
D12.776.826.119;Hepatocyte Nuclear Factor 4;D051557
D12.776.930.323.968;Hepatocyte Nuclear Factor 4;D051557
D12.776.930.669.119;Hepatocyte Nuclear Factor 4;D051557
D12.776.260.400.624;Onecut Transcription Factors;D051558
D12.776.930.620;Onecut Transcription Factors;D051558
D12.776.260.262.984;Hepatocyte Nuclear Factor 6;D051559
D12.776.260.400.624.500;Hepatocyte Nuclear Factor 6;D051559
D12.776.660.352.984;Hepatocyte Nuclear Factor 6;D051559
D12.776.930.323.984;Hepatocyte Nuclear Factor 6;D051559
D12.776.930.620.500;Hepatocyte Nuclear Factor 6;D051559
D12.776.260.660;Proto-Oncogene Proteins c-bcl-6;D051560
D12.776.624.664.700.170;Proto-Oncogene Proteins c-bcl-6;D051560
D12.776.930.633;Proto-Oncogene Proteins c-bcl-6;D051560
D12.776.124.486.274.045.387.500.374;Complement C3 Convertase, Alternative Pathway;D051561
D08.811.913.696.620.682.700.759;Proto-Oncogene Proteins c-bcr;D051562
D12.776.624.664.700.171;Proto-Oncogene Proteins c-bcr;D051562
D12.776.124.486.274.045.387.500.750;Complement C5 Convertase, Alternative Pathway;D051566
D12.644.360.024.326;Proto-Oncogene Proteins c-vav;D051567
D12.644.360.325.300.450;Proto-Oncogene Proteins c-vav;D051567
D12.776.157.057.155;Proto-Oncogene Proteins c-vav;D051567
D12.776.402.300.450;Proto-Oncogene Proteins c-vav;D051567
D12.776.476.024.411;Proto-Oncogene Proteins c-vav;D051567
D12.776.476.325.300.450;Proto-Oncogene Proteins c-vav;D051567
D12.776.624.664.700.198;Proto-Oncogene Proteins c-vav;D051567
D08.811.913.696.620.682.700.725.100;Protein Kinase C-alpha;D051571
D08.811.913.696.620.682.725.800.590;Proto-Oncogene Proteins c-hck;D051572
D12.776.624.664.700.181;Proto-Oncogene Proteins c-hck;D051572
D08.811.913.696.620.682.700.776;Proto-Oncogene Proteins c-pim-1;D051573
D12.776.624.664.700.191;Proto-Oncogene Proteins c-pim-1;D051573
D12.776.124.486.274.045.387.750.500;Complement C3 Convertase, Classical Pathway;D051574
D08.811.913.696.620.682.725.800.610;Proto-Oncogene Proteins c-yes;D051575
D12.776.624.664.700.199;Proto-Oncogene Proteins c-yes;D051575
D12.776.124.486.274.045.387.750.750;Complement C5 Convertase, Classical Pathway;D051577
D08.811.913.696.620.682.725.300;Proto-Oncogene Proteins c-fes;D051578
D12.776.624.664.700.177;Proto-Oncogene Proteins c-fes;D051578
D12.776.157.142.500;Neurogranin;D051579
D12.776.641.640;Neurogranin;D051579
D12.644.360.381.500;Neuronal Calcium-Sensor Proteins;D051580
D12.776.157.125.412.500;Neuronal Calcium-Sensor Proteins;D051580
D12.776.476.387.500;Neuronal Calcium-Sensor Proteins;D051580
D12.776.641.645;Neuronal Calcium-Sensor Proteins;D051580
D12.644.360.381.500.500;Neurocalcin;D051596
D12.776.157.125.412.500.500;Neurocalcin;D051596
D12.776.476.387.500.500;Neurocalcin;D051596
D12.776.641.645.500;Neurocalcin;D051596
D12.644.360.381.500.249;Hippocalcin;D051597
D12.776.157.125.412.500.249;Hippocalcin;D051597
D12.776.476.387.500.249;Hippocalcin;D051597
D12.776.641.645.249;Hippocalcin;D051597
E01.370.350.925;Whole Body Imaging;D051598
E05.979;Whole Body Imaging;D051598
D08.811.913.696.445.400;Glucose-1-Phosphate Adenylyltransferase;D051599
D12.644.360.381.500.750;Recoverin;D051603
D12.776.157.125.412.500.750;Recoverin;D051603
D12.776.306.750;Recoverin;D051603
D12.776.476.387.500.750;Recoverin;D051603
D12.776.641.645.750;Recoverin;D051603
D12.644.360.381.500.124;Guanylate Cyclase-Activating Proteins;D051604
D12.776.157.125.412.500.124;Guanylate Cyclase-Activating Proteins;D051604
D12.776.306.433;Guanylate Cyclase-Activating Proteins;D051604
D12.776.476.387.500.124;Guanylate Cyclase-Activating Proteins;D051604
D12.776.641.645.124;Guanylate Cyclase-Activating Proteins;D051604
D12.644.360.381.500.374;Kv Channel-Interacting Proteins;D051605
D12.776.157.125.412.500.374;Kv Channel-Interacting Proteins;D051605
D12.776.476.387.500.374;Kv Channel-Interacting Proteins;D051605
D12.776.641.645.374;Kv Channel-Interacting Proteins;D051605
D08.811.913.696.620.682.700.364.100;G-Protein-Coupled Receptor Kinase 1;D051606
D12.644.360.293.500;G-Protein-Coupled Receptor Kinase 1;D051606
D12.776.306.399;G-Protein-Coupled Receptor Kinase 1;D051606
D12.776.476.293.500;G-Protein-Coupled Receptor Kinase 1;D051606
D08.811.913.696.900.074;CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase;D051607
D12.644.360.075.437.500;Neuronal Apoptosis-Inhibitory Protein;D051616
D12.776.476.075.437.500;Neuronal Apoptosis-Inhibitory Protein;D051616
D12.776.641.642;Neuronal Apoptosis-Inhibitory Protein;D051616
D12.644.360.075.437.750;X-Linked Inhibitor of Apoptosis Protein;D051636
D12.776.476.075.437.750;X-Linked Inhibitor of Apoptosis Protein;D051636
D12.776.157.530.400.600.900.500;Shaker Superfamily of Potassium Channels;D051637
D12.776.543.550.425.750.900.500;Shaker Superfamily of Potassium Channels;D051637
D12.776.543.585.400.750.900.624;Shaker Superfamily of Potassium Channels;D051637
D12.776.157.530.400.600.900.249;Ether-A-Go-Go Potassium Channels;D051638
D12.776.543.550.425.750.900.249;Ether-A-Go-Go Potassium Channels;D051638
D12.776.543.585.400.750.900.249;Ether-A-Go-Go Potassium Channels;D051638
I03.450.642.378;Gardening;D051639
J01.040.413;Gardening;D051639
D12.776.157.530.400.600.150.750;Small-Conductance Calcium-Activated Potassium Channels;D051640
D12.776.543.550.425.750.150.750;Small-Conductance Calcium-Activated Potassium Channels;D051640
D12.776.543.585.400.750.150.750;Small-Conductance Calcium-Activated Potassium Channels;D051640
C04.557.450.565.590.425;Histiocytoma;D051642
D12.776.157.530.400.600.900.124.249;KCNQ Potassium Channels;D051656
D12.776.543.550.425.750.900.124.249;KCNQ Potassium Channels;D051656
D12.776.543.585.400.750.900.124.249;KCNQ Potassium Channels;D051656
D12.776.157.530.400.600.900.124.249.500;KCNQ1 Potassium Channel;D051657
D12.776.543.550.425.750.900.124.249.500;KCNQ1 Potassium Channel;D051657
D12.776.543.585.400.750.900.124.249.500;KCNQ1 Potassium Channel;D051657
D12.776.157.530.400.600.900.124.249.750;KCNQ2 Potassium Channel;D051658
D12.776.543.550.425.750.900.124.249.750;KCNQ2 Potassium Channel;D051658
D12.776.543.585.400.750.900.124.249.750;KCNQ2 Potassium Channel;D051658
D12.776.157.530.400.600.900.124.249.875;KCNQ3 Potassium Channel;D051659
D12.776.543.550.425.750.900.124.249.875;KCNQ3 Potassium Channel;D051659
D12.776.543.585.400.750.900.124.249.875;KCNQ3 Potassium Channel;D051659
D12.776.157.530.400.600.150.249;Intermediate-Conductance Calcium-Activated Potassium Channels;D051660
D12.776.543.550.425.750.150.249;Intermediate-Conductance Calcium-Activated Potassium Channels;D051660
D12.776.543.585.400.750.150.249;Intermediate-Conductance Calcium-Activated Potassium Channels;D051660
D12.776.157.530.400.600.900.500.124;Kv1.1 Potassium Channel;D051662
D12.776.543.550.425.750.900.124.311;Kv1.1 Potassium Channel;D051662
D12.776.543.550.425.750.900.500.124;Kv1.1 Potassium Channel;D051662
D12.776.543.585.400.750.900.624.124;Kv1.1 Potassium Channel;D051662
D12.776.157.530.400.600.900.500.186;Kv1.2 Potassium Channel;D051663
D12.776.543.550.425.750.900.124.342;Kv1.2 Potassium Channel;D051663
D12.776.543.550.425.750.900.500.186;Kv1.2 Potassium Channel;D051663
D12.776.543.585.400.750.900.624.186;Kv1.2 Potassium Channel;D051663
D12.776.157.530.400.600.900.500.217;Kv1.3 Potassium Channel;D051664
D12.776.543.550.425.750.900.124.358;Kv1.3 Potassium Channel;D051664
D12.776.543.585.400.750.900.624.217;Kv1.3 Potassium Channel;D051664
D12.776.157.530.400.600.900.500.233;Kv1.4 Potassium Channel;D051665
D12.776.543.550.425.750.900.500.233;Kv1.4 Potassium Channel;D051665
D12.776.543.585.400.750.900.624.233;Kv1.4 Potassium Channel;D051665
D12.776.157.530.400.600.900.124.374;Kv1.5 Potassium Channel;D051666
D12.776.157.530.400.600.900.500.241;Kv1.5 Potassium Channel;D051666
D12.776.543.550.425.750.900.124.374;Kv1.5 Potassium Channel;D051666
D12.776.543.550.425.750.900.500.241;Kv1.5 Potassium Channel;D051666
D12.776.543.585.400.750.900.124.374;Kv1.5 Potassium Channel;D051666
D12.776.543.585.400.750.900.624.241;Kv1.5 Potassium Channel;D051666
D12.776.157.530.400.600.900.500.245;Kv1.6 Potassium Channel;D051667
D12.776.543.550.425.750.900.124.437;Kv1.6 Potassium Channel;D051667
D12.776.543.585.400.750.900.624.245;Kv1.6 Potassium Channel;D051667
D12.776.157.530.400.600.900.124;Delayed Rectifier Potassium Channels;D051668
D12.776.543.550.425.750.900.124;Delayed Rectifier Potassium Channels;D051668
D12.776.543.585.400.750.900.124;Delayed Rectifier Potassium Channels;D051668
D12.776.157.530.400.600.900.124.500;Shab Potassium Channels;D051669
D12.776.157.530.400.600.900.500.249;Shab Potassium Channels;D051669
D12.776.543.550.425.750.900.124.500;Shab Potassium Channels;D051669
D12.776.543.550.425.750.900.500.249;Shab Potassium Channels;D051669
D12.776.543.585.400.750.900.124.500;Shab Potassium Channels;D051669
D12.776.543.585.400.750.900.624.249;Shab Potassium Channels;D051669
D12.776.157.530.400.600.900.500.750;Shaw Potassium Channels;D051670
D12.776.543.550.425.750.900.500.750;Shaw Potassium Channels;D051670
D12.776.543.585.400.750.900.624.750;Shaw Potassium Channels;D051670
D12.776.157.530.400.600.900.500.625;Shal Potassium Channels;D051672
D12.776.543.550.425.750.900.500.625;Shal Potassium Channels;D051672
D12.776.543.585.400.750.900.624.625;Shal Potassium Channels;D051672
D12.776.157.530.400.600.450.500;G Protein-Coupled Inwardly-Rectifying Potassium Channels;D051676
D12.776.543.550.425.750.450.500;G Protein-Coupled Inwardly-Rectifying Potassium Channels;D051676
D12.776.543.585.400.750.450.500;G Protein-Coupled Inwardly-Rectifying Potassium Channels;D051676
C04.557.450.565.590.425.360;Histiocytoma, Malignant Fibrous;D051677
C04.557.450.795.400;Histiocytoma, Malignant Fibrous;D051677
D12.776.260.108.061;Activating Transcription Factors;D051696
D12.776.930.127.061;Activating Transcription Factors;D051696
D12.776.260.108.061.500;Activating Transcription Factor 1;D051697
D12.776.930.127.061.500;Activating Transcription Factor 1;D051697
D12.776.260.108.061.750;Activating Transcription Factor 2;D051698
D12.776.930.127.061.750;Activating Transcription Factor 2;D051698
D12.776.260.108.186;Cyclic AMP Response Element-Binding Protein A;D051699
D12.776.930.127.186;Cyclic AMP Response Element-Binding Protein A;D051699
D12.776.260.108.061.875;Activating Transcription Factor 3;D051700
D12.776.930.127.061.875;Activating Transcription Factor 3;D051700
D12.776.260.108.061.937;Activating Transcription Factor 4;D051701
D12.776.930.127.061.937;Activating Transcription Factor 4;D051701
D12.644.360.011;Activating Transcription Factor 6;D051702
D12.776.260.108.061.968;Activating Transcription Factor 6;D051702
D12.776.476.011;Activating Transcription Factor 6;D051702
D12.776.930.127.061.968;Activating Transcription Factor 6;D051702
D12.776.260.522.750;Sp Transcription Factors;D051703
D12.776.930.375.750;Sp Transcription Factors;D051703
D12.776.260.522.750.500;Sp2 Transcription Factor;D051704
D12.776.930.375.750.500;Sp2 Transcription Factor;D051704
D12.776.260.522.750.750;Sp3 Transcription Factor;D051705
D12.776.930.375.750.750;Sp3 Transcription Factor;D051705
D12.776.260.522.750.875;Sp4 Transcription Factor;D051706
D12.776.930.375.750.875;Sp4 Transcription Factor;D051706
D12.776.260.700;Replication Protein A;D051716
D12.776.260.400.155;Fushi Tarazu Transcription Factors;D051717
D12.776.930.318;Fushi Tarazu Transcription Factors;D051717
D08.811.074.812;MutS Homolog 2 Protein;D051718
D08.811.277.040.025.281;MutS Homolog 2 Protein;D051718
D12.776.260.551;MutS Homolog 2 Protein;D051718
D12.776.624.664.700.130;MutS Homolog 2 Protein;D051718
D08.811.074.781;MutS DNA Mismatch-Binding Protein;D051719
D08.811.277.040.025.237;MutS DNA Mismatch-Binding Protein;D051719
D12.776.097.537;MutS DNA Mismatch-Binding Protein;D051719
D12.776.260.541;MutS DNA Mismatch-Binding Protein;D051719
D12.776.260.103.937;Upstream Stimulatory Factors;D051720
D12.776.930.125.937;Upstream Stimulatory Factors;D051720
D12.776.260.696;Rad52 DNA Repair and Recombination Protein;D051721
D08.811.277.656.675.374.102;ADAM Proteins;D051722
D09.400.430.500;ADAM Proteins;D051722
D12.776.395.033;ADAM Proteins;D051722
D08.811.464.938.750.562;Proto-Oncogene Proteins c-mdm2;D051736
D12.776.624.664.700.185;Proto-Oncogene Proteins c-mdm2;D051736
D12.776.660.764;Proto-Oncogene Proteins c-mdm2;D051736
D12.776.260.640;Origin Recognition Complex;D051738
D12.776.260.103.500.500;Microphthalmia-Associated Transcription Factor;D051739
D12.776.260.108.092.500;Microphthalmia-Associated Transcription Factor;D051739
D12.776.930.125.500.500;Microphthalmia-Associated Transcription Factor;D051739
D12.776.930.127.092.500;Microphthalmia-Associated Transcription Factor;D051739
D12.776.260.522.500;Ikaros Transcription Factor;D051740
D12.776.930.375.500;Ikaros Transcription Factor;D051740
D12.776.260.522;Kruppel-Like Transcription Factors;D051741
D12.776.930.375;Kruppel-Like Transcription Factors;D051741
D12.776.260.108.124.875;Transcription Factor CHOP;D051742
D12.776.660.167.875;Transcription Factor CHOP;D051742
D12.776.930.127.124.875;Transcription Factor CHOP;D051742
D12.776.260.108.124.812;CCAAT-Enhancer-Binding Protein-delta;D051743
D12.776.660.167.812;CCAAT-Enhancer-Binding Protein-delta;D051743
D12.776.930.127.124.812;CCAAT-Enhancer-Binding Protein-delta;D051743
D08.811.913.696.620.682.700.725.750;Protein Kinase C-epsilon;D051744
D08.811.913.696.620.682.700.725.400;Protein Kinase C-delta;D051745
D08.811.913.696.620.682.725.900;ZAP-70 Protein-Tyrosine Kinase;D051746
D12.776.476.950;ZAP-70 Protein-Tyrosine Kinase;D051746
D08.811.913.696.620.682.700.250;DNA-Activated Protein Kinase;D051747
D12.776.260.527;Leucine-Responsive Regulatory Protein;D051756
D12.776.930.386;Leucine-Responsive Regulatory Protein;D051756
D12.776.260.645.500;B-Cell-Specific Activator Protein;D051757
D12.776.930.626.500;B-Cell-Specific Activator Protein;D051757
D12.776.260.775.875.875;Transcription Factor TFIIH;D051758
D12.776.930.930.875.875;Transcription Factor TFIIH;D051758
D08.811.277.040.025.159.500;Xeroderma Pigmentosum Group D Protein;D051759
D08.811.399.340.500;Xeroderma Pigmentosum Group D Protein;D051759
D12.776.260.775.875.875.500;Xeroderma Pigmentosum Group D Protein;D051759
D12.776.930.930.875.875.500;Xeroderma Pigmentosum Group D Protein;D051759
D12.776.260.975;Xeroderma Pigmentosum Group A Protein;D051760
D12.776.260.645;Paired Box Transcription Factors;D051761
D12.776.930.626;Paired Box Transcription Factors;D051761
D12.776.260.645.750;PAX2 Transcription Factor;D051762
D12.776.930.626.750;PAX2 Transcription Factor;D051762
D12.776.260.400.812;PAX7 Transcription Factor;D051763
D12.776.260.645.875;PAX7 Transcription Factor;D051763
D12.776.930.626.875;PAX7 Transcription Factor;D051763
D12.776.260.645.937;PAX9 Transcription Factor;D051764
D12.776.930.626.937;PAX9 Transcription Factor;D051764
D12.776.260.158;Early Growth Response Transcription Factors;D051765
D12.776.460.525;Early Growth Response Transcription Factors;D051765
D12.776.930.313;Early Growth Response Transcription Factors;D051765
D12.776.260.158.500;Early Growth Response Protein 1;D051766
D12.776.460.525.500;Early Growth Response Protein 1;D051766
D12.776.930.313.500;Early Growth Response Protein 1;D051766
D12.776.260.158.750;Early Growth Response Protein 2;D051767
D12.776.460.525.750;Early Growth Response Protein 2;D051767
D12.776.930.313.750;Early Growth Response Protein 2;D051767
D12.776.260.158.875;Early Growth Response Protein 3;D051776
D12.776.460.525.875;Early Growth Response Protein 3;D051776
D12.776.930.313.875;Early Growth Response Protein 3;D051776
D12.776.097.049;AraC Transcription Factor;D051777
D12.776.260.703.099;AraC Transcription Factor;D051777
D12.776.930.122;AraC Transcription Factor;D051777
D12.776.930.700.500;AraC Transcription Factor;D051777
D12.776.260.103.500;Basic Helix-Loop-Helix Leucine Zipper Transcription Factors;D051778
D12.776.260.108.092;Basic Helix-Loop-Helix Leucine Zipper Transcription Factors;D051778
D12.776.930.125.500;Basic Helix-Loop-Helix Leucine Zipper Transcription Factors;D051778
D12.776.930.127.092;Basic Helix-Loop-Helix Leucine Zipper Transcription Factors;D051778
D12.776.260.103.500.750;Sterol Regulatory Element Binding Proteins;D051779
D12.776.260.108.092.750;Sterol Regulatory Element Binding Proteins;D051779
D12.776.930.125.500.750;Sterol Regulatory Element Binding Proteins;D051779
D12.776.930.127.092.750;Sterol Regulatory Element Binding Proteins;D051779
D12.776.260.103.500.750.500;Sterol Regulatory Element Binding Protein 1;D051780
D12.776.260.108.092.750.500;Sterol Regulatory Element Binding Protein 1;D051780
D12.776.930.125.500.750.500;Sterol Regulatory Element Binding Protein 1;D051780
D12.776.930.127.092.750.500;Sterol Regulatory Element Binding Protein 1;D051780
D12.776.260.103.500.750.750;Sterol Regulatory Element Binding Protein 2;D051782
D12.776.260.108.092.750.750;Sterol Regulatory Element Binding Protein 2;D051782
D12.776.930.125.500.750.750;Sterol Regulatory Element Binding Protein 2;D051782
D12.776.930.127.092.750.750;Sterol Regulatory Element Binding Protein 2;D051782
D12.776.260.536;Methyl-CpG-Binding Protein 2;D051783
D12.776.660.235.550;Methyl-CpG-Binding Protein 2;D051783
D12.776.664.235.700;Methyl-CpG-Binding Protein 2;D051783
D12.776.157.530.750.100;Aryl Hydrocarbon Receptor Nuclear Translocator;D051784
D12.776.260.103.625.500;Aryl Hydrocarbon Receptor Nuclear Translocator;D051784
D12.776.543.585.750.100;Aryl Hydrocarbon Receptor Nuclear Translocator;D051784
D12.776.930.125.625.500;Aryl Hydrocarbon Receptor Nuclear Translocator;D051784
D12.644.360.024.334;Smad Proteins;D051785
D12.776.157.057.170;Smad Proteins;D051785
D12.776.260.713;Smad Proteins;D051785
D12.776.476.024.417;Smad Proteins;D051785
D12.776.930.806;Smad Proteins;D051785
D12.776.260.108.217;Cyclic AMP Response Element Modulator;D051786
D12.776.930.127.217;Cyclic AMP Response Element Modulator;D051786
D12.776.210.500.570.595;Myogenic Regulatory Factor 5;D051787
D12.776.260.103.750.595;Myogenic Regulatory Factor 5;D051787
D12.776.930.125.750.595;Myogenic Regulatory Factor 5;D051787
D12.776.260.560;Myeloid-Lymphoid Leukemia Protein;D051788
D12.776.624.664.700.148;Myeloid-Lymphoid Leukemia Protein;D051788
D12.776.930.483;Myeloid-Lymphoid Leukemia Protein;D051788
D12.776.260.665.400;Proto-Oncogene Protein c-fli-1;D051789
D12.776.624.664.700.175.400;Proto-Oncogene Protein c-fli-1;D051789
D12.776.930.635.400;Proto-Oncogene Protein c-fli-1;D051789
D12.776.260.254;G-Box Binding Factors;D051790
D12.776.765.365;G-Box Binding Factors;D051790
D12.776.930.319;G-Box Binding Factors;D051790
D12.776.260.103;Basic Helix-Loop-Helix Transcription Factors;D051792
D12.776.930.125;Basic Helix-Loop-Helix Transcription Factors;D051792
D12.776.260.103.625;Hypoxia-Inducible Factor 1;D051793
D12.776.930.125.625;Hypoxia-Inducible Factor 1;D051793
D08.811.464.938.750.875;Von Hippel-Lindau Tumor Suppressor Protein;D051794
D12.776.624.776.865;Von Hippel-Lindau Tumor Suppressor Protein;D051794
D12.776.260.103.625.750;Hypoxia-Inducible Factor 1, alpha Subunit;D051795
D12.776.930.125.625.750;Hypoxia-Inducible Factor 1, alpha Subunit;D051795
D12.776.930.329;Inhibitor of Differentiation Proteins;D051796
D12.776.930.329.500;Inhibitor of Differentiation Protein 2;D051797
D12.776.930.329.249;Inhibitor of Differentiation Protein 1;D051798
C23.550.277;Delayed Graft Function;D051799
D12.776.260.790;Tristetraprolin;D051816
D12.776.460.762;Tristetraprolin;D051816
D12.776.930.960;Tristetraprolin;D051816
D12.776.157.725.030;Butyrate Response Factor 1;D051817
D12.776.260.114;Butyrate Response Factor 1;D051817
D12.776.460.287;Butyrate Response Factor 1;D051817
D12.776.664.962.061;Butyrate Response Factor 1;D051817
D12.776.260.702;Replication Protein C;D051818
D12.776.260.457;Immunoglobulin J Recombination Signal Sequence-Binding Protein;D051819
D12.776.660.486;Immunoglobulin J Recombination Signal Sequence-Binding Protein;D051819
D12.776.930.327;Immunoglobulin J Recombination Signal Sequence-Binding Protein;D051819
D12.776.260.730;TCF Transcription Factors;D051820
D12.776.660.235.400.800;TCF Transcription Factors;D051820
D12.776.664.235.400.800;TCF Transcription Factors;D051820
D12.776.930.875;TCF Transcription Factors;D051820
D12.776.260.730.500;Lymphoid Enhancer-Binding Factor 1;D051821
D12.776.660.235.400.800.500;Lymphoid Enhancer-Binding Factor 1;D051821
D12.776.664.235.400.800.500;Lymphoid Enhancer-Binding Factor 1;D051821
D12.776.930.875.500;Lymphoid Enhancer-Binding Factor 1;D051821
D12.776.260.730.750;T Cell Transcription Factor 1;D051822
D12.776.660.235.400.800.750;T Cell Transcription Factor 1;D051822
D12.776.664.235.400.800.750;T Cell Transcription Factor 1;D051822
D12.776.930.875.750;T Cell Transcription Factor 1;D051822
D12.776.260.698.209.039;COUP Transcription Factors;D051836
D12.776.826.209.039;COUP Transcription Factors;D051836
D12.776.930.669.209.039;COUP Transcription Factors;D051836
D12.776.260.698.209.039.500;COUP Transcription Factor II;D051837
D12.776.260.703.200;COUP Transcription Factor II;D051837
D12.776.826.209.039.500;COUP Transcription Factor II;D051837
D12.776.930.669.209.039.500;COUP Transcription Factor II;D051837
D12.776.930.700.750;COUP Transcription Factor II;D051837
D12.776.260.698.209.039.249;COUP Transcription Factor I;D051838
D12.776.826.209.039.249;COUP Transcription Factor I;D051838
D12.776.930.669.209.039.249;COUP Transcription Factor I;D051838
D12.776.260.605;NFI Transcription Factors;D051839
D12.776.930.612;NFI Transcription Factors;D051839
D12.776.260.108.124.937;Y-Box-Binding Protein 1;D051840
D12.776.660.167.937;Y-Box-Binding Protein 1;D051840
D12.776.930.127.124.937;Y-Box-Binding Protein 1;D051840
D12.776.260.600.500;Transcription Factor RelB;D051841
D12.776.660.600.500;Transcription Factor RelB;D051841
D12.776.930.600.500;Transcription Factor RelB;D051841
D12.644.360.543;Olfactory Marker Protein;D051842
D12.776.476.543;Olfactory Marker Protein;D051842
D12.776.641.652;Olfactory Marker Protein;D051842
D12.776.641.860;Synucleins;D051843
D12.776.641.860.500;alpha-Synuclein;D051844
D12.776.641.860.750;gamma-Synuclein;D051845
D12.776.641.860.625;beta-Synuclein;D051846
D12.776.529;Lithostathine;D051847
D12.776.313;Fanconi Anemia Complementation Group Proteins;D051856
D12.776.260.400.718;Otx Transcription Factors;D051857
D12.776.930.621;Otx Transcription Factors;D051857
D12.776.260.950.249;Forkhead Transcription Factors;D051858
D12.776.930.977.249;Forkhead Transcription Factors;D051858
D12.776.580.845;Neuroendocrine Secretory Protein 7B2;D051859
D12.776.641.615;Neuroendocrine Secretory Protein 7B2;D051859
D12.776.157.725.061;Fragile X Mental Retardation Protein;D051860
D12.776.641.299;Fragile X Mental Retardation Protein;D051860
D12.776.664.962.124;Fragile X Mental Retardation Protein;D051860
D12.776.395.550.016;Antigens, CD82;D051861
D12.776.543.550.182;Antigens, CD82;D051861
D12.776.543.982.182;Antigens, CD82;D051861
D12.776.624.776.052;Antigens, CD82;D051861
D23.050.301.264.035.182;Antigens, CD82;D051861
D23.101.100.110.182;Antigens, CD82;D051861
D12.776.930.325;Host Cell Factor C1;D051863
D12.776.260.719.049;Sex-Determining Region Y Protein;D051876
D12.776.660.235.400.750.049;Sex-Determining Region Y Protein;D051876
D12.776.664.235.400.750.049;Sex-Determining Region Y Protein;D051876
D12.776.930.823.049;Sex-Determining Region Y Protein;D051876
D08.811.913.696.445.735.270.887;RNA Polymerase Sigma 54;D051877
D12.776.097.698;RNA Polymerase Sigma 54;D051877
D12.776.260.103.875;Twist Transcription Factor;D051879
D12.776.930.125.875;Twist Transcription Factor;D051879
D12.776.543.750.725;Receptors, Notch;D051880
D12.776.930.670;Receptors, Notch;D051880
D12.776.543.750.725.500;Receptor, Notch1;D051881
D12.776.930.670.500;Receptor, Notch1;D051881
D12.776.543.750.725.750;Receptor, Notch2;D051883
D12.776.930.670.750;Receptor, Notch2;D051883
D12.644.360.024.334.500;Smad Proteins, Receptor-Regulated;D051896
D12.776.157.057.170.500;Smad Proteins, Receptor-Regulated;D051896
D12.776.260.713.500;Smad Proteins, Receptor-Regulated;D051896
D12.776.476.024.417.500;Smad Proteins, Receptor-Regulated;D051896
D12.776.744.741;Smad Proteins, Receptor-Regulated;D051896
D12.776.930.806.500;Smad Proteins, Receptor-Regulated;D051896
D12.644.360.024.334.200;Smad Proteins, Inhibitory;D051897
D12.776.157.057.170.249;Smad Proteins, Inhibitory;D051897
D12.776.476.024.417.249;Smad Proteins, Inhibitory;D051897
D12.644.360.024.334.500.100;Smad1 Protein;D051898
D12.776.157.057.170.500.100;Smad1 Protein;D051898
D12.776.260.713.500.100;Smad1 Protein;D051898
D12.776.476.024.417.500.100;Smad1 Protein;D051898
D12.776.744.741.500;Smad1 Protein;D051898
D12.776.930.806.500.100;Smad1 Protein;D051898
D12.644.360.024.334.500.200;Smad2 Protein;D051899
D12.776.157.057.170.500.200;Smad2 Protein;D051899
D12.776.476.024.417.500.200;Smad2 Protein;D051899
D12.776.744.741.750;Smad2 Protein;D051899
D12.776.930.806.500.200;Smad2 Protein;D051899
D12.644.360.024.334.500.300;Smad3 Protein;D051900
D12.776.157.057.170.500.300;Smad3 Protein;D051900
D12.776.260.713.500.300;Smad3 Protein;D051900
D12.776.476.024.417.500.300;Smad3 Protein;D051900
D12.776.744.741.875;Smad3 Protein;D051900
D12.776.930.806.500.300;Smad3 Protein;D051900
D12.644.360.024.334.750;Smad4 Protein;D051901
D12.776.157.057.170.750;Smad4 Protein;D051901
D12.776.260.713.750;Smad4 Protein;D051901
D12.776.476.024.417.750;Smad4 Protein;D051901
D12.776.624.776.760;Smad4 Protein;D051901
D12.776.930.806.750;Smad4 Protein;D051901
D12.644.360.024.334.500.500;Smad5 Protein;D051902
D12.776.157.057.170.500.500;Smad5 Protein;D051902
D12.776.260.713.500.500;Smad5 Protein;D051902
D12.776.476.024.417.500.500;Smad5 Protein;D051902
D12.776.744.741.937;Smad5 Protein;D051902
D12.776.930.806.500.500;Smad5 Protein;D051902
D12.776.157.725.444.500;Nuclear Factor 45 Protein;D051903
D12.776.930.616.500;Nuclear Factor 45 Protein;D051903
D12.644.360.024.334.500.800;Smad8 Protein;D051904
D12.776.157.057.170.500.800;Smad8 Protein;D051904
D12.776.260.713.500.800;Smad8 Protein;D051904
D12.776.476.024.417.500.800;Smad8 Protein;D051904
D12.776.744.741.968;Smad8 Protein;D051904
D12.776.930.806.500.800;Smad8 Protein;D051904
D12.644.360.024.334.200.600;Smad6 Protein;D051905
D12.776.157.057.170.249.600;Smad6 Protein;D051905
D12.776.476.024.417.249.600;Smad6 Protein;D051905
D12.776.930.806.875;Smad6 Protein;D051905
D12.644.360.024.334.200.700;Smad7 Protein;D051906
D12.776.157.057.170.249.700;Smad7 Protein;D051906
D12.776.476.024.417.249.700;Smad7 Protein;D051906
D12.776.395.550.550;Lysosome-Associated Membrane Glycoproteins;D051907
D12.776.543.550.527;Lysosome-Associated Membrane Glycoproteins;D051907
D12.776.124.486.274.920.124;Antigens, CD46;D051916
D12.776.543.750.705.833.124;Antigens, CD46;D051916
D23.050.301.264.035.146;Antigens, CD46;D051916
D23.101.100.110.146;Antigens, CD46;D051916
D12.644.233.800.174;Antigens, CD43;D051917
D12.776.395.560.631.650.143;Antigens, CD43;D051917
D12.776.395.700.174;Antigens, CD43;D051917
D23.050.301.264.035.143;Antigens, CD43;D051917
D23.101.100.110.143;Antigens, CD43;D051917
D12.776.395.550.200.810;Sialic Acid Binding Ig-like Lectin 2;D051918
D12.776.503.921.200;Sialic Acid Binding Ig-like Lectin 2;D051918
D12.776.543.550.200.810;Sialic Acid Binding Ig-like Lectin 2;D051918
D23.050.301.264.035.913.200;Sialic Acid Binding Ig-like Lectin 2;D051918
D23.050.301.350.720;Sialic Acid Binding Ig-like Lectin 2;D051918
D23.101.100.110.929.200;Sialic Acid Binding Ig-like Lectin 2;D051918
D12.776.543.750.705.895.800.820;NK Cell Lectin-Like Receptor Subfamily D;D051920
D23.050.301.264.035.579;NK Cell Lectin-Like Receptor Subfamily D;D051920
D23.101.100.110.579;NK Cell Lectin-Like Receptor Subfamily D;D051920
D12.776.260.108.311;Fos-Related Antigen-2;D051921
D12.776.930.127.311;Fos-Related Antigen-2;D051921
D12.644.360.024.310;PII Nitrogen Regulatory Proteins;D051922
D12.776.157.057.110;PII Nitrogen Regulatory Proteins;D051922
D12.776.476.024.400;PII Nitrogen Regulatory Proteins;D051922
D12.776.124.486.485.950.500;Antigens, CD79;D051925
D12.776.124.790.651.950.500;Antigens, CD79;D051925
D12.776.377.715.548.950.500;Antigens, CD79;D051925
D12.776.543.750.705.816.821.500;Antigens, CD79;D051925
D23.050.301.264.035.179;Antigens, CD79;D051925
D23.101.100.110.179;Antigens, CD79;D051925
D12.776.395.550.045;Antigens, CD147;D051926
D12.776.543.550.187;Antigens, CD147;D051926
D23.050.285.040;Antigens, CD147;D051926
D23.050.301.264.035.247;Antigens, CD147;D051926
D23.101.100.110.247;Antigens, CD147;D051926
D12.776.395.550.200.098;Antigens, CD24;D051927
D12.776.395.550.448.120;Antigens, CD24;D051927
D12.776.543.484.500.120;Antigens, CD24;D051927
D12.776.543.550.200.124;Antigens, CD24;D051927
D12.776.543.550.418.120;Antigens, CD24;D051927
D23.050.285.018;Antigens, CD24;D051927
D23.050.301.264.035.124;Antigens, CD24;D051927
D23.050.301.350.098;Antigens, CD24;D051927
D23.101.100.110.124;Antigens, CD24;D051927
D12.776.395.550.014;Antigens, CD47;D051928
D12.776.543.550.147;Antigens, CD47;D051928
D23.050.301.264.035.147;Antigens, CD47;D051928
D23.101.100.110.147;Antigens, CD47;D051928
D12.776.395.550.200.170;Antigens, CD146;D051929
D12.776.543.550.200.140;Antigens, CD146;D051929
D12.776.624.301.249;Antigens, CD146;D051929
D23.050.285.439.249;Antigens, CD146;D051929
D23.050.301.264.035.246;Antigens, CD146;D051929
D23.050.301.350.150;Antigens, CD146;D051929
D23.101.100.110.246;Antigens, CD146;D051929
D12.776.395.550.200.175;Antigens, CD164;D051930
D12.776.395.560.631.650.264;Antigens, CD164;D051930
D12.776.543.550.200.145;Antigens, CD164;D051930
D23.050.301.264.035.264;Antigens, CD164;D051930
D23.050.301.350.154;Antigens, CD164;D051930
D23.101.100.110.264;Antigens, CD164;D051930
D12.776.260.125;Centromere Protein B;D051936
D12.776.660.235.199;Centromere Protein B;D051936
D12.776.664.235.199;Centromere Protein B;D051936
D23.050.422.061;Centromere Protein B;D051936
D12.776.641.249;Dopamine and cAMP-Regulated Phosphoprotein 32;D051937
D12.776.744.459;Dopamine and cAMP-Regulated Phosphoprotein 32;D051937
D12.776.543.990.587;Munc18 Proteins;D051938
D12.776.765.675.500;Phytochrome B;D051939
D23.767.712.500;Phytochrome B;D051939
D12.776.467.150.200;Antigens, CD86;D051940
D12.776.543.095.200;Antigens, CD86;D051940
D23.050.301.264.035.276.200;Antigens, CD86;D051940
D23.050.301.285.200;Antigens, CD86;D051940
D23.101.100.110.276.200;Antigens, CD86;D051940
D23.529.168.200;Antigens, CD86;D051940
D08.811.913.696.620.682.725.400.020;fms-Like Tyrosine Kinase 3;D051941
D12.776.543.750.060.020;fms-Like Tyrosine Kinase 3;D051941
D12.776.624.664.700.114;fms-Like Tyrosine Kinase 3;D051941
D23.050.301.264.035.284;fms-Like Tyrosine Kinase 3;D051941
D23.101.100.110.284;fms-Like Tyrosine Kinase 3;D051941
D08.811.913.696.620.682.700.606;Phytochrome A;D051942
D12.776.765.675.249;Phytochrome A;D051942
D23.767.712.249;Phytochrome A;D051942
D12.776.260.400.124;Antennapedia Homeodomain Protein;D051943
D12.776.660.049;Antennapedia Homeodomain Protein;D051943
D12.776.930.120;Antennapedia Homeodomain Protein;D051943
D12.776.260.400.186;Goosecoid Protein;D051956
D12.776.930.322;Goosecoid Protein;D051956
D12.776.260.400.436;MSX1 Transcription Factor;D051957
D12.776.930.440;MSX1 Transcription Factor;D051957
D12.644.360.024.308.200;Nuclear Receptor Coactivator 2;D051958
D12.776.157.057.080.200;Nuclear Receptor Coactivator 2;D051958
D12.776.476.024.394.200;Nuclear Receptor Coactivator 2;D051958
D12.776.660.675.200;Nuclear Receptor Coactivator 2;D051958
D12.776.930.617.200;Nuclear Receptor Coactivator 2;D051958
D12.776.157.725.092;Hu Paraneoplastic Encephalomyelitis Antigens;D051959
D12.776.641.520;Hu Paraneoplastic Encephalomyelitis Antigens;D051959
D12.776.664.962.311;Hu Paraneoplastic Encephalomyelitis Antigens;D051959
D08.811.277.040.330.300.200.100.200.500;GTP-Binding Protein alpha Subunit, Gi2;D051960
D12.644.360.375.100.200.500;GTP-Binding Protein alpha Subunit, Gi2;D051960
D12.776.157.325.332.100.200.500;GTP-Binding Protein alpha Subunit, Gi2;D051960
D12.776.476.375.100.200.500;GTP-Binding Protein alpha Subunit, Gi2;D051960
D12.776.543.325.100.200.500;GTP-Binding Protein alpha Subunit, Gi2;D051960
D12.776.543.750.100.660.500;Receptors, Mating Factor;D051964
D12.776.543.750.775.500;Receptors, Mating Factor;D051964
D08.811.277.352.640.700.700.562.750;Phospholipase C gamma;D051966
D12.644.360.571.750;Phospholipase C gamma;D051966
D12.644.360.581;Phospholipase C gamma;D051966
D12.776.476.556.750;Phospholipase C gamma;D051966
D12.776.476.558;Phospholipase C gamma;D051966
D08.811.074.249.875;Uracil-DNA Glycosidase;D051981
D12.776.260.600.249;Transcription Factor RelA;D051996
D12.776.660.600.249;Transcription Factor RelA;D051996
D12.776.930.600.249;Transcription Factor RelA;D051996
D08.811.277.450.430.400.060.500;Antigens, CD38;D051997
D23.050.301.264.035.138;Antigens, CD38;D051997
D23.101.100.110.138;Antigens, CD38;D051997
D12.776.260.600.124;NF-kappa B p50 Subunit;D052002
D12.776.660.600.124;NF-kappa B p50 Subunit;D052002
D12.776.930.600.124;NF-kappa B p50 Subunit;D052002
D12.776.260.600.186;NF-kappa B p52 Subunit;D052003
D12.776.660.600.186;NF-kappa B p52 Subunit;D052003
D12.776.930.600.186;NF-kappa B p52 Subunit;D052003
D08.811.913.696.620.682.700.109;Bone Morphogenetic Protein Receptors;D052004
D12.776.543.750.750.400.049;Bone Morphogenetic Protein Receptors;D052004
D08.811.913.696.620.682.700.109.500;Bone Morphogenetic Protein Receptors, Type I;D052005
D12.776.543.750.750.400.049.500;Bone Morphogenetic Protein Receptors, Type I;D052005
D08.811.913.696.620.682.700.109.750;Bone Morphogenetic Protein Receptors, Type II;D052006
D12.776.543.750.750.400.049.750;Bone Morphogenetic Protein Receptors, Type II;D052006
C06.405.205.798;Mucositis;D052016
C07.465.584;Mucositis;D052016
F03.375.250;Bulimia Nervosa;D052018
G05.360.340.024.340.137.232.459;Hinge Exons;D052058
G05.360.340.024.340.335.300.249;Hinge Exons;D052058
V04.750.500.750;Research Support, N.I.H., Intramural;D052060
V04.750.500.500;Research Support, N.I.H., Extramural;D052061
C13.351.500.665.656;Vaginismus;D052065
C13.351.500.894.870;Vaginismus;D052065
F03.800.800.900;Vaginismus;D052065
D08.811.277.040.025.303;N-Ethylmaleimide-Sensitive Proteins;D052066
D12.776.543.990.812;Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins;D052067
B01.050.500.644.400.275;Conus Snail;D052078
E04.936.932;Warm Ischemia;D052096
A02.633.567.850;Quadriceps Muscle;D052097
D12.776.395.560.631.650;Sialomucins;D052116
D03.383.246.118;Benzodioxoles;D052117
D03.438.115;Benzodioxoles;D052117
D12.776.395.550.550.500;Lysosomal-Associated Membrane Protein 1;D052118
D12.776.395.550.625.449;Lysosomal-Associated Membrane Protein 1;D052118
D12.776.543.550.527.500;Lysosomal-Associated Membrane Protein 1;D052118
D12.776.543.550.625.449;Lysosomal-Associated Membrane Protein 1;D052118
D12.776.543.750.705.675.554;Lysosomal-Associated Membrane Protein 1;D052118
D23.050.301.264.035.512;Lysosomal-Associated Membrane Protein 1;D052118
D23.101.100.110.512;Lysosomal-Associated Membrane Protein 1;D052118
D12.776.395.550.550.750;Lysosomal-Associated Membrane Protein 2;D052119
D12.776.543.550.527.750;Lysosomal-Associated Membrane Protein 2;D052119
D23.050.301.264.035.531;Lysosomal-Associated Membrane Protein 2;D052119
D23.101.100.110.531;Lysosomal-Associated Membrane Protein 2;D052119
C10.597.606.643.455.562;Glycogen Storage Disease Type IIb;D052120
C14.280.238.458;Glycogen Storage Disease Type IIb;D052120
C16.320.322.201;Glycogen Storage Disease Type IIb;D052120
C16.320.565.202.449.510;Glycogen Storage Disease Type IIb;D052120
C18.452.648.202.449.510;Glycogen Storage Disease Type IIb;D052120
G05.360.340.024.340.375;Genes, Neoplasm;D052138
D12.644.360.381;Intracellular Calcium-Sensing Proteins;D052139
D12.776.157.125.412;Intracellular Calcium-Sensing Proteins;D052139
D12.776.476.387;Intracellular Calcium-Sensing Proteins;D052139
B04.280.535.050.606.611;Human papillomavirus 11;D052140
B04.909.204.210.655.050.606.611;Human papillomavirus 11;D052140
B04.909.574.204.655.050.606.611;Human papillomavirus 11;D052140
B04.909.624.050.606.611;Human papillomavirus 11;D052140
E05.916.039.312.500;SELEX Aptamer Technique;D052156
G02.607.750.155.249.500;SELEX Aptamer Technique;D052156
J01.897.836.249.249.500;SELEX Aptamer Technique;D052156
D13.695.578.424.224;Aptamers, Nucleotide;D052157
D12.644.082;Aptamers, Peptide;D052158
C12.706.316.096.624;Frasier Syndrome;D052159
C12.777.419.780.750.500.500;Frasier Syndrome;D052159
C13.351.875.253.096.624;Frasier Syndrome;D052159
C13.351.968.419.780.750.500.500;Frasier Syndrome;D052159
C16.131.939.316.096.624;Frasier Syndrome;D052159
C16.320.306;Frasier Syndrome;D052159
C19.391.119.096.624;Frasier Syndrome;D052159
D03.383.129.708.089;Benzothiazoles;D052160
D03.438.185;Benzothiazoles;D052160
B04.280.535.050.618;Human papillomavirus 18;D052161
B04.909.204.210.655.050.618;Human papillomavirus 18;D052161
B04.909.574.204.655.050.618;Human papillomavirus 18;D052161
B04.909.624.050.618;Human papillomavirus 18;D052161
B04.280.535.050.616;Human papillomavirus 16;D052162
B04.909.204.210.655.050.616;Human papillomavirus 16;D052162
B04.909.574.204.655.050.616;Human papillomavirus 16;D052162
B04.909.624.050.616;Human papillomavirus 16;D052162
B04.280.535.050.606;Human papillomavirus 6;D052163
B04.909.204.210.655.050.606;Human papillomavirus 6;D052163
B04.909.574.204.655.050.606;Human papillomavirus 6;D052163
B04.909.624.050.606;Human papillomavirus 6;D052163
D02.455.426.392.368.284.049;Azulenes;D052176
D02.455.426.559.847.133;Azulenes;D052176
D04.615.133;Azulenes;D052176
C12.777.419.403;Kidney Diseases, Cystic;D052177
C13.351.968.419.403;Kidney Diseases, Cystic;D052177
C13.703.420.235;Cephalopelvic Disproportion;D052178
D23.050.291;Antigens, Plant;D052179
V02;Publication Formats;D052180
V01;Publication Components;D052181
V03;Study Characteristics;D052182
B03.510.460.400.410.475.475.180;Lactobacillus brevis;D052196
B03.510.550.450.475.180;Lactobacillus brevis;D052196
B03.510.460.400.410.475.475.325;Lactobacillus fermentum;D052197
B03.510.550.450.475.325;Lactobacillus fermentum;D052197
B03.510.460.400.410.475.475.400;Lactobacillus helveticus;D052198
B03.510.550.450.475.400;Lactobacillus helveticus;D052198
B03.510.460.400.410.475.475.506;Lactobacillus leichmannii;D052199
B03.510.550.450.475.506;Lactobacillus leichmannii;D052199
B03.510.460.400.410.475.475.680;Lactobacillus reuteri;D052200
B03.510.550.450.475.680;Lactobacillus reuteri;D052200
B03.510.460.400.410.475.475.700;Lactobacillus rhamnosus;D052201
B03.510.550.450.475.700;Lactobacillus rhamnosus;D052201
C13.351.500.894.500;Hydrocolpos;D052202
D01.490.100.375;Ferumoxytol;D052203
D01.490.200.350;Ferumoxytol;D052203
D01.578.285;Ferumoxytol;D052203
D06.472.317.469.500.500;Glucagon-Like Peptide 1;D052216
D12.776.313.500;Fanconi Anemia Complementation Group A Protein;D052217
D12.776.660.264;Fanconi Anemia Complementation Group A Protein;D052217
D12.776.744.476;Fanconi Anemia Complementation Group A Protein;D052217
D12.776.313.750;Fanconi Anemia Complementation Group C Protein;D052218
D12.776.313.875;Fanconi Anemia Complementation Group F Protein;D052219
D12.776.660.293;Fanconi Anemia Complementation Group F Protein;D052219
D12.776.313.812;Fanconi Anemia Complementation Group D2 Protein;D052236
D12.776.660.285;Fanconi Anemia Complementation Group D2 Protein;D052236
D12.776.744.484;Fanconi Anemia Complementation Group D2 Protein;D052236
D12.776.313.843;Fanconi Anemia Complementation Group E Protein;D052239
D12.776.660.289;Fanconi Anemia Complementation Group E Protein;D052239
D08.811.464.938.750.186;Fanconi Anemia Complementation Group L Protein;D052240
D12.776.313.937;Fanconi Anemia Complementation Group L Protein;D052240
D12.776.313.906;Fanconi Anemia Complementation Group G Protein;D052241
D12.776.744.488;Fanconi Anemia Complementation Group G Protein;D052241
D06.472.699.042.249;Adiponectin;D052242
D12.644.276.024.249;Adiponectin;D052242
D12.644.548.011.249;Adiponectin;D052242
D12.776.467.024.249;Adiponectin;D052242
D23.529.024.249;Adiponectin;D052242
D06.472.699.042.750;Resistin;D052243
D12.644.276.024.750;Resistin;D052243
D12.644.548.011.750;Resistin;D052243
D12.776.467.024.750;Resistin;D052243
D23.529.024.750;Resistin;D052243
D27.505.696.353;Endocrine Disruptors;D052244
D27.888.284.295;Endocrine Disruptors;D052244
C09.218.458.341.186.500.500;Usher Syndromes;D052245
C09.218.458.341.887.886;Usher Syndromes;D052245
C10.597.751.418.341.186.500.500;Usher Syndromes;D052245
C10.597.751.418.341.887.886;Usher Syndromes;D052245
C10.597.751.941.162.625.500;Usher Syndromes;D052245
C11.768.585.658.500.813;Usher Syndromes;D052245
C11.966.075.375.500;Usher Syndromes;D052245
C16.131.077.299.500;Usher Syndromes;D052245
C16.320.290.684.500;Usher Syndromes;D052245
C23.888.592.763.393.341.887.886;Usher Syndromes;D052245
D27.505.519.389.310.500;Cyclooxygenase 2 Inhibitors;D052246
D27.505.696.663.850.014.040.500.500.500;Cyclooxygenase 2 Inhibitors;D052246
D27.505.954.158.030.500.500;Cyclooxygenase 2 Inhibitors;D052246
D08.811.682.664.500.772.500;Nitric Oxide Synthase Type II;D052247
D08.811.682.664.500.772.249;Nitric Oxide Synthase Type I;D052248
D08.811.682.664.500.772.750;Nitric Oxide Synthase Type III;D052250
C05.651.869;Tendinopathy;D052256
C26.874.800;Tendinopathy;D052256
D08.811.913.696.640.150.500;Creatine Kinase, BB Form;D052276
D08.811.913.696.640.150.625;Creatine Kinase, MB Form;D052279
E06.658.337;Orthodontic Anchorage Procedures;D052280
D08.811.913.696.640.150.750;Creatine Kinase, Mitochondrial Form;D052281
D12.776.575.186;Creatine Kinase, Mitochondrial Form;D052281
D08.811.913.696.640.150.875;Creatine Kinase, MM Form;D052283
G08.686.160;Clutch Size;D052284
G08.686.655;Ovoviviparity;D052285
G08.686.920;Viviparity, Nonmammalian;D052286
G08.686.650;Oviparity;D052287
V04;Support of Research;D052288
D06.472.317.469;Proglucagon;D052336
D06.472.699.587.469;Proglucagon;D052336
D12.644.548.586.469;Proglucagon;D052336
D12.776.811.700;Proglucagon;D052336
E02.095.301.500;Targeted Gene Repair;D052416
E05.393.420.301.500;Targeted Gene Repair;D052416
E05.393.420.601.575.500;Targeted Gene Repair;D052416
A10.165.114.830;Adipose Tissue, White;D052436
A11.329.114.249;Adipocytes, Brown;D052437
A11.329.114.500;Adipocytes, White;D052438
C18.452.584;Lipid Metabolism Disorders;D052439
C16.320.565.398.500.330;Hypoalphalipoproteinemias;D052456
C18.452.584.500.875.330;Hypoalphalipoproteinemias;D052456
C18.452.648.398.500.330;Hypoalphalipoproteinemias;D052456
C18.452.584.500.875.440.750;Hypobetalipoproteinemia, Familial, Apolipoprotein B;D052476
C17.800.849.391.700;Lipodystrophy, Familial Partial;D052496
C18.452.584.625.700;Lipodystrophy, Familial Partial;D052496
C18.452.880.391.700;Lipodystrophy, Familial Partial;D052496
C16.320.565.398.745;Lipodystrophy, Congenital Generalized;D052497
C17.800.849.391.550;Lipodystrophy, Congenital Generalized;D052497
C18.452.584.625.550;Lipodystrophy, Congenital Generalized;D052497
C18.452.648.398.745;Lipodystrophy, Congenital Generalized;D052497
C18.452.880.391.550;Lipodystrophy, Congenital Generalized;D052497
C10.228.140.163.100.435.825.850;Sulfatidosis;D052516
C16.320.565.189.435.825.850;Sulfatidosis;D052516
C16.320.565.398.641.803.925;Sulfatidosis;D052516
C16.320.565.595.554.825.850;Sulfatidosis;D052516
C18.452.132.100.435.825.850;Sulfatidosis;D052516
C18.452.584.687.803.925;Sulfatidosis;D052516
C18.452.648.189.435.825.850;Sulfatidosis;D052516
C18.452.648.398.641.803.925;Sulfatidosis;D052516
C18.452.648.595.554.825.850;Sulfatidosis;D052516
C10.228.140.163.100.435.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C16.320.565.189.435.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C16.320.565.398.641.803.925.750;Multiple Sulfatase Deficiency Disease;D052517
C16.320.565.595.554.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C18.452.132.100.435.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C18.452.584.687.803.925.750;Multiple Sulfatase Deficiency Disease;D052517
C18.452.648.189.435.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C18.452.648.398.641.803.925.750;Multiple Sulfatase Deficiency Disease;D052517
C18.452.648.595.554.825.850.750;Multiple Sulfatase Deficiency Disease;D052517
C10.228.140.163.100.435.825.700.500;Niemann-Pick Disease, Type A;D052536
C15.604.250.410.625.500;Niemann-Pick Disease, Type A;D052536
C16.320.565.189.435.825.700.500;Niemann-Pick Disease, Type A;D052536
C16.320.565.398.641.803.730.500;Niemann-Pick Disease, Type A;D052536
C16.320.565.595.554.825.700.500;Niemann-Pick Disease, Type A;D052536
C18.452.132.100.435.825.700.500;Niemann-Pick Disease, Type A;D052536
C18.452.584.687.803.730.500;Niemann-Pick Disease, Type A;D052536
C18.452.648.189.435.825.700.500;Niemann-Pick Disease, Type A;D052536
C18.452.648.398.641.803.730.500;Niemann-Pick Disease, Type A;D052536
C18.452.648.595.554.825.700.500;Niemann-Pick Disease, Type A;D052536
C10.228.140.163.100.435.825.700.750;Niemann-Pick Disease, Type B;D052537
C15.604.250.410.625.750;Niemann-Pick Disease, Type B;D052537
C16.320.565.189.435.825.700.750;Niemann-Pick Disease, Type B;D052537
C16.320.565.398.641.803.730.750;Niemann-Pick Disease, Type B;D052537
C16.320.565.595.554.825.700.750;Niemann-Pick Disease, Type B;D052537
C18.452.132.100.435.825.700.750;Niemann-Pick Disease, Type B;D052537
C18.452.584.687.803.730.750;Niemann-Pick Disease, Type B;D052537
C18.452.648.189.435.825.700.750;Niemann-Pick Disease, Type B;D052537
C18.452.648.398.641.803.730.750;Niemann-Pick Disease, Type B;D052537
C18.452.648.595.554.825.700.750;Niemann-Pick Disease, Type B;D052537
C10.228.140.163.100.435.825.700.875;Niemann-Pick Disease, Type C;D052556
C15.604.250.410.625.875;Niemann-Pick Disease, Type C;D052556
C16.320.565.189.435.825.700.875;Niemann-Pick Disease, Type C;D052556
C16.320.565.398.641.803.730.875;Niemann-Pick Disease, Type C;D052556
C16.320.565.595.554.825.700.875;Niemann-Pick Disease, Type C;D052556
C18.452.132.100.435.825.700.875;Niemann-Pick Disease, Type C;D052556
C18.452.584.687.803.730.875;Niemann-Pick Disease, Type C;D052556
C18.452.648.189.435.825.700.875;Niemann-Pick Disease, Type C;D052556
C18.452.648.398.641.803.730.875;Niemann-Pick Disease, Type C;D052556
C18.452.648.595.554.825.700.875;Niemann-Pick Disease, Type C;D052556
B03.300.390.400.200.690;Clostridium septicum;D052557
B03.510.415.400.200.690;Clostridium septicum;D052557
E07.357.500;Menstrual Hygiene Products;D052576
M01.060.703.520.460.600.500;Infant, Extremely Low Birth Weight;D052577
D27.720.844.500;Ionic Liquids;D052578
E02.779.483.750;Muscle Stretching Exercises;D052580
E02.831.387.750;Muscle Stretching Exercises;D052580
G11.427.590.530.698.277.249;Muscle Stretching Exercises;D052580
I03.350.249;Muscle Stretching Exercises;D052580
E01.370.600.425.500.500;Pinch Strength;D052581
G11.427.560.500.500;Pinch Strength;D052581
C05.651.869.870.800.800;Trigger Finger Disorder;D052582
B01.650.940.800.575.100.887;Sarraceniaceae;D052583
A18.450.500;Xylem;D052584
A18.700;Xylem;D052584
A18.011;Phloem;D052585
A18.450.249;Phloem;D052585
F01.145.113.252.748.300;Mating Preference, Animal;D052586
B01.650.940.800.575.100.100.613;Pulicaria;D052587
B01.650.940.800.575.100.401.698;Pongamia;D052596
B01.650.940.800.575.100.401.327;Hymenaea;D052597
B01.650.940.800.575.100.401.192;Dioclea;D052598
E05.196.155.800;Solid Phase Extraction;D052616
E05.196.155.800.500;Solid Phase Microextraction;D052617
G16.100.057.500.274;Allostasis;D052636
D20.633;Particulate Matter;D052638
B04.280.092;Caulimoviridae;D052639
B04.715.102;Caulimoviridae;D052639
B04.280.092.850;Tungrovirus;D052641
B04.715.102.850;Tungrovirus;D052641
B04.715.835;Tungrovirus;D052641
B04.280.382.530;Ictalurivirus;D052656
B04.280.498;Nanoviridae;D052657
B04.715.499;Nanoviridae;D052657
B04.715.499.100;Babuvirus;D052658
B04.280.580.650.040;Amdovirus;D052659
B04.909.204.671.650.040;Amdovirus;D052659
B04.280.580.650.085;Bocavirus;D052660
B04.909.204.671.650.085;Bocavirus;D052660
B04.280.580.650.600.437;H-1 parvovirus;D052661
B04.909.204.671.650.600.437;H-1 parvovirus;D052661
B04.820.069.080;Avastrovirus;D052676
B04.909.777.099.080;Avastrovirus;D052676
B04.715.260;Flexiviridae;D052677
B04.820.260;Flexiviridae;D052677
B04.820.340;Hepevirus;D052678
B04.909.777.420;Hepevirus;D052678
B04.715.435;Luteoviridae;D052679
B04.820.420;Luteoviridae;D052679
A06.407.747.500.500;Corticotrophs;D052680
A06.688.357.750.500.500;Corticotrophs;D052680
A08.186.211.730.317.357.352.435.500.500.500;Corticotrophs;D052680
A08.713.357.750.500.500;Corticotrophs;D052680
A11.382.500;Corticotrophs;D052680
A11.436.267;Corticotrophs;D052680
A06.407.747.500.750;Gonadotrophs;D052681
A06.688.357.750.500.750;Gonadotrophs;D052681
A08.186.211.730.317.357.352.435.500.500.750;Gonadotrophs;D052681
A08.713.357.750.500.750;Gonadotrophs;D052681
A11.382.750;Gonadotrophs;D052681
A11.436.319;Gonadotrophs;D052681
A06.407.747.500.812;Lactotrophs;D052682
A06.688.357.750.500.812;Lactotrophs;D052682
A08.186.211.730.317.357.352.435.500.500.812;Lactotrophs;D052682
A08.713.357.750.500.812;Lactotrophs;D052682
A11.382.875;Lactotrophs;D052682
A11.436.507;Lactotrophs;D052682
A06.407.747.500.937;Somatotrophs;D052683
A06.688.357.750.500.937;Somatotrophs;D052683
A08.186.211.730.317.357.352.435.500.500.937;Somatotrophs;D052683
A08.713.357.750.500.937;Somatotrophs;D052683
A11.382.968;Somatotrophs;D052683
A11.436.896;Somatotrophs;D052683
A06.407.747.500.968;Thyrotrophs;D052684
A06.688.357.750.500.968;Thyrotrophs;D052684
A08.186.211.730.317.357.352.435.500.500.968;Thyrotrophs;D052684
A08.713.357.750.500.968;Thyrotrophs;D052684
A11.382.984;Thyrotrophs;D052684
A11.436.925;Thyrotrophs;D052684
B04.280.535.050;Alphapapillomavirus;D052685
B04.909.204.210.655.050;Alphapapillomavirus;D052685
B04.909.574.204.655.050;Alphapapillomavirus;D052685
B04.909.624.050;Alphapapillomavirus;D052685
B04.280.535.100;Betapapillomavirus;D052686
B04.909.204.210.655.100;Betapapillomavirus;D052686
B04.909.574.204.655.100;Betapapillomavirus;D052686
B04.909.624.100;Betapapillomavirus;D052686
B04.280.535.200;Deltapapillomavirus;D052687
B04.909.204.210.655.200;Deltapapillomavirus;D052687
B04.909.574.204.655.200;Deltapapillomavirus;D052687
B04.909.624.200;Deltapapillomavirus;D052687
B04.280.535.200.100;Bovine papillomavirus 1;D052688
B04.909.204.210.655.200.100;Bovine papillomavirus 1;D052688
B04.909.574.204.655.200.100;Bovine papillomavirus 1;D052688
B04.909.624.200.100;Bovine papillomavirus 1;D052688
B04.280.535.400;Gammapapillomavirus;D052689
B04.909.204.210.655.400;Gammapapillomavirus;D052689
B04.909.574.204.655.400;Gammapapillomavirus;D052689
B04.909.624.400;Gammapapillomavirus;D052689
B04.280.535.500;Kappapapillomavirus;D052690
B04.909.204.210.655.500;Kappapapillomavirus;D052690
B04.909.574.204.655.500;Kappapapillomavirus;D052690
B04.909.624.500;Kappapapillomavirus;D052690
B04.280.535.520;Lambdapapillomavirus;D052691
B04.909.204.210.655.520;Lambdapapillomavirus;D052691
B04.909.574.204.655.520;Lambdapapillomavirus;D052691
B04.909.624.520;Lambdapapillomavirus;D052691
B04.280.535.540;Mupapillomavirus;D052692
B04.909.204.210.655.540;Mupapillomavirus;D052692
B04.909.574.204.655.540;Mupapillomavirus;D052692
B04.909.624.540;Mupapillomavirus;D052692
B04.280.535.950;Xipapillomavirus;D052696
B04.909.204.210.655.950;Xipapillomavirus;D052696
B04.909.574.204.655.950;Xipapillomavirus;D052696
B04.909.624.950;Xipapillomavirus;D052696
B04.280.535.950.150;Bovine papillomavirus 4;D052697
B04.909.204.210.655.950.150;Bovine papillomavirus 4;D052697
B04.909.574.204.655.950.150;Bovine papillomavirus 4;D052697
B04.909.624.950.150;Bovine papillomavirus 4;D052697
B04.820.565.290;Erbovirus;D052698
B04.909.777.618.290;Erbovirus;D052698
B04.820.565.500;Kobuvirus;D052699
B04.909.777.618.500;Kobuvirus;D052699
B04.820.565.830;Teschovirus;D052700
B04.909.777.618.830;Teschovirus;D052700
A06.407.747.750;Pituitary Gland, Intermediate;D052716
A06.688.357.750.750;Pituitary Gland, Intermediate;D052716
A08.186.211.730.317.357.352.435.500.750;Pituitary Gland, Intermediate;D052716
A08.713.357.750.750;Pituitary Gland, Intermediate;D052716
A06.407.747.750.500;Melanotrophs;D052717
A06.688.357.750.750.500;Melanotrophs;D052717
A08.186.211.730.317.357.352.435.500.750.500;Melanotrophs;D052717
A08.713.357.750.750.500;Melanotrophs;D052717
A11.382.937;Melanotrophs;D052717
A11.436.636;Melanotrophs;D052717
B04.820.650.070.120.700;Rous sarcoma virus;D052736
B04.909.574.807.070.120.700;Rous sarcoma virus;D052736
B04.909.777.731.070.120.700;Rous sarcoma virus;D052736
A02.835.583.405.200;Carpometacarpal Joints;D052737
H02.533;Nutritional Sciences;D052756
C13.351;Female Urogenital Diseases;D052776
G11.561.600;Nervous System Physiological Processes;D052778
G07.610.593;Nutrition Processes;D052796
G07.700.620;Nutrition Processes;D052796
C12.294.494.136.500;Balanitis Xerotica Obliterans;D052798
G10.261.326;Digestive System Processes;D052799
C12;Male Urogenital Diseases;D052801
A05.360.444.492.362;Foreskin;D052816
G02.111.087.678;Phototrophic Processes;D052817
G02.149.115.678;Phototrophic Processes;D052817
G03.495.795;Phototrophic Processes;D052817
G02.111.087.070;Autotrophic Processes;D052818
G02.149.115.070;Autotrophic Processes;D052818
G03.495.153;Autotrophic Processes;D052818
G02.111.087.490;Heterotrophic Processes;D052836
G02.149.115.490;Heterotrophic Processes;D052836
G03.495.505;Heterotrophic Processes;D052836
G02.111.087.070.314;Chemoautotrophic Growth;D052837
G02.149.115.070.314;Chemoautotrophic Growth;D052837
G03.495.153.314;Chemoautotrophic Growth;D052837
C12.777.829.707;Cystocele;D052858
C13.351.968.829.508;Cystocele;D052858
C23.300.842.624.249;Cystocele;D052858
B01.650.940.800.575.100.888.500;Houttuynia;D052859
C12.777.967;Urolithiasis;D052878
C13.351.968.967;Urolithiasis;D052878
C10.228.854.811;Subacute Combined Degeneration;D052879
C10.314.875;Subacute Combined Degeneration;D052879
C10.574.910;Subacute Combined Degeneration;D052879
C18.654.521.500.133.699.923.640;Subacute Combined Degeneration;D052879
C23.550.737.625;Subacute Combined Degeneration;D052879
C01.539.830.767;Pyomyositis;D052880
C05.651.594.909;Pyomyositis;D052880
C10.668.491.562.787;Pyomyositis;D052880
E05.650;Optical Tweezers;D052898
D12.776.543.695;Pore Forming Cytotoxic Proteins;D052899
N06.850.460.375;Environmental Remediation;D052918
C10.228.140.163.100.680.865;Refsum Disease, Infantile;D052919
C16.320.565.189.680.865;Refsum Disease, Infantile;D052919
C16.320.565.663.865;Refsum Disease, Infantile;D052919
C18.452.132.100.680.865;Refsum Disease, Infantile;D052919
C18.452.648.189.680.865;Refsum Disease, Infantile;D052919
C18.452.648.663.865;Refsum Disease, Infantile;D052919
H02.403.074;Bariatric Medicine;D052938
A11.870.740.800;Schizonts;D052939
B05.500.800;Schizonts;D052939
B05.775.740.800;Schizonts;D052939
G07.700.320.500.550.500.800;Schizonts;D052939
A11.870.740.800.500;Merozoites;D052940
B05.500.800.500;Merozoites;D052940
B05.775.740.800.500;Merozoites;D052940
G07.700.320.500.550.500.800.500;Merozoites;D052940
C04.182.872;Tarlov Cysts;D052958
C10.668.829.900;Tarlov Cysts;D052958
E01.370.225.875.595.399;Disk Diffusion Antimicrobial Tests;D052978
E05.200.875.595.399;Disk Diffusion Antimicrobial Tests;D052978
D05.500.562.488.490.500.500;Phycobiliproteins;D052979
D08.811.600.710.490.500.500;Phycobiliproteins;D052979
D03.383.129.578.840.468;Phycobilins;D052980
D03.549.909.468;Phycobilins;D052980
D04.345.783.468;Phycobilins;D052980
B01.300.381.541;Metarhizium;D052981
B01.300.381.103;Beauveria;D052982
D04.345.566.447;Microcystins;D052998
D12.644.641.447;Microcystins;D052998
D03.438.786.830;Quinazolinones;D052999
E05.196.059;Analytic Sample Preparation Methods;D053000
F01.145.113.840;Tool Use Behavior;D053001
C12.777.419.307.500;Pyonephrosis;D053018
C13.351.968.419.307.500;Pyonephrosis;D053018
G04.299.122.700;Quorum Sensing;D053038
G06.590.580.700;Quorum Sensing;D053038
C12.777.725.938;Ureterolithiasis;D053039
C12.777.967.374;Ureterolithiasis;D053039
C13.351.968.725.938;Ureterolithiasis;D053039
C13.351.968.967.374;Ureterolithiasis;D053039
C12.777.419.600;Nephrolithiasis;D053040
C12.777.967.249;Nephrolithiasis;D053040
C13.351.968.419.600;Nephrolithiasis;D053040
C13.351.968.967.249;Nephrolithiasis;D053040
A11.870.740.900;Trophozoites;D053058
B05.500.950;Trophozoites;D053058
B05.775.740.900;Trophozoites;D053058
G07.700.320.500.550.500.950;Trophozoites;D053058
D20.215.894.899.162;Dengue Vaccines;D053059
D20.215.894.899.962;West Nile Virus Vaccines;D053060
D20.215.894.899.290.130.400;Herpes Zoster Vaccine;D053061
G03.495.335.770.500;Membrane Potential, Mitochondrial;D053078
G04.580.550;Membrane Potential, Mitochondrial;D053078
G07.265.750.550;Membrane Potential, Mitochondrial;D053078
B04.820.650.375.700.850;Trager duck spleen necrosis virus;D053079
C05.116.198.816.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C12.777.419.815.647.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C13.351.968.419.815.647.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C16.320.322.239;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C16.320.565.618.544.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C16.320.565.861.647.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C18.452.174.845.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C18.452.648.618.544.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C18.452.648.861.647.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C18.654.521.500.133.770.734.500;Hypophosphatemic Rickets, X-Linked Dominant;D053098
C12.777.419.936.231;Azotemia;D053099
C13.351.968.419.936.231;Azotemia;D053099
C23.550.145;Azotemia;D053099
B04.820.545.405.400.214;Influenza A Virus, H1N1 Subtype;D053118
B04.909.777.545.405.400.214;Influenza A Virus, H1N1 Subtype;D053118
D03.132.089;Benzophenanthridines;D053119
D03.494.633.207;Benzophenanthridines;D053119
D03.549.131;Benzophenanthridines;D053119
C08.618.749;Respiratory Aspiration;D053120
C23.550.773;Respiratory Aspiration;D053120
B04.820.545.405.400.250;Influenza A Virus, H2N2 Subtype;D053121
B04.909.777.545.405.400.250;Influenza A Virus, H2N2 Subtype;D053121
B04.820.545.405.400.300;Influenza A Virus, H3N2 Subtype;D053122
B04.909.777.545.405.400.300;Influenza A Virus, H3N2 Subtype;D053122
B04.820.545.405.400.350;Influenza A Virus, H3N8 Subtype;D053123
B04.909.777.545.405.400.350;Influenza A Virus, H3N8 Subtype;D053123
B04.820.545.405.400.500;Influenza A Virus, H5N1 Subtype;D053124
B04.909.777.545.405.400.500;Influenza A Virus, H5N1 Subtype;D053124
B04.820.545.405.400.505;Influenza A Virus, H5N2 Subtype;D053125
B04.909.777.545.405.400.505;Influenza A Virus, H5N2 Subtype;D053125
B04.820.545.405.400.700;Influenza A Virus, H7N7 Subtype;D053126
B04.909.777.545.405.400.700;Influenza A Virus, H7N7 Subtype;D053126
B04.820.545.405.400.900;Influenza A Virus, H9N2 Subtype;D053127
B04.909.777.545.405.400.900;Influenza A Virus, H9N2 Subtype;D053127
D02.455.426.392.368.367.379;Cyclohexenes;D053138
D02.065.064.525;Oseltamivir;D053139
D02.455.426.392.368.367.379.500;Oseltamivir;D053139
G04.655;Organelle Shape;D053140
G04.670;Organelle Size;D053141
G04.670.560;Mitochondrial Size;D053142
D08.811.277.656.262.500.126.550.200;Caspase 2;D053143
D08.811.277.656.300.200.126.550.200;Caspase 2;D053143
D12.644.360.075.405.550.200;Caspase 2;D053143
D12.776.476.075.405.550.200;Caspase 2;D053143
G04.655.270;Cell Nucleus Shape;D053144
G04.670.160;Cell Nucleus Size;D053145
D08.811.277.656.300.760.530;Myeloblastin;D053146
D08.811.277.656.959.350.530;Myeloblastin;D053146
D20.215.721;Plant Exudates;D053147
D08.811.277.656.262.500.126.350.300;Caspase 3;D053148
D08.811.277.656.300.200.126.350.300;Caspase 3;D053148
D12.644.360.075.405.350.300;Caspase 3;D053148
D12.776.476.075.405.350.300;Caspase 3;D053148
D05.750.078.739;Plant Gums;D053149
D09.698.700;Plant Gums;D053149
D20.215.721.249;Plant Gums;D053149
B04.820.650.850.750;Simian foamy virus;D053150
B04.909.777.731.850.750;Simian foamy virus;D053150
C23.888.942.343.550;Nocturia;D053158
C23.888.942.343.274;Dysuria;D053159
D08.811.277.656.262.500.126.350.600;Caspase 6;D053178
D08.811.277.656.300.200.126.350.600;Caspase 6;D053178
D12.644.360.075.405.350.600;Caspase 6;D053178
D12.776.476.075.405.350.600;Caspase 6;D053178
D08.811.277.656.262.500.126.350.700;Caspase 7;D053179
D08.811.277.656.300.200.126.350.700;Caspase 7;D053179
D12.644.360.075.405.350.700;Caspase 7;D053179
D12.776.476.075.405.350.700;Caspase 7;D053179
H02.533.124;Animal Nutrition Sciences;D053180
D08.811.277.656.262.500.126.550.800;Caspase 8;D053181
D08.811.277.656.300.200.126.550.800;Caspase 8;D053181
D12.644.360.075.405.550.800;Caspase 8;D053181
D12.776.476.075.405.550.800;Caspase 8;D053181
H02.533.252;Child Nutrition Sciences;D053198
D12.644.360.024.296.600;TNF Receptor-Associated Death Domain Protein;D053199
D12.644.360.024.500.249;TNF Receptor-Associated Death Domain Protein;D053199
D12.644.360.075.421.600;TNF Receptor-Associated Death Domain Protein;D053199
D12.776.157.057.024.600;TNF Receptor-Associated Death Domain Protein;D053199
D12.776.157.057.500.249;TNF Receptor-Associated Death Domain Protein;D053199
D12.776.476.024.375.775;TNF Receptor-Associated Death Domain Protein;D053199
D12.776.476.024.500.249;TNF Receptor-Associated Death Domain Protein;D053199
D12.776.476.075.421.600;TNF Receptor-Associated Death Domain Protein;D053199
D12.644.360.024.296.200;Fas-Associated Death Domain Protein;D053200
D12.644.360.024.500.124;Fas-Associated Death Domain Protein;D053200
D12.644.360.075.421.200;Fas-Associated Death Domain Protein;D053200
D12.776.157.057.024.200;Fas-Associated Death Domain Protein;D053200
D12.776.157.057.500.124;Fas-Associated Death Domain Protein;D053200
D12.776.476.024.375.550;Fas-Associated Death Domain Protein;D053200
D12.776.476.024.500.124;Fas-Associated Death Domain Protein;D053200
D12.776.476.075.421.200;Fas-Associated Death Domain Protein;D053200
C12.777.829.866;Urinary Bladder, Overactive;D053201
C13.351.968.829.813;Urinary Bladder, Overactive;D053201
C23.888.942.343.780;Urinary Bladder, Overactive;D053201
C12.777.934.852.500;Urinary Incontinence, Urge;D053202
C13.351.968.934.814.750;Urinary Incontinence, Urge;D053202
C23.888.942.343.800.750;Urinary Incontinence, Urge;D053202
A18.400.875;Root Nodules, Plant;D053204
A18.024.249.500.249.500.500;Pollen Tube;D053205
C12.777.934.284.500;Nocturnal Enuresis;D053206
C13.351.968.934.252.500;Nocturnal Enuresis;D053206
F01.145.126.856.500;Nocturnal Enuresis;D053206
F03.550.375.400.500;Nocturnal Enuresis;D053206
C12.777.934.284.249;Diurnal Enuresis;D053207
C13.351.968.934.252.249;Diurnal Enuresis;D053207
F01.145.126.856.249;Diurnal Enuresis;D053207
F03.550.375.400.249;Diurnal Enuresis;D053207
E05.318.740.998.650;Kaplan-Meier Estimate;D053208
N05.715.360.750.795.650;Kaplan-Meier Estimate;D053208
N06.850.520.830.998.650;Kaplan-Meier Estimate;D053208
G07.690.320.443;Herbicide Resistance;D053209
D25.651;Pharmaceutical Preparations, Dental;D053210
D26.655;Pharmaceutical Preparations, Dental;D053210
D12.776.543.750.073;Receptors, Death Domain;D053218
D12.776.543.750.073.725;Receptors, Tumor Necrosis Factor, Member 25;D053219
D12.776.543.750.705.852.760.505;Receptors, Tumor Necrosis Factor, Member 25;D053219
D12.776.543.750.073.600;Receptors, TNF-Related Apoptosis-Inducing Ligand;D053220
D12.776.543.750.705.852.760.396;Receptors, TNF-Related Apoptosis-Inducing Ligand;D053220
D12.644.276.374.750.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D12.644.276.972.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D12.776.467.374.750.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D12.776.467.972.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D23.529.374.750.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D23.529.972.625;TNF-Related Apoptosis-Inducing Ligand;D053221
D12.644.276.374.750.249;Fas Ligand Protein;D053222
D12.644.276.972.249;Fas Ligand Protein;D053222
D12.776.395.550.312;Fas Ligand Protein;D053222
D12.776.467.374.750.249;Fas Ligand Protein;D053222
D12.776.467.972.249;Fas Ligand Protein;D053222
D12.776.543.550.312;Fas Ligand Protein;D053222
D23.050.301.264.035.283;Fas Ligand Protein;D053222
D23.101.100.110.283;Fas Ligand Protein;D053222
D23.529.374.750.249;Fas Ligand Protein;D053222
D23.529.972.249;Fas Ligand Protein;D053222
D12.776.543.750.705.852.760.500;Receptors, Tumor Necrosis Factor, Member 14;D053240
D12.776.543.750.925.850;Receptors, Tumor Necrosis Factor, Member 14;D053240
D10.532.350.500;Apoprotein(a);D053241
D12.776.521.400.500;Apoprotein(a);D053241
D02.078.370.926;Zanamivir;D053243
D02.241.081.844.562.668.775;Zanamivir;D053243
D02.241.511.902.562.668.775;Zanamivir;D053243
D03.383.663.859;Zanamivir;D053243
D03.830.859;Zanamivir;D053243
D09.067.687.668.775;Zanamivir;D053243
D09.811.589.668.775;Zanamivir;D053243
D12.776.543.750.705.852.760.949.249;Osteoprotegerin;D053244
D12.644.276.374.750.562;RANK Ligand;D053245
D12.644.276.972.562;RANK Ligand;D053245
D12.776.467.374.750.562;RANK Ligand;D053245
D12.776.467.972.562;RANK Ligand;D053245
D23.529.374.750.562;RANK Ligand;D053245
D23.529.972.562;RANK Ligand;D053245
D12.776.543.750.705.852.760.345;Receptor Activator of Nuclear Factor-kappa B;D053246
D12.776.543.750.705.852.760.245;Lymphotoxin beta Receptor;D053259
D20.633.937.339;Soot;D053260
D12.776.543.750.705.852.760.220;Antigens, CD137;D053261
D23.050.301.264.035.237;Antigens, CD137;D053261
D23.101.100.110.237;Antigens, CD137;D053261
D12.776.543.750.705.852.760.350;Receptors, OX40;D053262
D23.050.301.264.035.855;Receptors, OX40;D053262
D23.101.100.110.855;Receptors, OX40;D053262
G05.360.080.689.360;Gene Regulatory Networks;D053263
D12.644.276.374.750.061;B-Cell Activating Factor;D053264
D12.644.276.972.061;B-Cell Activating Factor;D053264
D12.776.395.191;B-Cell Activating Factor;D053264
D12.776.467.374.750.061;B-Cell Activating Factor;D053264
D12.776.467.972.061;B-Cell Activating Factor;D053264
D12.776.543.550.193;B-Cell Activating Factor;D053264
D23.529.374.750.061;B-Cell Activating Factor;D053264
D23.529.972.061;B-Cell Activating Factor;D053264
D12.776.543.750.705.852.760.222;B-Cell Activation Factor Receptor;D053265
D23.050.301.264.035.275;B-Cell Activation Factor Receptor;D053265
D23.101.100.110.275;B-Cell Activation Factor Receptor;D053265
D12.644.276.374.750.531;OX40 Ligand;D053278
D12.644.276.972.531;OX40 Ligand;D053278
D12.776.395.550.597;OX40 Ligand;D053278
D12.776.467.374.750.531;OX40 Ligand;D053278
D12.776.467.972.531;OX40 Ligand;D053278
D12.776.543.550.590;OX40 Ligand;D053278
D23.529.374.750.531;OX40 Ligand;D053278
D23.529.972.531;OX40 Ligand;D053278
D02.455.326.397.662;Polyacetylenes;D053279
D02.455.326.397.662.500;Diynes;D053280
D02.455.326.271.244;Enediynes;D053281
D02.455.326.397.662.500.500;Enediynes;D053281
D12.644.276.374.750.030;Antigens, CD70;D053282
D12.644.276.972.030;Antigens, CD70;D053282
D12.776.395.092;Antigens, CD70;D053282
D12.776.467.374.750.030;Antigens, CD70;D053282
D12.776.467.972.030;Antigens, CD70;D053282
D12.776.543.550.170;Antigens, CD70;D053282
D23.050.301.264.035.170;Antigens, CD70;D053282
D23.101.100.110.170;Antigens, CD70;D053282
D23.529.374.750.030;Antigens, CD70;D053282
D23.529.972.030;Antigens, CD70;D053282
D10.532.091.300.240;Apolipoprotein B-48;D053283
D12.776.070.400.300.240;Apolipoprotein B-48;D053283
D12.776.521.120.300.240;Apolipoprotein B-48;D053283
D02.065.160;Polyunsaturated Alkamides;D053284
D02.455.326.271.060;Polyunsaturated Alkamides;D053284
D02.455.326.397.675;Polyunsaturated Alkamides;D053284
D12.644.276.374.750.092;CD30 Ligand;D053285
D12.644.276.972.092;CD30 Ligand;D053285
D12.776.395.550.177;CD30 Ligand;D053285
D12.776.467.374.750.092;CD30 Ligand;D053285
D12.776.467.972.092;CD30 Ligand;D053285
D12.776.543.550.196;CD30 Ligand;D053285
D23.050.301.264.035.277;CD30 Ligand;D053285
D23.101.100.110.277;CD30 Ligand;D053285
D23.529.374.750.092;CD30 Ligand;D053285
D23.529.972.092;CD30 Ligand;D053285
D10.532.183.500;Chylomicron Remnants;D053298
D12.776.521.242.500;Chylomicron Remnants;D053298
D10.532.091.300.249;Apolipoprotein B-100;D053299
D12.776.070.400.300.249;Apolipoprotein B-100;D053299
D12.776.521.120.300.249;Apolipoprotein B-100;D053299
D12.644.276.374.750.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D12.644.276.972.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D12.776.467.374.750.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D12.776.467.972.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D23.529.374.750.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D23.529.972.656;Tumor Necrosis Factor Ligand Superfamily Member 13;D053300
D12.776.543.750.705.852.760.226;B-Cell Maturation Antigen;D053301
D10.532.091.400.500;Apolipoprotein C-I;D053302
D12.776.070.400.400.500;Apolipoprotein C-I;D053302
D12.776.521.120.400.500;Apolipoprotein C-I;D053302
D12.776.543.750.705.852.760.899;Transmembrane Activator and CAML Interactor Protein;D053303
D23.050.301.264.035.917;Transmembrane Activator and CAML Interactor Protein;D053303
D23.101.100.110.950;Transmembrane Activator and CAML Interactor Protein;D053303
D10.532.091.400.750;Apolipoprotein C-II;D053304
D12.776.070.400.400.750;Apolipoprotein C-II;D053304
D12.776.521.120.400.750;Apolipoprotein C-II;D053304
D10.532.091.400.875;Apolipoprotein C-III;D053305
D12.776.070.400.400.875;Apolipoprotein C-III;D053305
D12.776.521.120.400.875;Apolipoprotein C-III;D053305
C15.378.147.333.249;Hyper-IgM Immunodeficiency Syndrome;D053306
C20.673.430.249;Hyper-IgM Immunodeficiency Syndrome;D053306
C15.378.147.333.249.500;Hyper-IgM Immunodeficiency Syndrome, Type 1;D053307
C16.320.322.237;Hyper-IgM Immunodeficiency Syndrome, Type 1;D053307
C20.673.430.249.500;Hyper-IgM Immunodeficiency Syndrome, Type 1;D053307
D12.644.276.374.750.515;Lymphotoxin-beta;D053308
D12.644.276.972.515;Lymphotoxin-beta;D053308
D12.776.467.374.750.515;Lymphotoxin-beta;D053308
D12.776.467.972.515;Lymphotoxin-beta;D053308
D23.529.374.750.515;Lymphotoxin-beta;D053308
D23.529.972.515;Lymphotoxin-beta;D053308
D10.532.091.500.500;Apolipoprotein E3;D053318
D12.776.070.400.500.500;Apolipoprotein E3;D053318
D12.776.521.120.500.500;Apolipoprotein E3;D053318
D12.776.543.750.705.852.760.949;Tumor Necrosis Factor Decoy Receptors;D053319
D12.776.543.750.705.852.760.949.500;Receptors, Tumor Necrosis Factor, Member 10c;D053320
D12.776.543.750.705.852.760.949.400;Receptors, Tumor Necrosis Factor, Member 6b;D053323
D12.644.276.374.750.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D12.644.276.972.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D12.776.467.374.750.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D12.776.467.972.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D23.529.374.750.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D23.529.972.690;Tumor Necrosis Factor Ligand Superfamily Member 14;D053326
D10.532.091.500.750;Apolipoprotein E4;D053327
D12.776.070.400.500.750;Apolipoprotein E4;D053327
D12.776.521.120.500.750;Apolipoprotein E4;D053327
D10.532.091.500.249;Apolipoprotein E2;D053329
D12.776.070.400.500.249;Apolipoprotein E2;D053329
D12.776.521.120.500.249;Apolipoprotein E2;D053329
D12.644.276.374.750.065;4-1BB Ligand;D053330
D12.644.276.972.065;4-1BB Ligand;D053330
D12.776.395.192;4-1BB Ligand;D053330
D12.776.467.374.750.065;4-1BB Ligand;D053330
D12.776.467.972.065;4-1BB Ligand;D053330
D12.776.543.550.194;4-1BB Ligand;D053330
D23.529.374.750.065;4-1BB Ligand;D053330
D23.529.972.065;4-1BB Ligand;D053330
D12.644.276.374.750.186;Ectodysplasins;D053331
D12.644.276.972.186;Ectodysplasins;D053331
D12.776.395.550.275;Ectodysplasins;D053331
D12.776.467.374.750.186;Ectodysplasins;D053331
D12.776.467.972.186;Ectodysplasins;D053331
D12.776.543.550.275;Ectodysplasins;D053331
D23.529.374.750.186;Ectodysplasins;D053331
D23.529.972.186;Ectodysplasins;D053331
D12.776.543.750.705.852.760.347;Receptors, Ectodysplasin;D053338
D12.776.543.750.073.550;Edar Receptor;D053339
D12.776.543.750.705.852.760.347.500;Edar Receptor;D053339
D12.776.543.750.705.852.760.347.750;Xedar Receptor;D053340
C16.131.077.350.198;Ectodermal Dysplasia 1, Anhidrotic;D053358
C16.131.831.350.198;Ectodermal Dysplasia 1, Anhidrotic;D053358
C16.320.322.116;Ectodermal Dysplasia 1, Anhidrotic;D053358
C16.320.850.250.198;Ectodermal Dysplasia 1, Anhidrotic;D053358
C17.800.804.350.198;Ectodermal Dysplasia 1, Anhidrotic;D053358
C17.800.827.250.198;Ectodermal Dysplasia 1, Anhidrotic;D053358
C16.131.077.350.298;Ectodermal Dysplasia 3, Anhidrotic;D053359
C16.131.831.350.298;Ectodermal Dysplasia 3, Anhidrotic;D053359
C16.320.850.250.298;Ectodermal Dysplasia 3, Anhidrotic;D053359
C17.800.804.350.298;Ectodermal Dysplasia 3, Anhidrotic;D053359
C17.800.827.250.298;Ectodermal Dysplasia 3, Anhidrotic;D053359
C16.131.077.350.348;Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive;D053360
C16.131.831.350.348;Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive;D053360
C16.320.850.250.348;Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive;D053360
C17.800.804.350.348;Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive;D053360
C17.800.827.250.348;Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive;D053360
D12.644.276.374.750.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D12.644.276.972.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D12.776.467.374.750.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D12.776.467.972.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D23.529.374.750.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D23.529.972.505;Lymphotoxin alpha1, beta2 Heterotrimer;D053361
D12.644.360.024.296.100;Edar-Associated Death Domain Protein;D053362
D12.644.360.024.500.061;Edar-Associated Death Domain Protein;D053362
D12.644.360.075.421.100;Edar-Associated Death Domain Protein;D053362
D12.776.157.057.024.100;Edar-Associated Death Domain Protein;D053362
D12.776.157.057.500.061;Edar-Associated Death Domain Protein;D053362
D12.776.476.024.375.100;Edar-Associated Death Domain Protein;D053362
D12.776.476.024.500.061;Edar-Associated Death Domain Protein;D053362
D12.776.476.075.421.100;Edar-Associated Death Domain Protein;D053362
D12.776.641.199.500;Chromogranin B;D053378
D12.776.641.199.249;Chromogranin A;D053379
D12.644.276.374.750.720;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D12.644.276.972.720;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D12.776.467.374.750.710;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D12.776.467.972.720;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D23.529.374.750.710;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D23.529.972.720;Tumor Necrosis Factor Ligand Superfamily Member 15;D053380
D12.776.641.199.750;Secretogranin II;D053381
D10.532.091.450;Apolipoproteins D;D053399
D12.776.070.400.450;Apolipoproteins D;D053399
D12.776.521.120.450;Apolipoproteins D;D053399
A08.186.211.730.885.287.249.487.550.484;High Vocal Center;D053400
A13.468;High Vocal Center;D053400
A02.835.583.405.500.900;Volar Plate;D053401
A02.835.583.512.900;Volar Plate;D053401
D08.811.277.656.300.480.616;PHEX Phosphate Regulating Neutral Endopeptidase;D053402
D08.811.277.656.675.374.616;PHEX Phosphate Regulating Neutral Endopeptidase;D053402
D12.776.395.550.611;PHEX Phosphate Regulating Neutral Endopeptidase;D053402
D12.776.543.550.607;PHEX Phosphate Regulating Neutral Endopeptidase;D053402
A13.564;Lateral Line System;D053403
D12.644.360.024.296;Death Domain Receptor Signaling Adaptor Proteins;D053418
D12.644.360.075.421;Death Domain Receptor Signaling Adaptor Proteins;D053418
D12.776.157.057.024;Death Domain Receptor Signaling Adaptor Proteins;D053418
D12.776.476.024.375;Death Domain Receptor Signaling Adaptor Proteins;D053418
D12.776.476.075.421;Death Domain Receptor Signaling Adaptor Proteins;D053418
D10.532.473;Lipoproteins, IDL;D053419
D12.776.521.514;Lipoproteins, IDL;D053419
D12.644.360.024.131.186;CRADD Signaling Adaptor Protein;D053420
D12.644.360.024.296.050;CRADD Signaling Adaptor Protein;D053420
D12.644.360.024.500.050;CRADD Signaling Adaptor Protein;D053420
D12.644.360.075.358.186;CRADD Signaling Adaptor Protein;D053420
D12.644.360.075.421.050;CRADD Signaling Adaptor Protein;D053420
D12.776.157.057.004.186;CRADD Signaling Adaptor Protein;D053420
D12.776.157.057.024.050;CRADD Signaling Adaptor Protein;D053420
D12.776.157.057.500.050;CRADD Signaling Adaptor Protein;D053420
D12.776.476.024.139.186;CRADD Signaling Adaptor Protein;D053420
D12.776.476.024.375.050;CRADD Signaling Adaptor Protein;D053420
D12.776.476.024.500.050;CRADD Signaling Adaptor Protein;D053420
D12.776.476.075.358.186;CRADD Signaling Adaptor Protein;D053420
D12.776.476.075.421.050;CRADD Signaling Adaptor Protein;D053420
C10.668.829.380;Hand-Arm Vibration Syndrome;D053421
C14.907.440;Hand-Arm Vibration Syndrome;D053421
C24.400;Hand-Arm Vibration Syndrome;D053421
D08.811.913.696.620.682.700.801;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.644.360.024.296.400;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.644.360.024.500.186;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.644.360.075.421.400;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.776.157.057.024.400;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.776.157.057.500.186;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.776.476.024.375.662;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.776.476.024.500.186;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D12.776.476.075.421.400;Receptor-Interacting Protein Serine-Threonine Kinases;D053422
D10.532.432.700;Lipoproteins, HDL2;D053439
D12.776.521.479.735;Lipoproteins, HDL2;D053439
D10.532.432.850;Lipoproteins, HDL3;D053440
D12.776.521.479.867;Lipoproteins, HDL3;D053440
E07.695.755;Suture Anchors;D053441
E07.858.442.660.860;Suture Anchors;D053441
E07.858.690.650.860;Suture Anchors;D053441
D10.532.432.550;High-Density Lipoproteins, Pre-beta;D053442
D12.776.521.479.602;High-Density Lipoproteins, Pre-beta;D053442
H01.158.100.185.905;Visible Human Projects;D053443
J01.897.280.500.545.129.805;Visible Human Projects;D053443
L01.470.750.750.905;Visible Human Projects;D053443
L01.700.508.300.188.400.905;Visible Human Projects;D053443
G04.580.887.374;Inhibitory Postsynaptic Potentials;D053444
G07.265.337.615.500;Inhibitory Postsynaptic Potentials;D053444
G07.265.337.900.750.400;Inhibitory Postsynaptic Potentials;D053444
G07.265.750.887.374;Inhibitory Postsynaptic Potentials;D053444
G07.700.240.615.500;Inhibitory Postsynaptic Potentials;D053444
G07.700.240.900.750.400;Inhibitory Postsynaptic Potentials;D053444
G11.561.570.918.374;Inhibitory Postsynaptic Potentials;D053444
G11.561.600.625.500;Inhibitory Postsynaptic Potentials;D053444
G11.561.600.835.750.400;Inhibitory Postsynaptic Potentials;D053444
D12.644.360.024.296.024;CASP8 and FADD-Like Apoptosis Regulating Protein;D053446
D12.644.360.024.500.024;CASP8 and FADD-Like Apoptosis Regulating Protein;D053446
D12.644.360.075.421.024;CASP8 and FADD-Like Apoptosis Regulating Protein;D053446
D12.776.157.057.024.024;CASP8 and FADD-Like Apoptosis Regulating Protein;D053446
D12.776.476.075.421.024;CASP8 and FADD-Like Apoptosis Regulating Protein;D053446
C23.550.177;Channelopathies;D053447
C23.888.942.343.600;Prostatism;D053448
D12.644.360.024.500.906;TNF Receptor-Associated Factor 4;D053449
D12.776.157.057.500.906;TNF Receptor-Associated Factor 4;D053449
D12.776.476.024.500.906;TNF Receptor-Associated Factor 4;D053449
D12.776.543.750.705.852.760.238;Glucocorticoid-Induced TNFR-Related Protein;D053450
D08.811.277.656.262.500.126.550.900;Caspase 9;D053453
D08.811.277.656.300.200.126.550.900;Caspase 9;D053453
D12.644.360.075.405.550.900;Caspase 9;D053453
D12.776.476.075.405.550.900;Caspase 9;D053453
D08.811.277.656.262.500.126.550.920;Caspase 12;D053454
D08.811.277.656.300.200.126.550.920;Caspase 12;D053454
D12.644.360.075.405.550.920;Caspase 12;D053454
D12.776.476.075.405.550.920;Caspase 12;D053454
D08.811.277.656.262.500.126.550.910;Caspase 10;D053455
D08.811.277.656.300.200.126.550.910;Caspase 10;D053455
D12.644.360.075.405.550.910;Caspase 10;D053455
D12.776.476.075.405.550.910;Caspase 10;D053455
D08.811.277.656.262.500.126.350.900;Caspase 14;D053456
D08.811.277.656.300.200.126.350.900;Caspase 14;D053456
D12.644.360.075.405.350.900;Caspase 14;D053456
D12.776.476.075.405.350.900;Caspase 14;D053456
D12.644.360.024.131;CARD Signaling Adaptor Proteins;D053468
D12.644.360.075.358;CARD Signaling Adaptor Proteins;D053468
D12.776.157.057.004;CARD Signaling Adaptor Proteins;D053468
D12.776.476.024.139;CARD Signaling Adaptor Proteins;D053468
D12.776.476.075.358;CARD Signaling Adaptor Proteins;D053468
D08.811.277.656.262.500.126.350;Caspases, Effector;D053470
D08.811.277.656.300.200.126.350;Caspases, Effector;D053470
D12.644.360.075.405.350;Caspases, Effector;D053470
D12.776.476.075.405.350;Caspases, Effector;D053470
D08.811.277.656.262.500.126.550;Caspases, Initiator;D053471
D08.811.277.656.300.200.126.550;Caspases, Initiator;D053471
D12.644.360.075.405.550;Caspases, Initiator;D053471
D12.776.476.075.405.550;Caspases, Initiator;D053471
D12.644.360.024.307;Nod Signaling Adaptor Proteins;D053472
D12.776.157.057.068;Nod Signaling Adaptor Proteins;D053472
D12.776.476.024.391;Nod Signaling Adaptor Proteins;D053472
D12.644.360.024.131.500;Nod2 Signaling Adaptor Protein;D053473
D12.644.360.024.307.500;Nod2 Signaling Adaptor Protein;D053473
D12.644.360.075.358.500;Nod2 Signaling Adaptor Protein;D053473
D12.776.157.057.004.500;Nod2 Signaling Adaptor Protein;D053473
D12.776.157.057.068.500;Nod2 Signaling Adaptor Protein;D053473
D12.776.476.024.139.500;Nod2 Signaling Adaptor Protein;D053473
D12.776.476.024.391.500;Nod2 Signaling Adaptor Protein;D053473
D12.776.476.075.358.500;Nod2 Signaling Adaptor Protein;D053473
D12.644.360.024.131.249;Nod1 Signaling Adaptor Protein;D053474
D12.644.360.024.307.249;Nod1 Signaling Adaptor Protein;D053474
D12.644.360.075.358.249;Nod1 Signaling Adaptor Protein;D053474
D12.776.157.057.004.249;Nod1 Signaling Adaptor Protein;D053474
D12.776.157.057.068.249;Nod1 Signaling Adaptor Protein;D053474
D12.776.476.024.139.249;Nod1 Signaling Adaptor Protein;D053474
D12.776.476.024.391.249;Nod1 Signaling Adaptor Protein;D053474
D12.776.476.075.358.249;Nod1 Signaling Adaptor Protein;D053474
D08.811.913.696.620.682.700.801.500;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.644.360.024.131.750;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.644.360.024.500.186.500;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.644.360.075.358.750;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.776.157.057.004.750;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.776.157.057.500.186.500;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.776.476.024.139.750;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.776.476.024.500.186.500;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
D12.776.476.075.358.750;Receptor-Interacting Protein Serine-Threonine Kinase 2;D053475
G16.100.280;Extinction, Biological;D053476
D12.644.360.024.131.124;Apoptotic Protease-Activating Factor 1;D053477
D12.644.360.075.358.124;Apoptotic Protease-Activating Factor 1;D053477
D12.776.157.057.004.124;Apoptotic Protease-Activating Factor 1;D053477
D12.776.476.024.139.124;Apoptotic Protease-Activating Factor 1;D053477
D12.776.476.075.358.124;Apoptotic Protease-Activating Factor 1;D053477
D05.500.099;Apoptosomes;D053478
D09.400.430.750;Cholesterol Ester Transfer Proteins;D053480
D12.776.124.197;Cholesterol Ester Transfer Proteins;D053480
D12.776.157.165;Cholesterol Ester Transfer Proteins;D053480
D12.776.395.199;Cholesterol Ester Transfer Proteins;D053480
D12.644.822.500;Secretory Leukocyte Peptidase Inhibitor;D053481
D12.776.645.500;Secretory Leukocyte Peptidase Inhibitor;D053481
D12.776.124.117;beta 2-Glycoprotein I;D053482
D12.776.395.195;beta 2-Glycoprotein I;D053482
E01.370.380.230;Eye Movement Measurements;D053483
D08.811.277.040.025.159.249;RecQ Helicases;D053484
D08.811.277.040.025.800;RecQ Helicases;D053484
D08.811.399.340.249;RecQ Helicases;D053484
B04.820.504.540.150.665;Porcine epidemic diarrhea virus;D053485
B04.909.777.500.540.150.665;Porcine epidemic diarrhea virus;D053485
D06.472.699.327.935.531;Melanocortins;D053486
D06.472.699.631.525.600.531;Melanocortins;D053486
D12.644.400.400.935.531;Melanocortins;D053486
D12.644.548.365.935.531;Melanocortins;D053486
D12.644.548.691.525.690.531;Melanocortins;D053486
D12.776.641.650.405.935.531;Melanocortins;D053486
D08.811.913.696.445.735.720.249;DEAD-box RNA Helicases;D053487
D08.811.277.040.025.159.124;DnaB Helicases;D053488
D08.811.399.340.124;DnaB Helicases;D053488
C02.256.700.550;Mink Viral Enteritis;D053489
C22.557;Mink Viral Enteritis;D053489
B04.280.580.650.600.325.500;Mink enteritis virus;D053490
D12.644.822;Proteinase Inhibitory Proteins, Secretory;D053491
D12.776.645;Proteinase Inhibitory Proteins, Secretory;D053491
D12.644.822.437;Elafin;D053492
D12.776.645.437;Elafin;D053492
D08.244.453.915.149;Cholestanetriol 26-Monooxygenase;D053493
D08.811.682.690.708.170.915.150;Cholestanetriol 26-Monooxygenase;D053493
D08.811.682.690.708.783.150;Cholestanetriol 26-Monooxygenase;D053493
D12.776.422.220.453.915.250;Cholestanetriol 26-Monooxygenase;D053493
D12.644.276.374.625;Osteopontin;D053495
D12.776.395.700.837;Osteopontin;D053495
D12.776.467.374.625;Osteopontin;D053495
D12.776.860.300.762;Osteopontin;D053495
D23.529.374.625;Osteopontin;D053495
D12.776.157.530.400.150.760;Inositol 1,4,5-Trisphosphate Receptors;D053496
D12.776.543.550.425.150.760;Inositol 1,4,5-Trisphosphate Receptors;D053496
D12.776.543.585.400.150.760;Inositol 1,4,5-Trisphosphate Receptors;D053496
D12.776.826.179;Inositol 1,4,5-Trisphosphate Receptors;D053496
D06.472.699.327.935.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D06.472.699.631.525.600.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D12.644.400.400.935.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D12.644.548.365.935.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D12.644.548.691.525.690.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D12.776.641.650.405.935.498;Corticotropin-Like Intermediate Lobe Peptide;D053497
D08.811.277.040.025.125.500;Sarcoplasmic Reticulum Calcium-Transporting ATPases;D053498
D12.776.157.530.450.250.500.500;Sarcoplasmic Reticulum Calcium-Transporting ATPases;D053498
D12.776.543.585.450.250.500.500;Sarcoplasmic Reticulum Calcium-Transporting ATPases;D053498
D08.811.277.040.025.125.249;Plasma Membrane Calcium-Transporting ATPases;D053499
D12.776.157.530.450.250.500.249;Plasma Membrane Calcium-Transporting ATPases;D053499
D12.776.543.585.450.250.500.249;Plasma Membrane Calcium-Transporting ATPases;D053499
D06.472.699.327.935.518;gamma-Lipotropin;D053500
D06.472.699.631.525.600.518;gamma-Lipotropin;D053500
D12.644.400.400.935.518;gamma-Lipotropin;D053500
D12.644.548.365.935.518;gamma-Lipotropin;D053500
D12.644.548.691.525.690.518;gamma-Lipotropin;D053500
D12.776.641.650.405.935.518;gamma-Lipotropin;D053500
D08.811.277.040.025.047;Arsenite Transporting ATPases;D053501
D12.776.157.530.450.250.249;Arsenite Transporting ATPases;D053501
D12.776.543.585.450.250.249;Arsenite Transporting ATPases;D053501
D08.811.682.113;Arsenate Reductases;D053502
D12.776.157.530.400.875.200;Epithelial Sodium Channels;D053503
D12.776.543.550.425.875.200;Epithelial Sodium Channels;D053503
D12.776.543.585.400.875.200;Epithelial Sodium Channels;D053503
D08.811.277.656.300.480.525.300;Matrix Metalloproteinases, Membrane-Associated;D053504
D08.811.277.656.675.374.525.300;Matrix Metalloproteinases, Membrane-Associated;D053504
D12.776.543.493;Matrix Metalloproteinases, Membrane-Associated;D053504
D08.811.277.656.300.480.525.700;Matrix Metalloproteinases, Secreted;D053505
D08.811.277.656.675.374.525.700;Matrix Metalloproteinases, Secreted;D053505
D08.811.277.656.300.480.525.700.400;Matrix Metalloproteinase 10;D053506
D08.811.277.656.675.374.525.700.400;Matrix Metalloproteinase 10;D053506
D08.811.277.656.300.480.525.700.450;Matrix Metalloproteinase 11;D053507
D08.811.277.656.675.374.525.700.450;Matrix Metalloproteinase 11;D053507
D08.811.277.656.300.480.525.700.500;Matrix Metalloproteinase 12;D053508
D08.811.277.656.675.374.525.700.500;Matrix Metalloproteinase 12;D053508
D08.811.277.656.300.480.205.363;Matrix Metalloproteinase 13;D053509
D08.811.277.656.300.480.525.700.550;Matrix Metalloproteinase 13;D053509
D08.811.277.656.675.374.205.363;Matrix Metalloproteinase 13;D053509
D08.811.277.656.675.374.525.700.550;Matrix Metalloproteinase 13;D053509
D08.811.277.656.300.480.525.300.500;Matrix Metalloproteinase 14;D053511
D08.811.277.656.675.374.525.300.500;Matrix Metalloproteinase 14;D053511
D08.811.277.656.300.480.525.300.600;Matrix Metalloproteinase 16;D053513
D08.811.277.656.675.374.525.300.750;Matrix Metalloproteinase 16;D053513
D08.811.277.656.300.480.525.300.650;Matrix Metalloproteinase 17;D053515
D08.811.277.656.675.374.525.300.875;Matrix Metalloproteinase 17;D053515
D12.776.395.550.448.700;Matrix Metalloproteinase 17;D053515
D12.776.543.484.500.700;Matrix Metalloproteinase 17;D053515
D12.776.543.550.418.700;Matrix Metalloproteinase 17;D053515
D08.811.277.656.300.480.525.300.550;Matrix Metalloproteinase 15;D053517
D08.811.277.656.675.374.525.300.625;Matrix Metalloproteinase 15;D053517
D08.811.277.656.300.480.525.700.800;Matrix Metalloproteinase 20;D053519
D08.811.277.656.675.374.525.700.800;Matrix Metalloproteinase 20;D053519
B03.660.250.021.480;Marinobacter;D053520
B03.660.250.019;Alcanivoraceae;D053521
B03.660.250.565.600;Piscirickettsia;D053522
D12.776.231.500;Amelogenin;D053523
B03.440.400.645.100;Beggiatoa;D053524
B03.660.250.770.100;Beggiatoa;D053524
B03.440.400.645.800;Thiothrix;D053525
B03.660.250.770.800;Thiothrix;D053525
B03.440.450.900.500;Listonella;D053526
B03.660.250.830.500;Listonella;D053526
D05.750.078.593.450.600.400;Keratin-4;D053527
D12.776.220.475.450.600.400;Keratin-4;D053527
D12.776.860.607.650.400;Keratin-4;D053527
B03.440.400.425.967.500;Lysobacter;D053528
B03.660.250.915.500;Lysobacter;D053528
C16.320.850.542;Leukokeratosis, Hereditary Mucosal;D053529
C17.800.827.595;Leukokeratosis, Hereditary Mucosal;D053529
D05.750.078.593.450.300;Keratins, Type I;D053530
D12.776.220.475.450.300;Keratins, Type I;D053530
D12.776.860.607.300;Keratins, Type I;D053530
D05.750.078.593.450.600;Keratins, Type II;D053531
D12.776.220.475.450.600;Keratins, Type II;D053531
D12.776.860.607.650;Keratins, Type II;D053531
B03.660.250.915.930.049;Xanthomonas axonopodis;D053532
D05.750.078.593.450.600.800;Keratin-8;D053533
D12.776.220.475.450.600.800;Keratin-8;D053533
D12.776.860.607.650.800;Keratin-8;D053533
D05.750.078.593.450.600.900;Keratin-9;D053534
D12.776.220.475.450.600.900;Keratin-9;D053534
D12.776.860.607.650.900;Keratin-9;D053534
D05.750.078.593.450.300.300;Keratin-13;D053535
D12.776.220.475.450.300.300;Keratin-13;D053535
D12.776.860.607.300.300;Keratin-13;D053535
D05.750.078.593.450.300.600;Keratin-16;D053536
D12.776.220.475.450.300.600;Keratin-16;D053536
D12.776.860.607.300.600;Keratin-16;D053536
D05.750.078.593.450.300.700;Keratin-17;D053537
D12.776.220.475.450.300.700;Keratin-17;D053537
D12.776.860.607.300.700;Keratin-17;D053537
D05.750.078.593.450.300.800;Keratin-18;D053538
D12.776.220.475.450.300.800;Keratin-18;D053538
D12.776.860.607.300.800;Keratin-18;D053538
D05.750.078.593.450.300.900;Keratin-19;D053539
D12.776.220.475.450.300.900;Keratin-19;D053539
D12.776.860.607.300.900;Keratin-19;D053539
B03.660.250.540.500;Marinomonas;D053544
B03.280.697;Spirulina;D053545
C16.320.850.475.440.500;Keratoderma, Palmoplantar, Epidermolytic;D053546
C17.800.428.435.440.500;Keratoderma, Palmoplantar, Epidermolytic;D053546
C17.800.827.475.440.500;Keratoderma, Palmoplantar, Epidermolytic;D053546
D05.750.078.593.450.300.400;Keratin-14;D053547
D12.776.220.475.450.300.400;Keratin-14;D053547
D12.776.860.607.300.400;Keratin-14;D053547
C16.131.831.350.856;Pachyonychia Congenita;D053549
C16.320.850.250.856;Pachyonychia Congenita;D053549
C17.800.529.594;Pachyonychia Congenita;D053549
C17.800.804.350.856;Pachyonychia Congenita;D053549
C17.800.827.250.856;Pachyonychia Congenita;D053549
D05.750.078.593.450.300.100;Keratin-10;D053550
D12.776.220.475.450.300.100;Keratin-10;D053550
D12.776.860.607.300.100;Keratin-10;D053550
D05.750.078.593.450.300.200;Keratin-12;D053551
D12.776.220.475.450.300.200;Keratin-12;D053551
D12.776.860.607.300.200;Keratin-12;D053551
D05.750.078.593.450.600.700;Keratin-7;D053552
D12.776.220.475.450.600.700;Keratin-7;D053552
D12.776.860.607.650.700;Keratin-7;D053552
D05.750.078.593.450.600.600;Keratin-6;D053553
D12.776.220.475.450.600.600;Keratin-6;D053553
D12.776.860.607.650.600;Keratin-6;D053553
D05.750.078.593.450.300.950;Keratin-20;D053554
D12.776.220.475.450.300.950;Keratin-20;D053554
D12.776.860.607.300.950;Keratin-20;D053554
D05.750.078.593.450.600.500;Keratin-5;D053555
D12.776.220.475.450.600.500;Keratin-5;D053555
D12.776.860.607.650.500;Keratin-5;D053555
D05.750.078.593.450.600.100;Keratin-1;D053556
D12.776.220.475.450.600.100;Keratin-1;D053556
D12.776.860.607.650.100;Keratin-1;D053556
D05.750.078.593.450.600.200;Keratin-2;D053557
D12.776.220.475.450.600.200;Keratin-2;D053557
D12.776.860.607.650.200;Keratin-2;D053557
D05.750.078.593.450.600.300;Keratin-3;D053558
D12.776.220.475.450.600.300;Keratin-3;D053558
D12.776.860.607.650.300;Keratin-3;D053558
C11.204.236.218;Corneal Dystrophy, Juvenile Epithelial of Meesmann;D053559
C11.270.162.218;Corneal Dystrophy, Juvenile Epithelial of Meesmann;D053559
C16.320.290.162.204;Corneal Dystrophy, Juvenile Epithelial of Meesmann;D053559
C16.131.831.512.408;Ichthyosis Bullosa of Siemens;D053560
C16.320.850.402;Ichthyosis Bullosa of Siemens;D053560
C16.614.492.410;Ichthyosis Bullosa of Siemens;D053560
C17.800.428.333.330;Ichthyosis Bullosa of Siemens;D053560
C17.800.804.512.405;Ichthyosis Bullosa of Siemens;D053560
C17.800.827.403;Ichthyosis Bullosa of Siemens;D053560
D06.472.699.327.700.875.500;Somatostatin-28;D053561
D06.472.699.587.780.500;Somatostatin-28;D053561
D12.644.400.400.700.875.500;Somatostatin-28;D053561
D12.644.548.365.700.875.500;Somatostatin-28;D053561
D12.644.548.586.780.500;Somatostatin-28;D053561
D12.776.641.650.405.700.875.500;Somatostatin-28;D053561
D05.750.078.593.450.149;Keratins, Hair-Specific;D053564
D12.776.220.475.450.149;Keratins, Hair-Specific;D053564
D12.776.860.607.149;Keratins, Hair-Specific;D053564
C23.888.942.337;Hypercalciuria;D053565
E07.357;Feminine Hygiene Products;D053566
D12.776.220.475.450.300.500;Keratin-15;D053569
C02.256.200.500;Porcine Postweaning Multisystemic Wasting Syndrome;D053570
C22.905.690;Porcine Postweaning Multisystemic Wasting Syndrome;D053570
D12.776.543.750.705.852.420.300.500;Receptors, Interleukin-1 Type I;D053573
D23.050.301.264.035.697;Receptors, Interleukin-1 Type I;D053573
D23.101.100.110.697;Receptors, Interleukin-1 Type I;D053573
D12.776.543.750.705.852.420.300.750;Receptors, Interleukin-1 Type II;D053574
D23.050.301.264.035.699;Receptors, Interleukin-1 Type II;D053574
D23.101.100.110.699;Receptors, Interleukin-1 Type II;D053574
D12.776.543.750.705.852.420.300.249;Interleukin-1 Receptor Accessory Protein;D053577
C04.588.614.550.600;Opsoclonus-Myoclonus Syndrome;D053578
C04.730.856.596;Opsoclonus-Myoclonus Syndrome;D053578
C10.228.758.500;Opsoclonus-Myoclonus Syndrome;D053578
C10.292.562.831;Opsoclonus-Myoclonus Syndrome;D053578
C10.574.781.662;Opsoclonus-Myoclonus Syndrome;D053578
C10.597.350.500.500;Opsoclonus-Myoclonus Syndrome;D053578
C11.590.725;Opsoclonus-Myoclonus Syndrome;D053578
C12.777.419.815.491;Gitelman Syndrome;D053579
C13.351.968.419.815.491;Gitelman Syndrome;D053579
C16.320.565.861.491;Gitelman Syndrome;D053579
C18.452.648.861.491;Gitelman Syndrome;D053579
E01.370.600.425;Muscle Strength;D053580
G11.427.560;Muscle Strength;D053580
E07.230.460;Muscle Strength Dynamometer;D053581
D12.644.276.374.465.501.300;Interleukin-1alpha;D053582
D12.644.276.374.500.400.300;Interleukin-1alpha;D053582
D12.776.467.374.465.501.300;Interleukin-1alpha;D053582
D12.776.467.374.500.400.300;Interleukin-1alpha;D053582
D23.529.374.465.501.300;Interleukin-1alpha;D053582
D23.529.374.500.400.300;Interleukin-1alpha;D053582
D12.644.276.374.465.501.600;Interleukin-1beta;D053583
D12.644.276.374.500.400.600;Interleukin-1beta;D053583
D12.776.467.374.465.501.600;Interleukin-1beta;D053583
D12.776.467.374.500.400.600;Interleukin-1beta;D053583
D23.529.374.465.501.600;Interleukin-1beta;D053583
D23.529.374.500.400.600;Interleukin-1beta;D053583
C23.888.942.900;Urinoma;D053584
G06.590.875.715;Virus Attachment;D053585
G06.920.875.715;Virus Attachment;D053585
G06.590.875.755;Virus Internalization;D053586
G06.920.875.755;Virus Internalization;D053586
E01.370.600.700.500;Arthrometry, Articular;D053587
G11.427.760.500;Arthrometry, Articular;D053587
C13.703.413;Nuchal Cord;D053589
C16.300.790;Nuchal Cord;D053589
D12.644.276.374.460;Interleukin 1 Receptor Antagonist Protein;D053590
D12.776.467.374.460;Interleukin 1 Receptor Antagonist Protein;D053590
D23.529.374.460;Interleukin 1 Receptor Antagonist Protein;D053590
C10.597.617.894;Pain, Referred;D053591
C23.888.592.612.888;Pain, Referred;D053591
C23.888.646.690;Pain, Referred;D053591
D08.811.913.696.620.682.700.526;Interleukin-1 Receptor-Associated Kinases;D053592
D12.644.360.379;Interleukin-1 Receptor-Associated Kinases;D053592
D12.776.476.384;Interleukin-1 Receptor-Associated Kinases;D053592
H01.158.703.795.424;Forensic Toxicology;D053593
H02.628.795.424;Forensic Toxicology;D053593
I01.198.780.968;Forensic Toxicology;D053593
D12.644.360.024.305;Myeloid Differentiation Factor 88;D053594
D12.776.157.057.064;Myeloid Differentiation Factor 88;D053594
D12.776.476.024.390;Myeloid Differentiation Factor 88;D053594
A11.872.190;Embryonic Stem Cells;D053595
H02.478.676.227;Forensic Nursing;D053604
I01.198.780.952;Forensic Nursing;D053604
D12.644.276.374.470;Leukemia Inhibitory Factor;D053605
D12.776.467.374.470;Leukemia Inhibitory Factor;D053605
D23.529.374.470;Leukemia Inhibitory Factor;D053605
D12.776.543.750.705.852.500;Receptors, OSM-LIF;D053606
D12.776.543.750.705.852.555.800;Receptors, OSM-LIF;D053606
D06.472.699.077;Adrenomedullin;D053607
D12.644.548.017;Adrenomedullin;D053607
C10.597.606.358.800.500;Stupor;D053608
C23.888.592.604.359.800.500;Stupor;D053608
C10.597.606.441;Lethargy;D053609
C23.888.592.604.444;Lethargy;D053609
F01.700.470;Lethargy;D053609
D03.132.577;Opiate Alkaloids;D053610
D08.811.913.696.620.682.725.124;Janus Kinases;D053612
D12.776.476.393;Janus Kinases;D053612
D08.811.913.696.620.682.725.124.100;Janus Kinase 1;D053613
D12.776.476.393.100;Janus Kinase 1;D053613
D08.811.913.696.620.682.725.124.200;Janus Kinase 2;D053614
D12.776.476.393.200;Janus Kinase 2;D053614
D12.776.624.664.700.117;Janus Kinase 2;D053614
D08.811.913.696.620.682.725.124.300;Janus Kinase 3;D053616
D12.776.476.393.300;Janus Kinase 3;D053616
A16.254.500.533;Blastocyst Inner Cell Mass;D053624
E02.875.800.988;Sperm Retrieval;D053625
E04.936.537.750;Sperm Retrieval;D053625
E05.820.800.988;Sperm Retrieval;D053625
D02.806.550.312;Atovaquone;D053626
D04.615.638.721.186;Atovaquone;D053626
C12.294.365.700.253;Asthenozoospermia;D053627
D12.776.543.750.705.852.610;Receptors, Thrombopoietin;D053628
D23.050.301.264.035.881;Receptors, Thrombopoietin;D053628
D23.101.100.110.883;Receptors, Thrombopoietin;D053628
B01.650.940.800.575.100.075.937;Thapsia;D053629
D02.241.223.100.300.100;Depsides;D053630
D02.241.511.390.100;Depsides;D053630
D02.455.426.559.389.127.281.100;Depsides;D053630
D02.455.426.559.389.657.410.100;Depsides;D053630
D12.776.543.750.705.852.420.320.875;Interleukin Receptor Common gamma Subunit;D053631
D12.776.543.750.705.852.420.360.300.500;Interleukin Receptor Common gamma Subunit;D053631
D12.776.543.750.705.852.420.420.500;Interleukin Receptor Common gamma Subunit;D053631
D12.776.543.750.705.852.420.500.500;Interleukin Receptor Common gamma Subunit;D053631
D12.776.543.750.705.852.420.800.750;Interleukin Receptor Common gamma Subunit;D053631
D12.776.543.750.705.852.420.900.500;Interleukin Receptor Common gamma Subunit;D053631
D23.050.301.264.035.420;Interleukin Receptor Common gamma Subunit;D053631
D23.101.100.110.420;Interleukin Receptor Common gamma Subunit;D053631
C16.320.322.968;X-Linked Combined Immunodeficiency Diseases;D053632
C16.614.815.500;X-Linked Combined Immunodeficiency Diseases;D053632
C20.673.815.500;X-Linked Combined Immunodeficiency Diseases;D053632
D12.776.543.750.705.852.400.500;Receptor, Interferon alpha-beta;D053633
D08.811.913.696.620.682.725.124.650;TYK2 Kinase;D053634
D12.776.476.393.650;TYK2 Kinase;D053634
D02.478.480;Naphthalimides;D053644
D03.383.621.808.612;Naphthalimides;D053644
D03.438.531.460;Naphthalimides;D053644
D04.615.638.596;Naphthalimides;D053644
D12.776.543.750.705.852.420.320.500;Interleukin-2 Receptor alpha Subunit;D053645
D23.050.301.264.035.401;Interleukin-2 Receptor alpha Subunit;D053645
D23.101.100.110.401;Interleukin-2 Receptor alpha Subunit;D053645
D12.776.543.750.705.852.420.320.750;Interleukin-2 Receptor beta Subunit;D053646
D12.776.543.750.705.852.420.800.500;Interleukin-2 Receptor beta Subunit;D053646
D23.050.301.264.035.402;Interleukin-2 Receptor beta Subunit;D053646
D23.101.100.110.402;Interleukin-2 Receptor beta Subunit;D053646
D12.776.543.750.705.852.420.800;Receptors, Interleukin-15;D053647
D12.776.543.750.705.852.150.310.500;Cytokine Receptor Common beta Subunit;D053648
D12.776.543.750.705.852.420.340.350;Cytokine Receptor Common beta Subunit;D053648
D12.776.543.750.705.852.420.380.500;Cytokine Receptor Common beta Subunit;D053648
D12.776.543.750.750.400.200.420.500;Cytokine Receptor Common beta Subunit;D053648
D23.050.301.264.035.279;Cytokine Receptor Common beta Subunit;D053648
D23.101.100.110.279;Cytokine Receptor Common beta Subunit;D053648
D12.776.543.750.705.852.420.380;Receptors, Interleukin-5;D053649
D12.776.543.750.705.852.420.340.500;Interleukin-3 Receptor alpha Subunit;D053650
D23.050.301.264.035.403;Interleukin-3 Receptor alpha Subunit;D053650
D23.101.100.110.403;Interleukin-3 Receptor alpha Subunit;D053650
D12.776.543.750.705.852.420.500;Receptors, Interleukin-9;D053651
D23.050.301.264.035.816;Receptors, Interleukin-9;D053651
D23.101.100.110.816;Receptors, Interleukin-9;D053651
E05.393.580;Nuclear Transfer Techniques;D053652
E05.820.540;Nuclear Transfer Techniques;D053652
C12.777.419.570.821.358;Pyelocystitis;D053653
C12.777.829.495.750;Pyelocystitis;D053653
C13.351.968.419.570.821.358;Pyelocystitis;D053653
C13.351.968.829.495.750;Pyelocystitis;D053653
D12.776.543.750.705.852.420.900;Receptors, Interleukin-21;D053655
E04.555.710;Tenodesis;D053656
E04.987.775.900;Tenodesis;D053656
A12.207.152.693.600;Platelet-Rich Plasma;D053657
A12.207.270.695.600;Platelet-Rich Plasma;D053657
A15.145.693.600;Platelet-Rich Plasma;D053657
D12.776.543.750.705.852.420.360.300;Receptors, Interleukin-4, Type I;D053658
D12.776.543.750.705.852.420.360.600;Receptors, Interleukin-4, Type II;D053659
D12.776.543.750.705.852.420.600.800;Receptors, Interleukin-4, Type II;D053659
D12.776.543.750.705.852.420.600;Receptors, Interleukin-13;D053660
D12.776.543.750.705.852.420.360.600.500;Interleukin-13 Receptor alpha1 Subunit;D053661
D12.776.543.750.705.852.420.600.800.500;Interleukin-13 Receptor alpha1 Subunit;D053661
D23.050.301.264.035.412;Interleukin-13 Receptor alpha1 Subunit;D053661
D23.101.100.110.412;Interleukin-13 Receptor alpha1 Subunit;D053661
D12.776.543.750.705.852.420.360.300.200;Interleukin-4 Receptor alpha Subunit;D053662
D12.776.543.750.705.852.420.360.600.200;Interleukin-4 Receptor alpha Subunit;D053662
D12.776.543.750.705.852.420.600.800.200;Interleukin-4 Receptor alpha Subunit;D053662
D23.050.301.264.035.404;Interleukin-4 Receptor alpha Subunit;D053662
D23.101.100.110.404;Interleukin-4 Receptor alpha Subunit;D053662
D12.776.543.750.705.852.420.600.300;Interleukin-13 Receptor alpha2 Subunit;D053663
D23.050.301.264.035.413;Interleukin-13 Receptor alpha2 Subunit;D053663
D23.101.100.110.413;Interleukin-13 Receptor alpha2 Subunit;D053663
D12.776.543.750.705.852.420.380.750;Interleukin-5 Receptor alpha Subunit;D053666
D23.050.301.264.035.405;Interleukin-5 Receptor alpha Subunit;D053666
D23.101.100.110.405;Interleukin-5 Receptor alpha Subunit;D053666
D12.776.395.550.847;Syndecans;D053667
D12.776.395.650.350.500;Syndecans;D053667
D12.776.543.550.847;Syndecans;D053667
D12.776.395.550.847.100;Syndecan-1;D053668
D12.776.395.650.350.500.100;Syndecan-1;D053668
D12.776.543.550.847.100;Syndecan-1;D053668
D23.050.301.264.035.916;Syndecan-1;D053668
D23.101.100.110.940;Syndecan-1;D053668
D12.776.395.550.847.200;Syndecan-2;D053669
D12.776.395.650.350.500.200;Syndecan-2;D053669
D12.776.543.550.847.200;Syndecan-2;D053669
D12.776.395.550.847.600;Syndecan-3;D053670
D12.776.395.650.350.500.600;Syndecan-3;D053670
D12.776.543.550.847.300;Syndecan-3;D053670
D12.776.395.550.847.800;Syndecan-4;D053671
D12.776.395.650.350.500.800;Syndecan-4;D053671
D12.776.543.550.847.400;Syndecan-4;D053671
E02.319.341;Electrochemotherapy;D053672
E05.242.448.500;Electrochemotherapy;D053672
E05.301.500.500;Electrochemotherapy;D053672
D12.776.395.550.448.500;Glypicans;D053673
D12.776.395.650.350.249;Glypicans;D053673
D12.776.543.484.500.550;Glypicans;D053673
D12.776.543.550.418.500;Glypicans;D053673
D09.698.735.200.500;Aggrecans;D053674
D12.776.395.650.750.687.100;Aggrecans;D053674
D12.776.503.280.437.100;Aggrecans;D053674
D12.776.860.300.140;Aggrecans;D053674
D09.698.735.200.750;Versicans;D053675
D12.776.395.650.750.687.800;Versicans;D053675
D12.776.503.280.437.800;Versicans;D053675
D12.776.860.300.885;Versicans;D053675
D12.644.360.024.437;Syntenins;D053676
D12.776.157.057.374;Syntenins;D053676
D12.776.476.024.468;Syntenins;D053676
D12.776.543.750.705.852.555;Receptors, Oncostatin M;D053677
D12.776.543.750.705.852.555.600;Receptors, Oncostatin M, Type II;D053679
D12.776.543.750.705.852.500.750;Leukemia Inhibitory Factor Receptor alpha Subunit;D053680
D12.776.543.750.705.852.555.800.750;Leukemia Inhibitory Factor Receptor alpha Subunit;D053680
D12.776.543.750.750.400.550.250.750;Leukemia Inhibitory Factor Receptor alpha Subunit;D053680
D23.050.301.264.035.493;Leukemia Inhibitory Factor Receptor alpha Subunit;D053680
D23.101.100.110.493;Leukemia Inhibitory Factor Receptor alpha Subunit;D053680
D12.776.543.750.705.852.555.600.750;Oncostatin M Receptor beta Subunit;D053681
C05.651.869.870.800;Tendon Entrapment;D053682
D12.644.276.374.562;Oncostatin M;D053683
D12.776.467.374.562;Oncostatin M;D053683
D23.529.374.562;Oncostatin M;D053683
C05.651.869.870.800.200;De Quervain Disease;D053684
E02.594;Laser Therapy;D053685
E04.014.520;Laser Therapy;D053685
A11.872.220;Fetal Stem Cells;D053686
A11.872.040;Adult Stem Cells;D053687
D12.776.543.750.705.852.420.400.750;Interleukin-6 Receptor alpha Subunit;D053698
D23.050.301.264.035.406;Interleukin-6 Receptor alpha Subunit;D053698
D23.101.100.110.406;Interleukin-6 Receptor alpha Subunit;D053698
D12.776.543.750.705.852.420.420.450;Interleukin-7 Receptor alpha Subunit;D053699
D23.050.301.264.035.407;Interleukin-7 Receptor alpha Subunit;D053699
D23.101.100.110.407;Interleukin-7 Receptor alpha Subunit;D053699
D12.776.543.750.100.160.500.750;Receptors, Interleukin-8;D053700
D12.776.543.750.705.852.125.500.750;Receptors, Interleukin-8;D053700
D12.776.543.750.705.852.420.421;Receptors, Interleukin-8;D053700
D23.050.301.264.035.605.500.750;Receptors, Interleukin-8;D053700
D23.101.100.110.605.500.750;Receptors, Interleukin-8;D053700
D12.776.543.750.705.852.420.550;Receptors, Interleukin-10;D053701
D12.776.543.750.705.852.420.560;Receptors, Interleukin-11;D053702
D12.776.543.750.705.852.420.560.500;Interleukin-11 Receptor alpha Subunit;D053703
E01.370.388.250.250.250.140;Capsule Endoscopy;D053704
E07.230.220.260.140;Capsule Endoscopes;D053705
C01.539.463.850;Typhlitis;D053706
C06.405.205.932;Typhlitis;D053706
C06.405.469.110.708;Typhlitis;D053706
D12.776.543.750.705.852.420.580;Receptors, Interleukin-12;D053707
G05.355.680;Nuclear Reprogramming;D053708
D12.776.543.750.705.852.420.550.500;Interleukin-10 Receptor alpha Subunit;D053709
D23.050.301.264.035.409;Interleukin-10 Receptor alpha Subunit;D053709
D23.101.100.110.409;Interleukin-10 Receptor alpha Subunit;D053709
D12.776.543.750.705.852.420.550.750;Interleukin-10 Receptor beta Subunit;D053710
D23.050.301.264.035.410;Interleukin-10 Receptor beta Subunit;D053710
D23.101.100.110.410;Interleukin-10 Receptor beta Subunit;D053710
D12.776.543.750.705.852.420.580.500;Interleukin-12 Receptor beta 1 Subunit;D053711
D12.776.543.750.705.852.420.580.750;Interleukin-12 Receptor beta 2 Subunit;D053712
C12.294.365.700.380;Azoospermia;D053713
C12.294.365.700.126;Aspermia;D053714
E04.950.774.162;Cystotomy;D053715
C05.116.198.579.304;Female Athlete Triad Syndrome;D053716
C19.391.240;Female Athlete Triad Syndrome;D053716
F03.375.450;Female Athlete Triad Syndrome;D053716
C01.539.248.500;Pneumonia, Ventilator-Associated;D053717
C08.381.520.750.750;Pneumonia, Ventilator-Associated;D053717
C08.381.677.800;Pneumonia, Ventilator-Associated;D053717
C08.730.610.750;Pneumonia, Ventilator-Associated;D053717
C17.300.550.875;Scleromyxedema;D053718
E05.196.566.880;Tandem Mass Spectrometry;D053719
D12.776.543.750.705.852.420.800.550;Interleukin-15 Receptor alpha Subunit;D053720
D12.776.543.750.705.852.420.810;Receptors, Interleukin-16;D053721
D12.776.543.750.705.852.420.820;Receptors, Interleukin-17;D053722
D23.050.301.264.035.820;Receptors, Interleukin-17;D053722
D23.101.100.110.820;Receptors, Interleukin-17;D053722
B01.650.940.800.575.100.087.500.500;Panax notoginseng;D053723
D12.776.543.750.705.852.420.830;Receptors, Interleukin-18;D053724
D12.776.543.750.705.852.420.830.500;Interleukin-18 Receptor alpha Subunit;D053727
D23.050.301.264.035.417;Interleukin-18 Receptor alpha Subunit;D053727
D23.101.100.110.417;Interleukin-18 Receptor alpha Subunit;D053727
D12.776.543.750.705.852.420.830.750;Interleukin-18 Receptor beta Subunit;D053728
D23.050.301.264.035.418;Interleukin-18 Receptor beta Subunit;D053728
D23.101.100.110.418;Interleukin-18 Receptor beta Subunit;D053728
D12.776.543.750.705.852.420.900.450;Interleukin-21 Receptor alpha Subunit;D053738
D12.776.395.550.448.200;Ciliary Neurotrophic Factor Receptor alpha Subunit;D053739
D12.776.543.484.500.200;Ciliary Neurotrophic Factor Receptor alpha Subunit;D053739
D12.776.543.550.418.200;Ciliary Neurotrophic Factor Receptor alpha Subunit;D053739
D12.776.543.750.750.400.550.250.249;Ciliary Neurotrophic Factor Receptor alpha Subunit;D053739
J01.637.512.600;Nanoparticles;D053758
D12.644.276.374.465.759;Interleukin-23;D053759
D12.776.467.374.465.759;Interleukin-23;D053759
D23.529.374.465.759;Interleukin-23;D053759
D12.644.276.374.465.759.500;Interleukin-23 Subunit p19;D053760
D12.776.467.374.465.759.500;Interleukin-23 Subunit p19;D053760
D23.529.374.465.759.500;Interleukin-23 Subunit p19;D053760
J01.637.512.150;Nanocomposites;D053761
D12.644.276.374.465.512.500;Interleukin-12 Subunit p40;D053762
D12.644.276.374.465.759.249;Interleukin-12 Subunit p40;D053762
D12.776.467.374.465.512.500;Interleukin-12 Subunit p40;D053762
D12.776.467.374.465.759.249;Interleukin-12 Subunit p40;D053762
D23.529.374.465.512.500;Interleukin-12 Subunit p40;D053762
D23.529.374.465.759.249;Interleukin-12 Subunit p40;D053762
D12.776.543.696;Presenilins;D053763
D12.776.543.696.500;Presenilin-1;D053764
D12.644.276.374.465.512.249;Interleukin-12 Subunit p35;D053765
D12.776.467.374.465.512.249;Interleukin-12 Subunit p35;D053765
D23.529.374.465.512.249;Interleukin-12 Subunit p35;D053765
D12.776.543.696.750;Presenilin-2;D053766
D06.472.317.469.500.750;Glucagon-Like Peptide 2;D053767
J01.637.512.600.500;Metal Nanoparticles;D053768
D26.255.260.575;Nanocapsules;D053769
D27.720.280.260.575;Nanocapsules;D053769
E02.319.300.380.575;Nanocapsules;D053769
J01.637.512.600.575;Nanocapsules;D053769
J01.637.512.925;Nanowires;D053770
D06.472.317.469.249;Glicentin;D053771
D06.472.317.469.750;Oxyntomodulin;D053772
D12.644.276.374.687.100;Transforming Growth Factor beta1;D053773
D12.644.276.954.800.720.100;Transforming Growth Factor beta1;D053773
D12.644.276.963.720.100;Transforming Growth Factor beta1;D053773
D12.776.467.374.687.100;Transforming Growth Factor beta1;D053773
D12.776.467.942.800.720.100;Transforming Growth Factor beta1;D053773
D12.776.467.960.720.100;Transforming Growth Factor beta1;D053773
D23.529.374.687.100;Transforming Growth Factor beta1;D053773
D23.529.942.800.720.100;Transforming Growth Factor beta1;D053773
D23.529.960.720.100;Transforming Growth Factor beta1;D053773
D02.886.675.966;Thiazolidines;D053778
D12.776.157.458;Latent TGF-beta Binding Proteins;D053779
D12.644.276.374.687.200;Transforming Growth Factor beta2;D053781
D12.644.276.954.800.720.200;Transforming Growth Factor beta2;D053781
D12.644.276.963.720.200;Transforming Growth Factor beta2;D053781
D12.776.467.374.687.200;Transforming Growth Factor beta2;D053781
D12.776.467.942.800.720.200;Transforming Growth Factor beta2;D053781
D12.776.467.960.720.200;Transforming Growth Factor beta2;D053781
D23.529.374.687.200;Transforming Growth Factor beta2;D053781
D23.529.942.800.720.200;Transforming Growth Factor beta2;D053781
D23.529.960.720.200;Transforming Growth Factor beta2;D053781
D12.644.276.374.687.300;Transforming Growth Factor beta3;D053782
D12.644.276.954.800.720.300;Transforming Growth Factor beta3;D053782
D12.644.276.963.720.300;Transforming Growth Factor beta3;D053782
D12.776.467.374.687.300;Transforming Growth Factor beta3;D053782
D12.776.467.942.800.720.300;Transforming Growth Factor beta3;D053782
D12.776.467.960.720.300;Transforming Growth Factor beta3;D053782
D23.529.942.800.720.300;Transforming Growth Factor beta3;D053782
D23.529.960.720.300;Transforming Growth Factor beta3;D053782
E01.370.350.500.755;Magnetic Resonance Imaging, Interventional;D053783
E04.800.515;Magnetic Resonance Imaging, Interventional;D053783
E01.370.370.380.487;Magnetocardiography;D053798
E01.370.405.435;Magnetocardiography;D053798
E05.540.249;Magnetocardiography;D053798
D02.886.640.074;2-Pyridinylmethylsulfinylbenzimidazoles;D053799
D03.383.725.024;2-Pyridinylmethylsulfinylbenzimidazoles;D053799
D03.438.103.034;2-Pyridinylmethylsulfinylbenzimidazoles;D053799
D05.750.078.593.450.074;beta-Keratins;D053800
D12.776.220.475.450.074;beta-Keratins;D053800
D12.776.860.607.074;beta-Keratins;D053800
E05.196.181.400.150;Capillary Electrochromatography;D053801
E05.196.401.190.249;Capillary Electrochromatography;D053801
E05.301.300.190.500;Capillary Electrochromatography;D053801
D08.811.277.656.300.760.902;Tryptases;D053802
D08.811.277.656.959.350.902;Tryptases;D053802
H02.403.330.149;Forensic Genetics;D053803
I01.198.780.937.441;Forensic Genetics;D053803
D08.811.277.656.300.760.397;Granzymes;D053804
D08.811.277.656.959.350.397;Granzymes;D053804
G09.330.190.163.324.500;Fractional Flow Reserve, Myocardial;D053805
D08.811.277.656.300.760.103;Chymases;D053818
D08.811.277.656.959.350.103;Chymases;D053818
B01.050.150.900.649.801.400.600.075.075;Atelinae;D053819
B01.050.150.900.649.801.400.600.575;Pitheciidae;D053820
C01.539.190;Cardiovascular Infections;D053821
C14.260;Cardiovascular Infections;D053821
B01.050.150.900.649.147.050;Ailuridae;D053822
D12.644.276.671;Hedgehog Proteins;D053823
D12.776.467.671;Hedgehog Proteins;D053823
D23.529.671;Hedgehog Proteins;D053823
D08.811.277.352.650.775.300.600;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
D08.811.277.352.650.775.700.200;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
D12.644.360.585.600;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
D12.644.360.800.200;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
D12.776.476.564.600;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
D12.776.476.800.200;Protein Tyrosine Phosphatase, Non-Receptor Type 6;D053824
E07.695.752;Suburethral Slings;D053825
B01.050.150.900.649.147.320;Eupleridae;D053826
B01.050.150.900.649.147.575;Nandiniidae;D053827
E07.101.400.500;Stockings, Compression;D053828
D08.811.277.656.300.032;Amyloid Precursor Protein Secretases;D053829
D12.776.964.970.700;Plant Viral Movement Proteins;D053830
E07.858.690;Surgical Fixation Devices;D053831
E07.858.690.800;Surgical Tape;D053832
G16.500.275.960;Wetlands;D053833
N06.230.124.625;Wetlands;D053833
D27.720.317;Explosive Agents;D053834
D25.479.517.500;Unilamellar Liposomes;D053835
J01.637.051.479.517.500;Unilamellar Liposomes;D053835
J01.637.087.500.517.500;Unilamellar Liposomes;D053835
C23.550.717.273;DNA Degradation, Necrotic;D053836
G04.299.139.638.200;DNA Degradation, Necrotic;D053836
G05.355.180.220;DNA Degradation, Necrotic;D053836
G02.111.087.217;DNA Cleavage;D053837
G02.149.115.217;DNA Cleavage;D053837
G05.355.142;DNA Cleavage;D053837
E05.196.822.830;Scattering, Small Angle;D053838
G01.595.861.755;Scattering, Small Angle;D053838
B04.280.350.100;Begomovirus;D053839
B04.715.270.100;Begomovirus;D053839
C14.280.067.322;Brugada Syndrome;D053840
C16.320.100;Brugada Syndrome;D053840
E05.196.385;Electroosmosis;D053841
E05.301.270;Electroosmosis;D053841
G02.149.535.250;Electroosmosis;D053841
G02.149.767.645.250;Electroosmosis;D053841
G02.685.495.250;Electroosmosis;D053841
G02.842.700.495.250;Electroosmosis;D053841
G02.842.750.645.250;Electroosmosis;D053841
C23.550.362.590;Microsatellite Instability;D053842
G05.365.590.335.590;Microsatellite Instability;D053842
G05.370.590;Microsatellite Instability;D053842
G02.111.087.219.220;DNA Mismatch Repair;D053843
G02.149.115.219.220;DNA Mismatch Repair;D053843
G05.355.195.220;DNA Mismatch Repair;D053843
E07.632.490.490;Lasers, Solid-State;D053844
E07.710.520.490;Lasers, Solid-State;D053844
G03.495.553;Metabolic Networks and Pathways;D053858
E04.525.575;Pallidotomy;D053860
D27.888.569.213.444;Hemolytic Agents;D053878
G02.111.087.126;Biosynthetic Pathways;D053898
G02.149.115.126;Biosynthetic Pathways;D053898
G03.495.553.100;Biosynthetic Pathways;D053898
G05.355.180.210.220;DNA Breaks, Double-Stranded;D053903
G05.355.180.210.230;DNA Breaks, Single-Stranded;D053904
D20.215.894.899.498;Papillomavirus Vaccines;D053918
G05.355.180.230;DNA Fragmentation;D053938
B01.650.940.800.575.100.928.374;Dipterocarpaceae;D053958
D04.345.566.050.111;Alpha-Amanitin;D053959
D12.644.456.050.111;Alpha-Amanitin;D053959
D12.644.641.050.111;Alpha-Amanitin;D053959
D23.946.587.175.111;Alpha-Amanitin;D053959
G05.355.180.210;DNA Breaks;D053960
D02.145.074;Azabicyclo Compounds;D053961
D04.075.080.875.099;Azabicyclo Compounds;D053961
D02.455.849.919.530;Pentacyclic Triterpenes;D053978
B01.650.940.800.575.100.401.184;Cyclopia Plant;D053998
C04.557.665.560.700;Nevus, Sebaceous of Jadassohn;D054000
C10.562.700;Nevus, Sebaceous of Jadassohn;D054000
C16.131.077.633;Nevus, Sebaceous of Jadassohn;D054000
E07.632.490.244;Lasers, Excimer;D054018
E07.710.520.244;Lasers, Excimer;D054018
C20.608;Immune Reconstitution Inflammatory Syndrome;D054019
E07.632.490.367;Lasers, Gas;D054020
E07.710.520.367;Lasers, Gas;D054020
A08.186.211.730.885.287;Cerebrum;D054022
E07.632.490.480;Lasers, Semiconductor;D054023
E07.710.520.480;Lasers, Semiconductor;D054023
A08.186.211.865.467;Myelencephalon;D054024
E07.632.490.230;Lasers, Dye;D054025
E07.710.520.230;Lasers, Dye;D054025
C10.228.140.631.500.500;Posterior Leukoencephalopathy Syndrome;D054038
C10.228.140.695.875;Posterior Leukoencephalopathy Syndrome;D054038
C10.228.518.875;Posterior Leukoencephalopathy Syndrome;D054038
C17.800.529.478;Onycholysis;D054039
J01.637.870;Weapons;D054041
J01.637.870.175;Bombs;D054042
J01.637.870.575;Nuclear Weapons;D054043
J01.637.870.900.575;Nuclear Weapons;D054043
J01.637.870.900;Weapons of Mass Destruction;D054044
D20.215.226;Biological Warfare Agents;D054045
J01.637.870.125;Biological Warfare Agents;D054045
J01.637.870.900.100;Biological Warfare Agents;D054045
A18.024.750.650;Plant Stomata;D054046
A18.024.812.650;Plant Stomata;D054046
A10.850.720;Surgical Stomas;D054047
A01.923.047.025.600.700;Peritoneal Stomata;D054048
A10.810;Peritoneal Stomata;D054048
C14.280.647.124;Acute Coronary Syndrome;D054058
C14.280.647.187.074;Acute Coronary Syndrome;D054058
C14.907.585.124;Acute Coronary Syndrome;D054058
C14.907.585.187.074;Acute Coronary Syndrome;D054058
C23.888.646.215.500.074;Acute Coronary Syndrome;D054058
C14.280.647.250.272;Coronary Occlusion;D054059
C14.907.585.250.272;Coronary Occlusion;D054059
C08.381.746.500;Pulmonary Infarction;D054060
C14.907.355.350.700.500;Pulmonary Infarction;D054060
C05.550.323.734;Ischemic Contracture;D054061
C05.651.180.531;Ischemic Contracture;D054061
C05.651.197.734;Ischemic Contracture;D054061
C14.907.303.531;Ischemic Contracture;D054061
C09.218.458.341.186.500;Deaf-Blind Disorders;D054062
C10.597.751.418.341.186.500;Deaf-Blind Disorders;D054062
C10.597.751.941.162.625;Deaf-Blind Disorders;D054062
C11.966.075.375;Deaf-Blind Disorders;D054062
C16.131.077.299;Deaf-Blind Disorders;D054062
C23.888.592.763.393.341.186.500;Deaf-Blind Disorders;D054062
C23.888.592.763.941.162.625;Deaf-Blind Disorders;D054062
A07.231.908.224.667;Superior Sagittal Sinus;D054063
A07.231.908.224.833;Transverse Sinuses;D054064
C04.557.337.428.580.049;Leukemia, Large Granular Lymphocytic;D054066
C15.604.515.560.575.049;Leukemia, Large Granular Lymphocytic;D054066
C20.683.515.528.582.049;Leukemia, Large Granular Lymphocytic;D054066
C16.320.565.798.183;Dihydropyrimidine Dehydrogenase Deficiency;D054067
C18.452.648.798.183;Dihydropyrimidine Dehydrogenase Deficiency;D054067
C14.907.617.625;Livedo Reticularis;D054068
C17.800.862.355;Livedo Reticularis;D054068
C23.888.885.437;Livedo Reticularis;D054068
C16.320.565.100.614;Multiple Acyl Coenzyme A Dehydrogenase Deficiency;D054069
C18.452.648.100.614;Multiple Acyl Coenzyme A Dehydrogenase Deficiency;D054069
C18.452.660.612;Multiple Acyl Coenzyme A Dehydrogenase Deficiency;D054069
C14.907.355.830.925.462;Postthrombotic Syndrome;D054070
C14.907.952.880;Postthrombotic Syndrome;D054070
C10.228.140.163.100.680.430;Mevalonate Kinase Deficiency;D054078
C15.378.147.542.319;Mevalonate Kinase Deficiency;D054078
C16.320.382.750;Mevalonate Kinase Deficiency;D054078
C16.320.565.189.680.430;Mevalonate Kinase Deficiency;D054078
C16.320.565.663.480;Mevalonate Kinase Deficiency;D054078
C18.452.132.100.680.430;Mevalonate Kinase Deficiency;D054078
C18.452.648.189.680.430;Mevalonate Kinase Deficiency;D054078
C18.452.648.663.480;Mevalonate Kinase Deficiency;D054078
C20.683.460.319;Mevalonate Kinase Deficiency;D054078
C14.240.850;Vascular Malformations;D054079
C16.131.240.850;Vascular Malformations;D054079
C10.228.140.300.520.500;Vein of Galen Malformations;D054080
C10.500.190.500.500;Vein of Galen Malformations;D054080
C14.240.850.750.295.500;Vein of Galen Malformations;D054080
C14.240.850.875.500.500;Vein of Galen Malformations;D054080
C14.907.150.295.500;Vein of Galen Malformations;D054080
C14.907.253.560.400.500;Vein of Galen Malformations;D054080
C16.131.240.850.750.295.500;Vein of Galen Malformations;D054080
C16.131.240.850.875.500.500;Vein of Galen Malformations;D054080
C16.131.666.190.500.500;Vein of Galen Malformations;D054080
C10.500.507.750;Neuronal Migration Disorders;D054081
C16.131.666.507.812;Neuronal Migration Disorders;D054081
C10.500.507.249;Lissencephaly;D054082
C16.131.666.507.186;Lissencephaly;D054082
C14.240.400.422;Ectopia Cordis;D054083
C16.131.240.400.422;Ectopia Cordis;D054083
C14.240.400.210.500;Myocardial Bridging;D054084
C14.280.400.210.500;Myocardial Bridging;D054084
C16.131.240.400.210.500;Myocardial Bridging;D054084
A07.541.459.500;Foramen Ovale;D054085
D12.776.157.530.400.600.450.550;KATP Channels;D054086
D12.776.543.550.425.750.450.550;KATP Channels;D054086
D12.776.543.585.400.750.450.550;KATP Channels;D054086
A07.541.459.249;Atrial Septum;D054087
A07.541.459.750;Ventricular Septum;D054088
A07.541.459.374;Endocardial Cushions;D054089
A16.378.303.662;Endocardial Cushions;D054089
C10.500.507.750.750;Periventricular Nodular Heterotopia;D054091
C16.131.666.507.812.750;Periventricular Nodular Heterotopia;D054091
C14.240.400.560.375.258;Foramen Ovale, Patent;D054092
C14.280.400.560.375.258;Foramen Ovale, Patent;D054092
C16.131.240.400.560.375.258;Foramen Ovale, Patent;D054092
C15.378.140.855.850;Thrombocytopenia, Neonatal Alloimmune;D054098
C16.614.899;Thrombocytopenia, Neonatal Alloimmune;D054098
E07.595;Nanospheres;D054118
J01.637.512.600.612;Nanospheres;D054118
C05.660.585.174;Arachnodactyly;D054119
C16.131.621.585.174;Arachnodactyly;D054119
E07.632.500.460.500;Phakic Intraocular Lenses;D054120
C14.280.067.093.500;Sinus Arrest, Cardiac;D054138
C23.550.073.093.500;Sinus Arrest, Cardiac;D054138
C14.280.067.845.787;Tachycardia, Reciprocating;D054139
C23.550.073.845.787;Tachycardia, Reciprocating;D054139
E04.540.825;Refractive Surgical Procedures;D054140
C14.280.067.961;Ventricular Flutter;D054141
C23.550.073.961;Ventricular Flutter;D054141
C14.280.434.676;Heart Failure, Systolic;D054143
C14.280.434.611;Heart Failure, Diastolic;D054144
E02.706;Orthokeratologic Procedures;D054158
G01.374.676.860;Torsion, Mechanical;D054159
G01.595.540.860;Torsion, Mechanical;D054159
C23.888.447.500;Systolic Murmurs;D054160
C14.907.079.500;Angioedemas, Hereditary;D054179
C16.320.078;Angioedemas, Hereditary;D054179
C17.800.862.945.066.500;Angioedemas, Hereditary;D054179
C20.543.480.904.066.500;Angioedemas, Hereditary;D054179
C04.557.337.428.600;Precursor Cell Lymphoblastic Leukemia-Lymphoma;D054198
C15.604.515.560.600;Precursor Cell Lymphoblastic Leukemia-Lymphoma;D054198
C20.683.515.528.600;Precursor Cell Lymphoblastic Leukemia-Lymphoma;D054198
D02.033.100.624.853;Pseudoephedrine;D054199
D02.033.755.624.853;Pseudoephedrine;D054199
D02.092.063.624.788;Pseudoephedrine;D054199
D02.092.471.683.847;Pseudoephedrine;D054199
C04.557.337.428.600.620;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;D054218
C15.604.515.560.600.620;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;D054218
C20.683.515.528.600.620;Precursor T-Cell Lymphoblastic Leukemia-Lymphoma;D054218
C04.557.595;Neoplasms, Plasma Cell;D054219
C10.500.507;Malformations of Cortical Development;D054220
C16.131.666.507;Malformations of Cortical Development;D054220
C10.500.507.249.230;Classical Lissencephalies and Subcortical Band Heterotopias;D054221
C10.500.507.750.230;Classical Lissencephalies and Subcortical Band Heterotopias;D054221
C16.131.666.507.186.230;Classical Lissencephalies and Subcortical Band Heterotopias;D054221
C16.131.666.507.812.230;Classical Lissencephalies and Subcortical Band Heterotopias;D054221
C16.320.322.500.186;Classical Lissencephalies and Subcortical Band Heterotopias;D054221
C10.500.507.249.249;Cobblestone Lissencephaly;D054222
C10.500.507.750.249;Cobblestone Lissencephaly;D054222
C16.131.666.507.186.249;Cobblestone Lissencephaly;D054222
C16.131.666.507.812.249;Cobblestone Lissencephaly;D054222
E05.318.308.985.550.700;Perinatal Mortality;D054238
L01.280.975.550.700;Perinatal Mortality;D054238
N01.224.935.698.739;Perinatal Mortality;D054238
N06.850.505.400.975.550.700;Perinatal Mortality;D054238
N06.850.520.308.985.550.700;Perinatal Mortality;D054238
A16.331.042;Blastodisc;D054239
A16.830;Primitive Streak;D054240
M01.189;Emigrants and Immigrants;D054242
C02.782.580.830.825;Vesicular Stomatitis;D054243
C07.465.864.968;Vesicular Stomatitis;D054243
C22.952;Vesicular Stomatitis;D054243
A16.629;Neural Plate;D054258
A16.630;Neural Tube;D054259
B04.820.455.750.900.910;Vesicular stomatitis New Jersey virus;D054260
B04.909.777.455.750.900.910;Vesicular stomatitis New Jersey virus;D054260
G07.700.320.500.325.180.875;Neurulation;D054261
G07.700.320.500.325.180.812;Gastrulation;D054262
A11.251.860.590;Embryonal Carcinoma Stem Cells;D054278
A11.872.190.500;Embryonal Carcinoma Stem Cells;D054278
A11.872.650.500;Embryonal Carcinoma Stem Cells;D054278
D12.776.964.775.562;Human Immunodeficiency Virus Proteins;D054298
D12.776.964.775.325.164;env Gene Products, Human Immunodeficiency Virus;D054299
D12.776.964.775.562.500;env Gene Products, Human Immunodeficiency Virus;D054299
D12.776.964.970.880.325.164;env Gene Products, Human Immunodeficiency Virus;D054299
B03.280.612;Oscillatoria;D054300
B03.440.475.100.612;Oscillatoria;D054300
D12.776.775.330.650;gag Gene Products, Human Immunodeficiency Virus;D054301
D12.776.964.775.350.362;gag Gene Products, Human Immunodeficiency Virus;D054301
D12.776.964.775.562.750;gag Gene Products, Human Immunodeficiency Virus;D054301
D12.776.964.970.600.850.350.362;gag Gene Products, Human Immunodeficiency Virus;D054301
D12.776.775.360.650;pol Gene Products, Human Immunodeficiency Virus;D054302
D12.776.964.775.375.545;pol Gene Products, Human Immunodeficiency Virus;D054302
D12.776.964.775.562.875;pol Gene Products, Human Immunodeficiency Virus;D054302
D12.776.964.970.600.850.375.545;pol Gene Products, Human Immunodeficiency Virus;D054302
D08.811.913.696.445.308.300.750.187;HIV Reverse Transcriptase;D054303
D12.776.964.775.375.545.875;HIV Reverse Transcriptase;D054303
D12.776.964.775.375.750.187;HIV Reverse Transcriptase;D054303
D12.776.964.775.562.875.875;HIV Reverse Transcriptase;D054303
D12.776.964.970.600.850.375.545.875;HIV Reverse Transcriptase;D054303
D12.776.964.970.600.850.375.750.187;HIV Reverse Transcriptase;D054303
D06.472.334.984.500;Anti-Mullerian Hormone;D054304
D13.695.225;Dideoxynucleotides;D054306
B03.440.450.425.325.300.340;Enterotoxigenic Escherichia coli;D054307
B03.660.250.150.180.100.340;Enterotoxigenic Escherichia coli;D054307
B03.440.450.425.325.300.330;Enteropathogenic Escherichia coli;D054308
B03.660.250.150.180.100.330;Enteropathogenic Escherichia coli;D054308
D08.811.277.352.355.350.700.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D08.811.277.352.700.350.700.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D12.776.964.775.375.545.875.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D12.776.964.775.562.875.875.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D12.776.964.970.600.850.375.545.875.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D12.776.964.970.600.850.375.750.187.500;Ribonuclease H, Human Immunodeficiency Virus;D054309
D12.776.964.775.362.500;nef Gene Products, Human Immunodeficiency Virus;D054311
D12.776.964.775.562.760;nef Gene Products, Human Immunodeficiency Virus;D054311
D12.776.964.925.500.500;nef Gene Products, Human Immunodeficiency Virus;D054311
C01.252.410.040.552.475.247;Buruli Ulcer;D054312
C17.800.893.295;Buruli Ulcer;D054312
C23.996.100;Buruli Ulcer;D054312
G07.690.812.240.154;Drug Agonism;D054313
G07.700.680.240.154;Drug Agonism;D054313
G07.690.812.240.393;Drug Inverse Agonism;D054314
G07.700.680.240.393;Drug Inverse Agonism;D054314
E02.875.800.976;Oocyte Retrieval;D054315
E04.936.537.625;Oocyte Retrieval;D054315
E05.820.800.976;Oocyte Retrieval;D054315
D23.101.137;Biomarkers, Pharmacological;D054316
C14.907.585.500.562;No-Reflow Phenomenon;D054318
C23.550.513.677;No-Reflow Phenomenon;D054318
C10.228.140.163.510;Marchiafava-Bignami Disease;D054319
C10.314.475;Marchiafava-Bignami Disease;D054319
D12.776.964.775.468.500;vif Gene Products, Human Immunodeficiency Virus;D054320
D12.776.964.775.562.781;vif Gene Products, Human Immunodeficiency Virus;D054320
D12.776.964.925.875.500;vif Gene Products, Human Immunodeficiency Virus;D054320
D12.776.157.725.076.500;rev Gene Products, Human Immunodeficiency Virus;D054321
D12.776.664.962.186.500;rev Gene Products, Human Immunodeficiency Virus;D054321
D12.776.964.775.562.765;rev Gene Products, Human Immunodeficiency Virus;D054321
D12.776.964.925.984.385.500;rev Gene Products, Human Immunodeficiency Virus;D054321
D12.776.260.755.199.500;tat Gene Products, Human Immunodeficiency Virus;D054322
D12.776.930.900.199.500;tat Gene Products, Human Immunodeficiency Virus;D054322
D12.776.964.775.562.773;tat Gene Products, Human Immunodeficiency Virus;D054322
D12.776.964.925.984.400.500;tat Gene Products, Human Immunodeficiency Virus;D054322
B03.440.450.425.325.300.800;Shiga-Toxigenic Escherichia coli;D054323
B03.660.250.150.180.100.800;Shiga-Toxigenic Escherichia coli;D054323
B03.440.450.425.325.300.800.250;Enterohemorrhagic Escherichia coli;D054324
B03.660.250.150.180.100.800.250;Enterohemorrhagic Escherichia coli;D054324
D12.776.964.775.562.937;vpr Gene Products, Human Immunodeficiency Virus;D054325
D12.776.964.925.984.430.500;vpr Gene Products, Human Immunodeficiency Virus;D054325
A07.231.908.194.500;Coronary Sinus;D054326
D27.720.556;Lubricants;D054327
D27.505.519.389.848;Proton Pump Inhibitors;D054328
D09.546.142;Carbasugars;D054329
D09.546.849;Thiosugars;D054330
C12.294.365.700.754;Sertoli Cell-Only Syndrome;D054331
D20.215.894.582.480;Leishmaniasis Vaccines;D054332
G07.690.812.240.154.500;Drug Partial Agonism;D054333
G07.700.680.240.154.500;Drug Partial Agonism;D054333
D12.776.964.925;Viral Regulatory and Accessory Proteins;D054334
B01.650.940.800.575.100.065.812;Goniothalamus;D054335
B01.650.940.800.575.100.065.992;Xylopia;D054336
G04.299.145;Cell Dedifferentiation;D054337
G04.299.335;Cell Transdifferentiation;D054338
D12.776.260.698.925;Steroidogenic Factor 1;D054339
D12.776.826.925;Steroidogenic Factor 1;D054339
D12.776.930.669.925;Steroidogenic Factor 1;D054339
D12.776.543.750.705.895.500;Receptors, KIR;D054340
D12.776.543.750.705.895.500.500;Receptors, KIR3DL1;D054341
D23.050.301.264.035.848;Receptors, KIR3DL1;D054341
D23.101.100.110.848;Receptors, KIR3DL1;D054341
D12.776.543.750.705.895.500.249;Receptors, KIR2DL1;D054342
D23.050.301.264.035.835;Receptors, KIR2DL1;D054342
D23.101.100.110.835;Receptors, KIR2DL1;D054342
D12.776.543.750.705.895.500.374;Receptors, KIR2DL2;D054343
D23.050.301.264.035.838;Receptors, KIR2DL2;D054343
D23.101.100.110.838;Receptors, KIR2DL2;D054343
D12.776.543.750.705.895.500.437;Receptors, KIR2DL3;D054344
D23.050.301.264.035.842;Receptors, KIR2DL3;D054344
D23.101.100.110.842;Receptors, KIR2DL3;D054344
D12.776.543.750.705.895.500.468;Receptors, KIR2DL4;D054345
D23.050.301.264.035.846;Receptors, KIR2DL4;D054345
D23.101.100.110.846;Receptors, KIR2DL4;D054345
D12.776.543.750.705.895.500.484;Receptors, KIR2DL5;D054346
D12.776.543.750.705.895.500.750;Receptors, KIR3DL2;D054347
D23.050.301.264.035.849;Receptors, KIR3DL2;D054347
D23.101.100.110.849;Receptors, KIR3DL2;D054347
D12.776.543.750.705.895.500.890;Receptors, KIR3DS1;D054349
A08.850.180;Electrical Synapses;D054351
A11.284.149.165.420.471.180;Electrical Synapses;D054351
A11.284.149.165.420.780.180;Electrical Synapses;D054351
D12.776.543.695.875;Perforin;D054353
D01.490.500;Iron Carbonyl Compounds;D054354
D02.691.550.500;Iron Carbonyl Compounds;D054354
D12.644.276.374.200.120.500;Chemokine CXCL10;D054357
D12.776.467.374.200.120.500;Chemokine CXCL10;D054357
D23.125.300.120.500;Chemokine CXCL10;D054357
D23.469.200.120.500;Chemokine CXCL10;D054357
D23.529.374.200.120.500;Chemokine CXCL10;D054357
D04.808.247.222.537.888;Withanolides;D054358
D04.808.247.808.756.287.888;Withanolides;D054358
D12.644.276.374.200.120.050;Chemokine CXCL1;D054360
D12.776.467.374.200.120.050;Chemokine CXCL1;D054360
D12.776.624.664.700.049;Chemokine CXCL1;D054360
D23.125.300.120.050;Chemokine CXCL1;D054360
D23.469.200.120.050;Chemokine CXCL1;D054360
D23.529.374.200.120.050;Chemokine CXCL1;D054360
D02.092.146.307;Fenamates;D054361
D02.241.223.100.050.400.200;Fenamates;D054361
D02.455.426.559.389.127.020.906.750;Fenamates;D054361
B01.650.940.800.575.100.065.781;Cananga;D054362
C04.557.450.565.590.797.750;Solitary Fibrous Tumor, Pleural;D054363
C04.588.894.797.640.800;Solitary Fibrous Tumor, Pleural;D054363
C04.557.450.565.590.797;Solitary Fibrous Tumors;D054364
D12.644.276.374.200.120.250;Chemokine CXCL5;D054365
D12.776.467.374.200.120.250;Chemokine CXCL5;D054365
D23.125.300.120.250;Chemokine CXCL5;D054365
D23.469.200.120.250;Chemokine CXCL5;D054365
D23.529.374.200.120.250;Chemokine CXCL5;D054365
D12.644.276.049;Agouti Signaling Protein;D054366
D12.776.467.049;Agouti Signaling Protein;D054366
D23.529.049;Agouti Signaling Protein;D054366
D12.776.543.750.100.160.500.300;Receptors, CXCR3;D054367
D12.776.543.750.705.852.125.500.300;Receptors, CXCR3;D054367
D23.050.301.264.035.605.500.300;Receptors, CXCR3;D054367
D23.101.100.110.605.500.300;Receptors, CXCR3;D054367
D27.505.954.483.620;Laxatives;D054368
D12.644.276.074;Agouti-Related Protein;D054369
D12.776.467.074;Agouti-Related Protein;D054369
D23.529.074;Agouti-Related Protein;D054369
D12.644.276.374.200.120.450;Chemokine CXCL9;D054370
D12.776.467.374.200.120.450;Chemokine CXCL9;D054370
D23.125.300.120.450;Chemokine CXCL9;D054370
D23.469.200.120.450;Chemokine CXCL9;D054370
D23.529.374.200.120.450;Chemokine CXCL9;D054370
D12.644.276.374.200.120.550;Chemokine CXCL11;D054371
D12.776.467.374.200.120.550;Chemokine CXCL11;D054371
D23.125.300.120.550;Chemokine CXCL11;D054371
D23.469.200.120.550;Chemokine CXCL11;D054371
D23.529.374.200.120.550;Chemokine CXCL11;D054371
D12.644.276.374.200.120.600;Chemokine CXCL12;D054377
D12.776.467.374.200.120.600;Chemokine CXCL12;D054377
D23.125.300.120.600;Chemokine CXCL12;D054377
D23.469.200.120.600;Chemokine CXCL12;D054377
D23.529.374.200.120.600;Chemokine CXCL12;D054377
D02.033.415.054;Acetogenins;D054378
D02.455.326.146.049;Acetogenins;D054378
D02.540.205;Acetogenins;D054378
D03.383.312.200;Acetogenins;D054378
D10.289.054;Acetogenins;D054378
D12.776.543.750.100.160.500.500;Receptors, CXCR5;D054380
D12.776.543.750.705.852.125.500.500;Receptors, CXCR5;D054380
D23.050.301.264.035.605.500.500;Receptors, CXCR5;D054380
D23.101.100.110.605.500.500;Receptors, CXCR5;D054380
D12.644.276.374.200.120.650;Chemokine CXCL13;D054382
D12.776.467.374.200.120.650;Chemokine CXCL13;D054382
D23.125.300.120.650;Chemokine CXCL13;D054382
D23.469.200.120.650;Chemokine CXCL13;D054382
D23.529.374.200.120.650;Chemokine CXCL13;D054382
D12.776.543.750.100.160.500;Receptors, CXCR;D054387
D12.776.543.750.705.852.125.500;Receptors, CXCR;D054387
D23.050.301.264.035.605.500;Receptors, CXCR;D054387
D23.101.100.110.605.500;Receptors, CXCR;D054387
D12.776.543.750.100.160.150;Receptors, CCR;D054388
D12.776.543.750.705.852.125.150;Receptors, CCR;D054388
D23.050.301.264.035.605.150;Receptors, CCR;D054388
D23.101.100.110.605.150;Receptors, CCR;D054388
D12.776.543.750.100.160.150.100;Receptors, CCR1;D054389
D12.776.543.750.705.852.125.150.100;Receptors, CCR1;D054389
D23.050.301.264.035.605.150.100;Receptors, CCR1;D054389
D23.101.100.110.605.150.100;Receptors, CCR1;D054389
D12.776.543.750.100.160.150.200;Receptors, CCR2;D054390
D12.776.543.750.705.852.125.150.200;Receptors, CCR2;D054390
D23.050.301.264.035.605.150.200;Receptors, CCR2;D054390
D23.101.100.110.605.150.200;Receptors, CCR2;D054390
C04.557.386.480.750.199;Lymphoma, Extranodal NK-T-Cell;D054391
D06.472.699.042;Adipokines;D054392
D12.644.276.024;Adipokines;D054392
D12.644.548.011;Adipokines;D054392
D12.776.467.024;Adipokines;D054392
D23.529.024;Adipokines;D054392
D12.776.543.750.100.160.150.300;Receptors, CCR3;D054397
D12.776.543.750.705.852.125.150.300;Receptors, CCR3;D054397
D23.050.301.264.035.605.150.300;Receptors, CCR3;D054397
D23.101.100.110.605.150.300;Receptors, CCR3;D054397
D12.776.543.750.100.160.150.400;Receptors, CCR4;D054398
D12.776.543.750.705.852.125.150.400;Receptors, CCR4;D054398
D23.050.301.264.035.605.150.400;Receptors, CCR4;D054398
D23.101.100.110.605.150.400;Receptors, CCR4;D054398
D12.776.543.750.100.160.150.600;Receptors, CCR6;D054399
D12.776.543.750.705.852.125.150.600;Receptors, CCR6;D054399
D23.050.301.264.035.605.150.600;Receptors, CCR6;D054399
D23.101.100.110.605.150.600;Receptors, CCR6;D054399
D12.776.543.750.100.160.150.700;Receptors, CCR7;D054400
D12.776.543.750.705.852.125.150.700;Receptors, CCR7;D054400
D23.050.301.264.035.605.150.700;Receptors, CCR7;D054400
D23.101.100.110.605.150.700;Receptors, CCR7;D054400
D12.776.543.750.100.160.150.800;Receptors, CCR8;D054401
D12.776.543.750.705.852.125.150.800;Receptors, CCR8;D054401
D23.050.301.264.035.605.150.800;Receptors, CCR8;D054401
D23.101.100.110.605.150.800;Receptors, CCR8;D054401
D12.644.276.374.200.110.050;Chemokine CCL1;D054402
D12.776.467.374.200.110.050;Chemokine CCL1;D054402
D23.125.300.110.050;Chemokine CCL1;D054402
D23.469.200.110.050;Chemokine CCL1;D054402
D23.529.374.200.110.050;Chemokine CCL1;D054402
C04.557.337.428.080.562;Leukemia, Prolymphocytic, B-Cell;D054403
C04.557.337.428.565.745;Leukemia, Prolymphocytic, B-Cell;D054403
C15.604.515.560.080.562;Leukemia, Prolymphocytic, B-Cell;D054403
C15.604.515.560.550.745;Leukemia, Prolymphocytic, B-Cell;D054403
C20.683.515.528.080.562;Leukemia, Prolymphocytic, B-Cell;D054403
C20.683.515.528.565.745;Leukemia, Prolymphocytic, B-Cell;D054403
D12.644.276.374.200.110.150;Chemokine CCL3;D054405
D12.644.276.374.200.600.150;Chemokine CCL3;D054405
D12.776.467.374.200.110.150;Chemokine CCL3;D054405
D12.776.467.374.200.600.150;Chemokine CCL3;D054405
D23.125.300.110.150;Chemokine CCL3;D054405
D23.125.300.600.500;Chemokine CCL3;D054405
D23.469.200.110.150;Chemokine CCL3;D054405
D23.469.200.600.150;Chemokine CCL3;D054405
D23.529.374.200.110.150;Chemokine CCL3;D054405
D23.529.374.200.600.150;Chemokine CCL3;D054405
D20.215.894.135.620;Pseudomonas Vaccines;D054406
D12.644.276.374.200.110.200;Chemokine CCL4;D054407
D12.644.276.374.200.600.200;Chemokine CCL4;D054407
D12.776.467.374.200.110.200;Chemokine CCL4;D054407
D12.776.467.374.200.600.200;Chemokine CCL4;D054407
D23.125.300.110.200;Chemokine CCL4;D054407
D23.125.300.600.750;Chemokine CCL4;D054407
D23.469.200.110.200;Chemokine CCL4;D054407
D23.529.374.200.110.200;Chemokine CCL4;D054407
D23.529.374.200.600.200;Chemokine CCL4;D054407
D08.811.913.400.725.575;Nicotinamide Phosphoribosyltransferase;D054409
D12.644.276.374.200.110.990.800;Chemokine CCL7;D054410
D12.776.467.374.200.110.990.800;Chemokine CCL7;D054410
D23.125.300.110.990.800;Chemokine CCL7;D054410
D23.469.200.110.990.800;Chemokine CCL7;D054410
D23.529.374.200.110.990.750;Chemokine CCL7;D054410
D12.776.543.750.065.500;Receptors, Leptin;D054411
D12.644.276.374.200.110.990.900;Chemokine CCL8;D054412
D12.776.467.374.200.110.990.900;Chemokine CCL8;D054412
D23.125.300.110.990.900;Chemokine CCL8;D054412
D23.469.200.110.990.900;Chemokine CCL8;D054412
D23.529.374.200.110.990.875;Chemokine CCL8;D054412
D12.644.276.374.200.110.550;Chemokine CCL11;D054413
D12.776.467.374.200.110.550;Chemokine CCL11;D054413
D23.125.300.110.550;Chemokine CCL11;D054413
D23.469.200.110.550;Chemokine CCL11;D054413
D23.529.374.200.110.550;Chemokine CCL11;D054413
D12.644.276.374.200.110.850;Chemokine CCL17;D054414
D12.776.467.374.200.110.850;Chemokine CCL17;D054414
D23.125.300.110.850;Chemokine CCL17;D054414
D23.469.200.110.850;Chemokine CCL17;D054414
D23.529.374.200.110.850;Chemokine CCL17;D054414
D12.644.276.374.200.110.870;Chemokine CCL19;D054415
D12.644.276.374.200.600.870;Chemokine CCL19;D054415
D12.776.467.374.200.110.870;Chemokine CCL19;D054415
D12.776.467.374.200.600.870;Chemokine CCL19;D054415
D23.125.300.110.870;Chemokine CCL19;D054415
D23.125.300.600.870;Chemokine CCL19;D054415
D23.469.200.110.870;Chemokine CCL19;D054415
D23.469.200.600.870;Chemokine CCL19;D054415
D23.529.374.200.110.870;Chemokine CCL19;D054415
D23.529.374.200.600.870;Chemokine CCL19;D054415
D12.776.543.750.065;Receptors, Adipokine;D054417
D12.644.276.374.200.110.880;Chemokine CCL20;D054418
D12.644.276.374.200.600.880;Chemokine CCL20;D054418
D12.776.467.374.200.110.880;Chemokine CCL20;D054418
D12.776.467.374.200.600.880;Chemokine CCL20;D054418
D23.125.300.110.880;Chemokine CCL20;D054418
D23.125.300.600.880;Chemokine CCL20;D054418
D23.469.200.110.880;Chemokine CCL20;D054418
D23.469.200.600.880;Chemokine CCL20;D054418
D23.529.374.200.110.880;Chemokine CCL20;D054418
D23.529.374.200.600.880;Chemokine CCL20;D054418
D12.776.543.750.065.249;Receptors, Adiponectin;D054419
D12.776.124.486.485.950.750;Pre-B Cell Receptors;D054420
D12.776.124.790.651.950.750;Pre-B Cell Receptors;D054420
D12.776.377.715.548.950.750;Pre-B Cell Receptors;D054420
D12.776.543.750.705.816.821.750;Pre-B Cell Receptors;D054420
D12.644.276.374.200.110.890;Chemokine CCL21;D054421
D12.776.467.374.200.110.890;Chemokine CCL21;D054421
D23.125.300.110.890;Chemokine CCL21;D054421
D23.469.200.110.890;Chemokine CCL21;D054421
D23.529.374.200.110.890;Chemokine CCL21;D054421
D12.644.276.374.200.110.900;Chemokine CCL22;D054422
D12.776.467.374.200.110.900;Chemokine CCL22;D054422
D23.125.300.110.900;Chemokine CCL22;D054422
D23.469.200.110.900;Chemokine CCL22;D054422
D23.529.374.200.110.900;Chemokine CCL22;D054422
D12.644.276.374.200.110.910;Chemokine CCL24;D054423
D12.776.467.374.200.110.910;Chemokine CCL24;D054423
D23.125.300.110.910;Chemokine CCL24;D054423
D23.469.200.110.910;Chemokine CCL24;D054423
D23.529.374.200.110.910;Chemokine CCL24;D054423
D12.644.276.374.200.110.930;Chemokine CCL27;D054425
D12.776.467.374.200.110.930;Chemokine CCL27;D054425
D23.125.300.110.930;Chemokine CCL27;D054425
D23.469.200.110.930;Chemokine CCL27;D054425
D23.529.374.200.110.930;Chemokine CCL27;D054425
D12.644.276.374.200.120.100;Chemokine CXCL2;D054426
D12.644.276.374.200.600.940;Chemokine CXCL2;D054426
D12.776.467.374.200.120.100;Chemokine CXCL2;D054426
D12.776.467.374.200.600.940;Chemokine CXCL2;D054426
D23.125.300.120.100;Chemokine CXCL2;D054426
D23.125.300.600.940;Chemokine CXCL2;D054426
D23.469.200.120.100;Chemokine CXCL2;D054426
D23.469.200.600.940;Chemokine CXCL2;D054426
D23.529.374.200.120.100;Chemokine CXCL2;D054426
D23.529.374.200.600.940;Chemokine CXCL2;D054426
D12.644.276.374.200.120.300;Chemokine CXCL6;D054427
D12.776.467.374.200.120.300;Chemokine CXCL6;D054427
D23.125.300.120.300;Chemokine CXCL6;D054427
D23.469.200.120.300;Chemokine CXCL6;D054427
D23.529.374.200.120.300;Chemokine CXCL6;D054427
D12.644.276.374.200.130.500;Chemokine CX3CL1;D054428
D12.776.467.374.200.130.500;Chemokine CX3CL1;D054428
D12.776.543.193;Chemokine CX3CL1;D054428
D23.125.300.130.500;Chemokine CX3CL1;D054428
D23.469.200.130.500;Chemokine CX3CL1;D054428
D23.529.374.200.130.500;Chemokine CX3CL1;D054428
C04.557.337.539.525;Leukemia, Myelomonocytic, Juvenile;D054429
C15.378.190.615.520;Leukemia, Myelomonocytic, Juvenile;D054429
C15.378.190.615;Myelodysplastic-Myeloproliferative Diseases;D054437
C04.557.337.539.300;Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative;D054438
C15.378.190.615.500;Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative;D054438
D06.472.699.301;Ghrelin;D054439
D12.644.548.322;Ghrelin;D054439
D12.776.543.750.100.322;Receptors, Ghrelin;D054440
E01.370.225.500.335.500;Cell Migration Assays, Leukocyte;D054441
E01.370.225.812.125.500;Cell Migration Assays, Leukocyte;D054441
E05.200.500.335.500;Cell Migration Assays, Leukocyte;D054441
E05.200.812.125.500;Cell Migration Assays, Leukocyte;D054441
E05.242.335.500;Cell Migration Assays, Leukocyte;D054441
E05.478.594.122.500;Cell Migration Assays, Leukocyte;D054441
E01.370.225.500.335.750;Cell Migration Assays, Macrophage;D054442
E01.370.225.812.125.750;Cell Migration Assays, Macrophage;D054442
E05.200.500.335.750;Cell Migration Assays, Macrophage;D054442
E05.200.812.125.750;Cell Migration Assays, Macrophage;D054442
E05.242.335.750;Cell Migration Assays, Macrophage;D054442
E05.478.594.122.750;Cell Migration Assays, Macrophage;D054442
E01.370.225.500.335;Cell Migration Assays;D054443
E01.370.225.812.125;Cell Migration Assays;D054443
E05.200.500.335;Cell Migration Assays;D054443
E05.200.812.125;Cell Migration Assays;D054443
E05.242.335;Cell Migration Assays;D054443
E05.478.594.122;Cell Migration Assays;D054443
D12.776.124.486.485.705.750.775;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.124.486.485.950.750.500;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.124.790.651.705.750.775;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.124.790.651.950.750.500;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.377.715.548.705.750.775;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.377.715.548.950.750.500;Immunoglobulin Light Chains, Surrogate;D054444
D12.776.543.750.705.816.821.750.500;Immunoglobulin Light Chains, Surrogate;D054444
E04.936.450.262;Facial Transplantation;D054445
C04.557.386.480.750.800.507;Lymphoma, Primary Cutaneous Anaplastic Large Cell;D054446
C15.604.515.569.480.750.800.507;Lymphoma, Primary Cutaneous Anaplastic Large Cell;D054446
C20.683.515.761.480.750.800.507;Lymphoma, Primary Cutaneous Anaplastic Large Cell;D054446
D12.776.543.750.100.160.150.950;Receptors, CCR10;D054447
D12.776.543.750.705.852.125.150.950;Receptors, CCR10;D054447
D23.050.301.264.035.605.150.950;Receptors, CCR10;D054447
D23.101.100.110.605.150.950;Receptors, CCR10;D054447
A11.118.637.555.567.562.440;Precursor Cells, B-Lymphoid;D054448
A11.148.378.294.374;Precursor Cells, B-Lymphoid;D054448
A11.872.378.294.500;Precursor Cells, B-Lymphoid;D054448
E07.206.627;Tissue Scaffolds;D054457
E07.695.825;Tissue Scaffolds;D054457
E05.393.290.382;Amplified Fragment Length Polymorphism Analysis;D054458
E05.393.620.500.324;Amplified Fragment Length Polymorphism Analysis;D054458
E01.370.350.850.270;Elasticity Imaging Techniques;D054459
D08.811.913.696.620.682.700.814;rho-Associated Kinases;D054460
D12.644.360.590;rho-Associated Kinases;D054460
D12.776.476.595;rho-Associated Kinases;D054460
D08.811.913.696.620.682.700.542;Lim Kinases;D054461
D12.644.360.390;Lim Kinases;D054461
D12.776.476.396;Lim Kinases;D054461
D12.776.512.124;Lim Kinases;D054461
D08.811.913.696.620.682.700.596;p21-Activated Kinases;D054462
D12.644.360.552;p21-Activated Kinases;D054462
D12.776.476.548;p21-Activated Kinases;D054462
C16.131.077.899;Trichothiodystrophy Syndromes;D054463
C16.131.831.874;Trichothiodystrophy Syndromes;D054463
C16.320.850.895;Trichothiodystrophy Syndromes;D054463
C17.800.804.874;Trichothiodystrophy Syndromes;D054463
C17.800.827.895;Trichothiodystrophy Syndromes;D054463
D08.811.682.732.850;Peroxiredoxins;D054464
D08.811.277.352.100.680.750.937.300.500;Peroxiredoxin VI;D054465
D08.811.277.352.100.680.750.937.625.624;Peroxiredoxin VI;D054465
D08.811.682.732.850.500;Peroxiredoxin VI;D054465
D08.811.277.352.100.680.750.875;Phospholipases A1;D054466
D08.811.277.352.100.680.750.937;Phospholipases A2;D054467
A11.284.430.214.190.750.602.309;Axoneme;D054468
D08.811.682.667.084;Glutaredoxins;D054477
D12.776.183.186;Chloroplast Thioredoxins;D054479
D12.776.765.199.186;Chloroplast Thioredoxins;D054479
D12.776.915.249;Chloroplast Thioredoxins;D054479
D12.776.915.624;Thioredoxin h;D054480
D08.811.682.667.750.500;Thioredoxin Reductase 1;D054481
D08.811.682.667.750.750;Thioredoxin Reductase 2;D054482
D08.811.277.352.100.680.750.937.750;Phospholipases A2, Secretory;D054497
D08.811.277.352.100.680.750.937.750.100;Group I Phospholipases A2;D054498
D08.811.277.352.100.680.750.937.750.100.500;Group IA Phospholipases A2;D054499
D08.811.277.352.100.680.750.937.750.100.750;Group IB Phospholipases A2;D054500
D08.811.277.352.100.680.750.937.750.550;Group II Phospholipases A2;D054501
G12.425.901.519.500;Histocompatibility, Maternal-Fetal;D054502
A11.148.378.294;Lymphoid Progenitor Cells;D054503
A11.872.378.294;Lymphoid Progenitor Cells;D054503
A15.378.316.378.550;Lymphoid Progenitor Cells;D054503
A11.118.637.555.567.569.360;Precursor Cells, T-Lymphoid;D054504
A11.148.378.294.750;Precursor Cells, T-Lymphoid;D054504
A11.872.378.294.750;Precursor Cells, T-Lymphoid;D054504
D08.811.277.352.100.680.750.937.750.775;Group V Phospholipases A2;D054505
C17.800.030.575;Chloracne;D054506
C17.800.271.125.800;Chloracne;D054506
D12.776.543.750.783;Receptors, Phospholipase A2;D054507
C26.733.188;Acute Radiation Syndrome;D054508
N06.850.810.300.360.158;Acute Radiation Syndrome;D054508
D08.811.277.352.100.680.750.937.750.887;Group X Phospholipases A2;D054509
D08.811.277.352.100.680.750.937.625;Phospholipases A2, Cytosolic;D054510
D08.811.277.352.100.680.750.937.300;Phospholipases A2, Calcium-Independent;D054512
D08.811.277.352.100.680.750.937.625.249;Group IV Phospholipases A2;D054513
C11.250.616;Persistent Hyperplastic Primary Vitreous;D054514
C16.131.384.725;Persistent Hyperplastic Primary Vitreous;D054514
C13.351.500.944.902.368;Vulvar Vestibulitis;D054515
C11.675.387;Orbital Cellulitis;D054517
C17.300.185.500;Orbital Cellulitis;D054517
F02.463.593.932.145;Attentional Blink;D054518
V02.135;Aphorisms and Proverbs;D054519
D08.811.277.352.100.680.750.937.750.662;Group III Phospholipases A2;D054520
I01.880.143.364;Cultural Competency;D054521
D08.811.277.352.100.680.750.937.300.249;Group VI Phospholipases A2;D054522
M01.135.500;Adult Survivors of Child Abuse;D054523
M01.643.836.199;Adult Survivors of Child Abuse;D054523
N03.219.521.576.343.575.500;Medicare Part D;D054524
N03.219.521.576.343.840.938;Medicare Part D;D054524
N03.706.615.752;Medicare Part D;D054524
N01.400.512;Minority Health;D054525
N01.400.425;Men's Health;D054526
I01.198.240.856.800.537;Mass Casualty Incidents;D054527
I01.880.735.900.800.575;Mass Casualty Incidents;D054527
N06.230.100.160;Mass Casualty Incidents;D054527
C14.280.067.558.230;Atrioventricular Block;D054537
C23.550.073.425.062;Atrioventricular Block;D054537
M01.526.485.810.675;Occupational Health Physicians;D054538
N02.360.810.675;Occupational Health Physicians;D054538
N02.421.668.438;Medication Therapy Management;D054539
N03.219.521.576.343.575.500.500;Medication Therapy Management;D054539
N03.219.521.576.343.840.938.500;Medication Therapy Management;D054539
N04.590.661;Medication Therapy Management;D054539
M01.108;Child, Orphaned;D054540
F01.829.263.370.054;Family Conflict;D054541
F01.829.401.142;Family Conflict;D054541
K01.400.504.984.249;Iraq War, 2003 - 2011;D054542
I01.409.137.500.650;United States Department of Homeland Security;D054543
N03.540.348.500.500.650;United States Department of Homeland Security;D054543
E04.555.110.115;Arthroplasty, Subchondral;D054544
I01.409.137.500.997;United States Office of National Drug Control Policy;D054545
N03.540.348.500.500.997;United States Office of National Drug Control Policy;D054545
C10.228.662.262.249.937;Neuroacanthocytosis;D054546
C16.320.400.550;Neuroacanthocytosis;D054546
I01.409.137.500.600.480.150;National Cancer Institute (U.S.);D054547
N03.540.348.500.500.600.480.150;National Cancer Institute (U.S.);D054547
Z01.542.248.609;Montenegro;D054548
C14.280.945.900.500;Takotsubo Cardiomyopathy;D054549
I01.409.137.500.600.480.200;National Eye Institute (U.S.);D054554
N03.540.348.500.500.600.480.200;National Eye Institute (U.S.);D054554
I01.409.137.500.600.480.300;National Heart, Lung, and Blood Institute (U.S.);D054555
N03.540.348.500.500.600.480.300;National Heart, Lung, and Blood Institute (U.S.);D054555
C14.907.355.590.700;Venous Thromboembolism;D054556
C14.907.355.830.850.700;Venous Thromboembolism;D054556
D08.811.277.352.650.775.400;Receptor-Like Protein Tyrosine Phosphatases;D054557
D12.644.360.587;Receptor-Like Protein Tyrosine Phosphatases;D054557
D12.776.476.592;Receptor-Like Protein Tyrosine Phosphatases;D054557
D12.776.543.733;Receptor-Like Protein Tyrosine Phosphatases;D054557
D08.811.277.352.650.775.300;Protein Tyrosine Phosphatases, Non-Receptor;D054558
D12.644.360.585;Protein Tyrosine Phosphatases, Non-Receptor;D054558
D12.776.476.564;Protein Tyrosine Phosphatases, Non-Receptor;D054558
C18.452.750.199;Hyperphosphatemia;D054559
I01.409.137.500.600.480.325;National Human Genome Research Institute (U.S.);D054560
N03.540.348.500.500.600.480.325;National Human Genome Research Institute (U.S.);D054560
I01.409.137.500.600.480.465;National Institute on Aging (U.S.);D054561
N03.540.348.500.500.600.480.465;National Institute on Aging (U.S.);D054561
D08.811.277.352.650.775.300.100;Protein Tyrosine Phosphatase, Non-Receptor Type 1;D054562
D12.644.360.585.100;Protein Tyrosine Phosphatase, Non-Receptor Type 1;D054562
D12.776.476.564.100;Protein Tyrosine Phosphatase, Non-Receptor Type 1;D054562
I01.409.137.500.600.480.467;National Institute on Alcohol Abuse and Alcoholism (U.S.);D054563
N03.540.348.500.500.600.480.467;National Institute on Alcohol Abuse and Alcoholism (U.S.);D054563
I01.409.137.500.600.480.485;National Institute on Drug Abuse (U.S.);D054577
N03.540.348.500.500.600.480.485;National Institute on Drug Abuse (U.S.);D054577
D08.811.277.352.650.775.300.200;Protein Tyrosine Phosphatase, Non-Receptor Type 2;D054578
D12.644.360.585.200;Protein Tyrosine Phosphatase, Non-Receptor Type 2;D054578
D12.776.476.564.200;Protein Tyrosine Phosphatase, Non-Receptor Type 2;D054578
I01.409.137.500.600.480.400;National Institute of Allergy and Infectious Diseases (U.S.);D054579
N03.540.348.500.500.600.480.400;National Institute of Allergy and Infectious Diseases (U.S.);D054579
I01.409.137.500.600.480.425;National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.);D054580
N03.540.348.500.500.600.480.425;National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.);D054580
I01.409.137.500.600.480.435;National Institute of Biomedical Imaging and Bioengineering (U.S.);D054581
N03.540.348.500.500.600.480.435;National Institute of Biomedical Imaging and Bioengineering (U.S.);D054581
I01.409.137.500.600.480.440;National Institute of Child Health and Human Development (U.S.);D054582
N03.540.348.500.500.600.480.440;National Institute of Child Health and Human Development (U.S.);D054582
I01.409.137.500.600.480.470;National Institute on Deafness and Other Communication Disorders (U.S.);D054583
N03.540.348.500.500.600.480.470;National Institute on Deafness and Other Communication Disorders (U.S.);D054583
I01.409.137.500.600.480.445;National Institute of Dental and Craniofacial Research (U.S.);D054584
N03.540.348.500.500.600.480.445;National Institute of Dental and Craniofacial Research (U.S.);D054584
I01.409.137.500.600.480.455;National Institute of Environmental Health Sciences (U.S.);D054585
N03.540.348.500.500.600.480.455;National Institute of Environmental Health Sciences (U.S.);D054585
I01.409.137.500.600.480.450;National Institute of Diabetes and Digestive and Kidney Diseases (U.S.);D054586
N03.540.348.500.500.600.480.450;National Institute of Diabetes and Digestive and Kidney Diseases (U.S.);D054586
I01.409.137.500.600.480.457;National Institute of General Medical Sciences (U.S.);D054587
N03.540.348.500.500.600.480.457;National Institute of General Medical Sciences (U.S.);D054587
I01.409.137.500.600.480.462;National Institute of Nursing Research (U.S.);D054588
N03.540.348.500.500.600.480.462;National Institute of Nursing Research (U.S.);D054588
D08.811.277.352.650.775.300.300;Protein Tyrosine Phosphatase, Non-Receptor Type 3;D054589
D12.644.360.585.300;Protein Tyrosine Phosphatase, Non-Receptor Type 3;D054589
D12.776.476.564.300;Protein Tyrosine Phosphatase, Non-Receptor Type 3;D054589
D08.811.277.352.650.775.300.400;Protein Tyrosine Phosphatase, Non-Receptor Type 4;D054590
D12.644.360.585.400;Protein Tyrosine Phosphatase, Non-Receptor Type 4;D054590
D12.776.476.564.400;Protein Tyrosine Phosphatase, Non-Receptor Type 4;D054590
D08.811.277.352.650.775.300.800;Protein Tyrosine Phosphatase, Non-Receptor Type 11;D054592
D08.811.277.352.650.775.700.800;Protein Tyrosine Phosphatase, Non-Receptor Type 11;D054592
D12.644.360.585.800;Protein Tyrosine Phosphatase, Non-Receptor Type 11;D054592
D12.776.476.564.800;Protein Tyrosine Phosphatase, Non-Receptor Type 11;D054592
D12.776.476.800.800;Protein Tyrosine Phosphatase, Non-Receptor Type 11;D054592
D08.811.277.352.650.775.700;SH2 Domain-Containing Protein Tyrosine Phosphatases;D054593
D12.644.360.800;SH2 Domain-Containing Protein Tyrosine Phosphatases;D054593
D12.776.476.800;SH2 Domain-Containing Protein Tyrosine Phosphatases;D054593
D08.811.277.352.650.775.300.850;Protein Tyrosine Phosphatase, Non-Receptor Type 12;D054594
D12.644.360.585.850;Protein Tyrosine Phosphatase, Non-Receptor Type 12;D054594
D12.776.476.564.850;Protein Tyrosine Phosphatase, Non-Receptor Type 12;D054594
D08.811.277.352.650.775.300.860;Protein Tyrosine Phosphatase, Non-Receptor Type 13;D054595
D12.644.360.585.860;Protein Tyrosine Phosphatase, Non-Receptor Type 13;D054595
D12.776.476.564.860;Protein Tyrosine Phosphatase, Non-Receptor Type 13;D054595
D08.811.277.352.650.775.300.930;Protein Tyrosine Phosphatase, Non-Receptor Type 22;D054596
D12.644.360.585.930;Protein Tyrosine Phosphatase, Non-Receptor Type 22;D054596
D12.776.476.564.930;Protein Tyrosine Phosphatase, Non-Receptor Type 22;D054596
H02.403.230;Disaster Medicine;D054597
N03.219.521.710.305.090.125;Blue Cross Blue Shield Insurance Plans;D054598
D08.811.277.352.650.775.400.100;Receptor-Like Protein Tyrosine Phosphatases, Class 1;D054622
D12.644.360.587.100;Receptor-Like Protein Tyrosine Phosphatases, Class 1;D054622
D12.776.476.592.100;Receptor-Like Protein Tyrosine Phosphatases, Class 1;D054622
D12.776.543.733.937;Receptor-Like Protein Tyrosine Phosphatases, Class 1;D054622
D08.811.277.352.650.775.400.200;Receptor-Like Protein Tyrosine Phosphatases, Class 2;D054623
D12.644.360.587.200;Receptor-Like Protein Tyrosine Phosphatases, Class 2;D054623
D12.776.476.592.200;Receptor-Like Protein Tyrosine Phosphatases, Class 2;D054623
I01.240.425.675;Health Status Disparities;D054624
N01.224.425.437;Health Status Disparities;D054624
N06.850.505.400.425.675;Health Status Disparities;D054624
N04.590.374.380;Healthcare Disparities;D054625
N05.300.493;Healthcare Disparities;D054625
I02.233.332.186;Consumer Health Information;D054626
N02.421.143.827.407.228;Consumer Health Information;D054626
N02.421.726.407.228;Consumer Health Information;D054626
G05.360.340.370;Genome, Plastid;D054627
G05.360.340.370.200;Genome, Chloroplast;D054628
G05.360.340.360;Genome, Mitochondrial;D054629
D08.811.277.352.650.775.400.400;Receptor-Like Protein Tyrosine Phosphatases, Class 4;D054630
D12.644.360.587.400;Receptor-Like Protein Tyrosine Phosphatases, Class 4;D054630
D12.776.476.592.400;Receptor-Like Protein Tyrosine Phosphatases, Class 4;D054630
D08.811.277.352.650.775.400.300;Receptor-Like Protein Tyrosine Phosphatases, Class 3;D054631
D12.644.360.587.300;Receptor-Like Protein Tyrosine Phosphatases, Class 3;D054631
D12.776.476.592.300;Receptor-Like Protein Tyrosine Phosphatases, Class 3;D054631
D08.811.277.352.650.775.400.500;Receptor-Like Protein Tyrosine Phosphatases, Class 5;D054633
D12.644.360.587.500;Receptor-Like Protein Tyrosine Phosphatases, Class 5;D054633
D12.776.476.592.500;Receptor-Like Protein Tyrosine Phosphatases, Class 5;D054633
D08.811.277.352.650.775.400.700;Receptor-Like Protein Tyrosine Phosphatases, Class 7;D054634
D12.644.360.587.700;Receptor-Like Protein Tyrosine Phosphatases, Class 7;D054634
D12.776.476.592.700;Receptor-Like Protein Tyrosine Phosphatases, Class 7;D054634
D08.811.277.352.650.775.400.800;Receptor-Like Protein Tyrosine Phosphatases, Class 8;D054635
D12.644.360.587.800;Receptor-Like Protein Tyrosine Phosphatases, Class 8;D054635
D12.776.476.592.800;Receptor-Like Protein Tyrosine Phosphatases, Class 8;D054635
D08.811.277.352.650.625.225;Dual-Specificity Phosphatases;D054637
D08.811.277.352.650.775.250;Dual-Specificity Phosphatases;D054637
D12.644.360.268;Dual-Specificity Phosphatases;D054637
D12.776.476.268;Dual-Specificity Phosphatases;D054637
D08.811.277.352.650.587.200;Dual Specificity Phosphatase 1;D054638
D08.811.277.352.650.625.225.200;Dual Specificity Phosphatase 1;D054638
D08.811.277.352.650.775.250.200;Dual Specificity Phosphatase 1;D054638
D12.644.360.268.200;Dual Specificity Phosphatase 1;D054638
D12.644.360.445.100;Dual Specificity Phosphatase 1;D054638
D12.776.476.268.200;Dual Specificity Phosphatase 1;D054638
D12.776.476.445.200;Dual Specificity Phosphatase 1;D054638
D08.811.277.352.650.587;Mitogen-Activated Protein Kinase Phosphatases;D054639
D12.644.360.445;Mitogen-Activated Protein Kinase Phosphatases;D054639
D12.776.476.445;Mitogen-Activated Protein Kinase Phosphatases;D054639
D08.811.277.352.650.587.300;Dual Specificity Phosphatase 3;D054640
D08.811.277.352.650.625.225.300;Dual Specificity Phosphatase 3;D054640
D08.811.277.352.650.775.250.300;Dual Specificity Phosphatase 3;D054640
D12.644.360.268.300;Dual Specificity Phosphatase 3;D054640
D12.644.360.445.300;Dual Specificity Phosphatase 3;D054640
D12.776.476.268.300;Dual Specificity Phosphatase 3;D054640
D12.776.476.445.300;Dual Specificity Phosphatase 3;D054640
D08.811.277.352.650.587.250;Dual Specificity Phosphatase 2;D054641
D08.811.277.352.650.625.225.250;Dual Specificity Phosphatase 2;D054641
D08.811.277.352.650.775.250.250;Dual Specificity Phosphatase 2;D054641
D12.644.360.268.250;Dual Specificity Phosphatase 2;D054641
D12.644.360.445.250;Dual Specificity Phosphatase 2;D054641
D12.776.476.268.250;Dual Specificity Phosphatase 2;D054641
D12.776.476.445.250;Dual Specificity Phosphatase 2;D054641
D08.811.277.352.650.587.600;Dual Specificity Phosphatase 6;D054642
D08.811.277.352.650.625.225.600;Dual Specificity Phosphatase 6;D054642
D08.811.277.352.650.775.250.600;Dual Specificity Phosphatase 6;D054642
D12.644.360.268.600;Dual Specificity Phosphatase 6;D054642
D12.644.360.445.600;Dual Specificity Phosphatase 6;D054642
D12.776.476.268.600;Dual Specificity Phosphatase 6;D054642
D12.776.476.445.600;Dual Specificity Phosphatase 6;D054642
G05.355.600.370;INDEL Mutation;D054643
G05.365.590.500;INDEL Mutation;D054643
A09.246.272.197;Ear Auricle;D054644
D08.811.277.352.650.625.687;Protein Phosphatase 1;D054645
H01.158.273.180.350.349;Nutrigenomics;D054647
H01.158.273.343.350.349;Nutrigenomics;D054647
D08.811.277.352.650.625.706;Protein Phosphatase 2;D054648
D12.644.360.583;Protein Phosphatase 2;D054648
D12.776.476.561;Protein Phosphatase 2;D054648
A11.284.430.214.190.875.811.870;Ribosome Subunits;D054657
A11.284.430.214.190.875.811.870.700;Ribosome Subunits, Large;D054658
D03.383.606.385;Diketopiperazines;D054659
D08.811.277.352.640.150.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D08.811.277.352.640.155.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D12.644.360.008.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D12.644.360.009.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D12.776.476.008.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D12.776.476.009.100;Cyclic Nucleotide Phosphodiesterases, Type 1;D054677
D08.811.277.352.640.150.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
D08.811.277.352.640.155.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
D12.644.360.008.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
D12.644.360.009.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
D12.776.476.008.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
D12.776.476.009.200;Cyclic Nucleotide Phosphodiesterases, Type 2;D054678
A11.284.430.214.190.875.811.870.750;Ribosome Subunits, Small;D054679
A11.284.430.214.190.875.811.870.750.700;Ribosome Subunits, Small, Bacterial;D054680
A20.874;Ribosome Subunits, Small, Bacterial;D054680
A11.284.430.214.190.875.811.870.700.700;Ribosome Subunits, Large, Bacterial;D054681
A20.873;Ribosome Subunits, Large, Bacterial;D054681
A11.284.430.214.190.875.811.870.750.750;Ribosome Subunits, Small, Eukaryotic;D054682
A11.284.430.214.190.875.811.870.700.750;Ribosome Subunits, Large, Eukaryotic;D054683
D08.811.277.352.640.150.300;Cyclic Nucleotide Phosphodiesterases, Type 3;D054684
D12.644.360.008.300;Cyclic Nucleotide Phosphodiesterases, Type 3;D054684
D12.776.476.008.300;Cyclic Nucleotide Phosphodiesterases, Type 3;D054684
C04.557.386.480.150.592;Lymphoma, Primary Effusion;D054685
C15.604.515.569.480.150.592;Lymphoma, Primary Effusion;D054685
C20.683.515.761.480.150.592;Lymphoma, Primary Effusion;D054685
D27.888.569.199;Cytostatic Agents;D054697
B01.650.940.800.575.100.875.216;Clausena;D054700
I01.409.137.500.199;United States Agency for International Development;D054702
N03.540.348.500.500.199;United States Agency for International Development;D054702
D08.811.277.352.640.150.400;Cyclic Nucleotide Phosphodiesterases, Type 4;D054703
D12.644.360.008.400;Cyclic Nucleotide Phosphodiesterases, Type 4;D054703
D12.776.476.008.400;Cyclic Nucleotide Phosphodiesterases, Type 4;D054703
I01.409.137.500.099;Peace Corps;D054704
N03.540.348.500.500.099;Peace Corps;D054704
C04.557.450.565.465.249.500;Mastocytoma, Skin;D054705
C04.557.450.565.465.500.500;Mastocytoma, Skin;D054705
C17.800.508.236.500;Mastocytoma, Skin;D054705
C17.800.508.473.500;Mastocytoma, Skin;D054705
D08.811.277.352.640.150.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D08.811.277.352.640.155.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D12.644.360.008.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D12.644.360.009.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D12.776.476.008.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D12.776.476.009.500;Cyclic Nucleotide Phosphodiesterases, Type 5;D054706
D08.811.277.352.640.150.600;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D08.811.277.352.640.155.750;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D12.644.360.008.600;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D12.644.360.009.750;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D12.776.476.008.600;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D12.776.476.009.750;Cyclic Nucleotide Phosphodiesterases, Type 6;D054707
D08.811.277.352.640.150.700;Cyclic Nucleotide Phosphodiesterases, Type 7;D054708
D12.644.360.008.700;Cyclic Nucleotide Phosphodiesterases, Type 7;D054708
D12.776.476.008.700;Cyclic Nucleotide Phosphodiesterases, Type 7;D054708
D10.570.755.375.760.400.800.806;Lecithins;D054709
D20.215.784.500.492;Lecithins;D054709
V01.255.500.625;Interactive Tutorial;D054710
V02.600.249;Introductory Journal Article;D054711
G02.640.500;Salinity;D054712
G02.842.640.500;Salinity;D054712
D02.540.505.112;Bryostatins;D054713
D12.644.641.311;Echinocandins;D054714
D27.888.569.142;Cardiotoxins;D054715
D02.455.849.919.138;Cucurbitacins;D054728
D08.811.913.696.620.682.700.125.100;Calcium-Calmodulin-Dependent Protein Kinase Type 1;D054729
D12.644.360.100.100;Calcium-Calmodulin-Dependent Protein Kinase Type 1;D054729
D12.776.476.100.100;Calcium-Calmodulin-Dependent Protein Kinase Type 1;D054729
G02.111.570.790.709.610.640;Protein Interaction Domains and Motifs;D054730
G02.111.570.790.709.610.640.500;PDZ Domains;D054731
D08.811.913.696.620.682.700.125.200;Calcium-Calmodulin-Dependent Protein Kinase Type 2;D054732
D12.644.360.100.200;Calcium-Calmodulin-Dependent Protein Kinase Type 2;D054732
D12.776.476.100.200;Calcium-Calmodulin-Dependent Protein Kinase Type 2;D054732
D08.811.913.696.620.682.700.125.350;Calcium-Calmodulin-Dependent Protein Kinase Type 4;D054734
D12.644.360.100.350;Calcium-Calmodulin-Dependent Protein Kinase Type 4;D054734
D12.776.476.100.350;Calcium-Calmodulin-Dependent Protein Kinase Type 4;D054734
D13.695.578.424.575;Phosphorothioate Oligonucleotides;D054735
D08.811.913.696.620.682.700.125.425;Elongation Factor 2 Kinase;D054736
D12.644.360.100.425;Elongation Factor 2 Kinase;D054736
D12.776.476.100.425;Elongation Factor 2 Kinase;D054736
D08.811.913.696.620.682.700.125.049;Calcium-Calmodulin-Dependent Protein Kinase Kinase;D054737
D12.644.360.100.049;Calcium-Calmodulin-Dependent Protein Kinase Kinase;D054737
D12.776.476.100.049;Calcium-Calmodulin-Dependent Protein Kinase Kinase;D054737
A09.246.631.246.874;Scala Vestibuli;D054738
C04.557.227.199;Dendritic Cell Sarcoma, Interdigitating;D054739
C15.604.250.390.199;Dendritic Cell Sarcoma, Interdigitating;D054739
C04.557.227.190;Dendritic Cell Sarcoma, Follicular;D054740
C15.604.250.390.190;Dendritic Cell Sarcoma, Follicular;D054740
D02.540.232;Acyl-Butyrolactones;D054742
D08.811.913.696.620.682.700.150.125.750;Cyclic AMP-Dependent Protein Kinase Type I;D054743
D12.644.360.200.125.750;Cyclic AMP-Dependent Protein Kinase Type I;D054743
D12.776.476.200.125.750;Cyclic AMP-Dependent Protein Kinase Type I;D054743
D08.811.913.696.620.682.700.150.125.875;Cyclic AMP-Dependent Protein Kinase Type II;D054746
D12.644.360.200.125.875;Cyclic AMP-Dependent Protein Kinase Type II;D054746
D12.776.476.200.125.875;Cyclic AMP-Dependent Protein Kinase Type II;D054746
C04.557.227.380;Histiocytic Sarcoma;D054747
C15.604.250.390.380;Histiocytic Sarcoma;D054747
A11.284.430.214.190.875.811.870.700.349;Ribosome Subunits, Large, Archaeal;D054748
A11.284.430.214.190.875.811.870.750.349;Ribosome Subunits, Small, Archaeal;D054749
H01.158.273.248.500;Ecotoxicology;D054750
H01.158.703.795.211;Ecotoxicology;D054750
H01.277.249.500;Ecotoxicology;D054750
H02.628.795.211;Ecotoxicology;D054750
D08.811.913.696.620.682.700.150.125.750.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
D08.811.913.696.620.682.700.150.125.875.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
D12.644.360.200.125.750.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
D12.644.360.200.125.875.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
D12.776.476.200.125.750.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
D12.776.476.200.125.875.500;Cyclic AMP-Dependent Protein Kinase Catalytic Subunits;D054751
C04.557.227.500;Langerhans Cell Sarcoma;D054752
C15.604.250.390.500;Langerhans Cell Sarcoma;D054752
D08.811.913.696.620.682.700.150.125.750.750;Cyclic AMP-Dependent Protein Kinase RIbeta Subunit;D054753
D12.644.360.200.125.750.750;Cyclic AMP-Dependent Protein Kinase RIbeta Subunit;D054753
D12.776.476.200.125.750.249;Cyclic AMP-Dependent Protein Kinase RIbeta Subunit;D054753
D08.811.913.696.620.682.700.150.125.875.750;Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit;D054754
D12.644.360.200.125.875.750;Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit;D054754
D12.776.476.200.125.875.750;Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit;D054754
D12.776.827.137;Imidazoline Receptors;D054755
D08.811.913.696.620.682.700.150.125.750.625;Cyclic AMP-Dependent Protein Kinase RIalpha Subunit;D054756
D12.644.360.200.125.750.625;Cyclic AMP-Dependent Protein Kinase RIalpha Subunit;D054756
D12.776.476.200.125.750.124;Cyclic AMP-Dependent Protein Kinase RIalpha Subunit;D054756
D08.811.913.696.620.682.700.150.125.875.875;Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit;D054757
D12.644.360.200.125.875.875;Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit;D054757
D12.776.476.200.125.875.875;Cyclic AMP-Dependent Protein Kinase RIIbeta Subunit;D054757
D12.644.360.024.065;A Kinase Anchor Proteins;D054758
D12.776.157.057.002;A Kinase Anchor Proteins;D054758
D12.776.476.024.069;A Kinase Anchor Proteins;D054758
D08.811.913.696.620.682.700.364;G-Protein-Coupled Receptor Kinases;D054768
D12.644.360.293;G-Protein-Coupled Receptor Kinases;D054768
D12.776.476.293;G-Protein-Coupled Receptor Kinases;D054768
D08.811.913.696.620.682.700.364.049.200;G-Protein-Coupled Receptor Kinase 2;D054769
D12.644.360.293.249.200;G-Protein-Coupled Receptor Kinase 2;D054769
D12.776.476.293.249.200;G-Protein-Coupled Receptor Kinase 2;D054769
D08.811.913.696.620.682.700.364.049.300;G-Protein-Coupled Receptor Kinase 3;D054770
D12.644.360.293.249.300;G-Protein-Coupled Receptor Kinase 3;D054770
D12.776.476.293.249.300;G-Protein-Coupled Receptor Kinase 3;D054770
D08.811.913.696.620.682.700.364.550;G-Protein-Coupled Receptor Kinase 4;D054771
D12.644.360.293.750;G-Protein-Coupled Receptor Kinase 4;D054771
D12.776.476.293.750;G-Protein-Coupled Receptor Kinase 4;D054771
B01.050.150.900.649.865.635.505.700.550.408;Rats, Hairless;D054772
B03.510.400.800.872.260;Streptococcus gordonii;D054773
B03.510.550.737.872.260;Streptococcus gordonii;D054773
D08.811.913.696.620.682.700.364.775;G-Protein-Coupled Receptor Kinase 5;D054774
D12.644.360.293.875;G-Protein-Coupled Receptor Kinase 5;D054774
D12.776.476.293.875;G-Protein-Coupled Receptor Kinase 5;D054774
A09.246.631.663.500;Semicircular Ducts;D054776
A09.246.631.663.500.500;Hair Cells, Ampulla;D054777
D08.811.913.696.650.550.200;NM23 Nucleoside Diphosphate Kinases;D054778
D08.811.277.450.430.700;Ribosome Inactivating Proteins;D054788
D12.776.765.710;Ribosome Inactivating Proteins;D054788
D08.811.277.450.430.700.500;Ribosome Inactivating Proteins, Type 1;D054789
D12.776.765.710.500;Ribosome Inactivating Proteins, Type 1;D054789
D08.811.277.450.430.700.750;Ribosome Inactivating Proteins, Type 2;D054790
D12.776.765.678.906;Ribosome Inactivating Proteins, Type 2;D054790
D12.776.765.710.750;Ribosome Inactivating Proteins, Type 2;D054790
E01.370.350.850.865.249;Cervical Length Measurement;D054791
E01.370.378.630.865.249;Cervical Length Measurement;D054791
A10.690.552;Muscle, Striated;D054792
D12.776.422.316.762.932;Truncated Hemoglobins;D054793
H01.158.201.085.320;Glycomics;D054794
H01.158.273.180.350.150;Glycomics;D054794
H01.158.273.343.350.086;Glycomics;D054794
H01.181.122.508;Glycomics;D054794
D27.505.696.399.472.580;Incretins;D054795
E02.319.305;Drug Dosage Calculations;D054796
I03.450.642.845.932;Volleyball;D054798
D08.811.277.352.640.700.700.562.500;Phospholipase C beta;D054799
D12.644.360.571.500;Phospholipase C beta;D054799
D12.776.476.556.500;Phospholipase C beta;D054799
D08.811.277.352.640.700.700.249;Glycosylphosphatidylinositol Diacylglycerol-Lyase;D054800
D08.811.277.352.640.700.700.562;Phosphoinositide Phospholipase C;D054801
D12.644.360.571;Phosphoinositide Phospholipase C;D054801
D12.776.476.556;Phosphoinositide Phospholipase C;D054801
E05.196.655;Molecular Imprinting;D054802
D08.811.277.352.640.700.700.562.625;Phospholipase C delta;D054803
D12.644.360.571.625;Phospholipase C delta;D054803
D12.776.476.556.625;Phospholipase C delta;D054803
D12.644.050.099;Cathelicidins;D054804
D12.776.543.695.054.099;Cathelicidins;D054804
D12.644.050.400;Dermcidins;D054805
D12.776.543.695.054.400;Dermcidins;D054805
D12.644.050.500;Magainins;D054806
D12.776.543.695.054.500;Magainins;D054806
D12.644.050.149;Cecropins;D054807
D12.776.543.695.054.149;Cecropins;D054807
D12.644.050.450;Histatins;D054808
D12.644.848.500;Histatins;D054808
D12.776.543.695.054.450;Histatins;D054808
D12.776.850.550;Histatins;D054808
D12.644.050.800;Thionins;D054809
D12.776.543.695.054.800;Thionins;D054809
E03.295;Deep Sedation;D054810
D12.644.456.448.625;Phytochelatins;D054811
D02.455.426.392.368.138;Cyclitols;D054812
D05.750.078.789;Polyhydroxyalkanoates;D054813
D05.750.728.890;Polyhydroxyalkanoates;D054813
D10.751;Polyhydroxyalkanoates;D054813
M01.526.485.133;Anatomists;D054814
N02.360.133;Anatomists;D054814
D12.776.157.530.400.337;Cyclic Nucleotide-Gated Cation Channels;D054815
D12.776.543.550.425.452;Cyclic Nucleotide-Gated Cation Channels;D054815
D12.776.543.585.400.452;Cyclic Nucleotide-Gated Cation Channels;D054815
D02.241.081.751.324;Levopropoxyphene;D054816
G08.686.785.760.743;Pollination;D054817
G15.744.800;Pollination;D054817
D08.811.277.450.483.180.750;Hexosaminidase A;D054818
D08.811.277.450.483.180.875;Hexosaminidase B;D054819
D08.811.277.450.483.180.750.500;beta-Hexosaminidase alpha Chain;D054820
D08.811.277.450.483.180.750.750;beta-Hexosaminidase beta Chain;D054821
D08.811.277.450.483.180.875.500;beta-Hexosaminidase beta Chain;D054821
D27.505.519.625.375.425.712;Histamine H3 Antagonists;D054828
D27.505.696.577.375.425.712;Histamine H3 Antagonists;D054828
G02.111.570.790.709.600.040.985.500;RING Finger Domains;D054829
G02.111.570.790.709.610.640.625;RING Finger Domains;D054829
D02.455.849.842;Sesterterpenes;D054830
D03.132.032;Acridones;D054831
D03.494.046.109;Acridones;D054831
D06.472.699.857;Urocortins;D054832
D12.644.400.837;Urocortins;D054832
D12.644.548.887;Urocortins;D054832
D03.438.513;Isoindoles;D054833
D12.776.157.469;Lipocalins;D054834
D12.776.157.469.100;Lipocalin 1;D054835
D12.776.850.700;Lipocalin 1;D054835
D03.438.496.500;Indolizidines;D054836
D03.438.834.737;Quinolizidines;D054837
A03.556.500.760.906;von Ebner Glands;D054838
A10.336.779.906;von Ebner Glands;D054838
A14.549.760.906;von Ebner Glands;D054838
D12.776.124.698;Retinol-Binding Proteins, Plasma;D054839
D12.776.124.790.106.745;Retinol-Binding Proteins, Plasma;D054839
D12.776.157.469.550;Retinol-Binding Proteins, Plasma;D054839
D12.776.157.700.500;Retinol-Binding Proteins, Plasma;D054839
D12.776.377.715.085.745;Retinol-Binding Proteins, Plasma;D054839
D12.776.157.700.249;Retinol-Binding Proteins, Cellular;D054840
E02.309.610;Negative-Pressure Wound Therapy;D054843
E04.237.444;Negative-Pressure Wound Therapy;D054843
E04.987.550;Negative-Pressure Wound Therapy;D054843
D12.644.504;Peptaibols;D054848
H01.158.344.528.500;Cardiac Electrophysiology;D054849
H01.158.782.236.500;Cardiac Electrophysiology;D054849
H02.403.429.163.300;Cardiac Electrophysiology;D054849
C05.116.540.310.800;Osteophyte;D054850
B03.510.024.049.887;Tropheryma;D054851
D27.720.470.765;Small Molecule Libraries;D054852
C14.907.137.520;Malignant Atrophic Papulosis;D054853
C14.907.940.530;Malignant Atrophic Papulosis;D054853
C17.800.862.457;Malignant Atrophic Papulosis;D054853
E02.718.275.500;Vertebroplasty;D054854
E04.555.165.500;Vertebroplasty;D054854
E07.695.750.500;Drug-Eluting Stents;D054855
G02.111.570.790.486.550;G-Quadruplexes;D054856
G05.360.580.550;G-Quadruplexes;D054856
C15.378.140.855.440;Jacobsen Distal 11q Deletion Syndrome;D054868
C16.131.260.440;Jacobsen Distal 11q Deletion Syndrome;D054868
C16.320.180.440;Jacobsen Distal 11q Deletion Syndrome;D054868
N04.761.700.250;Clinical Audit;D054869
N05.700.175;Clinical Audit;D054869
D27.505.519.186.071.401;Fatty Acid Synthesis Inhibitors;D054872
D27.505.519.389.745.335;Dipeptidyl-Peptidase IV Inhibitors;D054873
D27.505.696.422.500;Dipeptidyl-Peptidase IV Inhibitors;D054873
I03.450.642.845.054;Athletic Performance;D054874
G02.111.087.675.871.790.600.925;Ubiquitination;D054875
G02.111.087.693.600.775;Ubiquitination;D054875
G02.149.115.675.871.790.600.831;Ubiquitination;D054875
G02.149.115.693.600.850;Ubiquitination;D054875
G03.495.770.871.790.600.831;Ubiquitination;D054875
G05.355.315.670.600.831;Ubiquitination;D054875
G02.111.087.679;Prenylation;D054876
G02.149.115.679;Prenylation;D054876
G03.495.797;Prenylation;D054876
C16.131.077.944;Wolf-Hirschhorn Syndrome;D054877
C16.131.260.985;Wolf-Hirschhorn Syndrome;D054877
C16.320.180.985;Wolf-Hirschhorn Syndrome;D054877
G02.111.087.535;Lipoylation;D054878
G02.149.115.535;Lipoylation;D054878
G03.495.520.875;Lipoylation;D054878
G02.111.087.485;Halogenation;D054879
G02.149.115.485;Halogenation;D054879
G03.495.496;Halogenation;D054879
C16.320.565.595.100;Aspartylglucosaminuria;D054880
C18.452.648.595.100;Aspartylglucosaminuria;D054880
E01.370.350.700.770;Sex Determination by Skeleton;D054881
E01.370.701.500;Sex Determination by Skeleton;D054881
C05.116.099.370.894.115;Antley-Bixler Syndrome Phenotype;D054882
C05.660.906.181;Antley-Bixler Syndrome Phenotype;D054882
C16.131.621.906.181;Antley-Bixler Syndrome Phenotype;D054882
C16.320.565.925.324;Antley-Bixler Syndrome Phenotype;D054882
C18.452.648.925.324;Antley-Bixler Syndrome Phenotype;D054882
D10.251.355.645;Oxylipins;D054883
G06.590.470;Host-Pathogen Interactions;D054884
G16.100.380;Host-Pathogen Interactions;D054884
A05.360.319.114.630.535.200.500;Cumulus Cells;D054885
A06.407.312.497.535.300.500;Cumulus Cells;D054885
A11.382.812.500;Cumulus Cells;D054885
A11.436.329.500;Cumulus Cells;D054885
D05.500.562.437.500;Fatty Acid Synthetase Complex, Type II;D054889
D08.811.600.317.500;Fatty Acid Synthetase Complex, Type II;D054889
D08.811.600.317.249;Fatty Acid Synthetase Complex, Type I;D054890
G05.360.340.550;Metagenome;D054892
E01.370.350.700.810.810.490;Cone-Beam Computed Tomography;D054893
E01.370.350.825.810.810.399;Cone-Beam Computed Tomography;D054893
E01.370.350.700.810.810.490.500;Spiral Cone-Beam Computed Tomography;D054894
E01.370.350.700.810.810.800.500;Spiral Cone-Beam Computed Tomography;D054894
E01.370.350.825.810.810.399.500;Spiral Cone-Beam Computed Tomography;D054894
E01.370.350.825.810.810.800.500;Spiral Cone-Beam Computed Tomography;D054894
C01.252.410.040.552.846.775.500;Extensively Drug-Resistant Tuberculosis;D054908
B01.050.500.740;Placozoa;D054909
A13.246;Compound Eye, Arthropod;D054910
E05.337.925;Validation Studies as Topic;D054928
N05.715.360.335.500;Validation Studies as Topic;D054928
C10.177.575;Primary Dysautonomias;D054969
C10.177.575.650;Pure Autonomic Failure;D054970
C10.177.575.600;Orthostatic Intolerance;D054971
C23.888.592.610;Orthostatic Intolerance;D054971
C10.177.575.600.625;Postural Orthostatic Tachycardia Syndrome;D054972
C04.557.450.692;Perivascular Epithelioid Cell Neoplasms;D054973
A11.284.149.165.165.142;Costameres;D054974
C04.445.622;Pallister-Hall Syndrome;D054975
C04.588.614.250.195.885.500.299;Pallister-Hall Syndrome;D054975
C05.660.585.600.374;Pallister-Hall Syndrome;D054975
C10.228.140.211.885.500.299;Pallister-Hall Syndrome;D054975
C10.228.140.617.477.299;Pallister-Hall Syndrome;D054975
C10.551.240.250.700.500.249;Pallister-Hall Syndrome;D054975
C16.131.077.690;Pallister-Hall Syndrome;D054975
C16.131.621.585.600.374;Pallister-Hall Syndrome;D054975
N04.452.115;Clinical Governance;D054976
C08.381.483.487;Idiopathic Interstitial Pneumonias;D054988
C17.800.553;Nephrogenic Fibrosing Dermopathy;D054989
C23.550.355.550;Nephrogenic Fibrosing Dermopathy;D054989
C08.381.483.487.500;Idiopathic Pulmonary Fibrosis;D054990
C08.381.765.500;Idiopathic Pulmonary Fibrosis;D054990
D20.215.894.135.098;Autovaccines;D054991
A11.284.149.165.420.548;Immunological Synapses;D054992
A15.382.370;Immunological Synapses;D054992
C08.381.483.581.062;Anthracosis;D055008
C08.381.520.702.062;Anthracosis;D055008
C05.116.900.938;Spondylosis;D055009
C05.116.900.596;Posterior Cervical Sympathetic Syndrome;D055010
E04.014;Ablation Techniques;D055011
G05.355.315.203.124;Chromosomal Position Effects;D055012
C05.116.900.853.625.399;Osteoarthritis, Spine;D055013
C05.550.114.606.750;Osteoarthritis, Spine;D055013
C05.550.114.865.399;Osteoarthritis, Spine;D055013
C05.799.613.750;Osteoarthritis, Spine;D055013
A11.148.378.590.675;Granulocyte-Macrophage Progenitor Cells;D055014
A11.627.635.675;Granulocyte-Macrophage Progenitor Cells;D055014
A11.872.378.590.635;Granulocyte-Macrophage Progenitor Cells;D055014
A15.378.316.378.590.675;Granulocyte-Macrophage Progenitor Cells;D055014
A11.148.378.590.837;Megakaryocyte-Erythroid Progenitor Cells;D055015
A11.872.378.590.817;Megakaryocyte-Erythroid Progenitor Cells;D055015
A15.378.316.378.590.837;Megakaryocyte-Erythroid Progenitor Cells;D055015
A11.148.378.590.837.625;Megakaryocyte Progenitor Cells;D055016
A11.872.378.590.817.625;Megakaryocyte Progenitor Cells;D055016
A15.378.316.378.590.837.625;Megakaryocyte Progenitor Cells;D055016
A11.148.378.590.675.750;Monocyte-Macrophage Precursor Cells;D055017
A11.148.580.500;Monocyte-Macrophage Precursor Cells;D055017
A11.627.482.665;Monocyte-Macrophage Precursor Cells;D055017
A11.627.624.249;Monocyte-Macrophage Precursor Cells;D055017
A11.627.635.675.750;Monocyte-Macrophage Precursor Cells;D055017
A11.872.378.590.635.875;Monocyte-Macrophage Precursor Cells;D055017
A15.378.316.378.590.675.750;Monocyte-Macrophage Precursor Cells;D055017
A11.436.275.365;Hemangioblasts;D055018
A11.872.378.270;Hemangioblasts;D055018
E05.393.285.240;Comparative Genomic Hybridization;D055028
E05.393.520.500;Comparative Genomic Hybridization;D055028
E05.393.661.187;Comparative Genomic Hybridization;D055028
G02.111.570.080.708.800.325;Inverted Repeat Sequences;D055029
G05.360.080.708.800.325;Inverted Repeat Sequences;D055029
M01.169;Drug Users;D055030
C14.907.725.675;Primary Graft Dysfunction;D055031
C23.550.767.877.750;Primary Graft Dysfunction;D055031
E01.370.350.825.249;Electron Microscope Tomography;D055032
E05.595.402.580.239;Electron Microscope Tomography;D055032
C05.116.821;Osteochondrosis;D055034
C05.116.821.500;Spinal Osteochondrosis;D055035
C05.116.900.808;Spinal Osteochondrosis;D055035
C05.660.142;Campomelic Dysplasia;D055036
C16.131.621.142;Campomelic Dysplasia;D055036
H02.403.400;Integrative Medicine;D055048
G07.700.062.796;Salt-Tolerance;D055049
E02.642.249.265;Diet, Gluten-Free;D055050
G07.610.240.265;Diet, Gluten-Free;D055050
B01.650.723;Salt-Tolerant Plants;D055051
E07.101.036;Athletic Tape;D055052
E07.858.442.743.159;Athletic Tape;D055052
G01.358.500.505.890;Terahertz Radiation;D055053
G01.750.250.890;Terahertz Radiation;D055053
G01.750.770.832;Terahertz Radiation;D055053
E05.196.867.945;Terahertz Spectroscopy;D055068
E01.370.350.780;Terahertz Imaging;D055069
E02.779.483.875;Resistance Training;D055070
E02.831.387.875;Resistance Training;D055070
G11.427.590.530.698.277.500;Resistance Training;D055070
I03.350.500;Resistance Training;D055070
E01.390.500;Early Detection of Cancer;D055088
C05.182.895;Tracheobronchomalacia;D055089
C08.127.719;Tracheobronchomalacia;D055089
C08.907.796;Tracheobronchomalacia;D055089
C16.131.621.953;Tracheobronchomalacia;D055089
C17.300.182.895;Tracheobronchomalacia;D055089
C05.182.895.500;Tracheomalacia;D055090
C08.907.796.500;Tracheomalacia;D055090
C16.131.621.953.500;Tracheomalacia;D055090
C17.300.182.895.500;Tracheomalacia;D055090
C05.182.895.249;Bronchomalacia;D055091
C08.127.719.500;Bronchomalacia;D055091
C16.131.621.953.249;Bronchomalacia;D055091
C17.300.182.895.249;Bronchomalacia;D055091
C05.182.310;Laryngomalacia;D055092
C08.360.563;Laryngomalacia;D055092
C09.400.563;Laryngomalacia;D055092
C16.131.621.568;Laryngomalacia;D055092
C17.300.182.310;Laryngomalacia;D055092
C07.465.714.354;Periodontal Atrophy;D055093
H02.163.232;Evidence-Based Dentistry;D055094
H02.249.500;Evidence-Based Dentistry;D055094
H01.671.617;Optics and Photonics;D055095
J01.293.688;Optics and Photonics;D055095
E07.632;Optical Devices;D055096
E02.190.204;Auriculotherapy;D055097
A11.382;Endocrine Cells;D055098
A11.382.944;Neuroendocrine Cells;D055099
E07.632.750;Optical Fibers;D055100
E01.370.225.992;Semen Analysis;D055101
E05.200.992;Semen Analysis;D055101
E02.319.267.510.795.500;Hypodermoclysis;D055103
E02.319.360.500;Hypodermoclysis;D055103
E02.319.267.510.795;Infusions, Subcutaneous;D055104
E01.370.600.115.100.160.560;Waist Circumference;D055105
E05.041.124.160.875;Waist Circumference;D055105
G07.100.100.160.560;Waist Circumference;D055105
E05.318.416.249;Genome-Wide Association Study;D055106
E05.318.780.392;Genome-Wide Association Study;D055106
E05.393.385.500;Genome-Wide Association Study;D055106
E05.393.522.500;Genome-Wide Association Study;D055106
E05.393.760.640.500;Genome-Wide Association Study;D055106
N06.850.520.445.392;Genome-Wide Association Study;D055106
N06.850.520.470.500;Genome-Wide Association Study;D055106
G13.750.829.833.500;Suntan;D055107
I03.450.642.922;Sunbathing;D055108
E01.370.370.140.049;Ankle Brachial Index;D055109
E05.799.669;Radiometric Dating;D055110
C10.597.617.232.199;Failed Back Surgery Syndrome;D055111
C23.550.767.225;Failed Back Surgery Syndrome;D055111
C13.351.500.852.544;Pyometra;D055112
C07.465.714.533.324;Chronic Periodontitis;D055113
E01.370.350.700.810.810.900;X-Ray Microtomography;D055114
E01.370.350.825.810.810.900;X-Ray Microtomography;D055114
E06.095.585;Light-Curing of Dental Adhesives;D055115
E06.095.850;Self-Curing of Dental Resins;D055116
E06.186.104;Curing Lights, Dental;D055117
E07.222.104;Curing Lights, Dental;D055117
F01.145.488.500.500;Medication Adherence;D055118
N05.300.150.600.600.500;Medication Adherence;D055118
G01.374.590.605;Elastic Modulus;D055119
B01.300.230;Blastocladiomycota;D055133
B01.300.230.074;Allomyces;D055134
B01.300.230.200;Coelomomyces;D055135
B01.300.665;Neocallimastigomycota;D055136
B01.300.320;Glomeromycota;D055137
G11.561.600.812;Sensory Gating;D055139
G04.366.249;Stem Cell Niche;D055153
C08.360.940.325;Dysphonia;D055154
C09.400.940.325;Dysphonia;D055154
C10.597.975.325;Dysphonia;D055154
C23.888.592.979.325;Dysphonia;D055154
B01.300.107.655;Ophiostomatales;D055155
B01.300.107.655.600;Ophiostoma;D055156
B01.300.107.795.200;Dipodascus;D055157
B01.300.930.330;Dipodascus;D055157
A02.633.567.800.680;Velopharyngeal Sphincter;D055158
A04.623.617.680;Velopharyngeal Sphincter;D055158
A14.724.617.680;Velopharyngeal Sphincter;D055158
B01.300.107.795.230;Endomyces;D055159
B01.300.930.340;Endomyces;D055159
B01.300.107.795.550;Lipomyces;D055160
B01.300.930.555;Lipomyces;D055160
E02.190.894;Speleotherapy;D055161
G02.111.087.095;Biocatalysis;D055162
G02.149.115.095;Biocatalysis;D055162
G02.149.170.500;Biocatalysis;D055162
G02.149.767.500.500;Biocatalysis;D055162
G02.842.750.500.500;Biocatalysis;D055162
G03.495.159;Biocatalysis;D055162
B01.300.107.795.575;Metschnikowia;D055163
B01.300.930.587;Metschnikowia;D055163
E04.680.800.500;Nerve Expansion;D055164
B01.300.107.795.190;Debaromyces;D055165
B01.300.930.323;Debaromyces;D055165
A11.561;Hepatic Stellate Cells;D055166
B01.300.107.795.192;Dekkera;D055167
B01.300.930.326;Dekkera;D055167
B01.300.381.137;Brettanomyces;D055168
B01.300.930.150;Brettanomyces;D055168
B01.300.107.795.250;Eremothecium;D055169
B01.300.930.350;Eremothecium;D055169
G15.744.747;Plant Root Nodulation;D055170
A02.165.407.550;Nasal Cartilages;D055171
A04.531.413;Nasal Cartilages;D055171
A02.835.232.781.324.971;Vomer;D055172
A04.531.591.469;Vomer;D055172
C23.550.767.137;Delayed Emergence from Anesthesia;D055191
A08.663.650.850.625.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A08.663.650.915.937.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A08.800.950.937.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A09.371.729.831.625.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A11.671.650.850.625.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A11.671.650.915.937.670.237;Retinal Photoreceptor Cell Inner Segment;D055211
A08.663.650.850.625.670.049;Photoreceptor Connecting Cilium;D055212
A08.663.650.915.937.670.049;Photoreceptor Connecting Cilium;D055212
A08.800.950.937.670.049;Photoreceptor Connecting Cilium;D055212
A09.371.729.831.625.670.049;Photoreceptor Connecting Cilium;D055212
A11.671.650.850.625.670.049;Photoreceptor Connecting Cilium;D055212
A11.671.650.915.937.670.049;Photoreceptor Connecting Cilium;D055212
A09.371.670.500;Retinal Pigment Epithelium;D055213
A09.371.729.887;Retinal Pigment Epithelium;D055213
A08.663.650.850.625.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
A08.663.650.915.937.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
A08.800.950.937.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
A09.371.729.831.625.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
A11.671.650.850.625.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
A11.671.650.915.937.670.375;Retinal Photoreceptor Cell Outer Segment;D055214
D03.383.773.532;Lincosamides;D055231
D09.408.471;Lincosamides;D055231
G02.111.570.790.709.600.040.752;Proline-Rich Protein Domains;D055232
D12.776.220.150;Cornified Envelope Proline-Rich Proteins;D055233
D12.776.543.200;Cornified Envelope Proline-Rich Proteins;D055233
A11.284.149.165.082;Cell-Derived Microparticles;D055252
F02.830.816.964.124;Color Vision;D055253
G11.561.600.810.964.124;Color Vision;D055253
G14.640.816.124;Color Vision;D055253
F02.830.816.964.249;Night Vision;D055254
G11.561.600.810.964.249;Night Vision;D055254
G14.640.816.249;Night Vision;D055254
F02.830.816.964.186;Mesopic Vision;D055255
G11.561.600.810.964.186;Mesopic Vision;D055255
G14.640.816.186;Mesopic Vision;D055255
N06.850.310.405;Infectious Disease Incubation Period;D055256
D12.644.848.750;Mucin-5B;D055257
D12.776.395.560.631.207;Mucin-5B;D055257
D12.776.850.850;Mucin-5B;D055257
F02.830.816.964.186.624;Rod-Cone Interaction;D055258
G11.561.600.810.964.186.624;Rod-Cone Interaction;D055258
G14.640.816.186.624;Rod-Cone Interaction;D055258
G12.425.742;Immunogenetic Processes;D055260
G12.500.349;Immunogenetic Processes;D055260
G12.500;Immunogenetic Phenomena;D055261
D12.776.395.560.631.161;Mucin-2;D055262
D12.776.395.550.565;Mucin-3;D055263
D12.776.395.560.631.184;Mucin-3;D055263
D12.776.543.550.542;Mucin-3;D055263
D12.644.360.534;Mucin-4;D055264
D12.776.395.560.631.195;Mucin-4;D055264
D12.776.476.534;Mucin-4;D055264
D12.776.395.560.631.300.500;Mucin 5AC;D055271
D12.776.395.560.631.300.750;Mucin-6;D055272
D12.644.848.937;Salivary Proline-Rich Proteins;D055273
D12.776.850.925;Salivary Proline-Rich Proteins;D055273
D08.811.277.450.066.050.500;Salivary alpha-Amylases;D055291
D12.644.848.875;Salivary alpha-Amylases;D055291
D12.776.850.887;Salivary alpha-Amylases;D055291
D08.811.277.450.066.050.249;Pancreatic alpha-Amylases;D055292
D12.776.543.750.887;Receptors, Urokinase Plasminogen Activator;D055293
D23.050.301.264.035.911;Receptors, Urokinase Plasminogen Activator;D055293
D23.101.100.110.917;Receptors, Urokinase Plasminogen Activator;D055293
D12.776.215.100;Cystatin A;D055312
D12.776.215.200;Cystatin B;D055313
D12.776.765.725;Seed Storage Proteins;D055314
D12.776.765.725.500;Prolamins;D055315
D12.776.215.300;Cystatin C;D055316
H02.249;Evidence-Based Practice;D055317
H02.249.875;Evidence-Based Nursing;D055318
H02.478.197;Evidence-Based Nursing;D055318
B01.300.107.795.830;Torulaspora;D055319
B01.300.930.910;Torulaspora;D055319
B01.300.107.795.905;Williopsis;D055320
B01.300.930.945;Williopsis;D055320
B01.300.107.795.393;Hanseniaspora;D055321
B01.300.930.443;Hanseniaspora;D055321
B01.300.381.490;Kloeckera;D055322
B01.300.930.530;Kloeckera;D055322
B01.300.107.320.125;Byssochlamys;D055323
B01.300.107.320.215;Eupenicillium;D055324
B01.300.107.320.218;Eurotium;D055325
B01.300.107.320.550;Neosartorya;D055326
B01.300.107.320.820;Thermoascus;D055327
B01.300.381.570;Neotyphodium;D055328
B01.300.107.501.310;Epichloe;D055329
B01.300.107.501.550;Nectria;D055330
C04.557.435.108;Adenomyoepithelioma;D055331
D12.776.215.500;Cystatin M;D055332
D12.776.624.776.418;Cystatin M;D055332
D12.644.848.906;Salivary Cystatins;D055333
D12.776.215.750;Salivary Cystatins;D055333
D12.776.850.906;Salivary Cystatins;D055333
A08.663.650.850;Retinal Neurons;D055351
A09.371.729.831;Retinal Neurons;D055351
A11.671.650.850;Retinal Neurons;D055351
B02.200.400.400.445;Halorubrum;D055352
B03.440.400.425.377.249;Chromohalobacter;D055353
B03.660.250.350.249;Chromohalobacter;D055353
A11.284.430.214.190.875.190.880.495;Exosomes;D055354
D12.776.306.466;Opsins;D055355
D23.767.930.750;Opsins;D055355
E04.014.240;Endometrial Ablation Techniques;D055356
E04.950.300.320;Endometrial Ablation Techniques;D055356
E02.520.360.575;Uterine Artery Embolization;D055357
E02.926.500.575;Uterine Artery Embolization;D055357
E04.950.300.883;Uterine Artery Embolization;D055357
D12.776.306.466.249;Cone Opsins;D055358
D23.767.930.750.249;Cone Opsins;D055358
D27.720.066;Antistatic Agents;D055359
M01.526.485.810.722;Osteopathic Physicians;D055360
N02.360.810.722;Osteopathic Physicians;D055360
N06.850.520.830.562;Multilevel Analysis;D055361
B01.300.179.100.107;Agrocybe;D055362
B01.300.179.100.205;Cortinarius;D055363
B01.300.179.100.360;Hebeloma;D055364
B01.300.179.100.215;Cyathus;D055365
G04.580.887;Synaptic Potentials;D055366
G07.265.337.900.750;Synaptic Potentials;D055366
G07.265.750.887;Synaptic Potentials;D055366
G07.700.240.900.750;Synaptic Potentials;D055366
G11.561.570.918;Synaptic Potentials;D055366
G11.561.600.835.750;Synaptic Potentials;D055366
B01.300.179.100.875;Volvariella;D055367
B01.300.179.100.645;Pholiota;D055368
G04.580.887.500;Miniature Postsynaptic Potentials;D055369
G07.265.337.900.750.560;Miniature Postsynaptic Potentials;D055369
G07.265.750.887.500;Miniature Postsynaptic Potentials;D055369
G07.700.240.900.750.560;Miniature Postsynaptic Potentials;D055369
G11.561.570.918.500;Miniature Postsynaptic Potentials;D055369
G11.561.600.835.750.560;Miniature Postsynaptic Potentials;D055369
C08.381.520;Lung Injury;D055370
C26.891.554;Lung Injury;D055370
C08.381.520.500;Acute Lung Injury;D055371
D08.811.913.696.620.682.700.085;AMP-Activated Protein Kinases;D055372
D12.644.360.062;AMP-Activated Protein Kinases;D055372
D12.776.476.062;AMP-Activated Protein Kinases;D055372
B01.300.179.100.660;Psilocybe;D055391
B01.300.179.100.125;Armillaria;D055392
B01.300.179.100.320;Flammulina;D055393
D08.811.277.656.675.374.525.700.900;Tolloid-Like Metalloproteinases;D055394
D12.644.276.948;Tolloid-Like Metalloproteinases;D055394
D12.776.467.948;Tolloid-Like Metalloproteinases;D055394
D23.529.948;Tolloid-Like Metalloproteinases;D055394
D08.811.277.656.300.480.525.700.049;Bone Morphogenetic Protein 1;D055395
D08.811.277.656.675.374.525.700.900.500;Bone Morphogenetic Protein 1;D055395
D12.644.276.948.500;Bone Morphogenetic Protein 1;D055395
D12.644.276.954.200.100;Bone Morphogenetic Protein 1;D055395
D12.776.467.942.200.100;Bone Morphogenetic Protein 1;D055395
D12.776.467.948.500;Bone Morphogenetic Protein 1;D055395
D23.529.942.200.100;Bone Morphogenetic Protein 1;D055395
D23.529.948.500;Bone Morphogenetic Protein 1;D055395
D12.644.276.954.200.200;Bone Morphogenetic Protein 2;D055396
D12.776.467.942.200.200;Bone Morphogenetic Protein 2;D055396
D23.529.942.200.200;Bone Morphogenetic Protein 2;D055396
C08.381.520.750;Ventilator-Induced Lung Injury;D055397
D12.644.276.954.200.300;Bone Morphogenetic Protein 3;D055398
D12.776.467.942.200.300;Bone Morphogenetic Protein 3;D055398
D23.529.942.200.300;Bone Morphogenetic Protein 3;D055398
B01.300.179.100.502;Laccaria;D055399
D12.644.276.954;TGF-beta Superfamily Proteins;D055411
D12.776.467.942;TGF-beta Superfamily Proteins;D055411
D23.529.942;TGF-beta Superfamily Proteins;D055411
D12.644.276.954.300;Growth Differentiation Factors;D055412
D12.776.467.942.300;Growth Differentiation Factors;D055412
D23.529.942.300;Growth Differentiation Factors;D055412
D12.644.276.954.200.950;Growth Differentiation Factor 10;D055413
D12.644.276.954.300.900;Growth Differentiation Factor 10;D055413
D12.776.467.942.200.950;Growth Differentiation Factor 10;D055413
D12.776.467.942.300.900;Growth Differentiation Factor 10;D055413
D23.529.942.200.950;Growth Differentiation Factor 10;D055413
D23.529.942.300.900;Growth Differentiation Factor 10;D055413
E01.370.350.130.875;Myocardial Perfusion Imaging;D055414
E01.370.350.710.600.500;Myocardial Perfusion Imaging;D055414
E01.370.370.380.500;Myocardial Perfusion Imaging;D055414
E01.370.384.730.354.500;Myocardial Perfusion Imaging;D055414
D12.644.276.954.200.400;Bone Morphogenetic Protein 4;D055415
D12.776.467.942.200.400;Bone Morphogenetic Protein 4;D055415
D23.529.942.200.400;Bone Morphogenetic Protein 4;D055415
H02.249.750.500;Evidence-Based Emergency Medicine;D055416
H02.403.200.400.500;Evidence-Based Emergency Medicine;D055416
D12.644.276.954.200.500;Bone Morphogenetic Protein 5;D055417
D12.776.467.942.200.500;Bone Morphogenetic Protein 5;D055417
D23.529.942.200.500;Bone Morphogenetic Protein 5;D055417
D12.644.276.954.200.600;Bone Morphogenetic Protein 6;D055418
D12.776.467.942.200.600;Bone Morphogenetic Protein 6;D055418
D23.529.942.200.600;Bone Morphogenetic Protein 6;D055418
D12.644.276.954.200.700;Bone Morphogenetic Protein 7;D055419
D12.776.467.942.200.700;Bone Morphogenetic Protein 7;D055419
D23.529.942.200.700;Bone Morphogenetic Protein 7;D055419
E01.370.350.710.600;Perfusion Imaging;D055420
E01.370.384.730.354;Perfusion Imaging;D055420
A07.231.908.950;Venous Valves;D055422
E02.642.249.650;Ketogenic Diet;D055423
G07.610.240.670;Ketogenic Diet;D055423
E01.370.350.130.500;Cardiac-Gated Imaging Techniques;D055424
E01.370.350.730;Respiratory-Gated Imaging Techniques;D055425
E01.370.386.730;Respiratory-Gated Imaging Techniques;D055425
E01.370.350.130.500.500;Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography;D055426
E01.370.350.350.800.800.500;Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography;D055426
E01.370.350.710.800.800.500;Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography;D055426
E01.370.350.825.800.800.500;Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography;D055426
E01.370.384.730.800.800.500;Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography;D055426
D12.644.276.954.200.910;Growth Differentiation Factor 2;D055427
D12.644.276.954.300.200;Growth Differentiation Factor 2;D055427
D12.776.467.942.200.910;Growth Differentiation Factor 2;D055427
D12.776.467.942.300.200;Growth Differentiation Factor 2;D055427
D23.529.942.200.910;Growth Differentiation Factor 2;D055427
D23.529.942.300.200;Growth Differentiation Factor 2;D055427
D12.644.276.954.300.500;Growth Differentiation Factor 5;D055428
D12.776.467.942.300.500;Growth Differentiation Factor 5;D055428
D23.529.942.300.500;Growth Differentiation Factor 5;D055428
D12.644.276.954.300.800;Growth Differentiation Factor 9;D055429
D12.776.467.942.300.800;Growth Differentiation Factor 9;D055429
D23.529.942.300.800;Growth Differentiation Factor 9;D055429
D12.644.276.954.200.900;Bone Morphogenetic Protein 15;D055430
D12.644.276.954.300.049;Bone Morphogenetic Protein 15;D055430
D12.776.467.942.200.900;Bone Morphogenetic Protein 15;D055430
D12.776.467.942.300.049;Bone Morphogenetic Protein 15;D055430
D23.529.942.200.900;Bone Morphogenetic Protein 15;D055430
D23.529.942.300.049;Bone Morphogenetic Protein 15;D055430
D12.644.276.954.300.600;Growth Differentiation Factor 6;D055431
D12.776.467.942.300.600;Growth Differentiation Factor 6;D055431
D23.529.942.300.600;Growth Differentiation Factor 6;D055431
H01.158.201.586;Metabolomics;D055432
H01.158.273.180.599;Metabolomics;D055432
H01.181.122.638;Metabolomics;D055432
B01.300.179.100.550;Marasmius;D055433
B01.300.179.100.780;Termitomyces;D055434
D12.644.276.954.300.925;Myostatin;D055435
D12.776.467.942.300.925;Myostatin;D055435
D23.529.942.300.925;Myostatin;D055435
D12.644.276.374.305;Growth Differentiation Factor 15;D055436
D12.644.276.954.300.915;Growth Differentiation Factor 15;D055436
D12.776.467.374.305;Growth Differentiation Factor 15;D055436
D12.776.467.942.300.915;Growth Differentiation Factor 15;D055436
D23.529.374.305;Growth Differentiation Factor 15;D055436
D23.529.942.300.915;Growth Differentiation Factor 15;D055436
G02.111.087;Biochemical Processes;D055438
G02.149.115;Biochemical Processes;D055438
B01.300.179.100.790;Tricholoma;D055439
B01.300.179.120.174.600;Poria;D055441
G03.500;Metabolome;D055442
D12.644.276.954.300.300;Growth Differentiation Factor 3;D055451
D12.644.276.954.550.300;Growth Differentiation Factor 3;D055451
D12.776.467.942.300.300;Growth Differentiation Factor 3;D055451
D12.776.467.942.550.300;Growth Differentiation Factor 3;D055451
D23.529.942.300.300;Growth Differentiation Factor 3;D055451
D23.529.942.550.300;Growth Differentiation Factor 3;D055451
D12.644.276.954.300.100;Growth Differentiation Factor 1;D055452
D12.644.276.954.550.100;Growth Differentiation Factor 1;D055452
D12.776.467.942.300.100;Growth Differentiation Factor 1;D055452
D12.776.467.942.550.100;Growth Differentiation Factor 1;D055452
D23.529.942.300.100;Growth Differentiation Factor 1;D055452
D23.529.942.550.100;Growth Differentiation Factor 1;D055452
B01.300.179.120.174;Coriolaceae;D055453
B01.300.179.120.174.850;Trametes;D055454
D12.644.276.954.550;Nodal Signaling Ligands;D055456
D12.776.467.942.550;Nodal Signaling Ligands;D055456
D23.529.942.550;Nodal Signaling Ligands;D055456
D12.644.276.954.550.650;Nodal Protein;D055457
D12.776.467.942.550.650;Nodal Protein;D055457
D23.529.942.550.650;Nodal Protein;D055457
D12.644.276.954.550.475;Left-Right Determination Factors;D055458
D12.776.467.942.550.475;Left-Right Determination Factors;D055458
D23.529.942.550.475;Left-Right Determination Factors;D055458
G01.154.100.280;Facilitated Diffusion;D055459
G01.595.100.280;Facilitated Diffusion;D055459
G01.595.200.374;Facilitated Diffusion;D055459
G02.149.767.560.500;Facilitated Diffusion;D055459
G02.842.750.560.500;Facilitated Diffusion;D055459
G03.495.166.427;Facilitated Diffusion;D055459
G01.595.200.750;Thermal Diffusion;D055471
G02.149.767.560.750;Thermal Diffusion;D055471
G02.842.750.560.750;Thermal Diffusion;D055471
B01.300.179.120.174.070;Antrodia;D055491
B01.300.179.120.760.675;Polyporus;D055492
A09.246.631.246.965;Spiral Ligament of Cochlea;D055493
B01.300.179.120.760.690;Pycnoporus;D055494
G04.299.151.912;Neurogenesis;D055495
G07.700.320.500.325.377.687;Neurogenesis;D055495
G08.686.785.760.170.450.500;Neurogenesis;D055495
C06.405.469.158.272.804;Neurogenic Bowel;D055496
J01.637.502;Jewelry;D055498
C01.539.195;Catheter-Related Infections;D055499
F02.940;Resilience, Psychological;D055500
C20.683.515.800;Macrophage Activation Syndrome;D055501
N02.421.726.825;Secondary Prevention;D055502
N06.850.780.750;Secondary Prevention;D055502
G02.111.087.697;Protein Multimerization;D055503
G02.149.115.697;Protein Multimerization;D055503
D12.644.360.024.301;Insulin Receptor Substrate Proteins;D055504
D12.776.157.057.039;Insulin Receptor Substrate Proteins;D055504
D12.776.476.024.382;Insulin Receptor Substrate Proteins;D055504
D12.644.276.200;CCN Intercellular Signaling Proteins;D055511
D12.776.467.200;CCN Intercellular Signaling Proteins;D055511
D12.776.860.300.200;CCN Intercellular Signaling Proteins;D055511
D23.529.237;CCN Intercellular Signaling Proteins;D055511
N02.421.726.860;Tertiary Prevention;D055512
N06.850.780.800;Tertiary Prevention;D055512
D12.644.276.200.100;Connective Tissue Growth Factor;D055513
D12.776.467.200.100;Connective Tissue Growth Factor;D055513
D12.776.860.300.200.100;Connective Tissue Growth Factor;D055513
D23.529.237.100;Connective Tissue Growth Factor;D055513
D12.644.276.200.500;Nephroblastoma Overexpressed Protein;D055514
D12.776.467.200.500;Nephroblastoma Overexpressed Protein;D055514
D12.776.860.300.200.500;Nephroblastoma Overexpressed Protein;D055514
D23.101.840.450;Nephroblastoma Overexpressed Protein;D055514
D23.529.237.600;Nephroblastoma Overexpressed Protein;D055514
D12.644.276.200.200;Cysteine-Rich Protein 61;D055515
D12.776.467.200.200;Cysteine-Rich Protein 61;D055515
D12.776.860.300.200.200;Cysteine-Rich Protein 61;D055515
D23.529.237.200;Cysteine-Rich Protein 61;D055515
D12.776.765.725.249;2S Albumins, Plant;D055516
D12.776.157.725.500.875.700;snRNP Core Proteins;D055517
D12.776.660.625.750;snRNP Core Proteins;D055517
D12.776.664.962.500.875.700;snRNP Core Proteins;D055517
D23.050.290.875;snRNP Core Proteins;D055517
D23.050.422.750;snRNP Core Proteins;D055517
D12.776.765.593;Photoreceptors, Plant;D055519
A11.284.430.106.279.345.447;Gemini of Coiled Bodies;D055531
D12.776.157.725.875;SMN Complex Proteins;D055532
D12.776.580.922;SMN Complex Proteins;D055532
D12.776.664.962.875;SMN Complex Proteins;D055532
D12.776.157.725.875.500;Survival of Motor Neuron 1 Protein;D055533
D12.776.580.922.500;Survival of Motor Neuron 1 Protein;D055533
D12.776.664.962.875.500;Survival of Motor Neuron 1 Protein;D055533
C10.228.854.468.399;Bulbo-Spinal Atrophy, X-Linked;D055534
C10.574.500.175;Bulbo-Spinal Atrophy, X-Linked;D055534
C10.574.562.500.374;Bulbo-Spinal Atrophy, X-Linked;D055534
C10.668.467.500.186;Bulbo-Spinal Atrophy, X-Linked;D055534
C16.320.322.076;Bulbo-Spinal Atrophy, X-Linked;D055534
C17.800.518;Morgellons Disease;D055535
E02.342.900;Vagus Nerve Stimulation;D055536
E02.779.468.900;Vagus Nerve Stimulation;D055536
G02.111.087.800.480;Light Signal Transduction;D055537
G02.149.115.800.480;Light Signal Transduction;D055537
G04.299.880.480;Light Signal Transduction;D055537
C15.378.071.141.150.875.575;delta-Thalassemia;D055538
C15.378.420.826.200;delta-Thalassemia;D055538
C16.320.070.875.575;delta-Thalassemia;D055538
C16.320.365.826.575;delta-Thalassemia;D055538
L01.178.820.090.615;MP3-Player;D055539
D12.776.157.725.875.750;Survival of Motor Neuron 2 Protein;D055540
D12.776.580.922.750;Survival of Motor Neuron 2 Protein;D055540
D12.776.664.962.875.750;Survival of Motor Neuron 2 Protein;D055540
D08.811.913.696.445.735.720.249.500;DEAD Box Protein 20;D055541
D12.776.157.725.875.249;DEAD Box Protein 20;D055541
D12.776.580.922.249;DEAD Box Protein 20;D055541
D12.776.664.962.875.249;DEAD Box Protein 20;D055541
D12.776.124.400.434.320;alpha-Globins;D055542
D12.776.422.316.762.403.320;alpha-Globins;D055542
D12.776.124.400.434.320.500;zeta-Globins;D055543
D12.776.422.316.762.403.320.500;zeta-Globins;D055543
D12.776.124.400.434.325;beta-Globins;D055544
D12.776.422.316.762.403.325;beta-Globins;D055544
D12.776.124.400.434.325.500;gamma-Globins;D055545
D12.776.422.316.762.403.325.500;gamma-Globins;D055545
D12.776.124.400.434.325.249;delta-Globins;D055546
D12.776.422.316.762.403.325.249;delta-Globins;D055546
D12.776.124.400.434.325.374;epsilon-Globins;D055547
D12.776.422.316.762.403.325.374;epsilon-Globins;D055547
G01.374.715.951;Vapor Pressure;D055548
D02.974;Volatile Organic Compounds;D055549
G02.111.700;Protein Stability;D055550
D12.776.580.216.270.625;HSP27 Heat-Shock Proteins;D055551
H02.403.429.480;Infectious Disease Medicine;D055552
D26.670;Prescription Drugs;D055553
D12.776.124.400.434;Hemoglobin Subunits;D055554
D12.776.422.316.762.403;Hemoglobin Subunits;D055554
E05.927.573;Nasal Lavage;D055556
G03.495.166.925;Secretory Pathway;D055571
G04.299.490.580;Secretory Pathway;D055571
D08.811.277.087.250;Ceramidases;D055572
D08.811.277.087.250.100;Acid Ceramidase;D055573
D08.811.277.087.250.300;Alkaline Ceramidase;D055574
D08.811.277.087.250.650;Neutral Ceramidase;D055576
C10.228.140.163.100.435.825.250;Farber Lipogranulomatosis;D055577
C16.320.565.189.435.825.250;Farber Lipogranulomatosis;D055577
C16.320.565.398.641.803.325;Farber Lipogranulomatosis;D055577
C16.320.565.595.554.825.250;Farber Lipogranulomatosis;D055577
C18.452.132.100.435.825.250;Farber Lipogranulomatosis;D055577
C18.452.584.687.803.325;Farber Lipogranulomatosis;D055577
C18.452.648.189.435.825.250;Farber Lipogranulomatosis;D055577
C18.452.648.398.641.803.325;Farber Lipogranulomatosis;D055577
C18.452.648.595.554.825.250;Farber Lipogranulomatosis;D055577
G01.060;Astronomical Phenomena;D055580
G01;Physical Phenomena;D055585
G01.595;Physical Processes;D055586
G01.060.249;Astronomical Objects;D055587
G01.060.374;Astronomical Processes;D055588
G01.595.060;Astronomical Processes;D055588
C06.689.750.860;Pancreatitis, Graft;D055589
G01.358.500;Electromagnetic Phenomena;D055590
G01.154;Biophysical Phenomena;D055592
G01.311;Geological Phenomena;D055593
G01.311.340;Geological Processes;D055594
G01.595.340;Geological Processes;D055594
G01.374;Mechanical Phenomena;D055595
G01.374.676;Mechanical Processes;D055596
G01.595.540;Mechanical Processes;D055596
G01.154.100;Biophysical Processes;D055597
G01.595.100;Biophysical Processes;D055597
G02;Chemical Phenomena;D055598
G02.149;Chemical Processes;D055599
G02.607;Organic Chemistry Phenomena;D055601
G02.149.465;Organic Chemistry Processes;D055602
G02.607.750;Organic Chemistry Processes;D055602
G02.842;Physicochemical Phenomena;D055605
G02.149.767;Physicochemical Processes;D055606
G02.842.750;Physicochemical Processes;D055606
D12.776.543.750.705.895;Receptors, Natural Killer Cell;D055607
G01.060.249.320;Galaxies;D055608
G01.060.249.750;Stars, Celestial;D055609
D23.050.301.264.035.100.500;Antigens, CD1d;D055610
D23.050.301.264.894.080.500;Antigens, CD1d;D055610
D23.101.100.110.100.500;Antigens, CD1d;D055610
D23.101.100.894.080.500;Antigens, CD1d;D055610
A11.118.637.555.567.569.290;Natural Killer T-Cells;D055611
A15.145.229.637.555.567.569.360;Natural Killer T-Cells;D055611
A15.382.490.555.567.569.470;Natural Killer T-Cells;D055611
A11.118.637.555.283;Cytokine-Induced Killer Cells;D055612
A11.251.476;Cytokine-Induced Killer Cells;D055612
A15.145.229.637.555.283;Cytokine-Induced Killer Cells;D055612
A15.382.490.555.283;Cytokine-Induced Killer Cells;D055612
C04.588.894.797.520.237;Multiple Pulmonary Nodules;D055613
C08.381.540.148;Multiple Pulmonary Nodules;D055613
C08.785.520.148;Multiple Pulmonary Nodules;D055613
G05;Genetic Phenomena;D055614
E07.305;Electrical Equipment and Supplies;D055615
H01.570;Microtechnology;D055616
J01.897.520.500;Microtechnology;D055616
E07.305.343;Micro-Electrical-Mechanical Systems;D055617
J01.637.509;Micro-Electrical-Mechanical Systems;D055617
E07.710;Radiation Equipment and Supplies;D055618
G01.590;Optical Phenomena;D055620
G01.590.770;Optical Processes;D055621
G01.595.640;Optical Processes;D055621
C05.651.594.728;Orbital Myositis;D055622
C10.668.491.562.537;Orbital Myositis;D055622
C11.675.426;Orbital Myositis;D055622
C04.834.450;Keratosis, Actinic;D055623
C17.800.428.570;Keratosis, Actinic;D055623
B03.300.390.400.800.750.100.500;Methicillin-Resistant Staphylococcus aureus;D055624
B03.510.100.750.750.100.500;Methicillin-Resistant Staphylococcus aureus;D055624
B03.510.400.790.750.100.500;Methicillin-Resistant Staphylococcus aureus;D055624
D12.776.543.750.705.895.750.100;Natural Cytotoxicity Triggering Receptor 1;D055627
D23.050.301.264.035.540;Natural Cytotoxicity Triggering Receptor 1;D055627
D23.101.100.110.540;Natural Cytotoxicity Triggering Receptor 1;D055627
D12.776.543.750.705.895.750.300;Natural Cytotoxicity Triggering Receptor 3;D055628
D23.050.301.264.035.547;Natural Cytotoxicity Triggering Receptor 3;D055628
D23.101.100.110.547;Natural Cytotoxicity Triggering Receptor 3;D055628
D12.776.543.750.705.895.750.200;Natural Cytotoxicity Triggering Receptor 2;D055629
D23.050.301.264.035.545;Natural Cytotoxicity Triggering Receptor 2;D055629
D23.101.100.110.545;Natural Cytotoxicity Triggering Receptor 2;D055629
D12.776.543.750.705.895.800;Receptors, NK Cell Lectin-Like;D055630
G07.690.812;Pharmacological Processes;D055632
G07.700.680;Pharmacological Processes;D055632
G12;Immune System Phenomena;D055633
G12.425;Immune System Processes;D055635
D12.776.543.750.705.895.750;Receptors, Natural Cytotoxicity Triggering;D055636
G15.744;Plant Physiological Processes;D055639
G17;Mathematical Concepts;D055641
D12.776.354.374;Killer Factors, Yeast;D055646
D23.946.587.531;Killer Factors, Yeast;D055646
B01.050.050.136.700;Rats, Transgenic;D055647
B01.050.150.900.649.865.635.505.700.825;Rats, Transgenic;D055647
G04.299;Cell Physiological Processes;D055648
D12.776.543.750.705.895.800.100;NK Cell Lectin-Like Receptor Subfamily A;D055650
D23.050.301.264.920.500;NK Cell Lectin-Like Receptor Subfamily A;D055650
D23.101.100.920.500;NK Cell Lectin-Like Receptor Subfamily A;D055650
D12.776.543.750.705.895.800.200;NK Cell Lectin-Like Receptor Subfamily B;D055651
D23.050.301.264.035.577;NK Cell Lectin-Like Receptor Subfamily B;D055651
D23.101.100.110.577;NK Cell Lectin-Like Receptor Subfamily B;D055651
C15.378.140.427;Gray Platelet Syndrome;D055652
C16.320.099.417;Gray Platelet Syndrome;D055652
C04.588.805.578.500;Muir-Torre Syndrome;D055653
C04.700.250.500.500;Muir-Torre Syndrome;D055653
C16.320.700.250.500.500;Muir-Torre Syndrome;D055653
C17.800.794.712.500;Muir-Torre Syndrome;D055653
C17.800.827.610;Muir-Torre Syndrome;D055653
C17.800.882.712.500;Muir-Torre Syndrome;D055653
D12.776.543.750.705.895.800.810;NK Cell Lectin-Like Receptor Subfamily C;D055654
D12.776.543.750.705.895.800.910;NK Cell Lectin-Like Receptor Subfamily K;D055655
D23.050.301.264.035.582;NK Cell Lectin-Like Receptor Subfamily K;D055655
D23.101.100.110.582;NK Cell Lectin-Like Receptor Subfamily K;D055655
N02.421.668.778;Prescriptions;D055656
E05.301;Electrochemical Techniques;D055664
C15.378.100.802.230;Purpura Fulminans;D055665
C23.550.414.950.230;Purpura Fulminans;D055665
C23.888.885.687.230;Purpura Fulminans;D055665
D10.477;Lipopeptides;D055666
D12.644.365;Lipopeptides;D055666
B03.510.024.049.050.287;Arcanobacterium;D055667
B03.510.460.400.400.049.049.200;Arcanobacterium;D055667
G02.149.767.690;Photochemical Processes;D055668
G02.842.750.690;Photochemical Processes;D055668
G16.500;Ecological and Environmental Phenomena;D055669
E02.190.488.585.700;Medicine, Korean Traditional;D055670
I01.076.201.450.654.558.700;Medicine, Korean Traditional;D055670
G01.358.500.249.820;Static Electricity;D055672
C10.500.034.500;Acrocallosal Syndrome;D055673
C16.131.666.034.500;Acrocallosal Syndrome;D055673
D27.720.556.500;Viscosupplements;D055675
D27.720.944.500;Viscosupplements;D055675
E02.319.267.530.380.500;Viscosupplementation;D055676
E02.718.875;Viscosupplementation;D055676
C18.654.521.687;Refeeding Syndrome;D055677
G06.590;Microbiological Processes;D055679
G06.590.875;Virus Physiological Processes;D055681
G06.920.875;Virus Physiological Processes;D055681
D27.720.944;Viscoelastic Substances;D055682
G06.099.112;Bacterial Processes;D055683
G06.590.110;Bacterial Processes;D055683
B01.300.381.723;Pyricularia grisea;D055685
E01.370.600.337;Metabolic Equivalent;D055686
G03.730.365;Metabolic Equivalent;D055686
G11;Musculoskeletal and Neural Physiological Phenomena;D055687
G10;Digestive System and Oral Physiological Phenomena;D055688
G10.549.235;Dental Physiological Processes;D055690
G16.500.240;Ecological and Environmental Processes;D055691
G16.100;Biological Processes;D055694
N02.421.668.778.750;Electronic Prescribing;D055695
F02.463.593.485;Olfactory Perception;D055696
F02.463.593.817;Taste Perception;D055697
F02.463.593.894;Touch Perception;D055698
I01.076.201.450.550.150.500;Cemeteries;D055699
I01.076.201.450.550.175;Cremation;D055700
G08.852.796;Urinary Tract Physiological Processes;D055702
G08.686;Reproductive Physiological Phenomena;D055703
G08.686.785;Reproductive Physiological Processes;D055704
G07.700;Physiological Processes;D055705
G07.265;Electrophysiological Phenomena;D055724
G07.265.337;Electrophysiological Processes;D055725
G07.700.240;Electrophysiological Processes;D055725
Z01.058.290.190.258;Cape Verde;D055726
C15.378.190.636.765;Primary Myelofibrosis;D055728
H01.158.201.085;Carbohydrate Biochemistry;D055731
C08.381.472.850;Pulmonary Aspergillosis;D055732
C08.381.472.850.750;Invasive Pulmonary Aspergillosis;D055744
A04.411.125.500;Bronchioles;D055745
D23.050.301.264.965;Stage-Specific Embryonic Antigens;D055746
D23.101.100.965;Stage-Specific Embryonic Antigens;D055746
D12.776.260.719;SOX Transcription Factors;D055747
D12.776.660.235.400.750;SOX Transcription Factors;D055747
D12.776.664.235.400.750;SOX Transcription Factors;D055747
D12.776.930.823;SOX Transcription Factors;D055747
D12.776.260.719.100;SOXB1 Transcription Factors;D055748
D12.776.660.235.400.750.100;SOXB1 Transcription Factors;D055748
D12.776.664.235.400.750.100;SOXB1 Transcription Factors;D055748
D12.776.930.823.100;SOXB1 Transcription Factors;D055748
D12.776.260.719.200;SOXB2 Transcription Factors;D055749
D12.776.660.235.400.750.200;SOXB2 Transcription Factors;D055749
D12.776.664.235.400.750.200;SOXB2 Transcription Factors;D055749
D12.776.930.823.200;SOXB2 Transcription Factors;D055749
B01.750.937.715.600;Phytophthora infestans;D055750
D12.776.260.719.300;SOXC Transcription Factors;D055751
D12.776.660.235.400.750.300;SOXC Transcription Factors;D055751
D12.776.664.235.400.750.300;SOXC Transcription Factors;D055751
D12.776.930.823.300;SOXC Transcription Factors;D055751
C04.588.894.797.520.109.220.624;Small Cell Lung Carcinoma;D055752
C08.381.540.140.750;Small Cell Lung Carcinoma;D055752
C08.785.520.100.220.750;Small Cell Lung Carcinoma;D055752
G03;Metabolic Phenomena;D055754
D12.776.260.719.400;SOXD Transcription Factors;D055755
D12.776.660.235.400.750.400;SOXD Transcription Factors;D055755
D12.776.664.235.400.750.400;SOXD Transcription Factors;D055755
D12.776.930.823.400;SOXD Transcription Factors;D055755
C04.588.614.250.580.150;Meningeal Carcinomatosis;D055756
C10.551.240.500.150;Meningeal Carcinomatosis;D055756
D12.776.260.719.500;SOXE Transcription Factors;D055757
D12.776.660.235.400.750.500;SOXE Transcription Factors;D055757
D12.776.664.235.400.750.500;SOXE Transcription Factors;D055757
D12.776.930.823.500;SOXE Transcription Factors;D055757
D12.776.260.719.500.500;SOX9 Transcription Factor;D055758
D12.776.660.235.400.750.500.500;SOX9 Transcription Factor;D055758
D12.776.664.235.400.750.500.500;SOX9 Transcription Factor;D055758
D12.776.930.823.500.500;SOX9 Transcription Factor;D055758
D12.776.260.719.600;SOXF Transcription Factors;D055760
D12.776.660.235.400.750.600;SOXF Transcription Factors;D055760
D12.776.664.235.400.750.600;SOXF Transcription Factors;D055760
D12.776.930.823.600;SOXF Transcription Factors;D055760
C22.131.780;Reticuloendotheliosis, Avian;D055761
A02.835.232.781.175;Cranial Fontanelles;D055762
B01.050.500.308.550;Myxozoa;D055764
D12.644.360.024.330;Shc Signaling Adaptor Proteins;D055765
D12.776.157.057.162;Shc Signaling Adaptor Proteins;D055765
D12.776.476.024.415;Shc Signaling Adaptor Proteins;D055765
B01.050.500.308.550.500;Myxobolus;D055766
D12.776.463;Immobilized Proteins;D055767
D02.355.726.601;Halogenated Diphenyl Ethers;D055768
D02.455.426.559.389.657.654.601;Halogenated Diphenyl Ethers;D055768
E03.091.430;Interpleural Analgesia;D055770
Z01.542.248.786;Serbia;D055771
J01.256.350;Green Chemistry Technology;D055772
J01.897.360;Green Chemistry Technology;D055772
E05.393.335.500;Gene Knockdown Techniques;D055785
E05.393.335.750;Gene Knockout Techniques;D055786
Z01.586.315.720;Prussia;D055787
Z01.586.725;Prussia;D055787
N02.421.585.525;Moving and Lifting Patients;D055805
A07.231.461;Microvessels;D055806
F01.145.126.950.500;Stalking;D055807
I01.880.735.223.500;Stalking;D055807
E05.295;Drug Discovery;D055808
H01.158.703.007.675;Drug Discovery;D055808
H01.181.466.675;Drug Discovery;D055808
F01.145.499;Illness Behavior;D055809
E05.318.308.461;Lot Quality Assurance Sampling;D055810
N05.715.360.775.700.500;Lot Quality Assurance Sampling;D055810
N06.850.520.308.461;Lot Quality Assurance Sampling;D055810
L01.178.682.099.325.500;Journal Impact Factor;D055811
L01.453.183.291.500;Journal Impact Factor;D055811
H01.770.644.193;Community-Based Participatory Research;D055812
N05.425.104;Community-Based Participatory Research;D055812
H02.403.959;Wilderness Medicine;D055813
G16.500.275.965;Wilderness;D055814
M01.060.116.815;Young Adult;D055815
F01.145.126.995;Wandering Behavior;D055816
N04.452.758.377.937;Telenursing;D055817
J01.219.843;Public-Private Sector Partnerships;D055818
N03.540.706;Public-Private Sector Partnerships;D055818
N02.278.421.556.330;Hospitals, Isolation;D055819
Z01.107.567.875.750.480.500;New Orleans;D055820
Z01.433.697;New Orleans;D055820
V02.712;Poetry;D055821
V02.272;Cookbooks;D055823
V02.480;Formularies;D055824
I01.409.137.500.600.480.461;National Institute of Neurological Disorders and Stroke;D055825
N03.540.348.500.500.600.480.461;National Institute of Neurological Disorders and Stroke;D055825
K01.400.504.984.124;Afghan Campaign 2001-;D055826
G13;Integumentary System Physiological Phenomena;D055827
C04.700.250.500;Lynch Syndrome II;D055847
C16.320.700.250.500;Lynch Syndrome II;D055847
E07.305.437.600;Nuclear Power Plants;D055848
E07.710.600.500;Nuclear Power Plants;D055848
J01.780.600;Nuclear Power Plants;D055848
G16.500.240.135.781;Droughts;D055864
G16.500.750.775.154;Droughts;D055864
F04.754.137.875;Sleep Phase Chronotherapy;D055865
G01.311.340.224;Earthquakes;D055866
G01.595.340.224;Earthquakes;D055866
G16.500.240.135.500;Cyclonic Storms;D055867
G16.500.240.135.812;Floods;D055868
G16.500.750.775.745;Tornadoes;D055869
E02.168.500;Drug Chronotherapy;D055870
E02.319.283.400;Drug Chronotherapy;D055870
G01.311.340.787;Tidal Waves;D055871
G16.500.240.135.875;Tidal Waves;D055871
N06.230.132.644.750.500;Tidal Waves;D055871
N05.300.450.760;Surge Capacity;D055872
G16.500.750.775.232;Extreme Cold;D055873
N06.230.300.100.725.154.500;Extreme Cold;D055873
N06.230.300.100.725.710.300.500;Extreme Cold;D055873
G16.500.750.775.271;Extreme Heat;D055874
N06.230.300.100.725.232.500;Extreme Heat;D055874
N06.230.300.100.725.710.380.500;Extreme Heat;D055874
G01.311.340.111;Avalanches;D055875
G01.595.340.111;Avalanches;D055875
G01.311.340.674;Landslides;D055876
G01.595.340.674;Landslides;D055876
N06.850.780.675.324;Biosurveillance;D055877
E05.393.335.249;Gene Knock-In Techniques;D055879
H01.158.580;Chronobiology Discipline;D055881
C04.557.665.560.580;Nevus, Halo;D055882
N06.230.750;Structure Collapse;D055883
N06.850.135.195;Chemical Hazard Release;D055884
N06.850.135.190;Biohazard Release;D055885
H01.277.687;Meteorology;D055904
H01.671.547;Meteorology;D055904
K01.400.504.968.750;Sverdlovsk Accidental Release;D055905
N06.850.135.190.500;Sverdlovsk Accidental Release;D055905
K01.400.504.968.700;Seveso Accidental Release;D055906
N06.850.135.195.500;Seveso Accidental Release;D055906
G16.500.240.135;Climatic Processes;D055907
K01.400.504.968.074;Bhopal Accidental Release;D055908
N06.850.135.195.249;Bhopal Accidental Release;D055908
E02.621;Magnetic Field Therapy;D055909
D12.776.124.486.485.114.207;Antibodies, Immobilized;D055910
D12.776.124.790.651.114.207;Antibodies, Immobilized;D055910
D12.776.377.715.548.114.207;Antibodies, Immobilized;D055910
D12.776.463.250;Antibodies, Immobilized;D055910
J01.576.423.200.200.500;Cookbooks as Topic;D055927
L01.178.682.192.402;Cookbooks as Topic;D055927
G13.750.829;Skin Physiological Processes;D055928
A11.284.430.214.190.875.450;Magnetosomes;D055944
A20.859;Magnetosomes;D055944
C05.660.207.532;Loeys-Dietz Syndrome;D055947
C14.907.055.050.362;Loeys-Dietz Syndrome;D055947
C14.907.055.239.587;Loeys-Dietz Syndrome;D055947
C14.907.109.139.587;Loeys-Dietz Syndrome;D055947
C16.131.077.537;Loeys-Dietz Syndrome;D055947
C16.320.510;Loeys-Dietz Syndrome;D055947
C10.597.613.612.500;Sarcopenia;D055948
C23.300.070.500.500;Sarcopenia;D055948
C23.888.592.608.612.500;Sarcopenia;D055948
C13.703.420.952;Vasa Previa;D055949
J02.500.525.425;Functional Food;D055951
C10.292.910.299;Cogan Syndrome;D055952
C11.180;Cogan Syndrome;D055952
C14.907.940.320;Cogan Syndrome;D055952
C10.228.140.300.275.600;Microscopic Polyangiitis;D055953
C14.907.253.329.600;Microscopic Polyangiitis;D055953
C14.907.940.897.249.500;Microscopic Polyangiitis;D055953
C20.111.193.750;Microscopic Polyangiitis;D055953
C11.204.278;Corneal Endothelial Cell Loss;D055954
C23.550.767.093;Corneal Endothelial Cell Loss;D055954
C09.218.855;Susac Syndrome;D055955
C10.228.140.300.787;Susac Syndrome;D055955
C10.597.825;Susac Syndrome;D055955
C11.768.400.500;Susac Syndrome;D055955
C11.966.858;Susac Syndrome;D055955
C14.907.137.780.500;Susac Syndrome;D055955
C23.888.307.750;Susac Syndrome;D055955
C23.888.592.848;Susac Syndrome;D055955
C10.228.140.380.254;Diffuse Neurofibrillary Tangles with Calcification;D055956
C10.574.945.374;Diffuse Neurofibrillary Tangles with Calcification;D055956
F03.087.400.370;Diffuse Neurofibrillary Tangles with Calcification;D055956
C10.597.617.682.675;Piriformis Muscle Syndrome;D055958
C10.668.829.500.675.399;Piriformis Muscle Syndrome;D055958
C10.668.829.550.500;Piriformis Muscle Syndrome;D055958
C10.668.829.600.675;Piriformis Muscle Syndrome;D055958
C23.888.592.612.664.675;Piriformis Muscle Syndrome;D055958
C23.888.646.508.675;Piriformis Muscle Syndrome;D055958
C23.888.646.587.750;Piriformis Muscle Syndrome;D055958
C05.116.900.153;Intervertebral Disc Degeneration;D055959
C08.127.108.054;Asthma, Aspirin-Induced;D055963
C08.674.095.054;Asthma, Aspirin-Induced;D055963
C20.543.206.189;Asthma, Aspirin-Induced;D055963
C20.543.480.149;Asthma, Aspirin-Induced;D055963
C10.597.606.881.350.099;Alien Hand Syndrome;D055964
C23.888.592.604.080.500;Alien Hand Syndrome;D055964
C23.888.592.604.882.350.099;Alien Hand Syndrome;D055964
F01.700.080.249;Alien Hand Syndrome;D055964
F01.700.875.350.099;Alien Hand Syndrome;D055964
A12.207.721;Nipple Aspirate Fluid;D055966
E07.305.092;Cathode Ray Tube;D055984
C01.252.410.040.552.846.122;Latent Tuberculosis;D055985
E01.370.600.875;Vital Signs;D055986
A07.231.114.940;Uterine Artery;D055988
E07.695.715;Septal Occluder Device;D055989
I01.880.604.473.650.960;Therapeutic Misconception;D055990
K01.316.366.850;Therapeutic Misconception;D055990
E05.318.308.940.968.249;Health Records, Personal;D055991
A11.497.248;Germ Cells, Plant;D055993
A18.024.249.500.249;Germ Cells, Plant;D055993
H01.277.625;Limnology;D055994
E05.599.595.500;Molecular Dynamics Simulation;D056004
G02.575.750;Molecular Dynamics Simulation;D056004
L01.224.160.500;Molecular Dynamics Simulation;D056004
C01.252.410.040.552.386.850;Leprosy, Paucibacillary;D056005
C01.252.410.040.552.386.775;Leprosy, Multibacillary;D056006
E01.370.520.049;Actigraphy;D056044
E05.003.500;Actigraphy;D056044
G05.347;Genetic Fitness;D056084
C14.280.067.441;Commotio Cordis;D056104
C10.597.617.947;Slit Ventricle Syndrome;D056124
C23.550.767.884;Slit Ventricle Syndrome;D056124
C23.888.592.612.441.500;Slit Ventricle Syndrome;D056124
C23.888.646.487.500;Slit Ventricle Syndrome;D056124
E04.950.774.860.619;Orchiopexy;D056126
H01.158.273.248.750;Hydrobiology;D056127
H01.277.249.750;Hydrobiology;D056127
C18.654.726.500.697;Obesity, Abdominal;D056128
E01.370.600.115.100.160.120.699.500.249;Obesity, Abdominal;D056128
G07.100.100.160.120.699.500.249;Obesity, Abdominal;D056128
G04.299.151.650.240;Gametogenesis, Plant;D056130
G08.686.785.760.310.249;Gametogenesis, Plant;D056130
G15.744.149;Gametogenesis, Plant;D056130
A04.623.490.600;Pyriform Sinus;D056144
H01.158.273.248.750.249;Freshwater Biology;D056145
H01.277.249.750.249;Freshwater Biology;D056145
H01.277.625.500;Freshwater Biology;D056145
C23.550.260.224.200;Corpse Dismemberment;D056146
C26.986.111;Corpse Dismemberment;D056146
I01.198.240.194;Corpse Dismemberment;D056146
E02.779.124.500;Equine-Assisted Therapy;D056147
E02.831.083.500;Equine-Assisted Therapy;D056147
F04.754.017.500;Equine-Assisted Therapy;D056147
E05.196.181.400.495;Chromatography, Reverse-Phase;D056148
E01.370.370.380.245.500;Epicardial Mapping;D056149
C17.800.033;Acute Generalized Exanthematous Pustulosis;D056150
C23.300.017;Airway Remodeling;D056151
G09.772.029;Airway Remodeling;D056151
E01.370.600.875.875;Respiratory Rate;D056152
G09.772.770.755.730;Respiratory Rate;D056152
I02.358.399.644.500;Teaching Rounds;D056164
B04.820.650.200.735.750;Simian T-lymphotropic virus 3;D056185
B04.909.574.807.200.735.750;Simian T-lymphotropic virus 3;D056185
B04.909.574.807.805.858;Simian T-lymphotropic virus 3;D056185
B04.909.777.731.200.735.750;Simian T-lymphotropic virus 3;D056185
H01.158.273.343.350.261;Metagenomics;D056186
B04.820.650.200.735.374;Human T-lymphotropic virus 3;D056187
B04.909.574.807.200.735.374;Human T-lymphotropic virus 3;D056187
B04.909.777.731.200.735.374;Human T-lymphotropic virus 3;D056187
G06.590.875.712;Viral Tropism;D056189
G06.920.875.712;Viral Tropism;D056189
A21;Viral Structures;D056224
A20;Bacterial Structures;D056226
F04.754.137.301.500;Feedback, Sensory;D056228
F04.754.308.500.500;Feedback, Sensory;D056228
F04.754.339;Feedback, Sensory;D056228
G07.700.360.732.500;Feedback, Sensory;D056228
L01.143.283.425.311.500;Feedback, Sensory;D056228
L01.143.283.425.624.750;Feedback, Sensory;D056228
A19;Fungal Structures;D056229
D08.811.277.040.025.176;Mi-2 Nucleosome Remodeling and Deacetylase Complex;D056245
D08.811.277.087.520.500;Mi-2 Nucleosome Remodeling and Deacetylase Complex;D056245
D08.811.600.620;Mi-2 Nucleosome Remodeling and Deacetylase Complex;D056245
H01.181.309;Chemistry, Analytic;D056246
D08.811.277.087.520.750;Sin3 Histone Deacetylase and Corepressor Complex;D056264
D08.811.600.795;Sin3 Histone Deacetylase and Corepressor Complex;D056264
D12.776.930.700.625.750;Sin3 Histone Deacetylase and Corepressor Complex;D056264
G06.590.580;Microbial Interactions;D056265
C16.320.850.337;Erythrokeratodermia Variabilis;D056266
C17.800.229.606;Erythrokeratodermia Variabilis;D056266
C17.800.428.304;Erythrokeratodermia Variabilis;D056266
C17.800.827.337;Erythrokeratodermia Variabilis;D056266
C04.557.386.480.750.800.550.600;Pagetoid Reticulosis;D056267
C15.604.515.569.480.750.800.550.600;Pagetoid Reticulosis;D056267
C20.683.515.761.480.750.800.550.600;Pagetoid Reticulosis;D056267
D08.811.277.087.520.500.100;Histone Deacetylase 1;D056284
D08.811.277.087.520.750.100;Histone Deacetylase 1;D056284
D08.811.600.620.100;Histone Deacetylase 1;D056284
D08.811.600.795.100;Histone Deacetylase 1;D056284
B01.300.381.258.300;Cryptococcus gattii;D056285
B01.300.930.316.300;Cryptococcus gattii;D056285
D12.644.360.024.328;Retinoblastoma Binding Proteins;D056286
D12.776.157.057.158;Retinoblastoma Binding Proteins;D056286
D12.776.476.024.414;Retinoblastoma Binding Proteins;D056286
D12.776.660.769;Retinoblastoma Binding Proteins;D056286
C05.116.482;Genu Valgum;D056304
C05.116.511;Genu Varum;D056305
E01.370.350.500.150.500;Diffusion Tensor Imaging;D056324
E01.370.350.578.750;Diffusion Tensor Imaging;D056324
E01.370.376.537.500;Diffusion Tensor Imaging;D056324
E05.629.750;Diffusion Tensor Imaging;D056324
D27.720.470.410.577;Neuronal Tract-Tracers;D056325
F02.463.217;Executive Function;D056344
F02.463.689;Theory of Mind;D056345
F02.739.897;Theory of Mind;D056345
E04.928.710;Sternotomy;D056346
E01.370.225.500.620.670.570;Neuroanatomical Tract-Tracing Techniques;D056347
E01.370.225.750.600.670.570;Neuroanatomical Tract-Tracing Techniques;D056347
E05.200.500.620.670.570;Neuroanatomical Tract-Tracing Techniques;D056347
E05.200.750.600.670.570;Neuroanatomical Tract-Tracing Techniques;D056347
F01.752.543.500;Emotional Intelligence;D056348
M01.072;Athletes;D056352
C04.182.199;Colloid Cysts;D056364
C04.588.614.250.387.200;Colloid Cysts;D056364
C10.500.142.200;Colloid Cysts;D056364
C10.551.240.375.200;Colloid Cysts;D056364
C16.131.666.142.200;Colloid Cysts;D056364
D08.811.277.040.025.142.500;Group I Chaperonins;D056384
D12.776.580.216.210.590;Group I Chaperonins;D056384
D08.811.277.040.025.142.750;Group II Chaperonins;D056385
D12.776.580.216.210.795;Group II Chaperonins;D056385
D08.811.277.040.025.142.750.500;Chaperonin Containing TCP-1;D056404
D12.776.580.216.210.795.500;Chaperonin Containing TCP-1;D056404
D08.811.277.040.025.142.750.750;Thermosomes;D056405
D12.776.090.825;Thermosomes;D056405
D12.776.580.216.210.795.750;Thermosomes;D056405
E04.188.200;Decompressive Craniectomy;D056424
E04.525.190.200;Decompressive Craniectomy;D056424
G05.360.340.024.380;Genetic Loci;D056426
G05.360.340.024.380.968;t-Complex Genome Region;D056427
D08.811.277.040.025.193.249.500;Axonemal Dyneins;D056444
D08.811.277.040.025.193.249.750;Cytoplasmic Dyneins;D056445
G11.427.695.380;Knee-Chest Position;D056446
E02.779.124;Animal Assisted Therapy;D056447
E02.831.083;Animal Assisted Therapy;D056447
F04.754.017;Animal Assisted Therapy;D056447
H01.277;Earth Sciences;D056448
B03.510.100;Bacillales;D056449
B03.510.100.050;Alicyclobacillus;D056450
B03.510.415.400.078;Alicyclobacillus;D056450
D08.811.277.087.520.500.200;Histone Deacetylase 2;D056464
D08.811.277.087.520.750.200;Histone Deacetylase 2;D056464
D08.811.600.620.200;Histone Deacetylase 2;D056464
D08.811.600.795.200;Histone Deacetylase 2;D056464
D12.644.360.024.328.100;Retinoblastoma-Binding Protein 1;D056465
D12.776.157.057.158.100;Retinoblastoma-Binding Protein 1;D056465
D12.776.476.024.414.100;Retinoblastoma-Binding Protein 1;D056465
D12.776.660.769.100;Retinoblastoma-Binding Protein 1;D056465
D08.811.682.662.582.475;Histone Demethylases;D056466
D08.811.682.662.582.475.500;Jumonji Domain-Containing Histone Demethylases;D056484
D08.811.682.690.416.388;Jumonji Domain-Containing Histone Demethylases;D056484
D08.811.682.662.582.475.500.500;Retinoblastoma-Binding Protein 2;D056485
D08.811.682.690.416.388.200;Retinoblastoma-Binding Protein 2;D056485
D12.644.360.024.328.200;Retinoblastoma-Binding Protein 2;D056485
D12.776.157.057.158.200;Retinoblastoma-Binding Protein 2;D056485
D12.776.476.024.414.200;Retinoblastoma-Binding Protein 2;D056485
D12.776.660.769.200;Retinoblastoma-Binding Protein 2;D056485
C06.552.195;Drug-Induced Liver Injury;D056486
C25.723.260;Drug-Induced Liver Injury;D056486
C06.552.195.200;Drug-Induced Liver Injury, Chronic;D056487
C25.723.260.200;Drug-Induced Liver Injury, Chronic;D056487
D12.776.580.219;Histone Chaperones;D056488
D12.776.580.219.500;Nucleoplasmins;D056489
D12.776.580.219.550;Nucleosome Assembly Protein 1;D056490
D12.776.580.219.200;Chromatin Assembly Factor-1;D056504
D05.500.781.750.500;Retinoblastoma-Binding Protein 4;D056505
D08.811.277.087.520.500.775;Retinoblastoma-Binding Protein 4;D056505
D08.811.277.087.520.750.775;Retinoblastoma-Binding Protein 4;D056505
D08.811.600.620.775;Retinoblastoma-Binding Protein 4;D056505
D08.811.600.795.775;Retinoblastoma-Binding Protein 4;D056505
D12.644.360.024.328.600;Retinoblastoma-Binding Protein 4;D056505
D12.776.157.057.158.600;Retinoblastoma-Binding Protein 4;D056505
D12.776.476.024.414.600;Retinoblastoma-Binding Protein 4;D056505
D12.776.580.219.200.500;Retinoblastoma-Binding Protein 4;D056505
D12.776.660.235.600.200.500;Retinoblastoma-Binding Protein 4;D056505
D12.776.660.769.600;Retinoblastoma-Binding Protein 4;D056505
D12.776.664.235.800.200.500;Retinoblastoma-Binding Protein 4;D056505
D12.776.930.700.890.200.500;Retinoblastoma-Binding Protein 4;D056505
B03.300.390.400.158.400;Geobacillus;D056506
B03.510.100.100.400;Geobacillus;D056506
B03.510.415.400.158.400;Geobacillus;D056506
B03.510.460.410.158.400;Geobacillus;D056506
B03.300.390.400.645;Paenibacillus;D056507
B03.510.100.645;Paenibacillus;D056507
B03.510.415.400.645;Paenibacillus;D056507
B03.510.460.410.645;Paenibacillus;D056507
H02.403.429.865;Sleep Medicine Specialty;D056508
B03.300.390.400.158.800;Thermoactinomyces;D056509
B03.300.390.400.850;Thermoactinomyces;D056509
B03.510.100.800;Thermoactinomyces;D056509
B03.510.415.400.850;Thermoactinomyces;D056509
B03.510.460.410.850;Thermoactinomyces;D056509
E05.318.740.600.650;Position-Specific Scoring Matrices;D056510
E05.393.760.670;Position-Specific Scoring Matrices;D056510
G02.111.570.580.175.500;Position-Specific Scoring Matrices;D056510
D12.776.580.612;Metallochaperones;D056511
D05.500.781.750.750;Retinoblastoma-Binding Protein 7;D056524
D08.811.277.087.520.500.887;Retinoblastoma-Binding Protein 7;D056524
D08.811.277.087.520.750.887;Retinoblastoma-Binding Protein 7;D056524
D08.811.600.620.887;Retinoblastoma-Binding Protein 7;D056524
D08.811.600.795.887;Retinoblastoma-Binding Protein 7;D056524
D12.644.360.024.328.700;Retinoblastoma-Binding Protein 7;D056524
D12.776.157.057.158.700;Retinoblastoma-Binding Protein 7;D056524
D12.776.476.024.414.700;Retinoblastoma-Binding Protein 7;D056524
D12.776.660.235.600.200.750;Retinoblastoma-Binding Protein 7;D056524
D12.776.660.769.700;Retinoblastoma-Binding Protein 7;D056524
D12.776.664.235.800.200.750;Retinoblastoma-Binding Protein 7;D056524
D12.776.930.700.890.200.750;Retinoblastoma-Binding Protein 7;D056524
D08.811.277.087.520.200;Group III Histone Deacetylases;D056545
B03.510.550;Lactobacillales;D056546
A08.186.211.464.405.099;CA1 Region, Hippocampal;D056547
A08.186.211.730.885.287.500.345.099;CA1 Region, Hippocampal;D056547
D08.811.277.087.520.200.650.100;Sirtuin 1;D056564
D12.776.476.900.100;Sirtuin 1;D056564
D08.811.277.087.520.200.650.200;Sirtuin 2;D056565
D08.811.913.400.725.115.961.200;Sirtuin 2;D056565
D12.776.476.900.200;Sirtuin 2;D056565
D08.811.277.087.520.200.650.600;Sirtuin 3;D056566
D08.811.913.400.725.115.961.600;Sirtuin 3;D056566
D12.776.476.900.600;Sirtuin 3;D056566
D12.776.575.875;Sirtuin 3;D056566
B03.510.550.030;Aerococcaceae;D056567
B03.510.550.130;Carnobacteriaceae;D056568
B03.510.550.250;Enterococcaceae;D056569
B03.510.400.030;Aerococcus;D056570
B03.510.550.030.030;Aerococcus;D056570
V02.731;Postcards;D056571
D27.505.519.389.360;Histone Deacetylase Inhibitors;D056572
B03.510.550.130.150;Carnobacterium;D056573
B03.510.550.475;Leuconostocaceae;D056584
B03.510.400.531;Oenococcus;D056585
B03.510.550.475.600;Oenococcus;D056585
C08.381.074;Acute Chest Syndrome;D056586
C08.618.009;Acute Chest Syndrome;D056586
C15.378.071.141.150.150.219;Acute Chest Syndrome;D056586
C15.378.420.155.219;Acute Chest Syndrome;D056586
C16.320.070.150.219;Acute Chest Syndrome;D056586
C16.320.365.155.219;Acute Chest Syndrome;D056586
C16.320.382.500;Cryopyrin-Associated Periodic Syndromes;D056587
C17.800.827.368.500;Cryopyrin-Associated Periodic Syndromes;D056587
D20.215.784.500.400;Grape Seed Extract;D056604
D26.667.500;Grape Seed Extract;D056604
E06.397.778.188;Apexification;D056624
A18.024.500.750.666;Endosperm;D056625
A18.024.249.500.624;Inflorescence;D056626
C06.844.610;Peritoneal Fibrosis;D056627
C23.550.355.625;Peritoneal Fibrosis;D056627
B04.525.165;Dicistroviridae;D056629
B04.820.215;Dicistroviridae;D056629
B04.909.777.216;Dicistroviridae;D056629
J01.040.207;Beekeeping;D056630
G16.100.200;Colony Collapse;D056631
D08.811.277.656.224.300;Cathepsin F;D056646
D08.811.277.656.262.500.146;Cathepsin F;D056646
D08.811.277.656.300.200.146;Cathepsin F;D056646
C14.907.940.897;Systemic Vasculitis;D056647
C14.907.940.897.249;Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;D056648
C20.111.193;Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;D056648
D08.811.277.656.224.350;Cathepsin G;D056649
D08.811.277.656.300.760.066;Cathepsin G;D056649
D08.811.277.656.959.350.066;Cathepsin G;D056649
C13.351.500.944.951;Vulvodynia;D056650
A08.186.211.464.405.149;CA2 Region, Hippocampal;D056651
A08.186.211.730.885.287.500.345.149;CA2 Region, Hippocampal;D056651
C05.550.114.154.728;Rheumatoid Vasculitis;D056653
C05.799.114.728;Rheumatoid Vasculitis;D056653
C14.907.940.897.750;Rheumatoid Vasculitis;D056653
C17.300.775.099.728;Rheumatoid Vasculitis;D056653
C20.111.199.581;Rheumatoid Vasculitis;D056653
A08.186.211.464.405.174;CA3 Region, Hippocampal;D056654
A08.186.211.730.885.287.500.345.174;CA3 Region, Hippocampal;D056654
D08.811.277.656.224.400;Cathepsin H;D056655
D08.811.277.656.262.500.153;Cathepsin H;D056655
D08.811.277.656.300.200.153;Cathepsin H;D056655
E07.305.343.500;Lab-On-A-Chip Devices;D056656
D08.811.277.656.224.405;Cathepsin K;D056657
D08.811.277.656.262.500.156;Cathepsin K;D056657
D08.811.277.656.300.200.156;Cathepsin K;D056657
C16.320.382;Hereditary Autoinflammatory Diseases;D056660
C17.800.827.368;Hereditary Autoinflammatory Diseases;D056660
B04.280.580.650.085.400;Human bocavirus;D056661
B01.050.150.900.649.833;Proboscidea Mammal;D056662
D08.811.277.656.224.425;Cathepsin Z;D056663
D08.811.277.656.262.249;Cathepsin Z;D056663
D08.811.277.656.350.245.270;Cathepsin Z;D056663
D08.811.277.656.224.417;Cathepsin W;D056664
D08.811.277.656.262.500.158;Cathepsin W;D056664
D08.811.277.656.300.200.158;Cathepsin W;D056664
B01.050.150.900.649.833.500;Mammoths;D056665
B01.050.150.900.649.833.525;Mastodons;D056666
E05.318.740.225.500;Biometric Identification;D056667
L01.725.249;Biometric Identification;D056667
N04.452.910.099;Biometric Identification;D056667
D08.811.277.656.224.407;Cathepsin L;D056668
D08.811.277.656.262.500.157;Cathepsin L;D056668
D08.811.277.656.300.200.157;Cathepsin L;D056668
D27.505.696.365;Galactogogues;D056669
C16.320.962;Yellow Nail Syndrome;D056684
C17.800.529.819;Yellow Nail Syndrome;D056684
C17.800.621.968;Yellow Nail Syndrome;D056684
C23.300.820.500;Yellow Nail Syndrome;D056684
C05.660.207.219;Costello Syndrome;D056685
C16.131.077.256;Costello Syndrome;D056685
C16.320.185;Costello Syndrome;D056685
B04.280.475;Mimiviridae;D056686
E02.319.307.500;Off-Label Use;D056687
B03.440.450.425.325.300.900;Uropathogenic Escherichia coli;D056689
B03.660.250.150.180.100.900;Uropathogenic Escherichia coli;D056689
D06.472.699.327.967;Prolactin-Releasing Hormone;D056690
D12.644.400.400.967;Prolactin-Releasing Hormone;D056690
D12.644.548.365.967;Prolactin-Releasing Hormone;D056690
D12.776.641.650.405.967;Prolactin-Releasing Hormone;D056690
D09.698.718.622;Prebiotics;D056692
J02.500.400.500;Prebiotics;D056692
J02.500.456.249;Prebiotics;D056692
J02.500.525.400.500;Prebiotics;D056692
C16.320.565.100.823;Propionic Acidemia;D056693
C18.452.648.100.823;Propionic Acidemia;D056693
G12.450.050;Adaptive Immunity;D056704
E02.046;Apitherapy;D056705
G12.450.050.420;Immunity, Humoral;D056724
C15.378.100.100.900.100;von Willebrand Disease, Type 1;D056725
C15.378.100.141.900.100;von Willebrand Disease, Type 1;D056725
C15.378.463.920.100;von Willebrand Disease, Type 1;D056725
C16.320.099.920.100;von Willebrand Disease, Type 1;D056725
E05.393.385;Genetic Association Studies;D056726
B01.050.050.565;Endangered Species;D056727
G16.500.275.157.049.250;Endangered Species;D056727
J01.256.214;Endangered Species;D056727
N06.230.080.200;Endangered Species;D056727
N06.230.124.049.250;Endangered Species;D056727
C15.378.100.100.900.200;von Willebrand Disease, Type 2;D056728
C15.378.100.141.900.200;von Willebrand Disease, Type 2;D056728
C15.378.463.920.200;von Willebrand Disease, Type 2;D056728
C16.320.099.920.200;von Willebrand Disease, Type 2;D056728
C15.378.100.100.900.300;von Willebrand Disease, Type 3;D056729
C15.378.100.141.900.300;von Willebrand Disease, Type 3;D056729
C15.378.463.920.300;von Willebrand Disease, Type 3;D056729
C16.320.099.920.300;von Willebrand Disease, Type 3;D056729
C05.660.207.925;Silver-Russell Syndrome;D056730
C16.131.077.855;Silver-Russell Syndrome;D056730
C16.131.260.870;Silver-Russell Syndrome;D056730
C16.320.180.870;Silver-Russell Syndrome;D056730
C16.320.240.937;Silver-Russell Syndrome;D056730
C05.660.207.325;Donohue Syndrome;D056731
C16.131.077.313;Donohue Syndrome;D056731
C16.320.215;Donohue Syndrome;D056731
C18.452.394.750.654;Donohue Syndrome;D056731
C19.246.537;Donohue Syndrome;D056731
C16.131.077.735;Prolidase Deficiency;D056732
C16.131.831.720;Prolidase Deficiency;D056732
C16.320.565.100.794;Prolidase Deficiency;D056732
C16.320.850.746;Prolidase Deficiency;D056732
C04.557.450.565.550.312;Carney Complex;D056733
C04.588.894.309.500;Carney Complex;D056733
C14.280.459.500;Carney Complex;D056733
C16.131.077.229;Carney Complex;D056733
C16.131.831.108;Carney Complex;D056733
C16.131.077.592;Monilethrix;D056734
C16.320.850.647;Monilethrix;D056734
C17.800.329.984;Monilethrix;D056734
C17.800.827.602;Monilethrix;D056734
C15.604.515.138;Autoimmune Lymphoproliferative Syndrome;D056735
C16.320.089;Autoimmune Lymphoproliferative Syndrome;D056735
C20.111.288;Autoimmune Lymphoproliferative Syndrome;D056735
C20.683.515.124;Autoimmune Lymphoproliferative Syndrome;D056735
I01.880.604.605.250.625;Drug Recalls;D056736
N04.452.706.310.500;Drug Recalls;D056736
N06.850.210.637.200;Drug Recalls;D056736
I01.880.604.605.250.812;Safety-Based Drug Withdrawals;D056737
N04.452.706.310.750;Safety-Based Drug Withdrawals;D056737
N06.850.210.637.700;Safety-Based Drug Withdrawals;D056737
G12.450.275;Cross Protection;D056738
A02.835.232.781.670;Pterygopalatine Fossa;D056739
A02.835.232.087.090.850.600;Olecranon Process;D056740
D12.644.360.262.150;Cyclin D;D056741
D12.776.167.218.150;Cyclin D;D056741
D12.776.476.262.150;Cyclin D;D056741
D12.644.360.262.150.200;Cyclin D2;D056742
D12.776.167.218.150.200;Cyclin D2;D056742
D12.776.476.262.150.200;Cyclin D2;D056742
D12.644.360.262.150.300;Cyclin D3;D056743
D12.776.167.218.150.300;Cyclin D3;D056743
D12.776.476.262.150.300;Cyclin D3;D056743
D12.644.360.262.120.100;Cyclin B1;D056744
D12.776.167.218.120.100;Cyclin B1;D056744
D12.776.476.262.120.100;Cyclin B1;D056744
D05.500.374.249;Cyclin C;D056745
D12.644.360.024.304.249;Cyclin C;D056745
D12.644.360.262.135;Cyclin C;D056745
D12.776.157.057.062.249;Cyclin C;D056745
D12.776.167.218.135;Cyclin C;D056745
D12.776.476.024.388.249;Cyclin C;D056745
D12.776.476.262.135;Cyclin C;D056745
D12.776.660.551.249;Cyclin C;D056745
D12.644.360.262.200;Cyclin G;D056746
D12.776.167.218.200;Cyclin G;D056746
D12.776.476.262.200;Cyclin G;D056746
E02.095.465;Immunomodulation;D056747
G12.425.746;Immunomodulation;D056747
D12.644.360.262.300;Cyclin H;D056748
D12.776.167.218.300;Cyclin H;D056748
D12.776.476.262.300;Cyclin H;D056748
D12.644.360.262.400;Cyclin I;D056749
D12.776.167.218.400;Cyclin I;D056749
D12.776.476.262.400;Cyclin I;D056749
D12.644.360.262.100.100;Cyclin A1;D056750
D12.776.167.218.100.100;Cyclin A1;D056750
D12.776.476.262.100.100;Cyclin A1;D056750
D12.644.360.262.100.200;Cyclin A2;D056751
D12.776.167.218.100.200;Cyclin A2;D056751
D12.776.476.262.100.200;Cyclin A2;D056751
D12.644.360.262.120.200;Cyclin B2;D056765
D12.776.167.218.120.200;Cyclin B2;D056765
D12.776.476.262.120.200;Cyclin B2;D056765
D12.644.360.262.200.100;Cyclin G1;D056766
D12.776.167.218.200.100;Cyclin G1;D056766
D12.776.476.262.200.100;Cyclin G1;D056766
D12.644.360.262.200.200;Cyclin G2;D056767
D12.776.167.218.200.200;Cyclin G2;D056767
D12.776.476.262.200.200;Cyclin G2;D056767
C10.500.300.490;Giant Axonal Neuropathy;D056768
C10.574.500.495.490;Giant Axonal Neuropathy;D056768
C10.668.829.325;Giant Axonal Neuropathy;D056768
C10.668.829.800.300.490;Giant Axonal Neuropathy;D056768
C16.131.666.300.490;Giant Axonal Neuropathy;D056768
C16.320.400.375.490;Giant Axonal Neuropathy;D056768
C10.500.300.099;Alstrom Syndrome;D056769
C10.574.500.495.099;Alstrom Syndrome;D056769
C10.668.829.800.300.099;Alstrom Syndrome;D056769
C11.270.684.249;Alstrom Syndrome;D056769
C16.131.077.080;Alstrom Syndrome;D056769
C16.131.666.300.099;Alstrom Syndrome;D056769
C16.320.290.684.249;Alstrom Syndrome;D056769
C16.320.400.375.099;Alstrom Syndrome;D056769
C16.131.077.619;Netherton Syndrome;D056770
C16.131.831.512.400.705;Netherton Syndrome;D056770
C16.320.850.400.705;Netherton Syndrome;D056770
C16.320.850.673;Netherton Syndrome;D056770
C16.614.492.400.705;Netherton Syndrome;D056770
C17.800.428.333.250.705;Netherton Syndrome;D056770
C17.800.804.512.400.705;Netherton Syndrome;D056770
C17.800.827.400.705;Netherton Syndrome;D056770
C17.800.827.655;Netherton Syndrome;D056770
A18.024.249.500.249.249;Ovule;D056771
C10.228.140.695;Leukoencephalopathies;D056784
C10.228.518;Leukoencephalopathies;D056784
E02.190.488.585.850;Medicine, Mongolian Traditional;D056785
I01.076.201.450.654.558.750;Medicine, Mongolian Traditional;D056785
D20.147;Biofuels;D056804
N06.230.132.644.124;Biofuels;D056804
E07.858.195;Consciousness Monitors;D056805
C10.228.140.163.100.937;Urea Cycle Disorders, Inborn;D056806
C16.320.565.100.940;Urea Cycle Disorders, Inborn;D056806
C16.320.565.189.937;Urea Cycle Disorders, Inborn;D056806
C18.452.132.100.937;Urea Cycle Disorders, Inborn;D056806
C18.452.648.100.940;Urea Cycle Disorders, Inborn;D056806
C18.452.648.189.937;Urea Cycle Disorders, Inborn;D056806
C10.228.140.163.100.937.124;Argininosuccinic Aciduria;D056807
C16.320.565.100.940.124;Argininosuccinic Aciduria;D056807
C16.320.565.189.937.124;Argininosuccinic Aciduria;D056807
C18.452.132.100.937.124;Argininosuccinic Aciduria;D056807
C18.452.648.100.940.124;Argininosuccinic Aciduria;D056807
C18.452.648.189.937.124;Argininosuccinic Aciduria;D056807
E05.318.740.237;Biostatistics;D056808
A04.411.715.512;Pneumocytes;D056809
A11.436.714;Pneumocytes;D056809
D27.720.723.070;Acaricides;D056810
G02.111.087.675.871.790.600.962;Unfolded Protein Response;D056811
G02.111.087.693.600.850;Unfolded Protein Response;D056811
G02.149.115.675.871.790.600.850;Unfolded Protein Response;D056811
G02.149.115.693.600.925;Unfolded Protein Response;D056811
G03.495.770.871.790.600.850;Unfolded Protein Response;D056811
G05.355.315.670.600.850;Unfolded Protein Response;D056811
C14.907.355.830.925.885;Upper Extremity Deep Vein Thrombosis;D056824
D12.644.861.762;Thyroxine-Binding Globulin;D056825
D12.776.124.885.500;Thyroxine-Binding Globulin;D056825
D12.776.157.785.500;Thyroxine-Binding Globulin;D056825
D12.776.395.832.500;Thyroxine-Binding Globulin;D056825
D12.776.872.762;Thyroxine-Binding Globulin;D056825
E02.875.800.500.500;Single Embryo Transfer;D056826
E05.820.800.500.500;Single Embryo Transfer;D056826
D05.500.199;Endosomal Sorting Complexes Required for Transport;D056827
D12.776.543.990.493;Endosomal Sorting Complexes Required for Transport;D056827
C14.907.079.500.500;Hereditary Angioedema Type III;D056828
C17.800.862.945.066.500.500;Hereditary Angioedema Type III;D056828
C20.543.480.904.066.500.500;Hereditary Angioedema Type III;D056828
C14.907.079.500.750;Hereditary Angioedema Types I and II;D056829
C17.800.862.945.066.500.750;Hereditary Angioedema Types I and II;D056829
C20.543.480.904.066.500.750;Hereditary Angioedema Types I and II;D056829
C14.240.400.660;Isolated Noncompaction of the Ventricular Myocardium;D056830
C14.280.238.281.500;Isolated Noncompaction of the Ventricular Myocardium;D056830
C14.280.400.660;Isolated Noncompaction of the Ventricular Myocardium;D056830
C16.131.077.477;Isolated Noncompaction of the Ventricular Myocardium;D056830
C16.131.240.400.655;Isolated Noncompaction of the Ventricular Myocardium;D056830
C16.320.322.370;Isolated Noncompaction of the Ventricular Myocardium;D056830
D01.234;Coordination Complexes;D056831
D02.256;Coordination Complexes;D056831
D02.691.214;Coordination Complexes;D056831
C11.768.175;Central Serous Chorioretinopathy;D056833
C23.888.646.100.600.500;Renal Colic;D056844
C23.888.646.100.800;Renal Colic;D056844
C23.888.821.030.500.500;Renal Colic;D056844
C23.888.821.030.750;Renal Colic;D056844
C05.116.099.343.957;Weill-Marchesani Syndrome;D056846
C05.116.099.875;Weill-Marchesani Syndrome;D056846
C11.270.921;Weill-Marchesani Syndrome;D056846
C16.131.077.941;Weill-Marchesani Syndrome;D056846
C16.320.290.842;Weill-Marchesani Syndrome;D056846
C16.320.887;Weill-Marchesani Syndrome;D056846
C17.300.899;Weill-Marchesani Syndrome;D056846
D08.811.913.696.620.682.700.200.387;Cyclin-Dependent Kinase 3;D056849
D08.811.913.696.620.682.700.646.500.812;Cyclin-Dependent Kinase 3;D056849
D12.644.360.250.387;Cyclin-Dependent Kinase 3;D056849
D12.776.167.200.387;Cyclin-Dependent Kinase 3;D056849
D12.776.476.250.387;Cyclin-Dependent Kinase 3;D056849
D05.500.374.500;Cyclin-Dependent Kinase 8;D056850
D08.811.913.696.620.682.700.200.547;Cyclin-Dependent Kinase 8;D056850
D12.644.360.024.304.500;Cyclin-Dependent Kinase 8;D056850
D12.644.360.250.547;Cyclin-Dependent Kinase 8;D056850
D12.776.157.057.062.500;Cyclin-Dependent Kinase 8;D056850
D12.776.476.024.388.500;Cyclin-Dependent Kinase 8;D056850
D12.776.660.551.500;Cyclin-Dependent Kinase 8;D056850
D26.530.500;Behind-the-Counter Drugs;D056864
E01.370.600.115.100.160.120.499;Ideal Body Weight;D056865
E05.041.124.160.750.650;Ideal Body Weight;D056865
G07.100.100.160.120.499;Ideal Body Weight;D056865
G07.700.320.249.314.120.650;Ideal Body Weight;D056865
A11.620.124;Interstitial Cells of Cajal;D056885
C10.900.300.087.125.249;Contrecoup Injury;D056886
C26.224;Contrecoup Injury;D056886
C26.260.118.150.249;Contrecoup Injury;D056886
C26.915.300.200.150.249;Contrecoup Injury;D056886
C23.300.842.624;Pelvic Organ Prolapse;D056887
E02.760.670;Patient Positioning;D056888
N02.421.585.700;Patient Positioning;D056888
C14.240.400.172;Barth Syndrome;D056889
C14.280.400.172;Barth Syndrome;D056889
C16.131.077.121;Barth Syndrome;D056889
C16.131.240.400.172;Barth Syndrome;D056889
C16.320.322.068;Barth Syndrome;D056889
C16.320.565.398.224;Barth Syndrome;D056889
C18.452.648.398.224;Barth Syndrome;D056889
B01;Eukaryota;D056890
B05;Organism Forms;D056891
D05.500.374;Mediator Complex;D056892
D12.644.360.024.304;Mediator Complex;D056892
D12.776.157.057.062;Mediator Complex;D056892
D12.776.476.024.388;Mediator Complex;D056892
D12.776.660.551;Mediator Complex;D056892
B01.043;Alveolata;D056893
B01.046;Amoebozoa;D056894
B01.046.550;Mycetozoa;D056895
B01.046.060;Archamoebae;D056896
B01.175;Choanoflagellata;D056897
B01.268;Euglenozoa;D056898
B01.625;Oxymonadida;D056899
B01.630;Parabasalidea;D056900
B01.680;Rhizaria;D056901
E07.230.200;Clinical Alarms;D056902
G05.355.180.210.170.500;Chromosome Breakpoints;D056905
D12.644.360.262.700;Cyclin T;D056906
D12.776.167.218.700;Cyclin T;D056906
D12.776.476.262.700;Cyclin T;D056906
D12.776.930.955.500.249;Cyclin T;D056906
B01.680.150;Cercozoa;D056907
B01.680.275;Foraminifera;D056908
B01.680.150.600;Plasmodiophorida;D056909
Z01.252.474.557.750;Republic of Korea;D056910
Z01.252.474.557.500;Democratic People's Republic of Korea;D056911
F03.375.175;Binge-Eating Disorder;D056912
D05.500.374.750;Mediator Complex Subunit 1;D056913
D12.644.360.024.304.750;Mediator Complex Subunit 1;D056913
D12.644.360.024.308.049;Mediator Complex Subunit 1;D056913
D12.776.157.057.062.750;Mediator Complex Subunit 1;D056913
D12.776.157.057.080.049;Mediator Complex Subunit 1;D056913
D12.776.476.024.388.750;Mediator Complex Subunit 1;D056913
D12.776.476.024.394.049;Mediator Complex Subunit 1;D056913
D12.776.660.551.750;Mediator Complex Subunit 1;D056913
D12.776.660.675.049;Mediator Complex Subunit 1;D056913
D12.776.930.617.049;Mediator Complex Subunit 1;D056913
G05.365.795.297;Genomic Structural Variation;D056914
G05.365.795.297.500;DNA Copy Number Variations;D056915
G02.111.570.080.708.565;Segmental Duplications, Genomic;D056916
G05.360.080.708.565;Segmental Duplications, Genomic;D056916
D12.644.360.024.308;Nuclear Receptor Coactivators;D056918
D12.776.157.057.080;Nuclear Receptor Coactivators;D056918
D12.776.476.024.394;Nuclear Receptor Coactivators;D056918
D12.776.660.675;Nuclear Receptor Coactivators;D056918
D12.776.930.617;Nuclear Receptor Coactivators;D056918
B01.675;Retortamonadidae;D056919
D08.811.913.050.134.407.100;Nuclear Receptor Coactivator 1;D056920
D12.644.360.024.308.100;Nuclear Receptor Coactivator 1;D056920
D12.776.157.057.080.100;Nuclear Receptor Coactivator 1;D056920
D12.776.476.024.394.100;Nuclear Receptor Coactivator 1;D056920
D12.776.660.675.100;Nuclear Receptor Coactivator 1;D056920
D12.776.930.617.100;Nuclear Receptor Coactivator 1;D056920
D08.811.913.050.134.407.150;Nuclear Receptor Coactivator 3;D056921
D12.644.360.024.308.300;Nuclear Receptor Coactivator 3;D056921
D12.776.157.057.080.300;Nuclear Receptor Coactivator 3;D056921
D12.776.476.024.394.300;Nuclear Receptor Coactivator 3;D056921
D12.776.660.675.300;Nuclear Receptor Coactivator 3;D056921
D12.776.930.617.300;Nuclear Receptor Coactivator 3;D056921
D12.644.128;Circadian Rhythm Signaling Peptides and Proteins;D056925
D12.776.189;Circadian Rhythm Signaling Peptides and Proteins;D056925
D08.811.913.050.134.407.049;CLOCK Proteins;D056926
D12.644.128.100;CLOCK Proteins;D056926
D12.776.189.200;CLOCK Proteins;D056926
D12.776.260.103.562;CLOCK Proteins;D056926
D12.776.930.125.562;CLOCK Proteins;D056926
E05.196.867.972;X-Ray Absorption Spectroscopy;D056928
C12.777.419.815.683;Liddle Syndrome;D056929
C13.351.968.419.815.683;Liddle Syndrome;D056929
C16.320.565.861.698;Liddle Syndrome;D056929
C18.452.648.861.698;Liddle Syndrome;D056929
D12.644.128.049;ARNTL Transcription Factors;D056930
D12.776.189.100;ARNTL Transcription Factors;D056930
D12.776.260.103.249;ARNTL Transcription Factors;D056930
D12.776.930.125.249;ARNTL Transcription Factors;D056930
D12.644.128.150;Cryptochromes;D056931
D12.776.189.250;Cryptochromes;D056931
D12.776.331.180;Cryptochromes;D056931
D12.776.765.593.500;Cryptochromes;D056931
A11.251.860.180.432;Hep G2 Cells;D056945
A11.436.348.500;Hep G2 Cells;D056945
E02.319.353.500;Enzyme Replacement Therapy;D056947
E04.545.562;Orthognathic Surgical Procedures;D056948
E04.555.580.289;Orthognathic Surgical Procedures;D056948
E06.645.562;Orthognathic Surgical Procedures;D056948
D12.776.765.593.750;Phototropins;D056949
D12.644.128.575;Period Circadian Proteins;D056950
D12.776.157.530.750.687;Period Circadian Proteins;D056950
D12.776.189.625;Period Circadian Proteins;D056950
D12.776.543.585.750.687;Period Circadian Proteins;D056950
E05.196.867.618;Photoelectron Spectroscopy;D056951
B01.630.399;Hypermastigia;D056952
D12.776.189.300;Nuclear Receptor Subfamily 1, Group D, Member 1;D056953
D12.776.260.698.209.080;Nuclear Receptor Subfamily 1, Group D, Member 1;D056953
D12.776.826.209.080;Nuclear Receptor Subfamily 1, Group D, Member 1;D056953
D12.776.930.669.209.080;Nuclear Receptor Subfamily 1, Group D, Member 1;D056953
E02.319.267.530.475;Injections, Intraocular;D056965
G02.111.087.800.800.100.500;Excitation Contraction Coupling;D056966
G04.299.880.199;Excitation Contraction Coupling;D056966
G11.427.590.540.235;Excitation Contraction Coupling;D056966
D12.776.097.521;Lac Repressors;D056968
D12.776.260.703.600;Lac Repressors;D056968
D12.776.930.700.781;Lac Repressors;D056968
E01.370.350.887;Voltage-Sensitive Dye Imaging;D056969
D12.776.930.700.625;Co-Repressor Proteins;D056970
D12.776.930.700.625.374;Nuclear Receptor Co-Repressor 1;D056971
E05.393.183.620.650.500;Optical Restriction Mapping;D056972
E05.393.712.500;Optical Restriction Mapping;D056972
E01.370.350.350.810.490;Four-Dimensional Computed Tomography;D056973
E01.370.350.400.350;Four-Dimensional Computed Tomography;D056973
E01.370.350.700.700.810.490;Four-Dimensional Computed Tomography;D056973
E01.370.350.700.810.810.645;Four-Dimensional Computed Tomography;D056973
E01.370.350.825.810.810.599;Four-Dimensional Computed Tomography;D056973
D12.776.930.700.625.400;Nuclear Receptor Co-Repressor 2;D056985
C03.752.300;Euglenozoa Infections;D056986
C14.907.946;Vasoplegia;D056987
C23.550.767.962;Vasoplegia;D056987
C14.280.647.500.093;Anterior Wall Myocardial Infarction;D056988
C14.907.585.500.093;Anterior Wall Myocardial Infarction;D056988
C14.280.647.500.187;Inferior Wall Myocardial Infarction;D056989
C14.907.585.500.187;Inferior Wall Myocardial Infarction;D056989
N02.421.726.755;Post-Exposure Prophylaxis;D056990
J01.293.069;Bioengineering;D057005
A11.872.040.500;Induced Pluripotent Stem Cells;D057026
A11.872.700.500;Induced Pluripotent Stem Cells;D057026
C06.405.117.119.500.484.500;Laryngopharyngeal Reflux;D057045
C08.360.577;Laryngopharyngeal Reflux;D057045
D20.215.780;Plant Nectar;D057048
C15.378.140.855.925;Thrombotic Microangiopathies;D057049
D08.811.913.696.620.682.725.400.093;Receptor Tyrosine Kinase-like Orphan Receptors;D057050
D12.776.543.750.060.233;Receptor Tyrosine Kinase-like Orphan Receptors;D057050
N06.850.210.637;Product Recalls and Withdrawals;D057051
N06.850.210.637.500;Medical Device Recalls;D057052
N06.850.210.637.750;Safety-Based Medical Device Withdrawals;D057053
E01.370.350.557;Molecular Imaging;D057054
E05.601.567;Molecular Imaging;D057054
D08.811.277.656.074;Aspartic Acid Proteases;D057055
D08.811.277.656.262;Cysteine Proteases;D057056
D08.811.277.656.959;Serine Proteases;D057057
D08.811.277.656.149.099;ATP-Dependent Endopeptidases;D057065
D08.811.277.656.300.065;ATP-Dependent Endopeptidases;D057065
C11.640.225;Low Tension Glaucoma;D057066
C26.404.550;Periprosthetic Fractures;D057068
E05.337.275.500;Diagnostic Test Approval;D057069
N06.850.210.275.500;Diagnostic Test Approval;D057069
A02.835.232.904.567.150;Cervical Rib;D057070
A02.835.583.475.650;Patellofemoral Joint;D057071
C26.404.505;Intra-Articular Fractures;D057072
D06.472.699.631.525.883.374;Thyrotropin Alfa;D057073
G06.590.875.776;Virus Release;D057074
G06.920.875.776;Virus Release;D057074
E05.196.427;Enzyme Assays;D057075
B01.050.500.131.166.132.419.900;Varroidae;D057077
B01.050.500.131.365.640;Pentastomida;D057078
B01.050.150.900.649.801.400.112.400.635;Pongo;D057079
B01.050.150.900.649.801.400.112.400.635.050;Pongo abelii;D057080
C07.793.818;Tooth Wear;D057085
E02.565.280.945.399;High-Intensity Focused Ultrasound Ablation;D057086
E04.014.380;High-Intensity Focused Ultrasound Ablation;D057086
E06.070;Dental Atraumatic Restorative Treatment;D057087
C17.300.116;Anetoderma;D057088
C17.800.804.108;Anetoderma;D057088
H01.158.201.636.475.750;Pathology, Molecular;D057089
H01.158.273.343.595.475.750;Pathology, Molecular;D057089
H01.181.122.650.475.680;Pathology, Molecular;D057089
H02.403.650.505;Pathology, Molecular;D057089
C04.557.470.200.025.500;Eccrine Porocarcinoma;D057090
C04.557.470.035.175.125.600;Poroma;D057091
C04.557.470.550.175.125.600;Poroma;D057091
C11.768.585.439.122;Geographic Atrophy;D057092
D12.776.260.698.209;Orphan Nuclear Receptors;D057093
D12.776.826.209;Orphan Nuclear Receptors;D057093
D12.776.930.669.209;Orphan Nuclear Receptors;D057093
D12.776.189.437;Nuclear Receptor Subfamily 1, Group F, Member 1;D057094
D12.776.260.698.209.100;Nuclear Receptor Subfamily 1, Group F, Member 1;D057094
D12.776.826.209.100;Nuclear Receptor Subfamily 1, Group F, Member 1;D057094
D12.776.930.669.209.100;Nuclear Receptor Subfamily 1, Group F, Member 1;D057094
D12.776.189.531;Nuclear Receptor Subfamily 1, Group F, Member 2;D057095
D12.776.260.698.209.110;Nuclear Receptor Subfamily 1, Group F, Member 2;D057095
D12.776.826.209.110;Nuclear Receptor Subfamily 1, Group F, Member 2;D057095
D12.776.930.669.209.110;Nuclear Receptor Subfamily 1, Group F, Member 2;D057095
C25.723.415.792;Shellfish Poisoning;D057096
G16.500.240.300.400;Harmful Algal Bloom;D057097
D12.776.260.698.209.400;Nuclear Receptor Subfamily 4, Group A, Member 1;D057105
D12.776.826.209.400;Nuclear Receptor Subfamily 4, Group A, Member 1;D057105
D12.776.930.669.209.400;Nuclear Receptor Subfamily 4, Group A, Member 1;D057105
D12.776.260.698.209.430;Nuclear Receptor Subfamily 4, Group A, Member 3;D057106
D12.776.826.209.430;Nuclear Receptor Subfamily 4, Group A, Member 3;D057106
D12.776.930.669.209.430;Nuclear Receptor Subfamily 4, Group A, Member 3;D057106
D12.776.260.698.209.255;Nuclear Receptor Subfamily 2, Group C, Member 1;D057107
D12.776.826.209.255;Nuclear Receptor Subfamily 2, Group C, Member 1;D057107
D12.776.930.669.209.255;Nuclear Receptor Subfamily 2, Group C, Member 1;D057107
C11.204.431;Corneal Wavefront Aberration;D057108
C11.744.345;Corneal Wavefront Aberration;D057108
E01.370.380.655;Scanning Laser Polarimetry;D057109
E04.540.825.374.112;Descemet Stripping Endothelial Keratoplasty;D057111
E04.936.580.262;Descemet Stripping Endothelial Keratoplasty;D057111
C11.204.365;Corneal Perforation;D057112
C26.260.275.250.270.500;Corneal Perforation;D057112
D12.776.260.698.209.327;Nuclear Receptor Subfamily 2, Group C, Member 2;D057125
D12.776.826.209.327;Nuclear Receptor Subfamily 2, Group C, Member 2;D057125
D12.776.930.669.209.327;Nuclear Receptor Subfamily 2, Group C, Member 2;D057125
D12.776.260.698.209.415;Nuclear Receptor Subfamily 4, Group A, Member 2;D057126
D12.776.826.209.415;Nuclear Receptor Subfamily 4, Group A, Member 2;D057126
D12.776.930.669.209.415;Nuclear Receptor Subfamily 4, Group A, Member 2;D057126
D12.644.541.500.650.500.800;Single-Chain Antibodies;D057127
D12.776.124.486.485.114.224.785;Single-Chain Antibodies;D057127
D12.776.124.486.485.680.650.500.800;Single-Chain Antibodies;D057127
D12.776.124.790.651.680.650.500.800;Single-Chain Antibodies;D057127
D12.776.377.715.548.680.650.500.795;Single-Chain Antibodies;D057127
E01.370.380.074;Aberrometry;D057128
C11.204.497;Iridocorneal Endothelial Syndrome;D057129
C11.941.375.322;Iridocorneal Endothelial Syndrome;D057129
C11.270.516;Leber Congenital Amaurosis;D057130
C11.768.364;Leber Congenital Amaurosis;D057130
G06.590.470.400;Immune Evasion;D057131
G12.425.700;Immune Evasion;D057131
G16.100.380.700;Immune Evasion;D057131
D12.776.260.698.209.182;Nuclear Receptor Subfamily 1, Group F, Member 3;D057132
D12.776.826.209.182;Nuclear Receptor Subfamily 1, Group F, Member 3;D057132
D12.776.930.669.209.182;Nuclear Receptor Subfamily 1, Group F, Member 3;D057132
D27.505.696.663.850.014.640;Dentin Desensitizing Agents;D057133
D27.505.954.427.040.437;Dentin Desensitizing Agents;D057133
D12.776.124.486.485.114.244;Antibodies, Neutralizing;D057134
D12.776.124.790.651.114.244;Antibodies, Neutralizing;D057134
D12.776.377.715.548.114.244;Antibodies, Neutralizing;D057134
C11.768.585.439.622;Wet Macular Degeneration;D057135
D12.776.260.698.209.572;Nuclear Receptor Subfamily 6, Group A, Member 1;D057136
D12.776.826.209.572;Nuclear Receptor Subfamily 6, Group A, Member 1;D057136
D12.776.930.669.209.572;Nuclear Receptor Subfamily 6, Group A, Member 1;D057136
D12.776.826.209.059;DAX-1 Orphan Nuclear Receptor;D057137
D12.776.930.669.209.059;DAX-1 Orphan Nuclear Receptor;D057137
D12.776.930.700.625.186;DAX-1 Orphan Nuclear Receptor;D057137
G07.700.085;Bacterial Shedding;D057138
J01.637.512.300;Nanofibers;D057139
J02.500.477;Fast Foods;D057140
J02.500.521;Food, Preserved;D057141
J01.637.512.600.500.575;Nanoshells;D057145
A11.284.430.214.190.875.190.880.337.500;Multivesicular Bodies;D057146
E07.700.510;Mosquito Nets;D057147
J01.494.221.750;Mosquito Nets;D057147
E07.700.510.500;Insecticide-Treated Bednets;D057148
D12.776.938;Ubiquitinated Proteins;D057149
C18.452.845;Proteostasis Deficiencies;D057165
E05.916.680;High-Throughput Screening Assays;D057166
D12.776.543.984.200;Claudins;D057167
E05.196.155.249;Distillation;D057168
F04.754.137.506.162;Eye Movement Desensitization Reprocessing;D057169
H01.770.644.145.675;Translational Medical Research;D057170
N03.706.615.049;American Recovery and Reinvestment Act;D057171
I01.261.425;Economic Recession;D057172
E02.831.580;Recreation Therapy;D057173
C10.228.140.380.266;Frontotemporal Lobar Degeneration;D057174
C10.574.950.300;Frontotemporal Lobar Degeneration;D057174
C18.452.845.800.300;Frontotemporal Lobar Degeneration;D057174
F03.087.400.380;Frontotemporal Lobar Degeneration;D057174
L01.178.820.090.703;Posters as Topic;D057175
E02.931.500;Compassionate Use Trials;D057176
E05.337.300.199;Compassionate Use Trials;D057176
C10.574.950;TDP-43 Proteinopathies;D057177
C18.452.845.800;TDP-43 Proteinopathies;D057177
C10.228.140.380.132.600;Primary Progressive Nonfluent Aphasia;D057178
C10.228.140.380.266.600;Primary Progressive Nonfluent Aphasia;D057178
C10.574.950.300.600;Primary Progressive Nonfluent Aphasia;D057178
C10.597.606.150.500.800.100.155.600;Primary Progressive Nonfluent Aphasia;D057178
C18.452.845.800.300.600;Primary Progressive Nonfluent Aphasia;D057178
C23.888.592.604.150.500.800.100.155.600;Primary Progressive Nonfluent Aphasia;D057178
F03.087.400.125.600;Primary Progressive Nonfluent Aphasia;D057178
F03.087.400.380.600;Primary Progressive Nonfluent Aphasia;D057178
H02.478.676.074;Advanced Practice Nursing;D057179
C10.228.140.380.266.299;Frontotemporal Dementia;D057180
C10.574.950.300.299;Frontotemporal Dementia;D057180
C18.452.845.800.300.299;Frontotemporal Dementia;D057180
F03.087.400.380.299;Frontotemporal Dementia;D057180
F01.470.867;Pleasure;D057181
F02.830.816.492;Pleasure;D057181
E05.318.416.500;Mendelian Randomization Analysis;D057182
N04.590.688;Nurse's Practice Patterns;D057184
N05.300.581;Nurse's Practice Patterns;D057184
F01.829.458.705;Sedentary Lifestyle;D057185
H01.770.644.145.360.500;Comparative Effectiveness Research;D057186
N05.425.157;Comparative Effectiveness Research;D057186
I03.050.500;Independent Living;D057187
N01.224.791.550;Independent Living;D057187
N06.850.505.400.800.550;Independent Living;D057187
L01.906.893;Workflow;D057188
N05.715.360.300.179;Checklist;D057189
F04.711.513.703;Stroop Test;D057190
N02.138;Capacity Building;D057191
N04.452.105;Capacity Building;D057191
G01.311.340.843;Tsunamis;D057192
G01.595.340.787;Tsunamis;D057192
I03.883.710;Medical Tourism;D057193
N05.300.515;Medical Tourism;D057193
N05.715.360.775.235.387.500.500;Intention to Treat Analysis;D057194
N06.850.520.450.535.365.500.500;Intention to Treat Analysis;D057194
E05.064;Automation, Laboratory;D057205
J01.897.104.416;Automation, Laboratory;D057205
E07.490.249;Child Restraint Systems;D057207
E07.700.175;Child Restraint Systems;D057207
J01.637.708.175;Child Restraint Systems;D057207
N03.540.630.480;Health Level Seven;D057208
N04.590.715.550;Hospital Rapid Response Team;D057209
E01.110;Delayed Diagnosis;D057210
E02.288;Delayed Diagnosis;D057210
L01.178.847.900.500;Webcasts as Topic;D057211
K01.316.333.132.750.775;Therapeutic Equipoise;D057212
K01.316.366.700;Therapeutic Equipoise;D057212
V02.545;Incunabula;D057213
Z01.586.687;Ottoman Empire;D057214
F03.875.149;Body Dysmorphic Disorders;D057215
E05.318.740.600.675;Propensity Score;D057216
N05.715.360.750.625.620;Propensity Score;D057216
N06.850.520.830.600.650;Propensity Score;D057216
I01.261.262;Economic Development;D057217
N03.219.206;Economic Development;D057217
L01.224.230.110.500.500;Blogging;D057218
G16.500.240.102;Biofouling;D057219
N06.850.460.150;Biofouling;D057219
N06.850.540.500;Biofouling;D057219
I02.233.332.186.500;Health Literacy;D057220
L01.143.450.500;Health Literacy;D057220
N02.421.143.827.407.228.500;Health Literacy;D057220
N02.421.726.407.228.500;Health Literacy;D057220
B04.820.545.405.400.216;Influenza A Virus, H1N2 Subtype;D057221
L01.470.625;Data Mining;D057225
L01.700.508.280.199;Data Mining;D057225
F01.145.209.372;Information Seeking Behavior;D057226
F01.145.535;Information Seeking Behavior;D057226
L01.143.458;Information Seeking Behavior;D057226
F01.145.813.199;Femininity;D057227
F01.393.446.250.500;Femininity;D057227
F01.752.747.385.200.500;Femininity;D057227
F01.145.813.376;Masculinity;D057228
F01.393.446.250.750;Masculinity;D057228
F01.752.747.385.200.750;Masculinity;D057228
M01.066;Alcoholics;D057229
E05.318.740.872.374;Limit of Detection;D057230
N05.715.360.750.725.500;Limit of Detection;D057230
N06.850.520.830.872.500;Limit of Detection;D057230
G16.500.240.135.374;Climate Change;D057231
G16.500.240.135.374.500;Global Warming;D057232
E07.715;Radio Frequency Identification Device;D057233
N04.452.653.500;Radio Frequency Identification Device;D057233
E04.614.937;Preoperative Period;D057234
N02.421.585.753.937;Preoperative Period;D057234
Z01.586.117;Austria-Hungary;D057235
H02.403.850;Travel Medicine;D057236
M01.142;Criminals;D057237
E05.978.808.500;Growth Charts;D057238
E05.337.250.432;Early Termination of Clinical Trials;D057239
E05.581.500.400;Early Termination of Clinical Trials;D057239
N04.761.559.590.800.379;Early Termination of Clinical Trials;D057239
N05.715.360.575.575.800.379;Early Termination of Clinical Trials;D057239
N04.452.822.360.600.500;Patient Preference;D057240
N05.300.150.600.630.500;Patient Preference;D057240
D08.811.913.555.500.350.100.750;Site-Specific DNA-Methyltransferase (Cytosine-N(4)-Specific);D057265
E02.574;Individualized Medicine;D057285
H02.403.200.700;Individualized Medicine;D057285
E05.318.308.940.968.625.500;Electronic Health Records;D057286
G05.355.600.805;Sequence Inversion;D057345
G05.365.590.770;Sequence Inversion;D057345
L01.470.875;Search Engine;D057386
V01.255.500.750;Webcasts;D057405
V02.990;Webcasts;D057405
G15.744.300.500;Seed Dormancy;D057445
G15.872;Seed Dormancy;D057445
G01.342;Hydrodynamics;D057446
G06.590.235;Catabolite Repression;D057465
D06.347.065.500;Nonsteroidal Anti-Androgens;D057466
D27.505.696.399.450.065.500;Nonsteroidal Anti-Androgens;D057466
G02.607.750.120;Carbon Cycle;D057486
G02.842.750.270;Carbon Cycle;D057486
G16.500.240.118;Carbon Cycle;D057486
E02.319.353;Enzyme Therapy;D057487
E07.695.950;Visual Prosthesis;D057488
E07.695.207;Embolic Protection Devices;D057505
A13.093;Arthropod Antennae;D057506
B01.050.150.900.649.865.635.505.500.400.025;Mice, 129 Strain;D057507
B01.050.150.900.649.865.635.505.500.550.025;Mice, 129 Strain;D057507
B01.050.150.900.649.865.635.505.500.800.500.025;Mice, 129 Strain;D057507
B03.440.400.425.251.100.110.490;Burkholderia cenocepacia;D057508
B03.660.075.077.100.110.490;Burkholderia cenocepacia;D057508
B01.268.475.868.887.680;Trypanosoma rangeli;D057509
E04.100.814.529;Endovascular Procedures;D057510
E04.800.382;Endovascular Procedures;D057510
F01.145.813.840;Social Stigma;D057545
F01.470.137;Apathy;D057565
E05.318.308.750.500;Self Report;D057566
L01.280.800.655;Self Report;D057566
N05.715.360.300.695.500;Self Report;D057566
N06.850.520.308.750.500;Self Report;D057566
F02.463.425.540.305;Memory, Long-Term;D057567
B03.440.450.019.025.150;Aeromonas caviae;D057585
B03.660.250.017.025.150;Aeromonas caviae;D057585
E04.540.980;Vitreoretinal Surgery;D057586
E01.370.388.250.630;Natural Orifice Endoscopic Surgery;D057605
E04.800.250.630;Natural Orifice Endoscopic Surgery;D057605
E05.196.401.831;Isotachophoresis;D057625
E05.301.300.831;Isotachophoresis;D057625
A02.633.567.300;Deltoid Muscle;D057645
G06.920.875.890;Virus Uncoating;D057646
B01.650.940.800.575.100.822.558;Melinis repens;D057665
V04.750.124;Research Support, American Recovery and Reinvestment Act;D057666
C26.324.436;Conducted Energy Weapon Injuries;D057667
E02.760.148;Bloodless Medical and Surgical Procedures;D057668
E04.079;Bloodless Medical and Surgical Procedures;D057668
N02.421.585.148;Bloodless Medical and Surgical Procedures;D057668
B01.650.449;Plant Weeds;D057685
G04.299.345;Cell-in-Cell Formation;D057686
G04.299.345.500;Emperipolesis;D057687
G03.495.166.962.500;Transcellular Cell Migration;D057688
G04.299.283.900;Transcellular Cell Migration;D057688
G04.299.345.500.500;Transcellular Cell Migration;D057688
G04.299.482.685.500;Transcellular Cell Migration;D057688
G04.299.490.790.500;Transcellular Cell Migration;D057688
V04.750;Research Support, U.S. Government;D057689
G04.299.345.750;Entosis;D057691
G04.299.283.950;Transendothelial and Transepithelial Migration;D057705
G07.700.560.500.180.500;Transendothelial and Transepithelial Migration;D057705
E04.936.537.687;Operative Blood Salvage;D057725
E06.721.189.675;Periodontal Debridement;D057747
E02.190.506;Mesotherapy;D057748
E02.218.660;Mesotherapy;D057748
E02.319.267.530.620.785;Mesotherapy;D057748
C06.405.117.620.209;Eosinophilic Esophagitis;D057765
C06.405.205.663.209;Eosinophilic Esophagitis;D057765
C15.378.553.231.341;Eosinophilic Esophagitis;D057765
C20.543.480.356;Eosinophilic Esophagitis;D057765
I01.655;Policy;D057766
N03.623;Policy;D057766
C05.116.099.708.534;Kashin-Beck Disease;D057767
C08.618.846.600;Infantile Apparent Life-Threatening Event;D057768
C23.888.248.500;Infantile Apparent Life-Threatening Event;D057768
C23.888.852.700;Infantile Apparent Life-Threatening Event;D057768
E04.100.376.719.666;Transmyocardial Laser Revascularization;D057769
E04.928.220.520.610;Transmyocardial Laser Revascularization;D057769
C16.320.850.368;Hyalinosis, Systemic;D057770
D12.644.132;Cystine-Knot Miniproteins;D057771
D12.776.217;Cystine-Knot Miniproteins;D057771
C14.907.937;Vascular System Injuries;D057772
C26.940;Vascular System Injuries;D057772
D12.644.360.175;Cold Shock Proteins and Peptides;D057773
D12.776.476.175;Cold Shock Proteins and Peptides;D057773
C10.177.575.600.537;Post-Exercise Hypotension;D057774
C14.907.514.611;Post-Exercise Hypotension;D057774
E02.587;Ischemic Postconditioning;D057775
E07.132;Catheters;D057785
D27.505.519.828;Peptidomimetics;D057786
B03.300.390.400.800.750.500;Staphylococcus lugdunensis;D057787
B03.510.100.750.750.500;Staphylococcus lugdunensis;D057787
B03.510.400.790.750.500;Staphylococcus lugdunensis;D057787
B03.300.390.400.800.750.435;Staphylococcus hyicus;D057788
B03.510.100.750.750.435;Staphylococcus hyicus;D057788
B03.510.400.790.750.435;Staphylococcus hyicus;D057788
B03.300.390.400.800.750.445;Staphylococcus intermedius;D057789
B03.510.100.750.750.445;Staphylococcus intermedius;D057789
B03.510.400.790.750.445;Staphylococcus intermedius;D057789
B03.300.390.400.800.750.750;Staphylococcus saprophyticus;D057790
B03.510.100.750.750.750;Staphylococcus saprophyticus;D057790
B03.510.400.790.750.750;Staphylococcus saprophyticus;D057790
E01.370.350.130;Cardiac Imaging Techniques;D057791
C06.130.120.135.812;Mirizzi Syndrome;D057792
B01.050.050.116.600;Pets;D057805
B01.050.500.500.294.700.775.600;Molineoidae;D057807
B01.050.500.500.294.700.775.600.550;Nematodirus;D057808
A11.251.210.172.750;HEK293 Cells;D057809
A11.436.334;HEK293 Cells;D057809
E05.196.401.250.500;Two-Dimensional Difference Gel Electrophoresis;D057825
E05.196.401.402.250.500;Two-Dimensional Difference Gel Electrophoresis;D057825
E05.301.300.230.500;Two-Dimensional Difference Gel Electrophoresis;D057825
E05.301.300.319.450.500;Two-Dimensional Difference Gel Electrophoresis;D057825
C11.768.585.439.433;Vitelliform Macular Dystrophy;D057826
C16.320.290.763;Vitelliform Macular Dystrophy;D057826
I01.880.604.473.650.718.500;Informed Consent By Minors;D057828
I01.880.604.583.427.384;Informed Consent By Minors;D057828
N03.706.437.650.312.500;Informed Consent By Minors;D057828
N03.706.535.489.384;Informed Consent By Minors;D057828
E02.906;Sex Reassignment Procedures;D057829
E02.906.500;Sex Reassignment Surgery;D057830
E04.680.750;Sex Reassignment Surgery;D057830
E04.950.449;Sex Reassignment Surgery;D057830
C01.252.400.388.350.700;Lemierre Syndrome;D057831
C07.550.174;Lemierre Syndrome;D057831
C09.775.262;Lemierre Syndrome;D057831
C14.907.355.830.925.770.500;Lemierre Syndrome;D057831
C14.907.617.718.788.500;Lemierre Syndrome;D057831
C14.907.940.740.910.500;Lemierre Syndrome;D057831
N04.761.559.590.900;Watchful Waiting;D057832
D08.811.913.400.725.850;Pyrimidine Phosphorylases;D057845
D12.644.098;Cell-Penetrating Peptides;D057846
D27.505.954.557;Lipid Regulating Agents;D057847
F02.463.593.932.594;Optic Flow;D057849
G14.700;Optic Flow;D057849
B05.275;Hermaphroditic Organisms;D057850
C11.297.500;Posterior Capsular Rupture, Ocular;D057851
A09.371.060.500.155.500;Posterior Capsule of the Lens;D057852
G12.450.192.500;Plant Immunity;D057865
G12.450.800;Plant Immunity;D057865
G15.602;Plant Immunity;D057865
A09.371.061;Anterior Capsule of the Lens;D057866
C14.907.055.501;Endoleak;D057867
C23.550.414.941.500;Endoleak;D057867
C23.550.767.850.500;Endoleak;D057867
C06.405.058;Anastomotic Leak;D057868
C23.550.767.071;Anastomotic Leak;D057868
D25.339.788;Pulp Capping and Pulpectomy Agents;D057872
D27.720.102.339.500;Pulp Capping and Pulpectomy Agents;D057872
J01.637.051.339.788;Pulp Capping and Pulpectomy Agents;D057872
C07.465.693;Peri-Implantitis;D057873
C07.465.714.282;Peri-Implantitis;D057873
C23.550.210.702.500;Triploidy;D057885
G05.365.590.175.677.500;Triploidy;D057885
G05.700.740.500;Triploidy;D057885
D27.720.642.315;Bleaching Agents;D057886
C07.793.494.630.500;Overbite;D057887
D02.455.849.575.500.500.500;Iridoid Glucosides;D057888
D03.383.663.491.500.500;Iridoid Glucosides;D057888
D03.830.491.500.500;Iridoid Glucosides;D057888
D09.408.348.387;Iridoid Glucosides;D057888
D09.408.423.500;Iridoid Glucosides;D057888
D02.455.849.575.500.500;Iridoid Glycosides;D057889
D03.383.663.491.500;Iridoid Glycosides;D057889
D03.830.491.500;Iridoid Glycosides;D057889
D09.408.423;Iridoid Glycosides;D057889
H01.158.273.180.350.074;Epigenomics;D057890
H01.158.273.343.350.042;Epigenomics;D057890
C23.550.210.702.249;Tetraploidy;D057891
G05.365.590.175.677.249;Tetraploidy;D057891
G05.700.740.249;Tetraploidy;D057891
A01.923.600.500;Lesser Pelvis;D057892
E04.545.550.280.280.350;Immediate Dental Implant Loading;D057893
E06.231.310.450;Immediate Dental Implant Loading;D057893
E06.645.550.280.280.450;Immediate Dental Implant Loading;D057893
E06.780.314.310.450;Immediate Dental Implant Loading;D057893
G16.500.275.157.130;Coral Reefs;D057894
N06.230.124.130;Coral Reefs;D057894
G05.365.590.029.530.587;Haploinsufficiency;D057895
G05.380.350.500;Haploinsufficiency;D057895
C23.888.885.800;Striae Distensae;D057896
E01.370.376.550.650.695;Reflex, Righting;D057897
E01.370.600.550.650.695;Reflex, Righting;D057897
G11.561.600.765.745;Reflex, Righting;D057897
G05.380.371;Hemizygote;D057898
G04.299.345.249;Cytophagocytosis;D057899
G04.299.482.350.545;Cytophagocytosis;D057899
G09.188.124.780.500;Cytophagocytosis;D057899
G12.425.899.500;Cytophagocytosis;D057899
G12.450.564.809.500;Cytophagocytosis;D057899
G03.495.166.962;Transcytosis;D057900
G04.299.482.685;Transcytosis;D057900
G04.299.490.790;Transcytosis;D057900
E05.242.950;Stem Cell Research;D057905
H01.770.644.145.512;Stem Cell Research;D057905
G07.180.562.094.500;Circadian Clocks;D057906
A08.850.800.500;Post-Synaptic Density;D057907
A11.284.149.165.420.780.800.500;Post-Synaptic Density;D057907
E02.154.402.054;Argon Plasma Coagulation;D057908
E02.520.089;Argon Plasma Coagulation;D057908
E04.014.170.402.054;Argon Plasma Coagulation;D057908
E04.350.500;Argon Plasma Coagulation;D057908
E06.892.500;Orthognathic Surgery;D057909
H02.163.876.886.500;Orthognathic Surgery;D057909
H02.403.810.481;Orthognathic Surgery;D057909
C23.550.470.251.500;Implant Capsular Contracture;D057910
C23.550.767.865.500;Implant Capsular Contracture;D057910
D27.505.519.162;Angiotensin Receptor Antagonists;D057911
D27.505.519.162.750;Angiotensin II Type 2 Receptor Blockers;D057912
E04.555.113.500;Joint Capsule Release;D057913
E04.555.350;Joint Capsule Release;D057913
E04.800.250.070.500;Joint Capsule Release;D057913
J01.040.044;Agricultural Irrigation;D057914
E02.319.307.312;Drug Substitution;D057915
N02.421.668.778.500.312;Drug Substitution;D057915
B04.820.545.405.400.690;Influenza A Virus, H7N1 Subtype;D057916
B04.909.777.545.405.400.690;Influenza A Virus, H7N1 Subtype;D057916
B04.820.545.405.400.692;Influenza A Virus, H7N2 Subtype;D057917
B04.909.777.545.405.400.692;Influenza A Virus, H7N2 Subtype;D057917
E05.978.808.249;Fiducial Markers;D057918
E07.695.237;Fiducial Markers;D057918
E07.710.259;Fiducial Markers;D057918
N06.850.460.350.080.500;Biological Oxygen Demand Analysis;D057919
N06.850.780.375.349;Biological Oxygen Demand Analysis;D057919
B04.820.545.405.400.694;Influenza A Virus, H7N3 Subtype;D057920
B04.909.777.545.405.400.694;Influenza A Virus, H7N3 Subtype;D057920
B04.820.545.405.400.920;Influenza A Virus, H10N7 Subtype;D057921
B04.909.777.545.405.400.920;Influenza A Virus, H10N7 Subtype;D057921
C05.550.384;Femoracetabular Impingement;D057925
C23.550.347;Femoracetabular Impingement;D057925
G02.842.312;Hydrophobic and Hydrophilic Interactions;D057927
E02.148.947.500;Intermittent Urethral Catheterization;D057928
E04.555.110.110.045;Arthroplasty, Replacement, Elbow;D057929
E04.650.110.045;Arthroplasty, Replacement, Elbow;D057929
E05.916.039.124;Click Chemistry;D057930
E05.916.079;Click Chemistry;D057930
G02.607.750.155.124;Click Chemistry;D057930
J01.897.836.249.124;Click Chemistry;D057930
G05.355.090.403.590;Self-Fertilization;D057945
G08.686.785.760.277.560;Self-Fertilization;D057945
G15.744.850;Self-Fertilization;D057945
B01.650.940.800.150;Charophyceae;D057946
D26.776.708.733;Parenteral Nutrition Solutions;D057947
D27.720.280.775.733;Parenteral Nutrition Solutions;D057947
B01.650.940;Viridiplantae;D057948
B01.650.940.800;Streptophyta;D057949
G02.842.750.270.500;Carbon Sequestration;D057965
D06.347.230;Calcimimetic Agents;D057966
D27.505.696.399.450.230;Calcimimetic Agents;D057966
E02.319.267.510.692;Infusions, Intraventricular;D057967
E07.935;Transdermal Patch;D057968
E02.319.490;Inappropriate Prescribing;D057970
N02.421.450.500.249;Inappropriate Prescribing;D057970
C11.297.249;Anterior Capsular Rupture, Ocular;D057971
A09.371.714;Posterior Eye Segment;D057972
C12.777.419.815.364;Dent Disease;D057973
C13.351.968.419.815.364;Dent Disease;D057973
C16.320.322.100;Dent Disease;D057973
C16.320.565.861.271;Dent Disease;D057973
C18.452.648.861.271;Dent Disease;D057973
D26.310.500;Multi-Ingredient Cold, Flu, and Allergy Medications;D057985
M01.526.485.810.485;General Practitioners;D058005
N02.360.810.485;General Practitioners;D058005
H02.403.340;General Practice;D058006
M01.526.485.810.800;Physicians, Primary Care;D058007
N02.360.810.795;Physicians, Primary Care;D058007
B04.820.650.375.930;Xenotropic murine leukemia virus-related virus;D058008
B01.750;Stramenopiles;D058009
F04.711.647.513.535;Millon Clinical Multiaxial Inventory;D058010
L01.470.625.500;Multifactor Dimensionality Reduction;D058011
L01.700.508.280.199.500;Multifactor Dimensionality Reduction;D058011
J01.219.921;Small Business;D058012
I02.399.890;Test Taking Skills;D058013
N01.400.850;Veterans Health;D058014
L01.143.350;Health Communication;D058015
N02.208;Health Communication;D058015
N02.278.216;Health Facility Administration;D058016
N04.452.418;Health Facility Administration;D058016
E04.100.814.868;Vascular Grafting;D058017
I02.158.405;Interdisciplinary Studies;D058025
F04.096.544.504;Neuropsychiatry;D058027
H02.403.690.754;Neuropsychiatry;D058027
H01.770.644.864;Research Report;D058028
L01.143.506.423.906.769;Research Report;D058028
J01.637.051.479.258;Artificial Cells;D058045
J01.637.087.500.254;Artificial Cells;D058045
C14.280.238.235;Diabetic Cardiomyopathies;D058065
C19.246.099.625;Diabetic Cardiomyopathies;D058065
C01.252.825.180;Digital Dermatitis;D058066
C01.539.800.720.180;Digital Dermatitis;D058066
C17.800.838.765.180;Digital Dermatitis;D058066
C22.214;Digital Dermatitis;D058066
E05.959;Wavelet Analysis;D058067
G17.915;Wavelet Analysis;D058067
L01.224.800.750;Wavelet Analysis;D058067
G05.695.224;Endophenotypes;D058068
C23.550.291.890;Neglected Diseases;D058069
C23.550.291.187;Asymptomatic Diseases;D058070
D01.490;Iron Compounds;D058085
D02.691.550;Iron Compounds;D058085
B05.080.500.600.500;Microalgae;D058086
B01.400;Haptophyta;D058087
C05.651.534.500.280.500;Sarcoglycanopathies;D058088
C08.618.923;Sarcoglycanopathies;D058088
C10.668.491.175.500.149.500;Sarcoglycanopathies;D058088
C14.280.238.812;Sarcoglycanopathies;D058088
C16.320.577.280.500;Sarcoglycanopathies;D058088
G02.149.883;Polymerization;D058105
E04.987;Wound Closure Techniques;D058106
E04.987.100;Abdominal Wound Closure Techniques;D058107
B01.650.232;Glaucophyta;D058108
E02.041;Airway Management;D058109
D26.099;Counterfeit Drugs;D058110
D08.811.277.040.330.300.700;Septins;D058112
D12.776.157.325.757;Septins;D058112
D12.776.220.932;Septins;D058112
D27.720.877.383.500;Cerumenolytic Agents;D058113
B01.650.940.800.150.200;Desmidiales;D058114
D01.045.625;Lewis Bases;D058115
D02.572;Lewis Bases;D058115
D01.029.630;Lewis Acids;D058116
D02.561;Lewis Acids;D058116
E07.305.250.319.381.500;Neural Prostheses;D058117
E07.695.202.381.500;Neural Prostheses;D058117
D12.776.260.730.875;Transcription Factor 7-Like 2 Protein;D058118
D12.776.660.235.400.800.875;Transcription Factor 7-Like 2 Protein;D058118
D12.776.664.235.400.800.875;Transcription Factor 7-Like 2 Protein;D058118
D12.776.930.875.875;Transcription Factor 7-Like 2 Protein;D058118
B01.650.940.800.150.200.150;Closterium;D058119
B01.650.940.800.150.200.500;Micrasterias;D058120
D12.776.260.730.812;Transcription Factor 7-Like 1 Protein;D058125
D12.776.660.235.400.800.812;Transcription Factor 7-Like 1 Protein;D058125
D12.776.664.235.400.800.812;Transcription Factor 7-Like 1 Protein;D058125
D12.776.930.875.812;Transcription Factor 7-Like 1 Protein;D058125
E03.155.197.682;Balanced Anesthesia;D058126
D12.776.260.103.500.875;Transcription Factor 3;D058127
D12.776.260.108.092.875;Transcription Factor 3;D058127
D12.776.930.125.500.875;Transcription Factor 3;D058127
D12.776.930.127.092.875;Transcription Factor 3;D058127
E07.101.400;Compression Bandages;D058128
B01.650.940.800.150.990;Zygnematales;D058129
B01.650.940.800.150.990.550;Mougeotia;D058130
B01.650.940.800.150.990.800;Spirogyra;D058131
G05.360.340.024.380.124;Achaete-Scute Complex Genome Region;D058145
C05.660.207.103;22q11 Deletion Syndrome;D058165
C14.240.400.021;22q11 Deletion Syndrome;D058165
C14.280.400.044;22q11 Deletion Syndrome;D058165
C15.604.451.249;22q11 Deletion Syndrome;D058165
C16.131.077.019;22q11 Deletion Syndrome;D058165
C16.131.240.400.021;22q11 Deletion Syndrome;D058165
C16.131.260.019;22q11 Deletion Syndrome;D058165
C16.131.482.249;22q11 Deletion Syndrome;D058165
C16.131.621.207.103;22q11 Deletion Syndrome;D058165
C16.320.180.019;22q11 Deletion Syndrome;D058165
C19.642.482.500;22q11 Deletion Syndrome;D058165
D01.490.100.375.500;Magnetite Nanoparticles;D058185
D01.490.200.350.500;Magnetite Nanoparticles;D058185
D01.578.285.500;Magnetite Nanoparticles;D058185
J01.637.507.500;Magnetite Nanoparticles;D058185
J01.637.512.600.500.287;Magnetite Nanoparticles;D058185
C12.777.419.780.050;Acute Kidney Injury;D058186
C13.351.968.419.780.050;Acute Kidney Injury;D058186
D27.720.642.315.500;Tooth Bleaching Agents;D058205
D27.720.269.430.214;Hair Bleaching Agents;D058206
D27.720.642.315.249;Hair Bleaching Agents;D058206
G02.111.087.675.871.790.600.925.500;Sumoylation;D058207
G02.111.087.693.600.775.500;Sumoylation;D058207
G02.149.115.675.871.790.600.831.500;Sumoylation;D058207
G02.149.115.693.600.850.500;Sumoylation;D058207
G03.495.770.871.790.600.831.500;Sumoylation;D058207
G05.355.315.670.600.831.500;Sumoylation;D058207
C23.300.821;Plaque, Amyloid;D058225
C23.300.823;Plaque, Atherosclerotic;D058226
D12.776.049.407;Amyloidogenic Proteins;D058227
D12.644.548.586.234;Islet Amyloid Polypeptide;D058228
D12.776.049.407.500;Islet Amyloid Polypeptide;D058228
F02.463.188.331;Cognitive Reserve;D058245
C14.907.653;Prehypertension;D058246
C17.800.329.937.122.348;Loose Anagen Hair Syndrome;D058247
C23.300.035.500;Loose Anagen Hair Syndrome;D058247
E01.370.225.812.735.845;Serum Bactericidal Antibody Assay;D058248
E05.200.812.735.845;Serum Bactericidal Antibody Assay;D058248
E05.478.594.760.845;Serum Bactericidal Antibody Assay;D058248
C04.700.212;Birt-Hogg-Dube Syndrome;D058249
C16.320.700.212;Birt-Hogg-Dube Syndrome;D058249
E06.323.428.187;Dental Restoration Repair;D058250
E06.780.345.737.112;Dental Restoration Repair;D058250
E07.695.190.190.250;Dental Restoration Repair;D058250
B01.050.500.131.617.750.200;Ctenocephalides;D058251
C15.604.515.292.507;Necrobiotic Xanthogranuloma;D058252
C17.300.200.495.772;Necrobiotic Xanthogranuloma;D058252
C17.800.550.772;Necrobiotic Xanthogranuloma;D058252
C18.452.584.750.487;Necrobiotic Xanthogranuloma;D058252
C23.550.382.984;Necrobiotic Xanthogranuloma;D058252
B01.050.500.131.617.750.800;Tunga;D058253
E07.325.220.500;Stretchers;D058254
N02.421.297.879.550;Stretchers;D058254
D12.644.822.468;Protease Nexins;D058255
D12.776.645.468;Protease Nexins;D058255
E01.370.376.300.150;Brain Waves;D058256
E01.370.405.245.287;Brain Waves;D058256
G07.265.087;Brain Waves;D058256
G11.561.127;Brain Waves;D058256
E07.325.877;Surgical Attire;D058257
E07.858.594;Surgical Attire;D058257
D12.644.822.468.750;Serpin E2;D058258
D12.644.822.750.695.850;Serpin E2;D058258
D12.776.645.468.750;Serpin E2;D058258
D12.776.645.750.695.850;Serpin E2;D058258
D12.776.872.695.850;Serpin E2;D058258
B01.050.500.131.617.750.950;Xenopsylla;D058260
D12.776.476.024.412;Receptor Activity-Modifying Proteins;D058261
D12.776.543.725;Receptor Activity-Modifying Proteins;D058261
D12.776.476.024.412.100;Receptor Activity-Modifying Protein 1;D058262
D12.776.543.725.100;Receptor Activity-Modifying Protein 1;D058262
D12.776.476.024.412.200;Receptor Activity-Modifying Protein 2;D058263
D12.776.543.725.200;Receptor Activity-Modifying Protein 2;D058263
D12.776.476.024.412.300;Receptor Activity-Modifying Protein 3;D058264
D12.776.543.725.300;Receptor Activity-Modifying Protein 3;D058264
D12.776.543.750.100.041;Receptors, Adrenomedullin;D058265
D12.776.543.750.750.049;Receptors, Adrenomedullin;D058265
E05.196.867.335;Dielectric Spectroscopy;D058266
C03.858.211.250;Flea Infestations;D058267
C03.858.211.250.800;Tungiasis;D058285
D12.776.543.750.100.011;Calcitonin Receptor-Like Protein;D058286
D12.776.543.750.100.360;Receptors, Islet Amyloid Polypeptide;D058287
C04.588.033.740;Sister Mary Joseph's Nodule;D058288
D12.776.543.990.150.875;Sorting Nexins;D058305
D12.776.543.750.100.200.700.600.100;Receptors, Prostaglandin E, EP1 Subtype;D058306
D12.776.543.750.100.200.700.600.200;Receptors, Prostaglandin E, EP2 Subtype;D058307
D12.776.543.750.100.200.700.600.300;Receptors, Prostaglandin E, EP3 Subtype;D058308
D12.776.543.750.100.200.700.600.400;Receptors, Prostaglandin E, EP4 Subtype;D058309
B01.050.500.131.617.690.050;Amblycera;D058325
B01.050.500.131.617.690.450;Ischnocera;D058326
E04.100.376.724;Norwood Procedures;D058327
E04.928.220.560;Norwood Procedures;D058327
C23.550.291.187.500;Asymptomatic Infections;D058345
C01.703.160.175;Candidiasis, Invasive;D058365
E04.035.137;Blalock-Taussig Procedure;D058366
E04.100.814.868.374;Blalock-Taussig Procedure;D058366
E04.100.376.062;Cardiac Valve Annuloplasty;D058385
E04.928.220.109;Cardiac Valve Annuloplasty;D058385
E04.100.376.062.500;Mitral Valve Annuloplasty;D058386
E04.928.220.109.500;Mitral Valve Annuloplasty;D058386
C01.539.757.360.150;Candidemia;D058387
C01.703.160.175.150;Candidemia;D058387
C01.703.360.150;Candidemia;D058387
C23.550.470.790.500.360.150;Candidemia;D058387
C04.557.450.795.315;Desmoplastic Small Round Cell Tumor;D058405
E02.342.124.500;Cardiac Resynchronization Therapy;D058406
E01.370.376.300.437;Electroencephalography Phase Synchronization;D058407
E01.370.405.245.575;Electroencephalography Phase Synchronization;D058407
G07.265.337.200;Electroencephalography Phase Synchronization;D058407
G02.111.840;Th1-Th2 Balance;D058408
E07.305.250.750.500;Cardiac Resynchronization Therapy Devices;D058409
D12.776.828.868.955;Vaccines, Virus-Like Particle;D058425
D20.215.894.865.955;Vaccines, Virus-Like Particle;D058425
D23.050.865.955;Vaccines, Virus-Like Particle;D058425
C23.550.722;Neointima;D058426
D27.720.369;Hygroscopic Agents;D058427
D27.720.470.370;Hygroscopic Agents;D058427
D01.837.725.700.379;Silica Gel;D058428
D20.280.320.687;Silica Gel;D058428
D26.255.165.320.687;Silica Gel;D058428
C03.335.508.700.750.380;Gnathostomiasis;D058429
A02.835.232.087.090.400.400;Humeral Head;D058430
B01.650.940.800.575.100.822.072;Brachypodium;D058431
A18.560;Sporangia;D058432
A19.800;Sporangia;D058432
E07.115.600;Photobioreactors;D058433
J01.897.120.115.600;Photobioreactors;D058433
N04.452.480;Knowledge Management;D058436
C11.768.346;Hypertensive Retinopathy;D058437
C14.907.489.815;Hypertensive Retinopathy;D058437
G01.311.340.950;Water Cycle;D058438
G16.500.240.795;Water Cycle;D058438
E05.240.550;Plant Somatic Embryogenesis Techniques;D058439
G15.744.749;Plant Somatic Embryogenesis Techniques;D058439
G02.842.750.643.500;Denitrification;D058440
G16.100.277;Denitrification;D058440
G16.500.240.250;Denitrification;D058440
G16.500.240.465.249;Denitrification;D058440
G16.500.240.630;Rhizosphere;D058441
G16.500.275.157.625;Rhizosphere;D058441
N06.230.124.437;Rhizosphere;D058441
C11.510.245.500;Capsule Opacification;D058442
F01.100.575;Catastrophization;D058443
F01.470.132.225;Catastrophization;D058443
F01.145.126.125.550;Bullying;D058445
D12.776.157.530.400.400;Ligand-Gated Ion Channels;D058446
D12.776.543.550.425.500;Ligand-Gated Ion Channels;D058446
D12.776.543.585.400.500;Ligand-Gated Ion Channels;D058446
C11.300.500;Eye Pain;D058447
C23.888.307.625;Eye Pain;D058447
C23.888.646.407;Eye Pain;D058447
G16.500.275.157.049.100;Biota;D058448
N06.230.124.049.100;Biota;D058448
E02.319.267.530.475.500;Intravitreal Injections;D058449
E02.393;Endotamponade;D058450
E02.520.392;Endotamponade;D058450
E04.540.342;Endotamponade;D058450
G02.607.750.660;Oxidative Coupling;D058451
G02.842.750.650.500;Oxidative Coupling;D058451
A09.371.199;Axial Length, Eye;D058452
E01.370.600.115.100.660.500;Axial Length, Eye;D058452
E01.370.380.850.950.750;Emmetropia;D058453
F02.463.593.932.901.750;Emmetropia;D058453
G14.940.750;Emmetropia;D058453
C11.768.748;Retinal Telangiectasis;D058456
C14.907.823.502;Retinal Telangiectasis;D058456
C11.338.912;Trichiasis;D058457
G02.111.087.599;Nitrogen Cycle;D058458
G02.149.115.599;Nitrogen Cycle;D058458
G02.607.750.560;Nitrogen Cycle;D058458
G02.842.750.643;Nitrogen Cycle;D058458
G16.500.240.465;Nitrogen Cycle;D058458
G16.500.240.465.500;Nitrification;D058465
D12.776.157.530.400.400.100;Cysteine Loop Ligand-Gated Ion Channel Receptors;D058466
D12.776.543.550.425.500.100;Cysteine Loop Ligand-Gated Ion Channel Receptors;D058466
D12.776.543.585.400.500.100;Cysteine Loop Ligand-Gated Ion Channel Receptors;D058466
D12.776.543.750.051;Cysteine Loop Ligand-Gated Ion Channel Receptors;D058466
B01.050.500.901;Tardigrada;D058467
D12.776.157.530.400.400.500;Receptors, Ionotropic Glutamate;D058468
D12.776.543.550.425.500.200;Receptors, Ionotropic Glutamate;D058468
D12.776.543.585.400.500.200;Receptors, Ionotropic Glutamate;D058468
D12.776.543.750.720.200.450.400;Receptors, Ionotropic Glutamate;D058468
D12.776.157.530.400.400.750;Receptors, Purinergic P2X;D058469
D12.776.543.550.425.500.600;Receptors, Purinergic P2X;D058469
D12.776.543.585.400.500.600;Receptors, Purinergic P2X;D058469
D12.776.543.750.720.700.720.500;Receptors, Purinergic P2X;D058469
D12.776.543.750.810.720.500;Receptors, Purinergic P2X;D058469
D12.776.543.750.100.700.720.500;Receptors, Purinergic P2Y;D058470
D12.776.543.750.720.700.720.750;Receptors, Purinergic P2Y;D058470
D12.776.543.750.810.720.750;Receptors, Purinergic P2Y;D058470
A12.383.800;Subretinal Fluid;D058471
D12.776.543.750.100.700.720.500.100;Receptors, Purinergic P2Y1;D058472
D12.776.543.750.720.700.720.750.100;Receptors, Purinergic P2Y1;D058472
D12.776.543.750.810.720.750.100;Receptors, Purinergic P2Y1;D058472
D12.776.543.750.100.700.720.500.200;Receptors, Purinergic P2Y2;D058473
D12.776.543.750.720.700.720.750.200;Receptors, Purinergic P2Y2;D058473
D12.776.543.750.810.720.750.200;Receptors, Purinergic P2Y2;D058473
D12.776.157.530.400.400.750.100;Receptors, Purinergic P2X1;D058474
D12.776.543.550.425.500.600.100;Receptors, Purinergic P2X1;D058474
D12.776.543.585.400.500.600.100;Receptors, Purinergic P2X1;D058474
D12.776.543.750.720.700.720.500.100;Receptors, Purinergic P2X1;D058474
D12.776.543.750.810.720.500.100;Receptors, Purinergic P2X1;D058474
A02.340.800;Tenon Capsule;D058475
A09.371.839;Tenon Capsule;D058475
D12.776.157.530.400.400.750.200;Receptors, Purinergic P2X2;D058476
D12.776.543.550.425.500.600.200;Receptors, Purinergic P2X2;D058476
D12.776.543.585.400.500.600.200;Receptors, Purinergic P2X2;D058476
D12.776.543.750.720.700.720.500.200;Receptors, Purinergic P2X2;D058476
D12.776.543.750.810.720.500.200;Receptors, Purinergic P2X2;D058476
D12.776.157.530.400.400.750.300;Receptors, Purinergic P2X3;D058477
D12.776.543.550.425.500.600.300;Receptors, Purinergic P2X3;D058477
D12.776.543.585.400.500.600.300;Receptors, Purinergic P2X3;D058477
D12.776.543.750.720.700.720.500.300;Receptors, Purinergic P2X3;D058477
D12.776.543.750.810.720.500.300;Receptors, Purinergic P2X3;D058477
D12.776.157.530.400.400.750.500;Receptors, Purinergic P2X5;D058485
D12.776.543.550.425.500.600.500;Receptors, Purinergic P2X5;D058485
D12.776.543.585.400.500.600.500;Receptors, Purinergic P2X5;D058485
D12.776.543.750.720.700.720.500.500;Receptors, Purinergic P2X5;D058485
D12.776.543.750.810.720.500.500;Receptors, Purinergic P2X5;D058485
D12.776.157.530.400.400.750.700;Receptors, Purinergic P2X7;D058486
D12.776.543.550.425.500.600.700;Receptors, Purinergic P2X7;D058486
D12.776.543.585.400.500.600.700;Receptors, Purinergic P2X7;D058486
D12.776.543.750.720.700.720.500.700;Receptors, Purinergic P2X7;D058486
D12.776.543.750.810.720.500.700;Receptors, Purinergic P2X7;D058486
B05.500.500.150;Cercaria;D058487
G07.700.320.500.550.500.500.150;Cercaria;D058487
B05.500.500.150.500;Metacercariae;D058488
G07.700.320.500.550.500.500.150.500;Metacercariae;D058488
C12.706.316.064;46, XX Disorders of Sex Development;D058489
C13.351.875.253.064;46, XX Disorders of Sex Development;D058489
C16.131.939.316.064;46, XX Disorders of Sex Development;D058489
C19.391.119.064;46, XX Disorders of Sex Development;D058489
F03.800.399.500;46, XX Disorders of Sex Development;D058489
C12.706.316.096;46, XY Disorders of Sex Development;D058490
C13.351.875.253.096;46, XY Disorders of Sex Development;D058490
C16.131.939.316.096;46, XY Disorders of Sex Development;D058490
C19.391.119.096;46, XY Disorders of Sex Development;D058490
F03.800.399.750;46, XY Disorders of Sex Development;D058490
E01.370.225.875.150.115;Bacterial Load;D058491
E01.370.225.875.220.115;Bacterial Load;D058491
E05.200.875.150.115;Bacterial Load;D058491
E05.200.875.220.115;Bacterial Load;D058491
G06.099.100;Bacterial Load;D058491
E02.319.307.124;Drug Repositioning;D058492
N02.421.668.778.500.124;Drug Repositioning;D058492
B01.050.500.131.617.289.797;Sarcophagidae;D058493
C10.500.507.249.249.500;Walker-Warburg Syndrome;D058494
C11.270.881;Walker-Warburg Syndrome;D058494
C16.131.666.507.186.249.500;Walker-Warburg Syndrome;D058494
C16.320.577.750;Walker-Warburg Syndrome;D058494
C16.131.077.889;Sotos Syndrome;D058495
C16.131.260.905;Sotos Syndrome;D058495
C16.320.180.905;Sotos Syndrome;D058495
C10.281.900;Smith-Magenis Syndrome;D058496
C16.131.077.879;Smith-Magenis Syndrome;D058496
C16.131.260.887;Smith-Magenis Syndrome;D058496
C16.320.180.887;Smith-Magenis Syndrome;D058496
C11.250.390;Fraser Syndrome;D058497
C16.131.077.371;Fraser Syndrome;D058497
C16.131.384.442;Fraser Syndrome;D058497
E02.718.275.500.500;Kyphoplasty;D058498
E04.555.165.500.500;Kyphoplasty;D058498
C11.768.585.658;Retinal Dystrophies;D058499
A13.077;Animal Fins;D058500
E01.370.225.500.508;Enzyme-Linked Immunospot Assay;D058501
E05.200.500.508;Enzyme-Linked Immunospot Assay;D058501
E05.242.508;Enzyme-Linked Immunospot Assay;D058501
E05.478.566.350.170.500;Enzyme-Linked Immunospot Assay;D058501
E05.478.566.380.360.500;Enzyme-Linked Immunospot Assay;D058501
E05.478.583.400.170.500;Enzyme-Linked Immunospot Assay;D058501
E05.601.495.350.170.500;Enzyme-Linked Immunospot Assay;D058501
E05.601.495.380.360.500;Enzyme-Linked Immunospot Assay;D058501
C10.500.680.705;Pentalogy of Cantrell;D058502
C16.131.077.696;Pentalogy of Cantrell;D058502
C16.131.666.680.705;Pentalogy of Cantrell;D058502
A11.600;Mesophyll Cells;D058503
A18.024.812.324;Mesophyll Cells;D058503
A11.118.637.555.567.550.500.400.915;Th17 Cells;D058504
A11.118.637.555.567.569.200.400.915;Th17 Cells;D058504
A11.118.637.555.567.569.500.400.915;Th17 Cells;D058504
A15.145.229.637.555.567.550.500.400.770;Th17 Cells;D058504
A15.145.229.637.555.567.569.200.400.770;Th17 Cells;D058504
A15.145.229.637.555.567.569.500.400.770;Th17 Cells;D058504
A15.382.490.555.567.550.500.400.915;Th17 Cells;D058504
A15.382.490.555.567.569.200.400.915;Th17 Cells;D058504
A15.382.490.555.567.569.500.400.915;Th17 Cells;D058504
A18.024.875.875.500;Cambium;D058506
A18.400.500.299;Cambium;D058506
G06.590.470.380;Host Specificity;D058507
G16.100.380.380;Host Specificity;D058507
G16.100.380.400.400;Host Specificity;D058507
E05.196.778;Quartz Crystal Microbalance Techniques;D058525
E05.978.673;Quartz Crystal Microbalance Techniques;D058525
A18.024.812.675;Plant Vascular Bundle;D058526
A18.024.937.625;Plant Vascular Bundle;D058526
A18.400.687;Plant Vascular Bundle;D058526
A18.450;Plant Vascular Bundle;D058526
C04.557.386.480.750.099;Enteropathy-Associated T-Cell Lymphoma;D058527
C15.604.515.569.480.750.399;Enteropathy-Associated T-Cell Lymphoma;D058527
C20.683.515.761.480.750.199;Enteropathy-Associated T-Cell Lymphoma;D058527
C14.240.850.976;Single Umbilical Artery;D058529
C16.131.240.850.952;Single Umbilical Artery;D058529
B01.650.940.800.575.100.905.188.550;Datura metel;D058530
C12.706.316.064.124;46, XX Testicular Disorders of Sex Development;D058531
C13.351.875.253.064.124;46, XX Testicular Disorders of Sex Development;D058531
C16.131.939.316.064.124;46, XX Testicular Disorders of Sex Development;D058531
C19.391.119.064.124;46, XX Testicular Disorders of Sex Development;D058531
C12.706.316.795;Sex Chromosome Disorders of Sex Development;D058533
C13.351.875.253.795;Sex Chromosome Disorders of Sex Development;D058533
C16.131.260.830.835;Sex Chromosome Disorders of Sex Development;D058533
C16.131.939.316.795;Sex Chromosome Disorders of Sex Development;D058533
C16.320.180.830.835;Sex Chromosome Disorders of Sex Development;D058533
C19.391.119.795;Sex Chromosome Disorders of Sex Development;D058533
D08.811.913.696.620.500.100.100;Class I Phosphatidylinositol 3-Kinases;D058534
D08.811.913.696.620.500.200.100;Class I Phosphatidylinositol 3-Kinases;D058534
D12.776.476.162;Class I Phosphatidylinositol 3-Kinases;D058534
C13.703.277.050;Echogenic Bowel;D058535
C16.300.050;Echogenic Bowel;D058535
C13.703.277.838;Pyelectasis;D058536
C16.131.939.831;Pyelectasis;D058536
C16.300.895;Pyelectasis;D058536
V01.255;Electronic Supplementary Materials;D058537
D08.811.913.696.620.500.200;Phosphatidylinositol-4-Phosphate 3-Kinase;D058538
D08.811.913.696.620.500.100;Phosphatidylinositol 3-Kinase;D058539
C10.500.034.687;Aicardi Syndrome;D058540
C11.270.019;Aicardi Syndrome;D058540
C16.131.162;Aicardi Syndrome;D058540
C16.131.666.034.687;Aicardi Syndrome;D058540
C16.320.290.019;Aicardi Syndrome;D058540
C16.320.322.030;Aicardi Syndrome;D058540
D08.811.913.696.620.500.100.200;Class II Phosphatidylinositol 3-Kinases;D058541
D08.811.913.696.620.500.200.200;Class II Phosphatidylinositol 3-Kinases;D058541
D12.776.476.168;Class II Phosphatidylinositol 3-Kinases;D058541
E07.305.250.319.381;Implantable Neurostimulators;D058542
E07.695.202.381;Implantable Neurostimulators;D058542
D08.811.913.696.620.500.100.100.100;Class Ia Phosphatidylinositol 3-Kinase;D058543
D08.811.913.696.620.500.200.100.100;Class Ia Phosphatidylinositol 3-Kinase;D058543
D12.776.476.162.100;Class Ia Phosphatidylinositol 3-Kinase;D058543
D08.811.913.696.620.500.100.100.200;Class Ib Phosphatidylinositol 3-Kinase;D058544
D08.811.913.696.620.500.200.100.200;Class Ib Phosphatidylinositol 3-Kinase;D058544
D12.776.476.162.200;Class Ib Phosphatidylinositol 3-Kinase;D058544
C25.467;Inhalant Abuse;D058545
F03.900.467;Inhalant Abuse;D058545
D08.811.913.696.620.500.100.300;Class III Phosphatidylinositol 3-Kinases;D058546
D12.776.476.171;Class III Phosphatidylinositol 3-Kinases;D058546
D12.776.543.990.175;Class III Phosphatidylinositol 3-Kinases;D058546
C10.228.140.430.249;Cerebral Ventriculitis;D058565
C10.228.228.245.169;Cerebral Ventriculitis;D058565
C05.550.114.854;Sacroiliitis;D058566
D25.339.574;Photoinitiators, Dental;D058567
D27.720.102.339.249;Photoinitiators, Dental;D058567
J01.637.051.339.574;Photoinitiators, Dental;D058567
C17.800.551;Necrolytic Migratory Erythema;D058568
C23.888.885.468;Necrolytic Migratory Erythema;D058568
E07.695.400.300;Elbow Prosthesis;D058569
D08.811.913.696.620.682.700.931;TOR Serine-Threonine Kinases;D058570
D12.776.476.925;TOR Serine-Threonine Kinases;D058570
D08.811.913.696.620.500.100.300.500;Vacuolar Sorting Protein VPS15;D058571
D08.811.913.696.620.682.700.965;Vacuolar Sorting Protein VPS15;D058571
D12.776.476.171.500;Vacuolar Sorting Protein VPS15;D058571
D12.776.543.990.175.500;Vacuolar Sorting Protein VPS15;D058571
G16.500.275.066;Carbon Footprint;D058572
N06.230.063;Carbon Footprint;D058572
D27.505.696.620;Performance-Enhancing Substances;D058573
D12.776.395.700.675;Integrin-Binding Sialoprotein;D058574
D12.776.744.527;Integrin-Binding Sialoprotein;D058574
D12.776.860.300.562;Integrin-Binding Sialoprotein;D058574
D12.776.395.650.750.625;Decorin;D058575
D12.776.395.650.750.562;Biglycan;D058578
D12.776.395.650.750.687;Hyalectins;D058579
D12.776.503.280.437;Hyalectins;D058579
D12.776.395.550.200.250.520.789;Neurocan;D058580
D12.776.395.650.750.687.450;Neurocan;D058580
D12.776.503.280.437.450;Neurocan;D058580
D12.776.543.550.200.250.520.789;Neurocan;D058580
D23.050.301.350.250.520.789;Neurocan;D058580
D12.776.395.650.750.687.275;Brevican;D058581
D12.776.503.280.437.275;Brevican;D058581
E01.370.388.250.250.250.180;Double-Balloon Enteroscopy;D058582
E04.800.250.250.250.180;Double-Balloon Enteroscopy;D058582
G07.265.500.385.500;Vestibular Evoked Myogenic Potentials;D058585
G07.265.500.712;Vestibular Evoked Myogenic Potentials;D058585
D23.297;Host-Derived Cellular Factors;D058605
C23.300.190;Accessory Atrioventricular Bundle;D058606
D02.241.081.114.968.500;Fibric Acids;D058607
D02.355.726.305;Fibric Acids;D058607
D02.455.426.559.389.657.654.305;Fibric Acids;D058607
J01.637.512.650;Nanopores;D058608
E01.370.380.850.962;Visual Field Tests;D058609
D02.241.081.114.968;Isobutyrates;D058610
D10.251.400.143.875;Isobutyrates;D058610
E02.190.438;Horticultural Therapy;D058611
F04.754.392;Horticultural Therapy;D058611
D01.268.150.200.550;Nanodiamonds;D058612
J01.637.512.600.580;Nanodiamonds;D058612
G01.154.767;Seed Dispersal;D058614
G15.744.735.500;Seed Dispersal;D058614
G15.808;Seed Dispersal;D058614
H01.158.273.904;Synthetic Biology;D058615
J01.293.069.500;Synthetic Biology;D058615
J02.500.456.716;Synbiotics;D058616
C04.557.386.150;Composite Lymphoma;D058617
C04.557.435.295;Composite Lymphoma;D058617
C15.604.515.569.150;Composite Lymphoma;D058617
C20.683.515.761.150;Composite Lymphoma;D058617
A13.825;Sensilla;D058618
D12.776.097.577.500.500;Maltose-Binding Proteins;D058619
G07.610.315;Elder Nutritional Physiological Phenomena;D058620
A15.145.229.093;Blood Buffy Coat;D058621
C06.552.308.500.177;End Stage Liver Disease;D058625
D01.362.740;Plasma Gases;D058626
C05.660.207.536;Macrocephaly;D058627
C10.500.507.374;Macrocephaly;D058627
C16.131.621.207.532;Macrocephaly;D058627
C16.131.666.507.343;Macrocephaly;D058627
A11.329.228.975;Myofibroblasts;D058628
A11.620.520.500;Myofibroblasts;D058628
E02.218.707;Plasma Skin Regeneration;D058629
G11.561.600.615.500;Spinal Cord Regeneration;D058630
G16.100.856.611.500;Spinal Cord Regeneration;D058630
C05.116.099.708.779;Pycnodysostosis;D058631
C16.320.565.595.800;Pycnodysostosis;D058631
C16.320.812;Pycnodysostosis;D058631
C18.452.648.595.800;Pycnodysostosis;D058631
D10.251.355.337.250.500;Neuroprostanes;D058632
D10.251.355.411.750;Neuroprostanes;D058632
D27.505.696.068;Antipyretics;D058633
J01.897.836.750;Molecular Farming;D058634
D12.776.543.484;Lipid-Linked Proteins;D058635
E07.325.137.750;Surgical Drapes;D058636
E07.858.642;Surgical Drapes;D058636
E07.325.409;Examination Tables;D058637
E07.325.662;Operating Tables;D058638
E07.858.421;Operating Tables;D058638
G07.700.830.249;Cold-Shock Response;D058639
B03.510.100.120;Brochothrix;D058640
B03.510.460.400.410.120;Brochothrix;D058640
B03.510.100.100.600;Planococcaceae;D058641
B03.510.400.630;Planococcaceae;D058641
B03.510.400.630.600;Planococcus Bacteria;D058642
B01.050.500.131.617.412.600;Planococcus Insect;D058643
B03.300.390.825;Sporosarcina;D058644
B03.510.100.100.600.700;Sporosarcina;D058644
B03.510.400.630.700;Sporosarcina;D058644
B03.510.415.700;Sporosarcina;D058644
E05.196.401.402.117;Denaturing Gradient Gel Electrophoresis;D058645
E05.301.300.319.201;Denaturing Gradient Gel Electrophoresis;D058645
D27.505.519.625.050.100.100.100;Adrenergic alpha-1 Receptor Agonists;D058646
D27.505.696.577.050.100.100.100;Adrenergic alpha-1 Receptor Agonists;D058646
D27.505.519.625.050.100.100.200;Adrenergic alpha-2 Receptor Agonists;D058647
D27.505.696.577.050.100.100.200;Adrenergic alpha-2 Receptor Agonists;D058647
D27.505.519.625.050.100.200.100;Adrenergic beta-1 Receptor Agonists;D058665
D27.505.696.577.050.100.200.100;Adrenergic beta-1 Receptor Agonists;D058665
D27.505.519.625.050.100.200.200;Adrenergic beta-2 Receptor Agonists;D058666
D27.505.696.577.050.100.200.200;Adrenergic beta-2 Receptor Agonists;D058666
D27.505.519.625.050.100.200.300;Adrenergic beta-3 Receptor Agonists;D058667
D27.505.696.577.050.100.200.300;Adrenergic beta-3 Receptor Agonists;D058667
D27.505.519.625.050.200.100.100;Adrenergic alpha-1 Receptor Antagonists;D058668
D27.505.696.577.050.200.100.100;Adrenergic alpha-1 Receptor Antagonists;D058668
D27.505.519.625.050.200.100.200;Adrenergic alpha-2 Receptor Antagonists;D058669
D27.505.696.577.050.200.100.200;Adrenergic alpha-2 Receptor Antagonists;D058669
C23.550.210.050.625;Tetrasomy;D058670
C23.550.210.182.249;Tetrasomy;D058670
G05.365.590.175.050.625;Tetrasomy;D058670
G05.365.590.175.183.249;Tetrasomy;D058670
G05.700.131.625;Tetrasomy;D058670
D27.505.519.625.050.200.200.100;Adrenergic beta-1 Receptor Antagonists;D058671
D27.505.696.577.050.200.200.100;Adrenergic beta-1 Receptor Antagonists;D058671
D27.505.519.625.050.200.200.200;Adrenergic beta-2 Receptor Antagonists;D058672
D27.505.696.577.050.200.200.200;Adrenergic beta-2 Receptor Antagonists;D058672
D27.505.519.625.050.200.200.300;Adrenergic beta-3 Receptor Antagonists;D058673
D27.505.696.577.050.200.200.300;Adrenergic beta-3 Receptor Antagonists;D058673
C23.550.210.182;Chromosome Duplication;D058674
G05.355.600.164;Chromosome Duplication;D058674
G05.365.590.175.183;Chromosome Duplication;D058674
B03.300.390.400.160;Brevibacillus;D058675
B03.510.100.117;Brevibacillus;D058675
B03.510.415.400.179;Brevibacillus;D058675
B03.510.460.410.165;Brevibacillus;D058675
B03.300.390.650;Pasteuria;D058676
B03.510.100.650;Pasteuria;D058676
B03.510.415.650;Pasteuria;D058676
B03.300.390.400.158.108;Anoxybacillus;D058677
B03.510.100.100.108;Anoxybacillus;D058677
B03.510.415.400.158.108;Anoxybacillus;D058677
B03.510.460.410.158.108;Anoxybacillus;D058677
B03.300.390.400.158.600;Halobacillus;D058678
B03.510.100.100.425;Halobacillus;D058678
B03.510.415.400.158.425;Halobacillus;D058678
B03.510.460.410.158.425;Halobacillus;D058678
B03.300.390.400.158.900;Virgibacillus;D058679
B03.510.415.400.158.900;Virgibacillus;D058679
B03.510.460.410.158.900;Virgibacillus;D058679
G05.420.556;Genetic Pleiotropy;D058685
G05.695.550;Genetic Pleiotropy;D058685
C14.280.647.250.647;Coronary-Subclavian Steal Syndrome;D058686
C14.907.585.250.647;Coronary-Subclavian Steal Syndrome;D058686
C23.550.767.115;Coronary-Subclavian Steal Syndrome;D058686
C14.280.383.610;Out-of-Hospital Cardiac Arrest;D058687
G08.686.701;Peripartum Period;D058725
D26.255.260.600;Nanoconjugates;D058726
D27.720.280.260.600;Nanoconjugates;D058726
E02.319.300.380.600;Nanoconjugates;D058726
J01.637.512.600.577;Nanoconjugates;D058726
D13.444.735.790.552;RNA, Small Untranslated;D058727
J01.040.947;Weed Control;D058728
C14.907.137.126.307.500;Peripheral Arterial Disease;D058729
C14.907.617.671;Peripheral Arterial Disease;D058729
E02.792.833.230.500;Blood Safety;D058731
E05.760.833.230.500;Blood Safety;D058731
N06.850.780.200.450.325;Blood Safety;D058731
A11.872.190.260;Embryoid Bodies;D058732
E01.370.388.250.520.500;Hand-Assisted Laparoscopy;D058733
E04.800.250.520.580;Hand-Assisted Laparoscopy;D058733
C23.550.414.734;Exsanguination;D058734
I01.655.500.608.180;Environmental Policy;D058735
I01.880.604.825.608.180;Environmental Policy;D058735
N03.623.500.608.180;Environmental Policy;D058735
N06.230.204;Environmental Policy;D058735
C26.392.500.500;Intrauterine Device Migration;D058736
E05.325.578;Intrauterine Device Migration;D058736
E04.555.110.110.010;Arthroplasty, Replacement, Ankle;D058737
E04.650.110.010;Arthroplasty, Replacement, Ankle;D058737
E02.148.106.500;Uterine Balloon Tamponade;D058738
E02.520.179.500;Uterine Balloon Tamponade;D058738
E02.926.500.074.500;Uterine Balloon Tamponade;D058738
C04.834.020;Aberrant Crypt Foci;D058739
C26.558.554.425;Iliotibial Band Syndrome;D058745
C26.844.150.425;Iliotibial Band Syndrome;D058745
A16.535;Gestational Sac;D058746
C16.131.077.239;CHARGE Syndrome;D058747
C16.320.165;CHARGE Syndrome;D058747
F02.463.593.504;Pain Perception;D058748
J01.086.339.445;Military Facilities;D058749
G04.299.335.500;Epithelial-Mesenchymal Transition;D058750
G07.700.320.500.325.180.781;Epithelial-Mesenchymal Transition;D058750
G08.686.785.760.170.104.812;Epithelial-Mesenchymal Transition;D058750
B01.050.050.116.500;Livestock;D058751
A10.850.710.500;Free Tissue Flaps;D058752
E07.862.710.500;Free Tissue Flaps;D058752
E04.580.371;Laryngoplasty;D058753
E02.190.525.123.500;Neurofeedback;D058765
F02.830.131.500;Neurofeedback;D058765
F04.754.137.301.750;Neurofeedback;D058765
F04.754.308.500.750;Neurofeedback;D058765
L01.143.283.425.624.500.500;Neurofeedback;D058765
D03.438.733.631.400.800.350.450.500;Levoleucovorin;D058766
E05.793;Protein Unfolding;D058767
G01.154.100.640.750;Protein Unfolding;D058767
G01.595.100.640.750;Protein Unfolding;D058767
G02.111.087.690.750;Protein Unfolding;D058767
G02.149.115.690.750;Protein Unfolding;D058767
D27.505.519.625.240.200.500;GABA-A Receptor Agonists;D058785
D27.505.696.577.240.200.500;GABA-A Receptor Agonists;D058785
D27.505.519.625.240.200.750;GABA-B Receptor Agonists;D058786
D27.505.696.577.240.200.750;GABA-B Receptor Agonists;D058786
D27.505.519.625.240.300.500;GABA-A Receptor Antagonists;D058787
D27.505.696.577.240.300.500;GABA-A Receptor Antagonists;D058787
D27.505.519.625.240.300.750;GABA-B Receptor Antagonists;D058788
D27.505.696.577.240.300.750;GABA-B Receptor Antagonists;D058788
D27.505.519.625.240.750;GABA Uptake Inhibitors;D058805
D27.505.519.625.600.535;GABA Uptake Inhibitors;D058805
D27.505.696.577.240.750;GABA Uptake Inhibitors;D058805
D27.505.696.577.600.535;GABA Uptake Inhibitors;D058805
D27.505.519.625.850.800.100;Serotonin 5-HT1 Receptor Agonists;D058825
D27.505.696.577.850.800.100;Serotonin 5-HT1 Receptor Agonists;D058825
D27.505.519.625.850.800.200;Serotonin 5-HT2 Receptor Agonists;D058826
D27.505.696.577.850.800.200;Serotonin 5-HT2 Receptor Agonists;D058826
D27.505.519.625.850.800.300;Serotonin 5-HT3 Receptor Agonists;D058827
D27.505.696.577.850.800.300;Serotonin 5-HT3 Receptor Agonists;D058827
D27.505.519.625.850.800.400;Serotonin 5-HT4 Receptor Agonists;D058828
D27.505.696.577.850.800.400;Serotonin 5-HT4 Receptor Agonists;D058828
D27.505.519.625.850.850.100;Serotonin 5-HT1 Receptor Antagonists;D058829
D27.505.696.577.850.850.100;Serotonin 5-HT1 Receptor Antagonists;D058829
D27.505.519.625.850.850.200;Serotonin 5-HT2 Receptor Antagonists;D058830
D27.505.696.577.850.850.200;Serotonin 5-HT2 Receptor Antagonists;D058830
D27.505.519.625.850.850.300;Serotonin 5-HT3 Receptor Antagonists;D058831
D27.505.696.577.850.850.300;Serotonin 5-HT3 Receptor Antagonists;D058831
D27.505.519.625.850.850.400;Serotonin 5-HT4 Receptor Antagonists;D058832
D27.505.696.577.850.850.400;Serotonin 5-HT4 Receptor Antagonists;D058832
D12.644.822.750.060;Antithrombin Proteins;D058833
D12.644.861.060;Antithrombin Proteins;D058833
D12.776.645.750.060;Antithrombin Proteins;D058833
D12.776.872.060;Antithrombin Proteins;D058833
B03.510.100.310;Gemella;D058834
B03.510.550.030.014;Abiotrophia;D058835
B03.510.550.475.900;Weissella;D058836
B03.300.390.400.525;Moorella;D058845
B03.510.415.400.525;Moorella;D058845
B03.510.460.410.525;Moorella;D058845
D12.776.124.486.485.114.224.075;Antibodies, Monoclonal, Murine-Derived;D058846
D12.776.124.790.651.114.224.075;Antibodies, Monoclonal, Murine-Derived;D058846
D12.776.377.715.548.114.224.284;Antibodies, Monoclonal, Murine-Derived;D058846
D05.500.224;Inflammasomes;D058847
D12.776.157.530.400.400.750.400;Receptors, Purinergic P2X4;D058848
D12.776.543.550.425.500.600.400;Receptors, Purinergic P2X4;D058848
D12.776.543.585.400.500.600.400;Receptors, Purinergic P2X4;D058848
D12.776.543.750.720.700.720.500.400;Receptors, Purinergic P2X4;D058848
D12.776.543.750.810.720.500.400;Receptors, Purinergic P2X4;D058848
E05.790;Protein Refolding;D058849
G01.154.100.640.501;Protein Refolding;D058849
G01.595.100.640.501;Protein Refolding;D058849
G02.111.087.690.501;Protein Refolding;D058849
G02.149.115.690.501;Protein Refolding;D058849
E02.319.620;Opiate Substitution Treatment;D058850
D12.776.395.550.448;GPI-Linked Proteins;D058851
D12.776.543.484.500;GPI-Linked Proteins;D058851
D12.776.543.550.418;GPI-Linked Proteins;D058851
B01.050.050.580;Introduced Species;D058865
G16.500.275.157.049.400;Introduced Species;D058865
N06.230.124.049.400;Introduced Species;D058865
C26.404.545;Osteoporotic Fractures;D058866
D27.505.519.374.600;Lipoprotein Lipase Activators;D058867
D27.505.954.557.500.601.500;Lipoprotein Lipase Activators;D058867
E07.161;Compressed Air;D058868
G16.500.275.063.150.500;Compressed Air;D058868
N06.230.300.100.150.592;Compressed Air;D058868
E01.370.600.293;Gynecological Examination;D058869
J02.500.519;Food, Organic;D058870
J01.040.895;Organic Agriculture;D058871
N06.850.290.200;Epidemics;D058872
N06.850.290.200.600;Pandemics;D058873
E05.830.666.500;Electrowetting;D058874
E01.370.225.875.150.125.457.500;Multilocus Sequence Typing;D058885
E05.200.875.150.125.457.500;Multilocus Sequence Typing;D058885
E05.393.542.500;Multilocus Sequence Typing;D058885
E05.393.760.700.650;Multilocus Sequence Typing;D058885
D08.244.453.915.880;Sterol 14-Demethylase;D058886
D08.811.682.690.708.170.915.880;Sterol 14-Demethylase;D058886
D08.811.682.690.708.783.880;Sterol 14-Demethylase;D058886
D12.776.422.220.453.915.880;Sterol 14-Demethylase;D058886
D27.505.519.389.049;14-alpha Demethylase Inhibitors;D058888
E01.370.225.875.150.125.457;Molecular Typing;D058889
E05.200.875.150.125.457;Molecular Typing;D058889
E05.393.542;Molecular Typing;D058889
C13.703.844.603.400;Granulomatous Mastitis;D058890
C17.800.090.968.400;Granulomatous Mastitis;D058890
D27.505.519.389.074;5-alpha Reductase Inhibitors;D058891
D27.505.519.389.092;Adenosine Deaminase Inhibitors;D058892
E05.393.542.249;DNA Barcoding, Taxonomic;D058893
E05.393.760.700.149;DNA Barcoding, Taxonomic;D058893
A13.655;Nematocyst;D058894
D27.505.519.625.725;Purinergic Agents;D058905
D27.505.696.577.725;Purinergic Agents;D058905
D27.505.519.625.725.200.100;Purinergic P1 Receptor Agonists;D058906
D27.505.696.577.725.200.100;Purinergic P1 Receptor Agonists;D058906
D27.505.519.625.725.200.100.100;Adenosine A1 Receptor Agonists;D058907
D27.505.696.577.725.200.100.100;Adenosine A1 Receptor Agonists;D058907
D27.505.519.625.725.200.100.200;Adenosine A2 Receptor Agonists;D058908
D27.505.696.577.725.200.100.200;Adenosine A2 Receptor Agonists;D058908
D27.505.519.625.725.200.100.300;Adenosine A3 Receptor Agonists;D058909
D27.505.696.577.725.200.100.300;Adenosine A3 Receptor Agonists;D058909
D27.505.519.625.725.200.200;Purinergic P2 Receptor Agonists;D058910
D27.505.696.577.725.200.200;Purinergic P2 Receptor Agonists;D058910
D27.505.519.625.725.200.200.100;Purinergic P2X Receptor Agonists;D058911
D27.505.696.577.725.200.200.100;Purinergic P2X Receptor Agonists;D058911
D27.505.519.625.725.200.200.200;Purinergic P2Y Receptor Agonists;D058912
D27.505.696.577.725.200.200.200;Purinergic P2Y Receptor Agonists;D058912
D27.505.519.625.725.200;Purinergic Agonists;D058913
D27.505.696.577.725.200;Purinergic Agonists;D058913
D27.505.519.625.725.400;Purinergic Antagonists;D058914
D27.505.696.577.725.400;Purinergic Antagonists;D058914
D27.505.519.625.725.400.100;Purinergic P1 Receptor Antagonists;D058915
D27.505.696.577.725.400.100;Purinergic P1 Receptor Antagonists;D058915
D27.505.519.625.725.400.100.100;Adenosine A1 Receptor Antagonists;D058916
D27.505.696.577.725.400.100.100;Adenosine A1 Receptor Antagonists;D058916
D27.505.519.625.725.400.100.200;Adenosine A2 Receptor Antagonists;D058917
D27.505.696.577.725.400.100.200;Adenosine A2 Receptor Antagonists;D058917
D27.505.519.625.725.400.100.300;Adenosine A3 Receptor Antagonists;D058918
D27.505.696.577.725.400.100.300;Adenosine A3 Receptor Antagonists;D058918
D27.505.519.625.725.400.200;Purinergic P2 Receptor Antagonists;D058919
D27.505.696.577.725.400.200;Purinergic P2 Receptor Antagonists;D058919
D27.505.519.625.725.400.200.100;Purinergic P2X Receptor Antagonists;D058920
D27.505.696.577.725.400.200.100;Purinergic P2X Receptor Antagonists;D058920
D27.505.519.625.725.400.200.200;Purinergic P2Y Receptor Antagonists;D058921
D27.505.696.577.725.400.200.200;Purinergic P2Y Receptor Antagonists;D058921
C04.588.180.576;Inflammatory Breast Neoplasms;D058922
C17.800.090.500.576;Inflammatory Breast Neoplasms;D058922
C05.651.426;Medial Tibial Stress Syndrome;D058923
C10.668.491.087;Medial Tibial Stress Syndrome;D058923
C26.558.705;Medial Tibial Stress Syndrome;D058923
D02.886.778.823;Thienopyridines;D058924
D03.383.725.849;Thienopyridines;D058924
D03.383.903.830;Thienopyridines;D058924
D03.438.928;Thienopyridines;D058924
D12.776.543.750.100.700.720.500.300;Receptors, Purinergic P2Y12;D058925
D12.776.543.750.720.700.720.750.300;Receptors, Purinergic P2Y12;D058925
D12.776.543.750.810.720.750.300;Receptors, Purinergic P2Y12;D058925
C23.550.505.400;Intraoperative Awareness;D058926
D12.776.157.057.001;5-Lipoxygenase-Activating Proteins;D058927
D12.776.476.024.034;5-Lipoxygenase-Activating Proteins;D058927
D12.776.543.019;5-Lipoxygenase-Activating Proteins;D058927
D13.444.735.544.427;Riboswitch;D058928
D13.444.735.790.878.942.500;Riboswitch;D058928
G02.111.570.080.689.687.124;Riboswitch;D058928
G05.360.080.689.687.124;Riboswitch;D058928
D08.811.682.690.416.583;Lipoxygenases;D058945
D12.776.556.579.374.568;Lipoxygenases;D058945
D27.505.519.389.086;5-Lipoxygenase-Activating Protein Inhibitors;D058946
G06.099.112.104;Bacterial Secretion Systems;D058947
G06.590.110.104;Bacterial Secretion Systems;D058947
E01.370.225.500.373;Cell Tracking;D058948
E01.370.350.557.500;Cell Tracking;D058948
E05.200.500.373;Cell Tracking;D058948
E05.242.373;Cell Tracking;D058948
D12.776.395.550.448.850;Uromodulin;D058949
D12.776.395.560.912;Uromodulin;D058949
D12.776.543.484.500.850;Uromodulin;D058949
D12.776.543.550.418.850;Uromodulin;D058949
D12.776.624.301;Melanoma-Specific Antigens;D058950
D23.050.285.439;Melanoma-Specific Antigens;D058950
D12.776.543.306;gp100 Melanoma Antigen;D058951
D12.776.624.301.500;gp100 Melanoma Antigen;D058951
D23.050.285.439.500;gp100 Melanoma Antigen;D058951
B04.280.535.050.631;Human papillomavirus 31;D058952
A11.872.653;Neural Stem Cells;D058953
A11.700;Pancreatic Stellate Cells;D058954
D01.268.513;Metalloids;D058955
E02.319.267.085;Administration, Mucosal;D058956
B04.820.504.540.150.215;Coronavirus NL63, Human;D058957
B04.909.777.500.540.150.215;Coronavirus NL63, Human;D058957
A01.635;Organs at Risk;D058958
D12.776.624.301.750;MART-1 Antigen;D058965
D23.050.285.439.750;MART-1 Antigen;D058965
D12.776.395.550.200.250.325;Contactins;D058966
D12.776.395.550.448.250;Contactins;D058966
D12.776.543.484.500.250;Contactins;D058966
D12.776.543.550.200.250.325;Contactins;D058966
D12.776.543.550.418.250;Contactins;D058966
D23.050.301.350.250.325;Contactins;D058966
D12.776.395.550.200.250.325.100;Contactin 1;D058967
D12.776.395.550.448.250.100;Contactin 1;D058967
D12.776.543.484.500.250.100;Contactin 1;D058967
D12.776.543.550.200.250.325.100;Contactin 1;D058967
D12.776.543.550.418.250.100;Contactin 1;D058967
D23.050.301.350.250.325.100;Contactin 1;D058967
C03.908.650;Pythiosis;D058968
C22.761;Pythiosis;D058968
D12.776.395.550.200.250.325.200;Contactin 2;D058969
D12.776.395.550.448.250.200;Contactin 2;D058969
D12.776.543.484.500.250.200;Contactin 2;D058969
D12.776.543.550.200.250.325.200;Contactin 2;D058969
D12.776.543.550.418.250.200;Contactin 2;D058969
D23.050.301.350.250.325.200;Contactin 2;D058969
E04.555.712;Tenotomy;D058971
D12.776.157.530.450.074.500.299;Folic Acid Transporters;D058972
D12.776.543.585.450.074.500.224;Folic Acid Transporters;D058972
D12.776.157.530.450.074.500.299.500;Folate Receptors, GPI-Anchored;D058973
D12.776.395.550.448.370;Folate Receptors, GPI-Anchored;D058973
D12.776.543.484.500.370;Folate Receptors, GPI-Anchored;D058973
D12.776.543.550.418.370;Folate Receptors, GPI-Anchored;D058973
D12.776.543.585.450.074.500.224.500;Folate Receptors, GPI-Anchored;D058973
D12.776.543.750.052;Folate Receptors, GPI-Anchored;D058973
H01.158.273.343.335.500;Phylogeography;D058974
H01.277.500.589;Phylogeography;D058974
D12.776.157.530.450.074.500.299.500.500;Folate Receptor 1;D058975
D12.776.395.550.448.370.500;Folate Receptor 1;D058975
D12.776.543.484.500.370.500;Folate Receptor 1;D058975
D12.776.543.550.418.370.500;Folate Receptor 1;D058975
D12.776.543.585.450.074.500.224.500.500;Folate Receptor 1;D058975
D12.776.543.750.052.500;Folate Receptor 1;D058975
D23.050.285.384;Folate Receptor 1;D058975
D12.776.157.530.450.074.500.299.500.750;Folate Receptor 2;D058976
D12.776.395.550.448.370.750;Folate Receptor 2;D058976
D12.776.543.484.500.370.750;Folate Receptor 2;D058976
D12.776.543.550.418.370.750;Folate Receptor 2;D058976
D12.776.543.585.450.074.500.224.500.750;Folate Receptor 2;D058976
D12.776.543.750.052.750;Folate Receptor 2;D058976
E05.393.760.479;Molecular Sequence Annotation;D058977
L01.453.245.667.580;Molecular Sequence Annotation;D058977
D12.776.157.530.450.074.500.299.750;Reduced Folate Carrier Protein;D058978
D12.776.157.530.450.162.359;Reduced Folate Carrier Protein;D058978
D12.776.543.550.190.608;Reduced Folate Carrier Protein;D058978
D12.776.543.585.450.074.500.224.750;Reduced Folate Carrier Protein;D058978
D12.776.543.585.450.162.359;Reduced Folate Carrier Protein;D058978
D12.776.157.530.450.074.500.299.625;Proton-Coupled Folate Transporter;D058979
D12.776.157.530.450.625.217;Proton-Coupled Folate Transporter;D058979
D12.776.543.585.450.074.500.224.625;Proton-Coupled Folate Transporter;D058979
D12.776.543.585.450.625.217;Proton-Coupled Folate Transporter;D058979
L01.143.450;Information Literacy;D058980
A11.872.785;Side-Population Cells;D058985
D27.505.519.389.735.500;Phosphodiesterase 5 Inhibitors;D058986
D27.505.519.389.735.249;Phosphodiesterase 3 Inhibitors;D058987
D27.505.519.389.735.374;Phosphodiesterase 4 Inhibitors;D058988
G01.595.680.625;Vitrification;D058989
E02.319.574;Molecular Targeted Therapy;D058990
N03.219.521.576.343.918;Patient Protection and Affordable Care Act;D058991
N03.706.615.806;Patient Protection and Affordable Care Act;D058991
I03.050.750;Social Participation;D058992
D20.280.055.750;Oral Sprays;D058993
D26.255.165.055.527;Oral Sprays;D058993
E04.950.300.715;Salpingectomy;D058994
E07.605.249;Dry Powder Inhalers;D058995
J01.293.754;Quality Improvement;D058996
N04.761.744;Quality Improvement;D058996
E01.370.520.750.500;Remote Sensing Technology;D058998
E05.925.500;Remote Sensing Technology;D058998
L01.178.847.675.500;Remote Sensing Technology;D058998
F01.145.342;Drug-Seeking Behavior;D058999
G16.500.275.071.387;El Nino-Southern Oscillation;D059000
B05.080;Aquatic Organisms;D059001
G16.500.275.810.650.075;Aquatic Organisms;D059001
D06.347.065.249;Androgen Receptor Antagonists;D059002
D27.505.696.399.450.065.249;Androgen Receptor Antagonists;D059002
D27.505.519.389.892;Topoisomerase Inhibitors;D059003
D27.505.954.248.794;Topoisomerase Inhibitors;D059003
D27.505.519.389.892.500;Topoisomerase I Inhibitors;D059004
D27.505.954.248.794.500;Topoisomerase I Inhibitors;D059004
D27.505.519.389.892.750;Topoisomerase II Inhibitors;D059005
D27.505.954.248.794.750;Topoisomerase II Inhibitors;D059005
A11.284.187.440;Chromosomes, Insect;D059006
G05.360.162.440;Chromosomes, Insect;D059006
A11.284.187.440.500;Polytene Chromosomes;D059007
A11.284.430.106.279.345.190.580;Polytene Chromosomes;D059007
G05.360.162.440.500;Polytene Chromosomes;D059007
E01.370.350.600.817;Time-Lapse Imaging;D059008
E05.712.657;Time-Lapse Imaging;D059008
L01.240.960.399;Time-Lapse Imaging;D059008
Z01.586.225;Confederate States of America;D059009
E05.242.900;Single-Cell Analysis;D059010
E05.318.780.438;Lost to Follow-Up;D059012
G06.550;Microbial Consortia;D059013
E05.393.760.319;High-Throughput Nucleotide Sequencing;D059014
L01.178.847.950;Wireless Technology;D059015
G04.366.500;Tumor Microenvironment;D059016
E02.760.611.735;Primary Care Nursing;D059017
E01.370.225.998.293;DNA Contamination;D059018
E05.200.998.293;DNA Contamination;D059018
E05.393.290.573;DNA Contamination;D059018
E05.393.760.700.224;DNA Contamination;D059018
I01.198.780.937.375.500;DNA Contamination;D059018
N04.452.758.708.200.400.500;Clinical Coding;D059019
N04.452.859.564.274;Clinical Coding;D059019
N05.715.360.300.715.500.249;Clinical Coding;D059019
N06.850.520.308.940.968.249;Clinical Coding;D059019
F01.145.126.980.875.149;Suicidal Ideation;D059020
I01.880.735.856.149;Suicidal Ideation;D059020
J01.897.608.500;Laboratory Proficiency Testing;D059021
N04.761.700.512;Laboratory Proficiency Testing;D059021
J01.576.423.850.730.500;Food Safety;D059022
N06.850.601.500;Food Safety;D059022
E01.370.360;Diagnostic Self Evaluation;D059026
F01.752.747.792.220;Diagnostic Self Evaluation;D059026
J01.256.675;Recycling;D059027
N06.850.780.200.800.800.525;Recycling;D059027
N06.850.860.510.244;Recycling;D059027
J01.086.339.034;Airports;D059028
N06.850.860.410.054;Airports;D059028
N06.850.460.710.189;Electronic Waste;D059029
I01.409.137.500.500;United States Department of Defense;D059030
N03.540.348.500.500.500;United States Department of Defense;D059030
F02.463.093;Anticipation, Psychological;D059031
F02.784.629.529.274;Learning Curve;D059032
N03.219.521.576.343.144;For-Profit Insurance Plans;D059033
N03.219.521.576.343.912;Not-For-Profit Insurance Plans;D059034
E04.614;Perioperative Period;D059035
N02.421.585.753;Perioperative Period;D059035
V02.697;Photographs;D059036
M01.526.244;Doulas;D059037
Z01.756.217;Black Sea;D059038
N04.761.789.900;Standard of Care;D059039
N05.715.840;Standard of Care;D059039
V01.255.500;Video-Audio Media;D059040
V02.970;Video-Audio Media;D059040
C05.660.207.707;Plagiocephaly;D059041
C16.131.621.207.707;Plagiocephaly;D059041
A11.284.430.106.279.345.190.160.180.270.500;Chromosomal Puffs;D059045
A11.284.430.106.279.345.190.580.500;Chromosomal Puffs;D059045
E02.319.529.500;Medication Reconciliation;D059065
N02.421.450.500.500;Medication Reconciliation;D059065
N04.452.528.460;Medication Reconciliation;D059065
N04.590.656;Medication Reconciliation;D059065
I01.261.587;Gross Domestic Product;D059066
D20.280.055.500;Nasal Sprays;D059085
D26.255.165.055.291;Nasal Sprays;D059085
B01.050.150.900.649.801.400.112.400.550;Neanderthals;D059125
B03.440.450.425.198;Cronobacter;D059126
B03.660.250.150.098;Cronobacter;D059126
B03.660.050.600;Phyllobacteriaceae;D059127
B03.660.050.600.500;Mesorhizobium;D059128
E04.555.110.110.850;Total Disc Replacement;D059145
E04.650.110.850;Total Disc Replacement;D059145
E04.480;Metastasectomy;D059146
F01.145.699.400;HIV Serosorting;D059147
F01.145.802.400;HIV Serosorting;D059147
G07.700.370;Hormesis;D059165
H01.158.100.720;Osteology;D059166
A08.663.500;Mirror Neurons;D059167
A11.671.487;Mirror Neurons;D059167
E01.370.350.850.150;Carotid Intima-Media Thickness;D059168
E01.370.370.180;Carotid Intima-Media Thickness;D059168
G09.330.210;Carotid Intima-Media Thickness;D059168
E02.186.079.500;Chemoradiotherapy, Adjuvant;D059186
E02.319.164.500;Chemoradiotherapy, Adjuvant;D059186
E02.815.160.500;Chemoradiotherapy, Adjuvant;D059186
N06.230.132.644;Renewable Energy;D059205
D20.345.369;Gas, Natural;D059206
N06.230.132.258.369;Gas, Natural;D059206
N06.230.132.644.186;Geothermal Energy;D059207
E01.370.225.932;Parasite Load;D059208
E05.200.932;Parasite Load;D059208
F02.463.593.504.500;Nociception;D059225
C10.597.617.735;Nociceptive Pain;D059226
C23.888.592.612.720;Nociceptive Pain;D059226
C23.888.646.511;Nociceptive Pain;D059226
G02.111.087.800.850.500;Postsynaptic Potential Summation;D059227
G02.149.115.800.850.500;Postsynaptic Potential Summation;D059227
G04.299.880.850.500;Postsynaptic Potential Summation;D059227
G04.580.887.750;Postsynaptic Potential Summation;D059227
G07.265.337.900.750.780;Postsynaptic Potential Summation;D059227
G07.265.750.887.750;Postsynaptic Potential Summation;D059227
G07.700.240.900.750.780;Postsynaptic Potential Summation;D059227
G11.561.570.918.750;Postsynaptic Potential Summation;D059227
G11.561.600.835.750.780;Postsynaptic Potential Summation;D059227
C12.777.419.787;Renal Nutcracker Syndrome;D059228
C13.351.968.419.787;Renal Nutcracker Syndrome;D059228
E04.545.637;Osteotomy, Sagittal Split Ramus;D059229
E04.555.580.790;Osteotomy, Sagittal Split Ramus;D059229
E06.645.637;Osteotomy, Sagittal Split Ramus;D059229
G11.561.600.765.781;Reflex, Trigeminocardiac;D059230
M01.526.502;Laboratory Personnel;D059232
C08.381.842.737;Transient Tachypnea of the Newborn;D059245
C08.618.842.737;Transient Tachypnea of the Newborn;D059245
C08.618.961.500;Transient Tachypnea of the Newborn;D059245
C16.614.521.563.737;Transient Tachypnea of the Newborn;D059245
C23.888.852.944.500;Transient Tachypnea of the Newborn;D059245
C08.618.961;Tachypnea;D059246
C23.888.852.944;Tachypnea;D059246
E02.875.800.625;Fertility Preservation;D059247
E04.936.537.562;Fertility Preservation;D059247
E05.820.800.625;Fertility Preservation;D059247
E02.186.079;Chemoradiotherapy;D059248
E02.319.164;Chemoradiotherapy;D059248
E02.815.160;Chemoradiotherapy;D059248
C01.703.658;Otomycosis;D059249
C09.218.736;Otomycosis;D059249
E02.319.283.199;Administration, Metronomic;D059250
C10.597.617.735.500;Visceral Pain;D059265
C23.888.592.612.720.500;Visceral Pain;D059265
C23.888.646.511.500;Visceral Pain;D059265
C05.116.852.087;Bisphosphonate-Associated Osteonecrosis of the Jaw;D059266
C05.500.086;Bisphosphonate-Associated Osteonecrosis of the Jaw;D059266
C07.320.086;Bisphosphonate-Associated Osteonecrosis of the Jaw;D059266
C23.550.717.732.183;Bisphosphonate-Associated Osteonecrosis of the Jaw;D059266
G09.330.190.281;Cardiomegaly, Exercise-Induced;D059267
C13.351.500.894.906.316;Atrophic Vaginitis;D059268
C06.405.469.158.093;Chilaiditi Syndrome;D059269
C01.539.160.495.750;Petrositis;D059270
C05.116.165.495.500;Petrositis;D059270
C09.218.705.663.841;Petrositis;D059270
G08.686.710.253;Pregnancy, Twin;D059285
G08.686.710.126;Pregnancy, Triplet;D059286
G08.686.710.030;Pregnancy, Quadruplet;D059287
G08.686.710.062;Pregnancy, Quintuplet;D059288
G09.330.940;Vascular Stiffness;D059289
A08.663.278;Dopaminergic Neurons;D059290
A11.671.270;Dopaminergic Neurons;D059290
G07.610.240.267;Diet, High-Fat;D059305
C05.651.180.297;Intra-Abdominal Hypertension;D059325
C14.907.303.297;Intra-Abdominal Hypertension;D059325
A08.663.895;Serotonergic Neurons;D059326
A11.671.895;Serotonergic Neurons;D059326
C05.660.585.262;Brachydactyly;D059327
C16.131.621.585.262;Brachydactyly;D059327
E02.190.262;Diffuse Noxious Inhibitory Control;D059328
E03.091.322;Diffuse Noxious Inhibitory Control;D059328
A08.663.127;Cholinergic Neurons;D059329
A11.671.188;Cholinergic Neurons;D059329
A08.663.289;GABAergic Neurons;D059330
A11.671.285;GABAergic Neurons;D059330
A08.663.100;Adrenergic Neurons;D059331
A11.671.761;Adrenergic Neurons;D059331
G11.561.148;Central Nervous System Sensitization;D059333
C10.228.140.300.275;Cerebral Small Vessel Diseases;D059345
C14.907.253.329;Cerebral Small Vessel Diseases;D059345
J01.637.507;Magnets;D059346
C12.777.419.780.400;Cardio-Renal Syndrome;D059347
C13.351.968.419.780.400;Cardio-Renal Syndrome;D059347
C14.280.434.156;Cardio-Renal Syndrome;D059347
C10.668.829.712;Peripheral Nerve Injuries;D059348
C10.900.575;Peripheral Nerve Injuries;D059348
C26.915.650;Peripheral Nerve Injuries;D059348
E01.370.225.998.762;Urine Specimen Collection;D059349
E05.200.998.762;Urine Specimen Collection;D059349
C10.597.617.258;Chronic Pain;D059350
C23.888.592.612.274;Chronic Pain;D059350
E02.674;Organ Sparing Treatments;D059351
C10.597.617.231;Musculoskeletal Pain;D059352
F02.830.816.353;Musculoskeletal Pain;D059352
G11.561.600.810.353;Musculoskeletal Pain;D059352
G02.111.087.750.112;Nonsense Mediated mRNA Decay;D059365
G02.111.780.500;Nonsense Mediated mRNA Decay;D059365
G02.149.115.750.112;Nonsense Mediated mRNA Decay;D059365
G03.495.839.112;Nonsense Mediated mRNA Decay;D059365
G05.355.315.700.112;Nonsense Mediated mRNA Decay;D059365
C08.127.108.495;Asthma, Occupational;D059366
C08.674.095.495;Asthma, Occupational;D059366
C20.543.480.680.095.495;Asthma, Occupational;D059366
C24.102;Asthma, Occupational;D059366
G02.111.087.723;RNA Cleavage;D059367
G02.149.115.723;RNA Cleavage;D059367
G05.355.780;RNA Cleavage;D059367
D13.444.735.064;RNA Isoforms;D059368
C01.539.160.495.875;Pott Puffy Tumor;D059369
C05.116.165.495.750;Pott Puffy Tumor;D059369
C11.675.689;Pott Puffy Tumor;D059369
G01.154.100.820;RNA Folding;D059370
G01.595.100.820;RNA Folding;D059370
G02.111.087.736;RNA Folding;D059370
G02.111.570.790.486.718;RNA Folding;D059370
G02.149.115.736;RNA Folding;D059370
G05.360.580.718;RNA Folding;D059370
D13.444.308.196;DNA, B-Form;D059371
G02.111.570.790.486.142;DNA, B-Form;D059371
G05.360.580.121;DNA, B-Form;D059371
G02.111.570.080.611;Nucleotide Motifs;D059372
G02.111.570.790.486.662;Nucleotide Motifs;D059372
G05.360.080.611;Nucleotide Motifs;D059372
G05.360.580.662;Nucleotide Motifs;D059372
C10.597.617.205;Mastodynia;D059373
C23.888.592.612.450;Mastodynia;D059373
F02.830.816.308;Mastodynia;D059373
G11.561.600.810.308;Mastodynia;D059373
E02.779.483.812;Plyometric Exercise;D059385
E02.831.387.812;Plyometric Exercise;D059385
G11.427.590.530.698.277.374;Plyometric Exercise;D059385
I03.350.374;Plyometric Exercise;D059385
E05.393.731;Reverse Genetics;D059386
E03.155.086.711.299.500;Sphenopalatine Ganglion Block;D059387
E04.525.210.550.500.500;Sphenopalatine Ganglion Block;D059387
C10.597.617.231.500;Pelvic Girdle Pain;D059388
C23.888.646.587.625;Pelvic Girdle Pain;D059388
C10.597.617.178;Breakthrough Pain;D059390
C23.888.646.182;Breakthrough Pain;D059390
F02.830.816.131;Breakthrough Pain;D059390
G11.561.600.810.444.393;Breakthrough Pain;D059390
N06.850.460.660;Petroleum Pollution;D059392
E05.196.867.917;Sun Protection Factor;D059405
E05.799.890;Sun Protection Factor;D059405
C11.187.631;Pinguecula;D059407
E02.745;Pain Management;D059408
N04.590.607.500;Pain Management;D059408
C10.228.140.300.275.800;Stroke, Lacunar;D059409
C10.228.140.300.775.600;Stroke, Lacunar;D059409
C14.907.253.329.800;Stroke, Lacunar;D059409
C14.907.253.855.600;Stroke, Lacunar;D059409
C23.888.942.343;Lower Urinary Tract Symptoms;D059411
C01.539.463;Intraabdominal Infections;D059413
E01.370.225.812.453;Interferon-gamma Release Tests;D059425
E05.200.812.453;Interferon-gamma Release Tests;D059425
E05.478.594.475;Interferon-gamma Release Tests;D059425
E05.478.707;Interferon-gamma Release Tests;D059425
C10.597.606.057;Anhedonia;D059445
C23.888.592.604.039;Anhedonia;D059445
F01.700.039;Anhedonia;D059445
C14.240.400.592;Heterotaxy Syndrome;D059446
C14.280.400.592;Heterotaxy Syndrome;D059446
C15.604.744.146;Heterotaxy Syndrome;D059446
C16.131.077.401;Heterotaxy Syndrome;D059446
C16.131.240.400.592;Heterotaxy Syndrome;D059446
G04.299.134.109;Cell Cycle Checkpoints;D059447
D20.215.261;Biosimilar Pharmaceuticals;D059451
C14.907.489.907;White Coat Hypertension;D059466
G02.111.087.847.750;Transcriptome;D059467
G02.149.115.847.750;Transcriptome;D059467
G05.355.310.700.750;Transcriptome;D059467
G05.360.920;Transcriptome;D059467
C14.907.489.861;Masked Hypertension;D059468
D12.776.543.982;Tetraspanins;D059470
E02.875.800.906;In Vitro Oocyte Maturation Techniques;D059471
E05.820.800.906;In Vitro Oocyte Maturation Techniques;D059471
G05.360.340.011;Exome;D059472
E04.210.471;Gastropexy;D059485
G04.299.134.220.625;Telomere Homeostasis;D059505
G04.299.233.750.500.500;Telomere Homeostasis;D059505
G05.355.105.610;Telomere Homeostasis;D059505
G07.700.320.249.410.750.500.750;Telomere Homeostasis;D059505
G02.111.087.222.940;Telomere Shortening;D059506
G02.149.115.222.940;Telomere Shortening;D059506
G04.299.119.630;Telomere Shortening;D059506
G05.355.200.940;Telomere Shortening;D059506
C08.360.840;Supraglottitis;D059525
C08.730.798;Supraglottitis;D059525
C09.400.840;Supraglottitis;D059525
E04.525.305;Foraminotomy;D059526
C04.588.364.738;Paraneoplastic Syndromes, Ocular;D059545
C04.730.900;Paraneoplastic Syndromes, Ocular;D059545
C11.319.466;Paraneoplastic Syndromes, Ocular;D059545
E04.545.668;Sinus Floor Augmentation;D059546
E04.555.130.550;Sinus Floor Augmentation;D059546
E06.645.668;Sinus Floor Augmentation;D059546
A11.284.180.800;Stereocilia;D059547
E02.718.050;Anterior Cruciate Ligament Reconstruction;D059549
E04.555.085;Anterior Cruciate Ligament Reconstruction;D059549
E04.555.110.026;Anterior Cruciate Ligament Reconstruction;D059549
E04.680.051;Anterior Cruciate Ligament Reconstruction;D059549
E05.940.900;Toxicity Tests, Subchronic;D059550
E05.940.850;Toxicity Tests, Subacute;D059551
G01.311.169;Caves;D059552
G16.500.275.067;Caves;D059552
N06.230.066;Caves;D059552
G04.299.134.109.500;G2 Phase Cell Cycle Checkpoints;D059565
G04.299.134.500.340.500;G2 Phase Cell Cycle Checkpoints;D059565
G04.299.134.109.750;M Phase Cell Cycle Checkpoints;D059566
G04.299.134.220.220.781.337;M Phase Cell Cycle Checkpoints;D059566
G04.299.134.109.249;G1 Phase Cell Cycle Checkpoints;D059585
G04.299.134.500.320.500;G1 Phase Cell Cycle Checkpoints;D059585
B01.300.381.299;Duddingtonia;D059586
D05.500.135;Calcifying Nanoparticles;D059587
J01.637.512.600.150;Calcifying Nanoparticles;D059587
E06.780.345.625.500;Dental Implant-Abutment Design;D059605
E06.912.145.750;Dental Implant-Abutment Design;D059605
C23.550.759;Polydipsia;D059606
C23.888.663;Polydipsia;D059606
C23.550.759.500;Polydipsia, Psychogenic;D059607
C23.888.663.500;Polydipsia, Psychogenic;D059607
F01.145.126.968;Polydipsia, Psychogenic;D059607
F01.700.812;Polydipsia, Psychogenic;D059607
C08.360.549;Laryngocele;D059608
C08.695.520;Laryngocele;D059608
C09.400.549;Laryngocele;D059608
C16.131.740.650;Laryngocele;D059608
A11.284.420.500;Mallory Bodies;D059609
B01.046.090;Balamuthia mandrillaris;D059611
E05.196.155.650;Liquid-Liquid Extraction;D059625
E05.196.155.650.500;Liquid Phase Microextraction;D059627
E01.370.350.350.800.700.500;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.350.810.645;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.600.350.700.810.490;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.600.350.800.399.500;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.700.700.810.645;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.700.810.810.722;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.710.800.399.500;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.825.800.399.500;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.350.825.810.810.699;Positron-Emission Tomography and Computed Tomography;D059628
E01.370.384.730.800.399.500;Positron-Emission Tomography and Computed Tomography;D059628
E05.318.740.872.875;Signal-To-Noise Ratio;D059629
E05.318.780.800.875;Signal-To-Noise Ratio;D059629
G17.800.500;Signal-To-Noise Ratio;D059629
N05.715.360.750.725.750;Signal-To-Noise Ratio;D059629
N05.715.360.780.700.840;Signal-To-Noise Ratio;D059629
N06.850.520.445.800.875;Signal-To-Noise Ratio;D059629
N06.850.520.830.872.750;Signal-To-Noise Ratio;D059629
A11.329.830.500;Mesenchymal Stromal Cells;D059630
A11.872.590.500;Mesenchymal Stromal Cells;D059630
A10.165.970;Wharton Jelly;D059631
G05.355.044.250.750;Mutation Rate;D059645
G05.365.590.612;Mutation Rate;D059645
G16.100.178.250.750;Mutation Rate;D059645
G05.360.340.037;Genome Size;D059646
G05.695.337;Gene-Environment Interaction;D059647
D12.644.276.836;Kisspeptins;D059648
D12.644.400.430;Kisspeptins;D059648
D12.776.624.776.546;Kisspeptins;D059648
E05.196.181.400.170.500;Immunochromatography;D059665
E05.478.566.335;Immunochromatography;D059665
D12.776.395.550.550.875;Lysosomal-Associated Membrane Protein 3;D059666
D12.776.543.550.527.875;Lysosomal-Associated Membrane Protein 3;D059666
D23.050.301.264.035.533;Lysosomal-Associated Membrane Protein 3;D059666
D23.101.100.110.533;Lysosomal-Associated Membrane Protein 3;D059666
E04.680.325;Herniorrhaphy;D059685
A05.360.490.690.680.500;Polar Bodies;D059705
A11.497.497.600.500;Polar Bodies;D059705
B03.440.450.900.050;Aliivibrio;D059706
B03.660.250.830.050;Aliivibrio;D059706
C01.252.400.050;Aliivibrio Infections;D059707
E04.943;Ultrasonic Surgical Procedures;D059708
E02.041.625.516;Interactive Ventilatory Support;D059725
E02.880.820.516;Interactive Ventilatory Support;D059725
E04.943.937;Piezosurgery;D059745
E02.365.476;Heimlich Maneuver;D059746
E04.580.392;Nasal Surgical Procedures;D059747
G02.111.087.710;Proteolysis;D059748
G02.149.115.710;Proteolysis;D059748
G03.495.802;Proteolysis;D059748
G05.355.760.615;Homologous Recombination;D059765
G02.111.087.219.200;DNA End-Joining Repair;D059766
G02.149.115.219.200;DNA End-Joining Repair;D059766
G05.355.195.200;DNA End-Joining Repair;D059766
G02.111.087.219.700;Recombinational DNA Repair;D059767
G02.149.115.219.700;Recombinational DNA Repair;D059767
G05.355.195.700;Recombinational DNA Repair;D059767
G05.355.760.615.612;Recombinational DNA Repair;D059767
G05.360.162.679;Karyotype;D059785
C23.550.210.024;Abnormal Karyotype;D059786
G05.360.162.679.500;Abnormal Karyotype;D059786
G05.365.590.175.024;Abnormal Karyotype;D059786
C10.597.617.088;Acute Pain;D059787
C23.888.646.115;Acute Pain;D059787
E01.370.225.124.100.232;Dried Blood Spot Testing;D059788
E05.200.124.100.232;Dried Blood Spot Testing;D059788
D12.776.395.550.509.400.440.100;HLA-DR alpha-Chains;D059805
D12.776.543.550.423.400.440.100;HLA-DR alpha-Chains;D059805
D23.050.301.500.400.400.440.100;HLA-DR alpha-Chains;D059805
D23.050.301.500.450.400.440.222;HLA-DR alpha-Chains;D059805
D23.050.705.552.410.400.440.100;HLA-DR alpha-Chains;D059805
D23.050.705.552.450.400.440.222;HLA-DR alpha-Chains;D059805
D12.776.395.550.509.400.440.200;HLA-DR beta-Chains;D059806
D12.776.543.550.423.400.440.200;HLA-DR beta-Chains;D059806
D23.050.301.500.400.400.440.200;HLA-DR beta-Chains;D059806
D23.050.301.500.450.400.440.333;HLA-DR beta-Chains;D059806
D23.050.705.552.410.400.440.200;HLA-DR beta-Chains;D059806
D23.050.705.552.450.400.440.333;HLA-DR beta-Chains;D059806
G04.299.134.109.875;S Phase Cell Cycle Checkpoints;D059807
G04.299.134.500.800.500;S Phase Cell Cycle Checkpoints;D059807
D02.455.426.559.389.657.715;Polyphenols;D059808
D03.438.150.266.450.260.777;Polyphenols;D059808
D12.776.395.550.509.400.440.400;HLA-DR Serological Subtypes;D059810
D12.776.543.550.423.400.440.400;HLA-DR Serological Subtypes;D059810
D23.050.301.500.400.400.440.400;HLA-DR Serological Subtypes;D059810
D23.050.301.500.450.400.440.389;HLA-DR Serological Subtypes;D059810
D23.050.705.552.410.400.440.389;HLA-DR Serological Subtypes;D059810
D23.050.705.552.450.400.440.389;HLA-DR Serological Subtypes;D059810
D12.776.395.550.509.400.440.200.010;HLA-DRB1 Chains;D059811
D12.776.543.550.423.400.440.200.010;HLA-DRB1 Chains;D059811
D23.050.301.500.400.400.440.200.010;HLA-DRB1 Chains;D059811
D23.050.301.500.450.400.440.333.500;HLA-DRB1 Chains;D059811
D23.050.705.552.410.400.440.200.010;HLA-DRB1 Chains;D059811
D23.050.705.552.450.400.440.333.500;HLA-DRB1 Chains;D059811
M01.526.485.067.739;Physical Therapists;D059825
N02.360.067.735;Physical Therapists;D059825
D12.776.395.550.509.400.440.200.030;HLA-DRB3 Chains;D059826
D12.776.543.550.423.400.440.200.030;HLA-DRB3 Chains;D059826
D23.050.301.500.400.400.440.200.030;HLA-DRB3 Chains;D059826
D23.050.301.500.450.400.440.333.750;HLA-DRB3 Chains;D059826
D23.050.705.552.410.400.440.200.030;HLA-DRB3 Chains;D059826
D23.050.705.552.450.400.440.333.750;HLA-DRB3 Chains;D059826
B01.300.053;Agricultural Inoculants;D059827
B03.054;Agricultural Inoculants;D059827
A11.750;Plant Cells;D059828
D12.776.395.550.509.400.440.200.040;HLA-DRB4 Chains;D059845
D12.776.543.550.423.400.440.200.040;HLA-DRB4 Chains;D059845
D23.050.301.500.400.400.440.200.040;HLA-DRB4 Chains;D059845
D23.050.301.500.450.400.440.333.875;HLA-DRB4 Chains;D059845
D23.050.705.552.410.400.440.200.040;HLA-DRB4 Chains;D059845
D23.050.705.552.450.400.440.333.875;HLA-DRB4 Chains;D059845
D27.505.696.663.850.014.580;Analgesics, Short-Acting;D059846
D27.505.954.427.040.381;Analgesics, Short-Acting;D059846
D12.776.395.550.509.400.440.200.050;HLA-DRB5 Chains;D059847
D12.776.543.550.423.400.440.200.050;HLA-DRB5 Chains;D059847
D23.050.301.500.400.400.440.200.050;HLA-DRB5 Chains;D059847
D23.050.301.500.450.400.440.333.937;HLA-DRB5 Chains;D059847
D23.050.705.552.410.400.440.200.050;HLA-DRB5 Chains;D059847
D23.050.705.552.450.400.440.333.937;HLA-DRB5 Chains;D059847
D12.776.395.550.509.400.430.500;HLA-DQ alpha-Chains;D059848
D12.776.543.550.423.400.430.500;HLA-DQ alpha-Chains;D059848
D23.050.301.500.400.400.430.500;HLA-DQ alpha-Chains;D059848
D23.050.301.500.450.400.430.500;HLA-DQ alpha-Chains;D059848
D23.050.705.552.410.400.430.500;HLA-DQ alpha-Chains;D059848
D23.050.705.552.450.400.430.500;HLA-DQ alpha-Chains;D059848
G03.495.710.344;Endoplasmic Reticulum Stress;D059865
G04.299.486;Endoplasmic Reticulum Stress;D059865
G04.434;Endoplasmic Reticulum Stress;D059865
D12.776.395.550.509.400.430.750;HLA-DQ beta-Chains;D059866
D12.776.543.550.423.400.430.750;HLA-DQ beta-Chains;D059866
D23.050.301.500.400.400.430.750;HLA-DQ beta-Chains;D059866
D23.050.301.500.450.400.430.750;HLA-DQ beta-Chains;D059866
D23.050.705.552.410.400.430.750;HLA-DQ beta-Chains;D059866
D23.050.705.552.450.400.430.750;HLA-DQ beta-Chains;D059866
D12.776.395.550.509.400.420.500;HLA-DP alpha-Chains;D059867
D12.776.543.550.423.400.420.500;HLA-DP alpha-Chains;D059867
D23.050.301.500.400.400.420.500;HLA-DP alpha-Chains;D059867
D23.050.301.500.450.400.420.500;HLA-DP alpha-Chains;D059867
D23.050.705.552.410.400.420.500;HLA-DP alpha-Chains;D059867
D23.050.705.552.450.400.420.500;HLA-DP alpha-Chains;D059867
D12.776.395.550.509.400.420.750;HLA-DP beta-Chains;D059868
D12.776.543.550.423.400.420.750;HLA-DP beta-Chains;D059868
D23.050.301.500.400.400.420.750;HLA-DP beta-Chains;D059868
D23.050.301.500.450.400.420.750;HLA-DP beta-Chains;D059868
D23.050.705.552.410.400.420.750;HLA-DP beta-Chains;D059868
D23.050.705.552.450.400.420.750;HLA-DP beta-Chains;D059868
E01.370.350.600.630.750;Radiostereometric Analysis;D059869
E01.370.350.700.750;Radiostereometric Analysis;D059869
D12.776.395.550.489.400.110;HLA-A11 Antigen;D059870
D12.776.543.550.421.400.110;HLA-A11 Antigen;D059870
D23.050.301.500.100.400.110;HLA-A11 Antigen;D059870
D23.050.301.500.450.370.110;HLA-A11 Antigen;D059870
D23.050.705.552.100.400.110;HLA-A11 Antigen;D059870
D23.050.705.552.450.370.500;HLA-A11 Antigen;D059870
D12.776.395.550.489.400.240;HLA-A24 Antigen;D059871
D12.776.543.550.421.400.240;HLA-A24 Antigen;D059871
D23.050.301.500.100.400.240;HLA-A24 Antigen;D059871
D23.050.301.500.450.370.240;HLA-A24 Antigen;D059871
D23.050.705.552.100.400.240;HLA-A24 Antigen;D059871
D23.050.705.552.450.370.600;HLA-A24 Antigen;D059871
C04.557.645.375.617;Kasabach-Merritt Syndrome;D059885
C15.378.140.855.645;Kasabach-Merritt Syndrome;D059885
C14.280.282.703;Endocarditis, Non-Infective;D059905
E01.370.350.578;Neuroimaging;D059906
E01.370.376.537;Neuroimaging;D059906
E05.629;Neuroimaging;D059906
E01.370.350.578.875;Functional Neuroimaging;D059907
E01.370.376.537.625;Functional Neuroimaging;D059907
E05.629.875;Functional Neuroimaging;D059907
D12.776.395.550.489.500.130;HLA-B13 Antigen;D059908
D12.776.543.550.421.500.130;HLA-B13 Antigen;D059908
D23.050.301.500.100.500.130;HLA-B13 Antigen;D059908
D23.050.301.500.450.380.130;HLA-B13 Antigen;D059908
D23.050.705.552.100.500.130;HLA-B13 Antigen;D059908
D23.050.705.552.450.380.130;HLA-B13 Antigen;D059908
D12.776.395.550.489.500.140;HLA-B14 Antigen;D059909
D12.776.543.550.421.500.140;HLA-B14 Antigen;D059909
D23.050.301.500.100.500.140;HLA-B14 Antigen;D059909
D23.050.301.500.450.380.140;HLA-B14 Antigen;D059909
D23.050.705.552.100.500.140;HLA-B14 Antigen;D059909
D23.050.705.552.450.380.140;HLA-B14 Antigen;D059909
D12.776.395.550.489.500.150;HLA-B15 Antigen;D059910
D12.776.543.550.421.500.150;HLA-B15 Antigen;D059910
D23.050.301.500.100.500.150;HLA-B15 Antigen;D059910
D23.050.301.500.450.380.150;HLA-B15 Antigen;D059910
D23.050.705.552.100.500.150;HLA-B15 Antigen;D059910
D23.050.705.552.450.380.150;HLA-B15 Antigen;D059910
D12.776.395.550.489.500.180;HLA-B18 Antigen;D059911
D12.776.543.550.421.500.180;HLA-B18 Antigen;D059911
D23.050.301.500.100.500.180;HLA-B18 Antigen;D059911
D23.050.301.500.450.380.180;HLA-B18 Antigen;D059911
D23.050.705.552.100.500.180;HLA-B18 Antigen;D059911
D23.050.705.552.450.380.180;HLA-B18 Antigen;D059911
D12.776.395.550.489.500.370;HLA-B37 Antigen;D059912
D12.776.543.550.421.500.370;HLA-B37 Antigen;D059912
D23.050.301.500.100.500.370;HLA-B37 Antigen;D059912
D23.050.301.500.450.380.370;HLA-B37 Antigen;D059912
D23.050.705.552.100.500.370;HLA-B37 Antigen;D059912
D23.050.705.552.450.380.370;HLA-B37 Antigen;D059912
A01.111;Anatomic Landmarks;D059925
D12.776.395.550.489.500.380;HLA-B38 Antigen;D059945
D12.776.543.550.421.500.380;HLA-B38 Antigen;D059945
D23.050.301.500.100.500.380;HLA-B38 Antigen;D059945
D23.050.301.500.450.380.380;HLA-B38 Antigen;D059945
D23.050.705.552.100.500.380;HLA-B38 Antigen;D059945
D23.050.705.552.450.380.380;HLA-B38 Antigen;D059945
D12.776.395.550.489.500.390;HLA-B39 Antigen;D059946
D12.776.543.550.421.500.390;HLA-B39 Antigen;D059946
D23.050.301.500.100.500.390;HLA-B39 Antigen;D059946
D23.050.301.500.450.380.390;HLA-B39 Antigen;D059946
D23.050.705.552.100.500.390;HLA-B39 Antigen;D059946
D23.050.705.552.450.380.390;HLA-B39 Antigen;D059946
D12.776.395.550.489.500.400;HLA-B40 Antigen;D059947
D12.776.543.550.421.500.400;HLA-B40 Antigen;D059947
D23.050.301.500.100.500.400;HLA-B40 Antigen;D059947
D23.050.301.500.450.380.400;HLA-B40 Antigen;D059947
D23.050.705.552.100.500.400;HLA-B40 Antigen;D059947
D23.050.705.552.450.380.400;HLA-B40 Antigen;D059947
D12.776.395.550.489.500.440;HLA-B44 Antigen;D059948
D12.776.543.550.421.500.440;HLA-B44 Antigen;D059948
D23.050.301.500.100.500.440;HLA-B44 Antigen;D059948
D23.050.301.500.450.380.440;HLA-B44 Antigen;D059948
D23.050.705.552.100.500.440;HLA-B44 Antigen;D059948
D23.050.705.552.450.380.440;HLA-B44 Antigen;D059948
D12.776.395.550.489.500.510;HLA-B51 Antigen;D059949
D12.776.543.550.421.500.510;HLA-B51 Antigen;D059949
D23.050.301.500.100.500.510;HLA-B51 Antigen;D059949
D23.050.301.500.450.380.510;HLA-B51 Antigen;D059949
D23.050.705.552.100.500.510;HLA-B51 Antigen;D059949
D23.050.705.552.450.380.510;HLA-B51 Antigen;D059949
D12.776.395.550.489.500.520;HLA-B52 Antigen;D059950
D12.776.543.550.421.500.520;HLA-B52 Antigen;D059950
D23.050.301.500.100.500.520;HLA-B52 Antigen;D059950
D23.050.301.500.450.380.520;HLA-B52 Antigen;D059950
D23.050.705.552.100.500.520;HLA-B52 Antigen;D059950
D23.050.705.552.450.380.520;HLA-B52 Antigen;D059950
D12.776.395.550.489.700;HLA-G Antigens;D059951
D12.776.543.550.421.700;HLA-G Antigens;D059951
D23.050.301.500.100.700;HLA-G Antigens;D059951
D23.050.301.500.450.700;HLA-G Antigens;D059951
D23.050.705.552.100.700;HLA-G Antigens;D059951
D23.050.705.552.450.700;HLA-G Antigens;D059951
C12.483;Pelvic Floor Disorders;D059952
C13.351.625;Pelvic Floor Disorders;D059952
C13.703.565;Pelvic Floor Disorders;D059952
B04.280.640.615.550;Merkel cell polyomavirus;D059965
D20.280.320.375.500;Cryogels;D059985
D26.255.165.320.375.187;Cryogels;D059985
E05.393.442;Genotyping Techniques;D060005
B05.237;Endophytes;D060026
G05.360.340.024.340.370;Genes, Modifier;D060045
E02.319.509;Maintenance Chemotherapy;D060046
G05.355.044.675;Reproductive Isolation;D060047
G16.100.178.802;Reproductive Isolation;D060047
C05.116.099.708.928;Slipped Capital Femoral Epiphyses;D060048
C05.116.425.500;Slipped Capital Femoral Epiphyses;D060048
G04.299.134.220.109;Asymmetric Cell Division;D060049
G04.299.151.224;Asymmetric Cell Division;D060049
G04.299.233.750.500.249;Asymmetric Cell Division;D060049
G05.355.105.109;Asymmetric Cell Division;D060049
G07.700.320.249.410.750.500.500;Asymmetric Cell Division;D060049
C14.280.647.187.362;Angina, Stable;D060050
C14.907.585.187.362;Angina, Stable;D060050
C23.888.646.215.500.575;Angina, Stable;D060050
C26.716;Occupational Injuries;D060051
A01.456.505.682;Nasolabial Fold;D060052
A01.935;Transplant Donor Site;D060053
B03.440.400.425.700.024;Agrobacterium;D060054
B03.660.050.730.024;Agrobacterium;D060054
G03.495.553.750;Protein Interaction Maps;D060066
C01.539.218;Coinfection;D060085
C02.219;Coinfection;D060085
C03.202;Coinfection;D060085
G01.311.355.750.500.400;Hydrothermal Vents;D060086
A13.079;Animal Shells;D060105
G01.311.580;Lakes;D060106
G16.500.275.280.500;Lakes;D060106
N06.230.232.500;Lakes;D060106
B01.050.150.900.493.130;Characiformes;D060125
B01.050.150.900.493.130.150;Characidae;D060126
E02.760.670.500;Kangaroo-Mother Care Method;D060127
N02.421.088.120.140;Kangaroo-Mother Care Method;D060127
N02.421.585.700.500;Kangaroo-Mother Care Method;D060127
L01.143.506.423.906.377.666;Text Messaging;D060145
L01.178.847.698.300.500;Text Messaging;D060145
G05.695.200;Ecotype;D060146
G16.500.275.157.049.230;Ecotype;D060146
N06.230.124.049.230;Ecotype;D060146
H01.158.273.180.350.162;HapMap Project;D060148
H01.158.273.343.249.199;HapMap Project;D060148
H01.158.273.343.350.130;HapMap Project;D060148
H01.770.644.145.350.249;HapMap Project;D060148
D12.776.395.550.550.249;Antigens, CD63;D060149
D12.776.543.550.527.249;Antigens, CD63;D060149
D12.776.543.982.163;Antigens, CD63;D060149
D12.776.543.990.024;Antigens, CD63;D060149
D23.050.301.264.035.163;Antigens, CD63;D060149
D23.101.100.110.163;Antigens, CD63;D060149
A11.063.438.450.300;B-Lymphocytes, Regulatory;D060151
A11.118.637.555.567.550.450.300;B-Lymphocytes, Regulatory;D060151
A11.118.637.555.567.562.450.300;B-Lymphocytes, Regulatory;D060151
A15.145.229.637.555.567.550.450.300;B-Lymphocytes, Regulatory;D060151
A15.145.229.637.555.567.562.450.300;B-Lymphocytes, Regulatory;D060151
A15.382.032.438.450.300;B-Lymphocytes, Regulatory;D060151
A15.382.490.555.567.562.450.300;B-Lymphocytes, Regulatory;D060151
G05.355.330.900;V(D)J Recombination;D060152
G05.355.760.932;V(D)J Recombination;D060152
D12.776.395.550.942;Uroplakins;D060165
D12.776.543.550.942;Uroplakins;D060165
E07.123;Capillary Tubing;D060166
D12.776.395.550.942.100;Uroplakin Ia;D060167
D12.776.543.550.942.100;Uroplakin Ia;D060167
D12.776.543.982.750;Uroplakin Ia;D060167
A11.118.637.555.567.569.360.800;Thymocytes;D060168
A11.148.378.294.750.800;Thymocytes;D060168
A11.872.378.294.750.800;Thymocytes;D060168
A11.900;Thymocytes;D060168
D12.776.395.550.942.150;Uroplakin Ib;D060169
D12.776.543.550.942.150;Uroplakin Ib;D060169
D12.776.543.982.875;Uroplakin Ib;D060169
D12.776.395.550.942.200;Uroplakin II;D060170
D12.776.543.550.942.200;Uroplakin II;D060170
D12.776.395.550.942.300;Uroplakin III;D060171
D12.776.543.550.942.300;Uroplakin III;D060171
D03.383.533.640.562;Morpholinos;D060172
D13.695.578.424.337;Morpholinos;D060172
D12.776.543.982.251;Antigens, CD151;D060185
D23.050.301.264.035.251;Antigens, CD151;D060185
D23.101.100.110.251;Antigens, CD151;D060185
E02.319.267.510.794;Infusions, Spinal;D060186
E02.926;Therapeutic Occlusion;D060205
D12.776.543.982.181;Antigens, CD81;D060225
D23.050.301.264.035.181;Antigens, CD81;D060225
D23.101.100.110.181;Antigens, CD81;D060225
A13.449;Head Kidney;D060226
A16.835.400;Head Kidney;D060226
A13.518;Imaginal Discs;D060227
D12.776.395.550.018;Antigens, CD9;D060245
D12.776.543.550.090;Antigens, CD9;D060245
D12.776.543.982.109;Antigens, CD9;D060245
D23.050.301.264.035.109;Antigens, CD9;D060245
D23.101.100.110.110;Antigens, CD9;D060245
D12.776.543.982.153;Antigens, CD53;D060265
D23.050.301.264.035.153;Antigens, CD53;D060265
D23.101.100.110.106;Antigens, CD53;D060265
D08.811.464.938.750.656;Receptors, Autocrine Motility Factor;D060285
D12.776.543.750.067;Receptors, Autocrine Motility Factor;D060285
N02.421.912;Transition to Adult Care;D060305
N04.590.233.727.210.500;Transition to Adult Care;D060305
E05.540;Magnetometry;D060306
E05.916.039;Chemistry Techniques, Synthetic;D060326
G02.607.750.155;Chemistry Techniques, Synthetic;D060326
J01.897.836.249;Chemistry Techniques, Synthetic;D060326
E05.916.039.500;Solid-Phase Synthesis Techniques;D060327
E05.916.840;Solid-Phase Synthesis Techniques;D060327
G02.607.750.155.500;Solid-Phase Synthesis Techniques;D060327
J01.897.836.249.500;Solid-Phase Synthesis Techniques;D060327
G01.358;Magnetic Phenomena;D060328
I02.233.213.500;Education of Visually Disabled;D060329
I02.233.213.199;Education of Hearing Disabled;D060345
D12.776.157.530.450.074.500.687.500;Sodium-Coupled Vitamin C Transporters;D060347
D12.776.157.530.450.625.405;Sodium-Coupled Vitamin C Transporters;D060347
D12.776.543.585.450.074.500.812.500;Sodium-Coupled Vitamin C Transporters;D060347
D12.776.543.585.450.625.531;Sodium-Coupled Vitamin C Transporters;D060347
B01.050.500.500.294.700.750.700.300.230.650;Dirofilaria repens;D060348
D12.776.183;Chloroplast Proteins;D060365
D12.776.765.199;Chloroplast Proteins;D060365
B03.440.860.300;Entomoplasmatales;D060366
B01.300.381.502;Lacazia;D060367
C01.539.800.200.475;Lobomycosis;D060368
C01.703.295.475;Lobomycosis;D060368
C17.800.838.208.475;Lobomycosis;D060368
M01.776;Sex Workers;D060386
D08.811.682.732.165;Ascorbate Peroxidases;D060387
L01.224.050.500;Support Vector Machines;D060388
L01.224.065.815;Support Vector Machines;D060388
L01.725.750;Support Vector Machines;D060388
J01.576.262;Construction Industry;D060389
D12.776.765.342;Florigen;D060405
D04.808.247.808.756.071;Brassinosteroids;D060406
C01.703.513.374;Cerebral Phaeohyphomycosis;D060425
C04.588.614.550.112;Anti-N-Methyl-D-Aspartate Receptor Encephalitis;D060426
C04.730.856.112;Anti-N-Methyl-D-Aspartate Receptor Encephalitis;D060426
C10.228.140.430.124;Anti-N-Methyl-D-Aspartate Receptor Encephalitis;D060426
C10.574.781.249;Anti-N-Methyl-D-Aspartate Receptor Encephalitis;D060426
C20.111.258.124;Anti-N-Methyl-D-Aspartate Receptor Encephalitis;D060426
D12.776.183.750;Thylakoid Membrane Proteins;D060431
D12.776.543.983;Thylakoid Membrane Proteins;D060431
D12.776.765.199.750;Thylakoid Membrane Proteins;D060431
F04.096.879.201.500;Anthropology, Medical;D060432
I01.076.284;Anthropology, Medical;D060432
E02.319.267.120.805;Administration, Ophthalmic;D060433
E02.319.267.639;Administration, Ophthalmic;D060433
F01.145.113.547.600;Herbivory;D060434
F01.145.407.758;Herbivory;D060434
F01.145.113.547.400;Carnivory;D060435
F01.145.407.299;Carnivory;D060435
G15.744.875;Self-Incompatibility in Flowering Plants;D060436
C11.510.174;Artificial Lens Implant Migration;D060437
C26.392.500.249;Artificial Lens Implant Migration;D060437
C01.539.800.200.637;Phaeohyphomycosis;D060446
C01.703.295.637;Phaeohyphomycosis;D060446
C01.703.726;Phaeohyphomycosis;D060446
C17.800.838.208.637;Phaeohyphomycosis;D060446
N06.230.100.121;Emergency Shelter;D060447
G02.149.115.800.925;Wnt Signaling Pathway;D060449
D05.500.117;Axin Signaling Complex;D060465
D12.776.476.081;Axin Signaling Complex;D060465
D05.500.117.500;Axin Protein;D060466
D12.776.476.081.500;Axin Protein;D060466
C23.550.291.671;Disease Resistance;D060467
G12.450.564.250;Disease Resistance;D060467
G12.450.800.250;Disease Resistance;D060467
G15.602.250;Disease Resistance;D060467
B03.140.600;Pedobacter;D060485
B03.440.400.425.611;Pedobacter;D060485
C10.228.140.546.399.750.725;Ophthalmoplegic Migraine;D060486
C10.292.562.750.375;Ophthalmoplegic Migraine;D060486
C10.292.675;Ophthalmoplegic Migraine;D060486
C10.314.687;Ophthalmoplegic Migraine;D060486
C10.597.622.447.600;Ophthalmoplegic Migraine;D060486
C11.590.472.375;Ophthalmoplegic Migraine;D060486
C23.888.592.636.447.600;Ophthalmoplegic Migraine;D060486
C01.703.513.124;Alternariosis;D060487
D12.776.526.600;Low Density Lipoprotein Receptor-Related Protein-6;D060488
D12.776.543.750.710.450.500.600;Low Density Lipoprotein Receptor-Related Protein-6;D060488
D12.776.543.750.962.781;Low Density Lipoprotein Receptor-Related Protein-6;D060488
E02.794.500;Prosthesis Retention;D060489
D12.776.543.750.962;Receptors, Wnt;D060490
D12.776.526.500;Low Density Lipoprotein Receptor-Related Protein-5;D060492
D12.776.543.750.710.450.500.400;Low Density Lipoprotein Receptor-Related Protein-5;D060492
D12.776.543.750.962.687;Low Density Lipoprotein Receptor-Related Protein-5;D060492
B03.140.190.800;Tenacibaculum;D060493
B03.440.400.425.310.800;Tenacibaculum;D060493
B03.140.190.700;Riemerella;D060494
B03.440.400.425.310.700;Riemerella;D060494
D12.776.467.984.300;Wnt3 Protein;D060508
D23.529.984.300;Wnt3 Protein;D060508
D12.776.467.984.350;Wnt3A Protein;D060509
D23.529.984.350;Wnt3A Protein;D060509
A08.800.800.720.450.680;Pudendal Nerve;D060525
G01.358.750;Magnetic Fields;D060526
A11.329.228.109;Corneal Keratocytes;D060527
D12.776.467.984.400;Wnt4 Protein;D060528
D23.529.984.400;Wnt4 Protein;D060528
C10.597.617.682.737;Pudendal Neuralgia;D060545
C10.668.829.550.650;Pudendal Neuralgia;D060545
C10.668.829.600.737;Pudendal Neuralgia;D060545
C23.888.592.612.664.737;Pudendal Neuralgia;D060545
C23.888.646.508.737;Pudendal Neuralgia;D060545
D08.811.277.352.355.350.810.500;Argonaute Proteins;D060565
D08.811.277.352.700.350.810.500;Argonaute Proteins;D060565
D12.776.157.725.500.906.500;Argonaute Proteins;D060565
D12.776.664.962.500.906.500;Argonaute Proteins;D060565
C01.539.800.200.383.500;Fusariosis;D060585
C01.703.295.328.500;Fusariosis;D060585
C01.703.513.500;Fusariosis;D060585
C17.800.838.208.416.500;Fusariosis;D060585
C01.703.875;Trichosporonosis;D060586
C08.381.483.125.841;Trichosporonosis;D060586
C08.674.055.682;Trichosporonosis;D060586
C20.543.480.680.075.682;Trichosporonosis;D060586
G01.311.355;Groundwater;D060587
D12.776.512;LIM Domain Proteins;D060588
D12.776.220.995;Zyxin;D060589
D12.776.512.500;Zyxin;D060589
D12.776.744.962;Zyxin;D060589
C01.539.800.200.383;Hyalohyphomycosis;D060605
C01.703.295.328;Hyalohyphomycosis;D060605
C01.703.513;Hyalohyphomycosis;D060605
C17.800.838.208.416;Hyalohyphomycosis;D060605
B01.300.381.802;Scopulariopsis;D060645
E02.041.249;Airway Extubation;D060666
E05.008;Airway Extubation;D060666
F01.058.788;Sense of Coherence;D060685
F01.752.747.792.925;Sense of Coherence;D060685
C10.597.606.150.550.099;Dyscalculia;D060705
C23.888.592.604.150.550.099;Dyscalculia;D060705
F03.550.350.500.099;Dyscalculia;D060705
F03.550.450.199;Dyscalculia;D060705
C13.351.500.852.952;Uterine Retroversion;D060725
C23.300.970.750;Uterine Retroversion;D060725
A01.923;Torso;D060726
N01.400.625;Reproductive Health;D060728
D20.633.110;Coal Ash;D060729
A05.810.453.324.359.372;Glomerular Filtration Barrier;D060730
A05.810.453.736.520.372;Glomerular Filtration Barrier;D060730
A07.500;Glomerular Filtration Barrier;D060730
M01.526.373;Emergency Responders;D060731
G01.358.500.505;Electromagnetic Radiation;D060733
G01.750.250;Electromagnetic Radiation;D060733
D01.146.275.500;Nacre;D060734
D01.200.275.150.150.500;Nacre;D060734
D01.578.200.500;Nacre;D060734
E05.337.800.600;Pharmacovigilance;D060735
L01.453.270.600;Pharmacovigilance;D060735
N06.850.505.636;Pharmacovigilance;D060735
C01.539.730;Reproductive Tract Infections;D060737
C12.294.604;Reproductive Tract Infections;D060737
C13.351.500.630;Reproductive Tract Infections;D060737
G01.249.675;Phonons;D060739
G01.750.770.776.783;Phonons;D060739
N06.850.275;Disease Eradication;D060740
E06.912.480;Gingival Retraction Techniques;D060745
G02.111.087.675.871.790.600.962.500;Endoplasmic Reticulum-Associated Degradation;D060746
G02.111.087.693.600.850.500;Endoplasmic Reticulum-Associated Degradation;D060746
G02.149.115.675.871.790.600.850.500;Endoplasmic Reticulum-Associated Degradation;D060746
G02.149.115.693.600.925.500;Endoplasmic Reticulum-Associated Degradation;D060746
G03.495.770.871.790.600.850.500;Endoplasmic Reticulum-Associated Degradation;D060746
G05.355.315.670.600.850.500;Endoplasmic Reticulum-Associated Degradation;D060746
D12.776.320.525;Fetal Globulins;D060747
D12.776.377.228;Fetal Globulins;D060747
D12.776.124.790.106.304;Fetuins;D060748
D12.776.157.125.283;Fetuins;D060748
D12.776.215.625;Fetuins;D060748
D12.776.377.715.085.304;Fetuins;D060748
D12.776.124.790.106.304.500;alpha-2-HS-Glycoprotein;D060749
D12.776.157.125.283.500;alpha-2-HS-Glycoprotein;D060749
D12.776.215.625.500;alpha-2-HS-Glycoprotein;D060749
D12.776.377.715.085.304.500;alpha-2-HS-Glycoprotein;D060749
D12.776.395.086;alpha-2-HS-Glycoprotein;D060749
C05.116.214.500;Bone Anteversion;D060750
C23.300.970.249;Bone Anteversion;D060750
C05.116.214.750;Bone Retroversion;D060751
C23.300.970.374;Bone Retroversion;D060751
D12.776.124.790.106.304.750;Fetuin-B;D060752
D12.776.157.125.283.750;Fetuin-B;D060752
D12.776.215.625.750;Fetuin-B;D060752
D12.776.377.715.085.304.750;Fetuin-B;D060752
N06.850.460.350.080.750;Water Quality;D060753
N06.850.460.790.730;Water Quality;D060753
D03.438.150.266.450.400.281;Equol;D060754
K01.752.667.555;Germ Theory of Disease;D060755
L01.143.910;Social Networking;D060756
D12.776.861;Secretoglobins;D060765
D01.455.900.300;Drinking Water;D060766
D01.650.550.925.199;Drinking Water;D060766
J02.200.418;Drinking Water;D060766
D12.776.861.249;Mammaglobin A;D060785
D23.101.840.425;Mammaglobin A;D060785
Z01.586.361;Holy Roman Empire;D060786
E01.789.612;Neoplasm Grading;D060787
D12.776.861.260;Mammaglobin B;D060788
D12.776.861.311;Prostatein;D060789
F01.470.132.650;Performance Anxiety;D060805
E05.196.712.516.099;Bioluminescence Resonance Energy Transfer Techniques;D060807
F03.087.250.700;Mild Cognitive Impairment;D060825
E02.718.275;Cementoplasty;D060826
E04.555.165;Cementoplasty;D060826
E02.319.499;Induction Chemotherapy;D060828
E02.860.500;Induction Chemotherapy;D060828
D12.776.092;Arthropod Proteins;D060829
E02.319.218;Consolidation Chemotherapy;D060830
C17.800.174.600.587;Hand-Foot Syndrome;D060831
C25.723.276.505.587;Hand-Foot Syndrome;D060831
G08.686.785.760.830.249;Apomixis;D060832
G15.744.074;Apomixis;D060832
G04.366;Cellular Microenvironment;D060833
F03.080.600.500;Obsessive Hoarding;D060845
E05.240.311;Cell Engineering;D060846
J01.293.069.249;Cell Engineering;D060846
E05.240.311.249;Metabolic Engineering;D060847
E05.393.420.526;Metabolic Engineering;D060847
J01.293.069.249.249;Metabolic Engineering;D060847
D12.776.092.249;Agatoxins;D060848
D20.888.065.870.324;Agatoxins;D060848
D23.946.833.065.870.324;Agatoxins;D060848
D12.776.260.529;LIM-Homeodomain Proteins;D060850
D12.776.512.249;LIM-Homeodomain Proteins;D060850
Z01.107.296;Gulf of Mexico;D060851
F02.463.425.540.739;Repetition Priming;D060865
N05.300.380.500;Accountable Care Organizations;D060866
N02.421.088.120.059;Facilitated Tucking;D060867
E05.393.620.500.487;Multiplex Polymerase Chain Reaction;D060885
D12.776.467.150;B7 Antigens;D060887
D12.776.543.095;B7 Antigens;D060887
D23.050.301.264.035.276;B7 Antigens;D060887
D23.050.301.285;B7 Antigens;D060887
D23.101.100.110.276;B7 Antigens;D060887
D23.529.168;B7 Antigens;D060887
E05.393.620.500.706;Real-Time Polymerase Chain Reaction;D060888
D12.776.543.750.705.222.812;Inducible T-Cell Co-Stimulator Protein;D060889
D23.050.301.264.035.285;Inducible T-Cell Co-Stimulator Protein;D060889
D23.050.301.264.894.580;Inducible T-Cell Co-Stimulator Protein;D060889
D23.101.100.110.285;Inducible T-Cell Co-Stimulator Protein;D060889
D23.101.100.894.580;Inducible T-Cell Co-Stimulator Protein;D060889
D12.776.467.150.300;Antigens, CD274;D060890
D12.776.543.095.300;Antigens, CD274;D060890
D23.050.301.264.035.276.300;Antigens, CD274;D060890
D23.050.301.285.400;Antigens, CD274;D060890
D23.101.100.110.276.300;Antigens, CD274;D060890
D23.529.168.300;Antigens, CD274;D060890
N05.715.360.700;Root Cause Analysis;D060891
C05.116.214.500.500;Coxa Vara;D060905
C05.550.353;Coxa Vara;D060905
C23.300.970.249.500;Coxa Vara;D060905
C05.116.214.750.500;Coxa Valga;D060906
C05.116.327;Coxa Valga;D060906
C05.550.338;Coxa Valga;D060906
C23.300.970.374.500;Coxa Valga;D060906
D12.776.467.150.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D12.776.543.095.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D23.050.301.264.035.276.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D23.050.301.285.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D23.101.100.110.276.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D23.529.168.900;V-Set Domain-Containing T-Cell Activation Inhibitor 1;D060907
D12.776.543.750.705.222.750;CTLA-4 Antigen;D060908
D23.050.301.264.035.281;CTLA-4 Antigen;D060908
D23.050.301.264.894.158;CTLA-4 Antigen;D060908
D23.101.100.110.281;CTLA-4 Antigen;D060908
D23.101.100.894.158;CTLA-4 Antigen;D060908
F04.096.628.286;Economics, Behavioral;D060909
N03.219.215;Economics, Behavioral;D060909
A16.835;Pronephros;D060910
N01.824.417.605;Remuneration;D060926
D12.776.467.150.500;Inducible T-Cell Co-Stimulator Ligand;D060945
D12.776.543.095.500;Inducible T-Cell Co-Stimulator Ligand;D060945
D23.050.301.264.035.276.500;Inducible T-Cell Co-Stimulator Ligand;D060945
D23.050.301.285.500;Inducible T-Cell Co-Stimulator Ligand;D060945
D23.101.100.110.276.500;Inducible T-Cell Co-Stimulator Ligand;D060945
D23.529.168.500;Inducible T-Cell Co-Stimulator Ligand;D060945
N02.421.668.475;Pharmaceutical Services, Online;D060946
G04.299.350;Clonal Evolution;D060965
G05.355.123;Clonal Evolution;D060965
G12.425.199;Clonal Selection, Antigen-Mediated;D060966
G12.450.050.184;Clonal Selection, Antigen-Mediated;D060966
G01.311.355.750;Natural Springs;D060985
G01.311.355.875;Water Wells;D060986
G01.311.718;Ponds;D061005
G16.500.275.280.625;Ponds;D061005
N06.230.232.625;Ponds;D061005
G01.311.625.080;Bays;D061006
D12.776.543.750.705.222;Costimulatory and Inhibitory T-Cell Receptors;D061025
D12.776.543.750.705.222.875;Programmed Cell Death 1 Receptor;D061026
D23.050.301.264.035.588;Programmed Cell Death 1 Receptor;D061026
D23.050.301.264.894.790;Programmed Cell Death 1 Receptor;D061026
D23.101.100.110.588;Programmed Cell Death 1 Receptor;D061026
D23.101.100.894.790;Programmed Cell Death 1 Receptor;D061026
D12.776.467.150.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
D12.776.543.095.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
D23.050.301.264.035.276.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
D23.050.301.285.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
D23.101.100.110.276.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
D23.529.168.800;Programmed Cell Death 1 Ligand 2 Protein;D061027
A01.947;Trigger Points;D061028
D20.215.191;Biological Control Agents;D061046
J01.040.226;Biological Control Agents;D061046
D02.540.576;Polyketides;D061065
D04.345.674;Polyketides;D061065
H01.158.273.200.675;Plant Pathology;D061066
H01.158.273.540.706;Plant Pathology;D061066
D12.776.124.486.485.114.224.060;Antibodies, Monoclonal, Humanized;D061067
D12.776.124.790.651.114.224.060;Antibodies, Monoclonal, Humanized;D061067
D12.776.377.715.548.114.224.200;Antibodies, Monoclonal, Humanized;D061067
C10.500.034;Agenesis of Corpus Callosum;D061085
C16.131.666.034;Agenesis of Corpus Callosum;D061085
C23.300.008;Agenesis of Corpus Callosum;D061085
D08.811.682.608.540.750;NADP Transhydrogenase, B-Specific;D061086
D12.776.097.541;NADP Transhydrogenase, B-Specific;D061086
D08.811.682.608.540.500;NADP Transhydrogenase, AB-Specific;D061087
E01.370.565;Photoacoustic Techniques;D061088
E05.696;Photoacoustic Techniques;D061088
E02.815.768;Radiotherapy, Image-Guided;D061089
D08.811.682.732.850.249;Peroxiredoxin III;D061105
D12.776.575.812;Peroxiredoxin III;D061105
E02.815.565;Radiotherapy Setup Errors;D061106
N02.421.450.800;Radiotherapy Setup Errors;D061106
D08.811.913.696.650.550.200.500;Nucleoside Diphosphate Kinase D;D061107
D12.776.575.781;Nucleoside Diphosphate Kinase D;D061107
L01.224.230.110.500.750;Social Media;D061108
G05.360.340.024.340.225;Genes, Chloroplast;D061125
G05.420.275.249;Genes, Chloroplast;D061125
E04.188.600;Microvascular Decompression Surgery;D061145
E04.525.500;Microvascular Decompression Surgery;D061145
D05.500.562.488.490.249;Chlorophyll Binding Proteins;D061146
D08.811.600.710.490.249;Chlorophyll Binding Proteins;D061146
D12.776.183.750.750.490.500;Chlorophyll Binding Proteins;D061146
D12.776.543.983.500.490.249;Chlorophyll Binding Proteins;D061146
D12.776.765.199.750.750.490.500;Chlorophyll Binding Proteins;D061146
E02.960;Therapy with Helminths;D061147
K01.752.667.875;Hygiene Hypothesis;D061148
B01.050.500.131.617.800;Thysanoptera;D061149
A02.835.232.087.783.450;Glenoid Cavity;D061165
G12.425.746.425.800.600;Peripheral Tolerance;D061166
G12.425.746.425.800.200;Central Tolerance;D061167
E02.631;Mechanical Thrombolysis;D061185
E04.100.814.842.500;Mechanical Thrombolysis;D061185
F01.145.407.199.500;Breast Milk Expression;D061186
C18.452.174.130.780;Vascular Calcification;D061205
C04.697.650.695;Neoplasm Micrometastasis;D061206
C23.550.727.650.695;Neoplasm Micrometastasis;D061206
D27.505.519.562.374.100;Calcium Ionophores;D061207
D27.720.395.100;Calcium Ionophores;D061207
E02.342.671;Pulsed Radiofrequency Treatment;D061208
E02.779.468.599;Pulsed Radiofrequency Treatment;D061208
D27.505.519.389.936.500;Proton Ionophores;D061209
D27.505.519.562.374.500;Proton Ionophores;D061209
D27.720.395.500;Proton Ionophores;D061209
D27.505.519.562.374.750;Sodium Ionophores;D061210
D27.720.395.750;Sodium Ionophores;D061210
F02.463.425.540.254;Memory, Episodic;D061212
E05.318.308.985.550.550;Mortality, Premature;D061213
L01.280.975.550.550;Mortality, Premature;D061213
N01.224.935.698.700;Mortality, Premature;D061213
N06.850.505.400.975.550.550;Mortality, Premature;D061213
N06.850.520.308.985.550.550;Mortality, Premature;D061213
N06.850.135.060.075.399;Patient Safety;D061214
J02.200.512;Energy Drinks;D061215
D27.505.519.562.374.400;Potassium Ionophores;D061216
D27.720.395.400;Potassium Ionophores;D061216
N02.370.650;Weight Reduction Programs;D061217
N02.421.726.507.650;Weight Reduction Programs;D061217
F03.600.300.387;Depressive Disorder, Treatment-Resistant;D061218
C10.292.262.687;Olfactory Nerve Injuries;D061219
C10.292.650.600;Olfactory Nerve Injuries;D061219
C10.900.300.218.487;Olfactory Nerve Injuries;D061219
C26.260.237.568;Olfactory Nerve Injuries;D061219
C26.915.300.400.562;Olfactory Nerve Injuries;D061219
C10.292.262.656;Oculomotor Nerve Injuries;D061220
C10.292.562.700.500;Oculomotor Nerve Injuries;D061220
C10.292.600.600;Oculomotor Nerve Injuries;D061220
C10.900.300.218.456;Oculomotor Nerve Injuries;D061220
C11.590.436.600;Oculomotor Nerve Injuries;D061220
C26.260.237.527;Oculomotor Nerve Injuries;D061220
C26.915.300.400.518;Oculomotor Nerve Injuries;D061220
C10.292.262.875;Trigeminal Nerve Injuries;D061221
C10.292.775.349;Trigeminal Nerve Injuries;D061221
C10.900.300.218.775;Trigeminal Nerve Injuries;D061221
C26.260.237.825;Trigeminal Nerve Injuries;D061221
C26.915.300.400.825;Trigeminal Nerve Injuries;D061221
C10.292.262.875.500;Lingual Nerve Injuries;D061222
C10.292.775.349.500;Lingual Nerve Injuries;D061222
C10.900.300.218.775.500;Lingual Nerve Injuries;D061222
C26.260.237.825.500;Lingual Nerve Injuries;D061222
C26.915.300.400.825.500;Lingual Nerve Injuries;D061222
C10.292.262.937;Vagus Nerve Injuries;D061223
C10.292.887.399;Vagus Nerve Injuries;D061223
C10.900.300.218.887;Vagus Nerve Injuries;D061223
C26.260.237.912;Vagus Nerve Injuries;D061223
C26.915.300.400.912;Vagus Nerve Injuries;D061223
C08.360.424;Laryngeal Nerve Injuries;D061224
C09.400.424;Laryngeal Nerve Injuries;D061224
C10.292.262.937.750;Laryngeal Nerve Injuries;D061224
C10.900.300.218.887.750;Laryngeal Nerve Injuries;D061224
C26.260.237.912.750;Laryngeal Nerve Injuries;D061224
C26.915.300.400.912.750;Laryngeal Nerve Injuries;D061224
C08.360.424.500;Recurrent Laryngeal Nerve Injuries;D061226
C09.400.424.500;Recurrent Laryngeal Nerve Injuries;D061226
C10.292.262.937.750.500;Recurrent Laryngeal Nerve Injuries;D061226
C10.900.300.218.887.750.500;Recurrent Laryngeal Nerve Injuries;D061226
C26.260.237.912.750.500;Recurrent Laryngeal Nerve Injuries;D061226
C26.915.300.400.912.750.500;Recurrent Laryngeal Nerve Injuries;D061226
C10.292.175.500;Accessory Nerve Injuries;D061227
C10.292.262.350;Accessory Nerve Injuries;D061227
C10.900.300.218.225;Accessory Nerve Injuries;D061227
C26.260.237.243;Accessory Nerve Injuries;D061227
C26.915.300.400.200;Accessory Nerve Injuries;D061227
C10.292.262.562;Hypoglossal Nerve Injuries;D061228
C10.292.525.500;Hypoglossal Nerve Injuries;D061228
C10.900.300.218.362;Hypoglossal Nerve Injuries;D061228
C26.260.237.406;Hypoglossal Nerve Injuries;D061228
C26.915.300.400.387;Hypoglossal Nerve Injuries;D061228
E01.370.225.875.074;Axenic Culture;D061245
E05.200.875.074;Axenic Culture;D061245
E05.240.124;Axenic Culture;D061245
C10.292.262.906;Trochlear Nerve Injuries;D061247
C10.900.300.218.831;Trochlear Nerve Injuries;D061247
C26.260.237.868;Trochlear Nerve Injuries;D061247
C26.915.300.400.868;Trochlear Nerve Injuries;D061247
E05.240.249.124;Batch Cell Culture Techniques;D061249
D12.776.157.427.750;Transferrins;D061250
D12.776.556.579.750;Transferrins;D061250
E01.370.225.500.223.500;Primary Cell Culture;D061251
E05.200.500.223.500;Primary Cell Culture;D061251
E05.240.249.500;Primary Cell Culture;D061251
E05.242.223.500;Primary Cell Culture;D061251
A11.251.538;Feeder Cells;D061252
D06.472.699.587.200.200;Biphasic Insulins;D061265
D12.644.548.586.200.200;Biphasic Insulins;D061265
D26.310.249;Biphasic Insulins;D061265
D06.472.699.587.200.400;Insulin, Short-Acting;D061266
D12.644.548.586.200.400;Insulin, Short-Acting;D061266
D06.472.699.587.200.400.100;Insulin Aspart;D061267
D12.644.548.586.200.400.100;Insulin Aspart;D061267
D06.472.699.587.200.400.500;Insulin Lispro;D061268
D12.644.548.586.200.400.500;Insulin Lispro;D061268
G05.232;DNA Transformation Competence;D061269
G06.099.112.805.500;DNA Transformation Competence;D061269
C08.460.595;Nasal Septal Perforation;D061270
C09.603.588;Nasal Septal Perforation;D061270
C26.670;Nasal Septal Perforation;D061270
B03.026;Acidobacteria;D061271
B03.440.400.050;Acidobacteria;D061271
C09.218.807.800.918;Vestibulocochlear Nerve Injuries;D061285
C10.292.262.968;Vestibulocochlear Nerve Injuries;D061285
C10.292.910.925;Vestibulocochlear Nerve Injuries;D061285
C10.900.300.218.943;Vestibulocochlear Nerve Injuries;D061285
C26.260.237.956;Vestibulocochlear Nerve Injuries;D061285
C26.915.300.400.956;Vestibulocochlear Nerve Injuries;D061285
E05.196.690;Osmometry;D061286
C10.292.262.531;Glossopharyngeal Nerve Injuries;D061287
C10.292.450.500;Glossopharyngeal Nerve Injuries;D061287
C10.900.300.218.331;Glossopharyngeal Nerve Injuries;D061287
C26.260.237.365;Glossopharyngeal Nerve Injuries;D061287
C26.915.300.400.343;Glossopharyngeal Nerve Injuries;D061287
E01.370.350.710.299;Lymphoscintigraphy;D061305
E01.370.384.730.176;Lymphoscintigraphy;D061305
B03.335;Fibrobacteres;D061306
B03.440.425.410.047;Fibrobacteres;D061306
A11.436.275.682;Human Umbilical Vein Endothelial Cells;D061307
C04.588.180.483;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C04.588.322.455.431;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C04.700.517;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C13.351.500.056.630.705.431;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C13.351.937.418.685.431;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C16.320.700.517;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C17.800.090.500.483;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C19.344.410.431;Hereditary Breast and Ovarian Cancer Syndrome;D061325
C19.391.630.705.431;Hereditary Breast and Ovarian Cancer Syndrome;D061325
E05.318.308.250.300.512;Index of Orthodontic Treatment Need;D061326
E06.208.421;Index of Orthodontic Treatment Need;D061326
N05.715.360.300.375.300.505;Index of Orthodontic Treatment Need;D061326
N06.850.520.308.250.300.512;Index of Orthodontic Treatment Need;D061326
N06.890.160.134;Index of Orthodontic Treatment Need;D061326
B03.440.930;Verrucomicrobia;D061327
B03.950;Verrucomicrobia;D061327
B03.440.614;Planctomycetales;D061328
B03.650;Planctomycetales;D061328
G01.311.687;Oil and Gas Fields;D061329
E01.370.350.350.810.800.500;Multidetector Computed Tomography;D061330
E01.370.350.600.350.700.810.800.500;Multidetector Computed Tomography;D061330
E01.370.350.700.700.810.800.500;Multidetector Computed Tomography;D061330
E01.370.350.700.810.810.800.249;Multidetector Computed Tomography;D061330
E01.370.350.825.810.810.800.249;Multidetector Computed Tomography;D061330
N02.421.143.827.363;Early Medical Intervention;D061345
E01.370.225.998.221.580.500;Laser Capture Microdissection;D061346
E05.200.998.221.580.500;Laser Capture Microdissection;D061346
E05.591.560.500;Laser Capture Microdissection;D061346
F01.470.383;Forgiveness;D061347
F01.829.401.166;Forgiveness;D061347
M01.526.485.500;Medical Chaperones;D061348
M01.898.828;Unrelated Donors;D061349
G05.910;Sympatry;D061350
E07.632.875;Telescopes;D061351
J01.576.423.200.850;Pasteurization;D061352
J01.576.423.850.700.700;Pasteurization;D061352
J01.576.423.200.387;Food Storage;D061353
A11.031;Acinar Cells;D061354
M01.686.754.133;Amish;D061365
E05.581.500.577;Numbers Needed To Treat;D061366
E05.581.500.902.500;Numbers Needed To Treat;D061366
D06.472.699.587.200;Insulins;D061385
D12.644.548.586.200;Insulins;D061385
D06.472.699.587.200.500.625.500;Insulin, Regular, Human;D061386
D12.644.548.586.200.500.625.500;Insulin, Regular, Human;D061386
C01.252.400.210.210.124;Chlamydial Pneumonia;D061387
C01.252.400.210.250.299;Chlamydial Pneumonia;D061387
C01.252.620.249;Chlamydial Pneumonia;D061387
C08.381.677.540.249;Chlamydial Pneumonia;D061387
C08.730.610.540.249;Chlamydial Pneumonia;D061387
M01.526.373.400;Firefighters;D061388
D06.472.699.587.200.500.625.700;Insulin, Regular, Pork;D061389
D12.644.548.586.200.500.625.700;Insulin, Regular, Pork;D061389
D06.472.699.587.200.300.300;Insulin, Lente;D061405
D12.644.548.586.200.300.300;Insulin, Lente;D061405
D06.472.699.587.200.300.800;Insulin, Ultralente;D061406
D12.644.548.586.200.300.800;Insulin, Ultralente;D061406
D03.383.742.698.553;Lopinavir;D061466
J01.637.847;Tobacco Use Cessation Products;D061485
E05.393.220.250.500;Cell Surface Display Techniques;D061505
E05.393.420.601.292;Cell Surface Display Techniques;D061505
A10.850.710.750;Perforator Flap;D061525
E07.862.710.750;Perforator Flap;D061525
D01.455.900.600.500;Carbonated Water;D061545
D01.650.550.925.600.500;Carbonated Water;D061545
J02.200.300.500;Carbonated Water;D061545
J02.200.418.500;Carbonated Water;D061545
E05.916.039.406;Cycloaddition Reaction;D061565
G02.607.750.155.374;Cycloaddition Reaction;D061565
J01.897.836.249.374;Cycloaddition Reaction;D061565
D12.776.157.530.400.875.750;Voltage-Gated Sodium Channels;D061566
D12.776.543.550.425.875.750;Voltage-Gated Sodium Channels;D061566
D12.776.543.585.400.875.750;Voltage-Gated Sodium Channels;D061566
D12.776.641.960;Voltage-Gated Sodium Channels;D061566
D27.505.519.562.750.500;Voltage-Gated Sodium Channel Blockers;D061567
D27.505.954.411.720.500;Voltage-Gated Sodium Channel Blockers;D061567
D27.505.519.562.625.500;Voltage-Gated Sodium Channel Agonists;D061585
E02.319.267.082;Administration, Intravenous;D061605
G02.111.570.060.040.750;Immunoreceptor Tyrosine-Based Activation Motif;D061625
G02.111.570.790.709.600.040.440;Immunoreceptor Tyrosine-Based Activation Motif;D061625
G02.111.570.060.040.875;Immunoreceptor Tyrosine-Based Inhibition Motif;D061626
G02.111.570.790.709.600.040.480;Immunoreceptor Tyrosine-Based Inhibition Motif;D061626
E02.218.042;Abdominoplasty;D061645
E04.680.025;Abdominoplasty;D061645
E04.614.374.500;Operative Time;D061646
N02.421.585.753.374.500;Operative Time;D061646
E02.760.928;Time-to-Treatment;D061665
N02.421.585.928;Time-to-Treatment;D061665
G08.686.210.500;Time-to-Pregnancy;D061685
C12.294.644.743;Premature Ejaculation;D061686
F03.800.800.700;Premature Ejaculation;D061686
E01.370.225.500.384.100.370;Image-Guided Biopsy;D061705
E01.370.225.998.054.370;Image-Guided Biopsy;D061705
E01.370.388.100.370;Image-Guided Biopsy;D061705
E04.074.370;Image-Guided Biopsy;D061705
E05.200.500.384.100.370;Image-Guided Biopsy;D061705
E05.200.998.054.370;Image-Guided Biopsy;D061705
E05.242.384.100.370;Image-Guided Biopsy;D061705
E05.003;Accelerometry;D061725
G02.111.570.080.689.675.700.040;Antioxidant Response Elements;D061745
G05.360.080.689.675.700.040;Antioxidant Response Elements;D061745
G05.360.340.024.340.137.750.680.765.040;Antioxidant Response Elements;D061745
E01.370.225.500.384.100.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.225.500.384.100.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.225.998.054.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.225.998.054.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.350.850.855.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.388.100.100.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E01.370.388.100.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E04.074.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E04.074.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E04.800.890.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.200.500.384.100.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.200.500.384.100.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.200.998.054.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.200.998.054.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.242.384.100.119.500.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E05.242.384.100.370.500;Endoscopic Ultrasound-Guided Fine Needle Aspiration;D061765
E02.815.435;Proton Therapy;D061766
G02.111.087.847.625;Transcription Initiation, Genetic;D061785
G02.149.115.847.625;Transcription Initiation, Genetic;D061785
G05.355.310.700.625;Transcription Initiation, Genetic;D061785
G02.111.087.847.562;Transcription Elongation, Genetic;D061805
G02.149.115.847.562;Transcription Elongation, Genetic;D061805
G05.355.310.700.562;Transcription Elongation, Genetic;D061805
G02.111.087.847.687;Transcription Termination, Genetic;D061806
G02.149.115.847.687;Transcription Termination, Genetic;D061806
G05.355.310.700.687;Transcription Termination, Genetic;D061806
E05.325.095;Catheter Obstruction;D061807
E07.132.249;Catheter Obstruction;D061807
E05.196.454.201;Air Filters;D061808
E07.039;Air Filters;D061808
E01.370.225.880.500;Human Papillomavirus DNA Tests;D061809
E05.200.880.500;Human Papillomavirus DNA Tests;D061809
E05.393.462;Human Papillomavirus DNA Tests;D061809
E05.393.520.750;Human Papillomavirus DNA Tests;D061809
E02.041.625.657;One-Lung Ventilation;D061810
E07.695.400.705;Metal-on-Metal Joint Prostheses;D061825
E07.858.442.743.659;Foot Orthoses;D061826
E05.318.780.725.500;Dimensional Measurement Accuracy;D061827
E05.337.851.500;Dimensional Measurement Accuracy;D061827
N05.715.360.780.685.500;Dimensional Measurement Accuracy;D061827
N06.850.520.445.725.500;Dimensional Measurement Accuracy;D061827
I01.655.249;Smoke-Free Policy;D061845
N02.278.421.434;Hospitals, Low-Volume;D061846
N02.278.421.414;Hospitals, High-Volume;D061847
E01.370.350.589;Optical Imaging;D061848
E05.642;Optical Imaging;D061848
E04.210.526;Hemorrhoidectomy;D061865
E05.198;Chromophore-Assisted Light Inactivation;D061885
E01.370.520.567;Neuromuscular Monitoring;D061886
E04.800.250.155;Conversion to Open Surgery;D061887
E02.815.230;Craniospinal Irradiation;D061888
N03.219.483.359;Healthcare Financing;D061889
D26.049;Controlled Substances;D061891
N03.219.416;External Debt;D061895
D12.644.541.500.650.500.900;Single-Domain Antibodies;D061905
D12.776.124.486.485.680.650.500.900;Single-Domain Antibodies;D061905
D12.776.124.790.651.680.650.500.900;Single-Domain Antibodies;D061905
D12.776.377.715.548.680.650.500.897;Single-Domain Antibodies;D061905
E02.365.152;Advanced Trauma Life Support Care;D061906
E02.760.440.040;Advanced Trauma Life Support Care;D061906
N02.421.297.028;Advanced Trauma Life Support Care;D061906
N02.421.585.440.040;Advanced Trauma Life Support Care;D061906
D13.444.404;Immobilized Nucleic Acids;D061925
D27.505.519.389.745.325.500;Caspase Inhibitors;D061945
D27.505.519.389.745.610;Matrix Metalloproteinase Inhibitors;D061965
A11.251.210.827;Madin Darby Canine Kidney Cells;D061985
A11.436.589;Madin Darby Canine Kidney Cells;D061985
A11.251.210.190.630;MCF-7 Cells;D061986
A11.251.210.891;Sf9 Cells;D061987
D27.505.519.389.745.705;Proteasome Inhibitors;D061988
E01.370.225.500.384.100.119.750;Biopsy, Large-Core Needle;D062005
E01.370.225.998.054.119.750;Biopsy, Large-Core Needle;D062005
E01.370.388.100.100.750;Biopsy, Large-Core Needle;D062005
E04.074.119.750;Biopsy, Large-Core Needle;D062005
E04.665.100.750;Biopsy, Large-Core Needle;D062005
E05.200.500.384.100.119.750;Biopsy, Large-Core Needle;D062005
E05.200.998.054.119.750;Biopsy, Large-Core Needle;D062005
E05.242.384.100.119.750;Biopsy, Large-Core Needle;D062005
C25.723.717;Organophosphate Poisoning;D062025
C10.228.140.546.399.750.124;Alice in Wonderland Syndrome;D062026
C10.597.606.762.150;Alice in Wonderland Syndrome;D062026
C10.597.751.941.036;Alice in Wonderland Syndrome;D062026
C23.888.592.604.764.150;Alice in Wonderland Syndrome;D062026
C23.888.592.763.941.036;Alice in Wonderland Syndrome;D062026
F01.700.750.150;Alice in Wonderland Syndrome;D062026
C17.800.865.622;Linear IgA Bullous Dermatosis;D062027
C20.111.585;Linear IgA Bullous Dermatosis;D062027
E05.111;Bioprinting;D062028
J01.293.069.124;Bioprinting;D062028
D02.715.650.850;Silorane Resins;D062047
D05.750.716.822.461.500;Silorane Resins;D062047
D05.750.900.925;Silorane Resins;D062047
D25.339.291.300.500;Silorane Resins;D062047
J01.637.051.339.291.300.500;Silorane Resins;D062047
E01.370.350.589.124;Narrow Band Imaging;D062048
E05.642.124;Narrow Band Imaging;D062048
D20.944.932;Waste Water;D062065
N06.850.460.710.865;Waste Water;D062065
G01.311.910;Water Resources;D062066
N06.850.135.060.075.199;Chemical Safety;D062067
M01.526.493;Inventors;D062068
J01.897.400;Inventions;D062069
H01.158.273.248.875;Hydrology;D062070
H01.277.249.875;Hydrology;D062070
J01.293.622;Hydrology;D062070
M01.060.703.520.520.500;Infant, Extremely Premature;D062071
E05.318.308.250.475.456;Patient Acuity;D062072
N05.715.360.300.375.375.364;Patient Acuity;D062072
N06.850.520.308.250.475.364;Patient Acuity;D062072
D13.444.735.790.375;RNA, Long Untranslated;D062085
E04.580.450.802;Transtympanic Micropressure Treatment;D062086
D05.750.078.764;Plant Mucilage;D062087
D09.698.709;Plant Mucilage;D062087
D25.720.099.718;Plant Mucilage;D062087
A17.815.180.040;Acellular Dermis;D062088
E07.945.750.040;Acellular Dermis;D062088
E05.599.595.249;Molecular Docking Simulation;D062105
L01.224.160.249;Molecular Docking Simulation;D062105
D12.776.643;Protein Degradation End Products;D062106
D12.776.643.249;Advanced Oxidation Protein Products;D062107
C14.240.850.906;May-Thurner Syndrome;D062108
C14.907.617.648;May-Thurner Syndrome;D062108
C16.131.240.850.890;May-Thurner Syndrome;D062108
E04.680.275;Dermatologic Surgical Procedures;D062109
E05.933;Thermometry;D062125
L01.470.750.750.300;Databases, Chemical;D062126
L01.700.508.300.188.400.300;Databases, Chemical;D062126
E01.370.378.630.582;Maternal Serum Screening Tests;D062145
D12.776.260.698.387;Receptors, Artificial;D062165
D12.776.543.750.066;Receptors, Artificial;D062165
D12.776.826.387;Receptors, Artificial;D062165
D12.776.930.669.387;Receptors, Artificial;D062165
J01.637.087.750;Receptors, Artificial;D062165
G09.330.190.075.600;Atrial Pressure;D062185
G09.330.380.037;Atrial Pressure;D062185
G09.330.380.076.347;Arterial Pressure;D062186
E02.342.735;Spinal Cord Stimulation;D062187
E02.779.468.699;Spinal Cord Stimulation;D062187
N05.300.420.700;Strategic Stockpile;D062205
N06.230.100.035.500;Strategic Stockpile;D062205
E05.318.740.933;Spatial Analysis;D062206
N05.715.360.750.746;Spatial Analysis;D062206
N06.850.520.830.933;Spatial Analysis;D062206
E07.305.076;Brain-Computer Interfaces;D062207
N02.278.421.473.500;Field Hospitals;D062208
N04.590.233.727.210.249;Patient Handoff;D062209
N05.715.840.500;Patient Handoff;D062209
V02.170.875;Personal Narratives;D062210
E05.318.740.933.500;Spatio-Temporal Analysis;D062211
N05.715.360.750.746.500;Spatio-Temporal Analysis;D062211
N06.850.520.830.933.500;Spatio-Temporal Analysis;D062211
L01.143.506.598.400.778;RxNorm;D062245
L01.700.508.280.875;RxNorm;D062245
N03.219.521.576.343.918.500;Health Insurance Exchanges;D062265
E05.318.389;Geographic Mapping;D062305
E05.318.740.933.249;Geographic Mapping;D062305
N05.715.360.750.746.249;Geographic Mapping;D062305
N06.850.520.830.933.249;Geographic Mapping;D062305
H01.277.500.097;Geography, Medical;D062306
H02.403.352;Geography, Medical;D062306
N03.706.615.473.500;Medical Device Legislation;D062307
E05.393.667;Optogenetics;D062308
I01.880.787.354;Community Integration;D062309
C23.996;Tropical Diseases;D062310
G16.500.275.505;Islands;D062312
N06.230.295;Islands;D062312
Z01.639;Islands;D062312
L01.470.750.750.400;Databases, Pharmaceutical;D062313
L01.700.508.300.188.400.400;Databases, Pharmaceutical;D062313
E02.774.465;Intense Pulsed Light Therapy;D062325
G04.299.730;Re-Epithelialization;D062326
G13.750.829.755;Re-Epithelialization;D062326
G16.100.856.891.750;Re-Epithelialization;D062326
D27.720.269.750;Skin Lightening Preparations;D062327
J01.516.213.500;Skin Lightening Preparations;D062327
E01.370.350.515.744;Nuclear Microscopy;D062345
E05.595.744;Nuclear Microscopy;D062345
H01.158.201.636.475;Molecular Medicine;D062346
H01.158.273.343.595.475;Molecular Medicine;D062346
H01.181.122.650.475;Molecular Medicine;D062346
H02.403.530;Molecular Medicine;D062346
D02.241.223.100.050;Aminobenzoates;D062365
D02.455.426.559.389.127.020;Aminobenzoates;D062365
D02.241.223.100.050.500;para-Aminobenzoates;D062366
D02.455.426.559.389.127.020.937;para-Aminobenzoates;D062366
D02.241.223.100.050.400;ortho-Aminobenzoates;D062367
D02.455.426.559.389.127.020.906;ortho-Aminobenzoates;D062367
D02.241.223.100.050.300;meta-Aminobenzoates;D062368
D02.455.426.559.389.127.020.452;meta-Aminobenzoates;D062368
D02.241.223.100.300;Hydroxybenzoates;D062385
D02.241.511.390;Hydroxybenzoates;D062385
D02.455.426.559.389.127.281;Hydroxybenzoates;D062385
D02.455.426.559.389.657.410;Hydroxybenzoates;D062385
F02.784.176.279.500;Motivational Interviewing;D062405
F04.408.413.349.500;Motivational Interviewing;D062405
N02.421.461.363.349.500;Motivational Interviewing;D062405
K01.400.504.984.186;Fukushima Nuclear Accident;D062406
N06.850.135.848.750;Fukushima Nuclear Accident;D062406
F01.145.407.432.500;Meals;D062407
F01.145.466.349.500;Meals;D062407
J02.500.590;Meals;D062407
F01.145.407.432.500.100;Breakfast;D062408
F01.145.466.349.500.100;Breakfast;D062408
J02.500.590.120;Breakfast;D062408
F01.145.407.432.500.550;Lunch;D062409
F01.145.466.349.500.550;Lunch;D062409
J02.500.590.560;Lunch;D062409
F01.145.407.432.500.775;Snacks;D062410
F01.145.466.349.500.775;Snacks;D062410
J02.500.590.780;Snacks;D062410
D02.241.223.100.300.350;Hydroxybenzoate Ethers;D062425
D02.241.511.390.350;Hydroxybenzoate Ethers;D062425
D02.355.726.675;Hydroxybenzoate Ethers;D062425
D02.455.426.559.389.127.281.350;Hydroxybenzoate Ethers;D062425
D02.455.426.559.389.657.654.638;Hydroxybenzoate Ethers;D062425
D12.776.543.984.200.100;Claudin-1;D062445
D12.776.543.984.200.200;Claudin-2;D062446
D12.776.543.984.200.300;Claudin-3;D062465
G09.772.770.755.349;Breath Holding;D062485
E05.318.308.250.700.324;Public Health Surveillance;D062486
N05.715.360.300.375.625.324;Public Health Surveillance;D062486
N06.850.520.308.250.700.324;Public Health Surveillance;D062486
N06.850.780.675.487;Public Health Surveillance;D062486
F01.145.813.817;Social Marginalization;D062487
I01.880.696;Social Marginalization;D062487
E05.318.308.237;Health Impact Assessment;D062489
N03.349.380.210.500;Health Impact Assessment;D062489
N03.219.521.576.343.981;Value-Based Purchasing;D062505
D12.776.543.984.200.400;Claudin-4;D062506
D12.776.543.984.200.500;Claudin-5;D062507
F04.754.570;Narrative Therapy;D062525
N04.590.720.500;Patient Navigation;D062526
N04.761.744.500;Meaningful Use;D062527
I01.880.334;Medicalization;D062528
D12.776.157.530.400.875.750.960;Voltage-Gated Sodium Channel beta Subunits;D062546
D12.776.543.550.425.875.750.970;Voltage-Gated Sodium Channel beta Subunits;D062546
D12.776.543.585.400.875.750.970;Voltage-Gated Sodium Channel beta Subunits;D062546
D12.776.641.960.970;Voltage-Gated Sodium Channel beta Subunits;D062546
D12.776.157.530.400.875.750.960.100;Voltage-Gated Sodium Channel beta-1 Subunit;D062547
D12.776.543.550.425.875.750.970.100;Voltage-Gated Sodium Channel beta-1 Subunit;D062547
D12.776.543.585.400.875.750.970.100;Voltage-Gated Sodium Channel beta-1 Subunit;D062547
D12.776.641.960.970.100;Voltage-Gated Sodium Channel beta-1 Subunit;D062547
D12.776.157.530.400.875.750.960.200;Voltage-Gated Sodium Channel beta-2 Subunit;D062548
D12.776.543.550.425.875.750.970.200;Voltage-Gated Sodium Channel beta-2 Subunit;D062548
D12.776.543.585.400.875.750.970.200;Voltage-Gated Sodium Channel beta-2 Subunit;D062548
D12.776.641.960.970.200;Voltage-Gated Sodium Channel beta-2 Subunit;D062548
D12.776.157.530.400.875.750.960.300;Voltage-Gated Sodium Channel beta-3 Subunit;D062549
D12.776.543.550.425.875.750.970.300;Voltage-Gated Sodium Channel beta-3 Subunit;D062549
D12.776.543.585.400.875.750.970.300;Voltage-Gated Sodium Channel beta-3 Subunit;D062549
D12.776.641.960.970.300;Voltage-Gated Sodium Channel beta-3 Subunit;D062549
D12.776.157.530.400.875.750.100;NAV1.1 Voltage-Gated Sodium Channel;D062550
D12.776.543.550.425.875.750.100;NAV1.1 Voltage-Gated Sodium Channel;D062550
D12.776.543.585.400.875.750.100;NAV1.1 Voltage-Gated Sodium Channel;D062550
D12.776.641.960.100;NAV1.1 Voltage-Gated Sodium Channel;D062550
D12.776.157.530.400.875.750.200;NAV1.2 Voltage-Gated Sodium Channel;D062551
D12.776.543.550.425.875.750.200;NAV1.2 Voltage-Gated Sodium Channel;D062551
D12.776.543.585.400.875.750.200;NAV1.2 Voltage-Gated Sodium Channel;D062551
D12.776.641.960.200;NAV1.2 Voltage-Gated Sodium Channel;D062551
D12.776.157.530.400.875.750.300;NAV1.3 Voltage-Gated Sodium Channel;D062552
D12.776.543.550.425.875.750.300;NAV1.3 Voltage-Gated Sodium Channel;D062552
D12.776.543.585.400.875.750.300;NAV1.3 Voltage-Gated Sodium Channel;D062552
D12.776.641.960.300;NAV1.3 Voltage-Gated Sodium Channel;D062552
D12.776.157.530.400.875.750.400;NAV1.4 Voltage-Gated Sodium Channel;D062553
D12.776.210.500.675;NAV1.4 Voltage-Gated Sodium Channel;D062553
D12.776.543.550.425.875.750.400;NAV1.4 Voltage-Gated Sodium Channel;D062553
D12.776.543.585.400.875.750.400;NAV1.4 Voltage-Gated Sodium Channel;D062553
D12.776.157.530.400.875.750.500;NAV1.5 Voltage-Gated Sodium Channel;D062554
D12.776.543.550.425.875.750.500;NAV1.5 Voltage-Gated Sodium Channel;D062554
D12.776.543.585.400.875.750.500;NAV1.5 Voltage-Gated Sodium Channel;D062554
D12.776.641.960.500;NAV1.5 Voltage-Gated Sodium Channel;D062554
D12.776.157.530.400.875.750.700;NAV1.7 Voltage-Gated Sodium Channel;D062556
D12.776.543.550.425.875.750.700;NAV1.7 Voltage-Gated Sodium Channel;D062556
D12.776.543.585.400.875.750.700;NAV1.7 Voltage-Gated Sodium Channel;D062556
D12.776.641.960.700;NAV1.7 Voltage-Gated Sodium Channel;D062556
D12.776.157.530.400.875.750.600;NAV1.6 Voltage-Gated Sodium Channel;D062557
D12.776.543.550.425.875.750.600;NAV1.6 Voltage-Gated Sodium Channel;D062557
D12.776.543.585.400.875.750.600;NAV1.6 Voltage-Gated Sodium Channel;D062557
D12.776.641.960.600;NAV1.6 Voltage-Gated Sodium Channel;D062557
D12.776.157.530.400.875.750.900;NAV1.9 Voltage-Gated Sodium Channel;D062558
D12.776.543.550.425.875.750.900;NAV1.9 Voltage-Gated Sodium Channel;D062558
D12.776.543.585.400.875.750.900;NAV1.9 Voltage-Gated Sodium Channel;D062558
D12.776.641.960.900;NAV1.9 Voltage-Gated Sodium Channel;D062558
D12.776.157.530.400.875.750.800;NAV1.8 Voltage-Gated Sodium Channel;D062559
D12.776.543.550.425.875.750.800;NAV1.8 Voltage-Gated Sodium Channel;D062559
D12.776.543.585.400.875.750.800;NAV1.8 Voltage-Gated Sodium Channel;D062559
D12.776.641.960.800;NAV1.8 Voltage-Gated Sodium Channel;D062559
D12.776.157.530.400.875.050;Acid Sensing Ion Channels;D062565
D12.776.543.550.425.875.050;Acid Sensing Ion Channels;D062565
D12.776.543.585.400.875.050;Acid Sensing Ion Channels;D062565
D12.776.641.024;Acid Sensing Ion Channels;D062565
D12.776.157.530.400.875.750.960.650;Voltage-Gated Sodium Channel beta-4 Subunit;D062585
D12.776.543.550.425.875.750.970.400;Voltage-Gated Sodium Channel beta-4 Subunit;D062585
D12.776.543.585.400.875.750.970.650;Voltage-Gated Sodium Channel beta-4 Subunit;D062585
D12.776.641.960.970.650;Voltage-Gated Sodium Channel beta-4 Subunit;D062585
D09.408.782.512;Quillaja Saponins;D062605
N02.278.421.830;Tertiary Care Centers;D062606
A19.530;Fungal Capsules;D062607
E07.230.210;Electronic Nose;D062609
E07.305.296;Electronic Nose;D062609
D09.698.357;Fungal Polysaccharides;D062610
D23.050.202.283;Fungal Polysaccharides;D062610
D20.944.730;Solid Waste;D062611
N06.850.460.710.730;Solid Waste;D062611
C04.557.450.565.590.595.050.500;Cystadenofibroma;D062625
C04.557.470.590.482;Cystadenofibroma;D062625
C04.557.470.625.050.500;Cystadenofibroma;D062625
D12.776.157.530.400.875.100;Degenerin Sodium Channels;D062626
D12.776.543.550.425.875.100;Degenerin Sodium Channels;D062626
D12.776.543.585.400.875.100;Degenerin Sodium Channels;D062626
E04.100.814.529.968;Percutaneous Coronary Intervention;D062645
E04.800.382.968;Percutaneous Coronary Intervention;D062645
D27.505.519.562.750.100;Acid Sensing Ion Channel Blockers;D062646
E05.318.375;Epidemiological Monitoring;D062665
N06.850.520.460;Epidemiological Monitoring;D062665
E07.132.750;Vascular Access Devices;D062666
C16.131.831.350.856.500;Steatocystoma Multiplex;D062685
C16.320.850.250.856.500;Steatocystoma Multiplex;D062685
C17.800.529.594.500;Steatocystoma Multiplex;D062685
C17.800.804.350.856.500;Steatocystoma Multiplex;D062685
C17.800.827.250.856.500;Steatocystoma Multiplex;D062685
D27.505.519.562.750.374;Epithelial Sodium Channel Blockers;D062686
D27.505.696.560.500.726.100;Epithelial Sodium Channel Blockers;D062686
D27.505.519.562.625;Sodium Channel Agonists;D062687
C02.256.650.810.217.500;Buschke-Lowenstein Tumor;D062688
C02.800.801.220.500;Buschke-Lowenstein Tumor;D062688
C02.825.810.110.500;Buschke-Lowenstein Tumor;D062688
C02.928.914.217.500;Buschke-Lowenstein Tumor;D062688
C04.557.470.200.450.500;Buschke-Lowenstein Tumor;D062688
C04.557.470.700.450.500;Buschke-Lowenstein Tumor;D062688
C17.800.838.790.810.110.500;Buschke-Lowenstein Tumor;D062688
C04.557.450.550.400.500;Lipoblastoma;D062689
D20.215.894.882;Vaccines, Live, Unattenuated;D062690
D20.215.894.899.024;Vaccines, Adenovirus;D062705
C23.888.672;Prodromal Symptoms;D062706
E01.599;Prodromal Symptoms;D062706
I03.946.449;Return to Work;D062707
N01.824.245.725;Return to Work;D062707
D27.505.519.562.625.249;Epithelial Sodium Channel Agonists;D062708
D12.776.543.984;Tight Junction Proteins;D062725
D12.776.395.550.200.537;Junctional Adhesion Molecules;D062726
D12.776.543.550.200.537;Junctional Adhesion Molecules;D062726
D12.776.543.984.600;Junctional Adhesion Molecules;D062726
D23.050.301.350.537;Junctional Adhesion Molecules;D062726
D12.776.395.550.200.537.500;Coxsackie and Adenovirus Receptor-Like Membrane Protein;D062727
D12.776.543.550.200.537.500;Coxsackie and Adenovirus Receptor-Like Membrane Protein;D062727
D12.776.543.750.925.124;Coxsackie and Adenovirus Receptor-Like Membrane Protein;D062727
D12.776.543.984.600.500;Coxsackie and Adenovirus Receptor-Like Membrane Protein;D062727
D23.050.301.350.537.500;Coxsackie and Adenovirus Receptor-Like Membrane Protein;D062727
D12.776.395.550.200.537.750;Junctional Adhesion Molecule A;D062745
D12.776.543.550.200.537.750;Junctional Adhesion Molecule A;D062745
D12.776.543.750.053;Junctional Adhesion Molecule A;D062745
D12.776.543.984.600.700;Junctional Adhesion Molecule A;D062745
D23.050.301.264.035.456;Junctional Adhesion Molecule A;D062745
D23.050.301.350.537.750;Junctional Adhesion Molecule A;D062745
D23.101.100.110.456;Junctional Adhesion Molecule A;D062745
D12.776.395.550.200.537.875;Junctional Adhesion Molecule B;D062765
D12.776.543.550.200.537.875;Junctional Adhesion Molecule B;D062765
D12.776.543.984.600.800;Junctional Adhesion Molecule B;D062765
D23.050.301.264.035.474;Junctional Adhesion Molecule B;D062765
D23.050.301.350.537.875;Junctional Adhesion Molecule B;D062765
D23.101.100.110.474;Junctional Adhesion Molecule B;D062765
E04.555.110.110.482;Hemiarthroplasty;D062785
E04.650.110.482;Hemiarthroplasty;D062785
D12.776.395.550.200.537.937;Junctional Adhesion Molecule C;D062786
D12.776.543.550.200.537.937;Junctional Adhesion Molecule C;D062786
D12.776.543.984.600.900;Junctional Adhesion Molecule C;D062786
D23.050.301.350.537.937;Junctional Adhesion Molecule C;D062786
C25.341;Drug Overdose;D062787
C25.723.276.531;Drug Overdose;D062787
E02.319.754.500;Drug Overdose;D062787
C13.351.500.852.113;Adenomyosis;D062788
J01.637.836;Tobacco Products;D062789
E05.799.638.602;Optically Stimulated Luminescence Dosimetry;D062791
N06.850.810.370.365;Optically Stimulated Luminescence Dosimetry;D062791
D12.776.543.488;MARVEL Domain-Containing Proteins;D062792
D12.776.543.488.500;Occludin;D062793
D12.776.543.984.750;Occludin;D062793
D12.776.543.488.249;MARVEL Domain Containing 2 Protein;D062794
D12.776.543.984.675;MARVEL Domain Containing 2 Protein;D062794
D12.776.543.488.750;Synaptogyrins;D062805
D12.776.543.990.831;Synaptogyrins;D062805
D12.776.641.775;Synaptogyrins;D062805
D10.570.780.249;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.543.488.374;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.543.620.264;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.543.990.681;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.641.580.249;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.816.249;Myelin and Lymphocyte-Associated Proteolipid Proteins;D062806
D12.776.543.984.900;Zonula Occludens Proteins;D062825
D12.776.543.984.900.500;Zonula Occludens-1 Protein;D062826
D12.776.543.984.900.750;Zonula Occludens-2 Protein;D062827
D02.241.081.018.214;Chloroacetates;D062845
D02.455.526.439.196;Chloroacetates;D062845
C15.604.496.660;Non-Filarial Lymphedema;D062846
D27.505.696.560.500.726;Diuretics, Potassium Sparing;D062865
E07.132.625;Urinary Catheters;D062885
E07.132.750.500;Central Venous Catheters;D062905
E07.132.750.249;Cardiac Catheters;D062906
D02.241.081.337.593.812.750;Oxaloacetic Acid;D062907
D02.241.755.648.750;Oxaloacetic Acid;D062907
D12.644.360.325.225.500;rho-Specific Guanine Nucleotide Dissociation Inhibitors;D062947
D12.776.402.225.500;rho-Specific Guanine Nucleotide Dissociation Inhibitors;D062947
D12.776.476.325.225.500;rho-Specific Guanine Nucleotide Dissociation Inhibitors;D062947
D12.644.360.325.225.500.100;rho Guanine Nucleotide Dissociation Inhibitor alpha;D062948
D12.776.402.225.500.100;rho Guanine Nucleotide Dissociation Inhibitor alpha;D062948
D12.776.476.325.225.500.100;rho Guanine Nucleotide Dissociation Inhibitor alpha;D062948
D12.644.360.325.225.500.200;rho Guanine Nucleotide Dissociation Inhibitor beta;D062949
D12.776.402.225.500.200;rho Guanine Nucleotide Dissociation Inhibitor beta;D062949
D12.776.476.325.225.500.200;rho Guanine Nucleotide Dissociation Inhibitor beta;D062949
D12.644.360.325.225.500.300;rho Guanine Nucleotide Dissociation Inhibitor gamma;D062950
D12.776.402.225.500.300;rho Guanine Nucleotide Dissociation Inhibitor gamma;D062950
D12.776.476.325.225.500.300;rho Guanine Nucleotide Dissociation Inhibitor gamma;D062950
G05.355.200.820;Endoreduplication;D062951
D01.362.670.600.500;Stratospheric Ozone;D062952
G16.500.275.063.700;Stratospheric Ozone;D062952
N06.230.300.100.700;Stratospheric Ozone;D062952
D08.811.913.696.620.682.700.150.150.500;Cyclic GMP-Dependent Protein Kinase Type I;D062965
D12.644.360.200.150.500;Cyclic GMP-Dependent Protein Kinase Type I;D062965
D12.776.476.200.150.500;Cyclic GMP-Dependent Protein Kinase Type I;D062965
G16.500.240.547;Ozone Depletion;D062966
N06.230.300.100.700.500;Ozone Depletion;D062966
D08.811.913.696.620.682.700.150.150.750;Cyclic GMP-Dependent Protein Kinase Type II;D062967
D12.644.360.200.150.750;Cyclic GMP-Dependent Protein Kinase Type II;D062967
D12.776.476.200.150.750;Cyclic GMP-Dependent Protein Kinase Type II;D062967
N02.421.325;Health Services for Transgendered Persons;D062985
L01.700.508.300.361;Health Information Systems;D063005
L01.399.500;Health Information Management;D063025
N03.109;Dual MEDICAID MEDICARE Eligibility;D063026
L01.280.179;Crowdsourcing;D063045
N02.421.143.827.407.228.500.500;Patient Medication Knowledge;D063046
N02.421.726.407.228.500.500;Patient Medication Knowledge;D063046
D02.705.429;Organophosphonates;D063065
D02.705.429.750;Organofluorophosphonates;D063066
D02.705.429.812;Organothiophosphonates;D063085
D02.705.539.692;Organothiophosphonates;D063085
D02.886.300.846;Organothiophosphonates;D063085
D02.705.400.625;Organothiophosphates;D063086
D02.705.539.345;Organothiophosphates;D063086
D02.886.300.692;Organothiophosphates;D063086
E02.041.625.591;Noninvasive Ventilation;D063087
E02.880.820.657;Noninvasive Ventilation;D063087
D01.695.625.675.650.425;Phosphoramides;D063088
D02.705.672;Phosphoramides;D063088
I01.880.787.839.500;Food Assistance;D063105
N03.219.521.346.506.281;Food Assistance;D063105
M01.909;Transgendered Persons;D063106
E02.148.093;Balloon Embolectomy;D063125
E04.100.814.445.500;Balloon Embolectomy;D063125
E02.148.108;Balloon Valvuloplasty;D063126
N04.452.758.849.775;Secondary Care;D063127
N05.300.745;Secondary Care;D063127
N04.452.758.849.887;Tertiary Healthcare;D063128
N05.300.787;Tertiary Healthcare;D063128
C23.550.260.730;Parental Death;D063129
I01.880.735.607;Parental Death;D063129
C13.703.401;Maternal Death;D063130
C23.550.260.730.500;Maternal Death;D063130
I01.880.735.607.500;Maternal Death;D063130
E01.370.350.578.875.500.249;Connectome;D063132
E01.370.376.537.625.500.249;Connectome;D063132
D05.500.781;Polycomb-Group Proteins;D063146
D12.776.660.235.600;Polycomb-Group Proteins;D063146
D12.776.664.235.800;Polycomb-Group Proteins;D063146
D12.776.930.700.890;Polycomb-Group Proteins;D063146
F01.145.113.069;Animal Distribution;D063147
G16.049;Animal Distribution;D063147
G15.744.735;Plant Dispersal;D063148
D05.500.781.100;Polycomb Repressive Complex 1;D063150
D08.811.464.938.750.280;Polycomb Repressive Complex 1;D063150
D12.776.660.235.600.100;Polycomb Repressive Complex 1;D063150
D12.776.664.235.800.100;Polycomb Repressive Complex 1;D063150
D12.776.930.700.890.100;Polycomb Repressive Complex 1;D063150
D05.500.781.750;Polycomb Repressive Complex 2;D063151
D08.811.913.555.500.800.400.500;Polycomb Repressive Complex 2;D063151
D12.776.660.235.600.200;Polycomb Repressive Complex 2;D063151
D12.776.664.235.800.200;Polycomb Repressive Complex 2;D063151
D12.776.930.700.890.200;Polycomb Repressive Complex 2;D063151
G04.299.630.750;Mitochondrial Dynamics;D063154
H02.403.600.500;Neurotology;D063165
H02.403.810.526.500;Neurotology;D063165
E06.645.562.750;Maxillary Osteotomy;D063166
E06.645.562.374;Mandibular Osteotomy;D063168
C05.660.207.540.229;Dentofacial Deformities;D063169
C07.650.500.229;Dentofacial Deformities;D063169
C16.131.621.207.540.315;Dentofacial Deformities;D063169
C16.131.850.500.229;Dentofacial Deformities;D063169
E01.370.380.112;Corneal Pachymetry;D063171
E06.645.562.249;Genioplasty;D063172
C05.660.207.540.460.827;Retrognathia;D063173
C07.320.610.827;Retrognathia;D063173
C07.650.500.460.827;Retrognathia;D063173
C16.131.850.500.460.827;Retrognathia;D063173
E06.645.562.500;Mandibular Reconstruction;D063175
E01.370.370.680;Pulse Wave Analysis;D063177
G05.355.315.203.311;Epigenetic Repression;D063185
E04.950.300.941;Uterine Myomectomy;D063186
N02.278.388.620;Nursing Stations;D063187
B01.050.150.900.090.180.708.210;Rana clamitans;D063188
E01.370.872;Symptom Assessment;D063189
B01.050.500.131.617.634;Odonata;D063191
C13.703.769;Pregnancy, Heterotopic;D063192
E02.815.250;Heavy Ion Radiotherapy;D063193
A10.165.189;Adventitia;D063194
C10.228.854.583;Pneumorrhachis;D063205
D08.811.913.050.134.423;N-Terminal Acetyltransferases;D063206
D08.811.277.656.350.100.633;Methionyl Aminopeptidases;D063208
D08.811.913.050.134.423.100;N-Terminal Acetyltransferase A;D063209
D08.811.913.050.134.423.200;N-Terminal Acetyltransferase B;D063210
D08.811.913.050.134.423.300;N-Terminal Acetyltransferase C;D063211
D08.811.913.050.134.407.074;N-Terminal Acetyltransferase D;D063212
D08.811.913.050.134.423.400;N-Terminal Acetyltransferase D;D063212
D08.811.913.050.134.423.500;N-Terminal Acetyltransferase E;D063213
D08.811.913.050.134.423.600;N-Terminal Acetyltransferase F;D063214
D02.715.312;Organically Modified Ceramics;D063225
D05.750.593;Organically Modified Ceramics;D063225
D25.264.688;Organically Modified Ceramics;D063225
D25.339.291.551;Organically Modified Ceramics;D063225
D25.720.593;Organically Modified Ceramics;D063225
J01.637.051.339.291.476;Organically Modified Ceramics;D063225
J01.637.051.720.628;Organically Modified Ceramics;D063225
A08.511.500;Central Pattern Generators;D063226
G07.700.320.625;Plant Development;D063245
G15.744.723;Plant Development;D063245
D12.776.503.921;Sialic Acid Binding Immunoglobulin-like Lectins;D063265
D23.050.301.264.035.913;Sialic Acid Binding Immunoglobulin-like Lectins;D063265
D23.101.100.110.929;Sialic Acid Binding Immunoglobulin-like Lectins;D063265
D12.776.503.921.100;Sialic Acid Binding Ig-like Lectin 1;D063267
D23.050.301.264.035.913.100;Sialic Acid Binding Ig-like Lectin 1;D063267
D23.101.100.110.929.100;Sialic Acid Binding Ig-like Lectin 1;D063267
D12.776.503.921.400;Sialic Acid Binding Ig-like Lectin 3;D063268
D23.050.301.264.035.913.300;Sialic Acid Binding Ig-like Lectin 3;D063268
D23.050.301.264.900.565;Sialic Acid Binding Ig-like Lectin 3;D063268
D23.101.100.110.929.300;Sialic Acid Binding Ig-like Lectin 3;D063268
D23.101.100.900.565;Sialic Acid Binding Ig-like Lectin 3;D063268
G04.299.630;Mitochondrial Turnover;D063269
E01.370.225.625.265;Fibrin Clot Lysis Time;D063285
E05.200.625.265;Fibrin Clot Lysis Time;D063285
G09.188.315;Fibrin Clot Lysis Time;D063285
B01.050.500.131.166.803.600;Brown Recluse Spider;D063287
E05.318.308.250.475.410;Organ Dysfunction Scores;D063305
N05.715.360.300.375.375.181;Organ Dysfunction Scores;D063305
N06.850.520.308.250.475.181;Organ Dysfunction Scores;D063305
G04.299.630.500;Mitochondrial Degradation;D063306
G02.111.570.080.689.687.061;AU Rich Elements;D063307
G05.360.080.689.687.061;AU Rich Elements;D063307
G05.360.340.024.220.880.880.500;AU Rich Elements;D063307
G05.360.340.024.340.137.910.880.500;AU Rich Elements;D063307
D12.776.395.550.583;Myelin-Oligodendrocyte Glycoprotein;D063308
D12.776.543.550.572;Myelin-Oligodendrocyte Glycoprotein;D063308
D12.776.543.620.550;Myelin-Oligodendrocyte Glycoprotein;D063308
D12.776.641.580.530;Myelin-Oligodendrocyte Glycoprotein;D063308
D23.050.422.625;Myelin-Oligodendrocyte Glycoprotein;D063308
D08.811.277.352.640.160.500;2',3'-Cyclic Nucleotide 3'-Phosphodiesterase;D063309
D12.776.641.580.124;2',3'-Cyclic Nucleotide 3'-Phosphodiesterase;D063309
D02.092.471.869;Tiapride Hydrochloride;D063325
D02.241.223.100.100.933;Tiapride Hydrochloride;D063325
D02.455.426.559.389.127.085.933;Tiapride Hydrochloride;D063325
D05.500.562.405;Exosome Multienzyme Ribonuclease Complex;D063326
D08.811.277.352.700.687;Exosome Multienzyme Ribonuclease Complex;D063326
D08.811.600.283;Exosome Multienzyme Ribonuclease Complex;D063326
D12.776.395.550.448.775;Oligodendrocyte-Myelin Glycoprotein;D063345
D12.776.543.484.500.775;Oligodendrocyte-Myelin Glycoprotein;D063345
D12.776.543.550.418.775;Oligodendrocyte-Myelin Glycoprotein;D063345
D12.776.543.620.895;Oligodendrocyte-Myelin Glycoprotein;D063345
D12.776.641.580.895;Oligodendrocyte-Myelin Glycoprotein;D063345
F01.145.113.055.800.500;Singing;D063346
G09.772.770.680.500;Singing;D063346
E05.196.401.402.625;Native Polyacrylamide Gel Electrophoresis;D063347
E05.301.300.319.725;Native Polyacrylamide Gel Electrophoresis;D063347
I01.198.240.903.149;Genocide;D063365
I01.880.735.944.903.149;Genocide;D063365
G01.311.625.540;Estuaries;D063366
F04.754.137.506.662;Virtual Reality Exposure Therapy;D063367
Z01.542.101;Balkan Peninsula;D063368
L01.178.682.099.325.750;Literature Based Discovery;D063369
C09.218.636;Myringosclerosis;D063371
M01.526.485.067.738;Physical Therapist Assistants;D063372
N02.360.067.732;Physical Therapist Assistants;D063372
N06.850.780.200.412;Hand Hygiene;D063373
D27.505.519.625.085;Cannabinoid Receptor Modulators;D063385
D27.505.696.399.472.188;Cannabinoid Receptor Modulators;D063385
D27.505.519.625.085.500;Cannabinoid Receptor Agonists;D063386
D27.505.696.399.472.188.500;Cannabinoid Receptor Agonists;D063386
D27.505.519.625.085.750;Cannabinoid Receptor Antagonists;D063387
D27.505.696.399.472.188.750;Cannabinoid Receptor Antagonists;D063387
D10.251.265;Endocannabinoids;D063388
H01.158.100.045;Anatomic Variation;D063405
C25.100.437;Binge Drinking;D063425
F01.145.317.269.500;Binge Drinking;D063425
F03.900.100.550;Binge Drinking;D063425
I01.240.600.525;Human Migration;D063426
N01.224.625.525;Human Migration;D063426
N06.850.505.400.700.525;Human Migration;D063426
J01.576.423.850.730;Food Quality;D063427
N06.850.601;Food Quality;D063427
E02.547.800.500;Skin Cream;D063465
J01.516.213.249;Skin Cream;D063465
C06.405.117.119.500.484.500.500;Respiratory Aspiration of Gastric Contents;D063466
C08.618.749.500;Respiratory Aspiration of Gastric Contents;D063466
C23.550.773.500;Respiratory Aspiration of Gastric Contents;D063466
C03.335.508.700.750.361.137;Acanthocheilonemiasis;D063485
B01.050.500.500.294.700.750.700.300.043;Acanthocheilonema;D063486
E02.319.754;Prescription Drug Misuse;D063487
F01.145.813.550.500;Racism;D063505
F01.145.813.629.625;Racism;D063505
F01.829.595.500;Racism;D063505
I01.880.735.768.500;Racism;D063505
F01.145.813.550.249;Ageism;D063506
F01.145.813.629.500;Ageism;D063506
F01.829.595.249;Ageism;D063506
F01.145.813.550.750;Sexism;D063507
F01.145.813.629.750;Sexism;D063507
F01.829.595.750;Sexism;D063507
F01.145.813.629;Social Discrimination;D063508
F01.145.813.550.374;Homophobia;D063509
F01.145.813.629.562;Homophobia;D063509
F01.829.595.374;Homophobia;D063509
K01.517.211.753;Personal Narratives as Topic;D063545

